PMID,OWN,STAT,DCOM,LR,IS,VI,IP,DP,TI,PG,LID,AB,FAU,AU,AD,LA,PT,PL,TA,JT,JID,RN,SB,MH,PMC,OTO,OT,COIS,EDAT,MHDA,CRDT,PHST,AID,PST,SO,GR,DEP,EIN,CI,AUID,MID,RF,CIN,TT,CN,CON,SI,OID,FIR,IR,OAB,OABL,PS,FPS,RIN
32134010,NLM,MEDLINE,20210118,20210118,0971-5916 (Print) 0971-5916 (Linking),151,1,2020 Jan,"Obesity subtypes, related biomarkers & heterogeneity.",11-21,10.4103/ijmr.IJMR_1768_17 [doi],"Obesity is a serious medical condition worldwide, which needs new approaches and recognized international consensus in treating diseases leading to morbidity. The aim of this review was to examine heterogeneous links among the various phenotypes of obesity in adults. Proteins and associated genes in each group were analysed to differentiate between biomarkers. A variety of terms for classification and characterization within this pathology are currently in use; however, there is no clear consensus in terminology. The most significant groups reviewed include metabolically healthy obese, metabolically abnormal obese, metabolically abnormal, normal weight and sarcopenic obese. These phenotypes do not define particular genotypes or epigenetic gene regulation, or proteins related to inflammation. There are many other genes linked to obesity, though the value of screening all of those for diagnosis has low predictive results, as there are no significant biomarkers. It is important to establish a consensus in the terminology used and the characteristics attributed to obesity subtypes. The identification of specific molecular biomarkers is also required for better diagnosis in subtypes of obesity.","['Mayoral, Laura Perez-Campos', 'Andrade, Gabriel Mayoral', 'Mayoral, Eduardo Perez-Campos', 'Huerta, Teresa Hernandez', 'Canseco, Socorro Pina', 'Rodal Canales, Francisco J', 'Cabrera-Fuentes, Hector Alejandro', 'Cruz, Margarito Martinez', 'Perez Santiago, Alma Dolores', 'Alpuche, Juan Jose', 'Zenteno, Edgar', 'Ruiz, Hector Martinez', 'Cruz, Ruth Martinez', 'Jeronimo, Julia Hernandez', 'Perez-Campos, Eduardo']","['Mayoral LP', 'Andrade GM', 'Mayoral EP', 'Huerta TH', 'Canseco SP', 'Rodal Canales FJ', 'Cabrera-Fuentes HA', 'Cruz MM', 'Perez Santiago AD', 'Alpuche JJ', 'Zenteno E', 'Ruiz HM', 'Cruz RM', 'Jeronimo JH', 'Perez-Campos E']","['Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'CONACyT-Faculty of Medicine, Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore; Institute of Biochemistry, Medical School, Justus-Liebig University, Giessen, Germany.', 'National Technological Institute of Mexico, ITOaxaca, Oaxaca, Mexico.', 'National Technological Institute of Mexico, ITOaxaca, Oaxaca, Mexico.', 'Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', 'Research Centre-Faculty of Medicine, National Autonomous University of Mexico-Benito Juarez Autonomous University of Oaxaca, Oaxaca, Mexico.', ""National Technological Institute of Mexico, ITOaxaca; Clinical Pathology Laboratory 'Dr. Eduardo Perez Ortega' Oaxaca, Mexico.""]",['eng'],"['Journal Article', 'Review']",India,Indian J Med Res,The Indian journal of medical research,0374701,"['0 (Biomarkers)', '0 (Proteins)']",IM,"['Adult', '*Biomarkers', 'Genotype', 'Humans', 'Obesity/classification/*diagnosis/epidemiology/*genetics', 'Phenotype', 'Proteins/*genetics']",PMC7055173,['NOTNLM'],"['Adipose tissue', 'HOMA', 'biomarkers', 'body fat', 'genome-wide association studies', 'heterogeneity', 'obesity', 'subtypes']",['None'],2020/03/07 06:00,2021/01/20 06:00,['2020/03/06 06:00'],"['2020/03/06 06:00 [entrez]', '2020/03/07 06:00 [pubmed]', '2021/01/20 06:00 [medline]']","['IndianJMedRes_2020_151_1_11_279134 [pii]', 'IJMR-151-11 [pii]', '10.4103/ijmr.IJMR_1768_17 [doi]']",ppublish,Indian J Med Res. 2020 Jan;151(1):11-21. doi: 10.4103/ijmr.IJMR_1768_17.,,,,,,,,,,,,,,,,,,,,
32437302,NLM,MEDLINE,20210517,20210517,1524-4571 (Electronic) 0009-7330 (Linking),126,11,2020 May 22,"Obesity Phenotypes, Diabetes, and Cardiovascular Diseases.",1477-1500,10.1161/CIRCRESAHA.120.316101 [doi],"This review addresses the interplay between obesity, type 2 diabetes mellitus, and cardiovascular diseases. It is proposed that obesity, generally defined by an excess of body fat causing prejudice to health, can no longer be evaluated solely by the body mass index (expressed in kg/m(2)) because it represents a heterogeneous entity. For instance, several cardiometabolic imaging studies have shown that some individuals who have a normal weight or who are overweight are at high risk if they have an excess of visceral adipose tissue-a condition often accompanied by accumulation of fat in normally lean tissues (ectopic fat deposition in liver, heart, skeletal muscle, etc). On the other hand, individuals who are overweight or obese can nevertheless be at much lower risk than expected when faced with excess energy intake if they have the ability to expand their subcutaneous adipose tissue mass, particularly in the gluteal-femoral area. Hence, excessive amounts of visceral adipose tissue and of ectopic fat largely define the cardiovascular disease risk of overweight and moderate obesity. There is also a rapidly expanding subgroup of patients characterized by a high accumulation of body fat (severe obesity). Severe obesity is characterized by specific additional cardiovascular health issues that should receive attention. Because of the difficulties of normalizing body fat content in patients with severe obesity, more aggressive treatments have been studied in this subgroup of individuals such as obesity surgery, also referred to as metabolic surgery. On the basis of the above, we propose that we should refer to obesities rather than obesity.","['Piche, Marie-Eve', 'Tchernof, Andre', 'Despres, Jean-Pierre']","['Piche ME', 'Tchernof A', 'Despres JP']","[""From the Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval (M.-E.P., A.T., J.-P.D.), Universite Laval, Quebec, QC, Canada."", 'Department of Medicine, Faculty of Medicine (M.-E.P.), Universite Laval, Quebec, QC, Canada.', ""From the Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval (M.-E.P., A.T., J.-P.D.), Universite Laval, Quebec, QC, Canada."", 'School of Nutrition (A.T.), Universite Laval, Quebec, QC, Canada.', ""From the Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Quebec - Universite Laval (M.-E.P., A.T., J.-P.D.), Universite Laval, Quebec, QC, Canada."", 'Vitam - Centre de recherche en sante durable, CIUSSS - Capitale-Nationale (J.-P.D.), Universite Laval, Quebec, QC, Canada.', 'Department of Kinesiology, Faculty of Medicine (J.-P.D.), Universite Laval, Quebec, QC, Canada.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Circ Res,Circulation research,0047103,,IM,"['Animals', 'Cardiovascular Diseases/epidemiology/*pathology/prevention & control', 'Diabetes Mellitus/epidemiology/*pathology', 'Humans', 'Obesity/epidemiology/*pathology']",,['NOTNLM'],"['body fat distribution', 'cardiovascular diseases', 'diabetes mellitus', 'heart failure', 'obesity']",,2020/05/22 06:00,2021/05/18 06:00,['2020/05/22 06:00'],"['2020/05/22 06:00 [entrez]', '2020/05/22 06:00 [pubmed]', '2021/05/18 06:00 [medline]']",['10.1161/CIRCRESAHA.120.316101 [doi]'],ppublish,Circ Res. 2020 May 22;126(11):1477-1500. doi: 10.1161/CIRCRESAHA.120.316101. Epub 2020 May 21.,['FDN-167278/CIHR/Canada'],20200521,['Circ Res. 2020 Jul 17;127(3):e107. PMID: 32673532'],,,,,,,,,,,,,,,,,
30721956,NLM,MEDLINE,20200827,20231005,2156-5376 (Electronic) 2161-8313 (Print) 2161-8313 (Linking),10,suppl_1,2019 Jan 1,Humans against Obesity: Who Will Win?,S4-S9,10.1093/advances/nmy055 [doi],"The global obesity epidemic continues its relentless advance, currently affecting >2 billion people. This paper explores alternative ways to assess the potential disease impact of the epidemic, which is currently based almost exclusively on body mass index (BMI) data. It also argues in favor of concerted efforts to modify the built ecosystem that is driving the obesity epidemic. Most of the epidemiologic data on obesity are based on BMI (in kg/m2) and use the ranges of 18.5-24.9 for normality, 25-29.9 for overweight, and >/=30 for obesity. But the gap between the median of the ""normal"" BMI distribution ( approximately 22) and the current population BMI of, for example, the United States (27.7) has become so wide that it is unlikely that we will be able to close that gap in the near future. Furthermore, the correlation between BMI and disease risk is not linear. Over 60% of the global disease burden of obesity affects individuals with a BMI >/=30, who comprise only  approximately 10% of the global population of overweight/obese persons. Furthermore, BMI accounts for only  approximately 17% of the risk of insulin resistance and subsequent type 2 diabetes in the BMI >/=25 population. Epigenetics, specifically DNA methylation, appears to play a far more important role than BMI in determining the risk of obesity's comorbidities, such as diabetes. Similarly, socioeconomic status carries a higher risk than BMI level for the development of obesity-related noncommunicable diseases. Finally, the built environment that sustains our species' lifestyle is a major driver of the obesity epidemic. Modifying that ecosystem will require no less than a social movement, one able to promote and sustain the necessary coordinated action of virtually all sectors of society.","['Caballero, Benjamin']",['Caballero B'],"['Global Obesity Prevention Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Adv Nutr,"Advances in nutrition (Bethesda, Md.)",101540874,,IM,"['*Body Mass Index', 'Comorbidity', '*Cost of Illness', 'DNA Methylation', 'Diabetes Mellitus, Type 2/etiology', 'Ecosystem', 'Environment Design', 'Epigenesis, Genetic', '*Global Health', 'Humans', 'Insulin Resistance', 'Life Style', 'Obesity/complications/epidemiology/genetics/*prevention & control', 'Social Class']",PMC6363526,,,,2019/02/06 06:00,2020/08/28 06:00,['2019/02/06 06:00'],"['2017/02/03 00:00 [received]', '2018/07/18 00:00 [accepted]', '2019/02/06 06:00 [entrez]', '2019/02/06 06:00 [pubmed]', '2020/08/28 06:00 [medline]']","['S2161-8313(22)00195-8 [pii]', 'nmy055 [pii]', '10.1093/advances/nmy055 [doi]']",ppublish,Adv Nutr. 2019 Jan 1;10(suppl_1):S4-S9. doi: 10.1093/advances/nmy055.,,,,,,,,,,,,,,,,,,,,
33270290,NLM,MEDLINE,20210729,20220302,1600-0609 (Electronic) 0902-4441 (Print) 0902-4441 (Linking),106,3,2021 Mar,The hematologic consequences of obesity.,306-319,10.1111/ejh.13560 [doi],"The prevalence of obesity is increasing and progressively influencing physician-patient interactions. While there is a sizable amount of data demonstrating that obesity is a state of low-grade inflammation, to our knowledge, there is no single review summarizing its effects on hematologic parameters and thrombotic risk. We performed a literature search which largely surfaced observational studies, with a few systematic reviews and meta-analyses of these studies. We took care to review the mechanisms driving an inflammatory state and obesity's effect on white blood cells, red blood cells, platelets, and thrombotic risk. There is an observed relative, and sometimes absolute leukocytosis driven by this inflammatory state. Obesity is also associated with increased platelet counts and an increased risk for venous thromboembolism (VTE). Lastly, the association between obesity, iron deficiency (ID), and red blood cell counts may be present but remains uncertain. Recognizing the above associations may provide clinicians with reassurance regarding otherwise unexplained hematologic abnormalities in obese individuals. We hope this review will prompt future studies to further understand the underlying mechanisms driving these abnormalities and identify modifiable risk factors and potential therapeutic targets to prevent the development of probable obesity-associated conditions with significant morbidity and mortality, such as ID and VTE.","['Purdy, Johanna C', 'Shatzel, Joseph J']","['Purdy JC', 'Shatzel JJ']","['Division of General Internal Medicine and Geriatrics, Oregon Health & Science University, Portland, OR, USA.', 'Division of Hematology and Oncology, Oregon Health & Science University, Portland, OR, USA.', 'Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR, USA.']",['eng'],"['Journal Article', 'Review']",England,Eur J Haematol,European journal of haematology,8703985,"['0 (Biomarkers)', '0 (Cytokines)', '0 (Inflammation Mediators)']",IM,"['Adipose Tissue/metabolism', 'Animals', 'Biomarkers', 'Cytokines/blood/metabolism', 'Disease Susceptibility', 'Humans', 'Inflammation/metabolism', 'Inflammation Mediators/blood/metabolism', 'Leukocyte Count', 'Leukocytosis', 'Obesity/*blood/*complications/etiology/metabolism', 'Sex Factors']",PMC8086364,['NOTNLM'],"['anemia', 'iron deficiency', 'leukocytosis', 'thrombocytosis', 'venous thromboembolism']","['Conflict-of-interest disclosure: J.J.S. is a consultant for Aronora, Inc. The', 'remaining authors declare no potential conflict of interest.']",2020/12/04 06:00,2021/07/30 06:00,['2020/12/03 12:11'],"['2020/09/01 00:00 [received]', '2020/11/28 00:00 [revised]', '2020/12/01 00:00 [accepted]', '2020/12/04 06:00 [pubmed]', '2021/07/30 06:00 [medline]', '2020/12/03 12:11 [entrez]']",['10.1111/ejh.13560 [doi]'],ppublish,Eur J Haematol. 2021 Mar;106(3):306-319. doi: 10.1111/ejh.13560. Epub 2020 Dec 13.,"['R01 HL151367/HL/NHLBI NIH HHS/United States', 'HL151367/National Institutes of Health, National Heart, Lung, and Blood', 'Institute/']",20201213,,['(c) 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.'],['ORCID: 0000-0002-7978-2345'],['NIHMS1652250'],,,,,,,,,,,,,,
34749902,NLM,MEDLINE,20211124,20211124,1558-1357 (Electronic) 0029-6465 (Linking),56,4,2021 Dec,Obesity's Impact.,xiii-xiv,S0029-6465(21)00081-5 [pii] 10.1016/j.cnur.2021.08.004 [doi],,"['Golden, Angela']",['Golden A'],"['NP from Home LLC and NP Obesity Treatment Clinic Flagstaff, AZ, USA; PO Box 25959, Munds Park, AZ 86017, USA. Electronic address: npfromhome@gmail.com.']",['eng'],['Editorial'],United States,Nurs Clin North Am,The Nursing clinics of North America,0042033,,IM,"['Global Health', '*Health Care Costs', '*Health Policy', 'Humans', ""Nurse's Role"", 'Obesity/*complications/epidemiology/*physiopathology', 'Overweight/complications/epidemiology']",,,,,2021/11/10 06:00,2021/11/25 06:00,['2021/11/09 05:47'],"['2021/11/09 05:47 [entrez]', '2021/11/10 06:00 [pubmed]', '2021/11/25 06:00 [medline]']","['S0029-6465(21)00081-5 [pii]', '10.1016/j.cnur.2021.08.004 [doi]']",ppublish,Nurs Clin North Am. 2021 Dec;56(4):xiii-xiv. doi: 10.1016/j.cnur.2021.08.004.,,,,,,,,,,,,,,,,,,,,
36774932,NLM,MEDLINE,20230404,20230407,1474-547X (Electronic) 0140-6736 (Linking),401,10382,2023 Apr 1,"Contemporary medical, device, and surgical therapies for obesity in adults.",1116-1130,S0140-6736(22)02403-5 [pii] 10.1016/S0140-6736(22)02403-5 [doi],"The goal of obesity management is to improve health. Sustained weight loss of more than 10% overall bodyweight improves many of the complications associated with obesity (eg, prevention and control of type 2 diabetes, hypertension, fatty liver disease, and obstructive sleep apnoea), as well as quality of life. Maintenance of weight loss is the major challenge of obesity management. Like all chronic diseases, managing obesity requires a long-term, multimodal approach, taking into account each individual's treatment goals, and the benefit and risk of different therapies. In conjunction with lifestyle interventions, anti-obesity medications and bariatric surgery improve the maintenance of weight loss and associated health gains. Most available anti-obesity medications act on central appetite pathways to reduce hunger and food reward. In the past 5 years, therapeutic advances have seen the development of targeted treatments for monogenic obesities and a new generation of anti-obesity medications. These highly effective anti-obesity medications are associated with weight losses of more than 10% of overall bodyweight in more than two-thirds of clinical trial participants. Long-term data on safety, efficacy, and cardiovascular outcomes are awaited. Long-term studies have shown that bariatric surgical procedures typically lead to a durable weight loss of 25% and rapid, sustained improvements in complications of obesity, although they have not yet been compared with new-generation highly effective anti-obesity medications. Further work is required to determine optimal patient-specific treatment strategies, including combinations of lifestyle interventions, anti-obesity medications, endoscopic and bariatric surgical procedures, and to ensure equitable access to effective treatments.","['Perdomo, Carolina M', 'Cohen, Ricardo V', 'Sumithran, Priya', 'Clement, Karine', 'Fruhbeck, Gema']","['Perdomo CM', 'Cohen RV', 'Sumithran P', 'Clement K', 'Fruhbeck G']","['Department of Endocrinology and Nutrition, Clinica Universidad de Navarra, Pamplona, Spain; Metabolic Research Laboratory, CIBEROBN, ISCIII, IdiSNA, Clinica Universidad de Navarra, Pamplona, Spain.', 'The Center for Obesity and Diabetes, Oswaldo Cruz German Hospital, Sao Paulo, Brazil.', ""Department of Medicine, St Vincent's Hospital, University of Melbourne, Melbourne, VIC, Australia; Department of Endocrinology, Austin Health, Melbourne, VIC, Australia."", 'Sorbonne Universite, INSERM, Nutrition and obesities: systemic approach research group, Nutriomics, Paris, France; Assistance Publique-Hopitaux de Paris, Nutrition Department, Pitie-Salpetriere Hospital, Paris, France.', 'Department of Endocrinology and Nutrition, Clinica Universidad de Navarra, Pamplona, Spain; Metabolic Research Laboratory, CIBEROBN, ISCIII, IdiSNA, Clinica Universidad de Navarra, Pamplona, Spain. Electronic address: gfruhbeck@unav.es.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Lancet,"Lancet (London, England)",2985213R,['0 (Anti-Obesity Agents)'],IM,"['Adult', 'Humans', '*Diabetes Mellitus, Type 2/drug therapy', 'Quality of Life', 'Obesity/complications/surgery/drug therapy', '*Bariatric Surgery/methods', '*Anti-Obesity Agents/therapeutic use', 'Body Weight', 'Weight Loss']",,,,"['Declaration of interests CMP reports speaker fees from Novo Nordisk. RVC reports', 'research grants paid to their institution from Johnson & Johnson Brazil and', 'Medtronic Brazil. RVC reports payment or honoraria for lectures from Johnson &', 'Johnson Brazil, Medtronic, Janssen Pharmaceuticals, Novo Nordisk, and Abbott. RVC', 'is on the scientific advisory board for GI Dynamics. PS reports research grants', 'paid to their institution from National Health and Medical Research Council. PS', 'reports speaker fees and medical writing assistance from Novo Nordisk. PS reports', 'unpaid positions at the Australian and New Zealand Obesity Society (council', 'member), The Obesity Collective (leadership group), and a Data Safety Monitoring', 'Board for an investigator-initiated (dietary intervention) study sponsored by the', 'University of Adelaide. KC reports research grants paid to their institution from', 'Confo Therapeutics, Integrative Phenomics, and the Novo Nordisk Jacobaeus Prize.', 'KC reports consulting fees paid to their institution from Danone Research. KC', 'reports payment to public association from Biocodex, and payment of honoraria for', 'lectures from Sanofi. KC is on the scientific advisory board for Ysopia and', 'Astanor. GF reports research grants paid to their Institution from the Carlos III', 'Health Institute. GF reports payment of honoraria for lectures from Novo Nordisk', 'as member of the OPEN Spain Initiative. GF reports payment or honoraria for', 'attendance to the 2022 Lilly Diabetes Global Medical Affairs Portfolio Advisory', 'Board. GF is a co-chair of the scientific advisory board of the European Society', 'for the Study of Obesity-it is an unpaid position.']",2023/02/13 06:00,2023/04/04 06:42,['2023/02/12 18:53'],"['2022/06/24 00:00 [received]', '2022/11/15 00:00 [revised]', '2022/11/18 00:00 [accepted]', '2023/04/04 06:42 [medline]', '2023/02/13 06:00 [pubmed]', '2023/02/12 18:53 [entrez]']","['S0140-6736(22)02403-5 [pii]', '10.1016/S0140-6736(22)02403-5 [doi]']",ppublish,Lancet. 2023 Apr 1;401(10382):1116-1130. doi: 10.1016/S0140-6736(22)02403-5. Epub 2023 Feb 9.,,20230209,,['Copyright (c) 2023 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
28292619,NLM,MEDLINE,20170605,20220318,1556-5653 (Electronic) 0015-0282 (Linking),107,4,2017 Apr,Obesity and female infertility: potential mediators of obesity's impact.,840-847,S0015-0282(17)30060-2 [pii] 10.1016/j.fertnstert.2017.01.017 [doi],"The worldwide upward trend in obesity has been dramatic, now affecting more than 20% of American women of reproductive age. Obesity is associated with many adverse maternal and fetal effects prenatally, but it also exerts a negative influence on female fertility. Obese women are more likely to have ovulatory dysfunction due to dysregulation of the hypothalamic-pituitary-ovarian axis. Women with polycystic ovarian syndrome who are also obese demonstrate a more severe metabolic and reproductive phenotype. Obese women have reduced fecundity even when eumenorrheic and demonstrate poorer outcomes with the use of in vitro fertilization. Obesity appears to affect the oocyte and the preimplantation embryo, with disrupted meiotic spindle formation and mitochondrial dynamics. Excess free fatty acids may have a toxic effect in reproductive tissues, leading to cellular damage and a chronic low-grade inflammatory state. Altered levels of adipokines, such as leptin, in the obese state can affect steroidogenesis and directly affect the developing embryo. The endometrium is also susceptible, with evidence of impaired stromal decidualization in obese women. This may explain subfecundity due to impaired receptivity, and may lead to placental abnormalities as manifested by higher rates of miscarriage, stillbirth, and preeclampsia in the obese population. Many interventions have been explored to mitigate the effect of obesity on infertility, including weight loss, physical activity, dietary factors, and bariatric surgery. These data are largely mixed, with few high quality studies to guide us. As we improve our understanding of the pathophysiology of obesity in human reproduction we hope to identify novel treatment strategies.","['Broughton, Darcy E', 'Moley, Kelle H']","['Broughton DE', 'Moley KH']","['Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri.', 'Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri. Electronic address: moleyk@wustl.edu.']",['eng'],"['Journal Article', 'Review']",United States,Fertil Steril,Fertility and sterility,0372772,,IM,"['Adipose Tissue/metabolism/*physiopathology', 'Adiposity', 'Bariatric Surgery', 'Diet/adverse effects', 'Female', '*Fertility', 'Genetic Predisposition to Disease', 'Healthy Lifestyle', 'Humans', 'Hypothalamo-Hypophyseal System/metabolism/physiopathology', 'Infertility, Female/*etiology/metabolism/physiopathology/prevention & control', 'Lipid Metabolism', 'Obesity/*complications/metabolism/physiopathology/therapy', 'Oocytes/metabolism', 'Ovary/metabolism/*physiopathology', 'Pregnancy', 'Pregnancy Complications/etiology', 'Risk Assessment', 'Risk Factors', 'Risk Reduction Behavior', 'Sedentary Behavior', 'Weight Loss']",,['NOTNLM'],"['Obesity', 'infertility', 'lipotoxicity']",,2017/03/16 06:00,2017/06/06 06:00,['2017/03/16 06:00'],"['2016/11/30 00:00 [received]', '2017/01/23 00:00 [revised]', '2017/01/25 00:00 [accepted]', '2017/03/16 06:00 [pubmed]', '2017/06/06 06:00 [medline]', '2017/03/16 06:00 [entrez]']","['S0015-0282(17)30060-2 [pii]', '10.1016/j.fertnstert.2017.01.017 [doi]']",ppublish,Fertil Steril. 2017 Apr;107(4):840-847. doi: 10.1016/j.fertnstert.2017.01.017. Epub 2017 Mar 11.,['P30 DK056341/DK/NIDDK NIH HHS/United States'],20170311,,"['Copyright (c) 2017 American Society for Reproductive Medicine. Published by', 'Elsevier Inc. All rights reserved.']",,,,,,,,,,,,,,,,
12119993,NLM,MEDLINE,20020926,20220321,1467-7881 (Print) 1467-7881 (Linking),2,4,2001 Nov,Quality of life and obesity.,219-29,,"Interest in the quality of life of patients with different diseases continues to grow. Recent years have witnessed a dramatic rise in the prevalence of obesity worldwide, stimulating interest in the health and quality of life consequences of this phenomenon. The body of research on the quality of life of obese individuals has grown to a point that a review of this literature is warranted. Numerous studies have demonstrated that obese persons experience significant impairments in quality of life as a result of their obesity, with greater impairments associated with greater degrees of obesity. Weight loss has been shown to improve quality of life in obese persons undergoing a variety of treatments. Further research is needed to clarify whether quality of life differs among subsets of obese persons. Until recently, there has been little standardization of quality of life measures in obesity. The SF-36 has been used in a number of studies of obese persons. Several obesity-specific instruments have also been developed and have shown great promise. The quality of life of obese individuals is an important issue that should be included in weight management treatment and research.","['Kolotkin, R L', 'Meter, K', 'Williams, G R']","['Kolotkin RL', 'Meter K', 'Williams GR']","['Duke University Medical Center, Department of Psychiatry, Durham, NC, USA. kolot001@mc.duke.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['Ethnicity', 'Female', '*Health Status', 'Humans', 'Male', 'Obesity/epidemiology/*physiopathology/*psychology', 'Prevalence', 'Quality of Life/*psychology', 'Weight Loss']",,,,,2002/07/18 10:00,2002/09/27 06:00,['2002/07/18 10:00'],"['2002/07/18 10:00 [pubmed]', '2002/09/27 06:00 [medline]', '2002/07/18 10:00 [entrez]']",['10.1046/j.1467-789x.2001.00040.x [doi]'],ppublish,Obes Rev. 2001 Nov;2(4):219-29. doi: 10.1046/j.1467-789x.2001.00040.x.,,,,,,,120,,,,,,,,,,,,,
15245383,NLM,MEDLINE,20041025,20220331,1467-7881 (Print) 1467-7881 (Linking),5,3,2004 Aug,Obesity as a disease: no lightweight matter.,145-51,,"The epidemic rise in obesity has fuelled the current debate over its classification as a disease. Contrary to just being a medical condition or risk factor for other diseases, obesity is a complex disease of multifaceted aetiology, with its own disabling capacities, pathophysiologies and comorbidities. It meets the medical definition of disease in that it is a physiological dysfunction of the human organism with environmental, genetic and endocrinological aetiologies. It is a response to environmental stimuli, genetic predisposition and abnormalities, and has a characteristic set of signs and symptoms with consistent anatomical alterations. Excess adipose tissue increases the work of the heart and leads to anatomical changes in this organ. It alters pulmonary, endocrine and immunological functions, all with adverse effects on health. Some of the complications of obesity include cardiovascular disease, non-insulin-dependent diabetes mellitus, obstructive pulmonary disease, arthritis and cancer. Given the excess mortality, substantial morbidity and the economic toll of obesity, this is a disease that warrants serious attention by the medical community. Obesity's status and acceptance as a disease is pivotal in determining its treatment, reimbursement for treatment and the development of widespread interventions.","['Conway, B', 'Rene, A']","['Conway B', 'Rene A']","['Department of Epidemiology, The University of North Texas School of Public Health, 3500 Camp Bowie Boulevard, EAD-709B, Fort Worth, TX 76107, USA. baqiyyah@yahoo.com']",['eng'],"['Journal Article', 'Review']",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['Body Composition', '*Environment', 'Humans', 'Immunity', 'Insulin Resistance', 'Joint Diseases/etiology', 'Obesity/*classification/complications/physiopathology', 'Respiration', 'Risk Factors']",,,,,2004/07/13 05:00,2004/10/27 09:00,['2004/07/13 05:00'],"['2004/07/13 05:00 [pubmed]', '2004/10/27 09:00 [medline]', '2004/07/13 05:00 [entrez]']","['OBR144 [pii]', '10.1111/j.1467-789X.2004.00144.x [doi]']",ppublish,Obes Rev. 2004 Aug;5(3):145-51. doi: 10.1111/j.1467-789X.2004.00144.x.,,,,,,,69,,,,,,,,,,,,,
28532816,NLM,MEDLINE,20180112,20220410,1096-1186 (Electronic) 1043-6618 (Linking),122,,2017 Aug,Obesity and hypertension.,1-7,S1043-6618(17)30462-0 [pii] 10.1016/j.phrs.2017.05.013 [doi],"Obesity and in particular the excessive visceral fat distribution is accompanied by several alterations at hormonal, inflammatory and endothelial level. These alterations induce a stimulation of several other mechanisms that contribute to the hypertensive state and on the other side to increase the cardiovascular morbidity. In these chapter we will examine the main mechanisms of obesity and obesity-related hypertension and in particular the role of sympathetic nervous system, the alterations of the renal function and at the microvascular level. We will also depict the role of insulin resistance as factor stimulating and potentiating the other mechanisms. The second part will be focalized on the major target organ damage linked with obesity and obesity-related hypertension. We will finally describe the management and treatment of obesity and the antihypertensive drug therapies more effective in hypertensive obeses.","['Seravalle, Gino', 'Grassi, Guido']","['Seravalle G', 'Grassi G']","['Cardiology Department, S. Luca Hospital, Istituto Auxologico Italiano IRCCS, Milan, Italy. Electronic address: g_seravalle@yahoo.com.', 'Medical Clinic, S. Gerardo Hospital, University Milano-Bicocca, Monza, Italy.']",['eng'],"['Journal Article', 'Review']",Netherlands,Pharmacol Res,Pharmacological research,8907422,"['0 (Anti-Obesity Agents)', '0 (Hypoglycemic Agents)']",IM,"['Animals', 'Anti-Obesity Agents/therapeutic use', 'Arteries/drug effects/physiopathology', 'Bariatric Surgery/methods', 'Diet Therapy/methods', 'Heart/drug effects/physiopathology', 'Humans', 'Hypertension/*etiology/*physiopathology/therapy', 'Hypoglycemic Agents/therapeutic use', 'Life Style', 'Obesity/*complications/*physiopathology/therapy']",,['NOTNLM'],"['Cardiovascular risk', 'Hypertension', 'Pathophysiological mechanisms', 'Target organ damage', 'Treatment', 'Visceral fat distribution']",,2017/05/24 06:00,2018/01/13 06:00,['2017/05/24 06:00'],"['2017/04/12 00:00 [received]', '2017/05/14 00:00 [revised]', '2017/05/15 00:00 [accepted]', '2017/05/24 06:00 [pubmed]', '2018/01/13 06:00 [medline]', '2017/05/24 06:00 [entrez]']","['S1043-6618(17)30462-0 [pii]', '10.1016/j.phrs.2017.05.013 [doi]']",ppublish,Pharmacol Res. 2017 Aug;122:1-7. doi: 10.1016/j.phrs.2017.05.013. Epub 2017 May 19.,,20170519,,['Copyright (c) 2017 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
29100895,NLM,MEDLINE,20181018,20181018,1879-0828 (Electronic) 0953-6205 (Linking),48,,2018 Feb,Obesity phenotypes and their paradoxical association with cardiovascular diseases.,6-17,S0953-6205(17)30428-4 [pii] 10.1016/j.ejim.2017.10.020 [doi],"The pro-inflammatory state of the visceral adipose tissue (VAT) is supposed to accelerate cardiovascular (CV) and metabolic diseases in obese subjects. Some studies have recently reported an improved CV prognosis in certain obese and overweight patients as compared with leaner ones. This phenomenon, known as the ""obesity paradox"" (OP), has been described in many chronic diseases. This narrative review is based on the material searched for and obtained via PubMed and Web of Science up to May 2017. The search terms we used were: ""obesity, paradox, adipose tissue"" in combination with ""cardiovascular, coronary heart disease, heart failure, arrhythmias"". Using the current Body Mass Index (BMI)-based obesity definition, individuals with different clinical and biochemical characteristics are gathered together in the same category. Emerging evidence point to the existence of many ""Obesity phenotypes"" with different association with CV risk, accordingly to physical and life-style features. In this narrative review, we discussed if obesity phenotypes may be associated with a different CV risk, potentially explaining the OP. As a globally accepted definition of obesity is still lacking, we emphasized the need of a new approach, which should consider the heterogeneity of obesity. Better defining ""obesities"" and related CV risk is critical to markedly improve the classical BMI-based definition of obesity.","['Vecchie, Alessandra', 'Dallegri, Franco', 'Carbone, Federico', 'Bonaventura, Aldo', 'Liberale, Luca', 'Portincasa, Piero', 'Fruhbeck, Gema', 'Montecucco, Fabrizio']","['Vecchie A', 'Dallegri F', 'Carbone F', 'Bonaventura A', 'Liberale L', 'Portincasa P', 'Fruhbeck G', 'Montecucco F']","['First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, 16132 Genoa, Italy.', ""First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, 16132 Genoa, Italy; Ospedale Policlinico San Martino, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, 10 Largo Benzi, 16132 Genoa, Italy."", 'First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, 16132 Genoa, Italy.', 'First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, 16132 Genoa, Italy.', 'First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, 16132 Genoa, Italy; Centre for Molecular Cardiology, University of Zurich, 12 Wagistrasse, 8952 Schlieren, Switzerland.', 'Clinica Medica ""A. Murri"", Department of Biomedical Sciences and Human Oncology, University of Bari ""Aldo Moro"" Medical School, Bari, Italy.', 'Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Spain; Metabolic Research Laboratory, Clinica Universidad de Navarra, 31008 Pamplona, Spain.', ""First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, 6 viale Benedetto XV, 16132 Genoa, Italy; Ospedale Policlinico San Martino, Istituto di Ricovero e Cura a Carattere Scientifico per l'Oncologia, 10 Largo Benzi, 16132 Genoa, Italy; Centre of Excellence for Biomedical Research (CEBR), University of Genoa, 9 viale Benedetto XV, 16132 Genoa, Italy. Electronic address: fabrizio.montecucco@unige.it.""]",['eng'],"['Journal Article', 'Review']",Netherlands,Eur J Intern Med,European journal of internal medicine,9003220,,IM,"['Body Mass Index', 'Cardiovascular Diseases/*epidemiology/physiopathology', 'Humans', 'Intra-Abdominal Fat/physiology', 'Life Style', 'Obesity/*classification/*complications', 'Phenotype', 'Prognosis']",,['NOTNLM'],"['Adipose tissue', 'Inflammation', 'Obesity', 'Obesity paradox']",,2017/11/05 06:00,2018/10/20 06:00,['2017/11/05 06:00'],"['2017/08/04 00:00 [received]', '2017/10/24 00:00 [revised]', '2017/10/26 00:00 [accepted]', '2017/11/05 06:00 [pubmed]', '2018/10/20 06:00 [medline]', '2017/11/05 06:00 [entrez]']","['S0953-6205(17)30428-4 [pii]', '10.1016/j.ejim.2017.10.020 [doi]']",ppublish,Eur J Intern Med. 2018 Feb;48:6-17. doi: 10.1016/j.ejim.2017.10.020.,,,,"['Copyright (c) 2017 European Federation of Internal Medicine. Published by Elsevier', 'B.V. All rights reserved.']",,,,,,,,,,,,,,,,
31498150,NLM,MEDLINE,20200608,20201001,1558-8238 (Electronic) 0021-9738 (Print) 0021-9738 (Linking),129,10,2019 Oct 1,Deciphering the cellular interplays underlying obesity-induced adipose tissue fibrosis.,4032-4040,129192 [pii] 10.1172/JCI129192 [doi],"Obesity originates from an imbalance between caloric intake and energy expenditure that promotes adipose tissue expansion, which is necessary to buffer nutrient excess. Patients with higher visceral fat mass are at a higher risk of developing severe complications such as type 2 diabetes and cardiovascular and liver diseases. However, increased fat mass does not fully explain obesity's propensity to promote metabolic diseases. With chronic obesity, adipose tissue undergoes major remodeling, which can ultimately result in unresolved chronic inflammation leading to fibrosis accumulation. These features drive local tissue damage and initiate and/or maintain multiorgan dysfunction. Here, we review the current understanding of adipose tissue remodeling with a focus on obesity-induced adipose tissue fibrosis and its relevance to clinical manifestations.","['Marcelin, Genevieve', 'Silveira, Ana Leticia M', 'Martins, Lais Bhering', 'Ferreira, Adaliene Vm', 'Clement, Karine']","['Marcelin G', 'Silveira ALM', 'Martins LB', 'Ferreira AV', 'Clement K']","['Nutrition and Obesities: Systemic Approaches (NutriOmics, UMRS U1269), INSERM, Sorbonne Universite, Paris, France.', 'Nutrition and Obesities: Systemic Approaches (NutriOmics, UMRS U1269), INSERM, Sorbonne Universite, Paris, France.', 'Immunometabolism, Department of Nutrition, Nursing School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Nutrition and Obesities: Systemic Approaches (NutriOmics, UMRS U1269), INSERM, Sorbonne Universite, Paris, France.', 'Immunometabolism, Department of Nutrition, Nursing School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Immunometabolism, Department of Nutrition, Nursing School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Nutrition and Obesities: Systemic Approaches (NutriOmics, UMRS U1269), INSERM, Sorbonne Universite, Paris, France.', 'Nutrition Department, Hopital Pitie-Salpetriere, Assistance Publique Hopitaux de Paris, Paris, France.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,J Clin Invest,The Journal of clinical investigation,7802877,,IM,"['Adipocytes/pathology', 'Adipose Tissue/blood supply/*pathology', 'Animals', 'Fibrosis', 'Humans', 'Inflammation/pathology', 'Metabolic Diseases/etiology', 'Mice', 'Myofibroblasts/pathology', 'Neovascularization, Physiologic', 'Obesity/complications/*pathology', 'Stem Cells/pathology']",PMC6763252,,,"['Conflict of interest: The authors have declared that no conflict of interest', 'exists.']",2019/09/10 06:00,2020/06/09 06:00,['2019/09/10 06:00'],"['2019/09/10 06:00 [pubmed]', '2020/06/09 06:00 [medline]', '2019/09/10 06:00 [entrez]']","['129192 [pii]', '10.1172/JCI129192 [doi]']",ppublish,J Clin Invest. 2019 Oct 1;129(10):4032-4040. doi: 10.1172/JCI129192.,,,,,,,,,,,,,,,,,,,,
20871401,NLM,MEDLINE,20110418,20110114,1473-6535 (Electronic) 0957-9672 (Linking),22,1,2011 Feb,Childhood obesity.,21-5,10.1097/MOL.0b013e32833f9c37 [doi],"PURPOSE OF REVIEW: As childhood obesity is associated with premature death in adults, a research is critical. This review focuses on the recent proceedings concerning genesis, prevention, and treatment. RECENT FINDINGS: Identifying genetic variants in well phenotyped small cohorts of extremely obese children (e.g., the search for copy number variants in obesity-associated large chromosomal deletions) confirmed afterwards in large population-based studies is a new promising genetic approach to understand the disposition to obesity. A further important finding is that obesity of mothers predisposes their offsprings to obesity by epigenetic, prenatal effects. Therefore, prevention programs targeting parents even before pregnancy should be developed. Prevention programs in kindergarten and schools without involving the parents failed to fight against the obesity epidemic. A new promising prevention approach is to change the environment (e.g., ban on sugar drinks in schools). Therapy of choice in already obese children is lifestyle intervention. Again, including their parents is crucial for success. However, this kind of intervention is only suitable for families motivated to change their lifestyle habits. Especially in extremely obese adolescents, additional therapeutic approaches such as drugs and bariatric surgery have to be considered. SUMMARY: Even if of knowledge of childhood obesity improves every year, many questions concerning prevention and treatment remain still open. Future longitudinal research has to focus on which children will benefit from which kind of intervention to develop specific therapies.","['Reinehr, Thomas', 'Wabitsch, Martin']","['Reinehr T', 'Wabitsch M']","['Department of Pediatric Endocrinology, Diabetes and Nutrition Medicine, Vestische Hospital for Children and Adolescents, University of Witten/Herdecke, Datteln, Germany.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Curr Opin Lipidol,Current opinion in lipidology,9010000,,IM,"['Adolescent', 'Child', 'Humans', 'Obesity/*epidemiology/prevention & control/therapy']",,,,,2010/09/28 06:00,2011/04/19 06:00,['2010/09/28 06:00'],"['2010/09/28 06:00 [entrez]', '2010/09/28 06:00 [pubmed]', '2011/04/19 06:00 [medline]']",['10.1097/MOL.0b013e32833f9c37 [doi]'],ppublish,Curr Opin Lipidol. 2011 Feb;22(1):21-5. doi: 10.1097/MOL.0b013e32833f9c37.,,,,,,,,,,,,,,,,,,,,
32326175,NLM,MEDLINE,20210125,20210125,1422-0067 (Electronic) 1422-0067 (Linking),21,8,2020 Apr 21,Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome.,,10.3390/ijms21082890 [doi] 2890,"Obesity has become a global epidemic and a public health crisis in the Western World, experiencing a threefold increase in prevalence since 1975. High-caloric diets and sedentary lifestyles have been identified as significant contributors to this widespread issue, although the role of genetic, social, and environmental factors in obesity's pathogenesis remain incompletely understood. In recent years, much attention has been drawn to the contribution of the gut microbiota in the development of obesity. Indeed, research has shown that in contrast to their healthier counterparts the microbiomes of obese individuals are structurally and functionally distinct, strongly suggesting microbiome as a potential target for obesity therapeutics. In particular, pre and probiotics have emerged as effective and integrative means of modulating the microbiome, in order to reverse the microbial dysbiosis associated with an obese phenotype. The following review brings forth animal and human research supporting the myriad of mechanisms by which the microbiome affects obesity, as well as the strengths and limitations of probiotic or prebiotic supplementation for the prevention and treatment of obesity. Finally, we set forth a roadmap for the comprehensive development of functional food solutions in combatting obesity, to capitalize on the potential of pre/probiotic therapies in optimizing host health.","['Green, Miranda', 'Arora, Karan', 'Prakash, Satya']","['Green M', 'Arora K', 'Prakash S']","['Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, Faculty of Medicine, McGill University, 3775 University Street, Montreal, QC H3A 2B4, Canada.', 'Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, Faculty of Medicine, McGill University, 3775 University Street, Montreal, QC H3A 2B4, Canada.', 'Department of Bioengineering, Faculty of Engineering, McGill University, 3775 University Street, Montreal, QC H3A 2B4, Canada.', 'Biena Inc., 2955 Rue Cartier, Saint-Hyacinthe, QC J2S 1L4, Canada.', 'Biomedical Technology and Cell Therapy Research Laboratory, Department of Biomedical Engineering, Faculty of Medicine, McGill University, 3775 University Street, Montreal, QC H3A 2B4, Canada.']",['eng'],"['Journal Article', 'Review']",Switzerland,Int J Mol Sci,International journal of molecular sciences,101092791,"['0 (Bile Acids and Salts)', '0 (Prebiotics)']",IM,"['Animals', 'Bile Acids and Salts/metabolism', 'Diet', 'Disease Susceptibility', 'Dysbiosis', 'Energy Metabolism', '*Functional Food', 'Gastrointestinal Microbiome', 'Humans', 'Metabolic Syndrome/*diet therapy/etiology', 'Microbiota', 'Obesity/*diet therapy/etiology', 'Prebiotics/*administration & dosage', 'Probiotics/*administration & dosage']",PMC7215979,['NOTNLM'],"['bile acid (BA)', 'inflammation', 'metabolic syndrome', 'metabolic syndrome (MetS)', 'microbiome', 'obesity', 'prebiotics', 'probiotics', 'short chain fatty acid (SCFA)']","['The authors (S.P. and M.G.) declare no conflict of interest. K.A. has blood', 'relationship with the founders of Biena Inc.']",2020/04/25 06:00,2021/01/26 06:00,['2020/04/25 06:00'],"['2020/03/11 00:00 [received]', '2020/04/09 00:00 [revised]', '2020/04/17 00:00 [accepted]', '2020/04/25 06:00 [entrez]', '2020/04/25 06:00 [pubmed]', '2021/01/26 06:00 [medline]']","['ijms21082890 [pii]', 'ijms-21-02890 [pii]', '10.3390/ijms21082890 [doi]']",epublish,Int J Mol Sci. 2020 Apr 21;21(8):2890. doi: 10.3390/ijms21082890.,['RGPIN-201806364/Natural Sciences and Engineering Research Council of Canada/'],20200421,,,,,,,,,,,,,,,,,,
34953778,NLM,MEDLINE,20220322,20220322,2213-3941 (Electronic) 0003-4266 (Linking),83,1,2022 Feb,Rare genetic causes of obesity: Diagnosis and management in clinical care.,63-72,S0003-4266(21)01109-4 [pii] 10.1016/j.ando.2021.12.003 [doi],"Rare genetic forms of obesity are linked to impaired energy balance (i.e., eating behaviour and energy expenditure) involving hypothalamic pathways. More than 60 genes coding for proteins located in the hypothalamic leptin/melanocortin pathway contribute to the development of these rare forms of obesity. The ambition of the French National Protocol for the Diagnosis and Care (PNDS) of Obesity of Rare Causes was to establish practical recommendations for assessment and management at all ages. This report is available on the website of the French Health Authority (HAS). In addition to severe obesity, patients often display obesity-related comorbidities and neuropsychological/psychiatric disorders. These complex conditions make clinical management particularly challenging. Early diagnosis is critical for the organization of coordinated specialized multidisciplinary care, with mandatory interaction between caregivers, social partners and families. Strategies to prevent aggravation of obesity consist in limiting access to food, establishing a reassuring daily eating environment, and the practice of sustained adapted supervised daily physical activity. The implementation of genetic diagnosis in clinical practice now enables a personalized medicine approach with access to new drug therapies, and improves the analysis of the risk/benefit ratio of bariatric surgery.","['Dubern, Beatrice', 'Mosbah, Helena', 'Pigeyre, Marie', 'Clement, Karine', 'Poitou, Christine']","['Dubern B', 'Mosbah H', 'Pigeyre M', 'Clement K', 'Poitou C']","['Paris Public Hospitals, PRADORT Competence Centre, Department of Paediatric Nutrition and Gastroenterology, CHU Trousseau, Paris, France; Sorbonne University/INSERM, Research Unit: Nutrition and Obesities; Systemic Approaches, NutriOmics, Paris, France.', 'Paris Public Hospitals, Reference Centre for Rare Diseases PRADORT (PRADer-Willi Syndrome and other Rare Obesities with Eating Disorders), Nutrition Department, Pitie-Salpetriere hospital, Paris, France.', 'Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Hamilton, ON, Canada; Department of Medicine, McMaster University, Michael G. DeGroote School of Medicine, Hamilton, ON, Canada.', 'Sorbonne University/INSERM, Research Unit: Nutrition and Obesities; Systemic Approaches, NutriOmics, Paris, France; Paris Public Hospitals, Reference Centre for Rare Diseases PRADORT (PRADer-Willi Syndrome and other Rare Obesities with Eating Disorders), Nutrition Department, Pitie-Salpetriere hospital, Paris, France.', 'Sorbonne University/INSERM, Research Unit: Nutrition and Obesities; Systemic Approaches, NutriOmics, Paris, France; Paris Public Hospitals, Reference Centre for Rare Diseases PRADORT (PRADer-Willi Syndrome and other Rare Obesities with Eating Disorders), Nutrition Department, Pitie-Salpetriere hospital, Paris, France. Electronic address: christine.poitou-bernert@aphp.fr.']",['eng'],"['Journal Article', 'Review']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,"['0 (LEP protein, human)', '0 (Leptin)']",IM,"['Bariatric Surgery', 'Energy Metabolism', 'Humans', 'Hypothalamus', 'Leptin', 'Obesity/*genetics', 'Obesity, Morbid/genetics']",,['NOTNLM'],"['Hypothalamic obesity', 'Leptin/melanocortin pathway', 'Monogenic obesity', 'Obesite hypothalamique', 'Obesite monogenique', 'Obesite syndromique', 'Syndromic obesity', 'Voie leptine-melanocortine']",,2021/12/27 06:00,2022/03/23 06:00,['2021/12/26 20:31'],"['2021/12/27 06:00 [pubmed]', '2022/03/23 06:00 [medline]', '2021/12/26 20:31 [entrez]']","['S0003-4266(21)01109-4 [pii]', '10.1016/j.ando.2021.12.003 [doi]']",ppublish,Ann Endocrinol (Paris). 2022 Feb;83(1):63-72. doi: 10.1016/j.ando.2021.12.003. Epub 2021 Dec 23.,,20211223,,['Copyright (c) 2021 Elsevier Masson SAS. All rights reserved.'],,,,,,,,,,,,,,,,
36043953,NLM,MEDLINE,20220908,20230125,2531-6745 (Electronic) 0392-4203 (Print) 0392-4203 (Linking),93,4,2022 Aug 31,Female obesity and infertility: outcomes and regulatory guidance.,e2022278,10.23750/abm.v93i4.13466 [doi] e2022278,"Obesity has been associated with reduced fertility, although the dynamics and mechanisms which link excess weight to reduced fertility are not yet fully clarified. Obese women, especially those with central obesity, are less likely to conceive per cycle. Obese women suffer from perturbations of the hypothalamus-pituitary-ovary axis, disturbances of the menstrual cycle and are up to three times more likely to suffer from oligo/anovulation. A delicate hormonal balance regulates follicular development and the maturation of oocytes and it has been observed that obesity can alter the hormonal environment: adipocytes, in fact, are responsible for the production of a hormone called leptin (present in high quantities in obese women) which has been associated with reduced fecundity. In addition to compromising ovulation, obesity negatively affects the development and implantation of the endometrium. The expression of polycystic ovary syndrome (PCOS) is regulated, in part, by weight, so obese women with PCOS often have a more severe phenotype and higher subfertility rates. Furthermore, obesity impairs women's response to medically assisted procreation (MAP) treatments. The authors have set out to delineate a broad-ranging overview of obesity's impact on female fertility, by drawing upon sources spanning the 1994-2022 period. Assisted reproductive technology (ART) procedures are also discussed as they relate to obese patients. In addition the dynamics by which maternal obesity reportedly affects fetal, neonatal and child development have also been briefly enunciated.","['Marinelli, Susanna', 'Napoletano, Gabriele', 'Straccamore, Marco', 'Basile, Giuseppe']","['Marinelli S', 'Napoletano G', 'Straccamore M', 'Basile G']","['School of Law, Universita Politecnica delle Marche, Ancona, Italy. susanna.marinelli@tiscali.it.', 'Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University or Rome, Rome, Italy. gabriele.napoletano@uniroma1.it.', 'Department of Anatomical, Histological, Forensic and Orthopedic Sciences, Sapienza University or Rome, Rome, Italy. marco.straccamore@uniroma1.it.', 'a:1:s:5:""en_US"";s:49:""IRCCS Orthopedic Institute Galeazzi, Milan, Italy"";. giuseppe.basilemilan@protonmail.com.']",['eng'],['Journal Article'],Italy,Acta Biomed,Acta bio-medica : Atenei Parmensis,101295064,,IM,"['*Anovulation/complications/therapy', 'Female', 'Fertility', 'Humans', '*Infertility, Female/etiology', 'Obesity/complications/metabolism', '*Polycystic Ovary Syndrome/complications', 'Pregnancy']",PMC9534231,,,"['Each author declares that he or she has no commercial associations (e.g.', 'consultancies, stock ownership, equity interest, patent/licensing arrangement', 'etc.) that might pose a conflict of interest in connection with the submitted', 'article.']",2022/09/01 06:00,2022/09/09 06:00,['2022/08/31 10:13'],"['2022/07/20 00:00 [received]', '2022/08/01 00:00 [accepted]', '2022/08/31 10:13 [entrez]', '2022/09/01 06:00 [pubmed]', '2022/09/09 06:00 [medline]']","['ACTA-93-278 [pii]', '10.23750/abm.v93i4.13466 [doi]']",epublish,Acta Biomed. 2022 Aug 31;93(4):e2022278. doi: 10.23750/abm.v93i4.13466.,,20220831,,,,,,,,,,,,,,,,,,
27154742,NLM,MEDLINE,20170411,20220410,1470-8736 (Electronic) 0143-5221 (Linking),130,12,2016 Jun 1,"Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity.",943-86,10.1042/CS20160136 [doi],"In high-, middle- and low-income countries, the rising prevalence of obesity is the underlying cause of numerous health complications and increased mortality. Being a complex and heritable disorder, obesity results from the interplay between genetic susceptibility, epigenetics, metagenomics and the environment. Attempts at understanding the genetic basis of obesity have identified numerous genes associated with syndromic monogenic, non-syndromic monogenic, oligogenic and polygenic obesity. The genetics of leanness are also considered relevant as it mirrors some of obesity's aetiologies. In this report, we summarize ten genetically elucidated obesity syndromes, some of which are involved in ciliary functioning. We comprehensively review 11 monogenic obesity genes identified to date and their role in energy maintenance as part of the leptin-melanocortin pathway. With the emergence of genome-wide association studies over the last decade, 227 genetic variants involved in different biological pathways (central nervous system, food sensing and digestion, adipocyte differentiation, insulin signalling, lipid metabolism, muscle and liver biology, gut microbiota) have been associated with polygenic obesity. Advances in obligatory and facilitated epigenetic variation, and gene-environment interaction studies have partly accounted for the missing heritability of obesity and provided additional insight into its aetiology. The role of gut microbiota in obesity pathophysiology, as well as the 12 genes associated with lipodystrophies is discussed. Furthermore, in an attempt to improve future studies and merge the gap between research and clinical practice, we provide suggestions on how high-throughput '-omic' data can be integrated in order to get closer to the new age of personalized medicine.","['Pigeyre, Marie', 'Yazdi, Fereshteh T', 'Kaur, Yuvreet', 'Meyre, David']","['Pigeyre M', 'Yazdi FT', 'Kaur Y', 'Meyre D']","['Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, L8S 4L8, Canada INSERM UMR 1190, Department of Nutrition, University of Lille, CHRU Lille, Lille, 59000, France.', 'Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, L8S 4L8, Canada.', 'Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, L8S 4L8, Canada.', 'Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, L8S 4L8, Canada Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, L8S 4L8, Canada meyred@mcmaster.ca.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Clin Sci (Lond),"Clinical science (London, England : 1979)",7905731,['0 (Leptin)'],IM,"['Epigenesis, Genetic/*genetics', '*Genetic Predisposition to Disease', 'Genome-Wide Association Study', 'Humans', '*Leptin/genetics/metabolism', '*Metagenomics', 'Obesity/epidemiology/*genetics/*physiopathology']",,['NOTNLM'],"['epigenetics', 'genetics', 'leanness', 'metagenomics', 'obesity and body fat distribution', 'pathophysiology', 'personalized medicine']",,2016/05/08 06:00,2017/04/12 06:00,['2016/05/08 06:00'],"['2015/12/09 00:00 [received]', '2016/02/24 00:00 [accepted]', '2016/05/08 06:00 [entrez]', '2016/05/08 06:00 [pubmed]', '2017/04/12 06:00 [medline]']","['CS20160136 [pii]', '10.1042/CS20160136 [doi]']",ppublish,Clin Sci (Lond). 2016 Jun 1;130(12):943-86. doi: 10.1042/CS20160136.,,,,"['(c) 2016 The Author(s). Published by Portland Press Limited on behalf of the', 'Biochemical Society.']",,,,,,,,,,,,,,,,
27903516,NLM,MEDLINE,20170626,20200930,1522-1490 (Electronic) 0363-6119 (Print) 0363-6119 (Linking),312,1,2017 Jan 1,Metabolic abnormalities and obesity's impact on the risk for developing preeclampsia.,R5-R12,10.1152/ajpregu.00440.2016 [doi],"Preeclampsia (PE), a hypertensive disorder of pregnancy, is increasing as a major contributor to perinatal and long-term morbidity of mother and offspring. PE is thought to originate from ischemic insults in the placenta driving the release of prohypertensive anti-angiogenic [soluble fms-like tyrosine kinase-1 (sFlt-1)] and proinflammatory [tumor necrosis factor-alpha (TNF-alpha)] factors into the maternal circulation. Whereas the increased incidence of PE is hypothesized to be largely due to the obesity pandemic, the mechanisms whereby obesity increases this risk are unknown. The maternal endothelium is targeted by placental and adipose tissue-derived factors like sFlt-1 and TNF-alpha that promote hypertension during pregnancy, resulting in vascular dysfunction and hypertension. Interestingly, not all obese pregnant women develop PE. Data suggest that obese pregnant women with the greatest metabolic abnormalities have the highest incidence of PE. Identifying obesity-related mechanisms driving hypertension in some obese pregnant women and pathways that protect normotensive obese pregnant women, may uncover novel protocols to treat PE. Metabolic abnormalities, such as increased circulating leptin, glucose, insulin, and lipids, are likely to increase the risk for PE in obese women. It is not only important to understand whether each of these metabolic factors contribute to the increased risk for PE in obesity, but also their cumulative effects. This is particularly relevant to obese pregnant women with gestational diabetes mellitus (GDM) where all of these factors are increased and the risk for PE is highest. It is speculated that these factors potentiate the anti-angiogenic and proinflammatory mechanisms of placental ischemia-induced vascular dysfunction thereby contributing to the increasing incidence of PE.","['Spradley, Frank T']",['Spradley FT'],"[""Department of Surgery, Department of Physiology and Biophysics, Cardiovascular-Renal Research Center, Women's Health Research Center, The University of Mississippi Medical Center, Jackson, Mississippi fspradley@umc.edu.""]",['eng'],"['Journal Article', 'Meta-Analysis', 'Research Support, N.I.H., Extramural', 'Review']",United States,Am J Physiol Regul Integr Comp Physiol,"American journal of physiology. Regulatory, integrative and comparative physiology",100901230,"['0 (Biomarkers)', '0 (Cytokines)', '0 (Immunologic Factors)']",IM,"['Biomarkers/blood', 'Causality', 'Comorbidity', 'Cytokines/immunology', 'Evidence-Based Medicine', 'Female', 'Humans', 'Immunologic Factors/immunology', 'Metabolic Diseases/*epidemiology/*immunology', 'Obesity/*epidemiology/*immunology', 'Pre-Eclampsia/*epidemiology/*immunology', 'Pregnancy', 'Risk Factors']",PMC5283940,['NOTNLM'],"['adipose tissue', 'endothelium', 'gestational diabetes mellitus', 'hypertension', ""women's health""]",,2016/12/03 06:00,2017/06/27 06:00,['2016/12/02 06:00'],"['2016/10/13 00:00 [received]', '2016/11/11 00:00 [revised]', '2016/11/29 00:00 [accepted]', '2016/12/03 06:00 [pubmed]', '2017/06/27 06:00 [medline]', '2016/12/02 06:00 [entrez]']","['ajpregu.00440.2016 [pii]', 'R-00440-2016 [pii]', '10.1152/ajpregu.00440.2016 [doi]']",ppublish,Am J Physiol Regul Integr Comp Physiol. 2017 Jan 1;312(1):R5-R12. doi: 10.1152/ajpregu.00440.2016. Epub 2016 Nov 30.,"['P20 GM104357/GM/NIGMS NIH HHS/United States', 'K99 HL130577/HL/NHLBI NIH HHS/United States']",20161130,,['Copyright (c) 2017 the American Physiological Society.'],,,,,,,,,,,,,,,,
11725724,NLM,MEDLINE,20020429,20191105,1389-9155 (Print) 1389-9155 (Linking),2,4,2001 Oct,Pediatric obesity.,371-83,,"Pediatric obesity can be defined as BMI > 95th percentile for age and sex from large surveys that were carried out in the past. Using these cut points, over 10% of all children and adolescents are obese, and another 10% are overweight (BMI > 85th percentile). Obesity in childhood is associated with many immediate consequences, including orthopedic, neurologic, pulmonary, gastroenterologic, endocrinologic, metabolic, and cardiovascular disorders. Psychosocial and economic problems also are seen in obese adolescents. Long-term consequences of pediatric obesity include risks for cardiovascular disease and death that are independent of adult body weight. The differential diagnosis of pediatric obesity includes many multi-system genetic syndromes and a limited number of endocrine disorders that include abnormalities in the leptin signaling pathway, but most children with excess body weight do not have an established diagnosis. Treatment is best carried out at specialized centers, and usually involves a program of behavioral modification, caloric restriction, increased activity, and decreased sedentary behaviors. Medication for pediatric obesity cannot be recommended at present outside the context of clinical trials. Gastric bypass surgery is effective, but should be considered a last resort for the child with life-threatening complications of obesity.","['Yanovski, J A']",['Yanovski JA'],"['Unit on Growth and Obesity, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institute of Health, 10 Center Drive, MSC 1862, Bldg. 10, Rm. 10N262, Bethesda, MD 20892-1862, USA.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S."", 'Review']",Germany,Rev Endocr Metab Disord,Reviews in endocrine & metabolic disorders,100940588,,IM,"['Body Mass Index', 'Child', 'Humans', 'Obesity/complications/diagnosis/*epidemiology/therapy']",,,,,2001/12/01 10:00,2002/05/01 10:01,['2001/12/01 10:00'],"['2001/12/01 10:00 [pubmed]', '2002/05/01 10:01 [medline]', '2001/12/01 10:00 [entrez]']",['10.1023/a:1011800532068 [doi]'],ppublish,Rev Endocr Metab Disord. 2001 Oct;2(4):371-83. doi: 10.1023/a:1011800532068.,['ZO1 HD-00641/HD/NICHD NIH HHS/United States'],,,,,,104,,,,,,,,,,,,,
10505492,NLM,MEDLINE,19991007,20190921,0033-0620 (Print) 0033-0620 (Linking),42,1,1999 Jul-Aug,Obesity and hypertension.,39-58,,"Substantial evidence from epidemiological data supports a link between obesity and hypertension. However, the relationship between the two disorders is not straightforward and most likely represents an interaction of demographic, genetic, hormonal, renal, and hemodynamic factors. Age, race, and sex also modulate the strength of the association between obesity and hypertension. Hyperinsulinemia, which is characteristic of obesity, can contribute to the probability of developing hypertension by activating the sympathetic nervous system (SNS) and by causing sodium retention. The pressor effect of insulin in obesity may be further enhanced by the observation that its vasodilator action can be blunted in obese subjects. Preliminary data have shown that leptin, whose levels are increased in most obese individuals, can contribute to hypertension in obesity through its effects on insulin, SNS, and sodium excretion. The kidney may also have a role in the pathophysiology of hypertension in obesity. Abnormal renal sodium handling coupled with structural changes in the kidney of an obese patient can raise blood pressure. In addition, obesity is associated with distinct cardiovascular hemodynamic alterations and development of eccentric myocardial hypertrophy. Most of these obesity-associated abnormalities, as well as hypertension itself, can be reversed by weight loss. Furthermore, weight loss can prevent, or at least delay, the development of hypertension in patients with high-normal blood pressure. Weight reduction should be the first-line treatment in every obese hypertensive patient. However, the majority of patients will need pharmacologic intervention in conjunction with weight loss. Selection of antihypertensive agents in the overweight patient should take into account the mechanisms leading to hypertension and the metabolic abnormalities that characterize the obese patient.","['Mikhail, N', 'Golub, M S', 'Tuck, M L']","['Mikhail N', 'Golub MS', 'Tuck ML']","['Veterans Affairs Greater Los Angeles Healthcare System, Sepulveda Ambulatory Care Center, CA, USA.']",['eng'],"['Journal Article', 'Review']",United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,['0 (Antihypertensive Agents)'],IM,"['Animals', 'Antihypertensive Agents/therapeutic use', 'Diet, Reducing', 'Energy Intake', 'Humans', 'Hypertension/epidemiology/*etiology/physiopathology/therapy', 'Obesity/*complications/epidemiology/physiopathology/therapy', 'Sex Factors']",,,,,1999/10/03 00:00,1999/10/03 00:01,['1999/10/03 00:00'],"['1999/10/03 00:00 [pubmed]', '1999/10/03 00:01 [medline]', '1999/10/03 00:00 [entrez]']","['S0033062099700083 [pii]', '10.1016/s0033-0620(99)70008-3 [doi]']",ppublish,Prog Cardiovasc Dis. 1999 Jul-Aug;42(1):39-58. doi: 10.1016/s0033-0620(99)70008-3.,,,,,,,152,,,,,,,,,,,,,
30167798,NLM,MEDLINE,20190906,20190906,1539-0829 (Electronic) 1534-4827 (Linking),18,10,2018 Aug 30,The Impact of Childhood and Adolescent Obesity on Cardiovascular Risk in Adulthood: a Systematic Review.,91,10.1007/s11892-018-1062-9 [doi],"PURPOSE OF REVIEW: Adult obesity and cardiovascular diseases are closely linked. Yet, the relationship of childhood and adolescent obesities with cardiovascular diseases in adulthood requires additional evidence. The goal of the review is to inspect the relationship between childhood- and adolescent-increased body mass index (BMI) and cardiovascular risk factors, fatal and non-fatal cardiovascular diseases in adulthood. RECENT FINDINGS: Cardiovascular diseases in adulthood are linked by most of the studies to childhood and adolescent obesities. Studies showed that childhood and adolescent obesities increased the incidence of cardiovascular disease risk factors and were linked to higher risk of cardiovascular morbidity and mortality in adulthood. Childhood and adolescent obesities were also associated, likely with a causal relationship, with an increased likelihood for various cardiovascular morbidities including ischemic heart disease, stroke, but also non-ischemic heart disease-related cardiac pathologies.","['Sommer, Adir', 'Twig, Gilad']","['Sommer A', 'Twig G']","['The Israel Defense Forces Medical Corps, Tel Hashomer, Ramat Gan, Israel.', 'The Israel Defense Forces Medical Corps, Tel Hashomer, Ramat Gan, Israel. Gilad.twig@gmail.com.', 'The Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Gilad.twig@gmail.com.', 'The Dr. Pinchas Bornstein Talpiot Medical Leadership Program, Sheba Medical Center, Ramat Gan, Israel. Gilad.twig@gmail.com.', 'Department of Military Medicine, Hebrew University, Jerusalem, Israel. Gilad.twig@gmail.com.']",['eng'],"['Journal Article', 'Systematic Review']",United States,Curr Diab Rep,Current diabetes reports,101093791,,IM,"['Adolescent', 'Adult', 'Body Mass Index', 'Cardiovascular Diseases/*etiology', 'Child', 'Comorbidity', 'Humans', 'Mendelian Randomization Analysis', 'Obesity/*complications', 'Risk Factors']",,['NOTNLM'],"['Adolescent', 'Body mass index', 'Cardiovascular disease', 'Childhood', 'Obesity']",,2018/09/01 06:00,2019/09/07 06:00,['2018/09/01 06:00'],"['2018/09/01 06:00 [entrez]', '2018/09/01 06:00 [pubmed]', '2019/09/07 06:00 [medline]']","['10.1007/s11892-018-1062-9 [pii]', '10.1007/s11892-018-1062-9 [doi]']",epublish,Curr Diab Rep. 2018 Aug 30;18(10):91. doi: 10.1007/s11892-018-1062-9.,,20180830,,,,,,,,,,,,,,,,,,
37791820,NLM,MEDLINE,20231102,20231102,1747-4132 (Electronic) 1747-4124 (Linking),17,10,2023 Jul-Dec,Stratification of obesity phenotypes to optimize future therapy (SOPHIA).,1031-1039,10.1080/17474124.2023.2264783 [doi],"INTRODUCTION: Obesity is considered a poor lifestyle choice. 'Obesity' is not a sufficient definition for patients, any more than 'cancer' or 'arthritis' would be. A major obstacle is the lack of understanding of pathogenesis. The disease of obesity is considered homogenous, while response to treatment is thought of as heterogeneous. This can change if pathogenesis, risk profiles for complications, and treatment responses are viewed within the context of obesity consisting of several subsets of disease. AREAS COVERED: The European Union-funded Innovative Medicine Initiative project Stratification of Obesity Phenotypes to Optimize Future Obesity Therapy is part of a momentum shift. Operational variables are being used to develop tests and therapies which may allow the prediction of risk of obesities and the prediction of response to obesity treatments. However, changing stakeholder perspectives on obesity may require more than high-quality data and analysis. EXPERT OPINION: For patients to benefit, clinicians need to integrate evidence-based treatments and payers need to reimburse the management of the disease of obesity. This will generate commercial opportunities for industry. We need to involve stakeholders (patients, clinicians, regulators, payer, patient organisations) to create a shared value for mutual gain.","['Tahrani, Abd A', 'Panova-Noeva, Marina', 'Schloot, Nanette C', 'Hennige, Anita M', 'Soderberg, Jeannette', 'Nadglowski, Joe', 'Tarasenko, Lisa', 'Ahmad, Nadia N', 'Sleypen, Barbara Sc', 'Bravo, Rafael', 'Al-Najim, Werd', 'le Roux, Carel W']","['Tahrani AA', 'Panova-Noeva M', 'Schloot NC', 'Hennige AM', 'Soderberg J', 'Nadglowski J', 'Tarasenko L', 'Ahmad NN', 'Sleypen BS', 'Bravo R', 'Al-Najim W', 'le Roux CW']","['Novo Nordisk A/S, soborg, Denmark.', 'Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany.', 'Lilly Deutschland GmbH, Bad Homburg, Germany.', 'Boehringer Ingelheim International GmbH, Biberach, Germany.', 'JDRF International.', 'Obesity Action Coalition, Tampa, FL.', 'Pfizer Inc, New York, NY, USA.', 'Eli Lilly and Company, Indianapolis, IN, USA.', 'Medtronic (Covidien AG).', 'Novo Nordisk A/S, soborg, Denmark.', 'Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.', 'Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.']",['eng'],"['Journal Article', 'Review']",England,Expert Rev Gastroenterol Hepatol,Expert review of gastroenterology & hepatology,101278199,,IM,"['Humans', '*Obesity/diagnosis/epidemiology/therapy', 'Forecasting', '*Life Style']",,['NOTNLM'],"['Obesity', 'SOPHIA', 'Shared-value', 'obesity stigma', 'obesity therapy', 'type 1 diabetes', 'type 2 diabetes']",,2023/10/04 12:42,2023/10/04 12:43,['2023/10/04 09:33'],"['2023/10/04 12:43 [medline]', '2023/10/04 12:42 [pubmed]', '2023/10/04 09:33 [entrez]']",['10.1080/17474124.2023.2264783 [doi]'],ppublish,Expert Rev Gastroenterol Hepatol. 2023 Jul-Dec;17(10):1031-1039. doi: 10.1080/17474124.2023.2264783. Epub 2023 Oct 24.,,20231024,,,,,,,,,,,,,,,,,,
10441935,NLM,MEDLINE,19990914,20191103,0098-6151 (Print) 0098-6151 (Linking),99,7,1999 Jul,Childhood obesity.,366-71,,"Childhood obesity has become one of the more alarming nutritional problems plaguing the American population, with estimates as high as 25% of all children being obese. Aside from obesity's associated risks, there are psychosocial and emotional burdens carried by obese children as well. Clinicians are encountering many of these children in their clinics everyday for other reasons and yet are failing to address the issue of obesity. The problem is not so much that physicians are not recognizing it, but rather that they are ignoring it, especially if the parent or child is unaware that there is a problem. Unfortunately, much controversy exists regarding the treatment of childhood obesity. This article attempts to sort through the myriad issues surrounding childhood obesity and to dispel some of the rumors and myths surrounding this subject.","['Holtz, C', 'Smith, T M', 'Winters, F D']","['Holtz C', 'Smith TM', 'Winters FD']","['Garden City Osteopathic Hospital, Mich., USA.']",['eng'],"['Journal Article', 'Review']",United States,J Am Osteopath Assoc,The Journal of the American Osteopathic Association,7503065,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Combined Modality Therapy', 'Female', 'Humans', 'Incidence', 'Male', 'Obesity/epidemiology/*etiology/*therapy', 'Prognosis', 'Risk Factors', 'United States/epidemiology']",,,,,1999/08/12 00:00,1999/08/12 00:01,['1999/08/12 00:00'],"['1999/08/12 00:00 [pubmed]', '1999/08/12 00:01 [medline]', '1999/08/12 00:00 [entrez]']",['10.7556/jaoa.1999.99.7.366 [doi]'],ppublish,J Am Osteopath Assoc. 1999 Jul;99(7):366-71. doi: 10.7556/jaoa.1999.99.7.366.,,,,,,,33,['J Am Osteopath Assoc. 1999 Jul;99(7):357. PMID: 10441933'],,,,,,,,,,,,
9919427,NLM,MEDLINE,19990318,20191102,0045-9380 (Print) 0045-9380 (Linking),29,1,1999 Jan,Childhood obesity.,1-29,,"Approximately 10% of children are obese. Twin and adoption studies demonstrate a large genetic component to obesity, especially in adults. However, the increasing prevalence of obesity over the last 20 years can only be explained by environmental factors. In most obese individuals, no measurable differences in metabolism can be detected. Few children engage in regular physical activity. Obese children and adults uniformly underreport the amount of food they eat. Obesity is particularly related to increased consumption of high-fat foods. BMI is a quick and easy way to screen for childhood obesity. Treating childhood obesity relies on positive family support and lifestyle changes involving the whole family. Food preferences are influenced early by parental eating habits, and when developed in childhood, they tend to remain fairly constant into adulthood. Children learn to be active or inactive from their parents. In addition, physical activity (or more commonly, physical inactivity) habits that are established in childhood tend to persist into adulthood. Weight loss is usually followed by changes in appetite and metabolism, predisposing individuals to regain their weight. However, when the right family dynamics exist--a motivated child with supportive parents--long-term success is possible.","['Strauss, R']",['Strauss R'],"['Division of Pediatric GI and Nutrition, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA.']",['eng'],"['Journal Article', 'Review']",United States,Curr Probl Pediatr,Current problems in pediatrics,1272515,,IM,"['Adolescent', 'Appetite', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Male', '*Obesity/complications/diagnosis/epidemiology/etiology/therapy', 'Physical Examination', 'Prevalence', 'Socioeconomic Factors']",,,,,1999/01/27 00:00,1999/01/27 00:01,['1999/01/27 00:00'],"['1999/01/27 00:00 [pubmed]', '1999/01/27 00:01 [medline]', '1999/01/27 00:00 [entrez]']","['S0045-9380(99)80011-5 [pii]', '10.1016/s0045-9380(99)80011-5 [doi]']",ppublish,Curr Probl Pediatr. 1999 Jan;29(1):1-29. doi: 10.1016/s0045-9380(99)80011-5.,,,,,,,251,,,,,,,,,,,,,
34169900,NLM,MEDLINE,20211022,20211112,1998-4049 (Electronic) 1319-3767 (Print) 1319-3767 (Linking),27,4,2021 Jul-Aug,"Obesity in inflammatory bowel disease: A review of its role in the pathogenesis, natural history, and treatment of IBD.",183-190,10.4103/sjg.sjg_30_21 [doi],"In contrast to previous perceptions that inflammatory bowel disease (IBD) patients are generally malnourished and underweight, there is mounting evidence to suggest that rates of obesity in IBD now mirror that of the general population. IBD is an immune-mediated condition that appears to develop in individuals who have not only a genetic predisposition to immune dysregulation but also likely exposure to various environmental factors which further potentiate this risk. With the surge in obesity alongside the rising incidence of IBD, particularly in developing nations, the role that obesity may play, not only in the pathogenesis but also in the natural history of disease has become a topic of growing interest. Currently available data exploring obesity's impact on the natural history of IBD are largely conflicting, potentially limited by the use of body mass index as a surrogate measure of obesity at varying time points throughout the disease course. While there are pharmacokinetic data to suggest possible detrimental effects that obesity may have on the response to medical therapy, results in this realm are also inconsistent. Moreover, not only is it unclear whether weight loss improves IBD outcomes, little is known about the safety and efficacy of available weight-loss strategies in this population. For these reasons, it becomes increasingly important to further understand the nature of any interaction between obesity and IBD.","['Johnson, Amanda M', 'Loftus, Edward V']","['Johnson AM', 'Loftus EV']","['Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, USA.', 'Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN, USA.']",['eng'],"['Journal Article', 'Review']",India,Saudi J Gastroenterol,Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association,9516979,,IM,"['Body Mass Index', '*Colitis, Ulcerative', 'Humans', '*Inflammatory Bowel Diseases/epidemiology', 'Obesity/complications/epidemiology', 'Risk Factors']",PMC8448008,['NOTNLM'],"[""Crohn's disease"", 'inflammatory bowel disease', 'obesity', 'ulcerative colitis']",['None'],2021/06/26 06:00,2021/11/16 06:00,['2021/06/25 08:42'],"['2021/06/26 06:00 [pubmed]', '2021/11/16 06:00 [medline]', '2021/06/25 08:42 [entrez]']","['319164 [pii]', 'SJG-27-183 [pii]', '10.4103/sjg.sjg_30_21 [doi]']",ppublish,Saudi J Gastroenterol. 2021 Jul-Aug;27(4):183-190. doi: 10.4103/sjg.sjg_30_21.,,,,,,,,['Saudi J Gastroenterol. 2021 Sep-Oct;27(5):316. PMID: 34472446'],,,,,,,,,,,,
37509120,NLM,MEDLINE,20230731,20230801,2218-273X (Electronic) 2218-273X (Linking),13,7,2023 Jul 6,Leptin: A Heavyweight Player in Obesity-Related Cancers.,,10.3390/biom13071084 [doi] 1084,"Obesity, defined as the abnormal or excessive expansion of white adipose tissue, has reached pandemic proportions and is recognized as an important health concern since it is a common root for several comorbidities, including malignancies. Indeed, the current knowledge of the white adipose tissue, which shifts its role from an energy storage tissue to an important endocrine and metabolic organ, has opened up new avenues for the discovery of obesity's effects on tumor biology. In this review, we will report the epidemiological studies concerning the strong impact of obesity in several types of cancer and describe the mechanisms underlying the heterotypic signals between cancer cell lines and adipocytes, with particular emphasis on inflammation, the insulin/IGF-1 axis, and adipokines. Among the adipokines, we will further describe the in vitro, in vivo, and clinical data concerning the role of leptin, recognized as one of the most important mediators of obesity-associated cancers. In fact, leptin physiologically regulates energy metabolism, appetite, and reproduction, and several studies have also described the role of leptin in affecting cancer development and progression. Finally, we will summarize the newest pharmacological strategies aimed at mitigating the protumorigenic effects of leptin, underlining their mechanisms of action.","['Caruso, Amanda', 'Gelsomino, Luca', 'Panza, Salvatore', 'Accattatis, Felice Maria', 'Naimo, Giuseppina Daniela', 'Barone, Ines', 'Giordano, Cinzia', 'Catalano, Stefania', 'Ando, Sebastiano']","['Caruso A', 'Gelsomino L', 'Panza S', 'Accattatis FM', 'Naimo GD', 'Barone I', 'Giordano C', 'Catalano S', 'Ando S']","['Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Centro Sanitario, Via P. Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Centro Sanitario, Via P. Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Centro Sanitario, Via P. Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Centro Sanitario, Via P. Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Department of Pharmacy, Health and Nutritional Sciences, Via P Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.', 'Centro Sanitario, Via P. Bucci, University of Calabria, Arcavacata di Rende (CS), 87036 Cosenza, Italy.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Switzerland,Biomolecules,Biomolecules,101596414,"['0 (Leptin)', '0 (Adipokines)']",IM,"['Humans', '*Leptin/metabolism', 'Adipose Tissue/metabolism', 'Obesity/complications/metabolism', 'Adipokines/metabolism', '*Neoplasms/metabolism']",PMC10377641,['NOTNLM'],"['breast cancer', 'cancers', 'cervical', 'colorectal', 'corpus uteri', 'glioma', 'leptin', 'lung', 'obesity', 'ovarian']",['The authors declare no conflict of interest.'],2023/07/29 11:53,2023/07/31 11:42,['2023/07/29 01:10'],"['2023/05/31 00:00 [received]', '2023/07/04 00:00 [revised]', '2023/07/05 00:00 [accepted]', '2023/07/31 11:42 [medline]', '2023/07/29 11:53 [pubmed]', '2023/07/29 01:10 [entrez]']","['biom13071084 [pii]', 'biomolecules-13-01084 [pii]', '10.3390/biom13071084 [doi]']",epublish,Biomolecules. 2023 Jul 6;13(7):1084. doi: 10.3390/biom13071084.,,20230706,,,['ORCID: 0000-0002-9769-1615'],,,,,,,,,,,,,,,
37191347,NLM,MEDLINE,20230531,20230603,1308-5735 (Electronic) 1308-5727 (Print),15,2,2023 May 29,Current Treatments for Patients with Genetic Obesity.,108-119,10.4274/jcrpe.galenos.2023.2023-3-2 [doi],"Obesity derives from impaired central control of body weight, implying interaction between environment and an individual genetic predisposition. Genetic obesities, including monogenic and syndromic obesities, are rare and complex neuro-endocrine pathologies where the genetic contribution is predominant. Severe and early-onset obesity with eating disorders associated with frequent comorbidities make these diseases challenging. Their current estimated prevalence of 5-10% in severely obese children is probably underestimated due to the limited access to genetic diagnosis. A central alteration of hypothalamic regulation of weight implies that the leptin-melanocortin pathway is responsible for the symptoms. The management of genetic obesity has so far been only based, above all, on lifestyle intervention, especially regarding nutrition and physical activity. New therapeutic options have emerged in the last years for these patients, raising great hope to manage their complex situation and improve quality of life. Implementation of genetic diagnosis in clinical practice is thus of paramount importance to allow individualized care. This review describes the current clinical management of genetic obesity and the evidence on which it is based. Some insights will also be provided into new therapies under evaluation.","['Faccioli, Nathan', 'Poitou, Christine', 'Clement, Karine', 'Dubern, Beatrice']","['Faccioli N', 'Poitou C', 'Clement K', 'Dubern B']","['Sorbonne Universite, Assistance Publique-Hopitaux de Paris, Department of Pediatric Nutrition and Gastroenterology, Trousseau Hospital, Paris, France', 'Sorbonne Universite, INSERM, Nutrition and Obesity: Systemic Approaches, NutriOmics, Research Unit, Paris, France', 'Reference Center for Rare Diseases (PRADORT, Prader-Willi Syndrome and Other Rare Forms of Obesity with Eating Behavior Disorders), Paris, France', 'Sorbonne Universite, INSERM, Nutrition and Obesity: Systemic Approaches, NutriOmics, Research Unit, Paris, France', 'Reference Center for Rare Diseases (PRADORT, Prader-Willi Syndrome and Other Rare Forms of Obesity with Eating Behavior Disorders), Paris, France', 'Sorbonne Universite, Assistance Publique-Hopitaux de Paris Nutrition Department, Pitie-Salpetriere Hospital, Paris, France', 'Sorbonne Universite, INSERM, Nutrition and Obesity: Systemic Approaches, NutriOmics, Research Unit, Paris, France', 'Reference Center for Rare Diseases (PRADORT, Prader-Willi Syndrome and Other Rare Forms of Obesity with Eating Behavior Disorders), Paris, France', 'Sorbonne Universite, Assistance Publique-Hopitaux de Paris Nutrition Department, Pitie-Salpetriere Hospital, Paris, France', 'Sorbonne Universite, Assistance Publique-Hopitaux de Paris, Department of Pediatric Nutrition and Gastroenterology, Trousseau Hospital, Paris, France', 'Sorbonne Universite, INSERM, Nutrition and Obesity: Systemic Approaches, NutriOmics, Research Unit, Paris, France', 'Reference Center for Rare Diseases (PRADORT, Prader-Willi Syndrome and Other Rare Forms of Obesity with Eating Behavior Disorders), Paris, France']",['eng'],"['Journal Article', 'Review']",Turkey,J Clin Res Pediatr Endocrinol,Journal of clinical research in pediatric endocrinology,101519456,,IM,"['Humans', 'Child', '*Quality of Life', '*Pediatric Obesity/genetics/therapy', 'Genetic Predisposition to Disease', 'Comorbidity']",PMC10234057,['NOTNLM'],"['Genetic obesity', 'syndromic obesity', 'personalized medicine', 'setmelanotide']",,2023/05/16 13:10,2023/05/31 06:42,['2023/05/16 08:36'],"['2023/05/31 06:42 [medline]', '2023/05/16 13:10 [pubmed]', '2023/05/16 08:36 [entrez]']","['60461 [pii]', '10.4274/jcrpe.galenos.2023.2023-3-2 [doi]']",ppublish,J Clin Res Pediatr Endocrinol. 2023 May 29;15(2):108-119. doi: 10.4274/jcrpe.galenos.2023.2023-3-2. Epub 2023 May 16.,,20230516,,"['(c)Copyright 2023 by Turkish Society for Pediatric Endocrinology and Diabetes | The', 'Journal of Clinical Research in Pediatric Endocrinology published by Galenos', 'Publishing House.']","['ORCID: 0000-0002-1230-5675', 'ORCID: 0000-0001-7769-6331', 'ORCID: 0000-0002-2489-3355', 'ORCID: 0000-0003-2614-7556']",,,,,,,,,,,,,,,
12442091,NLM,MEDLINE,20030212,20161031,0003-4266 (Print) 0003-4266 (Linking),63,5,2002 Oct,[Obesity and pregnancy].,470-5,,"As the prevalence of obesity is currently increasing in Western countries, maternal obesity is one of the most frequently encountered high-risk obstetrical situations. Pregnancies in obese women are characterized by a high incidence of maternal (gestational diabetes, hypertensive disorders) and fetal (macrosomia, neural tube defects, late fetal deaths) complications. Because of those complications, cesarean sections rate is higher in obese women than in lean women. The occurrence of materno-fetal complications parallels the level of obesity, but even moderate overweight amplifies the risk. Long-term complications include worsening of maternal obesity, type 2 diabetes in the mother, and development of childhood obesity. Prenatal care should include a tight monitoring of weight gain and screening for gestational diabetes. Long term follow-up is necessary.","['Galtier-Dereure, F', 'Bringer, J']","['Galtier-Dereure F', 'Bringer J']","['Service des Maladies Endocriniennes, Hopital Lapeyronie, CHU de Montpellier, 371, avenue du Doyen-Gaston-Giraud, 34295 Montpellier Cedex 5, France.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,,IM,"['Female', 'France/epidemiology', 'Humans', 'Kidney Diseases/etiology', 'Obesity/complications/epidemiology/*physiopathology/prevention & control', 'Pregnancy', 'Pregnancy Complications/*physiopathology', 'Prevalence']",,,,,2002/11/21 04:00,2003/02/14 04:00,['2002/11/21 04:00'],"['2002/11/21 04:00 [pubmed]', '2003/02/14 04:00 [medline]', '2002/11/21 04:00 [entrez]']",['MDOI-AE-10-2002-63-5-0003-4266-101019-ART3 [pii]'],ppublish,Ann Endocrinol (Paris). 2002 Oct;63(5):470-5.,,,,,,,47,,Obesite et grossesse.,,,,,,,,,,,
35164764,NLM,MEDLINE,20220216,20231102,1423-0127 (Electronic) 1021-7770 (Print) 1021-7770 (Linking),29,1,2022 Feb 14,The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy.,12,10.1186/s12929-022-00796-0 [doi] 12,"Obesity is nowadays considered a pandemic which prevalence's has been steadily increasingly in western countries. It is a dynamic, complex, and multifactorial disease which propitiates the development of several metabolic and cardiovascular diseases, as well as cancer. Excessive adipose tissue has been causally related to cancer progression and is a preventable risk factor for overall and cancer-specific survival, associated with poor prognosis in cancer patients. The onset of obesity features a state of chronic low-grade inflammation and secretion of a diversity of adipocyte-derived molecules (adipokines, cytokines, hormones), responsible for altering the metabolic, inflammatory, and immune landscape. The crosstalk between adipocytes and tumor cells fuels the tumor microenvironment with pro-inflammatory factors, promoting tissue injury, mutagenesis, invasion, and metastasis. Although classically established as a risk factor for cancer and treatment toxicity, recent evidence suggests mild obesity is related to better outcomes, with obese cancer patients showing better responses to treatment when compared to lean cancer patients. This phenomenon is termed obesity paradox and has been reported in different types and stages of cancer. The mechanisms underlying this paradoxical relationship between obesity and cancer are still not fully described but point to systemic alterations in metabolic fitness and modulation of the tumor microenvironment by obesity-associated molecules. Obesity impacts the response to cancer treatments, such as chemotherapy and immunotherapy, and has been reported as having a positive association with immune checkpoint therapy. In this review, we discuss obesity's association to inflammation and cancer, also highlighting potential physiological and biological mechanisms underlying this association, hoping to clarify the existence and impact of obesity paradox in cancer development and treatment.","['Assumpcao, Jose Antonio Fagundes', 'Pasquarelli-do-Nascimento, Gabriel', 'Duarte, Mariana Saldanha Viegas', 'Bonamino, Martin Hernan', 'Magalhaes, Kelly Grace']","['Assumpcao JAF', 'Pasquarelli-do-Nascimento G', 'Duarte MSV', 'Bonamino MH', 'Magalhaes KG']","['Laboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, Brasilia, DF, Brazil.', 'Laboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, Brasilia, DF, Brazil.', 'Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.', 'Immunology and Tumor Biology Program - Research Coordination, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.', 'Vice - Presidency of Research and Biological Collections (VPPCB), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil.', 'Laboratory of Immunology and Inflammation, Department of Cell Biology, University of Brasilia, Brasilia, DF, Brazil. kellymagalhaes@unb.br.']",['eng'],"['Journal Article', 'Review']",England,J Biomed Sci,Journal of biomedical science,9421567,['0 (Adipokines)'],IM,"['Adipocytes', 'Adipokines', 'Adipose Tissue', 'Humans', 'Immunotherapy', 'Inflammation', '*Neoplasms/complications/therapy', '*Obesity/complications', 'Tumor Microenvironment']",PMC8842976,['NOTNLM'],"['Adipose tissue', 'Cancer', 'Immunotherapy', 'Inflammation', 'Obesity']",['The authors declare that they have no competing interests.'],2022/02/16 06:00,2022/02/17 06:00,['2022/02/15 05:31'],"['2021/11/19 00:00 [received]', '2022/02/07 00:00 [accepted]', '2022/02/15 05:31 [entrez]', '2022/02/16 06:00 [pubmed]', '2022/02/17 06:00 [medline]']","['10.1186/s12929-022-00796-0 [pii]', '796 [pii]', '10.1186/s12929-022-00796-0 [doi]']",epublish,J Biomed Sci. 2022 Feb 14;29(1):12. doi: 10.1186/s12929-022-00796-0.,,20220214,,['(c) 2022. The Author(s).'],['ORCID: 0000-0002-7435-5272'],,,,,,,,,,,,,,,
29426061,NLM,MEDLINE,20190321,20190321,1467-789X (Electronic) 1467-7881 (Linking),19,6,2018 Jun,Microbiome-based mechanisms hypothesized to initiate obesity-associated rheumatoid arthritis.,786-797,10.1111/obr.12671 [doi],"Worldwide, the growing obesity pandemic contributes to a range of chronic diseases. Recent epidemiological studies have suggested an association between obesity and the development of rheumatoid arthritis (RA), particularly among young women, whereby pro-inflammatory effects of adipokines provide one explanatory hypothesis. Yet, recent clinical and laboratory-based studies provide emerging evidence indicating microbiome involvement in RA initiation and development, including anti-citrullinated antibody formation and Th17 cell activation. Obesity and RA-associated microbiome alteration might provide a plausible link to address the impact of obesity to RA pathogenesis. The microbiome's influence on RA development - at mucosal as well as articular sites - and relevant pathophysiological mechanisms regarding obesity's association with RA are presented herein to discuss this hypothesis and aid understanding of obesity's role in RA development.","['Luo, Y', 'Blackledge, W C']","['Luo Y', 'Blackledge WC']","['Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.', 'Tulsa, OK, 74133, USA.']",['eng'],"['Journal Article', 'Review']",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['Animals', 'Arthritis, Rheumatoid/*etiology/microbiology', 'Humans', '*Microbiota', 'Obesity/*complications/microbiology', 'Th17 Cells/*microbiology']",,['NOTNLM'],"['bone niche', 'microbiome', 'prevention', 'rheumatoid arthritis (RA)']",,2018/02/10 06:00,2019/03/22 06:00,['2018/02/10 06:00'],"['2017/09/26 00:00 [received]', '2017/12/11 00:00 [revised]', '2017/12/18 00:00 [accepted]', '2018/02/10 06:00 [pubmed]', '2019/03/22 06:00 [medline]', '2018/02/10 06:00 [entrez]']",['10.1111/obr.12671 [doi]'],ppublish,Obes Rev. 2018 Jun;19(6):786-797. doi: 10.1111/obr.12671. Epub 2018 Feb 9.,,20180209,,['(c) 2018 World Obesity Federation.'],,,,,,,,,,,,,,,,
27043948,NLM,MEDLINE,20170406,20181113,1590-1262 (Electronic) 1124-4909 (Linking),21,2,2016 Jun,Obesity or obesities? Controversies on the association between body mass index and premature mortality.,165-74,10.1007/s40519-016-0278-4 [doi],"Obesity is still defined on the basis of body mass index (BMI) and BMI in itself is generally accepted as a strong predictor of overall early mortality. However, an inverse association between BMI and mortality has been reported in patients with many disease states and in several clinical settings: hemodialysis, cardiovascular diseases, hypertension, stroke, diabetes, chronic obstructive pulmonary disease, surgery, etc. This unexpected phenomenon is usually called obesity-survival paradox (OP). The contiguous concepts of metabolically healthy obesity (MHO, a phenotype having BMI >/= 30 but not having any metabolic syndrome component and having a homeostasis model assessment of insulin resistance, HOMA, <2.5) and metabolically obese normal weight (MONW, normal-weight individuals displaying obesity-related phenotypic characteristics) have received a great deal of attention in recent years. The interactions that link MHO, MONW and OP with body composition, fat distribution, aging and cardiorespiratory fitness are other crucial areas of research. The article is an introductory narrative overview of the origin and current use of the concepts of MHO, MONW and OP. These phenomena are very controversial and appear as a consequence of the frail current diagnostic definition of obesity based only on BMI. A new commonly established characterization and classification of obesities based on a number of variables is needed urgently.","['Bosello, Ottavio', 'Donataccio, Maria Pia', 'Cuzzolaro, Massimo']","['Bosello O', 'Donataccio MP', 'Cuzzolaro M']","['Department of Medicine, Gerontology Unit, University of Verona, 37126, Verona, Italy.', 'Department of Medicine, Division of Cardiology, University of Verona, 37126, Verona, Italy.', 'Formerly Experimental Medicine Department, Medical Pathophysiology Section, Sapienza University of Rome, 57021, Campiglia Marittima, LI, Italy. massimo.cuzzolaro@gmail.com.']",['eng'],"['Journal Article', 'Review']",Germany,Eat Weight Disord,Eating and weight disorders : EWD,9707113,,IM,"['*Body Mass Index', 'Humans', '*Insulin Resistance', 'Metabolic Syndrome/metabolism/*mortality', 'Mortality, Premature', 'Obesity/metabolism/*mortality']",,['NOTNLM'],"['Body mass index', 'Metabolically healthy obesity', 'Metabolically obese normal weight', 'Obesity', 'Obesity paradox']",,2016/04/05 06:00,2017/04/07 06:00,['2016/04/05 06:00'],"['2016/04/05 06:00 [entrez]', '2016/04/05 06:00 [pubmed]', '2017/04/07 06:00 [medline]']","['10.1007/s40519-016-0278-4 [pii]', '10.1007/s40519-016-0278-4 [doi]']",ppublish,Eat Weight Disord. 2016 Jun;21(2):165-74. doi: 10.1007/s40519-016-0278-4.,,,,,['ORCID: 0000-0002-4961-9512'],,,,,,,,,,,,,,,
21470937,NLM,MEDLINE,20120130,20220310,1877-783X (Electronic) 1877-7821 (Linking),35,4,2011 Aug,"Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets.",309-19,10.1016/j.canep.2011.03.001 [doi],"BACKGROUND: Rates of distal and junctional adenocarcinomas are increasing in Western countries. METHODS: Systematic review of epidemiological evidence linking obesity to esophageal adenocarcinoma (EA) was performed for studies published from 2005 to 2010. The current understanding of obesity's role in the etiology and potential dysplastic progression of Barrett's esophagus (BE) to EA is reviewed. RESULTS: Accumulating epidemiological studies provide evidence of obesity's role as a driving force behind the increasing rates of EA. The simplest construct is that obesity promotes reflux, causing chronic inflammation and BE, predisposing to adenocarcinoma. However, as obesity is positively associated with the prevalence of many cancers, other mechanisms are important. A link may exist between fat distribution patterns and the risk of BE and EA. Altered metabolic profiles in the metabolic syndrome (MetS) may be a key factor in cell cycle/genetic abnormalities that mark the progression of BE towards cancer. Research highlighting a unique role of MetS in the length of BE, and its association with systemic inflammation and insulin resistance is discussed, as well as adipokine receptor expression in both BE and esophageal epithelium, and how MetS and the systemic response impacts on key regulators of inflammation and tumorigenesis. CONCLUSIONS/IMPACT: Obesity is positively associated with EA. The systemic inflammatory state consequent on the altered metabolism of obese patients, and the associated impact of adipocytokines and pro-coagulant factors released by adipocytes in central fat, may underlie obesity's relationship to this cancer. Novel therapeutic agents that may antagonize adipo-cytokines and potentially offer a promising role in cancer therapy are discussed.","['Ryan, Aoife M', 'Duong, Michelle', 'Healy, Laura', 'Ryan, Stephen A', 'Parekh, Niyati', 'Reynolds, John V', 'Power, Derek G']","['Ryan AM', 'Duong M', 'Healy L', 'Ryan SA', 'Parekh N', 'Reynolds JV', 'Power DG']","['Department of Nutrition, Food Studies & Public Health, New York University, New York, NY 10044, USA. aoife.ryan1@gmail.com']",['eng'],"['Journal Article', 'Review', 'Systematic Review']",Netherlands,Cancer Epidemiol,Cancer epidemiology,101508793,,IM,"['Adenocarcinoma/*epidemiology/etiology', 'Cohort Studies', 'Esophageal Neoplasms/*epidemiology/etiology', 'Humans', 'Metabolic Syndrome/*epidemiology/etiology', 'Obesity/*epidemiology/etiology', 'Prospective Studies']",,,,,2011/04/08 06:00,2012/01/31 06:00,['2011/04/08 06:00'],"['2010/09/09 00:00 [received]', '2011/02/24 00:00 [revised]', '2011/03/03 00:00 [accepted]', '2011/04/08 06:00 [entrez]', '2011/04/08 06:00 [pubmed]', '2012/01/31 06:00 [medline]']","['S1877-7821(11)00049-X [pii]', '10.1016/j.canep.2011.03.001 [doi]']",ppublish,Cancer Epidemiol. 2011 Aug;35(4):309-19. doi: 10.1016/j.canep.2011.03.001. Epub 2011 Apr 5.,,20110405,,['Copyright (c) 2011 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
32103702,NLM,MEDLINE,20210601,20210721,1753-4666 (Electronic) 1753-4658 (Print) 1753-4658 (Linking),14,,2020 Jan-Dec,Optimizing lifestyle interventions in adult patients with comorbid asthma and obesity.,1753466620906323,10.1177/1753466620906323 [doi] 1753466620906323,"The prevalence of obesity and asthma are both increasing at alarming rates. The link between obesity and asthma suggests that obesity contributes to both risk of new onset asthma and increased asthma severity. The emerging evidence demonstrating the role of obesity and other lifestyle factors, such as diet and physical activity, on asthma outcomes warrants lifestyle interventions that can address these components of asthma care. This review examines the current literature on the pathophysiology of obesity's role in asthma, as well as the role of diet and physical activity in weight loss and in asthma outcomes. We discuss recent studies that employ lifestyle interventions to target improved asthma outcomes. Finally, we discuss the future direction of research in this area. The reviews of this paper are available via the supplemental material section.","['Kuder, Margaret M', 'Nyenhuis, Sharmilee M']","['Kuder MM', 'Nyenhuis SM']","['Department of Allergy and Immunology, Cleveland Clinic, Cleveland, OH, USA.', 'Division of Pulmonary, Critical Care, Sleep and Allergy, Affiliate Faculty, Center for Dissemination and Implementation Science, University of Illinois at Chicago, 840 S. Wood St. MC 719, Chicago, IL 60612, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",England,Ther Adv Respir Dis,Therapeutic advances in respiratory disease,101316317,,IM,"['Animals', 'Asthma/diagnosis/epidemiology/physiopathology/*therapy', 'Comorbidity', 'Diet, Healthy', 'Exercise', '*Healthy Lifestyle', 'Humans', 'Lung/*physiopathology', 'Obesity/diagnosis/epidemiology/physiopathology/*therapy', 'Prevalence', '*Risk Reduction Behavior', 'Treatment Outcome', 'Weight Loss']",PMC7047422,['NOTNLM'],"['adult', 'asthma', 'lifestyle interventions', 'obesity']","['Conflict of interest statement: The authors declare no conflicts of interest in', 'preparing this article.']",2020/02/28 06:00,2021/06/02 06:00,['2020/02/28 06:00'],"['2020/02/28 06:00 [entrez]', '2020/02/28 06:00 [pubmed]', '2021/06/02 06:00 [medline]']","['10.1177_1753466620906323 [pii]', '10.1177/1753466620906323 [doi]']",ppublish,Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620906323. doi: 10.1177/1753466620906323.,['K01 HL133370/HL/NHLBI NIH HHS/United States'],,,,['ORCID: 0000-0002-7381-9733'],,,,,,,,,,,,,,,
2658285,NLM,MEDLINE,19890627,20190912,0195-5616 (Print) 0195-5616 (Linking),19,3,1989 May,"Obesity: occurrence, treatment, and prevention.",447-74,,"Obesity is the most common nutritionally related disease of dogs and cats. Several of the important health problems that are inherent with obesity are resolved when the patient's body weight is returned to normal. Proper dietary management is central to successful treatment and prevention. Low-fat, high-fiber diets provide fewer available calories but induce a greater degree of satiety than simple restriction of the obese patient's regular food. Care must be taken to assure that overweight cats are not fasted, because preliminary reports indicate an alarming association between severe caloric restriction and hepatic lipidosis in obese cats. Obesity prevention should ideally be proactive, owing to the predictability of obesity in certain groups of pets. The large number of reduced-energy maintenance type diets that are available for obesity prevention facilitate this goal.","['Hand, M S', 'Armstrong, P J', 'Allen, T A']","['Hand MS', 'Armstrong PJ', 'Allen TA']","['Department of Professional Education, Mark Morris Associates, Topeka, Kansas.']",['eng'],"['Journal Article', 'Review']",United States,Vet Clin North Am Small Anim Pract,The Veterinary clinics of North America. Small animal practice,7809942,,IM,"['Animals', 'Cat Diseases/*epidemiology/prevention & control/therapy', 'Cats', 'Dog Diseases/*epidemiology/prevention & control/therapy', 'Dogs', 'Obesity/complications/epidemiology/prevention & control/therapy/*veterinary']",,,,,1989/05/01 00:00,1989/05/01 00:01,['1989/05/01 00:00'],"['1989/05/01 00:00 [pubmed]', '1989/05/01 00:01 [medline]', '1989/05/01 00:00 [entrez]']","['S0195-5616(89)50055-X [pii]', '10.1016/s0195-5616(89)50055-x [doi]']",ppublish,Vet Clin North Am Small Anim Pract. 1989 May;19(3):447-74. doi: 10.1016/s0195-5616(89)50055-x.,,,,,,,112,,,,,,,,,,,,,
16929130,NLM,MEDLINE,20061018,20200511,0302-5144 (Print) 0302-5144 (Linking),151,,2006,Obesity and chronic kidney disease.,1-18,10.1159/000095315 [doi],"BACKGROUND/AIMS: The prevalence of obesity among U.S. adults has doubled within the past two decades, and if trends continue, over one-third of U.S. adults may be obese by the year 2008. Concurrent with the rising prevalence of obesity is an epidemic of chronic kidney disease (CKD) with an estimated 18 million U.S. adults currently affected. This review discusses the strong and consistent association between CKD risk and increasing body mass index noted in several observational studies. Potential mechanisms for obesity's role in the development and progression of CKD and secondary focal segmental glomerulosclerosis are also discussed. METHODS: Literature review. RESULTS: Although obesity is an important risk factor for diabetes and hypertension, the two most common etiologies of kidney failure, obesity itself may increase CKD risk by increasing the metabolic demands on the kidney, which leads to higher glomerular capillary pressures and glomerular hypertrophy. The hyperinsulinemia frequently linked with obesity may also accelerate structural damage by interacting with angiotensin II and increasing collagen production and deposition. The histologic changes in the kidney noted in some obese, especially morbidly obese, adults frequently mimic those changes associated with secondary focal segmental glomerulosclerosis, which may occur in disease states such as severely reduced nephron mass and hemodynamic stress. Given the presence of genetic susceptibility and/or reduced nephron mass, obesity may potentiate the development and progression of secondary focal segmental glomerulosclerosis. CONCLUSIONS: Obesity is an important risk factor for CKD. Treatment plans for obese adults with CKD should include weight loss and exercise because these interventions may simultaneously reduce the metabolic demands on the kidney, lower systemic and glomerular pressures, and improve insulin sensitivity. However, more studies are needed to further optimize the treatment and prevention of CKD associated with obesity.","['Kramer, Holly']",['Kramer H'],"['Loyola University Medical Center, Maywood, Ill., USA.']",['eng'],"['Journal Article', 'Review']",Switzerland,Contrib Nephrol,Contributions to nephrology,7513582,,IM,"['Humans', 'Kidney Failure, Chronic/*epidemiology', 'Obesity/*epidemiology', 'Prevalence', 'Risk Factors', 'United States/epidemiology']",,,,,2006/08/25 09:00,2006/10/19 09:00,['2006/08/25 09:00'],"['2006/08/25 09:00 [pubmed]', '2006/10/19 09:00 [medline]', '2006/08/25 09:00 [entrez]']","['000095315 [pii]', '10.1159/000095315 [doi]']",ppublish,Contrib Nephrol. 2006;151:1-18. doi: 10.1159/000095315.,,,,,,,97,,,,,,,,,,,,,
6123814,NLM,MEDLINE,19820826,20150616,0140-6736 (Print) 0140-6736 (Linking),2,8289,1982 Jul 10,Virally-induced obesity.,79-80,,,,,,['eng'],['Editorial'],England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Animals', 'Humans', 'Measles virus', 'Mice', 'Mice, Obese/microbiology', 'Obesity/*etiology/metabolism/physiopathology', 'Rats', '*Virus Diseases']",,,,,1982/07/10 00:00,1982/07/10 00:01,['1982/07/10 00:00'],"['1982/07/10 00:00 [pubmed]', '1982/07/10 00:01 [medline]', '1982/07/10 00:00 [entrez]']",['S0140-6736(82)91696-8 [pii]'],ppublish,Lancet. 1982 Jul 10;2(8289):79-80.,,,,,,,,,,,,,,,,,,,,
27422122,NLM,MEDLINE,20170130,20181113,1534-312X (Electronic) 1522-8037 (Linking),18,9,2016 Sep,The Critical Care Obesity Paradox and Implications for Nutrition Support.,45,10.1007/s11894-016-0519-8 [doi],"Obesity is a leading cause of preventable death worldwide. The prevalence of obesity has been increasing and is associated with an increased risk for other co-morbidities. In the critical care setting, nearly one third of patients are obese. Obese critically ill patients pose significant physical and on-physical challenges to providers, including optimization of nutrition therapy. Intuitively, obese patients would have worse critical care-related outcome. On the contrary, emerging data suggests that critically ill obese patients have improved outcomes, and this phenomenon has been coined ""the obesity paradox."" The purposes of this review will be to outline the historical views and pathophysiology of obesity and epidemiology of obesity, describe the challenges associated with obesity in the intensive care unit setting, review critical care outcomes in the obese, define the obesity-critical care paradox, and identify the challenges and role of nutrition support in the critically ill obese patient.","['Patel, Jayshil J', 'Rosenthal, Martin D', 'Miller, Keith R', 'Codner, Panna', 'Kiraly, Laszlo', 'Martindale, Robert G']","['Patel JJ', 'Rosenthal MD', 'Miller KR', 'Codner P', 'Kiraly L', 'Martindale RG']","['Division of Pulmonary & Critical Care Medicine, Department of Medicine, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Suite E5200 Pulmonary & Critical Care Medicine, Milwaukee, WI, 53226, USA. jpatel2@mcw.edu.', 'Department of Surgery, University of Florida, Gainesville, FL, USA.', 'Division of Trauma Surgery, Department of Surgery, University of Louisville, Louisville, KY, USA.', 'Division of Trauma Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA.', 'Division of Trauma Surgery, Department of Surgery, Oregon Health Science University, Portland, OR, USA.', 'Division of General Surgery, Department of Surgery, Oregon Health Science University, Portland, OR, USA.']",['eng'],"['Journal Article', 'Review']",United States,Curr Gastroenterol Rep,Current gastroenterology reports,100888896,,IM,"['Comorbidity', 'Critical Care/*methods', 'Critical Illness/therapy', 'Enteral Nutrition/methods', 'Humans', 'Nutritional Support/*methods', 'Obesity/complications/epidemiology/physiopathology/*therapy', 'Parenteral Nutrition/methods']",,['NOTNLM'],"['Critical care', 'Enteral nutrition', 'Intensive care', 'Nutrition', 'Obesity', 'Parenteral nutrition', 'Permissive underfeeding']",,2016/07/17 06:00,2017/01/31 06:00,['2016/07/17 06:00'],"['2016/07/17 06:00 [entrez]', '2016/07/17 06:00 [pubmed]', '2017/01/31 06:00 [medline]']","['10.1007/s11894-016-0519-8 [pii]', '10.1007/s11894-016-0519-8 [doi]']",ppublish,Curr Gastroenterol Rep. 2016 Sep;18(9):45. doi: 10.1007/s11894-016-0519-8.,,,,,,,,,,,,,,,,,,,,
8982059,NLM,MEDLINE,19970123,20191101,0011-5029 (Print) 0011-5029 (Linking),42,12,1996 Dec,Obesity: evaluation and treatment.,829-73,,"Obesity as a chronic condition among large numbers of people is a disease of recent origin, often but by no means always associated with dietary habits and sedentary lifestyle. Many obese people want to lose weight, and may have tried to do so numerous times with self-help or proprietary weight-loss programs. When they seek a physician for help in losing weight-or when a physician advises an obese patient to lose weight as part of a clinical strategy-care must be taken to ""match"" the patient to an appropriate therapeutic program with appropriate therapeutic goals. History and physical examination and psychologic evaluation are essential elements of patient screening. Complications of obesity must be taken into account in any treatment plan. The multidisciplinary management strategy is most likely to succeed in helping the patient lose weight. It also avoids untoward events associated with complications or concomitant disease. The multidisciplinary approach is especially important when the patient does not lose weight, and alternative strategies must be considered, such as surgical approaches.","['Blocker, W P Jr', 'Ostermann, H J']","['Blocker WP Jr', 'Ostermann HJ']","['Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, USA.']",['eng'],"['Journal Article', 'Review']",United States,Dis Mon,Disease-a-month : DM,0370657,['0 (Anti-Obesity Agents)'],IM,"['Anti-Obesity Agents/therapeutic use', 'Humans', 'Obesity/complications/diagnosis/physiopathology/*therapy', 'Obesity, Morbid/therapy', 'Treatment Failure', 'Weight Loss']",,,,,1996/12/01 00:00,2001/03/28 10:01,['1996/12/01 00:00'],"['1996/12/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1996/12/01 00:00 [entrez]']","['S0011-5029(96)80001-0 [pii]', '10.1016/s0011-5029(96)80001-0 [doi]']",ppublish,Dis Mon. 1996 Dec;42(12):829-73. doi: 10.1016/s0011-5029(96)80001-0.,,,,,,,93,,,,,,,,,,,,,
2315241,NLM,MEDLINE,19900418,20190713,0032-5481 (Print) 0032-5481 (Linking),87,4,1990 Mar,Childhood obesity.,"123-30, 133",,"More effort should be invested in preventing obesity than is currently practiced, because prevention is much more successful than treatment, in either children or adults. Most obese children or adults. Most obese children have exogenous obesity, which is caused by increased caloric intake, reduced energy output, or overly efficient calorie utilization. These children are often tall for their age and have advanced bone age. Obesity in childhood is strongly associated with obesity in adulthood. The relationship between infantile obesity and obesity in childhood is less clear. Preventive measures in infants may include promotion of breastfeeding and delay in introduction of solid foods. Treatment in children includes abolition of junk foods and reduction in saturated fat in the diet and encouragement of regular physical exercise.","['Leung, A K', 'Robson, W L']","['Leung AK', 'Robson WL']","[""Alberta Children's Hospital, Calgary, Canada.""]",['eng'],['Journal Article'],England,Postgrad Med,Postgraduate medicine,0401147,,IM,"['Child', 'Female', 'Humans', 'Male', '*Obesity/diagnosis/etiology/therapy']",,,,,1990/03/01 00:00,1990/03/01 00:01,['1990/03/01 00:00'],"['1990/03/01 00:00 [pubmed]', '1990/03/01 00:01 [medline]', '1990/03/01 00:00 [entrez]']",['10.1080/00325481.1990.11704600 [doi]'],ppublish,"Postgrad Med. 1990 Mar;87(4):123-30, 133. doi: 10.1080/00325481.1990.11704600.",,,,,,,,,,,,,,,,,,,,
26696274,NLM,MEDLINE,20161013,20191109,1526-4564 (Electronic) 1526-4564 (Linking),34,1,2016 Jan,A Focused Look at Obesity and the Preimplantation Trophoblast.,5-10,10.1055/s-0035-1570032 [doi],"Obesity is associated with a myriad of adverse reproductive outcomes including miscarriage, fetal growth abnormalities, and preeclampsia. While the mechanisms involved are likely multifactorial, the potential impact of obesity on the preimplantation embryonic trophoblast cannot be overlooked-particularly given the role the trophoblast plays in endometrial invasion and implantation. Appropriate trophoblast function is critical in establishing a normal pregnancy. Insufficient or impaired trophoblast invasion is associated with early miscarriage, fetal growth abnormalities, and preeclampsia. Thus, any negative impact obesity may impose on the trophoblast may represent a root cause for several adverse reproductive outcomes seen more commonly among obese women. While little is known about obesity's specific impact on the human trophoblast, in vitro studies and animal models provide insight. In this article, we review what is known on this topic and provide a basis for future work, investigating therapeutic targets for improved reproductive outcomes in the setting of maternal obesity.","['Broughton, Darcy E', 'Jungheim, Emily S']","['Broughton DE', 'Jungheim ES']","['Department of Obstetrics and Gynecology, Washington University, St. Louis, Missouri.', 'Department of Obstetrics and Gynecology, Washington University, St. Louis, Missouri.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Semin Reprod Med,Seminars in reproductive medicine,100909394,,IM,"['Blastocyst/*physiology', 'Embryo, Mammalian/physiology', 'Endometrium/physiopathology', 'Female', 'Fertilization in Vitro', 'Humans', 'Obesity/*physiopathology/therapy', 'Oocytes/physiology', 'Pregnancy', 'Pregnancy Complications/*physiopathology/therapy', 'Pregnancy Outcome', 'Trophoblasts/*physiology']",,,,,2015/12/24 06:00,2016/10/14 06:00,['2015/12/24 06:00'],"['2015/12/24 06:00 [entrez]', '2015/12/24 06:00 [pubmed]', '2016/10/14 06:00 [medline]']",['10.1055/s-0035-1570032 [doi]'],ppublish,Semin Reprod Med. 2016 Jan;34(1):5-10. doi: 10.1055/s-0035-1570032. Epub 2015 Dec 22.,"['UL1 TR000448/TR/NCATS NIH HHS/United States', 'UL1TR000448/TR/NCATS NIH HHS/United States', 'K12 HD063086/HD/NICHD NIH HHS/United States']",20151222,,"['Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.']",,,,,,,,,,,,,,,,
12090366,NLM,MEDLINE,20020731,20220316,0022-006X (Print) 0022-006X (Linking),70,3,2002 Jun,Obesity: responding to the global epidemic.,510-25,,"Obesity has reached epidemic proportions in the United States and other developed nations. In the United States, 27% of adults are obese and an additional 34% are overweight. Research in the past decade has shown that genetic influences clearly predispose some individuals to obesity. The marked increase in prevalence, however, appears to be attributable to a toxic environment that implicitly discourages physical activity while explicitly encouraging the consumption of supersized portions of high-fat, high-sugar foods. Management of the obesity epidemic will require a two-pronged approach. First, better treatments, including behavioral, pharmacologic, and surgical interventions, are needed for individuals who are already obese. The second and potentially more promising approach is to prevent the development of obesity by tackling the toxic environment. This will require bold public policy initiatives such as regulating food advertising directed at children. The authors call not for the adoption of a specific policy initiative, but instead propose that policy research, based on viewing obesity as a public health problem, become a central focus of research.","['Wadden, Thomas A', 'Brownell, Kelly D', 'Foster, Gary D']","['Wadden TA', 'Brownell KD', 'Foster GD']","['Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia 19104, USA. wadden@mail.med.upenn.edu']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S."", 'Review']",United States,J Consult Clin Psychol,Journal of consulting and clinical psychology,0136553,,IM,"['Algorithms', 'Body Mass Index', 'Environment', 'Health Status', 'Humans', 'Obesity/*epidemiology/etiology/*prevention & control/therapy']",,,,,2002/07/02 10:00,2002/08/01 10:01,['2002/07/02 10:00'],"['2002/07/02 10:00 [pubmed]', '2002/08/01 10:01 [medline]', '2002/07/02 10:00 [entrez]']",['10.1037//0022-006x.70.3.510 [doi]'],ppublish,J Consult Clin Psychol. 2002 Jun;70(3):510-25. doi: 10.1037//0022-006x.70.3.510.,"['DK56114/DK/NIDDK NIH HHS/United States', 'DK56124/DK/NIDDK NIH HHS/United States']",,,,,,202,,,,,,,,,,,,,
17030958,NLM,MEDLINE,20070116,20210430,1930-7381 (Print) 1930-7381 (Linking),14,9,2006 Sep,Obesity in older adults: a systematic review of the evidence for diagnosis and treatment.,1485-97,,"OBJECTIVE: Although obesity is increasing in older U.S. adults, treatment is controversial in this age group. We sought to examine evidence concerning obesity's health-related risks, diagnostic methods, and treatment outcomes in older individuals. RESEARCH METHODS AND PROCEDURES: We searched MEDLINE and Cochrane Library databases, consulted with experts, and examined bibliographies for English language studies discussing obesity in older adults (mean age > or = 60), published between January 1980 and November 2005. Inclusion criteria were met by 32 longitudinal analyses, seven diagnostic studies, and 17 randomized controlled trial articles. At least two authors independently reviewed and abstracted study design, population, results, and quality information. RESULTS: Correlations between body fat and three anthropometric measures (BMI, waist circumference, waist-to-hip ratio) decrease with age but remain clinically significant. Obesity contributes to risk for several cardiovascular endpoints, some cancers, and impaired mobility but protects against hip fracture. The association between obesity and mortality declines as age increases. Intensive counseling strategies incorporating behavioral, dietary, and exercise components promote a weight loss of 3 to 4 kg over 1 to 3.3 years. The loss is linked with improved glucose tolerance, improved physical functioning, reduced incidence of diabetes and a combined hypertension and cardiovascular endpoint, and reduced bone density. DISCUSSION: In older adults, obesity can be diagnosed with standard clinical measures. Intensive counseling can promote modest sustained weight loss, but data are insufficient to evaluate surgical or pharmacological options. Obesity treatment is most likely to benefit individuals with high cardiovascular risk. Limited data suggest possible functional improvement. Treatment should incorporate measures to avoid bone loss.","['McTigue, Kathleen M', 'Hess, Rachel', 'Ziouras, Jennifer']","['McTigue KM', 'Hess R', 'Ziouras J']","['Center for Research on Health Care, Division of General Internal Medicine, Pittsburgh, Pennsylvania 15213, USA. mctiguekm@upmc.edu']",['eng'],"['Journal Article', 'Meta-Analysis', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S."", 'Review', 'Systematic Review']",United States,Obesity (Silver Spring),"Obesity (Silver Spring, Md.)",101264860,,IM,"['Adipose Tissue/metabolism', 'Aged', '*Anthropometry', 'Cardiovascular Diseases/epidemiology', 'Diagnosis, Differential', 'Female', '*Geriatrics', 'Humans', 'Life Style', 'Male', 'Obesity/complications/*diagnosis/mortality/*therapy', 'Risk Factors', 'Treatment Outcome', 'Weight Loss/*physiology']",,,,,2006/10/13 09:00,2007/01/17 09:00,['2006/10/13 09:00'],"['2006/10/13 09:00 [pubmed]', '2007/01/17 09:00 [medline]', '2006/10/13 09:00 [entrez]']","['14/9/1485 [pii]', '10.1038/oby.2006.171 [doi]']",ppublish,Obesity (Silver Spring). 2006 Sep;14(9):1485-97. doi: 10.1038/oby.2006.171.,,,,,,,116,,,,,,,,,,,,,
2663391,NLM,MEDLINE,19890816,20191029,0011-5029 (Print) 0011-5029 (Linking),35,7,1989 Jul,Obesity: basic considerations and clinical approaches.,449-537,,"Obesity, defined as an excess of body fat, can be measured with a variety of techniques, but in most epidemiologic studies it is estimated from height and weight or from skinfold thickness. The ""gold standard"" for body fat is the body density from which fat and fat-free body mass can be calculated. The new technique of bioelectric impedance analysis may substantially improve the estimation of total body fat. For estimating regional fat distribution, either waist to hip circumference ratio or subscapular skinfold have been most useful. Using the body mass index, defined as weight in kilograms divided by the square of the height in meters (kilogram per square meter), the National Health and Nutrition Examination Survey estimated that 26%, or 34 million, adult Americans aged 20 to 75 were overweight. The prevalence of severe overweight (a body mass index above 30 kg/m2) is higher in the United States and Canada than in Great Britain, the Netherlands, or Australia. Obesity results from an increase in energy intake relative to expenditure. Total daily energy expenditure includes energy used during resting metabolism, energy associated with the ingestion of food, and energy needed for physical activity. The obese are often observed to be less active, but since carrying a heavier load requires more energy, their total energy expenditure may not be low. A low resting metabolic rate has been suggested as a predictor of future risk of becoming obese. Adipose tissue is the major site for fat storage and may contain more than 90% of total energy stores. The increase in body mass index or degree of body weight is associated with an increased risk of heart disease, hypertension, gall bladder disease, and diabetes mellitus. When fat is centrally located in either males or females, the risk for these diseases is also increased, and may be a more important risk factor than total overweight itself. Genetic factors form the background from which obesity develops. The best estimates suggest that these genetic factors may be of less importance than environmental events in determination of total body fat and its distribution. Obesity can be classified on the basis of the total number of fat cells and regional fat distribution by using the etiological factors which caused the obesity or by determining the age at which the obesity began. Regardless of the cause, treatment for obesity should be based on an evaluation of the individual's risk from obesity as compared with the risk of the treatment under consideration. (ABSTRACT TRUNCATED AT 400 WORDS)","['Bray, G A']",['Bray GA'],"['Section of Diabetes and Clinical Nutrition, USC School of Medicine, Los Angeles.']",['eng'],"['Journal Article', 'Review']",United States,Dis Mon,Disease-a-month : DM,0370657,,IM,"['Female', 'Humans', 'Male', 'Obesity/complications/epidemiology/etiology/*therapy']",,,,,1989/07/01 00:00,1989/07/01 00:01,['1989/07/01 00:00'],"['1989/07/01 00:00 [pubmed]', '1989/07/01 00:01 [medline]', '1989/07/01 00:00 [entrez]']",['10.1016/0011-5029(89)90007-2 [doi]'],ppublish,Dis Mon. 1989 Jul;35(7):449-537. doi: 10.1016/0011-5029(89)90007-2.,,,,,,,182,,,,,,,,,,,,,
35162148,NLM,MEDLINE,20220217,20220219,1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking),19,3,2022 Jan 20,Micronutrient Deficiency as a Confounder in Ascertaining the Role of Obesity in Severe COVID-19 Infection.,,10.3390/ijerph19031125 [doi] 1125,"Food insecurity in the United States has been exacerbated due to the socioeconomic strain of the coronavirus disease 2019 (COVID-19) pandemic. Populations experiencing poverty and, as a consequence, food insecurity in the United States are disproportionately affected by obesity, which was identified early in the pandemic as a major risk factor for increased susceptibility to COVID-19 infection and mortality. Given the focus on obesity and its role in immune dysregulation, it is also important to note the role of micronutrient deficiency, another sequalae of food insecurity. Micronutrients play an important role in the ability of the immune system to mount an appropriate response. Moreover, OBESE individuals are more likely to be micronutrient deficient. This review will explore the role of micronutrients, vitamin A, vitamin D, vitamin C, and zinc in respiratory immunity and COVID-19 and how micronutrient deficiency may be a possible confounder in obesity's association with severe outcomes. By illuminating the role of micronutrients in COVID-19, this paper expands the discussion from food insecurity and obesity to include micronutrient deficiency and how all of these interact in respiratory illnesses such as COVID-19.","['Chu, Brian A', 'Surampudi, Vijaya', 'Li, Zhaoping', 'Harris, Christina', 'Seeman, Teresa', 'Norris, Keith C', 'Vijayan, Tara']","['Chu BA', 'Surampudi V', 'Li Z', 'Harris C', 'Seeman T', 'Norris KC', 'Vijayan T']","['David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.', 'Center for Human Nutrition, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.', 'Department of Allergy and Immunology, Veterans Affairs Greater Los Angeles Healthcare System, Center for Human Nutrition, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.', 'Department of Internal Medicine, Veterans Affairs Greater Los Angeles Healthcare System, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.', 'Division of Geriatrics, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.', 'Division of General Internal Medicine-Health Services Research, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.', 'Division of Infectious Diseases, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",Switzerland,Int J Environ Res Public Health,International journal of environmental research and public health,101238455,"['0 (Micronutrients)', '0 (Vitamins)']",IM,"['*COVID-19', 'Humans', 'Micronutrients', 'Obesity/epidemiology', 'SARS-CoV-2', 'Vitamins']",PMC8834257,['NOTNLM'],"['COVID-19', 'SARS-CoV-2', 'coronavirus', 'food insecurity', 'micronutrients', 'obesity', 'respiratory infection', 'vitamin A', 'vitamin D']",['The authors declare no conflict of interest.'],2022/02/16 06:00,2022/02/19 06:00,['2022/02/15 01:13'],"['2021/11/30 00:00 [received]', '2022/01/11 00:00 [revised]', '2022/01/17 00:00 [accepted]', '2022/02/15 01:13 [entrez]', '2022/02/16 06:00 [pubmed]', '2022/02/19 06:00 [medline]']","['ijerph19031125 [pii]', 'ijerph-19-01125 [pii]', '10.3390/ijerph19031125 [doi]']",epublish,Int J Environ Res Public Health. 2022 Jan 20;19(3):1125. doi: 10.3390/ijerph19031125.,"['P30 AG021684/AG/NIA NIH HHS/United States', 'UL1 TR001881/TR/NCATS NIH HHS/United States']",20220120,,,"['ORCID: 0000-0002-0596-1842', 'ORCID: 0000-0002-7105-065X', 'ORCID: 0000-0002-8662-4310']",,,,,,,,,,,,,,,
7754750,NLM,MEDLINE,19950619,20190913,0374-5600 (Print) 0374-5600 (Linking),37,1,1995 Feb,Childhood obesity: pathophysiology and treatment.,1-6,,"Childhood obesity is among the most difficult problems which pediatricians treat. It is frequently ignored by the pediatrician or viewed as a form of social deviancy, and blame for treatment failure placed on the patients or their families. The definition of obesity is difficult. Using total body electrical conductivity (TOBEC) technology, total body fat ranges between 12% and 30% of total body weight in normal children and adolescents. This is influenced not only by age, but also by physical fitness. Anthropometry is the easiest way to define obesity. Children whose weight exceeds 120% of that expected for their height are considered overweight. Skinfold thickness and body mass index are indices of obesity that are more difficult to apply to the child. Childhood obesity is associated with obese parents, a higher socioeconomic status, increased parental education, small family size and a sedentary lifestyle. Genetics also clearly plays a role. Studies have demonstrated that obese and non-obese individuals have similar energy intakes implying that obesity results from very small imbalances of energy intake and expenditure. An excess intake of only 418 kJ per day can result in about 4.5 kg of excess weight gain per year. Small differences in basal metabolic rate or the thermic effects of food may also account for the difference in energy balance between the obese and non-obese. In the Prader Willi Syndrome, there appears to be a link between appetite and body fatness. When placed on growth hormone, lean body mass increases, body fat decreases, sometimes to normal, and appetite becomes more normal.(ABSTRACT TRUNCATED AT 250 WORDS)","['Klish, W J']",['Klish WJ'],"[""Department of Pediatric Nutrition and Gastroenterology, Baylor College of Medicine, Texas Children's Hospital, Houston 77030, USA.""]",['eng'],"['Journal Article', 'Review']",Australia,Acta Paediatr Jpn,Acta paediatrica Japonica : Overseas edition,0370357,,IM,"['Adolescent', 'Anthropometry', 'Behavior Therapy', 'Child', 'Child Health Services', 'Female', 'Health Promotion', 'Humans', 'Male', '*Obesity/epidemiology/physiopathology/therapy', 'Texas', 'United States/epidemiology']",,,,,1995/02/01 00:00,1995/02/01 00:01,['1995/02/01 00:00'],"['1995/02/01 00:00 [pubmed]', '1995/02/01 00:01 [medline]', '1995/02/01 00:00 [entrez]']",['10.1111/j.1442-200x.1995.tb03675.x [doi]'],ppublish,Acta Paediatr Jpn. 1995 Feb;37(1):1-6. doi: 10.1111/j.1442-200x.1995.tb03675.x.,,,,,,,18,,,,,,,,,,,,,
33512658,NLM,MEDLINE,20210423,20210731,1559-0100 (Electronic) 1355-008X (Print) 1355-008X (Linking),71,3,2021 Mar,Clinical management of patients with genetic obesity during COVID-19 pandemic: position paper of the ESE Growth & Genetic Obesity COVID-19 Study Group and Rare Endo-ERN main thematic group on Growth and Obesity.,653-662,10.1007/s12020-021-02619-y [doi],"This article aims to provide guidance on prevention and treatment of COVID-19 in patients with genetic obesity. Key principals of the management of patients with genetic obesity during COVID-19 pandemic for patients that have contracted COVID-19 are to be aware of: possible adrenal insufficiency (e.g., POMC deficiency, PWS); a more severe course in patients with concomitant immunodeficiency (e.g., LEP and LEPR deficiency), although defective leptin signalling could also be protective against the pro-inflammatory phenotype of COVID-19; disease severity being masked by insufficient awareness of symptoms in syndromic obesity patients with intellectual deficit (in particular PWS); to adjust medication dose to increased body size, preferably use dosing in m2; the high risk of malnutrition in patients with Sars-Cov2 infection, even in case of obesity. Key principals of the obesity management during the pandemic are to strive for optimal obesity management and a healthy lifestyle within the possibilities of the regulations to prevent weight (re)gain and to address anxiety within consultations, since prevalence of anxiety for COVID-19 is underestimated.","['De Groot, Cornelis Jan', 'Poitou Bernert, Christine', 'Coupaye, Muriel', 'Clement, Karine', 'Paschou, Stavroula A', 'Charmandari, Evangelia', 'Kanaka-Gantenbein, Christina', 'Wabitsch, Martin', 'Buddingh, Emilie P', 'Nieuwenhuijsen, Barbara', 'Marina, Ljiljana', 'Johannsson, Gudmundur', 'Van Den Akker, E L T']","['De Groot CJ', 'Poitou Bernert C', 'Coupaye M', 'Clement K', 'Paschou SA', 'Charmandari E', 'Kanaka-Gantenbein C', 'Wabitsch M', 'Buddingh EP', 'Nieuwenhuijsen B', 'Marina L', 'Johannsson G', 'Van Den Akker ELT']","[""Pediatric Endocrinology and Obesity Center CGG Erasmus MC, Rotterdam and Willem Alexander Children's Hospital, LUMC, Leiden, the Netherlands. c.j.degroot@erasmusmc.nl."", 'Assistance Publique-Hopitaux de Paris, Reference Center for Rare Diseases (PRADORT, Prader-Willi Syndrome and other rare obesities), Nutrition Department, Pitie-Salpetriere hospital, Paris, France.', 'Sorbonne Universite/INSERM, Nutrition and obesities; systemic approaches (NutriOmics) research Unit, Paris, France.', 'Assistance Publique-Hopitaux de Paris, Reference Center for Rare Diseases (PRADORT, Prader-Willi Syndrome and other rare obesities), Nutrition Department, Pitie-Salpetriere and Louis-Mourier hospitals, Paris, France.', 'Sorbonne Universite/INSERM, Nutrition and obesities; systemic approaches (NutriOmics) research Unit, Paris, France.', 'Assistance Publique-Hopitaux de Paris, Nutrition Department, Pitie-Salpetriere Hospital, Paris, France.', 'Division of Endocrinology, Diabetes and Metabolism, Department of Clinical Therapeutics, Alexandra Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.', 'Pediatric and Adolescent Endocrinology, National and Kapodistrian University of Athens Medical School, ""Aghia Sophia"" Children\'s Hospital, Athens, Greece.', 'Division of Endocrinology, Center for Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, 11527, Greece.', ""Division of Endocrinology, Diabetes and Metabolism, First Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, Aghia Sophia Children's Hospital, Athens, Greece."", 'Division of Pediatric Endocrinology and Diabetes Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.', ""Willem-Alexander Children's Hospital, LUMC, Leiden, the Netherlands."", 'Faculty of medicine, UMC Utrecht, Utrecht, the Netherlands.', 'Assistant Professor Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.', 'Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Department of Endocrinology, Sahlgrenska University Hospital, SE-413 45, Gothenburg, Sweden.', ""Pediatric Endocrinology and Obesity Center CGG, Erasmus MC Sophia Children's Hospital, Rotterdam, the Netherlands. e.l.t.vandenakker@erasmusmc.nl.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Endocrine,Endocrine,9434444,,IM,"['Anxiety', '*COVID-19', '*Disease Management', 'Healthy Lifestyle', 'Humans', 'Obesity/epidemiology/genetics/*therapy', '*Pandemics']",PMC7845285,['NOTNLM'],"['COVID-19', 'Genetic obesity', 'Monogenic obesity', 'Obesity syndrome', 'SARS-CoV-2']",['The authors declare that they have no conflict of interest.'],2021/01/30 06:00,2021/04/24 06:00,['2021/01/29 12:16'],"['2020/10/27 00:00 [received]', '2021/01/08 00:00 [accepted]', '2021/01/30 06:00 [pubmed]', '2021/04/24 06:00 [medline]', '2021/01/29 12:16 [entrez]']","['10.1007/s12020-021-02619-y [pii]', '2619 [pii]', '10.1007/s12020-021-02619-y [doi]']",ppublish,Endocrine. 2021 Mar;71(3):653-662. doi: 10.1007/s12020-021-02619-y. Epub 2021 Jan 29.,,20210129,,,['ORCID: 0000-0001-5352-9328'],,,,,,,,,,,,,,,
23814963,NLM,MEDLINE,20131203,20130702,1330-0164 (Print) 1330-0164 (Linking),66,5,2012 Dec,[Obesity--a public health problem and challenge].,347-55,,"Obesity is a major health problem today that grows into a global epidemic. According to the World Health Organization report, 1.5 billion adults were overweight, over 500 million of them were obese, and the prevalence of obesity is expected to rise in the years to come. A similar situation is recorded in Croatia, where there are 25.3% of obese men and 34.1% of obese women. There are multiple factors that cause obesity. Accelerated lifestyle, fast food, unhealthy eating habits and sedentary lifestyle are considered as the major risk factors of overweight and obesity development. Accumulation of fat tissue, especially visceral fat tissue has been demonstrated to be associated with some chronic changes and diseases of different organ systems. Some anthropometric measurements, especially body mass index, waist circumference and waist-to-hip ratio, have been used to diagnose obesity and estimate the health risk. Developing well-structured prevention programs that would encourage people to become aware of obesity as a disease and that imbalanced dietary habits and physical activity are important for obesity prevention and health, is a major public health challenge.","['Medanic, Darija', 'Pucarin-Cvetkovic, Jasna']","['Medanic D', 'Pucarin-Cvetkovic J']","['Klinicki bolnicki centar Zagreb, Zagreb, Hrvatska. darija.medanic@gmail.com']",['hrv'],"['English Abstract', 'Journal Article', 'Review']",Croatia,Acta Med Croatica,Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,9208249,,IM,"['Humans', '*Obesity/complications/epidemiology/etiology']",,,,,2013/07/03 06:00,2013/12/16 06:00,['2013/07/03 06:00'],"['2013/07/03 06:00 [entrez]', '2013/07/03 06:00 [pubmed]', '2013/12/16 06:00 [medline]']",,ppublish,Acta Med Croatica. 2012 Dec;66(5):347-55.,,,,,,,,,Pretilost--javnozdravstveni problem i izazov.,,,,,,,,,,,
34105090,NLM,MEDLINE,20220314,20220314,1573-2606 (Electronic) 1389-9155 (Linking),22,4,2021 Dec,The multifaceted progenitor fates in healthy or unhealthy adipose tissue during obesity.,1111-1119,10.1007/s11154-021-09662-0 [doi],"While obesity is defined as an excessive fat accumulation conferring a risk to metabolic health, increased adipose mass by itself does not fully explain obesity's propensity to promote metabolic alterations. Adipose tissue regulates multiple processes critical for energy homeostasis and its dysfunction favors the development and perpetuation of metabolic diseases. Obesity drives inflammatory leucocyte infiltration in adipose tissue and fibrotic transformation of the fat depots. Both features associate with metabolic alterations such as impaired glucose control and resistance to fat mass loss. In this context, adipose progenitors, an heterogenous resident population of mesenchymal stromal cells, display functions important to shape healthy or unhealthy adipose tissue expansion. We, here, outline the current understanding of adipose progenitor biology in the context of obesity-induced adipose tissue remodeling.","['Marcelin, Genevieve', 'Clement, Karine']","['Marcelin G', 'Clement K']","['Nutrition and Obesities : Systemic Approaches (NutriOmics, UMRS U1269), Sorbonne Universites, INSERM, Paris, France.', 'Nutrition and Obesities : Systemic Approaches (NutriOmics, UMRS U1269), Sorbonne Universites, INSERM, Paris, France. karine.clement@inserm.fr.', 'Nutrition Department, Assistance Publique Hopitaux de Paris (AP-HP), Hopital Pitie-Salpetriere, CRNH Ile de France, 75013, Paris, France. karine.clement@inserm.fr.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Germany,Rev Endocr Metab Disord,Reviews in endocrine & metabolic disorders,100940588,,IM,"['*Adipose Tissue/metabolism', 'Homeostasis', 'Humans', '*Metabolic Diseases/metabolism', 'Obesity/metabolism']",,['NOTNLM'],"['Adipose tissue', 'Fibrosis', 'Progenitors']",,2021/06/10 06:00,2022/03/15 06:00,['2021/06/09 06:58'],"['2021/06/01 00:00 [accepted]', '2021/06/10 06:00 [pubmed]', '2022/03/15 06:00 [medline]', '2021/06/09 06:58 [entrez]']","['10.1007/s11154-021-09662-0 [pii]', '10.1007/s11154-021-09662-0 [doi]']",ppublish,Rev Endocr Metab Disord. 2021 Dec;22(4):1111-1119. doi: 10.1007/s11154-021-09662-0. Epub 2021 Jun 8.,,20210608,,"['(c) 2021. The Author(s), under exclusive licence to Springer Science+Business', 'Media, LLC, part of Springer Nature.']",['ORCID: 0000-0002-2489-3355'],,,,,,,,,,,,,,,
16385859,NLM,MEDLINE,20070306,20060102,1505-1773 (Print) 1505-1773 (Linking),8,4,2005,Obesity in carnivores.,329-35,,"Obesity is the common nutritional disorder affecting more and more animals every year. Obese individuals have altered metabolism and disorders of many organs. Obesity may develop as a result of specific genetic, metabolic, nervous and environmental factors. Dietary management of obesity requires addressing the underlying metabolism of the animal, normalizing the glucose level and proper treatment of diabetes, which is usually associated with obesity. Novel nutrients like leptin, chromium, carnitine and starch added to the diet as well as new approaches in the obesity therapy are very important in successful weight management and treatment of this common disorder.","['Wisniewska, M E', 'Pomianowski, A', 'Madany, J', 'Juranek, J']","['Wisniewska ME', 'Pomianowski A', 'Madany J', 'Juranek J']","['Division of Internal Medicine, Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Warmia and Mazury, Olsztyn-Kortowo, Poland.']",['eng'],"['Journal Article', 'Review']",Germany,Pol J Vet Sci,Polish journal of veterinary sciences,101125473,,IM,"['Animals', '*Carnivora', 'Obesity/epidemiology/physiopathology/therapy/*veterinary']",,,,,2006/01/03 09:00,2007/03/07 09:00,['2006/01/03 09:00'],"['2006/01/03 09:00 [pubmed]', '2007/03/07 09:00 [medline]', '2006/01/03 09:00 [entrez]']",,ppublish,Pol J Vet Sci. 2005;8(4):329-35.,,,,,,,54,,,,,,,,,,,,,
15960858,NLM,MEDLINE,20050916,20190906,0029-6651 (Print) 0029-6651 (Linking),64,2,2005 May,Genetics of human obesity.,133-42,,"The rapid development of new concepts and tools has led to a change in the way in which researchers carry out nutrition-related research. Obesity is determined by the interaction between predisposing genetic and environmental aspects, but at present the gene-gene and gene-environment interactions contributing to the development of this complex disease cannot be analysed in detail. The purpose of the present paper is to provide some examples of the knowledge that is available in the field of obesity genetics, and also the new strategies being developed that are aimed at studying the relative contribution of numerous genes to obesity and their responses to environmental changes. In the rare cases of monogenic obesities in which a major gene is the cause the molecular approach has proved extremely powerful in the identification of the genes responsible and in defining new syndromes. However, in the common forms of obesity (polygenic obesity) most studies have analysed genotype-phenotype associations without sometimes taking into account the influence of environmental factors (diet, sedentary lifestyle). Among the aspects limiting this integrated approach to obesity are the difficulty of having large enough samples and the expansion of biocomputing tools developed for accessing the question of multiple interactions with no a priori hypotheses. This picture is rapidly changing. Large databases of clinical data and DNA and biological sample banks with more precise environmental information and patient phenotypes are being compiled. The capacity for studying multiple genes simultaneously at the DNA or RNA levels is also possible. Finally, the tremendous progress in biocomputing will allow the integration of these different types of data (relating to environment, phenotype, genotype, gene expression) and will improve the ability to deal with this complex disease.","['Clement, Karine']",['Clement K'],"['Inserm Avenir, Paris, EA3502 and Paris 6 University, Nutrition Department, Hotel-Dieu Hospital, France. karine.clement@htd.ap-hop-paris.fr']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Proc Nutr Soc,The Proceedings of the Nutrition Society,7505881,,IM,"['*Environment', 'Gene Expression Regulation', 'Genetic Predisposition to Disease', 'Genotype', 'Humans', 'Obesity/epidemiology/etiology/*genetics', 'Phenotype']",,,,,2005/06/18 09:00,2005/09/17 09:00,['2005/06/18 09:00'],"['2005/06/18 09:00 [pubmed]', '2005/09/17 09:00 [medline]', '2005/06/18 09:00 [entrez]']",['10.1079/pns2005416 [doi]'],ppublish,Proc Nutr Soc. 2005 May;64(2):133-42. doi: 10.1079/pns2005416.,,,,,,,72,,,,,,,,,,,,,
1861165,NLM,MEDLINE,19910830,20180330,0022-3166 (Print) 0022-3166 (Linking),121,8,1991 Aug,"Obesity, a disorder of nutrient partitioning: the MONA LISA hypothesis.",1146-62,,"The mechanisms underlying different types of obesity have been gradually clarified. Animal models with hypothalamic, genetic or dietary obesity have been examined with a feedback model. Four common final pathways are involved in this model. One of these final common pathways is the sympathetic nervous system. Most Obesities kNown Are Low In Sympathetic Activity states the MONA LISA Hypothesis. A second common pathway is the endocrine system involving adrenal glucocorticosteroids. The third common pathway is hyperphagia. Although not essential for most obesities, hyperphagia may be essential in animals with injury to the hypothalamic paraventricular nucleus. The final pathway is reduced physical activity. The tonic activity of these systems and their response to changes in the diet affect nutrient partitioning between fat and protein. This framework has been used to review genetic obesity, hypothalamic obesity and dietary obesity.","['Bray, G A']",['Bray GA'],"['Pennington Biomedical Research Center, Department of Medicine, Louisiana State University School of Medicine, Baton Rouge 70808-4124.']",['eng'],"['Journal Article', 'Review']",United States,J Nutr,The Journal of nutrition,0404243,,IM,"['Animals', 'Autonomic Nervous System/physiopathology', 'Diet', '*Disease Models, Animal', 'Endocrine Glands/physiopathology', 'Feedback', 'Hypothalamic Diseases/complications', '*Nutritional Physiological Phenomena', 'Obesity/*etiology/genetics/physiopathology', 'Sympathetic Nervous System/physiopathology']",,,,,1991/08/01 00:00,1991/08/01 00:01,['1991/08/01 00:00'],"['1991/08/01 00:00 [pubmed]', '1991/08/01 00:01 [medline]', '1991/08/01 00:00 [entrez]']",['10.1093/jn/121.8.1146 [doi]'],ppublish,J Nutr. 1991 Aug;121(8):1146-62. doi: 10.1093/jn/121.8.1146.,,,,,,,144,,,,,,,,,,,,,
3065483,NLM,MEDLINE,19890316,20190828,0022-3999 (Print) 0022-3999 (Linking),32,6,1988,Is obesity an eating disorder?,585-90,,"Obesity arises when energy intake exceeds energy expenditure over a long period. Excess weight has an energy value of 7000 kcal/kg. Theoretically excess weight might be gained either because energy expenditure was too low or energy intake was too high. Many studies have shown that on average obese people expand more energy than normal so, notwithstanding dietary histories to the contrary, they must on average have a higher energy intake to maintain body weight. However it is not possible to show that obese people have any significant defect in short-term regulation of energy intake. The likeliest hypothesis is that obesity is a disorder arising from a failure of the long-term regulation of energy intake, in which cognitive factors play an important part.","['Garrow, J S']",['Garrow JS'],"[""Dept of Human Nutrition, Medical College of St Bartholomew's Hospital, London, U.K.""]",['eng'],"['Journal Article', 'Review']",England,J Psychosom Res,Journal of psychosomatic research,0376333,,IM,"['Cognition', 'Energy Intake', 'Energy Metabolism', 'Humans', 'Obesity/*etiology/psychology']",,,,,1988/01/01 00:00,1988/01/01 00:01,['1988/01/01 00:00'],"['1988/01/01 00:00 [pubmed]', '1988/01/01 00:01 [medline]', '1988/01/01 00:00 [entrez]']",['10.1016/0022-3999(88)90007-4 [doi]'],ppublish,J Psychosom Res. 1988;32(6):585-90. doi: 10.1016/0022-3999(88)90007-4.,,,,,,,17,,,,,,,,,,,,,
10343340,NLM,MEDLINE,19990709,20190905,0029-6651 (Print) 0029-6651 (Linking),58,1,1999 Feb,Treatment of obesity: theory into practice.,53-8,,"The purpose of the present paper is to outline the current situation in the management of obesity in adults, and to make some suggestions as to how health professionals involved in obesity treatment can best address this growing problem. Dietitians and nutritionists have long been involved in the treatment of obesity, and have a vital role to play in the battle to reverse the increasing prevalence of this major public health problem. However, the current management of obesity is far from ideal. There is evidence to suggest that in general health care, even when there are clearly effective clinical interventions, health professionals may not practise in the best way. Furthermore, some professionals may also hold negative attitudes towards the obese. These are the subject of a systematic review on improving health professionals' practice and organization of care in obesity treatment, the preliminary findings of which will be discussed in the present paper (Harvey et al. 1998a,b). A new approach to obesity is required, encompassing effective treatment and prevention strategies. A greater understanding of the problems faced by the obese individual in attempting to lose weight is also needed, with a range of treatment approaches on offer to acknowledge the heterogeneity of obesity. Those health professionals involved in obesity treatment must consider the impact of dietary advice given in a consultation against the impact of environmental cues that assail the patient as soon as they leave the room. Tackling the obesity epidemic requires action at the individual and population level if we are to see any reduction in prevalence.","['Kirk, S F']",['Kirk SF'],"['Division of Public Health, Nuffield Institute for Health, University of Leeds, UK. s.f.l.kirk@leeds.ac.uk']",['eng'],"['Journal Article', 'Review', 'Systematic Review']",England,Proc Nutr Soc,The Proceedings of the Nutrition Society,7505881,,IM,"['Adult', 'Attitude of Health Personnel', 'Dietetics', 'Exercise', 'Humans', 'Obesity/complications/diet therapy/prevention & control/*therapy']",,,,,1999/05/27 00:00,1999/05/27 00:01,['1999/05/27 00:00'],"['1999/05/27 00:00 [pubmed]', '1999/05/27 00:01 [medline]', '1999/05/27 00:00 [entrez]']",['10.1079/pns19990008 [doi]'],ppublish,Proc Nutr Soc. 1999 Feb;58(1):53-8. doi: 10.1079/pns19990008.,,,,,,,51,,,,,,,,,,,,,
35951502,NLM,MEDLINE,20220815,20220826,1932-6203 (Electronic) 1932-6203 (Linking),17,8,2022,Obesity and outcomes in patients undergoing upper airway surgery for obstructive sleep apnea.,e0272331,10.1371/journal.pone.0272331 [doi] e0272331,"OBJECTIVE: Obesity is frequently debated as a factor associated with increased postoperative complications. Specifically, upper airway surgeries for obstructive sleep apnea (OSA), a common comorbidity among obese patients, may be complicated by obesity's impact on intraoperative ventilation. The aim of this retrospective study was to analyze the association of various degrees of obesity with postoperative outcomes in patients undergoing surgery for OSA. METHODS: The American College of Surgeons National Surgical Quality Improvement database between 2015 and 2019 was used to create a sample of patients diagnosed with OSA who underwent uvulopalatopharyngoplasty, tracheotomy, and surgeries at the base of tongue, maxilla, palate, or nose/turbinate. Inverse probability-weighted logistic regression and unadjusted multivariable logistic regression were used to compare outcomes of non-obese and obesity class 1, class 2, and class 3 groups (World Health Organization classification). Primary outcome was a composite of 30-day readmissions, reoperations, and/or postoperative complications, and a secondary outcome was all-cause same-day hospital admission. RESULTS: There were 1929 airway surgeries identified. The inverse probability-weighted regression comparing class 1, class 2, and class 3 obesity groups to non-obese patients showed no association between obesity and composite outcome and no association between obesity and hospital admission (all p-values > 0.05). CONCLUSION: These results do not provide evidence that obesity is associated with poorer outcomes or hospital admission surrounding upper airway surgery for OSA. While these data points towards the safety of upper airway surgery in obese patients with OSA, larger prospective studies will aid in elucidating the impact of obesity.","['Du, Austin L', 'Tully, Jeffrey L', 'Curran, Brian P', 'Gabriel, Rodney A']","['Du AL', 'Tully JL', 'Curran BP', 'Gabriel RA']","['School of Medicine, University of California, San Diego, La Jolla, California, United States of America.', 'Department of Anesthesiology, Division of Perioperative Informatics, University of California, San Diego, La Jolla, California, United States of America.', 'Department of Anesthesiology, Division of Perioperative Informatics, University of California, San Diego, La Jolla, California, United States of America.', 'Department of Medicine, Division of Biomedical Informatics, University of California, San Diego, La Jolla, California, United States of America.', 'Department of Anesthesiology, Division of Perioperative Informatics, University of California, San Diego, La Jolla, California, United States of America.', 'Department of Anesthesiology, Division of Perioperative Informatics, University of California, San Diego, La Jolla, California, United States of America.', 'Department of Medicine, Division of Biomedical Informatics, University of California, San Diego, La Jolla, California, United States of America.']",['eng'],['Journal Article'],United States,PLoS One,PloS one,101285081,,IM,"['Humans', 'Obesity/complications', 'Postoperative Complications/epidemiology/etiology', 'Prospective Studies', 'Retrospective Studies', '*Sleep Apnea, Obstructive/complications/diagnosis/surgery']",PMC9371252,,,"['The University of California San Diego has received funding and product for other', 'research projects from Epimed International (Farmers Branch, TX); Infutronics', '(Natick, MA); and SPR Therapeutics (Cleveland, OH) for Dr. Gabriel. The', 'University of California San Diego is a consultant for Avanos (Alpharetta, GA),', 'in which Dr. Gabriel represents. This does not alter our adherence to PLOS ONE', 'policies on sharing data and materials.']",2022/08/12 06:00,2022/08/16 06:00,['2022/08/11 13:33'],"['2022/02/27 00:00 [received]', '2022/07/18 00:00 [accepted]', '2022/08/11 13:33 [entrez]', '2022/08/12 06:00 [pubmed]', '2022/08/16 06:00 [medline]']","['PONE-D-22-05847 [pii]', '10.1371/journal.pone.0272331 [doi]']",epublish,PLoS One. 2022 Aug 11;17(8):e0272331. doi: 10.1371/journal.pone.0272331. eCollection 2022.,,20220811,,,['ORCID: 0000-0003-0313-0153'],,,,,,,,,,,,,,,
6391755,NLM,MEDLINE,19850215,20191031,0300-595X (Print) 0300-595X (Linking),13,3,1984 Nov,Energy expenditure in obesity.,563-80,,"Energy expenditure of obese subjects living in a respiration chamber is higher than that of lean controls; this is due to a greater basal metabolic rate in the obese. Groups of obese subjects with a family history of obesity and/or a childhood onset of obesity have a reduced thermogenic response after glucose or meal ingestion. However, this defect in diet-induced thermogenesis is not a uniform finding, since only a third of an unselected group of obese women exhibit a reduced response. Moreover, obese subjects with reduced thermogenesis have a higher overall energy expenditure than lean people, even in situations in which a thermogenic response is produced. After inducing loss of weight with a hypocaloric diet, the thermogenic defect does not disappear. Since basal metabolic rate decreases with weight loss, the postprandial energy expenditure of some 'post-obese' subjects can be lower than that of lean controls. It is concluded that a thermogenic defect can contribute to the development of obesity in some predisposed subjects. The mechanisms of the thermogenic defect in the obese are presently unknown; insulin resistance and/or a blunted response of the sympathetic nervous system have been reported, but this topic remains controversial. After weight loss, energy expenditure decreases by about 84 kJ/24 h (20 kcal/24 h) per kg of weight loss in all patients. The need to reset energy intake to a lower level than the previous maintenance food consumption represents a major difficulty in the treatment of obesity; failure to adjust energy intake to the new requirements contributes to the frequent relapse of body weight gain in the obese after completion of a period on a hypocaloric diet.","['Jequier, E']",['Jequier E'],,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Clin Endocrinol Metab,Clinics in endocrinology and metabolism,0357424,,IM,"['Adult', 'Body Temperature Regulation', 'Body Weight', 'Eating', '*Energy Metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*metabolism/physiopathology/therapy']",,,,,1984/11/01 00:00,1984/11/01 00:01,['1984/11/01 00:00'],"['1984/11/01 00:00 [pubmed]', '1984/11/01 00:01 [medline]', '1984/11/01 00:00 [entrez]']",['10.1016/s0300-595x(84)80038-9 [doi]'],ppublish,Clin Endocrinol Metab. 1984 Nov;13(3):563-80. doi: 10.1016/s0300-595x(84)80038-9.,,,,,,,78,,,,,,,,,,,,,
2643008,NLM,MEDLINE,19890215,20190817,0025-7125 (Print) 0025-7125 (Linking),73,1,1989 Jan,Psychological features of obesity.,47-66,,"The study of obesity from a variety of psychological perspectives has been exciting and inventive, although we still do not understand fully the role of psychological variables in the etiology of obesity. Many of the factors thought to be of etiologic significance--field dependence, lack of impulse control, inability to delay gratification, or a maladaptive eating style--have not been supported by experimental evidence. Other factors once thought to be of importance as causes of obesity, depression and dysphoria, for example, appear, instead, to be consequences of being obese and may serve to maintain and intensify weight-related problems. Dieting behavior in response to weight concerns appears, perversely, to be implicated in increasing overweight and adiposity. Finally, arousability in response to food cues in the environment may play a causal role in some obesities.","['Rodin, J', 'Schank, D', 'Striegel-Moore, R']","['Rodin J', 'Schank D', 'Striegel-Moore R']","['Department of Psychology, Yale University, New Haven, Connecticut.']",['eng'],"['Journal Article', 'Review']",United States,Med Clin North Am,The Medical clinics of North America,2985236R,,IM,"['Eating', 'Food', 'Humans', 'Obesity/*psychology', 'Personality']",,,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']","['S0025-7125(16)30691-5 [pii]', '10.1016/s0025-7125(16)30691-5 [doi]']",ppublish,Med Clin North Am. 1989 Jan;73(1):47-66. doi: 10.1016/s0025-7125(16)30691-5.,,,,,,,164,,,,,,,,,,,,,
31670528,NLM,MEDLINE,20210405,20210405,1939-1854 (Electronic) 0021-9010 (Linking),105,7,2020 Jul,Thinking big: An integrative conceptual review of the workplace consequences of obesity and a theoretical extension of the processes that create them.,671-692,10.1037/apl0000459 [doi],"Obesity is a condition that affects much of the world's population and generates substantial costs to organizations and their employees. Multiple scholarly disciplines have generated a significant body of literature on the workplace consequences of obesity. Strikingly, however, the applied psychology and management literatures-a natural home for such research-have largely ignored this topic while embracing related issues like health, wellness, disability, and others. This paper seeks to invigorate organizational research on obesity by collecting, cataloging, integrating, and extending the disparate research streams that have explored the workplace consequences of obesity. To do so, this paper reviews empirical and conceptual studies on the workplace consequences of obesity, identifies weaknesses limiting the field's growth and impact, and builds an integrative theoretical framework that addresses these weaknesses. In doing so, we extend the field's understanding of the processes leading to-and the boundary conditions related to-obesity's influence on work outcomes for employees. Specifically, we broaden the field's focus by looking beyond the psychological processes (primarily stigmatization) that underlie obesity effects to consider the impact of both economic and medical perspectives as well. In all, this review integrates the multidisciplinary obesity literature by challenging the view that obesity effects can be primarily understood through a stigma-based lens. In so doing, we offer contributions not just to the obesity literature, but to related areas of health and social categorizations as well, and hope to revitalize work on a serious issue facing today's organizations and the people who work in them. (PsycInfo Database Record (c) 2020 APA, all rights reserved).","['Johnson, Michael A', 'Schminke, Marshall']","['Johnson MA', 'Schminke M']","['Rucks Department of Management.', 'Department of Management.']",['eng'],"['Journal Article', 'Review']",United States,J Appl Psychol,The Journal of applied psychology,0222526,,IM,"['*Employment/economics/psychology', '*Health Expenditures', 'Humans', '*Obesity/complications/economics/psychology', '*Organizational Culture']",,,,,2019/11/02 06:00,2021/04/07 06:00,['2019/11/01 06:00'],"['2019/11/02 06:00 [pubmed]', '2021/04/07 06:00 [medline]', '2019/11/01 06:00 [entrez]']","['2019-63840-001 [pii]', '10.1037/apl0000459 [doi]']",ppublish,J Appl Psychol. 2020 Jul;105(7):671-692. doi: 10.1037/apl0000459. Epub 2019 Oct 31.,,20191031,,,['ORCID: 0000-0002-4856-2489'],,,,,,,,,,,,,,,
11519356,NLM,MEDLINE,20020227,20091111,0016-3813 (Print) 0016-3813 (Linking),137,4,2001 Jul-Aug,[Obesity in the 21st century. Progress in etiopathogenesis and treatment].,323-34,,"Obesity is complex in its etiology and treatment. Its global incidence is increasing significantly. Favoring weight-loss can only bring beneficial effects. Obesity is a chronic condition with multifactorial origin. The discovery of the ob gene and its product, the OB protein or Leptin, neuropeptide Y, and the alterations of the metabolism of lipogenic tissues that inhibit appetite are significant advances in the understanding of its etiopathogenesis and treatment. This new knowledge will change the philosophy of the management of obesity. Obesity responds poorly to nonsurgical therapies. Its treatment must be long-term in spite of the considerable social and biological pressure that favor the regaining of weight. Treatment of the obese patient must be performed by a multidisciplinary team, and should include a hypoenergetic diet, exercise program, behavioral modifications, and in some instances, family therapy. The treatment of obesity should be tailored for each individual. Drug use in the treatment of obesity is not a substitute for modifying the individual's diet and physical activity. Bariatric surgery is indicated only when the BMI is greater than 30 kg/m2. Physicians and patients must interact closely and assess possible risks that are involved in its treatment against real benefits. A good relation between practitioner and patient is essential.","['Chiprut, R', 'Castellanos-Urdaibay, A', 'Sanchez-Hernandez, C', 'Martinez-Garcia, D', 'Elena-Cortez, M', 'Chiprut, R', 'Del Conde Ovadia, P']","['Chiprut R', 'Castellanos-Urdaibay A', 'Sanchez-Hernandez C', 'Martinez-Garcia D', 'Elena-Cortez M', 'Chiprut R', 'Del Conde Ovadia P']","['Instituto Mexicano de Investigacion Clinica, UCLA, Cedars Sinai Medical Center, Los Angeles, California, USA.']",['spa'],"['English Abstract', 'Journal Article', 'Review']",Mexico,Gac Med Mex,Gaceta medica de Mexico,0010333,,IM,"['Causality', 'Humans', 'Obesity/classification/complications/epidemiology/*etiology/*therapy']",,,,,2001/08/25 10:00,2002/03/19 10:01,['2001/08/25 10:00'],"['2001/08/25 10:00 [pubmed]', '2002/03/19 10:01 [medline]', '2001/08/25 10:00 [entrez]']",,ppublish,Gac Med Mex. 2001 Jul-Aug;137(4):323-34.,,,,,,,53,,La obesidad en el siglo XXI. Avances en la etiopatogenia y tratamiento.,,,,,,,,,,,
23631209,NLM,MEDLINE,20130730,20130501,0047-1852 (Print) 0047-1852 (Linking),71,2,2013 Feb,"[Symptomatic obesity--classification, pathogenesis, diagnosis and therapy].",291-6,,"Obesity is mainly classified by two types, such as simple obesity and symptomatic obesity. Symptomatic obesity is not so rare, which occupies by approximately 10-20% among whole obese patients. Especially, when we encounter high-grade obese patients with BMI more than 35 kg/m2, we have to carefully find out masked symptomatic obesity through medical examinations. Symptomatic obesity is divided into 4 groups according to its pathogenesis, that include endocrinological-, hereditary-, central- and pharmacological obesity. Therapy to the disorder is, in principle, the treatment to original diseases leading to obesity, in addition to dietary-, exercise-, behavioral therapy required to simple obesity. We want to emphasize that the adequate discovery of symptomatic obesity, by our careful medical checks and various laboratory examinations could determine QOL and life prognosis of those obese patients.","['Inukai, Toshihiko']",['Inukai T'],"['Department of Internal Medicine (Diabetes, Endocrinology and Hematology), Dokkyo Medical University Koshigaya Hospital.']",['jpn'],"['Case Reports', 'English Abstract', 'Journal Article', 'Review']",Japan,Nihon Rinsho,Nihon rinsho. Japanese journal of clinical medicine,0420546,,IM,"['Adult', 'Behavior Therapy', 'Body Mass Index', 'Female', 'Humans', 'Obesity/classification/*diagnosis/etiology/*therapy', 'Quality of Life', 'Risk Factors', 'Treatment Outcome']",,,,,2013/05/02 06:00,2013/07/31 06:00,['2013/05/02 06:00'],"['2013/05/02 06:00 [entrez]', '2013/05/02 06:00 [pubmed]', '2013/07/31 06:00 [medline]']",,ppublish,Nihon Rinsho. 2013 Feb;71(2):291-6.,,,,,,,,,,,,,,,,,,,,
8353906,NLM,MEDLINE,19930923,20190623,0009-7322 (Print) 0009-7322 (Linking),88,3,1993 Sep,Obesity. Workshop III. AHA Prevention Conference III. Behavior change and compliance: keys to improving cardiovascular health.,1391-6,,"The workshop provided the opportunity to discuss issues and develop and integrate ideas. The following recommendations for public policies, education programs, and high-priority research initiatives were developed: Recommendations for Public Policies: Focus on prevention by requiring school programs to emphasize appropriate diet, physical activity, and general health guidance to promote cardiovascular health and prevent disease through federal funding. Provide better access to exercise (city planning, work-site interventions). Influence food availability and accessibility. Influence reimbursement policies for effective early intervention and prevention strategies for obesity. Reevaluate policies for use of drugs in the treatment of obesity. Recommendations for Education Programs: Sponsor scientific workshop to: Define the most appropriate weight standards for prevention and treatment. Identify who should lose weight and why, when, and how. Promote the fact that obesity is an important health risk factor, even at moderate levels, and that excess visceral fat is particularly hazardous. Target health care professionals, consumers, and the media for education about: Nature of obesity as a heterogeneous syndrome. Recommendations for diet, exercise, behavioral interventions, drugs, and surgery. Recognition of special needs of populations of different ethnicity, gender, age, etc. State-of-the-art treatment and treatment programs. High-Priority Research Initiatives: Build better bridges between basic research and treatment/prevention practices. Acknowledge that obesity is a heterogeneous syndrome that may best be characterized as different obesities. Research on defining subtypes. Implications for etiology and treatment. Better characterization of genotypes and phenotypes. Study the effects of weight loss, weight gain,and weight cycling on medical and psychosocial outcomes and mortality.(ABSTRACT TRUNCATED AT 250 WORDS)","['St Jeor, S T', 'Brownell, K D', 'Atkinson, R L', 'Bouchard, C', 'Dwyer, J', 'Foreyt, J P', 'Heber, D', 'Kris-Etherton, P', 'Stern, J S', 'Willett, W']","['St Jeor ST', 'Brownell KD', 'Atkinson RL', 'Bouchard C', 'Dwyer J', 'Foreyt JP', 'Heber D', 'Kris-Etherton P', 'Stern JS', 'Willett W', 'et al.']",,['eng'],"['Consensus Development Conference', 'Journal Article', 'Review']",United States,Circulation,Circulation,0147763,,IM,"['Animals', 'Body Weight', 'Cardiovascular Diseases/epidemiology/*prevention & control', 'Diet, Reducing', 'Female', 'Humans', '*Life Style', 'Male', 'Obesity/epidemiology/*prevention & control', 'Risk Factors']",,,,,1993/09/01 00:00,1993/09/01 00:01,['1993/09/01 00:00'],"['1993/09/01 00:00 [pubmed]', '1993/09/01 00:01 [medline]', '1993/09/01 00:00 [entrez]']",['10.1161/01.cir.88.3.1391 [doi]'],ppublish,Circulation. 1993 Sep;88(3):1391-6. doi: 10.1161/01.cir.88.3.1391.,,,,,,,33,,,,,,,,,,,,,
9017277,NLM,MEDLINE,19970403,20190905,0300-5208 (Print) 0300-5208 (Linking),201,,1996,Genetics of obesity in humans: current issues.,"108-15; discussion 115-7, 188-93",,"During the last decade, we have begun to understand some of the reasons why people become obese as assessed by excess body mass for height or excess total body fat content. Obesity frequently aggregates in families. However, this familial resemblance is caused not only by genetic effects but also by lifestyle, and environmental and cultural factors. Thus the genetic heritability of the obesity phenotypes accounts for up to 50% of the age- and gender-adjusted phenotypic variances. These results have been confirmed by overfeeding and negative energy balance studies. The effects of single segregating genes can be detected only under the correct experimental conditions. Most scientists in the area believe that these genes can be identified and that the DNA mutations associated with human obesities will be uncovered. Indeed, association and linkage studies, quantitative trait loci and positional cloning research strategies, and transgenic mouse models are sufficiently promising to suggest that these aims can be achieved. A review of the evidence reported thus far reveals that there are already four loci with strong evidence of linkage with obesity phenotypes in humans.","['Bouchard, C']",['Bouchard C'],"['Physical Activity Sciences Laboratory, Laval University, Sainte-Foy, Quebec, Canada.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Netherlands,Ciba Found Symp,Ciba Foundation symposium,0356636,,IM,"['Animals', 'Body Mass Index', 'Family', 'Genotype', 'Humans', 'Hyperphagia/complications', 'Obesity/epidemiology/*genetics', 'Phenotype', 'Prevalence', 'Risk Factors']",,,,,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",['10.1002/9780470514962.ch7 [doi]'],ppublish,"Ciba Found Symp. 1996;201:108-15; discussion 115-7, 188-93. doi: 10.1002/9780470514962.ch7.",,,,,,,14,,,,,,,,,,,,,
17585631,NLM,MEDLINE,20070815,20070625,1660-9379 (Print) 1660-9379 (Linking),3,111,2007 May 16,"[Childhood obesity: definition, consequences, and prevalence].",1262-9,,"Since the 1980s, an epidemic of obesity is occurring worldwide among adults and children. The body mass index (BMI) is useful to determine whether a child is overweight or obese because BMI relates strongly to body fat mass. However, contrary to adults, BMI changes with sex and age in children. Sex- and age-specific norms for BMI of the International obesity task force (IOTF) are now widely used. Approximately 15-20% of schoolchildren in Switzerland are currently overweight (or obese) and 2-5% are obese. Obesity is a major public health challenge. It is associated with numerous short and long term health hazards (in particular cardiovascular and metabolic disorders, e.g. diabetes) and it tracks form childhood throughout adulthood. This emphasizes the need for programs and polices aimed at preventing paediatric obesity.","['Chiolero, A', 'Lasserre, A M', 'Paccaud, F', 'Bovet, P']","['Chiolero A', 'Lasserre AM', 'Paccaud F', 'Bovet P']","['Institut universitaire de medecine sociale et preventive (IUMSP), Groupe cardiovasculaire et transition sanitaire, 1004 Lausanne. arnaud.chiolero@chuv.ch']",['fre'],"['English Abstract', 'Journal Article', 'Review']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Body Mass Index', 'Child', 'Humans', 'Obesity/*complications/diagnosis/*epidemiology', 'Prevalence']",,,,,2007/06/26 09:00,2007/08/19 09:00,['2007/06/26 09:00'],"['2007/06/26 09:00 [pubmed]', '2007/08/19 09:00 [medline]', '2007/06/26 09:00 [entrez]']",,ppublish,Rev Med Suisse. 2007 May 16;3(111):1262-9.,,,,,,,39,,"L'obesite chez les enfants: definition, consequences et prevalence.",,,,,,,,,,,
25725222,NLM,MEDLINE,20151116,20150301,1944-7930 (Electronic) 1539-6509 (Linking),19,103,2015 Feb,The guts of obesity: progress and challenges in linking gut microbes to obesity.,81-8,,"The sharp rise in prevalence of obesity in recent decades has been suggestively labeled as an ""epidemic,"" and the lack of fully explanatory causal factors has challenged existing understandings of obesity's etiology from a purely energetic standpoint. Much recent attention has been focused on the microbial members of the human gut for insights into their role in potentially causing or promoting obesity. The human gut is home to trillions of microbes, among which hundreds of distinct species of bacteria interact to form the human gut microbiome, and numerous studies in humans and animal models have linked shifts in the gut microbiome to obesity. In this review we explore contemporary understandings of the relationship between obesity and the microbiome from a high-level ecological and functional perspective, along with a survey of recently proposed interventions. We highlight areas of consensus and areas for further study in the field.","['Al-Ghalith, Gabriel A', 'Vangay, Pajau', 'Knights, Dan']","['Al-Ghalith GA', 'Vangay P', 'Knights D']","['Biomedical Informatics and Computational Biology, University of Minnesota, Minneapolis, MN 55455, USA.', 'Biomedical Informatics and Computational Biology, University of Minnesota, Minneapolis, MN 55455, USA.', 'Biotechnology Institute and Department of Computer Science and Engineering, University of Minnesota, Saint Paul, MN 55108, USA.']",['eng'],"['Journal Article', 'Review']",United States,Discov Med,Discovery medicine,101250006,,IM,"['Animals', 'Bacteria/classification', 'Gastrointestinal Tract/*microbiology/pathology', 'Humans', '*Microbiota', 'Obesity/*microbiology']",,,,,2015/03/01 06:00,2015/11/17 06:00,['2015/03/01 06:00'],"['2015/03/01 06:00 [entrez]', '2015/03/01 06:00 [pubmed]', '2015/11/17 06:00 [medline]']",,ppublish,Discov Med. 2015 Feb;19(103):81-8.,,,,,,,,,,,,,,,,,,,,
15166905,NLM,MEDLINE,20040923,20191108,1050-642X (Print) 1050-642X (Linking),14,3,2004 May,Role of the physician in childhood obesity.,161-8,,"OBJECTIVE: To suggest the role of the practicing physician in examining and treating childhood obesity. How should obesity be determined at clinical examination? Is there an obesity epidemic? What is the likely influence of obesity upon current and future health? What are the causes of obesity, and what does this imply for prevention and treatment? DATA SOURCES: Relevant articles in Medline and personal files. DATA SYNTHESIS: The 80th and 95th percentiles of body mass index and skinfold readings provide the most commonly accepted indices of overweight and obesity in the child. Over the last 20 years, the proportions of overweight and obese children have increased in both indigenous populations and most developed societies. Current methods of assessing physical activity and diet during childhood lack the precision to establish the primary cause of the obesity epidemic, but correlational analysis shows a close relationship between body fat content and a decline in daily energy expenditures. Immediate consequences of childhood obesity include an increased prevalence of atherosclerotic plaques, hypertension, and an adverse lipid profile, with a poor self-image that limits participation in physical activity. Tracking is such that many obese children become obese adults, and in consequence, the long-term risks of cardiovascular and all-cause deaths are increased. The prevention of obesity is easier than its cure. A combination of increased lifestyle activities, less sedentary behavior, and dietary modification seems the most effective approach. This should be supported by the use of behavioral modification techniques and changes in the urban environment that encourage an active lifestyle. CONCLUSIONS: The pediatric physician can contribute to the control of obesity by monitoring body mass index and skinfold thicknesses in all patients. Children above the 50th percentile of body fat need dietary modification and a greater amount of moderate physical activity. Physicians should also advocate quality daily physical education and an environment that encourages adoption of an active lifestyle.","['Shephard, Roy J']",['Shephard RJ'],"['Faculty of Physical and Health Education, University of Toronto, Toronto, Canada. royjshep@shaw.ca']",['eng'],"['Comparative Study', 'Journal Article', 'Review']",United States,Clin J Sport Med,Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine,9103300,,IM,"['Adolescent', 'Body Mass Index', 'Child', 'Female', 'Humans', 'Male', '*Obesity/diagnosis/epidemiology/genetics/therapy', ""*Physician's Role"", 'Risk Reduction Behavior']",,,,,2004/05/29 05:00,2004/09/24 05:00,['2004/05/29 05:00'],"['2004/05/29 05:00 [pubmed]', '2004/09/24 05:00 [medline]', '2004/05/29 05:00 [entrez]']","['00042752-200405000-00009 [pii]', '10.1097/00042752-200405000-00009 [doi]']",ppublish,Clin J Sport Med. 2004 May;14(3):161-8. doi: 10.1097/00042752-200405000-00009.,,,,,,,91,,,,,,,,,,,,,
10334083,NLM,MEDLINE,19990614,20191103,0098-6151 (Print) 0098-6151 (Linking),99,4 Suppl,1999 Apr,Advances in the understanding and treatment of obesity.,S7-11,,"The epidemic of obesity in the United States has major consequences for society. Healthcare providers need to have an appreciation for obesity's complexity and related multiple comorbid medical problems. This article reviews the epidemiology, definitions, and assessment of obesity with emphasis on its clinical consequences. In addition, current techniques in evaluating and treating the obese patient are also described.","['Still, C D']",['Still CD'],"['High Risk Obesity Clinic, PennState Geisinger Health System, Danville 17822-2111, USA. CStill@psghs.edu']",['eng'],"['Journal Article', 'Review']",United States,J Am Osteopath Assoc,The Journal of the American Osteopathic Association,7503065,,IM,"['Comorbidity', 'Female', 'Humans', 'Male', '*Obesity/complications/epidemiology/etiology/prevention & control', 'Pregnancy', 'Pregnancy Complications', 'United States/epidemiology']",,,,,1999/05/20 00:00,1999/05/20 00:01,['1999/05/20 00:00'],"['1999/05/20 00:00 [pubmed]', '1999/05/20 00:01 [medline]', '1999/05/20 00:00 [entrez]']",['10.7556/jaoa.1999.99.4.s7 [doi]'],ppublish,J Am Osteopath Assoc. 1999 Apr;99(4 Suppl):S7-11. doi: 10.7556/jaoa.1999.99.4.s7.,,,,,,,28,,,,,,,,,,,,,
19375759,NLM,MEDLINE,20090610,20090518,1532-8600 (Electronic) 0026-0495 (Linking),58,6,2009 Jun,Is obesity associated with lower body temperatures? Core temperature: a forgotten variable in energy balance.,871-6,10.1016/j.metabol.2009.02.017 [doi],"The global increase in obesity, along with the associated adverse health consequences, has heightened interest in the fundamental causes of excessive weight gain. Attributing obesity to ""gluttony and sloth"", blaming the obese for overeating and limiting physical activity, oversimplifies a complex problem, since substantial differences in metabolic efficiency between lean and obese have been decisively demonstrated. The underlying physiological basis for these differences have remained poorly understood. The energetic requirements of homeothermy, the maintenance of a constant core temperature in the face of widely divergent external temperatures, accounts for a major portion of daily energy expenditure. Changes in body temperature are associated with significant changes in metabolic rate. These facts raise the interesting possibility that differences in core temperature may play a role in the pathophysiology of obesity. This review explores the hypothesis that lower body temperatures contribute to the enhanced metabolic efficiency of the obese state.","['Landsberg, Lewis', 'Young, James B', 'Leonard, William R', 'Linsenmeier, Robert A', 'Turek, Fred W']","['Landsberg L', 'Young JB', 'Leonard WR', 'Linsenmeier RA', 'Turek FW']","['Northwestern University Comprehensive Center on Obesity, Chicago, IL 60611, USA. l-landsberg@northwestern.edu']",['eng'],"['Journal Article', 'Review']",United States,Metabolism,Metabolism: clinical and experimental,0375267,,IM,"['Basal Metabolism', '*Body Temperature Regulation', '*Energy Metabolism', 'Humans', 'Obesity/etiology/*physiopathology']",,,,,2009/04/21 09:00,2009/06/11 09:00,['2009/04/21 09:00'],"['2008/08/21 00:00 [received]', '2009/02/03 00:00 [accepted]', '2009/04/21 09:00 [entrez]', '2009/04/21 09:00 [pubmed]', '2009/06/11 09:00 [medline]']","['S0026-0495(09)00085-7 [pii]', '10.1016/j.metabol.2009.02.017 [doi]']",ppublish,Metabolism. 2009 Jun;58(6):871-6. doi: 10.1016/j.metabol.2009.02.017.,,,,,,,69,,,,,,,,,,,,,
23244211,NLM,MEDLINE,20140429,20130220,1935-990X (Electronic) 0003-066X (Linking),68,2,2013 Feb-Mar,"The modern obesity epidemic, ancestral hunter-gatherers, and the sensory/reward control of food intake.",88-96,10.1037/a0030684 [doi],"Obesity has become a true pandemic. In the United States, over two thirds of adults are obese or overweight. The prevalence of obesity has doubled since 1980. The increase in the prevalence of obese and overweight individuals has happened too rapidly for it to be due to an alteration in the genome. The gastrointestinal, sensory (taste and olfaction), and brain feeding mechanisms that developed during the past 2 million years were highly adaptive for ancestral hunter-gatherers living in an environment with limited high-density foods and periods of food deprivation. Today, however, humans in industrialized countries live in what has been called an ""obesogenic environment."" The nonhomeostatic brain reward circuitry that was acquired during evolution to seek out and eat as many nutritionally high-dense foods as possible is able to overrule the physiological inhibitory mechanisms that were designed to limit meal size and weight gain.","['King, Bruce M']",['King BM'],"['Department of Psychology, Clemson University, SC 29634, USA. bking2@clemson.edu']",['eng'],"['Journal Article', 'Review']",United States,Am Psychol,The American psychologist,0370521,,IM,"['*Biological Evolution', 'Eating/*psychology', 'Epidemics/*statistics & numerical data', 'Humans', 'Obesity/epidemiology/etiology/*physiopathology/psychology', '*Reward', 'United States/epidemiology']",,,,,2012/12/19 06:00,2014/04/30 06:00,['2012/12/19 06:00'],"['2012/12/19 06:00 [entrez]', '2012/12/19 06:00 [pubmed]', '2014/04/30 06:00 [medline]']","['2012-33465-001 [pii]', '10.1037/a0030684 [doi]']",ppublish,Am Psychol. 2013 Feb-Mar;68(2):88-96. doi: 10.1037/a0030684. Epub 2012 Dec 17.,,20121217,,"['(c) 2013 APA, all rights reserved.']",,,,,,,,,,,,,,,,
11533880,NLM,MEDLINE,20011204,20061115,0937-2032 (Print) 0937-2032 (Linking),51,9-10,2001 Sep-Oct,[Psychosomatic aspects of obesity].,336-49,,"Overweight and obesity are widespread in industrial countries and are considered to be serious health problems in these countries. Population-based studies in Germany have shown that between 12 and 18 % of the adult population is obese. Overweight and obesity are accompanied by a large spectrum of health disorders and extreme psychosocial burdens. Besides the hereditary disposition, the life style including both intra- and inter-individual aspects determines the complex etiology of obesity. Within the collective sample of the obese, one sub-sample is the ""psychogenic obese"" i. e. in which psychiatric disorders lead to a change in both eating and exercise behavior, the result then being a continuous positive energy reserve in the form of overweight and obesity. The paper describes the psychosocial problems of obese persons; especially the controverse question with regard to psychiatric morbidity in general and eating disorders in particular are emphasized. The results of past, mainly behavioral oriented treatment concepts are presented and various concepts beyond single school orientation are discussed. Finally, the problems with psychiatric psychological diagnostics in those obese patients with the request for surgical weight reduction within the context of insurance coverage and the surgeons are presented.","['Herpertz, S', 'Saller, B']","['Herpertz S', 'Saller B']","['Klinik fur Psychotherapie und Psychosomatik, Rheinische Kliniken, Universitat Essen. stephan.herpertz@uni-essen.de']",['ger'],"['English Abstract', 'Journal Article', 'Review']",Germany,Psychother Psychosom Med Psychol,"Psychotherapie, Psychosomatik, medizinische Psychologie",8002823,,IM,"['Animals', 'Humans', 'Obesity/complications/epidemiology/*physiopathology', '*Psychosomatic Medicine']",,,,,2001/09/05 10:00,2002/01/05 10:01,['2001/09/05 10:00'],"['2001/09/05 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/09/05 10:00 [entrez]']",['10.1055/s-2001-16901 [doi]'],ppublish,Psychother Psychosom Med Psychol. 2001 Sep-Oct;51(9-10):336-49. doi: 10.1055/s-2001-16901.,,,,,,,170,,Psychosomatische Aspekte der Adipositas.,,,,,,,,,,,
15927311,NLM,MEDLINE,20051219,20161018,0248-8663 (Print) 0248-8663 (Linking),26,10,2005 Oct,[Genetics of human obesity].,802-11,,"BACKGROUND: Both genetic and environmental aspects are recognized in the obesity field but we are not able to elucidate multiple genes and gene-environment interactions with the present resources and tools used in the study of this complex disease. The purpose of this paper is to present some examples of the knowledge acquired in the field of obesity genetics and the new ongoing tools and developments that aim at studying the contribution of genes to obesity and their response to environmental changes. MAIN POINTS: In rare cases of monogenic obesities, genetic tools have proved extremely powerful for identifying the genes responsible and for defining new syndromes. However, in common obesity, most studies include the search for genotype-phenotype associations without taking into account the influence of environment (diet, sedentary lifestyle) in the relationship. Among the limitations to this integrated approach, one can cite the difficulty of having large enough samples as well as biocomputing tools that are still in their infancy for accessing the question of multiple interactions with no ""a priori hypotheses"". This picture will probably change rapidly in the future. PERSPECTIVE: Large databases and DNA and biological sample banks will be available with updated environmental information and precise phenotypes thanks especially to European working groups. The capacity for studying multiple genes at once at the DNA or RNA levels is rapidly growing. Finally, tremendous progress in biocomputing will allow the integration of information from different sources (i.e. environment, phenotype, genotype, gene expression) and thus improve our ability to deal with complexity.","['Lubrano-Berthelier, C', 'Clement, K']","['Lubrano-Berthelier C', 'Clement K']","['Inserm Avenir, Paris EA3502, universite Pierre-et-Marie-Curie, Paris VI, France.']",['fre'],"['Comparative Study', 'English Abstract', 'Journal Article', 'Review']",France,Rev Med Interne,La Revue de medecine interne,8101383,"['0 (Leptin)', '0 (Receptor, Melanocortin, Type 4)', '0 (Receptors, Cell Surface)', '0 (Receptors, Leptin)']",IM,"['Adult', 'Animals', 'Child', 'Cohort Studies', 'Disease Models, Animal', 'Environment', 'Female', 'Forecasting', 'Gene Expression', 'Genetic Predisposition to Disease', 'Genotype', 'Homeostasis', 'Humans', 'Infant', 'Leptin/blood/genetics/therapeutic use', 'Male', 'Mice', 'Mutation', 'Obesity/drug therapy/etiology/*genetics/metabolism/prevention & control', 'Phenotype', 'Polymorphism, Genetic', 'Receptor, Melanocortin, Type 4/genetics', 'Receptors, Cell Surface/genetics', 'Receptors, Leptin', 'Risk', 'Syndrome']",,,,,2005/06/02 09:00,2005/12/20 09:00,['2005/06/02 09:00'],"['2005/01/06 00:00 [received]', '2005/03/29 00:00 [accepted]', '2005/06/02 09:00 [pubmed]', '2005/12/20 09:00 [medline]', '2005/06/02 09:00 [entrez]']","['S0248-8663(05)00167-0 [pii]', '10.1016/j.revmed.2005.03.017 [doi]']",ppublish,Rev Med Interne. 2005 Oct;26(10):802-11. doi: 10.1016/j.revmed.2005.03.017.,,,,,,,53,,Genetique de l'obesite humaine.,,,,,,,,,,,
21516909,NLM,MEDLINE,20110518,20191112,1753-3740 (Print) 1753-3740 (Linking),25,1,2011 Mar,The epidemiology and aetiology of obesity: a global challenge.,1-9,,"Positive energy imbalance Energy imbalance leads to obesity. A majority of the US population is overweight, a third obese and nearly 5% morbidly obese. In the developing world, this problem continues to evolve in an rapid manner, creating challenges for already burdened health systems. In many instances, the environment contributes to the problem. Factors ranging from the availability of calorie-dense foods, decreased time spent in physical activities, technologically assisted household chores to time spent watching television, all have some contribution to the problem. Much more needs to be done to control this obesity epidemic, both from a public health as well as a communal-expense perspective. Forced misuse of economic resources and wasted potential lives should drive a better coordinated effort to control what could possibly be the biggest health challenge of the 21st century.","['Selassie, Meron', 'Sinha, Ashish C']","['Selassie M', 'Sinha AC']","['University of Pennsylvania School of Medicine, Philadelphia, PA 19104-4283, USA.']",['eng'],"['Journal Article', 'Review']",Netherlands,Best Pract Res Clin Anaesthesiol,Best practice & research. Clinical anaesthesiology,101121446,,IM,"['Adult', 'Child', 'Energy Intake', 'Energy Metabolism/physiology', 'Environment', 'Humans', 'Life Style', 'Obesity/complications/*epidemiology/*etiology/genetics']",,,,,2011/04/27 06:00,2011/05/19 06:00,['2011/04/27 06:00'],"['2011/04/27 06:00 [entrez]', '2011/04/27 06:00 [pubmed]', '2011/05/19 06:00 [medline]']","['S1521-6896(11)00003-6 [pii]', '10.1016/j.bpa.2011.01.002 [doi]']",ppublish,Best Pract Res Clin Anaesthesiol. 2011 Mar;25(1):1-9. doi: 10.1016/j.bpa.2011.01.002.,,,,,,,,,,,,,,,,,,,,
37686443,NLM,MEDLINE,20230911,20230911,1422-0067 (Electronic) 1422-0067 (Linking),24,17,2023 Sep 4,Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans.,,10.3390/ijms241713636 [doi] 13636,"The endocannabinoid system (ECS) regulates various physiological processes, including energy homeostasis and kidney function. ECS upregulation in obese animals and humans suggests a potential link to obesity-induced chronic kidney disease (CKD). However, obesity-induced ECS changes in the kidney are mainly studied in rodents, leaving the impact on obese humans unknown. In this study, a total of 21 lean and obese males (38-71 years) underwent a kidney biopsy. Biochemical analysis, histology, and endocannabinoid (eCB) assessment were performed on kidney tissue and blood samples. Correlations between different parameters were evaluated using a comprehensive matrix. The obese group exhibited kidney damage, reflected in morphological changes, and elevated kidney injury and fibrotic markers. While serum eCB levels were similar between the lean and obese groups, kidney eCB analysis revealed higher anandamide in obese patients. Obese individuals also exhibited reduced expression of cannabinoid-1 receptor (CB1R) in the kidney, along with increased activity of eCB synthesizing and degrading enzymes. Correlation analysis highlighted connections between renal eCBs, kidney injury markers, obesity, and related pathologies. In summary, this study investigates obesity's impact on renal eCB ""tone"" in humans, providing insights into the ECS's role in obesity-induced CKD. Our findings enhance the understanding of the intricate interplay among obesity, the ECS, and kidney function.","['Permyakova, Anna', 'Rothner, Ariel', 'Knapp, Sarah', 'Nemirovski, Alina', 'Ben-Zvi, Danny', 'Tam, Joseph']","['Permyakova A', 'Rothner A', 'Knapp S', 'Nemirovski A', 'Ben-Zvi D', 'Tam J']","['Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.', 'Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.', 'Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah Medical School-The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.', 'Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.', 'Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel Canada, Hadassah Medical School-The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.', 'Obesity and Metabolism Laboratory, The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112001, Israel.']",['eng'],['Journal Article'],Switzerland,Int J Mol Sci,International journal of molecular sciences,101092791,"['0 (Endocannabinoids)', '3G6A5W338E (Caffeine)']",IM,"['Animals', 'Male', 'Humans', '*Endocannabinoids', 'Kidney', '*Renal Insufficiency, Chronic/etiology', 'Caffeine', 'Obesity/complications']",PMC10487429,['NOTNLM'],"['chronic kidney disease', 'endocannabinoid system', 'obesity']",['The authors declare no conflict of interest.'],2023/09/09 11:43,2023/09/11 06:43,['2023/09/09 01:14'],"['2023/07/06 00:00 [received]', '2023/08/28 00:00 [revised]', '2023/09/02 00:00 [accepted]', '2023/09/11 06:43 [medline]', '2023/09/09 11:43 [pubmed]', '2023/09/09 01:14 [entrez]']","['ijms241713636 [pii]', 'ijms-24-13636 [pii]', '10.3390/ijms241713636 [doi]']",epublish,Int J Mol Sci. 2023 Sep 4;24(17):13636. doi: 10.3390/ijms241713636.,['158/18/Israel Science Foundation/'],20230904,,,"['ORCID: 0000-0003-0247-742X', 'ORCID: 0009-0005-4501-6916', 'ORCID: 0000-0002-2598-0119', 'ORCID: 0000-0002-8697-9744', 'ORCID: 0000-0002-0948-0093']",,,,,,,,,,,,,,,
19777926,NLM,MEDLINE,20091014,20090925,0362-4064 (Print) 0362-4064 (Linking),78,9,2009 Sep,Morbidly watching obesity's growth.,4,,,"['Laws, Jerry']",['Laws J'],,['eng'],['Editorial'],United States,Occup Health Saf,"Occupational health & safety (Waco, Tex.)",7610574,,IM,"['Behavioral Risk Factor Surveillance System', 'Exercise', 'Humans', 'Obesity/*epidemiology/*prevention & control', '*Occupational Health', 'Risk Factors']",,,,,2009/09/26 06:00,2009/10/15 06:00,['2009/09/26 06:00'],"['2009/09/26 06:00 [entrez]', '2009/09/26 06:00 [pubmed]', '2009/10/15 06:00 [medline]']",,ppublish,Occup Health Saf. 2009 Sep;78(9):4.,,,,,,,,,,,,,,,,,,,,
16229869,NLM,MEDLINE,20060117,20051201,0031-9384 (Print) 0031-9384 (Linking),86,5,2005 Dec 15,Factors promoting and ameliorating the development of obesity.,633-9,,"Obesity develops when energy intake exceeds expenditure. A constant neural, metabolic and hormonal ""conversation"" between the brain and periphery underlies the defense of a given level of adiposity. For the majority of humans, obesity becomes a permanent condition once it develops, possibly because of irreversible changes in the distributed network of specialized ""metabolic sensing"" neurons which regulate energy intake, expenditure and storage. Plasma leptin and insulin are catabolic hormones whose levels reflect the amount of adiposity and act as signal to metabolic sensing neurons. Obesity-prone individuals have an inborn reduction in their catabolic responses to glucose, leptin and insulin. These raised metabolic and hormonal sensing thresholds precede the development of obesity and predispose individuals to become and remain obese on energy dense diets. High fat diets exacerbate this problem by independently inhibiting central insulin and leptin signaling. In addition, intake of highly palatable diets overrides the homeostatic controls of ingestion because it is regulated by neural systems mediating reward and motivation. The genetic predisposition to become obese is accentuated in offspring of mothers who are obese or nutritionally deprived during gestation and/or lactation or by overfeeding during the early postnatal period. On the other hand, chronic stress and illness can both reduce adiposity, as does gastric bypass surgery. However, for chronic obesity treatment, both exercise and pharmacotherapy help but both must be continued chronically to provide sustained lowering of body weight in obese subjects. Given the permanent upward resetting of body weight set-point that occurs when genetically predisposed individuals become obese, identification of factors that prevent the development of obesity is likely to be the most successful means of ameliorating the current obesity epidemic.","['Levin, Barry E']",['Levin BE'],"['385 Tremont Avenue, VA Medical Center, Neurology Service (127C) E.Orange, NJ 07018-1095, United States. levin@umdnj.edu']",['eng'],"['Journal Article', 'Review']",United States,Physiol Behav,Physiology & behavior,0151504,,IM,"['Energy Metabolism/physiology', 'Homeostasis/physiology', 'Humans', 'Obesity/*etiology/physiopathology/prevention & control']",,,,,2005/10/19 09:00,2006/01/18 09:00,['2005/10/19 09:00'],"['2005/07/05 00:00 [received]', '2005/08/25 00:00 [accepted]', '2005/10/19 09:00 [pubmed]', '2006/01/18 09:00 [medline]', '2005/10/19 09:00 [entrez]']","['S0031-9384(05)00391-4 [pii]', '10.1016/j.physbeh.2005.08.054 [doi]']",ppublish,Physiol Behav. 2005 Dec 15;86(5):633-9. doi: 10.1016/j.physbeh.2005.08.054. Epub 2005 Oct 17.,,20051017,,,,,123,,,,,,,,,,,,,
35960426,NLM,MEDLINE,20221018,20221104,1873-4626 (Electronic) 1091-255X (Linking),26,10,2022 Oct,Obesity Worsens Local and Systemic Complications of Necrotizing Pancreatitis and Prolongs Disease Course.,2128-2135,10.1007/s11605-022-05383-0 [doi],"BACKGROUND: Obesity is epidemic in the USA. Limited data exist examining obesity's influence on necrotizing pancreatitis (NP) disease course. METHODS: Retrospective review of prospectively maintained database of 571 adult necrotizing pancreatitis patients treated between 2007 and 2018. Patients were grouped according to body mass index (BMI) at disease onset. Patient characteristics, necrotizing pancreatitis course, and outcomes were compared between non-obese (BMI < 30) and obese (BMI > 30) patients. RESULTS: Among 536 patients with BMI data available, 304 (57%) were obese (BMI > 30), and 232 (43%) were non-obese (BMI < 30). NP etiology in the obese group was more commonly biliary (55% versus 46%, p = 0.04) or secondary to hypertriglyceridemia (10% versus 2%, p < 0.001) and less commonly alcohol (17% versus 26%, p = 0.01). Obese patients had a higher incidence of baseline comorbid disease. The CT severity index was similar between groups though obese patients had a higher rate of > 50% pancreatic gland necrosis (27% versus 19%, p = 0.02). The rates of infected necrosis and organ failure were higher among obese patients. Percutaneous drainage was more common in obese patients. Time to first necrosis intervention was earlier with increasing BMI. NP disease duration was longer in obese patients. The overall mortality rate of non-obese and obese patients did not differ. However, mortality rate increased with increasing BMI. CONCLUSION: Necrotizing pancreatitis in obese patients is characterized by a prolonged disease course, a higher risk of organ failure, infected necrosis, and the need for early necrosis-related intervention. Mortality increases with increasing BMI.","['McGuire, Sean P', 'Keller, Sydney L', 'Maatman, Thomas K', 'Lewellen, Kyle A', 'Ceppa, Eugene P', 'House, Michael G', 'Nakeeb, Attila', 'Nguyen, Trang K', 'Quigley, Stephen N', 'Schmidt, C Max', 'Zyromski, Nicholas J']","['McGuire SP', 'Keller SL', 'Maatman TK', 'Lewellen KA', 'Ceppa EP', 'House MG', 'Nakeeb A', 'Nguyen TK', 'Quigley SN', 'Schmidt CM', 'Zyromski NJ']","['Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA.', 'Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA.', 'Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA.', 'Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA.', 'Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA.', 'Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA.', 'Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA.', 'Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA.', 'Department of Surgery, Eastern Health, St. Johns, NL, Canada.', 'Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA.', 'Department of Surgery, Indiana University School of Medicine and Indiana University Health, 545 Barnhill Dr., Emerson Hall 519, Indianapolis, IN, 46202, USA. nzyromsk@iupui.edu.']",['eng'],['Journal Article'],United States,J Gastrointest Surg,Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract,9706084,,IM,"['Adult', 'Disease Progression', 'Drainage/adverse effects', 'Humans', 'Necrosis/etiology', 'Obesity/complications', '*Pancreatitis, Acute Necrotizing/surgery/therapy', 'Retrospective Studies']",,,,,2022/08/13 06:00,2022/10/19 06:00,['2022/08/12 11:21'],"['2021/12/07 00:00 [received]', '2022/04/30 00:00 [accepted]', '2022/08/13 06:00 [pubmed]', '2022/10/19 06:00 [medline]', '2022/08/12 11:21 [entrez]']","['10.1007/s11605-022-05383-0 [pii]', '10.1007/s11605-022-05383-0 [doi]']",ppublish,J Gastrointest Surg. 2022 Oct;26(10):2128-2135. doi: 10.1007/s11605-022-05383-0. Epub 2022 Aug 12.,,20220812,,['(c) 2022. The Society for Surgery of the Alimentary Tract.'],,,,,,,,,,,,,,,,
20739012,NLM,MEDLINE,20110107,20211020,1097-6868 (Electronic) 0002-9378 (Print) 0002-9378 (Linking),203,6,2010 Dec,Current knowledge of obesity's effects in the pre- and periconceptional periods and avenues for future research.,525-30,10.1016/j.ajog.2010.06.043 [doi],"The prevalence of obesity is growing among reproductive-age women. This is concerning because obesity has significant health-related consequences. Aside from the long-term risks of diabetes, heart disease, and some types of cancer, obesity poses immediate threats for young women including subfertility and adverse early and late pregnancy outcomes. Epidemiologic and experimental studies demonstrate associations between prepregnancy obesity and poor reproductive outcomes; however, the mechanisms involved are poorly understood. We discuss current knowledge of the pathophysiology of obesity in early reproductive events and how these events may affect reproductive outcomes including fertility and miscarriage risk. We also discuss avenues for future research and interventions to improve reproductive outcomes for obese women.","['Jungheim, Emily S', 'Moley, Kelle H']","['Jungheim ES', 'Moley KH']","['Department of Obstetrics and Gynecology, Washington University, St Louis, MO, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",United States,Am J Obstet Gynecol,American journal of obstetrics and gynecology,0370476,,IM,"['Body Mass Index', 'Female', 'Fertility/*physiology', 'Fetal Development/*physiology', 'Forecasting', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Obesity/*complications/diagnosis', 'Preconception Care', 'Pregnancy', 'Pregnancy Complications/epidemiology/*etiology/physiopathology', '*Pregnancy Outcome', 'Reproductive Techniques, Assisted', 'Research/trends', 'Risk Assessment', 'Severity of Illness Index']",PMC3718032,,,,2010/08/27 06:00,2011/01/08 06:00,['2010/08/27 06:00'],"['2010/04/06 00:00 [received]', '2010/05/18 00:00 [revised]', '2010/06/17 00:00 [accepted]', '2010/08/27 06:00 [entrez]', '2010/08/27 06:00 [pubmed]', '2011/01/08 06:00 [medline]']","['S0002-9378(10)00818-5 [pii]', '10.1016/j.ajog.2010.06.043 [doi]']",ppublish,Am J Obstet Gynecol. 2010 Dec;203(6):525-30. doi: 10.1016/j.ajog.2010.06.043. Epub 2010 Aug 24.,"['P30 DK056341/DK/NIDDK NIH HHS/United States', 'P30 DK056341-10/DK/NIDDK NIH HHS/United States', 'K12HD063086-01/HD/NICHD NIH HHS/United States', 'L50 HD062021/HD/NICHD NIH HHS/United States', 'K12 HD063086/HD/NICHD NIH HHS/United States']",20100824,,"['Copyright (c) 2010 Mosby, Inc. All rights reserved.']",,['NIHMS481192'],,,,,,,,,,,,,,
36762918,NLM,MEDLINE,20230522,20231101,1530-0293 (Electronic) 0090-3493 (Print) 0090-3493 (Linking),51,6,2023 Jun 1,Obesity Paradox and Functional Outcomes in Sepsis: A Multicenter Prospective Study.,742-752,10.1097/CCM.0000000000005801 [doi],"OBJECTIVES: In Asian populations, the correlation between sepsis outcomes and body mass is unclear. A multicenter, prospective, observational study conducted between September 2019 and December 2020 evaluated obesity's effects on sepsis outcomes in a national cohort. SETTING: Nineteen tertiary referral hospitals or university-affiliated hospitals in South Korea. PATIENTS: Adult patients with sepsis ( n = 6,424) were classified into obese ( n = 1,335) and nonobese groups ( n = 5,089). MEASUREMENTS AND RESULTS: Obese and nonobese patients were propensity score-matched in a ratio of 1:1. Inhospital mortality was the primary outcome. After propensity score matching, the nonobese group had higher hospital mortality than the obese group (25.3% vs 36.7%; p < 0.001). The obese group had a higher home discharge rate (70.3% vs 65.2%; p < 0.001) and lower median Clinical Frailty Scale (CFS) (4 vs 5; p = 0.007) at discharge than the nonobese group, whereas the proportion of frail patients at discharge (CFS >/= 5) was significantly higher in the nonobese group (48.7% vs 54.7%; p = 0.011). Patients were divided into four groups according to the World Health Organization body mass index (BMI) classification and performed additional analyses. The adjusted odds ratio of hospital mortality and frailty at discharge for underweight, overweight, and obese patients relative to normal BMI was 1.25 ( p = 0.004), 0.58 ( p < 0.001), and 0.70 ( p = 0.047) and 1.53 ( p < 0.001), 0.80 ( p = 0.095), and 0.60 ( p = 0.022), respectively. CONCLUSIONS: Obesity is associated with higher hospital survival and functional outcomes at discharge in Asian patients with sepsis.","['Yeo, Hye Ju', 'Kim, Tae Hwa', 'Jang, Jin Ho', 'Jeon, Kyeongman', 'Oh, Dong Kyu', 'Park, Mi Hyeon', 'Lim, Chae-Man', 'Kim, Kipoong', 'Cho, Woo Hyun']","['Yeo HJ', 'Kim TH', 'Jang JH', 'Jeon K', 'Oh DK', 'Park MH', 'Lim CM', 'Kim K', 'Cho WH']","['Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.', 'Department of Internal Medicine, School of Medicine, Pusan National University, BusanRepublic of Korea.', 'Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.', 'Department of Internal Medicine, School of Medicine, Pusan National University, BusanRepublic of Korea.', 'Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.', 'Department of Internal Medicine, School of Medicine, Pusan National University, BusanRepublic of Korea.', 'Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, SeoulRepublic of Korea.', 'Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.', 'Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.', 'Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.', 'Department of Statistics, Seoul National University, Seoul, Republic of Korea.', 'Division of Allergy, Pulmonary and Critical Care Medicine, Department of Internal Medicine, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea.', 'Department of Internal Medicine, School of Medicine, Pusan National University, BusanRepublic of Korea.']",['eng'],"['Journal Article', 'Multicenter Study', 'Observational Study', ""Research Support, Non-U.S. Gov't""]",United States,Crit Care Med,Critical care medicine,0355501,,IM,"['Adult', 'Humans', 'Prospective Studies', 'Obesity Paradox', '*Frailty', 'Obesity/complications/epidemiology', '*Sepsis', 'Body Mass Index', 'Retrospective Studies']",PMC10187629,,,"['The authors have disclosed that they do not have any potential conflicts of', 'interest.']",2023/02/11 06:00,2023/05/22 06:42,['2023/02/10 09:03'],"['2023/05/22 06:42 [medline]', '2023/02/11 06:00 [pubmed]', '2023/02/10 09:03 [entrez]']","['00003246-202306000-00005 [pii]', '10.1097/CCM.0000000000005801 [doi]']",ppublish,Crit Care Med. 2023 Jun 1;51(6):742-752. doi: 10.1097/CCM.0000000000005801. Epub 2023 Feb 9.,,20230209,,"['Copyright (c) 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on', 'behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc.']",,,,['Crit Care Med. 2023 Nov 1;51(11):e249-e250. PMID: 37902358'],,['Korean Sepsis Alliance (KSA) Investigators'],,,,,,,,,,
15181025,NLM,MEDLINE,20040719,20220409,0021-972X (Print) 0021-972X (Linking),89,6,2004 Jun,Metabolic and body composition factors in subgroups of obesity: what do we know?,2569-75,,"Obesity is thought to be a heterogeneous disorder with several possible etiologies; therefore, by examining subtypes of obesity we attempt to understand obesity's heterogeneous nature. The purpose of this review was to investigate the roles of metabolic, body composition, and cardiovascular disease risk in subtypes of obesity. We briefly consider two subtypes of obesity that have been identified in the literature. One subset of individuals, termed the metabolically healthy, but obese (MHO), despite having large amounts of fat mass compared with at risk obese individuals shows a normal metabolic profile, but remarkably normal to high levels of insulin sensitivity. Preliminary evidence suggests that this could be due at least in part to lower visceral fat levels and earlier onset of obesity. A second subset, termed the metabolically obese, but normal weight (MONW), present with normal body mass index, but have significant risk factors for diabetes, metabolic syndrome, and cardiovascular disease, which could be due to higher fat mass and plasma triglycerides as well as higher visceral fat and liver content. We also briefly consider the potential role of adipose and gastrointestinal hormonal profiles in MHO and MONW individuals, which could lead to a better understanding of potential factors that may regulate their body composition. This information will eventually be invaluable in helping us understand factors that predispose to or protect obese individuals from metabolic and cardiovascular disease. Collectively, a greater understanding of the MHO and MONW individual has important implications for therapeutic decision making, the characterization of subjects in research protocols, and medical education.","['Karelis, Antony D', 'St-Pierre, David H', 'Conus, Florence', 'Rabasa-Lhoret, Remi', 'Poehlman, Eric T']","['Karelis AD', 'St-Pierre DH', 'Conus F', 'Rabasa-Lhoret R', 'Poehlman ET']","['Departement de Nutrition, Unite Metabolique, Universite de Montreal, Montreal, Quebec, Canada H3T 1A8. antony.karelis@umontreal.ca']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,J Clin Endocrinol Metab,The Journal of clinical endocrinology and metabolism,0375362,,IM,"['Body Composition/*physiology', 'Energy Metabolism/*physiology', 'Humans', 'Obesity/*metabolism/*physiopathology']",,,,,2004/06/08 05:00,2004/07/20 05:00,['2004/06/08 05:00'],"['2004/06/08 05:00 [pubmed]', '2004/07/20 05:00 [medline]', '2004/06/08 05:00 [entrez]']","['89/6/2569 [pii]', '10.1210/jc.2004-0165 [doi]']",ppublish,J Clin Endocrinol Metab. 2004 Jun;89(6):2569-75. doi: 10.1210/jc.2004-0165.,,,,,,,40,,,,,,,,,,,,,
18331420,NLM,MEDLINE,20090114,20220316,1467-789X (Electronic) 1467-7881 (Linking),9,5,2008 Sep,Indirect costs of obesity: a review of the current literature.,489-500,10.1111/j.1467-789X.2008.00472.x [doi],"This study reviews the recent literature on the relationship between obesity and indirect (non-medical) costs. Medline and Web of Science searches were conducted to identify published studies from 1992 to present that report indirect costs by obesity status; 31 studies were included. The indirect costs were grouped into six categories: costs associated with absenteeism, disability, premature mortality, presenteeism, workers' compensation, and total indirect costs. Compared with non-obese workers, obese workers miss more workdays due to illness, injury, or disability. Costs of premature mortality vary substantially across countries. The results for presenteeism and workers' compensation were mixed. More research is needed to determine obesity's causal role in increasing indirect costs, especially for workers' compensation and presenteeism. Cohort and longitudinal study designs should be a priority.","['Trogdon, J G', 'Finkelstein, E A', 'Hylands, T', 'Dellea, P S', 'Kamal-Bahl, S J']","['Trogdon JG', 'Finkelstein EA', 'Hylands T', 'Dellea PS', 'Kamal-Bahl SJ']","['RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709-2194, USA. jtrogdon@rti.org']",['eng'],"['Journal Article', 'Meta-Analysis', 'Review']",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['*Cost of Illness', 'Humans', 'Obesity/economics/mortality/*physiopathology/*psychology', 'Physical Fitness', 'Quality of Life', 'Sick Leave/economics/*statistics & numerical data', ""Workers' Compensation/economics/*statistics & numerical data""]",,,,,2008/03/12 09:00,2009/01/15 09:00,['2008/03/12 09:00'],"['2008/03/12 09:00 [pubmed]', '2009/01/15 09:00 [medline]', '2008/03/12 09:00 [entrez]']","['OBR472 [pii]', '10.1111/j.1467-789X.2008.00472.x [doi]']",ppublish,Obes Rev. 2008 Sep;9(5):489-500. doi: 10.1111/j.1467-789X.2008.00472.x. Epub 2008 Mar 5.,,20080305,,,,,35,,,,,,,,,,,,,
10068710,NLM,MEDLINE,19990322,20071115,0002-838X (Print) 0002-838X (Linking),59,4,1999 Feb 15,Evaluation and treatment of childhood obesity.,"861-8, 871-3",,"The prevalence of childhood obesity in the United States has risen dramatically in the past several decades. Although 25 to 30 percent of children are affected, this condition is underdiagnosed and undertreated. Hormonal and genetic factors are rarely the cause of childhood obesity; unnecessary diagnostic evaluations can be avoided with a careful history and physical examination. Because obese children may suffer life-long physical and emotional consequences, it is imperative to discuss prevention with parents during well-child examinations. All obese children should be screened for cardiac risk factors, as well as for possible orthopedic, dermatologic and psychiatric sequelae. Treatment should be initiated when the trend in increasing weight obviously surpasses the trend in increasing height. Treatment plans should include reasonable weight-loss goals, dietary and physical activity management, behavior modification and family involvement, which may include weight loss in the parents. Anorexiant medications are not approved by the U.S. Food and Drug Administration for use in pediatric populations.","['Moran, R']",['Moran R'],,['eng'],"['Journal Article', 'Review']",United States,Am Fam Physician,American family physician,1272646,,IM,"['Child', 'Humans', '*Obesity/diagnosis/epidemiology/etiology/therapy', 'Patient Education as Topic', 'Prevalence', 'Severity of Illness Index', 'Teaching Materials', 'United States/epidemiology']",,,,,1999/03/09 00:00,1999/03/09 00:01,['1999/03/09 00:00'],"['1999/03/09 00:00 [pubmed]', '1999/03/09 00:01 [medline]', '1999/03/09 00:00 [entrez]']",,ppublish,"Am Fam Physician. 1999 Feb 15;59(4):861-8, 871-3.",,,,,,,35,"['Am Fam Physician. 1999 Feb 15;59(4):758, 761-2. PMID: 10068701']",,,,,,,,,,,,
11011952,NLM,MEDLINE,20010105,20190814,0340-6199 (Print) 0340-6199 (Linking),159 Suppl 1,,2000 Sep,"Overweight and obesity in European children: definition and diagnostic procedures, risk factors and consequences for later health outcome.",S8-13,,"In this article, information on the definition of obesity in childhood and adolescence, its differential diagnosis and its adverse health effects is provided. This information can be considered as a basis for the evaluation of an obese patient. Review of the international and European literature shows that the co-morbidities of childhood obesity cover a large medical area ranging from secondary hormonal disturbances to orthopaedic problems. Most of them have so far been underestimated. However, the most severe problem of an obese child is his or her psychosocial discrimination. Longitudinal data demonstrate a positive relationship between childhood obesity and increased morbidity and mortality in adulthood. CONCLUSION: Data from the literature are in some respect sparce since they do not allow to calculate the exact prevalence of adverse effects nor to assess the outcome of an obese child when it is successfully reducing the relative amount of body fat.","['Wabitsch, M']",['Wabitsch M'],"['Department of Paediatrics, University of Ulm, Germany. martin.wabitsch@medizin.uni-ulm.de']",['eng'],"['Journal Article', 'Review']",Germany,Eur J Pediatr,European journal of pediatrics,7603873,,IM,"['Adolescent', 'Child', 'Comorbidity', 'Energy Intake', 'Energy Metabolism', 'Europe/epidemiology', 'Humans', '*Obesity/complications/diagnosis/epidemiology/genetics/metabolism', 'Risk Factors', 'Social Isolation']",,,,,2000/09/30 11:00,2001/02/28 10:01,['2000/09/30 11:00'],"['2000/09/30 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/09/30 11:00 [entrez]']",['10.1007/pl00014368 [doi]'],ppublish,Eur J Pediatr. 2000 Sep;159 Suppl 1:S8-13. doi: 10.1007/pl00014368.,,,,,,,42,,,,,,,,,,,,,
31415263,NLM,MEDLINE,20211015,20230929,1550-5022 (Electronic) 1078-4659 (Print) 1078-4659 (Linking),27,1,2021 Jan/Feb,Identifying Novel Predictors of State Legislative Action to Address Obesity.,E9-E18,10.1097/PHH.0000000000001039 [doi],"OBJECTIVE: There is wide variation in the number and types of obesity policies enacted across states, and prior studies suggest that partisan factors may not fully explain this variation. In this exploratory analysis, we examined the association of a broad array of state-level factors with the number and types of obesity policies across states. DESIGN: We analyzed 32 predictor variables across 7 categories of state-level characteristics. We abstracted data from 1652 state obesity policies introduced during 2009-2014. We used multilevel regression models and principal component analysis to examine the association between state-level characteristics and policy outcomes. MAIN OUTCOME MEASURES: Our outcome measures included whether bills involved topics that were public health-oriented or business interest-oriented, whether bills were enacted into law, and the number of introduced bills and enacted laws per state. RESULTS: Numerous state-level characteristics were associated with obesity-related bill introduction and law enactment, and different state characteristics were associated with public health-oriented versus business interest-oriented policies. For example, state-level demographics, economic factors, policy environment, public programs, and the prevalence of obesity's downstream consequences were associated with the number of public health laws whereas obesity prevalence and policy environment were associated with the number of business interest laws. CONCLUSIONS: Our results support the hypothesis that a variety of factors contribute to a complex state obesity policymaking environment, highlighting the need for future research to disentangle these key predictors.","['Arons, Abigail', 'Pomeranz, Jennifer', 'Hamad, Rita']","['Arons A', 'Pomeranz J', 'Hamad R']","['Departments of Medicine and Pediatrics, University of California Los Angeles, Los Angeles, California (Dr Arons); Department of Public Health Policy and Management, College of Global Public Health, New York University, New York, New York (Dr Pomeranz); and Philip R. Lee Institute for Health Policy Studies, Department of Family and Community Medicine, University of California San Francisco, San Francisco, California (Dr Hamad).']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",United States,J Public Health Manag Pract,Journal of public health management and practice : JPHMP,9505213,,,"['Humans', '*Obesity/epidemiology/prevention & control', '*Policy Making', 'Prevalence', 'Public Health', 'United States/epidemiology']",PMC7012724,,,['DISCLOSURE: The authors declared no conflict of interest'],2019/08/16 06:00,2021/10/16 06:00,['2019/08/16 06:00'],"['2019/08/16 06:00 [pubmed]', '2021/10/16 06:00 [medline]', '2019/08/16 06:00 [entrez]']","['00124784-202101000-00018 [pii]', '10.1097/PHH.0000000000001039 [doi]']",ppublish,J Public Health Manag Pract. 2021 Jan/Feb;27(1):E9-E18. doi: 10.1097/PHH.0000000000001039.,"['K08 HL132106/HL/NHLBI NIH HHS/United States', 'UL1 TR001085/TR/NCATS NIH HHS/United States', 'UL1 TR003142/TR/NCATS NIH HHS/United States']",,,,,['NIHMS1527271'],,,,,,,,,,,,,,
1477410,NLM,MEDLINE,19930211,20051116,1061-222X (Print) 1061-222X (Linking),75,10,1992 Oct,Current treatment of obesity: a behavioral medicine perspective.,477-81,,"Obesity is a complex biopsychosocial phenomenon. It has a profound effect on patients' physical and psychological health. Due to the complexity of the problem and the recidivism following treatment, it is recommended that obese patients receive in-depth interdisciplinary evaluation to match them appropriately to comprehensive treatment. Participation in an interdisciplinary comprehensive active weight loss treatment program followed by participation in a professionally led biweekly behavioral maintenance program that included social influence and aerobic exercise has generated maintenance of 83% of initial weight loss at an 18-month follow up. This comprehensive multi-disciplinary treatment approach, best offered in a behavioral medicine center setting, represents state-of-the-art treatment at this time and can result in long-term medical and psychological benefits for the obese patient.","['Pera, V', 'Clark, M M', 'Abrams, D B']","['Pera V', 'Clark MM', 'Abrams DB']","['Center for Behavioral Medicine, Miriam Hospital, Providence, Rhode Island.']",['eng'],"['Journal Article', 'Review']",United States,R I Med,Rhode Island medicine,9203052,,IM,"['Behavior Therapy', 'Behavioral Medicine', 'Diet, Reducing', 'Energy Intake', 'Exercise', 'Female', 'Humans', 'Male', 'Obesity/epidemiology/etiology/*psychology/*therapy', 'Weight Loss']",,,,,1992/10/01 00:00,1992/10/01 00:01,['1992/10/01 00:00'],"['1992/10/01 00:00 [pubmed]', '1992/10/01 00:01 [medline]', '1992/10/01 00:00 [entrez]']",,ppublish,R I Med. 1992 Oct;75(10):477-81.,,,,,,,48,,,,,,,,,,,,,
10186466,NLM,MEDLINE,19981117,20181113,1170-7690 (Print) 1170-7690 (Linking),14,3,1998 Sep,Outcomes of pharmacological and surgical treatment for obesity.,269-83,,"The purpose of this article is to review the data from pharmacotherapeutic and surgical intervention studies for the management of obesity. Clinical outcomes assessed include weight changes over time and the effects of weight loss on blood pressure, serum lipid profiles and blood glucose control. Quality of life and economic data have been incorporated where available. Double-blind, randomised controlled trials were used preferentially over shorter term open studies. The literature evaluation was based on a Medline search of published data between January 1990 and January 1998. Obesity affects 65 million adults in the US. Estimates based on 1990 data suggest that obesity and comorbid illness contributed to $US46 billion in direct costs and $US23 billion in indirect costs in the US. Obesity is a chronic condition which requires long term management. The risk of developing cardiovascular disease, hypertension, type 2 (non-insulin-dependent) diabetes mellitus, osteoarthritis, Pickwickian syndrome and cancer is increased in the obese population, resulting in excess morbidity and mortality. There are no long term prospective studies that have demonstrated that weight reduction in obese patients improves survival. However, on the basis of epidemiological data using the prevalence of disease and associated body mass index, it is generally accepted that weight reduction of 5 to 10% in obese patients is associated with significant health benefits. Current treatment modalities include diet and behaviour modification, exercise and, where indicated, pharmacological intervention. Surgical intervention is reserved for the clinically severe obese patient [body mass index (BMI) > 40 kg/m2]. Many studies have demonstrated weight loss and improved metabolic fitness over 6 to 12 months. Few studies have been conducted over a longer period. Limited data are available regarding reduced morbidity and mortality, improved quality of life and functional or employment status and even fewer have incorporated any economic assessments of the impact of medical or surgical intervention. Although prospective data have demonstrated reduced morbidity following surgical intervention, only retrospective data have demonstrated reduced mortality. Studies of new drugs and interventions under development should demonstrate long term safety and efficacy in terms of sustained weight loss and subsequent weight maintenance. Future studies should incorporate assessment of patient perceived satisfaction with weight loss, health status and quality-of-life evaluations and pharmacoeconomic data to aid clinicians in the decision-making process in terms of weight management of their obese patients.","['Cerulli, J', 'Malone, M']","['Cerulli J', 'Malone M']","['Division of Pharmacy Practice, Albany College of Pharmacy, New York, USA. cerullij@panther.acp.edu']",['eng'],"['Journal Article', 'Review']",New Zealand,Pharmacoeconomics,PharmacoEconomics,9212404,,,"['Humans', 'Obesity/economics/epidemiology/*therapy', 'Quality of Life', 'Treatment Outcome']",,,,,1998/08/05 00:00,1998/08/05 00:01,['1998/08/05 00:00'],"['1998/08/05 00:00 [pubmed]', '1998/08/05 00:01 [medline]', '1998/08/05 00:00 [entrez]']",['10.2165/00019053-199814030-00004 [doi]'],ppublish,Pharmacoeconomics. 1998 Sep;14(3):269-83. doi: 10.2165/00019053-199814030-00004.,,,,,,,59,,,,,,,,,,,,,
21999692,NLM,MEDLINE,20120416,20211020,1874-4745 (Electronic) 1874-4737 (Print) 1874-4737 (Linking),4,3,2011 Sep,Variability in reward responsivity and obesity: evidence from brain imaging studies.,182-9,,"Advances in neuroimaging techniques have provided insight into the role of the brain in the regulation of food intake and weight. Growing evidence demonstrate that energy dense, palatable foods elicit similar responses in reward-related brain regions that mimic those of addictive substances. Currently, various models of obesity's relation to reward from food have been theorized. There is evidence to support a theory of hypo-responsivity of reward regions to food, where individuals consume excess amounts to overcome this reward deficit. There is also data to support a theory of hyper-responsivity of reward regions, where individuals who experience greater reward from food intake are at risk for overeating. However, these seemingly discordant theories are static in nature and do not account for the possible effects of repeated overeating on brain responsivity to food and initial vulnerability factors. Here we review data that support these theories and propose a dynamic vulnerability model of obesity that appears to offer a parsimonious theory that accommodates extant findings.","['Burger, Kyle S', 'Stice, Eric']","['Burger KS', 'Stice E']","['Oregon Research Institute, Eugene, OR 97401, USA.']",['eng'],"['Journal Article', 'Review']",United Arab Emirates,Curr Drug Abuse Rev,Current drug abuse reviews,101468123,,IM,"['Animals', 'Behavior, Addictive/physiopathology/psychology', 'Functional Neuroimaging/methods/*psychology', 'Humans', 'Magnetic Resonance Imaging/methods/*psychology', 'Neural Pathways/physiopathology', 'Obesity/*physiopathology/*psychology', '*Reward']",PMC3462740,,,,2011/10/18 06:00,2012/04/17 06:00,['2011/10/18 06:00'],"['2011/12/17 00:00 [received]', '2011/02/22 00:00 [revised]', '2011/02/25 00:00 [accepted]', '2011/10/18 06:00 [entrez]', '2011/10/18 06:00 [pubmed]', '2012/04/17 06:00 [medline]']","['BSP/CDAR/E-Pub/000044 [pii]', '10.2174/1874473711104030182 [doi]']",ppublish,Curr Drug Abuse Rev. 2011 Sep;4(3):182-9. doi: 10.2174/1874473711104030182.,['R01 DK080760/DK/NIDDK NIH HHS/United States'],,,,,['NIHMS405209'],,,,,,,,,,,,,,
37861907,NLM,MEDLINE,20231102,20231102,1573-8221 (Electronic) 0007-4888 (Linking),175,5,2023 Sep,Associations of Fatty Acid Profile with Abdominal Obesity in Men.,629-632,10.1007/s10517-023-05915-x [doi],"The content of individual unsaturated fatty acids in blood plasma (measured by HPLC) and their association with abdominal obesity in a group of men (mean age 52.2 years) was analyzed. The abdominal obesity was diagnosed according to the criteria of the All-Russian Scientific Society of Cardiology (waist circumference >94 cm). Men with abdominal obesity had higher levels of omega-6 gamma-linolenic and dihomo-gamma-linolenic acids, as well as omega-3 eicosapentaenoic and docosahexaenoic acids. They also had significantly elevated plasma levels of triglycerides and glucose and lower levels of HDL. Using single-factor ROC analysis we determined optimal cut-off thresholds for fatty acid levels indicating the presence of abdominal obesity. The results of regression analysis showed that the level of gamma-linolenic acid is directly associated with the chance of abdominal obesity.s.","['Shramko, V S', 'Shcherbakova, L V', 'Kashtanova, E V', 'Stakhneva, E M', 'Polonskaya, Ya V', 'Ragino, Yu I']","['Shramko VS', 'Shcherbakova LV', 'Kashtanova EV', 'Stakhneva EM', 'Polonskaya YV', 'Ragino YI']","['Research Institute of Internal and Preventive Medicine - Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia. nosova@211.ru.', 'Research Institute of Internal and Preventive Medicine - Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.', 'Research Institute of Internal and Preventive Medicine - Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.', 'Research Institute of Internal and Preventive Medicine - Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.', 'Research Institute of Internal and Preventive Medicine - Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.', 'Research Institute of Internal and Preventive Medicine - Branch of Federal Research Center Institute of Cytology and Genetics, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia.']",['eng'],['Journal Article'],United States,Bull Exp Biol Med,Bulletin of experimental biology and medicine,0372557,"['0 (Fatty Acids)', '0 (Fatty Acids, Unsaturated)', '0 (Fatty Acids, Omega-3)']",IM,"['Male', 'Humans', 'Middle Aged', '*Fatty Acids', 'Obesity, Abdominal/epidemiology', 'Obesity', 'Fatty Acids, Unsaturated', '*Fatty Acids, Omega-3']",,['NOTNLM'],"['abdominal obesity', 'blood', 'body mass index', 'fatty acids']",,2023/10/20 12:42,2023/11/02 12:43,['2023/10/20 11:11'],"['2023/02/22 00:00 [received]', '2023/11/02 12:43 [medline]', '2023/10/20 12:42 [pubmed]', '2023/10/20 11:11 [entrez]']","['10.1007/s10517-023-05915-x [pii]', '10.1007/s10517-023-05915-x [doi]']",ppublish,Bull Exp Biol Med. 2023 Sep;175(5):629-632. doi: 10.1007/s10517-023-05915-x. Epub 2023 Oct 20.,,20231020,,"['(c) 2023. Springer Science+Business Media, LLC, part of Springer Nature.']",,,,,,,,,,,,,,,,
37525005,NLM,MEDLINE,20230913,20230928,1759-5037 (Electronic) 1759-5029 (Linking),19,10,2023 Oct,Unravelling leptin variants: advancing precision medicine in obesity.,562-563,10.1038/s41574-023-00882-9 [doi],,"['Dubern, Beatrice', 'Clement, Karine']","['Dubern B', 'Clement K']","['Assistance Publique-Hopitaux de Paris, French Reference Center for Prader-Willi Syndrome and other rare obesities (PRADORT), Paris, France. beatrice.dubern@aphp.fr.', 'Nutrition and Obesities: Systemic Approaches Research Unit (Nutriomics), Sorbonne Universite, INSERM, Paris, France. beatrice.dubern@aphp.fr.', 'Assistance Publique-Hopitaux de Paris, French Reference Center for Prader-Willi Syndrome and other rare obesities (PRADORT), Paris, France.', 'Nutrition and Obesities: Systemic Approaches Research Unit (Nutriomics), Sorbonne Universite, INSERM, Paris, France.']",['eng'],"['Comment', 'Journal Article']",England,Nat Rev Endocrinol,Nature reviews. Endocrinology,101500078,"['0 (Leptin)', '0 (Receptors, Leptin)']",IM,"['Humans', '*Leptin/genetics', '*Precision Medicine', 'Obesity/genetics/therapy', 'Receptors, Leptin/genetics']",,,,,2023/08/01 01:08,2023/09/13 06:42,['2023/07/31 23:32'],"['2023/09/13 06:42 [medline]', '2023/08/01 01:08 [pubmed]', '2023/07/31 23:32 [entrez]']","['10.1038/s41574-023-00882-9 [pii]', '10.1038/s41574-023-00882-9 [doi]']",ppublish,Nat Rev Endocrinol. 2023 Oct;19(10):562-563. doi: 10.1038/s41574-023-00882-9.,,,,,['ORCID: 0000-0002-0065-5344'],,,,,,['N Engl J Med. 2023 Jun 15;388(24):2253-2261. PMID: 37314706'],,,,,,,,,
17986703,NLM,MEDLINE,20071108,20161017,1538-3598 (Electronic) 0098-7484 (Linking),298,17,2007 Nov 7,Is disability obesity's price of longevity?,2066-7,,,"['Gregg, Edward W', 'Guralnik, Jack M']","['Gregg EW', 'Guralnik JM']",,['eng'],"['Comment', 'Editorial', 'Research Support, N.I.H., Intramural']",United States,JAMA,JAMA,7501160,,IM,"['*Activities of Daily Living', '*Cost of Illness', '*Disabled Persons', 'Humans', '*Longevity', 'Morbidity', '*Obesity/epidemiology', 'Risk']",,,,,2007/11/08 09:00,2007/11/09 09:00,['2007/11/08 09:00'],"['2007/11/08 09:00 [pubmed]', '2007/11/09 09:00 [medline]', '2007/11/08 09:00 [entrez]']","['298/17/2066 [pii]', '10.1001/jama.298.17.2066 [doi]']",ppublish,JAMA. 2007 Nov 7;298(17):2066-7. doi: 10.1001/jama.298.17.2066.,['Intramural NIH HHS/United States'],,,,,,,,,,['JAMA. 2007 Nov 7;298(17):2020-7. PMID: 17986695'],,,,,,,,,
9630380,NLM,MEDLINE,19980804,20221004,0954-3007 (Print) 0954-3007 (Linking),52,5,1998 May,Swedish obese subjects (SOS): an obesity intervention study with a nutritional perspective.,316-22,,"OBJECTIVES: Swedish Obese Subjects (SOS) is a multidisciplinary project involving aspects of obesity ranging from description of the severely obese state to effects of surgical intervention on long-term mortality and morbidity. Dietary studies, which represent an integral part of SOS research activities, are the focus of this review. SUBJECTS AND METHODS: Due to the large number of obese subjects included in the SOS data bases ( > 5000), an early priority of the project was to develop a dietary assessment method which: (i) described usual intake patterns; (ii) could be self-administered by subjects and rapidly processed; and (iii) was equally valid in obese and non-obese individuals. RESULTS: The SOS method has met these requirements and is now being completed by all subjects at baseline and during the intervention, and by a non-obese reference population. A number of dietary features distinguishing obese subjects have emerged, including: elevated intakes of energy and energy-percent fat; low consumption of alcohol, fruits and vegetables; high dietary disinhibition; frequent consumption of light meals and snacks; and night eating. In the surgical intervention group, a relatively high consumption of sweet foods was associated with better weight loss and maintenance. CONCLUSIONS: The SOS method appears to be less susceptible to obesity-related under-reporting than traditional dietary methods, and if the distribution of foods and nutrients can be assumed to be as unbiased as the energy intakes, this method should make it possible to capture associations between diet and obesity-related diseases in the future.","['Lissner, L', 'Lindroos, A K', 'Sjostrom, L']","['Lissner L', 'Lindroos AK', 'Sjostrom L']","['Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Eur J Clin Nutr,European journal of clinical nutrition,8804070,,IM,"['Energy Intake', 'Humans', 'Nutrition Assessment', '*Nutritional Physiological Phenomena', 'Obesity/diet therapy/surgery/*therapy', 'Registries', 'Sweden', 'Weight Loss']",,,,,1998/06/18 00:00,1998/06/18 00:01,['1998/06/18 00:00'],"['1998/06/18 00:00 [pubmed]', '1998/06/18 00:01 [medline]', '1998/06/18 00:00 [entrez]']",['10.1038/sj.ejcn.1600567 [doi]'],ppublish,Eur J Clin Nutr. 1998 May;52(5):316-22. doi: 10.1038/sj.ejcn.1600567.,,,,,,,34,,,,,,,,,,,,,
11743134,NLM,MEDLINE,20020107,20190607,1535-3702 (Print) 1535-3699 (Linking),226,11,2001 Dec,Genetics of pathways regulating body weight in the development of obesity in humans.,991-6,,"Although rapid globalization of the Westernized way of life is responsible for the large rise in the number of obesity cases (about 1 billion individuals are now overweight or frankly obese), obesity is a typical common multifactorial disease in that environmental and genetic factors interact, resulting in a disease state. There is strong evidence for a genetic component to human obesity: e.g., the familial clustering (the relative risk among siblings being 3-7) and the high concordance of body composition in monozygotic twins. However, the role of genetic factors in many human obesities (referred to as ""common obesity"" in this review) is complex, being determined by interaction of several genes (polygenic), each of which may have relatively small effects (i.e., they are ""susceptibility"" genes and work in combination with each other as well as with environmental factors such as nutrients, physical activity, and smoking).","['Froguel, P', 'Boutin, P']","['Froguel P', 'Boutin P']","['Centre National de la Recherche Scientifique, Institute of Biology of Lille, Pasteur Institute of Lille, France. froguel@mail-good.pasteur-lille.fr']",['eng'],"['Journal Article', 'Review']",England,Exp Biol Med (Maywood),"Experimental biology and medicine (Maywood, N.J.)",100973463,['0 (Leptin)'],IM,"['Adipocytes/metabolism', 'Body Weight/*genetics', 'Chromosome Mapping', 'Diseases in Twins', 'Family Health', 'Genetic Linkage', 'Humans', 'Hypothalamus/metabolism', 'Leptin/metabolism', 'Models, Biological', 'Obesity/*genetics/metabolism/*physiopathology', 'Polymorphism, Genetic/genetics']",,,,,2001/12/18 10:00,2002/01/10 10:01,['2001/12/18 10:00'],"['2001/12/18 10:00 [pubmed]', '2002/01/10 10:01 [medline]', '2001/12/18 10:00 [entrez]']",['10.1177/153537020122601105 [doi]'],ppublish,Exp Biol Med (Maywood). 2001 Dec;226(11):991-6. doi: 10.1177/153537020122601105.,,,,,,,36,,,,,,,,,,,,,
22938745,NLM,MEDLINE,20130108,20130805,1878-7541 (Electronic) 1550-8307 (Linking),8,5,2012 Sep-Oct,Evidence and potential mechanisms for mindfulness practices and energy psychology for obesity and binge-eating disorder.,271-6,10.1016/j.explore.2012.06.003 [doi],"Obesity is a growing epidemic. Chronic stress produces endocrine and immune factors that are contributors to obesity's etiology. These biochemicals also can affect appetite and eating behaviors that can lead to binge-eating disorder. The inadequacies of standard care and the problem of patient noncompliance have inspired a search for alternative treatments. Proposals in the literature have called for combination therapies involving behavioral or new biological therapies. This manuscript suggests that mind-body interventions would be ideal for such combinations. Two mind-body modalities, energy psychology and mindfulness meditation, are reviewed for their potential in treating weight loss, stress, and behavior modification related to binge-eating disorder. Whereas mindfulness meditation and practices show more compelling evidence, energy psychology, in the infancy stages of elucidation, exhibits initially promising outcomes but requires further evidence-based trials.","['Sojcher, Renee', 'Gould Fogerite, Susan', 'Perlman, Adam']","['Sojcher R', 'Gould Fogerite S', 'Perlman A']","['Institute for Complementary and Alternative Medicine, School of Health-Related Professions, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103, USA. reneesojcher@gmail.com']",['eng'],"['Journal Article', 'Review']",United States,Explore (NY),"Explore (New York, N.Y.)",101233160,,IM,"['*Behavior Therapy', 'Binge-Eating Disorder/etiology/psychology/*therapy', 'Humans', 'Meditation/*methods', 'Mind-Body Therapies/*methods', 'Obesity/etiology/psychology/*therapy', 'Stress, Psychological/complications/*therapy', '*Weight Loss']",,,,,2012/09/04 06:00,2013/01/09 06:00,['2012/09/04 06:00'],"['2011/03/21 00:00 [received]', '2012/09/04 06:00 [entrez]', '2012/09/04 06:00 [pubmed]', '2013/01/09 06:00 [medline]']","['S1550-8307(12)00128-0 [pii]', '10.1016/j.explore.2012.06.003 [doi]']",ppublish,Explore (NY). 2012 Sep-Oct;8(5):271-6. doi: 10.1016/j.explore.2012.06.003.,,,,['Copyright (c) 2012 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
2678268,NLM,MEDLINE,19891103,20041117,0306-0632 (Print) 0306-0632 (Linking),13,1,1989,The etiologic basis for the classification of obesity.,45-66,,"Obesity is a widespread condition, with different etiologies, that is usually treated only symptomatically i.e. through lowered energy intake. The existence of a latent situation of pre-obesity is postulated. The preobese is defined as a lean individual susceptible to easily develop obesity with unlimited food availability. The physiologic and metabolic pathways responsible of the appearance of obesity are revisited, as well as the current theories on body weight regulatory mechanisms. From this information, a classification of obesities is proposed: 1) Hypothalamic, 2) Bulimic, 3) Digestive, 4) Hyperinsulinemic, 5) Hypothermogenic, 6) Hypothyroid, and 7) Set point. These conditions should not be treated therapeutically in the same way, as the causes of development of the illness are not equal. The need to determine the individualized causes of obesity prior to any treatment is stressed.","['Alemany, M']",['Alemany M'],"['Departamento de Bioquimica y Fisiologia, Universidad de Barcelona, Spain.']",['eng'],"['Journal Article', 'Review']",England,Prog Food Nutr Sci,Progress in food & nutrition science,7508713,,IM,"['Adipose Tissue/pathology', 'Eating', 'Energy Metabolism', 'Humans', 'Obesity/*classification/etiology/therapy', 'Weight Gain']",,,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Prog Food Nutr Sci. 1989;13(1):45-66.,,,,,,,187,,,,,,,,,,,,,
14707898,NLM,MEDLINE,20040305,20161031,0003-4266 (Print) 0003-4266 (Linking),64,5 Pt 2,2003 Nov,[From obesity to obesities: from concepts to practices].,S7-15,,"In the singular, obesity is a symptom reflecting an excess of energy stores as fat mass, the only trait obese people are sharing. Long time ago we proposed to use the plural to account for the large diversity characterizing obese subjects that conceptual evolutions have put to the fore during the past three decades. Weight gain and obesity are resulting from a positive energy balance produced by the conjunction of a number of etiopathogenetic factors associated in various proportions according to patients and evolutive status. Decreasing physical activity, increasing sedentarity, quantitative and qualitative energy consumption unadapted to energy expenditure and to lipid oxidation capabilities, reinforced by psychological needs, are catching out the control of food intake, particularly since it is more efficient to defend against famine than to protect against plethora. These environmental factors, responsible for obesity pandemia, lead to obesity subjects predisposed by their genetic background, in itself extremely variable. The clinical heterogeneity of obesity is patent and a careful phenotypic analysis is a prerequisite to design the management strategy. Obesity is a chronic situation that needs a long-term treatment. The goals of treatment cannot be longer reduced to weight loss only, which in addition should be realistic, i.e. moderate. Management strategies must be conceived on a long-term basis, focused on prevention of weight regain, multifaceted and individually tailored. A number of tools are available and the state of the art is to use them appropriately to avoid being counter productive. Obesity may be viewed as an adaptive symptom in subjects poorly prepared to cope with recent environmental changes, but it is also a disease due to its prevalence, the number of weight dependent comorbidities and its socio economic costs. A specific medical approach of obesity has still to be developed.","['Guy-Grand, B']",['Guy-Grand B'],"['Service de Nutrition, Hotel-Dieu, F-75181 Paris 04. bernard.guy-grand@htd.ap-hop-paris.fr']",['fre'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,,IM,"['Behavior Therapy', 'Diet', 'Digestive System Surgical Procedures', 'Environment', 'Exercise', 'Genetic Predisposition to Disease', 'Health Care Costs', 'Humans', '*Obesity/complications/epidemiology/etiology/therapy']",,,,,2004/01/07 05:00,2004/03/06 05:00,['2004/01/07 05:00'],"['2004/01/07 05:00 [pubmed]', '2004/03/06 05:00 [medline]', '2004/01/07 05:00 [entrez]']",['MDOI-AE-11-2003-64-5-C2-0003-4266-101019-ART2 [pii]'],ppublish,Ann Endocrinol (Paris). 2003 Nov;64(5 Pt 2):S7-15.,,,,,,,23,,De l'obesite aux obesites: des concepts aux pratiques.,,,,,,,,,,,
32211204,NLM,MEDLINE,20210519,20210519,2090-0716 (Electronic) 2090-0708 (Print) 2090-0708 (Linking),2020,,2020,The Effects of Obesity on Outcome in Preclinical Animal Models of Infection and Sepsis: A Systematic Review and Meta-Analysis.,1508764,10.1155/2020/1508764 [doi] 1508764,"BACKGROUND: Clinical studies suggest obesity paradoxically increases survival during bacterial infection and sepsis but decreases it with influenza, but these studies are observational. By contrast, animal studies of obesity in infection can prospectively compare obese versus nonobese controls. We performed a systematic review and meta-analysis of animal investigations to further examine obesity's survival effect in infection and sepsis. METHODS: Databases were searched for studies comparing survival in obese versus nonobese controls. We performed a systematic review and meta-analysis of animal investigations to further examine obesity's survival effect in infection and sepsis. Methods. Databases were searched for studies comparing survival in obese versus nonobese animals following bacteria, lipopolysaccharide, or influenza virus challenges. RESULTS: Twenty-one studies (761 obese and 603 control animals) met the inclusion criteria. Obesity reduced survival in 19 studies (11 significantly) and the odds ratio (95% CI) of survival (0.21(0.13, 0.35); I (2) = 64%, p < 0.01p < 0.01p < 0.01) but with high heterogeneity. Obesity reduced survival (1) consistently in both single-strain bacteria- and lipopolysaccharide-challenged studies (n = 6 studies, 0.21(0.13, 0.34); I (2) = 64%, p < 0.01p < 0.01) but with high heterogeneity. Obesity reduced survival (1) consistently in both single-strain bacteria- and lipopolysaccharide-challenged studies (n = 6 studies, 0.21(0.13, 0.34); I (2) = 64%, p < 0.01p < 0.01) but with high heterogeneity. Obesity reduced survival (1) consistently in both single-strain bacteria- and lipopolysaccharide-challenged studies (n = 6 studies, 0.21(0.13, 0.34); I (2) = 64%, p < 0.01p < 0.01) but with high heterogeneity. Obesity reduced survival (1) consistently in both single-strain bacteria- and lipopolysaccharide-challenged studies (n = 6 studies, 0.21(0.13, 0.34); I (2) = 64%, p < 0.01p < 0.01p < 0.01) but with high heterogeneity. Obesity reduced survival (1) consistently in both single-strain bacteria- and lipopolysaccharide-challenged studies (n = 6 studies, 0.21(0.13, 0.34); I (2) = 31%, p=0.20 and n = 5, 0.22(0.13, 0.36); I (2) = 0%, p=0.59, respectively), (2) not significantly with cecal ligation and puncture (n = 4, 0.72(0.08, 6.23); I (2) = 75%, p < 0.01), and (3) significantly with influenza but with high heterogeneity (n = 6, 0.12(0.04, 0.34); I (2) = 73%, p < 0.01). Obesity's survival effects did not differ significantly comparing the four challenge types (p=0.49). Animal models did not include antimicrobials or glycemic control and study quality was low. CONCLUSIONS: Preclinical and clinical studies together emphasize the need for prospective studies in patients accurately assessing obesity's impact on survival during severe infection.","['Xu, Wanying', 'Pepper, Dominique', 'Sun, Junfeng', 'Welsh, Judith', 'Cui, Xizhong', 'Eichacker, Peter Q']","['Xu W', 'Pepper D', 'Sun J', 'Welsh J', 'Cui X', 'Eichacker PQ']","['Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.', 'Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.', 'Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.', 'National Institutes of Health Library, National Institutes of Health, Bethesda, MD 20892, USA.', 'Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.', 'Critical Care Medicine Department, NIH Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.']",['eng'],"['Journal Article', 'Meta-Analysis', 'Research Support, N.I.H., Intramural', 'Systematic Review']",United States,J Obes,Journal of obesity,101526295,,IM,"['Animals', '*Disease Models, Animal', '*Obesity', '*Sepsis']",PMC7053456,,,['The authors declare that they have no conflicts of interest.'],2020/03/27 06:00,2021/05/20 06:00,['2020/03/27 06:00'],"['2019/03/26 00:00 [received]', '2020/01/24 00:00 [accepted]', '2020/03/27 06:00 [entrez]', '2020/03/27 06:00 [pubmed]', '2021/05/20 06:00 [medline]']",['10.1155/2020/1508764 [doi]'],epublish,J Obes. 2020 Feb 17;2020:1508764. doi: 10.1155/2020/1508764. eCollection 2020.,,20200217,,['Copyright (c) 2020 Wanying Xu et al.'],['ORCID: 0000-0001-5470-4677'],,,,,,,,,,,,,,,
31462398,NLM,MEDLINE,20200921,20200921,1538-7755 (Electronic) 1055-9965 (Print) 1055-9965 (Linking),28,11,2019 Nov,Obesity at Diagnosis and Prostate Cancer Prognosis and Recurrence Risk Following Primary Treatment by Radical Prostatectomy.,1917-1925,10.1158/1055-9965.EPI-19-0488 [doi],"BACKGROUND: The association of obesity at diagnosis with prostate cancer progression is uncertain. This study aimed to examine the relationship between body mass index (BMI; 18.5-<25, 25-<30, 30-<35, >/=35 kg/m(2)) and prognostic risk at diagnosis, compare the concordance between prognostic risk assessed at diagnostic biopsy versus pathologic risk assessed at surgery across BMI categories, and investigate the association between obesity and prostate cancer recurrence and all-cause death. METHODS: We examined men enrolled in CaPSURE who underwent radical prostatectomy between 1995 and 2017. Multiple imputation methods were used to handle missing data and reported along with complete case findings. RESULTS: Participants (n = 5,200) were followed for a median of 4.5 years; 685 experienced recurrence. Obesity was associated with higher prognostic risk at time of diagnosis (OR(obese) = 1.5; OR(very obese) = 1.7) and upward reclassification of disease between biopsy and surgery, driven by change in tumor stage (OR(obese) = 1.3; OR(very obese) = 1.6). We observed an association between BMI and recurrence with adjustment for disease severity using diagnostic factors (HR(very obese) = 1.7); this association disappeared when adjusting for disease severity factors obtained at surgery. CONCLUSIONS: Our findings suggest that residual confounding may partially explain the conflicting evidence regarding obesity's influence on prostate cancer progression. Assessing T-stage via digital rectal exam may be complicated in larger men, potentially affecting clinical treatment decisions. A strong association with all-cause mortality demonstrates healthier BMI at diagnosis may still improve overall survival. IMPACT: Patients with greater BMI are prone to more advanced disease at diagnosis and may be more likely to have their tumor stage underestimated at diagnosis.","['Langlais, Crystal S', 'Cowan, Janet E', 'Neuhaus, John', 'Kenfield, Stacey A', 'Van Blarigan, Erin L', 'Broering, Jeanette M', 'Cooperberg, Matthew R', 'Carroll, Peter', 'Chan, June M']","['Langlais CS', 'Cowan JE', 'Neuhaus J', 'Kenfield SA', 'Van Blarigan EL', 'Broering JM', 'Cooperberg MR', 'Carroll P', 'Chan JM']","['Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California. crystal.langlais@ucsf.edu.', 'Department of Urology, University of California, San Francisco, San Francisco, California.', 'Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.', 'Department of Urology, University of California, San Francisco, San Francisco, California.', 'Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.', 'Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.', 'Department of Urology, University of California, San Francisco, San Francisco, California.', 'Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.', 'Department of Urology, University of California, San Francisco, San Francisco, California.', 'Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.', 'Department of Urology, University of California, San Francisco, San Francisco, California.', 'Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.', 'Department of Urology, University of California, San Francisco, San Francisco, California.', 'Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.', 'Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.', 'Department of Urology, University of California, San Francisco, San Francisco, California.', 'Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Cancer Epidemiol Biomarkers Prev,"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",9200608,,IM,"['Disease Progression', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*diagnosis', 'Prostatectomy/*methods', 'Prostatic Neoplasms/*etiology/pathology', 'Recurrence', 'Risk Factors']",PMC6825577,,,['Conflicts of Interest: The authors declare no potential conflicts of interest.'],2019/08/30 06:00,2020/09/22 06:00,['2019/08/30 06:00'],"['2019/04/30 00:00 [received]', '2019/07/11 00:00 [revised]', '2019/08/23 00:00 [accepted]', '2019/08/30 06:00 [pubmed]', '2020/09/22 06:00 [medline]', '2019/08/30 06:00 [entrez]']","['1055-9965.EPI-19-0488 [pii]', '10.1158/1055-9965.EPI-19-0488 [doi]']",ppublish,Cancer Epidemiol Biomarkers Prev. 2019 Nov;28(11):1917-1925. doi: 10.1158/1055-9965.EPI-19-0488. Epub 2019 Aug 28.,"['K07 CA197077/CA/NCI NIH HHS/United States', 'T32 AG049663/AG/NIA NIH HHS/United States']",20190828,,['(c)2019 American Association for Cancer Research.'],"['ORCID: 0000-0001-5654-5542', 'ORCID: 0000-0001-5079-3385', 'ORCID: 0000-0002-7580-8931']",['NIHMS1538607'],,,,,,,,,,,,,,
37537402,NLM,MEDLINE,20230911,20230922,1573-2606 (Electronic) 1389-9155 (Print) 1389-9155 (Linking),24,5,2023 Oct,Phenotyping the obesities: reality or utopia?,767-773,10.1007/s11154-023-09829-x [doi],"In this thematic issue on phenotyping the obesities, prominent international experts offer an insightful and comprehensive collection of articles covering the current knowledge in the field. In order to actually capture all the polyhedral determinants of the diverse types of obesity, the granularity of the phenotypic information acquired must be expanded in the context of a personalized approach. Whilst the use of precision medicine has been successfully implemented in areas like cancer and other diseases, health care providers are more reluctant to embrace detailed phenotyping to guide diagnosis, treatment and prevention in obesity. Given its multiple complex layers, phenotyping necessarily needs to go beyond the multi-omics approach and incorporate all the diverse spheres that conform the reality of people living with obesity. Potential barriers, difficulties, roadblocks and opportunities together with their interaction in a syndemic context are analyzed. Plausible lacunae are also highlighted in addition to pointing to the need of redefining new conceptual frameworks. Therefore, this extraordinary collection of state-ofthe-art reviews provides useful information to both experienced clinicians and trainees as well as academics to steer clinical practice and research in the management of people living with obesity irrespective of practice setting or career stage.","['Portincasa, Piero', 'Fruhbeck, Gema']","['Portincasa P', 'Fruhbeck G']","['Department of Precision and Regenerative Medicine and Ionian Area (DiMePre-J), Clinica Medica ""A. Murri"", University of Bari Medical School, 70124, Bari, Italy.', 'Department of Endocrinology and Nutrition, Clinica Universidad de Navarra, 31008, Pamplona, Spain. gfruhbeck@unav.es.', 'Metabolic Research Laboratory, Clinica Universidad de Navarra, 31008, Pamplona, Spain. gfruhbeck@unav.es.', 'Centro de Investigacion Biomedica en Red Fisiopatologia de La Obesidad Y Nutricion (CIBEROBN), 31008, Pamplona, Spain. gfruhbeck@unav.es.', 'Navarra Institute for Health Research, IdiSNA, 31008, Pamplona, Spain. gfruhbeck@unav.es.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Germany,Rev Endocr Metab Disord,Reviews in endocrine & metabolic disorders,100940588,,IM,"['Humans', '*Utopias', '*Obesity/diagnosis']",PMC10492876,['NOTNLM'],"['Clustering', 'Comorbidities', 'Heterogeneity', 'Obesity', 'Patient stratification', 'Phenotypes']","['GF declares research grants paid to the Institution from the Spanish Institute of', 'Health ISCIII and payment of honoraria for lectures from Novo Nordisk as Member', 'of the OPEN Spain Initiative as well as payment or honoraria for attendance to', 'Advisory Boards from Lilly. PP declares no conflict of interest.']",2023/08/04 01:08,2023/09/11 06:43,['2023/08/03 23:30'],"['2023/07/27 00:00 [accepted]', '2023/09/11 06:43 [medline]', '2023/08/04 01:08 [pubmed]', '2023/08/03 23:30 [entrez]']","['10.1007/s11154-023-09829-x [pii]', '9829 [pii]', '10.1007/s11154-023-09829-x [doi]']",ppublish,Rev Endocr Metab Disord. 2023 Oct;24(5):767-773. doi: 10.1007/s11154-023-09829-x. Epub 2023 Aug 4.,,20230804,,['(c) 2023. The Author(s).'],"['ORCID: 0000-0001-5359-1471', 'ORCID: 0000-0002-8305-7154']",,,,,,,,,,,,,,,
19802427,NLM,MEDLINE,20100707,20181201,0034-9887 (Print) 0034-9887 (Linking),137,7,2009 Jul,[Statement about diagnosis assessment ano non pharmacological treatment of obesity].,963-71,,"The risk of complications of obesity is proportional to body mass index and is higher in severe or morbid obesities and when abdominal or visceral fat is predominant. In Chile the prevalence of obesity is increasing. According to the World Health Organization, obese subjects must reduce at least a 5% of their weight to reduce the risk of complications. Although this amount of reduction is seldom achieved with non pharmacological treatments, better results are obtained with multidisciplinary/ approaches that include a medical, psychosocial and laboratory assessment, to determine obesity level and different factors involved and the associated complications. In a second stage, goals of treatment are set and a personalized treatment is designed including dietary changes and physical activity. The aim is to obtain perdurable lifestyles modifications.","['Manrique E, Monica', 'de la Maza, Maria Pia', 'Carrasco, Fernando', 'Moreno, Manuel', 'Albala, Cecilia', 'Garcia, Jaime', 'Diaz, Jaime', 'Liberman, Claudio']","['Manrique E M', 'de la Maza MP', 'Carrasco F', 'Moreno M', 'Albala C', 'Garcia J', 'Diaz J', 'Liberman C']","['Instituto Medico Nutramed, Universidad de Chile, Santiago, Chile. mmanrique@nutramed.cl']",['spa'],"['Journal Article', 'Review']",Chile,Rev Med Chil,Revista medica de Chile,0404312,,IM,"['Body Mass Index', 'Cognitive Behavioral Therapy', 'Humans', 'Life Style', 'Obesity/*diagnosis/*therapy']",,,,,2009/10/06 06:00,2010/07/08 06:00,['2009/10/06 06:00'],"['2009/10/06 06:00 [entrez]', '2009/10/06 06:00 [pubmed]', '2010/07/08 06:00 [medline]']",['S0034-98872009000700016 [pii]'],ppublish,Rev Med Chil. 2009 Jul;137(7):963-71. Epub 2009 Sep 24.,,20090924,,,,,25,,"Diagnostico, evaluacion y tratamiento no farmacologico del paciente con sobrepeso u obesidad.",,,,,,,,,,,
24581763,NLM,MEDLINE,20140430,20220409,1879-1883 (Electronic) 0002-9610 (Linking),207,3,2014 Mar,Obesity in trauma: outcomes and disposition trends.,387-92; discussion 391-2,S0002-9610(13)00725-3 [pii] 10.1016/j.amjsurg.2013.10.013 [doi],"BACKGROUND: Obesity's effect on the outcomes of trauma patients remains inconclusive. METHODS: A retrospective review of all falls, motor vehicle collisions (MVCs), and penetrating trauma patients admitted from January 2008 to December 2012 was performed. The outcomes evaluated included mortality, length of stay at hospital, and discharge disposition. Patients were grouped according to the body mass index (BMI) and stratified by injury severity scores. RESULTS: Two thousand one hundred ninety six patients were analyzed; 132 penetrating, 913 falls, and 1,151 MVCs. Penetrating traumas had no significant difference in outcomes. In falls, obese patients had a lower mortality (P = .035). In MVCs, obese patients had longer hospitalizations (P = .02), and mild and moderate MVC injuries were less likely to be discharged home (P = .032 and .003). Obese patients sustained fewer head injuries in falls and MVCs (P = .005 and .043, respectively). CONCLUSIONS: In falls, a higher BMI may benefit patients. However, an increasing BMI is associated with a longer length of stay at hospital, and decreased likelihood of discharge to home.","['Osborne, Zachary', 'Rowitz, Blair', 'Moore, Henry', 'Oliphant, Uretz', 'Butler, JoAnn', 'Olson, Michelle', 'Aucar, John']","['Osborne Z', 'Rowitz B', 'Moore H', 'Oliphant U', 'Butler J', 'Olson M', 'Aucar J']","['Carle Foundation Hospital, IL, USA; University of Illinois at Urbana Champaign, IL, USA. Electronic address: Zachary.Osborne@carle.com.', 'Carle Foundation Hospital, IL, USA; University of Illinois at Urbana Champaign, IL, USA.', 'Carle Foundation Hospital, IL, USA; University of Illinois at Urbana Champaign, IL, USA.', 'Carle Foundation Hospital, IL, USA; University of Illinois at Urbana Champaign, IL, USA.', 'Carle Foundation Hospital, IL, USA; Carle Foundation Hospital, IL, USA.', 'Carle Foundation Hospital, IL, USA; University of Illinois at Urbana Champaign, IL, USA.', 'Carle Foundation Hospital, IL, USA.']",['eng'],['Journal Article'],United States,Am J Surg,American journal of surgery,0370473,,IM,"['Accidental Falls/*statistics & numerical data', 'Accidents, Traffic/*statistics & numerical data', 'Body Mass Index', 'Comorbidity', 'Humans', 'Illinois/epidemiology', 'Injury Severity Score', 'Length of Stay', 'Obesity/*complications/epidemiology', 'Outcome Assessment, Health Care', 'Patient Discharge/statistics & numerical data', 'Registries', 'Retrospective Studies', 'Wounds and Injuries/epidemiology', 'Wounds, Penetrating/*epidemiology']",,['NOTNLM'],"['Blunt trauma', 'Body mass index', 'Fall', 'Motor vehicle collision', 'Obesity', 'Wounds and injuries']",,2014/03/04 06:00,2014/05/03 06:00,['2014/03/04 06:00'],"['2013/07/16 00:00 [received]', '2013/10/19 00:00 [revised]', '2013/10/21 00:00 [accepted]', '2014/03/04 06:00 [entrez]', '2014/03/04 06:00 [pubmed]', '2014/05/03 06:00 [medline]']","['S0002-9610(13)00725-3 [pii]', '10.1016/j.amjsurg.2013.10.013 [doi]']",ppublish,Am J Surg. 2014 Mar;207(3):387-92; discussion 391-2. doi: 10.1016/j.amjsurg.2013.10.013. Epub 2013 Dec 19.,,20131219,,['Copyright (c) 2014 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
29175866,NLM,MEDLINE,20190424,20220330,1470-2738 (Electronic) 0143-005X (Linking),72,2,2018 Feb,Tackling Obesities: 10 years on.,93,10.1136/jech-2017-210121 [doi],,"['Savona, Natalie', 'Rutter, Harry', 'Cummins, Steven']","['Savona N', 'Rutter H', 'Cummins S']","['Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.', 'Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.', 'Department of Social and Environmental Health Research, London School of Hygiene & Tropical Medicine, London, UK.']",['eng'],['Editorial'],England,J Epidemiol Community Health,Journal of epidemiology and community health,7909766,,IM,"['Humans', 'Obesity/*prevention & control', 'Policy Making', 'Public Health', '*Research Report']",,['NOTNLM'],"['Diet', 'Obesity', 'Public Health']",['Competing interests: None declared.'],2017/11/28 06:00,2019/04/25 06:00,['2017/11/28 06:00'],"['2017/10/16 00:00 [received]', '2017/11/02 00:00 [revised]', '2017/11/04 00:00 [accepted]', '2017/11/28 06:00 [pubmed]', '2019/04/25 06:00 [medline]', '2017/11/28 06:00 [entrez]']","['jech-2017-210121 [pii]', '10.1136/jech-2017-210121 [doi]']",ppublish,J Epidemiol Community Health. 2018 Feb;72(2):93. doi: 10.1136/jech-2017-210121. Epub 2017 Nov 24.,,20171124,,,['ORCID: 0000-0002-3006-3681'],,,,,,,,,,,,,,,
8383634,NLM,MEDLINE,19930412,20140603,,17,1,1993 Jan,Obesity in free-ranging rhesus macaques.,1-9,,"Spontaneous obesity in free-ranging rhesus macaques (Macaca mulatta) was assessed in terms of body size, body fat distribution, endocrinological/metabolic indices, and social and familial factors. Eleven animals (six females, five males), or 7% of the adult population surveyed, were defined as obese on the basis of morphometric indices of adiposity > 2 s.d. above the mean for adults in this colony. The age of the obese animals ranged from 9-16 years; obese males were older than females (average 14 vs. 12 years), but this difference was not significant. Mean body weights for obese males and females were 14.1 +/- 0.5 and 13.5 +/- 0.7 kg, respectively. There were no gender differences in either the incidence of obesity or measures of body fat. Serum concentrations of cholesterol and testosterone were not significantly different between obese and nonobese monkeys. Serum triglyceride levels were somewhat higher in obese animals, but this difference was not significant. Glucose clearance was within normal limits in both obese and age- and sex-matched non-obese monkeys (> 2% per min). Although increased adiposity was significantly correlated with fasting insulin and the insulin response to glucose loading, differences between obese and non-obese animals in these values did not achieve significance. The incidence of obesity ranged from 0-20% among the eleven matrilines studied, and several primary familial relationships were observed within the obese sample. Most obese females were from a high ranking matriline whereas only one of the obese males was high ranking at the time of the survey.(ABSTRACT TRUNCATED AT 250 WORDS)","['Schwartz, S M', 'Kemnitz, J W', 'Howard, C F Jr']","['Schwartz SM', 'Kemnitz JW', 'Howard CF Jr']","['Caribbean Primate Research Center, University of Puerto Rico, San Juan 00936.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Int J Obes Relat Metab Disord,International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,9313169,,IM,"['Animals', 'Blood Chemical Analysis', 'Body Constitution', 'Female', 'Glucose Tolerance Test', 'Macaca mulatta/*physiology', 'Male', 'Monkey Diseases/*epidemiology', 'Obesity/epidemiology/genetics/physiopathology/*veterinary', 'Puerto Rico/epidemiology', 'Social Behavior', 'Social Environment']",,,,,1993/01/01 00:00,2001/03/28 10:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Int J Obes Relat Metab Disord. 1993 Jan;17(1):1-9.,"['AG-05838/AG/NIA NIH HHS/United States', 'AG-07831/AG/NIA NIH HHS/United States', 'RR-03640/RR/NCRR NIH HHS/United States', 'etc.']",,,,,,,,,,,,,,,,,,,
12827362,NLM,MEDLINE,20040429,20181113,1435-2443 (Print) 1435-2443 (Linking),388,6,2003 Dec,Medical management of obesity.,369-74,,"BACKGROUND: Obesity is associated with elevated morbidity and death rates. The World Health Organization defines obesity as a chronic disease. The percentage of obese persons is increasing worldwide. Many different treatment modalities are available. Long-term success rates are not convincing. RESEARCH FOCUS: Overweight and obesity should be treated in an interdisciplinary and multimodal approach. The best results in loosing body weight, especially body fat use very low calorie diets followed by a fat-reduced, carbohydrate-rich diets. Weight-loss drugs should be used only in a weight-loss program including diet and physical activity. Surgical intervention is necessary in a small group of persons refractory to conservative obesity treatment. CONCLUSIONS: New structured guidelines oriented and quality controlled programs for treatment of obese patients are necessary.","['Wechsler, J G', 'Leopold, K']","['Wechsler JG', 'Leopold K']","['Medical Department, Hospital Barmherzige Bruder, Romanstrasse 93, 80639, Munich, Germany. Prof.Wechsler@barmherzige-muenchen.de']",['eng'],['Journal Article'],Germany,Langenbecks Arch Surg,Langenbeck's archives of surgery,9808285,,IM,"['Diet, Reducing', 'Energy Intake', 'Humans', '*Obesity/diet therapy/drug therapy/epidemiology/surgery/therapy', 'Weight Loss']",,,,,2003/06/27 05:00,2004/04/30 05:00,['2003/06/27 05:00'],"['2003/03/28 00:00 [received]', '2003/03/28 00:00 [accepted]', '2003/06/27 05:00 [pubmed]', '2004/04/30 05:00 [medline]', '2003/06/27 05:00 [entrez]']",['10.1007/s00423-003-0377-3 [doi]'],ppublish,Langenbecks Arch Surg. 2003 Dec;388(6):369-74. doi: 10.1007/s00423-003-0377-3. Epub 2003 Jun 21.,,20030621,,,,,,,,,,,,,,,,,,
27892501,NLM,MEDLINE,20180710,20181113,2045-2322 (Electronic) 2045-2322 (Linking),6,,2016 Nov 28,A social contagious model of the obesity epidemic.,37961,10.1038/srep37961 [doi] 37961,"Obesity has been recognized as a global epidemic by WHO, followed by many empirical evidences to prove its infectiousness. However, the inter-person spreading dynamics of obesity are seldom studied. A distinguishing feature of the obesity epidemic is that it is driven by a social contagion process which cannot be perfectly described by the infectious disease models. In this paper, we propose a novel belief decision model based on the famous Dempster-Shafer theory of evidence to model obesity epidemic as the competing spread of two obesity-related behaviors: physical inactivity and physical activity. The transition of health states is described by an SIS model. Results reveal the existence of obesity epidemic threshold, above which obesity is quickly eradicated. When increasing the fading level of information spread, enlarging the clustering of initial obese seeds, or introducing small-world characteristics into the network topology, the threshold is easily met. Social discrimination against the obese people plays completely different roles in two cases: on one hand, when obesity cannot be eradicated, social discrimination can reduce the number of obese people; on the other hand, when obesity is eradicable, social discrimination may instead cause it breaking out.","['Huang, He', 'Yan, Zhijun', 'Chen, Yahong', 'Liu, Fangyan']","['Huang H', 'Yan Z', 'Chen Y', 'Liu F']","['School of Management and Economics, Beijing Institute of Technology, Beijing 100081, China.', 'School of Management and Economics, Beijing Institute of Technology, Beijing 100081, China.', 'School of Management and Economics, Beijing Institute of Technology, Beijing 100081, China.', 'School of Management and Economics, Beijing Institute of Technology, Beijing 100081, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Sci Rep,Scientific reports,101563288,,IM,"['Exercise/psychology', 'Humans', 'Models, Theoretical', 'Obesity/*epidemiology/etiology/*psychology', 'Social Discrimination', 'Social Environment']",PMC5124998,,,,2016/11/29 06:00,2018/07/11 06:00,['2016/11/29 06:00'],"['2016/04/22 00:00 [received]', '2016/10/27 00:00 [accepted]', '2016/11/29 06:00 [entrez]', '2016/11/29 06:00 [pubmed]', '2018/07/11 06:00 [medline]']","['srep37961 [pii]', '10.1038/srep37961 [doi]']",epublish,Sci Rep. 2016 Nov 28;6:37961. doi: 10.1038/srep37961.,,20161128,,,,,,,,,,,,,,,,,,
23128768,NLM,MEDLINE,20130422,20160523,1664-2155 (Electronic) 1664-2147 (Linking),73,,2012,Starting early: obesity prevention during infancy.,81-94,10.1159/000341300 [doi],"Obesity prevalence among infants and young children has increased rapidly during the past 4 decades, a disturbing trend given early obesity's association with later life obesity and its comorbidities. Fortunately, infancy is a period of great behavioral and metabolic plasticity offering numerous targets for preventive interventions. Modifiable factors that may affect early rapid weight gain and obesity risk include infant sleep duration, feeding to soothe infant distress, and the introduction of solid foods and transitional feeding. We discuss evidence linking these factors to weight outcomes, as well as results from behavioral obesity interventions in infancy, from our laboratory and others'. For example, in a recent pilot intervention, we focused on helping new mothers address three areas of infant behavior hypothesized to affect weight gain and early obesity risk: infant sleeping, crying, and feeding. First-time mothers were randomly assigned to receive either a Soothe/Sleep intervention, an Introduction of Solids intervention, both interventions, or no interventions. The interventions were delivered via home visits and showed positive effects on infant behaviors and weight outcomes at 1 year. Based on evidence from such pilot interventions, we assess the plausibility of targeting behavioral factors in infancy and suggest next steps for early prevention research.","['Birch, Leann L', 'Anzman-Frasca, Stephanie', 'Paul, Ian M']","['Birch LL', 'Anzman-Frasca S', 'Paul IM']","['Center for Childhood Obesity Research, Noll Laboratory, The Pennsylvania State University, University Park, PA, Hershey, PA 16802, USA. llb15@psu.edu']",['eng'],"['Journal Article', 'Randomized Controlled Trial']",Switzerland,Nestle Nutr Inst Workshop Ser,Nestle Nutrition Institute workshop series,101577268,,IM,"['*Feeding Behavior', 'Female', '*Health Behavior', 'Humans', 'Infant', 'Infant Care/*methods', 'Infant Nutritional Physiological Phenomena', 'Male', 'Obesity/*epidemiology/*prevention & control', 'Pilot Projects', 'Randomized Controlled Trials as Topic', 'Sleep/physiology', 'Weight Gain/physiology']",,,,,2012/11/07 06:00,2013/04/23 06:00,['2012/11/07 06:00'],"['2012/11/07 06:00 [entrez]', '2012/11/07 06:00 [pubmed]', '2013/04/23 06:00 [medline]']","['000341300 [pii]', '10.1159/000341300 [doi]']",ppublish,Nestle Nutr Inst Workshop Ser. 2012;73:81-94. doi: 10.1159/000341300. Epub 2012 Oct 29.,,20121029,,"['Copyright (c) 2012 Nestec Ltd., Vevey/S. Karger AG, Basel.']",,,,,,,,,,,,,,,,
17267711,NLM,MEDLINE,20070312,20231105,1541-0048 (Electronic) 0090-0036 (Print) 0090-0036 (Linking),97,3,2007 Mar,"Work, obesity, and occupational safety and health.",428-36,,"There is increasing evidence that obesity and overweight may be related, in part, to adverse work conditions. In particular, the risk of obesity may increase in high-demand, low-control work environments, and for those who work long hours. In addition, obesity may modify the risk for vibration-induced injury and certain occupational musculoskeletal disorders. We hypothesized that obesity may also be a co-risk factor for the development of occupational asthma and cardiovascular disease that and it may modify the worker's response to occupational stress, immune response to chemical exposures, and risk of disease from occupational neurotoxins. We developed 5 conceptual models of the interrelationship of work, obesity, and occupational safety and health and highlighted the ethical, legal, and social issues related to fuller consideration of obesity's role in occupational health and safety.","['Schulte, Paul A', 'Wagner, Gregory R', 'Ostry, Aleck', 'Blanciforti, Laura A', 'Cutlip, Robert G', 'Krajnak, Kristine M', 'Luster, Michael', 'Munson, Albert E', ""O'Callaghan, James P"", 'Parks, Christine G', 'Simeonova, Petia P', 'Miller, Diane B']","['Schulte PA', 'Wagner GR', 'Ostry A', 'Blanciforti LA', 'Cutlip RG', 'Krajnak KM', 'Luster M', 'Munson AE', ""O'Callaghan JP"", 'Parks CG', 'Simeonova PP', 'Miller DB']","['National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Cincinnati, Ohio, USA. pas4@cdc.gov']",['eng'],['Journal Article'],United States,Am J Public Health,American journal of public health,1254074,,IM,"['Adult', 'Asthma/etiology', 'Cardiovascular Diseases/etiology', 'Health Behavior', 'Humans', 'Middle Aged', '*Models, Theoretical', 'Musculoskeletal Diseases/etiology', '*Obesity/complications/epidemiology/prevention & control/psychology', 'Occupational Diseases/etiology', '*Occupational Exposure/adverse effects/economics/ethics/prevention & control', '*Occupational Health', 'Prejudice', 'Privacy', 'Risk Factors', 'Social Responsibility', 'Stress, Psychological/etiology', '*Work/ethics/physiology/psychology', ""Workers' Compensation""]",PMC1805035,,,,2007/02/03 09:00,2007/03/14 09:00,['2007/02/03 09:00'],"['2007/02/03 09:00 [pubmed]', '2007/03/14 09:00 [medline]', '2007/02/03 09:00 [entrez]']","['AJPH.2006.086900 [pii]', '0970428 [pii]', '10.2105/AJPH.2006.086900 [doi]']",ppublish,Am J Public Health. 2007 Mar;97(3):428-36. doi: 10.2105/AJPH.2006.086900. Epub 2007 Jan 31.,,20070131,,,,,,,,,,,,,,,,,,
23054519,NLM,MEDLINE,20130516,20211021,1528-1132 (Electronic) 0009-921X (Print) 0009-921X (Linking),471,4,2013 Apr,Does obesity affect fracture healing in children?,1208-13,10.1007/s11999-012-2626-7 [doi],"BACKGROUND: Obesity is a risk factor for various orthopaedic diseases, including fractures. Obesity's influence on circulating hormones and cytokines and bone mineralization ultimately influences the body's osteogenic response and bone mineralization, potentially increasing the risk of fracture and impacting fracture healing. QUESTIONS/PURPOSES: Does obesity delay fracture recovery in overweight or obese children as measured by the time to release to normal activity? Is this average time for return to activity influenced by the mechanism of the injury? Does obesity's effect on mineralization and loading in overweight or obese children lead to a greater proportion of upper extremity fracture versus lower extremity fracture? METHODS: We prospectively followed 273 patients with nonpathologic long bone fractures treated from January 2010 to October 2011. Patients were stratified into obese/overweight, normal weight, and underweight groups. All patients were followed until release to regular activities (mean, 41 days; range, 13-100 days). RESULTS: Release to regular activities occurred sooner in obese/overweight than in normal weight patients: 39 and 42 days, respectively. A greater proportion of obese/overweight patients had low to moderate energy mechanisms of injury than did normal weight patients, but we found no difference between the groups in terms of return to activity when stratified by mechanism. There was also no difference in the proportion of upper extremity injuries between the two groups. CONCLUSIONS: Obese/overweight children did not have a delay in release to activities compared with children of normal weight. LEVEL OF EVIDENCE: Level II, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.","['Lee, Rushyuan J', 'Hsu, Nigel N', 'Lenz, Colleen M', 'Leet, Arabella I']","['Lee RJ', 'Hsu NN', 'Lenz CM', 'Leet AI']","['Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, MD, USA.']",['eng'],['Journal Article'],United States,Clin Orthop Relat Res,Clinical orthopaedics and related research,0075674,,IM,"['Adolescent', 'Body Mass Index', 'Child', 'Child, Preschool', 'Female', 'Fracture Healing/*physiology', 'Fractures, Bone/*etiology/*physiopathology', 'Humans', 'Infant', 'Male', 'Obesity/*complications/*physiopathology', 'Prospective Studies', 'Risk Factors']",PMC3586024,,,,2012/10/12 06:00,2013/05/17 06:00,['2012/10/12 06:00'],"['2012/10/12 06:00 [entrez]', '2012/10/12 06:00 [pubmed]', '2013/05/17 06:00 [medline]']","['2626 [pii]', '10.1007/s11999-012-2626-7 [doi]']",ppublish,Clin Orthop Relat Res. 2013 Apr;471(4):1208-13. doi: 10.1007/s11999-012-2626-7.,,,,,,,,,,,,,,,,,,,,
17939036,NLM,MEDLINE,20081014,20080728,0167-6806 (Print) 0167-6806 (Linking),111,2,2008 Sep,Is obesity an independent prognosis factor in woman breast cancer?,329-42,,"BACKGROUND: Breast cancer and obesity represent important public health issues in most western countries. A number of studies found a negative prognosis effect of obesity or excess of weight in woman breast cancer. However, to date, this issue remains controversial. The objectives of this study were to confirm the prognosis role of obesity on a large cohort of patients and to investigate a potential independent effect. MATERIALS AND METHODS: We constituted a cohort of 14,709 patients who were recruited and treated at the Curie Institute (Paris) from 1981 to 1999. These patients were followed prospectively for a first unilateral invasive breast cancer without distant metastasis. Obesity was defined by a Body Mass Index (BMI) above 30 kg/m(2) according to the World Health Organization recommendations. RESULTS: Obese patients (8%) presented more extended tumors at diagnosis time suggesting a delayed breast cancer diagnosis. However, obesity appeared as a negative prognosis factor for several events in respectively univariate and multivariate survival analysis: metastasis recurrence (HR = 1.32[1.19-1.48]; HR = 1.12[1.00-1.26]), disease free interval (1.20[1.08-1.32]; 1.10[0.99-1.22]), overall survival (1.43[1.28-1.60]; 1.12[0.99-1.25]) and second primary cancer outcome (1.57[1.19-2.07]; 1.43[1.09-1.89]). Even if obese patients presented more advanced tumors at diagnosis time, multivariate analysis showed that there was a relevant independent effect. Other BMI codings, distinguishing overweight patients or using BMI as a continuous variable, showed a consistent correlation between BMI's value and prognosis effect. Interaction analysis revealed a more important obesity effect in the presence of tumor estrogen receptors and among limited extent tumors. CONCLUSIONS: This survey confirms the prognosis role of obesity on one of the largest cohort by investigating several prognosis events. While independent obesity effect linked to hormonal disorders appeared consistent as obesity's mechanism, we stress that obesity prognosis effect was also related to breast cancer presentation at diagnosis time.","['Majed, Bilal', 'Moreau, Thierry', 'Senouci, Kamel', 'Salmon, Remi J', 'Fourquet, Alain', 'Asselain, Bernard']","['Majed B', 'Moreau T', 'Senouci K', 'Salmon RJ', 'Fourquet A', 'Asselain B']","['Biostatistics Department, Curie Institute, 75005, Paris, France. bmajed@free.fr']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Netherlands,Breast Cancer Res Treat,Breast cancer research and treatment,8111104,,IM,"['Adolescent', 'Adult', 'Body Mass Index', 'Breast Neoplasms/*mortality', 'Cohort Studies', 'Female', 'Humans', 'Middle Aged', 'Obesity/*complications', 'Prognosis', 'Proportional Hazards Models', 'Prospective Studies']",,,,,2007/10/17 09:00,2008/10/15 09:00,['2007/10/17 09:00'],"['2007/05/04 00:00 [received]', '2007/10/05 00:00 [accepted]', '2007/10/17 09:00 [pubmed]', '2008/10/15 09:00 [medline]', '2007/10/17 09:00 [entrez]']",['10.1007/s10549-007-9785-3 [doi]'],ppublish,Breast Cancer Res Treat. 2008 Sep;111(2):329-42. doi: 10.1007/s10549-007-9785-3. Epub 2007 Oct 16.,,20071016,,,,,,,,,,,,,,,,,,
33280394,NLM,MEDLINE,20210820,20220425,1938-2715 (Electronic) 1049-9091 (Linking),38,10,2021 Oct,The Impact of Obesity in End of Life Care in Patients With End Stage Liver Disease: An Observational Study.,1177-1181,10.1177/1049909120978768 [doi],"BACKGROUND: Both obesity and end stage liver disease (ESLD) are increasing. Obesity's impact on hospice and palliative care in patients with ESLD is unknown. METHODS: We retrospectively evaluated patients admitted to an academic, Midwestern, tertiary center between January 2016 and May 2019 with a diagnosis of ESLD. Body Mass Index and MELD Na were calculated for each patient's first admission during the study period. Patients with MELD Na scores >/= 21 or 18-20 with additional criteria were considered potentially eligible for hospice and palliative care referrals. RESULTS: Of 3863 patients admitted with ESLD, 1556 (40%) were potentially eligible for hospice and palliative care referrals. Of these, 703 (45%) were obese. Comorbidity burden was higher in obese patients (15.6% of obese patients had a Charlson Comorbidity Index >/= 5, while 5% of non-obese patients had a comorbidity index of >/= 5 (p < 0.001). Referral rates to hospice and palliative services in obese patients were 10.1% and 16.4% respectively. Hospice and palliative referral rates among non-obese patients were similar (10.1% and 15.5%). Among patients who died within 6 months of the first hospitalization, the mean time to referral to hospice or palliative care from index admission was longer in obese patients. CONCLUSION: Obesity is common in patients hospitalized with ESLD who may be approaching the end of life. Referral rates to hospice and palliative care services are low and similar regardless of BMI and despite higher co-morbidity burdens in obese patients. Obesity may delay referrals to hospice and palliative care.","['Subramoney, Kavitha', 'Orman, Eric', 'Johnson, Amy W', 'Kara, Areeba']","['Subramoney K', 'Orman E', 'Johnson AW', 'Kara A']","['10668Indiana University School of Medicine, Indianapolis, IN, USA.', '10668Indiana University School of Medicine, Indianapolis, IN, USA.', '10668Indiana University School of Medicine, Indianapolis, IN, USA.', '10668Indiana University School of Medicine, Indianapolis, IN, USA.']",['eng'],"['Journal Article', 'Observational Study']",United States,Am J Hosp Palliat Care,The American journal of hospice & palliative care,9008229,,IM,"['*End Stage Liver Disease', '*Hospice Care', 'Humans', 'Obesity/complications/epidemiology', 'Palliative Care', 'Retrospective Studies', '*Terminal Care']",,['NOTNLM'],"['body mass index', 'end stage liver disease', 'hospice', 'obesity', 'palliative care']",,2020/12/08 06:00,2021/08/21 06:00,['2020/12/07 05:21'],"['2020/12/08 06:00 [pubmed]', '2021/08/21 06:00 [medline]', '2020/12/07 05:21 [entrez]']",['10.1177/1049909120978768 [doi]'],ppublish,Am J Hosp Palliat Care. 2021 Oct;38(10):1177-1181. doi: 10.1177/1049909120978768. Epub 2020 Dec 7.,,20201207,,,['ORCID: 0000-0001-5229-8273'],,,,,,,,,,,,,,,
37698918,NLM,MEDLINE,20231109,20231109,2379-3708 (Electronic) 2379-3708 (Linking),8,19,2023 Sep 12,Calorie restriction outperforms bariatric surgery in a murine model of obesity and triple-negative breast cancer.,,10.1172/jci.insight.172868 [doi] e172868,"Obesity promotes triple-negative breast cancer (TNBC), and effective interventions are urgently needed to break the obesity-TNBC link. Epidemiologic studies indicate that bariatric surgery reduces TNBC risk, while evidence is limited or conflicted for weight loss via low-fat diet (LFD) or calorie restriction (CR). Using a murine model of obesity-driven TNBC, we compared the antitumor effects of vertical sleeve gastrectomy (VSG) with LFD, chronic CR, and intermittent CR. Each intervention generated weight and fat loss and suppressed tumor growth relative to obese mice (greatest suppression with CR). VSG and CR regimens exerted both similar and unique effects, as assessed using multiomics approaches, in reversing obesity-associated transcript, epigenetics, secretome, and microbiota changes and restoring antitumor immunity. Thus, in a murine model of TNBC, bariatric surgery and CR each reverse obesity-driven tumor growth via shared and distinct antitumor mechanisms, and CR is superior to VSG in reversing obesity's procancer effects.","['Camp, Kristina K', 'Coleman, Michael F', 'McFarlane, Tori L', 'Doerstling, Steven S', 'Khatib, Subreen A', 'Rezeli, Erika T', 'Lewis, Alfor G', 'Pfeil, Alexander J', 'Smith, Laura A', 'Bowers, Laura W', 'Fouladi, Farnaz', 'Gong, Weida', 'Glenny, Elaine M', 'Parker, Joel S', 'Milne, Ginger L', 'Carroll, Ian M', 'Fodor, Anthony A', 'Seeley, Randy J', 'Hursting, Stephen D']","['Camp KK', 'Coleman MF', 'McFarlane TL', 'Doerstling SS', 'Khatib SA', 'Rezeli ET', 'Lewis AG', 'Pfeil AJ', 'Smith LA', 'Bowers LW', 'Fouladi F', 'Gong W', 'Glenny EM', 'Parker JS', 'Milne GL', 'Carroll IM', 'Fodor AA', 'Seeley RJ', 'Hursting SD']","['Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'College of Computing and Informatics, University of North Carolina at Charlotte, Charlotte, North Carolina, USA.', 'Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'College of Computing and Informatics, University of North Carolina at Charlotte, Charlotte, North Carolina, USA.', 'Department of Surgery, University of Michigan, Ann Arbor, Michigan, USA.', 'Department of Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.', 'Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, North Carolina, USA.']",['eng'],['Journal Article'],United States,JCI Insight,JCI insight,101676073,,IM,"['Humans', 'Mice', 'Animals', '*Triple Negative Breast Neoplasms', 'Caloric Restriction', 'Disease Models, Animal', 'Obesity/complications/surgery', '*Bariatric Surgery']",PMC10629811,['NOTNLM'],"['Breast cancer', 'Metabolism', 'Obesity', 'Oncology']",,2023/09/12 18:42,2023/11/09 06:42,['2023/09/12 12:02'],"['2023/06/07 00:00 [received]', '2023/08/29 00:00 [accepted]', '2023/11/09 06:42 [medline]', '2023/09/12 18:42 [pubmed]', '2023/09/12 12:02 [entrez]']","['172868 [pii]', '10.1172/jci.insight.172868 [doi]']",epublish,JCI Insight. 2023 Sep 12;8(19):e172868. doi: 10.1172/jci.insight.172868.,['R35 CA197627/CA/NCI NIH HHS/United States'],20230912,,,,,,,,,,,,,,,,,,
18804936,NLM,MEDLINE,20090403,20220330,0738-3991 (Print) 0738-3991 (Linking),74,1,2009 Jan,Obesity-related knowledge and beliefs in obese adults attending a specialist weight-management service: implications for weight loss over 1 year.,70-6,10.1016/j.pec.2008.07.045 [doi],"OBJECTIVE: Cognitive approaches to obesity management assume that weight loss is more likely to occur if individuals perceive many benefits and few costs. Research to-date has been limited by the lack of prospective studies. METHODS: A longitudinal study design. At baseline, obese patients attending weight-management clinics (n=104) completed a questionnaire that assessed knowledge and beliefs regarding obesity's health and social/aesthetic consequences (Obesity Risk Knowledge (ORK-10) scale and the Obesity Beliefs scale), self-reported weight/height, goal weight, health-related quality of life, and sociodemographic characteristics. Medical records were also reviewed. At the 12-month follow-up, a second questionnaire assessed self-reported weight/height. RESULTS: At baseline, average ORK-10 scale scores were 4/10. At follow-up, 32 out of the 66 participants retained on the study did not gain weight (48.5%). For these participants, weight loss was associated with endorsement of the health (r(s)=0.40) and the social/aesthetic (r(s)=0.31) costs of obesity (p<0.05). CONCLUSION: Despite their high-risk status, participants demonstrated low levels of knowledge regarding obesity's health risks. Weight loss was associated with greater awareness of the health and social/aesthetic costs of obesity. PRACTICE IMPLICATIONS: This study suggests that health education is required to facilitate informed choices and supports the use of cognitive approaches which promote both the health and social/aesthetic consequences of obesity.","['Swift, Judy Anne', 'Glazebrook, Cris', 'Anness, Abigail', 'Goddard, Rebecca']","['Swift JA', 'Glazebrook C', 'Anness A', 'Goddard R']","['Division of Nutritional Sciences, School of Biosciences, The University of Nottingham, UK. judy.swift@nottingham.ac.uk']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Ireland,Patient Educ Couns,Patient education and counseling,8406280,,,"['Adult', 'Ambulatory Care Facilities', '*Attitude to Health', 'Body Mass Index', 'Cost of Illness', 'Educational Status', 'Female', 'Follow-Up Studies', '*Health Knowledge, Attitudes, Practice', 'Health Services Needs and Demand', 'Humans', 'Male', 'Middle Aged', 'Obesity/complications/prevention & control/*psychology', 'Patient Education as Topic/*organization & administration', 'Quality of Life/psychology', 'Risk Factors', 'Statistics, Nonparametric', 'Surveys and Questionnaires', 'United Kingdom', 'Weight Loss']",,,,,2008/09/23 09:00,2009/04/04 09:00,['2008/09/23 09:00'],"['2007/11/13 00:00 [received]', '2008/06/19 00:00 [revised]', '2008/07/23 00:00 [accepted]', '2008/09/23 09:00 [pubmed]', '2009/04/04 09:00 [medline]', '2008/09/23 09:00 [entrez]']","['S0738-3991(08)00395-9 [pii]', '10.1016/j.pec.2008.07.045 [doi]']",ppublish,Patient Educ Couns. 2009 Jan;74(1):70-6. doi: 10.1016/j.pec.2008.07.045. Epub 2008 Sep 19.,,20080919,,,,,,,,,,,,,,,,,,
36872175,NLM,MEDLINE,20230414,20230503,1532-7361 (Electronic) 0039-6060 (Linking),173,5,2023 May,The association between obesity and postoperative outcomes in a broad surgical population: A 7-year American College of Surgeons National Surgical Quality Improvement analysis.,1213-1219,S0039-6060(23)00047-8 [pii] 10.1016/j.surg.2023.02.001 [doi],"BACKGROUND: The number of obese surgical patients continues to grow, and yet obesity's association with surgical outcomes is not totally clear. This study examined the association between obesity and surgical outcomes across a broad surgical population using a very large sample size. METHODS: This was an analysis of the 2012 to 2018 American College of Surgeons National Surgical Quality Improvement database, including all patients from 9 surgical specialties (general, gynecology, neurosurgery, orthopedics, otolaryngology, plastics, thoracic, urology, and vascular). Preoperative characteristics and postoperative outcomes were compared by body mass index class (normal weight 18.5-24.9 kg/m(2), overweight 25.0-29.9, obese class I 30.0-34.9, obese II 35.0-39.9, obese III >/=40). Adjusted odds ratios were computed for adverse outcomes by body mass index class. RESULTS: A total of 5,572,019 patients were included; 44.6% were obese. Median operative times were marginally higher for obese patients (89 vs 83 minutes, P < .001). Compared to normal weight patients, overweight and obese patients in classes I, II, and III all had higher adjusted odds of developing infection, venous thromboembolism, and renal complications, but they did not exhibit elevated odds of other postoperative complications (mortality, overall morbidity, pulmonary, urinary tract infection, cardiac, bleeding, stroke, unplanned readmission, or discharge not home (except for class III patients). CONCLUSION: Obesity was associated with increased odds of postoperative infection, venous thromboembolism, and renal but not the other American College of Surgeons National Surgical Quality Improvement complications. Obese patients need to be carefully managed for these complications.","['Madsen, Helen J', 'Gillette, Riley A', 'Colborn, Kathryn L', 'Henderson, William G', 'Dyas, Adam R', 'Bronsert, Michael R', 'Lambert-Kerzner, Anne', 'Meguid, Robert A']","['Madsen HJ', 'Gillette RA', 'Colborn KL', 'Henderson WG', 'Dyas AR', 'Bronsert MR', 'Lambert-Kerzner A', 'Meguid RA']","['Surgical Outcomes and Applied Research Program, Department of Surgery, University of Colorado School of Medicine, Aurora, CO. Electronic address: helen.madsen@CUAnschutz.edu.', 'Surgical Outcomes and Applied Research Program, Department of Surgery, University of Colorado School of Medicine, Aurora, CO.', 'Surgical Outcomes and Applied Research Program, Department of Surgery, University of Colorado School of Medicine, Aurora, CO; Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO. Electronic address: https://twitter.com/ColbornKathryn.', 'Surgical Outcomes and Applied Research Program, Department of Surgery, University of Colorado School of Medicine, Aurora, CO; Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO; Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO.', 'Surgical Outcomes and Applied Research Program, Department of Surgery, University of Colorado School of Medicine, Aurora, CO.', 'Surgical Outcomes and Applied Research Program, Department of Surgery, University of Colorado School of Medicine, Aurora, CO; Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO.', 'Surgical Outcomes and Applied Research Program, Department of Surgery, University of Colorado School of Medicine, Aurora, CO; Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO.', 'Surgical Outcomes and Applied Research Program, Department of Surgery, University of Colorado School of Medicine, Aurora, CO; Adult and Child Center for Health Outcomes Research and Delivery Science, University of Colorado School of Medicine, Aurora, CO. Electronic address: https://twitter.com/MeguidRobert.']",['eng'],['Journal Article'],United States,Surgery,Surgery,0417347,,IM,"['Humans', 'United States/epidemiology', 'Overweight/complications', 'Risk Factors', '*Venous Thromboembolism', 'Quality Improvement', 'Obesity/complications/epidemiology', 'Postoperative Complications/epidemiology/etiology', '*Surgeons', 'Body Mass Index', 'Retrospective Studies']",,,,,2023/03/06 06:00,2023/04/14 06:41,['2023/03/05 22:06'],"['2022/11/14 00:00 [received]', '2023/01/22 00:00 [revised]', '2023/02/02 00:00 [accepted]', '2023/04/14 06:41 [medline]', '2023/03/06 06:00 [pubmed]', '2023/03/05 22:06 [entrez]']","['S0039-6060(23)00047-8 [pii]', '10.1016/j.surg.2023.02.001 [doi]']",ppublish,Surgery. 2023 May;173(5):1213-1219. doi: 10.1016/j.surg.2023.02.001. Epub 2023 Mar 3.,,20230303,,['Copyright (c) 2023 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
15552238,NLM,MEDLINE,20050125,20051116,0030-1876 (Print) 0030-1876 (Linking),97,10,2004 Oct,Overview and management of obesity in adults.,422-6,,"Teaching Points. The prevalence of overweight or overtly obese adults in the United States is growing and associated with significant morbidity and mortality. Office evaluation of the overweight or obese adult includes a thorough history and physical examination complemented by several laboratory tests that evaluate for co-morbid conditions. Treatment of the overweight or obese adult requires a step-wise approach beginning with lifestyle modification followed by pharmacologic or surgical interventions in selected patients. Treatment decisions should take into consideration body mass index, waist circumference and the presence of comorbidities or obesity-associated risk factors.","['Jackson, Rhett L', 'Bronze, Michael S']","['Jackson RL', 'Bronze MS']","['Department of Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma 73104, USA.']",['eng'],"['Journal Article', 'Review']",United States,J Okla State Med Assoc,The Journal of the Oklahoma State Medical Association,7503043,,IM,"['Adult', 'Humans', 'Obesity/complications/epidemiology/*therapy', 'United States/epidemiology']",,,,,2004/11/24 09:00,2005/01/26 09:00,['2004/11/24 09:00'],"['2004/11/24 09:00 [pubmed]', '2005/01/26 09:00 [medline]', '2004/11/24 09:00 [entrez]']",,ppublish,J Okla State Med Assoc. 2004 Oct;97(10):422-6.,,,,,,,30,,,,,,,,,,,,,
36073157,NLM,MEDLINE,20230104,20230328,1866-0452 (Electronic) 1866-0452 (Linking),119,39,2022 Sep 30,Auditing Practices of the Medical Service Regarding Hospitalizations of Patients With a Secondary Diagnosis of Obesity.,658-663,arztebl.m2022.0256 [pii] 10.3238/arztebl.m2022.0256 [doi],"BACKGROUND: It has been observed that the Medical Service (Medizinischer Dienst, an auditing body of the German statutory health insurance system) is more likely to audit the bill for a hospitalization in a psychosomatic clinic if the patient carries a secondary diagnosis of obesity. METHODS: In an exploratory study, we retrospectively analyzed 771 datasets collected in 2019 as part of the standard documentation of acute psychosomatic hospitalizations. RESULTS: In 2019, the Medical Service audited bills for psychosomatic hospital - izations much more often in obese than in non-obese patients (odds ratio [OR] 2.499; 95% confidence interval [1.69; 3.69]). This was accounted for by a very high audit rate for patients with a secondary diagnosis of grade 3 obesity (OR = 3.972 [2.30; 6.86]). The audit categories ""quality of coding"" and ""possible incorrect admission"" were examined. CONCLUSION: Treatments of markedly obese inpatients that incurred greater expenses presumably led to a higher hospitalization audit rate as an automatic consequence of the auditing algorithms used. An unintentional statistical discrimination arose from the unjustified linkage of the audit category ""quality of coding"" of the secondary diagnosis (obesity) with the audit category ""possible incorrect admission"" with regard to the main diagnosis. Similar effects may be occurring with economically relevant secondary diagnoses in other areas of medicine as well.","['Imgart, Hartmut', 'Haase, Ingo']","['Imgart H', 'Haase I']","['Parkland Clinic, Clinic for Psychosomatic Medicine and Psychotherapy, Bad Wildungen.']",['eng'],['Journal Article'],Germany,Dtsch Arztebl Int,Deutsches Arzteblatt international,101475967,,IM,"['Humans', 'Retrospective Studies', '*Hospitalization', '*Obesity/diagnosis/epidemiology/therapy', 'Inpatients', 'Medical Audit']",PMC9811546,,,,2022/09/09 06:00,2023/01/05 06:00,['2022/09/08 03:52'],"['2022/02/16 00:00 [received]', '2022/02/16 00:00 [revised]', '2022/06/15 00:00 [accepted]', '2022/09/09 06:00 [pubmed]', '2023/01/05 06:00 [medline]', '2022/09/08 03:52 [entrez]']","['arztebl.m2022.0256 [pii]', '10.3238/arztebl.m2022.0256 [doi]']",ppublish,Dtsch Arztebl Int. 2022 Sep 30;119(39):658-663. doi: 10.3238/arztebl.m2022.0256.,,,,,,,,,,,,,,,,,,,,
35638538,NLM,MEDLINE,20230915,20230915,2212-3873 (Electronic) 1871-5303 (Linking),23,11,2023,Parental Perceptions and Concerns Related to the Consequences of Pediatric Obesity: Feeling or Real Problem?,1380-1391,10.2174/1871530322666220530121012 [doi],"Lifestyle modifications (i.e., nutrition and physical activity) remain the main tools in the context of childhood obesity's treatment and prevention of short and long-term consequences. At the same time, parental perception of child weight represents an even more important tool. It is known that more than half of parents of overweight/obese children underestimate their child's weight status or are not worried about the risks associated with childhood overweight/obesity. Consequently, parental perception of childhood obesity can often be erroneous, and, even when accurate, subsequent parental behaviors can inadvertently contribute to the onset or persistence of childhood and adult obesity. Starting from the evidence that targeting a parent to induce a behavioral change is more effective than targeting the child only without parental participation, parental perceptions of childhood obesity can therefore represent a very important tool to take into consideration to achieve improvements in the context of childhood obesity. Therefore, knowledge of parental perception of children's weight status is needed to help pediatricians to organize and adapt activities and programs that promote healthy weight management among children. Specifically, early assessments of parents' perceptions of a child's weight, followed by regular follow-up visits, appropriate feedback, continuing education efforts, and efforts to follow the child's weight status over time, can be potentially very helpful.","['Puma, Andrea', 'Pecoraro, Luca', 'Salvottini, Chiara', 'Carbonare, Luca Dalle', 'Piacentini, Giorgio', 'Pietrobelli, Angelo']","['Puma A', 'Pecoraro L', 'Salvottini C', 'Carbonare LD', 'Piacentini G', 'Pietrobelli A']","['Department of Surgical Sciences, Pediatric Unit, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.', 'Department of Surgical Sciences, Pediatric Unit, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.', 'Department of Medicine, University of Verona, Verona, Italy.', 'Department of Surgical Sciences, Pediatric Unit, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.', 'Department of Medicine, University of Verona, Verona, Italy.', 'Department of Surgical Sciences, Pediatric Unit, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.', 'Department of Surgical Sciences, Pediatric Unit, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.', 'Pennington Biomedical Research Center, Baton Rouge, LA, USA.']",['eng'],['Journal Article'],United Arab Emirates,Endocr Metab Immune Disord Drug Targets,"Endocrine, metabolic & immune disorders drug targets",101269157,,IM,"['Adult', 'Humans', 'Child', '*Pediatric Obesity/diagnosis/epidemiology/therapy', 'Body Mass Index', 'Health Knowledge, Attitudes, Practice', 'Parents', 'Overweight', 'Body Weight', 'Surveys and Questionnaires']",,['NOTNLM'],"['BMI', 'Pediatric obesity', 'cardiovascular diseases', 'childhood obesity', 'diabetes', 'long-term consequences of pediatric-obesity', 'parental perceptions of pediatric obesity', 'short-term consequences of pediatric obesity']",,2022/06/01 06:00,2023/09/15 06:43,['2022/05/31 15:01'],"['2022/02/03 00:00 [received]', '2022/04/09 00:00 [revised]', '2022/04/19 00:00 [accepted]', '2023/09/15 06:43 [medline]', '2022/06/01 06:00 [pubmed]', '2022/05/31 15:01 [entrez]']","['EMIDDT-EPUB-124060 [pii]', '10.2174/1871530322666220530121012 [doi]']",ppublish,Endocr Metab Immune Disord Drug Targets. 2023;23(11):1380-1391. doi: 10.2174/1871530322666220530121012.,,,,"['Copyright(c) Bentham Science Publishers; For any queries, please email at', 'epub@benthamscience.net.']","['ORCID: 0000-0001-8056-4487', 'ORCID: 0000-0002-9765-8006', 'ORCID: 0000-0002-8863-2605', 'ORCID: 0000-0003-3263-6671', 'ORCID: 0000-0003-1324-4373', 'ORCID: 0000-0002-9912-3232']",,,,,,,,,,,,,,,
23156652,NLM,MEDLINE,20130109,20121119,1320-159X (Print) 1320-159X (Linking),20,1,2012 Sep,"Childhood obesity, parental duties of care and strategies for intervention.",124-51,,"Childhood obesity is an increasingly serious issue which causes significant health problems among children. There are numerous causes of childhood obesity. However, the ultimate responsibility for the problems and costs associated with an obese child should be attributed to that child's parents. Parents owe a duty of care to their child and, when their child is obese, have arguably breached that duty. However, if parents were required to pay their child damages, this would arguably be problematic and of little utility. Rather, intervention strategies should be implemented which seek to treat and prevent childhood obesity and to address the identified causes of childhood obesity.","['Nolan, Elise Jane']",['Nolan EJ'],"['Office of the Director of Public Prosecutions (ODPP), Queensland. Elise.Nolan@justice.qld.gov.au']",['eng'],['Journal Article'],Australia,J Law Med,Journal of law and medicine,9431853,,IM,"['Child', 'Child Welfare', 'Humans', 'Obesity/epidemiology/etiology/*prevention & control', 'Parenting', '*Parents', 'Public Health']",,,,,2012/11/20 06:00,2013/01/10 06:00,['2012/11/20 06:00'],"['2012/11/20 06:00 [entrez]', '2012/11/20 06:00 [pubmed]', '2013/01/10 06:00 [medline]']",,ppublish,J Law Med. 2012 Sep;20(1):124-51.,,,,,,,,,,,,,,,,,,,,
18022138,NLM,MEDLINE,20080401,20161031,0003-4266 (Print) 0003-4266 (Linking),68,6,2007 Dec,[Genetic obesities].,430-7,,"Obesity has become an increasingly prevalent public health problem and results of the complex interaction of genetic and environmental factors. The study of rare syndromic forms of obesity enables progress in identifying molecular and physiological mechanisms, underlying the development of adiposity, food intake and energy expenditure. The identified role of the hypothalamic leptin-melanocortin pathway as major in monogenic forms of obesity, has led to the recognition of new genes controlling energy homeostasis and new pharmacological targets.","['Pigeyre, M', 'Romon, M']","['Pigeyre M', 'Romon M']","['Service de nutrition, CHRU de Lille, hopital Jeanne-de-Flandre, 59037 Lille, France. mariepigeyre@hotmail.com']",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,"['0 (Receptors, Melanocortin)']",IM,"['Bardet-Biedl Syndrome/diagnosis', 'Humans', 'Obesity/classification/etiology/*genetics', 'Prader-Willi Syndrome/diagnosis', 'Receptors, Melanocortin/genetics']",,,,,2007/11/21 09:00,2008/04/02 09:00,['2007/11/21 09:00'],"['2007/06/04 00:00 [received]', '2007/09/07 00:00 [revised]', '2007/09/17 00:00 [accepted]', '2007/11/21 09:00 [pubmed]', '2008/04/02 09:00 [medline]', '2007/11/21 09:00 [entrez]']","['S0003-4266(07)00255-7 [pii]', '10.1016/j.ando.2007.09.001 [doi]']",ppublish,Ann Endocrinol (Paris). 2007 Dec;68(6):430-7. doi: 10.1016/j.ando.2007.09.001. Epub 2007 Nov 19.,,20071119,,,,,65,,Obesites genetiques.,,,,,,,,,,,
14707902,NLM,MEDLINE,20040305,20161031,0003-4266 (Print) 0003-4266 (Linking),64,5 Pt 2,2003 Nov,[Management of childhood obesity].,S34-9,,"The prevalence of obesity is currently increasing in children and young adolescents in France, and affects about 10 to 14% of them. Therapeutic objectives should aim to improve, on the long-term, the weight/body mass index curve. Restrictive diet and weight loss should not be the primary target. The focus has to be on a balanced healthy diet, tailored to children growth, associated with a regular physical activity. Children weight management should be within the usual life conditions, taking into account familial and social environmental conditions, through a multidisciplinary team approach as those implemented in our paediatric medical centre. The objectives, management steps and current results of our therapeutic educational project are described.","['Serban, A', 'Brunard, F']","['Serban A', 'Brunard F']","['Centre Medical Pediatrique, Francheville, France.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,,IM,"['Adolescent', 'Body Mass Index', 'Child', 'Diet', 'Exercise', 'Humans', 'Obesity/epidemiology/*therapy', 'Patient Education as Topic', 'Risk Factors', 'Treatment Outcome']",,,,,2004/01/07 05:00,2004/03/06 05:00,['2004/01/07 05:00'],"['2004/01/07 05:00 [pubmed]', '2004/03/06 05:00 [medline]', '2004/01/07 05:00 [entrez]']",['MDOI-AE-11-2003-64-5-C2-0003-4266-101019-ART6 [pii]'],ppublish,Ann Endocrinol (Paris). 2003 Nov;64(5 Pt 2):S34-9.,,,,,,,26,,Prise en charge de l'enfant et de l'adolescent obeses.,,,,,,,,,,,
800707,NLM,MEDLINE,19770812,20151119,0003-4037 (Print) 0003-4037 (Linking),30,2-3,1976,[Dietary behavior during obesity].,211-8,,"Human alimentary behavior deals with a threefold need: energetic, hedonic and sociocultural. Among the clinical constellation offered by obese patients it could be worthwile to distinguish: 1. Some constitutional and organic obesities, pathogenesis of which does not imply an abnormality of alimentary behavior; 2. Conversely, in some other cases, psychological induced behavioral abnormalities are able to lead to an overstepping of the so called ""normal"" weight; 3. In other instances, the alimentary behavior reflects the elevation of the set point for weight. All these mechanisms are mutally reinforcing and could act simultaneously or successively accounting for the great variability of the individual situations. In any case environmental conditions are operating and play a pathogenic role more especially as the anatomic, physiologic and psychologic background is predisposed.","['Guy-Grand, B', 'Apfelbaum, M']","['Guy-Grand B', 'Apfelbaum M']",,['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Ann Nutr Aliment,Annales de la nutrition et de l'alimentation,0372653,,IM,"['Adolescent', 'Adult', 'Child', 'Cultural Characteristics', 'Diet/*adverse effects', 'Energy Intake', '*Feeding Behavior', 'Feeding and Eating Disorders/complications', 'Humans', 'Hyperplasia', 'Infant', '*Obesity/etiology/metabolism', 'Sociology']",,,,,1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Ann Nutr Aliment. 1976;30(2-3):211-8.,,,,,,,21,,Comportement alimentaire au cours de l'obesite.,,,,,,,,,,,
37162651,NLM,MEDLINE,20230911,20230922,1573-2606 (Electronic) 1389-9155 (Print) 1389-9155 (Linking),24,5,2023 Oct,Towards an adiposity-related disease framework for the diagnosis and management of obesities.,795-807,10.1007/s11154-023-09797-2 [doi],"Obesity is a complex disease that relapses frequently and associates with multiple complications that comprise a worldwide health priority because of its rising prevalence and association with numerous complications, including metabolic disorders, mechanic pathologies, and cancer, among others. Noteworthy, excess adiposity is accompanied by chronic inflammation, oxidative stress, insulin resistance, and subsequent organ dysfunction. This dysfunctional adipose tissue is initially stored in the visceral depot, overflowing subsequently to produce lipotoxicity in ectopic depots like liver, heart, muscle, and pancreas, among others. People living with obesity need a diagnostic approach that considers an exhaustive pathophysiology and complications assessment. Thus, it is essential to warrant a holistic diagnosis and management that guarantees an adequate health status, and quality of life. The present review summarizes the different complications associated with obesity, at the same time, we aim to fostering a novel framework that enhances a patient-centered approach to obesity management in the precision medicine era.","['Perdomo, Carolina M', 'Aviles-Olmos, Iciar', 'Dicker, Dror', 'Fruhbeck, Gema']","['Perdomo CM', 'Aviles-Olmos I', 'Dicker D', 'Fruhbeck G']","['Department of Endocrinology and Nutrition. Clinica, Universidad de Navarra, Pamplona, Spain.', 'IdiSNA (Instituto de Investigacion en la Salud de Navarra), Pamplona, Spain.', 'CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain.', 'IdiSNA (Instituto de Investigacion en la Salud de Navarra), Pamplona, Spain.', 'Department of Neurology, Clinica Universidad de Navarra, Pamplona, Spain.', 'Department of Internal Medicine D, Rabin Medical Center, Hasharon Hospital, Petah Tikva, Israel.', 'Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.', 'Department of Endocrinology and Nutrition. Clinica, Universidad de Navarra, Pamplona, Spain. gfruhbeck@unav.es.', 'IdiSNA (Instituto de Investigacion en la Salud de Navarra), Pamplona, Spain. gfruhbeck@unav.es.', 'CIBEROBN, Instituto de Salud Carlos III, Madrid, Spain. gfruhbeck@unav.es.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Germany,Rev Endocr Metab Disord,Reviews in endocrine & metabolic disorders,100940588,,IM,"['Humans', '*Adiposity', 'Quality of Life', 'Obesity/diagnosis/therapy/complications', 'Adipose Tissue/metabolism', 'Inflammation/metabolism', '*Insulin Resistance/physiology']",PMC10492748,['NOTNLM'],"['Adiposity-based chronic disease', 'Adiposopathy', 'Cardiovascular disease', 'Obesity', 'Obesity-related adipose tissue disease', 'Visceral adipose tissue']",,2023/05/10 12:42,2023/09/11 06:42,['2023/05/10 11:12'],"['2023/03/10 00:00 [accepted]', '2023/09/11 06:42 [medline]', '2023/05/10 12:42 [pubmed]', '2023/05/10 11:12 [entrez]']","['10.1007/s11154-023-09797-2 [pii]', '9797 [pii]', '10.1007/s11154-023-09797-2 [doi]']",ppublish,Rev Endocr Metab Disord. 2023 Oct;24(5):795-807. doi: 10.1007/s11154-023-09797-2. Epub 2023 May 10.,,20230510,,['(c) 2023. The Author(s).'],"['ORCID: 0000-0002-5748-0581', 'ORCID: 0000-0002-1645-7406', 'ORCID: 0000-0001-8546-6245', 'ORCID: 0000-0002-8305-7154']",,,,,,,,,,,,,,,
22349363,NLM,MEDLINE,20120824,20220317,1878-5506 (Electronic) 1389-9457 (Linking),13,5,2012 May,Obesity plays an independent worsening modifying effect on nocturnal hypoxia in obstructive sleep apnea.,524-8,10.1016/j.sleep.2012.01.005 [doi],"OBJECTIVE: Obesity's association with obstructive sleep apnea syndrome (OSAS) is well established. The aim of this study was to examine the impact of obesity on nocturnal hypoxia. METHODS: Twenty two thousand seven hundred and ninety three patients aged 21-80 years who underwent whole night polysomnography during 2000-2009 were included in the study. For each patient, percent sleep time spent with oxyhemoglobin desaturation lower than 90% was calculated (%NODP). Nocturnal hypoxia was analyzed by gender, age, OSAS severity, and body mass index (BMI) categories. RESULTS: Nocturnal hypoxia was positively correlated with BMI, OSAS severity, and age, but not with gender. The differences in %NODP between the two obese groups and non-obese varied from 0.55% to more than a 20% increase and were correlated with age and OSAS severity. The %NODP ratio between the two obese groups and the non-obese was independent of age and OSAS severity. There was a nearly twofold increase in %NODP in obese patients and a threefold increase in the morbidly obese relative to the non-obese. CONCLUSIONS: Our results indicate that obesity plays an independent worsening modifying effect on nocturnal hypoxia in OSAS.","['Gabbay, Itay E', 'Gabbay, Uri', 'Lavie, Peretz']","['Gabbay IE', 'Gabbay U', 'Lavie P']","['Lloyd Rigler Sleep Apnea Laboratory, Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel. igabbay@gmail.com']",['eng'],['Journal Article'],Netherlands,Sleep Med,Sleep medicine,100898759,,IM,"['Adult', 'Age Factors', 'Aged', 'Aged, 80 and over', 'Analysis of Variance', 'Body Mass Index', 'Female', 'Humans', 'Hypoxia/*etiology', 'Male', 'Middle Aged', 'Obesity/*complications/physiopathology', 'Polysomnography', 'Retrospective Studies', 'Severity of Illness Index', 'Sex Factors', 'Sleep Apnea, Obstructive/*complications/physiopathology', 'Young Adult']",,,,,2012/02/22 06:00,2012/08/25 06:00,['2012/02/22 06:00'],"['2011/07/07 00:00 [received]', '2011/12/24 00:00 [revised]', '2012/01/05 00:00 [accepted]', '2012/02/22 06:00 [entrez]', '2012/02/22 06:00 [pubmed]', '2012/08/25 06:00 [medline]']","['S1389-9457(12)00061-5 [pii]', '10.1016/j.sleep.2012.01.005 [doi]']",ppublish,Sleep Med. 2012 May;13(5):524-8. doi: 10.1016/j.sleep.2012.01.005. Epub 2012 Feb 19.,,20120219,,['Copyright (c) 2012 Elsevier B.V. All rights reserved.'],,,,,,,,,,,,,,,,
25331486,NLM,MEDLINE,20161107,20161230,1360-0443 (Electronic) 0965-2140 (Linking),110,2,2015 Feb,Stigma and the addiction paradigm for obesity: lessons from 1950s America.,217-25,10.1111/add.12774 [doi],"AIMS: To discuss an historical episode in which obesity was conceptualized as an addictive disorder and declared to be a major epidemic in the early postwar United States. This history illuminates past consequences of framing obesity as an addiction in ways that may inform constructive policy responses today. METHODS: Review of secondary and primary sources, including archival documents, relating to obesity in biomedical and popular thought of the 1940s and 1950s. RESULTS: In the United States in the late 1940s and 1950s, new medical thinking about obesity reinterpreted overweight and obesity as chiefly the consequence of addiction (understood in the then dominant psychodynamic theory as a psychological defect, oral fixation). This new conception was rapidly taken up in popular discourse and clinical practice, with adverse effects through amplification of weight stigma. Further, in the conservative political context, the addiction concept contributed to an ineffective policy response to the alarming new epidemiological evidence about obesity's consequences. Despite a lack of evidence for efficacy of the intervention, public health efforts focused on correcting individual eating behaviour among obese people by encouraging self-help in lay groups modelled, in part, on Alcoholics Anonymous. Population-level intervention was neglected. CONCLUSIONS: Current public health policy initiatives must be mindful of the risks of reframing obesity as an addiction. These include inadvertently reinforcing stigma, narrowing responses to those aiming to modify individual behaviour and biology and neglecting population policies aiming to reduce the consumption of energy-dense foods, as all occurred in the 1950s United States.","['Rasmussen, Nicolas']",['Rasmussen N'],"['School of Humanities and Languages, University of New South Wales, Sydney, NSW, Australia.']",['eng'],"['Historical Article', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Addiction,"Addiction (Abingdon, England)",9304118,,IM,"['Attitude to Health', 'Drug Industry/history', 'Female', 'History, 20th Century', 'Humans', 'Male', 'Newspapers as Topic/history', 'Obesity/*history/psychology', 'Public Health/history', 'Public Opinion/history', 'Self-Help Groups/history', '*Social Stigma', 'Substance-Related Disorders/*history/psychology', 'United States']",,['NOTNLM'],"['Addiction', 'Bruch Hilde', 'David', 'Rutstein', 'chronic disease', 'epidemiology', 'history-United States', 'obesity', 'stigma']",,2014/10/22 06:00,2016/11/08 06:00,['2014/10/22 06:00'],"['2014/05/26 00:00 [received]', '2014/07/07 00:00 [revised]', '2014/10/13 00:00 [accepted]', '2014/10/22 06:00 [entrez]', '2014/10/22 06:00 [pubmed]', '2016/11/08 06:00 [medline]']",['10.1111/add.12774 [doi]'],ppublish,Addiction. 2015 Feb;110(2):217-25. doi: 10.1111/add.12774. Epub 2014 Nov 20.,,20141120,,['(c) 2014 Society for the Study of Addiction.'],,,,,,,,,,,,,,,,
20615656,NLM,MEDLINE,20101029,20161209,2213-0276 (Electronic) 0755-4982 (Linking),39,9,2010 Sep,[Management of childhood obesity].,960-8,10.1016/j.lpm.2010.04.017 [doi],"Endocrine diseases (hypothyroidism, growth hormone deficiency, hypercortisolism) are exceptional in obese children and are searched only in case of short stature. It is not necessary to test systematically glucose tolerance (fasting glucose; oral glucose tolerance test) and lipids in order to look for obesity related comorbidities. Decreased caloric intake is the main goal for the treatment. Ways to succeed need to be adapted to each child with pragmatism and without dogmatism. Goals for treatment are reasonable (stabilization of weight excess). Weight loss surgery in obese children may be discussed in some cases with multidisciplinary expert team (doctors, surgeons, psychologist...) and close collaboration between adults teams and paediatricians.","['Dubern, Beatrice']",['Dubern B'],"['Hopital Armand-Trousseau, service de gastroenterologie et nutrition pediatriques, 26, avenue du Dr-Arnold-Netter, 75012 Paris, France. beatrice.dubern@trs.aphp.fr']",['fre'],"['English Abstract', 'Journal Article']",France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,,IM,"['Child', 'Humans', 'Obesity/complications/*diagnosis/*therapy']",,,,,2010/07/10 06:00,2010/10/30 06:00,['2010/07/10 06:00'],"['2009/10/15 00:00 [received]', '2010/02/06 00:00 [revised]', '2010/04/07 00:00 [accepted]', '2010/07/10 06:00 [entrez]', '2010/07/10 06:00 [pubmed]', '2010/10/30 06:00 [medline]']","['S0755-4982(10)00360-X [pii]', '10.1016/j.lpm.2010.04.017 [doi]']",ppublish,Presse Med. 2010 Sep;39(9):960-8. doi: 10.1016/j.lpm.2010.04.017. Epub 2010 Jul 7.,,20100707,,['Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.'],,,,,Prise en charge de l'obesite de l'enfant.,,,,,,,,,,,
25396756,NLM,MEDLINE,20150122,20141126,1538-7488 (Electronic) 0002-936X (Linking),114,12,2014 Dec,"CE: The obesity epidemic, part 1: understanding the origins.",40-6; quiz 47-8,10.1097/01.NAJ.0000457410.83963.4b [doi],"The obesity epidemic remains a significant health problem in the United States and worldwide, with multiple associated physical and societal costs. To contribute to obesity's treatment and prevention, nurses must be conversant in a wide range of theoretical and clinical perspectives on the problem. This article, the first in a two-part series, defines the terms used in the treatment of obesity and outlines pathophysiologic, psychological, and social factors that influence weight control. Part 2, which will appear in next month's issue, presents a theoretical framework that can be used to guide nursing assessment of both patient and family, thereby informing intervention.","['Budd, Geraldine M', 'Peterson, Jane Anthony']","['Budd GM', 'Peterson JA']","['Geraldine M. Budd is an associate professor and assistant dean for the Harrisburg campus in the Widener University School of Nursing, Harrisburg, PA, and Jane Anthony Peterson is a clinical associate professor in the School of Nursing and Health Studies at the University of Missouri-Kansas City. Contact author: Geraldine M. Budd, gmbudd@widener.edu. The authors and planners have disclosed no potential conflicts of interest, financial or otherwise.']",['eng'],['Journal Article'],United States,Am J Nurs,The American journal of nursing,0372646,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Body Mass Index', 'Child', 'Child, Preschool', 'Education, Continuing', 'Epidemics/*prevention & control', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*epidemiology/genetics/*physiopathology/psychology', 'Prevalence', 'Socioeconomic Factors', 'United States/epidemiology', 'Weight Gain/*physiology', 'Young Adult']",,,,,2014/11/15 06:00,2015/01/23 06:00,['2014/11/15 06:00'],"['2014/11/15 06:00 [entrez]', '2014/11/15 06:00 [pubmed]', '2015/01/23 06:00 [medline]']",['10.1097/01.NAJ.0000457410.83963.4b [doi]'],ppublish,Am J Nurs. 2014 Dec;114(12):40-6; quiz 47-8. doi: 10.1097/01.NAJ.0000457410.83963.4b.,,,,,,,,,,,,,,,,,,,,
16585666,NLM,MEDLINE,20060421,20190619,1539-3704 (Electronic) 0003-4819 (Linking),144,7,2006 Apr 4,"Adiposity of the heart, revisited.",517-24,,"Obesity is a major risk factor for heart disease. In the face of obesity's growing prevalence, it is important for physicians to be aware of emerging research of novel mechanisms through which adiposity adversely affects the heart. Conventional wisdom suggests that either hemodynamic (that is, increased cardiac output and hypertension) or metabolic (that is, dyslipidemic) derangements associated with obesity may predispose individuals to coronary artery disease and heart failure. The purpose of this review is to highlight a novel mechanism for heart disease in obesity whereby excessive lipid accumulation within the myocardium is directly cardiotoxic and causes left ventricular remodeling and dilated cardiomyopathy. Studies in animal models of obesity reveal that intracellular accumulation of triglyceride renders organs dysfunctional, which leads to several well-recognized clinical syndromes related to obesity (including type 2 diabetes). In these rodent models, excessive lipid accumulation in the myocardium causes left ventricular hypertrophy and nonischemic, dilated cardiomyopathy. Novel magnetic resonance spectroscopy techniques are now available to quantify intracellular lipid content in the myocardium and various other human tissues, which has made it possible to translate these studies into a clinical setting. By using this technology, we have recently begun to study the role of myocardial steatosis in the development of obesity-specific cardiomyopathy in humans. Recent studies in healthy individuals and patients with heart failure reveal that myocardial lipid content increases with the degree of adiposity and may contribute to the adverse structural and functional cardiac adaptations seen in obese persons. These studies parallel the observations in obese animals and provide evidence that myocardial lipid content may be a biomarker and putative therapeutic target for cardiac disease in obese patients.","['McGavock, Jonathan M', 'Victor, Ronald G', 'Unger, Roger H', 'Szczepaniak, Lidia S']","['McGavock JM', 'Victor RG', 'Unger RH', 'Szczepaniak LS']","['University of Texas Southwestern Medical Center, Dallas, Texas 75390-8899, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",United States,Ann Intern Med,Annals of internal medicine,0372351,,IM,"['Animals', 'Cardiomyopathy, Dilated/*etiology/metabolism', 'Humans', 'Hypertrophy, Left Ventricular/*etiology/metabolism', '*Lipid Metabolism', 'Myocardium/*metabolism', 'Obesity/*complications/*metabolism']",,,,,2006/04/06 09:00,2006/04/25 09:00,['2006/04/06 09:00'],"['2006/04/06 09:00 [pubmed]', '2006/04/25 09:00 [medline]', '2006/04/06 09:00 [entrez]']","['144/7/517 [pii]', '10.7326/0003-4819-144-7-200604040-00011 [doi]']",ppublish,Ann Intern Med. 2006 Apr 4;144(7):517-24. doi: 10.7326/0003-4819-144-7-200604040-00011.,"['K-25 HL-68736/HL/NHLBI NIH HHS/United States', 'M01-RR00633/RR/NCRR NIH HHS/United States']",,,,,,43,"['Ann Intern Med. 2006 Oct 3;145(7):553-4; author reply 555. PMID: 17015876', 'Ann Intern Med. 2006 Oct 3;145(7):554-5; author reply 555. PMID: 17015879', 'Ann Intern Med. 2006 Oct 3;145(7):554; author reply 555. PMID: 17015880', 'Ann Intern Med. 2006 Oct 3;145(7):554; author reply 555. PMID: 17015881']",,['American College of Physicians and the American Physiological Society'],,,,,,,,,,
24829481,NLM,MEDLINE,20150109,20230216,2156-5376 (Electronic) 2161-8313 (Print) 2161-8313 (Linking),5,3,2014 May,Principles and pitfalls in the differential diagnosis and management of childhood obesities.,299S-305S,10.3945/an.113.004853 [doi],"Obesity is currently the most prevalent chronic childhood disease in Western countries. It is one of the most frequent consultations in general pediatrics and is even more common in pediatric endocrinology. As might be predicted, the prevalence of obesity-associated comorbidities is also increasing in children and adolescents. It is widely accepted that this increase in obesity results from an imbalance between energy intake and expenditure, with an increase in positive energy balance being closely associated with the current lifestyle in Western countries. However, there is increasing evidence indicating that an individual's genetic background is important in determining obesity risk. The physiologic mechanisms controlling appetite and energy expenditure are being revealed in part because of the identification of new causes of human monogenic, syndromic, and endocrine-related obesity. Thus, it is no longer appropriate to talk about obesity, but rather about ""obesities"" or ""different diseases causing obesity,"" because their pathophysiologic bases differ. Moreover, these obesities require different diagnostic and management approaches. The pediatrician must be aware of this issue and focus the clinical history and physical examination toward specific clinical signs and symptoms to better exploit the available diagnostic and therapeutic resources when facing a child with obesity. Genetic, genomic, and metabolomic studies are often necessary to obtain a more appropriate diagnosis. Cognitive behavioral therapy is fundamental in obese children. The identification of potential targets will hopefully result in new pharmacologic approaches for translational and personalized medicine for obesity in the near future.","['Martos-Moreno, Gabriel A', 'Barrios, Vicente', 'Munoz-Calvo, Maria T', 'Pozo, Jesus', 'Chowen, Julie A', 'Argente, Jesus']","['Martos-Moreno GA', 'Barrios V', 'Munoz-Calvo MT', 'Pozo J', 'Chowen JA', 'Argente J']","['Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Nino Jesus; Instituto de Investigacion La Princesa; Department of Pediatrics, Universidad Autonoma de Madrid; CIBER Fisiopatologia Obesidad y Nutricion; Instituto de Salud Carlos III, Madrid, Spain.', 'Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Nino Jesus; Instituto de Investigacion La Princesa; Department of Pediatrics, Universidad Autonoma de Madrid; CIBER Fisiopatologia Obesidad y Nutricion; Instituto de Salud Carlos III, Madrid, Spain.', 'Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Nino Jesus; Instituto de Investigacion La Princesa; Department of Pediatrics, Universidad Autonoma de Madrid; CIBER Fisiopatologia Obesidad y Nutricion; Instituto de Salud Carlos III, Madrid, Spain.', 'Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Nino Jesus; Instituto de Investigacion La Princesa; Department of Pediatrics, Universidad Autonoma de Madrid; CIBER Fisiopatologia Obesidad y Nutricion; Instituto de Salud Carlos III, Madrid, Spain.', 'Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Nino Jesus; Instituto de Investigacion La Princesa; Department of Pediatrics, Universidad Autonoma de Madrid; CIBER Fisiopatologia Obesidad y Nutricion; Instituto de Salud Carlos III, Madrid, Spain.', 'Department of Pediatrics and Pediatric Endocrinology, Hospital Infantil Universitario Nino Jesus; Instituto de Investigacion La Princesa; Department of Pediatrics, Universidad Autonoma de Madrid; CIBER Fisiopatologia Obesidad y Nutricion; Instituto de Salud Carlos III, Madrid, Spain argentefen@terra.com.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Adv Nutr,"Advances in nutrition (Bethesda, Md.)",101540874,,IM,"['Adolescent', 'Appetite', 'Child', 'Chronic Disease', 'Comorbidity', 'Diagnosis, Differential', 'Energy Intake', 'Energy Metabolism', 'Humans', 'Incidence', 'Life Style', 'Metabolic Syndrome/diagnosis/*epidemiology/prevention & control', 'Pediatric Obesity/*diagnosis/*epidemiology/*prevention & control', 'Prevalence', 'Risk Factors']",PMC4013186,,,"['Author disclosures: G. A. Martos-Moreno, V. Barrios, M. T. Munoz-Calvo, J. Pozo,', 'J. A. Chowen, and J. Argente, no conflicts of interest.']",2014/05/16 06:00,2015/01/13 06:00,['2014/05/16 06:00'],"['2014/05/16 06:00 [entrez]', '2014/05/16 06:00 [pubmed]', '2015/01/13 06:00 [medline]']","['S2161-8313(22)01207-8 [pii]', '004853 [pii]', '10.3945/an.113.004853 [doi]']",epublish,Adv Nutr. 2014 May 14;5(3):299S-305S. doi: 10.3945/an.113.004853. Print 2014 May.,,20140514,,['(c) 2014 American Society for Nutrition.'],,,,,,,,,,,,,,,,
34663932,NLM,MEDLINE,20220317,20220426,1759-5037 (Electronic) 1759-5029 (Linking),17,12,2021 Dec,Into the wild: early time-window for wild microbes to confer resistance to obesity.,711-712,10.1038/s41574-021-00580-4 [doi],,"['Le Roy, Tiphaine', 'Clement, Karine']","['Le Roy T', 'Clement K']","['Nutrition and Obesities: Systemic Approaches Research Unit, NutriOmics, Sorbonne Universite, Inserm, Paris, France.', 'Nutrition and Obesities: Systemic Approaches Research Unit, NutriOmics, Sorbonne Universite, Inserm, Paris, France. karine.clement@inserm.fr.', 'Nutrition department, Pitie-Salpetriere Hospital, Assistance Publique-hopitaux de Paris, Paris, France. karine.clement@inserm.fr.']",['eng'],"['Comment', 'Journal Article']",England,Nat Rev Endocrinol,Nature reviews. Endocrinology,101500078,,IM,"['Humans', '*Obesity']",,,,,2021/10/20 06:00,2022/03/18 06:00,['2021/10/19 06:23'],"['2021/10/20 06:00 [pubmed]', '2022/03/18 06:00 [medline]', '2021/10/19 06:23 [entrez]']","['10.1038/s41574-021-00580-4 [pii]', '10.1038/s41574-021-00580-4 [doi]']",ppublish,Nat Rev Endocrinol. 2021 Dec;17(12):711-712. doi: 10.1038/s41574-021-00580-4.,,,,,['ORCID: 0000-0002-0874-1490'],,,,,,['Nat Metab. 2021 Aug;3(8):1042-1057. PMID: 34417593'],,,,,,,,,
27817165,NLM,MEDLINE,20180404,20181202,1863-4362 (Electronic) 0021-1265 (Linking),186,3,2017 Aug,Obesity is not a descriptive factor for oxidative stress and viscosity in follicular fluid of in vitro fertilization patients.,641-646,10.1007/s11845-016-1523-6 [doi],"BACKGROUND: Obesity's impact on micro-environmental oxidative stress and follicular fluid (FF) viscosity and whether or not it has any effect on in vitro fertilization (IVF) success is a matter of debate. AIMS: In this study, our aim was to evaluate the levels of oxidative stress markers and the FF viscosity in obese and non-obese patients. METHODS: Eighty norm-responder patients undergoing IVF were prospectively grouped according to their body mass indexes (BMI). Group 1 (n = 40) and group 2 (n = 40) had BMI values of </=24.9 and >/=25.0, respectively. Total sulfhydryl (RSH) levels (nmol/m) and the formation of thiobarbituric acid-reactive substances (malondialdehyde, or MDA) (micromol/ml) in FFs were quantified. For the first time in our study, FF viscosity with changing BMI values was also determined. RESULTS: The mean levels of MDA (micromol/ml) and RSH (nmol/ml) were not significantly different between groups (1.37 +/- 0.51; 1.51 +/- 0.51; p > 0.05 for MDA and 0.42 +/- 0.30; 0.41 +/- 0.20; p > 0.05 for RSH, respectively). Similarly, the FF viscosity (centipoise) was not different between groups (1.28 +/- 0.28; 1.30 +/- 0.19; p < 0.05, respectively). Independent of BMI, no correlation was found between FF levels of oxidative markers and the number of oocytes retrieved or the fertilization rates. CONCLUSIONS: In our study, we found no difference in the levels of follicular oxidative and anti-oxidative markers or the follicular fluid viscosity with changing BMI values. We also demonstrated that the levels of oxidative stress markers and the viscosity of follicular fluid did not affect clinical outcomes.","['Yuksel, B', 'Kilic, S', 'Yilmaz, N', 'Goktas, T', 'Keskin, U', 'Seven, A', 'Ulubay, M', 'Batioglu, S']","['Yuksel B', 'Kilic S', 'Yilmaz N', 'Goktas T', 'Keskin U', 'Seven A', 'Ulubay M', 'Batioglu S']","['Department of Obstetrics, Gynecology and Infertility, Dumlupinar University Faculty of Medicine, Kutahya, Turkey. berilyuksel@gmail.com.', 'Department of Obstetrics, Gynecology and Infertility, Bahcesehir University Faculty of Medicine, Istanbul, Turkey.', ""Department of Infertility, Dr. Zekai Tahir Burak Women's Health Research Hospital, Ankara, Turkey."", 'Department of Physiology, Gazi University School of Medicine, Ankara, Turkey.', 'Department of Obstetrics, Gynecology and Infertility, Gulhane Military Medical Faculty, Ankara, Turkey.', 'Department of Obstetrics, Gynecology and Infertility, Dumlupinar University Faculty of Medicine, Kutahya, Turkey.', 'Department of Obstetrics, Gynecology and Infertility, Gulhane Military Medical Faculty, Ankara, Turkey.', ""Department of Infertility, Dr. Zekai Tahir Burak Women's Health Research Hospital, Ankara, Turkey.""]",['eng'],['Journal Article'],Ireland,Ir J Med Sci,Irish journal of medical science,7806864,,IM,"['Adult', 'Female', 'Fertilization in Vitro/*methods', 'Follicular Fluid/*immunology', 'Humans', 'Obesity/*complications/pathology', 'Oxidative Stress/*immunology', 'Viscosity']",,['NOTNLM'],"['Body mass index', 'Follicular fluid', 'Malondialdehyde (MDA)', 'Oxidative stress', 'Sulfhydryl group (RSH)', 'Viscosity']",,2016/11/07 06:00,2018/04/05 06:00,['2016/11/07 06:00'],"['2016/01/23 00:00 [received]', '2016/10/25 00:00 [accepted]', '2016/11/07 06:00 [pubmed]', '2018/04/05 06:00 [medline]', '2016/11/07 06:00 [entrez]']","['10.1007/s11845-016-1523-6 [pii]', '10.1007/s11845-016-1523-6 [doi]']",ppublish,Ir J Med Sci. 2017 Aug;186(3):641-646. doi: 10.1007/s11845-016-1523-6. Epub 2016 Nov 5.,,20161105,,,,,,,,,,,,,,,,,,
28645355,NLM,MEDLINE,20180123,20180123,2213-3941 (Electronic) 0003-4266 (Linking),77 Suppl 1,,2016 Oct,[Obesities: What's new in 2016?].,S29-S35,S0003-4266(17)30075-6 [pii] 10.1016/S0003-4266(17)30075-6 [doi],"Since 1997, the World Health Organisation considered obesity, defined as an excess of fat mass, as a disease. Many plans have been set up to fight against obesity in industrialised countries. However, the prevalence of obesity is still increasing. The goal of this paper is to report some of the major scientific publications in terms of epidemiology, physiopathology or therapeutic in the field of obersity mainly published during year 2015-2016 or presented at ENDO meeting 2016.","['Gatta-Cherifi, B']",['Gatta-Cherifi B'],"[""Service d'endocrinologie, diabetologie et nutrition, CHU de Bordeaux, Hopital Haut-Leveque, Avenue du Magellan, 33604 Pessac cedex, France. Electronic address: blandine.gatta-cherifi@CHU-Bordeaux.fr.""]",['fre'],"['Journal Article', 'Review']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,,IM,"['Bariatric Surgery', 'Humans', 'Obesity/diet therapy/epidemiology/genetics/*therapy', 'Prevalence']",,['NOTNLM'],"['Bariatric surgery', 'Chirurgie bariatrique', 'Diet', 'Dietetique', 'Epidemiology', 'Obesity', 'Obesite', 'Pharmacologie', 'Pharmacology', 'Epidemiologie']",,2017/06/25 06:00,2018/01/24 06:00,['2017/06/25 06:00'],"['2017/06/25 06:00 [entrez]', '2017/06/25 06:00 [pubmed]', '2018/01/24 06:00 [medline]']","['S0003-4266(17)30075-6 [pii]', '10.1016/S0003-4266(17)30075-6 [doi]']",ppublish,Ann Endocrinol (Paris). 2016 Oct;77 Suppl 1:S29-S35. doi: 10.1016/S0003-4266(17)30075-6.,,,,['(c) 2016 Elsevier Masson SAS. Tous droits reserves.'],,,,,Obesites : quoi de neuf en 2016 ?,,,,,,,,,,,
2654327,NLM,MEDLINE,19890614,20061115,0094-3509 (Print) 0094-3509 (Linking),28,5,1989 May,An analytic review of current therapies for obesity.,610-6,,"Weight control is a cornerstone objective for many diseases common in medicine. Substantial, prolonged weight loss is difficult to achieve. Nutrition counseling, very low calorie diets, behavior modification, exercise, intragastric balloon, and gastric restriction surgery are interventions that physicians may recommend for obese patients. This paper analyzes the efficacy of these methods with attention to attrition rates, maximum weight loss, long-term maintenance of weight loss, and morbidity. Strategies for intervention for various classes of obese patients are recommended.","['Holmes, M D', 'Zysow, B', 'Delbanco, T L']","['Holmes MD', 'Zysow B', 'Delbanco TL']","['Department of Medicine, Harvard Medical School, Beth Israel Hospital, Boston, Massachusetts.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S."", 'Review']",United States,J Fam Pract,The Journal of family practice,7502590,,IM,"['Humans', 'Obesity/diet therapy/surgery/*therapy']",,,,,1989/05/01 00:00,1989/05/01 00:01,['1989/05/01 00:00'],"['1989/05/01 00:00 [pubmed]', '1989/05/01 00:01 [medline]', '1989/05/01 00:00 [entrez]']",,ppublish,J Fam Pract. 1989 May;28(5):610-6.,,,,,,,65,,,,,,,,,,,,,
27163945,NLM,MEDLINE,20170630,20181113,1535-4989 (Electronic) 1044-1549 (Print) 1044-1549 (Linking),55,2,2016 Aug,Mouse Modeling of Obese Lung Disease. Insights and Caveats.,153-8,10.1165/rcmb.2016-0063PS [doi],"As the obesity epidemic has worsened, its impact on lung health and disease has become progressively evident. The interactions between obesity and the accompanying metabolic syndrome and diseases such as asthma, pneumonia, and acute respiratory distress syndrome (ARDS) have proven complex and often counterintuitive in human studies. Hence, there is a growing need for relevant experimental approaches to understand the interactions between obesity and the lung. To this end, researchers have increasingly exploited mouse models combining both obesity and lung diseases, including ARDS, pneumonia, and asthma. Such models have both complemented and advanced the understanding we have gained from clinical studies and have allowed elegant dissections of obesity's effects on the pathogenesis of lung disease. Yet these models come with several critically important caveats that we must reflect on when interpreting their results.","['Suratt, Benjamin T']",['Suratt BT'],"['University of Vermont College of Medicine, Department of Medicine, Burlington, Vermont.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",United States,Am J Respir Cell Mol Biol,American journal of respiratory cell and molecular biology,8917225,,IM,"['Animals', 'Disease Models, Animal', 'Lung Diseases/*complications/*pathology', 'Mice', 'Obesity/*complications/*pathology']",PMC4979373,,,,2016/05/11 06:00,2017/07/01 06:00,['2016/05/11 06:00'],"['2016/05/11 06:00 [entrez]', '2016/05/11 06:00 [pubmed]', '2017/07/01 06:00 [medline]']",['10.1165/rcmb.2016-0063PS [doi]'],ppublish,Am J Respir Cell Mol Biol. 2016 Aug;55(2):153-8. doi: 10.1165/rcmb.2016-0063PS.,"['P30 GM103532/GM/NIGMS NIH HHS/United States', 'R03 AI117069/AI/NIAID NIH HHS/United States']",,,,['ORCID: 0000-0002-4946-029X'],,,,,,,,,,,,,,,
17265814,NLM,MEDLINE,20070227,20191210,1660-9379 (Print) 1660-9379 (Linking),2,88,2006 Nov 22,"[Children with obesity, and respect for private life].",2704,,,"['Nau, Jean-Yves']",['Nau JY'],,['fre'],"['Journal Article', 'Review']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Advertising', 'Child', 'Child, Preschool', 'Denmark', 'Europe/epidemiology', 'Humans', 'Incidence', 'Life', 'Mass Media', '*Obesity/epidemiology/prevention & control', '*Privacy', 'Risk Factors', 'World Health Organization']",,,,,2007/02/03 09:00,2007/02/28 09:00,['2007/02/03 09:00'],"['2007/02/03 09:00 [pubmed]', '2007/02/28 09:00 [medline]', '2007/02/03 09:00 [entrez]']",,ppublish,Rev Med Suisse. 2006 Nov 22;2(88):2704.,,,,,,,1,,Enfants obeses et respect de la vie privee.,,,,,,,,,,,
36521446,NLM,MEDLINE,20230316,20230425,1662-4033 (Electronic) 1662-4025 (Print) 1662-4025 (Linking),16,2,2023,From Dyspnea to Skin Grafting: The Difficulties of Managing a Patient with Extreme Obesity.,212-215,10.1159/000527092 [doi],"While the prevalence of severe obesity is increasing worldwide, caregivers are often challenged with the management of patients with extreme weight. A 30-year-old woman (weight 245 kg, body mass index 85 kg/m2) presented with dyspnea, for which investigations led to suspect pulmonary embolism. The patient's weight made it impossible to perform adapted imaging; thus, an empirical anticoagulant treatment was initiated. A hematoma of the thigh occurred as a consequence of a transient antivitamin K overdose, leading to a 15-cm necrotic wound worsened by a state of malnutrition. Multidisciplinary and comprehensive care was performed including wound trimming, antibiotics, skin grafting, treatment of malnutrition, and psychological support, but with marked difficulties due to the lack of adapted medical equipment and facilities as well as appropriate medical guidelines. Overall, 7 months of hospitalization including 4 months of physiotherapy and rehabilitation were needed before the patient could return home. This case highlights how difficult managing patients with extreme obesity can be and points to the importance for healthcare systems to adapt to the specific needs of these patients and to design specific guidelines for treatment dosage and malnutrition prevention and treatment in this setting.","['Lambert, Flora', 'Chalopin, Sarah', 'Bedock, Dorothee', 'Ciangura, Cecile', 'Aron-Wisnewsky, Judith', 'Faucher, Pauline', 'Aviles Marquez, Laura', 'Louhou, Rufin', 'Poitou, Christine', 'Oppert, Jean-Michel', 'Bel Lassen, Pierre']","['Lambert F', 'Chalopin S', 'Bedock D', 'Ciangura C', 'Aron-Wisnewsky J', 'Faucher P', 'Aviles Marquez L', 'Louhou R', 'Poitou C', 'Oppert JM', 'Bel Lassen P']","['Nutrition Department, Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, CRNH Ile-de-France, Sorbonne Universite, Paris, France.', 'Nutrition Department, Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, CRNH Ile-de-France, Sorbonne Universite, Paris, France.', 'Nutrition Department, Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, CRNH Ile-de-France, Sorbonne Universite, Paris, France.', 'Nutrition Department, Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, CRNH Ile-de-France, Sorbonne Universite, Paris, France.', 'Nutrition Department, Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, CRNH Ile-de-France, Sorbonne Universite, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition & Obesities: Systemic Approaches Research Group (NutriOmics), Paris, France.', 'Nutrition Department, Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, CRNH Ile-de-France, Sorbonne Universite, Paris, France.', 'Nutrition department, Assistance Publique Hopitaux de Paris, Hopital Maritime de Berck, Berck, France.', 'Nutrition department, Assistance Publique Hopitaux de Paris, Hopital Maritime de Berck, Berck, France.', 'Nutrition Department, Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, CRNH Ile-de-France, Sorbonne Universite, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition & Obesities: Systemic Approaches Research Group (NutriOmics), Paris, France.', 'Nutrition Department, Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, CRNH Ile-de-France, Sorbonne Universite, Paris, France.', 'Nutrition Department, Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, CRNH Ile-de-France, Sorbonne Universite, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition & Obesities: Systemic Approaches Research Group (NutriOmics), Paris, France.']",['eng'],['Case Reports'],Switzerland,Obes Facts,Obesity facts,101469429,,IM,"['Female', 'Humans', 'Adult', 'Skin Transplantation', 'Obesity/complications/therapy', '*Obesity, Morbid/complications/surgery', '*Malnutrition/complications', 'Dyspnea/etiology']",PMC10028363,['NOTNLM'],"['Extreme obesity', 'Obesity', 'Weight bias']",['The authors declare that they have no conflict of interest.'],2022/12/16 06:00,2023/03/17 06:00,['2022/12/15 18:33'],"['2022/06/24 00:00 [received]', '2022/09/11 00:00 [accepted]', '2022/12/16 06:00 [pubmed]', '2023/03/17 06:00 [medline]', '2022/12/15 18:33 [entrez]']","['000527092 [pii]', 'ofa-0016-0212 [pii]', '10.1159/000527092 [doi]']",ppublish,Obes Facts. 2023;16(2):212-215. doi: 10.1159/000527092. Epub 2022 Dec 15.,,20221215,,"['(c) 2022 The Author(s). Published by S. Karger AG, Basel.']",,,,,,,,,,,,,,,,
29806707,NLM,MEDLINE,20190703,20190703,2044-835X (Electronic) 0261-510X (Linking),37,1,2019 Mar,Thin idealization and causal attributions mediate the association between culture and obesity stereotypes: An examination of Chinese and American adolescents.,14-32,10.1111/bjdp.12250 [doi],"Few studies have examined age or cultural differences in the stereotypes adolescents have of persons with obesity. The present research explored the hypotheses that American adolescents have more negative obesity stereotypes than Chinese adolescents and that the effects of culture are mediated by weight attributions and thin idealization. Participants (N = 335; 181 female; M age = 14.83 years, SD = 1.57 years) completed measures of thin idealization and causal attributions and made generalizations from and attributions of stereotypical personality characteristics to obese figures. Not only did stereotypes differ between countries, but generalizations of negative characteristics from obese figures increased with age. In addition, American adolescents more firmly endorsed the 'thin ideal' and were more likely to attribute obesity to internal causes that Chinese adolescents. As anticipated, between-country differences in stereotyping were mediated by thin idealization and causal attributions. Findings are discussed in terms of the 'doctrine of the mean', social identity theory, and dual-process theories. Statement of Contribution The development of obesity stereotypes has been the subject of a number of recent studies. Although scarce, research on adolescents' obesity stereotypes indicates that the strength of these stereotypes increases with age and that these increases are mediated by thin idealization and causal attributions. The current research adds to this growing literature that differences between Chinese adolescents' and American adolescents' obesity stereotypes - in terms of the assignment of stereotypical traits to people with obesity and the generalization of negative traits from an individual person with obesity to people with obesity as a group - are mediated by thin idealization and attributions about obesity's causes. The research also indicates that (1) age differences in obesity stereotyping vary as a function of the method used to measure stereotypes, (2) Chinese adolescents are less likely than American adolescents to attribute obesity to characterological flaws, and (3) American adolescents idealize thinness more than Chinese adolescents.","['Klaczynski, Paul A', 'Felmban, Wejdan S']","['Klaczynski PA', 'Felmban WS']","['University of Northern Colorado, Greeley, Colorado, USA.', 'Effat University, Jeddah, Saudi Arabia.', 'Effat University, Jeddah, Saudi Arabia.']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Br J Dev Psychol,The British journal of developmental psychology,8308022,,IM,"['Adolescent', '*Adolescent Development', 'China/ethnology', '*Cross-Cultural Comparison', 'Female', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Male', 'Obesity/*ethnology', '*Social Perception', '*Stereotyping', 'Thinness/*ethnology', 'United States']",,['NOTNLM'],"['adolescent development', 'culture', 'dual-process theories', 'obesity stereotypes', 'social cognition', 'social identity theory']",,2018/05/29 06:00,2019/07/04 06:00,['2018/05/29 06:00'],"['2017/08/08 00:00 [received]', '2018/04/23 00:00 [revised]', '2018/05/29 06:00 [pubmed]', '2019/07/04 06:00 [medline]', '2018/05/29 06:00 [entrez]']",['10.1111/bjdp.12250 [doi]'],ppublish,Br J Dev Psychol. 2019 Mar;37(1):14-32. doi: 10.1111/bjdp.12250. Epub 2018 May 28.,,20180528,,['(c) 2018 The British Psychological Society.'],['ORCID: 0000-0002-1013-5780'],,,,,,,,,,,,,,,
30216730,NLM,MEDLINE,20190424,20190424,1715-5320 (Electronic) 1715-5312 (Linking),44,1,2019 Jan,Safety of 8-h time restricted feeding in adults with obesity.,107-109,10.1139/apnm-2018-0389 [doi],"This study examines the safety of time restricted feeding (TRF; 8-h feeding window/16-h fasting window daily) in obese adults. Twenty-three subjects participated in an 8-h TRF intervention for 12 weeks. Self-reported adverse events, body image perception, complete blood count, and disordered eating patterns did not change from baseline to week 12. These findings suggest that consuming food within an 8-h window can safely facilitate weight loss in subjects with obesity.","['Gabel, Kelsey', 'Hoddy, Kristin K', 'Varady, Krista A']","['Gabel K', 'Hoddy KK', 'Varady KA']","['Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA.', 'Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA.', 'Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA.', 'Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA.', 'Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA.', 'Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL 60612, USA.']",['eng'],['Journal Article'],Canada,Appl Physiol Nutr Metab,"Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",101264333,,IM,"['Adult', 'Aged', 'Chicago', '*Fasting/adverse effects', '*Feeding Behavior', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/diagnosis/*diet therapy/physiopathology/psychology', 'Patient Safety', 'Pilot Projects', 'Risk Factors', 'Time Factors', 'Treatment Outcome', '*Weight Loss']",,['NOTNLM'],"['Intermittent fasting', 'adultes obeses', 'adverse events', 'alimentation limitee dans le temps', 'jeune intermittent', 'obese adults', 'perte de poids', 'safety', 'securite', 'time restricted feeding', 'weight-loss', 'evenements indesirables']",,2018/09/15 06:00,2019/04/25 06:00,['2018/09/15 06:00'],"['2018/09/15 06:00 [pubmed]', '2019/04/25 06:00 [medline]', '2018/09/15 06:00 [entrez]']",['10.1139/apnm-2018-0389 [doi]'],ppublish,Appl Physiol Nutr Metab. 2019 Jan;44(1):107-109. doi: 10.1139/apnm-2018-0389. Epub 2018 Sep 14.,,20180914,,,,,,,,,,,,,,,,,,
33037328,NLM,MEDLINE,20211220,20211220,1476-5497 (Electronic) 0307-0565 (Print) 0307-0565 (Linking),45,1,2021 Jan,Type 2 diabetes is associated with impaired jejunal enteroendocrine GLP-1 cell lineage in human obesity.,170-183,10.1038/s41366-020-00694-1 [doi],"OBJECTIVES: Altered enteroendocrine cell (EEC) function in obesity and type 2 diabetes is not fully understood. Understanding the transcriptional program that controls EEC differentiation is important because some EEC types harbor significant therapeutic potential for type 2 diabetes. METHODS: EEC isolation from jejunum of obese individuals with (ObD) or without (Ob) type 2 diabetes was obtained with a new method of cell sorting. EEC transcriptional profiles were established by RNA-sequencing in a first group of 14 Ob and 13 ObD individuals. EEC lineage and densities were studied in the jejunum of a second independent group of 37 Ob, 21 ObD and 22 non obese (NOb) individuals. RESULTS: The RNA seq analysis revealed a distinctive transcriptomic signature and a decreased differentiation program in isolated EEC from ObD compared to Ob individuals. In the second independent group of ObD, Ob and NOb individuals a decreased GLP-1 cell lineage and GLP-1 maturation from proglucagon, were observed in ObD compared to Ob individuals. Furthermore, jejunal density of GLP-1-positive cells was significantly reduced in ObD compared to Ob individuals. CONCLUSIONS: These results highlight that the transcriptomic signature of EEC discriminate obese subjects according to their diabetic status. Furthermore, type 2 diabetes is associated with reduced GLP-1 cell differentiation and proglucagon maturation leading to low GLP-1-cell density in human obesity. These mechanisms could account for the decrease plasma GLP-1 observed in metabolic diseases.","['Osinski, Celine', 'Le Gleau, Lea', 'Poitou, Christine', 'de Toro-Martin, Juan', 'Genser, Laurent', 'Fradet, Magali', 'Soula, Hedi Antoine', 'Leturque, Armelle', 'Blugeon, Corinne', 'Jourdren, Laurent', 'Hubert, Edwige Ludiwyne', 'Clement, Karine', 'Serradas, Patricia', 'Ribeiro, Agnes']","['Osinski C', 'Le Gleau L', 'Poitou C', 'de Toro-Martin J', 'Genser L', 'Fradet M', 'Soula HA', 'Leturque A', 'Blugeon C', 'Jourdren L', 'Hubert EL', 'Clement K', 'Serradas P', 'Ribeiro A']","['Sorbonne Universite, INSERM, Nutrition and obesities: systemic approaches, F-75013, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition and obesities: systemic approaches, F-75013, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition and obesities: systemic approaches, F-75013, Paris, France.', 'Nutrition Department, Pitie-Salpetriere hospital, Assistance Publique/Hopitaux de Paris, F-75013, Paris, France.', 'Sorbonne Universite, Universite de Paris, INSERM, Cordeliers Research Center, F-75006, Paris, France.', 'Institute of Nutrition and Functional Foods (INAF), School of Nutrition, Universite Laval, Quebec, QC, Canada.', 'Sorbonne Universite, INSERM, Nutrition and obesities: systemic approaches, F-75013, Paris, France.', 'Hepato-Biliary-Pancreatic Gastrointestinal Surgery and Liver Transplantation, Pitie-Salpetriere Hospital, Assistance Publique/Hopitaux de Paris, F-75013, Paris, France.', 'Cytometry platform, Institut Cardiometabolism and Nutrition, F-75013, Paris, France.', 'Institut de Biologie, CIRB, College de France, F-75005, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition and obesities: systemic approaches, F-75013, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition and obesities: systemic approaches, F-75013, Paris, France.', ""Genomics core facility, Departement de biologie, Institut de Biologie de l'ENS (IBENS), Ecole normale superieure, CNRS, INSERM, Universite PSL, 75005, Paris, France."", ""Genomics core facility, Departement de biologie, Institut de Biologie de l'ENS (IBENS), Ecole normale superieure, CNRS, INSERM, Universite PSL, 75005, Paris, France."", 'Sorbonne Universite, Universite de Paris, INSERM, Cordeliers Research Center, F-75006, Paris, France.', 'SERVIER, ADIR, F-92284, Suresnes, cedex, France.', 'Sorbonne Universite, INSERM, Nutrition and obesities: systemic approaches, F-75013, Paris, France.', 'Nutrition Department, Pitie-Salpetriere hospital, Assistance Publique/Hopitaux de Paris, F-75013, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition and obesities: systemic approaches, F-75013, Paris, France. patricia.serradas_pacheco@sorbonne-universite.fr.', 'Sorbonne Universite, INSERM, Nutrition and obesities: systemic approaches, F-75013, Paris, France. agnes.ribeiro@sorbonne-universite.fr.']",['eng'],"['Clinical Trial', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Int J Obes (Lond),International journal of obesity (2005),101256108,,IM,"['Adult', 'Cells, Cultured', '*Diabetes Mellitus, Type 2/complications/epidemiology/metabolism', 'Enteroendocrine Cells/cytology/*metabolism', 'Female', 'Humans', 'Jejunum/*cytology', 'Male', 'Middle Aged', '*Obesity/complications/epidemiology/metabolism']",PMC7752761,,,['The authors declare that they have no conflict of interest.'],2020/10/11 06:00,2021/12/21 06:00,['2020/10/10 05:32'],"['2020/03/05 00:00 [received]', '2020/09/26 00:00 [accepted]', '2020/09/07 00:00 [revised]', '2020/10/11 06:00 [pubmed]', '2021/12/21 06:00 [medline]', '2020/10/10 05:32 [entrez]']","['10.1038/s41366-020-00694-1 [pii]', '694 [pii]', '10.1038/s41366-020-00694-1 [doi]']",ppublish,Int J Obes (Lond). 2021 Jan;45(1):170-183. doi: 10.1038/s41366-020-00694-1. Epub 2020 Oct 9.,,20201009,,,"['ORCID: 0000-0001-5820-8785', 'ORCID: 0000-0002-2489-3355', 'ORCID: 0000-0002-6652-9746', 'ORCID: 0000-0003-2063-6084']",,,,,,,,,,,,,,,
21602112,NLM,MEDLINE,20111123,20110622,1695-9531 (Electronic) 1695-4033 (Linking),75,1,2011 Jul,[Paediatric obesities: from childhood to adolescence].,63.e1-23,10.1016/j.anpedi.2011.03.018 [doi],"Obesity, as in every western country, is currently the most prevalent chronic disease in childhood in Spain. This has led to obesity being one of the most common consultations in general paediatrics and, particularly, in paediatric endocrinology. Furthermore, obesity associated comorbidities are increasing in prevalence in children and adolescents. It is widely accepted that this increase in the prevalence of obesity is derived from an imbalance between energy intake and expenditure, associated to the lifestyle in western countries. However, there is increasing evidence of the role of individual and familial genetic background in the risk of developing obesity. The pathophysiological basis of the mechanisms responsible for the control of appetite and energy expenditure are being discovered on the basis of the increasing known cases of human monogenic, syndromic and endocrine obesity. Thus it is no longer appropriate to talk about obesity but rather about <<obesities>>, as their pathophysiological bases differ and they require different diagnostic and management approaches. In 2011, the paediatrician must be aware of this issue and focus the clinical history and physical examination towards these specific clinical sign and symptoms, to better manage the available diagnostic and therapeutic resources when faced with a child with obesity.","['Martos-Moreno, G A', 'Argente, J']","['Martos-Moreno GA', 'Argente J']","['Departamento de Pediatria, Universidad Autonoma de Madrid, Madrid, Espana.']",['spa'],"['English Abstract', 'Journal Article', 'Review']",Spain,An Pediatr (Barc),"Anales de pediatria (Barcelona, Spain : 2003)",101162596,,IM,"['Adolescent', 'Child', 'Humans', '*Obesity/complications/diagnosis/etiology/therapy']",,,,,2011/05/24 06:00,2011/12/13 00:00,['2011/05/24 06:00'],"['2011/03/21 00:00 [received]', '2011/03/22 00:00 [accepted]', '2011/05/24 06:00 [entrez]', '2011/05/24 06:00 [pubmed]', '2011/12/13 00:00 [medline]']","['S1695-4033(11)00203-7 [pii]', '10.1016/j.anpedi.2011.03.018 [doi]']",ppublish,An Pediatr (Barc). 2011 Jul;75(1):63.e1-23. doi: 10.1016/j.anpedi.2011.03.018. Epub 2011 May 23.,,20110523,,"['Copyright (c) 2011 Asociacion Espanola de Pediatria. Published by Elsevier Espana.', 'All rights reserved.']",,,,,Obesidades pediatricas: de la lactancia a la adolescencia.,,,,,,,,,,,
33094623,NLM,MEDLINE,20210831,20220210,1802-9973 (Electronic) 0862-8408 (Print) 0862-8408 (Linking),69,Suppl 2,2020 Sep 30,Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R).,S245-S254,,"Leptin-melanocortin pathway plays an essential role in the body weight regulation. Enhanced melanocortin signaling in the hypothalamus results in both decreased food intake and increased energy expenditure. The discovery of monogenic obesities with dysfunction of melanocortin-4 receptor (MC4R) greatly contributed to understanding of energy balance regulation. This review presents phenotypical characterization and prevalence of the MC4R gene mutations. Genome-wide association studies revealed that MC4R gene is significantly related not only to monogenic obesities but also to common obesity. An interaction of variants in the MC4R gene with fat mass and obesity associated (FTO) gene significantly increases the risk for obesity, particularly in adolescence. On the other hand, about 15 % of the MC4R gene variants result in a gain of function that protects against obesity and is associated with favorable metabolic profile. Long-term attempts to activate the MC4R have recently been finalized by a discovery of setmelanotide, a novel specific MC4R agonist that is devoid of untoward cardiovascular side-effects. The employment of specific MC4R agonists may open new horizons not only in the treatment of rare monogenic obesities but also in some common obesities where stimulation of MC4R could be achieved.","['Hainer, V', 'Aldhoon Hainerova, I', 'Kunesova, M', 'Taxova Braunerova, R', 'Zamrazilova, H', 'Bendlova, B']","['Hainer V', 'Aldhoon Hainerova I', 'Kunesova M', 'Taxova Braunerova R', 'Zamrazilova H', 'Bendlova B']","['Obesity Management Center, Institute of Endocrinology, Prague, Czech Republic. vhainer@endo.cz.']",['eng'],"['Journal Article', 'Review']",Czech Republic,Physiol Res,Physiological research,9112413,"['0 (Anti-Obesity Agents)', '0 (Receptor, Melanocortin, Type 4)', '581-05-5 (alpha-MSH)']",IM,"['Animals', 'Anti-Obesity Agents/pharmacology', 'Genome-Wide Association Study', 'Humans', 'Molecular Targeted Therapy', '*Mutation', 'Obesity/*drug therapy/genetics/*metabolism', 'Receptor, Melanocortin, Type 4/genetics/*metabolism', 'alpha-MSH/pharmacology']",PMC8603737,,,['Conflict of Interest There is no conflict of interest.'],2020/10/24 06:00,2021/09/01 06:00,['2020/10/23 08:38'],"['2020/10/23 08:38 [entrez]', '2020/10/24 06:00 [pubmed]', '2021/09/01 06:00 [medline]']","['934512 [pii]', 'pr69_s245 [pii]', '10.33549/physiolres.934512 [doi]']",ppublish,Physiol Res. 2020 Sep 30;69(Suppl 2):S245-S254. doi: 10.33549/physiolres.934512.,,,,,,,,,,,,,,,,,,,,
34930871,NLM,MEDLINE,20220506,20231020,1473-6519 (Electronic) 1363-1950 (Linking),25,2,2022 Mar 1,Nutrition priorities in obese critically ill patients.,99-109,10.1097/MCO.0000000000000803 [doi],"PURPOSE OF REVIEW: During critical illness, several neuroendocrine, inflammatory, immune, adipokine, and gastrointestinal tract hormone pathways are activated; some of which are more intensified among obese compared with nonobese patients. Nutrition support may mitigate some of these effects. Nutrition priorities in obese critically ill patients include screening for nutritional risk, estimation of energy and protein requirement, and provision of macronutrients and micronutrients. RECENT FINDINGS: Estimation of energy requirement in obese critically ill patients is challenging because of variations in body composition among obese patients and absence of reliable predictive equations for energy expenditure. Whereas hypocaloric nutrition with high protein has been advocated in obese critically ill patients, supporting data are scarce. Recent studies did not show differences in outcomes between hypocaloric and eucaloric nutrition, except for better glycemic control. Sarcopenia is common among obese patients, and the provision of increased protein intake has been suggested to mitigate catabolic changes especially after the acute phase of critical illness. However, high-quality data on high protein intake in these patients are lacking. Micronutrient deficiencies among obese critically ill patients are common but the role of their routine supplementation requires further study. SUMMARY: An individualized approach for nutritional support may be needed for obese critically ill patients but high-quality evidence is lacking. Future studies should focus on nutrition priorities in this population, with efficient and adequately powered studies.","['Al-Dorzi, Hasan M', 'Stapleton, Renee D', 'Arabi, Yaseen M']","['Al-Dorzi HM', 'Stapleton RD', 'Arabi YM']","['College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, and Intensive Care Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.', 'Pulmonary and Critical Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.', 'College of Medicine, King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center, and Intensive Care Department, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.']",['eng'],"['Journal Article', 'Review']",England,Curr Opin Clin Nutr Metab Care,Current opinion in clinical nutrition and metabolic care,9804399,['0 (Dietary Proteins)'],IM,"['*Critical Illness/therapy', '*Dietary Proteins', 'Energy Intake', 'Humans', 'Nutritional Requirements', 'Nutritional Support', 'Obesity/complications/metabolism/therapy']",,,,,2021/12/22 06:00,2022/05/07 06:00,['2021/12/21 06:06'],"['2021/12/22 06:00 [pubmed]', '2022/05/07 06:00 [medline]', '2021/12/21 06:06 [entrez]']","['00075197-202203000-00010 [pii]', '10.1097/MCO.0000000000000803 [doi]']",ppublish,Curr Opin Clin Nutr Metab Care. 2022 Mar 1;25(2):99-109. doi: 10.1097/MCO.0000000000000803.,,,,"['Copyright (c) 2021 Wolters Kluwer Health, Inc. All rights reserved.']",,,,,,,,"['ClinicalTrials.gov/NCT04475666', 'ClinicalTrials.gov/NCT03021902']",,,,,,,,
17174231,NLM,MEDLINE,20070126,20061218,1532-8414 (Electronic) 1071-9164 (Linking),12,9,2006 Dec,Impact of obesity on the health status of heart failure patients.,700-6,,"BACKGROUND: Obesity is a recognized, preventable risk factor for the development of heart failure (HF); however, little is understood about its effects on patients with established HF. Furthermore, few researchers have assessed obesity's effect on the health status of established HF patients. This study evaluated the influence of obesity on the health status, at baseline and 1 year later, on patients with established HF. METHODS AND RESULTS: Comprehensive clinical data, health status, and obesity classification of 543 HF outpatients from 13 centers was assessed at baseline and 1 year later. Health status was quantified with the generic Short Form-12 and disease-specific Kansas City Cardiomyopathy Questionnaire Overall Summary score. Cross-sectional and longitudinal risk-adjusted general linear models were computed comparing the health status of patients who were classified as either underweight, normal weight, overweight, or obese. Obesity classification was not significantly associated with patients' baseline health status and did not predict 1-year health status. CONCLUSIONS: Although obesity has been reported to confer a survival advantage to patients with HF, it was not associated with better health status at baseline, or after 1 year, in our cohort. Better understanding of the relationship among HF, body weight, and health status is needed before evidence-based recommendations can be made regarding weight management for HF patients.","['Conard, Mark W', 'Haddock, C Keith', 'Poston, Walker S Carlos', 'Havranek, Edward', 'McCullough, Peter', 'Spertus, John']","['Conard MW', 'Haddock CK', 'Poston WS', 'Havranek E', 'McCullough P', 'Spertus J']","['University of Missouri, Kansas City, Missouri, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,J Card Fail,Journal of cardiac failure,9442138,,IM,"['Aged', 'Body Mass Index', 'Cardiac Output, Low/*complications/mortality/*physiopathology', 'Cohort Studies', 'Diabetes Complications', 'Female', 'Follow-Up Studies', '*Health Status', 'Humans', 'Hypertension/etiology', 'Linear Models', 'Male', 'Middle Aged', 'Obesity/classification/*complications/physiopathology', 'Overweight']",,,,,2006/12/19 09:00,2007/01/27 09:00,['2006/12/19 09:00'],"['2006/04/21 00:00 [received]', '2006/07/15 00:00 [revised]', '2006/08/10 00:00 [accepted]', '2006/12/19 09:00 [pubmed]', '2007/01/27 09:00 [medline]', '2006/12/19 09:00 [entrez]']","['S1071-9164(06)00883-9 [pii]', '10.1016/j.cardfail.2006.08.006 [doi]']",ppublish,J Card Fail. 2006 Dec;12(9):700-6. doi: 10.1016/j.cardfail.2006.08.006.,,,,,,,,,,['Cardiovascular Outcomes Research Consortium'],,,,,,,,,,
9866261,NLM,MEDLINE,19990112,20161018,0212-6567 (Print) 0212-6567 (Linking),22,8,1998 Nov 15,[New etiopathogenic aspects of obesity].,527-32,,,"['Orozco, P']",['Orozco P'],"['ABS Gotic, Barcelona.']",['spa'],"['Comparative Study', 'Journal Article', 'Review']",Spain,Aten Primaria,Atencion primaria,9111075,"['0 (Leptin)', '0 (Proteins)']",IM,"['Adipose Tissue/metabolism', 'Animals', 'Diseases in Twins/genetics', 'Genetic Predisposition to Disease', 'Humans', 'Leptin', 'Mice', 'Mice, Obese/genetics', 'Obesity/*etiology/genetics/physiopathology/psychology', 'Obesity, Morbid/etiology/genetics/physiopathology/psychology', 'Proteins/genetics/metabolism']",,,,,1998/12/29 00:00,1998/12/29 00:01,['1998/12/29 00:00'],"['1998/12/29 00:00 [pubmed]', '1998/12/29 00:01 [medline]', '1998/12/29 00:00 [entrez]']",,ppublish,Aten Primaria. 1998 Nov 15;22(8):527-32.,,,,,,,23,,Nuevos aspectos etiopatogenicos de la obesidad.,,,,,,,,,,,
31899773,NLM,MEDLINE,20200406,20200408,1932-6203 (Electronic) 1932-6203 (Linking),15,1,2020,Perceptions of risk and influences of choice in pregnant women with obesity. An evidence synthesis of qualitative research.,e0227325,10.1371/journal.pone.0227325 [doi] e0227325,"BACKGROUND: Between 7-35% of the maternity population are obese in high income countries and 1-40% in lower or middle-income countries. Women with obesity are traditionally limited by the choices available to them during pregnancy and birth because of the higher risk of complications. This evidence synthesis set out to summarise how women with obesity's perceptions of pregnancy and birth risk influence the care choices that they make. METHODS: A search of medical and health databases for qualitative studies written in the English language, published Jan 1993-April 2019 and reporting on pregnant women with obesity's perception of risk and influence of pregnancy and birth choices. Data was extracted by two reviewers onto a questions framework and then analysed using a thematic synthesis technique. Confidence in the qualitative findings was assessed using GRADE-CERQual. RESULTS: 23 full texts were included. The common themes on perception of risk were: 'Self-blame arising from others' stereotyped beliefs ', 'Normalisation', 'Lack of preparation', 'Fearful acceptance and inevitability' and 'Baby prioritised over mother'. For influence of choices, the themes were: 'External influences from personal stresses', 'Restrictive guidelines', 'Relationship with healthcare professional' and 'Perception of Risk'. CONCLUSIONS: Evidence on what influences women with obesity's pregnancy choices is limited. Further research is needed on the best methods to discuss the risks of pregnancy and birth for women with obesity in a sensitive and acceptable manner and to identify the key influences when women with obesity make choices antenatally and for birth planning.","['Relph, Sophie', 'Ong, Melissa', 'Vieira, Matias C', 'Pasupathy, Dharmintra', 'Sandall, Jane']","['Relph S', 'Ong M', 'Vieira MC', 'Pasupathy D', 'Sandall J']","[""Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom."", ""Guy's, King's and St Thomas' School of Medical Education, King's College London, London, United Kingdom."", ""Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom."", ""Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom."", ""Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,PLoS One,PloS one,101285081,,IM,"['Adult', 'Female', 'Health Knowledge, Attitudes, Practice', 'Health Personnel', 'Humans', 'Infant, Newborn', '*Mothers', 'Obesity/complications/*epidemiology/physiopathology', 'Pregnancy', 'Pregnancy Complications/*epidemiology/physiopathology', '*Pregnant Women', 'Risk Factors']",PMC6941828,,,['The authors have declared that no competing interests exist.'],2020/01/04 06:00,2020/04/09 06:00,['2020/01/04 06:00'],"['2019/11/15 00:00 [received]', '2019/12/17 00:00 [accepted]', '2020/01/04 06:00 [entrez]', '2020/01/04 06:00 [pubmed]', '2020/04/09 06:00 [medline]']","['PONE-D-19-31821 [pii]', '10.1371/journal.pone.0227325 [doi]']",epublish,PLoS One. 2020 Jan 3;15(1):e0227325. doi: 10.1371/journal.pone.0227325. eCollection 2020.,['DH_/Department of Health/United Kingdom'],20200103,,,['ORCID: 0000-0002-2007-9647'],,,,,,,,,,,,,,,
12901472,NLM,MEDLINE,20030917,20171206,0026-4075 (Print) 0026-4075 (Linking),168,7,2003 Jul,Childhood obesity's relationship to time spent in sedentary behavior.,583-6,,"OBJECTIVE: The purpose of this study was to evaluate various types of sedentary behavior children participate in and to look for an association to childhood obesity. METHODS: Questionnaires were used to gather data on physical and sedentary activity, dietary intake, demographics, and anthropometrics of 9- to 12-year-old military dependents and their parents. RESULTS: Using body mass index (BMI), 39.8% of children were obese. A significant relationship was found between childhood obesity and computer usage, television watching, total hours in sedentary behavior, and maternal BMI. An indirect significant relationship with childhood obesity was also shown if a parent was home when the child got home from school and if a father participated in exercise with their child. Caloric intake, total time in physical activity, demographic variables, and father's BMI showed no significant relationship with children's BMI. CONCLUSION: Interventions should be designed targeting total time spent on the computer, total time watching television, and maternal obesity in child obesity programs.","['Arluk, Shaye L', 'Branch, J David', 'Swain, David P', 'Dowling, Elizabeth A']","['Arluk SL', 'Branch JD', 'Swain DP', 'Dowling EA']","['Undergraduate Exercise Science Program, Old Dominion University, Norfolk, VA 23529, USA.']",['eng'],['Journal Article'],England,Mil Med,Military medicine,2984771R,,IM,"['Anthropometry', 'Body Mass Index', 'Child', 'Computers', 'Cross-Sectional Studies', 'Diet Surveys', 'Energy Intake', 'Energy Metabolism', '*Exercise', 'Female', 'Humans', 'Life Style', 'Male', 'Military Medicine', 'Military Personnel/*statistics & numerical data', '*Nuclear Family', 'Obesity/diagnosis/epidemiology/*etiology', 'Population Surveillance', 'Risk Factors', 'Television', 'Time Factors', 'Virginia/epidemiology']",,,,,2003/08/07 05:00,2003/09/18 05:00,['2003/08/07 05:00'],"['2003/08/07 05:00 [pubmed]', '2003/09/18 05:00 [medline]', '2003/08/07 05:00 [entrez]']",,ppublish,Mil Med. 2003 Jul;168(7):583-6.,,,,,,,,,,,,,,,,,,,,
19397051,NLM,MEDLINE,20090519,20221207,0885-6028 (Print) 0885-6028 (Linking),19,2,2008 Dec,Relationship between obesity's adverse health risk and body mass index in African-American women.,28-34,,"Overweight and obesity are major threats to public health in the United States, affecting more than 60% of the adult population. African-American women are disproportionately represented in the largest increases of overweight and obese Americans, and they are at greater risk for poor health and obesity's related disorders. This descriptive study assessed African-American women's knowledge of obesity's adverse consequences and examined the relationship between their knowledge of obesity's health risk and their body mass index (BMI). Data were analyzed using Pearson Product Moment Correlation, ANOVA, paired t test, and Chi-square test. Findings from the study suggested that African-American women in this study had a moderate knowledge of obesity's adverse consequences. No relationship was observed between African-American women's knowledge of obesity's adverse consequences and their BMIs. In addition, findings suggested that there is a strong need to develop educational programs addressing obesity's adverse consequences, targeting women with a high school or less education.","['Stephens, Eva W']",['Stephens EW'],"['College of Pharmacy, Nursing, Pharmacy, and Allied Health, Howard University, 501 Bryant Street, NW, Washington, DC 20059, USA. estephens@Howard.edu']",['eng'],['Journal Article'],United States,J Natl Black Nurses Assoc,Journal of National Black Nurses' Association : JNBNA,8703519,,,"['Adult', 'Aged', 'Analysis of Variance', '*Black People', '*Body Mass Index', 'Chi-Square Distribution', 'Health Status', 'Humans', 'Middle Aged', 'Obesity/complications/*physiopathology', 'Risk Assessment', 'United States']",,,,,2009/04/29 09:00,2009/05/20 09:00,['2009/04/29 09:00'],"['2009/04/29 09:00 [entrez]', '2009/04/29 09:00 [pubmed]', '2009/05/20 09:00 [medline]']",,ppublish,J Natl Black Nurses Assoc. 2008 Dec;19(2):28-34.,,,,,,,,,,,,,,,,,,,,
17041253,NLM,MEDLINE,20061205,20061016,0889-5899 (Print) 0889-5899 (Linking),52,10,2006 Oct,Obesity: changing the face of geriatric care.,"36-8, 40-4",,"Statistics suggest that more and more older Americans are carrying extra weight-an estimated 40% of individuals between the ages of 60 and 69 have a body mass index >30 and 30% of persons between ages of 70 and 79 years are obese. Obesity, coupled with the challenges of aging, leads to an unfortunate burden of chronic disease, functional decline, poor quality of life, and an increased risk of being homebound. Physical assessment of the elderly obese patient should include measurement of height, weight (to determine body mass index) and waist circumference (to address central obesity) and consideration of vascular, skin, and mobility issues. Weight management strategies such as diet and hydration should balance nutritional requirements with weight loss; particular attention to protein needs in chair- and bedbound patients is necessary. Additional approaches such as exercise, bariatric weight loss surgery, and weight loss medication should be considered on an individual basis related to their inherent risks in this population. Weight loss/management options framed from an interdisciplinary perspective can improve quality of life for these patients and their caregivers. Research specific to obesity in this age group is warranted.","['Gallagher Camden, Susan', 'Gates, Judy']","['Gallagher Camden S', 'Gates J']","['Celebration Institute, Inc., Houston, TX, USA. Susan@celebrationinsitute.com']",['eng'],"['Case Reports', 'Journal Article']",United States,Ostomy Wound Manage,Ostomy/wound management,8912029,,,"['Aged', 'Bariatrics', 'Body Mass Index', 'Exercise', 'Female', '*Health Services for the Aged', 'Homebound Persons', 'Humans', '*Obesity/complications/physiopathology/surgery/therapy', 'Skin Diseases/complications']",,,,,2006/10/17 09:00,2006/12/09 09:00,['2006/10/17 09:00'],"['2006/10/17 09:00 [pubmed]', '2006/12/09 09:00 [medline]', '2006/10/17 09:00 [entrez]']",,ppublish,"Ostomy Wound Manage. 2006 Oct;52(10):36-8, 40-4.",,,,,,,,,,,,,,,,,,,,
22607862,NLM,MEDLINE,20120731,20120521,1097-6744 (Electronic) 0002-8703 (Linking),163,5,2012 May,"Understanding childhood obesity in America: linkages between household income, community resources, and children's behaviors.",836-43,10.1016/j.ahj.2012.02.025 [doi],"BACKGROUND: Understanding childhood obesity's root causes is critical to the creation of strategies to improve our children's health. We sought to define the association between childhood obesity and household income and how household income and childhood behaviors promote childhood obesity. METHODS: We assessed body mass index in 109,634 Massachusetts children, identifying the percentage of children who were overweight/obese versus the percentage of children in each community residing in low-income homes. We compared activity patterns and diet in 999 sixth graders residing in 4 Michigan communities with varying annual household income. RESULTS: In Massachusetts, percentage of overweight/obese by community varied from 9.6% to 42.8%. As household income dropped, percentage of overweight/obese children rose. In Michigan sixth graders, as household income goes down, frequency of fried food consumption per day doubles from 0.23 to 0.54 (P < .002), and daily TV/video time triples from 0.55 to 2.00 hours (P < .001), whereas vegetable consumption and moderate/vigorous exercise go down. CONCLUSIONS: The prevalence of overweight/obese children rises in communities with lower household income. Children residing in lower income communities exhibit poorer dietary and physical activity behaviors, which affect obesity.","['Eagle, Taylor F', 'Sheetz, Anne', 'Gurm, Roopa', 'Woodward, Alan C', 'Kline-Rogers, Eva', 'Leibowitz, Robert', 'Durussel-Weston, Jean', 'Palma-Davis, LaVaughn', 'Aaronson, Susan', 'Fitzgerald, Catherine M', 'Mitchell, Lindsey R', 'Rogers, Bruce', 'Bruenger, Patricia', 'Skala, Katherine A', 'Goldberg, Caren', 'Jackson, Elizabeth A', 'Erickson, Steven R', 'Eagle, Kim A']","['Eagle TF', 'Sheetz A', 'Gurm R', 'Woodward AC', 'Kline-Rogers E', 'Leibowitz R', 'Durussel-Weston J', 'Palma-Davis L', 'Aaronson S', 'Fitzgerald CM', 'Mitchell LR', 'Rogers B', 'Bruenger P', 'Skala KA', 'Goldberg C', 'Jackson EA', 'Erickson SR', 'Eagle KA']","['Cardiovascular Center, University of Michigan Health System, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5852, USA.']",['eng'],"['Comparative Study', 'Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",United States,Am Heart J,American heart journal,0370465,,IM,"['Adolescent', 'Attitude to Health', '*Body Mass Index', 'Child', '*Child Behavior', 'Cross-Sectional Studies', 'Diet', 'Exercise/*physiology', 'Family Characteristics', 'Health Status Disparities', 'Humans', 'Income', '*Life Style', 'Male', 'Mass Screening/organization & administration', 'Massachusetts/epidemiology', 'Michigan/epidemiology', 'Obesity/diagnosis/*epidemiology', 'Obesity, Morbid/diagnosis/epidemiology', 'Overweight/diagnosis/epidemiology', 'Prevalence', 'Residence Characteristics', 'Risk Assessment', 'School Health Services', 'Socioeconomic Factors']",,,,,2012/05/23 06:00,2012/08/01 06:00,['2012/05/22 06:00'],"['2011/11/15 00:00 [received]', '2012/02/19 00:00 [accepted]', '2012/05/22 06:00 [entrez]', '2012/05/23 06:00 [pubmed]', '2012/08/01 06:00 [medline]']","['S0002-8703(12)00174-3 [pii]', '10.1016/j.ahj.2012.02.025 [doi]']",ppublish,Am Heart J. 2012 May;163(5):836-43. doi: 10.1016/j.ahj.2012.02.025.,['2 R25 CA57712/CA/NCI NIH HHS/United States'],,,"['Copyright (c) 2012 Mosby, Inc. All rights reserved.']",,,,,,,,,,,,,,,,
9473815,NLM,MEDLINE,19980305,20150901,0001-6578 (Print) 0001-6578 (Linking),38,6,1997 Nov-Dec,Childhood obesity in Taiwan.,438-42,,"As other developed countries of the world, obesity has become a major health problem of children and adolescents in Taiwan. According to an island-wide survey, the prevalence of obesity varied from 4.3% to 17.4% in children aged three to nineteen years. Obesity is defined as an excess of body fat. Since the standard references of weight-for-height and body mass index for Taiwanese are not available, a weight-for-length index has been introduced. We have found that its easy computation and interpretation with high reliability make it a desirable measure of relative weight either in clinical practice or in research. The family background of the obese children has been investigated by many workers. In our own series, the obese children were about five times as likely to have an obese parent as control. There was also a significant difference in the chance of having an obese sibling between the obese and control groups. Several health sequelae of childhood obesity have been studied in Taiwan. Obese children appear to have high prevalence of hypertension, hyperlipidemia, and abnormal glucose metabolism. Of several cutaneous manifestations of obesity, colored striae were sometimes overlooked. In our experience, 40% of the moderate to severe obese cases have such striking marks prominently located on the thighs, arms and abdomen. A few pediatric weight-losing programs have been carried out in Taiwan. In our Pediatric Anti-Obesity Club, four fundamental components: diet, exercise, behavior modification and parent involvement were included in the treatment program. In family-based parent-directed program, 11% of the participants showed decreases in degree of obesity after one year follow-up, compared to 3% of a control group. In another individualized outpatient counseling clinic, the success rate was 59% after one year. Although the long-term effectiveness cannot determined, it seems rational that a realistic and culturally sensitive weight reduction program should be developed for countries, such as Taiwan, with increasing prevalence of childhood obesity.","['Chen, W']",['Chen W'],"['China Medical College, Taichung, Taiwan, R.O.C.']",['eng'],['Journal Article'],China (Republic : 1949- ),Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi,Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui,16210470R,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*epidemiology/etiology/therapy', 'Prevalence', 'Risk Factors', 'Taiwan/epidemiology']",,,,,1998/02/25 00:00,1998/02/25 00:01,['1998/02/25 00:00'],"['1998/02/25 00:00 [pubmed]', '1998/02/25 00:01 [medline]', '1998/02/25 00:00 [entrez]']",,ppublish,Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1997 Nov-Dec;38(6):438-42.,,,,,,,,,,,,,,,,,,,,
15075417,NLM,MEDLINE,20040609,20190513,0016-9013 (Print) 0016-9013 (Linking),44,2,2004 Apr,Obesity's effects on the onset of functional impairment among older adults.,206-16,,"PURPOSE: This study has two purposes. First, it determines if there is a relationship between body weight and the onset of functional impairment across time among this sample of older adults. More specifically, it examines if obese older adults are more likely to experience the onset of functional impairment. Second, it explores how health behaviors and health conditions may explain the relationship between body weight and the onset of functional impairment. DESIGN AND METHODS: With the use of longitudinal data from the Asset and Health Dynamics Among the Oldest Old (AHEAD) survey, logistic regression models on the onset of functional impairment over two time points are estimated for older adults. RESULTS: Results indicate that body weight (more specifically being overweight or obese) makes one more likely to experience the onset of functional impairment across various domains of impairment. Outside of health behaviors and health conditions, obesity has an independent effect on the onset of impairment in strength, lower body mobility, and activities of daily living. IMPLICATIONS: Study findings support the active treatment of weight problems in older adults. Future directions for research in this area should address effective weight management interventions targeting issues related to older individuals.","['Jenkins, Kristi Rahrig']",['Jenkins KR'],"['The Institute for Social Research, University of Michigan, 426 Thompson Street, Box 1248, Room 2044, Ann Arbor, MI 48106-1248, USA. kristirj@isr.umich.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Gerontologist,The Gerontologist,0375327,,IM,"['*Activities of Daily Living', 'Aged', 'Aged, 80 and over', 'Body Weight', 'Chronic Disease/epidemiology', 'Disabled Persons/*statistics & numerical data', 'Exercise', 'Female', 'Humans', 'Longitudinal Studies', 'Male', 'Motor Activity/physiology', 'Movement/physiology', 'Obesity/complications/epidemiology/*physiopathology', 'Risk-Taking', 'United States/epidemiology']",,,,,2004/04/13 05:00,2004/06/21 10:00,['2004/04/13 05:00'],"['2004/04/13 05:00 [pubmed]', '2004/06/21 10:00 [medline]', '2004/04/13 05:00 [entrez]']",['10.1093/geront/44.2.206 [doi]'],ppublish,Gerontologist. 2004 Apr;44(2):206-16. doi: 10.1093/geront/44.2.206.,['5T32 AG 00221/AG/NIA NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
31155994,NLM,MEDLINE,20190702,20190702,1941-9260 (Electronic) 0032-5481 (Linking),131,5,2019 Jun,Implications of differing attitudes and experiences between providers and persons with obesity: results of the national ACTION study.,357-365,10.1080/00325481.2019.1620616 [doi],"Objective: Our aim was to explore how differing attitudes, expectations, and experiences among people with obesity (PwO) and healthcare providers (HCPs) might have an impact on effectively implementing current obesity treatment guidelines. Methods: Online surveys were conducted among 3,008 adult PwO (BMI>/=30 by self-reported height and weight) and 606 HCPs. Results: PwO with weight loss >/= 10% during the previous three years were more likely to have been diagnosed with obesity and to have discussed a weight loss plan with an HCP. However, only 21% believe HCPs have a responsibility to actively contribute to their obesity treatment. Further, HCPs tend not to effectively communicate the diagnosis of obesity, its nature as a serious and chronic disease, the full range of treatment options, and obesity's implications for health and quality of life. Regarding treatment goals, HCPs more often focus on BMI reduction, while PwO's goals focus on improved functioning, energy, and appearance. HCPs also tend to underestimate their patients' motivation to address their obesity. Twenty-eight percent of HCPs 'completely agreed' that losing weight was a high priority for PwO, whereas more than half of PwO 'completely agreed' that losing weight was a high priority for them. When asked how their HCP could better support them, PwO most often expressed a desire for helpful resources, as well as assistance with specific and realistic goal-setting to improve health. Conclusions: HCPs can more effectively implement obesity treatment guidelines by more clearly and proactively communicating with PwO about their diagnosis, health implications of obesity, desired treatment goals, and the full range of treatment options. HCPs should understand that most PwO believe that managing their disease is solely their own responsibility. HCPs can also encourage more effective conversations by better appreciating their patients' motivation and treatment goals.","['Look, Michelle', 'Kolotkin, Ronette L', 'Dhurandhar, Nikhil V', 'Nadglowski, Joseph', 'Stevenin, Boris', 'Golden, Angela']","['Look M', 'Kolotkin RL', 'Dhurandhar NV', 'Nadglowski J', 'Stevenin B', 'Golden A']","['a San Diego Sports Medicine and Family Health , San Diego , CA , USA.', 'b Quality of Life Consulting , Durham , NC , USA.', 'c Department of Community and Family Medicine , Duke University School of Medicine , Durham , NC , USA.', 'd Faculty of Health Studies , Western Norway University of Applied Sciences , Forde , Norway.', 'e Forde Hospital Trust , Forde , Norway.', 'f Morbid Obesity Centre, Vestfold Hospital Trust , Tonsberg , Norway.', 'g Nutritional Sciences , Texas Tech University , Lubbock , TX , USA.', 'h Obesity Action Coalition , Tampa , FL , USA.', 'i Novo Nordisk Inc ., Plainsboro , NJ , USA.', 'j NP from Home, LLC ., Munds Park , AZ , USA.']",['eng'],['Journal Article'],England,Postgrad Med,Postgraduate medicine,0401147,,IM,"['Adult', '*Attitude of Health Personnel', '*Attitude to Health', 'Female', 'Health Personnel/*psychology', 'Humans', 'Male', 'Middle Aged', 'Obesity/*pathology/therapy', '*Self Report', 'Self-Management/psychology', 'Social Support', 'Weight Loss']",,['NOTNLM'],"['People with obesity', 'attitudes towards obesity', 'clinical treatment guidelines', 'obesity management', 'weight loss']",,2019/06/04 06:00,2019/07/03 06:00,['2019/06/04 06:00'],"['2019/06/04 06:00 [pubmed]', '2019/07/03 06:00 [medline]', '2019/06/04 06:00 [entrez]']",['10.1080/00325481.2019.1620616 [doi]'],ppublish,Postgrad Med. 2019 Jun;131(5):357-365. doi: 10.1080/00325481.2019.1620616. Epub 2019 Jun 3.,,20190603,,,,,,,,,,,,,,,,,,
31667648,NLM,MEDLINE,20210520,20210520,1573-3572 (Electronic) 1068-9583 (Linking),27,4,2020 Dec,Stages of Change Readiness and Treatment Eagerness Scale in Overweight and Obesity's Psychometric Properties (SOCRATES-OO).,805-817,10.1007/s10880-019-09672-w [doi],"The present study investigated the psychometric properties of the Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) in the context of overweight and obesity. The instrument was investigated in a non-probabilistic sample of 177 individuals who were overweight or obese. A confirmatory factor analysis (CFA) was performed in order to provide evidence based on the internal consistency of the SOCRATES-OO scale with three correlated factors and two correlated factors. In addition, the University of Rhode Island Change Assessment (URICA) raw score was used to provide evidence in terms of convergent validity by its correlation with the domains of the best SOCRATES-OO solution. According to CFA, the theoretical solution with two correlated factors provided a better statistical fit. The psychometric evaluation of the 19 items of SOCRATES-OO presented a good fit under the two-factor model and satisfactory internal consistency by Omega of AMREC (Ambivalence + Recognition) 0.924 and Action 0.942.","['Vieira da Silva, Renata', 'de Oliveira, Irismar Reis', 'Lopes Velasquez, Michella']","['Vieira da Silva R', 'de Oliveira IR', 'Lopes Velasquez M']","['Department of Neurosciences and Mental Health, Federal University of Bahia (UFBA), Salvador, BA, Brazil. ctcrenata@gmail.com.', 'Department of Neurosciences and Mental Health, Federal University of Bahia (UFBA), Salvador, BA, Brazil.', 'Department of Neurosciences and Mental Health, Federal University of Bahia (UFBA), Salvador, BA, Brazil.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,J Clin Psychol Med Settings,Journal of clinical psychology in medical settings,9435680,,IM,"['Adolescent', 'Adult', 'Brazil', 'Factor Analysis, Statistical', 'Female', 'Humans', 'Male', 'Middle Aged', 'Motivation', 'Obesity/psychology/therapy', 'Overweight/*psychology/*therapy', 'Patient Acceptance of Health Care/*psychology/statistics & numerical data', 'Psychometrics', 'Reproducibility of Results', 'Surveys and Questionnaires', 'Young Adult']",,['NOTNLM'],"['Factor analysis', 'Motivation', 'Obesity', 'Overweight', 'Psychometric']",,2019/11/02 06:00,2021/05/21 06:00,['2019/11/01 06:00'],"['2019/11/02 06:00 [pubmed]', '2021/05/21 06:00 [medline]', '2019/11/01 06:00 [entrez]']","['10.1007/s10880-019-09672-w [pii]', '10.1007/s10880-019-09672-w [doi]']",ppublish,J Clin Psychol Med Settings. 2020 Dec;27(4):805-817. doi: 10.1007/s10880-019-09672-w.,,,,,['ORCID: 0000-0002-7094-4168'],,,,,,,,,,,,,,,
27916684,NLM,MEDLINE,20170531,20220409,1878-1632 (Electronic) 1529-9430 (Linking),17,5,2017 May,The impact of obesity on compensatory mechanisms in response to progressive sagittal malalignment.,681-688,S1529-9430(16)31110-X [pii] 10.1016/j.spinee.2016.11.016 [doi],"BACKGROUND CONTEXT: Obesity's impact on standing sagittal alignment remains poorly understood, especially with respect to the role of the lower limbs. Given energetic expenditure in standing, a complete understanding of compensation in obese patients with sagittal malalignment remains relevant. PURPOSE: This study compares obese and non-obese patients with progressive sagittal malalignment for differences in recruitment of pelvic and lower-limb mechanisms. STUDY DESIGN/SETTING: Single-center retrospective review. PATIENT SAMPLE: A total of 554 patients (277 obese, 277 non-obese) were identified for analysis. OUTCOME MEASURES: Upper body alignment parameters: sagittal vertical axis (SVA) and T1 spinopelvic inclination (T1SPi). Compensatory lower-limb mechanisms: pelvic translation (pelvic shift [PS]), knee (KA) and ankle (AA) flexion, hip extension (sacrofemoral angle [SFA]), and global sagittal angle (GSA). METHODS: Inclusion criteria were patients >/=18 years who underwent full-body stereographic x-rays. Included patients were categorized as non-obese (N-Ob: body mass index [BMI]<30 kg/m(2)) or obese (Ob: BMI>/=30 kg/m(2)). To control for potential confounders, groups were propensity score matched by age, gender, and baseline pelvic incidence (PI), and subsequently categorized by increasing spinopelvic (pelvic incidence minus lumbar lordosis [PI-LL]) mismatch: <10 degrees , 10 degrees -20 degrees , >20 degrees . Independent t tests and linear regression models compared sagittal (SVA, T1SPi) and lower limb (PS, KA, AA, SFA, GSA) parameters between obesity cohorts. RESULTS: A total of 554 patients (277 Ob, 277 N-Ob) were included for analysis and were stratified to the following mismatch categories: <10 degrees : n=367; 10 degrees -20 degrees : n=91; >20 degrees : n=96. Obese patients had higher SVA, KA, PS, and GSA than N-Ob patients (p<.001 all). Low PI-LL mismatch Ob patients had greater SVA with lower SFA (142.22 degrees  vs. 156.66 degrees , p=.032), higher KA (5.22 degrees  vs. 2.93 degrees , p=.004), and higher PS (4.91 vs. -5.20 mm, p<.001) than N-Ob patients. With moderate PI-LL mismatch, Ob patients similarly demonstrated greater SVA, KA, and PS, combined with significantly lower PT (23.69 degrees  vs. 27.14 degrees , p=.012). Obese patients of highest (>20 degrees ) PI-LL mismatch showed greatest forward malalignment (SVA, T1SPi) with significantly greater PS, and a concomitantly high GSA (12.86 degrees  vs. 9.67 degrees , p=.005). Regression analysis for lower-limb compensation revealed that increasing BMI and PI-LL predicted KA (r(2)=0.234) and GSA (r(2)=0.563). CONCLUSIONS: With progressive sagittal malalignment, obese patients differentially recruit lower extremity compensatory mechanisms, whereas non-obese patients preferentially recruit pelvic mechanisms. The ability to compensate for progressive sagittal malalignment with the pelvic retroversion is limited by obesity.","['Jalai, Cyrus M', 'Diebo, Bassel G', 'Cruz, Dana L', 'Poorman, Gregory W', 'Vira, Shaleen', 'Buckland, Aaron J', 'Lafage, Renaud', 'Bess, Shay', 'Errico, Thomas J', 'Lafage, Virginie', 'Passias, Peter G']","['Jalai CM', 'Diebo BG', 'Cruz DL', 'Poorman GW', 'Vira S', 'Buckland AJ', 'Lafage R', 'Bess S', 'Errico TJ', 'Lafage V', 'Passias PG']","['Department of Orthopaedic Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, 301 East 17th St, New York, NY 10003, USA.', 'Department of Orthopaedic Surgery, Hospital for Special Surgery, 535 E 70th St, New York, NY 10021, USA.', 'Department of Orthopaedic Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, 301 East 17th St, New York, NY 10003, USA.', 'Department of Orthopaedic Surgery, Hospital for Special Surgery, 535 E 70th St, New York, NY 10021, USA.', 'Department of Orthopaedic Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, 301 East 17th St, New York, NY 10003, USA.', 'Department of Orthopaedic Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, 301 East 17th St, New York, NY 10003, USA.', 'Department of Orthopaedic Surgery, Hospital for Special Surgery, 535 E 70th St, New York, NY 10021, USA.', 'Department of Orthopaedic Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, 301 East 17th St, New York, NY 10003, USA.', 'Department of Orthopaedic Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, 301 East 17th St, New York, NY 10003, USA.', 'Department of Orthopaedic Surgery, Hospital for Special Surgery, 535 E 70th St, New York, NY 10021, USA.', 'Department of Orthopaedic Surgery, Hospital for Joint Diseases, NYU Langone Medical Center, 301 East 17th St, New York, NY 10003, USA. Electronic address: peter.passias@nyumc.org.']",['eng'],['Journal Article'],United States,Spine J,The spine journal : official journal of the North American Spine Society,101130732,,IM,"['Adult', 'Aged', 'Female', 'Humans', 'Lordosis/complications/*diagnostic imaging', 'Male', 'Middle Aged', 'Obesity/*complications', '*Posture', 'Radiography']",,['NOTNLM'],"['Compensatory mechanisms', 'Full-body imaging', 'Lower extremities', 'Obesity', 'Sagittal malalignment', 'Spinopelvic mismatch']",,2016/12/06 06:00,2017/06/01 06:00,['2016/12/06 06:00'],"['2016/05/20 00:00 [received]', '2016/09/15 00:00 [revised]', '2016/11/28 00:00 [accepted]', '2016/12/06 06:00 [pubmed]', '2017/06/01 06:00 [medline]', '2016/12/06 06:00 [entrez]']","['S1529-9430(16)31110-X [pii]', '10.1016/j.spinee.2016.11.016 [doi]']",ppublish,Spine J. 2017 May;17(5):681-688. doi: 10.1016/j.spinee.2016.11.016. Epub 2016 Dec 1.,,20161201,,['Copyright (c) 2016. Published by Elsevier Inc.'],,,,,,,,,,,,,,,,
11928533,NLM,MEDLINE,20021030,20130702,0212-1611 (Print) 0212-1611 (Linking),17 Suppl 1,,2002 Feb,[Genetic polymorphisms and new perspectives in the prevention and treatment of obesity].,23-33,,"The prevalence of obesity has increased to an extraordinary degree, especially over the last three decades, so that if these trends persist, practically all of the adult population would be obese in the course of only two generations. On the basis of family and adoption studies, it has been estimated that the genetic component in obesity ranges from 20% to 80%. Thus, the most common forms of obesity would depend on the interaction of multiple genes as well as on the influence of various environmental factors, such as eating behaviour and lifestyle. Although none of these genes potentially involved in the control of body weight seems to be directly responsible for the syndrome, there have been reports of interesting associations between polymorphisms of certain candidate genes and obesity or its metabolic complications. The studies into associations between genotypes and obese phenotype have increased over the last few years and have basically focussed on the genes involved in the control of the energy balance, giving rise to a whole series of results which might constitute the basis for extremely interesting strategies for the prevention and treatment of this serious problem.","['Palou, A', 'Proenza, A M', 'Ramis, J M']","['Palou A', 'Proenza AM', 'Ramis JM']","['Departamento de Biologia Fundamental y Ciencias de la Salud, Universidad de las Islas Baleares, Espana. dbfapo0@ps.uib.es']",['spa'],"['English Abstract', 'Journal Article', 'Review']",Spain,Nutr Hosp,Nutricion hospitalaria,9100365,,IM,"['Humans', 'Obesity/etiology/*genetics/prevention & control/*therapy', 'Phenotype', '*Polymorphism, Genetic']",,,,,2002/04/04 10:00,2002/11/01 04:00,['2002/04/04 10:00'],"['2002/04/04 10:00 [pubmed]', '2002/11/01 04:00 [medline]', '2002/04/04 10:00 [entrez]']",,ppublish,Nutr Hosp. 2002 Feb;17 Suppl 1:23-33.,,,,,,,135,,Polimorfismos geneticos y nuevas perspectivas en la prevencion y tratamiento de la obesidad.,,,,,,,,,,,
35382771,NLM,MEDLINE,20220407,20220509,1471-2253 (Electronic) 1471-2253 (Linking),22,1,2022 Apr 5,A review on the anesthetic management of obese patients undergoing surgery.,98,10.1186/s12871-022-01579-8 [doi] 98,"There has been an observed increase in theprevalence of obesity over the past few decades. The prevalence of anesthesiology related complications is also observed more frequently in obese patients as compared to patients that are not obese. Due to the increased complications that accompany obesity, obese patients are now more often requiring surgical interventions. Therefore, it is important that anesthesiologists be aware of this development and is equipped to manage these patients effectively and appropriately. As a result, this review highlights the effective management of obese patients undergoing surgery focusing on the preoperative, perioperative and postoperative care of these patients.","['Seyni-Boureima, Rimanatou', 'Zhang, Zongze', 'Antoine, Malyn M L K', 'Antoine-Frank, Chrystal D']","['Seyni-Boureima R', 'Zhang Z', 'Antoine MMLK', 'Antoine-Frank CD']","['Department of Anaesthesiology, Zhongnan Hospital, Wuhan University, East Lake Road, 430071, Wuhan, Hubei, China.', 'Department of Anaesthesiology, Zhongnan Hospital, Wuhan University, East Lake Road, 430071, Wuhan, Hubei, China. zhangzz@whu.edu.cn.', 'Department of Endocrinology, Zhongnan Hospital, Wuhan University, East Lake Road, 430071, Wuhan, Hubei, China.', ""Department of Anatomical Sciences, St. George's University, True Blue,Grand Anse, West Indies, St. George, Grenada.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,BMC Anesthesiol,BMC anesthesiology,100968535,['0 (Anesthetics)'],IM,"['*Anesthetics', 'Body Mass Index', 'Humans', 'Obesity/complications/epidemiology/surgery', '*Postoperative Complications/epidemiology']",PMC8985303,['NOTNLM'],"['Anesthesia', 'Body Mass Index', 'Obesity', 'Surgery']",['The authors of this paper declare no competing of interests.'],2022/04/07 06:00,2022/04/08 06:00,['2022/04/06 05:21'],"['2021/01/16 00:00 [received]', '2022/01/27 00:00 [accepted]', '2022/04/06 05:21 [entrez]', '2022/04/07 06:00 [pubmed]', '2022/04/08 06:00 [medline]']","['10.1186/s12871-022-01579-8 [pii]', '1579 [pii]', '10.1186/s12871-022-01579-8 [doi]']",epublish,BMC Anesthesiol. 2022 Apr 5;22(1):98. doi: 10.1186/s12871-022-01579-8.,,20220405,,['(c) 2022. The Author(s).'],['ORCID: 0000-0002-1774-0799'],,,,,,,,,,,,,,,
32237628,NLM,MEDLINE,20200501,20200501,2101-017X (Electronic) 0035-2640 (Linking),69,9,2019 Nov,[Genetics and epigenetics of obesity: keys to understand].,1016-1019,,"Genetics and epigenetics of obesity: the keys to understand. Obesity is a multifactorial disease due to central dysregulation of energy homeostasis. The contribution of genetics is constant but varies according to the situations from the rare forms of non-syndromic and syndromic monogenic obesities (about 5% of cases) and the socalled polygenic obesity (or common obesity) which is the most frequent situation (95% of cases). Environmental factors (early pre- and post-natal, societal or psychological determinants) always interact closely with the genetic factors of predisposition. The better understanding of these different actors should lead in the future to a real personalized medicine (targeted drug treatments according to the identified genetic anomaly and / or multidisciplinary management or even bariatric surgery according to clinical situations).","['Dubern, Beatrice']",['Dubern B'],"['Nutrition et gastroenterologie pediatriques, hopital Trousseau, Sorbonne Universite, Paris.']",['fre'],['Journal Article'],France,Rev Prat,La Revue du praticien,0404334,,IM,"['*Epigenesis, Genetic', '*Genetic Predisposition to Disease', 'Humans', '*Obesity/genetics']",,['NOTNLM'],"['epigenetics of obesity', 'obesity']","['B. Dubern declare des liens ponctuels (interventions et/ou prise en charge lors', 'de congres) avec Shire, Nutricia, Fresenius Kabi et Rythm.']",2020/04/03 06:00,2020/05/02 06:00,['2020/04/03 06:00'],"['2020/04/03 06:00 [entrez]', '2020/04/03 06:00 [pubmed]', '2020/05/02 06:00 [medline]']",,ppublish,Rev Prat. 2019 Nov;69(9):1016-1019.,,,,,,,,,Genetique et epigenetique de l'obesite : les pistes pour comprendre.,,,,,,,,,,,
37037398,NLM,MEDLINE,20230508,20230508,1096-1186 (Electronic) 1043-6618 (Linking),191,,2023 May,Novel therapeutics in rare genetic obesities: A narrative review.,106763,S1043-6618(23)00119-6 [pii] 10.1016/j.phrs.2023.106763 [doi],"The better understanding of the molecular causes of rare genetic obesities and its associated phenotype involving the hypothalamus allows today to consider innovative therapeutics focused on hunger control. Several new pharmacological molecules benefit patients with monogenic or syndromic obesity. They are likely to be among the treatment options for these patients in the coming years, helping clinicians and patients prevent rapid weight progression and eventually limit bariatric surgery procedures, which is less effective in these patients. Their positioning in the management of such patients will be needed to be well defined to develop precision medicine in genetic forms of obesity.","['Dubern, Beatrice', 'Faccioli, Nathan', 'Poitou, Christine', 'Clement, Karine']","['Dubern B', 'Faccioli N', 'Poitou C', 'Clement K']","['Assistance Publique Hopitaux de Paris, Trousseau Hospital, Pediatric Nutrition and Gastroenterology Department, French Reference Center for Prader-Willi Syndrome and other rare obesities (PRADORT), Paris, France; Systemic approaches, NutriOmics research group, 75013 Paris, France; Sorbonne Universite, INSERM, Nutrition and obesities, NutriOmics research group, 75013 Paris, France. Electronic address: beatrice.dubern@aphp.fr.', 'Assistance Publique Hopitaux de Paris, Trousseau Hospital, Pediatric Nutrition and Gastroenterology Department, French Reference Center for Prader-Willi Syndrome and other rare obesities (PRADORT), Paris, France; Systemic approaches, NutriOmics research group, 75013 Paris, France; Sorbonne Universite, INSERM, Nutrition and obesities, NutriOmics research group, 75013 Paris, France.', 'Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, Nutrition Department, Paris, France; Systemic approaches, NutriOmics research group, 75013 Paris, France; Sorbonne Universite, INSERM, Nutrition and obesities, NutriOmics research group, 75013 Paris, France.', 'Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, Nutrition Department, Paris, France; Systemic approaches, NutriOmics research group, 75013 Paris, France; Sorbonne Universite, INSERM, Nutrition and obesities, NutriOmics research group, 75013 Paris, France.']",['eng'],"['Journal Article', 'Review']",Netherlands,Pharmacol Res,Pharmacological research,8907422,,IM,"['Humans', '*Obesity/drug therapy/genetics', '*Bariatric Surgery']",,['NOTNLM'],"['Childhood obesity', 'Genetics', 'Hypothalamus', 'Melanocortins', 'Monogenic obesity']","['Declaration of Competing Interest The authors declare the following financial', 'interests/personal relationships which may be considered as potential competing', 'interests: Dubern reports a relationship with rhythm Pharmaceuticals, Novo', 'Nordisks that includes: consulting or advisory, speaking and lecture fees, and', 'travel reimbursement.']",2023/04/11 06:00,2023/05/08 06:41,['2023/04/10 19:23'],"['2023/02/08 00:00 [received]', '2023/04/04 00:00 [revised]', '2023/04/07 00:00 [accepted]', '2023/05/08 06:41 [medline]', '2023/04/11 06:00 [pubmed]', '2023/04/10 19:23 [entrez]']","['S1043-6618(23)00119-6 [pii]', '10.1016/j.phrs.2023.106763 [doi]']",ppublish,Pharmacol Res. 2023 May;191:106763. doi: 10.1016/j.phrs.2023.106763. Epub 2023 Apr 8.,,20230408,,['Copyright (c) 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.'],,,,,,,,,,,,,,,,
18386674,NLM,MEDLINE,20080603,20171116,1660-9379 (Print) 1660-9379 (Linking),4,143,2008 Feb 6,[Metabolic syndrome: jumble syndrome of obesity or specific entity? Which treatment: diet or polypill?].,366-73,,"The reality of metabolic syndrome (MS) as a specific entity is debatable. However, the simple measure of waist circumference (>94 cm in men and >80 cm in women) is useful: (1) to check for insulin resistance by measuring serum levels of fasted glucose and insuline, cholesterol, triglycerides; (2) to look for diseases associated with MS such as hypertension, non alcohoolic steatohepatitis, sleep apnea, polycystic ovary disease, hypogonadism and to measure serum levels of ferritine, ALAT, ASAT, urate acid, CRP hs, testosterone and (3) to make obese people aware of their risk of becoming diabetic and to motivate them to change their life style. The utility of exercise and of various diets is discussed as well as the efficiency of drugs acting on different components of MS such as rimonabant, orlistat, metformin, glitazones, telmisartan and testosterone. The importance of political measures to fight the obesity epidemic is underlined.","['Martin-Du Pan, Remy C', 'Ruiz, Juan']","['Martin-Du Pan RC', 'Ruiz J']",['martindupan@bluewin.ch'],['fre'],"['Journal Article', 'Review']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Diet, Reducing', 'Drug Therapy, Combination', 'Humans', 'Metabolic Syndrome/classification/*diagnosis/*therapy', 'Obesity/complications/prevention & control']",,,,,2008/04/05 09:00,2008/06/05 09:00,['2008/04/05 09:00'],"['2008/04/05 09:00 [pubmed]', '2008/06/05 09:00 [medline]', '2008/04/05 09:00 [entrez]']",,ppublish,Rev Med Suisse. 2008 Feb 6;4(143):366-73.,,,,,,,82,,Syndrome metabolique: syndrome fourre-tout des patients obeses ou entite specifique? Quel traitement: hygiene de vie ou potypill?,,,,,,,,,,,
21557184,NLM,MEDLINE,20111129,20220317,0041-4131 (Print) 0041-4131 (Linking),89,5,2011 May,[Obesity has a protective effect on radiographic joint damage in rheumatoid arthritis].,462-5,,"BACKGROUND: Obesity is a state of chronic low-grade inflammation that predisposes people to several diseases and that is increasingly prevalent. Rheumatoid arthritis (RA) is marked by the presence of proinflammatory cytokines and, in general, the presence of high levels of inflammatory markers is associated with a severe disease course and joint damage. AIM: To assess the impact of obesity on disease activity, quality of life and articular damage in patients with established RA. METHODS: Between July 2009 to December 2009, 119 RA patients were included and divided in two groups according to the body mass index (obeses and controls). RA activity was assessed by the Disease Activity Score (DAS) 28, quality of life by the Health Assessment Questionnaire (HAQ) and radiographic joint damage by the modified Sharp score. RESULTS: Obesity was not correlated with worsen RA activity (p=0.71) nor quality of life impairment (p=0.51). The obese group had a lower modified Sharp score than the control group (64.97versus113.64; p < 0.032) and this association remained significant after adjustment for age, sex, disease activity, extraarticular manifestations, comorbidities, presence of rheumatoid factor, and disease duration. CONCLUSION: Obesity does not have an impact on disease activity nor changes in quality of life, but it has a protective effect on the amount of joint destruction in established rheumatoid arthritis.","['Tekaya, Raoudha', 'Sahli, Hana', 'Zribi, Saida', 'Mahmoud, Ines', 'Ben Hadj Yahia, Chiraz', 'Abdelmoula, Leila', 'Chaabouni, Lilia', 'Zouari, Rafik']","['Tekaya R', 'Sahli H', 'Zribi S', 'Mahmoud I', 'Ben Hadj Yahia C', 'Abdelmoula L', 'Chaabouni L', 'Zouari R']","['Hopital Charles Nicolle, Tunis, Tunisie.']",['fre'],['Journal Article'],Tunisia,Tunis Med,La Tunisie medicale,0413766,,IM,"['Adipose Tissue/pathology/physiology', 'Adult', 'Aged', 'Arthritis, Rheumatoid/*complications/diagnostic imaging/*pathology', 'Arthrography', 'Body Mass Index', 'Case-Control Studies', 'Comorbidity', 'Cytoprotection/physiology', 'Female', 'Humans', 'Joints/*pathology', 'Male', 'Middle Aged', 'Motor Activity', 'Obesity/*complications/diagnostic imaging/*pathology', 'Quality of Life', 'Young Adult']",,,,,2011/05/11 06:00,2011/12/13 00:00,['2011/05/11 06:00'],"['2011/05/11 06:00 [entrez]', '2011/05/11 06:00 [pubmed]', '2011/12/13 00:00 [medline]']",['/article-medicale-tunisie.php?article=1716 [pii]'],ppublish,Tunis Med. 2011 May;89(5):462-5.,,,,,,,,,L'obesite est un facteur protecteur contre l'atteinte structurale au cours de la polyarthrite rhumatoide.,,,,,,,,,,,
21930957,NLM,MEDLINE,20120509,20221207,1538-7755 (Electronic) 1055-9965 (Print) 1055-9965 (Linking),20,11,2011 Nov,The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model.,2450-6,10.1158/1055-9965.EPI-11-0547 [doi],"BACKGROUND: The United States has experienced an alarming and unexplained increase in the incidence of esophageal adenocarcinoma (EAC) since the 1970s. A concurrent increase in obesity has led some to suggest a relationship between the two trends. We explore the extent of this relationship. METHODS: Using a previously validated disease simulation model of white males in the United States, we estimated EAC incidence 1973 to 2005 given constant obesity prevalence and low population progression rates consistent with the early 1970s. Introducing only the observed, rising obesity prevalence, we calculated the incremental incidence caused by obesity. We compared these with EAC incidence data from the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) registry to determine obesity's contribution to the rise therein. Incidences were converted to absolute numbers of cases using U.S. population data. RESULTS: Using constant obesity prevalence, we projected a total of 30,555 EAC cases cumulatively over 1973 to 2005 and 1,151 in 2005 alone. Incorporating the observed obesity trend resulted in 35,767 cumulative EACs and 1,608 in 2005. Estimates derived from SEER data showed 111,223 cumulative and 7,173 cases in 2005. We conclude that the rise in obesity accounted for 6.5% of the increase in EAC cases that occurred from 1973 to 2005 and 7.6% in the year 2005. CONCLUSION: Using published OR for EAC among obese individuals, we found that only a small percentage of the rise in EAC incidence is attributable to secular trends in obesity. IMPACT: Other factors, alone and in combination, should be explored as causes of the EAC epidemic.","['Kong, Chung Yin', 'Nattinger, Kevin J', 'Hayeck, Tristan J', 'Omer, Zehra B', 'Wang, Y Claire', 'Spechler, Stuart J', 'McMahon, Pamela M', 'Gazelle, G Scott', 'Hur, Chin']","['Kong CY', 'Nattinger KJ', 'Hayeck TJ', 'Omer ZB', 'Wang YC', 'Spechler SJ', 'McMahon PM', 'Gazelle GS', 'Hur C']","['Institute for Technology Assessment, Harvard Medical School, Boston, MA 02114, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",United States,Cancer Epidemiol Biomarkers Prev,"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology",9200608,,IM,"['Adenocarcinoma/*epidemiology/ethnology/etiology', 'Computer Simulation', 'Esophageal Neoplasms/*epidemiology/ethnology/etiology', 'Female', 'Humans', 'Incidence', 'Male', 'Models, Statistical', 'Obesity/complications/*epidemiology/ethnology', 'Registries', 'Risk Factors', 'SEER Program', 'United States/epidemiology', 'White People']",PMC3382986,,,"['Conflict of Interest Disclosures: All authors have completed and submitted the', 'form for Disclosure of Potential Conflicts of Interest and the following were', 'reported: Stuart Spechler: AstraZeneca Pharmaceuticals: Grant/Research Support', 'Ironwood Pharmaceuticals Inc.: Consulting fee Takeda Pharmaceutical Company Ltd:', 'Grant/Research Support XenoPort, Inc.: Consulting fee Torax Medical: Consulting', 'fee BARRX Medical, Inc.: Grant/Research Support G Scott Gazelle: GE Healthcare:', 'Consulting fee The remaining authors disclosed no potential conflicts of', 'interest.']",2011/09/21 06:00,2012/05/10 06:00,['2011/09/21 06:00'],"['2011/09/21 06:00 [entrez]', '2011/09/21 06:00 [pubmed]', '2012/05/10 06:00 [medline]']","['1055-9965.EPI-11-0547 [pii]', '10.1158/1055-9965.EPI-11-0547 [doi]']",ppublish,Cancer Epidemiol Biomarkers Prev. 2011 Nov;20(11):2450-6. doi: 10.1158/1055-9965.EPI-11-0547. Epub 2011 Sep 19.,"['K25 CA133141/CA/NCI NIH HHS/United States', 'U01 CA152926-01/CA/NCI NIH HHS/United States', 'R01 CA140574/CA/NCI NIH HHS/United States', 'R01CA140574/CA/NCI NIH HHS/United States', 'R00 CA126147/CA/NCI NIH HHS/United States', 'U01CA152926/CA/NCI NIH HHS/United States', 'K25CA133141/CA/NCI NIH HHS/United States', 'U01 CA152926/CA/NCI NIH HHS/United States', 'T32 ES007142/ES/NIEHS NIH HHS/United States', 'R00CA126147/CA/NCI NIH HHS/United States', 'R01 CA140574-02/CA/NCI NIH HHS/United States']",20110919,,['(c) 2011 AACR.'],,['NIHMS326069'],,,,,,,,,,,,,,
21516917,NLM,MEDLINE,20110518,20191112,1753-3740 (Print) 1753-3740 (Linking),25,1,2011 Mar,Intensive care in the obese.,95-108,,"Nearly 20% of all patients admitted to an intensive-care unit are obese. Their excess weight puts them at risk for several problems and complications during their intensive-care unit stay. Especially, pulmonary problems need particular attention, and comprehensive knowledge of the specific pathophysiologic changes of the respiratory system is important. Lung protective ventilation strategies, supplemented by lung-recruiting manoeuvres, may be feasible in critically ill obese patients with lung injury. Careful positioning of the obese is essential to optimise ventilation and facilitate weaning from mechanical ventilation. Optimal hypocaloric nutrition with a high proportion of proteins is advised to control hyperglycaemia. Because mortality in obese patients is similar to or lower than in non-obese ones, it is conceivable that obesity has a protective effect in the critically ill.","['Lewandowski, Klaus', 'Lewandowski, Monika']","['Lewandowski K', 'Lewandowski M']","['Department of Anaesthesia, Critical Care and Pain Therapy, Elisabeth-Krankenhaus Essen, Klara-Kopp-Weg 1, 45138 Essen, Germany. k.lewandowski@contilia.de']",['eng'],"['Journal Article', 'Review']",Netherlands,Best Pract Res Clin Anaesthesiol,Best practice & research. Clinical anaesthesiology,101121446,,IM,"['Critical Care/*methods', 'Humans', 'Intensive Care Units', 'Obesity/epidemiology/physiopathology/*therapy', 'Posture', 'Respiration, Artificial', 'Respiratory Physiological Phenomena', 'Treatment Outcome', 'Ventilator Weaning']",,,,,2011/04/27 06:00,2011/05/19 06:00,['2011/04/27 06:00'],"['2011/04/27 06:00 [entrez]', '2011/04/27 06:00 [pubmed]', '2011/05/19 06:00 [medline]']","['S1521-6896(10)00093-5 [pii]', '10.1016/j.bpa.2010.12.003 [doi]']",ppublish,Best Pract Res Clin Anaesthesiol. 2011 Mar;25(1):95-108. doi: 10.1016/j.bpa.2010.12.003.,,,,,,,,,,,,,,,,,,,,
31025085,NLM,MEDLINE,20200409,20200409,1863-2300 (Electronic) 1863-2297 (Linking),41,4,2019 Jul,Impact of bariatric surgery on type 2 diabetes: contribution of inflammation and gut microbiome?,461-475,10.1007/s00281-019-00738-3 [doi],"Obesity is a chronic low-grade inflammatory disease (both at the systemic and adipose tissue level) that continues to rise worldwide. It is associated with an abundance of comorbidities, including type 2 diabetes (T2D). Bariatric surgery, which induces modifications of the intestinal tract, is to date the most successful treatment for obesity. Its use has dramatically increased in number as it enables both weight reduction and metabolic improvements, with 60% of patients even achieving diabetes remission. Several mechanisms are actually demonstrated to be involved in those clinical improvements. Importantly, both obesity and T2D share many phenotypic characteristics, including increased systemic and adipose tissue inflammation, as well as gut microbiota dysbiosis. These characteristics are deeply modulated after bariatric surgery. This review will address the host metabolic changes observed after bariatric surgery, focusing on the induced gut architectural changes, as well as on the modifications of the inflammatory tone and the gut microbiota.","['Debedat, Jean', 'Amouyal, Chloe', 'Aron-Wisnewsky, Judith', 'Clement, Karine']","['Debedat J', 'Amouyal C', 'Aron-Wisnewsky J', 'Clement K']","[""Sorbonne Universite, INSERM UMRS, Nutrition and Obesities; Systemic Approaches (NutriOmics), 47-83 Bd de l'hopital, 75013, Paris, France."", ""Sorbonne Universite, INSERM UMRS, Nutrition and Obesities; Systemic Approaches (NutriOmics), 47-83 Bd de l'hopital, 75013, Paris, France."", ""Sorbonne Universite, INSERM UMRS, Nutrition and Obesities; Systemic Approaches (NutriOmics), 47-83 Bd de l'hopital, 75013, Paris, France. judith.aron-wisnewsky@psl.aphp.fr."", ""Assistance Publique Hopitaux de Paris, Nutrition Departement, CRNH Ile-de-France, Pitie-Salpetriere Hospital, Sorbonne Universite, Faculty of Medicine, 47-83 Bd de l'hopital, 75013, Paris, France. judith.aron-wisnewsky@psl.aphp.fr."", ""Sorbonne Universite, INSERM UMRS, Nutrition and Obesities; Systemic Approaches (NutriOmics), 47-83 Bd de l'hopital, 75013, Paris, France. karine.clement@inserm.fr."", ""Assistance Publique Hopitaux de Paris, Nutrition Departement, CRNH Ile-de-France, Pitie-Salpetriere Hospital, Sorbonne Universite, Faculty of Medicine, 47-83 Bd de l'hopital, 75013, Paris, France. karine.clement@inserm.fr.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Germany,Semin Immunopathol,Seminars in immunopathology,101308769,,IM,"['Adipose Tissue/metabolism/microbiology/pathology/surgery', 'Bariatric Surgery/*adverse effects', '*Diabetes Mellitus, Type 2/metabolism/microbiology/pathology/surgery', '*Dysbiosis/etiology/metabolism/microbiology/pathology', '*Gastrointestinal Microbiome', 'Humans', 'Inflammation/metabolism/microbiology/pathology/surgery', 'Obesity/metabolism/microbiology/pathology/surgery', '*Postoperative Complications/metabolism/microbiology/pathology']",,['NOTNLM'],"['Bariatric surgery', 'Gut microbiota', 'Inflammation', 'Microbiome', 'Obesity', 'Type 2 diabetes']",,2019/04/27 06:00,2020/04/10 06:00,['2019/04/27 06:00'],"['2019/03/05 00:00 [received]', '2019/03/15 00:00 [accepted]', '2019/04/27 06:00 [pubmed]', '2020/04/10 06:00 [medline]', '2019/04/27 06:00 [entrez]']","['10.1007/s00281-019-00738-3 [pii]', '10.1007/s00281-019-00738-3 [doi]']",ppublish,Semin Immunopathol. 2019 Jul;41(4):461-475. doi: 10.1007/s00281-019-00738-3. Epub 2019 Apr 25.,,20190425,,,,,,,,,,,,,,,,,,
14912740,NLM,MEDLINE,20040215,20181201,0035-3655 (Print) 0035-3655 (Linking),71,10,1951 Oct,[Overeating in obesity].,649-59,,,"['DEMOLE, M']",['DEMOLE M'],,['und'],['Journal Article'],Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,,OM,"['Humans', '*Hyperphagia', 'Obesity/*etiology']",,['NLM'],['*OBESITY/etiology and pathogenesis'],,1951/10/01 00:00,1951/10/01 00:01,['1951/10/01 00:00'],"['1951/10/01 00:00 [pubmed]', '1951/10/01 00:01 [medline]', '1951/10/01 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1951 Oct;71(10):649-59.,,,,,,,,,Les obeses mangent-ils vraiment trop?,,,,['CLML: 5221:43332:264'],,,,,,,
20674258,NLM,MEDLINE,20101029,20161209,2213-0276 (Electronic) 0755-4982 (Linking),39,9,2010 Sep,[Nonsurgical management of obesity in adults].,930-44,10.1016/j.lpm.2010.05.017 [doi],"General practitioners are placed in an ideal position to manage obesity. First, they have to consider the motivation of the obese patient to change his habits. When the patient is not motivated to loss weight, their role is to identify and treat co-morbidities, to evaluate the risk related to the obesity and to establish a therapeutic diagnosis to evaluate motivation and ability to change. If the patient is motivated, the therapeutic choices have to be adapted individually to each patient. An inadequate management may not only result in a failure but may increase obesity. The objectives in obesity treatment are to achieve weight loss in order to reduce health risk as far as possible, to maintain that weight loss, to restore quality of life. Goals and methods must be realistic. Even a modest weight loss (5-10 % of initial weight) will improve health indices in an obese patient. Dietary treatment and physical activity are fundamental to the management of obesity. Compliance with the diet is the major problem, especially during the phase of weight maintenance after the excess weight loss has been lost. Initial weight reduction depends on the level of energy deficit and weight maintenance on compliance to a low fat diet and a physical activity programme. Cognitive behavioural approaches should be an integral part of the management of a chronic disease. This treatment is very useful to improve body image, self-esteem, management of stress and control of disordered eating patterns. A psychotherapeutic approach is often necessary, especially when the obesity is psycho-determined. Obesity drugs should be used for carefully selected patients, as an adjunct to diet therapy and lifestyle modifications, under medical supervision.","['Quilliot, Didier', 'Roche, Gaelle', 'Mohebbi, Halle', 'Sirvaux, Marie-Aude', 'Bohme, Philip', 'Ziegler, Olivier']","['Quilliot D', 'Roche G', 'Mohebbi H', 'Sirvaux MA', 'Bohme P', 'Ziegler O']","['CHU de Nancy, service de diabetologie, maladies metaboliques et nutrition, BP 303, 54201 Toul cedex, France. d.quilliot@chu-nancy.fr']",['fre'],"['English Abstract', 'Journal Article']",France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,,IM,"['Adult', 'Combined Modality Therapy', 'Humans', 'Motivation', 'Obesity/complications/diagnosis/psychology/*therapy']",,,,,2010/08/03 06:00,2010/10/30 06:00,['2010/08/03 06:00'],"['2010/02/09 00:00 [received]', '2010/04/26 00:00 [revised]', '2010/05/10 00:00 [accepted]', '2010/08/03 06:00 [entrez]', '2010/08/03 06:00 [pubmed]', '2010/10/30 06:00 [medline]']","['S0755-4982(10)00413-6 [pii]', '10.1016/j.lpm.2010.05.017 [doi]']",ppublish,Presse Med. 2010 Sep;39(9):930-44. doi: 10.1016/j.lpm.2010.05.017. Epub 2010 Jul 31.,,20100731,,['Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.'],,,,,Prise en charge de l'obesite de l'adulte.,,,,,,,,,,,
26227516,NLM,MEDLINE,20160502,20150803,1878-0369 (Electronic) 0001-2092 (Linking),102,2,2015 Aug,The bariatric patient: an overview of perioperative care.,116-31,S0001-2092(15)00441-X [pii] 10.1016/j.aorn.2015.05.007 [doi],"Obesity (ie, a body mass index of >/=30 kg/m(2)) is increasing in the United States. As a result, more overweight individuals are being surgically treated for weight loss, thus making it imperative for perioperative RNs to understand obesity's effects on patients' health, its contribution to significant comorbidities (eg, diabetes, cardiovascular disease, hypertension, sleep apnea, musculoskeletal issues, stroke), the perioperative care requirements (eg, specialized instruments and equipment, positioning and lifting aids), and unique needs of these patients (eg, diet, counseling). It is vital that the perioperative nurse accurately assesses the patient undergoing bariatric surgery to provide safe and appropriate nursing interventions during the perioperative continuum of care.","['Fencl, Jennifer L', 'Walsh, Angela', 'Vocke, Dawn']","['Fencl JL', 'Walsh A', 'Vocke D']",,['eng'],"['Journal Article', 'Review']",United States,AORN J,AORN journal,0372403,,IM,"['Adult', '*Bariatric Surgery', 'Child', 'Education, Nursing, Continuing', 'Humans', 'Obesity/*surgery', '*Perioperative Care']",,['NOTNLM'],"['bariatric surgery', 'bariatric surgical patient', 'obesity', 'perioperative care']",,2015/08/01 06:00,2016/05/03 06:00,['2015/08/01 06:00'],"['2014/11/26 00:00 [received]', '2015/02/04 00:00 [revised]', '2015/05/13 00:00 [accepted]', '2015/08/01 06:00 [entrez]', '2015/08/01 06:00 [pubmed]', '2016/05/03 06:00 [medline]']","['S0001-2092(15)00441-X [pii]', '10.1016/j.aorn.2015.05.007 [doi]']",ppublish,AORN J. 2015 Aug;102(2):116-31. doi: 10.1016/j.aorn.2015.05.007.,,,,"['Copyright (c) 2015 AORN, Inc. Published by Elsevier Inc. All rights reserved.']",,,,,,,,,,,,,,,,
23596737,NLM,MEDLINE,20130617,20130419,1660-9379 (Print) 1660-9379 (Linking),9,379,2013 Mar 27,[Obese patients malnourished].,651,,,"['Golay, Alain', 'Giusti, Vittorio']","['Golay A', 'Giusti V']",,['fre'],['Editorial'],Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['*Energy Intake', 'Humans', 'Malnutrition/*epidemiology', 'Nutritional Requirements', 'Obesity/*physiopathology/therapy']",,,,,2013/04/20 06:00,2013/06/19 06:00,['2013/04/20 06:00'],"['2013/04/20 06:00 [entrez]', '2013/04/20 06:00 [pubmed]', '2013/06/19 06:00 [medline]']",,ppublish,Rev Med Suisse. 2013 Mar 27;9(379):651.,,,,,,,,,Patients obeses mal nourris!,,,,,,,,,,,
2643002,NLM,MEDLINE,19890215,20220409,0025-7125 (Print) 0025-7125 (Linking),73,1,1989 Jan,Classification and evaluation of the obesities.,161-84,,Obesity is a condition of multifactorial etiology that can be associated with important health and functional consequences. Suggestions for the proper evaluation of obese patients have been presented along with brief descriptions of the rationales for their use. The evaluation protocol has been summarized in two algorithms to aid in the performance of a complete and organized work-up.,"['Bray, G A']",['Bray GA'],"['Section of Diabetes and Clinical Nutrition, University of Southern California, USC/LAC School of Medicine.']",['eng'],"['Journal Article', 'Review']",United States,Med Clin North Am,The Medical clinics of North America,2985236R,,IM,"['Adipose Tissue/pathology', 'Animals', 'Body Weight', 'Humans', 'Obesity/*classification/diagnosis/etiology/pathology']",,,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']","['S0025-7125(16)30697-6 [pii]', '10.1016/s0025-7125(16)30697-6 [doi]']",ppublish,Med Clin North Am. 1989 Jan;73(1):161-84. doi: 10.1016/s0025-7125(16)30697-6.,,,,,,,97,,,,,,,,,,,,,
12953016,NLM,MEDLINE,20031110,20220317,1524-4563 (Electronic) 0194-911X (Linking),42,4,2003 Oct,Measures of obesity are associated with vascular stiffness in young and older adults.,468-73,,"Obesity has reached epidemic levels and carries a risk for cardiovascular disease. Obesity's effects on the vascular systems of young adults and African Americans have not been well characterized. The aim of this study was to assess the association between measures of obesity and aortic stiffness in 186 young adults (20 to 40 years, 50% African American) and 177 older adults (41 to 70 years, 33% African American). Aortic stiffness was measured by aortic pulse-wave velocity. The median pulse-wave velocity value was 468 cm/s for young adults and 627 cm/s for older adults (P<0.001). Higher body weight, body mass index, waist and hip circumferences, and waist-hip ratio were strongly correlated with higher pulse-wave velocity, independent of age, systolic blood pressure, race, and sex overall and among both age groups (P<0.01 for all). Even among the 20- to 30-year-olds, obese individuals (body mass index>30) had a mean pulse-wave velocity value 47 cm/s higher than did nonobese individuals (P<0.001). Obesity measures were among the strongest independent predictors of pulse-wave velocity overall and for both age groups. Results were consistent by race. In conclusion, excess body weight is associated with higher aortic stiffness in whites and African Americans as young as 20 to 30 years. The strength of the association, the early age at which it appears, and the prevalence of obesity among the young warn of substantially increased cardiovascular disease incidence as this cohort ages.","['Wildman, Rachel P', 'Mackey, Rachel H', 'Bostom, Andrew', 'Thompson, Trina', 'Sutton-Tyrrell, Kim']","['Wildman RP', 'Mackey RH', 'Bostom A', 'Thompson T', 'Sutton-Tyrrell K']","['Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA 15261, USA.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Hypertension,"Hypertension (Dallas, Tex. : 1979)",7906255,,IM,"['Adult', 'Age Factors', 'Aged', 'Aorta/*physiopathology', 'Compliance', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/diagnosis/ethnology/*physiopathology', 'Pulsatile Flow']",,,,,2003/09/04 05:00,2003/11/11 05:00,['2003/09/04 05:00'],"['2003/09/04 05:00 [pubmed]', '2003/11/11 05:00 [medline]', '2003/09/04 05:00 [entrez]']","['01.HYP.0000090360.78539.CD [pii]', '10.1161/01.HYP.0000090360.78539.CD [doi]']",ppublish,Hypertension. 2003 Oct;42(4):468-73. doi: 10.1161/01.HYP.0000090360.78539.CD. Epub 2003 Sep 2.,['AG14108/AG/NIA NIH HHS/United States'],20030902,,,,,,,,,,,,,,,,,,
21343171,NLM,MEDLINE,20111121,20211020,1553-3514 (Electronic) 1553-3506 (Print) 1553-3506 (Linking),18,2,2011 Jun,Teaching medical students about obesity: a pilot program to address an unmet need through longitudinal relationships with bariatric surgery patients.,176-83,10.1177/1553350611399298 [doi],"BACKGROUND: Despite obesity's relevance and impact, curricula addressing obesity are underrepresented in clinical medical education. A novel pilot program to begin teaching medical students about care of the obese patient was developed and student attitudes toward obesity and bariatric surgery were assessed. METHODS: The authors paired third-year students with obese patients undergoing bariatric surgery. Students established a longitudinal patient relationship, received faculty mentorship, and kept a reflections journal. An attitude assessment survey was administered before and after third year. Reflections were analyzed for common themes. RESULTS: Baseline student responses differed from those previously reported for practicing physicians on many survey statements, including more strongly agreeing with the relationship between obesity and serious medical conditions (P < .001), the need to educate patients about obesity risks (P < .001), and willingness to recommend bariatric surgery evaluation (P = .004). These differences were maintained after clinical clerkships. Reflection themes included recognition of obesity stereotypes, improved estimation of body mass index, and awareness of physicians' attitudes about obesity. CONCLUSION: Development and assessment of a novel pilot program to teach third-year medical students about obesity and bariatric surgery suggests a potential impact on student attitudes and understanding of obesity and obesity surgery. Students today may have different attitudes toward obesity than those reflected in prior data for physicians in practice, and programs such as this may help maintain positive attitudes.","['Roberts, David H', 'Kane, Erin M', 'Jones, Daniel B', 'Almeida, Jacqueline M', 'Bell, Sigall K', 'Weinstein, Amy R', 'Schwartzstein, Richard M']","['Roberts DH', 'Kane EM', 'Jones DB', 'Almeida JM', 'Bell SK', 'Weinstein AR', 'Schwartzstein RM']","['Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dhrobert@bidmc.harvard.edu']",['eng'],['Journal Article'],United States,Surg Innov,Surgical innovation,101233809,,IM,"['Academic Medical Centers', '*Attitude of Health Personnel', 'Bariatric Surgery/*education', 'Boston', '*Curriculum', '*Education, Medical, Undergraduate/methods', 'Female', 'Humans', 'Longitudinal Studies', 'Male', 'Obesity/diagnosis/prevention & control/*surgery', 'Pilot Projects', 'Students, Medical']",PMC3372903,,,,2011/02/24 06:00,2011/12/13 00:00,['2011/02/24 06:00'],"['2011/02/24 06:00 [entrez]', '2011/02/24 06:00 [pubmed]', '2011/12/13 00:00 [medline]']","['1553350611399298 [pii]', '10.1177/1553350611399298 [doi]']",ppublish,Surg Innov. 2011 Jun;18(2):176-83. doi: 10.1177/1553350611399298. Epub 2011 Feb 22.,['R01 EB010037/EB/NIBIB NIH HHS/United States'],20110222,,,,['NIHMS379898'],,,,,,,,,,,,,,
20339364,NLM,MEDLINE,20110607,20220409,1930-739X (Electronic) 1930-7381 (Linking),18,12,2010 Dec,"Association between obesity, flow rate of whole saliva, and dental caries in adolescents.",2367-73,10.1038/oby.2010.63 [doi],"In a cross-sectional study design, we test the hypothesis whether childhood obesity is associated with reduced flow rate of stimulated whole saliva and dental caries. Obese adolescents (n = 65) with a mean age of 14.5 years and normal weight subjects (n = 65) with a mean age of 14.2 years were clinically examined with respect to dental caries, visible plaque accumulation (visible plaque index (VPI%)), gingival inflammation in terms of bleeding on probing (BOP%) as well as answered a questionnaire concerning medical history, medication, oral hygiene habits, smoking habits, and sociodemographic background. The flow rate of stimulated whole saliva (ml/min) was determined. BMI was calculated and adjusted for age and gender (BMI-sds). The obese subjects exhibited higher number of decayed surfaces (DS), 0.7 vs. 0.1 (P = 0.008) and lower flow rate of stimulated whole saliva 1.2 vs. 2.0 ml/min (P < 0.001). Of obese patients, 17 subjects had VPI% >25 and 21 had BOP% >25, both compared to only 5 subjects of the normal weight with P values of 0.005 and <0.001, respectively. In a multivariate logistic regression model BMI-sds was significantly associated with the flow rate of stimulated whole saliva less than the median value 1.5 ml/min (P < 0.001; odds ratio (OR) 1.36) as well as with DS (DS >0) (P = 0.002; OR 1.31) and the associations were not found to be confounded by any of the studied variables. The results indicate that childhood obesity is associated with reduced flow rate of stimulated whole saliva and dental caries and further strengthens obesity's negative effect on children's oral health.","['Modeer, Thomas', 'Blomberg, Cecilia C', 'Wondimu, Biniyam', 'Julihn, Annika', 'Marcus, Claude']","['Modeer T', 'Blomberg CC', 'Wondimu B', 'Julihn A', 'Marcus C']","['Division of Pediatric Dentistry, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden. thomas.modeer@ki.se']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Obesity (Silver Spring),"Obesity (Silver Spring, Md.)",101264860,,IM,"['Adolescent', 'Body Mass Index', 'Case-Control Studies', 'Child', 'Cross-Sectional Studies', 'DMF Index', 'Dental Caries/epidemiology/*etiology', 'Dental Plaque Index', 'Gingivitis/*etiology', 'Humans', 'Logistic Models', 'Obesity/complications/*physiopathology', 'Periodontal Index', 'Prevalence', 'Reference Values', 'Saliva/*metabolism', '*Salivation']",,,,,2010/03/27 06:00,2011/06/08 06:00,['2010/03/27 06:00'],"['2010/03/27 06:00 [entrez]', '2010/03/27 06:00 [pubmed]', '2011/06/08 06:00 [medline]']","['oby201063 [pii]', '10.1038/oby.2010.63 [doi]']",ppublish,Obesity (Silver Spring). 2010 Dec;18(12):2367-73. doi: 10.1038/oby.2010.63. Epub 2010 Mar 25.,,20100325,,,,,,,,,,,,,,,,,,
27067614,NLM,MEDLINE,20170623,20220408,1879-0828 (Electronic) 0953-6205 (Linking),32,,2016 Jul,Obese and diabetic patients with end-stage renal disease: Peritoneal dialysis or hemodialysis?,1-6,S0953-6205(16)30036-X [pii] 10.1016/j.ejim.2016.03.016 [doi],"Obesity is a chronic disease that is increasingly prevalent around the world and is a well-recognized risk factor for type 2 diabetes and hypertension, leading causes of end-stage renal disease (ESRD). The obese diabetic patient with ESRD is a challenge for the nephrologist with regard to the type of renal replacement therapy that should be suggested and offered to the patient. There is no evidence that either peritoneal dialysis or hemodialysis is contraindicated in obese ESRD patients. In the literature, we can find a discrepancy in the impact of obesity on mortality among hemodialysis vs. peritoneal dialysis patients. Several studies in hemodialysis patients suggest that a higher BMI confers a survival advantage - the so-called ""reverse epidemiology"". In contrast, the literature among obese peritoneal dialysis patients is inconsistent, with various studies reporting an increased risk of death, no difference, or a decreased risk of death. Many of these studies only spanned across a few years, and this is probably too short of a time frame for a realistic assessment of obesity's impact on mortality in ESRD patients. The decision for dialysis modality in an obese diabetic patient with ESRD should be individualized. According to the results of published studies, we cannot suggest PD or HD as a better solution for all obese diabetic patients. The obese patient should be educated about all their dialysis options, including home dialysis therapies. In this review, the available literature related to the dialysis modality in obese patients with diabetes and ESRD was reviewed.","['Ekart, Robert', 'Hojs, Radovan']","['Ekart R', 'Hojs R']","['University Medical Centre Maribor, Clinic for Internal Medicine, Department of Dialysis, Maribor, Slovenia; University of Maribor, Faculty of Medicine, Maribor, Slovenia. Electronic address: robert.ekart2@guest.arnes.si.', 'University of Maribor, Faculty of Medicine, Maribor, Slovenia; University Medical Centre Maribor, Clinic for Internal Medicine, Department of Nephrology, Maribor, Slovenia.']",['eng'],"['Journal Article', 'Review']",Netherlands,Eur J Intern Med,European journal of internal medicine,9003220,,IM,"['Body Mass Index', 'Diabetes Mellitus, Type 2/*complications', 'Humans', 'Kidney Failure, Chronic/complications/*therapy', 'Obesity/*complications', 'Peritoneal Dialysis/*methods', 'Renal Dialysis/methods', 'Survival Rate', 'Treatment Outcome']",,['NOTNLM'],"['End-stage renal disease', 'Hemodialysis', 'Obesity', 'Peritoneal dialysis']",,2016/04/14 06:00,2017/06/24 06:00,['2016/04/13 06:00'],"['2015/12/20 00:00 [received]', '2016/02/20 00:00 [revised]', '2016/03/18 00:00 [accepted]', '2016/04/13 06:00 [entrez]', '2016/04/14 06:00 [pubmed]', '2017/06/24 06:00 [medline]']","['S0953-6205(16)30036-X [pii]', '10.1016/j.ejim.2016.03.016 [doi]']",ppublish,Eur J Intern Med. 2016 Jul;32:1-6. doi: 10.1016/j.ejim.2016.03.016. Epub 2016 Apr 7.,,20160407,,"['Copyright (c) 2016 European Federation of Internal Medicine. Published by Elsevier', 'B.V. All rights reserved.']",,,,,,,,,,,,,,,,
22449273,NLM,MEDLINE,20120821,20120420,1466-187X (Electronic) 0142-159X (Linking),34,5,2012,Medical student-developed obesity education program uses modified team-based learning to motivate adolescents.,414-6,10.3109/0142159X.2012.668238 [doi],"BACKGROUND: Childhood obesity is reaching epidemic proportions and requires intervention. AIMS: To educate high school (HS) students on the effects of obesity and implement small healthy changes. Train medical students to educate and motivate adolescents and utilize a modified team-based learning format. METHODS: A medical student-created HS-based module was developed to educate adolescents on obesity's effects on health. Over 2 years, 25 medical students from each semester were trained and presented to 1590 freshmen and sophomores at suburban HSs in Milwaukee, Wisconsin. The program included an interactive power point and a 30-day challenge to make small measurable changes in their current health behaviors. A modified team-based learning format was included to engage students and increase classroom interaction. RESULTS: Medical students reported the program improved their ability to communicate with adolescents and enhanced their training as future physicians. Teachers felt students had sustained retention of knowledge at the end of 30 days and the majority of students fulfilled their self-imposed challenge. CONCLUSION: A student-run HS obesity education module using a portion of team-based learning was successfully implemented into HS health science curriculums, exposed medical students to community advocacy while educating and motivating adolescents to improve health behaviors.","['McAndrew, Sarah', 'Jackman, Carina', 'Sisto, Paola Palma']","['McAndrew S', 'Jackman C', 'Sisto PP']","['Medical College of Wisconsin, Chicago, IL 60614, USA. sarahmcandrew3@gmail.com']",['eng'],['Journal Article'],England,Med Teach,Medical teacher,7909593,,IM,"['Adolescent', 'Adolescent Behavior/*psychology', 'Curriculum', 'Education, Medical, Undergraduate', 'Female', '*Group Processes', 'Health Behavior', 'Health Education/*methods/*organization & administration', 'Humans', 'Male', 'Motivation', 'Obesity/*prevention & control/psychology', ""*Physician's Role"", 'Program Development', '*Students, Medical', 'Teaching/methods', 'Wisconsin']",,,,,2012/03/28 06:00,2012/08/22 06:00,['2012/03/28 06:00'],"['2012/03/28 06:00 [entrez]', '2012/03/28 06:00 [pubmed]', '2012/08/22 06:00 [medline]']",['10.3109/0142159X.2012.668238 [doi]'],ppublish,Med Teach. 2012;34(5):414-6. doi: 10.3109/0142159X.2012.668238. Epub 2012 Mar 27.,,20120327,,,,,,,,,,,,,,,,,,
9278580,NLM,MEDLINE,19971022,20180330,0022-3166 (Print) 0022-3166 (Linking),127,9,1997 Sep,Single gene obesities in rodents: possible relevance to human obesity.,1908S,,"Obesity is a complex phenotype which ""resolves"" the influences of genes, development and environment. In any individual - and in the same individual at different times of life - the relative influence of these factors may vary. In this sense, obesity is a prototype of many of the diseases now confronting medical science. Among the most important concepts regarding such phenotypes is the idea that relevant genes mediate susceptibility to disease in a specific environmental context, not the inevitable occurrence of the phenotype regardless of the environment. Individuals with otherwise potent genetic predisposition to obesity will be lean in an environment of food deprivation/high demand for physical activity, and individuals not genetically predisposed to obesity may become so in an environment that includes tasty, calorically dense foods and/or few inducements to physical activity. Thus, in any effort to elucidate the genetic bases for susceptibility to obesity, the ""environment"" in which the obesity is occurring remains a critical factor regarding what sorts of genes will be identified. Because the genes that mediate susceptibility to obesity may affect energy intake, energy expenditure and/or the partitioning of calories between lean tissues and fat, the ability to define the gross metabolic basis for the obesity is very important in determining which genes are relevant to the phenotype. Because it is so difficult to experimentally define/control the environment of humans, and because the attainment of an obese state may actually rectify the metabolic differences predisposing to obesity, animal models of obesity have been looked at intensively for clues to the relevant genes in humans. Over the past 40 years, a series of autosomal dominant (Yellow) and recessive (obese, diabetes, tubby, fat, fatty) obesity mutations have been described in mice and rats. The molecular cloning of all of these genes has been accomplished within the past 4 years, providing an exciting array of new reagents for the molecular analysis of obesity. These genes encode molecules that appear to interact in physiologic systems that influence body fat stores. The genes and their apparent functions are summarized in the Table . The locations of these genes in the genomes of rodents and human are known, as are their genetic structure/sequence. Thus, their role(s) in human obesity can now be assessed directly.","['Leibel, R L']",['Leibel RL'],"['Laboratory of Human Behavior & Metabolism, The Rockefeller University, New York, NY 10021, USA.']",['eng'],"['Comparative Study', 'Journal Article']",United States,J Nutr,The Journal of nutrition,0404243,,IM,"['Animals', 'Humans', 'Mice', 'Mutation', 'Obesity/*genetics', 'Phenotype', 'Rats', 'Species Specificity']",,,,,1997/09/01 00:00,1997/09/01 00:01,['1997/09/01 00:00'],"['1997/09/01 00:00 [pubmed]', '1997/09/01 00:01 [medline]', '1997/09/01 00:00 [entrez]']",['10.1093/jn/127.9.1908S [doi]'],ppublish,J Nutr. 1997 Sep;127(9):1908S. doi: 10.1093/jn/127.9.1908S.,,,,,,,,,,,,,,,,,,,,
18600013,NLM,MEDLINE,20080915,20080707,1421-9875 (Electronic) 0257-2753 (Linking),26,1,2008,Psychological profile of obese patients.,36-9,10.1159/000109384 [doi],"Nowadays obesity is recognized to be one of the greatest public health problems worldwide. There is no indication that the huge increase in obesity seen the last decades is declining. The examination of psychological aspects of persons with morbid obesity is essential. Identification of the psychological factors associated with weight loss expands our knowledge about behaviors which are crucial in order to avoid failures in treatment. Most information on this is obtained preoperatively. Although there is no single personality type characteristic of the morbidly obese, they differ from the general population as their self-esteem and impulse control is lower. They have passive dependent and passive aggressive personality traits, as well as a trend for somatization and problem denial. Their thinking is usually dichotomous and catastrophic. Obese patients also show low cooperativeness and fail to see the self as autonomous and integrated. In the morbidly obese before undergoing surgical treatment, unusual prevalence of psychopathology, namely depression and anxiety disorders, is observed. They are subject to prejudice and discrimination and should be treated with concern to help alleviate their feelings of rejection and guilt. Information on the psychological profile of obese persons is limited. Future studies are warranted, since there is a pressured need for these people to built cognitive skills and control their body weight.","['Lykouras, Lefteris']",['Lykouras L'],"['Athens University Medical School, 2nd Department of Psychiatry, Attikon General Hospital, Athens, Greece. elykoura@med.uoa.gr']",['eng'],"['Journal Article', 'Review']",Switzerland,Dig Dis,"Digestive diseases (Basel, Switzerland)",8701186,,IM,"['Humans', 'Obesity/*psychology/surgery', 'Personality', 'Prejudice', 'Weight Loss']",,,,,2008/07/05 09:00,2008/09/16 09:00,['2008/07/05 09:00'],"['2008/07/05 09:00 [pubmed]', '2008/09/16 09:00 [medline]', '2008/07/05 09:00 [entrez]']","['000109384 [pii]', '10.1159/000109384 [doi]']",ppublish,Dig Dis. 2008;26(1):36-9. doi: 10.1159/000109384. Epub 2008 Feb 15.,,20080215,,"['Copyright 2008 S. Karger AG, Basel.']",,,24,,,,,,,,,,,,,
34091873,NLM,MEDLINE,20210805,20220218,1865-8652 (Electronic) 0741-238X (Print) 0741-238X (Linking),38,7,2021 Jul,Intraoperative Monitoring of the Obese Patient Undergoing Surgery: A Narrative Review.,3622-3651,10.1007/s12325-021-01774-y [doi],"With the increasing prevalence of obesity in the population, anaesthetists must confidently manage both the pathophysiological and technical challenges presented in bariatric and non-bariatric surgery. The intraoperative period represents an important opportunity to optimise and mitigate risk. However, there is little formal guidance on what intraoperative monitoring techniques should be used in this population. This narrative review collates the existing evidence for intraoperative monitoring devices in the obese patients. Although a number of non-invasive blood pressure monitors have been tested, an invasive arterial line remains the most reliable monitor if accurate, continuous monitoring is required. Goal-directed fluid therapy is recommended by clinical practice guidelines, but the methods tested to assess this had guarded applicability to the obese population. Transcutaneous carbon dioxide (CO(2)) monitoring may offer additional benefit to standard capnography in this population. Individually titrated positive end expiratory pressure (PEEP) and recruitment manoeuvres improved intraoperative mechanics but yielded no benefit in the immediate postoperative period. Depth of anaesthesia monitoring appears to be beneficial in the perioperative period regarding recovery times and complications. Objective confirmation of reversal of neuromuscular blockade continues to be a central tenet of anaesthesia practice, particularly relevant to this group who have been characterised as an ""at risk"" extubation group. Where deep neuromuscular blockade is used, continuous neuromuscular blockade is suggested. Both obesity and the intraoperative context represent somewhat unstable search terms, as the clinical implications of the obesity phenotype are not uniform, and the type and urgency of surgery have significant impact on the intraoperative setting. This renders the generation of summary conclusions around what intraoperative monitoring techniques are suitable in this population highly challenging.","['Haren, Andrea P', 'Nair, Shrijit', 'Pace, Maria C', 'Sansone, Pasquale']","['Haren AP', 'Nair S', 'Pace MC', 'Sansone P']","[""Department of Anaesthesia, St Vincent's University Hospital, Dublin 4, Dublin, Ireland."", ""Department of Anaesthesia, St Vincent's University Hospital, Dublin 4, Dublin, Ireland."", 'University of Campania ""Luigi Vanvitelli"", Naples, Italy.', 'University of Campania ""Luigi Vanvitelli"", Naples, Italy. pasquale.sansone@unicampania.it.']",['eng'],"['Journal Article', 'Review']",United States,Adv Ther,Advances in therapy,8611864,,,"['*Anesthesia', 'Humans', 'Monitoring, Intraoperative', '*Neuromuscular Blockade', 'Obesity/complications/epidemiology/surgery', 'Positive-Pressure Respiration']",PMC8179704,['NOTNLM'],"['Intraoperative', 'Monitoring', 'Obese', 'Obesity', 'Perioperative']",,2021/06/07 06:00,2021/08/06 06:00,['2021/06/06 21:19'],"['2021/02/17 00:00 [received]', '2021/05/05 00:00 [accepted]', '2021/06/07 06:00 [pubmed]', '2021/08/06 06:00 [medline]', '2021/06/06 21:19 [entrez]']","['10.1007/s12325-021-01774-y [pii]', '1774 [pii]', '10.1007/s12325-021-01774-y [doi]']",ppublish,Adv Ther. 2021 Jul;38(7):3622-3651. doi: 10.1007/s12325-021-01774-y. Epub 2021 Jun 5.,,20210605,,['(c) 2021. The Author(s).'],,,,,,,,,,,,,,,,
12951183,NLM,MEDLINE,20031118,20190827,0248-8663 (Print) 0248-8663 (Linking),24,9,2003 Sep,[Extreme obesity in Prader-Willi Syndrome (PWS)].,617-20,,"INTRODUCTION: Prader-Willi Syndrome (PWS) belong to genetic obesities and we report a caricatural observation. DEVELOPMENT: The early onset of (PWS) is characterised by a severe neonatal hypotonia with poor suck reflex--which may lead to tube feeding--and poor weight gain. Later appears insatiable appetite, morbid obesity associated with short stature, dysmorphic syndrome with small hands and behavioural disorders. Although diagnosis is based on clinical features, it must be confirmed by genetic test looking for the characteristic deletion of the chromosome 15q11-q13 region. PWS is the first example in humans of genetic imprinting. CONCLUSION: Today, the challenge in PWS is it early management which may authorise Growth Hormone administration.","['Damiano, J', 'Ficko, C', 'Garrabe, E', 'Mayaudon, H', 'Dupuy, O', 'Carmoi, T', 'Bordier, L', 'Bauduceau, B']","['Damiano J', 'Ficko C', 'Garrabe E', 'Mayaudon H', 'Dupuy O', 'Carmoi T', 'Bordier L', 'Bauduceau B']","[""Service d'endocrinologie, hopital Begin, 69, avenue de Paris, 94160 Saint-Mande, France.""]",['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",France,Rev Med Interne,La Revue de medecine interne,8101383,['12629-01-5 (Human Growth Hormone)'],IM,"['Adult', 'Body Height', '*Chromosomes, Human, Pair 15', 'Female', 'Genetic Testing', 'Human Growth Hormone/therapeutic use', 'Humans', 'Obesity, Morbid/*etiology/pathology', 'Prader-Willi Syndrome/*complications/diagnosis/genetics']",,,,,2003/09/03 05:00,2003/12/03 05:00,['2003/09/03 05:00'],"['2003/09/03 05:00 [pubmed]', '2003/12/03 05:00 [medline]', '2003/09/03 05:00 [entrez]']","['S024886630300225X [pii]', '10.1016/s0248-8663(03)00225-x [doi]']",ppublish,Rev Med Interne. 2003 Sep;24(9):617-20. doi: 10.1016/s0248-8663(03)00225-x.,,,,,,,,,Obesite extreme au cours d'un syndrome de Willi-Prader.,,,,,,,,,,,
20183544,NLM,MEDLINE,20100608,20151119,1465-3966 (Electronic) 1354-8506 (Linking),14,6,2009 Dec,Comprehensive review of obesity and psychological considerations for treatment.,716-25,10.1080/13548500903431501 [doi],"Although obesity is considered to be a medical condition, psychosocial variables influence its development, course, and treatment. To date, obesity research focuses heavily on the associated physical problems and the identification of effective treatments. While an array of behavioral, pharmacological and surgical treatments has been developed, their ability to demonstrate long-term weight losses is not convincing. Thus, there has been a shift towards the identification of psychological and social factors that may assist in the prediction of successful treatments, most notably in the surgical treatment of obesity. As a result, less emphasis has been placed on post-treatment psychosocial influences. As the treatment of obesity becomes increasing multidimensional, the need for attention to psychosocial factors and the involvement of mental health providers increases. For the allied or mental health provider, a comprehensive understanding of obesity's physical, psychological and social basis is vital to ensure proper assessment or treatment, as it is warranted.","['Davin, Sara A', 'Taylor, Nicole M']","['Davin SA', 'Taylor NM']","['Department of Psychology, University of Indianapolis, Indianapolis, IN 46227, USA.']",['eng'],['Journal Article'],England,Psychol Health Med,"Psychology, health & medicine",9604099,['0 (Psychotropic Drugs)'],IM,"['Adolescent', 'Adult', 'Bariatric Surgery/statistics & numerical data', 'Body Mass Index', 'Female', 'Health Status', 'Humans', 'Male', 'Mental Disorders/*drug therapy/*etiology', 'Obesity/*psychology/*surgery', 'Patient Acceptance of Health Care/statistics & numerical data', 'Psychotropic Drugs/*therapeutic use', 'Quality of Life/psychology', 'Social Alienation', 'Surveys and Questionnaires', 'Young Adult']",,,,,2010/02/26 06:00,2010/06/09 06:00,['2010/02/26 06:00'],"['2010/02/26 06:00 [entrez]', '2010/02/26 06:00 [pubmed]', '2010/06/09 06:00 [medline]']","['919141492 [pii]', '10.1080/13548500903431501 [doi]']",ppublish,Psychol Health Med. 2009 Dec;14(6):716-25. doi: 10.1080/13548500903431501.,,,,,,,,,,,,,,,,,,,,
26106614,NLM,MEDLINE,20160318,20181113,2314-6141 (Electronic) 2314-6133 (Print),2015,,2015,The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders.,781543,10.1155/2015/781543 [doi] 781543,"OBJECTIVE: Obesity is a worldwide concern with detrimental health effects including decreased fecundity. However, obesity's impact on in vitro fertilization (IVF) is inconclusive and there is little data concerning poor ovarian responders (POR). This study explored the effects of overweight and obesity on IVF outcomes of POR. Design. We retrospectively evaluated 188 POR undergoing IVF cycles. METHODS: Patients were categorized into three groups. Group 1 was normal weight POR (18.5-24.9 kg/m(2), n = 96); Group 2 was overweight POR (25.0-29.9 kg/m(2), n = 52); and Group 3 was obese POR (>/=30.0 kg/m(2), n = 40). Main measured outcomes included IVF outcomes. RESULTS: The oocyte maturity, total gonadotropin dose-duration, and cycle cancellation rates were similar. Obese women had significantly decreased LH levels. LH < 4 mIU/mL had a sensitivity (62%) and a specificity (86%) for IVF failure (AUC: 0.71). Fertilization rates of obese subjects were significantly lower than normal and overweight subjects (p = 0.04). Obese women's clinical pregnancy rates were significantly lower (15%) than normal weight women (33.3%, p = 0.01). CONCLUSIONS: Despite similar counts of recruited mature oocytes, obese POR women had decreased fertilization and clinical pregnancy rates. Obesity rather than overweight significantly decreased IVF outcomes in POR.","['Vural, Fisun', 'Vural, Birol', 'Cakiroglu, Yigit']","['Vural F', 'Vural B', 'Cakiroglu Y']","['Department of Obstetrics and Gynecology, Haydarpasa Numune Teaching Hospital, Istanbul, Turkey.', 'Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Kocaeli University School of Medicine, Kocaeli, Turkey.', 'Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Kocaeli University School of Medicine, Kocaeli, Turkey.']",['eng'],['Journal Article'],United States,Biomed Res Int,BioMed research international,101600173,['0 (Gonadotropins)'],IM,"['Adult', 'Female', '*Fertilization in Vitro', 'Gonadotropins/metabolism', 'Humans', 'Obesity/*physiopathology', 'Overweight/*physiopathology', '*Ovulation Induction', 'Pregnancy', 'Pregnancy Rate']",PMC4461701,,,,2015/06/25 06:00,2016/03/19 06:00,['2015/06/25 06:00'],"['2015/02/01 00:00 [received]', '2015/04/23 00:00 [revised]', '2015/05/11 00:00 [accepted]', '2015/06/25 06:00 [entrez]', '2015/06/25 06:00 [pubmed]', '2016/03/19 06:00 [medline]']",['10.1155/2015/781543 [doi]'],ppublish,Biomed Res Int. 2015;2015:781543. doi: 10.1155/2015/781543. Epub 2015 May 27.,,20150527,,,,,,['Biomed Res Int. 2015;2015:318902. PMID: 26509148'],,,,,,,,,,,,
15384322,NLM,MEDLINE,20040930,20220408,0007-1145 (Print) 0007-1145 (Linking),92 Suppl 1,,2004 Aug,The utility of animal models of human energy homeostasis.,S41-5,,"The prevalence of obesity among adults and children has increased steadily over the last few years worldwide, reaching epidemic proportions. Particularly alarming is the link between obesity and the development of chronic disorders such as heart disease, type 2 diabetes, hypertension and some cancers (Bjorntorp, 1997). Environmental causes of obesity are thought to include a sedentary lifestyle and an abundance of highly palatable energy-dense foods (Hill et al. 2003). Genetic factors also contribute to susceptibility to obesity, although the genetic basis of most human obesities is thought to be polygenic (Comuzzie & Allison, 1998; Barsh et al. 2000). The present paper considers some of the animal models used to infer aspects of human obesity, with an emphasis upon their usefulness.","['Thibault, Louise', 'Woods, Stephen C', 'Westerterp-Plantenga, Margriet S']","['Thibault L', 'Woods SC', 'Westerterp-Plantenga MS']","['School of Dietetics and Human Nutrition, Macdonald Campus of McGill University, 21 111 Lakeshore Road, Ste-Anne de Bellevue, H9X 3V9 Quebec, Canada. louise.thibault@mcgill.ea']",['eng'],"['Journal Article', 'Review']",England,Br J Nutr,The British journal of nutrition,0372547,,IM,"['Animals', 'Eating/physiology', 'Energy Metabolism/physiology', 'Ethics, Medical', 'Food Preferences/physiology', 'Homeostasis/*physiology', 'Humans', '*Models, Animal', 'Obesity/genetics/*physiopathology']",,,,,2004/09/24 05:00,2004/10/01 05:00,['2004/09/24 05:00'],"['2004/09/24 05:00 [pubmed]', '2004/10/01 05:00 [medline]', '2004/09/24 05:00 [entrez]']","['S0007114504001746 [pii]', '10.1079/bjn20041141 [doi]']",ppublish,Br J Nutr. 2004 Aug;92 Suppl 1:S41-5. doi: 10.1079/bjn20041141.,,,,,,,61,,,,,,,,,,,,,
18307702,NLM,MEDLINE,20080425,20171116,1467-789X (Electronic) 1467-7881 (Linking),9 Suppl 1,,2008 Mar,Costs of metabolic syndrome-related diseases induced by obesity in Taiwan.,68-73,10.1111/j.1467-789X.2007.00441.x [doi],"The objective of this paper is to estimate the cost of obesity's contribution to the metabolic syndrome diseases in Taiwan. We used individual data from the Cardiovascular Disease Risk Factors Two-Township Study survey and medical use and expenditures data from the Bureau of National Health Insurance (NHI) of Taiwan. By adopting the prevalence-based and population attributable risk (PAR) approaches, direct costs of obesity for six kinds of obesity related metabolic syndrome diseases have been estimated. Comorbidities used in our analysis included ischemic heart diseases, congestive heart failure, cerebrovascular disease accident, diabetes, hyper-cholesterolaemia and hypertension. The results indicate that overweight and obesity are associated with a higher prevalence and costs of the metabolic syndrome related diseases. PAR increases as the obese [body mass index (BMI)] prevalence increases. About 4-9% of the costs of those diseases can be attributed to overweight (24 < or = BMI < 27) and about 7-13% and 8-19% of such costs are attributable to the first and second degree obesity (27 < or = BMI < 30 and BMI > or = 30). The cost of obesity derived from the PAR and medical costs of metabolic syndrome diseases accounts for 2.9% of the national total healthcare expenditure. We therefore conclude that overweight and obesity have increased health costs and resulted in higher prevalence of and greater costs from metabolic syndrome related diseases in Taiwan. These findings provide important support for implementing obesity prevention programs in Taiwan.","['Fu, T', 'Wen, T', 'Yeh, P', 'Chang, H']","['Fu T', 'Wen T', 'Yeh P', 'Chang H']","['Institute of Economics, Academia Sinica, Taipei, Taiwan. tfu@econ.sinica.edu.tw']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['Adult', '*Cost of Illness', 'Female', 'Health Surveys', 'Humans', 'Male', 'Metabolic Syndrome/*economics/etiology', 'Middle Aged', 'Obesity/complications/*economics', 'Risk', 'Taiwan']",,,,,2008/03/01 09:00,2008/04/26 09:00,['2008/03/01 09:00'],"['2008/03/01 09:00 [pubmed]', '2008/04/26 09:00 [medline]', '2008/03/01 09:00 [entrez]']","['OBR441 [pii]', '10.1111/j.1467-789X.2007.00441.x [doi]']",ppublish,Obes Rev. 2008 Mar;9 Suppl 1:68-73. doi: 10.1111/j.1467-789X.2007.00441.x.,,,,,,,,,,,,,,,,,,,,
31870836,NLM,MEDLINE,20210618,20210618,2468-7189 (Electronic) 2468-7189 (Linking),48,6,2020 Jun,[Can robotic surgery help reduce medical discrimination for obese patients?].,475-476,S2468-7189(19)30401-5 [pii] 10.1016/j.gofs.2019.12.002 [doi],,"['Azais, H', 'Belghiti, J', 'Nikpayam, M', 'Gonthier, C', 'Canlorbe, G', 'Uzan, C']","['Azais H', 'Belghiti J', 'Nikpayam M', 'Gonthier C', 'Canlorbe G', 'Uzan C']","[""Service de chirurgie et oncologie gynecologique et mammaire, hopital universitaire Pitie-Salpetriere, AP-HP, 45-83, boulevard de l'Hopital, 75013 Paris, France. Electronic address: henriazais@gmail.com."", ""Service de chirurgie et oncologie gynecologique et mammaire, hopital universitaire Pitie-Salpetriere, AP-HP, 45-83, boulevard de l'Hopital, 75013 Paris, France."", ""Service de chirurgie et oncologie gynecologique et mammaire, hopital universitaire Pitie-Salpetriere, AP-HP, 45-83, boulevard de l'Hopital, 75013 Paris, France."", ""Service de chirurgie et oncologie gynecologique et mammaire, hopital universitaire Pitie-Salpetriere, AP-HP, 45-83, boulevard de l'Hopital, 75013 Paris, France."", ""Service de chirurgie et oncologie gynecologique et mammaire, hopital universitaire Pitie-Salpetriere, AP-HP, 45-83, boulevard de l'Hopital, 75013 Paris, France; Inserm UMR S 938 << Biologie et Therapeutiques du Cancer >>, Hopital Saint-Antoine, Paris, France; Institut universitaire de cancerologie, Sorbonne Universite, Paris, France."", ""Service de chirurgie et oncologie gynecologique et mammaire, hopital universitaire Pitie-Salpetriere, AP-HP, 45-83, boulevard de l'Hopital, 75013 Paris, France; Inserm UMR S 938 << Biologie et Therapeutiques du Cancer >>, Hopital Saint-Antoine, Paris, France; Institut universitaire de cancerologie, Sorbonne Universite, Paris, France.""]",['fre'],['Editorial'],France,Gynecol Obstet Fertil Senol,"Gynecologie, obstetrique, fertilite & senologie",101693805,,IM,"['Female', 'Gynecologic Surgical Procedures/*methods', 'Humans', 'Laparoscopy/*methods', 'Obesity/*complications', '*Robotic Surgical Procedures', 'Social Discrimination/*prevention & control']",,['NOTNLM'],"['Chirurgie robotique', 'Coelioscopie', 'Gynecology', 'Gynecologie', 'Laparoscopy', 'Obesity', 'Obesite', 'Robotic surgery']",,2019/12/25 06:00,2021/06/22 06:00,['2019/12/25 06:00'],"['2019/12/16 00:00 [received]', '2019/12/25 06:00 [pubmed]', '2021/06/22 06:00 [medline]', '2019/12/25 06:00 [entrez]']","['S2468-7189(19)30401-5 [pii]', '10.1016/j.gofs.2019.12.002 [doi]']",ppublish,Gynecol Obstet Fertil Senol. 2020 Jun;48(6):475-476. doi: 10.1016/j.gofs.2019.12.002. Epub 2019 Dec 20.,,20191220,,,,,,,La chirurgie robotique peut-elle contribuer a diminuer la discrimination medicale a l'egard des patientes obeses ?,,,,,,,,,,,
20054190,NLM,MEDLINE,20100128,20211020,1662-4025 (Print) 1662-4033 (Electronic) 1662-4025 (Linking),1,6,2008,Should we really treat every obese individual?,287-91,10.1159/000182615 [doi],,"['Muller, Manfred J', 'Hebebrand, Johannes']","['Muller MJ', 'Hebebrand J']",,['eng'],"['Editorial', 'Introductory Journal Article']",Switzerland,Obes Facts,Obesity facts,101469429,,IM,"['Age Factors', 'Body Mass Index', 'Chronic Disease', 'Humans', 'Obesity/classification/complications/*therapy', 'Risk Factors']",PMC6452125,,,,2008/01/01 00:00,2010/01/29 06:00,['2010/01/08 06:00'],"['2010/01/08 06:00 [entrez]', '2008/01/01 00:00 [pubmed]', '2010/01/29 06:00 [medline]']","['000182615 [pii]', 'ofa-0001-0287 [pii]', '10.1159/000182615 [doi]']",ppublish,Obes Facts. 2008;1(6):287-91. doi: 10.1159/000182615. Epub 2008 Dec 12.,,20081212,,,,,,,,,,,,,,,,,,
28258555,NLM,MEDLINE,20170810,20181202,1496-8975 (Electronic) 0832-610X (Linking),64,5,2017 May,Propofol induction: normalizing the dose in morbidly obese patients.,456-460,10.1007/s12630-017-0854-8 [doi],,"['Friesen, John H P']",['Friesen JH'],"['Department of Anesthesia & Perioperative Medicine, University of Manitoba, Winnipeg, MB, Canada. john.friesen@umanitoba.ca.']",['eng'],"['Comment', 'Editorial']",United States,Can J Anaesth,Canadian journal of anaesthesia = Journal canadien d'anesthesie,8701709,"['0 (Anesthetics, Intravenous)', 'YI7VU623SF (Propofol)']",IM,"['Anesthesia, Intravenous', 'Anesthetics, Intravenous', 'Humans', '*Obesity, Morbid', '*Propofol']",,,,,2017/03/05 06:00,2017/08/11 06:00,['2017/03/05 06:00'],"['2017/01/11 00:00 [received]', '2017/02/21 00:00 [accepted]', '2017/02/14 00:00 [revised]', '2017/03/05 06:00 [pubmed]', '2017/08/11 06:00 [medline]', '2017/03/05 06:00 [entrez]']","['10.1007/s12630-017-0854-8 [pii]', '10.1007/s12630-017-0854-8 [doi]']",ppublish,Can J Anaesth. 2017 May;64(5):456-460. doi: 10.1007/s12630-017-0854-8. Epub 2017 Mar 3.,,20170303,,,,,,,L'induction au propofol: normalisation de la posologie destinee aux patients obeses morbides.,,['Can J Anaesth. 2017 May;64(5):471-479. PMID: 28243855'],,,,,,,,,
6696351,NLM,MEDLINE,19840322,20220408,0003-0805 (Print) 0003-0805 (Linking),129,2 Pt 2,1984 Feb,The ventilatory stress of exercise in obesity.,S90-2,,"The effect of obesity as a factor limiting exercise tolerance is described and can be attributed to three mechanisms: (a) the increased metabolic and therefore ventilatory requirement to perform a given work task; (b) the increased metabolic cost of breathing because of interfering chest wall and abdominal obesity and high breathing frequency; and (c) pulmonary insufficiency in response to the high breathing work and lung atelectasis. The role of support and posture minimizing the effect of obesity should be considered when attempting to improve the work tolerance of obese patients. One cannot predict accurately the O2 cost of exercise in the obese patient from the ergometer load because of uncertainties of distribution of the adipose tissue, the uncertain effects on breathing work, and often reduced motor efficiency or skill. The metabolic cost of exercise in the obese patient, therefore, needs to be directly measured; only then can one establish the degree of normality of the physiologic responses to exercise, e.g., heart rate, blood pressure, cardiac output, and minute ventilation.","['Whipp, B J', 'Davis, J A']","['Whipp BJ', 'Davis JA']",,['eng'],['Journal Article'],United States,Am Rev Respir Dis,The American review of respiratory disease,0370523,,IM,"['Humans', 'Male', 'Obesity/complications/metabolism/*physiopathology', '*Physical Exertion', '*Respiration', 'Respiration Disorders/etiology', 'Stress, Mechanical']",,,,,1984/02/01 00:00,1984/02/01 00:01,['1984/02/01 00:00'],"['1984/02/01 00:00 [pubmed]', '1984/02/01 00:01 [medline]', '1984/02/01 00:00 [entrez]']",['10.1164/arrd.1984.129.2P2.S90 [doi]'],ppublish,Am Rev Respir Dis. 1984 Feb;129(2 Pt 2):S90-2. doi: 10.1164/arrd.1984.129.2P2.S90.,,,,,,,,,,,,,['NASA: 84126302'],,,,,,,
12823953,NLM,MEDLINE,20030806,20181217,0165-6147 (Print) 0165-6147 (Linking),24,6,2003 Jun,Do regional differences in adipocyte biology provide new pathophysiological insights?,276-83,,"Obesity is an increasing health problem in many countries. Striking differences exist in the magnitude of the impact of different obesities on comorbidities. Individuals with peripheral obesity ('pears') possess fat distributed subcutaneously in gluteofemoral areas and the lower part of the abdomen, and are at little risk of metabolic complications. Conversely, individuals with upper-body obesity ('apples') accumulate fat in subcutaneous and visceral deposits and are more prone to metabolic and cardiovascular problems, particularly when visceral fat deposits are abundant. In this article, whether the different risk factors for obesity of 'apples' and 'pears' are largely related to the heterogeneity of function and responsiveness of the adipocytes from visceral and subcutaneous deposits is questioned. Possible pharmacological approaches to the treatment of obesity and related diseases are also considered.","['Lafontan, Max', 'Berlan, Michel']","['Lafontan M', 'Berlan M']","['Unite de Recherches sur les Obesites-Unite INSERM 586, Institut Louis Bugnard, Universite Paul Sabatier, CHU Rangueil, 31403 Toulouse cedex 4, France. Max.Lafontan@toulouse.inserm.fr']",['eng'],"['Journal Article', 'Review']",England,Trends Pharmacol Sci,Trends in pharmacological sciences,7906158,"['0 (Catecholamines)', '0 (Cytokines)', '0 (Hormones)', '0 (Insulin)']",IM,"['Abdomen/pathology', 'Adipocytes/*pathology', 'Adipose Tissue/*pathology', '*Body Composition', 'Catecholamines/physiology', 'Cytokines/biosynthesis', 'Hormones/biosynthesis', 'Humans', 'Insulin/metabolism', 'Insulin Secretion', 'Lipolysis/physiology', 'Metabolic Diseases/etiology', 'Obesity/blood/complications/*pathology', 'Peptide Biosynthesis', 'Risk Factors', 'Viscera/pathology']",,,,,2003/06/26 05:00,2003/08/07 05:00,['2003/06/26 05:00'],"['2003/06/26 05:00 [pubmed]', '2003/08/07 05:00 [medline]', '2003/06/26 05:00 [entrez]']","['S0165-6147(03)00132-9 [pii]', '10.1016/S0165-6147(03)00132-9 [doi]']",ppublish,Trends Pharmacol Sci. 2003 Jun;24(6):276-83. doi: 10.1016/S0165-6147(03)00132-9.,,,,,,,87,,,,,,,,,,,,,
16005242,NLM,MEDLINE,20051114,20071114,1043-2760 (Print) 1043-2760 (Linking),16,6,2005 Aug,Molecular physiology of syndromic obesities in humans.,267-72,,"Obesity has become an increasingly prevalent public health problem and represents the complex interaction of genetic, developmental, behavioral and environmental influences. Although rare, the study of syndromic forms of obesity provides insight into underlying molecular and physiological mechanisms by which adiposity is regulated through food intake, energy expenditure and partitioning of stored calories.","['Chung, Wendy K', 'Leibel, Rudolph L']","['Chung WK', 'Leibel RL']","['Division of Molecular Genetics and the Naomi Berrie Diabetes Center, Columbia University Medical College, Russell Berrie Medical Science Pavilion, Room 620, 1150 St Nicholas Avenue, New York, NY 10032, USA. wkc15@columbia.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, U.S. Gov't, P.H.S."", 'Review']",United States,Trends Endocrinol Metab,Trends in endocrinology and metabolism: TEM,9001516,,IM,"['Eating', 'Energy Metabolism', 'Humans', 'Obesity/*genetics', 'Syndrome']",,,,,2005/07/12 09:00,2005/11/15 09:00,['2005/07/12 09:00'],"['2004/10/29 00:00 [received]', '2005/04/11 00:00 [revised]', '2005/06/24 00:00 [accepted]', '2005/07/12 09:00 [pubmed]', '2005/11/15 09:00 [medline]', '2005/07/12 09:00 [entrez]']","['S1043-2760(05)00131-1 [pii]', '10.1016/j.tem.2005.06.009 [doi]']",ppublish,Trends Endocrinol Metab. 2005 Aug;16(6):267-72. doi: 10.1016/j.tem.2005.06.009.,['DK 52431/DK/NIDDK NIH HHS/United States'],,,,,,61,,,,,,,,,,,,,
17400158,NLM,MEDLINE,20070606,20070402,1932-2275 (Print) 1932-2275 (Linking),25,1,2007 Mar,Management of the obese trauma patient.,"91-8, ix",,"Obese persons are more likely to be involved in vehicle accidents, probably because of the presence of sleep apnea. They are more likely to suffer chest, pelvis, and extremity fractures. Mildly overweight persons are less prone to intra-abdominal injury because of the protective effect of the abdominal fat, known as the cushion effect. Obese trauma patients are far more likely to develop in-hospital complications, especially pulmonary, renal, and thromboembolic complications. The BMI is an independent risk factor for morbidity and mortality after trauma. Because only limited data exist about the right clinical approach to obese trauma patients, it is necessary to rely on general knowledge about treating obese patients in the ICU. More research is needed to improve the treatment of obese trauma patients.","['Meroz, Yuval', 'Gozal, Yaacov']","['Meroz Y', 'Gozal Y']","['Department of Anesthesiology & CCM, Hadassah Hebrew University School of Medicine, Hadassah Medical Organization, Kiryat Hadassah, P.O. Box 12000, Jerusalem 91120, Israel.']",['eng'],"['Journal Article', 'Review']",United States,Anesthesiol Clin,Anesthesiology clinics,101273663,,IM,"['Body Mass Index', 'Emergency Medical Services', 'Humans', 'Obesity/*complications/epidemiology/mortality/*therapy', 'Risk', 'Wounds and Injuries/epidemiology/mortality/*therapy']",,,,,2007/04/03 09:00,2007/06/07 09:00,['2007/04/03 09:00'],"['2007/04/03 09:00 [pubmed]', '2007/06/07 09:00 [medline]', '2007/04/03 09:00 [entrez]']","['S0889-8537(06)00095-2 [pii]', '10.1016/j.atc.2006.11.005 [doi]']",ppublish,"Anesthesiol Clin. 2007 Mar;25(1):91-8, ix. doi: 10.1016/j.atc.2006.11.005.",,,,,,,35,,,,,,,,,,,,,
10524161,NLM,MEDLINE,19991021,20051116,1056-8670 (Print) 1056-8670 (Linking),8,3,1999 Jul,The obese patient as a surgical risk.,109-17,,"Obesity has become a serious problem in the United States. The increasing prevalence of obesity makes the likelihood of clinicians caring for these individuals high. Several considerations for the preoperative care of these patients include appropriate assessment, particularly of the cardiopulmonary systems, and a thorough clinical examination. Intraoperative concerns include appropriate equipment, medication, positioning, and cardiopulmonary monitoring. Postoperative care for the obese patient requires special concern regarding oxygenation and wound healing.","['Keller, C']",['Keller C'],"['Department of Family Nursing Care, University of Texas Health Science Center at San Antonio 78284-7951, USA.']",['eng'],"['Journal Article', 'Review']",United States,Semin Perioper Nurs,Seminars in perioperative nursing,9206988,,,"['Humans', 'Nursing Assessment/methods', 'Obesity/complications/epidemiology/*nursing/*surgery', 'Patient Care Planning', 'Perioperative Care/*nursing', 'Risk Factors', 'United States/epidemiology']",,,,,1999/10/19 00:00,1999/10/19 00:01,['1999/10/19 00:00'],"['1999/10/19 00:00 [pubmed]', '1999/10/19 00:01 [medline]', '1999/10/19 00:00 [entrez]']",,ppublish,Semin Perioper Nurs. 1999 Jul;8(3):109-17.,,,,,,,50,,,,,,,,,,,,,
17316292,NLM,MEDLINE,20070501,20230815,1467-7881 (Print) 1467-7881 (Linking),8 Suppl 1,,2007 Mar,Executive summary: Foresight 'Tackling Obesities: Future Choices' project.,vi-ix,,,"['Kopelman, P', 'Jebb, S A', 'Butland, B']","['Kopelman P', 'Jebb SA', 'Butland B']",,['eng'],"['Editorial', 'Review']",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['Health Behavior', 'Health Policy', 'Humans', 'Obesity/*physiopathology/prevention & control/therapy', 'United Kingdom']",,,,,2007/02/24 09:00,2007/05/02 09:00,['2007/02/24 09:00'],"['2007/02/24 09:00 [pubmed]', '2007/05/02 09:00 [medline]', '2007/02/24 09:00 [entrez]']","['OBR344 [pii]', '10.1111/j.1467-789X.2007.00344.x [doi]']",ppublish,Obes Rev. 2007 Mar;8 Suppl 1:vi-ix. doi: 10.1111/j.1467-789X.2007.00344.x.,['MC_U105960389/MRC_/Medical Research Council/United Kingdom'],,,,,,34,,,,,,,,,,,,,
25706743,NLM,MEDLINE,20160108,20220311,1932-6203 (Electronic) 1932-6203 (Linking),10,2,2015,Acknowledging individual responsibility while emphasizing social determinants in narratives to promote obesity-reducing public policy: a randomized experiment.,e0117565,10.1371/journal.pone.0117565 [doi] e0117565,"This study tests whether policy narratives designed to increase support for obesity-reducing public policies should explicitly acknowledge individual responsibility while emphasizing social, physical, and economic (social) determinants of obesity. We use a web-based, randomized experiment with a nationally representative sample of American adults (n = 718) to test hypotheses derived from theory and research on narrative persuasion. Respondents exposed to narratives that acknowledged individual responsibility while emphasizing obesity's social determinants were less likely to engage in counterargument and felt more empathy for the story's main character than those exposed to a message that did not acknowledge individual responsibility. Counterarguing and affective empathy fully mediated the relationship between message condition and support for policies to reduce rates of obesity. Failure to acknowledge individual responsibility in narratives emphasizing social determinants of obesity may undermine the persuasiveness of policy narratives. Omitting information about individual responsibility, a strongly-held American value, invites the public to engage in counterargument about the narratives and reduces feelings of empathy for a character that experiences the challenges and benefits of social determinants of obesity.","['Niederdeppe, Jeff', 'Roh, Sungjong', 'Shapiro, Michael A']","['Niederdeppe J', 'Roh S', 'Shapiro MA']","['Department of Communication, Cornell University, Ithaca, New York, United States of America.', 'Department of Communication, Cornell University, Ithaca, New York, United States of America.', 'Department of Communication, Cornell University, Ithaca, New York, United States of America.']",['eng'],"['Journal Article', 'Randomized Controlled Trial', ""Research Support, Non-U.S. Gov't""]",United States,PLoS One,PloS one,101285081,,IM,"['*Health Policy', 'Humans', 'Narration', 'Obesity/epidemiology/*prevention & control', '*Social Responsibility', '*Socioeconomic Factors', 'United States/epidemiology']",PMC4338108,,,['Competing Interests: The authors have declared that no competing interests exist.'],2015/02/24 06:00,2016/01/09 06:00,['2015/02/24 06:00'],"['2014/09/04 00:00 [received]', '2014/12/27 00:00 [accepted]', '2015/02/24 06:00 [entrez]', '2015/02/24 06:00 [pubmed]', '2016/01/09 06:00 [medline]']","['PONE-D-14-38923 [pii]', '10.1371/journal.pone.0117565 [doi]']",epublish,PLoS One. 2015 Feb 23;10(2):e0117565. doi: 10.1371/journal.pone.0117565. eCollection 2015.,,20150223,,,,,,,,,,,,,,,,,,
24863328,NLM,MEDLINE,20150105,20151119,1439-1074 (Electronic) 0939-2661 (Linking),49,5,2014 May,[The obese patient in the intensive care unit--what is different?].,288-96,10.1055/s-0034-1376446 [doi],"In many countries over the past years there has been a marked increase in the number of people with severe overweight - especially among the younger age groups up to 35 years. Accordingly, the number of intensive care patients suffering additionally from a significant obesity is also increasing continuously. Some particular features of these patients need to be observed. Differences to normal-weight patients involve, for example, respiratory physiology: the obesity leads to a decrease of lung volume and to a marked increase in breathing work as well as oxygen consumption. Clinically relevant changes occur in the upper airways and neck. Thus, mask ventilation, intubation or surgical interventions to secure the airways are clearly more difficult than in normal-weight patients. Obese intensive care patients are therefore primarily to be considered as patients with difficult airway conditions. In addition in cases of extreme obesity, drug distribution, degradation and excretion can differ from those of normal-weight patients. This must be taken into account for medication dosing. In spite of the overweight, obese patients may be undernourished upon admission to the ICU. Thus, for this group of patients also, enteral nutrition should be started as early as possible. Although obesity is accompanied by a higher mortality on account of the many possible comorbidities, numerous studies have confirmed that even extreme obesity does not increase the mortality rate in comparison with that of normal-weight patients.","['Bone, Hans-Georg', 'Freyhoff, Jorg', 'Utech, Markus']","['Bone HG', 'Freyhoff J', 'Utech M']",,['ger'],"['English Abstract', 'Journal Article', 'Review']",Germany,Anasthesiol Intensivmed Notfallmed Schmerzther,"Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS",9109478,,IM,"['Bariatric Surgery/*methods', 'Critical Care/*methods', 'Humans', 'Intensive Care Units', 'Obesity/*complications/epidemiology/surgery/*therapy', 'Obesity, Morbid/surgery', 'Perioperative Care', 'Treatment Outcome']",,,,,2014/05/28 06:00,2015/01/06 06:00,['2014/05/28 06:00'],"['2014/05/28 06:00 [entrez]', '2014/05/28 06:00 [pubmed]', '2015/01/06 06:00 [medline]']",['10.1055/s-0034-1376446 [doi]'],ppublish,Anasthesiol Intensivmed Notfallmed Schmerzther. 2014 May;49(5):288-96. doi: 10.1055/s-0034-1376446. Epub 2014 May 26.,,20140526,,['(c) Georg Thieme Verlag Stuttgart . New York.'],,,,,Der adipose Patient auf der Intensivstation--Was ist anders?,,,,,,,,,,,
15107724,NLM,MEDLINE,20040519,20191108,0003-4509 (Print) 0003-4509 (Linking),62,2,2004 Mar,[Natural course of obesities].,80-6,,"Obesity is a chronic disease. At the initial phase, behavioral and environmental factors play a key role in the constitution of adipose tIssue excess. Progressively biological alterations of adipose tIssue metabolism lead to some degree of irreversibility of the disease and contribute to the development of its metabolic and cardio-vascular complications.","['Basdevant, A']",['Basdevant A'],"['Service de Nutrition, Hotel Dieu, F75181 Paris Cedex 04.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Ann Pharm Fr,Annales pharmaceutiques francaises,2985176R,,IM,"['Adaptation, Physiological/genetics/physiology', 'Adipose Tissue/physiology', 'Disease Progression', 'Energy Metabolism/genetics/physiology', 'Humans', 'Obesity/genetics/*physiopathology']",,,,,2004/04/27 05:00,2004/05/20 05:00,['2004/04/27 05:00'],"['2004/04/27 05:00 [pubmed]', '2004/05/20 05:00 [medline]', '2004/04/27 05:00 [entrez]']","['MDOI-APF-03-2004-62-2-0003-4509-101019-ART2 [pii]', '10.1016/s0003-4509(04)94285-x [doi]']",ppublish,Ann Pharm Fr. 2004 Mar;62(2):80-6. doi: 10.1016/s0003-4509(04)94285-x.,,,,,,,10,,Histoire naturelle des obesites.,,,,,,,,,,,
35514242,NLM,MEDLINE,20220615,20220731,1365-2362 (Electronic) 0014-2972 (Print) 0014-2972 (Linking),52,7,2022 Jul,'Obesities': Position statement on a complex disease entity with multifaceted drivers.,e13811,10.1111/eci.13811 [doi] e13811,"Academic medicine fosters research that moves from discovery to translation, at the same time as promoting education of the next generation of professionals. In the field of obesity, the supposed integration of knowledge, discovery and translation research to clinical care is being particularly hampered. The classification of obesity based on the body mass index does not account for several subtypes of obesity. The lack of a universally shared definition of ""obesities"" makes it impossible to establish the real burden of the different obesity phenotypes. The individual's genotype, adipotype, enterotype and microbiota interplays with macronutrient intake, appetite, metabolism and thermogenesis. Further investigations based on the concept of differently diagnosed ""obesities"" are required.","['Yarnoz-Esquiroz, Patricia', 'Olazaran, Laura', 'Aguas-Ayesa, Maite', 'Perdomo, Carolina M', 'Garcia-Goni, Marta', 'Silva, Camilo', 'Fernandez-Formoso, Jose Antonio', 'Escalada, Javier', 'Montecucco, Fabrizio', 'Portincasa, Piero', 'Fruhbeck, Gema']","['Yarnoz-Esquiroz P', 'Olazaran L', 'Aguas-Ayesa M', 'Perdomo CM', 'Garcia-Goni M', 'Silva C', 'Fernandez-Formoso JA', 'Escalada J', 'Montecucco F', 'Portincasa P', 'Fruhbeck G']","['Department of Endocrinology & Nutrition, Clinica Universidad de Navarra, Pamplona, Spain.', 'CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), ISCIII, Pamplona, Spain.', 'Obesity and Adipobiology Group, Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.', 'Department of Endocrinology & Nutrition, Clinica Universidad de Navarra, Pamplona, Spain.', 'CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), ISCIII, Pamplona, Spain.', 'Obesity and Adipobiology Group, Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.', 'Department of Endocrinology & Nutrition, Clinica Universidad de Navarra, Pamplona, Spain.', 'CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), ISCIII, Pamplona, Spain.', 'Department of Endocrinology & Nutrition, Clinica Universidad de Navarra, Pamplona, Spain.', 'CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), ISCIII, Pamplona, Spain.', 'Department of Endocrinology & Nutrition, Clinica Universidad de Navarra, Pamplona, Spain.', 'Department of Endocrinology & Nutrition, Clinica Universidad de Navarra, Pamplona, Spain.', 'CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), ISCIII, Pamplona, Spain.', 'Obesity and Adipobiology Group, Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.', 'CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), ISCIII, Pamplona, Spain.', 'Department of Endocrinology & Nutrition, Clinica Universidad de Navarra, Pamplona, Spain.', 'CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), ISCIII, Pamplona, Spain.', 'Obesity and Adipobiology Group, Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.', 'First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Genoa, Italy.', 'IRCCS Ospedale Policlinico San Martino Genoa - Italian Cardiovascular Network, Genoa, Italy.', 'Clinica Medica ""A. Murri"", Department of Biomedical Sciences and Human Oncology, University of Bari ""Aldo Moro"", Bari, Italy.', 'Department of Endocrinology & Nutrition, Clinica Universidad de Navarra, Pamplona, Spain.', 'CIBER Fisiopatologia de la Obesidad y Nutricion (CIBEROBN), ISCIII, Pamplona, Spain.', 'Obesity and Adipobiology Group, Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.']",['eng'],['Journal Article'],England,Eur J Clin Invest,European journal of clinical investigation,0245331,,IM,"['Body Mass Index', 'Humans', '*Obesity/metabolism']",PMC9285368,['NOTNLM'],"['Obesity phenotypes', 'Sarcopenic obesity', 'dysfunctional adipose tissue', 'metabolically healthy obesity', 'non-communicable diseases (NCDs)', 'precision medicine']",['The authors declare no conflicts of interest.'],2022/05/07 06:00,2022/06/16 06:00,['2022/05/06 04:12'],"['2022/04/15 00:00 [revised]', '2022/01/27 00:00 [received]', '2022/05/04 00:00 [accepted]', '2022/05/07 06:00 [pubmed]', '2022/06/16 06:00 [medline]', '2022/05/06 04:12 [entrez]']","['ECI13811 [pii]', '10.1111/eci.13811 [doi]']",ppublish,Eur J Clin Invest. 2022 Jul;52(7):e13811. doi: 10.1111/eci.13811. Epub 2022 May 12.,['PI19/00785/Spanish Institute of Health ISCIII and CIBEROBN/'],20220512,,"['(c) 2022 The Authors. European Journal of Clinical Investigation published by John', 'Wiley & Sons Ltd on behalf of Stichting European Society for Clinical', 'Investigation Journal Foundation.']","['ORCID: 0000-0002-5748-0581', 'ORCID: 0000-0003-0823-8729', 'ORCID: 0000-0001-5359-1471', 'ORCID: 0000-0002-8305-7154']",,,,,,,,,,,,,,,
19114468,NLM,MEDLINE,20090305,20081230,1059-8405 (Print) 1059-8405 (Linking),24,6,2008 Dec,"Examining attendance, academic performance, and behavior in obese adolescents.",379-87,10.1177/1059840508324246 [doi],"Although academics and safety continue to rank as high-priority issues in public schools, educators and administrators are beginning to recognize the importance of student health on school success. This move toward a holistic approach suggests that efforts to improve a student's physical, social, and emotional well-being are as important as efforts to increase test scores. Adolescent obesity is epidemic, and it is a complex integration of social, psychological, and physical factors that exacerbate the turbulent transitional years of adolescence. Adolescents are vulnerable to issues related to weight, and they are at risk for suffering obesity's negative effects, thereby resulting in unfortunate school outcomes such as decreased rates of attendance, poor academic performance, and school suspensions. Disparities related to overweight and obesity exist; therefore, the negative effects of obesity may disproportionately affect minorities and poor schoolchildren. Examining school outcomes for the overweight or obese adolescent is crucial and may provide valuable insight into constructive changes required for a responsive school environment.","['Daniels, Dianne Yow']",['Daniels DY'],"['Pfeiffer University, Misenheimer, NC, USA.']",['eng'],"['Journal Article', 'Review']",United States,J Sch Nurs,The Journal of school nursing : the official publication of the National Association of School Nurses,9206498,,,"['Absenteeism', 'Adolescent', '*Educational Status', 'Humans', 'Obesity/prevention & control/*psychology', 'Prejudice', 'School Nursing', 'Self Concept', 'Students/*psychology']",,,,,2008/12/31 09:00,2009/03/06 09:00,['2008/12/31 09:00'],"['2008/12/31 09:00 [entrez]', '2008/12/31 09:00 [pubmed]', '2009/03/06 09:00 [medline]']","['24/6/379 [pii]', '10.1177/1059840508324246 [doi]']",ppublish,J Sch Nurs. 2008 Dec;24(6):379-87. doi: 10.1177/1059840508324246.,,,,,,,79,,,,,,,,,,,,,
31560645,NLM,MEDLINE,20200702,20200702,1545-1151 (Electronic) 1545-1151 (Linking),16,,2019 Sep 26,"Data for Decision-Making: Exploring the Division of Nutrition, Physical Activity, and Obesity's Data, Trends, and Maps.",E131,10.5888/pcd16.190043 [doi] E131,"Public health practitioners need quick and easy access to reliable surveillance data to monitor states' progress over time, compare benchmarks nationally or among states, and make strategic decisions about priorities and resources. Data, Trends, and Maps (DTM) at https://www.cdc.gov/nccdphp/dnpao/data-trends-maps/index.html is a free, online interactive database that houses and displays data on nutrition, physical activity, breastfeeding, and obesity that practitioners can use for public health action. Created in 2015 by the Centers for Disease Control and Prevention's (CDC) Division of Nutrition, Physical Activity, and Obesity, DTM was updated and relaunched in April 2017 with the capability to customize and download data sets directly; DTM also has other user-friendly features, such as visualization options. Since its relaunch, DTM has received more than 386,000 page views from approximately 110,000 unique visitors. However, the potential exists for more widespread use of DTM if more public health practitioners understood what the site offered and how others have used it in the field. Here, we explain how public health practitioners can explore the most recent state-level data on nutrition, physical activity, breastfeeding, and obesity and use this data to inform programmatic and policy efforts to prevent and control chronic diseases. We demonstrate 3 different ways practitioners can visualize data (ie, Explore by Location, Explore by Topic, and the Open Data Portal) and present 3 real-world examples to highlight DTM's utility as a public health tool.","['Lange, Samantha J', 'Moore, Latetia V', 'Galuska, Deborah A']","['Lange SJ', 'Moore LV', 'Galuska DA']","['Oak Ridge Institute for Science and Education, Research Participation Program, Division of Nutrition, Physical Activity, and Obesity, Centers for Disease Control and Prevention, Atlanta, Georgia.', 'Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop S107-5, Atlanta, GA 30341. Email: nya7@cdc.gov.', 'Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.', 'Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.']",['eng'],['Journal Article'],United States,Prev Chronic Dis,Preventing chronic disease,101205018,,IM,"['Centers for Disease Control and Prevention, U.S.', 'Databases, Factual', '*Decision Making', '*Exercise', 'Humans', '*Nutritional Status', 'Obesity/*epidemiology/*etiology', 'Population Surveillance', 'Public Health', 'United States']",PMC6795071,,,,2019/09/29 06:00,2020/07/03 06:00,['2019/09/28 06:00'],"['2019/09/28 06:00 [entrez]', '2019/09/29 06:00 [pubmed]', '2020/07/03 06:00 [medline]']","['E131 [pii]', '19_0043 [pii]', '10.5888/pcd16.190043 [doi]']",epublish,Prev Chronic Dis. 2019 Sep 26;16:E131. doi: 10.5888/pcd16.190043.,,20190926,,,,,,,,,,,,,,,,,,
723639,NLM,MEDLINE,19790212,20190725,0026-0495 (Print) 0026-0495 (Linking),27,12 Suppl 2,1978 Dec,Hyperinsulinemia in obesity syndromes: its metabolic consequences and possible etiology.,1881-92,,"Animal models with genetic or experimentally produced (lesions of hypothalamus) obesities are numerous and unlikely to ever be reduced to a single pathophysiologic entity. However, obese animals have many similar traits in common. They are all hyperinsulinemic, an abnormality that occurs early in the development of these syndromes and appears to be of prime importance in producing most of the metabolic changes observed both in the early and late phases of the obesity syndromes. In all instances, obesity is an evolutional syndrome in which the early phase is different from the later one. The early phase is principally characterized by increased hepatic very low density lipoprotein (VLDL) output, increased adipose tissue lipogenesis and VLDL uptake, hence, increased fat accretion and fat cell size. These abnormalities are secondary to hyperinsulinemia and can be reversed toward normal by normalizing circulating insulin levels. The late phase is characterized by the continuation of the disorders of the early one plus a superimposed abnormality, the insulin resistance state, that is detectable particularly at the level of adipose and muscle tissues, and eventually brings about hyperglycemia. Insulin resistance is a multifactorial pathological condition that includes at least: (a) a decrease (more or less marked) in insulin binding to target tissues that is responsible for the decrease in tissue sensitivity to the hormone; (b) intracellular defects that are probably responsible for the decreased insulin responsiveness of target tissues. The origin of hyperinsulinemia in animal obesities is still ill-defined. Lesions of the ventromedial hypothalamus (VMH) produce rapid and lasting hyperinsulinemia. Such lesions produce, in addition, increased secretion of insulin and glucagon and changes in pancreatic insulin, glucagon, and somatostatin content in subsequently perfused pancreases. The locus responsible for these effects is not defined and may actually involve a series of interrelated loci. Whatever the latter may be, one of the routes of CNS influence upon endocrine pancreas is the vagus nerve, although a humoral factor has also been claimed. The etiology of hyperinsulinemia in genetically obese animals is unknown. Genetic inheritance could bear primarily upon some hypothalamic or other CNS sites, with secondary alterations in the endocrine pancreas function, or primarily on the islets of Langerhans with possible alteration in the respective function of the A, B, and D cells with resulting excessive insulin secretion.","['Jeanrenaud, B']",['Jeanrenaud B'],,['eng'],['Journal Article'],United States,Metabolism,Metabolism: clinical and experimental,0375267,['0 (Insulin)'],IM,"['Animals', 'Disease Models, Animal', 'Glycolysis', 'Hyperinsulinism/*blood/complications', 'Insulin/*blood', 'Mice', 'Mice, Obese', 'Muscles/metabolism', 'Obesity/*blood/complications/genetics', 'Rats', 'Rats, Inbred Strains', 'Syndrome']",,,,,1978/12/01 00:00,1978/12/01 00:01,['1978/12/01 00:00'],"['1978/12/01 00:00 [pubmed]', '1978/12/01 00:01 [medline]', '1978/12/01 00:00 [entrez]']","['0026-0495(78)90244-5 [pii]', '10.1016/s0026-0495(78)80006-7 [doi]']",ppublish,Metabolism. 1978 Dec;27(12 Suppl 2):1881-92. doi: 10.1016/s0026-0495(78)80006-7.,,,,,,,,,,,,,,,,,,,,
25485991,NLM,MEDLINE,20150407,20181113,1662-4033 (Electronic) 1662-4025 (Print) 1662-4025 (Linking),7,5,2014,Beyond BMI--phenotyping the obesities.,322-8,10.1159/000368783 [doi],,"['Blundell, John E', 'Dulloo, Abdul G', 'Salvador, Javier', 'Fruhbeck, Gema']","['Blundell JE', 'Dulloo AG', 'Salvador J', 'Fruhbeck G']","['Institute of Psychological Sciences, Faculty of Medicine and Health, University of Leeds, Leeds, UK.']",['eng'],['Journal Article'],Switzerland,Obes Facts,Obesity facts,101469429,,IM,"['*Adipose Tissue', '*Body Composition', '*Body Mass Index', 'Humans', '*Obesity/classification', '*Phenotype']",PMC5644899,,,,2014/12/09 06:00,2015/04/08 06:00,['2014/12/09 06:00'],"['2014/06/25 00:00 [received]', '2014/07/14 00:00 [accepted]', '2014/12/09 06:00 [entrez]', '2014/12/09 06:00 [pubmed]', '2015/04/08 06:00 [medline]']","['000368783 [pii]', 'ofa-0007-0322 [pii]', '10.1159/000368783 [doi]']",ppublish,Obes Facts. 2014;7(5):322-8. doi: 10.1159/000368783. Epub 2014 Oct 23.,['Wellcome Trust/United Kingdom'],20141023,,,,,,,,['EASO SAB Working Group on BMI'],,,,"['Farpour-Lambert, Nathalie', 'Fogelholm, Mikael', 'Micic, Dragan', 'Oppert, Jean-Michel', 'Toplak, Hermann', 'Vidal-Puig, Toni', 'Visscher, Tommy', 'Yumuk, Volkan']","['Farpour-Lambert N', 'Fogelholm M', 'Micic D', 'Oppert JM', 'Toplak H', 'Vidal-Puig T', 'Visscher T', 'Yumuk V']",,,,,
29572720,NLM,MEDLINE,20190923,20190923,1496-8975 (Electronic) 0832-610X (Linking),65,7,2018 Jul,"A 25-year retrospective analysis of the American Society of Anesthesiologists physical status classification: did we ""up-code"" young obese patients when obesity was not yet considered a disease?",776-785,10.1007/s12630-018-1096-0 [doi],"PURPOSE: The influence of obesity on anesthetic risk remains controversial, and obesity has only recently been specifically identified as a criterion by which a patient can be given a higher American Society of Anesthesiologists-physical status (ASA-PS) score. Nevertheless, we hypothesized that clinicians had assigned obese patients a greater ASA-PS score before obesity became an ""official"" criterion in 2015. METHODS: Basic demographic and physical details were collected on patients receiving anesthetics in the Virginia Commonwealth University Health System between 1986 and 2010. The risk ratio (RR) of ""up-coding"" ASA-PS classification assignments was calculated for patients of varying body mass index (BMI). We specifically focused on the subset of patients aged 20-29 yr in whom the medical sequelae of obesity would not yet likely be manifest. RESULTS: Among a total of 194,698 patients, the percentage who were obese increased from 20% to 39% between 1986 and 2010. Obese patients of all ages were more likely than non-obese patients to be classified as ASA-PS II-IV rather than ASA-PS I. The RR and ratio of RR analyses indicated a consistent pattern of up-coding patients with greater BMI (contingency table Chi-square: P < 0.001). Most notably, relative to patients with a normal BMI, young obese patients aged 20-29 yr had an increased likelihood of up-coding in ASA-PS compared with obese patients in the older cohorts. CONCLUSIONS: These findings suggest a consistent and temporally stable practice of up-coding obese patients despite this lack of explicit guidance. The ASA House of Delegates' recent decision to specifically mention obesity reinforces long-existing practices regarding ASA-PS coding and will likely not degrade the validity of data sets collected before the change.","['Guerry, Christopher', 'Butterworth, John F 4th']","['Guerry C', 'Butterworth JF 4th']","['Department of Anesthesiology, Virginia Commonwealth University School of Medicine, VCU, P.O. Box 980695, Richmond, VA, 23298-0695, USA. cguerry@jhsph.edu.', 'Department of Anesthesiology, Virginia Commonwealth University School of Medicine, VCU, P.O. Box 980695, Richmond, VA, 23298-0695, USA.']",['eng'],['Journal Article'],United States,Can J Anaesth,Canadian journal of anaesthesia = Journal canadien d'anesthesie,8701709,,IM,"['Adult', 'Age Factors', 'Aged', 'Aged, 80 and over', '*Anesthesiologists', '*Body Mass Index', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications', 'Retrospective Studies', 'Societies, Medical', 'Young Adult']",,,,,2018/03/25 06:00,2019/09/24 06:00,['2018/03/25 06:00'],"['2017/03/15 00:00 [received]', '2018/01/08 00:00 [accepted]', '2018/01/06 00:00 [revised]', '2018/03/25 06:00 [pubmed]', '2019/09/24 06:00 [medline]', '2018/03/25 06:00 [entrez]']","['10.1007/s12630-018-1096-0 [pii]', '10.1007/s12630-018-1096-0 [doi]']",ppublish,Can J Anaesth. 2018 Jul;65(7):776-785. doi: 10.1007/s12630-018-1096-0. Epub 2018 Mar 23.,,20180323,,,['ORCID: 0000-0002-7387-3529'],,,,Vingt-cinq ans de retrospective sur la classification du statut physique selon l'American Society of Anesthesiologists : avons-nous << gonfle >> le codage des jeunes patients obeses alors que l'obesite n'etait pas encore consideree comme une maladie?,,,,,,,,,,,
19233604,NLM,MEDLINE,20090422,20161209,2213-0276 (Electronic) 0755-4982 (Linking),38,4,2009 Apr,[Hypertension in obese patients: Pathophysiology and management].,609-13,10.1016/j.lpm.2009.01.006 [doi],"Obesity is a major risk factor for hypertension. Adipose tissue releases numerous substances that act on the pathophysiologic mechanisms of blood pressure. Management of obese patients with high blood pressure includes weight loss efforts, but antihypertensive treatment is most often necessary. Beta-blockers, alone or with thiazide diuretics, increase the risk of diabetes in hypertensive patients. Treatment against hypertension must include a renin-angiotensin system blocker, with a calcium channel blocker or a thiazide diuretic, if necessary.","['Girerd, Xavier', 'Hansel, Boris']","['Girerd X', 'Hansel B']","[""Service d'endocrinologie metabolisme, Hopital de la Pitie, F-75013 Paris, France. xavier.girerd@psl.aphp.fr""]",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,"['0 (Adiponectin)', '0 (Antihypertensive Agents)', '0 (Leptin)']",IM,"['Adiponectin/physiology', 'Adipose Tissue/physiopathology', 'Antihypertensive Agents/*therapeutic use', 'Blood Pressure/physiology', 'Combined Modality Therapy', 'Humans', 'Hypertension/*drug therapy/*physiopathology', 'Insulin Resistance/physiology', 'Leptin/physiology', 'Obesity/*complications/*physiopathology', 'Sympathetic Nervous System/physiopathology', 'Weight Loss/physiology']",,,,,2009/02/24 09:00,2009/04/23 09:00,['2009/02/24 09:00'],"['2008/09/19 00:00 [received]', '2009/01/21 00:00 [accepted]', '2009/02/24 09:00 [entrez]', '2009/02/24 09:00 [pubmed]', '2009/04/23 09:00 [medline]']","['S0755-4982(09)00042-6 [pii]', '10.1016/j.lpm.2009.01.006 [doi]']",ppublish,Presse Med. 2009 Apr;38(4):609-13. doi: 10.1016/j.lpm.2009.01.006. Epub 2009 Feb 23.,,20090223,,,,,26,,Hypertension arterielle chez les patients obeses : physiopathologie et prise en charge.,,,,,,,,,,,
6919927,NLM,MEDLINE,19820807,20041117,0029-6465 (Print) 0029-6465 (Linking),17,2,1982 Jun,"An overview of obesity: its significance to nursing: definition, prevalence, etiologic concerns, and treatment strategies.",191-8,,"This article has presented an overview of obesity. It has explored the significance of obesity to nursing today. The definition of obesity vis-a-vis overweight has been delineated. The psychological, physiologic and socioenvironmental causes of obesity were discussed. Finally, some of the important treatment strategies, past and current, were discussed, concluding that a combination of strategies are needed to treat this complex health problem caused by the interaction of several factors--environmental, physiologic in the form of predisposition, and psychological. The following articles provide the reader with an understanding of obese people and the specific nursing interventions associated with caring for these individuals. Whether the obese patient has a postoperative bypass or is a child in a school system within the community, the nurse's role must be based on an understanding of obesity, its causes, and current treatments.","['White, J H']",['White JH'],,['eng'],['Journal Article'],United States,Nurs Clin North Am,The Nursing clinics of North America,0042033,,IM,"['Adipose Tissue', 'Adolescent', 'Adult', 'Aged', 'Child', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*etiology/psychology/therapy', 'Socioeconomic Factors', 'Somatotypes']",,,,,1982/06/01 00:00,1982/06/01 00:01,['1982/06/01 00:00'],"['1982/06/01 00:00 [pubmed]', '1982/06/01 00:01 [medline]', '1982/06/01 00:00 [entrez]']",,ppublish,Nurs Clin North Am. 1982 Jun;17(2):191-8.,,,,,,,,,,,,,,,,,,,,
1504871,NLM,MEDLINE,19920922,20191210,0001-4079 (Print) 0001-4079 (Linking),176,4,1992 Apr,[Advertisements for the treatment of obesity or deceit without limits].,497-506; discussion 506-10,,"In magazines the advertisements for slimming diets or products are more and more frequent. The study of these advertisements shows that most of them do not give any indication on the composition of products or on the nature of the proposed methods. The selling arguments are the most often fallacious: freely diminution of body weight without dieting and physical activities, lack of checks, no successive increase of body weight, dramatic and quick slimming, debatable informations on the mechanisms of actions. In addition these treatments are followed without medical supervision. They are the antithesis of the right therapeutics of obesities. The diffusion of these methods as that of the numerous books on the slimming diets or technics in various European countries requires a study in order to protect the patients against their exploitation and a proposal of legislation for the European Countries in the whole which will make up the future Great European Community.","['Debry, G', 'Debry, A']","['Debry G', 'Debry A']","['Centre de nutrition humaine, Universite de Nancy I.']",['fre'],['Journal Article'],Netherlands,Bull Acad Natl Med,Bulletin de l'Academie nationale de medecine,7503383,,IM,"['Advertising/*standards', '*Deception', '*Diet Fads', 'Humans', 'Obesity/*diet therapy']",,,,,1992/04/01 00:00,1992/04/01 00:01,['1992/04/01 00:00'],"['1992/04/01 00:00 [pubmed]', '1992/04/01 00:01 [medline]', '1992/04/01 00:00 [entrez]']",,ppublish,Bull Acad Natl Med. 1992 Apr;176(4):497-506; discussion 506-10.,,,,,,,,,Les publicites pour le traitement des obesites ou la tromperie n'a pas de limites.,,,,,,,,,,,
35234284,NLM,MEDLINE,20220524,20220524,1600-0765 (Electronic) 0022-3484 (Linking),57,3,2022 Jun,Association between serum miRNAs and gingival gene expression in an obese rat model.,502-509,10.1111/jre.12979 [doi],"INTRODUCTION: Recent studies have reported a relationship between periodontitis and obesity; however, the mechanisms of obesity's effects on periodontitis are not well understood. On the other hand, microRNAs (miRNAs) are known to play key roles in the post-transcriptional regulation gene expression by suppressing translation and protein synthesis. We examined the association between obesity-related miRNAs and gene expression in gingival tissue using miRNA-messenger RNA (mRNA) pairing analysis in an obese rat model. METHODS: Sixteen male Wistar rats aged 8 weeks old were divided into two groups: the control group was fed a normal powdered food for 8 weeks, and the obesity group was fed a high-fat diet for 8 weeks. Distance from the cement-enamel junction to the alveolar bone crest of the first molars was measured. miRNA microarray analysis was performed on samples of serum and gingival tissue; the resulting data were used to calculate fold changes in miRNA levels in the obesity group relative to the control group, and miRNA-mRNA pairing analysis was performed to identify mRNAs potentially targeted by miRNAs of interest. RESULTS: Alveolar bone loss in the obesity group exceeded that in the control group (p = .017). miRNA-mRNA pairing analysis identified an association between 4 miRNAs (miR-759, miR-9a-3p, miR-203b-3p, and miR-878) that were differentially expressed in the obesity and control groups and 7 genes (Ly86, Arid5b, Rgs18, Mlana, P2ry13, Kif1b, and Myt1) expressed in gingival tissue. CONCLUSION: This study revealed that several miRNAs play an important role in the mechanism of periodontal disease progression induced by the obesity.","['Maruyama, Takayuki', 'Kobayashi, Terumasa', 'Sugiura, Yoshio', 'Yoneda, Toshiki', 'Ekuni, Daisuke', 'Morita, Manabu']","['Maruyama T', 'Kobayashi T', 'Sugiura Y', 'Yoneda T', 'Ekuni D', 'Morita M']","['Department of Preventive Dentistry, Okayama University Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.', 'Advanced Research Center for Oral and Craniofacial Sciences, Okayama University Dental School, Okayama, Japan.', 'Department of Preventive Dentistry, Okayama University Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.', 'Department of Preventive Dentistry, Okayama University Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.', 'Department of Preventive Dentistry, Okayama University Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.', 'Department of Preventive Dentistry, Okayama University Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.', 'Department of Preventive Dentistry, Okayama University Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.']",['eng'],['Journal Article'],United States,J Periodontal Res,Journal of periodontal research,0055107,"['0 (MicroRNAs)', '0 (RNA, Messenger)']",IM,"['Animals', 'Gene Expression', 'Gene Expression Profiling', 'Male', '*MicroRNAs/genetics/metabolism', 'Obesity/complications/genetics', '*Periodontitis/genetics', 'RNA, Messenger/metabolism', 'Rats', 'Rats, Wistar']",,['NOTNLM'],"['experimental animal model', 'mRNA', 'microRNA', 'obesity', 'periodontitis']",,2022/03/03 06:00,2022/05/25 06:00,['2022/03/02 08:42'],"['2022/01/19 00:00 [revised]', '2021/08/26 00:00 [received]', '2022/02/07 00:00 [accepted]', '2022/03/03 06:00 [pubmed]', '2022/05/25 06:00 [medline]', '2022/03/02 08:42 [entrez]']",['10.1111/jre.12979 [doi]'],ppublish,J Periodontal Res. 2022 Jun;57(3):502-509. doi: 10.1111/jre.12979. Epub 2022 Mar 2.,"['Grant-in-Aid for Scientific Research (No. 17K17371) from the Ministry of', 'Education, Culture, Sports, Science and Technology, Tokyo, Japan/', '17K17371/Ministry of Education, Culture, Sports, Science and Technology, Tokyo,', 'Japan/']",20220302,,['(c) 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.'],"['ORCID: 0000-0003-2205-8310', 'ORCID: 0000-0001-6803-9233', 'ORCID: 0000-0002-1876-5605', 'ORCID: 0000-0002-3104-6517']",,,,,,,,,,,,,,,
37061669,NLM,MEDLINE,20230418,20230423,2731-4553 (Electronic) 2731-4553 (Linking),24,1,2023 Apr 15,Characterization of an obese population: a retrospective longitudinal study from real-world data in northern Portugal.,99,10.1186/s12875-023-02023-7 [doi] 99,"BACKGROUND: Obesity is a serious and largely preventable global health problem. Obesity-related electronic health records can be a useful resource to identify and address obesity. The analysis of real-world data from T82-coded (International Classification of Primary Care coding, for obesity) primary care individuals can be an excellent national source of data on obesity's prevalence, characteristics, and impact on the National Health Service. METHODS: Retrospective longitudinal study, based on a database of electronic medical records, from the Regional Health Administration of northern Portugal. The study objectives were to determine the prevalence of obesity and to characterize an adult obese population in northern Portugal from a bio-demographic point of view along with profiles of comorbidities and the use of health resources. This study used a database of 266,872 patients in December 2019 and screened for diagnostic code T82 from the International Classification of Primary Care. RESULTS: The prevalence of obesity was 10.2% and the highest prevalence of obesity was in the 65-74 age group (16.1%). The most prevalent morbidities in patients with obesity as coded through ICPC-2 were K86 (uncomplicated hypertension), T90 (non-insulin-dependent diabetes), and K87 (complicated hypertension). Descriptive information showed that T82 subjects used more consultations, medications, and diagnostic tests than non-T82 subjects. CONCLUSIONS: Routine recording of weight and height deserves special attention to allow obesity recognition at an early stage and move on to the appropriate intervention. Future work is necessary to automate the codification of obesity for subjects under 18 years of age, to raise awareness and anticipate the prevention of problems associated with obesity. Practical strategies need to be implemented, such as the creation of a specific program consultation with truly targeted approaches to obesity.","['Pascoa, Rosalia', 'Teixeira, Andreia', 'Henriques, Teresa S', 'Monteiro, Hugo', 'Monteiro, Rosario', 'Martins, Carlos']","['Pascoa R', 'Teixeira A', 'Henriques TS', 'Monteiro H', 'Monteiro R', 'Martins C']","['Faculty of Medicine, Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), University of Porto, Al. Prof. Hernani Monteiro, 4200 - 319, Porto, Portugal. rosaliapascoa@hotmail.com.', 'University of Porto, Centre for Health Technology and Services Research (CINTESIS), Porto, Portugal. rosaliapascoa@hotmail.com.', 'Administracao Regional de Saude do Norte IP, Health Centre Grouping Porto Ocidental, Family Health Unit Homem do Leme, Porto, Portugal. rosaliapascoa@hotmail.com.', 'Faculty of Medicine, Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), University of Porto, Al. Prof. Hernani Monteiro, 4200 - 319, Porto, Portugal.', 'University of Porto, Centre for Health Technology and Services Research (CINTESIS), Porto, Portugal.', 'Instituto Politecnico de Viana do Castelo (IPVC), ADiT-LAB, Viana do Castelo, Portugal.', 'Faculty of Medicine, Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), University of Porto, Al. Prof. Hernani Monteiro, 4200 - 319, Porto, Portugal.', 'University of Porto, Centre for Health Technology and Services Research (CINTESIS), Porto, Portugal.', 'Studies and Planning Department, Administracao Regional de Saude do Norte IP, Porto, Portugal.', 'Faculty of Medicine, Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), University of Porto, Al. Prof. Hernani Monteiro, 4200 - 319, Porto, Portugal.', 'University of Porto, Centre for Health Technology and Services Research (CINTESIS), Porto, Portugal.', 'Administracao Regional de Saude do Norte IP, Health Centre Grouping Porto Ocidental, Family Health Unit Homem do Leme, Porto, Portugal.', 'University of Porto, Centre for Health Technology and Services Research (CINTESIS), Porto, Portugal.', '#H4A Primary Healthcare Research Network, Porto, Portugal.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,BMC Prim Care,BMC primary care,9918300889006676,,IM,"['Adult', 'Humans', 'Adolescent', 'Retrospective Studies', 'Longitudinal Studies', 'Portugal/epidemiology', '*State Medicine', 'Obesity/epidemiology', '*Hypertension/epidemiology']",PMC10105387,['NOTNLM'],"['Obesity', 'Preventive medicine', 'Primary care', 'Real-world data']",['None declared.'],2023/04/16 06:00,2023/04/18 06:42,['2023/04/15 23:33'],"['2022/06/12 00:00 [received]', '2023/02/28 00:00 [accepted]', '2023/04/18 06:42 [medline]', '2023/04/15 23:33 [entrez]', '2023/04/16 06:00 [pubmed]']","['10.1186/s12875-023-02023-7 [pii]', '2023 [pii]', '10.1186/s12875-023-02023-7 [doi]']",epublish,BMC Prim Care. 2023 Apr 15;24(1):99. doi: 10.1186/s12875-023-02023-7.,,20230415,,['(c) 2023. The Author(s).'],"['ORCID: 0000-0001-8782-0260', 'ORCID: 0000-0003-1199-2220', 'ORCID: 0000-0002-4032-9594', 'ORCID: 0000-0003-1552-5507', 'ORCID: 0000-0001-8561-5167']",,,,,,,,,,,,,,,
14644897,NLM,MEDLINE,20031211,20220409,1539-3704 (Electronic) 0003-4819 (Linking),139,11,2003 Dec 2,Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force.,933-49,,"BACKGROUND: Obesity poses a considerable and growing health burden. This review examines evidence for screening and treating obesity in adults. DATA SOURCES: MEDLINE and Cochrane Library (January 1994 through February 2003). STUDY SELECTION: Systematic reviews; randomized, controlled trials; and observational studies of obesity's health outcomes or efficacy of obesity treatment. DATA EXTRACTION: Two reviewers independently abstracted data on study design, sample, sample size, treatment, outcomes, and quality. DATA SYNTHESIS: No trials evaluated mass screening for obesity, so the authors evaluated indirect evidence for efficacy. Pharmacotherapy or counseling interventions produced modest (generally 3 to 5 kg) weight loss over at least 6 or 12 months, respectively. Counseling was most effective when intensive and combined with behavioral therapy. Maintenance strategies helped retain weight loss. Selected surgical patients lost substantial weight (10 to 159 kg over 1 to 5 years). Weight reduction improved blood pressure, lipid levels, and glucose metabolism and decreased diabetes incidence. The internal validity of the treatment trials was fair to good, and external validity was limited by the minimal ethnic or gender diversity of volunteer participants. No data evaluated counseling harms. Primary adverse drug effects included hypertension with sibutramine (mean increase, 0 mm Hg to 3.5 mm Hg) and gastrointestinal distress with orlistat (1% to 37% of patients). Fewer than 1% (pooled samples) of surgical patients died; up to 25% needed surgery again over 5 years. CONCLUSIONS: Counseling and pharmacotherapy can promote modest sustained weight loss, improving clinical outcomes. Pharmacotherapy appears safe in the short term; long-term safety has not been as strongly established. In selected patients, surgery promotes large amounts of weight loss with rare but sometimes severe complications.","['McTigue, Kathleen M', 'Harris, Russell', 'Hemphill, Brian', 'Lux, Linda', 'Sutton, Sonya', 'Bunton, Audrina J', 'Lohr, Kathleen N']","['McTigue KM', 'Harris R', 'Hemphill B', 'Lux L', 'Sutton S', 'Bunton AJ', 'Lohr KN']","['University of Pittsburgh, Pittsburgh, Pennsylvania, USA.']",['eng'],"['Journal Article', 'Meta-Analysis', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Ann Intern Med,Annals of internal medicine,0372351,,IM,"['Adult', 'Behavior Therapy', 'Counseling', 'Evidence-Based Medicine', 'Humans', '*Mass Screening', 'Obesity/*prevention & control/therapy', 'Observation', 'Randomized Controlled Trials as Topic', 'Review Literature as Topic']",,,,,2003/12/04 05:00,2003/12/12 05:00,['2003/12/04 05:00'],"['2003/12/04 05:00 [pubmed]', '2003/12/12 05:00 [medline]', '2003/12/04 05:00 [entrez]']","['139/11/933 [pii]', '10.7326/0003-4819-139-11-200312020-00013 [doi]']",ppublish,Ann Intern Med. 2003 Dec 2;139(11):933-49. doi: 10.7326/0003-4819-139-11-200312020-00013.,['290-97-0011/PHS HHS/United States'],,,,,,,"['Ann Intern Med. 2003 Dec 2;139(11):I57. PMID: 14644909', 'Ann Intern Med. 2004 Aug 3;141(3):245-6; author reply 246. PMID: 15289231']",,,,,,,,,,,,
37133956,NLM,MEDLINE,20230505,20230505,1660-9379 (Print) 1660-9379 (Linking),19,823,2023 Apr 19,[Bone consequences of intentional weight loss in overweight or obese patients].,756-760,10.53738/REVMED.2023.19.823.756 [doi],"Although weight loss results in significant improvements in most comorbidities in people with overweight/obesity, one possible side effect is its negative impact on bone health. This review summarizes the effects of intentional weight loss achieved by non-surgical (lifestyle changes, drugs) and surgical (bariatric surgery) interventions on bone outcomes in individuals with overweight/obesity and discusses strategies to monitor and preserve bone health during weight loss.","['Papageorgiou, Maria', 'Biver, Emmanuel']","['Papageorgiou M', 'Biver E']","['Service des maladies osseuses, Departement de medecine, Hopitaux universitaires de Geneve et Faculte de medecine, 1205 Geneve.', 'Service des maladies osseuses, Departement de medecine, Hopitaux universitaires de Geneve et Faculte de medecine, 1205 Geneve.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Humans', '*Overweight/therapy', 'Obesity/therapy/surgery', 'Weight Loss', '*Bariatric Surgery', 'Life Style']",,,,"[""Les auteurs n'ont declare aucun conflit d'interets en relation avec cet article.""]",2023/05/03 12:42,2023/05/05 06:42,['2023/05/03 12:03'],"['2023/05/05 06:42 [medline]', '2023/05/03 12:42 [pubmed]', '2023/05/03 12:03 [entrez]']","['RMS0823-004 [pii]', '10.53738/REVMED.2023.19.823.756 [doi]']",ppublish,Rev Med Suisse. 2023 Apr 19;19(823):756-760. doi: 10.53738/REVMED.2023.19.823.756.,,,,,"['ORCID: 0000-0002-9943-6976', 'ORCID: 0000-0001-6174-1951']",,,,Consequences osseuses de la perte de poids intentionnelle des patients en surpoids ou obeses.,,,,,,,,,,,
17015201,NLM,MEDLINE,20070110,20061003,1550-7289 (Print) 1550-7289 (Linking),2,5,2006 Sep-Oct,The impact of morbid obesity on the state economy: an initial evaluation.,504-8,,"BACKGROUND: Obesity's impact on a state's economy has not been fully analyzed. This study compared bariatric surgery demographics at a large university hospital to that of a broader region's population statistics. From this comparison, an economic model was derived that evaluated, for the state of New Mexico, the cost of obesity in terms of lost business output, employment, and income. METHODS: Between September 2003 and September 2005, we analyzed the charts of all of our patients from New Mexico who underwent laparoscopic gastric bypass and laparoscopic banding. Input-output analysis estimate margins, the purchase prices for goods and services, and regional purchase coefficients, the percent of spending by local suppliers, were used to model the regional economy. Collected patient data, used in conjunction with IMPLAN model data, were used to estimate, on a regional basis, an industry-by-industry formulation of input-output accounts to calculate multipliers in order to assess the impact of economic costs of the obese on the general economy. RESULTS: Total labor income impacts are nearly 200 million dollars, 1,660 dollars of output income per household and 245 dollars of labor income per household. Obesity cost New Mexico more than 7,300 jobs and cut state and local tax revenues by more than 48 million dollars. CONCLUSION: Obesity's impact of more than 1.3 billion dollars amounts to 2.5% of New Mexico's gross state product. Governmental measures to combat this menace are warranted.","['Frezza, Eldo E', 'Wachtel, Mitchell S', 'Ewing, Bradley T']","['Frezza EE', 'Wachtel MS', 'Ewing BT']","['Department of Surgery, Division of General Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas 79415, USA. eldo.frezza@ttuhsc.edu <eldo.frezza@ttuhsc.edu>']",['eng'],['Journal Article'],United States,Surg Obes Relat Dis,Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery,101233161,,IM,"['Adult', '*Cost of Illness', 'Female', 'Gastric Bypass/*economics', 'Gastroplasty/*economics', '*Health Care Costs', 'Hospitals, University/economics', 'Humans', 'Male', 'New Mexico', 'Obesity, Morbid/*economics/surgery', 'State Government']",,,,,2006/10/04 09:00,2007/01/11 09:00,['2006/10/04 09:00'],"['2006/02/24 00:00 [received]', '2006/05/18 00:00 [revised]', '2006/05/22 00:00 [accepted]', '2006/10/04 09:00 [pubmed]', '2007/01/11 09:00 [medline]', '2006/10/04 09:00 [entrez]']","['S1550-7289(06)00740-4 [pii]', '10.1016/j.soard.2006.08.003 [doi]']",ppublish,Surg Obes Relat Dis. 2006 Sep-Oct;2(5):504-8. doi: 10.1016/j.soard.2006.08.003.,,,,,,,,,,,,,,,,,,,,
8703121,NLM,MEDLINE,19961017,20190905,0938-8990 (Print) 0938-8990 (Linking),7,9,1996 Sep,Sensitivity to dietary obesity linked to a locus on chromosome 15 in a CAST/Ei x C57BL/6J F2 intercross.,677-81,,"Details of a new model of diet-dependent polygenic obesity are presented. CAST/Ei (Mus m. castaneus) mice remain lean after 12 weeks on a high-fat (32 kcal% fat) diet, while C57BL/6J mice become obese. The genes responsible for the obesity segregate in an F2 population derived from an intercross between CAST/Ei and C57BL/6J mice. Quantitative trait analysis, with simple sequence length polymorphisms (SSLPs) at loci previously linked to rodent obesities, identified a quantitative trait locus (QTL) on Chromosome (Chr) 15, accounting for approximately 9% of the variance in adiposity and 14% of the variance in mesenteric depot size. This locus appears to be at the same location as the dietary obesity-3 (Do3) locus controlling body fat content, which was previously identified in an F2 population derived from an SWR/J x AKR/J cross. This is also at the same location as the multigenic obesity-4 (Mob4) locus found in BSB mice, which display spontaneous polygenic obesity. Suggestive linkage also was found at loci close to the single gene mutations Ay on Chr 2 and tub on Chr 7.","['York, B', 'Lei, K', 'West, D B']","['York B', 'Lei K', 'West DB']","['Obesity, Diabetes and Metabolism Section, Pennington Biomedical Research Center, 6400 Perkins Road, Louisiana State University, Baton Rouge, Louisiana 70808, USA.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Mamm Genome,Mammalian genome : official journal of the International Mammalian Genome Society,9100916,"['0 (Dietary Fats)', '0 (Genetic Markers)']",IM,"['Adipose Tissue/anatomy & histology', 'Analysis of Variance', 'Animals', 'Body Weight', '*Chromosome Mapping', 'Crosses, Genetic', '*Dietary Fats', 'Female', 'Genetic Linkage', 'Genetic Markers', 'Genotype', 'Lod Score', 'Male', 'Mice', 'Mice, Inbred C57BL/genetics', 'Mice, Inbred Strains/*genetics', 'Multigene Family', 'Obesity/etiology/*genetics', '*Polymorphism, Genetic', 'Recombination, Genetic']",,,,,1996/09/01 00:00,1996/09/01 00:01,['1996/09/01 00:00'],"['1996/09/01 00:00 [pubmed]', '1996/09/01 00:01 [medline]', '1996/09/01 00:00 [entrez]']",['10.1007/s003359900204 [doi]'],ppublish,Mamm Genome. 1996 Sep;7(9):677-81. doi: 10.1007/s003359900204.,['DK45895/DK/NIDDK NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
20664561,NLM,MEDLINE,20110106,20151119,1523-1755 (Electronic) 0085-2538 (Linking),78,7,2010 Oct,Independent influence of dietary protein on markers of kidney function and disease in obesity.,693-7,10.1038/ki.2010.184 [doi],"Obesity is associated with glomerular hyperfiltration and increased urinary protein excretion, as well as structural and functional changes that lead to kidney disease and failure. Dietary protein mimics obesity's effects on the glomerular filtration rate (GFR) and proteinuria and, in certain circumstances, may have the potential to adversely affect kidney function. Here we tested the hypothesis that dietary protein independently explains elevations in the GFR and proteinuria found in obese persons with a normal serum creatinine. Seventeen patients were randomized in a double-blind, crossover fashion for 1-week periods to high (140 g/day) and low (50 g/day) protein diets with a 1-week washout interval separating these periods. High protein consumption was associated with a very modest but significant increase in the GFR of 5 +/- 6 ml/min. Hence, while dietary protein does modulate kidney parameters, it is unlikely to fully account for the elevations in GFR and proteinuria found in obesity.","['Friedman, Allon N', 'Yu, Zhangsheng', 'Juliar, Beth E', 'Nguyen, James T', 'Strother, Matthew', 'Quinney, Sara K', 'Li, Lang', 'Inman, Margaret', 'Gomez, Gerardo', 'Shihabi, Zak', 'Moe, Sharon']","['Friedman AN', 'Yu Z', 'Juliar BE', 'Nguyen JT', 'Strother M', 'Quinney SK', 'Li L', 'Inman M', 'Gomez G', 'Shihabi Z', 'Moe S']","['Division of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. allfried@iupui.edu']",['eng'],"['Journal Article', 'Randomized Controlled Trial', 'Research Support, N.I.H., Extramural']",United States,Kidney Int,Kidney international,0323470,"['0 (Biomarkers)', '0 (Dietary Proteins)']",IM,"['Adult', 'Biomarkers', 'Cross-Over Studies', 'Dietary Proteins/*administration & dosage', 'Double-Blind Method', 'Female', 'Glomerular Filtration Rate', 'Humans', 'Kidney/*physiopathology', 'Kidney Diseases/*etiology', 'Male', 'Middle Aged', 'Obesity/complications/*physiopathology']",,,,,2010/07/29 06:00,2011/01/07 06:00,['2010/07/29 06:00'],"['2010/07/29 06:00 [entrez]', '2010/07/29 06:00 [pubmed]', '2011/01/07 06:00 [medline]']","['S0085-2538(15)54603-6 [pii]', '10.1038/ki.2010.184 [doi]']",ppublish,Kidney Int. 2010 Oct;78(7):693-7. doi: 10.1038/ki.2010.184. Epub 2010 Jul 21.,['K23 RR019615/RR/NCRR NIH HHS/United States'],20100721,,,,,,['Kidney Int. 2010 Oct;78(7):633-5. PMID: 20842147'],,,,,,,,,,,,
762359,NLM,MEDLINE,19790428,20041117,0002-8223 (Print) 0002-8223 (Linking),74,3,1979 Mar,Attitudes toward obesity and the obese among professionals.,331-6,,"Negative attitudes toward obese patients by health professionals have been attributed to termination of weight reducing attempts. This study measured attitudes concerning the obese held by professional participants in a continuing education conference on causes and treatment of obesity. Substantial variation was found on items comprising obesity-related belief dimensions: (a) Disparaging image of the obese; (b) causes of obesity; and (c) ways to lose weight. Evidence is presented for the association among measures of these dimensions. While background and educational characteristics and conditions of practice were not related to such attitudes, the professional's personal experience with successful weight reduction was the best predictor of favorable attitudes.","['Maiman, L A', 'Wang, V L', 'Becker, M H', 'Finlay, J', 'Simonson, M']","['Maiman LA', 'Wang VL', 'Becker MH', 'Finlay J', 'Simonson M']",,['eng'],['Journal Article'],United States,J Am Diet Assoc,Journal of the American Dietetic Association,7503061,,IM,"['*Attitude of Health Personnel', '*Dietetics/education', 'Female', 'Humans', 'Male', 'Obesity/diet therapy/etiology/*psychology/therapy', 'Patient Care Team', '*Professional-Patient Relations', 'Sex Factors']",,,,,1979/03/01 00:00,1979/03/01 00:01,['1979/03/01 00:00'],"['1979/03/01 00:00 [pubmed]', '1979/03/01 00:01 [medline]', '1979/03/01 00:00 [entrez]']",,ppublish,J Am Diet Assoc. 1979 Mar;74(3):331-6.,,,,,,,,,,,,,,,,,,,,
17514927,NLM,MEDLINE,20070824,20151119,1660-9379 (Print) 1660-9379 (Linking),3,105,2007 Apr 4,[Micronutrition: a global approach for obese patients].,863-7,,"Micronutrition is proposed as a global approach for the obese person and aims at satisfying needs in micronutrients through a Mediterranean diet. This diet is associated with a personalized complementation if needed. First of all, a consultation in micronutrition consists of detecting possible deficits (iron, chromium, iodine, vitamins and mineral) with the means of patients history, questionnaires and, if needed, biological measurements. Micronutritional deficits are frequent in obese patients on restrictive diets. The balance in essential fatty acids (omega 3/6) and the content of essential amino acids (tryptophan) are crucial for the obese patients follow-up. Finally, intestinal flora seems to play an important role in the physiopathology in obesity.","['Chos, D', 'Badel, S', 'Golay, A']","['Chos D', 'Badel S', 'Golay A']","['Institut europeen de dietetique et de micronutrition, 20, rue Emeriau, 75015 Paris. contact@iedm.asso.fr']",['fre'],"['English Abstract', 'Journal Article', 'Review']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,"['0 (Amino Acids, Essential)', '0 (Fatty Acids, Omega-3)', '0 (Micronutrients)', '0 (Vitamins)']",IM,"['Amino Acids, Essential/therapeutic use', '*Diet, Mediterranean', 'Fatty Acids, Omega-3/administration & dosage', 'Humans', 'Intestinal Mucosa/microbiology', '*Micronutrients/administration & dosage/blood', 'Obesity/blood/*diet therapy/*drug therapy/microbiology', 'Surveys and Questionnaires', 'Vitamins/therapeutic use']",,,,,2007/05/23 09:00,2007/08/25 09:00,['2007/05/23 09:00'],"['2007/05/23 09:00 [pubmed]', '2007/08/25 09:00 [medline]', '2007/05/23 09:00 [entrez]']",,ppublish,Rev Med Suisse. 2007 Apr 4;3(105):863-7.,,,,,,,27,,Hicronutrition: une approche globale pour tes patients obeses.,,,,,,,,,,,
9634415,NLM,MEDLINE,19980618,20190619,0036-8075 (Print) 0036-8075 (Linking),280,5368,1998 May 29,Uncoupling proteins provide new clue to obesity's causes.,1369-70,,,"['Gura, T']",['Gura T'],,['eng'],['News'],United States,Science,"Science (New York, N.Y.)",0404511,"['0 (Carrier Proteins)', '0 (Ion Channels)', '0 (Membrane Proteins)', '0 (Membrane Transport Proteins)', '0 (Mitochondrial Proteins)', '0 (Proteins)', '0 (Uncoupling Agents)', '0 (Uncoupling Protein 1)', '0 (Uncoupling Protein 2)', '0 (Uncoupling Protein 3)', '8L70Q75FXE (Adenosine Triphosphate)']",IM,"['Adenosine Triphosphate/metabolism', 'Adipocytes/metabolism', 'Animals', '*Body Weight', 'Carrier Proteins/genetics/*metabolism', '*Energy Metabolism', 'Humans', 'Ion Channels', 'Membrane Proteins/genetics/*metabolism', '*Membrane Transport Proteins', 'Mitochondria/metabolism', '*Mitochondrial Proteins', 'Muscles/metabolism', 'Obesity/*etiology/genetics/metabolism', 'Oxygen Consumption', 'Polymorphism, Genetic', 'Proteins/genetics/*metabolism', 'Uncoupling Agents/metabolism', 'Uncoupling Protein 1', 'Uncoupling Protein 2', 'Uncoupling Protein 3']",,,,,1998/06/20 00:00,1998/06/20 00:01,['1998/06/20 00:00'],"['1998/06/20 00:00 [pubmed]', '1998/06/20 00:01 [medline]', '1998/06/20 00:00 [entrez]']",['10.1126/science.280.5368.1369 [doi]'],ppublish,Science. 1998 May 29;280(5368):1369-70. doi: 10.1126/science.280.5368.1369.,,,,,,,,,,,,,,,,,,,,
14557790,NLM,MEDLINE,20040519,20191108,1363-1950 (Print) 1363-1950 (Linking),6,6,2003 Nov,Neural systems controlling food intake and energy balance in the modern world.,615-20,,"PURPOSE OF REVIEW: Obesity continues to increase around the globe, and creates a major health problem because of its comorbidities such as diabetes and cardiovascular disease. Considering that the major cause of most human obesities is the modern lifestyle in a rapidly changing environment, this suggests that the battle is between brain areas controlling internal metabolic homeostasis and those dealing with cognitive and emotional processing of external information. Thus, this review is intended to bridge this apparent neural dichotomy and highlight possible ways of interactions between these homeostatic and nonhomeostatic systems. RECENT FINDINGS: Rapid progress has been made in identifying the molecular mechanisms underlying the neural circuits regulating food intake and energy balance. Specific populations of peptidergic neurons in the medial hypothalamus can be considered metabolic integrators sensing both short and long-term availability of fuels. These cell groups in turn connect with various other brain regions to orchestrate adaptive responses through changes in food intake, as well as endocrine and autonomic responses. Alternatively, the impact of the environmental changes on ingestive behavior have been documented, and many of the underlying cortico-limbic pathways are starting to be identified. It has been proposed that a switch from instinctual control of energy balance to a more cognitive control will be necessary to stop the obesity epidemic. SUMMARY: The realization that there is nothing wrong with the homeostatic regulatory system in common obesity suggests that a systematic investigation of pathways that link the 'cognitive' with the 'metabolic' brain might be a more promising area of research. Such an investigation would reveal new molecular and cellular mechanisms providing new drug targets, leading to behavioral therapies that are directed more towards the causes of common obesity.","['Berthoud, Hans-Rudolf']",['Berthoud HR'],"['Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA 70808, USA. berthohr@pbrc.edu']",['eng'],"['Journal Article', 'Review']",England,Curr Opin Clin Nutr Metab Care,Current opinion in clinical nutrition and metabolic care,9804399,,IM,"['*Developed Countries', '*Diet', 'Energy Metabolism/*physiology', 'Food Preferences/physiology', 'Homeostasis/physiology', 'Humans', 'Hypothalamus, Middle/*physiology', 'Models, Neurological', 'Neural Pathways/physiology', 'Obesity/*etiology/physiopathology']",,,,,2003/10/15 05:00,2004/05/20 05:00,['2003/10/15 05:00'],"['2003/10/15 05:00 [pubmed]', '2004/05/20 05:00 [medline]', '2003/10/15 05:00 [entrez]']",['10.1097/00075197-200311000-00002 [doi]'],ppublish,Curr Opin Clin Nutr Metab Care. 2003 Nov;6(6):615-20. doi: 10.1097/00075197-200311000-00002.,,,,,,,38,,,,,,,,,,,,,
9025456,NLM,MEDLINE,19970227,20220310,1078-7496 (Print) 1078-7496 (Linking),3,2,1996 Apr-Jun,The obese trauma patient: treatment strategies.,36-44; quiz 45-6,,"Despite numerous unique features in the responses to trauma among obese and morbidly obese patients, very little literature exists on the care of the injured obese person. Factors such as body composition, psychosocial factors, coexisting illness, size, and weight necessitate modifications to treatment protocols in almost all aspects of trauma care. Adaptations in hygiene, pharmacologic management, pulmonary support, rehabilitation, prevention of complications, and injury detection are needed to provide effective care to injured obese people. Body habitus, technical limitations of equipment, and unique injury patterns may increase the risk of missed injuries in this population. This article reviews the needs of the obese trauma patient and recommends strategies for effective multidisciplinary care.","['Goodell, T T']",['Goodell TT'],"['Oregon Health Sciences School of Nursing, Portland, USA.']",['eng'],"['Case Reports', 'Journal Article', 'Review']",United States,J Trauma Nurs,Journal of trauma nursing : the official journal of the Society of Trauma Nurses,9512997,,,"['Adult', 'Humans', 'Male', 'Multiple Trauma/*complications/*nursing', 'Obesity/classification/*complications/*nursing', 'Patient Care Planning', 'Patient Care Team']",,,,,1996/04/01 00:00,1996/04/01 00:01,['1996/04/01 00:00'],"['1996/04/01 00:00 [pubmed]', '1996/04/01 00:01 [medline]', '1996/04/01 00:00 [entrez]']",['10.1097/00043860-199604000-00005 [doi]'],ppublish,J Trauma Nurs. 1996 Apr-Jun;3(2):36-44; quiz 45-6. doi: 10.1097/00043860-199604000-00005.,,,,,,,32,,,,,,,,,,,,,
531736,NLM,MEDLINE,19800423,20190727,0039-6109 (Print) 0039-6109 (Linking),59,6,1979 Dec,Personality and morbid obesity. Implications for dietary management through behavior modification.,1007-15,,"Psychological investigations have failed to reveal a distinct personality type or psychodynamic conflict pattern in moderately and massively obese persons. Many of the psychological problems noted in the obese such as anxiety, depression, and poor self-esteem seem to be the result of, rather than the cause of, the obese state. Morbidly obese persons share an addictive behavior pattern that is also seen in persons with other types of addictions. The extent of their obesity points to the strong substance abuse component of the eating disorder. Behavior modification programs aimed at changing problematic eating patterns and teaching self-management skills in relation to food consumption have been moderately successful and have been shown to result in a mean post-treatment weiht loss of seven to 16 pounds. However, the majority of morbidly obese persons will not lose enough weight to make this an effective treatment program for them.","['Leon, G R']",['Leon GR'],,['eng'],['Journal Article'],United States,Surg Clin North Am,The Surgical clinics of North America,0074243,,IM,"['Behavior Therapy/*methods', 'Feeding Behavior', 'Female', 'Humans', 'Male', 'Obesity/diet therapy/*psychology/therapy', 'Personality']",,,,,1979/12/01 00:00,1979/12/01 00:01,['1979/12/01 00:00'],"['1979/12/01 00:00 [pubmed]', '1979/12/01 00:01 [medline]', '1979/12/01 00:00 [entrez]']","['S0039-6109(16)41980-8 [pii]', '10.1016/s0039-6109(16)41980-8 [doi]']",ppublish,Surg Clin North Am. 1979 Dec;59(6):1007-15. doi: 10.1016/s0039-6109(16)41980-8.,,,,,,,,,,,,,,,,,,,,
6046046,NLM,MEDLINE,19671119,20181113,0008-1264 (Print) 0008-1264 (Linking),106,5,1967 May,The obese person as an adolescent.,368-71,,"Obesity constitutes a major health problem in the United States. Hypertension, atherosclerosis, coronary artery disease, diabetes and gout are often associated with obesity and may be a direct result of persistent obesity in adult life. Obesity frequently has its beginnings in childhood and adolescence. Unfortunately, obesity which develops in early life is a progressive problem. Eighty per cent of overweight children and adolescents will continue to be overweight as adults.(12) Furthermore, adults with a history of obesity in childhood are the most resistant to treatment. Recent studies have shown there is more than one body constitutional type among obese adolescents. Obese adolescents tend to eat less than non-obese controls. While obesity may be found to have many different causative factors, efforts to control this disease may be most successful in the area of primary prevention.","['Garell, D C']",['Garell DC'],,['eng'],['Journal Article'],United States,Calif Med,California medicine,0410260,,IM,"['Adolescent', 'Humans', '*Obesity/complications/metabolism/therapy']",PMC1502710,,,,1967/05/01 00:00,1967/05/01 00:01,['1967/05/01 00:00'],"['1967/05/01 00:00 [pubmed]', '1967/05/01 00:01 [medline]', '1967/05/01 00:00 [entrez]']",,ppublish,Calif Med. 1967 May;106(5):368-71.,,,,,,,,,,,,,,,,,,,,
12181392,NLM,MEDLINE,20030130,20151119,1071-7323 (Print) 1071-7323 (Linking),10,8,2002 Aug,Use of the health and activities limitation index as a measure of quality of life in obesity.,824-32,,"OBJECTIVE: Obesity reduces the quality of life (QOL); however, quantification of obesity's impact on QOL is cumbersome. Utility indices reduce QOL measurements to a single numerical value that can be used in the calculation of Quality-Adjusted Life-Years and the cost effectiveness for obesity treatment. The purpose of this investigation is to assess the sensitivity of the Health and Activities Limitation Index (HALex) utility index to obesity. RESEARCH METHODS AND PROCEDURES: The answers to five questions regarding an individual's self-perception of his or her health status and information about limitation in daily and work activities were collected from 32,440 adults in the 1998 National Health Information Survey. Answers to the questions were scored and converted to a utility index score ranging from 0 (near-death state) to 1 (perfect health) with no limitations. Average values for indices corresponding to differing body mass indices were obtained and significance determined by ANOVA. RESULTS: The utility index for normal weight males and females was 0.86 +/- 0.19 and fell to 0.68 +/- 0.27 for superobese males and 0.60 +/- 0.28 in superobese females. Utility indices fell linearly with increasing body mass index and were lower for respondents having obesity-related comorbid conditions known to reduce the quality of life. DISCUSSION: There is a statistically significant decrease in the QOL with increasing obesity, slightly worse for women compared with men. The Health and Activities Limitation Index can quantitate the effect obesity and its complications have on quality of life.","['Livingston, Edward H', 'Ko, Clifford Y']","['Livingston EH', 'Ko CY']","['Department of Surgery, Veterans Administration Greater Los Angeles Health Care System, Los Angeles, California, USA. elivingston@mednet.ucla.edu']",['eng'],['Journal Article'],United States,Obes Res,Obesity research,9305691,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Body Mass Index', 'Emotions', 'Female', '*Health Status Indicators', 'Humans', 'Male', 'Mental Disorders', 'Middle Aged', 'Obesity/classification/*physiopathology/psychology', '*Quality of Life', 'Sensitivity and Specificity', 'Surveys and Questionnaires', 'Work']",,,,,2002/08/16 10:00,2003/01/31 04:00,['2002/08/16 10:00'],"['2002/08/16 10:00 [pubmed]', '2003/01/31 04:00 [medline]', '2002/08/16 10:00 [entrez]']",['10.1038/oby.2002.111 [doi]'],ppublish,Obes Res. 2002 Aug;10(8):824-32. doi: 10.1038/oby.2002.111.,,,,,,,,,,,,,,,,,,,,
10499495,NLM,MEDLINE,19991012,20131121,0013-7227 (Print) 0013-7227 (Linking),140,10,1999 Oct,Rats with hypothalamic obesity are insensitive to central leptin injections.,4426-33,,"Genetically determined obesities, involving leptin- and melanocortin-signaling pathways, have focused attention on the four medial hypothalamic nuclei as primary sources of feeding- and metabolically-based obesity. All four medial cell groups contain leptin receptors. To determine which of these cell groups normally mediates the effects of leptin on food intake and body weight gain, we injected colchicine bilaterally into each nucleus and determined the pathophysiological effects of disruption and responsivity to leptin injected intracerebroventricularly. Intracerebroventricular injections of leptin in sham-lesioned rats decreased food intake during the dark period, but not during the light period. Lesions of the arcuate (ARC), paraventricular (PVN), and ventromedial (VMN) nuclei all resulted in leptin insensitivity; by contrast, lesions of the dorsomedial nuclei (DMN) augmented sensitivity to leptin on feeding and body weight gain. Although rats with ARC and PVN lesions were obese, they were still capable of reducing caloric efficiency over the 5 days of study and increasing uncoupling protein content in interscapular brown adipose tissue. Caloric efficiency and uncoupling protein content were unchanged in rats with VMN and DMN lesions. Finally, the slope of the relationship between leptin and mesenteric white adipose tissue was increased in rats with VMN lesions and abolished in rats with ARC lesions. Thus, lesions of the ARC, PVN, and VMN produced obesity via separate pathways. We conclude that the medial hypothalamic cell groups, each with a different role in energy balance, are all necessary for normal leptin responsiveness.","['Choi, S', 'Sparks, R', 'Clay, M', 'Dallman, M F']","['Choi S', 'Sparks R', 'Clay M', 'Dallman MF']","['Department of Physiology, University of California, San Francisco 94143-0444, USA. suchoi@itsa.ucsf.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Endocrinology,Endocrinology,0375040,"['0 (Leptin)', '0 (Proteins)', 'SML2Y3J35T (Colchicine)']",IM,"['Animals', 'Body Weight/drug effects', 'Colchicine', 'Dorsomedial Hypothalamic Nucleus/drug effects', 'Eating/drug effects', 'Hypothalamic Diseases/chemically induced/*complications', 'Injections, Intraventricular', 'Leptin', 'Male', 'Obesity/*etiology/pathology/*physiopathology', 'Proteins/administration & dosage/*pharmacology', 'Rats', 'Rats, Sprague-Dawley', 'Ventromedial Hypothalamic Nucleus/drug effects']",,,,,1999/09/28 00:00,1999/09/28 00:01,['1999/09/28 00:00'],"['1999/09/28 00:00 [pubmed]', '1999/09/28 00:01 [medline]', '1999/09/28 00:00 [entrez]']",['10.1210/endo.140.10.7064 [doi]'],ppublish,Endocrinology. 1999 Oct;140(10):4426-33. doi: 10.1210/endo.140.10.7064.,"['2-R25-MH-18910/MH/NIMH NIH HHS/United States', 'DK-09519/DK/NIDDK NIH HHS/United States', 'DK-28172/DK/NIDDK NIH HHS/United States']",,,,,,,,,,,,,,,,,,,
3299706,NLM,MEDLINE,19870825,20220409,0036-8075 (Print) 0036-8075 (Linking),237,4813,1987 Jul 24,Severely impaired adipsin expression in genetic and acquired obesity.,405-8,,"Adipsin, a serine protease homolog, is synthesized and secreted by adipose cells and is found in the bloodstream. The expression of adipsin messenger RNA (mRNA) and protein was analyzed in rodents during metabolic perturbations and in several experimental models of obesity. Adipsin mRNA abundance is increased in adipose tissue during fasting in normal rats and in diabetes due to streptozotocin-induced insulin deficiency. Adipsin mRNA abundance decreased during the continuous infusion of glucose, which induces a hyperglycemic, hyperinsulinemic state that is accompanied by an increased adipose mass; it is suppressed (greater than 100-fold) in two strains of genetically obese mice (db/db and ob/ob), compared to their congenic counterparts, and is also reduced when obesity is induced chemically by injection of monosodium glutamate into newborn mice. Circulating adipsin protein is decreased in these animal models of obesity, as determined by immunoblotting with antisera to adipsin. Little change in adipsin expression is observed in a model of obesity obtained by pure overfeeding of normal rats (cafeteria model). These data suggest a possible role for adipsin in the above-mentioned disordered metabolic states, and raise the possibility that adipsin expression may be used to distinguish obesities that arise from certain genetic or metabolic defects from those that result from pure overfeeding.","['Flier, J S', 'Cook, K S', 'Usher, P', 'Spiegelman, B M']","['Flier JS', 'Cook KS', 'Usher P', 'Spiegelman BM']",,['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Science,"Science (New York, N.Y.)",0404511,"['0 (Antigen-Antibody Complex)', '0 (Immune Sera)', '0 (RNA, Messenger)', 'EC 3.4.- (Endopeptidases)', 'EC 3.4.21.- (Serine Endopeptidases)', 'EC 3.4.21.46 (Complement Factor D)', 'EC 3.4.21.46 (complement factor D, mouse)']",IM,"['Adipose Tissue/enzymology', 'Animals', 'Antigen-Antibody Complex', 'Complement Factor D', 'Endopeptidases/*genetics/metabolism', 'Immune Sera', 'Mice', 'Mice, Obese', 'Obesity/*enzymology/genetics', 'RNA, Messenger/genetics', 'Reference Values', '*Serine Endopeptidases', '*Transcription, Genetic']",,,,,1987/07/24 00:00,1987/07/24 00:01,['1987/07/24 00:00'],"['1987/07/24 00:00 [pubmed]', '1987/07/24 00:01 [medline]', '1987/07/24 00:00 [entrez]']",['10.1126/science.3299706 [doi]'],ppublish,Science. 1987 Jul 24;237(4813):405-8. doi: 10.1126/science.3299706.,"['AM28082/AM/NIADDK NIH HHS/United States', 'AM31405/AM/NIADDK NIH HHS/United States', 'DK34605/DK/NIDDK NIH HHS/United States', 'etc.']",,,,,,,,,,,,,,,,,,,
23259716,NLM,MEDLINE,20130417,20220321,1471-2458 (Electronic) 1471-2458 (Linking),12,,2012 Dec 21,Nutrition and physical activity programs for obesity treatment (PRONAF study): methodological approach of the project.,1100,10.1186/1471-2458-12-1100 [doi],"BACKGROUND: At present, scientific consensus exists on the multifactorial etiopatogenia of obesity. Both professionals and researchers agree that treatment must also have a multifactorial approach, including diet, physical activity, pharmacology and/or surgical treatment. These two last ones should be reserved for those cases of morbid obesities or in case of failure of the previous ones. The aim of the PRONAF study is to determine what type of exercise combined with caloric restriction is the most appropriate to be included in overweigth and obesity intervention programs, and the aim of this paper is to describe the design and the evaluation methods used to carry out the PRONAF study. METHODS/DESIGN: One-hundred nineteen overweight (46 males) and 120 obese (61 males) subjects aged 18-50 years were randomly assigned to a strength training group, an endurance training group, a combined strength + endurance training group or a diet and physical activity recommendations group. The intervention period was 22 weeks (in all cases 3 times/wk of training for 22 weeks and 2 weeks for pre and post evaluation). All subjects followed a hypocaloric diet (25-30% less energy intake than the daily energy expenditure estimated by accelerometry). 29-34% of the total energy intake came from fat, 14-20% from protein, and 50-55% from carbohydrates. The mayor outcome variables assesed were, biochemical and inflamatory markers, body composition, energy balance, physical fitness, nutritional habits, genetic profile and quality of life. 180 (75.3%) subjects finished the study, with a dropout rate of 24.7%. Dropout reasons included: personal reasons 17 (28.8%), low adherence to exercise 3 (5.1%), low adherence to diet 6 (10.2%), job change 6 (10.2%), and lost interest 27 (45.8%). DISCUSSION: Feasibility of the study has been proven, with a low dropout rate which corresponds to the estimated sample size. Transfer of knowledge is foreseen as a spin-off, in order that overweight and obese subjects can benefit from the results. The aim is to transfer it to sports centres. Effectiveness on individual health-related parameter in order to determine the most effective training programme will be analysed in forthcoming publications. TRIAL REGISTRATION: ClinicalTrials.gov NCT01116856.","['Zapico, Augusto G', 'Benito, Pedro J', 'Gonzalez-Gross, Marcela', 'Peinado, Ana B', 'Morencos, Esther', 'Romero, Blanca', 'Rojo-Tirado, Miguel A', 'Cupeiro, Rocio', 'Szendrei, Barbara', 'Butragueno, Javier', 'Bermejo, Maite', 'Alvarez-Sanchez, Maria', 'Garcia-Fuentes, Miguel', 'Gomez-Candela, Carmen', 'Bermejo, Laura M', 'Fernandez-Fernandez, Ceila', 'Calderon, Francisco J']","['Zapico AG', 'Benito PJ', 'Gonzalez-Gross M', 'Peinado AB', 'Morencos E', 'Romero B', 'Rojo-Tirado MA', 'Cupeiro R', 'Szendrei B', 'Butragueno J', 'Bermejo M', 'Alvarez-Sanchez M', 'Garcia-Fuentes M', 'Gomez-Candela C', 'Bermejo LM', 'Fernandez-Fernandez C', 'Calderon FJ']","['Department of Health and Human Performance, Faculty of Physical Activity and Sport Sciences-INEF, Technical University of Madrid, C/Martin Fierro 7, Madrid 28040, Spain. azapico@edu.ucm.es']",['eng'],"['Journal Article', 'Randomized Controlled Trial', ""Research Support, Non-U.S. Gov't""]",England,BMC Public Health,BMC public health,100968562,,IM,"['Adolescent', 'Adult', '*Caloric Restriction', 'Combined Modality Therapy/methods', 'Exercise Therapy/*methods', 'Health Promotion/*methods', 'Humans', 'Male', 'Middle Aged', 'Obesity/diet therapy/*therapy', 'Overweight/diet therapy/*therapy', 'Program Evaluation/methods', 'Research Design', 'Young Adult']",PMC3577471,,,,2012/12/25 06:00,2013/04/19 06:00,['2012/12/25 06:00'],"['2012/12/03 00:00 [received]', '2012/12/17 00:00 [accepted]', '2012/12/25 06:00 [entrez]', '2012/12/25 06:00 [pubmed]', '2013/04/19 06:00 [medline]']","['1471-2458-12-1100 [pii]', '10.1186/1471-2458-12-1100 [doi]']",epublish,BMC Public Health. 2012 Dec 21;12:1100. doi: 10.1186/1471-2458-12-1100.,,20121221,,,,,,,,,,['ClinicalTrials.gov/NCT01116856'],,,,,,,,
23709177,NLM,MEDLINE,20141124,20140416,1473-4257 (Electronic) 0306-6800 (Linking),40,5,2014 May,Is it acceptable to use animals to model obese humans? A critical discussion of two arguments against the use of animals in obesity research.,320-4,10.1136/medethics-2011-100368 [doi],"Animal use in medical research is widely accepted on the basis that it may help to save human lives and improve their quality of life. Recently, however, objections have been made specifically to the use of animals in scientific investigation of human obesity. This paper discusses two arguments for the view that this form of animal use, unlike some other forms of animal-based medical research, cannot be defended. The first argument leans heavily on the notion that people themselves are responsible for developing obesity and so-called 'lifestyle' diseases; the second involves the claim that animal studies of obesity's causes and therapies distract attention from preventive efforts. Drawing on both empirical data and moral reasoning, we argue that the relevant attributions of responsibility and claims about distraction are not plausible, and that, therefore, there is no reason to single out the use of animals in obesity research as especially problematic.","['Lund, Thomas Boker', 'Sorensen, Thorkild I A', 'Olsson, I Anna S', 'Hansen, Axel Kornerup', 'Sandoe, Peter']","['Lund TB', 'Sorensen TI', 'Olsson IA', 'Hansen AK', 'Sandoe P']","['Department of Food and Resource Economics, University of Copenhagen, , Frederiksberg, Denmark.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,J Med Ethics,Journal of medical ethics,7513619,,IM,"['Animal Experimentation/*ethics', 'Animals', '*Disease Models, Animal', 'Ethics, Research', 'Humans', '*Life Style', '*Obesity/prevention & control/therapy', '*Personal Autonomy', 'Primary Prevention', 'Reproducibility of Results', '*Social Responsibility']",,['NOTNLM'],"['Animal Experimentation', 'Public Policy', 'Research Ethics']",,2013/05/28 06:00,2014/12/15 06:00,['2013/05/28 06:00'],"['2013/05/28 06:00 [entrez]', '2013/05/28 06:00 [pubmed]', '2014/12/15 06:00 [medline]']","['medethics-2011-100368 [pii]', '10.1136/medethics-2011-100368 [doi]']",ppublish,J Med Ethics. 2014 May;40(5):320-4. doi: 10.1136/medethics-2011-100368. Epub 2013 May 24.,,20130524,,,,,,,,,,,,,,,,,,
21818149,NLM,MEDLINE,20120703,20211020,1930-739X (Electronic) 1930-7381 (Print) 1930-7381 (Linking),20,4,2012 Apr,Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans.,802-10,10.1038/oby.2011.208 [doi],"Patients with type 2 diabetes (T2DM), particularly women, are at risk for heart failure. Myocardial substrate metabolism derangements contribute to cardiac dysfunction in diabetic animal models. The purpose of this study was to determine the effects of diabetes and sex on myocardial metabolism and diastolic function in humans, separate from those of obesity. Thirty-six diabetic subjects (22 women) and 36 nondiabetic, BMI-matched subjects (21 women) underwent positron emission tomography (myocardial metabolism) and echocardiography (structure, function). Myocardial blood flow and oxygen consumption (MVO(2)) were higher in women than men (P = 0.003 and <0.0001, respectively). Plasma fatty acid (FA) levels were higher in diabetics (vs. obese, P < 0.003) and sex and diabetes status interacted in its prediction (P = 0.03). Myocardial FA utilization, oxidation, and esterification were higher and percent FA oxidation lower in diabetics (vs. obese, P = 0.0004, P = 0.007, P = 0.002, P = 0.02). FA utilization and esterification were higher and percent FA oxidation lower in women (vs. men, P = 0.03, P = 0.01, P = 0.03). Diabetes and sex did not affect myocardial glucose utilization, but myocardial glucose uptake/plasma insulin was lower in the diabetics (P = 0.04). Left ventricular relaxation was lower in diabetics (P < 0.0001) and in men (P = 0.001), and diabetes and sex interacted in its prediction (P = 0.03). Sex, T2DM, or their interaction affect myocardial blood flow, MVO(2), FA metabolism, and relaxation separate from obesity's effects. Sexually dimorphic myocardial metabolic and relaxation responses to diabetes may play a role in the known cardiovascular differences between men and women with diabetes.","['Peterson, Linda R', 'Saeed, Ibrahim M', 'McGill, Janet B', 'Herrero, Pilar', 'Schechtman, Kenneth B', 'Gunawardena, Ratnasiri', 'Recklein, Carol L', 'Coggan, Andrew R', 'DeMoss, Amanda J', 'Dence, Carmen S', 'Gropler, Robert J']","['Peterson LR', 'Saeed IM', 'McGill JB', 'Herrero P', 'Schechtman KB', 'Gunawardena R', 'Recklein CL', 'Coggan AR', 'DeMoss AJ', 'Dence CS', 'Gropler RJ']","['Division of Cardiovascular Diseases, Department of Medicine, Washington University School of Medicine, St Louis, Missouri, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",United States,Obesity (Silver Spring),"Obesity (Silver Spring, Md.)",101264860,"['0 (Blood Glucose)', '0 (Fatty Acids)']",IM,"['Adult', 'Blood Glucose/metabolism', 'Body Mass Index', 'Cross-Sectional Studies', 'Diabetes Mellitus, Type 2/diagnosis/*metabolism/physiopathology', 'Echocardiography', 'Fatty Acids/metabolism', 'Female', 'Humans', 'Insulin Resistance', 'Male', 'Middle Aged', 'Muscle Relaxation', 'Myocardium/*metabolism', 'Obesity/diagnosis/*metabolism/physiopathology', 'Oxygen Consumption', 'Positron-Emission Tomography', 'Sex Factors', 'Ventricular Dysfunction, Left/diagnosis/*metabolism/physiopathology']",PMC3314727,,,['DISCLOSURES The authors have no conflicts to disclose.'],2011/08/06 06:00,2012/07/04 06:00,['2011/08/06 06:00'],"['2011/08/06 06:00 [entrez]', '2011/08/06 06:00 [pubmed]', '2012/07/04 06:00 [medline]']","['oby2011208 [pii]', '10.1038/oby.2011.208 [doi]']",ppublish,Obesity (Silver Spring). 2012 Apr;20(4):802-10. doi: 10.1038/oby.2011.208. Epub 2011 Aug 4.,"['5 P60 DK020579/DK/NIDDK NIH HHS/United States', 'R01 HL073120-05/HL/NHLBI NIH HHS/United States', 'UL1 RR024992/RR/NCRR NIH HHS/United States', 'K12 HD001459-02/HD/NICHD NIH HHS/United States', 'P01 HL013851/HL/NHLBI NIH HHS/United States', 'K12 HD001459/HD/NICHD NIH HHS/United States', 'P60 DK020579/DK/NIDDK NIH HHS/United States', 'P30 DK020579/DK/NIDDK NIH HHS/United States', 'P30 DK056341-11/DK/NIDDK NIH HHS/United States', 'P01 HL013851-42/HL/NHLBI NIH HHS/United States', 'P30 DK056341/DK/NIDDK NIH HHS/United States', 'UL1 RR024992-03/RR/NCRR NIH HHS/United States', 'R01 HL073120/HL/NHLBI NIH HHS/United States', 'HD145902/HD/NICHD NIH HHS/United States', 'P01-HL13851/HL/NHLBI NIH HHS/United States', 'R01-HL073120/HL/NHLBI NIH HHS/United States', 'P60 DK020579-30/DK/NIDDK NIH HHS/United States', 'DK 56341/DK/NIDDK NIH HHS/United States']",20110804,,,,['NIHMS339937'],,,,,,"['ClinicalTrials.gov/NCT00572624', 'ClinicalTrials.gov/NCT00577590']",,,,,,,,
16354528,NLM,MEDLINE,20060420,20220330,0960-8923 (Print) 0960-8923 (Linking),15,10,2005 Nov-Dec,Alterations in T-cell subset frequency in peripheral blood in obesity.,1463-8,,"BACKGROUND: Obesity affects the regulation of immune and inflammatory responses. This study characterizes differences in peripheral blood lymphocyte phenotype in obese humans. METHODS: Frequencies of lymphocyte subsets among peripheral blood mononuclear cells were compared between 10 obese (BMI > or = 35) and 10 lean subjects, as determined by antibodies directed against cluster differentiation (CD) markers. RESULTS: Obese patients demonstrated an increased frequency of CD3+CD4+ T-cells (mean difference 12%, P=0.004), a decreased frequency of CD3+CD8+ T-cells (mean difference 9.4%, P=0.016) and an increased frequency of CD3+CD8+CD95+ T-cells (mean difference 13.3%, P=0.032). No other differences among T-cell or monocyte subsets were noted. CONCLUSIONS: Obesity is associated with alterations in frequencies of peripheral CD4+ and CD8+ T-cells and aberrations in the expression of CD95 among CD8+ T-cells. These data suggest both CD4+ and CD8+ T-cell compartments, as well as the regulation of CD95 expression on CD8+ T-cells, as targets for further study into obesity's effects on the immune system.","[""O'Rourke, Robert W"", 'Kay, Thomas', 'Scholz, Mark H', 'Diggs, Brian', 'Jobe, Blair A', 'Lewinsohn, David M', 'Bakke, Antony C']","[""O'Rourke RW"", 'Kay T', 'Scholz MH', 'Diggs B', 'Jobe BA', 'Lewinsohn DM', 'Bakke AC']","['Department of Surgery, Oregon Health & Science University, Portland, OR 97239, USA. orourkro@ohsu.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",United States,Obes Surg,Obesity surgery,9106714,"['0 (Antigens, CD)']",IM,"['Adult', 'Antigens, CD/*blood', 'Body Mass Index', 'Case-Control Studies', 'Female', 'Humans', 'Lymphocyte Count', 'Middle Aged', 'Obesity, Morbid/*blood/immunology', 'T-Lymphocyte Subsets/*metabolism']",,,,,2005/12/16 09:00,2006/04/21 09:00,['2005/12/16 09:00'],"['2005/12/16 09:00 [pubmed]', '2006/04/21 09:00 [medline]', '2005/12/16 09:00 [entrez]']",['10.1381/096089205774859308 [doi]'],ppublish,Obes Surg. 2005 Nov-Dec;15(10):1463-8. doi: 10.1381/096089205774859308.,['5 M01 RR000334/RR/NCRR NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
24783734,NLM,MEDLINE,20140701,20140502,1660-9379 (Print) 1660-9379 (Linking),10,423,2014 Mar 26,[Role of the psychiatrist in the management of obesity].,"686-8, 690",,"The management of obese patients is complex and often generates a sense of powerlessness on the part of caregivers. Psychopathologies associated with obesity are omnipresent and require greater attention from the somaticians to better assist their patients in this chronic disease and to guide their care. Despite the often legitimate reluctance of patients, it remains fundamental to question the symptom, weight, beyond any prejudice. Obesity, with or without bypass project, requires support in the long term by a multidisciplinary team with an holistic approach in order to avoid creating a new failure as is the case with the methods of food restrictions perpetuate eating disorders.","['Corminboeuf, Y', 'Giusti, V']","['Corminboeuf Y', 'Giusti V']",,['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Body Mass Index', 'Humans', 'Mental Disorders/psychology/therapy', 'Obesity/*psychology/*therapy', 'Patient Care Team', ""*Physician's Role"", '*Psychiatry', '*Psychotherapy', 'Risk Factors']",,,,,2014/05/03 06:00,2014/07/02 06:00,['2014/05/03 06:00'],"['2014/05/03 06:00 [entrez]', '2014/05/03 06:00 [pubmed]', '2014/07/02 06:00 [medline]']",,ppublish,"Rev Med Suisse. 2014 Mar 26;10(423):686-8, 690.",,,,,,,,,Role de l'approche psychologique dans la prise en charge des patients obeses.,,,,,,,,,,,
8128423,NLM,MEDLINE,19940411,20061115,0040-5957 (Print) 0040-5957 (Linking),48,4,1993 Jul-Aug,[Pharmacokinetic changes in obesity].,397-402,,"The obesity-induced kinetic changes have been studied only from twenty years, despite the frequency of such a pathological state; thus many work need to be done in this area. The tissular distribution of drugs may depend on the obesity-induced changes in the body composition taking into account the degree of drug liposolubility. Some other factors such as protein binding and regional blood flow may also be involved in tissular diffusion of drugs in obesity. Drug binding to albumin does not seem to be modified in obesity. On the contrary, the protein binding of some basic drugs is increased because of the rise of the plasma alpha 1 glycoprotein acid levels in obesity. Although the cardiac output and the total blood volume are increased in obese patients, the blood flow recalculated according to the adipose tissue weight, is less than in non obese subjects: this point could reduce the diffusion of some lipophilic drugs. More complex are the obesity induced changes in the hepatic clearance of drugs: some reactions such as oxydo-reduction and acetylation do not vary, some others such as sulfoconjugation or glucuronoconjugation are increased. The renal clearance is increased for drugs totally eliminated by glomerular filtration and for drugs which are both filtrated and secreted. According to the liposolubility characteristic of a drug and its clearance, one can calculate the loading dose and the maintenance dose.","['Girardin, E', 'Bruguerolle, B']","['Girardin E', 'Bruguerolle B']","['Laboratoire de Pharmacologie Medicale et Clinique, Faculte de Medecine, Marseille.']",['fre'],"['English Abstract', 'Journal Article']",France,Therapie,Therapie,0420544,,IM,"['Female', 'Humans', 'Male', 'Obesity/drug therapy/*metabolism/physiopathology', 'Pharmacokinetics', 'Tissue Distribution']",,,,,1993/07/01 00:00,1993/07/01 00:01,['1993/07/01 00:00'],"['1993/07/01 00:00 [pubmed]', '1993/07/01 00:01 [medline]', '1993/07/01 00:00 [entrez]']",,ppublish,Therapie. 1993 Jul-Aug;48(4):397-402.,,,,,,,,,"Modifications, pharmacocinetiques dans l'obesite.",,,,,,,,,,,
778504,NLM,MEDLINE,19760901,20041117,0090-6956 (Print) 0090-6956 (Linking),9,,1976,The obese patient.,1-450,,,"['Bray, G A']",['Bray GA'],,['eng'],"['Journal Article', 'Review']",United States,Major Probl Intern Med,Major problems in internal medicine,1262076,['0 (Appetite Depressants)'],IM,"['Adipose Tissue/metabolism', 'Animals', 'Appetite Depressants/therapeutic use', 'Diet, Reducing', 'Energy Metabolism', 'Exercise Therapy', 'Feeding Behavior', 'Humans', '*Obesity/complications/diet therapy/drug therapy/etiology/metabolism/surgery']",,,,,1976/01/01 00:00,1976/01/01 00:01,['1976/01/01 00:00'],"['1976/01/01 00:00 [pubmed]', '1976/01/01 00:01 [medline]', '1976/01/01 00:00 [entrez]']",,ppublish,Major Probl Intern Med. 1976;9:1-450.,,,,,,,999,,,,,,,,,,,,,
8433952,NLM,MEDLINE,19930316,20190713,0032-5481 (Print) 0032-5481 (Linking),93,2,1993 Feb,When your obese patient can't lose weight.,"155-62, 168-9, 172",,"""I can't lose weight"" is a frequent refrain among obese patients. Even though a patient desires to lose extra pounds and apparently is complying with his or her physician's recommendations, the expected weight loss often does not occur. To achieve a more successful outcome in obese patients, the authors suggest that physicians become active rather than passive participants in the weight loss regimen.","['Neil, K M', 'Kushner, R F']","['Neil KM', 'Kushner RF']",['University of Chicago Nutrition and Weight Control Clinic.'],['eng'],"['Case Reports', 'Journal Article', 'Review']",England,Postgrad Med,Postgraduate medicine,0401147,,IM,"['Animals', 'Diet, Reducing', 'Energy Intake', 'Exercise', 'Humans', 'Male', 'Middle Aged', 'Obesity/etiology/physiopathology/psychology/*therapy', 'Treatment Refusal', 'Weight Loss']",,,,,1993/02/01 00:00,1993/02/01 00:01,['1993/02/01 00:00'],"['1993/02/01 00:00 [pubmed]', '1993/02/01 00:01 [medline]', '1993/02/01 00:00 [entrez]']",['10.1080/00325481.1993.11701606 [doi]'],ppublish,"Postgrad Med. 1993 Feb;93(2):155-62, 168-9, 172. doi: 10.1080/00325481.1993.11701606.",,,,,,,27,,,,,,,,,,,,,
11026089,NLM,MEDLINE,20001113,20171116,0040-5930 (Print) 0040-5930 (Linking),57,8,2000 Aug,[Weight reduction through physical exercise and diet--how much is enough and is too much possible?].,516-21,,Presently available literature reveals that a combination of approach has the potential to induce a body weight loss and favor weight maintenance in a reduced-obese state while also normalizing the metabolic profile of these individuals. Further weight loss is thus no longer justified and might be harmful to weight maintenance and health although these individuals could still be diagnosed as obese according to actual classifying criteria for defining obesity.,"['Doucet, E', 'Tremblay, A']","['Doucet E', 'Tremblay A']","['Department of Social and Preventive Medicine, Laval University, Ste-Foy, Quebec, Canada.']",['ger'],"['Journal Article', 'Review']",Switzerland,Ther Umsch,Therapeutische Umschau. Revue therapeutique,0407224,['0 (Anti-Obesity Agents)'],IM,"['Anti-Obesity Agents/therapeutic use', 'Body Weight', 'Contraindications', 'Diet, Reducing/*methods', 'Energy Metabolism', '*Exercise', 'Humans', '*Lipid Metabolism', 'Obesity/diet therapy/drug therapy/metabolism/psychology/*therapy', 'Weight Loss']",,,,,2000/10/12 11:00,2001/02/28 10:01,['2000/10/12 11:00'],"['2000/10/12 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/10/12 11:00 [entrez]']",['10.1024/0040-5930.57.8.516 [doi]'],ppublish,Ther Umsch. 2000 Aug;57(8):516-21. doi: 10.1024/0040-5930.57.8.516.,,,,,,,43,,Verminderung des Korpergewichtes durch korperliche Aktivitat und Ernahrung--wieviel ist genug und ist ein Zuviel moglich?,,,,,,,,,,,
35902180,NLM,MEDLINE,20220801,20221007,1558-3597 (Electronic) 0735-1097 (Linking),80,5,2022 Aug 2,Outcomes of Metabolic Surgery in the Elderly Obese Population.,e35,S0735-1097(22)05165-8 [pii] 10.1016/j.jacc.2022.05.026 [doi],,"['van Veldhuisen, Sophie L', 'Gorter, Thomas M']","['van Veldhuisen SL', 'Gorter TM']",,['eng'],"['Comment', 'Letter']",United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,,IM,"['Aged', '*Bariatric Surgery', 'Humans', 'Obesity/complications/epidemiology/surgery']",,,,,2022/07/29 06:00,2022/08/02 06:00,['2022/07/28 21:04'],"['2022/05/16 00:00 [received]', '2022/05/17 00:00 [accepted]', '2022/07/28 21:04 [entrez]', '2022/07/29 06:00 [pubmed]', '2022/08/02 06:00 [medline]']","['S0735-1097(22)05165-8 [pii]', '10.1016/j.jacc.2022.05.026 [doi]']",ppublish,J Am Coll Cardiol. 2022 Aug 2;80(5):e35. doi: 10.1016/j.jacc.2022.05.026.,,,,,,,,,,,['J Am Coll Cardiol. 2022 Apr 19;79(15):1429-1437. PMID: 35422238'],,,,,,,,,
18328051,NLM,MEDLINE,20080617,20151119,1365-2524 (Electronic) 0966-0410 (Linking),16,3,2008 May,"Gender, ethnicity, culture and social class influences on childhood obesity among Australian schoolchildren: implications for treatment, prevention and community education.",282-90,10.1111/j.1365-2524.2008.00768.x [doi],"The aim of the study was to explore the associations between obesity, weight perceptions and gender, ethnicity, culture and social class in a large national study of Australian school children. Primary and high schools (N = 47) were recruited from every state and territory of Australia and included 7889 children from government, private and Catholic schools (82% response rate) in August-November, 2006. The socioeconomic status (SES) of schools was based on a government survey of total family income. A questionnaire completed by students, measured demographic details of gender, age, weight perceptions and ethnic/cultural background. Height and weight were measured by trained research assistants. Outcome measures included body mass index (BMI), prevalence of obesity, overweight, weight perceptions. Prevalence of obesity was 6.4% of males and 5.6% of females in primary school students (P = 0.34). More high school males were obese than females (7.7% vs. 5.7%, P = 0.001). Obesity was more prevalent among students from Pacific Islander backgrounds. Adolescents who were most likely to be obese were boys and girls of low SES or Pacific Islander or Middle Eastern/Arabic background. The least likely to be obese were Anglo/Caucasian or Asian students and in particular, the girls. Obese female adolescents from Aboriginal, Middle Eastern/Arabic and Pacific Islander backgrounds were less likely than their Caucasian or Asian peers to perceive themselves as 'too fat'.Those working in clinical, community or educational settings with young people and in particular, obese young people, should be aware that obesity is likely to be more prevalent, more culturally acceptable and perhaps more desirable among children and teens from low SES communities and/or Middle Eastern and Pacific Islander backgrounds. Health and social work professionals should be careful not to exaggerate the risks of overweight or obesity or inadvertently create weight concerns among young people. The different body image perceptions identified in this study should be taken into account when planning clinical, community or preventive initiatives among children or adolescents from varying ethnic groups.","[""O'Dea, Jennifer A""]","[""O'Dea JA""]","[""Faculty of Education & Social Work, University of Sydney, NSW, Australia. j.o'dea@edfac.usyd.edu.au""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Health Soc Care Community,Health & social care in the community,9306359,,IM,"['Adolescent', 'Attitude to Health', 'Australia/epidemiology', 'Body Image', 'Child', '*Culture', 'Female', 'Humans', 'Male', 'Obesity/epidemiology/*ethnology/prevention & control/therapy', '*Social Class', 'Surveys and Questionnaires']",,,,,2008/03/11 09:00,2008/06/18 09:00,['2008/03/11 09:00'],"['2008/03/11 09:00 [pubmed]', '2008/06/18 09:00 [medline]', '2008/03/11 09:00 [entrez]']","['HSC768 [pii]', '10.1111/j.1365-2524.2008.00768.x [doi]']",ppublish,Health Soc Care Community. 2008 May;16(3):282-90. doi: 10.1111/j.1365-2524.2008.00768.x. Epub 2008 Mar 5.,,20080305,,,,,,,,,,,,,,,,,,
3882910,NLM,MEDLINE,19850418,20180330,0022-3166 (Print) 0022-3166 (Linking),115,3,1985 Mar,Description of a new model of genetic obesity: the dbPas mouse.,327-33,,"A new strain of genetically obese mouse, the dbPas mouse, has been studied in terms of fat pad cellularity, serum parameters and thermogenesis. This obesity was observed in the inbred DW strain of mice at the Institut Pasteur-France, and is due to a recessive mutation on chromosome 4 at the diabetes locus. The mice became grossly obese, gaining weight until at least 16 mo of age. By 6 mo of age they exhibited hyperphagia, hypercholesterolemia, severe hyperinsulinemia, hypertrophy and hyperplasia of adipocytes, and impaired fertility. In contrast with other diabetic strains of mice, glycemia was normal in females and slightly elevated in males. This result indicates that the mutation of the db locus does not necessarily lead to a frank diabetes. Body temperature was normal either at 22 degrees C or after a cold exposure at 4 degrees C. GDP (guanosine diphosphate) binding to brown adipose tissue mitochondria was normal in obese mice as compared to lean. These data differentiate this model from other genetic obesities in mice and rats. This new model of genetic obesity offers interesting characteristics for the study of obesity.","['Aubert, R', 'Herzog, J', 'Camus, M C', 'Guenet, J L', 'Lemonnier, D']","['Aubert R', 'Herzog J', 'Camus MC', 'Guenet JL', 'Lemonnier D']",,['eng'],['Journal Article'],United States,J Nutr,The Journal of nutrition,0404243,['0 (Insulin)'],IM,"['Adipose Tissue/cytology', 'Animals', 'Body Temperature Regulation', 'Diabetes Mellitus, Experimental/genetics/metabolism/pathology', 'Disease Models, Animal', 'Female', 'Insulin/blood', 'Male', 'Mice', 'Mice, Obese/blood/growth & development/*metabolism', 'Obesity/blood/*genetics/metabolism']",,,,,1985/03/01 00:00,1985/03/01 00:01,['1985/03/01 00:00'],"['1985/03/01 00:00 [pubmed]', '1985/03/01 00:01 [medline]', '1985/03/01 00:00 [entrez]']",['10.1093/jn/115.3.327 [doi]'],ppublish,J Nutr. 1985 Mar;115(3):327-33. doi: 10.1093/jn/115.3.327.,,,,,,,,,,,,,,,,,,,,
2031488,NLM,MEDLINE,19910620,20180507,0002-9165 (Print) 0002-9165 (Linking),53,6 Suppl,1991 Jun,Current understanding of the etiology of obesity: genetic and nongenetic factors.,1561S-1565S,10.1093/ajcn/53.6.1561S [doi],"Four types of human obesities are defined by topography of fat deposition. The focus of the paper is on the genetic determinants and the nongenetic correlates of the first type, which is commonly defined as excess weight-for-height or excess body fat without a particular concentration of fat in a given area of the body. The heritability of fat mass or percent body fat derived from underwater-weighing assessment of body density reaches approximately 25% of the age- and gender-adjusted phenotypic variance. The within-identical-twin-pair resemblance in the response to a standardized overfeeding protocol emphasizes the importance of the genotype in determining individual differences in body weight and body composition. In this regard, the proneness to store energy primarily as fat or as lean tissue is a major determinant of the response to a caloric surplus.","['Bouchard, C']",['Bouchard C'],"['Physical Activity Sciences Laboratory, Laval University, Ste-Foy, Quebec, Canada.']",['eng'],['Journal Article'],United States,Am J Clin Nutr,The American journal of clinical nutrition,0376027,['0 (Dietary Fats)'],IM,"['*Adipose Tissue', 'Age Factors', '*Body Composition', '*Body Mass Index', 'Cultural Characteristics', 'Dietary Fats/adverse effects', 'Energy Intake', 'Energy Metabolism', 'Exercise', 'Female', 'Humans', 'Male', 'Models, Biological', 'Obesity/classification/epidemiology/*genetics', 'Phenotype', 'Risk Factors', 'Sex Factors']",,,,,1991/06/01 00:00,1991/06/01 00:01,['1991/06/01 00:00'],"['1991/06/01 00:00 [pubmed]', '1991/06/01 00:01 [medline]', '1991/06/01 00:00 [entrez]']",['10.1093/ajcn/53.6.1561S [doi]'],ppublish,Am J Clin Nutr. 1991 Jun;53(6 Suppl):1561S-1565S. doi: 10.1093/ajcn/53.6.1561S.,,,,,,,,,,,,,,,,,,,,
19772195,NLM,MEDLINE,20091117,20171116,1660-9379 (Print) 1660-9379 (Linking),5,214,2009 Aug 26,"[Metabolically obese normal-weight individuals and metabolically healthy, but obese, subjects].","1644-6, 1648-9",,"The relationships between body weight and metabolic abnormalities are not so simple. Indeed, there are metabolically obese normal-weight (MONW) individuals, who are frequently not detected because of a falsely reassuring body weight, and, in contrast, metabolically healthy, but obese, people (MHO). The different topography and hormonal-metabolic and pro-inflammatory activities of various adipose depots seem to play a major role to explain this paradox. The present review paper aims at describing the main principles of management of MONW individuals, with the objective to reduce the higher risk of type 2 diabetes and cardiovascular disease, and to discuss both the advantages and uncertainties of a classical weight-reducing approach in MHO people.","['Beck, E', 'Esser, N', 'Paquot, N', 'Scheen, A J']","['Beck E', 'Esser N', 'Paquot N', 'Scheen AJ']","['Universite de Liege, Service de diabetologie, nutrition et maladies metaboliques, Departement de medecine, CHU Sart Tilman, 4000 Liege, Belgique.']",['fre'],"['Journal Article', 'Review']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,['0 (Anti-Obesity Agents)'],IM,"['Adiposity', 'Anthropometry', 'Anti-Obesity Agents/therapeutic use', 'Body Fat Distribution', '*Body Mass Index', '*Body Weight', 'Cardiovascular Diseases/metabolism/prevention & control', 'Diabetes Mellitus, Type 2/metabolism/prevention & control', '*Exercise', '*Health Behavior', 'Humans', 'Metabolic Syndrome/metabolism/*prevention & control', 'Obesity/*metabolism/*prevention & control/therapy', 'Risk Factors', 'Treatment Outcome', 'Waist Circumference']",,,,,2009/09/24 06:00,2009/11/18 06:00,['2009/09/24 06:00'],"['2009/09/24 06:00 [entrez]', '2009/09/24 06:00 [pubmed]', '2009/11/18 06:00 [medline]']",,ppublish,"Rev Med Suisse. 2009 Aug 26;5(214):1644-6, 1648-9.",,,,,,,46,,"Sujets de poids normal ""metaboliquement obeses"" et sujets obeses ""metaboliquement sains"".",,,,,,,,,,,
333945,NLM,MEDLINE,19771130,20171213,0002-9513 (Print) 0002-9513 (Linking),233,3,1977 Sep,Comparison of metabolic alterations in hypothalamic and high fat diet-induced obesity.,R162-8,,"The heterogeneous nature of the experimental obesities induced by ventromedial hypothalamic (VMH) lesion and high fat diet (HFD) have been demonstrated by comparing VMH-lesioned and sham-operated rats fed a HFD or low fat diet (LFD). VMH rats had increased fat mass serum insulin and serum triglycerides but lower serum glucagon and smaller salivary glands than sham-operated animals. The body weight of HFD obese rats was intermediate between VMH and sham-operated animals on the LDF. Liver and fat pad weights showed effects of lesions and diet. Diet did not affect plasma glucagon or insulin. Pair-feeding VMH rats with sham-operated rats prevented weight gain but did not prevent the increase in insulin and fall in glucagon. Studies of insulin secretion from isolated perifused islets showed that basal and both phases of stimulated secretion were significantly increased in VMH groups. The changes in plasma insulin, plasma glucagon, and salivary gland weight in VMH groups are interpreted as showing decreased activity of the sympathetic nervous system following VMH lesions.","['Inoue, S', 'Campfield, L A', 'Bray, G A']","['Inoue S', 'Campfield LA', 'Bray GA']",,['eng'],"['Comparative Study', 'Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Physiol,The American journal of physiology,0370511,"['0 (Blood Glucose)', '0 (Dietary Fats)', '0 (Insulin)', '9007-92-5 (Glucagon)']",IM,"['Animals', 'Blood Glucose', 'Denervation', '*Dietary Fats', 'Female', 'Glucagon/blood', 'Hypothalamus/*physiology', 'Insulin/blood', 'Islets of Langerhans/metabolism', 'Mathematics', 'Models, Biological', 'Obesity/etiology/*metabolism', 'Rats']",,,,,1977/09/01 00:00,1977/09/01 00:01,['1977/09/01 00:00'],"['1977/09/01 00:00 [pubmed]', '1977/09/01 00:01 [medline]', '1977/09/01 00:00 [entrez]']",['10.1152/ajpregu.1977.233.3.R162 [doi]'],ppublish,Am J Physiol. 1977 Sep;233(3):R162-8. doi: 10.1152/ajpregu.1977.233.3.R162.,,,,,,,,,,,,,,,,,,,,
3812777,NLM,MEDLINE,19870324,20171213,0002-9513 (Print) 0002-9513 (Linking),252,2 Pt 2,1987 Feb,"Diet, lighting, and food intake affect norepinephrine turnover in dietary obesity.",R402-8,,"The effects of dietary fat content, lighting cycle, and feeding time on norepinephrine turnover in interscapular brown adipose tissue, heart, and pancreas, and on blood 3-hydroxybutyrate, serum glucose, insulin, and corticosterone have been studied in two strains of rats that differ in their susceptibility to dietary obesity. S 5B/Pl rats, which are resistant to dietary obesity, have a more rapid turnover of norepinephrine in interscapular brown adipose tissue and heart and a greater increase in the concentration of norepinephrine in brown fat when eating a high-fat diet than do Osborne-Mendel rats, which are sensitive to fat-induced obesity. Light cycle and feeding schedule are important modulators of sympathetic activity in heart and pancreas but not in brown fat. Rats of the resistant strain also have higher blood 3-hydroxybutyrate concentrations and lower insulin and corticosterone levels than do rats of the susceptible strain. A high-fat diet increases 3-hydroxybutyrate concentrations and reduces insulin levels in both strains. These studies show, in rats eating a high-fat diet, that differences in norepinephrine turnover, particularly in brown adipose tissue, may play an important role in whether dietary obesity develops and in the manifestations of resistance to this phenomenon observed in the S 5B/Pl rat.","['Yoshida, T', 'Fisler, J S', 'Fukushima, M', 'Bray, G A', 'Schemmel, R A']","['Yoshida T', 'Fisler JS', 'Fukushima M', 'Bray GA', 'Schemmel RA']",,['eng'],['Journal Article'],United States,Am J Physiol,The American journal of physiology,0370511,['X4W3ENH1CV (Norepinephrine)'],IM,"['Animals', 'Body Weight', '*Diet/adverse effects', '*Eating', 'Female', '*Lighting', 'Norepinephrine/*metabolism', 'Obesity/blood/etiology/*metabolism', 'Osmolar Concentration', 'Rats', 'Rats, Inbred Strains']",,,,,1987/02/01 00:00,1987/02/01 00:01,['1987/02/01 00:00'],"['1987/02/01 00:00 [pubmed]', '1987/02/01 00:01 [medline]', '1987/02/01 00:00 [entrez]']",['10.1152/ajpregu.1987.252.2.R402 [doi]'],ppublish,Am J Physiol. 1987 Feb;252(2 Pt 2):R402-8. doi: 10.1152/ajpregu.1987.252.2.R402.,,,,,,,,,,,,,,,,,,,,
29209925,NLM,MEDLINE,20190409,20190409,1496-8975 (Electronic) 0832-610X (Linking),65,3,2018 Mar,Preventing hypotension-induced nausea and vomiting during spinal anesthesia for Cesarean delivery in obese parturients: a small solution for a big problem?,235-238,10.1007/s12630-017-1035-5 [doi],,"['Ngan Kee, Warwick D']",['Ngan Kee WD'],"['Department of Anesthesiology, Sidra Medical and Research Center, P.O. Box 26999, Doha, Qatar. wngankee@sidra.org.']",['eng'],"['Comment', 'Editorial']",United States,Can J Anaesth,Canadian journal of anaesthesia = Journal canadien d'anesthesie,8701709,['1WS297W6MV (Phenylephrine)'],IM,"['*Anesthesia, Spinal', 'Cesarean Section', 'Female', 'Humans', '*Hypotension', 'Nausea', 'Obesity', 'Phenylephrine', 'Pregnancy', 'Vomiting']",,,,,2017/12/07 06:00,2019/04/10 06:00,['2017/12/07 06:00'],"['2017/09/15 00:00 [received]', '2017/11/23 00:00 [accepted]', '2017/12/07 06:00 [pubmed]', '2019/04/10 06:00 [medline]', '2017/12/07 06:00 [entrez]']","['10.1007/s12630-017-1035-5 [pii]', '10.1007/s12630-017-1035-5 [doi]']",ppublish,Can J Anaesth. 2018 Mar;65(3):235-238. doi: 10.1007/s12630-017-1035-5. Epub 2017 Dec 5.,,20171205,,,['ORCID: 0000-0003-1000-7735'],,,,La prevention des nausees et vomissements induits par l'hypotension pendant une rachianesthesie lors d'une cesarienne chez les parturientes obeses : petite solution a un grand probleme?,,['Can J Anaesth. 2018 Mar;65(3):254-262. PMID: 29209926'],,,,,,,,,
19237486,NLM,MEDLINE,20090630,20151119,1359-1053 (Print) 1359-1053 (Linking),14,2,2009 Mar,Greater history of weight-related stigmatizing experience is associated with greater weight loss in obesity treatment.,190-9,10.1177/1359105308100203 [doi],"Experiences of obesity stigmatization and fear of fat, body image and self-esteem, were examined in relation to weight loss and weight maintenance. Participants in obesity treatment (N = 185) with more stigmatizing experiences had poorer body image and greater fear of fat. Higher initial BMI, more stigmatizing experiences, lower body dissatisfaction and greater fear of fat predicted greater weight loss. Higher initial BMI and more stigmatizing experiences predicted greater weight maintenance after six months in treatment. These findings suggest that despite the negative psychological correlates of stigmatization, experience and fear of obesity's negative consequences may also be associated with improved treatment outcome.","['Latner, Janet D', 'Wilson, G Terence', 'Jackson, Mary L', 'Stunkard, Albert J']","['Latner JD', 'Wilson GT', 'Jackson ML', 'Stunkard AJ']","['University of Hawaii at Manoa, USA. jlatner@hawaii.edu']",['eng'],['Journal Article'],England,J Health Psychol,Journal of health psychology,9703616,,IM,"['Aged', 'Body Image', 'Female', 'Humans', 'Male', 'Middle Aged', 'New Jersey', 'Obesity/*psychology/*therapy', 'Pennsylvania', '*Prejudice', 'Surveys and Questionnaires']",,,,,2009/02/25 09:00,2009/07/01 09:00,['2009/02/25 09:00'],"['2009/02/25 09:00 [entrez]', '2009/02/25 09:00 [pubmed]', '2009/07/01 09:00 [medline]']","['14/2/190 [pii]', '10.1177/1359105308100203 [doi]']",ppublish,J Health Psychol. 2009 Mar;14(2):190-9. doi: 10.1177/1359105308100203.,,,,,,,,,,,,,,,,,,,,
22590786,NLM,MEDLINE,20120703,20120517,1062-3388 (Print) 1062-3388 (Linking),21,4,2012 Apr,Obesity's link to certain cancers puts wellness programs on trial.,50-1,,,"['Diamond, Frank']",['Diamond F'],,['eng'],['Journal Article'],United States,Manag Care,"Managed care (Langhorne, Pa.)",9303583,,,"['Female', '*Health Promotion', 'Humans', 'Male', 'Neoplasms/*etiology/mortality', 'Obesity/*complications', 'United States/epidemiology']",,,,,2012/05/18 06:00,2012/07/04 06:00,['2012/05/18 06:00'],"['2012/05/18 06:00 [entrez]', '2012/05/18 06:00 [pubmed]', '2012/07/04 06:00 [medline]']",,ppublish,Manag Care. 2012 Apr;21(4):50-1.,,,,,,,,,,,,,,,,,,,,
382957,NLM,MEDLINE,19791017,20131121,0003-4037 (Print) 0003-4037 (Linking),33,1,1979,Animal obesities.,27-38,,"Genetically or experimentally-produced (e.g. via lesions of the hypothalamus) obese animals have several common features such as increased hepatic lipogenesis (resulting in fat infiltration) and increased hepatic lipoprotein secretion, together, with increased adipose tissue lipogenesis. These abnormalities appear to be related primarily to hyperinsulinemia as they are reversed to or toward normal when hyperinsulinemia is corrected or, conversely, as they develop concomitantly with hyperinsulinemia. In the liver (ob/ob mice), another defect can be demonstrated, i.e. a decreased hepatic insulin clearance. This defect is also related to hyperinsulinemia and is markedly reduced upon normalizing hyperinsulinemia of obese mice. Hyperinsulinemia may thus be a key feature of the obesity syndromes, and bring about most of the abnormalities noted, including the subsequent state of insulin resistance known to exist in obese animals. The etiology of hyperinsulinemia of genetically obese animals is still unknown. Among the possible mechanisms one should cite possible primary dysfunction of the pancreas, possible primary dysregulation, by the hypothalamus, of overall endocrine pancreas activity.","['Jeanrenaud, B']",['Jeanrenaud B'],,['eng'],"['Journal Article', 'Review']",France,Ann Nutr Aliment,Annales de la nutrition et de l'alimentation,0372653,"['0 (Insulin)', 'IY9XDZ35W2 (Glucose)']",IM,"['Adipose Tissue/metabolism', 'Animals', 'Disease Models, Animal', 'Glucose/metabolism', 'Hypothalamus/injuries', 'Insulin/blood/metabolism', 'Insulin Resistance', 'Islets of Langerhans/physiopathology', 'Liver/metabolism', 'Mice', 'Mice, Obese', '*Obesity/etiology/genetics/metabolism', 'Rats']",,,,,1979/01/01 00:00,1979/01/01 00:01,['1979/01/01 00:00'],"['1979/01/01 00:00 [pubmed]', '1979/01/01 00:01 [medline]', '1979/01/01 00:00 [entrez]']",,ppublish,Ann Nutr Aliment. 1979;33(1):27-38.,,,,,,,47,,,,,,,,,,,,,
3710687,NLM,MEDLINE,19860708,20161123,,10,1,1986,Obesity in 16-year-olds assessed by relative weight and doctors' rating.,3-10,,"Weights and heights at age 16 of 5652 boys and 5280 girls from the National Child Development Study (NCDS) were measured. At this examination, school medical officers rated the boys and girls into one of the following categories: grossly obese, moderately obese, normal, thin or very thin. A comparison is made between doctors' rating and assessment of obesity by relative weight (RW). Obesity was defined as RW greater than 120. Overall 803 (15.2 per cent) girls were rated obese by doctors compared with 469 (8.9 per cent) identified by RW. Only 414 (7.8 per cent) girls were considered obese by both methods. In boys the difference between the two methods was less marked. There were 362 (6.4 per cent) boys rated as obese by doctors, 404 (7.2 per cent) by relative weight and 262 (4.6 per cent) by both methods. The discrepancies demonstrate that one method of assessment cannot replace another. Doctors' rated considerably more girls than boys as obese. Although at this age girls were heavier than boys for a given height, the doctors' rating may also reflect the different attitudes towards obesity in men and women which are prevalent in our society. Without comparison with a more accurate measure of adiposity it is not possible to reach a definite conclusion as to whether clinical assessment, relative weight, or indeed both methods combined are the most suitable for identifying obese adolescents.","['Moynihan, C M', 'Stark, O', 'Peckham, C S']","['Moynihan CM', 'Stark O', 'Peckham CS']",,['eng'],"['Comparative Study', 'Journal Article']",England,Int J Obes,International journal of obesity,7703240,,IM,"['Adolescent', 'Body Height', 'Body Weight', 'Female', 'Humans', 'Male', 'Obesity/classification/*diagnosis/epidemiology', 'United Kingdom']",,,,,1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1986;10(1):3-10.,,,,,,,,,,,,,,,,,,,,
20440990,NLM,MEDLINE,20100610,20181201,1660-9379 (Print) 1660-9379 (Linking),6,242,2010 Mar 31,[Motivational interviewing integrated into cognitive behavioral therapy in obesity treatment].,677-81,,"Cognitive behavioural therapy is a well-known approach which has proved its efficacy in the treatment of eating disorders and obesity. Nevertheless, eating disordered and obese patients are often ambivalent towards treatment and as a consequence, they can't benefit fully from therapy or drop out easily. Nowadays, motivational issues are widely recognized as a critical point. Motivational Interviewing is now considered as valuable to enhance compliance to treatments.","['Reiner, M', 'Carrard, I', 'Golay, A']","['Reiner M', 'Carrard I', 'Golay A']","[""Service d'enseignement therapeutique pour maladies chroniques, Departement de medecine communautaire, HUG, 1211 Geneve 14.""]",['fre'],['Journal Article'],Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Cognitive Behavioral Therapy/*methods', 'Humans', 'Obesity/psychology/*therapy']",,,,,2010/05/06 06:00,2010/06/11 06:00,['2010/05/06 06:00'],"['2010/05/06 06:00 [entrez]', '2010/05/06 06:00 [pubmed]', '2010/06/11 06:00 [medline]']",,ppublish,Rev Med Suisse. 2010 Mar 31;6(242):677-81.,,,,,,,,,L'entretien motivationnel dans la therapie cognitivo-comportementale des patients obeses.,,,,,,,,,,,
17144157,NLM,MEDLINE,20070129,20191110,1295-0661 (Print) 1295-0661 (Linking),200,1,2006,[Feeding regulatory peptides: hopes and limits for the treatment of obesities].,7-16,,"Excessive weight gain is directly related to a positive energy balance which is due to both a decreased physical activity and overeating. Obesity prevalence is increasing since thirty years and the treatment of obesities is particularly necessary to solve this public health and economical problem. The receptors of numerous hypothalamic neuropeptides are potential targets for such drug treatments. Hormones of the gastro-intestinal tract or produced by the adipose tissue directly interact with these central pathways to regulate feeding behavior. The use of leptin, an adipose tissue hormone that inhibits food intake, has not been conclusive because of the development of leptin resistance in obese subjects. Similar disappointing results have been obtained with antagonists of neuropeptide Y (NPY), one of the most potent orexigenic peptide. This was linked to the complexity and redundancy of the circuits involved in feeding regulation. Consequently, a multitherapy targeting several pathways simultaneously is probably the best option to cure obesity. Among these pathways, PYY 3-36 has been tested in man and some encouraging data have been obtained in animals with antagonists of some other orexigenic peptides such as orexins and melanin-concentrating hormone. A few gene therapy trials in the rat brain have restored interest for the leptin and NPY pathways. Their general use is however not planed in a next future. According to the type of obesity, these new treatments might be associated with either current (or almost current) drugs acting either on serotoninergic/catecholaminergic or cannabinoid pathways, or with surgery. Behavioral changes (food intake, exercise) and preventive actions during early life (in utero, young children) will remain for a while the best solutions to limit overweight development. The new treatments will help obese people to adhere to these behavioral changes by improving their efficiency to induce weight loss.","['Beck, Bernard']",['Beck B'],"['INSERM U724 et UHP/Neurocal, Faculte de Medecine, 9, avenue de la Foret de Haye BP 184, 54505 Vandoeuvre-les-Nancy, France. Bernard.Beck@nancy.inserm.fr']",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,J Soc Biol,Journal de la Societe de biologie,100890617,"['0 (Appetite Depressants)', '0 (Peptide Hormones)']",IM,"['Appetite Depressants/therapeutic use', '*Feeding Behavior', 'Humans', 'Models, Biological', 'Obesity/*prevention & control', 'Peptide Hormones/physiology', 'Stress, Physiological/physiopathology', 'Weight Gain/*drug effects']",,,,,2006/12/06 09:00,2007/01/30 09:00,['2006/12/06 09:00'],"['2006/12/06 09:00 [pubmed]', '2007/01/30 09:00 [medline]', '2006/12/06 09:00 [entrez]']",['10.1051/jbio:2006002 [doi]'],ppublish,J Soc Biol. 2006;200(1):7-16. doi: 10.1051/jbio:2006002.,,,,,,,99,,Les peptides modulateurs du comportement alimentaire: espoirs et limites pour le traitement de l'obesite.,,,,,,,,,,,
7869939,NLM,MEDLINE,19950329,20190725,0026-0495 (Print) 0026-0495 (Linking),44,2 Suppl 2,1995 Feb,Chronobiometric identification of disorders of hunger sensation in essential obesity: therapeutic effects of dexfenfluramine.,50-6,,"In human beings, hunger is a proprioceptive signal that shows intraday (circadian components) and within-day (ultradian components) recursivity. Both periodic components can be investigated by chronobiometric procedures by combining the Cosinor method with spectral analysis. A 24-hour profile of hunger sensation (HS) can be plotted on a 1-to-10 scale of intensity using self-rated scores performed every half-hour of the day. Circadian and ultradian components were studied in 60 patients affected by essential obesity (20 men and 40 women; mean age, 38.4 years; mean body weight, 101 kg) before and after treatment with dexfenfluramine (Isomeride; Servier, Orleans, France) 15 mg orally twice daily, for 30 days. The control group consisted of 30 clinically healthy subjects (15 men and 15 women; mean age, 37.5 years; mean body weight, 69 kg). Chronobiometric analysis shows three patterns in obese patients, which suggests that HS may be normal (eurectic obesity), exaggerated (hyperrectic obesity), or diminished (hyporectic obesity). After dexfenfluramine administration, HS was showed a substantial decrease in the daily mean level. The spectrum of resolution in circadian and ultradian components was found to be maintained in eurectic obesity and partially readjusted in hyperrectic and hyporectic obesities. This demonstrates that dexfenfluramine acts not only as an anorectic but also as a chronizer by interfering with the recursive components of HS. The anorectic and chronizing effects suggest that dexfenfluramine is a ""chronoanorectic drug"" that interacts with the chronobiologic properties of the serotoninergic system.","['Cugini, P', 'Battisti, P', 'Paggi, A', 'Di Stasio, M E', 'Di Palma, L', 'Morelli, F', 'Pisculli, M', 'Lavielle, R']","['Cugini P', 'Battisti P', 'Paggi A', 'Di Stasio ME', 'Di Palma L', 'Morelli F', 'Pisculli M', 'Lavielle R']","['Institute of Medical Clinic II (Chronobiology Unit), University of Rome La Sapienza, Italy.']",['eng'],['Journal Article'],United States,Metabolism,Metabolism: clinical and experimental,0375267,['2DS058H2CF (Fenfluramine)'],IM,"['Adult', '*Circadian Rhythm', 'Female', 'Fenfluramine/*therapeutic use', 'Humans', '*Hunger', 'Male', 'Middle Aged', 'Obesity/drug therapy/*physiopathology']",,,,,1995/02/01 00:00,1995/02/01 00:01,['1995/02/01 00:00'],"['1995/02/01 00:00 [pubmed]', '1995/02/01 00:01 [medline]', '1995/02/01 00:00 [entrez]']","['0026-0495(95)90211-2 [pii]', '10.1016/0026-0495(95)90211-2 [doi]']",ppublish,Metabolism. 1995 Feb;44(2 Suppl 2):50-6. doi: 10.1016/0026-0495(95)90211-2.,,,,,,,,,,,,,,,,,,,,
32523035,NLM,MEDLINE,20211108,20211108,1476-5497 (Electronic) 0307-0565 (Print) 0307-0565 (Linking),44,12,2020 Dec,Who's a good boy? Effects of dog and owner body weight on veterinarian perceptions and treatment recommendations.,2455-2464,10.1038/s41366-020-0622-7 [doi],"BACKGROUND: Weight bias against persons with obesity impairs health care delivery and utilization and contributes to poorer health outcomes. Despite rising rates of pet obesity (including among dogs), the potential for weight bias in veterinary settings has not been examined. SUBJECTS/METHODS: In two online, 2 x 2 experimental studies, the effects of dog and owner body weight on perceptions and treatment recommendations were investigated in 205 practicing veterinarians (Study 1) and 103 veterinary students (Study 2). In both studies, participants were randomly assigned to view one of four vignettes of a dog and owners with varying weight statuses (lean vs. obesity). Dependent measures included emotion/liking ratings toward the dog and owners; perceived causes of the dog's weight; and treatment recommendations and compliance expectations. Other clinical practices, such as terms to describe excess weight in dogs, were also assessed. RESULTS: Veterinarians and students both reported feeling more blame, frustration, and disgust toward dogs with obesity and their owners than toward lean dogs and their owners (p values < 0.001). Interactions between dog and owner body weight emerged for perceived causes of obesity, such that owners with obesity were perceived as causing the dog with obesity's weight, while lean owners were perceived as causing the lean dog's weight. Participants were pessimistic about treatment compliance from owners of the dog with obesity, and weight loss treatment was recommended for the dog with obesity when presenting with a medical condition ambiguous in its relationship to weight. Veterinarians and students also reported use of stigmatizing terms to describe excess weight in dogs. CONCLUSIONS: Findings from this investigation, with replication, have implications for training and practice guidelines in veterinary medicine.","['Pearl, Rebecca L', 'Wadden, Thomas A', 'Bach, Caroline', 'Leonard, Sharon M', 'Michel, Kathryn E']","['Pearl RL', 'Wadden TA', 'Bach C', 'Leonard SM', 'Michel KE']","['Center for Weight and Eating Disorders, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. rpearl@pennmedicine.upenn.edu.', 'Center for Weight and Eating Disorders, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.', 'Center for Weight and Eating Disorders, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.', 'Center for Weight and Eating Disorders, Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.', 'Department of Clinical Sciences and Advanced Medicine, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",England,Int J Obes (Lond),International journal of obesity (2005),101256108,,IM,"['Adult', 'Animals', '*Attitude of Health Personnel', '*Body Weight', '*Dogs', 'Emotions', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/etiology/*veterinary', 'Ownership', 'Pets', 'Stereotyping', '*Veterinarians']",PMC7686094,,,"['Competing Interests: The authors have no competing interests to disclose. RLP is', 'supported by a K23 Mentored Patient-Oriented Research Career Development Award', 'from the National Heart, Lung and Blood Institute of the NIH (K23HL140176).']",2020/06/12 06:00,2021/11/09 06:00,['2020/06/12 06:00'],"['2020/01/24 00:00 [received]', '2020/05/22 00:00 [accepted]', '2020/05/03 00:00 [revised]', '2020/06/12 06:00 [pubmed]', '2021/11/09 06:00 [medline]', '2020/06/12 06:00 [entrez]']","['10.1038/s41366-020-0622-7 [pii]', '10.1038/s41366-020-0622-7 [doi]']",ppublish,Int J Obes (Lond). 2020 Dec;44(12):2455-2464. doi: 10.1038/s41366-020-0622-7. Epub 2020 Jun 10.,['K23 HL140176/HL/NHLBI NIH HHS/United States'],20200610,,,,['NIHMS1597378'],,,,,,,,,,,,,,
13048249,NLM,MEDLINE,20030501,20181201,0035-2640 (Print) 0035-2640 (Linking),2,16,1952 Jun 1,[Obesities; introduction].,979-89,,,"['HARVIER, P']",['HARVIER P'],,['und'],['Journal Article'],France,Rev Prat,La Revue du praticien,0404334,,OM,"['Humans', '*Obesity']",,['NLM'],['*OBESITY'],,1952/06/01 00:00,1952/06/01 00:01,['1952/06/01 00:00'],"['1952/06/01 00:00 [pubmed]', '1952/06/01 00:01 [medline]', '1952/06/01 00:00 [entrez]']",,ppublish,Rev Prat. 1952 Jun 1;2(16):979-89.,,,,,,,,,Les obesites; avant-propos.,,,,['CLML: 5324:18659:451'],,,,,,,
21994130,NLM,MEDLINE,20120112,20211020,1545-5017 (Electronic) 1545-5009 (Print) 1545-5009 (Linking),58,1,2012 Jan,An overview of mongenic and syndromic obesities in humans.,122-8,10.1002/pbc.23372 [doi],"Obesity is increasing in prevalence in the United States with over 65% of adults considered overweight and 16% of children with BMI > 95 percentile. The heritability of obesity is estimated between 40% and 70%, but the genetics of obesity for most individuals are complex and involve the interaction of multiple genes and environment. There are however several syndromic and non-syndromic forms of obesity that are monogenic and oligogenic that provide insight into the underlying molecular control of food intake and the neural networks that control ingestive behavior and satiety to regulate body weight and which may interact with treatment exposures to produce or exacerbate obesity in childhood cancer survivors.","['Chung, Wendy K']",['Chung WK'],"['Division of Molecular Genetics and Naomi Berrie Diabetes Center, Columbia University Medical College, Russell Berrie Medical Science Pavilion, New York, New York 10032, USA. wkc15@columbia.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",United States,Pediatr Blood Cancer,Pediatric blood & cancer,101186624,,IM,"['Adult', 'Body Mass Index', 'Body Weight', 'Child', 'Eating', 'Humans', 'Obesity/*epidemiology/*genetics', '*Overweight', 'Prevalence', 'United States/epidemiology']",PMC3215910,,,,2011/10/14 06:00,2012/01/13 06:00,['2011/10/14 06:00'],"['2011/09/06 00:00 [received]', '2011/09/06 00:00 [accepted]', '2011/10/14 06:00 [entrez]', '2011/10/14 06:00 [pubmed]', '2012/01/13 06:00 [medline]']",['10.1002/pbc.23372 [doi]'],ppublish,Pediatr Blood Cancer. 2012 Jan;58(1):122-8. doi: 10.1002/pbc.23372. Epub 2011 Oct 12.,"['R01 DK052431/DK/NIDDK NIH HHS/United States', 'R01 DK052431-13/DK/NIDDK NIH HHS/United States', 'DK52431/DK/NIDDK NIH HHS/United States']",20111012,,"['Copyright (c) 2011 Wiley Periodicals, Inc.']",,['NIHMS323313'],,,,,,,,,,,,,,
8793172,NLM,MEDLINE,19961113,20180215,0008-6312 (Print) 0008-6312 (Linking),87,4,1996 Jul-Aug,Left ventricular systolic and diastolic function in severe obesity: a radionuclide study.,347-53,,"To verify the impact of sever obesity (defined as body mass index > 31 kg/m2) on left ventricular (LV) function, 32 asymptomatic obese but otherwise healthy subjects (16 men; age 38 +/- 11 years) voluntarily underwent first-pass and equilibrium 99mTc radionuclide angiography at rest and, in 22 of them, during bicycle supine exercise. Data were compared to those obtained from 10 normal volunteers (age 48 +/- 13; p < 0.05, vs. obeses). End-diastolic and stroke volumes did not differ between the two groups, whereas end-systolic volume was significantly higher in obese subjects (67 +/- 20 vs. 49 +/- 20 ml; p < 0.05), and, as a consequence, LV ejection fraction at rest was decreased in obese subjects (59 +/- 7%) compared to normals (65 +/- 6%; p < 0.05). Due to the higher heart rate in obese subjects (81 +/- 13 vs. 69 +/- 10 pbm, respectively; p < 0.05) cardiac output was significantly greater compared to normals (7.1 +/- 0.8 vs. 6.2 +/- 0.2 liters/min, respectively; p < 0.01). During exercise, ejection fraction normally increased in normals (70 +/- 7%; p < 0.001, vs. baseline) but not in obese subjects (60 +/- 9%; p = nonsignificant vs. baseline). In addition, systolic blood pressure/end-systolic volume ratio was significantly decreased in obese subjects (23 +/- 1.3) compared to normals (2.8 +/- 1.6; p < 0.05). Peak filling rate, normalized to end-diastolic counts per second, was significantly lower in obese subjects (2.2 +/- 1.3) compared to normals (2.8 +/- 1.6; P < 0.05). This difference was also true when peak filling rate was computed in stroke counts per second (3.8 +/- 0.8 in obeses vs. 4.4 +/- 0.4 in normals; p < 0.05). Repeat analysis in a subgroup of 10 young obese subjects (age < or = 30 years) confirmed decreased ejection fraction at rest (60 +/- 4%; p < 0.05) and peak filling rate (2.4 +/- 0.4 end-diastolic counts/s; p < 0.05), as well as the lack of ejection fraction increase during exercise (59 +/- 9%). Thus, these data indicate a subclinical impairement of LV systolic and diastolic function at rest and during exercise in asymptomatic severely obese but otherwise healthy subjects.","['Ferraro, S', 'Perrone-Filardi, P', 'Desiderio, A', 'Betocchi, S', ""D'Alto, M"", 'Liguori, L', 'Trimigliozzi, P', 'Turco, S', 'Chiariello, M']","['Ferraro S', 'Perrone-Filardi P', 'Desiderio A', 'Betocchi S', ""D'Alto M"", 'Liguori L', 'Trimigliozzi P', 'Turco S', 'Chiariello M']","['Division of Cardiology, Federico II University, Naples, Italy.']",['eng'],"['Comparative Study', 'Journal Article']",Switzerland,Cardiology,Cardiology,1266406,['0 (Technetium Tc 99m Aggregated Albumin)'],IM,"['Adult', 'Body Mass Index', 'Diastole', 'Exercise', 'Female', 'Hemodynamics', 'Humans', 'Male', 'Middle Aged', 'Obesity, Morbid/complications/diagnostic imaging/*physiopathology', 'Radionuclide Angiography/methods', 'Radionuclide Ventriculography/methods', 'Systole', 'Technetium Tc 99m Aggregated Albumin', 'Ventricular Dysfunction, Left/diagnostic imaging/etiology/*physiopathology', 'Ventricular Function, Left/*physiology']",,,,,1996/07/01 00:00,1996/07/01 00:01,['1996/07/01 00:00'],"['1996/07/01 00:00 [pubmed]', '1996/07/01 00:01 [medline]', '1996/07/01 00:00 [entrez]']",['10.1159/000177118 [doi]'],ppublish,Cardiology. 1996 Jul-Aug;87(4):347-53. doi: 10.1159/000177118.,,,,,,,,,,,,,,,,,,,,
33080591,NLM,MEDLINE,20210416,20210416,1662-4033 (Electronic) 1662-4025 (Print) 1662-4025 (Linking),13,5,2020,Postural Stability in Obese Preoperative Bariatric Patients Using Static and Dynamic Evaluation.,499-513,10.1159/000509163 [doi],"INTRODUCTION: Globally, 300 million adults have clinical obesity. Heightened adiposity and inadequate musculature secondary to obesity alter bipedal stance and gait, diminish musculoskeletal tissue quality, and compromise neuromuscular feedback; these physiological changes alter stability and increase injury risk from falls. Studies in the field focus on obese patients across a broad range of body mass indices (BMI >30 kg/m2) but without isolating the most morbidly obese subset (BMI >/=40 kg/m2). We investigated the impact of obesity in perturbing postural stability in morbidly obese subjects elected for bariatric intervention, harboring a higher-spectrum BMI. SUBJECTS AND METHODS: Traditional force plate measurements and stabilograms are gold standards employed when measuring center of pressure (COP) and postural sway. To quantify the extent of postural instability in subjects with obesity before bariatric surgery, we assessed 17 obese subjects with an average BMI of 40 kg/m2 in contrast to 13 nonobese subjects with an average BMI of 30 kg/m2. COP and postural sway were measured from static and dynamic tasks. Involuntary movements were measured when patients performed static stances, with eyes either opened or closed. Two additional voluntary movements were measured when subjects performed dynamic, upper torso tasks with eyes opened. RESULTS: Mean body weight was 85% (p < 0.001) greater in obese than nonobese subjects. Following static balance assessments, we observed greater sway displacement in the anteroposterior (AP) direction in obese subjects with eyes open (87%, p < 0.002) and eyes closed (76%, p = 0.04) versus nonobese subjects. Obese subjects also exhibited a higher COP velocity in static tests when subjects' eyes were open (47%, p = 0.04). Dynamic tests demonstrated no differences between groups in sway displacement in either direction; however, COP velocity in the mediolateral (ML) direction was reduced (31%, p < 0.02) in obese subjects while voluntarily swaying in the AP direction, but increased in the same cohort when swaying in the ML direction (40%, p < 0.04). DISCUSSION AND CONCLUSION: Importantly, these data highlight obesity's contribution towards increased postural instability. Obese subjects exhibited greater COP displacement at higher AP velocities versus nonobese subjects, suggesting that clinically obese individuals show greater instability than nonobese subjects. Identifying factors contributory to instability could encourage patient-specific physical therapies and presurgical measures to mitigate instability and monitor postsurgical balance improvements.","['Pagnotti, Gabriel M', 'Haider, Amna', 'Yang, Ariel', 'Cottell, Kathryn E', 'Tuppo, Catherine M', 'Tong, Kai-Yu', 'Pryor, Aurora D', 'Rubin, Clinton T', 'Chan, M Ete']","['Pagnotti GM', 'Haider A', 'Yang A', 'Cottell KE', 'Tuppo CM', 'Tong KY', 'Pryor AD', 'Rubin CT', 'Chan ME']","['Department of Biomedical Engineering, Stony Brook University, Stony Brook, New York, USA.', 'Department of Biomedical Engineering, Stony Brook University, Stony Brook, New York, USA.', 'Department of Biomedical Engineering, Stony Brook University, Stony Brook, New York, USA.', 'Bariatric and Metabolic Weight Loss Center, Stony Brook Medicine, Stony Brook, New York, USA.', 'Bariatric and Metabolic Weight Loss Center, Stony Brook Medicine, Stony Brook, New York, USA.', 'Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, Hong Kong.', 'Bariatric and Metabolic Weight Loss Center, Stony Brook Medicine, Stony Brook, New York, USA.', 'Department of Biomedical Engineering, Stony Brook University, Stony Brook, New York, USA.', 'Department of Biomedical Engineering, Stony Brook University, Stony Brook, New York, USA, meilin.chan@stonybrook.edu.']",['eng'],['Journal Article'],Switzerland,Obes Facts,Obesity facts,101469429,,IM,"['Adolescent', 'Adult', 'Aged', '*Bariatrics', 'Body Mass Index', 'Cohort Studies', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity, Morbid/*physiopathology/surgery', 'Physical Therapy Modalities', '*Postural Balance', 'Preoperative Period', 'Young Adult']",PMC7670358,['NOTNLM'],"['Bariatric intervention', 'Fall risk', 'Musculoskeletal health', 'Obesity', 'Postural instability']","['C.T. Rubin is a cofounder of Marodyne Medical, LLC and has several patents', 'related to the ability of mechanical signals to control metabolic disorders. A.D.', 'Pryor is a speaker for Ethicon Endo-Surgery Inc., Gore Industries, and Medtronic,', 'and is a consultant for Apollo Endosurgery and Intuitive Surgical Inc. The other', 'authors have no competing interests to declare.']",2020/10/21 06:00,2021/04/17 06:00,['2020/10/20 20:14'],"['2020/02/13 00:00 [received]', '2020/06/01 00:00 [accepted]', '2020/10/21 06:00 [pubmed]', '2021/04/17 06:00 [medline]', '2020/10/20 20:14 [entrez]']","['000509163 [pii]', 'ofa-0013-0499 [pii]', '10.1159/000509163 [doi]']",ppublish,Obes Facts. 2020;13(5):499-513. doi: 10.1159/000509163. Epub 2020 Oct 20.,,20201020,,"['(c) 2020 The Author(s) Published by S. Karger AG, Basel.']",,,,,,,,,,,,,,,,
23318724,NLM,MEDLINE,20140505,20220318,1476-5497 (Electronic) 0307-0565 (Linking),37,9,2013 Sep,"Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity.",1198-203,10.1038/ijo.2012.228 [doi],"CONTEXT: The care of patients with hypothalamic obesity is challenging. OBJECTIVE: To compare body composition, basal metabolic rate (BMR) and metabolic outcomes of adults, with lesional or genetic hypothalamic obesity, with obese patients suffering from primary obesity, once matched for body mass index (BMI). DESIGN AND PATIENTS: Adults with hypothalamic obesity of genetic origin (Prader Willi syndrome (PWS)) or acquired hypothalamic damage (HD), such as craniopharygioma, were compared with obese control candidates awaiting bariatric surgery (C), with a BMI between 35 and 65 kg m(-)(2), and aged between 18 and 50 years. MAIN OUTCOME MEASURES: Body composition measured by whole-body dual-energy X-ray absorptiometry scanning, BMR using indirect calorimetry, hormonal and metabolic assessments. RESULTS: A total of 27 adults with a genetic diagnosis of PWS, 15 obese subjects with HD and 206 obese controls with similar BMI were studied. Compared with the control group, PWS patients had an increased percentage of fat mass (FM), and a decreased percentage of android FM. The BMR of PWS patients was significantly lower than controls and highly correlated with lean body mass in PWS and C patients. Body composition of HD was similar with those of obese patients. A trend toward an increased prevalence of diabetes in HD patients and of cytolysis in PWS was observed in comparison with primary obese patients. CONCLUSION: Genetic and lesional hypothalamic obesities have different consequences for phenotypic features such as body composition or BMR compared with primary obese patients. The mechanisms of adipose tissue development and metabolic complications may be different between genetic and lesional obesities.","['Lloret-Linares, C', 'Faucher, P', 'Coupaye, M', 'Alili, R', 'Green, A', 'Basdevant, A', 'Clement, K', 'Poitou, C']","['Lloret-Linares C', 'Faucher P', 'Coupaye M', 'Alili R', 'Green A', 'Basdevant A', 'Clement K', 'Poitou C']","['1] Assistance Publique-Hopitaux de Paris, Hopital Lariboisiere, Unit of Therapeutic Research, Department of Internal Medicine, Paris, France [2] INSERM U705, CNRS UMR 8206, Neuropsychopharmacology of Drug Addiction, Faculty of Pharmacy, University Paris Descartes, Paris, France.']",['eng'],"['Comparative Study', 'Journal Article']",England,Int J Obes (Lond),International journal of obesity (2005),101256108,,IM,"['Absorptiometry, Photon', 'Adolescent', 'Adult', '*Basal Metabolism', '*Body Composition', 'Body Fat Distribution', 'Body Mass Index', 'Female', 'France/epidemiology', 'Humans', 'Hypothalamic Diseases/complications/epidemiology/*metabolism', 'Male', 'Middle Aged', 'Obesity/epidemiology/etiology/*metabolism', 'Prader-Willi Syndrome/complications/epidemiology/*metabolism']",,,,,2013/01/16 06:00,2014/05/06 06:00,['2013/01/16 06:00'],"['2012/09/21 00:00 [received]', '2012/12/04 00:00 [revised]', '2012/12/10 00:00 [accepted]', '2013/01/16 06:00 [entrez]', '2013/01/16 06:00 [pubmed]', '2014/05/06 06:00 [medline]']","['ijo2012228 [pii]', '10.1038/ijo.2012.228 [doi]']",ppublish,Int J Obes (Lond). 2013 Sep;37(9):1198-203. doi: 10.1038/ijo.2012.228. Epub 2013 Jan 15.,,20130115,,,,,,,,,,,,,,,,,,
11686056,NLM,MEDLINE,20011207,20151119,0013-7006 (Print) 0013-7006 (Linking),27,4,2001 Jul-Aug,"[Obesity, alexithymia, psychopathology and binge eating: a comparative study of 40 obese patients and 32 controls].",343-50,,"Alexithymia may be considered as a personality feature characterized by poorness of imaginary life, speech focused on actual facts and physical sensations, general inaccuracy in or paucity of the words used to express emotions, and recourse to acting out to avoid intrapsychic conflicts. The possible link between alexithymia and psychosomatic or psychopathological disorders is now well documented. In particular, studies suggested that alexithymia may be frequently observed in obese or bulimic patients. This study was designed to investigate the link between obesity and alexithymia according to the presence or not of binge eating problems; 40 obese female patients (BMI > or = 27.3) seeking obesity treatment and 32 normal weight women used as controls were included in the study. In the obese group, 11 patients (27.5%) exhibited binge-eating disorder according to the DSM IV criteria. Alexithymia was assessed using the Toronto Alexithymia Scale (TAS), and past and current mental disorders were assessed by means of the Structured Clinical Interview for DSM III-R (SCID). In addition, current depression was assessed using the Beck Depression Inventory (BDI). The mean TAS score was found significantly higher in obese patients than in controls (72.6 +/- 11.8 vs 65.2 +/- 9.3, respectively; p < 0.005). In the same way, alexithymia (defined by TAS score > or = 74) was found significantly more frequent in obese patients than in controls (52.5% vs 21.8%, respectively; p < 0.03). However, among obese patients no significant difference was found between patients with and without binge-eating disorder. Current major depression was also found significantly more frequent in obese patients than in controls (15% vs 0%, respectively; p < 0.03), and the mean BDI score was very significantly higher in obese patients (12.2 +/- 8.7 vs 4.6 +/- 4.6, respectively; p < 0.0001). Comparisons between obese patients with and without binge-eating disorder showed that only past major depression was found significantly more frequent in those with binge-eating disorder (81.8% vs 10.3%, respectively; p < 0.0001), although the mean BDI score was significantly higher in patients with binge-eating disorder (18.5 +/- 11.7 vs 9.8 +/- 5.9, respectively; p < 0.02). Group by group comparisons suggested that two factors may play a role in the correlation found between obesity and alexithymia. First, the mean TAS score was found significantly higher in subjects with low educational level (p < 0.05), obese patients exhibiting significantly lower educational level when compared to controls (p < 0.002). Then, a significant positive correlation was found between TAS scores and BDI scores (Spearman's test: p < 0.01), obese patients showing significantly higher BDI scores than controls (p < 0.0001). In order to confirm these results, a logistic regression procedure was performed in the total sample (obese patients + controls). Three factors were found significantly increasing the risk to get a TAS score > or = 74: low educational level (odds ratio: 3.56), past and/or current major depression (odds ratio: 2.77), and BDI score > or = 8 (odds ratio: 2.18). Obesity in itself had no significant effect on TAS scores. Our results confirm that alexithymia is a psychological feature frequently observed in obese patients. In our study, the correlation found between obesity and alexithymia appears to be irrespective of binge-eating disorder, and seems to be mediated by the educational level and the frequency of associated depression. However, further investigations need to be done in order to specify the relationships between obesity, alexithymia, low educational level, and depression.","['De Chouly De Lenclave, M B', 'Florequin, C', 'Bailly, D']","['De Chouly De Lenclave MB', 'Florequin C', 'Bailly D']","[""Centre d'Information et de Traitement des Dependances, Centre Hospitalier Regional Universitaire, 57, boulevard de Metz, 59037 Lille.""]",['fre'],"['Comparative Study', 'English Abstract', 'Journal Article']",France,Encephale,L'Encephale,7505643,,IM,"['Adult', 'Affective Symptoms/diagnosis/epidemiology/*psychology', 'Body Mass Index', 'Comorbidity', 'Feeding and Eating Disorders/diagnosis/epidemiology/*psychology', 'Female', 'Humans', 'Imagination', 'Male', 'Mental Disorders/epidemiology', 'Obesity/diagnosis/epidemiology/*psychology', 'Psychiatric Status Rating Scales', 'Severity of Illness Index']",,,,,2001/11/01 10:00,2002/01/05 10:01,['2001/11/01 10:00'],"['2001/11/01 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/11/01 10:00 [entrez]']",,ppublish,Encephale. 2001 Jul-Aug;27(4):343-50.,,,,,,,,,"Obesite, alexithymie, troubles psychopathologiques et binge eating: etude comparative entre 40 obeses et 32 temoins.",,,,,,,,,,,
31433285,NLM,MEDLINE,20210129,20210129,0300-9831 (Print) 0300-9831 (Linking),91,1-2,2021 Jan,No association between zinc and thyroid activity in obese women.,40-47,10.1024/0300-9831/a000600 [doi],"Obesity is characterized by changes in the metabolism of zinc and thyroid hormones. Studies have also shown the role of zinc in the function and metabolism of thyroid. The present study aimed to evaluate the relationship between serum concentrations of thyroid hormones, dietary zinc intake and zinc distribution in obese women. A case-control study was conducted enrolling 98 women aged between 20 and 50 years old who were divided into case group (BMI >/= 35 kg/m(2)) and control group (BMI = 18.5-24.9 kg/m(2)). Patients underwent anthropometric measurements and analysis of dietary zinc intake, which was performed by a three-day food record. Zinc concentrations in plasma and erythrocytes were determined by inductively coupled plasma optical emission spectrometry. Serum concentrations of thyroid hormones and antibodies were determined by chemiluminescence. Mean values of dietary zinc intake were higher than recommended (10.37 +/- 3.12 mg/day and 11.37 +/- 4.36 mg/day for control and obeses, respectively). Obese women had reduced plasma (67.22 +/- 5.96 mug/dL) and erythrocyte (37.16 +/- 3.64 mug Zn/gHb) zinc concentrations when compared to the control group (plasma: 89.71 +/- 13.33 mug/dL; erythrocyte: 42.68 +/- 3.73 mug Zn/gHb) (p < 0.001). Serum TSH (control: 2.62 +/- 1.29 muIU/mL; obeses: 3.08 +/- 1.13 muIU/mL), Free T3 (control: 2.19 +/- 0.63 pg/dL; obeses: 2.09 +/- 0.34 pg/dL), and Free T4 (control: 1.12 +/- 0.31 ng/dL; obeses: 1.09 +/- 0.19 ng/dL) concentrations were within the normal range in both groups, without significant difference between them (p > 0.05). There was no correlation between thyroid hormone concentrations and zinc parameters (p > 0.05). Although obese women presented hypozincemia, they had normal levels of thyroid hormones and no correlation was found between the studied parameters.","['Beserra, Jessica Batista', 'Morais, Jennifer Beatriz Silva', 'Severo, Juliana Soares', 'Cruz, Kyria Jayanne Climaco', 'de Oliveira, Ana Raquel Soares', 'de Oliveira, Francisco Erasmo', 'de Matos Neto, Emidio Marques', 'Henriques, Gilberto Simeone', 'Marreiro, Dilina do Nascimento']","['Beserra JB', 'Morais JBS', 'Severo JS', 'Cruz KJC', 'de Oliveira ARS', 'de Oliveira FE', 'de Matos Neto EM', 'Henriques GS', 'Marreiro DDN']","['Department of Nutrition, Federal University of Piaui, Campus Minister Petronio Portela, Ininga, Teresina, Piaui, Brazil.', 'Department of Nutrition, Federal University of Piaui, Campus Minister Petronio Portela, Ininga, Teresina, Piaui, Brazil.', 'Department of Nutrition, Federal University of Piaui, Campus Minister Petronio Portela, Ininga, Teresina, Piaui, Brazil.', 'Department of Nutrition, Federal University of Piaui, Campus Minister Petronio Portela, Ininga, Teresina, Piaui, Brazil.', 'Department of Nutrition, Federal University of Piaui, Campus Minister Petronio Portela, Ininga, Teresina, Piaui, Brazil.', 'Laboratory Med Imagem, Center (South), Teresina, Piaui, Brazil.', 'Departamento of Physical Education, Federal University of Piaui, Campus Minister Petronio Portela, Ininga, Teresina, Piaui, Brazil.', 'School of Nursing, Federal University of Minas Gerais, Brazil.', 'Department of Nutrition, Federal University of Piaui, Campus Minister Petronio Portela, Ininga, Teresina, Piaui, Brazil.']",['eng'],['Journal Article'],Switzerland,Int J Vitam Nutr Res,International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,1273304,"['0 (Thyroid Hormones)', 'J41CSQ7QDS (Zinc)']",IM,"['Adult', 'Case-Control Studies', 'Female', 'Humans', 'Middle Aged', 'Obesity', '*Thyroid Gland', 'Thyroid Hormones', 'Young Adult', '*Zinc']",,['NOTNLM'],"['Obesity', 'Thyroid Hormones', 'Zinc']",,2019/08/23 06:00,2021/01/30 06:00,['2019/08/22 06:00'],"['2019/08/23 06:00 [pubmed]', '2021/01/30 06:00 [medline]', '2019/08/22 06:00 [entrez]']",['10.1024/0300-9831/a000600 [doi]'],ppublish,Int J Vitam Nutr Res. 2021 Jan;91(1-2):40-47. doi: 10.1024/0300-9831/a000600. Epub 2019 Aug 21.,,20190821,,,,,,,,,,,,,,,,,,
30449394,NLM,MEDLINE,20190228,20190228,1259-4792 (Print) 1259-4792 (Linking),39,305,2018 Nov-Dec,"[Obese teenagers and food, between experiences and sensations].",22-24,S1259-4792(18)30128-7 [pii] 10.1016/j.spp.2018.09.005 [doi],"Several types of nutrition workshops can be organised in day hospitals for obese teenagers. This support enables young patients to develop a better perception of the sensations they get from food, to improve their relationship with food and to adopt healthy behaviour. This dietetic approach is part of a multi-disciplinary project. The parents play a key role and are involved on the psychological and educational levels.","['Buysschaert, Helene']",['Buysschaert H'],"[""Maison des adolescents de l'Hopital Cochin-Maison de Solenn, AP-HP, 97 boulevard de Port-Royal, 75014 Paris, France. Electronic address: helene.buysschaert@aphp.fr.""]",['fre'],['Journal Article'],France,Soins Pediatr Pueric,"Soins. Pediatrie, puericulture",9604503,,,"['Adolescent', 'Feeding Behavior/*psychology', '*Health Behavior', 'Humans', 'Pediatric Obesity/*psychology/*therapy']",,['NOTNLM'],"['atelier', 'cognitive restriction', 'comportement alimentaire', 'eating habits', 'nutrition', 'obesity', 'obesite', 'restriction cognitive', 'workshop']",,2018/11/20 06:00,2019/03/01 06:00,['2018/11/20 06:00'],"['2018/11/20 06:00 [entrez]', '2018/11/20 06:00 [pubmed]', '2019/03/01 06:00 [medline]']","['S1259-4792(18)30128-7 [pii]', '10.1016/j.spp.2018.09.005 [doi]']",ppublish,Soins Pediatr Pueric. 2018 Nov-Dec;39(305):22-24. doi: 10.1016/j.spp.2018.09.005.,,,,['Copyright (c) 2018 Elsevier Masson SAS. All rights reserved.'],,,,,"Adolescents obeses et alimentation, entre experiences et sensations.",,,,,,,,,,,
35164921,NLM,MEDLINE,20220216,20220216,1259-4792 (Print) 1259-4792 (Linking),43,324,2022 Jan-Feb,[The Bomoko workshop in a day hospital for obese adolescents].,15-22,S1259-4792(21)00161-9 [pii] 10.1016/j.spp.2021.12.004 [doi],"The Bomoko workshop of the Maison de Solenn-Maison des adolescents of the Cochin hospital is aimed at obese adolescents who are treated at the day hospital during a therapeutic education day. It was born from the common and multidisciplinary desire of a team to propose an innovative device combining psychomotricity and Photolanguage(R) to encourage the connection between body sensations, emotions and thoughts. Thanks to the time of body mediation, the work of expression and psychic elaboration is facilitated during the Photolanguage(R).","['Hellier, Eloise', 'Rietsch, Joanne']","['Hellier E', 'Rietsch J']","[""Maison de Solenn - Maison des adolescents de l'hopital Cochin, AP-HP, 97 boulevard de Port-Royal, 75014 Paris, France. Electronic address: eloise.hellier@aphp.fr."", ""Maison de Solenn - Maison des adolescents de l'hopital Cochin, AP-HP, 97 boulevard de Port-Royal, 75014 Paris, France.""]",['fre'],['Journal Article'],France,Soins Pediatr Pueric,"Soins. Pediatrie, puericulture",9604503,,,"['Adolescent', 'Day Care, Medical', 'Emotions', 'Hospitals', 'Humans', '*Pediatric Obesity/therapy']",,['NOTNLM'],"['adolescence', 'body mediation', 'emotion', 'mind-body unit', 'multidisciplinarity', 'mediation corporelle', 'obesity', 'obesite', 'photolangage(R)', 'photolanguage(R)', 'pluridisciplinarite', 'stigma', 'stigmatisation', 'unite psychocorporelle', 'emotion']",,2022/02/16 06:00,2022/02/17 06:00,['2022/02/15 05:32'],"['2022/02/15 05:32 [entrez]', '2022/02/16 06:00 [pubmed]', '2022/02/17 06:00 [medline]']","['S1259-4792(21)00161-9 [pii]', '10.1016/j.spp.2021.12.004 [doi]']",ppublish,Soins Pediatr Pueric. 2022 Jan-Feb;43(324):15-22. doi: 10.1016/j.spp.2021.12.004. Epub 2021 Dec 21.,,20211221,,['Copyright (c) 2021 Elsevier Masson SAS. All rights reserved.'],,,,,L'atelier Bomoko en hopital de jour pour adolescents obeses.,,,,,,,,,,,
37942907,NLM,MEDLINE,20231110,20231129,1552-4604 (Electronic) 0091-2700 (Linking),63 Suppl 2,,2023 Nov,Inclusion of Subjects who are Obese in Drug Development: Current Status and Opportunities.,S10-S17,10.1002/jcph.2327 [doi],"The prevalence of obesity has grown tremendously in recent years and this population has an increased risk of disease comorbidities. The presence of disease comorbidities requires treatment interventions and proper dosing guidelines. However, drug development programs often do not have adequate representation of individuals who are obese in clinical trials, leaving gaps in the understanding of treatment response leading to a lack of adequate individualization options. Based on a recent survey of approved drug product package inserts, very few approved products included specific dosing based on obesity, in both adults and pediatrics. Reasons for the limited information on patients who are obese may include the under-reporting of information regarding such patients and a lack of clinical trial diversity in enrolling patient groups in whom obesity or obesity-related comorbidities are more prevalent. An inadvertent impact of the practice of exclusion of subsets of patients with some comorbidities in clinical trials may play a role in the reduced enrollment of individuals who are obese. Recently, regulatory authorities have taken specific initiatives to promote clinical trial diversity, including engaging with stakeholders and publishing regulatory guidance. These guidance documents highlight the need to enroll diverse clinical trial populations and provide recommendations on concepts related to drug development for obese populations. Such efforts will help to address the gap in information regarding drug response and dosing in patients who are obese.","['Vaidyanathan, Jayabharathi', 'Fletcher, Elimika Pfuma', 'Ramamoorthy, Anuradha', 'Madabushi, Rajanikanth', 'Burckart, Gilbert J']","['Vaidyanathan J', 'Fletcher EP', 'Ramamoorthy A', 'Madabushi R', 'Burckart GJ']","['Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.', 'Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.', 'Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.', 'Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.', 'Office of Clinical Pharmacology, Office of Translational Sciences, Center of Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.']",['eng'],['Journal Article'],England,J Clin Pharmacol,Journal of clinical pharmacology,0366372,,IM,"['Adult', 'Humans', 'Child', '*Obesity/complications/drug therapy/epidemiology', '*Drug Development']",,['NOTNLM'],"['FDA guidance', 'clinical pharmacology', 'clinical trial diversity', 'dosing', 'obesity']",,2023/11/09 12:42,2023/11/10 06:45,['2023/11/09 07:43'],"['2023/05/08 00:00 [received]', '2023/08/01 00:00 [accepted]', '2023/11/10 06:45 [medline]', '2023/11/09 12:42 [pubmed]', '2023/11/09 07:43 [entrez]']",['10.1002/jcph.2327 [doi]'],ppublish,J Clin Pharmacol. 2023 Nov;63 Suppl 2:S10-S17. doi: 10.1002/jcph.2327.,,,,"['Published 2023. This article is a U.S. Government work and is in the public', 'domain in the USA.']","['ORCID: 0009-0004-2367-3643', 'ORCID: 0000-0003-2005-9301']",,,,,,,,,,,,,,,
16403350,NLM,MEDLINE,20060124,20061115,1603-6824 (Electronic) 0041-5782 (Linking),168,2,2006 Jan 9,[Psychological aspects of obesity].,194-6,,"Although knowledge of the biological aspects of obesity is increasing very rapidly, psychological approaches are increasingly in demand. Psychological theory and research concerning the emotional and cognitive impacts of being obese, the psychological causes involved in obesity, and the psychological elements of treatment and motivations for treatment are requested. There is no clear separation between the psychological factors that function as causes of obesity and the psychological effects of obesity. Rather, they appear to be related in a circle of interconnectedness. This is important to keep in mind when seeking ways to motivate and support obese patients.","['Madsen, Svend Aage', 'Gronbaek, Helle', 'Olsen, Hanne']","['Madsen SA', 'Gronbaek H', 'Olsen H']","['H:S Rigshospitalet, Klinik for Psykologi, Paedagogik og Socialradgivning, Kobenhavn O. svaam@rh.dk']",['dan'],"['English Abstract', 'Journal Article']",Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,IM,"['Emotions', 'Humans', 'Motivation', 'Obesity/etiology/*psychology/therapy', 'Self Concept', 'Social Support', 'Socioeconomic Factors']",,,,,2006/01/13 09:00,2006/01/25 09:00,['2006/01/13 09:00'],"['2006/01/13 09:00 [pubmed]', '2006/01/25 09:00 [medline]', '2006/01/13 09:00 [entrez]']",['VP46239 [pii]'],ppublish,Ugeskr Laeger. 2006 Jan 9;168(2):194-6.,,,,,,,,,Psykologiske aspekter ved overvaegt.,,,,,,,,,,,
29088479,NLM,MEDLINE,20190628,20190628,1708-8305 (Electronic) 1195-1982 (Linking),24,6,2017 Sep 1,Health challenges of international travel for obese patients.,,10.1093/jtm/tax065 [doi],,"['Mozo, Mico V', 'Finucane, Francis M', 'Flaherty, Gerard T']","['Mozo MV', 'Finucane FM', 'Flaherty GT']","['School of Medicine, National University of Ireland Galway, Galway, Ireland.', 'School of Medicine, National University of Ireland Galway, Galway, Ireland.', 'Bariatric Medicine Service, Galway Diabetes Research Centre and Health Research Board Clinical Research Facility, Galway, Ireland.', 'National Institute for Preventive Cardiology, Galway, Ireland.', 'School of Medicine, National University of Ireland Galway, Galway, Ireland.', 'National Institute for Preventive Cardiology, Galway, Ireland.', 'School of Medicine, International Medical University, Kuala Lumpur, Malaysia.']",['eng'],['Journal Article'],England,J Travel Med,Journal of travel medicine,9434456,,IM,"['Humans', 'Obesity/*complications/psychology', '*Travel']",,['NOTNLM'],"['bariatric surgery', 'medical tourism', 'obese', 'obesity', 'travel', 'weight']",,2017/11/01 06:00,2019/06/30 06:00,['2017/11/01 06:00'],"['2017/07/07 00:00 [received]', '2017/08/15 00:00 [accepted]', '2017/11/01 06:00 [entrez]', '2017/11/01 06:00 [pubmed]', '2019/06/30 06:00 [medline]']","['4191321 [pii]', '10.1093/jtm/tax065 [doi]']",ppublish,J Travel Med. 2017 Sep 1;24(6). doi: 10.1093/jtm/tax065.,,,,,,,,,,,,,,,,,,,,
36302474,NLM,MEDLINE,20230116,20230124,2468-7189 (Electronic) 2468-7189 (Linking),51,1,2023 Jan,[Are gestational weight gain guidelines for obese women still appropriate?].,73-75,S2468-7189(22)00317-8 [pii] 10.1016/j.gofs.2022.10.004 [doi],"Guidelines for adequate gestational weight gain were proposed in 2009 by the Institute of Medicine. In case of a BMI>30kg/m(2), the recommended gestational weight gain should be between 5 and 9kg. However, these recommendations do not distinguish between different grades of obesity. Recent data suggest that the IOM recommendations are not restrictive enough for obese pregnant women and should be adapted to the grade of obesity.","['Deruelle, P', 'Anahory, T', 'Ranisavljevic, N', 'Duraes, M', 'Fuchs, F']","['Deruelle P', 'Anahory T', 'Ranisavljevic N', 'Duraes M', 'Fuchs F']","['Faculte de medecine, maieutique et sciences de la sante, Strasbourg, France; Pole Gynecologie, obstetrique Fertilite, Hopitaux Universitaires de Strasbourg, Strasbourg, France. Electronic address: pderuelle@unistra.fr.', 'Service de gynecologie obstetrique, CHU de Montpellier, Montpellier, France; Faculte de medecine, Montpellier-Nimes, France.', 'Service de gynecologie obstetrique, CHU de Montpellier, Montpellier, France; Faculte de medecine, Montpellier-Nimes, France.', 'Service de gynecologie obstetrique, CHU de Montpellier, Montpellier, France; Faculte de medecine, Montpellier-Nimes, France.', 'Service de gynecologie obstetrique, CHU de Montpellier, Montpellier, France; Faculte de medecine, Montpellier-Nimes, France.']",['fre'],"['English Abstract', 'Journal Article']",France,Gynecol Obstet Fertil Senol,"Gynecologie, obstetrique, fertilite & senologie",101693805,,IM,"['United States', 'Pregnancy', 'Female', 'Humans', '*Gestational Weight Gain', 'Pregnancy Outcome', '*Pregnancy Complications/therapy', 'Obesity/complications', 'National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division', 'Body Mass Index']",,['NOTNLM'],"['1000 days', '1000 jours', 'Complications', 'Gestational weight gain', 'Grossesse', 'Guidelines', 'Pregnancy', 'Prise de poids gravidique', 'Recommandations']",,2022/10/28 06:00,2023/01/17 06:00,['2022/10/27 19:22'],"['2022/09/13 00:00 [received]', '2022/10/13 00:00 [revised]', '2022/10/16 00:00 [accepted]', '2022/10/28 06:00 [pubmed]', '2023/01/17 06:00 [medline]', '2022/10/27 19:22 [entrez]']","['S2468-7189(22)00317-8 [pii]', '10.1016/j.gofs.2022.10.004 [doi]']",ppublish,Gynecol Obstet Fertil Senol. 2023 Jan;51(1):73-75. doi: 10.1016/j.gofs.2022.10.004. Epub 2022 Oct 24.,,20221024,,['Copyright (c) 2022 Elsevier Masson SAS. All rights reserved.'],,,,,Les recommandations de prise de poids gestationnelle pour les femmes obeses sont-elles encore adaptees ?,,,,,,,,,,,
37633689,NLM,MEDLINE,20231102,20231102,1293-8505 (Print) 1293-8505 (Linking),72,293,2023 Aug-Sep,[The city-hospital link in the care of severely obese patients].,29-32,S1293-8505(23)00245-2 [pii] 10.1016/j.revinf.2023.07.007 [doi],"After the initial weekday hospital stay, a personalized, multidisciplinary care pathway is offered to each patient followed at the specialized obesity center (CSO). This article illustrates the support approach adopted by the CSO at Caen Normandy University Hospital.","['Savey, Veronique', 'Bedar, Anais', 'Queslier, Caroline', 'Thouret, Aurore', 'Vastel, Elise']","['Savey V', 'Bedar A', 'Queslier C', 'Thouret A', 'Vastel E']","[""Centre specialise de l'obesite (CSO) Caen Normandie, CHU de Caen Normandie, Avenue de la Cote-de-Nacre, 14000 Caen, France. Electronic address: savey-v@chu-caen.fr."", ""Centre specialise de l'obesite (CSO) Caen Normandie, CHU de Caen Normandie, Avenue de la Cote-de-Nacre, 14000 Caen, France."", ""Centre specialise de l'obesite (CSO) Caen Normandie, CHU de Caen Normandie, Avenue de la Cote-de-Nacre, 14000 Caen, France."", ""Centre specialise de l'obesite (CSO) Caen Normandie, CHU de Caen Normandie, Avenue de la Cote-de-Nacre, 14000 Caen, France."", ""Centre specialise de l'obesite (CSO) Caen Normandie, CHU de Caen Normandie, Avenue de la Cote-de-Nacre, 14000 Caen, France.""]",['fre'],"['English Abstract', 'Journal Article']",France,Rev Infirm,Revue de l'infirmiere,1267175,,,"['Humans', '*Obesity/therapy', '*Hospitals']",,['NOTNLM'],"['activite physique adaptee', 'adapted physical activity', 'care pathway', ""centre specialise de l'obesite"", 'dietetics', 'dietetique', 'parcours de soins', 'psychologie', 'psychology', 'specialized obesity center', 'therapeutic patient education', 'education therapeutique du patient']",,2023/08/27 05:44,2023/08/27 05:45,['2023/08/26 20:58'],"['2023/08/27 05:45 [medline]', '2023/08/27 05:44 [pubmed]', '2023/08/26 20:58 [entrez]']","['S1293-8505(23)00245-2 [pii]', '10.1016/j.revinf.2023.07.007 [doi]']",ppublish,Rev Infirm. 2023 Aug-Sep;72(293):29-32. doi: 10.1016/j.revinf.2023.07.007. Epub 2023 Aug 17.,,20230817,,['Copyright (c) 2023 Elsevier Masson SAS. All rights reserved.'],,,,,Le lien ville-hopital dans le parcours de soins des patients obeses severes.,,,,,,,,,,,
16551291,NLM,MEDLINE,20060912,20060322,0894-0959 (Print) 0894-0959 (Linking),19,2,2006 Mar-Apr,Adiposity in dialysis: good or bad?,136-40,,"There exists in the general population a complex and mostly positive relationship between adiposity and mortality risk. Because the dialysis population has a high prevalence of excess adiposity, in addition to a strikingly elevated mortality rate, the effects of obesity are of potential clinical importance. In contrast to the general population, the preponderance of data in dialysis, particularly hemodialysis patients, suggest that adiposity has a neutral or even protective association with mortality. Although methodological concerns exist with regards to confounding and survival bias, among others, the major limitation of this body of literature is its inability to establish causality. Thus, although obese dialysis patients, with certain exceptions, appear to live longer, there is no evidence to suggest that intentional weight loss adversely affects patient outcomes. In light of these limitations and the substantial body of literature implicating obesity as a pathophysiological state, it is currently premature to advocate for excess adiposity as being beneficial or intentional weight loss as dangerous. Decisions regarding optimal weight should be made by clinicians on an individual basis and with close supervision and follow-up. Efforts should be made to preserve lean mass during weight loss regimens by encouraging exercise and recommending sufficient protein consumption. Future research efforts in this area should focus on interventional trials designed to manipulate weight and measure outcomes, identifying potentially beneficial secretory products of adipose tissue, and documenting obesity's effects on quality of life and resource utilization in the dialysis setting.","['Friedman, Allon N']",['Friedman AN'],"['Division of Nephrology, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. allfried@ipui.edu']",['eng'],"['Journal Article', 'Review']",United States,Semin Dial,Seminars in dialysis,8911629,,IM,"['Body Mass Index', 'Humans', 'Kidney Failure, Chronic/complications/*mortality/therapy', 'Obesity/complications/*mortality', 'Renal Dialysis/*mortality', 'Risk Factors', 'Survival Analysis']",,,,,2006/03/23 09:00,2006/09/13 09:00,['2006/03/23 09:00'],"['2006/03/23 09:00 [pubmed]', '2006/09/13 09:00 [medline]', '2006/03/23 09:00 [entrez]']","['SDI139 [pii]', '10.1111/j.1525-139X.2006.00139.x [doi]']",ppublish,Semin Dial. 2006 Mar-Apr;19(2):136-40. doi: 10.1111/j.1525-139X.2006.00139.x.,,,,,,,24,,,,,,,,,,,,,
6730499,NLM,MEDLINE,19840725,20181113,0093-0415 (Print) 0093-0415 (Linking),140,5,1984 May,Approach to obese patients.,794-7,,,"['Boisaubin, E V']",['Boisaubin EV'],,['eng'],['Journal Article'],United States,West J Med,The Western journal of medicine,0410504,,IM,"['Humans', 'Obesity/complications/etiology/*therapy', 'Prognosis']",PMC1011112,,,,1984/05/01 00:00,1984/05/01 00:01,['1984/05/01 00:00'],"['1984/05/01 00:00 [pubmed]', '1984/05/01 00:01 [medline]', '1984/05/01 00:00 [entrez]']",,ppublish,West J Med. 1984 May;140(5):794-7.,,,,,,,,,,,,,,,,,,,,
16199657,NLM,MEDLINE,20051201,20190818,0029-7844 (Print) 0029-7844 (Linking),106,4,2005 Oct,"ACOG committee opinion. Number 319, October 2005. The role of obstetrician-gynecologist in the assessment and management of obesity.",895-9,,Approximately one third of all women in the United States are obese. Obstetrician-gynecologists should evaluate all women for obesity by calculating body mass index (BMI) measurement and should offer appropriate interventions or referrals to promote a health weight and lifestyle.,,,,['eng'],['Journal Article'],United States,Obstet Gynecol,Obstetrics and gynecology,0401101,,IM,"['Female', '*Gynecology', 'Humans', 'Obesity/diagnosis/*prevention & control/psychology', '*Obstetrics', ""*Physician's Role""]",,,,,2005/10/04 09:00,2005/12/13 09:00,['2005/10/04 09:00'],"['2005/10/04 09:00 [pubmed]', '2005/12/13 09:00 [medline]', '2005/10/04 09:00 [entrez]']","['106/4/895 [pii]', '10.1097/00006250-200510000-00055 [doi]']",ppublish,Obstet Gynecol. 2005 Oct;106(4):895-9. doi: 10.1097/00006250-200510000-00055.,,,,,,,,,,['ACOG Committee on Gynecologic Practice'],,,,,,,,,,
24828650,NLM,MEDLINE,20140710,20211021,1529-2401 (Electronic) 0270-6474 (Print) 0270-6474 (Linking),34,20,2014 May 14,"Hyperlipidemic diet causes loss of olfactory sensory neurons, reduces olfactory discrimination, and disrupts odor-reversal learning.",6970-84,10.1523/JNEUROSCI.3366-13.2014 [doi],"Currently, 65% of Americans are overweight, which leads to well-supported cardiovascular and cognitive declines. Little, however, is known concerning obesity's impact on sensory systems. Because olfaction is linked with ingestive behavior to guide food choice, its potential dysfunction during obesity could evoke a positive feedback loop to perpetuate poor ingestive behaviors. To determine the effect of chronic energy imbalance and reveal any structural or functional changes associated with obesity, we induced long-term, diet-induced obesity by challenging mice to high-fat diets: (1) in an obesity-prone (C57BL/6J) and obesity-resistant (Kv1.3(-/-)) line of mice, and compared this with (2) late-onset, genetic-induced obesity in MC4R(-/-) mice in which diabetes secondarily precipitates after disruption of the hypothalamic axis. We report marked loss of olfactory sensory neurons and their axonal projections after exposure to a fatty diet, with a concomitant reduction in electro-olfactogram amplitude. Loss of olfactory neurons and associated circuitry is linked to changes in neuronal proliferation and normal apoptotic cycles. Using a computer-controlled, liquid-based olfactometer, mice maintained on fatty diets learn reward-reinforced behaviors more slowly, have deficits in reversal learning demonstrating behavioral inflexibility, and exhibit reduced olfactory discrimination. When obese mice are removed from their high-fat diet to regain normal body weight and fasting glucose, olfactory dysfunctions are retained. We conclude that chronic energy imbalance therefore presents long-lasting structural and functional changes in the operation of the sensory system designed to encode external and internal chemical information and leads to altered olfactory- and reward-driven behaviors.","['Thiebaud, Nicolas', 'Johnson, Melissa C', 'Butler, Jessica L', 'Bell, Genevieve A', 'Ferguson, Kassandra L', 'Fadool, Andrew R', 'Fadool, James C', 'Gale, Alana M', 'Gale, David S', 'Fadool, Debra A']","['Thiebaud N', 'Johnson MC', 'Butler JL', 'Bell GA', 'Ferguson KL', 'Fadool AR', 'Fadool JC', 'Gale AM', 'Gale DS', 'Fadool DA']","['Department of Biological Science and Program in Neuroscience, Florida State University, Tallahassee, Florida 32306.', 'Department of Biology, University of West Georgia, Carrollton, Georgia 30118.', 'Department of Biological Science and Program in Neuroscience, Florida State University, Tallahassee, Florida 32306.', 'Department of Biological Science and Program in Neuroscience, Florida State University, Tallahassee, Florida 32306.', 'Department of Biological Science and Program in Neuroscience, Florida State University, Tallahassee, Florida 32306.', 'Department of Biological Science and Program in Neuroscience, Florida State University, Tallahassee, Florida 32306.', 'Department of Mechanical Engineering, Florida State University, Tallahassee, Florida 32310.', 'Larry A. Ryle High School, Union, Kentucky 41091, and.', 'Larry A. Ryle High School, Union, Kentucky 41091, and.', 'Department of Biological Science and Program in Neuroscience, Florida State University, Tallahassee, Florida 32306, Institute of Molecular Biophysics, Florida State University, Tallahassee, Florida 32306 dfadool@bio.fsu.edu.']",['eng'],"['Journal Article', 'Research Support, American Recovery and Reinvestment Act', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",United States,J Neurosci,The Journal of neuroscience : the official journal of the Society for Neuroscience,8102140,['0 (Blood Glucose)'],IM,"['Animals', 'Blood Glucose', 'Diet, High-Fat/*adverse effects', 'Discrimination Learning/*physiology', 'Male', 'Mice', 'Obesity/etiology/physiopathology', 'Odorants', 'Olfactory Perception/*physiology', 'Reversal Learning/*physiology', 'Sensory Receptor Cells/*physiology', 'Smell/*physiology']",PMC4019806,['NOTNLM'],"['chemical senses', 'circuitry', 'metabolism', 'obesity', 'olfactory', 'sensory']",,2014/05/16 06:00,2014/07/11 06:00,['2014/05/16 06:00'],"['2014/05/16 06:00 [entrez]', '2014/05/16 06:00 [pubmed]', '2014/07/11 06:00 [medline]']","['JNEUROSCI.3366-13.2014 [pii]', '3366-13 [pii]', '10.1523/JNEUROSCI.3366-13.2014 [doi]']",ppublish,J Neurosci. 2014 May 14;34(20):6970-84. doi: 10.1523/JNEUROSCI.3366-13.2014.,"['R01 DC013080/DC/NIDCD NIH HHS/United States', 'ARRA-R01003387-SUMM/PHS HHS/United States', 'R01DC13080/DC/NIDCD NIH HHS/United States', 'R01DC003387/DC/NIDCD NIH HHS/United States', 'R01 DC003387/DC/NIDCD NIH HHS/United States', 'T32 DC000044/DC/NIDCD NIH HHS/United States']",,,['Copyright (c) 2014 the authors 0270-6474/14/346970-15$15.00/0.'],,,,['Nat Rev Neurosci. 2014 Jul;15(7):428. PMID: 24894584'],,,,,,,,,,,,
19418934,NLM,MEDLINE,20090707,20150826,0370-629X (Print) 0370-629X (Linking),64,3,2009 Mar,[Metabolically normal obese subjects].,148-57,,"Around 30 to 50% of obese subjects are metabolically normal (MNO) whereas numerous non obese subjects are metabolically abnormal. The distribution and the function of adipose depots seem to play a crucial role to explain this apparent discrepancy. The present article describes the clinical and biological characteristics of these metabolically healthy, but obese patients, analyzes the underlying pathophysiological mechanisms, assess the prognosis, especially regarding the cardiovascular risk, and finally discuss the advantages and disadvantages of a classical therapeutic strategy.","['Esser, N', 'Scheen, A J']","['Esser N', 'Scheen AJ']",['Universite de Liege.'],['fre'],"['English Abstract', 'Journal Article']",Belgium,Rev Med Liege,Revue medicale de Liege,0404317,,IM,"['Humans', 'Obesity/diagnosis/epidemiology/*metabolism/physiopathology/therapy', 'Prevalence', 'Prognosis']",,,,,2009/05/08 09:00,2009/07/08 09:00,['2009/05/08 09:00'],"['2009/05/08 09:00 [entrez]', '2009/05/08 09:00 [pubmed]', '2009/07/08 09:00 [medline]']",,ppublish,Rev Med Liege. 2009 Mar;64(3):148-57.,,,,,,,,,Sujets obeses sans anomalies metaboliques.,,,,,,,,,,,
25219172,NLM,MEDLINE,20141009,20140915,0025-7206 (Print) 0025-7206 (Linking),91,4,2014 Feb 25,"Obesity's growing threat. While the adult obesity rate went up again in 2013, associated health problems could explode in the next 10 years unless patients and physicians take action.","36, 38-41",,,"['Zamosky, Lisa']",['Zamosky L'],,['eng'],['Journal Article'],United States,Med Econ,Medical economics,2985239R,,,"['Adult', 'Aged', 'Cost of Illness', 'Humans', 'Middle Aged', 'Obesity/*complications/diet therapy/economics/*epidemiology', 'Prevalence', 'United States/epidemiology', 'Young Adult']",,,,,2014/09/16 06:00,2014/10/10 06:00,['2014/09/16 06:00'],"['2014/09/16 06:00 [entrez]', '2014/09/16 06:00 [pubmed]', '2014/10/10 06:00 [medline]']",,ppublish,"Med Econ. 2014 Feb 25;91(4):36, 38-41.",,,,,,,,,,,,,,,,,,,,
6394527,NLM,MEDLINE,19850301,20140603,,8,5,1984,Hormonal changes: are they useful in the classification of obesities?,579-90,,"Changes in hormonal levels and/or actions have frequently been implicated as either antecedent or concomitant factors in the etiology and progression of obesity. Therefore, various hormones are likely to be important in a classification schema for the obesities. Using selected hormones and experimental approaches as examples, this review emphasizes the complexity associated with the multiple measurable aspects of hormone levels and functions, and identifies some of the problems associated with simplistic or uni-dimensional assessments of hormonal factors in obesity. A framework is presented for the evaluation of each hormone for its possible contribution to a classification of the obesities.","['Hansen, B C']",['Hansen BC'],,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S."", 'Review']",England,Int J Obes,International journal of obesity,7703240,"['0 (Hormones)', '0 (Insulin)', '59763-91-6 (Pancreatic Polypeptide)', '9007-92-5 (Glucagon)']",IM,"['Animals', 'Basal Metabolism', 'Body Weight', 'Glucagon/blood', 'Hormones/*blood', 'Humans', 'Insulin/blood/pharmacology', 'Macaca mulatta', 'Obesity/blood/*classification', 'Pancreatic Polypeptide/blood']",,,,,1984/01/01 00:00,1984/01/01 00:01,['1984/01/01 00:00'],"['1984/01/01 00:00 [pubmed]', '1984/01/01 00:01 [medline]', '1984/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1984;8(5):579-90.,['AM33502/AM/NIADDK NIH HHS/United States'],,,,,,53,,,,,,,,,,,,,
19683699,NLM,MEDLINE,20100304,20161031,2213-3941 (Electronic) 0003-4266 (Linking),70,6,2009 Dec,"[Binge eating disorder and obesity: Epidemiological, clinical and psychopathological aspects. A study of an obese population in Sfax (Tunisia)].",462-7,10.1016/j.ando.2009.07.002 [doi],"OBJECTIVES: To evaluate the prevalence of binge eating disorder (BED) in a population of obese patients, to appreciate the impact of obesity on BED through a comparison between the obese group and a control group, and to assess anxiety, depression and quality of life in obese patients with BED. PATIENTS AND METHODS: A cross-sectional study including 60 obese patients and 60 controls. BED was diagnosed using the Binge Eating Scale. Quality of life was assessed by the Quality Of Life, Obesity and Dietetics Scale, and depression and anxiety symptoms by the Hospital Anxiety and Depression Scale. RESULTS: The obese group had a higher prevalence of BED than the control group (40% versus 8.3%; p < 0.001; OR = 3.5). The average score of BES was also higher (p < 0.001). Obese patients with BED were younger (p = 0.034). BED was correlated with an early onset of obesity (p = 0.01; OR = 1.12), depression (p = 0.002), anxiety (p = 0.008) and a poorer quality of life. CONCLUSION: This study confirms the relationship between obesity and BED, which is correlated with a high prevalence of anxiety and depression and with a poorer quality of life.","['Ketata, W', 'Aloulou, J', 'Charfi, N', 'Abid, M', 'Amami, O']","['Ketata W', 'Aloulou J', 'Charfi N', 'Abid M', 'Amami O']","['Service de psychiatrie B, CHU Hedi-Chaker, Sfax, Tunisie.']",['fre'],"['English Abstract', 'Journal Article']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,,IM,"['Adolescent', 'Adult', 'Anxiety/epidemiology', 'Binge-Eating Disorder/*epidemiology', 'Body Mass Index', 'Depression/epidemiology', 'Female', 'Humans', 'Male', 'Obesity/*psychology', 'Quality of Life', 'Tunisia/epidemiology']",,,,,2009/08/18 09:00,2010/03/05 06:00,['2009/08/18 09:00'],"['2009/04/20 00:00 [received]', '2009/06/25 00:00 [revised]', '2009/07/07 00:00 [accepted]', '2009/08/18 09:00 [entrez]', '2009/08/18 09:00 [pubmed]', '2010/03/05 06:00 [medline]']","['S0003-4266(09)00167-X [pii]', '10.1016/j.ando.2009.07.002 [doi]']",ppublish,Ann Endocrinol (Paris). 2009 Dec;70(6):462-7. doi: 10.1016/j.ando.2009.07.002. Epub 2009 Aug 15.,,20090815,,,,,,,"Hyperphagie boulimique et obesite : aspects epidemiologiques, cliniques et psychopathologiques. Etude d'une population d'obeses a Sfax (Tunisie).",,,,,,,,,,,
35485040,NLM,MEDLINE,20220502,20220502,0297-2964 (Print) 0297-2964 (Linking),,147,2022 Feb 10,[The preoperative shower for obese patients: What patients and caregivers say].,92-99,10.3917/rsi.147.0092 [doi],"Introduction : At least one preoperative shower is recommended to avoid surgical site infection. Caregivers must explain the showering technique, help the patient if necessary, and assess skin cleanliness after showering.Context : Showering may be more difficult for obese patients because of inadequate equipment and difficulties moving, as well as insufficient explanation regarding the showering technique and an insufficient skin cleanliness assessment from caregivers.Objective : to assess whether patients and/or caregivers report difficulties in the preoperative shower process that could be linked to patient obesity. Methods : pilot qualitative survey with semi-structured interviews conducted with 9 obese surgery patients and 11 surgery caregivers.Results : Patients did not report feelings of discrimination. They described no problem with equipment, but declared having received little explanation on the showering technique and no visual skin cleanliness assessment. Caregivers reported equipment as inadequate, they stated having delivered detailed information, but found the skin cleanliness assessment difficult.Discussion : The lack of skin cleanliness assessment by caregivers after preoperative showering is new information. Limits : preliminary study with a small number of interviews and no non-obese patients.Conclusion : the subject warrants additional work with both quantitative and qualitative surveys to better understand the difficulties with preoperative showering.",,,,['fre'],['Journal Article'],France,Rech Soins Infirm,Recherche en soins infirmiers,9715370,,,"['*Caregivers', 'Humans', '*Obesity']",,,,,2022/04/30 06:00,2022/05/03 06:00,['2022/04/29 04:07'],"['2022/04/29 04:07 [entrez]', '2022/04/30 06:00 [pubmed]', '2022/05/03 06:00 [medline]']",['10.3917/rsi.147.0092 [doi]'],ppublish,Rech Soins Infirm. 2022 Feb 10;(147):92-99. doi: 10.3917/rsi.147.0092.,,,,,,,,,La douche preoperatoire chez les patients obeses : ce qu'en disent les patients et les soignants.,,,,,,,,,,,
34140143,NLM,MEDLINE,20220203,20220203,1768-3181 (Electronic) 0003-3928 (Linking),71,1,2022 Feb,[Associated factors and sub-clinical myocardial dysfunction in obese patients with masked hypertension].,6-10,S0003-3928(21)00071-8 [pii] 10.1016/j.ancard.2021.05.005 [doi],"INTRODUCTION: Obesity is a worldwide health problem. Masked hypertension is a relatively recent reported entity with a diagnostic problem. The aim of this study was to determine the clinical and paraclinical characteristics and to identify the predictive factors of masked hypertension in obese patients. METHODS: It is a prospective study including obese patients with normal arterial pressure at office. All of these patients were given ambulatory blood pressure measurement (ABPM) to screen for masked hypertension, laboratory tests and a complete echocardiography study. RESULTS: A total of 50 patients were included. The mean age was 46.52+/-10.4 years. The mean systolic blood pressure (BP) at office was 120.8+/-8.8mmHg and the mean diastolic BP was 75+/-7.3mmHg. The prevalence of masked hypertension in obese adults was 36% with a predominantly non-dipper profile (38%). The study of echocardiographic parameters found dilated left atrium (LA) in 16 patients (32%). The left ventricle (LV) was hypertrophied in 32 patients (64%). The overall LV global longitudinal strain (GLS) was on average -18.85+/-0.9% and the LA GLS was on average 37.35+/-4.5%. In our study, metabolic syndrome, low HDL cholesterol, elevated fasting blood glucose, hyperuricemia, LA dilatation, LV hypertrophy, diastolic LV dysfunction and altered myocardial deformities were factors associated with masked hypertension in obese adults. CONCLUSION: It is important to screen for hypertension by ambulatory measurement in at-risk obese patients who present associated cardiovascular risk factors to reduce morbidity and mortality. Echocardiography and speckle tracking analysis could be helpful in detection sub-clinical myocardial deterioration in obese patients with masked hypertension.","['Charfeddine, S', 'Hadj Kacem, F', 'Bahloul, A', 'Triki, F', 'Hammami, R', 'Rebai, M', 'Abid, M', 'Abid, L', 'Kammoun, S']","['Charfeddine S', 'Hadj Kacem F', 'Bahloul A', 'Triki F', 'Hammami R', 'Rebai M', 'Abid M', 'Abid L', 'Kammoun S']","[""Service de cardiologie, faculte de medecine de Sfax, universite de Sfax, hopital Hedi Chaker, Sfax, Tunisie; Unite de recherche de l'insuffisance cardiaque UR17ES37, faculte de medecine de Sfax, Universite de Sfax, Tunisie. Electronic address: selma_charfeddine@yahoo.fr."", ""Service d'endocrinologie, faculte de medecine de Sfax, universite de Sfax, hopital Hedi Chaker, Sfax Tunisie."", ""Service de cardiologie, faculte de medecine de Sfax, universite de Sfax, hopital Hedi Chaker, Sfax, Tunisie; Unite de recherche de l'insuffisance cardiaque UR17ES37, faculte de medecine de Sfax, Universite de Sfax, Tunisie."", ""Service de cardiologie, faculte de medecine de Sfax, universite de Sfax, hopital Hedi Chaker, Sfax, Tunisie; Unite de recherche de l'insuffisance cardiaque UR17ES37, faculte de medecine de Sfax, Universite de Sfax, Tunisie."", ""Service de cardiologie, faculte de medecine de Sfax, universite de Sfax, hopital Hedi Chaker, Sfax, Tunisie; Unite de recherche de l'insuffisance cardiaque UR17ES37, faculte de medecine de Sfax, Universite de Sfax, Tunisie."", 'Departement de medecine de famille, faculte de medecine de Sfax, Universite de Sfax, Tunisie.', ""Service d'endocrinologie, faculte de medecine de Sfax, universite de Sfax, hopital Hedi Chaker, Sfax Tunisie."", ""Service de cardiologie, faculte de medecine de Sfax, universite de Sfax, hopital Hedi Chaker, Sfax, Tunisie; Unite de recherche de l'insuffisance cardiaque UR17ES37, faculte de medecine de Sfax, Universite de Sfax, Tunisie."", ""Service de cardiologie, faculte de medecine de Sfax, universite de Sfax, hopital Hedi Chaker, Sfax, Tunisie; Unite de recherche de l'insuffisance cardiaque UR17ES37, faculte de medecine de Sfax, Universite de Sfax, Tunisie.""]",['fre'],['Journal Article'],France,Ann Cardiol Angeiol (Paris),Annales de cardiologie et d'angeiologie,0142167,,IM,"['Adult', 'Blood Pressure', 'Blood Pressure Monitoring, Ambulatory', 'Humans', '*Hypertension/complications/epidemiology', '*Masked Hypertension/complications/diagnosis/epidemiology', 'Middle Aged', 'Obesity/complications/epidemiology', 'Prospective Studies']",,['NOTNLM'],"['Ambulatory blood pressure', 'Cardiovascular risk', 'Hypertension', 'Hypertension arterielle', 'Hypertension arterielle masquee', 'Masked hypertension', 'Mesure ambulatoire de la pression arterielle', 'Obesity', 'Obesite', 'Risque cardio-vasculaire']",,2021/06/19 06:00,2022/02/04 06:00,['2021/06/18 05:41'],"['2021/05/02 00:00 [received]', '2021/05/20 00:00 [accepted]', '2021/06/19 06:00 [pubmed]', '2022/02/04 06:00 [medline]', '2021/06/18 05:41 [entrez]']","['S0003-3928(21)00071-8 [pii]', '10.1016/j.ancard.2021.05.005 [doi]']",ppublish,Ann Cardiol Angeiol (Paris). 2022 Feb;71(1):6-10. doi: 10.1016/j.ancard.2021.05.005. Epub 2021 Jun 16.,,20210616,,['Copyright (c) 2021 Elsevier Masson SAS. All rights reserved.'],,,,,L'hypertension arterielle masquee chez les obeses : facteurs associes et atteinte myocardique infraclinique.,,,,,,,,,,,
31611297,NLM,MEDLINE,20210216,20210216,1468-3288 (Electronic) 0017-5749 (Print) 0017-5749 (Linking),69,7,2020 Jul,Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health.,1229-1238,10.1136/gutjnl-2019-319322 [doi],"OBJECTIVE: The gut microbiota has been implicated in the aetiology of obesity and associated comorbidities. Patients with Prader-Willi syndrome (PWS) are obese but partly protected against insulin resistance. We hypothesised that the gut microbiota of PWS patients differs from that of non-genetically obese controls and correlate to metabolic health. Therefore, here we used PWS as a model to study the role of gut microbiota in the prevention of metabolic complications linked to obesity. DESIGN: We conducted a case-control study with 17 adult PWS patients and 17 obese subjects matched for body fat mass index, gender and age. The subjects were metabolically characterised and faecal microbiota was profiled by 16S ribosomal RNA gene sequencing. The patients' parents were used as a non-obese control group. Stool samples from two PWS patients and two obese controls were used for faecal microbiota transplantations in germ-free mice to examine the impact of the microbiota on glucose metabolism. RESULTS: The composition of the faecal microbiota in patients with PWS differed from that of obese controls, and was characterised by higher phylogenetic diversity and increased abundance of several taxa such as Akkermansia, Desulfovibrio and Archaea, and decreased abundance of Dorea. Microbial taxa prevalent in the PWS microbiota were associated with markers of insulin sensitivity. Improved insulin resistance of PWS was partly transmitted by faecal microbiota transplantations into germ-free mice. CONCLUSION: The gut microbiota of PWS patients is similar to that of their non-obese parents and might play a role for the protection of PWS patients from metabolic complications.","['Olsson, Lisa M', 'Poitou, Christine', 'Tremaroli, Valentina', 'Coupaye, Muriel', 'Aron-Wisnewsky, Judith', 'Backhed, Fredrik', 'Clement, Karine', 'Caesar, Robert']","['Olsson LM', 'Poitou C', 'Tremaroli V', 'Coupaye M', 'Aron-Wisnewsky J', 'Backhed F', 'Clement K', 'Caesar R']","['The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.', 'INSERM, Nutrition and obesities; systemic approaches (NutriOmics) research Unit, Sorbonne Universite, Paris, Ile-de-France, France.', 'Assistance Publique-Hopitaux de Paris, Reference Center for Rare Diseases (Prader-Willi Syndrome), Nutrition Department, University Hospital Pitie Salpetriere, Paris, Ile-de-France, France.', 'The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.', 'Assistance Publique-Hopitaux de Paris, Reference Center for Rare Diseases (Prader-Willi Syndrome), Nutrition Department, University Hospital Pitie Salpetriere, Paris, Ile-de-France, France.', 'INSERM, Nutrition and obesities; systemic approaches (NutriOmics) research Unit, Sorbonne Universite, Paris, Ile-de-France, France.', 'Assistance Publique-Hopitaux de Paris, Reference Center for Rare Diseases (Prader-Willi Syndrome), Nutrition Department, University Hospital Pitie Salpetriere, Paris, Ile-de-France, France.', 'The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.', 'Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Receptology and Enteroendocrinology, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.', 'INSERM, Nutrition and obesities; systemic approaches (NutriOmics) research Unit, Sorbonne Universite, Paris, Ile-de-France, France Robert.Caesar@wlab.gu.se karine.clement@inserm.fr.', 'Assistance Publique-Hopitaux de Paris, Reference Center for Rare Diseases (Prader-Willi Syndrome), Nutrition Department, University Hospital Pitie Salpetriere, Paris, Ile-de-France, France.', 'The Wallenberg Laboratory, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden Robert.Caesar@wlab.gu.se karine.clement@inserm.fr.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Gut,Gut,2985108R,"['0 (RNA, Ribosomal, 16S)', 'IY9XDZ35W2 (Glucose)']",IM,"['Adult', 'Animals', 'Case-Control Studies', 'Fecal Microbiota Transplantation', 'Feces/microbiology', 'Female', '*Gastrointestinal Microbiome/genetics/physiology', 'Glucose/metabolism', 'Humans', 'Male', 'Mice', 'Obesity/complications/metabolism/*microbiology', 'Prader-Willi Syndrome/complications/metabolism/*microbiology', 'RNA, Ribosomal, 16S/genetics']",PMC7306984,['NOTNLM'],"['diabetes mellitus', 'glucose metabolism', 'intestinal bacteria']","['Competing interests: FB is in the Scientific Advisory Board of MetaboGen, Sweden.']",2019/10/16 06:00,2021/02/17 06:00,['2019/10/16 06:00'],"['2019/06/20 00:00 [received]', '2019/09/20 00:00 [revised]', '2019/09/23 00:00 [accepted]', '2019/10/16 06:00 [pubmed]', '2021/02/17 06:00 [medline]', '2019/10/16 06:00 [entrez]']","['gutjnl-2019-319322 [pii]', '10.1136/gutjnl-2019-319322 [doi]']",ppublish,Gut. 2020 Jul;69(7):1229-1238. doi: 10.1136/gutjnl-2019-319322. Epub 2019 Oct 14.,,20191014,,"['(c) Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No', 'commercial re-use. See rights and permissions. Published by BMJ.']","['ORCID: 0000-0001-9730-1915', 'ORCID: 0000-0003-1017-2933']",,,,,,,,,,,,,,,
322053,NLM,MEDLINE,19770512,20190827,0031-3955 (Print) 0031-3955 (Linking),24,1,1977 Feb,Management of the obese adolescent.,123-32,,"Obesity as a health problem appears to be increasing in incidence. Adolescent obesity is generally exogenous in type. The teenagers are basically healthy with advanced sexual and bone maturation. They suffer from peer ridicule and exclusion from activities. The weight problem bars them from successful adult adjustment in their social lives and career choice. To the physician who treats the obese adolescent, it would be wise to review the pitfalls of previous programs. The multidisciplinary approach is an attempt to combine dietary restriction and increased physical activity to gradually mobilize fat stores and provide psychologic support. Motivation is reinforced by a committed staff and by the patients' own obese peers with whom they meet weekly. Despite the repeated record of failure in adolescent weight reduction programs, it is hoped that the challenge of obesity management spurs the interest of physicians to increase their knowledge of nutrition and to intervene with early effective preventive measures.","['Meyer, E E', 'Neumann, C G']","['Meyer EE', 'Neumann CG']",,['eng'],"['Journal Article', 'Review']",United States,Pediatr Clin North Am,Pediatric clinics of North America,0401126,,IM,"['Adolescent', 'Diet, Reducing', 'Energy Metabolism', 'Female', 'Humans', 'Male', 'Obesity/*diet therapy/etiology/therapy', 'Physical Fitness']",,,,,1977/02/01 00:00,1977/02/01 00:01,['1977/02/01 00:00'],"['1977/02/01 00:00 [pubmed]', '1977/02/01 00:01 [medline]', '1977/02/01 00:00 [entrez]']","['S0031-3955(16)33393-4 [pii]', '10.1016/s0031-3955(16)33393-4 [doi]']",ppublish,Pediatr Clin North Am. 1977 Feb;24(1):123-32. doi: 10.1016/s0031-3955(16)33393-4.,,,,,,,34,,,,,,,,,,,,,
30449393,NLM,MEDLINE,20190228,20190228,1259-4792 (Print) 1259-4792 (Linking),39,305,2018 Nov-Dec,[Photolangage((R)) workshops in the therapeutic education of obese teenagers].,18-21,S1259-4792(18)30127-5 [pii] 10.1016/j.spp.2018.09.004 [doi],"A photolanguage workshop was organised as part of a therapeutic education day for obese teenagers. It is a valuable way of establishing links between their eating habits and their emotions, and to help them become aware of the benefit of psychotherapy. In addition this workshop helps to remove the common inhibitions of these young people, helping them to express themselves around the often painful experience of being overweight and their relational and family difficulties.","['Hellier, Eloise']",['Hellier E'],"[""Maison des adolescents de l'Hopital Cochin-Maison de Solenn, AP-HP, 97, boulevard de Port-Royal, 75014 Paris, France. Electronic address: eloise.hellier@aphp.fr.""]",['fre'],['Journal Article'],France,Soins Pediatr Pueric,"Soins. Pediatrie, puericulture",9604503,,,"['Adolescent', 'Humans', 'Patient Education as Topic/*methods', 'Pediatric Obesity/psychology/*therapy', '*Photography', '*Psychotherapy, Group']",,['NOTNLM'],"['Photolangage((R))', 'adolescent', 'emotion', 'mediation', 'mediation', 'obesity', 'obesite', 'teenager', 'therapeutic education', 'education therapeutique', 'emotion']",,2018/11/20 06:00,2019/03/01 06:00,['2018/11/20 06:00'],"['2018/11/20 06:00 [entrez]', '2018/11/20 06:00 [pubmed]', '2019/03/01 06:00 [medline]']","['S1259-4792(18)30127-5 [pii]', '10.1016/j.spp.2018.09.004 [doi]']",ppublish,Soins Pediatr Pueric. 2018 Nov-Dec;39(305):18-21. doi: 10.1016/j.spp.2018.09.004.,,,,['Copyright (c) 2018 Elsevier Masson SAS. All rights reserved.'],,,,,L'atelier Photolangage((R)) dans l'education therapeutique des adolescents obeses.,,,,,,,,,,,
18469621,NLM,MEDLINE,20081118,20161018,1536-5948 (Electronic) 1076-2752 (Linking),50,5,2008 May,The association of diabetes with job absenteeism costs among obese and morbidly obese workers.,527-34,10.1097/JOM.0b013e31816ed029 [doi],"OBJECTIVE: To determine the extent to which absenteeism costs associated with obesity and morbid obesity are traceable to diabetes, and whether obesity and morbid obesity remain predictors of absenteeism costs after controlling for diabetes. METHODS: Data from the Medical Expenditure Panel Survey for 2000-2004 are examined. Outcomes are probability of missing work in the previous year and number of workdays missed. Predictors include diabetes, obesity and morbid obesity, age, education, occupation category, and race. Models are estimated by gender. RESULTS: Probability of missing work in the past year, number of days missed, and absenteeism costs rise significantly with diabetes among the obese and morbidly obese, with costs higher for the morbidly obese, after controlling for diabetes. CONCLUSIONS: Diabetes is strongly predictive of absenteeism among obese and morbidly obese workers. Employer efforts to reduce absenteeism should include consideration of anti-obesity interventions and diabetes prevention.","['Cawley, John', 'Rizzo, John A', 'Haas, Kara']","['Cawley J', 'Rizzo JA', 'Haas K']","['Department of Policy Analysis and Management, Cornell University, Ithaca, New York 14853, USA. JHC38@cornell.edu']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,J Occup Environ Med,Journal of occupational and environmental medicine,9504688,,IM,"['*Absenteeism', 'Adolescent', 'Adult', 'Body Mass Index', 'Diabetes Mellitus/*economics/epidemiology/etiology/prevention & control', 'Female', 'Health Surveys', 'Humans', 'Male', 'Middle Aged', 'Obesity/complications/*economics/epidemiology/prevention & control', 'Obesity, Morbid/complications/economics/epidemiology/prevention & control', 'Regression Analysis', 'Sex Distribution', 'United States/epidemiology']",,,,,2008/05/13 09:00,2008/11/19 09:00,['2008/05/13 09:00'],"['2008/05/13 09:00 [pubmed]', '2008/11/19 09:00 [medline]', '2008/05/13 09:00 [entrez]']","['00043764-200805000-00002 [pii]', '10.1097/JOM.0b013e31816ed029 [doi]']",ppublish,J Occup Environ Med. 2008 May;50(5):527-34. doi: 10.1097/JOM.0b013e31816ed029.,,,,,,,,['J Occup Environ Med. 2008 Oct;50(10):1094; author reply 1094-5. PMID: 18849754'],,,,,,,,,,,,
37352694,NLM,MEDLINE,20231115,20231122,1873-135X (Electronic) 0027-5107 (Linking),827,,2023 Jul-Dec,Oxidative and DNA damage in obese patients undergoing bariatric surgery: A one-year follow-up study.,111827,S0027-5107(23)00014-3 [pii] 10.1016/j.mrfmmm.2023.111827 [doi],"The pathogenesis of obesity and related comorbidities has long been associated with oxidative stress. The excess of adipose tissue contributes to the production of free radicals that sustain both a local and a systemic chronic inflammatory state, whereas its reduction can bring to an improvement in inflammation and oxidative stress. In our work, using the fluorescent lipid probe BODIPY(R) 581/591 C(11) and the gammaH2AX foci assay, a well-known marker of DNA double strand breaks (DSB), we evaluated the extent of cell membrane oxidation and DNA damage in peripheral blood lymphocytes of normal weight (NW) controls and obese patients sampled before and after bariatric surgery. Compared to NW controls, we observed a marked increase in both the frequencies of oxidized cells or nuclei exhibiting phosphorylation of histone H2AX in preoperatory obese patients. After bariatric surgery, obese patients, resampled over one-year follow-up, improved oxidative damage and reduced the presence of DSB. In conclusion, the present study highlights the importance for obese patients undergoing bariatric surgery to also monitor these molecular markers during their postoperative follow-up.","['Chiaramonte, Anna', 'Testi, Serena', 'Pelosini, Caterina', 'Micheli, Consuelo', 'Falaschi, Aurora', 'Ceccarini, Giovanni', 'Santini, Ferruccio', 'Scarpato, Roberto']","['Chiaramonte A', 'Testi S', 'Pelosini C', 'Micheli C', 'Falaschi A', 'Ceccarini G', 'Santini F', 'Scarpato R']","['Unita di Genetica, Dipartimento di Biologia, University of Pisa, Pisa, Italy.', 'Unita di Genetica, Dipartimento di Biologia, University of Pisa, Pisa, Italy.', 'Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital, Pisa, Italy.', 'Unita di Genetica, Dipartimento di Biologia, University of Pisa, Pisa, Italy.', 'Unita di Genetica, Dipartimento di Biologia, University of Pisa, Pisa, Italy.', 'Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital, Pisa, Italy.', 'Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital, Pisa, Italy.', 'Unita di Genetica, Dipartimento di Biologia, University of Pisa, Pisa, Italy. Electronic address: roberto.scarpato@unipi.it.']",['eng'],['Journal Article'],Netherlands,Mutat Res,Mutation research,0400763,,IM,"['Humans', 'Follow-Up Studies', '*Obesity/genetics/surgery/metabolism', '*Bariatric Surgery', 'Oxidative Stress', 'DNA Damage']",,['NOTNLM'],"['Bariatric surgery', 'DSB', 'H2AX', 'Inflammation', 'Obesity', 'Oxidation']","['Declaration of Competing Interest The authors declare that they have no known', 'competing financial interests or personal relationships that could have appeared', 'to influence the work reported in this paper.']",2023/06/23 19:11,2023/11/15 06:43,['2023/06/23 18:06'],"['2023/03/12 00:00 [received]', '2023/06/07 00:00 [revised]', '2023/06/13 00:00 [accepted]', '2023/11/15 06:43 [medline]', '2023/06/23 19:11 [pubmed]', '2023/06/23 18:06 [entrez]']","['S0027-5107(23)00014-3 [pii]', '10.1016/j.mrfmmm.2023.111827 [doi]']",ppublish,Mutat Res. 2023 Jul-Dec;827:111827. doi: 10.1016/j.mrfmmm.2023.111827. Epub 2023 Jun 16.,,20230616,,['Copyright (c) 2023 The Authors. Published by Elsevier B.V. All rights reserved.'],,,,,,,,,,,,,,,,
30473320,NLM,MEDLINE,20191227,20191227,1769-6690 (Electronic) 0399-077X (Linking),49,4,2019 Jun,Scabies in an obese patient: How should the ivermectin dosing be adapted?,286-288,S0399-077X(18)30722-4 [pii] 10.1016/j.medmal.2018.09.007 [doi],,"['Mellon, G', 'Hermet, L', 'Toutain, P L', 'Dulioust, A', 'Lespine, A']","['Mellon G', 'Hermet L', 'Toutain PL', 'Dulioust A', 'Lespine A']","['Service de medecine, etablissement public de sante national de Fresnes, 1, allee des Thuyas, 94260 Fresnes, France; Service des maladies infectieuses et tropicales, hopital Saint-Louis, assistance publique des hopitaux de Paris, 1, avenue Claude-Vellefaux, 75010 Paris, France. Electronic address: guillaume.mellon@aphp.fr.', 'Service de medecine, etablissement public de sante national de Fresnes, 1, allee des Thuyas, 94260 Fresnes, France.', 'INTHERES, universite de Toulouse, INRA, ENVT, 23 chemin des Capelles, 31300 Toulouse, France.', 'Service de medecine, etablissement public de sante national de Fresnes, 1, allee des Thuyas, 94260 Fresnes, France.', 'INTHERES, universite de Toulouse, INRA, ENVT, 23 chemin des Capelles, 31300 Toulouse, France.']",['eng'],"['Case Reports', 'Letter']",France,Med Mal Infect,Medecine et maladies infectieuses,0311416,"['0 (Antiparasitic Agents)', '70288-86-7 (Ivermectin)']",IM,"['Administration, Oral', 'Adult', 'Antiparasitic Agents/*administration & dosage', 'Dose-Response Relationship, Drug', 'Drug Dosage Calculations', 'Humans', 'Ivermectin/*administration & dosage', 'Male', 'Obesity/complications/*drug therapy', 'Precision Medicine', 'Scabies/complications/*drug therapy']",,['NOTNLM'],"['Gale', 'Ivermectin', 'Ivermectine', 'Obese patients', 'Patients obeses', 'Scabies']",,2018/11/27 06:00,2019/12/28 06:00,['2018/11/27 06:00'],"['2018/06/27 00:00 [received]', '2018/07/12 00:00 [revised]', '2018/09/18 00:00 [accepted]', '2018/11/27 06:00 [pubmed]', '2019/12/28 06:00 [medline]', '2018/11/27 06:00 [entrez]']","['S0399-077X(18)30722-4 [pii]', '10.1016/j.medmal.2018.09.007 [doi]']",ppublish,Med Mal Infect. 2019 Jun;49(4):286-288. doi: 10.1016/j.medmal.2018.09.007. Epub 2018 Nov 22.,,20181122,,,,,,,,,,,,,,,,,,
392336,NLM,MEDLINE,19800327,20061115,0026-4806 (Print) 0026-4806 (Linking),70,51,1979 Nov 17,[Various types of reducing diets].,3475-91,,"It must be readily understood that the only possibility of fighting obesity is by bringing about a reversal in the energy balance so that inputs are smaller than outputs. At least theoretically, then, obesity's special quality is that it does not present any therapeutic problem. Restriction in food intake is currently the treatment of choice; to be effective, food intake must be cut so that the energy provided is below the obese person's daily consumption, on average below 1200 calories per day, while at the same time holding a comparatively high intake of indispensable elements (proteins, vitamins, certain minerals and oligo-elements). The physician has a choice of various possibilities represented by fasting, a variety of free or controlled diets, protein diets or diets with low carbohydrate content and with a variable fat content; dissociated, zig-zag, one food diets etc. Substantially all these tend to limit the total quantity of glycides and boost the feeling of satiety by increasing the total volume of good while keeping total calories unvaried. It is clear that each of them has specific indications and clear-cut contraindications. The aim is to produce a calory shortfall, not cause denutrition. The diet must therefore be suited to the individual directed during subsequent stages of weight loss in relation to the patient's specific requirements (number of meals, etc.).","['Giorgino, R', 'Scardapane, R', 'Lattanzi, V', 'Cignarelli, M']","['Giorgino R', 'Scardapane R', 'Lattanzi V', 'Cignarelli M']",,['ita'],"['English Abstract', 'Journal Article', 'Review']",Italy,Minerva Med,Minerva medica,0400732,,IM,"['Adolescent', 'Adult', 'Aged', '*Diet, Reducing', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*diet therapy']",,,,,1979/11/17 00:00,1979/11/17 00:01,['1979/11/17 00:00'],"['1979/11/17 00:00 [pubmed]', '1979/11/17 00:01 [medline]', '1979/11/17 00:00 [entrez]']",,ppublish,Minerva Med. 1979 Nov 17;70(51):3475-91.,,,,,,,82,,I vari tipi di diete dimagranti.,,,,,,,,,,,
30078586,NLM,MEDLINE,20190204,20190215,1873-2534 (Electronic) 0165-2427 (Linking),202,,2018 Aug,"Circulating regulatory T cells (Treg), leptin and induction of proinflammatory activity in obese Labrador Retriever dogs.",122-129,S0165-2427(18)30179-X [pii] 10.1016/j.vetimm.2018.07.004 [doi],"Over-nutrition and obesity have been associated with impaired immunity and low-grade inflammation in humans and mouse models. In this context, a causal role for unbalanced T regulatory cell (Treg)-dependent mechanisms has been largely suggested. Obesity is the most common nutritional disorder in dogs. However, it is not defined whether canine obesity may influence circulating Treg as well as if their number variation might be associated with the occurrence of systemic inflammation. The present study investigated the immune profile of healthy adult obese dogs belonging to the Labrador Retriever breed, in comparison with the normal weight counterpart. Indeed, obesity has been described as particularly evident in this dogs. With this purpose, 26healthy dogs were enrolled and divided into two groups based on body condition score (BCS): controls (CTR: BCS 4-5) and obeses (OB: BCS>/=7). Our data indicate that adult obese Labrador Retrievers are characterised by the inverse correlation between leptin serum concentration and circulating Treg (CD4(+)CD25(high)Foxp3(+)) levels. In addition, an increased number of cytotoxic T cell effectors (CD3(+)CD8(+)) and a higher IFN-gamma production by cytotoxic T lymphocytes were observed in OB group. These results may provide new insights into the immunological dysregulation frequently associated to obesity in humans and still undefined in dogs.","['Palatucci, Anna Teresa', 'Piantedosi, Diego', 'Rubino, Valentina', 'Giovazzino, Angela', 'Guccione, Jacopo', 'Pernice, Vlenia', 'Ruggiero, Giuseppina', 'Cortese, Laura', 'Terrazzano, Giuseppe']","['Palatucci AT', 'Piantedosi D', 'Rubino V', 'Giovazzino A', 'Guccione J', 'Pernice V', 'Ruggiero G', 'Cortese L', 'Terrazzano G']","['Istituto di Endocrinologia e Oncologia Sperimentale (IEOS), Consiglio Nazionale delle Ricerche (CNR), Via Pansini 5, 80131, Napoli, Italy,; Dipartimento di Scienze, Universita della Basilicata, Via Nazario Sauro 85, 85100, Potenza, Italy.', 'Dipartimento di Medicina Veterinaria e Produzioni Animali, Universita Federico II, Via Federico Delpino 1, 80137, Napoli, Italy.', 'Dipartimento di Scienze, Universita della Basilicata, Via Nazario Sauro 85, 85100, Potenza, Italy.', 'Dipartimento di Scienze Mediche Traslazionali, Universita Federico II, Via Pansini 5, 80131, Napoli, Italy.', 'Dipartimento di Medicina Veterinaria e Produzioni Animali, Universita Federico II, Via Federico Delpino 1, 80137, Napoli, Italy.', 'Dipartimento di Scienze Mediche Traslazionali, Universita Federico II, Via Pansini 5, 80131, Napoli, Italy.', 'Dipartimento di Scienze Mediche Traslazionali, Universita Federico II, Via Pansini 5, 80131, Napoli, Italy. Electronic address: giruggie@unina.it.', 'Dipartimento di Medicina Veterinaria e Produzioni Animali, Universita Federico II, Via Federico Delpino 1, 80137, Napoli, Italy.', 'Dipartimento di Scienze, Universita della Basilicata, Via Nazario Sauro 85, 85100, Potenza, Italy; Dipartimento di Scienze Mediche Traslazionali, Universita Federico II, Via Pansini 5, 80131, Napoli, Italy.']",['eng'],['Journal Article'],Netherlands,Vet Immunol Immunopathol,Veterinary immunology and immunopathology,8002006,"['0 (Leptin)', '82115-62-6 (Interferon-gamma)']",IM,"['Animals', 'Dogs', 'Inflammation/etiology/*veterinary', 'Interferon-gamma/immunology', 'Leptin/*blood', 'Obesity/blood/immunology/*veterinary', 'T-Lymphocytes, Cytotoxic/immunology', 'T-Lymphocytes, Regulatory/*immunology']",,['NOTNLM'],"['Canine obesity', 'Cytotoxic T cells', 'Interferon-gamma', 'Labrador retrievers', 'Leptin', 'Treg']",,2018/08/07 06:00,2019/02/05 06:00,['2018/08/07 06:00'],"['2018/04/26 00:00 [received]', '2018/06/25 00:00 [revised]', '2018/07/05 00:00 [accepted]', '2018/08/07 06:00 [entrez]', '2018/08/07 06:00 [pubmed]', '2019/02/05 06:00 [medline]']","['S0165-2427(18)30179-X [pii]', '10.1016/j.vetimm.2018.07.004 [doi]']",ppublish,Vet Immunol Immunopathol. 2018 Aug;202:122-129. doi: 10.1016/j.vetimm.2018.07.004. Epub 2018 Jul 7.,,20180707,,['Copyright (c) 2018 Elsevier B.V. All rights reserved.'],,,,,,,,,,,,,,,,
16646369,NLM,MEDLINE,20060830,20061115,1660-9379 (Print) 1660-9379 (Linking),2,59,2006 Mar 29,[The obese patient's therapeutic course].,"858, 860-3",,"Obesity as a chronic disease needs a global approach taking into account, not only usual anthropometrical measurements allowing to define severity and the type of obesity (BMI and waist circumference) but also others parameters to evaluate the patient's morbid conscience and his level of motivation towards a potential treatment. Obese patient's possible therapeutic course is developed in this article according to three important parameters: eating disorders, motivation and capacity of introspection. The aim is to give tools to the generalist to select patients needing a multidisciplinary follow up in a specialized centre and those who can be treated in the office.","['Giusti, V']",['Giusti V'],"[""Service d'endocrinologie, diabetologie et metabolisme, Consultation d'obesite et des troubles du comportement alimentaire, CHUV, Lausanne. vittorio.giusti@chuv.ch""]",['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Decision Trees', 'Humans', 'Obesity/psychology/*therapy']",,,,,2006/05/02 09:00,2006/08/31 09:00,['2006/05/02 09:00'],"['2006/05/02 09:00 [pubmed]', '2006/08/31 09:00 [medline]', '2006/05/02 09:00 [entrez]']",,ppublish,"Rev Med Suisse. 2006 Mar 29;2(59):858, 860-3.",,,,,,,,,Le parcours therapeutique du patient obese.,,,,,,,,,,,
6760283,NLM,MEDLINE,19830311,20191031,0181-1916 (Print) 0181-1916 (Linking),20,5B,1980,Neuroendocrinology of hyperphagias and obesities.,1545-62,,,"['Louis-Sylvestre, J']",['Louis-Sylvestre J'],,['eng'],"['Journal Article', 'Review']",France,Reprod Nutr Dev (1980),"Reproduction, nutrition, developpement",8005903,"['0 (Dietary Carbohydrates)', '0 (Insulin)', '0 (Lipids)']",IM,"['Adipose Tissue/physiopathology', 'Adipose Tissue, Brown/physiopathology', 'Animals', 'Body Temperature Regulation', 'Body Weight', 'Circadian Rhythm', 'Dietary Carbohydrates/adverse effects', 'Endocrine Glands/*physiopathology', 'Energy Intake', 'Fasting', 'Feeding and Eating Disorders/*physiopathology', 'Food', 'Humans', 'Hyperphagia/etiology/*physiopathology', 'Hypothalamus/physiology', 'Insulin/blood', 'Insulin Resistance', 'Lipids/biosynthesis', 'Nervous System/*physiopathology', 'Obesity/etiology/genetics/*physiopathology', 'Stress, Physiological/complications']",,,,,1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']",['10.1051/rnd:19800901 [doi]'],ppublish,Reprod Nutr Dev (1980). 1980;20(5B):1545-62. doi: 10.1051/rnd:19800901.,,,,,,,139,,,,,,,,,,,,,
21888108,NLM,MEDLINE,20110927,20170214,1757-9139 (Print) 1757-9147 (Linking),131,4,2011 Jul,What public health professionals can learn from obese people.,146,,,"['Keady, Patrick']",['Keady P'],,['eng'],['Editorial'],United States,Perspect Public Health,Perspectives in public health,101499631,,IM,"['Diet', 'Exercise', 'Female', 'Humans', 'Male', 'Obesity/complications/epidemiology/*prevention & control/psychology', '*Public Health Practice', 'United Kingdom/epidemiology', '*Weight Loss']",,,,,2011/09/06 06:00,2011/09/29 06:00,['2011/09/06 06:00'],"['2011/09/06 06:00 [entrez]', '2011/09/06 06:00 [pubmed]', '2011/09/29 06:00 [medline]']",['10.1177/1757913911412467 [doi]'],ppublish,Perspect Public Health. 2011 Jul;131(4):146. doi: 10.1177/1757913911412467.,,,,,,,,,,,,,,,,,,,,
2048987,NLM,MEDLINE,19910718,20041117,0300-8495 (Print) 0300-8495 (Linking),20,4,1991 Apr,The obese patient.,"417, 421",,"For motivated obese patients, the three main strategies to achieve weight reduction are appropriate dietary advice, counselling, and regular review, which are maintained even after the goal weight has been reached. The patient's limited objectives should include gradual weight reduction and eating less of the food they normally enjoy.","['Kaczmarczyk, W']",['Kaczmarczyk W'],['WA Faculty of the Family Medicine Programme.'],['eng'],['Journal Article'],Australia,Aust Fam Physician,Australian family physician,0326701,,IM,"['Humans', 'Obesity/psychology/*therapy']",,,,,1991/04/01 00:00,1991/04/01 00:01,['1991/04/01 00:00'],"['1991/04/01 00:00 [pubmed]', '1991/04/01 00:01 [medline]', '1991/04/01 00:00 [entrez]']",,ppublish,"Aust Fam Physician. 1991 Apr;20(4):417, 421.",,,,,,,,,,,,,,,,,,,,
31546722,NLM,MEDLINE,20200615,20211204,2073-4409 (Electronic) 2073-4409 (Linking),8,10,2019 Sep 22,"A 2-Min Transient Ischemia Confers Cerebral Ischemic Tolerance in Non-Obese Gerbils, but Results in Neuronal Death in Obese Gerbils by Increasing Abnormal mTOR Activation-Mediated Oxidative Stress and Neuroinflammation.",,10.3390/cells8101126 [doi] 1126,"A brief episode of transient ischemia (TI) can confer cerebral ischemic tolerance against a subsequent severer TI under standard condition. The brain under obesity's conditions is more sensitive to ischemic injury. However, the impact of a brief episode of TI under obesity's conditions has not been fully addressed yet. Thus, the objective of this study was to determine the effect of a brief TI in the hippocampus of high-fat diet (HFD)-induced obese gerbils and related mechanisms. Gerbils were maintained on HFD or normal diet (ND) for 12 weeks and subjected to 2 min TI. HFD gerbils were heavier, with higher blood glucose, serum total cholesterol, triglycerides, and leptin levels. Massive loss of pyramidal neurons occurred in the hippocampal cornu ammonis 1 (CA1) field of HFD animals at 5 days after 2 min of TI, but 2 min of TI did not elicit death of pyramidal neurons in ND gerbils. The HFD group showed significantly increased levels of oxidative stress indicators (dihydroethidium and 4-hydroxynonenal) and proinflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta) and microglial activation in pre- and/or post-ischemic phases compared to the ND group. Levels of mammalian target of rapamycin (mTOR) and phosphorylated-mTOR in the CA1 field of the HFD group were also significantly higher than the ND group. On the other hand, inhibition of mTOR activation by rapamycin (an allosteric mTOR inhibitor) significantly attenuated neuronal death induced by HFD, showing reduction of HFD-induced increases of oxidative stress indicators and proinflammatory cytokines, and microglia activation. Taken together, a brief episode of TI can evoke neuronal death under obesity's conditions. It might be closely associated with an abnormal increase of mTOR activation-mediated, severe oxidative stress and neuroinflammation in pre- and/or post-ischemic phases.","['Park, Joon Ha', 'Ahn, Ji Hyeon', 'Song, Minah', 'Kim, Hyunjung', 'Park, Cheol Woo', 'Park, Young Eun', 'Lee, Tae-Kyeong', 'Lee, Jae-Chul', 'Kim, Dae Won', 'Lee, Choong-Hyun', 'Hwang, In Koo', 'Yan, Bing Chun', 'Ryoo, Sungwoo', 'Kim, Young-Myeong', 'Kang, Il Jun', 'Won, Moo-Ho', 'Choi, Soo Young']","['Park JH', 'Ahn JH', 'Song M', 'Kim H', 'Park CW', 'Park YE', 'Lee TK', 'Lee JC', 'Kim DW', 'Lee CH', 'Hwang IK', 'Yan BC', 'Ryoo S', 'Kim YM', 'Kang IJ', 'Won MH', 'Choi SY']","['Department of Anatomy, College of Korean Medicine, Dongguk University, Gyeongju, Gyeongbuk 38066, Korea. parkfamilyda@hanmail.net.', 'Department of Biomedical Science and Research Institute for Bioscience and Biotechnology, Hallym University, Chuncheon, Gangwon 24252, Korea. jh-ahn@hallym.ac.kr.', 'Center for Virus Research and Testing, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea. zlscydn@naver.com.', 'Knotus Co. Ltd., Incheon 22014, Korea. nicolehkim@naver.com.', 'Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, Gangwon 24341, Korea. flfhflfh@naver.com.', 'Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, Gangwon 24341, Korea. taeparo@naver.com.', 'Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, Gangwon 24341, Korea. xorud312@naver.com.', 'Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, Gangwon 24341, Korea. anajclee@kangwon.ac.kr.', 'Department of Biochemistry and Molecular Biology, and Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju National University, Gangneung, Gangwon 25457, Korea. kimdw@gwnu.ac.kr.', 'Department of Pharmacy, College of Pharmacy, Dankook University, Cheonan, Chungnam 31116, Korea. anaphy@dankook.ac.kr.', 'Department of Anatomy and Cell Biology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Korea. vetmed2@snu.ac.kr.', 'Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Medical college of Yangzhou University, Yangzhou 225001, China. bcyan@yzu.edu.cn.', 'Department of Biological Sciences, College of Natural Sciences, Kangwon National University, Chuncheon, Gangwon 24341, Korea. ryoosw08@kangwon.ac.kr.', 'Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University, Chuncheon, Gangwon 24341, Korea. ymkim@kangwon.ac.kr.', 'Department of Food Science and Nutrition, Hallym University, Chuncheon, Gangwon 24252, Korea. ijkang@hallym.ac.kr.', 'Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, Gangwon 24341, Korea. mhwon@kangwon.ac.kr.', 'Department of Biomedical Science and Research Institute for Bioscience and Biotechnology, Hallym University, Chuncheon, Gangwon 24252, Korea. sychoi@hallym.ac.kr.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Switzerland,Cells,Cells,101600052,"['0 (Interleukin-1beta)', '0 (Tumor Necrosis Factor-alpha)', 'EC 2.7.11.1 (TOR Serine-Threonine Kinases)', 'W36ZG6FT64 (Sirolimus)']",IM,"['Animals', 'Case-Control Studies', 'Cell Death', 'Diet, High-Fat/adverse effects', 'Disease Models, Animal', 'Gerbillinae', 'Hippocampus/cytology/metabolism/*pathology', 'Interleukin-1beta/metabolism', 'Ischemic Attack, Transient/*complications/metabolism/pathology', 'Male', 'Neurons/cytology/metabolism', 'Obesity/chemically induced/*metabolism/*pathology', 'Oxidative Stress/drug effects', 'Phosphorylation', 'Sirolimus/pharmacology', 'TOR Serine-Threonine Kinases/*metabolism', 'Tumor Necrosis Factor-alpha/metabolism', 'Up-Regulation']",PMC6830098,['NOTNLM'],"['brief transient ischemia', 'mammalian target of rapamycin', 'neuroinflammation', 'neuronal death', 'obesity', 'oxidative stress']",['The authors have no financial conflict of interest.'],2019/09/25 06:00,2020/06/17 06:00,['2019/09/25 06:00'],"['2019/08/24 00:00 [received]', '2019/09/19 00:00 [revised]', '2019/09/20 00:00 [accepted]', '2019/09/25 06:00 [entrez]', '2019/09/25 06:00 [pubmed]', '2020/06/17 06:00 [medline]']","['cells8101126 [pii]', 'cells-08-01126 [pii]', '10.3390/cells8101126 [doi]']",epublish,Cells. 2019 Sep 22;8(10):1126. doi: 10.3390/cells8101126.,,20190922,,,"['ORCID: 0000-0002-0533-4638', 'ORCID: 0000-0003-0314-5195', 'ORCID: 0000-0002-7178-6501']",,,,,,,,,,,,,,,
31133313,NLM,MEDLINE,20200701,20200701,0737-0806 (Print) 0737-0806 (Linking),77,,2019 Jun,"Insulin Resistance as a Result of Body Condition Categorized as Thin, Moderate, and Obese in Domesticated U.S. Donkeys (Equus asinus).",31-35,S0737-0806(18)30731-7 [pii] 10.1016/j.jevs.2019.02.011 [doi],"Donkeys are often kept, especially in industrialized countries, as companion animals. Donkeys have greater digestive efficiency and tend to expend less energy than horses or ponies, which contributes to obesity in nonworking donkeys. Obesity in all equine species increases risk of chronic health conditions such as laminitis and insulin resistance. Previous studies in horses and ponies have documented obesity's potential effects on glucose-insulin dynamics with lower insulin sensitivity and higher insulin responses to glucose. However, limited studies on obesity and its health impacts in donkeys exist, so these effects on glucose-insulin dynamics have not been fully studied. Twenty-four donkeys were selected according to initial body condition score (BCS) and divided into three categories with eight donkeys in each: thin, moderate, and obese. A frequently sampled glucose-insulin tolerance test was performed with subsequent MINMOD analysis to determine the effects of BCS on glucose-insulin dynamics. Basal insulin was highest in obese donkeys when compared with moderate and thin donkeys (P = .02 and P = .01, respectively). There was an overall trend across groups for BCS to lower insulin sensitivity (P = .06). No other effect was found. Body condition score seems to affect donkeys in a similar manner to horses and ponies as higher BCS was associated with higher basal insulin and may lower insulin sensitivity. Higher basal insulin concentrations in obese donkeys could negatively influence health and contribute to serious, chronic conditions.","['Pritchard, Abby', 'Nielsen, Brian', 'McLean, Amy', 'Robison, Cara', 'Yokoyama, Melvin', 'Hengemuehle, Susan', 'Bailey, Simon', 'Harris, Patricia']","['Pritchard A', 'Nielsen B', 'McLean A', 'Robison C', 'Yokoyama M', 'Hengemuehle S', 'Bailey S', 'Harris P']","['Michigan State University, East Lansing, Michigan, USA. Electronic address: pritch66@msu.edu.', 'Michigan State University, East Lansing, Michigan, USA.', 'University of California Davis, Davis, California, USA.', 'Michigan State University, East Lansing, Michigan, USA.', 'Michigan State University, East Lansing, Michigan, USA.', 'Michigan State University, East Lansing, Michigan, USA.', 'The University of Melbourne, Parkville, Victoria, Australia.', 'Waltham Centre for Pet Nutrition, Waltham on the Wolds, Leicestershire, UK.']",['eng'],['Journal Article'],United States,J Equine Vet Sci,Journal of equine veterinary science,8216840,['0 (Insulin)'],IM,"['Animals', 'Equidae', 'Glucose Tolerance Test/veterinary', 'Horses', 'Insulin', '*Insulin Resistance', 'Obesity/veterinary']",,['NOTNLM'],"['Body condition', 'Donkeys', 'Insulin resistance', 'Obesity']",,2019/05/28 06:00,2020/07/02 06:00,['2019/05/29 06:00'],"['2018/11/15 00:00 [received]', '2019/02/07 00:00 [revised]', '2019/02/13 00:00 [accepted]', '2019/05/29 06:00 [entrez]', '2019/05/28 06:00 [pubmed]', '2020/07/02 06:00 [medline]']","['S0737-0806(18)30731-7 [pii]', '10.1016/j.jevs.2019.02.011 [doi]']",ppublish,J Equine Vet Sci. 2019 Jun;77:31-35. doi: 10.1016/j.jevs.2019.02.011. Epub 2019 Feb 21.,,20190221,,['Copyright (c) 2019 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
34444866,NLM,MEDLINE,20210922,20210922,2072-6643 (Electronic) 2072-6643 (Linking),13,8,2021 Aug 6,Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans.,,10.3390/nu13082706 [doi] 2706,"BACKGROUND: The gut microbiota and its metabolites are essential for host health and dysbiosis has been involved in several pathologic conditions such as type 2 diabetes (T2D) and cardiovascular disease (CVD). Recent studies have identified that plasma imidazole propionate (ImP), a microbial-produced metabolite, is increased in patients with prediabetes and T2D. More recently, ImP was found to be significantly increased in patients with overt CVD. Here, we aimed to investigate the association between ImP and CVD risk factors: blood pressure, HDL-cholesterol, LDL-cholesterol and insulin-resistance in overweight and obese subjects without T2D or use of any metabolic diseases-related medication. METHODS: Plasma metabolites, including ImP, were determined in 107 male or post-menopausal women with overweight/obesity, but without T2D. Insulin-sensitivity was assessed with the gold standard method: the hyperinsulinemic-euglycemic clamp using the isotope [6,6-(2)H(2)] glucose and expressed as glucose rate of disposal (Rd) for peripheral insulin sensitivity and suppression of endogenous glucose production (EGP) for hepatic insulin sensitivity. RESULTS: Partial correlation analysis controlled for BMI and age showed a significant correlation between ImP and diastolic blood pressure (r(s) = 0.285, p = 0.004) and a borderline significance with systolic blood pressure (r(s) = 0.187, p = 0.060); however, systolic and diastolic blood pressure did not correlate with ImP precursor histidine (r(s) = 0.063, p = 0.526 and r = -0.038, p = 0.712, respectively). We did not find a correlation between ImP with LDL-cholesterol or HDL-cholesterol (r(s) = -0.181, p = 0.064 and r(s) = 0.060, p = 0.546, respectively). Furthermore, there was no association between plasma ImP concentrations and Rd and EGP suppression. CONCLUSION: In this cohort with overweight/obese subjects without T2D, plasma ImP concentrations were positively correlated with diastolic blood pressure but not with insulin-sensitivity.","['van Son, Jamie', 'Serlie, Mireille J', 'Stahlman, Marcus', 'Backhed, Fredrik', 'Nieuwdorp, Max', 'Aron-Wisnewsky, Judith']","['van Son J', 'Serlie MJ', 'Stahlman M', 'Backhed F', 'Nieuwdorp M', 'Aron-Wisnewsky J']","['Department of Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.', 'Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.', 'Department of Endocrinology and Metabolism, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.', 'Wallenberg Laboratory, University of Gothenburg, Bruna Straket 16, SE-413 45 Gothenburg, Sweden.', 'Wallenberg Laboratory, University of Gothenburg, Bruna Straket 16, SE-413 45 Gothenburg, Sweden.', 'Department of Clinical Physiology, Sahlgrenska University Hospital, Region Vastra Gotaland, Bla Straket 5, SE-413 45 Gothenburg, Sweden.', 'Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.', 'Department of Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.', 'Department of Internal Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.', 'Department of Vascular Medicine, Amsterdam University Medical Centers, Location AMC, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands.', 'Nutrition and Obesities, Systemic Approaches (NutriOmics) Research Group, Sorbonne Universite, Inserm, 75013 Paris, France.', 'Assistante Publique Hopitaux de Paris, Nutrition Department, Pitie-Salpetriere Hospital, CRNH Ile de France, 75013 Paris, France.']",['eng'],['Journal Article'],Switzerland,Nutrients,Nutrients,101521595,"['0 (Biomarkers)', '0 (Imidazoles)', '0 (Lipids)', '1074-59-5 (5-imidazolepropionic acid)']",IM,"['Bacteria/*metabolism', 'Biomarkers/blood', '*Blood Pressure', 'Female', '*Gastrointestinal Microbiome', 'Humans', 'Imidazoles/*blood', 'Insulin Resistance', 'Lipids/blood', 'Male', 'Middle Aged', 'Obesity/*blood/microbiology/physiopathology']",PMC8399073,['NOTNLM'],"['cardiovascular disease', 'gut microbiota', 'hyperinsulinemic-euglycemic clamp', 'imidazole propionate', 'insulin resistance', 'obesity']","['The authors declare that there are no conflict of interest associated with this', 'manuscript.']",2021/08/28 06:00,2021/09/23 06:00,['2021/08/27 01:21'],"['2021/06/25 00:00 [received]', '2021/07/30 00:00 [revised]', '2021/08/03 00:00 [accepted]', '2021/08/27 01:21 [entrez]', '2021/08/28 06:00 [pubmed]', '2021/09/23 06:00 [medline]']","['nu13082706 [pii]', 'nutrients-13-02706 [pii]', '10.3390/nu13082706 [doi]']",epublish,Nutrients. 2021 Aug 6;13(8):2706. doi: 10.3390/nu13082706.,"['17CVD01/Fondation Leducq/', 'NNF15OC0016798/Novo Nordisk Foundation Center for Basic Metabolic Research/', 'Fondation Bettencourt Schueller/', '09150182010020/ZONMW_/ZonMw/Netherlands', 'CAMIT grant 2018/Novo Nordisk/', '2017-01996_3/Joint Programming Initiative A healthy diet for a healthy life/', 'AFA insurances/']",20210806,,,"['ORCID: 0000-0002-9876-2876', 'ORCID: 0000-0002-4202-0339', 'ORCID: 0000-0002-4871-8818', 'ORCID: 0000-0002-3104-9769']",,,,,,,,,,,,,,,
18379527,NLM,MEDLINE,20080604,20080401,1523-1755 (Electronic) 0085-2538 (Linking),73,8,2008 Apr,Supersized kidneys: Lessons from the preclinical obese kidney.,909-10,10.1038/ki.2008.42 [doi],"The worldwide prevalence of obesity continues to rise. Obesity has been shown to increase the risk of both the development and the progression of renal failure, even after correction for other comorbid conditions. The ability of nephrologists to intervene will require greater understanding of obesity's renal physiologic effects. Kidney biopsies and functional studies performed on morbidly obese patients without overt renal disease who presented for bariatric surgery have helped to elucidate the earliest obesity-related structural and functional responses.","[""D'Agati, V D"", 'Markowitz, G S']","[""D'Agati VD"", 'Markowitz GS']","['Department of Pathology, Columbia University, New York, New York 10032, USA. vdd1@columbia.edu']",['eng'],"['Comment', 'Journal Article']",United States,Kidney Int,Kidney international,0323470,,IM,"['Humans', 'Kidney Glomerulus/*pathology', 'Obesity, Morbid/*pathology']",,,,,2008/04/02 09:00,2008/06/05 09:00,['2008/04/02 09:00'],"['2008/04/02 09:00 [pubmed]', '2008/06/05 09:00 [medline]', '2008/04/02 09:00 [entrez]']","['S0085-2538(15)53113-X [pii]', '10.1038/ki.2008.42 [doi]']",ppublish,Kidney Int. 2008 Apr;73(8):909-10. doi: 10.1038/ki.2008.42.,,,,,,,,,,,['Kidney Int. 2008 Apr;73(8):947-55. PMID: 18216780'],,,,,,,,,
8346880,NLM,MEDLINE,19930907,20061115,0066-2097 (Print) 0066-2097 (Linking),40,5,1993 May,[Energy metabolism in obese children].,291-6,,"Childhood obesity results from excessive dietary intake as compared with energy expenditure. This imbalance can result from either overeating or a constitutional decrease in one or several of the components of energy expenditure: resting metabolic rate, diet-induced thermogenesis, or exercise-related thermogenesis. Decreased energy expenditure is probably at least partly genetic in origin, contributing to the significant clustering of obesity in families. Management aims at reducing the imbalance by decreasing the caloric intake. Once the desired weight is achieved, intake must be adjusted to expenditure to avoid weight regain.","['Tounian, P', 'Girardet, J P']","['Tounian P', 'Girardet JP']","['Service de Gastro-Enterologie et Nutrition Pediatriques, Hopital Armand-Trousseau, Paris.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Ann Pediatr (Paris),Annales de pediatrie,2984696R,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Diet, Reducing', '*Energy Metabolism', 'Female', 'Humans', 'Infant', 'Infant, Newborn', 'Male', 'Obesity/diet therapy/etiology/genetics/*metabolism']",,,,,1993/05/01 00:00,1993/05/01 00:01,['1993/05/01 00:00'],"['1993/05/01 00:00 [pubmed]', '1993/05/01 00:01 [medline]', '1993/05/01 00:00 [entrez]']",,ppublish,Ann Pediatr (Paris). 1993 May;40(5):291-6.,,,,,,,18,,Metabolisme energetique des enfants obeses.,,,,,,,,,,,
18354852,HSR,MEDLINE,20080411,20080520,1553-0671 (Electronic) 1553-0671 (Linking),13,3,2008 Jan,"The shape of things to come: obesity, aging, and disability.",1-4,,"Rising obesity represents one of the most disturbing health trends in the U.S. and elsewhere. Obese people are at greater risk for diabetes, cardiovascular disease, disability, and mortality. However, recent studies also suggest that the obese population has grown ""healthier"" since the 1960s, probably due to improved medical care for cardiovascular disease. It is unclear whether these improvements have resulted in more or less disability in obese people as they age. This issue Brief summarizes two studies that examine the prevalence of obesity over time in the elderly and disabled, and the changing relationship of obesity and disability.","['Alley, Dawn E', 'Chang, Virginia W', 'Doshi, Jalpa']","['Alley DE', 'Chang VW', 'Doshi J']","['Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA.']",['eng'],['Journal Article'],United States,LDI Issue Brief,LDI issue brief,9815837,,,"['Aged', 'Aging', '*Disabled Persons', 'Forecasting', 'Humans', 'Medicare', 'Obesity/complications/*epidemiology/therapy', 'United States/epidemiology']",,,,,2008/03/22 09:00,2008/04/12 09:00,['2008/03/22 09:00'],"['2008/03/22 09:00 [pubmed]', '2008/04/12 09:00 [medline]', '2008/03/22 09:00 [entrez]']",,ppublish,LDI Issue Brief. 2008 Jan;13(3):1-4.,,,,,,,,,,,,,,,,,,,,
10953639,NLM,MEDLINE,20001103,20091111,0036-5327 (Print) 0036-5327 (Linking),101,1,2000,Respiratory quotient in obesity: its association with an ability to retain weight loss and with parental obesity.,99-104,,"A high fasting respiratory quotient (RQ) was observed during the treatment by very low calorie diet (VLCD) in obese patients who regained weight at two-year follow-up (weight regainers) or in those who exhibited repeated cycles of weight loss with a subsequent weight regain (weight cyclers). In contrast obese patients who succeeded to retain the weight loss achieved initially by the VLCD at 2-yr follow-up (weight losers) or those who did not exhibit weight fluctuations (weight noncyclers) were characterized by a significantly lower RQ. Therefore a high fasting RQ during the VLCD treatment should be considered predictive of body weight gain. Resting metabolic rate (RMR) expressed per kg fat free mass (FFM) did not influence body weight changes. A high RQ revealed in obese subjects reporting parental obesity and a low fasting RQ observed in those obese without family history of obesity suggest a role of hereditary factors in the ability to oxidize fat in severely obese subjects. In contrast, parental history of obesity did not affect RMR in severely obese individuals.","['Hainer, V', 'Kunesova, M', 'Parizkova, J', 'Stich, V', 'Mikulova, R', 'Slaba, S']","['Hainer V', 'Kunesova M', 'Parizkova J', 'Stich V', 'Mikulova R', 'Slaba S']","['IIIrd Department of Internal Medicine, 1st Medical Faculty, Charles University, Prague, Czech Republic. vhai@lf1.cuni.cz']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Czech Republic,Sb Lek,Sbornik lekarsky,0025770,,IM,"['Adult', '*Basal Metabolism', 'Calorimetry, Indirect', 'Diet, Reducing', 'Humans', 'Obesity/diet therapy/*genetics/*metabolism', '*Oxygen Consumption', 'Weight Gain', '*Weight Loss']",,,,,2000/08/23 11:00,2001/02/28 10:01,['2000/08/23 11:00'],"['2000/08/23 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/08/23 11:00 [entrez]']",,ppublish,Sb Lek. 2000;101(1):99-104.,,,,,,,,,,,,,,,,,,,,
15835558,NLM,MEDLINE,20050527,20051116,1096-6293 (Print) 1096-6293 (Linking),13,4,2005 Apr,Meeting the needs of severely obese patients.,"43-4, 46",,,"['Crouch, Judy']",['Crouch J'],"['Mercy General Health Partners Center for Weight Management, Muskegon, Michigan, USA.']",['eng'],"['Journal Article', 'Review']",United States,Adv Nurse Pract,Advance for nurse practitioners,9892010,,,"['Humans', 'Needs Assessment', 'Nurse-Patient Relations', '*Nursing Assessment', 'Obesity/*nursing/physiopathology/psychology', '*Patient Care Planning', 'Prejudice', 'Self Concept']",,,,,2005/04/20 09:00,2005/05/28 09:00,['2005/04/20 09:00'],"['2005/04/20 09:00 [pubmed]', '2005/05/28 09:00 [medline]', '2005/04/20 09:00 [entrez]']",,ppublish,"Adv Nurse Pract. 2005 Apr;13(4):43-4, 46.",,,,,,,8,,,,,,,,,,,,,
30869272,NLM,MEDLINE,20190520,20190520,0035-2640 (Print) 0035-2640 (Linking),68,6,2018 Jun,[Obesities do not all require the same care].,e241,,,"['Jouret, Beatrice', 'Tauber, Maithe']","['Jouret B', 'Tauber M']","['Hopital des Enfants, 31059 Toulouse Cedex 9, France.', 'Hopital des Enfants, 31059 Toulouse Cedex 9, France.']",['fre'],['Journal Article'],France,Rev Prat,La Revue du praticien,0404334,,IM,"['Humans', '*Obesity']",,['NOTNLM'],"['Child', 'Obesity']","[""B. Jouret et M. Tauber declarent n'avoir aucun lien d'interets.""]",2019/03/15 06:00,2019/05/21 06:00,['2019/03/15 06:00'],"['2019/03/15 06:00 [entrez]', '2019/03/15 06:00 [pubmed]', '2019/05/21 06:00 [medline]']",,ppublish,Rev Prat. 2018 Jun;68(6):e241.,,,,,,,,,Toutes les obesites ne necessitent pas la meme prise en charge.,,,,,,,,,,,
17918488,NLM,MEDLINE,20071108,20071008,1660-9379 (Print) 1660-9379 (Linking),3,123,2007 Sep 5,[Liver disease in obese patients].,1939-41,,"Due to obesity epidemics, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are becoming the main causes of chronic liver disease in western countries. Nonalcoholic steatohepatitis is a potentially progressive disease that may cause cirrhosis. We analysed liver histology in 505 patients at the time of gastric by-pass surgery. Steatosis was present in 92% of these patients, mild (< 30% of hepatocytes) in 46%, moderate (30-60% of hepatocytes) in 30%, and severe in 23%. Insulin resistance, diabetes, elevated ferritin and elevated liver tests were independent predictors of NASH in the liver these obese patients. Early identification of these factors might help to select patients at risk of NASH in whom liver biopsy should be considered.","['Giostra, Emiliano', 'Huber, Olivier', 'Morel, Philippe', 'Hadengue, Antoine']","['Giostra E', 'Huber O', 'Morel P', 'Hadengue A']","['Service de gastroenterologie et hepatologie, HUG, 1211 Geneve 14.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Bariatric Surgery', 'Fatty Liver/*complications', 'Humans', 'Obesity/*complications/surgery']",,,,,2007/10/09 09:00,2007/11/09 09:00,['2007/10/09 09:00'],"['2007/10/09 09:00 [pubmed]', '2007/11/09 09:00 [medline]', '2007/10/09 09:00 [entrez]']",,ppublish,Rev Med Suisse. 2007 Sep 5;3(123):1939-41.,,,,,,,9,,Maladie hepatique chez les patients obeses.,,,,,,,,,,,
37888144,NLM,MEDLINE,20231107,20231107,1479-683X (Electronic) 0804-4643 (Linking),189,4,2023 Oct 17,A novel pathogenic variant in MRAP2 in an obese patient with successful outcome of bariatric surgery.,K15-K18,10.1093/ejendo/lvad132 [doi],"Mutations in genes encoding proteins located in the leptin/melanocortin pathway have been identified in the rare cases of genetic obesities. Heterozygous variants of MRAP2, encoding a G coupled-protein receptor accessory protein implicated in energy control notably via the melanocortin-4 receptor, have been recently identified. A 24-year-old patient with early-onset severe obesity (body mass index [BMI]: 64 kg/m2) associated with hypertension, respiratory complications, nonalcoholic fatty liver disease, and type 2 diabetes was referred to our department. Sleeve gastrectomy was successful. A new heterozygous variant in MRAP2 (NM_138409.4: c.154G>C/p.G52R) variant was identified in the patient DNA. Functional assessment confirmed that this new variant was pathogenic. We report a new pathogenic loss-of-function mutation in MRAP2 in a patient suffering from a severe multicomplicated obesity. This confirms the metabolic phenotype in patients with this monogenic form of obesity. Longer follow-up will be necessary. Our finding will allow a personalized medicine.","['Gatta-Cherifi, Blandine', 'Laboye, Alexandre', 'Gronnier, Caroline', 'Monsaingeon-Henry, Maud', 'Meulebrouck, Sarah', 'Baron, Morgane', 'Bertin, Francoise', 'Pupier, Emilie', 'Cambos, Sophie', 'Poitou, Christine', 'Beyec-Le Bihan, Johanne Le', 'Bonnefond, Amelie']","['Gatta-Cherifi B', 'Laboye A', 'Gronnier C', 'Monsaingeon-Henry M', 'Meulebrouck S', 'Baron M', 'Bertin F', 'Pupier E', 'Cambos S', 'Poitou C', 'Beyec-Le Bihan JL', 'Bonnefond A']","['CHU Bordeaux, Groupe Hospitalier Sud, Hopital Haut Leveque Service Endocrinologie, Diabetologie, Nutrition, Avenue de Magellan, 33600 Pessac, France.', 'Neurocentre Magendie, Equipe ""physiopathologie de la balance energetique et obesite"" INSERMU1215, 33000 Bordeaux, France.', 'CHU Bordeaux, Groupe Hospitalier Sud, Hopital Haut Leveque Service Endocrinologie, Diabetologie, Nutrition, Avenue de Magellan, 33600 Pessac, France.', 'CHU Bordeaux, Groupe Hospitalier Sud, Hopital Haut Leveque Service Chirurgie digestive et endocrinienne, Avenue de Magellan, 33600 Pessac, France.', 'CHU Bordeaux, Groupe Hospitalier Sud, Hopital Haut Leveque Service Endocrinologie, Diabetologie, Nutrition, Avenue de Magellan, 33600 Pessac, France.', 'Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille University Hospital, 59000 Lille, France.', 'Universite de Lille, 59000 Lille, France.', 'Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille University Hospital, 59000 Lille, France.', 'Universite de Lille, 59000 Lille, France.', ""Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, UF Genetique de l'obesite et des Dyslipidemies, Service de Biochimie Endocrinienne et Oncologique, 75013 Paris, France."", 'CHU Bordeaux, Groupe Hospitalier Sud, Hopital Haut Leveque Service Endocrinologie, Diabetologie, Nutrition, Avenue de Magellan, 33600 Pessac, France.', 'CHU Bordeaux, Groupe Hospitalier Sud, Hopital Haut Leveque Service Endocrinologie, Diabetologie, Nutrition, Avenue de Magellan, 33600 Pessac, France.', 'Sorbonne Universite, 75013 Paris, France.', 'Nutrition Department, Assistance Publique Hopitaux de Paris, Reference Center for Rare Diseases PRADORT, Pitie-Salpetriere Hospital, 75013 Paris, France.', 'INSERM, Nutrition and Obesities: systemic approaches Research Unit (NutriOmics), 75013 Paris, France.', ""Assistance Publique Hopitaux de Paris, Pitie-Salpetriere Hospital, UF Genetique de l'obesite et des Dyslipidemies, Service de Biochimie Endocrinienne et Oncologique, 75013 Paris, France."", 'Sorbonne Universite, 75013 Paris, France.', ""INSERM, UMR-S1149, Centre de recherche sur l'inflammation, 75013 Paris, France."", 'Inserm UMR1283, CNRS UMR8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, Lille University Hospital, 59000 Lille, France.', 'Universite de Lille, 59000 Lille, France.', 'Department of Metabolism, Imperial College London, London, United Kingdom.']",['eng'],"['Case Reports', 'Journal Article']",England,Eur J Endocrinol,European journal of endocrinology,9423848,"['0 (Adaptor Proteins, Signal Transducing)', '0 (Carrier Proteins)', '0 (Receptor, Melanocortin, Type 4)']",IM,"['Humans', 'Young Adult', 'Adaptor Proteins, Signal Transducing/genetics', '*Bariatric Surgery', 'Carrier Proteins/genetics', '*Diabetes Mellitus, Type 2/complications/genetics/surgery', 'Obesity/complications/genetics/surgery', 'Receptor, Melanocortin, Type 4/genetics/metabolism']",,['NOTNLM'],"['MRAP2', 'bariatric surgery', 'genetic obesity', 'leptin-melanocortin pathway', 'personalized medicine']",['Conflict of interest: None declared.'],2023/10/27 12:42,2023/10/30 06:46,['2023/10/27 07:11'],"['2023/04/11 00:00 [received]', '2023/07/20 00:00 [revised]', '2023/08/10 00:00 [accepted]', '2023/10/30 06:46 [medline]', '2023/10/27 12:42 [pubmed]', '2023/10/27 07:11 [entrez]']","['7330868 [pii]', '10.1093/ejendo/lvad132 [doi]']",ppublish,Eur J Endocrinol. 2023 Oct 17;189(4):K15-K18. doi: 10.1093/ejendo/lvad132.,"['National Center for Precision Diabetic Medicine/', 'ANR-18-IBHU-0001/French National Agency for Research/', '101043671/European Regional Development Fund/']",,,"['(c) The Author(s) 2023. Published by Oxford University Press on behalf of European', 'Society of Endocrinology. All rights reserved. For permissions, please e-mail:', 'journals.permissions@oup.com.']","['ORCID: 0000-0002-7399-1330', 'ORCID: 0000-0001-7769-6331']",,,,,,,,,,,,,,,
13059982,NLM,MEDLINE,20030501,20181201,0010-5309 (Print) 0010-5309 (Linking),75,12,1953 Mar 21,[Obesities; pathogenic study].,1077-8,,,"['KERMORGANT, Y']",['KERMORGANT Y'],,['und'],['Journal Article'],France,Concours Med,Concours medical,2984731R,,OM,"['Humans', 'Obesity/*etiology']",,['NLM'],['*OBESITY/etiology and pathogenesis'],,1953/03/21 00:00,1953/03/21 00:01,['1953/03/21 00:00'],"['1953/03/21 00:00 [pubmed]', '1953/03/21 00:01 [medline]', '1953/03/21 00:00 [entrez]']",,ppublish,Concours Med. 1953 Mar 21;75(12):1077-8.,,,,,,,,,Les obesites; essai pathogenique.,,,,['CLML: 5324:30626:452'],,,,,,,
6357849,NLM,MEDLINE,19840107,20191031,0071-335X (Print) 0071-335X (Linking),44,,1983,Energy fuel and hormonal profile in experimental obesities.,57-76,,"Several types of experimental obesities are characterized by the occurrence of an early hypersecretion of insulin that produces an increase in both triglyceride secretion by the liver and fat deposition in adipose tissue. This hypersecretion of insulin, together with other ill-defined factors, is subsequently responsible for a state of insulin resistance. The early oversecretion of insulin in hypothalamic and genetic (e.g. fa/fa rats) obesities can be experimentally demonstrated. Thus, within 20 min of acute lesion of the ventromedial hypothalamus (VMH), glucose-induced insulin secretion is greater in lesioned than in non-lesioned control rats; this increase can be blocked by superimposed, acute vagotomy. Moreover, an infusion of glucose to 17-day-old, pre-weaned control and genetically pre-obese rats (i.e. animals genetically-determined to become obese but with a normal body weight at this age) elicits much greater insulinaemia in the pre-obese than in the controls, despite similar basal, pre-infusion values in both. This increased insulin secretion in the pre-obese rats can be restored to normal by pre-treating them acutely with the cholinergic inhibitor, atropine. Thus, in these two types of obesity, an increased vagal tone appears to be of importance for the early occurrence of insulin over-secretion. Hyperinsulinaemia produced by increased tone of the vagus nerve appears to be reinforced by the decreased activity of the sympathetic system observed in obese rodents. In many obese rodents, plasma growth hormone levels are abnormally low. The inadequate secretion of this hyperglycaemic hormone may explain why, in some types of obesity syndrome, hyperglycaemia is not necessarily present, despite insulin resistance. Insulin resistance in experimental obesities has been shown to occur at the level of the adipose tissue, the muscles and more recently, the liver. The latter has been demonstrated using the in vivo euglycaemic clamp technique; thus, glycogenolysis of genetically obese (fa/fa) rats could not be shut off, as in controls, by either basal or increased plasma insulin levels. This particular pathway is therefore insulin resistant. The precise etiology of the early over-secretion of insulin in VMH-lesioned rats is, however, unknown: with VMH lesions, the origin is clearly the central nervous system (CNS), but the pathways actually interrupted by the lesions and those responsible for the hyperactivity of the vagus, remain to be determined.(ABSTRACT TRUNCATED AT 400 WORDS)","['Jeanrenaud, B']",['Jeanrenaud B'],,['eng'],"['Journal Article', 'Review']",Switzerland,Experientia Suppl,Experientia. Supplementum,0320043,"['0 (Insulin)', '9005-79-2 (Glycogen)', 'IY9XDZ35W2 (Glucose)']",IM,"['Adipose Tissue/metabolism', 'Animals', '*Energy Metabolism', 'Glucose/metabolism', 'Glycogen/metabolism', 'Hyperinsulinism/etiology', 'Hypothalamus, Middle/*physiology', 'Insulin/*metabolism', 'Insulin Resistance', 'Insulin Secretion', 'Liver/metabolism', 'Models, Biological', 'Muscles/metabolism', 'Obesity/genetics/*metabolism', 'Rats', 'Vagus Nerve/physiopathology']",,,,,1983/01/01 00:00,1983/01/01 00:01,['1983/01/01 00:00'],"['1983/01/01 00:00 [pubmed]', '1983/01/01 00:01 [medline]', '1983/01/01 00:00 [entrez]']",['10.1007/978-3-0348-6540-1_5 [doi]'],ppublish,Experientia Suppl. 1983;44:57-76. doi: 10.1007/978-3-0348-6540-1_5.,,,,,,,48,,,,,,,,,,,,,
6999431,NLM,MEDLINE,19801218,20061115,0369-8114 (Print) 0369-8114 (Linking),28,7,1980 Sep,[Obesity and the nociceptive reflex (author's transl)].,462-4,,"Using electrophysiological methods for studying pain in human, the authors have studied comparatively the sensation of pain and the threshold of a nociceptive flexion reflex of the lower limb, both elicited by electrical stimulation of sural nerve in 20 obese women (weight greater than or equal to 30 p. 100 of ideal weight) and 14 normal weighing women as controls. In obeses, the threshold of the nociceptive flexion reflex is very significantly lower (5,4 +/- 2 mA in obesity, 9,7 +/- 1,6 mA in controls p < 0,0001). The authors suggests an hypothesis of insufficiency of endogenous opiate releasing in human obesity.","['Pradalier, A', 'Dry, J', 'Willer, J C', 'Boureau, F']","['Pradalier A', 'Dry J', 'Willer JC', 'Boureau F']",,['fre'],"['English Abstract', 'Journal Article']",France,Pathol Biol (Paris),Pathologie-biologie,0265365,"['0 (Endorphins)', '0 (Enkephalins)']",IM,"['Adolescent', 'Adult', 'Aged', 'Electrophysiology', 'Endorphins/physiology', 'Enkephalins/physiology', 'Female', 'Humans', 'Middle Aged', 'Obesity/*physiopathology', 'Pain/*physiopathology', 'Sensory Thresholds/physiology']",,,,,1980/09/01 00:00,1980/09/01 00:01,['1980/09/01 00:00'],"['1980/09/01 00:00 [pubmed]', '1980/09/01 00:01 [medline]', '1980/09/01 00:00 [entrez]']",,ppublish,Pathol Biol (Paris). 1980 Sep;28(7):462-4.,,,,,,,,,Obesite et baisse du seuil nociceptif.,,,,,,,,,,,
31725689,NLM,MEDLINE,20200206,20210115,1528-1159 (Electronic) 0362-2436 (Linking),44,23,2019 Dec 1,Complications with Minimally Invasive Transforaminal Lumbar Interbody Fusion for Degenerative Spondylolisthesis in the Obese Population.,E1401-E1408,10.1097/BRS.0000000000003160 [doi],"STUDY DESIGN: A level-3 retrospective cohort analysis. OBJECTIVE: The aim of this study was to describe obesity's effect on complications and outcomes in degenerative spondylolisthesis patients treated by minimally invasive transforaminal lumbar interbody fusion (MI TLIF). SUMMARY OF BACKGROUND DATA: Obesity is associated with a greater complication rate among lumbar spine surgery patients. Poor clinical outcomes might likewise be supposed, but the association is not well established. Minimally invasive techniques have been developed to reduce complications and improve clinical outcomes in comparison to traditional open techniques. METHODS: We reviewed 134 consecutive patients with degenerative spondylolisthesis undergoing MI TLIF. Subjects were grouped into nonobese (N = 65) and obese (N = 69) cohorts. The obese group was further subdivided by BMI. Patient demographics, perioperative complications, and outcome scores were collected over a minimum of 24 months. Four periods (intraoperative, postoperative hospitalization, 6-month, and 24-month postoperative) were assessed. RESULTS: Cohort demographics were not significantly different, but it was noted that obese patients had more major comorbidities than nonobese patients. There was no difference in intraoperative complications between the two groups. The in-hospital complication rate was significantly greater in the obese group. The 6-month postoperative complication rate was not different between cohorts. Wound drainage was most common and noted only in the obese cohort. Complications at 24 months were not different but did trend toward significance in the obese for recurrence of symptoms and total complications. Functional outcome was better among nonobese subjects compared with obese subjects at every interval (significant at 6 and 12 months). Back pain scores were significantly better among nonobese subjects than obese subjects at 24 months, but Leg Pain scores were not different. CONCLUSIONS: MI TLIF can be safely performed in the obese population despite a higher in-hospital complication rate. Knowledge of common complications will help the treatment team appropriately manage obese patients with degenerative spondylolisthesis. LEVEL OF EVIDENCE: 3.","['Buyuk, Abdul Fettah', 'Shafa, Eiman', 'Dawson, John M', 'Schwender, James D']","['Buyuk AF', 'Shafa E', 'Dawson JM', 'Schwender JD']","['Twin Cities Spine Center, Minneapolis, MN.']",['eng'],['Journal Article'],United States,Spine (Phila Pa 1976),Spine,7610646,,IM,"['Adult', 'Aged', 'Cohort Studies', 'Female', 'Humans', 'Intraoperative Complications/*etiology/prevention & control', 'Lumbar Vertebrae/*surgery', 'Male', 'Middle Aged', 'Minimally Invasive Surgical Procedures/*adverse effects/methods', 'Obesity/epidemiology/*surgery', 'Postoperative Complications/etiology/prevention & control', 'Retrospective Studies', 'Spinal Fusion/*adverse effects/methods', 'Spondylolisthesis/epidemiology/*surgery', 'Treatment Outcome']",,,,,2019/11/15 06:00,2020/02/07 06:00,['2019/11/15 06:00'],"['2019/11/15 06:00 [entrez]', '2019/11/15 06:00 [pubmed]', '2020/02/07 06:00 [medline]']","['00007632-201912010-00018 [pii]', '10.1097/BRS.0000000000003160 [doi]']",ppublish,Spine (Phila Pa 1976). 2019 Dec 1;44(23):E1401-E1408. doi: 10.1097/BRS.0000000000003160.,,,,,,,,,,,,,,,,,,,,
35909311,NLM,MEDLINE,20230330,20230407,1460-2229 (Electronic) 0263-2136 (Linking),40,2,2023 Mar 28,High prevalence of abdominal obesities and metabolically unhealthy individuals in a highly urbanized district of India: findings of a cross-sectional survey in Puducherry.,282-289,10.1093/fampra/cmac082 [doi],"BACKGROUND: Abdominal obesities are better markers for predicting cardiovascular abnormalities than risk stratification based only on body mass index (BMI). We aimed to estimate the prevalence of abdominal adiposities using predictive equations for Asian Indian adults and to determine the prevalence of metabolically healthy subjects among those overweight/obese and with normal BMI. METHODS: A community-based survey was conducted among those aged 18-69 years in the district of Puducherry between February 2019 and February 2020. We surveyed 2,560 individuals selected through multi-stage cluster random sampling from urban and rural areas (50 wards and 50 villages, respectively) of the district. Anthropometric measurements, such as height, weight, waist circumference, and blood pressure were recorded from each participant. Fasting blood sample was collected from each alternate participant to estimate metabolic risk factors. RESULTS: Over four-fifths (85.6%; 95% CI: 84.2-86.9) and two-thirds (69.7%; 95% CI: 67.9-71.6) of the population in the district had high levels of intra-abdominal adipose tissue (IAAT) and total abdominal fat (TAF), respectively. Both the risk factors were significantly higher among women and urban population. About 43% (95% CI: 41-44.9) of the population had high abdominal subcutaneous adipose tissue (SCAT) with a significantly higher prevalence among the urban population. Among those overweight/obese (n = 773), almost all 99.4% (95% CI: 98.7-99.9) were metabolically unhealthy. Among subjects with normal BMI (n = 314), only about 2.9% (95% CI: 1.3-4.8) were metabolically healthy. CONCLUSION: We highlight the substantially high prevalence of IAAT, TAF, and SCAT in the district of Puducherry. Almost all the study population was metabolically unhealthy irrespective of their BMI levels.","['Sivanantham, Parthibane', 'Sahoo, Jaya Prakash', 'Lakshminarayanan, Subitha', 'Bobby, Zachariah', 'Kar, Sitanshu Sekhar']","['Sivanantham P', 'Sahoo JP', 'Lakshminarayanan S', 'Bobby Z', 'Kar SS']","['Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.', 'Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.', 'Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.', 'Department of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.', 'Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Fam Pract,Family practice,8500875,,IM,"['Adult', 'Humans', 'Female', '*Obesity, Abdominal/epidemiology', '*Overweight/epidemiology', 'Cross-Sectional Studies', 'Prevalence', 'Obesity/epidemiology', 'Risk Factors', 'Body Mass Index']",,['NOTNLM'],"['body mass index', 'fat distribution', 'metabolic syndrome', 'obesity', 'phenotype', 'waist circumference']",,2022/08/02 06:00,2023/03/30 06:11,['2022/08/01 02:02'],"['2023/03/30 06:11 [medline]', '2022/08/02 06:00 [pubmed]', '2022/08/01 02:02 [entrez]']","['6652637 [pii]', '10.1093/fampra/cmac082 [doi]']",ppublish,Fam Pract. 2023 Mar 28;40(2):282-289. doi: 10.1093/fampra/cmac082.,,,,"['(c) The Author(s) 2022. Published by Oxford University Press. All rights reserved.', 'For permissions, please e-mail: journals.permissions@oup.com.']","['ORCID: 0000-0002-0808-1453', 'ORCID: 0000-0002-8805-143X', 'ORCID: 0000-0002-1205-5741', 'ORCID: 0000-0002-9438-7319', 'ORCID: 0000-0001-7122-523X']",,,,,,,,,,,"['The distribution of abdominal fat is a better predictor of cardiovascular', 'abnormalities in an individual than the risk assessment based only on body mass', 'index (BMI). We conducted a community-based cross-sectional survey to estimate', 'the prevalence of abdominal adiposities using predictive equations for Asian', 'Indian adults and determine the prevalence of metabolically healthy subjects', 'among those overweight/obese and with normal BMI. We surveyed 2,560 adults aged', '18-69 years in the district of Puducherry between February 2019 and February', ""2020. We recorded each participant's anthropometric measurements, such as height,"", 'weight, waist circumference, and blood pressure and collected a fasting blood', 'sample to assess their metabolic health status. Over four-fifths (85.6%) and', 'two-thirds (69.7%) of the population in the district had high levels of', 'intra-abdominal adipose tissue (IAAT) and total abdominal fat (TAF),', 'respectively. Nearly half (43%) of the population had high abdominal subcutaneous', 'adipose tissue (SCAT). Both the risk factors were substantially higher among', 'women and the urban population. Among those overweight/obese, almost all (99.4%)', 'were metabolically unhealthy; among those with normal BMI, only about 2.9% were', 'metabolically healthy. From this study, we highlight the immediate need for', 'population-based health promotion interventions, especially among women and urban', 'residents of Puducherry district.']",['eng'],,,
11787370,NLM,MEDLINE,20020131,20161031,0003-4266 (Print) 0003-4266 (Linking),62,4 Pt 2,2001 Sep,[Physical activity and management of obese patients].,S37-42,,"Physical activity is recognized as an integral part of obesity treatment, in association with other therapeutic means. A major benefit of physical activity is the association with better long-term maintenance of weight loss. Physical activity has also positive psychological effects and increases quality of life. An evaluation of the usual level of physical activity and inactivity is needed for each patient. Physical activity counselling should be individualized and graded, in a perspective of individual progression. In subjects with massive obesity, remobilization based on physiotherapy techniques is the first step. All patients should be given simple advice to decrease sedentary behavior: use the stairs instead of the escalators, limit the time spent seated, etc. In general, current physical activity recommendations for the general population fit well with a majority of obese patients, i.e. a minimum of 30 minutes/day of moderate intensity physical activity (brisk walking or equivalent) on most, and preferably all, days of the week. Physical activities of higher intensities (endurance training programme) can be proposed on an individual basis. The type of physical activity required for long-term weight maintenance, and the question of adherence to physical activity recommendations in obese patients should be further investigated.","['Oppert, J M', 'Balarac, N']","['Oppert JM', 'Balarac N']","['Service de Medecine et Nutrition, Hotel-Dieu, 75004 Paris. jean-michel.oppert@htd.ap-hop-paris.fr']",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,,IM,"['*Exercise', 'Humans', 'Obesity/*therapy', 'Patient Compliance', 'Patient Education as Topic', 'Weight Loss']",,,,,2002/01/15 10:00,2002/02/01 10:01,['2002/01/15 10:00'],"['2002/01/15 10:00 [pubmed]', '2002/02/01 10:01 [medline]', '2002/01/15 10:00 [entrez]']",,ppublish,Ann Endocrinol (Paris). 2001 Sep;62(4 Pt 2):S37-42.,,,,,,,26,,Activite physique et prise en charge des patients obeses.,,,,,,,,,,,
12357736,NLM,MEDLINE,20021016,20081121,0035-3655 (Print) 0035-3655 (Linking),122,8,2002 Aug,[Perioperative problems in obese patients].,405-10,,,"['Magnusson, Lennart', 'Ravussin, Patrick']","['Magnusson L', 'Ravussin P']","[""Service d'anesthesie, CHUV, 1011 Lausanne. lennart.magnusson@chuv.hospvd.ch""]",['fre'],"['Journal Article', 'Review']",Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,,IM,"['Anesthesia, General/*adverse effects', 'Cardiovascular Physiological Phenomena', 'Comorbidity', 'Humans', 'Incidence', 'Obesity/*complications', 'Postoperative Care', '*Postoperative Complications', 'Preoperative Care', 'Risk Factors']",,,,,2002/10/03 04:00,2002/10/17 04:00,['2002/10/03 04:00'],"['2002/10/03 04:00 [pubmed]', '2002/10/17 04:00 [medline]', '2002/10/03 04:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 2002 Aug;122(8):405-10.,,,,,,,35,['Rev Med Suisse Romande. 2002 Aug;122(8):403. PMID: 12357735'],Problemes perioperatoires chez les patients obeses.,,,,,,,,,,,
11565458,NLM,MEDLINE,20011025,20111117,0075-4439 (Print) 0075-4439 (Linking),,,2001,[Glycemic anomalies observed in obese adolescents].,159-63,,,"['Lefevre, H', 'Le Stunff, C', 'Bougneres, P F']","['Lefevre H', 'Le Stunff C', 'Bougneres PF']","[""Service d'Endocrinologie de l'Enfant, Hopital Saint-Vincent-de-Paul, 75014 Paris.""]",['fre'],"['Journal Article', 'Review']",France,Journ Annu Diabetol Hotel Dieu,Journees annuelles de diabetologie de l'Hotel-Dieu,0424745,"['0 (Blood Glucose)', '0 (Insulin)']",IM,"['Adolescent', 'Blood Glucose/*analysis', 'Diabetes Mellitus/blood', 'Diabetes Mellitus, Type 2/blood', 'Humans', 'Insulin/blood', 'Obesity/*blood']",,,,,2001/09/22 10:00,2001/10/26 10:01,['2001/09/22 10:00'],"['2001/09/22 10:00 [pubmed]', '2001/10/26 10:01 [medline]', '2001/09/22 10:00 [entrez]']",,ppublish,Journ Annu Diabetol Hotel Dieu. 2001:159-63.,,,,,,,14,,Anomalies glycemiques observees chez les adolescents obeses.,,,,,,,,,,,
6869161,NLM,MEDLINE,19830811,20081121,0002-838X (Print) 0002-838X (Linking),28,1,1983 Jul,The obese child.,129-34,,"Forty-five percent of adult obesity cases begin in infancy. Obese children can be identified early; eating and activity patterns are characteristic. It is not known whether obesity is genetically or environmentally determined, but it clearly runs in families; the child of obese parents is at risk. After endogenous obesity has been ruled out, management requires caloric restriction, increased physical activity, and careful record keeping.","['Richmond, D A', 'Blyler, E M', 'Linscheid, T R']","['Richmond DA', 'Blyler EM', 'Linscheid TR']",,['eng'],['Journal Article'],United States,Am Fam Physician,American family physician,1272646,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Diet, Reducing', 'Energy Intake', 'Female', 'Humans', 'Hyperphagia/diet therapy', 'Male', 'Obesity/diet therapy/etiology/genetics/*psychology', 'Peer Group', 'Physical Exertion', ""Physician's Role""]",,,,,1983/07/01 00:00,1983/07/01 00:01,['1983/07/01 00:00'],"['1983/07/01 00:00 [pubmed]', '1983/07/01 00:01 [medline]', '1983/07/01 00:00 [entrez]']",,ppublish,Am Fam Physician. 1983 Jul;28(1):129-34.,,,,,,,,,,,,,,,,,,,,
22051896,NLM,MEDLINE,20130212,20120827,1532-8449 (Electronic) 0882-5963 (Linking),27,5,2012 Oct,Body mass index and injury severity in adolescent males.,508-13,10.1016/j.pedn.2011.10.001 [doi],"Childhood obesity's relationship to injury severity has not been determined. This study examined the relationship between obesity and injury severity, differences in injury severity between weight groups, and injury predictors. The sample included 611 adolescent males treated for injury at a 10-day camping event in Virginia. Findings indicate a significant relationship between body mass index percentile and injury severity (r = .08, p = .04) and less injury severity in normal-weight adolescents, F(2, 608) = 5.27, p < .01. Predictors of injury severity were cause, place injury occurred and injury type, R(2) change = .07, F(5, 601) = 6.52, p < .01. Implications are that overweight/obese adolescents may have increased risk of serious injuries. Examining predictors may decrease incidence of injuries at future events.","['Burns, Kathleen', 'Murrock, Carolyn J', 'Graor, Christine Heifner']","['Burns K', 'Murrock CJ', 'Graor CH']","['Medina Hospital, Medina, OH, USA. kburnscns@gmail.com']",['eng'],['Journal Article'],United States,J Pediatr Nurs,Journal of pediatric nursing,8607529,,IM,"['Adolescent', 'Analysis of Variance', '*Body Mass Index', 'Camping', 'Humans', 'Incidence', '*Injury Severity Score', 'Linear Models', 'Male', 'Obesity/*complications', 'Prospective Studies', 'Risk Factors', 'Virginia/epidemiology', 'Wounds and Injuries/*epidemiology']",,,,,2011/11/05 06:00,2013/02/13 06:00,['2011/11/05 06:00'],"['2011/03/22 00:00 [received]', '2011/09/19 00:00 [revised]', '2011/10/02 00:00 [accepted]', '2011/11/05 06:00 [entrez]', '2011/11/05 06:00 [pubmed]', '2013/02/13 06:00 [medline]']","['S0882-5963(11)00637-3 [pii]', '10.1016/j.pedn.2011.10.001 [doi]']",ppublish,J Pediatr Nurs. 2012 Oct;27(5):508-13. doi: 10.1016/j.pedn.2011.10.001. Epub 2011 Nov 12.,,20111112,,['Copyright (c) 2012 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
17336789,NLM,MEDLINE,20070614,20151119,1471-0153 (Print) 1471-0153 (Linking),8,2,2007 Apr,Taking action to lose weight: toward an understanding of individual differences.,185-94,,"The purpose of the present study was to understand differences in obese/overweight individuals who do and do not seek ongoing external assistance for weight loss. Help-seeking was examined as a dichotomous and as a continuous variable. Measures of body mass index, comorbid medical conditions, socioeconomic status, psychological distress, disordered eating behavior, body image, and obesity-related knowledge were administered to a community sample of 120 overweight women (age: 22-65 y, BMI: 25-63 kg/m(2)). Fewer predictors of help-seeking were identified when measuring help-seeking as a dichotomy than when measuring it as a continuum. All predictors were from psychosocial domains, with obesity-related knowledge being the strongest, most consistent predictor. Help-seeking for weight control in a community sample of overweight and obese individuals appears to be motivated by psychological aspects of obesity, rather than obesity's physical or medical burden.","['Annunziato, Rachel A', 'Lowe, Michael R']","['Annunziato RA', 'Lowe MR']","['Mount Sinai School of Medicine, Department of Psychiatry, One Gustave L. Levy Place, Box 1230, New York, NY 10029, USA. rachel.annunziato@mssm.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Eat Behav,Eating behaviors,101090048,,IM,"['Adult', 'Attitude to Health', 'Body Image', 'Body Mass Index', 'Diet, Reducing/psychology', 'Female', 'Humans', '*Individuality', 'Internal-External Control', 'Middle Aged', '*Motivation', 'Obesity/*psychology', '*Overweight', 'Patient Acceptance of Health Care/psychology', 'Personality Inventory', 'Quality of Life/psychology', 'Surveys and Questionnaires', '*Weight Loss']",,,,,2007/03/06 09:00,2007/06/15 09:00,['2007/03/06 09:00'],"['2005/11/04 00:00 [received]', '2006/04/18 00:00 [revised]', '2006/04/24 00:00 [accepted]', '2007/03/06 09:00 [pubmed]', '2007/06/15 09:00 [medline]', '2007/03/06 09:00 [entrez]']","['S1471-0153(06)00033-X [pii]', '10.1016/j.eatbeh.2006.04.004 [doi]']",ppublish,Eat Behav. 2007 Apr;8(2):185-94. doi: 10.1016/j.eatbeh.2006.04.004. Epub 2006 May 22.,,20060522,,,,,,,,,,,,,,,,,,
28967598,NLM,MEDLINE,20180619,20180620,2468-7189 (Electronic) 2468-7189 (Linking),45,10,2017 Oct,[Anemia due to vitamin deficiencies in obese pregnant women].,573-575,S2468-7189(17)30198-8 [pii] 10.1016/j.gofs.2017.08.005 [doi],,"['Gac, M M', 'Raimond, E', 'Orquevaux, P', 'Pelissier, A', 'Graesslin, O']","['Gac MM', 'Raimond E', 'Orquevaux P', 'Pelissier A', 'Graesslin O']","['Departement de gynecologie-obstetrique, hopital Maison Blanche, universite de Reims-Champagne-Ardenne, 45, rue Cognacq-Jay, 51092 Reims cedex, France.', 'Departement de gynecologie-obstetrique, hopital Maison Blanche, universite de Reims-Champagne-Ardenne, 45, rue Cognacq-Jay, 51092 Reims cedex, France. Electronic address: eraimond@chu-reims.fr.', 'Departement de medecine interne, hopital Robert-Debre, universite de Reims-Champagne-Ardenne, 45, rue Cognacq-Jay, 51092 Reims cedex, France.', 'Departement de gynecologie-obstetrique, hopital Maison Blanche, universite de Reims-Champagne-Ardenne, 45, rue Cognacq-Jay, 51092 Reims cedex, France.', 'Departement de gynecologie-obstetrique, hopital Maison Blanche, universite de Reims-Champagne-Ardenne, 45, rue Cognacq-Jay, 51092 Reims cedex, France.']",['fre'],"['Case Reports', 'Letter']",France,Gynecol Obstet Fertil Senol,"Gynecologie, obstetrique, fertilite & senologie",101693805,,IM,"['Adult', 'Anemia/*etiology', 'Avitaminosis/*complications/*diagnosis', 'Female', 'Humans', 'Obesity/*complications', 'Pregnancy', 'Pregnancy Complications/*diagnosis', 'Pregnancy Outcome', 'Vitamin B 12 Deficiency/complications']",,,,,2017/10/03 06:00,2018/06/21 06:00,['2017/10/03 06:00'],"['2016/07/07 00:00 [received]', '2017/08/24 00:00 [accepted]', '2017/10/03 06:00 [pubmed]', '2018/06/21 06:00 [medline]', '2017/10/03 06:00 [entrez]']","['S2468-7189(17)30198-8 [pii]', '10.1016/j.gofs.2017.08.005 [doi]']",ppublish,Gynecol Obstet Fertil Senol. 2017 Oct;45(10):573-575. doi: 10.1016/j.gofs.2017.08.005. Epub 2017 Sep 28.,,20170928,,,,,,,Anemie par carence en vitamines B12 et B9 chez les femmes enceintes obeses.,,,,,,,,,,,
7465738,NLM,MEDLINE,19810424,20190830,0033-3174 (Print) 0033-3174 (Linking),42,6,1980 Nov,Eating style of obese and nonobese males.,529-38,,"Variables traditionally thought to differentiate an obese eating style were examined in six nonobese and six obese males consuming a sandwich lunch. Determinations of meal size, meal duration, bites, bites per sandwich quarter, and various measures of rate of ingestion revealed no significant differences between groups. A trend suggested that the nonobese consumed a greater proportion of their meal during the first half of the meal as compared to the obese. These observations were confirmed in the second experiment, including significant findings of differential patterning of rate. Thus the cumulative intake curves of the nonobese were negatively accelerated, whereas those of the obese more closely approximated a linear curve. In the second experiment six nonobese and six obese males consumed their lunch at normal, fast, and slow rates. A trend indicated that more food was ingested at the fast rate, regardless of weight class. Sandwiches tasted better at the conclusion of meals consumed at rapid rates. Implications for the physiology of satiety and the diagnosis and treatment of obesity are discussed.","['Kaplan, D L']",['Kaplan DL'],,['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Psychosom Med,Psychosomatic medicine,0376505,,IM,"['*Feeding Behavior', 'Humans', 'Male', 'Obesity/diagnosis/*psychology/therapy', 'Satiety Response/physiology', 'Time Factors']",,,,,1980/11/01 00:00,1980/11/01 00:01,['1980/11/01 00:00'],"['1980/11/01 00:00 [pubmed]', '1980/11/01 00:01 [medline]', '1980/11/01 00:00 [entrez]']",['10.1097/00006842-198011000-00001 [doi]'],ppublish,Psychosom Med. 1980 Nov;42(6):529-38. doi: 10.1097/00006842-198011000-00001.,['MH-15767/MH/NIMH NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
4027694,NLM,MEDLINE,19851022,20190719,0361-9230 (Print) 0361-9230 (Linking),14,6,1985 Jun,Comparison of the metabolic and behavioral disturbances following paraventricular- and ventromedial-hypothalamic lesions.,551-9,,"Lesions of the ventromedial hypothalamus (VMH) result in an obesity syndrome with several metabolic and behavioral manifestations. It has also been reported that damage to the paraventricular hypothalamus (PVH) leads to changes characteristic of obesity. However, little is known about the consequence of PVH lesions, especially in contrast to the extensive documentation of VMH lesion-induced effects. To assess the basic features of the two hypothalamic obesity syndromes, rats underwent VMH, PVH, or sham lesions and, for 15 weeks, were maintained ad lib on a series of test diets. Both lesions groups were hyperphagic and showed similar weight gains. Although both lesion groups became obese (measured by % carcass fat), VMH rats were fatter than PVH animals. Similarly, only VMH rats were hyperinsulinemic. Further tests were conducted in PVH and VMH rats restricted to control body weights. VMH, but not PVH, rats developed a persisting elevation in basal gastric acid secretion. As well, only VMH, and not PVH, animals developed an obesity when restricted to normal weights. These data indicate similarities in PVH and VMH rats maintained ad lib but experiments on restricted animals reveal fundamental differences in the two obesities and point to different etiologies.","['Weingarten, H P', 'Chang, P K', 'McDonald, T J']","['Weingarten HP', 'Chang PK', 'McDonald TJ']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Brain Res Bull,Brain research bulletin,7605818,,IM,"['Animals', 'Behavior, Animal/physiology', 'Body Weight', 'Feeding Behavior/*physiology', 'Food Deprivation', 'Male', 'Obesity/metabolism/*physiopathology', 'Paraventricular Hypothalamic Nucleus/*physiology', 'Rats', 'Rats, Inbred Strains', 'Time Factors', 'Ventromedial Hypothalamic Nucleus/*physiology']",,,,,1985/06/01 00:00,1985/06/01 00:01,['1985/06/01 00:00'],"['1985/06/01 00:00 [pubmed]', '1985/06/01 00:01 [medline]', '1985/06/01 00:00 [entrez]']","['0361-9230(85)90104-2 [pii]', '10.1016/0361-9230(85)90104-2 [doi]']",ppublish,Brain Res Bull. 1985 Jun;14(6):551-9. doi: 10.1016/0361-9230(85)90104-2.,,,,,,,,,,,,,,,,,,,,
12357735,NLM,MEDLINE,20021016,20041117,0035-3655 (Print) 0035-3655 (Linking),122,8,2002 Aug,[Perioperative problems in obese patients].,403,,,"['Ravussin, Patrick', 'Magnusson, Lennart']","['Ravussin P', 'Magnusson L']",,['fre'],"['Comment', 'Editorial']",Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,,IM,"['*Anesthesia, General', 'Humans', 'Obesity/*complications', 'Patient Care Planning', '*Postoperative Complications', 'Risk Factors', '*Surgical Procedures, Operative']",,,,,2002/10/03 04:00,2002/10/17 04:00,['2002/10/03 04:00'],"['2002/10/03 04:00 [pubmed]', '2002/10/17 04:00 [medline]', '2002/10/03 04:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 2002 Aug;122(8):403.,,,,,,,,,Problemes perioperatoires chez les patients obeses.,,['Rev Med Suisse Romande. 2002 Aug;122(8):405-10. PMID: 12357736'],,,,,,,,,
17091906,NLM,MEDLINE,20070220,20081121,0035-3639 (Print) 0035-3639 (Linking),27,4,2006 Sep,[Experience of obesity's treatment by an interdisciplinary team].,S375-82,,"Owing to the multifactorial origin of obesity, we have created an interdisciplinary team devoted to a limited-in-time treatment, following three axles : nutritional education, body self-perception and emotions expression. The philosophy of this approach and some results are presented.","['Vindevogel, M', 'Farber, B', 'Gourmet, L M', 'Verbanck, P', 'Kutnowski, M', 'Minner, P']","['Vindevogel M', 'Farber B', 'Gourmet LM', 'Verbanck P', 'Kutnowski M', 'Minner P']","[""Service de Psychiatrie et de Psychologie Medicale et Clinique Interdisciplinaire du Traitement de I'Obesite, C.H.U. Brugmann, Bruxelles.""]",['fre'],"['English Abstract', 'Journal Article']",Belgium,Rev Med Brux,Revue medicale de Bruxelles,8003474,,IM,"['Humans', 'Obesity/diet therapy/*therapy', '*Patient Care Team', 'Psychotherapy', 'Relaxation Therapy']",,,,,2006/11/10 09:00,2007/02/21 09:00,['2006/11/10 09:00'],"['2006/11/10 09:00 [pubmed]', '2007/02/21 09:00 [medline]', '2006/11/10 09:00 [entrez]']",,ppublish,Rev Med Brux. 2006 Sep;27(4):S375-82.,,,,,,,,,Experience d'une prise en charge interdisciplinaire de l'obesite.,,,,,,,,,,,
21545017,NLM,MEDLINE,20110531,20171116,1660-9379 (Print) 1660-9379 (Linking),7,288,2011 Mar 30,[What is the evolution of metabolically normal obesity?].,692-4,,"A subgroup of obese subjects which could be protected from the cardiometabolic complications of obesity is described in the literature as ""metabolically normal obese subjects"". However, the lack of a joint definition of metabolic normality makes the available data difficult to interpret and to compare. A recent analysis of more than 1200 subjects in a prospective study showed that 21% of obese metabolically normal subjects at baseline developed the metabolic syndrome after three years. The obese subjects who remained metabolically normal showed, at three years, significantly higher values of cardiometabolic parameters as compared to subjects with normal body weight. In conclusion, the obese subjects even without any metabolic abnormality should benefit of a closer medical monitoring as well as a regular follow-up to avoid further weight gain.","['Pataky, Z', 'Bobbioni-Harsch, E', 'Makoundou, V', 'Golay, A']","['Pataky Z', 'Bobbioni-Harsch E', 'Makoundou V', 'Golay A']","[""Service d'enseignement therapeutique pour maladies chroniques, Centre collaborateur de l'Organisation mondiale de la sante, Departement de medecine communautaire et de premier recours, HUG, Geneve. Zoltan.Pataky@hcuge.ch""]",['fre'],['Journal Article'],Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Health Status', 'Humans', 'Insulin Resistance', 'Metabolic Syndrome/metabolism', 'Obesity/*metabolism']",,,,,2011/05/07 06:00,2011/06/01 06:00,['2011/05/07 06:00'],"['2011/05/07 06:00 [entrez]', '2011/05/07 06:00 [pubmed]', '2011/06/01 06:00 [medline]']",,ppublish,Rev Med Suisse. 2011 Mar 30;7(288):692-4.,,,,,,,,,"Que deviennent tes sujets obeses ""metaboliquement"" normaux?",,,,,,,,,,,
26598822,NLM,MEDLINE,20160901,20181202,1881-7742 (Electronic) 0301-4800 (Linking),61 Suppl,,2015,Effect of Exericse and Nutrition upon Lifestyle-Related Disease and Cognitive Function.,S122-4,10.3177/jnsv.61.S122 [doi],"Bray has proposed the ""MONA LISA"" hypothesis, an acronym for Most Obesities kNown Are Low In Sympathetic Activity indicating that obesity is associated with a relative or absolute reduction in the activity of the thermogenic component of the sympathetic nervous system. Our series of studies have suggested a potential reversibility in ANS activity regulating fat metabolism and appetite control by regular exercise training in middle aged individuals and obese children with depressed ANS activity. In other words habitual exercise plays a vital role in enhancing not only fat and glucose metabolism, but also ANS activities in the prevention of obesity and appetite control. There are growing expectations that too much sitting is a real and substantial risk to health. One of the intriguing findings from these accelerometer measurement studies is that breaks in sedentary time were shown to have beneficial associations with metabolic biomarkers, due possibly to challenging and enhancing autonomic nervous system that regulates body weight and appetite. Recent findings of brain-derived neurotrophic factors (BDNF) seem to have shed some light upon age-related neurodegenerative diseases and appear to influence energy metabolism, appetite and aspects of neuro-cognitive function. These data strongly suggest that a lack of exercise as characterized by a sedentary lifestyle and an unhealthy diet may lead to accelerated ageing, diseases of the body and brain, and an overall decline in the quality of life.","['Moritani, Toshio', 'Akamatsu, Yasunori']","['Moritani T', 'Akamatsu Y']","['Graduate School of Human and Environmental Studies, Kyoto University.']",['eng'],['Journal Article'],Japan,J Nutr Sci Vitaminol (Tokyo),Journal of nutritional science and vitaminology,0402640,"['0 (Brain-Derived Neurotrophic Factor)', '7171WSG8A2 (BDNF protein, human)']",IM,"['Adult', 'Aged', 'Appetite Regulation', '*Autonomic Nervous System', 'Brain-Derived Neurotrophic Factor/metabolism', 'Child', '*Cognition', 'Cognition Disorders/etiology/metabolism/*prevention & control', '*Dietary Supplements', 'Exercise/*physiology', 'Humans', '*Life Style', 'Middle Aged', 'Neurodegenerative Diseases/etiology/metabolism/prevention & control', 'Obesity/etiology/*prevention & control', 'Sedentary Behavior']",,,,,2015/11/26 06:00,2016/09/02 06:00,['2015/11/25 06:00'],"['2015/11/25 06:00 [entrez]', '2015/11/26 06:00 [pubmed]', '2016/09/02 06:00 [medline]']",['10.3177/jnsv.61.S122 [doi]'],ppublish,J Nutr Sci Vitaminol (Tokyo). 2015;61 Suppl:S122-4. doi: 10.3177/jnsv.61.S122.,,,,,,,,,,,,,,,,,,,,
16032534,NLM,MEDLINE,20051005,20181201,0941-3790 (Print) 0941-3790 (Linking),67 Suppl 1,,2005 Aug,"Utilization of out- and inpatient health services by obese adults: a population-based study in the Augsburg region, Germany.",S150-7,,"The aim of this study is to compare out- and inpatient health services utilization by obese and normal weight adults. In a subsample of the KORA-Survey S4 1999/2001 in the Augsburg region, Germany (n = 947, age: 25-74 years), number of visits to general practitioners (GP) and inpatient hospital days were self-reported in three computer-aided telephone interviews (CATI) over half a year. Body mass index, based on measured body height and weight, was used to define obesity according to WHO classification. Participants, stratified in normal weight (18.5 < or = BMI < 25), preobese (25 < r = BMI < 30), obese class 1 (30 < or = BMI < 35) and obese classes 2-3 (BMI > or = 35), were compared via logistic, zero-truncated negative binomial, and multinomial models to elucidate obesity's associations with utilization at all, its frequency, and high utilization. Sex, age, social class, health insurance, and place of residence were adjusted for in all models. Respondents in obesity class 1 were more prone to report at least one visit to a GP than those normal weight (OR = 1.84, p < 0.01), while obesity classes 2-3 were associated with frequent (IRR = 1.63, p < 0.05) and high utilization (OR = 3.57, p < 0.05). Regarding days in hospital, only the extremely obese (i. e. classes 2-3) reported significantly more utilization than those normal weight (days if hospitalized at all: IRR = 3.24, p < 0.05; high utilization: OR = 5.4, p < 0.01). Sex did not play a significant role in any model. Older respondents reported more utilization in terms of GP-visits, while only tending to do so regarding inpatient utilization. Both those with statutory (vs. private) health insurance and rural (vs. urban) place of residence had higher odds to visit a GP at all. Results point to an excess utilization of out- and inpatient health services by especially extremely obese adults, and underline the need to contrast obesity classes 2-3 vs. 1 in health services utilization research.","['von Lengerke, T', 'Happich, M', 'Reitmeir, P', 'John, J']","['von Lengerke T', 'Happich M', 'Reitmeir P', 'John J']","['GSF-National Research Center for Environment and Health, Institute of Health Economics and Health Care Management, Neuherberg, Germany. lengerke.thomas@mh-hannover.de']",['eng'],"['Clinical Trial', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",Germany,Gesundheitswesen,Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)),9204210,,IM,"['Adult', 'Aged', 'Ambulatory Care/*statistics & numerical data', 'Cohort Studies', 'Comorbidity', 'Delivery of Health Care/*statistics & numerical data', 'Female', 'Germany/epidemiology', 'Hospitalization/*statistics & numerical data', 'Humans', 'Incidence', 'Inpatients/statistics & numerical data', 'Length of Stay/statistics & numerical data', 'Male', 'Middle Aged', 'Obesity/*epidemiology/*therapy', 'Outpatients/statistics & numerical data', 'Population Surveillance/methods', '*Registries', 'Research Design', 'Risk Assessment/*methods', 'Risk Factors', 'Survival Analysis']",,,,,2005/07/21 09:00,2005/10/06 09:00,['2005/07/21 09:00'],"['2005/07/21 09:00 [pubmed]', '2005/10/06 09:00 [medline]', '2005/07/21 09:00 [entrez]']",['10.1055/s-2005-858510 [doi]'],ppublish,Gesundheitswesen. 2005 Aug;67 Suppl 1:S150-7. doi: 10.1055/s-2005-858510.,,,,,,,,,,['Kora Study Group'],,,,,,,,,,
9767995,NLM,MEDLINE,19981027,20161209,0755-4982 (Print) 0755-4982 (Linking),27,9,1998 Mar 7,[Preoperative management of subjects at risk. Obese patients].,452-4,,,"['Servin, F']",['Servin F'],"[""Service d'Anesthesie-Reanimation, Hopital Bichat, Paris.""]",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,,IM,"['Anesthesia, Conduction/adverse effects/methods', 'Humans', 'Obesity/complications/metabolism/physiopathology/*surgery', 'Preoperative Care/*methods', 'Risk Factors']",,,,,1998/10/13 00:00,1998/10/13 00:01,['1998/10/13 00:00'],"['1998/10/13 00:00 [pubmed]', '1998/10/13 00:01 [medline]', '1998/10/13 00:00 [entrez]']",,ppublish,Presse Med. 1998 Mar 7;27(9):452-4.,,,,,,,20,,Prise en charge peri-operatoire des sujets a risque. Les sujets obeses.,,,,,,,,,,,
6521441,NLM,MEDLINE,19850321,20041117,0037-5683 (Print) 0037-5683 (Linking),26,3-4,1984,The obese child.,121-7,,,"['Wong, H B']",['Wong HB'],,['eng'],['Journal Article'],Singapore,J Singapore Paediatr Soc,The Journal of the Singapore Paediatric Society,7507223,,IM,"['Child', 'Female', 'Humans', 'Male', '*Obesity/epidemiology/etiology/therapy', 'Singapore']",,,,,1984/01/01 00:00,1984/01/01 00:01,['1984/01/01 00:00'],"['1984/01/01 00:00 [pubmed]', '1984/01/01 00:01 [medline]', '1984/01/01 00:00 [entrez]']",,ppublish,J Singapore Paediatr Soc. 1984;26(3-4):121-7.,,,,,,,,,,,,,,,,,,,,
25478934,NLM,MEDLINE,20150512,20220309,1945-7197 (Electronic) 0021-972X (Linking),100,3,2015 Mar,Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity.,850-9,10.1210/jc.2014-3127 [doi],"CONTEXT: Prader-Willi syndrome (PWS), the most frequent syndrome of obesity, is a model of early fat mass (FM) development, but scarce data exist on adipose tissue characteristics. OBJECTIVE: The objective of the study was to compare metabolic, fat distribution, and transcriptomic signatures of sc adipose tissue (scAT) in PWS adults, with matched obese adults with primary obesities. MAIN OUTCOMES AND MEASURES: Hormonal and metabolic assessments, systemic inflammation, and gene expression in scAT were compared between PWS patients and obese controls (OCs). Each 42nd PWS patient was matched with one randomly paired control with primary obesity. Matching factors were age, gender, fat mass (percentage), and diabetic status. RESULTS: Compared with OCs, the PWS group had a decreased percentage of trunk FM and a better metabolic profile with decreased insulin and homeostasis model assessment, an index of insulin-resistance, and increased concentrations of serum adiponectin and ghrelin. Adipocyte size relative to body fat was significantly higher in PWS vs OCs. scAT in PWS patients was characterized by a transcriptomic functional signature with enrichment of themes related to immunoinflammation, the extracellular matrix, and angiogenesis. A RT-PCR targeted study revealed that candidate genes encoding proinflammatory markers and remodeling molecules, CD68, CD3e, IL-1beta, chemokine (C-C motif) ligand 5, collagen type 4-alpha, and lysyl oxidase, were down-regulated. CONCLUSION: Matched for FM, PWS subjects have a better metabolic profile, a phenotype that could be linked to changes in scAT remodeling and promotion of adipocyte growth.","['Lacroix, Delphine', 'Moutel, Sandrine', 'Coupaye, Muriel', 'Huvenne, Helene', 'Faucher, Pauline', 'Pelloux, Veronique', 'Rouault, Christine', 'Bastard, Jean-Philippe', 'Cagnard, Nicolas', 'Dubern, Beatrice', 'Clement, Karine', 'Poitou, Christine']","['Lacroix D', 'Moutel S', 'Coupaye M', 'Huvenne H', 'Faucher P', 'Pelloux V', 'Rouault C', 'Bastard JP', 'Cagnard N', 'Dubern B', 'Clement K', 'Poitou C']","['INSERM, U1166, Nutriomic team 6 (D.L., H.H., V.P., C.R., B.D., K.C., C.P.), Sorbonne Universities (D.L., H.H., V.P., C.R., B.D., K.C., C.P.), University Pierre et Marie Curie-Paris 6, Unite Mixte de Recherche en Sante Unite 1166, and Institute of Cardiometabolism and Nutrition (ICAN) (S.M., M.C., P.F., K.C., C.P.), Assistance Publique Hopitaux de Paris, Department of Nutrition, and French Reference Centre for Prader-Willi Syndrome, Pitie-Salpetriere Hospital, Paris, F-75013 France; Functional Unit of Inflammatory and Metabolic Biomarkers (J.-P.B.), Department of Biochemistry and Hormonology, Tenon Hospital, Assistance Publique des Hopitaux de Paris, F-75970 Paris, France; Bioinformatics Platform (N.C.), Plateforme de Bioinformatique, SFR Necker, University Paris V, F-75015 Paris, France; and Department of Pediatric Nutrition and Gastroenterology (B.D.), Trousseau Hospital, Assistance Publique Hopitaux de Paris, F-37044 Paris, France.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,J Clin Endocrinol Metab,The Journal of clinical endocrinology and metabolism,0375362,,IM,"['Adiposity/*genetics', 'Adolescent', 'Adult', 'Body Fat Distribution', 'Case-Control Studies', 'Diabetes Mellitus, Type 2/complications/genetics/metabolism', 'Female', 'Gene Expression Profiling', 'Humans', 'Male', 'Microarray Analysis', 'Obesity/complications/genetics/metabolism', 'Prader-Willi Syndrome/complications/*genetics/*metabolism', 'Subcutaneous Fat/*metabolism', '*Transcriptome', 'Young Adult']",,,,,2014/12/06 06:00,2015/05/13 06:00,['2014/12/06 06:00'],"['2014/12/06 06:00 [entrez]', '2014/12/06 06:00 [pubmed]', '2015/05/13 06:00 [medline]']",['10.1210/jc.2014-3127 [doi]'],ppublish,J Clin Endocrinol Metab. 2015 Mar;100(3):850-9. doi: 10.1210/jc.2014-3127. Epub 2014 Dec 5.,,20141205,,,,,,,,,,,,,,,,,,
10446527,NLM,MEDLINE,19990903,20150826,0370-629X (Print) 0370-629X (Linking),54,6,1999 Jun,[How I evaluate ... a overweight or obese patient].,553-6,,"The evaluation of an obese subject aims at better understanding the disease, its causes and consequences, in order to optimize its management. Schematically, this task can be done in three successive steps. First, it is necessary to analyse data from the past, by asking about family and personal history. Then, the present data should be carefully analysed, especially the severity of overweight, its type of distribution and the importance of associated complications. Finally, it is mandatory to project these data into the future, in order to assess the final prognosis of the obese patient allowing a better definition of the goals and the therapeutical strategies.","['Scheen, A J', 'Luyckx, F H']","['Scheen AJ', 'Luyckx FH']","['Service de Diabetologie, Nutrition et Maladies metaboliques, Universite de Liege.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",Belgium,Rev Med Liege,Revue medicale de Liege,0404317,,IM,"['Humans', 'Medical History Taking', 'Obesity/blood/*diagnosis/etiology/*therapy', 'Patient Care Planning', 'Prognosis', 'Risk Factors', 'Severity of Illness Index']",,,,,1999/08/14 00:00,1999/08/14 00:01,['1999/08/14 00:00'],"['1999/08/14 00:00 [pubmed]', '1999/08/14 00:01 [medline]', '1999/08/14 00:00 [entrez]']",,ppublish,Rev Med Liege. 1999 Jun;54(6):553-6.,,,,,,,14,,Comment j'explore ... un sujet avec un exces ponderal ou une obesite.,,,,,,,,,,,
16550121,NLM,MEDLINE,20060425,20191026,0755-4982 (Print) 0755-4982 (Linking),35,3 Pt 1,2006 Mar,[Obese patients: role of bariatric surgery].,371-2,,,"['Christoforov, Boyan']",['Christoforov B'],,['fre'],['Editorial'],France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,,IM,"['Bariatric Surgery/*methods', 'Gastrectomy/*methods', 'Humans', 'Obesity/*surgery', 'Prognosis', 'Treatment Outcome']",,,,,2006/03/22 09:00,2006/04/28 09:00,['2006/03/22 09:00'],"['2006/03/22 09:00 [pubmed]', '2006/04/28 09:00 [medline]', '2006/03/22 09:00 [entrez]']","['S0755-4982(06)74595-X [pii]', '10.1016/s0755-4982(06)74595-x [doi]']",ppublish,Presse Med. 2006 Mar;35(3 Pt 1):371-2. doi: 10.1016/s0755-4982(06)74595-x.,,,,,,,,,Patients obeses: quelle place pour la chirurgie bariatrique?,,,,,,,,,,,
24953311,NLM,MEDLINE,20160104,20140708,1769-6682 (Electronic) 1297-9589 (Linking),42,7-8,2014 Jul-Aug,[Are lifestyle interventions for overweight and obese pregnant women useful?].,526-7,S1297-9589(14)00161-1 [pii] 10.1016/j.gyobfe.2014.05.016 [doi],,"['Marx-Deseure, A', 'Pigeyre, M', 'Deruelle, P']","['Marx-Deseure A', 'Pigeyre M', 'Deruelle P']","[""Pole femme mere nouveau-ne, clinique d'obstetrique, maternite Jeanne-de-Flandre, CHRU de Lille, 1, rue Eugene-Avinee, 59037 Lille cedex, France; EA4489, environnement perinatal et croissance, faculte de medecine. universite Lille 2, Lille, France."", 'Service de nutrition, hopital Huriez, CHRU de Lille, 59037 Lille cedex, France.', ""Pole femme mere nouveau-ne, clinique d'obstetrique, maternite Jeanne-de-Flandre, CHRU de Lille, 1, rue Eugene-Avinee, 59037 Lille cedex, France; EA4489, environnement perinatal et croissance, faculte de medecine. universite Lille 2, Lille, France. Electronic address: philippe.deruelle@univ-lille2.fr.""]",['fre'],['Journal Article'],France,Gynecol Obstet Fertil,"Gynecologie, obstetrique & fertilite",100936305,,IM,"['Diet', 'Exercise', 'Female', 'Humans', '*Life Style', 'Obesity/complications/*therapy', 'Overweight/complications/*therapy', 'Pregnancy', 'Pregnancy Complications/*therapy']",,['NOTNLM'],"['Grossesse', 'Nutrition', 'Obesity', 'Obesite', 'Pregnancy']",,2014/06/24 06:00,2016/01/05 06:00,['2014/06/24 06:00'],"['2014/04/18 00:00 [received]', '2014/06/24 06:00 [entrez]', '2014/06/24 06:00 [pubmed]', '2016/01/05 06:00 [medline]']","['S1297-9589(14)00161-1 [pii]', '10.1016/j.gyobfe.2014.05.016 [doi]']",ppublish,Gynecol Obstet Fertil. 2014 Jul-Aug;42(7-8):526-7. doi: 10.1016/j.gyobfe.2014.05.016. Epub 2014 Jun 19.,,20140619,,,,,,,Faut-il proposer un programme hygieno-dietetique pour les femmes enceintes obeses ou en surpoids ?,,,,,,,,,,,
31402043,NLM,MEDLINE,20200203,20200203,2213-3941 (Electronic) 0003-4266 (Linking),80,4,2019 Sep,"Serum FSH level is lower in dysovulating than in ovulating non-PCOS obese women, independently of body mass index.",225-228,S0003-4266(19)30018-6 [pii] 10.1016/j.ando.2018.11.003 [doi],"OBJECTIVES: The prevalence of ovulation disorder (OD) is 3-fold higher in obese than normal-weight women. Most ODs are associated with concomitant polycystic ovary syndrome (PCOS), but obesity by itself can cause OD, through mechanisms that remain poorly documented. The literature on obese non-PCOS women with OD is sparse. The aim of the present study was to analyze a population of obese non-PCOS women with OD to shed further light on the mechanism of ovulation disorder. MATERIAL AND METHODS: This retrospective observational study of infertile obese women without PCOS compared a control group without OD (n=45) to a study group with OD (n=30) (OD group). Clinical, hormonal, and ultrasound characteristics were collected between cycle days 2 and 5. Women older than 37 years and women with PCOM (polycystic ovarian morphology) or hormonal disorder were excluded. RESULTS: Body mass index (BMI) was significantly higher in the OD group, as were waist circumference and insulin and leptin serum levels. Conversely, serum follicle stimulating hormone (FSH) levels were significantly lower. After adjustment for BMI, only serum FSH level remained significantly different between the 2 groups. Discriminant analysis suggested that FSH may have a much stronger effect on OD than BMI. CONCLUSION: Low serum FSH level may contribute to OD in some obese women, independently of BMI. The pathophysiological mechanism of this finding and its impact on therapeutic strategies must be clarified.","['Catteau-Jonard, Sophie', 'Brunel, Anne', 'Dumont, Agathe', 'Robin, Geoffroy', 'Pigny, Pascal', 'Dewailly, Didier']","['Catteau-Jonard S', 'Brunel A', 'Dumont A', 'Robin G', 'Pigny P', 'Dewailly D']","['Department of Endocrine Gynecology and Reproductive Medicine, University of Lille, CHU de Lille, 59000 Lille, France; Inserm U1172 Team 2, JPARC, University of Lille, 59000 Lille, France. Electronic address: sophie.jonard@chru-lille.fr.', 'Department of Endocrine Gynecology and Reproductive Medicine, University of Lille, CHU de Lille, 59000 Lille, France. Electronic address: nanneb@hotmail.fr.', 'Department of Endocrine Gynecology and Reproductive Medicine, University of Lille, CHU de Lille, 59000 Lille, France. Electronic address: agathe.dumont@chru-lille.fr.', 'Department of Endocrine Gynecology and Reproductive Medicine, University of Lille, CHU de Lille, 59000 Lille, France. Electronic address: geoffroy.robin@chru-lille.fr.', 'Laboratory of Biochemistry and Hormonology, University of Lille, CHU de Lille, 59000 Lille, France. Electronic address: pascal.pigny@chru-lille.fr.', 'Department of Endocrine Gynecology and Reproductive Medicine, University of Lille, CHU de Lille, 59000 Lille, France; Inserm U1172 Team 2, JPARC, University of Lille, 59000 Lille, France. Electronic address: didier.dewailly@chru-lille.fr.']",['eng'],"['Journal Article', 'Observational Study']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,['9002-68-0 (Follicle Stimulating Hormone)'],IM,"['Adolescent', 'Adult', '*Body Mass Index', 'Case-Control Studies', 'Female', 'Follicle Stimulating Hormone/*blood', 'Humans', 'Infertility, Female/blood/diagnosis/etiology', 'Menstruation Disturbances/*blood/etiology', 'Obesity/*blood/*complications', 'Ovulation/*blood/physiology', 'Polycystic Ovary Syndrome/blood/complications', 'Retrospective Studies', 'Young Adult']",,['NOTNLM'],"['BMI', 'Dysovulation', 'FSH', 'Femmes obeses', 'IMC', 'Leptin', 'Leptine', 'Obese women', 'Ovulation disorder']",,2019/08/14 06:00,2020/02/06 06:00,['2019/08/13 06:00'],"['2018/06/20 00:00 [received]', '2018/10/12 00:00 [revised]', '2018/11/10 00:00 [accepted]', '2019/08/14 06:00 [pubmed]', '2020/02/06 06:00 [medline]', '2019/08/13 06:00 [entrez]']","['S0003-4266(19)30018-6 [pii]', '10.1016/j.ando.2018.11.003 [doi]']",ppublish,Ann Endocrinol (Paris). 2019 Sep;80(4):225-228. doi: 10.1016/j.ando.2018.11.003. Epub 2019 Jan 29.,,20190129,,['Copyright (c) 2019 Elsevier Masson SAS. All rights reserved.'],,,,,,,,,,,,,,,,
2736649,NLM,MEDLINE,19890802,20061115,0069-2328 (Print) 0069-2328 (Linking),44,4,1989 Apr,[Problems in evaluating obesity in childhood].,223-6,,For screening of obese children and marginal obesities the authors elaborated tables for boys and girls aged 6 to 18 years. The tables are based on height and body weight of the Czechoslovak population examined in 1985.,"['Blaha, P', 'Lisa, L']","['Blaha P', 'Lisa L']",,['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Cesk Pediatr,Ceskoslovenska pediatrie,0403576,,IM,"['Adolescent', 'Anthropometry/methods', 'Body Height', 'Body Weight', 'Child', 'Female', 'Humans', 'Male', 'Obesity/*diagnosis']",,,,,1989/04/01 00:00,1989/04/01 00:01,['1989/04/01 00:00'],"['1989/04/01 00:00 [pubmed]', '1989/04/01 00:01 [medline]', '1989/04/01 00:00 [entrez]']",,ppublish,Cesk Pediatr. 1989 Apr;44(4):223-6.,,,,,,,,,Problemy hodnoceni obezity v detskem veku.,,,,,,,,,,,
9702551,NLM,MEDLINE,19981027,20190512,0360-7283 (Print) 0360-7283 (Linking),23,3,1998 Aug,"The obese client: myths, facts, assessment, and intervention.",195-202,,"The myth that weight (size) is solely under the control of the individual is perpetuated by the $30 billion per year diet industry. Efforts to shape societal attitudes and beliefs about how much people should weigh have been so successful that some professionals have adopted the industry's biases. Because of the widespread concern with weight, social workers need to understand the difference between fact and myth. This article counters many of the weight myths and examines the cultural, social, biological, and psychological factors to be considered when assessing clients who are considered obese. The article also presents a framework for developing an appropriate service plan.","['Melcher, J', 'Bostwick, G J Jr']","['Melcher J', 'Bostwick GJ Jr']","['School of Social Work, University of Cincinnati, OH 45221-0108, USA.']",['eng'],['Journal Article'],United States,Health Soc Work,Health & social work,7611528,,IM,"['Adolescent', 'Adult', 'Attitude to Health', 'Diet, Reducing', 'Female', 'Humans', 'Male', '*Obesity/diagnosis/epidemiology/psychology/therapy', 'Prejudice', 'Social Work', 'Stereotyping', 'United States/epidemiology']",,,,,1998/08/14 02:01,2001/03/28 10:01,['1998/08/14 02:01'],"['1998/08/14 02:01 [pubmed]', '2001/03/28 10:01 [medline]', '1998/08/14 02:01 [entrez]']",['10.1093/hsw/23.3.195 [doi]'],ppublish,Health Soc Work. 1998 Aug;23(3):195-202. doi: 10.1093/hsw/23.3.195.,,,,,,,,,,,,,,,,,,,,
17959335,NLM,MEDLINE,20080116,20071126,1769-6623 (Electronic) 0750-7658 (Linking),26,11,2007 Nov,[Out-of-hospital management characteristics of severe obese patients].,921-6,,"OBJECTIVES: Assessment of prehospital management difficulties in morbid obese patients. Registration in several emergency departments for medical devices usable for morbid obese patients. STUDY DESIGN: Descriptive clinical study and regional survey. PATIENTS AND METHODS: During one year, all morbid obese patients managed by the prehospital emergency mobile unit (PEMU) were recorded. Pre hospital medical management and hospital admission difficulties were systematically recorded and analyzed. A regional survey was also performed in clinical and radiological departments, which are likely to receive these patients in emergency situations. RESULTS: During the period of study, 92 patients were managed by the PEMU. Medical difficulties were numerous: impossibility to measure arterial pressure in 8 patients, difficulties in peripheral line placement for 12 patients, difficult airway management in 5 of 25 (20%) patients requiring tracheal intubation. The handling of obese patients needed additional rescuer in 27 (33%) patients transported to hospital. The regional survey showed that many obese patients could not profit from several specialized diagnostic and therapeutics devices because of their weight restriction. CONCLUSION: Management of morbid obese patients in the context of the out-of-hospital emergency medicine is frequently associated with specific and major technical difficulties. Numerous diagnostic and therapeutic devices are not currently adapted to the most severe overweight patients.","['Jbeili, C', 'Penet, C', 'Jabre, P', 'Kachout, L', 'Schvahn, S', 'Margenet, A', 'Marty, J', 'Combes, X']","['Jbeili C', 'Penet C', 'Jabre P', 'Kachout L', 'Schvahn S', 'Margenet A', 'Marty J', 'Combes X']","[""Departement d'anesthesie-reanimation chirurgicale et Samu-Smur, 94, hopital Henri-Mondor, 51, avenue du Marechal-de-Lattre-de-Tassigny, 94010 Creteil, France.""]",['fre'],"['English Abstract', 'Journal Article']",France,Ann Fr Anesth Reanim,Annales francaises d'anesthesie et de reanimation,8213275,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Blood Pressure', 'Body Mass Index', 'Emergencies', 'Health Surveys', 'Humans', 'Middle Aged', 'Obesity/*rehabilitation', 'Obesity, Morbid/*rehabilitation', '*Outpatients']",,,,,2007/10/26 09:00,2008/01/17 09:00,['2007/10/26 09:00'],"['2007/02/01 00:00 [received]', '2007/09/11 00:00 [accepted]', '2007/10/26 09:00 [pubmed]', '2008/01/17 09:00 [medline]', '2007/10/26 09:00 [entrez]']","['S0750-7658(07)00460-1 [pii]', '10.1016/j.annfar.2007.09.008 [doi]']",ppublish,Ann Fr Anesth Reanim. 2007 Nov;26(11):921-6. doi: 10.1016/j.annfar.2007.09.008. Epub 2007 Oct 23.,,20071023,,,,,,,Particularites prehospitalieres de la prise en charge des patients obeses severes et morbides.,,,,,,,,,,,
28671792,NLM,MEDLINE,20180410,20180410,1660-9379 (Print) 1660-9379 (Linking),12,527,2016 Aug 24,[Comparative efficacy of three bariatric surgery procedures in obese patients with type 2 diabetes].,1378-1382,,"This retrospective work compares the efficacy of three procedures of bariatric surgery in obese patients with type 2 diabetes : gastric bypass (n = 22), sleeve gastrectomy (n = 18) and Magenstrasse & Mill gastroplasty (also known as reversible sleeve (n = 19). The three interventions result in a remarkable weight loss after one year, a better glycaemic control, with often a remission of diabetes, a reduction of blood pressure and an improvement of lipid profile, allowing an interruption or a dose reduction of concomitant medications. Overall, classical sleeve provides almost similar results as gastric bypass and appears slightly better than reversible sleeve. These results deserve confirmation in studies with more patients followed for a longer term.","['Bessemans, Severine', 'Scheen, Andre J']","['Bessemans S', 'Scheen AJ']","['Service de diabetologie, nutrition et maladies metaboliques, Departement de medecine, CHU de Liege, 4000 Liege, Belgique.', 'Service de diabetologie, nutrition et maladies metaboliques, Departement de medecine, CHU de Liege, 4000 Liege, Belgique.']",['fre'],"['Comparative Study', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,"['0 (Blood Glucose)', '0 (Lipids)']",IM,"['Adult', 'Aged', 'Bariatric Surgery/methods', 'Blood Glucose', 'Diabetes Mellitus, Type 2/*etiology', 'Female', 'Gastrectomy/*methods', 'Gastric Bypass/*methods', 'Gastroplasty/*methods', 'Humans', 'Lipids/blood', 'Male', 'Middle Aged', 'Obesity/complications/*surgery', 'Retrospective Studies', 'Treatment Outcome', 'Weight Loss']",,,,"['Les auteurs remercient les differentes equipes chirurgicales du CHU de Liege et', 'du CHR de la Citadelle qui ont realise les differentes procedures de chirurgie', 'bariatrique, les membres des equipes multidisciplinaires qui ont mis au point et', ""suivi les patients operes et Madame Monique Marchand pour l'aide dans l'analyse"", 'statistique des donnees.']",2017/07/04 06:00,2018/04/11 06:00,['2017/07/04 06:00'],"['2017/07/04 06:00 [entrez]', '2017/07/04 06:00 [pubmed]', '2018/04/11 06:00 [medline]']",,ppublish,Rev Med Suisse. 2016 Aug 24;12(527):1378-1382.,,,,,,,,,Efficacite de trois techniques de chirurgie bariatrique chez des sujets obeses diabetiques de type 2.,,,,,,,,,,,
32739864,NLM,MEDLINE,20210607,20231113,2352-3964 (Electronic) 2352-3964 (Linking),58,,2020 Aug,A surrogate of Roux-en-Y gastric bypass (the enterogastro anastomosis surgery) regulates multiple beta-cell pathways during resolution of diabetes in ob/ob mice.,102895,S2352-3964(20)30270-X [pii] 10.1016/j.ebiom.2020.102895 [doi] 102895,"BACKGROUND: Bariatric surgery is an effective treatment for type 2 diabetes. Early post-surgical enhancement of insulin secretion is key for diabetes remission. The full complement of mechanisms responsible for improved pancreatic beta cell functionality after bariatric surgery is still unclear. Our aim was to identify pathways, evident in the islet transcriptome, that characterize the adaptive response to bariatric surgery independently of body weight changes. METHODS: We performed entero-gastro-anastomosis (EGA) with pyloric ligature in leptin-deficient ob/ob mice as a surrogate of Roux-en-Y gastric bypass (RYGB) in humans. Multiple approaches such as determination of glucose tolerance, GLP-1 and insulin secretion, whole body insulin sensitivity, ex vivo glucose-stimulated insulin secretion (GSIS) and functional multicellular Ca(2+)-imaging, profiling of mRNA and of miRNA expression were utilized to identify significant biological processes involved in pancreatic islet recovery. FINDINGS: EGA resolved diabetes, increased pancreatic insulin content and GSIS despite a persistent increase in fat mass, systemic and intra-islet inflammation, and lipotoxicity. Surgery differentially regulated 193 genes in the islet, most of which were involved in the regulation of glucose metabolism, insulin secretion, calcium signaling or beta cell viability, and these were normalized alongside changes in glucose metabolism, intracellular Ca(2+) dynamics and the threshold for GSIS. Furthermore, 27 islet miRNAs were differentially regulated, four of them hubs in a miRNA-gene interaction network and four others part of a blood signature of diabetes resolution in ob/ob mice and in humans. INTERPRETATION: Taken together, our data highlight novel miRNA-gene interactions in the pancreatic islet during the resolution of diabetes after bariatric surgery that form part of a blood signature of diabetes reversal. FUNDING: European Union's Horizon 2020 research and innovation programme via the Innovative Medicines Initiative 2 Joint Undertaking (RHAPSODY), INSERM, Societe Francophone du Diabete, Institut Benjamin Delessert, Wellcome Trust Investigator Award (212625/Z/18/Z), MRC Programme grants (MR/R022259/1, MR/J0003042/1, MR/L020149/1), Diabetes UK (BDA/11/0004210, BDA/15/0005275, BDA 16/0005485) project grants, National Science Foundation (310030-188447), Fondation de l'Avenir.","['Amouyal, Chloe', 'Castel, Julien', 'Guay, Claudiane', 'Lacombe, Amelie', 'Denom, Jessica', 'Migrenne-Li, Stephanie', 'Rouault, Christine', 'Marquet, Florian', 'Georgiadou, Eleni', 'Stylianides, Theodoros', 'Luquet, Serge', 'Le Stunff, Herve', 'Scharfmann, Raphael', 'Clement, Karine', 'Rutter, Guy A', 'Taboureau, Olivier', 'Magnan, Christophe', 'Regazzi, Romano', 'Andreelli, Fabrizio']","['Amouyal C', 'Castel J', 'Guay C', 'Lacombe A', 'Denom J', 'Migrenne-Li S', 'Rouault C', 'Marquet F', 'Georgiadou E', 'Stylianides T', 'Luquet S', 'Le Stunff H', 'Scharfmann R', 'Clement K', 'Rutter GA', 'Taboureau O', 'Magnan C', 'Regazzi R', 'Andreelli F']","['Sorbonne Universite, INSERM, Nutrition and Obesities; Systemic approaches (NutriOmics), Paris, France; AP-HP, Pitie-Salpetriere Hospital, Diabetology department, F-75013 Paris, France.', 'Universite de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.', 'Department of Fundamental Neurosciences, University of Lausanne, Rue du Bugnon 9, CH-1005, Lausanne, Switzerland.', 'PreclinICAN, Institute of Cardiometabolism and Nutrition, Paris, France.', 'Universite de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.', 'Universite de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.', 'Sorbonne Universite, INSERM, Nutrition and Obesities; Systemic approaches (NutriOmics), Paris, France.', 'Sorbonne Universite, INSERM, Nutrition and Obesities; Systemic approaches (NutriOmics), Paris, France.', 'Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK.', 'Loughborough University, Loughborough, UK.', 'Universite de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.', 'Universite de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.', 'Universite de Paris, Cochin Institute, Inserm U1016, Paris 75014, France.', 'Sorbonne Universite, INSERM, Nutrition and Obesities; Systemic approaches (NutriOmics), Paris, France; APHP, Pitie-Salpetriere Hospital, Nutrition department, F-75013 Paris, France.', 'Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK; Lee Kong Chian School of Medicine, Nan Yang Technological University, Singapore.', 'Universite de Paris, BFA, Team CMPLI, Inserm U1133, CNRS UMR 8251, Paris, France.', 'Universite de Paris, BFA, UMR 8251, CNRS, F-75013 Paris, France.', 'Department of Fundamental Neurosciences, University of Lausanne, Rue du Bugnon 9, CH-1005, Lausanne, Switzerland; Department of Biomedical Sciences, University of Lausanne, Rue du Bugnon 7, CH-1005 Lausanne, Switzerland.', 'Sorbonne Universite, INSERM, Nutrition and Obesities; Systemic approaches (NutriOmics), Paris, France; AP-HP, Pitie-Salpetriere Hospital, Diabetology department, F-75013 Paris, France. Electronic address: fabrizio.andreelli@aphp.fr.']",['eng'],['Journal Article'],Netherlands,EBioMedicine,EBioMedicine,101647039,"['0 (Insulin)', '0 (MicroRNAs)', '89750-14-1 (Glucagon-Like Peptide 1)']",IM,"['Animals', 'Diabetes Mellitus, Type 2/genetics/metabolism/*surgery', 'Disease Models, Animal', 'Gastric Bypass', 'Gene Expression Profiling', 'Gene Expression Regulation', '*Gene Regulatory Networks', 'Glucagon-Like Peptide 1/metabolism', 'Glucose Tolerance Test', 'Humans', 'Insulin/metabolism', 'Insulin-Secreting Cells/*chemistry', 'Male', 'Mice', 'Mice, Obese', 'MicroRNAs/*genetics', 'Obesity/genetics/metabolism/*surgery']",PMC7393530,['NOTNLM'],"['Bariatric surgery', 'Beta cell function', 'Diabetes', 'Insulin secretion', 'microRNA', 'ob/ob mouse']","['Declaration of Competing Interest G.R. has received research grant funding from', 'Sun Pharmaceuticals Inc and Les Laboratoires Servier, and is a consultant for Sun', 'Pharmaceuticals. Other authors have nothing to disclose.']",2020/08/03 06:00,2021/06/08 06:00,['2020/08/03 06:00'],"['2020/05/04 00:00 [received]', '2020/06/26 00:00 [revised]', '2020/06/30 00:00 [accepted]', '2020/08/03 06:00 [pubmed]', '2021/06/08 06:00 [medline]', '2020/08/03 06:00 [entrez]']","['S2352-3964(20)30270-X [pii]', '102895 [pii]', '10.1016/j.ebiom.2020.102895 [doi]']",ppublish,EBioMedicine. 2020 Aug;58:102895. doi: 10.1016/j.ebiom.2020.102895. Epub 2020 Jul 30.,"['MR/R022259/1/MRC_/Medical Research Council/United Kingdom', 'MR/K001981/1/MRC_/Medical Research Council/United Kingdom', 'MR/N020472/1/MRC_/Medical Research Council/United Kingdom', 'MR/M012646/1/MRC_/Medical Research Council/United Kingdom', 'MR/R010676/1/MRC_/Medical Research Council/United Kingdom', 'MR/L02036X/1/MRC_/Medical Research Council/United Kingdom', 'MR/K023667/1/MRC_/Medical Research Council/United Kingdom']",20200730,,['Copyright (c) 2020 The Authors. Published by Elsevier B.V. All rights reserved.'],,,,['EBioMedicine. 2020 Sep;59:102936. PMID: 32810821'],,,,,,,,,,,,
24866140,NLM,MEDLINE,20141017,20160726,1524-4563 (Electronic) 0194-911X (Linking),64,2,2014 Aug,Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients.,431-7,10.1161/HYPERTENSIONAHA.113.02988 [doi],"Weight loss improves insulin sensitivity and exerts sympathomodulatory effects. No data, however, are available on the effects of the weight loss induced by vertical sleeve gastrectomy on sympathetic neural drive, insulin sensitivity, and their reciprocal cross talks. In 10 severe obese hypertensives (age, 54.0+/-2.3 years [mean+/-SEM]), we measured sphygmomanometric blood pressure, heart rate, body mass index, homeostatic model assessment index, plasma leptin, muscle sympathetic nerve traffic (microneurography), and baroreflex sensitivity (vasoactive drug technique). Measurements were performed 2 to 3 days before surgery and repeated 6 and 12 months after the procedure. Ten matched hypertensive obeses not undergoing gastrectomy served as controls. Six months after bariatric surgery, a significant (P<0.05) reduction in body mass index (-9.1+/-1.4 kg/m(2)), sphygmomanometric systolic blood pressure (-10.2+/-4.5 mm Hg), heart rate (-11.0+/-2.4 bpm), homeostatic model assessment index (-3-3+/-1.3 AU), plasma leptin (-53.6+/-8.8 mug/L), and muscle sympathetic nerve traffic (-15.0+/-3.4 bursts/100 heart beats) was observed. The weight loss, the plasma leptin reduction, and the sympathetic inhibition were maintained after 12 months, whereas homeostatic model assessment index showed a tendency to return toward presurgery values. A significant improvement in baroreflex control of sympathetic nerve traffic was observed both 6 (+32.1%; P<0.05) and 12 months (+60.7%; P<0.01) after gastrectomy. No significant changes in the above-mentioned variables were detected in the control group. These data provide evidence that massive weight loss induced by sleeve gastrectomy triggers profound sympathoinhibitory effects, associated with a stable and significant reduction in plasma leptin levels, whereas the improvement in insulin sensitivity was attenuated with time and unrelated to the sympathoinhibition.","['Seravalle, Gino', 'Colombo, Manuela', 'Perego, Paolo', 'Giardini, Vittorio', 'Volpe, Marco', ""Dell'Oro, Raffaella"", 'Mancia, Giuseppe', 'Grassi, Guido']","['Seravalle G', 'Colombo M', 'Perego P', 'Giardini V', 'Volpe M', ""Dell'Oro R"", 'Mancia G', 'Grassi G']","['From the Istituto Auxologico Italiano, Milan, Italy (G.S., G.M.); Clinica Medica, Department of Health Science (M.C., M.V., R.D., G.G.) and Chirurgia II (P.P., V.G.), University of Milano-Bicocca, Monza, Italy; Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Milan, Italy (G.M., G.G.); and IRCCS Multimedica, Sesto San Giovanni, Milan, Italy (G.G.).', 'From the Istituto Auxologico Italiano, Milan, Italy (G.S., G.M.); Clinica Medica, Department of Health Science (M.C., M.V., R.D., G.G.) and Chirurgia II (P.P., V.G.), University of Milano-Bicocca, Monza, Italy; Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Milan, Italy (G.M., G.G.); and IRCCS Multimedica, Sesto San Giovanni, Milan, Italy (G.G.).', 'From the Istituto Auxologico Italiano, Milan, Italy (G.S., G.M.); Clinica Medica, Department of Health Science (M.C., M.V., R.D., G.G.) and Chirurgia II (P.P., V.G.), University of Milano-Bicocca, Monza, Italy; Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Milan, Italy (G.M., G.G.); and IRCCS Multimedica, Sesto San Giovanni, Milan, Italy (G.G.).', 'From the Istituto Auxologico Italiano, Milan, Italy (G.S., G.M.); Clinica Medica, Department of Health Science (M.C., M.V., R.D., G.G.) and Chirurgia II (P.P., V.G.), University of Milano-Bicocca, Monza, Italy; Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Milan, Italy (G.M., G.G.); and IRCCS Multimedica, Sesto San Giovanni, Milan, Italy (G.G.).', 'From the Istituto Auxologico Italiano, Milan, Italy (G.S., G.M.); Clinica Medica, Department of Health Science (M.C., M.V., R.D., G.G.) and Chirurgia II (P.P., V.G.), University of Milano-Bicocca, Monza, Italy; Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Milan, Italy (G.M., G.G.); and IRCCS Multimedica, Sesto San Giovanni, Milan, Italy (G.G.).', 'From the Istituto Auxologico Italiano, Milan, Italy (G.S., G.M.); Clinica Medica, Department of Health Science (M.C., M.V., R.D., G.G.) and Chirurgia II (P.P., V.G.), University of Milano-Bicocca, Monza, Italy; Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Milan, Italy (G.M., G.G.); and IRCCS Multimedica, Sesto San Giovanni, Milan, Italy (G.G.).', 'From the Istituto Auxologico Italiano, Milan, Italy (G.S., G.M.); Clinica Medica, Department of Health Science (M.C., M.V., R.D., G.G.) and Chirurgia II (P.P., V.G.), University of Milano-Bicocca, Monza, Italy; Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Milan, Italy (G.M., G.G.); and IRCCS Multimedica, Sesto San Giovanni, Milan, Italy (G.G.).', 'From the Istituto Auxologico Italiano, Milan, Italy (G.S., G.M.); Clinica Medica, Department of Health Science (M.C., M.V., R.D., G.G.) and Chirurgia II (P.P., V.G.), University of Milano-Bicocca, Monza, Italy; Centro Interuniversitario di Fisiologia Clinica e Ipertensione, Milan, Italy (G.M., G.G.); and IRCCS Multimedica, Sesto San Giovanni, Milan, Italy (G.G.). guido.grassi@unimib.it.']",['eng'],['Journal Article'],United States,Hypertension,"Hypertension (Dallas, Tex. : 1979)",7906255,['0 (Leptin)'],IM,"['Bariatric Surgery', 'Baroreflex/physiology', 'Blood Pressure/*physiology', 'Body Mass Index', 'Female', 'Heart Rate/physiology', 'Humans', 'Hypertension/complications/physiopathology/*surgery', 'Insulin Resistance/*physiology', 'Leptin/blood', 'Male', 'Middle Aged', 'Obesity/complications/physiopathology/*surgery', 'Sympathetic Nervous System/*physiopathology', 'Treatment Outcome', 'Weight Loss/physiology']",,['NOTNLM'],"['bariatric surgery', 'baroreflex', 'body weight', 'insulin resistance', 'leptin', 'obesity', 'sympathetic nervous system']",,2014/05/29 06:00,2014/10/18 06:00,['2014/05/29 06:00'],"['2014/05/29 06:00 [entrez]', '2014/05/29 06:00 [pubmed]', '2014/10/18 06:00 [medline]']","['HYPERTENSIONAHA.113.02988 [pii]', '10.1161/HYPERTENSIONAHA.113.02988 [doi]']",ppublish,Hypertension. 2014 Aug;64(2):431-7. doi: 10.1161/HYPERTENSIONAHA.113.02988. Epub 2014 May 27.,,20140527,,"['(c) 2014 American Heart Association, Inc.']",,,,['Hypertension. 2014 Aug;64(2):235-6. PMID: 24866141'],,,,,,,,,,,,
22382717,NLM,MEDLINE,20120716,20221207,2150-6000 (Electronic) 0022-1465 (Linking),53,1,2012 Mar,Trajectories of body mass and self-concept in black and white girls: the lingering effects of stigma.,2-16,10.1177/0022146511419205 [doi],"As a stigmatizing condition, obesity may lead to the internalization of devalued labels and threats to self-concept. Modified labeling theory suggests that the effects of stigma may outlive direct manifestations of the discredited characteristic itself. This article considers whether obesity's effects on self-concept linger when obese youth enter the normal body mass range. Using longitudinal data from the National Growth and Health Study on 2,206 black and white girls, we estimated a parallel-process growth mixture model of body mass linked to growth models of body image discrepancy and self-esteem. We found that discrepancy was higher and self-esteem lower in formerly obese girls compared to girls always in the normal range and comparable to chronically obese girls. Neither body image discrepancy nor self-esteem rebounded in white girls despite reduction in body mass, suggesting that the effects of stigma linger. Self-esteem, but not discrepancy, did rebound in black girls.","['Mustillo, Sarah A', 'Hendrix, Kimber L', 'Schafer, Markus H']","['Mustillo SA', 'Hendrix KL', 'Schafer MH']","['Purdue University, West Lafayette, IN, USA. smustillo@purdue.edu']",['eng'],['Journal Article'],United States,J Health Soc Behav,Journal of health and social behavior,0103130,,IM,"['Black or African American/*psychology', '*Body Image', '*Body Mass Index', 'Child', 'Female', 'Humans', 'Longitudinal Studies', 'Mental Health', 'Obesity/epidemiology/psychology', '*Prejudice', 'Psychometrics', 'Self Concept', '*Social Stigma', 'Statistics as Topic', 'Time Factors', 'United States/epidemiology', 'White People/*psychology', ""Women's Health""]",,,,,2012/03/03 06:00,2012/07/17 06:00,['2012/03/03 06:00'],"['2012/03/03 06:00 [entrez]', '2012/03/03 06:00 [pubmed]', '2012/07/17 06:00 [medline]']","['53/1/2 [pii]', '10.1177/0022146511419205 [doi]']",ppublish,J Health Soc Behav. 2012 Mar;53(1):2-16. doi: 10.1177/0022146511419205.,,,,,,,,,,,,,,,,,,,,
7793098,NLM,MEDLINE,19950725,20131121,0042-8809 (Print) 0042-8809 (Linking),41,2,1995 Mar-Apr,[Features of tissue oxygenation in patients with alimentary-constitutional and hypothalamic obesity].,49-51,,"Tissue oxygen consumption was studied in 111 patients with alimentary-constitutional and hypothalamic obesities. Polarography was used to study oxygen tension by means of oxygen and ischemic tests. Great impairments of oxygen consumption were found in the tissue of patients with hypothalamic obesity at the initial state, while in alimentary-constitutional obesity they increased during the oxygen test as the obesity progressed and was characterized by impairments of both oxygen supply and consumption, depending on the type of obesity. It is recommended to examine initial pO2 in the patients' skin as one of objective criteria for differential diagnosis of obesity.","['Sokur, S A']",['Sokur SA'],,['rus'],"['English Abstract', 'Journal Article']",Russia (Federation),Vopr Med Khim,Voprosy meditsinskoi khimii,0416601,['S88TT14065 (Oxygen)'],IM,"['Diet', 'Humans', 'Hypothalamic Diseases/*complications', 'Obesity/etiology/*metabolism', 'Oxygen/*metabolism']",,,,,1995/03/01 00:00,1995/03/01 00:01,['1995/03/01 00:00'],"['1995/03/01 00:00 [pubmed]', '1995/03/01 00:01 [medline]', '1995/03/01 00:00 [entrez]']",,ppublish,Vopr Med Khim. 1995 Mar-Apr;41(2):49-51.,,,,,,,,,Osobennosti oksigenatsii tkanei u bol'nykh s alimentarno-konstitutsional'nym i gipotalamicheskim ozhireniem.,,,,,,,,,,,
27138596,NLM,MEDLINE,20170726,20220317,1932-6203 (Electronic) 1932-6203 (Linking),11,5,2016,Physical Activity and Sedentary Behavior in Metabolically Healthy versus Unhealthy Obese and Non-Obese Individuals - The Maastricht Study.,e0154358,10.1371/journal.pone.0154358 [doi] e0154358,"BACKGROUND: Both obesity and the metabolic syndrome are associated with increased risk of cardiovascular diseases and type 2 diabetes. Although both frequently occur together in the same individual, obesity and the metabolic syndrome can also develop independently from each other. The (patho)physiology of ""metabolically healthy obese"" (i.e. obese without metabolic syndrome) and ""metabolically unhealthy non-obese"" phenotypes (i.e. non-obese with metabolic syndrome) is not fully understood, but physical activity and sedentary behavior may play a role. OBJECTIVE: To examine objectively measured physical activity and sedentary behavior across four groups: I) ""metabolically healthy obese"" (MHO); II) ""metabolically unhealthy obese"" (MUO); III)""metabolically healthy non-obese"" (MHNO); and IV) ""metabolically unhealthy non-obese"" (MUNO). METHODS: Data were available from 2,449 men and women aged 40-75 years who participated in The Maastricht Study from 2010 to 2013. Participants were classified into the four groups according to obesity (BMI>/=30kg/m2) and metabolic syndrome (ATPIII definition). Daily activity was measured for 7 days with the activPAL physical activity monitor and classified as time spent sitting, standing, and stepping. RESULTS: In our study population, 562 individuals were obese. 19.4% of the obese individuals and 72.7% of the non-obese individuals was metabolically healthy. After adjustments for age, sex, educational level, smoking, alcohol use, waking time, T2DM, history of CVD and mobility limitation, MHO (n = 107) spent, per day, more time stepping (118.2 versus 105.2 min; p<0.01) and less time sedentary (563.5 versus 593.0 min., p = 0.02) than MUO (n = 440). In parallel, MHNO (n = 1384) spent more time stepping (125.0 versus 115.4 min; p<0.01) and less time sedentary (553.3 versus 576.6 min., p<0.01) than MUNO (n = 518). CONCLUSION: Overall, the metabolically healthy groups were less sedentary and more physically active than the metabolically unhealthy groups. Therefore, physical activity and sedentary time may partly explain the presence of the metabolic syndrome in obese as well as non-obese individuals.","['de Rooij, Belle H', 'van der Berg, Julianne D', 'van der Kallen, Carla J H', 'Schram, Miranda T', 'Savelberg, Hans H C M', 'Schaper, Nicolaas C', 'Dagnelie, Pieter C', 'Henry, Ronald M A', 'Kroon, Abraham A', 'Stehouwer, Coen D A', 'Koster, Annemarie']","['de Rooij BH', 'van der Berg JD', 'van der Kallen CJ', 'Schram MT', 'Savelberg HH', 'Schaper NC', 'Dagnelie PC', 'Henry RM', 'Kroon AA', 'Stehouwer CD', 'Koster A']","['Department of Social medicine, Maastricht University, Maastricht, the Netherlands.', 'CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, the Netherlands.', 'Department of Social medicine, Maastricht University, Maastricht, the Netherlands.', 'CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, the Netherlands.', 'Department of Internal Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.', 'Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands.', 'Department of Internal Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.', 'Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands.', 'Department of Human Movement Sciences, Maastricht University, Maastricht, the Netherlands.', 'School for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, the Netherlands.', 'CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, the Netherlands.', 'Department of Internal Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.', 'Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands.', 'CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, the Netherlands.', 'Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands.', 'Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.', 'Department of Internal Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.', 'Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands.', 'Department of Internal Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.', 'Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands.', 'Department of Internal Medicine, Maastricht University Medical Centre (MUMC+), Maastricht, the Netherlands.', 'Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, the Netherlands.', 'Department of Social medicine, Maastricht University, Maastricht, the Netherlands.', 'CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, the Netherlands.']",['eng'],['Journal Article'],United States,PLoS One,PloS one,101285081,,IM,"['Adult', 'Aged', '*Exercise', 'Female', 'Humans', 'Male', 'Metabolic Syndrome/*complications', 'Middle Aged', 'Obesity/*complications/epidemiology/*metabolism/physiopathology', '*Sedentary Behavior']",PMC4854448,,,"['Competing Interests: This study received funding from Janssen-Cilag B.V, Novo', 'Nordisk Farma B.V. and Sanofi-Aventis Netherlands B.V. There are no patents,', 'products in development or marketed products to declare. This does not alter the', ""authors' adherence to all the PLOS ONE policies on sharing data and materials, as"", 'detailed online in the guide for authors.']",2016/05/04 06:00,2017/07/27 06:00,['2016/05/04 06:00'],"['2015/10/31 00:00 [received]', '2016/04/12 00:00 [accepted]', '2016/05/04 06:00 [entrez]', '2016/05/04 06:00 [pubmed]', '2017/07/27 06:00 [medline]']","['PONE-D-15-47757 [pii]', '10.1371/journal.pone.0154358 [doi]']",epublish,PLoS One. 2016 May 3;11(5):e0154358. doi: 10.1371/journal.pone.0154358. eCollection 2016.,,20160503,,,['ORCID: 0000-0002-0172-0857'],,,,,,,,,,,,,,,
1251230,NLM,MEDLINE,19760427,20190702,0038-4348 (Print) 0038-4348 (Linking),69,2,1976 Feb,Current views on the management of obesity.,138-40,,"In the last five years, much information has been gathered about the efficacy of several technics for managing obesity. Hospitalization with fasting, surgery, drugs, weight reducing clubs, and behavior modification methods have proven efficacious for select groups of obese individuals. Methods of behavior modification appear to offer some of the most promising management technics, since results are good, and cost and discomfort to the patient are minimal.","['Malcolm, T']",['Malcolm T'],,['eng'],['Journal Article'],United States,South Med J,Southern medical journal,0404522,,IM,"['Behavior Therapy', 'Hospitalization', 'Humans', 'Obesity/drug therapy/etiology/surgery/*therapy', 'Self-Help Groups']",,,,,1976/02/01 00:00,1976/02/01 00:01,['1976/02/01 00:00'],"['1976/02/01 00:00 [pubmed]', '1976/02/01 00:01 [medline]', '1976/02/01 00:00 [entrez]']",['10.1097/00007611-197602000-00004 [doi]'],ppublish,South Med J. 1976 Feb;69(2):138-40. doi: 10.1097/00007611-197602000-00004.,,,,,,,,,,,,,,,,,,,,
11804445,NLM,MEDLINE,20020215,20061115,0002-838X (Print) 0002-838X (Linking),65,1,2002 Jan 1,Medical care for obese patients: advice for health care professionals.,81-8,,"More than 60 percent of adults in the United States are overweight or obese, and obese persons are more likely to be ill than those who are not. Obesity presents challenges to physicians and patients and also has a negative impact on health status. Some patients who are obese may delay medical care because of concerns about disparagement by physicians and health care staff, or fear of being weighed. Simple accommodations, such as providing large-sized examination gowns and armless chairs, as well as weighing patients in a private area, may make the medical setting more accessible and more comfortable for obese patients. Extremely obese patients often have special health needs, such as lower extremity edema or respiratory insufficiency that require targeted evaluation and treatment. Although physical examination may be more difficult in obese patients, their disproportionate risk for some illnesses that are amenable to early detection increases the priority for preventive evaluations. Physicians can encourage improvements in healthy behaviors, regardless of the patient's desire for, or success with, weight loss treatment.",,,,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Am Fam Physician,American family physician,1272646,,IM,"['Body Weight', 'Counseling', 'Humans', '*Obesity/complications/psychology', 'Obesity, Morbid', '*Physical Examination', 'Preventive Medicine']",,,,,2002/01/24 10:00,2002/02/16 10:01,['2002/01/24 10:00'],"['2002/01/24 10:00 [pubmed]', '2002/02/16 10:01 [medline]', '2002/01/24 10:00 [entrez]']",,ppublish,Am Fam Physician. 2002 Jan 1;65(1):81-8.,,,,,,,,,,['National Task Force on the Prevention and Treatment of Obesity.'],,,,,,,,,,
30683825,NLM,MEDLINE,20190218,20190219,1899-1505 (Electronic) 0867-5910 (Linking),69,5,2018 Oct,"The influence of orlistat, metformin and diet on serum levels of insulin-like growth factor-1 in obeses women with and without insulin resistance.",,10.26402/jpp.2018.5.08 [doi],"A range of studies showed confusing data about the relationship between obesity, weight reduction and circulating total insulin-like growth factor -1 (IGF-1). The aim of the study was to compare the influence of orlistat (IO), metformin (IM), or calorie-restricted diet (LC) on IGF-1, with special respect to insulin-resistance status. One hundred and fourteen obese women aged from 18 to 40 years were divided into insulin sensitive (IS) and insulin resistant (IR) groups and received a low calorie diet (LC), or an isocaloric diet and 500 mg metformin twice daily (IM), or isocaloric diet with 120 mg orlistat three times daily (IO). Before and after the intervention anthropometric parameters, serum lipid profile, serum concentrations of alanine aminotransferase, aspartate aminotransferase, insulin, glucose, IGF-1, HOMA-IR (homeostatic model assessment), and visceral adiposity index (VAI), and their changes were registered. Although the reductions in weight and body fat were comparable in IS and IR groups, only women with IR showed a significant increase in IGF-1 concentration as a result of all interventions. We found significant positive correlations of DeltaIGF-1 with initial and Delta values of: HOMA-IR, triglyceride/high-density cholesterol ratio, VAI. IR premenopausal women show significant increase in IGF-1 serum concentrations regardless the method of intervention. The increase in IGF-1 was parallel to the improvement of insulin resistance parameters.","['Kujawska-Luczak, M', 'Szulinska, M', 'Skrypnik, D', 'Musialik, K', 'Swora-Cwynar, E', 'Kregielska-Narozna, M', 'Markuszewski, L', 'Grzymislawska, M', 'Bogdanski, P']","['Kujawska-Luczak M', 'Szulinska M', 'Skrypnik D', 'Musialik K', 'Swora-Cwynar E', 'Kregielska-Narozna M', 'Markuszewski L', 'Grzymislawska M', 'Bogdanski P']","['Department of Internal Medicine, Metabolic Disorders, and Hypertension, Poznan University of Medical Sciences, Poznan, Poland.', 'Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Poznan, Poland.', 'Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Poznan, Poland. damian.skrypnik@gmail.com.', 'Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Poznan, Poland.', 'Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.', 'Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Poznan, Poland.', ""Department of Endocrinology and Metabolic Diseases, Polish Mother's Memorial Hospital Research Institute, Lodz, Poland."", 'Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, Poznan, Poland.', 'Department of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Poznan, Poland.']",['eng'],"['Journal Article', 'Randomized Controlled Trial']",Poland,J Physiol Pharmacol,Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,9114501,"['0 (Anti-Obesity Agents)', '0 (Hypoglycemic Agents)', '0 (IGF1 protein, human)', '67763-96-6 (Insulin-Like Growth Factor I)', '9100L32L2N (Metformin)', '95M8R751W8 (Orlistat)']",IM,"['Adult', 'Anti-Obesity Agents/*therapeutic use', '*Caloric Restriction', 'Diet', 'Female', 'Humans', 'Hypoglycemic Agents/*therapeutic use', '*Insulin Resistance', 'Insulin-Like Growth Factor I/*analysis', 'Intra-Abdominal Fat', 'Metformin/*therapeutic use', 'Obesity/blood/*therapy', 'Orlistat/*therapeutic use', 'Premenopause/blood']",,,,,2019/01/27 06:00,2019/02/20 06:00,['2019/01/27 06:00'],"['2018/08/28 00:00 [received]', '2018/10/30 00:00 [accepted]', '2019/01/27 06:00 [entrez]', '2019/01/27 06:00 [pubmed]', '2019/02/20 06:00 [medline]']",['10.26402/jpp.2018.5.08 [doi]'],ppublish,J Physiol Pharmacol. 2018 Oct;69(5). doi: 10.26402/jpp.2018.5.08. Epub 2019 Jan 21.,,20190121,,,,,,,,,,,,,,,,,,
10540896,NLM,MEDLINE,19991109,20131121,0030-6002 (Print) 0030-6002 (Linking),140,40,1999 Oct 3,[The combined effect of psychotherapy and fluoxetine on obesity].,2221-5,,"Obesity as psychosomatic disease is a mass phenomenon. The number of obese males (BMI > 30) became doubled in the last ten years. In the etiology of obesity play an important role the reactive obesity. In the background of ""yo-yo syndrome"" often could be found depression, or other psychotic disorder. The low self-esteem, body dissatisfaction, tension, anxiety disorders is well-known in a slimming diet. Obese subjects (n = 29) who were admitted on their request with a view to losing weight were examined (Hamilton Depressive Scala, Hamilton Anxietas Scala, Eating Attitude Test) Physical Conditioning and internal Medicine Department of National Sports Medicine Institute, Budapest. Among obesities with mild and severe depression as treatment of somatic complications was used fluoxetine, in severe cases and depression with severe anxiety was associated with supportive or cognitive-behavioral treatment. The prevalence of binge eating disorders were at 57% and bulimia nervosa was at 3% in using population (n = 29). Decreasing of anxiety and grade of depression significantly correlated with body mass index (p < 0.023, F = 1.997, p < 0.034, F = 3.131). The treatment of fluoxetine significantly correlated with body mass index (T1: p < 0.023, T2: p < 0.03, T3: p < 0.004). The patients indicated their well being as fluoxetine reduced eating, satiety and lower binges.","['Resch, M', 'Jako, P', 'Sido, Z', 'Haasz, P']","['Resch M', 'Jako P', 'Sido Z', 'Haasz P']","['IV. Pszichiatriai Osztaly, Jahn F. Del-pesti Korhaz, Budapest.']",['hun'],"['English Abstract', 'Journal Article']",Hungary,Orv Hetil,Orvosi hetilap,0376412,"['0 (Antidepressive Agents, Second-Generation)', '01K63SUP8D (Fluoxetine)']",IM,"['Adult', 'Aged', 'Antidepressive Agents, Second-Generation/*therapeutic use', 'Anxiety/etiology/therapy', 'Depression/etiology/therapy', 'Female', 'Fluoxetine/*therapeutic use', 'Humans', 'Male', 'Middle Aged', 'Obesity, Morbid/diet therapy/drug therapy/etiology/*psychology', '*Psychotherapy', 'Treatment Outcome']",,,,,1999/11/30 00:00,1999/11/30 00:01,['1999/11/30 00:00'],"['1999/11/30 00:00 [pubmed]', '1999/11/30 00:01 [medline]', '1999/11/30 00:00 [entrez]']",,ppublish,Orv Hetil. 1999 Oct 3;140(40):2221-5.,,,,,,,,,A pszichoterapia es a fluoxetin hatekonysaga obesitasban.,,,,,,,,,,,
13347357,NLM,MEDLINE,20030501,20181201,0025-4053 (Print) 0025-4053 (Linking),93,6,1956,[Experimental obesities and human obesity].,541-70,,,"['Vague, J', 'Benoit, M']","['Vague J', 'Benoit M']",,['fre'],['Journal Article'],France,Mars Med,Marseille medical,2985228R,,OM,"['Humans', 'Obesity/*etiology']",,['NLM'],['*OBESITY/etiology and pathogenesis'],,1956/01/01 00:00,1956/01/01 00:01,['1956/01/01 00:00'],"['1956/01/01 00:00 [pubmed]', '1956/01/01 00:01 [medline]', '1956/01/01 00:00 [entrez]']",,ppublish,Mars Med. 1956;93(6):541-70.,,,,,,,,,Obesites experimentales et obesites humaines.,,,,['CLML: 5630:55937'],,,,,,,
12270014,NLM,MEDLINE,20021127,20191106,0952-3871 (Print) 0952-3871 (Linking),15,5,2002 Oct,Dietitians' views of overweight and obese people and reported management practices.,331-47,,"OBJECTIVES: To examine dietitians' views of overweight and obese people, to explore the role of level of severity on these perceptions (overweight vs. obesity), and to explore the relationship between dietitians' views and their reported weight management practices. DESIGN: An independent measures survey, questioning dietitians about either overweight or obese people. PARTICIPANTS: One-hundred and eighty-seven members of the British Dietetic Association. MEASUREMENTS: A questionnaire exploring beliefs about the causes, attitudes, perceptions of responsibility and reported weight management practices. RESULTS: Physical inactivity was identified as an important causative factor for both overweight and obesity. Mood, eating too much of the wrong foods, repeated dieting and interpersonal factors were also seen as relatively important for both groups. Attitudes were mixed, but were generally neutral to positive. The most negative attitudes were described in terms of perceived reduced self-esteem, sexual attractiveness and health. Dietitians rated obese people more negatively than overweight people. They viewed both overweight and obese people as being responsible for their excess weight. They also reported very similar management practices for overweight and obese people. Beliefs about the causes of overweight explained more of the variance in practice than dietitians' attitudes towards or perceived responsibility of overweight and obese people. However, these associations were not consistent and strong, and other factors not investigated here are likely to have a greater influence on weight management practices.","['Harvey, E L', 'Summerbell, C D', 'Kirk, S F L', 'Hill, A J']","['Harvey EL', 'Summerbell CD', 'Kirk SF', 'Hill AJ']","['Centre for Research in Primary Care, Nuffield Institute, Leeds, UK. e.l.harvey@leeds.ac.uk']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,J Hum Nutr Diet,Journal of human nutrition and dietetics : the official journal of the British Dietetic Association,8904840,,IM,"['Affect', '*Attitude of Health Personnel', 'Diet', 'Diet, Reducing', '*Dietetics', 'Exercise', 'Humans', 'Obesity/etiology/psychology/*therapy', '*Perception', 'Surveys and Questionnaires']",,,,,2002/09/25 06:00,2002/11/28 04:00,['2002/09/25 06:00'],"['2002/09/25 06:00 [pubmed]', '2002/11/28 04:00 [medline]', '2002/09/25 06:00 [entrez]']","['385 [pii]', '10.1046/j.1365-277x.2002.00385.x [doi]']",ppublish,J Hum Nutr Diet. 2002 Oct;15(5):331-47. doi: 10.1046/j.1365-277x.2002.00385.x.,,,,,,,,,,,,,,,,,,,,
13658986,NLM,MEDLINE,20000701,20190619,0036-8075 (Print) 0036-8075 (Linking),129,3362,1959 Jun 5,Storage of steroid hormones by adipose tissue in two experimental obesities.,1546-7,,It appears that obese animals retain proportionally more steroid hormones than nonobese animals. The retention of these hormones does not appear to be a function of the nature of the obesity syndrome but simply a function of the increased fat content.,"['ZOMZELY, C', 'ASTI, R', 'MAYER, J']","['ZOMZELY C', 'ASTI R', 'MAYER J']",,['eng'],['Journal Article'],United States,Science,"Science (New York, N.Y.)",0404511,"['0 (Hormones)', '0 (Steroids)']",OM,"['Adipose Tissue/*metabolism', 'Animals', '*Hormones', '*Lipid Metabolism', '*Obesity', 'Steroids/*metabolism']",,['NLM'],"['*FATTY TISSUE/metabolism', '*OBESITY/experimental', '*STEROIDS/metabolism']",,1959/06/05 00:00,1959/06/05 00:01,['1959/06/05 00:00'],"['1959/06/05 00:00 [pubmed]', '1959/06/05 00:01 [medline]', '1959/06/05 00:00 [entrez]']",['10.1126/science.129.3362.1546 [doi]'],ppublish,Science. 1959 Jun 5;129(3362):1546-7. doi: 10.1126/science.129.3362.1546.,,,,,,,,,,,,,['CLML: 5936:32953:205:382:508'],,,,,,,
23306055,NLM,MEDLINE,20131119,20161125,1773-0430 (Electronic) 0150-9918 (Linking),42,3,2013 May,[Could we perform quality second trimester ultrasound among obese pregnant women?].,275-81,S0368-2315(12)00369-9 [pii] 10.1016/j.jgyn.2012.11.010 [doi],"OBJECTIVE: To compare the quality of second trimester ultrasound images and their anatomical quality scores among obese women and those with a normal body mass index (BMI). MATERIALS AND METHODS: This prospective study, which took place from 2009 to 2011, included every obese pregnant woman (prepregnancy BMI greater than 30 kg/m(2)) who had an ultrasound examination at 20 to 24 weeks in our hospital and a control group with a normal BMI (20-24.9kg/m(2)) who had the same examination. A single operator evaluated the quality of all images, reviewing the standardized ultrasound planes - three biometric and six anatomical - required by French guidelines and scoring the quality of the six anatomical images. Each image was assessed according to 4-6 criteria, each worth one point. We sought excellent quality, defined as the frequency of maximum points for a given image. RESULTS: The obese group included 223 women and the control group 60. The completion rate for each image was at least 95 % in the control group and 90 % in the obese group, except for diaphragm and right outflow tract images. Overall, the excellence rate varied from 35 % to 92 % in the normal BMI group and 18 % to 58 % in the obese group and was significantly lower in the latter for all images except abdominal circumference (P=0.26) and the spine (P=0.06). Anatomical quality scores were also significantly lower in the obese group (22.3 vs. 27.2 ; P=0.001). CONCLUSION: Image quality and global anatomical scores in second trimester ultrasound scans were significantly lower among obese than normal-weight women.","['Fuchs, F', 'Voulgaropoulos, A', 'Houllier, M', 'Senat, M-V']","['Fuchs F', 'Voulgaropoulos A', 'Houllier M', 'Senat MV']","['Service de gynecologie obstetrique, hopital Bicetre, assistance publique hopitaux de Paris (AP-HP), 78, rue du General-Leclerc, 94275 Le Kremlin-Bicetre, France. florent.fuchs@bct.aphp.fr']",['fre'],['Journal Article'],France,J Gynecol Obstet Biol Reprod (Paris),"Journal de gynecologie, obstetrique et biologie de la reproduction",0322206,,IM,"['Adult', 'Case-Control Studies', 'Female', 'Follow-Up Studies', 'Humans', 'Middle Aged', 'Obesity/*diagnostic imaging/epidemiology', 'Pregnancy', 'Pregnancy Complications/*diagnostic imaging/epidemiology', '*Pregnancy Trimester, Second/physiology', 'Quality Control', 'Ultrasonography, Prenatal/methods/*standards']",,,,,2013/01/12 06:00,2013/11/20 06:00,['2013/01/12 06:00'],"['2012/10/11 00:00 [received]', '2012/11/15 00:00 [revised]', '2012/11/26 00:00 [accepted]', '2013/01/12 06:00 [entrez]', '2013/01/12 06:00 [pubmed]', '2013/11/20 06:00 [medline]']","['S0368-2315(12)00369-9 [pii]', '10.1016/j.jgyn.2012.11.010 [doi]']",ppublish,J Gynecol Obstet Biol Reprod (Paris). 2013 May;42(3):275-81. doi: 10.1016/j.jgyn.2012.11.010. Epub 2013 Jan 8.,,20130108,,['Copyright (c) 2012 Elsevier Masson SAS. All rights reserved.'],,,,,Peut-on faire des echographies obstetricales de qualite chez les patientes obeses ? Etude monocentrique sur 30 mois.,,,,,,,,,,,
21475009,NLM,MEDLINE,20110627,20220311,1528-1140 (Electronic) 0003-4932 (Linking),253,4,2011 Apr,Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35.,699-703,10.1097/SLA.0b013e318203ae44 [doi],"OBJECTIVE: Biliopancreatic diversion (BPD) resolves type 2 diabetes in near totality of morbidly obeses [BMI (body mass index) >/=35 kg/m]. However, studies of BPD effect in BMI range 25.0 to 34.9 kg/m, including about 90% of diabetic patients, are lacking. MATERIALS AND METHODS: If BPD effects are independent of weight changes, they should be maintained in patients who, being mildly obese or overweight, will lose little or no weight after operation. Thirty type 2 diabetic patients with BMI 25 to 34.9 were submitted to BPD and monitored 12 months. Thirty-eight diabetic patients selected from a large database, kept 1 year on medical therapy, served as controls. RESULTS: Nineteen male and 11 female. Mean age 56.4 +/- 7.4 years, weight 84.8 +/- 11.1 kg, BMI 30.6 +/- 2.9 kg/m, waist circumference 104 +/- 9.4 cm, diabetes duration 11.2 +/- 6.9 years, HbA1c 9.3+/-1.5. Twelve patients on insulin. Fifteen (2 F) with BMI < 30 (mean: 28.1). No mortality or major adverse events occurred. BMI progressively decreased, stabilizing around 25 since the fourth month, without excessive weight loss. One year after BPD, mean HbA1c was 6.3%+/-0.8, with 25 patients (83%) controlled (HbA1c</=7%) on free diet, without antidiabetics, and the remaining improved. Acute insulin response to intravenous glucose had increased from 1.2 +/- 2.9 to 4.2 +/- 4.4 muIU/mL. Diabetes resolution correlated positively with BMI. HbA1c decreased at 1 year in the control group, along with an overall increased amount of antidiabetic therapy. CONCLUSIONS: BPD improves or resolves diabetes in BMI 25 to 35 without causing excessive weight loss, its action being on insulin sensitivity and beta-cell function. The strikingly different response between morbidly obese and low BMI patients might depend on different beta-cell defect. ClinicalTrials.gov Identifier: NCT00996294.","['Scopinaro, Nicola', 'Adami, Giovanni F', 'Papadia, Francesco S', 'Camerini, Giovanni', 'Carlini, Flavia', 'Fried, Martin', 'Briatore, Lucia', ""D'Alessandro, Gabriele"", 'Andraghetti, Gabriella', 'Cordera, Renzo']","['Scopinaro N', 'Adami GF', 'Papadia FS', 'Camerini G', 'Carlini F', 'Fried M', 'Briatore L', ""D'Alessandro G"", 'Andraghetti G', 'Cordera R']","['Department of Surgery, University of Genoa, Italy. nicola.scopinaro@unige.it']",['eng'],['Journal Article'],United States,Ann Surg,Annals of surgery,0372354,"['0 (Blood Glucose)', '0 (Hypoglycemic Agents)']",IM,"['Adult', 'Aged', 'Biliopancreatic Diversion/adverse effects/*methods', 'Blood Glucose/metabolism', '*Body Mass Index', 'Case-Control Studies', 'Diabetes Mellitus, Type 2/complications/drug therapy/*surgery', 'Female', 'Follow-Up Studies', 'Humans', 'Hypoglycemic Agents/therapeutic use', 'Male', 'Middle Aged', 'Obesity/complications/diagnosis/*surgery', 'Postoperative Complications/physiopathology', 'Preoperative Care/methods', 'Reference Values', 'Risk Assessment', 'Treatment Outcome', '*Weight Loss']",,,,,2011/04/09 06:00,2011/06/28 06:00,['2011/04/09 06:00'],"['2011/04/09 06:00 [entrez]', '2011/04/09 06:00 [pubmed]', '2011/06/28 06:00 [medline]']","['00000658-201104000-00010 [pii]', '10.1097/SLA.0b013e318203ae44 [doi]']",ppublish,Ann Surg. 2011 Apr;253(4):699-703. doi: 10.1097/SLA.0b013e318203ae44.,,,,,,,,,,,,['ClinicalTrials.gov/NCT00996294'],,,,,,,,
11346661,NLM,MEDLINE,20010920,20221207,1071-7323 (Print) 1071-7323 (Linking),9,1,2001 Jan,Hypertension and type 2 diabetes comorbidity in adults in the United States: risk of overall and regional adiposity.,1-9,,"OBJECTIVE: To evaluate the impact of generalized, abdominal, and truncal fat deposits on the risk of hypertension and/or diabetes and to determine whether ethnic differences in these fat patterns are independently associated with increased risk for the hypertension-diabetes comorbidity (HDC). RESEARCH METHODS AND PROCEDURES: Data (n = 7075) from the Third U.S. National Health and Nutrition Examination Survey were used for this investigation. To assess risks of hypertension and/or diabetes that were due to different fat patterns, odds ratios of men and women with various cut-points of adiposities were compared with normal subjects in logistic regression models, adjusting for age, smoking, and alcohol intake. To evaluate the contribution of ethnic differences in obesity to the risks of HDC, we compared blacks and Hispanics with whites. RESULTS: Generalized and abdominal obesities were independently associated with increased risk of hypertension, diabetes and HDC in white, black, and Hispanic men and women. The risk of HDC due to generalized, truncal, and abdominal obesities tended to be higher in whites than blacks and Hispanics. In men, the contribution of black and Hispanic ethnicities to the increased risk of HDC due to the various obesity phenotypes was approximately 73% and approximately 61%, respectively. The corresponding values for black and Hispanic women were approximately 115% and approximately 125%, respectively. CONCLUSIONS: In addition to advocating behavioral lifestyles to curb the epidemic of obesity among at-risk populations in the United States, there is also the need for primary health care practitioners to craft their advice to the degree and type of obesity in these at-risk groups.","['Okosun, I S', 'Chandra, K M', 'Choi, S', 'Christman, J', 'Dever, G E', 'Prewitt, T E']","['Okosun IS', 'Chandra KM', 'Choi S', 'Christman J', 'Dever GE', 'Prewitt TE']","['Department of Community Medicine, Mercer University School of Medicine, Macon, Georgia 31207, USA. okosun_i@mercer.edu']",['eng'],"['Comparative Study', 'Journal Article']",United States,Obes Res,Obesity research,9305691,,IM,"['Adipose Tissue/*anatomy & histology', 'Adult', 'Black or African American', 'Aged', 'Body Mass Index', 'Comorbidity', 'Diabetes Mellitus/*epidemiology/ethnology', 'Diabetes Mellitus, Type 2/*epidemiology/ethnology', 'Female', 'Hispanic or Latino', 'Humans', 'Hypertension/*epidemiology/ethnology', 'Male', 'Middle Aged', 'Nutrition Surveys', 'Obesity/*complications/epidemiology/ethnology', 'Odds Ratio', 'Phenotype', 'Regression Analysis', 'Risk Factors', 'Skinfold Thickness', 'United States/epidemiology', 'White People']",,,,,2001/05/11 10:00,2001/09/21 10:01,['2001/05/11 10:00'],"['2001/05/11 10:00 [pubmed]', '2001/09/21 10:01 [medline]', '2001/05/11 10:00 [entrez]']",['10.1038/oby.2001.1 [doi]'],ppublish,Obes Res. 2001 Jan;9(1):1-9. doi: 10.1038/oby.2001.1.,,,,,,,,,,,,,,,,,,,,
5308369,NLM,MEDLINE,19700302,20130101,0021-7654 (Print) 0021-7654 (Linking),23,1,1968 Jan-Feb,[Rheumatism in severe obesity patients].,33-46,,,"['Francon, F', 'Fabre, M']","['Francon F', 'Fabre M']",,['fre'],['Journal Article'],Belgium,J Belge Rhumatol Med Phys,Journal belge de rhumatologie et de medecine physique = Belgisch tijdschrift voor reumatologie en fysische geneeskunde,0071414,,IM,"['Aged', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications', 'Rheumatic Diseases/*etiology']",,,,,1968/01/01 00:00,1968/01/01 00:01,['1968/01/01 00:00'],"['1968/01/01 00:00 [pubmed]', '1968/01/01 00:01 [medline]', '1968/01/01 00:00 [entrez]']",,ppublish,J Belge Rhumatol Med Phys. 1968 Jan-Feb;23(1):33-46.,,,,,,,,,Contribution a l'etude des rhumatismes chez les grands obeses.,,,,,,,,,,,
10726195,NLM,MEDLINE,20000413,20190915,0300-2896 (Print) 0300-2896 (Linking),36,2,2000 Feb,[The evaluation of the efficacy of a multidisciplinary treatment in a group of obese patients with a BMI > or = 35 and a change in lung function].,77-83,,"OBJECTIVE: To assess the efficacy of an interdisciplinary protocol for treating obesity in a group of patients with BMI > or = 35 and with altered respiratory function that was not necessarily related to obesity or not. PATIENTS AND METHOD: Forty obese individuals between 18 and 60 years of age with altered respiratory function were enrolled. Spirometric values, plethysmograph volumes, arterial blood gases, and nighttime respiratory polygraphs were recorded. Following psychological and nutritional evaluation, the patients commenced year-long treatment for obesity involving a personalized diet and psychological counseling. Follow-up was weekly and individualized at first; in later sessions, patients were grouped. Lung function tests were repeated after loss of 5 kg. Sleep polygraphy was repeated after loss of 10 kg. RESULTS: Weight loss over 15 kg was achieved by 48.6% of the patients. Respiratory function variables: FVC, FEV1, RV, ERV, PaO2 and SatO2 after treatment changed significantly from initial levels. Significant differences were also seen in the severity of sleep apnea and pressures needed for continuous positive airway pressure. Uric acid, glucose and triglyceride blood levels became normal in 89%, 61% and 50% of the patients, respectively, after weight loss. No characteristic psychological profile was identified for severe obesity, although levels of anxiety, eating behavior, marital adjustment and perception of body image were aspects that were fundamentally altered. CONCLUSIONS: In the difficult group of obese patients with BMI > or = 35, interdisciplinary treatment has proven effective for achieving substantial weight loss, while improving respiratory function and severity of sleep disorder. This therapy, which is at present viable for few centers, deserves consideration in the interest of benefiting the increasing number of obese patients.","['Luque, R', 'Berdejo, R', 'Elbusto, A', 'Arrazola, X', 'Royo, I', 'Salegi, I', 'del Campo, L', 'de la Torre, P']","['Luque R', 'Berdejo R', 'Elbusto A', 'Arrazola X', 'Royo I', 'Salegi I', 'del Campo L', 'de la Torre P']","['Servicio de Neumologia, Hospital Aranzazu, Donostia.']",['spa'],"['Comparative Study', 'English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",Spain,Arch Bronconeumol,Archivos de bronconeumologia,0354720,,IM,"['Adult', '*Body Mass Index', 'Combined Modality Therapy', 'Female', 'Humans', 'Lung/*physiopathology', 'Male', 'Middle Aged', 'Obesity/diagnosis/pathology/physiopathology/*therapy', '*Patient Care Team/statistics & numerical data', 'Psychopathology', 'Weight Loss']",,,,,2000/03/22 09:00,2000/04/15 09:00,['2000/03/22 09:00'],"['2000/03/22 09:00 [pubmed]', '2000/04/15 09:00 [medline]', '2000/03/22 09:00 [entrez]']","['S0300-2896(15)30212-X [pii]', '10.1016/s0300-2896(15)30212-x [doi]']",ppublish,Arch Bronconeumol. 2000 Feb;36(2):77-83. doi: 10.1016/s0300-2896(15)30212-x.,,,,,,,,,Valoracion de la eficacia de un tratamiento multidisciplinario en un grupo de pacientes obesos con IMC > o = 35 y alteracion de la funcion pulmonar.,,,,,,,,,,,
6363496,NLM,MEDLINE,19840229,20190908,0165-1838 (Print) 0165-1838 (Linking),9,1,1983 Oct,The origins and role of efferent vagal nuclei in hyperinsulinemia in hypothalamic and genetically obese rodents.,173-84,,"The main brainstem parasympathetic efferent neurons that ultimately reach the pancreas and facilitate insulin secretion are located in the nucleus ambiguus (NA) and the dorsal motor nucleus of the vagus nerve (DMX). With regard to insulin secretion, hypothalamic (produced by ventromedial hypothalamic (VMH) lesions) and genetic obesities have features in common: (a) insulin oversecretion is an early abnormality in both syndromes; and (b) this abnormality is vagus nerve-mediated. VMH lesions and possible, spontaneously occurring (i.e. genetic) CNS-located abnormalities appear to result in an increased parasympathetic efferent tone together with decreased sympathetic efferent tone that is likely to be responsible for the occurrence of hyperinsulinemia, obesity and, eventually, insulin resistance.","['Rohner-Jeanrenaud, F', 'Ionescu, E', 'Jeanrenaud, B']","['Rohner-Jeanrenaud F', 'Ionescu E', 'Jeanrenaud B']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Netherlands,J Auton Nerv Syst,Journal of the autonomic nervous system,8003419,['0 (Insulin)'],IM,"['Animals', 'Efferent Pathways/physiopathology', 'Hypothalamus/*physiology', 'Insulin/*blood/metabolism', 'Insulin Secretion', 'Obesity/blood/genetics/metabolism/*physiopathology', 'Parasympathetic Nervous System/physiology', 'Rats/genetics', 'Vagus Nerve/*physiopathology']",,,,,1983/10/01 00:00,1983/10/01 00:01,['1983/10/01 00:00'],"['1983/10/01 00:00 [pubmed]', '1983/10/01 00:01 [medline]', '1983/10/01 00:00 [entrez]']","['0165-1838(83)90139-X [pii]', '10.1016/0165-1838(83)90139-x [doi]']",ppublish,J Auton Nerv Syst. 1983 Oct;9(1):173-84. doi: 10.1016/0165-1838(83)90139-x.,,,,,,,,,,,,,,,,,,,,
20076867,NLM,MEDLINE,20100525,20191111,1809-4546 (Electronic) 0100-6991 (Linking),36,1,2009 Feb,[Changes the sexual quality of life of the obeses submitted Fobi-Capella gastroplasty surgery].,42-8,S0100-69912009000100009 [pii],"OBJECTIVES: Examine changes in the quality of sexual life of men with morbid obesity offered by a reduction in body weight following Fobi-Capella gastroplasty. METHOD: A quantitative, prospective, longitudinal, cross-sectional study was carried out on 21 men with morbid obesity between March 2005 and March 2007. Inclusion criteria were: aged 20 to 50 years, body mass index (BMI) = 40 kg/m(2) and failure in attempts of clinical treatment for obesity in the previous two years. Data collection from clinical records and the administering of a specific questionnaire on issues relating to sexual function was performed prior to and six months following surgery. Scores were analyzed with the help of the Epi-Info 6 program, using the Student's t-test for paired samples. RESULTS: The total score increased at the six-month post operative in 76.19%; remained unaltered in 14.29%; and decreased in 9.52%. Scores in areas related to erectile function and sexual relations increased in 71.42%; sexual desire increased in 52.38%; and orgasms increased in 28.57%. General sexual satisfaction increased in 57.14%. The average total score and scores on the domains of the questionnaire prior to and six months following surgery revealed statistically significant differences, except those relating to sexual desire and orgasm. CONCLUSION: The quality of sexual life in morbid obese men improves following Fobi-Capella surgery. Favorable changes occurred in sexual function after these individuals underwent this type of bariatric surgery.","['Araujo, Araken Almeida de', 'Brito, Ana Maria de', 'Ferreira, Moacir de Novaes Lima', 'Petribu, Katia', 'Mariano, Maria Helena de Araujo']","['Araujo AA', 'Brito AM', 'Ferreira Mde N', 'Petribu K', 'Mariano MH']","['Departamento de Cirurgia, Faculdade de Ciencias Medicas, Universidade de Pernambuco, PE, BR. arakenaa@elogica.com.br']",['por'],"['English Abstract', 'Journal Article']",Brazil,Rev Col Bras Cir,Revista do Colegio Brasileiro de Cirurgioes,7809515,,IM,"['Adult', 'Cross-Sectional Studies', 'Gastroplasty/*methods', 'Humans', 'Male', 'Obesity/*surgery', 'Prospective Studies', '*Quality of Life', '*Sexuality', 'Surveys and Questionnaires']",,,,,2010/01/16 06:00,2010/05/26 06:00,['2010/01/16 06:00'],"['2008/08/08 00:00 [received]', '2008/10/08 00:00 [accepted]', '2010/01/16 06:00 [entrez]', '2010/01/16 06:00 [pubmed]', '2010/05/26 06:00 [medline]']","['S0100-69912009000100009 [pii]', '10.1590/s0100-69912009000100009 [doi]']",ppublish,Rev Col Bras Cir. 2009 Feb;36(1):42-8. doi: 10.1590/s0100-69912009000100009.,,,,,,,,,Modificacoes da qualidade de vida sexual de obesos submetidos a cirurgia de Fobi-Capella.,,,,,,,,,,,
28721709,NLM,MEDLINE,20180426,20180426,1660-9379 (Print) 1660-9379 (Linking),13,555,2017 Mar 22,[Paradoxal decrease and metabolic effects of BNP in obese patient].,660-663,,"Natriuretic peptides (NP), ANP and BNP, are produced by cardiomyocytes when there is stretching of the ventricular and auricular walls in heart failure (HF). Their vasodilatator and natriuretic effect oppose to volume and pressure overload occurring in HF. Several studies have observed decreased levels of NP in obese and diabetic people and in patients with insulin resistance. This decrease could contribute to hypertension, frequently observed in obesity. NP have also a lipolytic action. Low levels of NP could promote obesity. Therefore in obese patients normal BNP levels cannot a priori exclude HF. Normal values must be adjusted according to obesity degree and heart failure stage.","['Martin-Du-Pan, Remy C', 'Golay, Alain']","['Martin-Du-Pan RC', 'Golay A']","['Specialiste FMH-Medecine interne-endocrinologie, 47 chemin Sur-Rang, 1234 Vessy.', ""Service d'enseignement therapeutique pour maladies chroniques, Centre collaborateur de l'OMS, Departement de medecine communautaire, de premier recours et des urgences, HUG et Universite de Geneve, 1211 Geneve 14.""]",['fre'],['Journal Article'],Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,"['114471-18-0 (Natriuretic Peptide, Brain)']",IM,"['Diabetes Mellitus/metabolism', 'Heart Failure/metabolism/physiopathology', 'Humans', 'Hypertension/epidemiology/*etiology', 'Insulin Resistance', 'Natriuretic Peptide, Brain/*metabolism', 'Obesity/*metabolism/physiopathology']",,,,"[""Les auteurs n'ont declare aucun conflit d'interets en relation avec cet article.""]",2017/07/20 06:00,2018/04/27 06:00,['2017/07/20 06:00'],"['2017/07/20 06:00 [entrez]', '2017/07/20 06:00 [pubmed]', '2018/04/27 06:00 [medline]']",,ppublish,Rev Med Suisse. 2017 Mar 22;13(555):660-663.,,,,,,,,,Baisse paradoxale et effet metabolique du BNP chez les obeses.,,,,,,,,,,,
6988768,NLM,MEDLINE,19800616,20161123,0369-8114 (Print) 0369-8114 (Linking),28,3,1980 Mar,[Mechanical effects of obesity on lung function (author's transl)].,149-54,,"Spirometry, blood gases, steady state diffusing lung capacity for carbon monoxyde, ductance for carbon monoxyde were determined in 27 obeses. In 13 of them we also measured closing volume. In 80 per cent of these patients we observed a decrease in expiratory reserve volume certainly due to a shift on the right of the chest wall volume-pressure curve. In 50% of the obeses we found an arterial hypoxia, usually observed when the expiratory level was lower than closing volume. Finally in 20% of the subjects we observed a decrease in diffusing lung capacity and/or ductances probably due to an important fall in and expiratory level at the closing volume level with impairment of the distribution of ventilation.","['Prefaut, C', 'Ramonatxo, M', 'Monnier, L', 'Mirouze, J', 'Chardon, G']","['Prefaut C', 'Ramonatxo M', 'Monnier L', 'Mirouze J', 'Chardon G']",,['fre'],['Journal Article'],France,Pathol Biol (Paris),Pathologie-biologie,0265365,['7U1EE4V452 (Carbon Monoxide)'],IM,"['Adolescent', 'Adult', 'Aged', 'Blood Gas Analysis', 'Carbon Monoxide', 'Female', 'Humans', 'Hypoxia/complications', 'Lung Volume Measurements', 'Male', 'Middle Aged', 'Obesity/blood/complications/*physiopathology', 'Pulmonary Diffusing Capacity', '*Respiration', 'Respiratory Function Tests', 'Spirometry']",,,,,1980/03/01 00:00,1980/03/01 00:01,['1980/03/01 00:00'],"['1980/03/01 00:00 [pubmed]', '1980/03/01 00:01 [medline]', '1980/03/01 00:00 [entrez]']",,ppublish,Pathol Biol (Paris). 1980 Mar;28(3):149-54.,,,,,,,,,Retentissement mecanique de l'obesite sur la fonction respiratoire.,,,,,,,,,,,
3095255,NLM,MEDLINE,19861212,20140603,,10,4,1986,Effect of soya saponins on gold thioglucose (GTG)-induced obesity in mice.,293-302,,"The effect of oral administration of total soya saponins (TS) on the development of obesity induced by (GTG) injection was examined. In the GTG-obese group, the serum immunoreactive insulin (IRI) levels were significantly increased and food consumption was suggestively increased. In addition, sucrase activity in the intestinal mucosa was increased and the surface area of intestinal villi was significantly greater, suggesting enhanced gastrointestinal function. Oral administration of TS prevented development of obesity and prevented an increased level of IRI in GTG-obese animals. It also restored the sucrase activity and the surface area of intestinal villi to normal. Thus, TS may be effective in preventing development of obesity.","['Kawano-Takahashi, Y', 'Ohminami, H', 'Okuda, H', 'Kitagawa, I', 'Yoshikawa, M', 'Arichi, S', 'Hayashi, T']","['Kawano-Takahashi Y', 'Ohminami H', 'Okuda H', 'Kitagawa I', 'Yoshikawa M', 'Arichi S', 'Hayashi T']",,['eng'],['Journal Article'],England,Int J Obes,International journal of obesity,7703240,"['0 (Saponins)', '2P2V9Q0E78 (Aurothioglucose)']",IM,"['Animals', 'Aurothioglucose', 'Female', 'Mice', 'Mice, Inbred ICR', 'Mice, Obese', 'Obesity/chemically induced/metabolism/*prevention & control', 'Saponins/*pharmacology', '*Soybeans']",,,,,1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1986;10(4):293-302.,,,,,,,,,,,,,,,,,,,,
17079587,NLM,MEDLINE,20061114,20220318,1098-4275 (Electronic) 0031-4005 (Linking),118,5,2006 Nov,"Exercise therapy as a treatment for psychopathologic conditions in obese and morbidly obese adolescents: a randomized, controlled trial.",2126-34,,"OBJECTIVE: We conducted a proof-of-concept, randomized, controlled trial to investigate the effects of a supervised exercise therapy intervention on psychopathologic outcomes in obese adolescents. METHODS: The participant sample consisted of 81 adolescents (age: 11-16 years) who had been referred to a children's hospital for evaluation of obesity or who responded to a community advertisement. Participants were assigned randomly to exercise therapy, an equal-contact exercise placebo intervention, or usual care. Intervention participants attended 3 one-on-one sessions per week for 8 weeks and then completed a home program for another 6 weeks. Outcomes included self-perceptions (self-esteem), depression, affect, physical activity, aerobic fitness, and BMI. RESULTS: A total of 18 of 81 participants were categorized as morbidly obese (BMI SD score: > 3.5; adult equivalent BMI: > or = 40). At baseline, 30.3% of participants had a Children's Depression Inventory score of > or = 13, and 27% reported recent suicidal ideation. Repeated-measures mixed analysis of covariance (controlling for baseline scores) revealed significant changes in physical self-worth, associated measures of self-esteem, and physical activity over time, consistently favoring exercise therapy. There were no significant changes in BMI. CONCLUSIONS: Findings confirmed psychopathologic conditions as a serious health concern in obese and morbidly obese adolescents. Our study is the first randomized, controlled trial to demonstrate that a brief supervised exercise therapy intervention has the potential to improve psychopathologic outcomes significantly and to increase physical activity in obese adolescents, relative to usual care.","['Daley, Amanda J', 'Copeland, Robert J', 'Wright, Neil P', 'Roalfe, Andrea', 'Wales, Jerry K H']","['Daley AJ', 'Copeland RJ', 'Wright NP', 'Roalfe A', 'Wales JK']","['Department of Primary Care and General Practice, University of Birmingham, Clinical Sciences Building, Birmingham, B15 2TT, United Kingdom. a.daley@bham.ac.uk']",['eng'],"['Journal Article', 'Randomized Controlled Trial', ""Research Support, Non-U.S. Gov't""]",United States,Pediatrics,Pediatrics,0376422,,IM,"['Adolescent', 'Child', '*Exercise Therapy', 'Female', 'Humans', 'Male', 'Mental Disorders/etiology/therapy', 'Obesity/complications/*psychology/*therapy', 'Obesity, Morbid/complications/psychology/therapy']",,,,,2006/11/03 09:00,2006/11/15 09:00,['2006/11/03 09:00'],"['2006/11/03 09:00 [pubmed]', '2006/11/15 09:00 [medline]', '2006/11/03 09:00 [entrez]']","['118/5/2126 [pii]', '10.1542/peds.2006-1285 [doi]']",ppublish,Pediatrics. 2006 Nov;118(5):2126-34. doi: 10.1542/peds.2006-1285.,,,,,,,,,,,,,,,,,,,,
17873317,NLM,MEDLINE,20071018,20191110,1355-008X (Print) 1355-008X (Linking),31,2,2007 Apr,The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses.,93-9,,"Type 2 diabetes mellitus (T2DM) is a heterogeneous disorder characterized by defects in insulin secretion and action and obesity plays an important role in the deterioration of glucose metabolism. In the present study we evaluated the degree of insulin resistance and first-phase insulin secretion of beta-cell in obese subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and T2DM in Chinese. A total of 220 subjects underwent standard 75 g oral glucose tolerance test (OGTT) and insulin-modified frequently sampled intravenous glucose tolerance test (FSIGT). Insulin sensitivity index (S I) was assessed by the reduced sample number (n = 12) of Bergman's minimal model method with FSIGT. Insulin secretion capacities were determined by the insulinogenic index (I 30 min - I 0 min)/(G 30 min - G 0 min) in OGTT and the acute insulin response to glucose (AIR) in FSIGT. The disposition index (DI), the product of AIR and S I was used to determine whether AIR was adequate to compensate for insulin resistance. The S I in healthy lean control group was significantly higher than that in NGT, IGT, and T2DM group, but there was no significant difference among NGT, IGT, and T2DM group. The AIR in NGT group was significantly greater than that in control group, but then it was progressively decreased in IGT and T2DM group. The value of DI in control group was significantly higher than that in those three abnormal groups, and was decreased from NGT to IGT and T2DM group with significant difference. It indicates that obese subjects with different glucose tolerances have a similar degree of insulin resistance but differ in insulin secretion in Chinese Han population.","['Hong, Jie', 'Gu, Wei-Qiong', 'Zhang, Yi-Fei', 'Yang, Yi-Sheng', 'Shen, Chun-Fang', 'Xu, Min', 'Li, Xiao-Ying', 'Wang, Wei-Qing', 'Ning, Guang']","['Hong J', 'Gu WQ', 'Zhang YF', 'Yang YS', 'Shen CF', 'Xu M', 'Li XY', 'Wang WQ', 'Ning G']","['Department of Endocrinology and Metabolism, Shanghai Institute of Endocrine and Metabolic Diseases, Rui-Jin Hospital, Shanghai Jiaotong University School of Medicine, Ruijin 2nd Road, Shanghai, 200025, PR China.']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Endocrine,Endocrine,9434444,"['0 (Blood Glucose)', '0 (Insulin)']",IM,"['Adult', 'Aged', 'Blood Glucose/analysis', 'Case-Control Studies', 'China', 'Diabetes Mellitus, Type 2/blood/*etiology/pathology', 'Female', 'Glucose Tolerance Test', 'Humans', 'Insulin/blood/metabolism', '*Insulin Resistance', 'Insulin Secretion', 'Insulin-Secreting Cells/*pathology', 'Male', 'Middle Aged', 'Obesity/blood/*complications/pathology']",,,,,2007/09/18 09:00,2007/10/19 09:00,['2007/09/18 09:00'],"['1999/11/30 00:00 [received]', '1999/11/30 00:00 [revised]', '1999/11/30 00:00 [accepted]', '2007/09/18 09:00 [pubmed]', '2007/10/19 09:00 [medline]', '2007/09/18 09:00 [entrez]']","['ENDO:31:2:93 [pii]', '10.1007/s12020-007-0002-2 [doi]']",ppublish,Endocrine. 2007 Apr;31(2):93-9. doi: 10.1007/s12020-007-0002-2.,,,,,,,,,,,,,,,,,,,,
25130342,NLM,MEDLINE,20151019,20161125,2157-1740 (Electronic) 2157-1740 (Linking),4,2,2014 Summer,My story: evolving obesities.,96-8,10.1353/nib.2014.0046 [doi],,,,,['eng'],['Journal Article'],United States,Narrat Inq Bioeth,Narrative inquiry in bioethics,101603418,,IM,"['Aged', 'Body Image/*psychology', 'Body Mass Index', 'Diet, Reducing', 'Exercise/physiology', 'Feeding Behavior/*psychology', 'Female', 'Humans', 'Life Style', 'Narration', 'Obesity/diagnosis/*psychology/*therapy', 'Quality of Life', 'Self Concept', 'Weight Loss/physiology']",,,,,2014/08/19 06:00,2015/10/20 06:00,['2014/08/19 06:00'],"['2014/08/19 06:00 [entrez]', '2014/08/19 06:00 [pubmed]', '2015/10/20 06:00 [medline]']","['S2157174014200066 [pii]', '10.1353/nib.2014.0046 [doi]']",ppublish,Narrat Inq Bioeth. 2014 Summer;4(2):96-8. doi: 10.1353/nib.2014.0046.,,,,,,,,,,['Anonymous One'],,,,,,,,,,
2125883,NLM,MEDLINE,19910306,20161020,1000-0607 (Print) 1000-0607 (Linking),15,3,1990,[Effect of acupuncture and moxibustion on the high density lipoprotein cholesterol in simple obesity].,227-31,,"For the purpose of understanding regulatory effect of acupuncture and moxibustion, we have observed the changes of the obese indices and the lipid indices in 196 sample obesities before and after the acupuncture and moxibustion. The results showed that a good therapeutic effect of acupuncture and moxibustion on obesity was obtained. At the same time, there are the benign regulatory effect of acupuncture and moxibustion on the lipid metabolism and high density lipoprotein cholesterol.","['Liu, Z']",['Liu Z'],"['Dept. of Acupuncture & Moxibustion, Nanjing College of T.C.M.']",['chi'],"['English Abstract', 'Journal Article']",China,Zhen Ci Yan Jiu,Zhen ci yan jiu = Acupuncture research,8507710,"['0 (Cholesterol, HDL)']",IM,"['Acupuncture Points', '*Acupuncture Therapy', 'Adolescent', 'Adult', 'Cholesterol, HDL/*blood', 'Ear, External', 'Female', 'Humans', 'Male', 'Middle Aged', '*Moxibustion', 'Obesity/blood/*therapy', 'Pressure', 'Seeds']",,,,,1990/01/01 00:00,1990/01/01 00:01,['1990/01/01 00:00'],"['1990/01/01 00:00 [pubmed]', '1990/01/01 00:01 [medline]', '1990/01/01 00:00 [entrez]']",,ppublish,Zhen Ci Yan Jiu. 1990;15(3):227-31.,,,,,,,,,,,,,,,,,,,,
18640006,NLM,MEDLINE,20090129,20220316,0899-9007 (Print) 0899-9007 (Linking),24,11-12,2008 Nov-Dec,High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.,1097-102,10.1016/j.nut.2008.05.017 [doi],"OBJECTIVE: We correlated dietary profile and markers of visceral and somatic obesities in non-alcoholic fatty liver disease. METHODS: Patients with histologically proven fatty infiltration of the liver (n = 25, 52 +/- 11 y of age, 64% women) underwent abdominal computed tomography, bioelectrical impedance, and anthropometric measurements. Insulin resistance was evaluated (homeostasis model assessment) and dietary intake of macronutrients was estimated by 24-h recall. Main outcome measurements were correlation of carbohydrate and fat ingestion with liver histology. RESULTS: Metabolic syndrome was present in 72% of the population, and increased waist circumference and low high-density lipoprotein cholesterol occurred in 66%. Total body fat (bioimpedance) and dietary intake of lipids were higher in patients with non-alcoholic steatohepatitis (P < 0.05), but not in diabetic subjects who exhibited more steatosis than non-alcoholic steatohepatitis. Waist circumference exhibited a good correlation with homeostasis model assessment, total energy intake, and ingestion of specific fatty acids. Body mass index correlated well with somatic and visceral adiposities. CONCLUSION: Energy intake and visceral adiposity were predisposing factors for fatty liver disease. Lipid input correlated with non-alcoholic steatohepatitis in the entire group and after stratification for diabetes. These findings suggest that lipid intake may play a greater role in non-alcoholic steatohepatitis than hitherto suspected.","['Vilar, Lisis', 'Oliveira, Claudia P M S', 'Faintuch, Joel', 'Mello, Evandro S', 'Nogueira, Monize A', 'Santos, Telma E', 'Alves, Venancio A F', 'Carrilho, Flair J']","['Vilar L', 'Oliveira CP', 'Faintuch J', 'Mello ES', 'Nogueira MA', 'Santos TE', 'Alves VA', 'Carrilho FJ']","['Hospital das Clinicas and Sao Paulo University Medical School, Sao Paulo, Brazil.']",['eng'],['Journal Article'],United States,Nutrition,"Nutrition (Burbank, Los Angeles County, Calif.)",8802712,"['0 (Dietary Fats)', '97C5T2UQ7J (Cholesterol)']",IM,"['Anthropometry', 'Body Composition/drug effects/physiology', 'Cholesterol/*blood', 'Dietary Fats/*administration & dosage/*adverse effects', 'Disease Progression', 'Energy Intake/*physiology', 'Fatty Liver/epidemiology/*etiology/pathology', 'Female', 'Humans', 'Insulin Resistance', 'Intra-Abdominal Fat/metabolism', 'Male', 'Metabolic Syndrome/blood/complications/metabolism', 'Middle Aged', 'Obesity/blood/*complications/metabolism', 'Risk Factors']",,,,,2008/07/22 09:00,2009/01/30 09:00,['2008/07/22 09:00'],"['2007/07/27 00:00 [received]', '2008/04/01 00:00 [revised]', '2008/05/17 00:00 [accepted]', '2008/07/22 09:00 [pubmed]', '2009/01/30 09:00 [medline]', '2008/07/22 09:00 [entrez]']","['S0899-9007(08)00259-1 [pii]', '10.1016/j.nut.2008.05.017 [doi]']",ppublish,Nutrition. 2008 Nov-Dec;24(11-12):1097-102. doi: 10.1016/j.nut.2008.05.017. Epub 2008 Jul 21.,,20080721,,,,,,,,,,,,,,,,,,
10929158,NLM,MEDLINE,20001012,20071205,0960-8923 (Print) 0960-8923 (Linking),10,3,2000 Jun,"Bariatric surgery in some ""Central and East-European (former Eastern bloc)"" countries- current status and prediction for the next millennium.",255-8,,"BACKGROUND: Obesity is increasing globally, including in the formerly ""Eastern Bloc"" countries. METHODS: A survey was made of obesity and bariatric surgery. RESULTS: In the 8 East and Central European countries studied, with total population 300 million, roughly 43% of the population was overweight (BMI 25-30), 23% obese (BMI > 30), with about 15 million people morbidly obese (BMI > 40). From 0-10 morbidly obese individuals/100,000/year undergo bariatric surgery. CONCLUSION: Most countries were found to provide inadequate treatment for obesity. The majority of the morbidly obese are not treated effectively. However, health-care awareness of obesity and bariatric surgeons are slowly increasing.","['Fried, M', 'Peskova, M', 'Kasalicky, M']","['Fried M', 'Peskova M', 'Kasalicky M']","['First Surgical Department, Charles University General Faculty Hospital, Prague, Czech Republic.']",['eng'],['Journal Article'],United States,Obes Surg,Obesity surgery,9106714,,IM,"['Body Mass Index', 'Data Collection', 'Digestive System Surgical Procedures/statistics & numerical data', 'Europe, Eastern/epidemiology', 'Humans', 'Obesity/classification/diagnosis/*epidemiology/therapy']",,,,,2000/08/06 11:00,2000/10/14 11:01,['2000/08/06 11:00'],"['2000/08/06 11:00 [pubmed]', '2000/10/14 11:01 [medline]', '2000/08/06 11:00 [entrez]']",['10.1381/096089200321643557 [doi]'],ppublish,Obes Surg. 2000 Jun;10(3):255-8. doi: 10.1381/096089200321643557.,,,,,,,,,,,,,,,,,,,,
18488744,NLM,MEDLINE,20080617,20080519,1660-9379 (Print) 1660-9379 (Linking),4,151,2008 Apr 2,[Meeting obese young people's health needs: a youth clinic approach in Geneva].,"824-6, 828",,"Obese young people face more difficulties negotiating the tasks of adolescence than their healthy peers. Developmental issues and psychosocial aspects specific to this age group have to be part of regular health care strategies. We developed a global health assessment and a group approach based on health education principles focusing on knowledge, body sensations and emotional aspects in a developmentally appropriate way. This approach allows active participation of young people which has been shown to improve adherence to treatment and health outcomes.","['Chamay-Weber, Catherine', 'Meynard, Anne', 'Gal, Claudine', 'Guillermin-Spahr, Marie-Luce', 'Narring, Francoise']","['Chamay-Weber C', 'Meynard A', 'Gal C', 'Guillermin-Spahr ML', 'Narring F']","[""Unite sante jeunes, Departement de l'enfant et de l'adolescent et Service d'enseignement therapeutique pour maladies chroniques, HUG, Geneve. catherine.chamay-weber@hcuge.ch""]",['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Adolescent', 'Adolescent Behavior/psychology', 'Ambulatory Care Facilities', '*Health Services Needs and Demand', 'Humans', 'Obesity/*prevention & control', 'Switzerland']",,,,,2008/05/21 09:00,2008/06/18 09:00,['2008/05/21 09:00'],"['2008/05/21 09:00 [pubmed]', '2008/06/18 09:00 [medline]', '2008/05/21 09:00 [entrez]']",,ppublish,"Rev Med Suisse. 2008 Apr 2;4(151):824-6, 828.",,,,,,,,,Repondre aux besoins de sante des jeunes obeses: l'apport d'une consultation specialisee pour adolescents a Geneve.,,,,,,,,,,,
13350393,NLM,MEDLINE,20030501,20181201,0033-0450 (Print) 0033-0450 (Linking),84,10,1956 May 24,[Cholesterolytic property of blood in obesity].,204,,,"['KERMORGANT, Y']",['KERMORGANT Y'],,['fre'],['Journal Article'],France,Prog Med (Paris),Le Progres medical,2984825R,['97C5T2UQ7J (Cholesterol)'],OM,"['*Blood', 'Cholesterol/*metabolism', 'Humans', '*Lipid Metabolism', 'Obesity/*blood']",,['NLM'],"['*BLOOD', '*CHOLESTEROL/metabolism', '*OBESITY/blood in']",,1956/05/24 00:00,1956/05/24 00:01,['1956/05/24 00:00'],"['1956/05/24 00:00 [pubmed]', '1956/05/24 00:01 [medline]', '1956/05/24 00:00 [entrez]']",,ppublish,Prog Med (Paris). 1956 May 24;84(10):204.,,,,,,,,,A propos du pouvoir cholesterolytique du serum des obeses.,,,,['CLML: 5630:58975'],,,,,,,
8545559,NLM,MEDLINE,19960209,20041117,0392-291X (Print) 0392-291X (Linking),17,2-3,1995 Mar-Jun,Follow-up of obese child.,77-80,,"A long-term follow-up which is still being carried out was started in the school-year 1985-86 in a Primary School of Rome and we suggested a written diet of 1300 calories and correct physical exercises. During this long follow-up we studied the changes in percentage of obesity of these subjects, considering their familiarity with obesity. It resulted that after a starting benefit due to the diet and the sport activity, which lasted till 1989, the youngsters with familiarity have subsequently regained the initial situation in 62.5% of cases, unlike those without familiarity who have kept themselves slim in 75% of cases. Even many other facts have been considered, as for example the psychologic approach, blood-tests for cholesterol, triglycerides etc, arterial pressure and above all a very careful feeding recall that has shown as the now obese subjects intake more calories than not obese one, with and excess of calories from fats to the detriment of carbon hydrates.","['Menghetti, E', 'Di Feo, G', 'Mucedola, G', 'Montaleone, M', 'Carratelli, T J', 'Agolini, D', 'Martino, F', 'Marulli, P']","['Menghetti E', 'Di Feo G', 'Mucedola G', 'Montaleone M', 'Carratelli TJ', 'Agolini D', 'Martino F', 'Marulli P']","['Pediatrics and Neuropsychiatry Department, La Sapienza, University of Rome.']",['eng'],"['Clinical Trial', 'Journal Article']",Italy,Riv Eur Sci Med Farmacol,Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,8100897,,IM,"['Child', 'Female', 'Follow-Up Studies', 'Humans', 'Italy/epidemiology', 'Male', 'Obesity/*diet therapy/epidemiology/psychology']",,,,,1995/03/01 00:00,1995/03/01 00:01,['1995/03/01 00:00'],"['1995/03/01 00:00 [pubmed]', '1995/03/01 00:01 [medline]', '1995/03/01 00:00 [entrez]']",,ppublish,Riv Eur Sci Med Farmacol. 1995 Mar-Jun;17(2-3):77-80.,,,,,,,,,,,,,,,,,,,,
9404427,NLM,MEDLINE,19980106,20090213,0003-9683 (Print) 0003-9683 (Linking),90,8,1997 Aug,[Alteration of cardiovascular vagosympathetic control evaluated by spectral analysis of variations of heart rate and blood pressure in obesity].,1155-8,,"Several studies suggest alterations of parasympathetic and sympathetic control in obesity. We have already shown that more than 40% of non diabetic obese subjects have alterations of parasympathetic control of heart rate (HR) variations. The present study aimed to investigate parasympathetic and sympathetic cardiovascular control by using spectral analysis. Sixty-two non diabetic obese subjects were compared to 38 sex-matched healthy controls. Spectral analysis was performed by Anapres system and identified two particular peaks: the one of high frequency (0.20-0.25 Hz) for heart rate variations during controlled breathing which depends on parasympathetic activity, the other of low frequency (around 0.10 Hz) for systolic BP variations in the standing position which mainly depend on sympathetic activity. In control subjects the amplitude of the high frequency peak (r = -0.556, p < 0.0001) but not the amplitude of the low frequency peak correlated negatively with age. In the obese subjects both the high and low frequency peaks correlated negatively with age (r = -0.249; p = 0.05 and r = -0.289, p = 0.036 respectively) and did not correlate with body mass index. The high frequency peak was significantly lower than in controls (4.80 +/- 3.37 (SD) vs 8.38 +/- 4.14; p < 0.0001). In the 25 obese subjects over 40 years the low frequency peak was also significantly lower than in controls (10.00 +/- 3.10 vs 11.95 +/- 4.25; p < 0.05). This study suggests that 1) age must be taken into account when interpreting the cardiovascular parameters under vagosympathetic control; 2) in non diabetic obese subjects vagal activity is decreased and in those over 40 years sympathetic activity is also decreased.","['Sibony-Prat, J', 'Paries, J', 'Chabert, M', 'Attali, J R', 'Valensi, P']","['Sibony-Prat J', 'Paries J', 'Chabert M', 'Attali JR', 'Valensi P']","[""Service d'endocrinologie-diabetologie-nutrition, hopital Jean-Verdier, Bondy.""]",['fre'],"['English Abstract', 'Journal Article']",France,Arch Mal Coeur Vaiss,Archives des maladies du coeur et des vaisseaux,0406011,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Autonomic Nervous System Diseases/*physiopathology', 'Blood Pressure', 'Blood Pressure Determination/instrumentation', 'Cardiovascular System/physiopathology', 'Female', 'Heart Rate', 'Humans', 'Male', 'Middle Aged', 'Obesity/complications/*physiopathology', 'Plethysmography', 'Spectrum Analysis']",,,,,1997/08/01 00:00,1997/12/24 00:01,['1997/08/01 00:00'],"['1997/08/01 00:00 [pubmed]', '1997/12/24 00:01 [medline]', '1997/08/01 00:00 [entrez]']",,ppublish,Arch Mal Coeur Vaiss. 1997 Aug;90(8):1155-8.,,,,,,,,,Alteration du controle vagosympathique cardiovasculaire evalue par l'analyse spectrale des variations de frequence cardiaque et de pression arterielle chez les obeses.,,,,,,,,,,,
5849355,NLM,MEDLINE,19660220,20041118,0048-8062 (Print) 0048-8062 (Linking),6,3,1965 May-Jun,[Contribution to the physiopathogenesis of diabetes in the obese. II. 11-oxygenated androgens].,213-20,,,"['Sonka, J', 'Gregorova, I', 'Skamenova, B']","['Sonka J', 'Gregorova I', 'Skamenova B']",,['fre'],['Journal Article'],France,Rev Fr Endocrinol Clin,"La Revue francaise d'endocrinologie clinique, nutrition, et metabolisme",0404335,['0 (Androgens)'],IM,"['Adult', 'Androgens/*metabolism', 'Diabetes Mellitus/*metabolism', 'Female', 'Humans', 'Middle Aged', '*Obesity', 'Urine']",,,,,1965/05/01 00:00,1965/05/01 00:01,['1965/05/01 00:00'],"['1965/05/01 00:00 [pubmed]', '1965/05/01 00:01 [medline]', '1965/05/01 00:00 [entrez]']",,ppublish,Rev Fr Endocrinol Clin. 1965 May-Jun;6(3):213-20.,,,,,,,,,Contribution a la physiopathogenie du diabete des obeses. II. Androgenes oxygenes en 11.,,,,,,,,,,,
13282851,NLM,MEDLINE,20030501,20220321,0002-9165 (Print) 0002-9165 (Linking),4,1,1956 Jan-Feb,"The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease.",20-34,,,"['VAGUE, J']",['VAGUE J'],,['eng'],['Journal Article'],United States,Am J Clin Nutr,The American journal of clinical nutrition,0376027,,OM,"['*Atherosclerosis', '*Diabetes Mellitus', '*Gout', 'Humans', 'Obesity/*complications']",,['NLM'],['*OBESITY/complications'],,1956/01/01 00:00,1956/01/01 00:01,['1956/01/01 00:00'],"['1956/01/01 00:00 [pubmed]', '1956/01/01 00:01 [medline]', '1956/01/01 00:00 [entrez]']",['10.1093/ajcn/4.1.20 [doi]'],ppublish,Am J Clin Nutr. 1956 Jan-Feb;4(1):20-34. doi: 10.1093/ajcn/4.1.20.,,,,,,,,,,,,,['CLML: 5629:35035'],,,,,,,
8681057,NLM,MEDLINE,19960816,20191101,1071-7323 (Print) 1071-7323 (Linking),4,2,1996 Mar,"The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. 1956.",204-12,,,"['Vague, J']",['Vague J'],,['eng'],"['Biography', 'Classical Article', 'Comparative Study', 'Historical Article', 'Journal Article']",United States,Obes Res,Obesity research,9305691,,IM,"['Body Composition', 'Body Constitution', 'Female', 'History, 20th Century', 'Humans', 'Male', '*Obesity/complications', '*Sex Characteristics']",,,,,1996/03/01 00:00,1996/03/01 00:01,['1996/03/01 00:00'],"['1996/03/01 00:00 [pubmed]', '1996/03/01 00:01 [medline]', '1996/03/01 00:00 [entrez]']",['10.1002/j.1550-8528.1996.tb00536.x [doi]'],ppublish,Obes Res. 1996 Mar;4(2):204-12. doi: 10.1002/j.1550-8528.1996.tb00536.x.,,,,,,,,['Obes Res. 1996 Mar;4(2):189-92. PMID: 8681053'],,,,,,,,,,['Vague J'],"['Vague, J']",
11109945,NLM,MEDLINE,20010125,20191210,0929-693X (Print) 0929-693X (Linking),7,11,2000 Nov,[Personal sports training in the management of obese boys aged 12 to 16 years].,1185-93,,"OBJECTIVE: Estimation of both physical and psychological effects of an adapted physical training on children undergoing an obesity treatment. MATERIAL AND METHODS: The survey was carried out on 36 obese boys (ages = 12-16 years) who stayed in the medical center for at least four months. Eighteen of them were trained with the SELF method (the SELF-training is global, progressive, adapted to each boy, controlled and takes place within a ten-week period with five sessions a fortnight, each session lasting 30 to 40 minutes). The parameters that were studied concerned auxology, breathing function exploration, aerobic and anaerobic capacities, muscle strength and psychomotor qualities; the subjective effects of the training were estimated with a questionnaire about life quality, and the hand test. At inclusion the results were reported to a standard kind of population. At the end of the training the results of the 18 boys that were trained were compared to those of the 18 controls. RESULTS: Compared to a standard population, the obese children' aerobic capacity is diminished for the maximum power but is identical in absolute value for the VO2 max; their anaerobic capacities, muscle strength and psychomotor capacities are lower and their psyche is affected by the disease. After a three-month training period and after comparison with the 'control' group, there can be noticed a significant improvement in the psychomotor capacities, a major tendency for the improvement of the aerobic capacities and very positive effects on the psyche. CONCLUSION: SELF-training in association with dietetics appears to be very useful in the therapeutic care of obese children. For the follow-up at home it would need to be registered within the domain of physiotherapy.","['Dupuis, J M', 'Vivant, J F', 'Daudet, G', 'Bouvet, A', 'Clement, M', 'Dazord, A', 'Dumet, N', 'David, M', 'Bellon, G']","['Dupuis JM', 'Vivant JF', 'Daudet G', 'Bouvet A', 'Clement M', 'Dazord A', 'Dumet N', 'David M', 'Bellon G']","['Unite medecine du sport, service de pediatrie, centre hospitalier Lyon-Sud, France.']",['fre'],"['Clinical Trial', 'Journal Article']",France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,,IM,"['Adolescent', 'Child', 'Diet', 'Energy Metabolism', '*Exercise Therapy', 'Humans', 'Male', 'Obesity/*therapy', '*Physical Fitness', 'Programmed Instructions as Topic', 'Self Concept', '*Sports', 'Treatment Outcome']",,,,,2000/12/08 11:00,2001/02/28 10:01,['2000/12/08 11:00'],"['2000/12/08 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/12/08 11:00 [entrez]']","['S0929693X00001287 [pii]', '10.1016/s0929-693x(00)00128-7 [doi]']",ppublish,Arch Pediatr. 2000 Nov;7(11):1185-93. doi: 10.1016/s0929-693x(00)00128-7.,,,,,,,,,Entrainement sportif personnalise dans la prise en charge de garcons obeses ages de 12 a 16 ans.,,,,,,,,,,,
18423556,NLM,MEDLINE,20080930,20220409,0003-4266 (Print) 0003-4266 (Linking),69,3,2008 Jun,[Effects of intermittent walk program on the body mass and composition in obese women].,227-30,10.1016/j.ando.2008.01.006 [doi],"The obese patients adhere weakly to rehabilitation programs; therefore the expected gains are often disappointing. This is possibly linked to the monotony of constant velocity exercises frequently proposed. Consequently, other less monotonous exercises such as the intermittent walk may be more appropriated. OBJECTIVES: The main objectives of this study were to determine if the obese women prefer a constant velocity walk or an intermittent walk, and to analyze the effects of a rehabilitation program based on the intermittent walk. MATERIALS AND METHODS: Twenty obese women were recruited. To determine the preferred walk modality, 10 obese women performed a constant velocity walk and an intermittent walk (with a similar duration and velocity) on a treadmill. The preferred walk modality was determined by lower ratings of perceived exertion. Then, these same 10 women participated in a rehabilitation program of 10 weeks (three days per week) consisting of intermittent walks. The 10 other women did not participate in a training program. RESULTS: The ratings of perceived exertion were not significantly different between the two walk modalities. However, the women who participated in a training program increased their maximal distance during a 6 min walking test and they have stabilized theirs anthropometric data. Meanwhile, the untrained women have increased their body mass, body mass index and percentage of body fat. CONCLUSION: The obese patients preferred similarly the constant velocity walk and the intermittent walk, and a rehabilitation program based on an intermittent walk is effective in avoiding the obesity aggravation.","['Coquart, J B J', 'Lemaire, C', 'Douillard, C', 'Garcin, M']","['Coquart JB', 'Lemaire C', 'Douillard C', 'Garcin M']","[""Laboratoire d'etudes de la motricite humaine, universite de Lille-2, 9, rue de l'Universite, 59790 Ronchin, France. jeremy.coquart@univ-lille2.fr""]",['fre'],"['English Abstract', 'Journal Article']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,,IM,"['Adult', '*Body Composition', '*Body Mass Index', 'Female', 'Humans', 'Middle Aged', 'Obesity/psychology/*rehabilitation', 'Perception', 'Physical Exertion', '*Walking']",,,,,2008/04/22 09:00,2008/10/01 09:00,['2008/04/22 09:00'],"['2007/10/09 00:00 [received]', '2008/01/03 00:00 [accepted]', '2008/04/22 09:00 [pubmed]', '2008/10/01 09:00 [medline]', '2008/04/22 09:00 [entrez]']","['S0003-4266(08)00034-6 [pii]', '10.1016/j.ando.2008.01.006 [doi]']",ppublish,Ann Endocrinol (Paris). 2008 Jun;69(3):227-30. doi: 10.1016/j.ando.2008.01.006.,,,,,,,,,Effets d'un programme de marche intermittente sur la masse et la composition corporelles de femmes obeses.,,,,,,,,,,,
24683850,NLM,MEDLINE,20140527,20161125,0038-0814 (Print) 0038-0814 (Linking),,782,2014 Jan-Feb,[Team work for managing obese persons].,9,,,"['Mauduit, Laurence']",['Mauduit L'],,['fre'],['News'],France,Soins,Soins; la revue de reference infirmiere,20910580R,,,"['Bariatric Surgery/nursing', '*Cooperative Behavior', 'Feeding Behavior', 'Female', 'France', 'Health Behavior', 'Humans', '*Interdisciplinary Communication', 'Life Style', 'Male', 'Obesity/etiology/*nursing/prevention & control']",,,,,2014/04/02 06:00,2014/05/28 06:00,['2014/04/02 06:00'],"['2014/04/02 06:00 [entrez]', '2014/04/02 06:00 [pubmed]', '2014/05/28 06:00 [medline]']",,ppublish,Soins. 2014 Jan-Feb;(782):9.,,,,,,,,,Le travail en equipe pour accompagner les personnes obeses.,,,,,,,,,,,
8039038,NLM,MEDLINE,19940819,20220331,0578-1337 (Print) 0578-1337 (Linking),53,5,1994 May,Effect of caffeine on the levels of brain serotonin and catecholamine in the genetically obese mice.,257-61,,"BACKGROUND: Most obesities are known low in sympathetic activity, and brain neurotransmitters may play roles in the defective exhibitions of obesity. Caffeine, a stimulant, which can prompt lipolysis, has been applied on the therapy of obesity. Although the interactive combinations between caffeine and certain neurotransmitters has been appreciated recently, but its regulatory mechanisms are still obscure. This study investigated the effect of caffeine on the body fat deposition, and its interactions with brain serotonin and catecholamine in the genetically obese (ob/ob) mice. METHODS: At 12-week of age, obese mice and their lean counterparts (+/?) were administered with caffeine (4 mg/d) in water for 4 weeks. The brain neurotransmitters levels and body fat content were measured. RESULTS: The obese mice without caffeine treatment had lower brain norepinephrine and epinephrine levels than the lean controls. And there had no difference between obese and lean mice in brain levels of serotonin, tryptophan, and 5-hydroxyindoleacetic acid. Caffeine treatment showed no effect on the food intake, but decreased the body fat content significantly in obese mice. Mice with caffeine treatment showed increase of the levels of brain neurotransmitters in both phenotypes; this effect was more predominant in obese mice. CONCLUSIONS: This study indicated that the effect of caffeine to decrease body fat deposition in the obese mice might be associated with the recovered increases of sympathetic activity.","['Chen, M D', 'Lin, W H', 'Song, Y M', 'Lin, P Y', 'Ho, L T']","['Chen MD', 'Lin WH', 'Song YM', 'Lin PY', 'Ho LT']","['Department of Medicine, Taichung Veterans General Hospital, Taiwan, R.O.C.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",China (Republic : 1949- ),Zhonghua Yi Xue Za Zhi (Taipei),Zhonghua yi xue za zhi = Chinese medical journal; Free China ed,0005327,"['0 (Catecholamines)', '333DO1RDJY (Serotonin)', '3G6A5W338E (Caffeine)']",IM,"['Adipose Tissue/drug effects', 'Animals', 'Brain/*drug effects/metabolism', 'Caffeine/*pharmacology', 'Catecholamines/*metabolism', 'Female', 'Male', 'Mice', 'Mice, Obese', 'Obesity/genetics/*metabolism', 'Serotonin/*metabolism']",,,,,1994/05/01 00:00,1994/05/01 00:01,['1994/05/01 00:00'],"['1994/05/01 00:00 [pubmed]', '1994/05/01 00:01 [medline]', '1994/05/01 00:00 [entrez]']",,ppublish,Zhonghua Yi Xue Za Zhi (Taipei). 1994 May;53(5):257-61.,,,,,,,,,,,,,,,,,,,,
18879615,NLM,MEDLINE,20081020,20201005,0035-3655 (Print) 0035-3655 (Linking),68,8,1948 Aug 25,[Treatment of functional obesities].,514-25,,,"['LEVEN, R']",['LEVEN R'],,['fre'],['Journal Article'],Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,,OM,['Obesity/*therapy'],,['NLM'],['*OBESITY/therapy'],,1948/08/25 00:00,2008/10/24 09:00,['1948/08/25 00:00'],"['1948/08/25 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1948/08/25 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1948 Aug 25;68(8):514-25.,,,,,,,,,Traitement des obesites fonctionnelles.,,,,['CLML: 4815:1004g1'],,,,,,,
5738362,NLM,MEDLINE,19700205,20190816,0012-186X (Print) 0012-186X (Linking),4,4,1968 Aug,[Levels of pancreatic hydrolases in pancreas and small bowel of two types of obese mice with hyperinsulinism: the obese-hyperglycemic Bar-Harbor mouse (OH) and the New-Zealand mouse (NZO)].,232-5,,,"['Khayat, M H', 'Rathe, J', 'Vandermeers, A', 'Christophe, J']","['Khayat MH', 'Rathe J', 'Vandermeers A', 'Christophe J']",,['fre'],['Journal Article'],Germany,Diabetologia,Diabetologia,0006777,"['9002-08-8 (Trypsinogen)', 'EC 3.- (Hydrolases)', 'EC 3.1.- (Ribonucleases)', 'EC 3.1.1.3 (Lipase)', 'EC 3.2.1.- (Amylases)', 'EC 3.4.21.1 (Chymotrypsin)', 'EC 3.4.21.4 (Trypsin)']",IM,"['Amylases/analysis', 'Animals', 'Chymotrypsin/analysis', 'Female', 'Hydrolases/*analysis', 'Hyperglycemia/enzymology', 'Hyperinsulinism/*enzymology', 'Intestine, Small/*enzymology', 'Lipase/analysis', 'Male', 'Mice/*enzymology', 'Obesity/congenital/*enzymology', 'Pancreas/*enzymology', 'Ribonucleases/analysis', 'Species Specificity', 'Trypsin/analysis', 'Trypsinogen/analysis']",,,,,1968/08/01 00:00,1968/08/01 00:01,['1968/08/01 00:00'],"['1968/08/01 00:00 [pubmed]', '1968/08/01 00:01 [medline]', '1968/08/01 00:00 [entrez]']",['10.1007/BF00430100 [doi]'],ppublish,Diabetologia. 1968 Aug;4(4):232-5. doi: 10.1007/BF00430100.,,,,,,,,,Niveaux des hydrolases pancreatiques dans le pancreas et l'intestin grele de deux types de souris obeses presentant un hyperinsulinisme: la souris obese-hyperglycemique (OH) de Bar Harbor et la souris Neo-Zelandaise (NZO).,,,,,,,,,,,
4706702,NLM,MEDLINE,19730723,20131121,0301-1534 (Print),2,2,1973,[Psychological factors in the etiology of obesity and in the long-term treatment of psychiatric obese].,171-6,,,"['Gaind, R']",['Gaind R'],,['fre'],['Journal Article'],Canada,Vie Med Can Fr,La Vie medicale au Canada francais,0316264,['2DS058H2CF (Fenfluramine)'],IM,"['Fenfluramine/therapeutic use', 'Humans', 'Obesity/drug therapy/*etiology/therapy', 'Psychology']",,,,,1973/01/01 00:00,1973/01/01 00:01,['1973/01/01 00:00'],"['1973/01/01 00:00 [pubmed]', '1973/01/01 00:01 [medline]', '1973/01/01 00:00 [entrez]']",,ppublish,Vie Med Can Fr. 1973;2(2):171-6.,,,,,,,,,Les facteurs psychologiques dans l'etiologie de l'obesite et dans le traitement a long terme de l'obese psychiatrique.,,,,,,,,,,,
8009086,NLM,MEDLINE,19940719,20190825,0248-8663 (Print) 0248-8663 (Linking),14,10,1993,[Evaluation of the participation of proinsulin in hyperinsulinism in patients with obesity and glucose intolerance].,993,,"The comparison of the results of two insulin assays, a RIA using a polyclonal antibody and a EMIA using two monoclonal antibodies in blood samples collected during an oral glucose load in normal, obese, glucose intolerant and type II diabetic patients indicated that hyperinsulinemia of obese and glucose intolerant patients is not associated to increased proinsulin/insulin ratio.","['Blickle, J F', 'Sapin, R', 'Caro-Sampara, F', 'Grasser, F', 'Brogard, J M']","['Blickle JF', 'Sapin R', 'Caro-Sampara F', 'Grasser F', 'Brogard JM']","['Service de medecine interne, Hopitaux Universitaires, Strasbourg.']",['fre'],"['English Abstract', 'Journal Article']",France,Rev Med Interne,La Revue de medecine interne,8101383,['9035-68-1 (Proinsulin)'],IM,"['Adult', 'Glucose Intolerance/blood/*complications', 'Humans', 'Hyperinsulinism/blood/*etiology', 'Middle Aged', 'Obesity/blood/*complications', 'Proinsulin/*blood']",,,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']","['S0248-8663(05)80111-0 [pii]', '10.1016/s0248-8663(05)80111-0 [doi]']",ppublish,Rev Med Interne. 1993;14(10):993. doi: 10.1016/s0248-8663(05)80111-0.,,,,,,,,,Evaluation de la participation de la proinsuline dans l'hyperinsulinisme des obeses et intolerants au glucose.,,,,,,,,,,,
26979022,NLM,MEDLINE,20160513,20160316,0035-2640 (Print) 0035-2640 (Linking),65,10,2015 Dec,[Organization of care for obese children and teenagers].,1283-4,,,"['Tauber, Maithe']",['Tauber M'],,['fre'],['Journal Article'],France,Rev Prat,La Revue du praticien,0404334,,IM,"['Adolescent', 'Body Mass Index', 'Child', 'Child, Preschool', 'France', 'Humans', 'Overweight/rehabilitation', 'Patient Care Team/*organization & administration', 'Pediatric Obesity/diagnosis/prevention & control/*rehabilitation', 'Rehabilitation Centers/*organization & administration', 'Treatment Outcome']",,,,,2016/03/17 06:00,2016/05/14 06:00,['2016/03/17 06:00'],"['2016/03/17 06:00 [entrez]', '2016/03/17 06:00 [pubmed]', '2016/05/14 06:00 [medline]']",,ppublish,Rev Prat. 2015 Dec;65(10):1283-4.,,,,,,,,,Organisation des soins de l'enfant et de l'adolescent obeses.,,,,,,,,,,,
13627234,NLM,MEDLINE,20000701,20181201,0002-9513 (Print) 0002-9513 (Linking),196,3,1959 Mar,Fat metabolism in experimental obesities. IX. Lipogenesis and cholesterogenesis in yellow obese mice.,611-3,,,"['ZOMZELY, C', 'MAYER, J']","['ZOMZELY C', 'MAYER J']",,['eng'],['Journal Article'],United States,Am J Physiol,The American journal of physiology,0370511,['97C5T2UQ7J (Cholesterol)'],OM,"['*Adipogenesis', 'Animals', 'Cholesterol/*metabolism', '*Lipid Metabolism', '*Lipogenesis', 'Mice', 'Mice, Obese', 'Obesity/*metabolism']",,['NLM'],"['*CHOLESTEROL/metabolism', '*LIPIDS/metabolism', '*OBESITY/metabolism']",,1959/03/01 00:00,1959/03/01 00:01,['1959/03/01 00:00'],"['1959/03/01 00:00 [pubmed]', '1959/03/01 00:01 [medline]', '1959/03/01 00:00 [entrez]']",['10.1152/ajplegacy.1959.196.3.611 [doi]'],ppublish,Am J Physiol. 1959 Mar;196(3):611-3. doi: 10.1152/ajplegacy.1959.196.3.611.,,,,,,,,,,,,,['CLML: 5936:1014:129:312:382'],,,,,,,
9177603,NLM,MEDLINE,19970710,20061115,0392-291X (Print) 0392-291X (Linking),18,2,1996 Mar-Apr,Serum osteocalcin levels in postmenopausal obese women.,73-7,,"In epidemiology of osteoporosis, obesity is to be considered one of its protecting factors. However there are in the literature discordant opinions: some authors describe a protective effect of obesity on the trabecular bone, others on the cortical one, others no effects at all and others finally a positive influence on both the trabecular and the cortical bone. However, only few studies on obesity's impact on bone metabolism are available. Bone mineral density at forearm and serum osteocalcin levels, a specific and sensitive marker of bone turn-over, in a group of postmenopausal obese women with those of a nonobese control group were compared. Obese women showed higher densitometric measurements than nonobese, but only the values of the third distal site of forearm resulted higher in a significant way. Serum osteocalcin values were similar between the two groups but the obese women showed a greater dispersion of the values (8.15 +/- 4.96 ng/ml) compared to nonobese (8.35 +/- 1.63 ng/ml). This high variability suggests an heterogeneity of bone turn-over in obese subjects and could explain the discordant results of the literature.","['Perfetto, F', 'Tarquini, R', 'Lombardi, V', 'Naldi, E', 'Piluso, A', 'Tarquini, B']","['Perfetto F', 'Tarquini R', 'Lombardi V', 'Naldi E', 'Piluso A', 'Tarquini B']","['Cattedra di Medicina Interna I, Istituto di Clinica Medica IV-University of Florence, Italy.']",['eng'],"['Clinical Trial', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",Italy,Riv Eur Sci Med Farmacol,Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques,8100897,['104982-03-8 (Osteocalcin)'],IM,"['Bone Density', 'Female', 'Humans', 'Middle Aged', 'Obesity/*blood', 'Osteocalcin/*blood', 'Postmenopause/*blood']",,,,,1996/03/01 00:00,1996/03/01 00:01,['1996/03/01 00:00'],"['1996/03/01 00:00 [pubmed]', '1996/03/01 00:01 [medline]', '1996/03/01 00:00 [entrez]']",,ppublish,Riv Eur Sci Med Farmacol. 1996 Mar-Apr;18(2):73-7.,,,,,,,,,,,,,,,,,,,,
6281913,NLM,MEDLINE,19820708,20061115,,58,15,1982 Apr 15,[Short and long term results in the treatment of obesity. A study in 173 patients (author's transl)].,944-50,,"Short and long term weight loss was studied in 173 obese patients treated by a low-calorie diet. Significant weight loss was observed in 78% of the patients after 6 months and in 58% after 4 years. These results are similar to those published in other studies but the comparison is difficult because the methods used are not strictly comparable. A detailed study of 116 patients showed that weight loss is not significantly influenced by such variables as age, sex, previous calorie intake, complications, and severity or duration of the obesity.","['Lorcy, Y', 'Allannic, H', 'Favreau, A M', 'Heim, J']","['Lorcy Y', 'Allannic H', 'Favreau AM', 'Heim J']",,['fre'],"['English Abstract', 'Journal Article']",France,Sem Hop,La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,9410059,,IM,"['Adult', '*Diet, Reducing', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Obesity/*diet therapy', 'Prognosis', 'Time Factors']",,,,,1982/04/15 00:00,1982/04/15 00:01,['1982/04/15 00:00'],"['1982/04/15 00:00 [pubmed]', '1982/04/15 00:01 [medline]', '1982/04/15 00:00 [entrez]']",,ppublish,Sem Hop. 1982 Apr 15;58(15):944-50.,,,,,,,,,Resultats a court et long terme du traitement de l'obesite. Etude chez cent soixante-treize obeses.,,,,,,,,,,,
27188051,NLM,MEDLINE,20160616,20160518,1660-9379 (Print) 1660-9379 (Linking),12,511,2016 Mar 23,[How to support obese patients in a long-term process of change?].,"584, 586-90",,"It is illusory to think losing weight effectively by acting only on diet or physical activity. To lose weight satisfactorily and to maintain that weight loss, we should move more on lifestyle changes, namely changes in behavior on several axes. Through concrete examples of an obese patient wanting to lose weight, we will see what skills he must acquire to achieve its objective and what tools the therapist can use to help.","['Locatelli, Loic', 'Pataky, Zoltan', 'Joly, Catherine', 'Goly, Alain']","['Locatelli L', 'Pataky Z', 'Joly C', 'Goly A']",,['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['*Health Behavior', 'Humans', '*Life Style', '*Motivation', 'Obesity/*therapy', 'Patient Care Team', 'Patient Education as Topic', '*Weight Loss']",,,,,2016/05/18 06:00,2016/06/17 06:00,['2016/05/19 06:00'],"['2016/05/19 06:00 [entrez]', '2016/05/18 06:00 [pubmed]', '2016/06/17 06:00 [medline]']",,ppublish,"Rev Med Suisse. 2016 Mar 23;12(511):584, 586-90.",,,,,,,,,Comment accompagner les patients obeses dans un processus de changement a long-terme?,,,,,,,,,,,
21545016,NLM,MEDLINE,20110531,20110505,1660-9379 (Print) 1660-9379 (Linking),7,288,2011 Mar 30,[Understanding the life of the obese patient. A contribution to therapeutic patient education].,686-90,,"This article presents an approach of obesity centered on patients' experience. How is obesity defined by these latter? Is it considered as a disease? Is it apprehended by them as an element to fight or as a potentially meaningful event? Has the sick person the feeling to suffer from obesity or to have resources to face it? At the crossroads of three human sciences (sociology, anthropology and education), this approach aims to enrich and increase the efficiency of therapeutic patient education for obese patients. Extended experience narration extracts are presented in this article, obtained from research interviews. They show the importance of taking into account the ""subjective experience"" of the disease when accompanying persons affected by obesity.","['Charmillot, M', 'Lagger, G', 'Moutet, A Lasserre', 'Golay, A']","['Charmillot M', 'Lagger G', 'Moutet AL', 'Golay A']","[""Faculte de psychologie et des sciences de l'education Universite de Geneve, Geneve. Maryvonne.Charmillot@unige.ch""]",['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Humans', 'Obesity/*psychology/*therapy', '*Patient Education as Topic']",,,,,2011/05/07 06:00,2011/06/01 06:00,['2011/05/07 06:00'],"['2011/05/07 06:00 [entrez]', '2011/05/07 06:00 [pubmed]', '2011/06/01 06:00 [medline]']",,ppublish,Rev Med Suisse. 2011 Mar 30;7(288):686-90.,,,,,,,,,Comprendre l'experience de vie des personnes obeses: un apport pour l'education therapeutique du patient.,,,,,,,,,,,
15481768,NLM,MEDLINE,20050207,20191026,,21,8,1997 Aug,Regulation of ammonia-metabolizing enzymes expression in the liver of obese rats: differences between genetic and nutritional obesities.,681-5,,"OBJECTIVE: To determine the expression of carbamoylphosphate synthetase (CPS) and glutamine synthetase (GS) in two different models of obese rats: genetically obese rats and diet obese rats. SUBJECTS: Lean and genetically obese (fa/fa) Zucker rats were used. DESIGN: Lean animals (30-60 d old) were fed for 30 d with standard chow pellets or with a hypercaloric cafeteria diet. Genetically obese rats were fed with standard chow pellets. MEASUREMENTS: Enzyme activity, protein (Western blot) and mRNA (Northern blot) contents of CPS and GS were measured in liver homogenates. RESULTS: In genetically obese animals CPS mRNA content was higher, and GS mRNA content was lower than in control animals; CPS protein content did not change and CPS activity was lower than in control rats. Diet-obese rats had higher levels of CPS and GS mRNAs than control animals; GS protein content and activity was higher than in the control group and at the same time, CPS activity was very low. CONCLUSIONS: In the genetically obese animals the expression of CPS and GS is mainly regulated at the pre-translational level, whereas in the diet obese rats there is a noticeable post-translational component. A reciprocal regulation between CPS and GS can be established at pre-translational levels, whereas at post-transcriptional levels it cannot. It can be concluded that in diet-obese animals the mechanisms involved in retaining nitrogen (low CPS activity) are modulated at the post-translational level.","['Roig, R', 'Esteve, M', 'Remesar, X', 'Lamers, W H', 'Arola, L', 'Salvado, J']","['Roig R', 'Esteve M', 'Remesar X', 'Lamers WH', 'Arola L', 'Salvado J']","['Department de Bioquimica i Biotecnologia, Facultat de Quimica, Universitat Rovira i Virgili, Tarragona, Spain.']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Int J Obes Relat Metab Disord,International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,9313169,"['63231-63-0 (RNA)', '7664-41-7 (Ammonia)', 'EC 6.3.1.2 (Glutamate-Ammonia Ligase)', 'EC 6.3.4.16 (Carbamoyl-Phosphate Synthase (Ammonia))', 'N762921K75 (Nitrogen)']",IM,"['Ammonia/*metabolism', 'Analysis of Variance', 'Animals', 'Blotting, Northern/methods', 'Blotting, Western/methods', 'Carbamoyl-Phosphate Synthase (Ammonia)/genetics/metabolism', 'Cohort Studies', '*Gene Expression Regulation, Enzymologic', 'Glutamate-Ammonia Ligase/genetics/metabolism', 'Liver/*enzymology', 'Male', 'Nitrogen/metabolism', 'Obesity/*enzymology/genetics', 'Odds Ratio', 'Overnutrition', 'RNA/analysis', 'Rats', 'Rats, Zucker', 'Retrospective Studies']",,,,,1997/08/01 00:00,2005/03/25 09:00,['1997/08/01 00:00'],"['1997/08/01 00:00 [pubmed]', '2005/03/25 09:00 [medline]', '1997/08/01 00:00 [entrez]']",['10.1038/sj.ijo.0800460 [doi]'],ppublish,Int J Obes Relat Metab Disord. 1997 Aug;21(8):681-5. doi: 10.1038/sj.ijo.0800460.,,,,,,,,,,,,,,,,,,,,
1482258,NLM,MEDLINE,19930209,20090213,0003-9683 (Print) 0003-9683 (Linking),85,8,1992 Aug,[Microalbuminuria and hypertension in obese patients].,1193-5,,"The present study was designed to evaluate the frequency of an increase in the urinary albumin excretion rate (UAER) and the factors involved in this parameter in non-diabetic obese patients; 122 non-diabetic obese patients were investigated. None had proteinuria or history of nephropathy or uropathy. Fourty of them had moderate hypertension. Compared with a group of 22 lean controls, UAER was significantly higher in the obese patients (19.0 +/- 2.0 (SEM) mg/24 h vs 3.2 +/- 0.6 mg/24 h, p < 0.001). UAER was elevated (> 20 mg/24 h) in 29 patients (23.7%). Prevalence of microalbuminuria was not significantly different in hypertensive than in normotensive patients. However UAER was significantly higher in the 32 patients with a family history of hypertension (29.6 +/- 6.3 mg/24 h vs 15.3 +/- 1.5 mg/24 h, p < 0.002). In patients with microalbuminuria, body weight was significantly higher (100.3 +/- 3.9 kg vs 91.8 +/- 1.9 kg, p < 0.05), plasma albumin was significantly lower (38.3 +/- 0.6 g/l vs 40.3 +/- 0.3 g/l, p < 0.005) and the estimated value of fractional albumin clearance was significantly higher. These results show the high frequency of microalbuminuria in non-diabetic obese patients. They suggest that UAER level may be an index of family hypertension in obese patients and that microalbuminuria is part of a widespread abnormality of the capillary permeability.","['Valensi, P', 'Busby, M', 'Combes, M E', 'Attali, J R']","['Valensi P', 'Busby M', 'Combes ME', 'Attali JR']","[""Service d'endocrinologie-diabetologie-nutrition, hopital Jean-Verdier, Universite Paris-Nord, Bondy.""]",['fre'],"['English Abstract', 'Journal Article']",France,Arch Mal Coeur Vaiss,Archives des maladies du coeur et des vaisseaux,0406011,,IM,"['Adult', 'Albuminuria/*etiology', 'Glucose Tolerance Test', 'Humans', 'Hypertension/*etiology', 'Obesity/*complications', 'Prognosis']",,,,,1992/08/01 00:00,1992/08/01 00:01,['1992/08/01 00:00'],"['1992/08/01 00:00 [pubmed]', '1992/08/01 00:01 [medline]', '1992/08/01 00:00 [entrez]']",,ppublish,Arch Mal Coeur Vaiss. 1992 Aug;85(8):1193-5.,,,,,,,,,Microalbuminurie et hypertension arterielle chez les obeses.,,,,,,,,,,,
24783735,NLM,MEDLINE,20140701,20140502,1660-9379 (Print) 1660-9379 (Linking),10,423,2014 Mar 26,[Rehabilitation: a case for obese patients?].,"691-2, 694-5",,"In the word obesity, a clinical concept of chronic systemic disease pairs up with pejorative individual or social representations. Being obese is also facing situations of disability, organ failure, uncertainty of the fate and stigmatization. A care concept inspired by rehabilitation and therapeutic patient education could offer a new way and other purposes to the treatment of obesity. Restoring functions, learning how to adapt and change their environment, obese people may live better today, out of their isolation and develop partners in their projects of life and health. Rehabilitation of an obese patient is much more than weight loss!","['Sittarame, F', 'Lagger, G', 'Chambouleyron, M', 'Lasserre-Moutet, A', 'Joly, C', 'Vergotte, S', 'Pataky, Z', 'Golay, A']","['Sittarame F', 'Lagger G', 'Chambouleyron M', 'Lasserre-Moutet A', 'Joly C', 'Vergotte S', 'Pataky Z', 'Golay A']",,['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Body Mass Index', 'Chronic Disease', 'Humans', 'Obesity/psychology/*rehabilitation', '*Patient Education as Topic', 'Stereotyping', '*Weight Loss']",,,,,2014/05/03 06:00,2014/07/02 06:00,['2014/05/03 06:00'],"['2014/05/03 06:00 [entrez]', '2014/05/03 06:00 [pubmed]', '2014/07/02 06:00 [medline]']",,ppublish,"Rev Med Suisse. 2014 Mar 26;10(423):691-2, 694-5.",,,,,,,,,Readaptation: les patients obeses aussi?,,,,,,,,,,,
15047470,NLM,MEDLINE,20040830,20131121,0003-3898 (Print) 0003-3898 (Linking),62,2,2004 Mar-Apr,[Polymorphism insertion/deletion of apolipoprotein B gene: effect on lipid levels in obese patients].,183-8,,"Apolipoprotein B (apoB) is the major proteic component of LDL, VLDL and chylomicrons. Numerous polymorphisms of the apolipoprotein B gene have been described. Particularly, a polymorphism of insertion/deletion located in the coding part of the signal peptide of apoB, associated with modifications of lipid concentrations and the risk of cardiovascular disease, has been reported in the general population. Since obesity is frequently associated with dyslipidemias, the aim of our study was to assess the effect of the insertion/deletion polymorphism of the apolipoprotein B gene on lipid levels in obese subjects. 234 unrelated caucasian obese subjects (74 men and 160 women, aged 39.3 +/- 10.5, BMI : 32.8 +/- 4.7) were recruited. The insertion/deletion polymorphism was determined by electrophoresis in polyacrylamide gels after PCR amplification. The relative frequencies of the Ins and Del alleles were 0.71 and 0.29 respectively. These frequencies were similar to those found in other Caucasian populations. In the whole population, individuals with the Del/Del genotype had significantly higher total-cholesterol to HDL-cholesterol ratios (p = 0.004), LDL-cholesterol to HDL-cholesterol ratios (p = 0.01) and TG-VLDL levels (p < 0.05). They also showed a tendency for higher triglyceride levels (p = 0.09) and lower HDL-cholesterol, apolipoprotein AI and LpAI levels. The allele deletion results in the absence of three amino acids (Leu-Ala-Leu) in the signal peptide of apo B. In the obese people, these structural changes may have some effect on lipid metabolism and cause variation in serum lipid concentrations.","['Jemaa, R', 'Mebazaa, A', 'Fumeron, F']","['Jemaa R', 'Mebazaa A', 'Fumeron F']","['Laboratoire de biochimie, Hopital la Rabta, Tunis.']",['fre'],"['English Abstract', 'Journal Article']",France,Ann Biol Clin (Paris),Annales de biologie clinique,2984690R,"['0 (Apolipoproteins)', '0 (Apolipoproteins B)', '97C5T2UQ7J (Cholesterol)']",IM,"['Adult', 'Apolipoproteins/*blood', 'Apolipoproteins B/*genetics', 'Cholesterol/*blood', 'Female', 'Gene Deletion', 'Humans', 'Male', 'Mutagenesis, Insertional', 'Obesity/*blood/*genetics', '*Polymorphism, Genetic']",,,,,2004/03/30 05:00,2004/08/31 05:00,['2004/03/30 05:00'],"['2004/03/30 05:00 [pubmed]', '2004/08/31 05:00 [medline]', '2004/03/30 05:00 [entrez]']",,ppublish,Ann Biol Clin (Paris). 2004 Mar-Apr;62(2):183-8.,,,,['Copyright John Libbey Eurotext 20003.'],,,,,Polymorphisme insertion/deletion du gene de l'apolipoproteine B: effet sur les concentrations lipidiques chez les sujets obeses.,,,,,,,,,,,
12538103,NLM,MEDLINE,20030226,20191106,0003-3944 (Print) 0003-3944 (Linking),127,10,2002 Dec,[The suprahepatic approach. An easy laparoscopic access to the hiatus in obese patients].,791-3,,The conventional laparoscopic access to the gastroesophageal junction involves the retraction the left hepatic lobe upward. This approach could be particularly difficult in obese patients because of a huge fatty liver. The technique described here aims to overcome this difficulty be using a suprahepatic route by displacing the left lobe downward after dividing the left triangular ligament. This approach allows a good exposure of the gastroesophageal junction to perform a fundoplication or a gastric banding.,"['Slim, K']",['Slim K'],"['Service de chirurgie generale et digestive, Hotel-Dieu, Boulevard Leon-Malfreyt, F-63058, Clermont-Ferrand cedex, France. kslim@chu-clermontferrand.fr']",['fre'],"['English Abstract', 'Journal Article']",France,Ann Chir,Annales de chirurgie,0140722,,IM,"['Digestive System Surgical Procedures/*methods', 'Fundoplication/*methods', 'Gastroesophageal Reflux/*surgery', 'Humans', 'Laparoscopy/*methods', 'Liver/surgery', 'Obesity/*complications']",,,,,2003/01/23 04:00,2003/02/27 04:00,['2003/01/23 04:00'],"['2003/01/23 04:00 [pubmed]', '2003/02/27 04:00 [medline]', '2003/01/23 04:00 [entrez]']","['S0003394402008775 [pii]', '10.1016/s0003-3944(02)00877-5 [doi]']",ppublish,Ann Chir. 2002 Dec;127(10):791-3. doi: 10.1016/s0003-3944(02)00877-5.,,,,,,,,,La voie supra-hepatique. Un abord laparoscopique aise de la region hiatale chez les patients obeses.,,,,,,,,,,,
7171179,NLM,MEDLINE,19830610,20061115,0003-410X (Print) 0003-410X (Linking),133,8,1982,[Pain sensitivity in obese individuals].,528-31,,"Using the measure of the nociceptive threshold by saphenobicipital reflex method in 30 obese women (30 p. cent or more above ideal weight) and 20 controls, the authors observe that in the obese group the threshold of the nociceptive flexion reflex is significantly lower than in controls (6.57 +/- 3.52 mA in obese; 9.42 +/- 1.90 mA in controls). There is a significant reverse correlation between degree of overweight and the threshold of the nociceptive reflex. The authors suggest the hypothesis of an abnormality of the endogenous morphine-like system or of its control in human obesity.","['Pradalier, A', 'Willer, J C', 'Dry, J']","['Pradalier A', 'Willer JC', 'Dry J']",,['fre'],"['English Abstract', 'Journal Article']",France,Ann Med Interne (Paris),Annales de medecine interne,0171744,['0 (Endorphins)'],IM,"['Adult', 'Aged', 'Body Weight', 'Electrophysiology', 'Endorphins/physiology', 'Female', 'Humans', 'Middle Aged', 'Obesity/*physiopathology', 'Pain/*physiopathology']",,,,,1982/01/01 00:00,1982/01/01 00:01,['1982/01/01 00:00'],"['1982/01/01 00:00 [pubmed]', '1982/01/01 00:01 [medline]', '1982/01/01 00:00 [entrez]']",,ppublish,Ann Med Interne (Paris). 1982;133(8):528-31.,,,,,,,,,Etude de la sensibilite a la douleur chez les obeses.,,,,,,,,,,,
18146959,NLM,MEDLINE,20071227,20201005,0025-7648 (Print) 0025-7648 (Linking),7,166,1949 Jul 1,[Active obesities and passive obesities].,9-14,,,"['NOGUER MORE, J']",['NOGUER MORE J'],,['spa'],['Journal Article'],Spain,Medicamenta (Madr),Medicamenta,0400716,,OM,"['Humans', '*Obesity']",,['NLM'],['*OBESITY'],,1949/07/01 00:00,2008/05/31 09:00,['1949/07/01 00:00'],"['1949/07/01 00:00 [pubmed]', '2008/05/31 09:00 [medline]', '1949/07/01 00:00 [entrez]']",,ppublish,Medicamenta (Madr). 1949 Jul 1;7(166):9-14.,,,,,,,,,Obesidades activas y obesidades pasivas.,,,,['CLML: 4917:703b1'],,,,,,,
15430260,NLM,MEDLINE,20040930,20181201,0032-7867 (Print) 0032-7867 (Linking),58,36,1950 Jun 7,[The heart in obese subjects].,643,,,"['RIVET, L']",['RIVET L'],,['und'],['Journal Article'],France,Presse Med (1893),La Presse medicale,0312556,,OM,"['*Heart', 'Humans', '*Obesity']",,['NLM'],"['*HEART', '*OBESITY']",,1950/06/07 00:00,1950/06/07 00:01,['1950/06/07 00:00'],"['1950/06/07 00:00 [pubmed]', '1950/06/07 00:01 [medline]', '1950/06/07 00:00 [entrez]']",,ppublish,Presse Med (1893). 1950 Jun 7;58(36):643.,,,,,,,,,Le coeur des obeses.,,,,['CLML: 5019:20637:106:172'],,,,,,,
5924171,NLM,MEDLINE,19670129,20081212,0032-7867 (Print) 0032-7867 (Linking),74,52,1966 Dec 3,[Clinical study in 100 obese patients of a new anorexigenic agent active by the oral route: RO-4 5282].,2695-6,,,"['Bricaire, H', 'Philbert, M']","['Bricaire H', 'Philbert M']",,['fre'],['Journal Article'],France,Presse Med (1893),La Presse medicale,0312556,"['0 (Appetite Depressants)', '0 (Ethylamines)']",IM,"['Adolescent', 'Adult', 'Aged', 'Appetite Depressants/*therapeutic use', 'Child', 'Ethylamines/*therapeutic use', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*drug therapy']",,,,,1966/12/03 00:00,1966/12/03 00:01,['1966/12/03 00:00'],"['1966/12/03 00:00 [pubmed]', '1966/12/03 00:01 [medline]', '1966/12/03 00:00 [entrez]']",,ppublish,Presse Med (1893). 1966 Dec 3;74(52):2695-6.,,,,,,,,,Etude clinique chez 100 obeses d'un nouvel anorexigene actif par voie buccale: le RO-4 5282.,,,,,,,,,,,
3897356,NLM,MEDLINE,19851015,20191022,0391-4097 (Print) 0391-4097 (Linking),8,3,1985 Jun,Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.,233-9,,"The authors have studied insulin receptors on peripheral blood monocytes and insulin sensitivity, evaluated by simultaneous infusion of glucose, insulin and somatostatin in 10 control subjects and in 20 obese patients with normal glucose tolerance. The obese patients have been divided into two groups, normo (NO) and hyperinsulinemic (HO), according to the total insulin response during OGTT. We considered HO patients with insulin response higher than M + 2DS of controls. Obese patients showed, in comparison to the controls, a lower specific binding and higher degree of insulin resistance. The subdivision of obese patients allowed us to distinguish two groups. The first was characterized by basal hyperinsulinemia, normal insulin response to the stimulus, reduced number of insulin receptors and normal or slightly reduced sensitivity. The second group showed high basal and after stimulus insulinemic values, reduced number of insulin receptors and high level of insulin resistance. When we compared the two groups of obeses we found that the first has a shorter duration of obesity and lower blood glucose values after OGTT. However both groups show the same reduction of insulin bound and the same degree of basal hyperinsulinemia. These data suggest that a reduction of insulin receptors is not the main factor responsible for insulin resistance in obesity. Furthermore, the presence of basal hyperinsulinemia and normal insulin sensitivity in our first group suggests that the modification of basal insulin concentrations is not dependent on the presence of insulin resistance.","['Carducci Artenisio, A', 'Ragonese, F', 'Forte, F', 'Saitta, G', 'Perrone, G', 'Lettina, G', 'Campisi, R', 'Consolo, F']","['Carducci Artenisio A', 'Ragonese F', 'Forte F', 'Saitta G', 'Perrone G', 'Lettina G', 'Campisi R', 'Consolo F']",,['eng'],['Journal Article'],Italy,J Endocrinol Invest,Journal of endocrinological investigation,7806594,"['0 (Blood Glucose)', '0 (C-Peptide)', '0 (Insulin)', '9007-92-5 (Glucagon)', 'EC 2.7.10.1 (Receptor, Insulin)']",IM,"['Adult', 'Blood Glucose/metabolism', 'C-Peptide/blood', 'Glucagon/blood', 'Glucose Tolerance Test', 'Humans', 'Hyperinsulinism/complications/*metabolism', 'Insulin/blood', '*Insulin Resistance', 'Middle Aged', 'Obesity/complications/*metabolism', 'Receptor, Insulin/*metabolism']",,,,,1985/06/01 00:00,1985/06/01 00:01,['1985/06/01 00:00'],"['1985/06/01 00:00 [pubmed]', '1985/06/01 00:01 [medline]', '1985/06/01 00:00 [entrez]']",['10.1007/BF03348483 [doi]'],ppublish,J Endocrinol Invest. 1985 Jun;8(3):233-9. doi: 10.1007/BF03348483.,,,,,,,,,,,,,,,,,,,,
6534893,NLM,MEDLINE,19850708,20140603,,8 Suppl 1,,1984,"Anorectic potency of inhibiting GABA transaminase in brain: studies of hypothalamic, dietary and genetic obesities.",191-200,,"A variety of recent literature suggests that brain gamma-aminobutyric acid (GABA) plays an important role in the control of feeding. One such line of evidence is that pharmacological inhibition of brain GABA transaminase (GABA-T) produces dose-dependent anorexia in otherwise normal rats. To determine the generality of these findings we tested the ability of the GABA-T inhibitor ethanolamine-O-sulfate (EOS), to produce anorexia in three animal models of obesity: rats with medial hypothalamic lesions, rats exposed to palatable foods or Zucker fatty rats. Following intracisternal injection of 100, 200 or 400 micrograms EOS, all three models of chronic overeating showed dose-dependent anorexia of similar magnitude and duration to that seen in appropriate controls. These observations provide empirical support for previous suggestions that treatments which enhance brain GABA neurotransmission merit investigation for their potential use in treating excess energy consumption.","['Coscina, D V', 'Nobrega, J N']","['Coscina DV', 'Nobrega JN']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Int J Obes,International journal of obesity,7703240,"['0 (Ethanolamines)', '9C8F910HLK (ethanolamine O-sulfate)', 'EC 2.6.1.19 (4-Aminobutyrate Transaminase)']",IM,"['4-Aminobutyrate Transaminase/*antagonists & inhibitors', 'Animals', 'Appetite/*physiology', 'Brain/*enzymology', 'Diet', 'Ethanolamines/pharmacology', 'Female', 'Hypothalamus/*physiopathology', 'Obesity/enzymology/genetics/*physiopathology', 'Rats', 'Rats, Inbred Strains', 'Rats, Zucker', 'Ventromedial Hypothalamic Nucleus/physiopathology']",,,,,1984/01/01 00:00,1984/01/01 00:01,['1984/01/01 00:00'],"['1984/01/01 00:00 [pubmed]', '1984/01/01 00:01 [medline]', '1984/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1984;8 Suppl 1:191-200.,,,,,,,,,,,,,,,,,,,,
2534744,NLM,MEDLINE,19900813,20061115,0037-9026 (Print) 0037-9026 (Linking),183,5,1989,[Sleep alterations of obese night shiftworkers].,449-56,,"The night shiftwork on the one hand, the obesity on the other hand, are at the origin of sleep modifications. Is the overweight an aggravating factor which damages the recovering sleep? A study on sleep conducted in the laboratory on 7 reference subjects and 7 obese subjects, randomly allocated with regard to age, seniority and Body Mass Index, has shown only a small influence of the overweight on the slow wave sleep during the night shortened by shift work. Obesity does not seem to alter the REM sleep.","['Stempfer, M O', 'Di Nisi, J', 'Machacek, A', 'Libert, J P', 'Ehrhart, J']","['Stempfer MO', 'Di Nisi J', 'Machacek A', 'Libert JP', 'Ehrhart J']","['Laboratoire de Physiologie et de Psychologie Environnementales, CNRS, Strasbourg.']",['fre'],"['Clinical Trial', 'English Abstract', 'Journal Article', 'Randomized Controlled Trial']",France,C R Seances Soc Biol Fil,Comptes rendus des seances de la Societe de biologie et de ses filiales,7505439,,IM,"['Adult', 'Humans', 'Obesity/*physiopathology', 'Random Allocation', 'Sleep/*physiology', 'Sleep, REM/physiology']",,,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,C R Seances Soc Biol Fil. 1989;183(5):449-56.,,,,,,,,,Sommeil des travailleurs obeses en poste de nuit.,,,,,,,,,,,
6840967,NLM,MEDLINE,19830617,20140603,,7,1,1983,Psychosocial functioning of two groups of morbidly obese patients.,53-9,,"Fourteen morbidly obese women who were candidates for intestinal bypass surgery were compared in terms of psychosocial functioning and dietary behavior to 14 morbidly obese women who elected not to undergo the bypass procedure. Each patient underwent a psychiatric evaluation which included a developmental and dietary history, a mental status exam, and the administration of the MMPI. Diagnoses were based on the DSM-III multi-axial system. There was no difference between the bypass group and the non-bypass group on the Axis I diagnoses, however the bypass group did have a significantly higher frequency of Axis II diagnoses. The bypass group demonstrated significantly higher levels of psychosocial stressors (Axis IV) and lower levels of adaptive functioning (Axis V) when compared to the non-bypass group. The bypass patients also had a significantly higher frequency of past suicide attempts. On the MMPI, the bypass group had significantly higher elevations on scales 2 (depression), 4 (psychopathic deviate), 6 (paranoia), and 0 (social introversion). There were no significant differences between the groups in terms of dietary history and behavior, except that significantly fewer bypass patients could place a numerical estimate on their daily energy intake. These results were discussed in terms of their implications for the assessment and treatment of morbidly obese patients.","['Rosen, L W', 'Aniskiewicz, A S']","['Rosen LW', 'Aniskiewicz AS']",,['eng'],"['Comparative Study', 'Journal Article']",England,Int J Obes,International journal of obesity,7703240,,IM,"['Adult', 'Female', 'Humans', 'MMPI', 'Mental Disorders/complications', 'Obesity/complications/diet therapy/*psychology/therapy', '*Social Adjustment', 'Stress, Psychological', 'Suicide, Attempted']",,,,,1983/01/01 00:00,1983/01/01 00:01,['1983/01/01 00:00'],"['1983/01/01 00:00 [pubmed]', '1983/01/01 00:01 [medline]', '1983/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1983;7(1):53-9.,,,,,,,,,,,,,,,,,,,,
21545018,NLM,MEDLINE,20110531,20181201,1660-9379 (Print) 1660-9379 (Linking),7,288,2011 Mar 30,[A new program of therapeutic education for obese patients].,"695-6, 698-9",,"Obesity is a chronic disease which is increasing over the past thirty years. This disease is complex and its treatment is difficult and generally frustrating for the patients and the medical team because of a high risk of relapse. Indeed, a dietetic approach alone is most of the time not good enough to obtain a long-lasting weight loss; the few drugs on the market should also be prescribed as a part of a more global approach. A multidisciplinary approach with a long-standing follow-up including a cognitive-behavioral therapy coupled to a diet and physical activity is mandatory to avoid any weight regain. We propose a new multidisciplinary program of two years with in hospital-stay and ambulatory follow-up which is showing some promising results (90% of success at one year).","['Gaillard, S', 'Barthassat, V', 'Pataky, Z', 'Golay, A']","['Gaillard S', 'Barthassat V', 'Pataky Z', 'Golay A']","[""Service d'enseignement therapeutique pour maladies chroniques, Centre collaborateur de I'Organisation mondiale de la sante, Departement de medecine communautaire et de premier recours HUG, 1211 Geneve 14. Stephanie.Gaillard@hcuge.ch""]",['fre'],['Journal Article'],Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Cognitive Behavioral Therapy', 'Diet', 'Humans', 'Obesity/*therapy']",,,,,2011/05/07 06:00,2011/06/01 06:00,['2011/05/07 06:00'],"['2011/05/07 06:00 [entrez]', '2011/05/07 06:00 [pubmed]', '2011/06/01 06:00 [medline]']",,ppublish,"Rev Med Suisse. 2011 Mar 30;7(288):695-6, 698-9.",,,,,,,,,Un nouveau programme d'education therapeutique pour les patients obeses.,,,,,,,,,,,
8047779,NLM,MEDLINE,19940901,20131121,0761-8417 (Print) 0761-8417 (Linking),49,5,1993,[Gas exchange during spontaneous and controlled ventilation in obese subjects with chronic bronchitis. Value of normalized CO intake].,199-208,,"In obese subjects with chronic bronchitis hypercapnia by limitation of tidal volume regresses if a slow ventilatory frequency is imposed by lengthening of expiration time. But hypoxemia due to shunt effect can either be corrected by global improvement of alveolar ventilation VA or persist and become worse by low pulmonary volume ventilation which lowers VA/Q. The effect of bradypnoea on 11 elderly patients with moderate obesity has been evaluated by simultaneous measurements of blood gases, ventilatory output coefficients, gas flow rate and steady state transfer for CO. Although hypo-VA disappeared in bradypnoea, hypoxemia persisted in 5 cases, the increase of P(Aa)O2 was accentuated in 7 cases, VCO always remained in deficit compared with VCO2 (in healthy subjects at rest, VCO and VCO2 are interrelated by a proportionally constant whatever the respiratory regimen: VCO/VCO2 = specific VCO, or VCO Sp). The VCO/VA variation correlated negatively with the P(Aa)O2 variation. This study: 1) confirms the link between PaCO2 and VT and the persistence of shunt effect bradypnoea compatible with the deficit of VCO versus VCO2; 2) distinguishes the efficiency of bradypnoea in ventilation and in alveolo-capillary exchange; 3) compares the variations of VCO Sp with those of PaO2 in relation to VT; 4) defines the characteristics of respiratory insufficiency in the obese and bronchitic subjects examined, and 5) specifies the value of VCO Sp measurement in testing the controlled ventilation technique used.","['Breant, J', 'Fleury, M F', 'Goudin, J', 'Bance, N']","['Breant J', 'Fleury MF', 'Goudin J', 'Bance N']","[""Service d'Insuffisants respiratoires, La Musse, Saint Sebastien de Morsent.""]",['fre'],"['English Abstract', 'Journal Article']",France,Rev Pneumol Clin,Revue de pneumologie clinique,8406312,['7U1EE4V452 (Carbon Monoxide)'],IM,"['Adult', 'Aged', 'Blood Gas Analysis', 'Bronchitis/*complications/physiopathology', 'Carbon Monoxide/metabolism', 'Chronic Disease', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications/physiopathology', '*Pulmonary Gas Exchange', 'Respiration', 'Respiratory Insufficiency/*etiology/physiopathology']",,,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",,ppublish,Rev Pneumol Clin. 1993;49(5):199-208.,,,,,,,,,Echanges en ventilation spontanee et dirigee d'obeses bronchiteux chroniques. Interet de la prise de CO normalisee.,,,,,,,,,,,
13048252,NLM,MEDLINE,20030501,20181201,0035-2640 (Print) 0035-2640 (Linking),2,16,1952 Jun 1,[Diagnosis and therapy of common obesities].,1003-7,,,"['VAGUE, J']",['VAGUE J'],,['und'],['Journal Article'],France,Rev Prat,La Revue du praticien,0404334,,OM,"['Humans', '*Obesity']",,['NLM'],['*OBESITY'],,1952/06/01 00:00,1952/06/01 00:01,['1952/06/01 00:00'],"['1952/06/01 00:00 [pubmed]', '1952/06/01 00:01 [medline]', '1952/06/01 00:00 [entrez]']",,ppublish,Rev Prat. 1952 Jun 1;2(16):1003-7.,,,,,,,,,Diagnostic et traitement des obesites communes.,,,,['CLML: 5324:18662:451'],,,,,,,
18862533,NLM,MEDLINE,20081016,20201005,,8,3,1948 Feb 10,[Treatment of functional obesities].,33-6,,,"['LEVEN, R']",['LEVEN R'],,['fre'],['Journal Article'],France,Med Gen Fr,Le Medecin generaliste de France,7508660,,OM,"['Humans', '*Obesity']",,['NLM'],['*OBESITY'],,1948/02/10 00:00,2008/10/24 09:00,['1948/02/10 00:00'],"['1948/02/10 00:00 [pubmed]', '2008/10/24 09:00 [medline]', '1948/02/10 00:00 [entrez]']",,ppublish,Med Gen Fr. 1948 Feb 10;8(3):33-6.,,,,,,,,,Traitement des obesites fonctionnelles.,,,,['CLML: 4815:277d'],,,,,,,
13048254,NLM,MEDLINE,20030501,20181201,0035-2640 (Print) 0035-2640 (Linking),2,16,1952 Jun 1,[Obesities of nervous origin].,1017-21,,,"['DE GENNES, L', 'BUGE, A']","['DE GENNES L', 'BUGE A']",,['und'],['Journal Article'],France,Rev Prat,La Revue du praticien,0404334,,OM,"['*Anxiety', 'Humans', '*Nervous System Diseases', 'Obesity/*etiology']",,['NLM'],"['*NERVOUS SYSTEM/diseases', '*OBESITY/etiology and pathogenesis']",,1952/06/01 00:00,1952/06/01 00:01,['1952/06/01 00:00'],"['1952/06/01 00:00 [pubmed]', '1952/06/01 00:01 [medline]', '1952/06/01 00:00 [entrez]']",,ppublish,Rev Prat. 1952 Jun 1;2(16):1017-21.,,,,,,,,,Les obesites d'origine nerveuse.,,,,['CLML: 5324:18664:435:452'],,,,,,,
427678,NLM,MEDLINE,19790629,20081120,0008-4409 (Print) 0008-4409 (Linking),120,3,1979 Feb 3,[For the obese: stop eating compulsively].,"369, 372",,,,,,['fre'],['News'],Canada,Can Med Assoc J,Canadian Medical Association journal,0414110,,IM,"['Canada', 'Humans', 'Obesity/*diet therapy/psychology', '*Self-Help Groups']",PMC1819020,,,,1979/02/03 00:00,1979/02/03 00:01,['1979/02/03 00:00'],"['1979/02/03 00:00 [pubmed]', '1979/02/03 00:01 [medline]', '1979/02/03 00:00 [entrez]']",,ppublish,"Can Med Assoc J. 1979 Feb 3;120(3):369, 372.",,,,,,,,,Pour les obeses: cesser de manger avec compulsion.,,,,,,,,,,,
7930866,NLM,MEDLINE,19941116,20041117,0024-6921 (Print) 0024-6921 (Linking),146,8,1994 Aug,Are there effective treatments for the severely obese?,348-54,,"Obesity is a major contributor to the costs of several chronic diseases and disabilities. Over 30% of adults in Louisiana are moderately to severely obese (defined as a body mass index > 28). As weight increases so do sick days and bedridden days. The estimated direct economic costs of not treating obesity effectively are over $40 billion nationwide, or 5.5% of all medical costs. Even though weight loss reduces the medication needs of obese individuals with hypertension, diabetes, and osteoarthritis, physicians have been reluctant to treat obese people because many treatments fail and are not considered cost effective. We present the available treatment options including their advantages and disadvantages. These treatments help between 25% and 85% of those referred to special centers specializing in obesity treatments. All physicians can help their obese patients by being aware of the costs, risks, and benefits of modern medically-supervised weight management programs.","['Martin, L F', 'Hunter, S M']","['Martin LF', 'Hunter SM']","['Dept of Health Systems Research and Development and Surgery, Louisiana State University Medical Center, New Orleans.']",['eng'],['Journal Article'],United States,J La State Med Soc,The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,7505618,,IM,"['Gastric Bypass', 'Humans', 'Obesity/complications/diagnosis/economics/*therapy', '*Weight Loss']",,,,,1994/08/01 00:00,1994/08/01 00:01,['1994/08/01 00:00'],"['1994/08/01 00:00 [pubmed]', '1994/08/01 00:01 [medline]', '1994/08/01 00:00 [entrez]']",,ppublish,J La State Med Soc. 1994 Aug;146(8):348-54.,,,,,,,,,,,,,,,,,,,,
1186358,NLM,MEDLINE,19760117,20190817,0025-7125 (Print) 0025-7125 (Linking),59,6,1975 Nov,An approach to the obese adolescent.,1507-16,,,"['Barnes, H V', 'Berger, R']","['Barnes HV', 'Berger R']",,['eng'],['Journal Article'],United States,Med Clin North Am,The Medical clinics of North America,2985236R,,IM,"['Adolescent', 'Behavior Therapy', 'Diagnosis, Differential', 'Diet, Reducing', 'Humans', '*Obesity/diagnosis/metabolism/therapy']",,,,,1975/11/01 00:00,1975/11/01 00:01,['1975/11/01 00:00'],"['1975/11/01 00:00 [pubmed]', '1975/11/01 00:01 [medline]', '1975/11/01 00:00 [entrez]']","['S0025-7125(16)31951-4 [pii]', '10.1016/s0025-7125(16)31951-4 [doi]']",ppublish,Med Clin North Am. 1975 Nov;59(6):1507-16. doi: 10.1016/s0025-7125(16)31951-4.,,,,,,,,,,,,,,,,,,,,
22512135,NLM,MEDLINE,20120503,20120419,1660-9379 (Print) 1660-9379 (Linking),8,334,2012 Mar 28,[The dilemma between the functional deficits of obese people and recommended physical activity: what part can dance therapy play?].,687-91,,"Obese people may have trouble with walking and may present reduced postural control. Medical doctors or therapists should guide the patient to restart doing physical activities that are gentle and progressive. Exercise should take into account walking difficulties. Thus, the first challenge is to help obese individuals start exercising without risk, or excessive strain on the joints. The second stage should encourage individuals to persevere in the chosen activity. Enjoyment is a key factor for attaining these objectives. Dance therapy, with its psychological and physiological impact, could help individuals take on the challenge.","['Muller-Pinget, Solange', 'Pataky, Zoltan', 'Golay, Alain', 'Armand, Stephane', 'Allet, Lara']","['Muller-Pinget S', 'Pataky Z', 'Golay A', 'Armand S', 'Allet L']","['Departement de medecine communautaire, WHO Collaborating Centre, HUG, Geneve. solange.muller-pinget@hcuge.ch']",['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Dance Therapy/*methods', 'Exercise Therapy/*methods/psychology', 'Humans', 'Motor Activity', 'Obesity/physiopathology/psychology/*therapy', 'Postural Balance', 'Walking']",,,,,2012/04/20 06:00,2012/05/04 06:00,['2012/04/20 06:00'],"['2012/04/20 06:00 [entrez]', '2012/04/20 06:00 [pubmed]', '2012/05/04 06:00 [medline]']",,ppublish,Rev Med Suisse. 2012 Mar 28;8(334):687-91.,,,,,,,,,Deficits fonctionnels des personnes obeses et role de la danse-therapie.,,,,,,,,,,,
6987592,NLM,MEDLINE,19800514,20061115,0369-8114 (Print) 0369-8114 (Linking),28,1,1980 Jan,[Morphology of adipose tissue. Study in 102 obese subjects in reference to some clinical and biological criteria (author's transl)].,17-24,,"In spite of the methodological reserves that the measure of adipocyte volume and the calculation of the number of adipocytes evoke, it appeared interesting to us to study these parameters in a group of 102 obese subjects in reference to some clinical and biological criteria. The following conclusions come out of this study. The greater the obesity, the greater the adipocyte volume. There is a positive correlation between the importance of obesity and cellularity of the adipose tissue. However, this correlation is no longer found for the most obese patients, in whom adipocyte hypertrophy intervenes but no longer the multiplication of the fat cells. The onset of obesity at adolescence pairs with a number of adipocytes higher than in the other chronological forms: obesity appearing at adolescence would be thus more frequently hyperplastic. This characteristic is not discovered in the cases of obesity appearing in infancy. No relation was found between the existence of impaired glucose tolerance and mean adipocyte diameter and/or the number of adipocytes. It has been the same for the cases of hyperlipidemia.","['Lubetzki, J', 'Roussel, C', 'Mosse, A', 'Duprey, J', 'Warnet, A', 'Bargy, D']","['Lubetzki J', 'Roussel C', 'Mosse A', 'Duprey J', 'Warnet A', 'Bargy D']",,['fre'],"['Comparative Study', 'English Abstract', 'Journal Article']",France,Pathol Biol (Paris),Pathologie-biologie,0265365,"['0 (Blood Glucose)', '0 (Lipids)']",IM,"['Adipose Tissue/cytology/*pathology', 'Adolescent', 'Adult', 'Age Factors', 'Anthropometry/methods', 'Blood Glucose/metabolism', 'Cell Count', 'Cell Division', 'Child', 'Female', 'Glucose Tolerance Test', 'Humans', 'Infant', 'Lipids/blood', 'Male', 'Obesity/*pathology']",,,,,1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']",,ppublish,Pathol Biol (Paris). 1980 Jan;28(1):17-24.,,,,,,,,,Morphologie du tissu adipeux. Etude chez 102 obeses en fonction de differents criteres cliniques et biologiques.,,,,,,,,,,,
19517910,NLM,MEDLINE,20090707,20090612,0035-3639 (Print) 0035-3639 (Linking),30,2,2009 Mar-Apr,[Type 2 prediabetic state in obese children and adolescents: galloping epidemiology that needs to tracked down by physicians. Introduction: the possible incestuous connection of type 1 and type 2 diabetes].,119-20; discussion 120-2,,,"['Dorchy, H']",['Dorchy H'],"['Clinique de Diabetologie, Hopital Universitaire des Enfants Reine Fabiola, Bruxelles.']",['fre'],['Journal Article'],Belgium,Rev Med Brux,Revue medicale de Bruxelles,8003474,,IM,"['Adolescent', 'Child', 'Diabetes Mellitus, Type 1/*epidemiology', 'Diabetes Mellitus, Type 2/*epidemiology', 'Humans', 'Obesity/complications/*epidemiology', 'Prediabetic State/complications/*epidemiology']",,,,,2009/06/13 09:00,2009/07/08 09:00,['2009/06/13 09:00'],"['2009/06/13 09:00 [entrez]', '2009/06/13 09:00 [pubmed]', '2009/07/08 09:00 [medline]']",,ppublish,Rev Med Brux. 2009 Mar-Apr;30(2):119-20; discussion 120-2.,,,,,,,,,(Pre)diabete de type 2 chez les enfants et les adolescents obeses: epidemie galopante a depister par les medecins. Introit: le possible couple incestueux des diabetes de types 1 & 2.,,,,,,,,,,,
2766001,NLM,MEDLINE,19891011,20131121,0001-4079 (Print) 0001-4079 (Linking),173,3,1989 Mar,[Sexual differentiation of the adipose tissue-muscle ratio. Its metabolic impact].,309-18; discussion 318-9,,"Muscle and fat development are regulated by opposite and also cooperating factors. Adipo-muscular ratio is the result of those forces. The need of a determined fat mass and of its corollary a determined muscle mass is an important physiologic parameter. Sexual differentiation is the main factor adipo-muscular ratio. Feminine fat is twice as big as masculine fat: it predominates in the lower body, masculine fat in the upper body. Brachio-femoral adipo-muscular ratio is, among others, a good index of fat sexual differentiation. Android obesity, predominating in both sexes in the upper body, is, with genetic predispositions, the main factor of non insulin dependent diabetes carbohydrate sensitive hyperlipoproteinemia, hyperuricemia, atherosclerosis. Easy determination on fat topography before the age of 30 is, particularly in women, the best tool for an efficacious prophylaxis of obesity's metabolic complications.","['Vague, J', 'Vague, P', 'Jubelin, J', 'Barre, A M']","['Vague J', 'Vague P', 'Jubelin J', 'Barre AM']",,['fre'],"['English Abstract', 'Journal Article']",Netherlands,Bull Acad Natl Med,Bulletin de l'Academie nationale de medecine,7503383,"['0 (Gonadal Steroid Hormones)', 'WI4X0X7BPJ (Hydrocortisone)']",IM,"['Adipose Tissue/anatomy & histology/*physiology', 'Adult', 'Body Constitution', 'Body Weight', 'Female', 'Gonadal Steroid Hormones/physiology', 'Humans', 'Hydrocortisone/physiology', 'Male', '*Metabolism', 'Muscles/anatomy & histology/*physiology', 'Obesity/genetics/metabolism', '*Sex Characteristics']",,,,,1989/03/01 00:00,1989/03/01 00:01,['1989/03/01 00:00'],"['1989/03/01 00:00 [pubmed]', '1989/03/01 00:01 [medline]', '1989/03/01 00:00 [entrez]']",,ppublish,Bull Acad Natl Med. 1989 Mar;173(3):309-18; discussion 318-9.,,,,,,,,,La differenciation sexuelle du rapport adipo-musculaire. Ses incidences metaboliques.,,,,,,,,,,,
6653861,NLM,MEDLINE,19840214,20061115,0338-1684 (Print) 0338-1684 (Linking),9,3,1983 Sep,[Evaluation of tolerance of a modified protein diet in obese subjects].,224-31,,"The purpose of this investigation was to evaluate the benefits and the potential risks of a very low calorie protein-diet in obese patients with metabolic abnormalities and at increased cardiovascular risk. To this end, the 420 kcal diet (with 50% of energy as protein) was administered for 10 days to 10 grossly obese subjects with glucose intolerance, hyperlipemia, arterial hypertension, ischemic cardiopathy and thrombotic risk related to high levels of fibrinogen factor VIII and reduced fibrinolytic activity. Weights loss averaged 360 g/day with a mean protein loss of 17 g/day occurring essentially during the very early phase of the diet. There was a rapid normalisation of blood pressure, plasma lipids and glycaemia. With the exception of a slightly negative potassium balance other ion remained in balance. There was no change in electrocardiogram, in parameters of blood coagulation or in hepatic and renal function. There was only a moderate increase in ketonaemia and plasma urate. It appears therefore, that an 8 to 10 day very low calorie protein-diet is well tolerated even in obese patients with increased cardiovascular risk, and that it corrects of several metabolic abnormalities without alteration in cardiac, hepatic or renal function.","['Kolanowski, J', 'Col-Debeys, C', 'Brohet, C R']","['Kolanowski J', 'Col-Debeys C', 'Brohet CR']",,['fre'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",France,Diabete Metab,Diabete & metabolisme,7604157,['0 (Dietary Proteins)'],IM,"['Blood Coagulation', 'Blood Platelets/physiology', 'Blood Pressure', 'Cardiovascular Diseases/*complications', '*Diet, Reducing', 'Dietary Proteins/*administration & dosage', 'Electrocardiography', 'Energy Metabolism', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/complications/*diet therapy']",,,,,1983/09/01 00:00,2000/03/11 09:00,['1983/09/01 00:00'],"['1983/09/01 00:00 [pubmed]', '2000/03/11 09:00 [medline]', '1983/09/01 00:00 [entrez]']",,ppublish,Diabete Metab. 1983 Sep;9(3):224-31.,,,,,,,,,Evaluation de la tolerance d'une diete protidique modifiee chez les sujets obeses.,,,,,,,,,,,
3142431,NLM,MEDLINE,19881201,20090213,0003-9683 (Print) 0003-9683 (Linking),81 Spec No,,1988 Jun,[Regional hemodynamics of the forearm. Comparison between obese and non-obese hypertensive patients].,65-9,,"Forearm hemodynamics using pulsed Doppler flowmetry were studied in 83 men: 15 non-obese and 8 obese normotensive subjects; and 30 non-obese and 30 obese hypertensive patients. Mean ages were similar in the four subgroups. The blood pressure of normotensives and hypertensives was identical in obese and non-obese subjects. Blood flow expressed in ml/mn was significantly higher in obese subjects whether normotensive or hypertensive. However, when blood flow was expressed per unit liter of forearm volume, it was similar in the four subgroups. Forearm vascular resistance, whether expressed as absolute of normalized values, was significantly higher (p less than 0.001) in non-obese hypertensives. When obese and non-obese hypertensives were compared, the former were characterized by higher values of blood velocity and blood flow, and lower values of vascular resistance, whether absolute or normalized values were used. The present study shows that: (i) forearm vascular resistance in hypertensives is increased exclusively in non-obese subjects, and (ii) obese hypertensives, when compared with non-obese hypertensives, are characterized by a hyperkinetic forearm circulation.","['Raison, J', 'London, G', 'Safar, M']","['Raison J', 'London G', 'Safar M']","['Centre de diagnostic, hopital Broussais, Paris.']",['fre'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",France,Arch Mal Coeur Vaiss,Archives des maladies du coeur et des vaisseaux,0406011,,IM,"['Adult', 'Blood Flow Velocity', 'Blood Pressure', 'Forearm/*blood supply', '*Hemodynamics', 'Humans', 'Hypertension/complications/*physiopathology', 'Male', 'Obesity/complications/*physiopathology', 'Ultrasonography', 'Vascular Resistance']",,,,,1988/06/01 00:00,1988/06/01 00:01,['1988/06/01 00:00'],"['1988/06/01 00:00 [pubmed]', '1988/06/01 00:01 [medline]', '1988/06/01 00:00 [entrez]']",,ppublish,Arch Mal Coeur Vaiss. 1988 Jun;81 Spec No:65-9.,,,,,,,,,Hemodynamique regionale de l'avant-bras. Comparaison entre patients hypertendus obeses ou non obeses.,,,,,,,,,,,
14930541,NLM,MEDLINE,20040215,20181201,0035-3655 (Print) 0035-3655 (Linking),72,1,1952 Jan,[New treatment of obese rheumatics; sulfur-amphetamine association].,45-51,,,"['JUNET, R']",['JUNET R'],,['und'],['Journal Article'],Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,"['0 (Amphetamines)', '70FD1KFU70 (Sulfur)', 'CK833KGX7E (Amphetamine)']",OM,"['Amphetamine/*therapeutic use', '*Amphetamines', 'Humans', 'Obesity/*therapy', 'Rheumatic Diseases/*complications', 'Sulfur/*therapeutic use']",,['NLM'],"['*AMPHETAMINE/therapeutic use', '*OBESITY/therapy', '*RHEUMATISM/complications', '*SULFUR/therapeutic use']",,1952/01/01 00:00,1952/01/01 00:01,['1952/01/01 00:00'],"['1952/01/01 00:00 [pubmed]', '1952/01/01 00:01 [medline]', '1952/01/01 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1952 Jan;72(1):45-51.,,,,,,,,,Un nouveau traitement des obeses rhumatisants; l'association soufreamphetamine.,,,,['CLML: 5222:16545:22:317:401:444'],,,,,,,
5608114,NLM,MEDLINE,19690625,20051117,0025-4053 (Print) 0025-4053 (Linking),104,5,1967,[Respiratory insufficiency in obese patients. Pickwick's syndrome].,531-6,,,"['Gascard, E']",['Gascard E'],,['fre'],['Journal Article'],France,Mars Med,Marseille medical,2985228R,,IM,"['Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications', 'Obesity Hypoventilation Syndrome/complications', 'Respiratory Insufficiency/*etiology']",,,,,1967/01/01 00:00,1967/01/01 00:01,['1967/01/01 00:00'],"['1967/01/01 00:00 [pubmed]', '1967/01/01 00:01 [medline]', '1967/01/01 00:00 [entrez]']",,ppublish,Mars Med. 1967;104(5):531-6.,,,,,,,,,L'insuffisance respiratoire des obeses. Syndrome de Pickwick.,,,,,,,,,,,
12047992,NLM,MEDLINE,20020712,20150616,0140-6736 (Print) 0140-6736 (Linking),359,9317,2002 May 4,IOU surgery and obese patients.,1618,,,"['Nelson, Michael', 'Stephenson, Brian M']","['Nelson M', 'Stephenson BM']",,['eng'],['Letter'],England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Humans', 'Motivation', 'Obesity/*complications/*prevention & control/psychology', '*Surgical Procedures, Operative', '*Waiting Lists', 'Weight Loss']",,,,,2002/06/06 10:00,2002/07/13 10:01,['2002/06/06 10:00'],"['2002/06/06 10:00 [pubmed]', '2002/07/13 10:01 [medline]', '2002/06/06 10:00 [entrez]']","['S0140-6736(02)08494-5 [pii]', '10.1016/S0140-6736(02)08494-5 [doi]']",ppublish,Lancet. 2002 May 4;359(9317):1618. doi: 10.1016/S0140-6736(02)08494-5.,,,,,,,,,,,,,,,,,,,,
17949632,NLM,MEDLINE,20080429,20211020,0212-6567 (Print) 1578-1275 (Electronic) 0212-6567 (Linking),39,10,2007 Oct,[Obese patients in primary care: characteristics and monitoring].,573-4,,,"['Janer-Llobera, Juana Maria', 'Arellano Roman, Maria Magdalena', 'Mestre Sanso, Margalida', 'Serrano Gomila, Natalia']","['Janer-Llobera JM', 'Arellano Roman MM', 'Mestre Sanso M', 'Serrano Gomila N']",,['spa'],['Letter'],Spain,Aten Primaria,Atencion primaria,9111075,,IM,"['Female', 'Humans', 'Male', '*Obesity/complications/epidemiology/therapy', 'Primary Health Care']",PMC7659489,,,,2007/10/24 09:00,2008/04/30 09:00,['2007/10/24 09:00'],"['2007/10/24 09:00 [pubmed]', '2008/04/30 09:00 [medline]', '2007/10/24 09:00 [entrez]']","['13110739 [pii]', '10.1157/13110739 [doi]']",ppublish,Aten Primaria. 2007 Oct;39(10):573-4. doi: 10.1157/13110739.,,,,,,,,,Pacientes obesos en atencion primaria: caracteristicas y seguimiento.,,,,,,,,,,,
7433085,NLM,MEDLINE,19810129,20041117,0301-1518 (Print) 0301-1518 (Linking),9,37,1980 Oct 11,[Hypersensitivity to pain in the obese].,2746,,,"['Pradalier, A', 'Willer, J C', 'Boureau, F', 'Dry, J']","['Pradalier A', 'Willer JC', 'Boureau F', 'Dry J']",,['fre'],['Journal Article'],France,Nouv Presse Med,La Nouvelle presse medicale,0312552,,IM,"['Female', 'Humans', 'Nociceptors', 'Obesity/*physiopathology', '*Pain', '*Sensory Thresholds']",,,,,1980/10/11 00:00,1980/10/11 00:01,['1980/10/11 00:00'],"['1980/10/11 00:00 [pubmed]', '1980/10/11 00:01 [medline]', '1980/10/11 00:00 [entrez]']",,ppublish,Nouv Presse Med. 1980 Oct 11;9(37):2746.,,,,,,,,,Hypersensibilite a la douleur chez les obeses.,,,,,,,,,,,
14866231,NLM,MEDLINE,20040215,20181201,0370-9590 (Print) 0370-9590 (Linking),27,27,1951 Jun 14,[Heart and vessels in the obese].,444-51,,,"['BARDIN, P']",['BARDIN P'],,['und'],['Journal Article'],Argentina,Sem Med,La Semana medica,0404403,,OM,"['*Cardiovascular System', '*Heart', 'Humans', '*Obesity']",,['NLM'],"['*CARDIOVASCULAR SYSTEM', '*OBESITY']",,1951/06/14 00:00,1951/06/14 00:01,['1951/06/14 00:00'],"['1951/06/14 00:00 [pubmed]', '1951/06/14 00:01 [medline]', '1951/06/14 00:00 [entrez]']",,ppublish,Sem Med. 1951 Jun 14;27(27):444-51.,,,,,,,,,Coeur et vaisseaux des obeses.,,,,['CLML: 5120:99892:99:177'],,,,,,,
2704479,NLM,MEDLINE,19890524,20131121,0028-8535 (Print) 0028-8535 (Linking),82,1,1989 Feb,Managing an obese and immobile patient.,23-5,,,"['Owen, J']",['Owen J'],,['eng'],"['Case Reports', 'Journal Article']",New Zealand,N Z Nurs J,The New Zealand nursing journal. Kai tiaki,19110850R,,,"['Biomechanical Phenomena', 'Female', 'Humans', 'Middle Aged', 'Nursing Assessment', 'Obesity/*nursing/psychology/rehabilitation']",,,,,1989/02/01 00:00,1989/02/01 00:01,['1989/02/01 00:00'],"['1989/02/01 00:00 [pubmed]', '1989/02/01 00:01 [medline]', '1989/02/01 00:00 [entrez]']",,ppublish,N Z Nurs J. 1989 Feb;82(1):23-5.,,,,,,,,,,,,,,,,,,,,
5427624,NLM,MEDLINE,19700826,20041117,0024-7790 (Print) 0024-7790 (Linking),223,26,1970 Jun 28,"[Life and death of the obese. II. The woman. 462 obese women in 1,144 cases observed from 1951 to 1967].",1269-86,,,"['Planchu, M', 'Pousset, G', 'de Montgolfier, R', 'Jeannot, G']","['Planchu M', 'Pousset G', 'de Montgolfier R', 'Jeannot G']",,['fre'],['Journal Article'],France,Lyon Med,Lyon medical,0335015,,IM,"['Adult', 'Age Factors', 'Aged', 'Diabetes Mellitus/*mortality', 'Female', 'France', 'Humans', 'Middle Aged', 'Obesity/complications/*epidemiology/*mortality']",,,,,1970/06/28 00:00,1970/06/28 00:01,['1970/06/28 00:00'],"['1970/06/28 00:00 [pubmed]', '1970/06/28 00:01 [medline]', '1970/06/28 00:00 [entrez]']",,ppublish,Lyon Med. 1970 Jun 28;223(26):1269-86.,,,,,,,,,Vie et mort de l'obese. II. La femme. A propos de 462 obeses sur 1144 cas observes de 1951 a 1967.,,,,,,,,,,,
5446203,NLM,MEDLINE,19700707,20131121,0032-7867 (Print) 0032-7867 (Linking),78,22,1970 May 2,[Sensitivity to ACTH of the adrenal gland in obese subjects].,1022,,,"['Boyer, J', 'Dzieniszewski, J', 'Vague, J']","['Boyer J', 'Dzieniszewski J', 'Vague J']",,['fre'],['Journal Article'],France,Presse Med (1893),La Presse medicale,0312556,['WI4X0X7BPJ (Hydrocortisone)'],IM,"['Adrenal Glands/physiopathology', 'Adrenocortical Hyperfunction/*etiology', 'Humans', 'Hydrocortisone/*blood', 'Hypersensitivity', 'Obesity/*complications']",,,,,1970/05/02 00:00,1970/05/02 00:01,['1970/05/02 00:00'],"['1970/05/02 00:00 [pubmed]', '1970/05/02 00:01 [medline]', '1970/05/02 00:00 [entrez]']",,ppublish,Presse Med (1893). 1970 May 2;78(22):1022.,,,,,,,,,La sensibilite a l'ACTH de la glande cortico-surrenale des sujets obeses.,,,,,,,,,,,
4251958,NLM,MEDLINE,19710608,20031114,0037-9026 (Print) 0037-9026 (Linking),164,7,1970,[Catecholamine load in the median eminence of male mice grown obese after administration of auro-thioglucose].,1627-9,,,"['Lefranc, G', ""L'Hermite, A"", 'Kenerve, S']","['Lefranc G', ""L'Hermite A"", 'Kenerve S']",,['fre'],['Journal Article'],France,C R Seances Soc Biol Fil,Comptes rendus des seances de la Societe de biologie et de ses filiales,7505439,"['0 (Catecholamines)', '7440-57-5 (Gold)']",IM,"['Animals', 'Catecholamines/*analysis/metabolism', '*Gold', 'Histocytochemistry', 'Hypothalamus/*analysis/metabolism/pathology', 'Male', 'Mice', 'Obesity/*chemically induced/metabolism']",,,,,1970/01/01 00:00,1970/01/01 00:01,['1970/01/01 00:00'],"['1970/01/01 00:00 [pubmed]', '1970/01/01 00:01 [medline]', '1970/01/01 00:00 [entrez]']",,ppublish,C R Seances Soc Biol Fil. 1970;164(7):1627-9.,,,,,,,,,Charge en catecholamines de l'eminence mediane de souris males devenues obeses apres administration d'auro-thioglucose.,,,,,,,,,,,
5971305,NLM,MEDLINE,19670907,20051117,0035-3787 (Print) 0035-3787 (Linking),115,3,1966 Sep,"[Comparative polygraphic study of the circadian cycle in narcoleptics, Pickwickians, the obese and patients with respiratory insufficiency].",456-62,,,"['Gastaut, H', 'Duron, B', 'Papy, J J', 'Tassinari, C A', 'Waltregny, A']","['Gastaut H', 'Duron B', 'Papy JJ', 'Tassinari CA', 'Waltregny A']",,['fre'],['Journal Article'],France,Rev Neurol (Paris),Revue neurologique,2984779R,,IM,"['*Circadian Rhythm', 'Electroencephalography', 'Humans', 'Narcolepsy/*physiopathology', 'Obesity/*physiopathology', 'Obesity Hypoventilation Syndrome/physiopathology', 'Respiratory Insufficiency/*physiopathology', '*Sleep']",,,,,1966/09/01 00:00,1966/09/01 00:01,['1966/09/01 00:00'],"['1966/09/01 00:00 [pubmed]', '1966/09/01 00:01 [medline]', '1966/09/01 00:00 [entrez]']",,ppublish,Rev Neurol (Paris). 1966 Sep;115(3):456-62.,,,,,,,,,"Etude polygraphique comparative du cycle nycthemerique chez les narcoleptiques, les Pickwickiens, les obeses et les insuffisants respiratoires.",,,,,,,,,,,
4324434,NLM,MEDLINE,19710617,20181130,0003-4266 (Print) 0003-4266 (Linking),31,5,1970 Sep-Oct,[The secretory response of the adrenal gland in obese patients to the injection of beta 1-24 corticotropin].,869-77,,,"['Boyer, J', 'Girodengo, M', 'Dzieniszewski, J', 'Vague, J']","['Boyer J', 'Girodengo M', 'Dzieniszewski J', 'Vague J']",,['fre'],['Journal Article'],France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,"['9002-60-2 (Adrenocorticotropic Hormone)', 'WI4X0X7BPJ (Hydrocortisone)']",IM,"['Adolescent', 'Adrenal Glands/drug effects/*physiopathology', 'Adrenocortical Hyperfunction/diagnosis', '*Adrenocorticotropic Hormone', 'Adult', 'Female', 'Humans', 'Hydrocortisone/metabolism', 'Injections, Intravenous', 'Male', 'Obesity/*physiopathology', 'Pituitary-Adrenal Function Tests', 'Time Factors']",,,,,1970/09/01 00:00,1970/09/01 00:01,['1970/09/01 00:00'],"['1970/09/01 00:00 [pubmed]', '1970/09/01 00:01 [medline]', '1970/09/01 00:00 [entrez]']",,ppublish,Ann Endocrinol (Paris). 1970 Sep-Oct;31(5):869-77.,,,,,,,,,La reponse secretoire cortico-surrenale des sujets obeses a l'injection de beta 1-24 corticotrophine.,,,,,,,,,,,
4657871,NLM,MEDLINE,19730606,20151119,0007-439X (Print) 0007-439X (Linking),8,5,1972 Sep-Oct,[Respiratory and right function in different types of obese patients].,915-35,,,"['Meunier-Carus, J', 'Lampert, E', 'Lonsdorfer, J', 'Kurtz, D', 'Micheletti, G']","['Meunier-Carus J', 'Lampert E', 'Lonsdorfer J', 'Kurtz D', 'Micheletti G']",,['fre'],['Journal Article'],France,Bull Physiopathol Respir (Nancy),Bulletin de physio-pathologie respiratoire,7611945,,IM,"['Adult', 'Aged', 'Blood Gas Analysis', 'Bronchitis/complications/*physiopathology', 'Chronic Disease', 'Heart/physiopathology', 'Heart Failure/*etiology', 'Heart Function Tests', 'Hemodynamics', 'Humans', 'Hypoventilation/etiology/*physiopathology', 'Lung/physiopathology', 'Middle Aged', 'Obesity/complications/*physiopathology', 'Obesity Hypoventilation Syndrome/physiopathology', 'Reflex', 'Respiratory Function Tests', 'Respiratory Insufficiency/etiology/physiopathology', 'Sleep Wake Disorders/*physiopathology', 'Ventilation-Perfusion Ratio']",,,,,1972/09/01 00:00,1972/09/01 00:01,['1972/09/01 00:00'],"['1972/09/01 00:00 [pubmed]', '1972/09/01 00:01 [medline]', '1972/09/01 00:00 [entrez]']",,ppublish,Bull Physiopathol Respir (Nancy). 1972 Sep-Oct;8(5):915-35.,,,,,,,,,La fonction respiratoire et cardiaque droite des obeses selon leur type.,,,,,,,,,,,
13251434,NLM,MEDLINE,20030501,20181201,0016-5557 (Print) 0016-5557 (Linking),61,13,1954 Jul 1,[Pathogenesis and treatment of obesities].,875-81,,,"['DE GENNES, L']",['DE GENNES L'],,['fre'],['Journal Article'],France,Gaz Med Fr,Gazette medicale de France,0034270,,OM,"['*Diencephalon', '*Disease', 'Humans', 'Obesity/*etiology']",,['NLM'],"['*DIENCEPHALON/diseases', '*OBESITY/etiology and pathogenesis']",,1954/07/01 00:00,1954/07/01 00:01,['1954/07/01 00:00'],"['1954/07/01 00:00 [pubmed]', '1954/07/01 00:01 [medline]', '1954/07/01 00:00 [entrez]']",,ppublish,Gaz Med Fr. 1954 Jul 1;61(13):875-81.,,,,,,,,,Pathogenie et traitement des obesites.,,,,['CLML: 5629:3237'],,,,,,,
13693384,NLM,MEDLINE,19981101,20181130,0024-3507 (Print) 0024-3507 (Linking),5,,1960,[Obesities of the puberal period].,565-73,,,"['CHRISTIAENS, L']",['CHRISTIAENS L'],,['fre'],['Journal Article'],France,Lille Med,Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,8203780,,OM,"['Adolescent', 'Humans', '*Obesity', '*Pediatric Obesity']",,['NLM'],['*OBESITY/in adolescence'],,1960/01/01 00:00,1960/01/01 00:01,['1960/01/01 00:00'],"['1960/01/01 00:00 [pubmed]', '1960/01/01 00:01 [medline]', '1960/01/01 00:00 [entrez]']",,ppublish,Lille Med. 1960;5:565-73.,,,,,,,,,,,,,,,,,,,,
13651802,NLM,MEDLINE,20000701,20181201,0001-4079 (Print) 0001-4079 (Linking),143,9-10,1959 Mar 10-17,[Blood disorders in the obese].,187-8,,,"['KERMORGANT, Y']",['KERMORGANT Y'],,['fre'],['Journal Article'],Netherlands,Bull Acad Natl Med,Bulletin de l'Academie nationale de medecine,7503383,,OM,"['Humans', 'Obesity/*blood']",,['NLM'],['*OBESITY/blood in'],,1959/03/10 00:00,1959/03/10 00:01,['1959/03/10 00:00'],"['1959/03/10 00:00 [pubmed]', '1959/03/10 00:01 [medline]', '1959/03/10 00:00 [entrez]']",,ppublish,Bull Acad Natl Med. 1959 Mar 10-17;143(9-10):187-8.,,,,,,,,,Troubles pathologiques du serum chez les obeses.,,,,['CLML: 5936:25758:382'],,,,,,,
12979408,NLM,MEDLINE,20030501,20181201,0010-5309 (Print) 0010-5309 (Linking),74,15,1952 Apr 12,[The legs of the obese].,1393-4,,,"['KERMORGANT, Y']",['KERMORGANT Y'],,['und'],['Journal Article'],France,Concours Med,Concours medical,2984731R,,OM,"['Humans', '*Leg', '*Obesity']",,['NLM'],['*OBESITY'],,1952/04/12 00:00,1952/04/12 00:01,['1952/04/12 00:00'],"['1952/04/12 00:00 [pubmed]', '1952/04/12 00:01 [medline]', '1952/04/12 00:00 [entrez]']",,ppublish,Concours Med. 1952 Apr 12;74(15):1393-4.,,,,,,,,,Les jambes des obeses.,,,,['CLML: 5323:3641:383'],,,,,,,
18179015,NLM,MEDLINE,20080207,20080108,1259-4792 (Print) 1259-4792 (Linking),,239,2007 Dec,[Medium-stay centers for obese children].,35-7,,,"['Frelut, Marie-Laure']",['Frelut ML'],"['Centre therapeutique pediatrique, Margency. mfrelut@ctpmargency.com']",['fre'],['Journal Article'],France,Soins Pediatr Pueric,"Soins. Pediatrie, puericulture",9604503,,,"['Adolescent', 'Bariatric Surgery', 'Child', 'Child Nutrition Disorders/epidemiology/*therapy', 'Community Health Centers/*organization & administration', 'France/epidemiology', 'Humans', 'Obesity/epidemiology/*therapy', 'Patient Admission', 'Patient Care Team/*organization & administration', 'Patient Selection', 'Prevalence', 'Residential Treatment/*organization & administration', 'Treatment Outcome']",,,,,2008/01/09 09:00,2008/02/08 09:00,['2008/01/09 09:00'],"['2008/01/09 09:00 [pubmed]', '2008/02/08 09:00 [medline]', '2008/01/09 09:00 [entrez]']",,ppublish,Soins Pediatr Pueric. 2007 Dec;(239):35-7.,,,,,,,,,Les centres de moyen sejour pour enfants obeses.,,,,,,,,,,,
4921316,NLM,MEDLINE,19710113,20041117,0369-8114 (Print) 0369-8114 (Linking),18,21,1970 Nov,[Adipose tissue pinocytosis and catecholamines in fasting obese persons].,935-41,,,"['Sdrobici, D', 'Petrovici, A', 'Bonaparte, H', 'Pieptea, R', 'Mihalache, N']","['Sdrobici D', 'Petrovici A', 'Bonaparte H', 'Pieptea R', 'Mihalache N']",,['fre'],['Journal Article'],France,Pathol Biol (Paris),Pathologie-biologie,0265365,['0 (Catecholamines)'],IM,"['Adipose Tissue/*analysis/pathology', 'Animals', 'Biopsy', 'Catecholamines/*analysis', 'Cell Membrane Permeability', '*Fasting', 'Humans', 'Lipoma/metabolism/pathology', 'Microscopy, Electron', 'Microscopy, Fluorescence', 'Obesity/*metabolism/pathology', '*Pinocytosis', 'Rats']",,,,,1970/11/01 00:00,1970/11/01 00:01,['1970/11/01 00:00'],"['1970/11/01 00:00 [pubmed]', '1970/11/01 00:01 [medline]', '1970/11/01 00:00 [entrez]']",,ppublish,Pathol Biol (Paris). 1970 Nov;18(21):935-41.,,,,,,,,,Pinocytose et catecholamines du tissu adipeux des obeses soumis au jeune.,,,,,,,,,,,
3613367,NLM,MEDLINE,19870831,20091119,0075-4439 (Print) 0075-4439 (Linking),,,1986,[Influence of fructose on erythrocyte insulin receptors in obese diabetics and non-diabetics].,207-17,,,"['Rizkalla, S W', 'Baigts, F', 'Fumeron, F', 'Grigoresco, C', 'Jean-Joseph-Halfon, P', 'Apfelbaum, M', 'Tchobroutsky, G', 'Slama, G']","['Rizkalla SW', 'Baigts F', 'Fumeron F', 'Grigoresco C', 'Jean-Joseph-Halfon P', 'Apfelbaum M', 'Tchobroutsky G', 'Slama G']",,['fre'],['Journal Article'],France,Journ Annu Diabetol Hotel Dieu,Journees annuelles de diabetologie de l'Hotel-Dieu,0424745,"['30237-26-4 (Fructose)', 'EC 2.7.10.1 (Receptor, Insulin)']",IM,"['Adult', 'Diabetes Mellitus/*physiopathology', 'Erythrocytes/*drug effects/physiology', 'Female', 'Fructose/*pharmacology', 'Humans', 'Male', 'Obesity/*physiopathology', 'Receptor, Insulin/*physiology']",,,,,1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",,ppublish,Journ Annu Diabetol Hotel Dieu. 1986:207-17.,,,,,,,,,Influence du fructose sur les recepteurs erythrocytaires de l'insuline chez les obeses diabetiques et non diabetiques.,,,,,,,,,,,
7818018,NLM,MEDLINE,19950206,20041117,0002-1148 (Print) 0002-1148 (Linking),34 Spec No 1,,1994,[Changes in thoracopulmonary compliance in normal and obese subjects in prone position].,48,,,"['Mulazzi, D', 'Baratta, P', 'Calappi, E', 'Parma, A', 'Signoroni, G', 'Tomaselli, P']","['Mulazzi D', 'Baratta P', 'Calappi E', 'Parma A', 'Signoroni G', 'Tomaselli P']","[""Departement d'anesthesie reanimation II, Universite de Milan.""]",['fre'],['Journal Article'],France,Agressologie,Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,0121575,,IM,"['Adult', 'Aged', 'Anesthesia, General', 'Female', 'Humans', '*Lung Compliance', 'Male', 'Middle Aged', 'Obesity/*physiopathology', 'Prone Position']",,,,,1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",,ppublish,Agressologie. 1994;34 Spec No 1:48.,,,,,,,,,Variations de la compliance thoraco-pulmonaire chez les sujets normotypes et les obeses en decubitus ventral.,,,,,,,,,,,
18128265,NLM,MEDLINE,20071227,20201005,,18,167,1949 Feb,[Active obesities and passive obesities].,129,,,"['NOGUER MORE, J']",['NOGUER MORE J'],,['spa'],['Journal Article'],Spain,Rev Esp Tuberc,Revista espanola de tuberculosis,0416675,,OM,"['Humans', '*Obesity']",,['NLM'],['*OBESITY'],,1949/02/01 00:00,2008/05/31 09:00,['1949/02/01 00:00'],"['1949/02/01 00:00 [pubmed]', '2008/05/31 09:00 [medline]', '1949/02/01 00:00 [entrez]']",,ppublish,Rev Esp Tuberc. 1949 Feb;18(167):129.,,,,,,,,,Obesidades activas y obesidades pasivas.,,,,['CLML: 4917:96a'],,,,,,,
18116211,NLM,MEDLINE,20071227,20201005,0366-1334 (Print) 0366-1334 (Linking),65,5-6,1949 Feb 1-18,[Para-basedowian febrile obesities with headache].,111-7,,,"['NETTER, A', 'MATHE, G']","['NETTER A', 'MATHE G', 'et al.']",,['fre'],['Journal Article'],France,Bull Mem Soc Med Hop Paris,Bulletins et memoires de la Societe medicale des hopitaux de Paris,7503472,,OM,"['*Headache', 'Humans', '*Obesity']",,['NLM'],"['*HEADACHE', '*OBESITY']",,1949/02/01 00:00,2008/05/31 09:00,['1949/02/01 00:00'],"['1949/02/01 00:00 [pubmed]', '2008/05/31 09:00 [medline]', '1949/02/01 00:00 [entrez]']",,ppublish,Bull Mem Soc Med Hop Paris. 1949 Feb 1-18;65(5-6):111-7.,,,,,,,,,Les obesites febriles para-basedowiennes avec cephalees.,,,,['CLML: 4916:953d'],,,,,,,
12688169,NLM,MEDLINE,20030429,20091111,0036-5327 (Print) 0036-5327 (Linking),103,4,2002,[Care of obese patients in ambulatory practice].,535-41,,"This presentation characterizes some actual obesity problems and describes some treatment possibilities of obesity in the outpatient department. Obesity is a serious chronic disease. The prevalence of the obesity as one of the serious global problems is increasing in industrialized societies. Care for obese patients requires general approach including dietetic and behavioural parts, movement activity and pharmacotherapy. Most often we use reduction diet with limited consummation of energy and fat in outpatient department.","['Hlubik, P']",['Hlubik P'],"['Katedra hygieny, Vojenska lekarska akademie JEP, Trebesska 1575, 500 01 Hradec Kralove, Czech Republic. hlubik@pmfhk.cz']",['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Sb Lek,Sbornik lekarsky,0025770,,IM,"['Humans', 'Obesity/classification/etiology/*therapy']",,,,,2003/04/12 05:00,2003/04/30 05:00,['2003/04/12 05:00'],"['2003/04/12 05:00 [pubmed]', '2003/04/30 05:00 [medline]', '2003/04/12 05:00 [entrez]']",,ppublish,Sb Lek. 2002;103(4):535-41.,,,,,,,,,Pece o obezni pacienty v ambulanci.,,,,,,,,,,,
256026,NLM,MEDLINE,19790829,20161123,0029-6465 (Print) 0029-6465 (Linking),14,2,1979 Jun,A sensible approach to the obese patient.,229-45,,,"['Mahan, L K']",['Mahan LK'],,['eng'],['Journal Article'],United States,Nurs Clin North Am,The Nursing clinics of North America,0042033,,IM,"['Appetite Regulation', 'Behavior Therapy', 'Energy Metabolism', 'Exercise Therapy', 'Feeding Behavior', 'Humans', 'Life Style', 'Obesity/classification/diet therapy/psychology/*therapy', 'Patient Education as Topic']",,,,,1979/06/01 00:00,1979/06/01 00:01,['1979/06/01 00:00'],"['1979/06/01 00:00 [pubmed]', '1979/06/01 00:01 [medline]', '1979/06/01 00:00 [entrez]']",,ppublish,Nurs Clin North Am. 1979 Jun;14(2):229-45.,,,,,,,,,,,,,,,,,,,,
253362,NLM,MEDLINE,19790428,20041117,0095-4543 (Print) 0095-4543 (Linking),5,4,1978 Dec,Categorization and modification of the exogenously obese.,635-45,,,"['Adams, D B', 'Shaffer, M']","['Adams DB', 'Shaffer M']",,['eng'],['Journal Article'],United States,Prim Care,Primary care,0430463,,IM,"['*Behavior Therapy', 'Humans', 'Obesity/psychology/*therapy']",,,,,1978/12/01 00:00,1978/12/01 00:01,['1978/12/01 00:00'],"['1978/12/01 00:00 [pubmed]', '1978/12/01 00:01 [medline]', '1978/12/01 00:00 [entrez]']",,ppublish,Prim Care. 1978 Dec;5(4):635-45.,,,,,,,,,,,,,,,,,,,,
5837511,NLM,MEDLINE,19660108,20131121,0010-5309 (Print) 0010-5309 (Linking),87,22,1965 May 29,[Personalization of the dietary regime of the obese].,3769-70,,,"['Kermorgant, Y']",['Kermorgant Y'],,['fre'],['Journal Article'],France,Concours Med,Concours medical,2984731R,['97C5T2UQ7J (Cholesterol)'],IM,"['*Cholesterol', '*Diet, Reducing', 'Humans', 'Obesity/*metabolism']",,,,,1965/05/29 00:00,1965/05/29 00:01,['1965/05/29 00:00'],"['1965/05/29 00:00 [pubmed]', '1965/05/29 00:01 [medline]', '1965/05/29 00:00 [entrez]']",,ppublish,Concours Med. 1965 May 29;87(22):3769-70.,,,,,,,,,Personnalisation du regime des obeses.,,,,,,,,,,,
5623691,NLM,MEDLINE,19701013,20080213,0368-8291 (Print) 0368-8291 (Linking),93,22,1967 Oct 18,[Surgical treatment by low route of endometrial cancer in the severely obese with atresic vagina with the aid of the strategem of posterior perineal debridement].,713-8,,,"['Lolmede, M']",['Lolmede M'],,['fre'],['Journal Article'],France,Mem Acad Chir (Paris),Memoires. Academie de chirurgie (France),0236701,,IM,"['Aged', 'Carcinoma/*surgery', 'Debridement', 'Endometrium/surgery', 'Female', 'Humans', '*Hysterectomy', 'Methods', 'Middle Aged', 'Obesity/*complications', 'Perineum/surgery', 'Uterine Neoplasms/*surgery', 'Vagina']",,,,,1967/10/18 00:00,1967/10/18 00:01,['1967/10/18 00:00'],"['1967/10/18 00:00 [pubmed]', '1967/10/18 00:01 [medline]', '1967/10/18 00:00 [entrez]']",,ppublish,Mem Acad Chir (Paris). 1967 Oct 18;93(22):713-8.,,,,,,,,,Traitement chirurgical par voie basse du cancer de l'endometre chez les grandes obeses a vagin atresique grace a l'artifice du debridement perineal posterieur.,,,,,,,,,,,
411584,NLM,MEDLINE,19780127,20191021,,285,7,1977 Oct 3,"[Comparison in genetically obese and normal rats of the uptake and incorporation of labelled lauric acid, oleic acid, and glycerol by the isolated perfused liver].",793-6,,"Lauric acid, labelled oleic acid and glycerol are perfused in isolated liver of fafa Rats and Wistar Rats previously subjected to fasting. They synthesize TG and PL de novo, though in long time experiments with the normal Rat, the most important method of synthesis is an exchange of AG of the endogenous glycerolipids. However PL are not synthesized with lauric acid. In the livers of fafa Rats the synthesis of TG with oleic acid and glycerol is higher than in livers of Wistar Rats: 16:0 18 : 1 18: 1, 16:0 18: 1 18: 2, 18 : 1 18 :1 18:1, 16 : 0 16 :0 18 : 1 (this TG is not present in liver of Wistar Rat). The hepatic synthesis of PL by the fafa Rat, is less important after 15 min while it is important with Wistar Rats. The synthesized TG with lauric acid (only the TG 12 : 0 12 : 0 12 : 0 with the fafa Rat) are more rapidly oxidized by liver of obese Rat than by liver of normal Rat.","['Chanussot, F', 'Debry, G']","['Chanussot F', 'Debry G']",,['fre'],"['Comparative Study', 'English Abstract', 'Journal Article']",France,C R Acad Hebd Seances Acad Sci D,Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,7501107,"['0 (Lauric Acids)', '0 (Oleic Acids)', '0 (Phospholipids)', '0 (Triglycerides)', 'PDC6A3C0OX (Glycerol)']",IM,"['Animals', 'Glycerol/*metabolism', 'Lauric Acids/*metabolism', 'Liver/*metabolism', 'Male', 'Obesity/genetics/*metabolism', 'Oleic Acids/*metabolism', 'Phospholipids/biosynthesis', 'Rats', 'Triglycerides/biosynthesis']",,,,,1977/10/03 00:00,1977/10/03 00:01,['1977/10/03 00:00'],"['1977/10/03 00:00 [pubmed]', '1977/10/03 00:01 [medline]', '1977/10/03 00:00 [entrez]']",,ppublish,C R Acad Hebd Seances Acad Sci D. 1977 Oct 3;285(7):793-6.,,,,,,,,,"Comparaison chez des rats genetiquement obeses et des rats normaux, de la captation et de l'incorporation, d'acide laurique, d'acide oleique et de glycerol marques par le foie isole et perfuse.",,,,,,,,,,,
13647977,NLM,MEDLINE,20000701,20181201,0991-9112 (Print) 0991-9112 (Linking),40,3,1959 Mar,[Possible complications of the treatment of obesities are never a contraindication to their treatment].,247 passim,,,"['MILLER, G']",['MILLER G'],,['fre'],['Journal Article'],France,Vie Med,"Vie medicale (Paris, France : 1920)",0174065,,OM,"['Humans', 'Obesity/*therapy']",,['NLM'],['*OBESITY/therapy'],,1959/03/01 00:00,1959/03/01 00:01,['1959/03/01 00:00'],"['1959/03/01 00:00 [pubmed]', '1959/03/01 00:01 [medline]', '1959/03/01 00:00 [entrez]']",,ppublish,Vie Med. 1959 Mar;40(3):247 passim.,,,,,,,,,Les incidents eventuels du traitement des obesites ne sont jamais une contre-indication a ce traitement.,,,,['CLML: 5936:21876:383'],,,,,,,
13408937,NLM,MEDLINE,20020501,20181201,0036-5440 (Print) 0036-5440 (Linking),110,2,1957 Jan 12,[Helping the obese by employment of A 66 or preludin].,45-6,,,"['ERNOULD, H J', 'DECAMPS, G']","['ERNOULD HJ', 'DECAMPS G']",,['fre'],['Journal Article'],Belgium,Scalpel (Brux),Le Scalpel,0412023,"['0 (Sympathomimetics)', 'XA501VL3VR (Phenmetrazine)']",OM,"['*Employment', 'Obesity/*therapy', '*Phenmetrazine', 'Sympathomimetics/*therapeutic use']",,['NLM'],"['*OBESITY/therapy', '*SYMPATHOMIMETICS/therapeutic use']",,1957/01/12 00:00,1957/01/12 00:01,['1957/01/12 00:00'],"['1957/01/12 00:00 [pubmed]', '1957/01/12 00:01 [medline]', '1957/01/12 00:00 [entrez]']",,ppublish,Scalpel (Brux). 1957 Jan 12;110(2):45-6.,,,,,,,,,Aide approtee aux obeses par l'emploi de A 66 ou preludine.,,,,['CLML: 5732:6790'],,,,,,,
410533,NLM,MEDLINE,19771229,20191021,,285,5,1977 Sep 19,[Comparison in genetically obese and normal rats in the secretion of lipids synthesized from labeled lauric and oleic acids and glycerol in isolated perfused liver].,551-4,,"(1) Isolated livers of previously fasted fafa and Wistar Rats are perfused with labelled oleic acid and glycerol. Two pools of synthesized lipids are studied: --a pool of liver lipids: labelled TG 16:0, 16:0, 18:1, 16:0, 18:1, 18:1 and 18:1, 18:1, 18:1 are synthesized more by the fafa than by the Wistar Rat liver, The TG 16:0, 18:1, 18:2 appears in the liver of the 2 rat strains. After a 30 min. perfusion, the PL are synthesized less by the fafa than by Wistar Rat liver; --a pool of lipids released in the circulation. The labelled tG 16:0, 18:1, 18:2, are increased in the perfusate of fafa rat. The labelled TG 18:1, 18:1, 18:2 and 18:1, 18:2, 18:2 are in the same amount. (2) The liver synthesis of TG 12:0, 12:0, 12:0 is demonstrated in the fafa Rat by a lauric acid perfusion. This TG is not present in circulation, when a Wistar Rat liver synthesizes and releases with this TG, TG containing 1 or 2 molecules of lauric acid.","['Chanussot, F', 'Debry, G']","['Chanussot F', 'Debry G']",,['fre'],"['Comparative Study', 'English Abstract', 'Journal Article']",France,C R Acad Hebd Seances Acad Sci D,Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,7501107,"['0 (Carbon Radioisotopes)', '0 (Lauric Acids)', '0 (Oleic Acids)', '0 (Phospholipids)', '0 (Triglycerides)', '10028-17-8 (Tritium)', 'PDC6A3C0OX (Glycerol)']",IM,"['Animals', 'Carbon Radioisotopes', 'Glycerol/*metabolism', 'Homozygote', 'In Vitro Techniques', 'Isotope Labeling', 'Lauric Acids/*metabolism', '*Lipid Metabolism', 'Liver/*metabolism', 'Male', 'Obesity/genetics/*metabolism', 'Oleic Acids/*metabolism', 'Phospholipids/biosynthesis', 'Rats', 'Triglycerides/biosynthesis', 'Tritium']",,,,,1977/09/19 00:00,1977/09/19 00:01,['1977/09/19 00:00'],"['1977/09/19 00:00 [pubmed]', '1977/09/19 00:01 [medline]', '1977/09/19 00:00 [entrez]']",,ppublish,C R Acad Hebd Seances Acad Sci D. 1977 Sep 19;285(5):551-4.,,,,,,,,,"Comparaison chez des rats genetiquement obeses et des Rats normaux des secretions des lipides synthetises par les foies isoles et perfuses par de l'acide laurique, de l'acide oleique et du glycerol marques.",,,,,,,,,,,
5056533,NLM,MEDLINE,19721025,20131121,0003-3898 (Print) 0003-3898 (Linking),30,3,1972,[Influence of oral glucose load on the blood sugar and hormonal response during oral glucose tolerance tests over 5 hours in obese non-diabetic subjects].,225-32,,,"['Eschwege, E', 'Valleron, A J', 'Papoz, L', 'Rosselin, E G']","['Eschwege E', 'Valleron AJ', 'Papoz L', 'Rosselin EG']",,['fre'],['Journal Article'],France,Ann Biol Clin (Paris),Annales de biologie clinique,2984690R,"['0 (Blood Glucose)', '0 (Insulin)', '9002-72-6 (Growth Hormone)', 'WI4X0X7BPJ (Hydrocortisone)']",IM,"['Administration, Oral', 'Adult', 'Blood Glucose/*analysis', 'Female', 'Glucose Tolerance Test', 'Growth Hormone/*blood', 'Humans', 'Hydrocortisone/*blood', 'Insulin/*blood', 'Male', 'Obesity/*blood/physiopathology', 'Statistics as Topic', 'Time Factors']",,,,,1972/01/01 00:00,1972/01/01 00:01,['1972/01/01 00:00'],"['1972/01/01 00:00 [pubmed]', '1972/01/01 00:01 [medline]', '1972/01/01 00:00 [entrez]']",,ppublish,Ann Biol Clin (Paris). 1972;30(3):225-32.,,,,,,,,,Influence de la charge orale de glucose sur les reponses glycemiques et hormonales au cours de l'hyperglycemie provoquee per os sur 5 heures chez des sujets obeses non diabetiques.,,,,,,,,,,,
5582435,NLM,MEDLINE,19680428,20131121,0037-9042 (Print) 0037-9042 (Linking),49,12,1967,[In vitro metabolism of adipose tissue. VI. In vitro metabolism of acetate in epididymal adipose tissue of 2 kinds of young obese mice: the Bar Harbor obese-hyperglycemic mouse (O-H) and the New Zealand mouse (NZO)].,1845-62,,,"['Winand, J', 'Furnelle, J', 'Christophe, J']","['Winand J', 'Furnelle J', 'Christophe J']",,['fre'],['Journal Article'],France,Bull Soc Chim Biol (Paris),Bulletin de la Societe de chimie biologique,7503398,"['0 (Acetates)', '0 (Carbon Isotopes)', '0 (Fatty Acids)', '0 (Fatty Acids, Nonesterified)', '0 (Glycerides)', '0 (Lipids)', '0 (Malonates)', '0 (Phospholipids)', 'YKH834O4BH (Epinephrine)']",IM,"['Acetates/*metabolism', 'Adipose Tissue/*metabolism', 'Animals', 'Carbon Isotopes', 'Epididymis/*metabolism', 'Epinephrine/pharmacology', 'Fatty Acids/biosynthesis', 'Fatty Acids, Nonesterified/metabolism', 'Glycerides/metabolism', 'Hypertrophy/metabolism', 'Lipids/biosynthesis', 'Male', 'Malonates/metabolism', 'Mice', 'Obesity/genetics/*metabolism', 'Phospholipids/metabolism', 'Time Factors']",,,,,1967/01/01 00:00,1967/01/01 00:01,['1967/01/01 00:00'],"['1967/01/01 00:00 [pubmed]', '1967/01/01 00:01 [medline]', '1967/01/01 00:00 [entrez]']",,ppublish,Bull Soc Chim Biol (Paris). 1967;49(12):1845-62.,,,,,,,,,Metabolisme in vitro du tissue adipeux. VI. Metabolisme in vitro de l'acetate dans le tissu adipeux epididymaire de deux souris obeses jeunes: la souris obese-hyperglycemique de bar harbor (O-H) et la souris neo-zelandaise (NZO).,,,,,,,,,,,
224497,NLM,MEDLINE,19791026,20061115,,55,9-10,1979 Mar 8-15,[Study of an homogeneous population of obeses people and of its regression of weight under hypocaloric diet in hospital. II. - Weight loss (author's transl)].,475-9,,"A study of 79 obese patients who were hospitalized and treated with a low calorie diet demonstrated that the weight loss occurred in a univocal manner, according to a semilogarithmic law. It was not influenced, as far as initial results were concerned, by the age, sex, or morphotype of the patient, or whether weight gain was recent or of long-standing. Factors affecting results, however, are the existence of functional signs, the amount of natriuresis during the first few days, and the quantity of alcohol ingested regularly. Short term results, one month after leaving hospital, appear to be moderate only. A diet supplying 800 calories causes weight loss at the expense of body fat. Individual variations in minimal calorie requirements during the treatment can be used as a basis for prescribing a personalized supplementary diet.","['Melin, J P', 'Legieda, M', 'Labram, C', 'Lestradet, H', 'Berger, C']","['Melin JP', 'Legieda M', 'Labram C', 'Lestradet H', 'Berger C']",,['fre'],"['English Abstract', 'Journal Article']",France,Sem Hop,La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,9410059,['0 (Proteins)'],IM,"['Adult', 'Age Factors', 'Alcohol Drinking', 'Body Weight', '*Diet, Reducing', 'Energy Intake', 'Female', 'Humans', 'Male', 'Middle Aged', 'Natriuresis', 'Obesity/*diet therapy', 'Proteins/metabolism', 'Sex Factors']",,,,,1979/03/08 00:00,1979/03/08 00:01,['1979/03/08 00:00'],"['1979/03/08 00:00 [pubmed]', '1979/03/08 00:01 [medline]', '1979/03/08 00:00 [entrez]']",,ppublish,Sem Hop. 1979 Mar 8-15;55(9-10):475-9.,,,,,,,,,Etude d'une population homogene d'obeses et de sa regression ponderale sous regime hypocalorique en milieu hospitalier. II. - La regression ponderale.,,,,,,,,,,,
19852897,NLM,MEDLINE,20091102,20091026,1603-6824 (Electronic) 0041-5782 (Linking),171,43,2009 Oct 19,[Healthy obese subjects. Is weight loss treatment indicated?].,3092-4,,"Recent studies have shown that about 20% of obese subjects are metabolically healthy with no increased risk for development of cardio-vascular disease or type 2 diabetes. This group is characterized by normal metabolic parameters (do not have metabolic syndrome) and by minimal ectopic fat accumulation in the visceral depot, in the liver etc. It is argued that treatment intensity to obtain a weight loss should take the benign form of obesity into account since more active treatments such as pharmacotherapy and surgery may potentially be harmful rather than having a beneficial effect in this subgroup of obese subjects.","['Richelsen, Bjorn', 'Pedersen, Steen B']","['Richelsen B', 'Pedersen SB']","['Medicinsk Afdeling, Arhus Sygehus Arhus Universitetshospital, DK-8000 Aarhus C, Denmark. brich@dadlnet.dk']",['dan'],"['English Abstract', 'Journal Article']",Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,IM,"['Adipose Tissue/metabolism', 'Body Fat Distribution', 'Humans', 'Lipid Metabolism', 'Obesity/diagnosis/metabolism/*therapy', 'Weight Loss']",,,,,2009/10/27 06:00,2009/11/03 06:00,['2009/10/27 06:00'],"['2009/10/27 06:00 [entrez]', '2009/10/27 06:00 [pubmed]', '2009/11/03 06:00 [medline]']",['VP11080542 [pii]'],ppublish,Ugeskr Laeger. 2009 Oct 19;171(43):3092-4.,,,,,,,,,Raske overvaegtige. Er vaegttabsbehandling indiceret?,,,,,,,,,,,
5745286,NLM,MEDLINE,19700624,20071115,0010-0234 (Print) 0010-0234 (Linking),7,1,1968 Jan,[Latent heart failure in the obese].,63-6,,,"['Negoita, C', 'Marco, C', 'Berneaga, O']","['Negoita C', 'Marco C', 'Berneaga O']",,['fre'],['Journal Article'],France,Coeur Med Interne,Coeur et medecine interne,0373165,,IM,"['Adult', 'Female', 'Heart Failure/*etiology', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications']",,,,,1968/01/01 00:00,1968/01/01 00:01,['1968/01/01 00:00'],"['1968/01/01 00:00 [pubmed]', '1968/01/01 00:01 [medline]', '1968/01/01 00:00 [entrez]']",,ppublish,Coeur Med Interne. 1968 Jan;7(1):63-6.,,,,,,,,,Recherches sur l'insuffisance cardiaque latente chez les obeses.,,,,,,,,,,,
18860549,NLM,MEDLINE,20081016,20201005,0016-5557 (Print) 0016-5557 (Linking),55,10,1948 May,[Current endocrine obesities and their treatment].,369,,,"['LERAY, J']",['LERAY J'],,['fre'],['Journal Article'],France,Gaz Med Fr,Gazette medicale de France,0034270,,OM,"['Humans', '*Obesity']",,['NLM'],['*OBESITY/endocrine'],,1948/05/01 00:00,1948/05/01 00:01,['1948/05/01 00:00'],"['1948/05/01 00:00 [pubmed]', '1948/05/01 00:01 [medline]', '1948/05/01 00:00 [entrez]']",,ppublish,Gaz Med Fr. 1948 May;55(10):369.,,,,,,,,,Les obesites endocriniennes actuelles et leur traitement.,,,,['CLML: 4815:190u1'],,,,,,,
13064148,NLM,MEDLINE,20030501,20181201,0032-7867 (Print) 0032-7867 (Linking),61,16,1953 Mar 7,[Comments on obesities so called endogenous].,321-2,,,"['DREYFUS, G']",['DREYFUS G'],,['und'],['Journal Article'],France,Presse Med (1893),La Presse medicale,0312556,,OM,"['*Endocrine System Diseases', 'Obesity/*etiology']",,['NLM'],['*OBESITY/etiology and pathogenesis'],,1953/03/07 00:00,1953/03/07 00:01,['1953/03/07 00:00'],"['1953/03/07 00:00 [pubmed]', '1953/03/07 00:01 [medline]', '1953/03/07 00:00 [entrez]']",,ppublish,Presse Med (1893). 1953 Mar 7;61(16):321-2.,,,,,,,,,Reflexions sur les obesites dites endogenes.,,,,['CLML: 5324:34803:452'],,,,,,,
5295817,NLM,MEDLINE,19660726,20041117,0035-2659 (Print) 0035-2659 (Linking),33,4,1966 Apr,[The rheumatism of the extremely obese].,204-10,,,"['Francon, F', 'Fabre, M']","['Francon F', 'Fabre M']",,['fre'],['Journal Article'],France,Rev Rhum Mal Osteoartic,Revue du rhumatisme et des maladies osteo-articulaires,0407211,,IM,"['Adult', 'Aged', 'Female', 'Humans', 'Joint Diseases/*complications', 'Male', 'Middle Aged', 'Obesity/*complications', 'Rheumatic Diseases/*complications']",,,,,1966/04/01 00:00,1966/04/01 00:01,['1966/04/01 00:00'],"['1966/04/01 00:00 [pubmed]', '1966/04/01 00:01 [medline]', '1966/04/01 00:00 [entrez]']",,ppublish,Rev Rhum Mal Osteoartic. 1966 Apr;33(4):204-10.,,,,,,,,,Les rhumatismes des grands obeses.,,,,,,,,,,,
3256890,NLM,MEDLINE,19891026,20041117,0032-6518 (Print) 0032-6518 (Linking),232,1460,1988 Dec,How I treat ... the obese patient.,1353-6,,,"['Hooper, J', 'Walters, A', 'Pilkington, T']","['Hooper J', 'Walters A', 'Pilkington T']",,['eng'],['Journal Article'],England,Practitioner,The Practitioner,0404245,,IM,"['Acupuncture Therapy', 'Female', 'Humans', 'Obesity/diet therapy/surgery/*therapy', 'Self-Help Groups']",,,,,1988/12/01 00:00,1988/12/01 00:01,['1988/12/01 00:00'],"['1988/12/01 00:00 [pubmed]', '1988/12/01 00:01 [medline]', '1988/12/01 00:00 [entrez]']",,ppublish,Practitioner. 1988 Dec;232(1460):1353-6.,,,,,,,,,,,,,,,,,,,,
15445854,NLM,MEDLINE,20040930,20181201,0412-7994 (Print) 0412-7994 (Linking),8,,1961 Oct,Hydrochlorothiazide with potassium in resistant exogenous obesities.,1899-904,,,"['RAY, R E']",['RAY RE'],,['eng'],['Journal Article'],United States,Clin Med (Northfield),"Clinical medicine (Northfield, Ill.)",7708504,"['0J48LPH2TH (Hydrochlorothiazide)', 'RWP5GA015D (Potassium)']",OM,"['Humans', '*Hydrochlorothiazide', '*Nutrition Therapy', 'Obesity/*therapy', 'Potassium/*therapy']",,['NLM'],"['*OBESITY/therapy', '*POTASSIUM/therapy']",,1961/10/01 00:00,1961/10/01 00:01,['1961/10/01 00:00'],"['1961/10/01 00:00 [pubmed]', '1961/10/01 00:01 [medline]', '1961/10/01 00:00 [entrez]']",,ppublish,Clin Med (Northfield). 1961 Oct;8:1899-904.,,,,,,,,,,,,,,,,,,,,
7256046,NLM,MEDLINE,19810922,20161123,0370-629X (Print) 0370-629X (Linking),36,13-14,1981 Jul 1-15,[The anamnesis of 24 obese patients].,556-62,,,"['Baudrihaye-Gerard, M F']",['Baudrihaye-Gerard MF'],,['fre'],['Journal Article'],Belgium,Rev Med Liege,Revue medicale de Liege,0404317,,IM,"['Adipose Tissue/metabolism', 'Adolescent', 'Adult', 'Aged', 'Diet, Reducing', 'Feeding Behavior', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/complications/*diagnosis/etiology', 'Physical Exertion']",,,,,1981/07/01 00:00,1981/07/01 00:01,['1981/07/01 00:00'],"['1981/07/01 00:00 [pubmed]', '1981/07/01 00:01 [medline]', '1981/07/01 00:00 [entrez]']",,ppublish,Rev Med Liege. 1981 Jul 1-15;36(13-14):556-62.,,,,,,,,,A propos de l'anamnese de quatre-vingts patients obeses.,,,,,,,,,,,
1338399,NLM,MEDLINE,19930428,20161209,0755-4982 (Print) 0755-4982 (Linking),21,44,1992 Dec 19-26,[Corticotropin-releasing factor test in obese subjects].,2154,,,"['Girardin, E', 'Riou, J P']","['Girardin E', 'Riou JP']",,['fre'],['Letter'],France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,"['9002-60-2 (Adrenocorticotropic Hormone)', '9015-71-8 (Corticotropin-Releasing Hormone)', 'WI4X0X7BPJ (Hydrocortisone)']",IM,"['Adrenocorticotropic Hormone/*analysis', 'Adult', '*Corticotropin-Releasing Hormone', 'Cushing Syndrome/*diagnosis', 'Diagnosis, Differential', 'Female', 'Humans', 'Hydrocortisone/*analysis', 'Male', 'Obesity/*metabolism']",,,,,1992/12/19 00:00,1992/12/19 00:01,['1992/12/19 00:00'],"['1992/12/19 00:00 [pubmed]', '1992/12/19 00:01 [medline]', '1992/12/19 00:00 [entrez]']",,ppublish,Presse Med. 1992 Dec 19-26;21(44):2154.,,,,,,,,,Test a la corticoliberine chez les obeses.,,,,,,,,,,,
1342775,NLM,MEDLINE,19940217,20161123,0003-4487 (Print) 0003-4487 (Linking),150,6,1992 Jun-Jul,[Obese bulimic patients: a misunderstood sub-group].,440-2; discussion 443,,,"['Gaillac, V', 'Samuel-Lajeunesse, B']","['Gaillac V', 'Samuel-Lajeunesse B']","['CMME, Paris.']",['fre'],['Journal Article'],France,Ann Med Psychol (Paris),Annales medico-psychologiques,2984692R,,IM,"['Adult', 'Body Mass Index', 'Bulimia/classification/diagnosis/*psychology', 'Circadian Rhythm', 'Diet, Reducing/psychology', 'Energy Intake', 'Feeding Behavior/psychology', 'Female', 'Humans', 'Obesity/classification/diagnosis/*psychology', 'Personality Inventory', 'Satiety Response']",,,,,1992/06/01 00:00,1992/06/01 00:01,['1992/06/01 00:00'],"['1992/06/01 00:00 [pubmed]', '1992/06/01 00:01 [medline]', '1992/06/01 00:00 [entrez]']",,ppublish,Ann Med Psychol (Paris). 1992 Jun-Jul;150(6):440-2; discussion 443.,,,,,,,,,Les obeses boulimiques: un sous-groupe meconnu.,,,,,,,,,,,
5571512,NLM,MEDLINE,19711116,20041117,0012-1770 (Print) 0012-1770 (Linking),19,1,1971 Jan-Mar,[Microangiopathy in obese patients. Histometric study].,42-6,,,"['Romani, J D']",['Romani JD'],,['fre'],['Journal Article'],France,Diabete,Le Diabete,2984746R,,IM,"['Adult', 'Capillaries/*pathology', 'Female', 'Humans', 'Male', 'Obesity/*pathology']",,,,,1971/01/01 00:00,1971/01/01 00:01,['1971/01/01 00:00'],"['1971/01/01 00:00 [pubmed]', '1971/01/01 00:01 [medline]', '1971/01/01 00:00 [entrez]']",,ppublish,Diabete. 1971 Jan-Mar;19(1):42-6.,,,,,,,,,La microangiopathie des obeses. Etude histometrique.,,,,,,,,,,,
14378753,NLM,MEDLINE,20030501,20181201,0001-4079 (Print) 0001-4079 (Linking),139,9-10,1955 Mar 8-15,[Variability of the cholesterolytic power of the serum of the obese].,180-1,,,"['KERMORGANT, Y']",['KERMORGANT Y'],,['fre'],['Journal Article'],Netherlands,Bull Acad Natl Med,Bulletin de l'Academie nationale de medecine,7503383,,OM,"['*Blood', 'Humans', 'Obesity/*blood']",,['NLM'],"['*BLOOD', '*OBESITY/blood in']",,1955/03/08 00:00,1955/03/08 00:01,['1955/03/08 00:00'],"['1955/03/08 00:00 [pubmed]', '1955/03/08 00:01 [medline]', '1955/03/08 00:00 [entrez]']",,ppublish,Bull Acad Natl Med. 1955 Mar 8-15;139(9-10):180-1.,,,,,,,,,De la variabilite du pouvoir cholesterolytique du serum des obeses.,,,,['CLML: 5528:29791:83:399'],,,,,,,
1101839,NLM,MEDLINE,19751228,20131121,0003-9780 (Print) 0003-9780 (Linking),216,2,1975 Aug,Hypothalamic and nutritional obesities in mice. A comparative study of growth and body composition.,288-314,,"Obesities induced in mice by a single injection of gold thioglucose or by a change to a fat-enriched diet(containing 8% fat) were studied in young and adult mice of Charles River strain. These two forms of obesity were compared and contrasted with normal animals maintained on 2.5% fat diet for life. The comparison was based on individual growth, age-realted fat, water and defatted dry weight of carcasses and their distribution of weights within larger populations. Young animals on diets containing 8% fat showed an elevated accumulation of fat but not of water. Individual variations lead to an abnormally distributed population where in some animals the excess in weight was characterized by an excessive fat and lean body mass and in others by an excess fat only. Some animals showed no excessive weight when compared to animals maintained on 2.5% fat. The rapid gain in weight which followed a successful injection with gold thioglucose showed a normal distrubution and was correlated with an accumulation of fat in young and adult animals. A significant retention of water was observed only in adults. The relative merits of these obesities as models for human regulatory obesities are briefly discussed.","['De Laey, P']",['De Laey P'],,['eng'],"['Comparative Study', 'Journal Article']",Belgium,Arch Int Pharmacodyn Ther,Archives internationales de pharmacodynamie et de therapie,0405353,"['0 (Dietary Fats)', '2P2V9Q0E78 (Aurothioglucose)']",IM,"['Adipose Tissue/metabolism', 'Aging', 'Animals', 'Aurothioglucose/pharmacology', 'Body Water/metabolism', 'Body Weight/drug effects', 'Dietary Fats/adverse effects', '*Disease Models, Animal', 'Hypothalamus/*physiopathology', 'Liver/drug effects', 'Mice', 'Mice, Inbred Strains', 'Obesity/chemically induced/*physiopathology', 'Organ Size/drug effects']",,,,,1975/08/01 00:00,1975/08/01 00:01,['1975/08/01 00:00'],"['1975/08/01 00:00 [pubmed]', '1975/08/01 00:01 [medline]', '1975/08/01 00:00 [entrez]']",,ppublish,Arch Int Pharmacodyn Ther. 1975 Aug;216(2):288-314.,,,,,,,,,,,,,,,,,,,,
3648398,NLM,MEDLINE,19870807,20041117,0388-5585 (Print) 0388-5585 (Linking),8,4,1987 Apr,[Attempt at weight reduction in obese patients at the department of psychiatry].,371-7,,,"['Morimoto, M', 'Takada, K', 'Kitaya, M', 'Bando, M', 'Sugimoto, M']","['Morimoto M', 'Takada K', 'Kitaya M', 'Bando M', 'Sugimoto M']",,['jpn'],['Journal Article'],Japan,Kurinikaru Sutadi,Kurinikaru sutadi = Clinical study,8302118,,,"['Humans', 'Obesity/psychology/*therapy', '*Psychotherapy']",,,,,1987/04/01 00:00,1987/04/01 00:01,['1987/04/01 00:00'],"['1987/04/01 00:00 [pubmed]', '1987/04/01 00:01 [medline]', '1987/04/01 00:00 [entrez]']",,ppublish,Kurinikaru Sutadi. 1987 Apr;8(4):371-7.,,,,,,,,,,,,,,,,,,,,
6061574,NLM,MEDLINE,19680122,20181130,0366-1334 (Print) 0366-1334 (Linking),118,2,1967 Jan 27,[Demonstration of prolonged antidiuresis after the administration of salidiuretics in the obese].,115-21,,,"['Decourt, J', 'Robel, P', 'Louchart, J', 'Ehrmann, S']","['Decourt J', 'Robel P', 'Louchart J', 'Ehrmann S']",,['fre'],['Journal Article'],France,Bull Mem Soc Med Hop Paris,Bulletins et memoires de la Societe medicale des hopitaux de Paris,7503472,"['11000-17-2 (Vasopressins)', '77W477J15H (Chlorothiazide)']",IM,"['Adult', 'Chlorothiazide/*adverse effects', 'Diuresis/*drug effects', 'Female', 'Humans', 'Obesity/*drug therapy', 'Vasopressins/*metabolism']",,,,,1967/01/27 00:00,1967/01/27 00:01,['1967/01/27 00:00'],"['1967/01/27 00:00 [pubmed]', '1967/01/27 00:01 [medline]', '1967/01/27 00:00 [entrez]']",,ppublish,Bull Mem Soc Med Hop Paris. 1967 Jan 27;118(2):115-21.,,,,,,,,,Mise en evidence d'une antidiurese prolongee apres l'administration de salidiuretiques chez des obeses.,,,,,,,,,,,
13140965,NLM,MEDLINE,20030501,20181201,0001-4079 (Print) 0001-4079 (Linking),138,3-4,1954 Jan 26-Feb 2,[Variability in the quantity of sodium in the serum of the obese].,71-2,,,"['KERMORGANT, Y']",['KERMORGANT Y'],,['und'],['Journal Article'],Netherlands,Bull Acad Natl Med,Bulletin de l'Academie nationale de medecine,7503383,['9NEZ333N27 (Sodium)'],OM,"['Humans', 'Obesity/*blood', 'Sodium/*metabolism']",,['NLM'],"['*OBESITY/blood in', '*SODIUM/metabolism']",,1954/01/26 00:00,1954/01/26 00:01,['1954/01/26 00:00'],"['1954/01/26 00:00 [pubmed]', '1954/01/26 00:01 [medline]', '1954/01/26 00:00 [entrez]']",,ppublish,Bull Acad Natl Med. 1954 Jan 26-Feb 2;138(3-4):71-2.,,,,,,,,,Variabilite de la quantite de sodium contenu dans le serum des obeses.,,,,['CLML: 5426:3399:314:410'],,,,,,,
5844430,NLM,MEDLINE,19660204,20170214,0009-9228 (Print) 0009-9228 (Linking),4,11,1965 Nov,"The obese adolescent. Observations on etiology, management, prevention.",649-54,,,"['Massengale, O N']",['Massengale ON'],,['eng'],['Journal Article'],United States,Clin Pediatr (Phila),Clinical pediatrics,0372606,,IM,"['*Adolescent', '*Child', 'Diet, Reducing', 'Female', 'Humans', 'Male', '*Obesity/diagnosis/etiology/therapy', 'Psychology, Adolescent']",,,,,1965/11/01 00:00,1965/11/01 00:01,['1965/11/01 00:00'],"['1965/11/01 00:00 [pubmed]', '1965/11/01 00:01 [medline]', '1965/11/01 00:00 [entrez]']",['10.1177/000992286500401107 [doi]'],ppublish,Clin Pediatr (Phila). 1965 Nov;4(11):649-54. doi: 10.1177/000992286500401107.,,,,,,,,,,,,,,,,,,,,
4385401,NLM,MEDLINE,19680814,20041117,0025-4053 (Print) 0025-4053 (Linking),102,5,1965,[Practical data on the treatment of obesities].,391-6,,,"['Codaccioni, J L']",['Codaccioni JL'],,['fre'],['Journal Article'],France,Mars Med,Marseille medical,2985228R,"['0 (Appetite Depressants)', '0 (Central Nervous System Stimulants)', '0 (Diuretics)']",IM,"['Appetite Depressants/*therapeutic use', 'Central Nervous System Stimulants/*therapeutic use', '*Diet, Reducing', 'Diuretics/*therapeutic use', 'Humans', 'Obesity/*therapy']",,,,,1965/01/01 00:00,1965/01/01 00:01,['1965/01/01 00:00'],"['1965/01/01 00:00 [pubmed]', '1965/01/01 00:01 [medline]', '1965/01/01 00:00 [entrez]']",,ppublish,Mars Med. 1965;102(5):391-6.,,,,,,,,,Donnees pratiques sur le traitement des obesites.,,,,,,,,,,,
13360209,NLM,MEDLINE,20020501,20181201,0036-7672 (Print) 0036-7672 (Linking),86,35,1956 Sep 1,[Microelectrophoresis and study of lipids in obese].,975-6,,,"['FISCHER, R', 'MONNIER, J']","['FISCHER R', 'MONNIER J']",,['fre'],['Journal Article'],Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,"['0 (Lipids)', '0 (Lipoproteins)']",OM,"['Humans', '*Lipids', 'Lipoproteins/*blood', 'Obesity/*blood']",,['NLM'],"['*LIPOPROTEINS/in blood', '*OBESITY/blood in']",,1956/09/01 00:00,1956/09/01 00:01,['1956/09/01 00:00'],"['1956/09/01 00:00 [pubmed]', '1956/09/01 00:01 [medline]', '1956/09/01 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1956 Sep 1;86(35):975-6.,,,,,,,,,Microelectrophorese et etude des lipides chez les obeses.,,,,['CLML: 5731:6270'],,,,,,,
1050532,NLM,MEDLINE,19770216,20190823,0022-4391 (Print) 0022-4391 (Linking),46,10,1976 Dec,Weight reduction and weight control strategies for obese individuals: a case for behavior modification.,602-6,,,"['Werner, R T']",['Werner RT'],,['eng'],['Journal Article'],United States,J Sch Health,The Journal of school health,0376370,,IM,"['*Behavior Therapy', 'Humans', 'Jejunum/surgery', 'Obesity/diet therapy/drug therapy/*therapy']",,,,,1976/12/01 00:00,1976/12/01 00:01,['1976/12/01 00:00'],"['1976/12/01 00:00 [pubmed]', '1976/12/01 00:01 [medline]', '1976/12/01 00:00 [entrez]']",['10.1111/j.1746-1561.1976.tb01986.x [doi]'],ppublish,J Sch Health. 1976 Dec;46(10):602-6. doi: 10.1111/j.1746-1561.1976.tb01986.x.,,,,,,,,,,,,,,,,,,,,
2034701,NLM,MEDLINE,19910627,20071115,0266-8130 (Print) 0266-8130 (Linking),6,9,1991 Jun,A positive change for a healthier life: Weight reduction strategies for obese people.,524-7,,"People who are obese have increased risk of a range of conditions, and also often suffer socially and psychologically. To successfully reduce their weight, they need to make lifelong changes in their eating and exercise habits.","['Gatenby, S J']",['Gatenby SJ'],,['eng'],['Journal Article'],England,Prof Nurse,"Professional nurse (London, England)",8612884,,,"['Humans', 'Obesity/etiology/psychology/*therapy', 'Patient Education as Topic', '*Weight Loss']",,,,,1991/06/01 00:00,1991/06/01 00:01,['1991/06/01 00:00'],"['1991/06/01 00:00 [pubmed]', '1991/06/01 00:01 [medline]', '1991/06/01 00:00 [entrez]']",,ppublish,Prof Nurse. 1991 Jun;6(9):524-7.,,,,,,,,,,,,,,,,,,,,
13537887,NLM,MEDLINE,20000701,20190629,0014-4754 (Print) 0014-4754 (Linking),14,3,1958 Mar 15,Fat metabolism in experimental obesities. VIII. Blood total lipids and ketones in four kinds of obese mice.,96-9,,,"['MAYER, J', 'SILIDES, D J']","['MAYER J', 'SILIDES DJ']",,['eng'],['Journal Article'],Switzerland,Experientia,Experientia,0376547,"['0 (Ketones)', '0 (Lipids)']",OM,"['Animals', 'Ketones/*blood', '*Lipid Metabolism', 'Lipids/*blood', 'Mice', 'Mice, Obese', '*Obesity']",,['NLM'],"['*KETONES/in blood', '*LIPIDS/in blood', '*OBESITY/experimental']",,1958/03/15 00:00,1958/03/15 00:01,['1958/03/15 00:00'],"['1958/03/15 00:00 [pubmed]', '1958/03/15 00:01 [medline]', '1958/03/15 00:00 [entrez]']",['10.1007/BF02159235 [doi]'],ppublish,Experientia. 1958 Mar 15;14(3):96-9. doi: 10.1007/BF02159235.,,,,,,,,,,,,,['CLML: 5834:30427:321:344:423'],,,,,,,
6519909,NLM,MEDLINE,19850301,20140603,,8,5,1984,Workshop on methods for characterizing human obesities. Purposes and types of classifications.,481-90,,"The data base describing human obesities has expanded rapidly in the recent past, and the heterogeneity of this set of conditions is becoming clearer. Nevertheless, our lack of adequate understanding both of etiology and of functional consequences inhibits our ability to devise classifications which are therapeutically useful. A first step is the delineation of criteria for detailed characterization of obesity. In devising such criteria, it will be useful to bear in mind the purposes of classification schemes (etiologic, functional, therapeutic, prognostic) and the extent to which our existing understanding and conceptual categories (both scientific and cultural) direct our thinking.","['Harrison, G G']",['Harrison GG'],,['eng'],['Journal Article'],England,Int J Obes,International journal of obesity,7703240,,IM,"['Cystic Fibrosis/classification', 'Humans', 'Obesity/*classification/etiology/therapy', 'Prognosis']",,,,,1984/01/01 00:00,1984/01/01 00:01,['1984/01/01 00:00'],"['1984/01/01 00:00 [pubmed]', '1984/01/01 00:01 [medline]', '1984/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1984;8(5):481-90.,,,,,,,,,,,,,,,,,,,,
5696111,NLM,MEDLINE,19681230,20041117,0550-4031 (Print) 0550-4031 (Linking),10,4,1968,[Study of the effect of dividing the daily caloric intake into 7 meals on weight loss in obese subjects].,288-96,,,"['Debry, G', 'Rohr, R', 'Azouaou, G', 'Vassilitch, I', 'Mottaz, G']","['Debry G', 'Rohr R', 'Azouaou G', 'Vassilitch I', 'Mottaz G']",,['fre'],['Journal Article'],Switzerland,Nutr Dieta Eur Rev Nutr Diet,Nutritio et dieta; European review of nutrition and dietetics,0250415,"['0 (Dietary Carbohydrates)', '0 (Dietary Fats)', '0 (Dietary Proteins)']",IM,"['Adolescent', 'Adult', 'Aged', 'Body Weight', 'Coronary Disease', 'Diabetes Mellitus', '*Diet', 'Diet Therapy', '*Diet, Reducing', 'Dietary Carbohydrates', 'Dietary Fats', 'Dietary Proteins', 'Female', 'Humans', 'Male', 'Middle Aged', '*Obesity/complications', 'Periodicity', 'Sex Factors', 'Time Factors', 'Tuberculosis, Renal']",,,,,1968/01/01 00:00,1968/01/01 00:01,['1968/01/01 00:00'],"['1968/01/01 00:00 [pubmed]', '1968/01/01 00:01 [medline]', '1968/01/01 00:00 [entrez]']",,ppublish,Nutr Dieta Eur Rev Nutr Diet. 1968;10(4):288-96.,,,,,,,,,Etude de l'influence du fractionnement de l'apport calorique quotidien en 7 repas sur la chute ponderale des obeses.,,,,,,,,,,,
5339822,NLM,MEDLINE,19670924,20131121,,14,21,1966 Nov,[Variations in the plasma concentration of nonesterified fatty acids after an intravenous perfusion of glucose in fasting obese subjects].,1053-6,,,"['Sdrobici, D', 'Pieptea, R', 'Mihalache, N', 'Antonescu, E']","['Sdrobici D', 'Pieptea R', 'Mihalache N', 'Antonescu E']",,['fre'],['Journal Article'],France,Pathol Biol,Pathologie et biologie,0266544,"['0 (Fatty Acids)', '0 (Fatty Acids, Nonesterified)', 'IY9XDZ35W2 (Glucose)']",IM,"['Adult', 'Aged', 'Fatty Acids/*blood', 'Fatty Acids, Nonesterified/blood', 'Female', 'Glucose/*metabolism', 'Humans', 'Injections, Intravenous', 'Middle Aged', 'Obesity/*blood']",,,,,1966/11/01 00:00,1966/11/01 00:01,['1966/11/01 00:00'],"['1966/11/01 00:00 [pubmed]', '1966/11/01 00:01 [medline]', '1966/11/01 00:00 [entrez]']",,ppublish,Pathol Biol. 1966 Nov;14(21):1053-6.,,,,,,,,,Variations de la concentration plasmatique des acides GRAS NON-esterifies apres une perfusion intra-veineuse de glucose chez les obeses soumis au jeune.,,,,,,,,,,,
8135607,NLM,MEDLINE,19940421,20161123,0003-9764 (Print) 0003-9764 (Linking),50,6,1993 Jun-Jul,[A controlled study of food behavior and emotional manifestation in a population of obese female adolescents].,479-84,,"BACKGROUND: Obesity is a major Public Health problem in developed countries. It is frequently associated with psychological difficulties that may interfere with treatment. PATIENTS AND METHODS: 22 obese female adolescents, aged 13 to 19 years, and 24 age-matched female controls, were compared with regard to emotional pathology (anxiety, depression), eating behaviors, self-esteem, body image and parental history of depression. The evaluation was both categorical (DSM III-R criteria) and dimensional for depression and anxiety. It also included a self-esteem scale and questionnaires. RESULTS: The obese adolescents had more depressive symptoms, more prevalent anxiety disorders, more frequent histories of parental depression, eating behaviors characterized by over-eating and/or restricted intake, lower self-esteem and dissatisfaction with their body image, leading to avoidance behaviors in some of them. CONCLUSIONS: Psychological manifestations, although they are still insufficiently documented, especially in adolescents, may aggravate obesity and interfere with treatment.","['Isnard-Mugnier, P', 'Vila, G', 'Nollet-Clemencon, C', 'Vera, L', 'Rault, G', 'Mouren-Simeoni, M C']","['Isnard-Mugnier P', 'Vila G', 'Nollet-Clemencon C', 'Vera L', 'Rault G', 'Mouren-Simeoni MC']","[""Service de Psychiatrie de l'Enfant et de l'Adolescent de l'Hopital Necker-Enfants Malades, Paris.""]",['fre'],"['Clinical Trial', 'Comparative Study', 'Journal Article']",France,Arch Fr Pediatr,Archives francaises de pediatrie,0372421,,IM,"['Adolescent', '*Adolescent Behavior', 'Anxiety Disorders/psychology', 'Body Image', 'Depressive Disorder/psychology', '*Feeding Behavior', 'Female', 'Humans', 'Obesity/*psychology', 'Parent-Child Relations', 'Self Concept']",,,,,1993/06/01 00:00,1993/06/01 00:01,['1993/06/01 00:00'],"['1993/06/01 00:00 [pubmed]', '1993/06/01 00:01 [medline]', '1993/06/01 00:00 [entrez]']",,ppublish,Arch Fr Pediatr. 1993 Jun-Jul;50(6):479-84.,,,,,,,,,Etude controlee des conduites alimentaires et des manifestations emotionnelles dans une population d'adolescentes obeses.,,,,,,,,,,,
5904995,NLM,MEDLINE,19660520,20141120,0021-8324 (Print) 0021-8324 (Linking),20,2,1966 Feb-Mar,[Apropos of the respiratory disorders of the obese. The importance of the venous contamination factor].,195-200,,,"['Galy, P', 'Brune, J', 'Lheureux, P', 'Wiesendanger, T', 'Brune, A']","['Galy P', 'Brune J', 'Lheureux P', 'Wiesendanger T', 'Brune A']",,['fre'],['Journal Article'],France,J Fr Med Chir Thorac,Journal francais de medecine et chirurgie thoraciques,0376571,,IM,"['Adult', 'Aged', 'Blood Gas Analysis', 'Bronchitis/*physiopathology', 'Female', 'Humans', 'In Vitro Techniques', 'Male', 'Middle Aged', 'Obesity/*complications', 'Respiratory Insufficiency/*etiology']",,,,,1966/02/01 00:00,1966/02/01 00:01,['1966/02/01 00:00'],"['1966/02/01 00:00 [pubmed]', '1966/02/01 00:01 [medline]', '1966/02/01 00:00 [entrez]']",,ppublish,J Fr Med Chir Thorac. 1966 Feb-Mar;20(2):195-200.,,,,,,,,,A propos des troubles respiratoires des obeses. L'importance du facteur contamination veineuse.,,,,,,,,,,,
7451911,NLM,MEDLINE,19810327,20061115,0368-2315 (Print) 0150-9918 (Linking),9,5,1980,[Pregnancy in obese women who have had jejuno-ileal short-circuit operations (author's transl)].,543-7,,"The authors report two cases of obese women who had had intestinal short-circuit operations for obesity 18 months and 24 months previously. They review the indications for this type of operations and the effects the operation has on the body. It has been possible to find 85 other cases in the literature. In general the pregnancy proceeds well but it is important to carry out very strict supervision of the electrolyte balance, of the hypoprotinaemia and of the blood count. Mechanical complications of the short-circuit operation are rare. While abortions and premature labours are not more frequent in these than in other cases the child is often moderately small-for-dates. Congenital malformations can be raised and are of the order of 7 per cent. These fetal abnormalities, as well as maternal digestive troubles, are definitely more frequent if the interval between the operation and the pregnancy is short. It is therefore preferable to wait for two years before allowing a woman who has had a short-circuit type of operation to become pregnant.","['Monnier, J C', 'Buvat, J', 'Proye, C', 'Le Coutour, X', 'Dansette, A', 'Boulogne, M', 'Lanciaux, B', 'Dognin, C', 'Baviere, H', 'Fourneau, A']","['Monnier JC', 'Buvat J', 'Proye C', 'Le Coutour X', 'Dansette A', 'Boulogne M', 'Lanciaux B', 'Dognin C', 'Baviere H', 'Fourneau A']",,['fre'],"['Case Reports', 'English Abstract', 'Journal Article']",France,J Gynecol Obstet Biol Reprod (Paris),"Journal de gynecologie, obstetrique et biologie de la reproduction",0322206,,IM,"['Adult', 'Female', 'Humans', 'Ileum/*surgery', 'Jejunum/*surgery', 'Obesity/*surgery', 'Pregnancy', 'Pregnancy Complications/*physiopathology']",,,,,1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']",,ppublish,J Gynecol Obstet Biol Reprod (Paris). 1980;9(5):543-7.,,,,,,,,,La grossesse chez les obeses ayant subi une derivation jejuno-ileale.,,,,,,,,,,,
13305017,NLM,MEDLINE,20030501,20181201,0001-4036 (Print) 0001-4036 (Linking),242,2,1956 Jan 9,[Nutritional requirements of obese and normal mice].,285-8,,,"['ANLIKER, J', 'MAYER, J']","['ANLIKER J', 'MAYER J']",,['fre'],['Journal Article'],France,C R Hebd Seances Acad Sci,Comptes rendus hebdomadaires des seances de l'Academie des sciences,7501108,,OM,"['Animals', 'Mice', '*Nutritional Physiological Phenomena', '*Nutritional Requirements', '*Nutritional Sciences', '*Nutritional Status', '*Obesity']",,['NLM'],"['*NUTRITION', '*OBESITY/experimental']",,1956/01/09 00:00,1956/01/09 00:01,['1956/01/09 00:00'],"['1956/01/09 00:00 [pubmed]', '1956/01/09 00:01 [medline]', '1956/01/09 00:00 [entrez]']",,ppublish,C R Hebd Seances Acad Sci. 1956 Jan 9;242(2):285-8.,,,,,,,,,Comportement alimentaire de souris obeses et des souris normales.,,,,['CLML: 5630:13223'],,,,,,,
13614509,NLM,MEDLINE,20000701,20181201,0033-0450 (Print) 0033-0450 (Linking),86,21,1958 Nov 10,[Hematology of obese subjects on preludin therapy].,384 passim,,,"['MILLER, G']",['MILLER G'],,['fre'],['Journal Article'],France,Prog Med (Paris),Le Progres medical,2984825R,"['0 (Sympathomimetics)', 'XA501VL3VR (Phenmetrazine)']",OM,"['*Hematology', 'Obesity/*therapy', '*Phenmetrazine', 'Sympathomimetics/*therapeutic use']",,['NLM'],"['*OBESITY/therapy', '*SYMPATHOMIMETICS/therapeutic use']",,1958/11/10 00:00,1958/11/10 00:01,['1958/11/10 00:00'],"['1958/11/10 00:00 [pubmed]', '1958/11/10 00:01 [medline]', '1958/11/10 00:00 [entrez]']",,ppublish,Prog Med (Paris). 1958 Nov 10;86(21):384 passim.,,,,,,,,,Etude hematologique des sujets obeses soumis a la preludinotherapie.,,,,['CLML: 5935:44159:414:571'],,,,,,,
13048253,NLM,MEDLINE,20030501,20181201,0035-2640 (Print) 0035-2640 (Linking),2,16,1952 Jun 1,[So-called endocrine obesities; critical considerations and therapy].,1009-16,,,"['DECOURT, J']",['DECOURT J'],,['und'],['Journal Article'],France,Rev Prat,La Revue du praticien,0404334,,OM,"['*Endocrine System Diseases', 'Humans', 'Obesity/*etiology']",,['NLM'],"['*ENDOCRINE DISEASES/manifestations', '*OBESITY/etiology and pathogenesis']",,1952/06/01 00:00,1952/06/01 00:01,['1952/06/01 00:00'],"['1952/06/01 00:00 [pubmed]', '1952/06/01 00:01 [medline]', '1952/06/01 00:00 [entrez]']",,ppublish,Rev Prat. 1952 Jun 1;2(16):1009-16.,,,,,,,,,Les obesites dites endocriniennes; etude critique et therapeutique.,,,,['CLML: 5324:18663:219:452'],,,,,,,
18140862,NLM,MEDLINE,20071227,20201005,0369-8394 (Print) 0369-8394 (Linking),38,38,1949 Sep 22,[The volume of extra-cellular fluid in obese].,834-9,,,"['ODIER, J', 'MACH, R S']","['ODIER J', 'MACH RS']",,['fre'],['Journal Article'],Switzerland,Praxis,Praxis,0401230,,OM,"['*Body Fluids', '*Feces', '*Fluids and Secretions', '*Obesity']",,['NLM'],"['*FLUIDS', '*OBESITY']",,1949/09/22 00:00,2008/10/31 09:00,['1949/09/22 00:00'],"['1949/09/22 00:00 [pubmed]', '2008/10/31 09:00 [medline]', '1949/09/22 00:00 [entrez]']",,ppublish,Praxis. 1949 Sep 22;38(38):834-9.,,,,,,,,,Le volume du liquide extra-cellulaire chez les obeses.,,,,['CLML: 4917:1015o'],,,,,,,
18117219,NLM,MEDLINE,20071227,20201005,0366-1334 (Print) 0366-1334 (Linking),65,7-8,1949 Feb 25-Mar 4,[The osmotic pressure of proteins in obese].,187-91,,,"['MAY, E']",['MAY E'],,['fre'],['Journal Article'],France,Bull Mem Soc Med Hop Paris,Bulletins et memoires de la Societe medicale des hopitaux de Paris,7503472,,OM,"['Humans', '*Obesity']",,['NLM'],['*OBESITY'],,1949/02/25 00:00,2008/05/31 09:00,['1949/02/25 00:00'],"['1949/02/25 00:00 [pubmed]', '2008/05/31 09:00 [medline]', '1949/02/25 00:00 [entrez]']",,ppublish,Bull Mem Soc Med Hop Paris. 1949 Feb 25-Mar 4;65(7-8):187-91.,,,,,,,,,La pression osmotique des protides chez les obeses.,,,,['CLML: 4916:1006m'],,,,,,,
13281570,NLM,MEDLINE,20030501,20181201,,31,66,1955 Nov 10,[The distinction of android and gynoid obesities as the base for their prognosis].,3503-9,,,"['VAGUE, J']",['VAGUE J'],,['fre'],['Journal Article'],France,Sem Hop,La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,9410059,['V9EFU16ZIF (Methyltestosterone)'],OM,"['Humans', '*Methyltestosterone', '*Obesity', 'Prognosis']",,['NLM'],['*OBESITY'],,1955/11/10 00:00,1955/11/10 00:01,['1955/11/10 00:00'],"['1955/11/10 00:00 [pubmed]', '1955/11/10 00:01 [medline]', '1955/11/10 00:00 [entrez]']",,ppublish,Sem Hop. 1955 Nov 10;31(66):3503-9.,,,,,,,,,La distinction des obesites en androides et gynoides; base de leur pronostic.,,,,['CLML: 5629:33711'],,,,,,,
4640112,NLM,MEDLINE,19730208,20041117,0301-1534 (Print),1,6,1972 Jun,[Discovery of the number of obese children and summarized study of the socioeconomic status of their families].,572-8,,,"['Boileau, J G', 'Lizotte, P']","['Boileau JG', 'Lizotte P']",,['fre'],['Journal Article'],Canada,Vie Med Can Fr,La Vie medicale au Canada francais,0316264,,IM,"['Adolescent', 'Age Factors', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Male', 'Obesity/*epidemiology', 'Quebec', 'Sex Factors', 'Social Class', 'Social Conditions', 'Socioeconomic Factors']",,,,,1972/06/01 00:00,1972/06/01 00:01,['1972/06/01 00:00'],"['1972/06/01 00:00 [pubmed]', '1972/06/01 00:01 [medline]', '1972/06/01 00:00 [entrez]']",,ppublish,Vie Med Can Fr. 1972 Jun;1(6):572-8.,,,,,,,,,Depistage du nombre d'enfants obeses et etude sommaire du statut socio-economique de leur famille.,,,,,,,,,,,
3222293,NLM,MEDLINE,19890323,20061115,0031-8280 (Print) 0031-8280 (Linking),41,3,1988 Jul-Oct,[The flow of venous blood in the obese].,493-9,,"The increase of adipose tissue disturbs the cutaneous venous circulation. In the normal subject, this flow, in the subcutaneous space, occurs between two networks joined by drainage veins. The responsible motor forces are multiple (residual arteriolar pressure, negative transmural pressure) (effect of compression). In the obese patient, hypertrophy of the adipose tissue-mass damages the drainage veins and provokes stasis, evolving in two stages: at first the disorders are reversible (venous dilatation); then definitive tissular damage occurs (epidermis, plexus, veins, muscles, fatty masses). This disintegration accounts for the clinical symptoms (oedema, varicose veins, trophic disorders). There are three conclusions to be drawn from this: adiposity will always be accompanied by venous insufficiency; it is dangerous to make a long-overweight patient reduce weight; adiposity must be treated very early on.","['Lemaire, R']",['Lemaire R'],,['fre'],"['English Abstract', 'Journal Article']",France,Phlebologie,Phlebologie,0376212,,IM,"['Blood Circulation', 'Humans', 'Obesity/*physiopathology', 'Veins/*physiopathology']",,,,,1988/07/01 00:00,1988/07/01 00:01,['1988/07/01 00:00'],"['1988/07/01 00:00 [pubmed]', '1988/07/01 00:01 [medline]', '1988/07/01 00:00 [entrez]']",,ppublish,Phlebologie. 1988 Jul-Oct;41(3):493-9.,,,,,,,,,L'ecoulement du sang veineux chez les obeses.,,,,,,,,,,,
5575624,NLM,MEDLINE,19710706,20181130,0021-7867 (Print) 0021-7867 (Linking),4,3,1971 Mar,[Function of the adrenal gland in obese children].,843-4 passim,,,"['Matajc, L']",['Matajc L'],,['fre'],['Journal Article'],France,Bord Med,Bordeaux medical,0134233,"['0 (Adrenal Cortex Hormones)', 'WI4X0X7BPJ (Hydrocortisone)']",IM,"['Adrenal Cortex Hormones/biosynthesis', 'Adrenal Glands/*physiopathology', 'Adrenocortical Hyperfunction/etiology', 'Child', 'Child, Preschool', 'Humans', 'Hydrocortisone/*metabolism', 'Infant', 'Obesity/*physiopathology']",,,,,1971/03/01 00:00,1971/03/01 00:01,['1971/03/01 00:00'],"['1971/03/01 00:00 [pubmed]', '1971/03/01 00:01 [medline]', '1971/03/01 00:00 [entrez]']",,ppublish,Bord Med. 1971 Mar;4(3):843-4 passim.,,,,,,,,,Fonctionnement de la surrenale chez les enfants obeses.,,,,,,,,,,,
14809048,NLM,MEDLINE,20040215,20181201,0035-3655 (Print) 0035-3655 (Linking),70,12,1950 Dec,[Therapeutic effects of benzedrine (amphetamine) in obese rheumatics].,713-20,,,"['JUNET, R']",['JUNET R'],,['und'],['Journal Article'],Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,"['0 (Amphetamines)', 'CK833KGX7E (Amphetamine)']",OM,"['*Amphetamine', '*Amphetamines', 'Humans', '*Obesity', '*Rheumatic Diseases']",,['NLM'],"['*AMPHETAMINE', '*OBESITY', '*RHEUMATISM']",,1950/12/01 00:00,1950/12/01 00:01,['1950/12/01 00:00'],"['1950/12/01 00:00 [pubmed]', '1950/12/01 00:01 [medline]', '1950/12/01 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1950 Dec;70(12):713-20.,,,,,,,,,Les effets therapeutiques de la benzedrine (amphetamine) chez les obeses rhumatisants.,,,,['CLML: 5120:40400:33:99:236'],,,,,,,
842033,NLM,MEDLINE,19770428,20081121,0043-5325 (Print) 0043-5325 (Linking),89,5,1977 Mar 4,[Myocardial performance during therapeutic starvation in obese subjects].,154-7,,"The effect was studied of therapeutic total starvation of two weeks' duration on myocardial performance in 12 obeses patients. Half of these subjects were trained for 10 minutes daily on a bicycle ergometer, whilst the other half had no training. After two weeks of total fasting no significant changes were observed either inter- or intracollectively with regard to systolic time intervals, ejection fraction and the index of myocardial contractility, nor in respect to serum electrolytes. Physical training had no influence on the systolic time intervals and the other noninvasive parameters of left ventricular performance. The inclusion of previous data obtained in a similar investigation enabled the establishment of a correlation between the serum potassium level and the ejection franction.","['Aigner, A', 'Lisch, H J', 'Knapp, E', 'Sailer, S', 'Raas, E']","['Aigner A', 'Lisch HJ', 'Knapp E', 'Sailer S', 'Raas E']",,['ger'],"['English Abstract', 'Journal Article']",Austria,Wien Klin Wochenschr,Wiener klinische Wochenschrift,21620870R,['0 (Electrolytes)'],IM,"['Adult', 'Electrolytes/blood', 'Female', 'Heart/*physiopathology', 'Hemodynamics', 'Humans', 'Male', 'Middle Aged', 'Myocardial Contraction', 'Obesity/*diagnosis/therapy', 'Physical Exertion', 'Physical Fitness', 'Starvation/*physiopathology']",,,,,1977/03/04 00:00,1977/03/04 00:01,['1977/03/04 00:00'],"['1977/03/04 00:00 [pubmed]', '1977/03/04 00:01 [medline]', '1977/03/04 00:00 [entrez]']",,ppublish,Wien Klin Wochenschr. 1977 Mar 4;89(5):154-7.,,,,,,,,,Kardiale Leistungsfahigkeit von Fettsuchtigen wahrend Nullkalorien-Diat.,,,,,,,,,,,
13442449,NLM,MEDLINE,20020501,20181201,0249-7581 (Print) 0249-7581 (Linking),,6,1956 Nov-Dec,[Biological examinations of obese subjects with abarticular rheumatism].,285-90,,,"['EYQUEM, A', 'FAUCONNIER, J', 'DE TRAVERSE, P M', 'VAN MOOR LEGHEM, G']","['EYQUEM A', 'FAUCONNIER J', 'DE TRAVERSE PM', 'VAN MOOR LEGHEM G']",,['fre'],['Journal Article'],France,Rhumatologie,Rhumatologie,0421126,,OM,"['Humans', 'Obesity/*complications', '*Physical Examination', '*Rheumatic Diseases']",,['NLM'],"['*OBESITY/complications', '*RHEUMATISM']",,1956/11/01 00:00,1956/11/01 00:01,['1956/11/01 00:00'],"['1956/11/01 00:00 [pubmed]', '1956/11/01 00:01 [medline]', '1956/11/01 00:00 [entrez]']",,ppublish,Rhumatologie. 1956 Nov-Dec;(6):285-90.,,,,,,,,,Examens biologiques de sujets obeses atteints de rhumatisme abarticulaire.,,,,['CLML: 5732:40735'],,,,,,,
4266617,NLM,MEDLINE,19730606,20071115,0007-439X (Print) 0007-439X (Linking),8,5,1972 Sep-Oct,[Pulmonary hemodynamics in obese patients: a brief review].,1005-10,,,"['Denolin, H']",['Denolin H'],,['fre'],['Journal Article'],France,Bull Physiopathol Respir (Nancy),Bulletin de physio-pathologie respiratoire,7611945,,IM,"['Cardiac Output', 'Cardiomegaly/etiology', 'Heart Failure/etiology', 'Heart Ventricles', '*Hemodynamics', 'Humans', 'Hypertension, Pulmonary/*etiology', 'Hypoventilation/etiology', 'Obesity/complications/*physiopathology', 'Oxygen Consumption', 'Prognosis', '*Pulmonary Circulation', 'Pulmonary Heart Disease/etiology']",,,,,1972/09/01 00:00,1972/09/01 00:01,['1972/09/01 00:00'],"['1972/09/01 00:00 [pubmed]', '1972/09/01 00:01 [medline]', '1972/09/01 00:00 [entrez]']",,ppublish,Bull Physiopathol Respir (Nancy). 1972 Sep-Oct;8(5):1005-10.,,,,,,,,,L'hemodynamique pulmonaire chez les obeses: une breve revue.,,,,,,,,,,,
5509648,NLM,MEDLINE,19710602,20131121,0012-1770 (Print) 0012-1770 (Linking),18,1,1970 Jan-Mar,[Effect of a single dose of metformin on glucose tolerance in normal and obese patients].,35-9,,,"['Vague, P']",['Vague P'],,['fre'],['Journal Article'],France,Diabete,Le Diabete,2984746R,['9100L32L2N (Metformin)'],IM,"['Diabetes Mellitus/*drug therapy', '*Glucose Tolerance Test', 'Humans', 'Metformin/*therapeutic use', 'Obesity/*metabolism']",,,,,1970/01/01 00:00,1970/01/01 00:01,['1970/01/01 00:00'],"['1970/01/01 00:00 [pubmed]', '1970/01/01 00:01 [medline]', '1970/01/01 00:00 [entrez]']",,ppublish,Diabete. 1970 Jan-Mar;18(1):35-9.,,,,,,,,,Effet d'une dose unique de metformine sur la tolerance au glucose des sujets normaux ou obeses.,,,,,,,,,,,
13150721,NLM,MEDLINE,20030501,20181201,0010-5309 (Print) 0010-5309 (Linking),76,12,1954 Mar 20,[Variations of the sodium content in the blood of obese persons; clinical and therapeutic deductions].,1169-70,,,"['KERMORGANT, Y']",['KERMORGANT Y'],,['und'],['Journal Article'],France,Concours Med,Concours medical,2984731R,"['0 (Sodium, Dietary)', '9NEZ333N27 (Sodium)']",OM,"['*Blood', 'Humans', 'Obesity/*blood', 'Sodium/*blood', '*Sodium, Dietary']",,['NLM'],"['*BLOOD', '*OBESITY/blood in', '*SODIUM/in blood']",,1954/03/20 00:00,1954/03/20 00:01,['1954/03/20 00:00'],"['1954/03/20 00:00 [pubmed]', '1954/03/20 00:01 [medline]', '1954/03/20 00:00 [entrez]']",,ppublish,Concours Med. 1954 Mar 20;76(12):1169-70.,,,,,,,,,Variabilites de la teneur en sodium du serum des obeses; deductions cliniques et therapeutiques.,,,,['CLML: 5426:13260:68:314:410'],,,,,,,
11402972,NLM,MEDLINE,20010719,20161124,0041-5782 (Print) 0041-5782 (Linking),163,21,2001 May 21,[What are the characteristics of overweight and obese individuals?].,2927-9,,,"['Rossner, S']",['Rossner S'],"['Overviktsenheten, Huddinge Universitetssjukhus, Stockholm. Stephan.Rossner@medhs.ki.se']",['swe'],['Journal Article'],Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,IM,"['Behavior Therapy', 'Feeding Behavior', 'Female', '*Global Health', 'Humans', 'Life Style', 'Male', '*Obesity/epidemiology/etiology/psychology/therapy', 'Socioeconomic Factors']",,,,,2001/06/14 10:00,2001/07/20 10:01,['2001/06/14 10:00'],"['2001/06/14 10:00 [pubmed]', '2001/07/20 10:01 [medline]', '2001/06/14 10:00 [entrez]']",,ppublish,Ugeskr Laeger. 2001 May 21;163(21):2927-9.,,,,,,,,,Vad karakteriserar overviktiga och feta individer?,,,,,,,,,,,
3222298,NLM,MEDLINE,19890323,20041117,0031-8280 (Print) 0031-8280 (Linking),41,3,1988 Jul-Oct,[Phlebographic data of the lower extremities in the obese].,539-41,,,"['Picard, J D']",['Picard JD'],"[""Service d'Electro-Radiologie, CMC Foch, Suresnes.""]",['fre'],['Journal Article'],France,Phlebologie,Phlebologie,0376212,,IM,"['Humans', 'Leg/*blood supply', 'Obesity/*complications', '*Phlebography']",,,,,1988/07/01 00:00,1988/07/01 00:01,['1988/07/01 00:00'],"['1988/07/01 00:00 [pubmed]', '1988/07/01 00:01 [medline]', '1988/07/01 00:00 [entrez]']",,ppublish,Phlebologie. 1988 Jul-Oct;41(3):539-41.,,,,,,,,,Les donnees de la phlebographie des membres inferieurs chez les obeses.,,,,,,,,,,,
2527117,NLM,MEDLINE,19890918,20041117,0009-9074 (Print) 0009-9074 (Linking),129,3,1989 May 15,[Advise for the general practitioner: information for the obese patient].,219-21,,,"['Cairella, M']",['Cairella M'],,['ita'],['Journal Article'],Italy,Clin Ter,La Clinica terapeutica,0372604,,IM,"['Exercise', 'Feeding Behavior', 'Humans', 'Obesity/diet therapy/psychology/*therapy', 'Physicians, Family', 'Weight Loss']",,,,,1989/05/15 00:00,1989/05/15 00:01,['1989/05/15 00:00'],"['1989/05/15 00:00 [pubmed]', '1989/05/15 00:01 [medline]', '1989/05/15 00:00 [entrez]']",,ppublish,Clin Ter. 1989 May 15;129(3):219-21.,,,,,,,,,Consigli per il medico pratico: informazioni per i pazienti obesi.,,,,,,,,,,,
5324922,NLM,MEDLINE,19660526,20131121,0366-1334 (Print) 0366-1334 (Linking),116,14,1965 Nov 12,[Contribution to the study of hydrosodium balance in obese persons].,1485-7,,,"['Robel, P', 'Decourt, J', 'Saltiel, H']","['Robel P', 'Decourt J', 'Saltiel H']",,['fre'],"['Clinical Trial', 'Journal Article']",France,Bull Mem Soc Med Hop Paris,Bulletins et memoires de la Societe medicale des hopitaux de Paris,7503472,['77W477J15H (Chlorothiazide)'],IM,"['Chlorothiazide/*pharmacology', 'Clinical Trials as Topic', 'Female', 'Humans', 'Obesity/*physiopathology', 'Water-Electrolyte Balance/*physiology']",,,,,1965/11/12 00:00,1965/11/12 00:01,['1965/11/12 00:00'],"['1965/11/12 00:00 [pubmed]', '1965/11/12 00:01 [medline]', '1965/11/12 00:00 [entrez]']",,ppublish,Bull Mem Soc Med Hop Paris. 1965 Nov 12;116(14):1485-7.,,,,,,,,,Contribution a l'etude de la regulation hydro-sodee chez les obeses.,,,,,,,,,,,
13468180,NLM,MEDLINE,20000701,20181201,0041-6959 (Print) 0041-6959 (Linking),86,9,1957 Sep,[Study of blood cholesterol in obese diabetics under the influence of phenmetrazine (preludine)].,961-2,,,"['ROBILLARD, R', 'SAUCIER, R']","['ROBILLARD R', 'SAUCIER R']",,['fre'],['Journal Article'],Canada,Union Med Can,L'union medicale du Canada,0030444,"['0 (Sympathomimetics)', '97C5T2UQ7J (Cholesterol)', 'XA501VL3VR (Phenmetrazine)']",OM,"['Cholesterol/*blood', 'Diabetes Mellitus/*blood', 'Humans', '*Leadership', 'Obesity/*therapy', '*Phenmetrazine', 'Sympathomimetics/*therapeutic use']",,['NLM'],"['*CHOLESTEROL/in blood', '*DIABETES MELLITUS/blood in', '*OBESITY/therapy', '*SYMPATHOMIMETICS/therapeutic use']",,1957/09/01 00:00,1957/09/01 00:01,['1957/09/01 00:00'],"['1957/09/01 00:00 [pubmed]', '1957/09/01 00:01 [medline]', '1957/09/01 00:00 [entrez]']",,ppublish,Union Med Can. 1957 Sep;86(9):961-2.,,,,,,,,,Etude du cholesterol sanguin chez les diabetiques obeses soumis a la phenmetrazine (preludine).,,,,['CLML: 5833:10852:123:155:361:492'],,,,,,,
5596129,NLM,MEDLINE,19681007,20161031,0003-4266 (Print) 0003-4266 (Linking),28,6,1967 Nov-Dec,[A study of the mobilization of free plasma fatty acids by noradrenaline in obese patients].,798-806,,,"['Hanoune, J', 'Salmon, D', 'Laudat, P', 'de Gennes, J L']","['Hanoune J', 'Salmon D', 'Laudat P', 'de Gennes JL']",,['fre'],['Journal Article'],France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,"['0 (Fatty Acids, Nonesterified)', 'X4W3ENH1CV (Norepinephrine)']",IM,"['Fatty Acids, Nonesterified/*blood/*metabolism', 'Female', 'Humans', 'Lipodystrophy/blood', 'Male', 'Norepinephrine/*pharmacology', 'Obesity/*blood/metabolism']",,,,,1967/11/01 00:00,1967/11/01 00:01,['1967/11/01 00:00'],"['1967/11/01 00:00 [pubmed]', '1967/11/01 00:01 [medline]', '1967/11/01 00:00 [entrez]']",,ppublish,Ann Endocrinol (Paris). 1967 Nov-Dec;28(6):798-806.,,,,,,,,,Etude de la mobilisation des acides gras libres pasmatiques par la noadrenaline chiz les obeses.,,,,,,,,,,,
5909920,NLM,MEDLINE,19660626,20041117,0021-7883 (Print) 0021-7883 (Linking),47,94,1966 Mar 5,[Pulmonary ventilation in the obese (apropos of the respiratory functional exploration in 59 obese patients)].,363-80,,,"['Plauchu, M', 'Bourlier, V', 'Meunier, P', 'Savoye, B', 'Molinie, C']","['Plauchu M', 'Bourlier V', 'Meunier P', 'Savoye B', 'Molinie C']",,['fre'],['Journal Article'],France,J Med Lyon,Journal de medecine de Lyon,2985084R,,IM,"['Adolescent', 'Adult', 'Aged', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*physiopathology', 'Respiratory Function Tests', 'Respiratory Insufficiency/*etiology']",,,,,1966/03/05 00:00,1966/03/05 00:01,['1966/03/05 00:00'],"['1966/03/05 00:00 [pubmed]', '1966/03/05 00:01 [medline]', '1966/03/05 00:00 [entrez]']",,ppublish,J Med Lyon. 1966 Mar 5;47(94):363-80.,,,,,,,,,La ventilation pulmonaire chez les obeses (a propos de l'exploration fonctionnelle respiratoire de 59 obeses).,,,,,,,,,,,
4706699,NLM,MEDLINE,19730723,20131121,0301-1534 (Print),2,2,1973,"[Effects of fenfluramine, administered on short or long-term basis, on lipolysis of obese subjects].",157-62,,,"['Balasse, E O']",['Balasse EO'],,['fre'],['Journal Article'],Canada,Vie Med Can Fr,La Vie medicale au Canada francais,0316264,['2DS058H2CF (Fenfluramine)'],IM,"['Fenfluramine/pharmacology/*therapeutic use', 'Humans', 'Lipid Mobilization/*drug effects', 'Obesity/*drug therapy']",,,,,1973/01/01 00:00,1973/01/01 00:01,['1973/01/01 00:00'],"['1973/01/01 00:00 [pubmed]', '1973/01/01 00:01 [medline]', '1973/01/01 00:00 [entrez]']",,ppublish,Vie Med Can Fr. 1973;2(2):157-62.,,,,,,,,,"Effets de la fenfluramine, administree a court terme ou a long terme, sur la lipolyse de sujets obeses.",,,,,,,,,,,
4600429,NLM,MEDLINE,19740830,20091111,0006-3258 (Print) 0006-3258 (Linking),6,3,1973,[Organ culture of isolated islands of Langerhans from the obeses hyperglycemic mouse. Ultrastructural study].,205-15,,,"['Stock, C', 'Kedinger, M', 'Haffen, K', 'Grenier, J F']","['Stock C', 'Kedinger M', 'Haffen K', 'Grenier JF']",,['fre'],"['English Abstract', 'Journal Article']",France,Biol Gastroenterol (Paris),Biologie et gastro-enterologie,0146364,,IM,"['Animals', 'Cells, Cultured', 'Chick Embryo', 'Cytoplasmic Granules', 'Hybrid Cells', 'Hyperglycemia/metabolism', 'Islets of Langerhans/*metabolism', 'Kidney/embryology', 'Methods', 'Mice', 'Microscopy, Electron', 'Obesity/*metabolism']",,,,,1973/01/01 00:00,1973/01/01 00:01,['1973/01/01 00:00'],"['1973/01/01 00:00 [pubmed]', '1973/01/01 00:01 [medline]', '1973/01/01 00:00 [entrez]']",,ppublish,Biol Gastroenterol (Paris). 1973;6(3):205-15.,,,,,,,,,Culture organotypique d'ilots de Langerhans isoles chez la souris obese hyperglycermique. Etude ultrastructurale.,,,,,,,,,,,
5596128,NLM,MEDLINE,19681007,20161031,0003-4266 (Print) 0003-4266 (Linking),28,6,1967 Nov-Dec,[Fluctuations in plasma free fatty acids following oral administration of glucose in obese patients].,787-97,,,"['Vague, P', 'Scornavachi, J C', 'Rouvier-Leroy, C']","['Vague P', 'Scornavachi JC', 'Rouvier-Leroy C']",,['fre'],['Journal Article'],France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,"['0 (Fatty Acids, Nonesterified)', 'IY9XDZ35W2 (Glucose)']",IM,"['Adult', 'Body Weight', 'Diabetes Mellitus/*blood', 'Fatty Acids, Nonesterified/*blood', 'Female', 'Glucose/*pharmacology', 'Glucose Tolerance Test', 'Humans', 'Hyperglycemia/chemically induced', 'Male', 'Middle Aged', 'Obesity/*blood']",,,,,1967/11/01 00:00,1967/11/01 00:01,['1967/11/01 00:00'],"['1967/11/01 00:00 [pubmed]', '1967/11/01 00:01 [medline]', '1967/11/01 00:00 [entrez]']",,ppublish,Ann Endocrinol (Paris). 1967 Nov-Dec;28(6):787-97.,,,,,,,,,Variation des acides gras libres plasmatiques apr.es dministration orale de glucose chez les obeses.,,,,,,,,,,,
216085,NLM,MEDLINE,19790313,20081121,,54,29-32,1978 Oct 8-15,[Weight loss of obese patients and fatigue. Study of muscular performance and weight changes].,942-6,,,"['Schrub, J C', 'Courtois, H', 'Vuillermet, P', 'Viardot, N', 'Mezaize, D']","['Schrub JC', 'Courtois H', 'Vuillermet P', 'Viardot N', 'Mezaize D']",,['fre'],"['English Abstract', 'Journal Article']",France,Sem Hop,La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,9410059,,IM,"['Body Weight', '*Diet, Reducing', 'Energy Intake', 'Fatigue/*etiology/physiopathology', 'Female', 'Humans', 'Male', 'Obesity/*diet therapy/physiopathology', 'Physical Exertion']",,,,,1978/10/08 00:00,1978/10/08 00:01,['1978/10/08 00:00'],"['1978/10/08 00:00 [pubmed]', '1978/10/08 00:01 [medline]', '1978/10/08 00:00 [entrez]']",,ppublish,Sem Hop. 1978 Oct 8-15;54(29-32):942-6.,,,,,,,,,Amaigrissement des obeses et fatigue. Etude des performances musculaires et evolution ponderale.,,,,,,,,,,,
6688303,NLM,MEDLINE,19830920,20091111,0036-5327 (Print) 0036-5327 (Linking),85,5,1983 May,[Processing of data on obese patients by the GUHA (General Unitary Hypothesis Automaton) method].,133-40,,,"['Hlavova, Z', 'Sonka, J']","['Hlavova Z', 'Sonka J']",,['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Sb Lek,Sbornik lekarsky,0025770,,IM,"['*Computers', 'Humans', 'Obesity/*diagnosis/etiology', '*Software']",,,,,1983/05/01 00:00,1983/05/01 00:01,['1983/05/01 00:00'],"['1983/05/01 00:00 [pubmed]', '1983/05/01 00:01 [medline]', '1983/05/01 00:00 [entrez]']",,ppublish,Sb Lek. 1983 May;85(5):133-40.,,,,,,,,,Zpracovani udaju o obeznich pacientech metodou GUHA.,,,,,,,,,,,
5841325,NLM,MEDLINE,19660121,20041117,0021-7883 (Print) 0021-7883 (Linking),46,79,1965 Jun 20,[The mortality of the obese. Apropos of hospital statistics of 110 cases supported by other unpublished statistics].,1147-80,,,"['Plauchu, M', 'Bourlier, V', 'Meunier, P']","['Plauchu M', 'Bourlier V', 'Meunier P']",,['fre'],['Journal Article'],France,J Med Lyon,Journal de medecine de Lyon,2985084R,,IM,"['Adult', 'Aged', 'Female', 'France', 'Humans', 'Male', 'Middle Aged', 'Mortality', '*Obesity']",,,,,1965/06/20 00:00,1965/06/20 00:01,['1965/06/20 00:00'],"['1965/06/20 00:00 [pubmed]', '1965/06/20 00:01 [medline]', '1965/06/20 00:00 [entrez]']",,ppublish,J Med Lyon. 1965 Jun 20;46(79):1147-80.,,,,,,,,,La mortalite des obeses. A propos d'une statistique hospitaliere de 110 cas etayee par d'autres statistiques inedites.,,,,,,,,,,,
6505590,NLM,MEDLINE,19850124,20061115,0035-2640 (Print) 0035-2640 (Linking),34,55,1984 Dec 1,[Can we recognize clinically obese subjects at risk for complications?].,3101-10,,,"['Badier, C', 'Tramoni, M', 'Vague, P']","['Badier C', 'Tramoni M', 'Vague P']",,['fre'],"['English Abstract', 'Journal Article']",France,Rev Prat,La Revue du praticien,0404334,,,"['Adipose Tissue/pathology', 'Adult', 'Anthropometry/methods', 'Female', 'Humans', 'Male', 'Metabolic Diseases/etiology', 'Middle Aged', 'Obesity/*complications', 'Risk', 'Skinfold Thickness']",,,,,1984/12/01 00:00,1984/12/01 00:01,['1984/12/01 00:00'],"['1984/12/01 00:00 [pubmed]', '1984/12/01 00:01 [medline]', '1984/12/01 00:00 [entrez]']",,ppublish,Rev Prat. 1984 Dec 1;34(55):3101-10.,,,,,,,,,Peut-on reconnaitre cliniquement les obeses a risque de complications?,,,,,,,,,,,
5989006,NLM,MEDLINE,19680302,20131121,0036-7672 (Print) 0036-7672 (Linking),96,28,1966 Jul 16,[Glucose tolerance and insulinemia in obese patients treated with hydrochlorothiazide].,909-13,,,"['Schelling, J L', 'Moody, A J', 'Felber, J P']","['Schelling JL', 'Moody AJ', 'Felber JP']",,['fre'],['Journal Article'],Switzerland,Schweiz Med Wochenschr,Schweizerische medizinische Wochenschrift,0404401,"['0 (Blood Glucose)', '0 (Fatty Acids, Nonesterified)', '0 (Insulin)', '0J48LPH2TH (Hydrochlorothiazide)', 'IY9XDZ35W2 (Glucose)', 'RWP5GA015D (Potassium)']",IM,"['Adult', 'Aged', 'Blood Glucose/analysis', 'Diet, Reducing', 'Fatty Acids, Nonesterified/blood', 'Female', 'Glucose/*metabolism', 'Humans', 'Hydrochlorothiazide/*therapeutic use', 'Insulin/blood', 'Male', 'Middle Aged', 'Obesity/drug therapy/*metabolism', 'Potassium/urine']",,,,,1966/07/16 00:00,1966/07/16 00:01,['1966/07/16 00:00'],"['1966/07/16 00:00 [pubmed]', '1966/07/16 00:01 [medline]', '1966/07/16 00:00 [entrez]']",,ppublish,Schweiz Med Wochenschr. 1966 Jul 16;96(28):909-13.,,,,,,,,,Tolerance au glucose et insulinemie chez les obeses recevant de l'hydrochlorothiazide.,,,,,,,,,,,
4009528,NLM,MEDLINE,19850806,20161123,0221-0363 (Print) 0221-0363 (Linking),66,3,1985 Mar,[False mass of the thoracic wall in obese adolescent girls].,215-7,,"Each of four obese adolescent females were thought to have pre-sternal anterior chest wall ""masses"" when evaluated by lateral chest radiograph. All had normal physical examinations. The apparent chest wall masses were found to be an artifact created by partial midline contact of both, large breasts, surrounded by a partial midline air space adding contrast to the adjacent soft tissue. Manual abduction of the breasts was followed by disappearance of the apparent radiographic abnormality.","['Cleveland, R H', 'Kushner, D C', 'Herman, T E']","['Cleveland RH', 'Kushner DC', 'Herman TE']",,['fre'],['Journal Article'],France,J Radiol,Journal de radiologie,7906266,,IM,"['Adolescent', 'Diagnosis, Differential', 'Female', 'Humans', 'Obesity/*diagnostic imaging', 'Pain/etiology', '*Radiography, Thoracic', 'Thorax']",,,,,1985/03/01 00:00,1985/03/01 00:01,['1985/03/01 00:00'],"['1985/03/01 00:00 [pubmed]', '1985/03/01 00:01 [medline]', '1985/03/01 00:00 [entrez]']",,ppublish,J Radiol. 1985 Mar;66(3):215-7.,,,,,,,,,Fausse masse de la paroi thoracique chez des adolescentes obeses.,,,,,,,,,,,
18179013,NLM,MEDLINE,20080207,20141120,1259-4792 (Print) 1259-4792 (Linking),,239,2007 Dec,[The follow-up and educational nursing consultation for obese children].,31-2,,,"['Merville, Virginie']",['Merville V'],"['Service de Pedatrie, CH Abbeville.']",['fre'],['Journal Article'],France,Soins Pediatr Pueric,"Soins. Pediatrie, puericulture",9604503,,,"['Aftercare/*organization & administration', 'Child', 'Child Nutrition Disorders/diagnosis/epidemiology/*prevention & control', 'Child Nutrition Sciences/education', 'Dietetics/organization & administration', 'France/epidemiology', 'Humans', 'Incidence', 'Life Style', 'Motivation', 'Nursing Assessment/*organization & administration', 'Nutrition Assessment', 'Obesity/diagnosis/epidemiology/*prevention & control', '*Patient Discharge', 'Patient Education as Topic/*organization & administration', 'Pediatric Nursing', 'Psychology, Child']",,,,,2008/01/09 09:00,2008/02/08 09:00,['2008/01/09 09:00'],"['2008/01/09 09:00 [pubmed]', '2008/02/08 09:00 [medline]', '2008/01/09 09:00 [entrez]']",,ppublish,Soins Pediatr Pueric. 2007 Dec;(239):31-2.,,,,,,,,,La consultation infirmiere de suivi et d'education pour enfants obeses.,,,,,,,,,,,
3645145,NLM,MEDLINE,19870427,20080213,0253-0465 (Print) 0253-0465 (Linking),80,2,1987 Feb,[An application of the nursing process in pediatrics: the obese child].,41-3,,,"['Chatagnat, C']",['Chatagnat C'],,['fre'],['Journal Article'],Switzerland,Krankenpfl Soins Infirm,Krankenpflege. Soins infirmiers,8000153,,,"['Child', 'Child, Preschool', 'Feeding Behavior', 'Humans', 'Obesity/*nursing/psychology/therapy', 'Parent-Child Relations', 'Pediatric Nursing', 'Social Isolation']",,,,,1987/02/01 00:00,1987/02/01 00:01,['1987/02/01 00:00'],"['1987/02/01 00:00 [pubmed]', '1987/02/01 00:01 [medline]', '1987/02/01 00:00 [entrez]']",,ppublish,Krankenpfl Soins Infirm. 1987 Feb;80(2):41-3.,,,,,,,,,Une application du processus de soins en pediatrie: l'enfant obese.,,,,,,,,,,,
13101254,NLM,MEDLINE,20030501,20181201,0035-3655 (Print) 0035-3655 (Linking),73,6,1953 Jun,[Emaciation therapy; choice of treatment of arterial hypertension in the obese].,475-81,,,"['JUNET, R']",['JUNET R'],,['und'],['Journal Article'],Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,,OM,"['*Diet', '*Emaciation', 'Humans', 'Hypertension/*complications', 'Obesity/*complications']",,['NLM'],"['*DIETS', '*HYPERTENSION/complications', '*OBESITY/complications']",,1953/06/01 00:00,1953/06/01 00:01,['1953/06/01 00:00'],"['1953/06/01 00:00 [pubmed]', '1953/06/01 00:01 [medline]', '1953/06/01 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1953 Jun;73(6):475-81.,,,,,,,,,La cure amaigrissante; traitement de choix de l'hypertension arterielle des obeses.,,,,['CLML: 5425:22230:141:229:328'],,,,,,,
4961595,NLM,MEDLINE,19670907,20131121,0033-6890 (Print) 0033-6890 (Linking),3,3,1966 Sep,[Functional activity of the reticuloendothelial system in obese mice].,236-49,,,"['Stiffel, C', 'Mouton, D', 'Bouthillier, Y', 'Decreusefond, C', 'Biozzi, G']","['Stiffel C', 'Mouton D', 'Bouthillier Y', 'Decreusefond C', 'Biozzi G']",,['fre'],['Journal Article'],United States,J Reticuloendothel Soc,Journal of the Reticuloendothelial Society,0206462,['97C5T2UQ7J (Cholesterol)'],IM,"['Animals', 'Body Weight', 'Cholesterol', 'Female', 'Hypercholesterolemia', 'Liver/analysis', 'Male', 'Mice', 'Mononuclear Phagocyte System/*metabolism/*physiology', 'Mycobacterium tuberculosis', 'Obesity/*physiopathology', 'Organ Size', '*Phagocytosis', 'Spleen/analysis']",,,,,1966/09/01 00:00,1966/09/01 00:01,['1966/09/01 00:00'],"['1966/09/01 00:00 [pubmed]', '1966/09/01 00:01 [medline]', '1966/09/01 00:00 [entrez]']",,ppublish,J Reticuloendothel Soc. 1966 Sep;3(3):236-49.,,,,,,,,,"Activite fonctionnelle du systeme reticulo-endothelial chez des souris ""obeses"".",,,,,,,,,,,
5386104,NLM,MEDLINE,19701013,20131121,0040-5922 (Print) 0040-5922 (Linking),45,10,1969 Dec,[Action of phenformin in latent diabetes of non-obese patients].,987-92,,,"['Schrub, J C', 'Hillemand, B', 'Delgove, H', 'Dubuisson, M']","['Schrub JC', 'Hillemand B', 'Delgove H', 'Dubuisson M']",,['fre'],['Journal Article'],France,Therapeutique,Therapeutique (La Semaine des hopitaux),0415606,['DD5K7529CE (Phenformin)'],IM,"['Adolescent', 'Adult', 'Aged', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/complications', 'Phenformin/*therapeutic use', 'Prediabetic State/complications/*drug therapy']",,,,,1969/12/01 00:00,1969/12/01 00:01,['1969/12/01 00:00'],"['1969/12/01 00:00 [pubmed]', '1969/12/01 00:01 [medline]', '1969/12/01 00:00 [entrez]']",,ppublish,Therapeutique. 1969 Dec;45(10):987-92.,,,,,,,,,L'action de la phenformine dans le diabete latent des sujets non obeses.,,,,,,,,,,,
1462084,NLM,MEDLINE,19930108,20041117,0035-3655 (Print) 0035-3655 (Linking),112,11,1992 Nov,[Weight loss in obese patients. Importance of assessment of body composition].,943-9,,,"['Crausaz, F M', 'Bracco, D', 'Stalder, H', 'Schutz, Y']","['Crausaz FM', 'Bracco D', 'Stalder H', 'Schutz Y']","['Policlinique universitaire de medecine, Hopital cantonal, Geneve.']",['fre'],['Journal Article'],Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,,IM,"['Adipose Tissue', 'Adult', '*Body Composition', 'Diet, Reducing', 'Exercise', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/drug therapy/*physiopathology', 'Skinfold Thickness']",,,,,1992/11/01 00:00,1992/11/01 00:01,['1992/11/01 00:00'],"['1992/11/01 00:00 [pubmed]', '1992/11/01 00:01 [medline]', '1992/11/01 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1992 Nov;112(11):943-9.,,,,,,,,,Perte ponderale chez des patients obeses. Importance de l'evaluation de la composition corporelle.,,,,,,,,,,,
7871287,NLM,MEDLINE,19950330,20171116,0370-629X (Print) 0370-629X (Linking),50,1,1995 Jan,[How I examine... an obese patient prior to a potential gastroplasty].,46-7,,,"['Scheen, A J']",['Scheen AJ'],"['Service de Diabetologie, Nutrition et Maladies metaboliques, Universite de Liege.']",['fre'],['Journal Article'],Belgium,Rev Med Liege,Revue medicale de Liege,0404317,,IM,"['Contraindications', 'Diabetes Mellitus/drug therapy', '*Gastroplasty', 'Humans', 'Hypertension/drug therapy', 'Obesity/*diagnosis/etiology/surgery', '*Preoperative Care']",,,,,1995/01/01 00:00,1995/01/01 00:01,['1995/01/01 00:00'],"['1995/01/01 00:00 [pubmed]', '1995/01/01 00:01 [medline]', '1995/01/01 00:00 [entrez]']",,ppublish,Rev Med Liege. 1995 Jan;50(1):46-7.,,,,,,,,,Comment j'explore ... un patient obese avant une eventuelle gastroplastie?,,,,,,,,,,,
992195,NLM,MEDLINE,19770125,20131121,0338-1684 (Print) 0338-1684 (Linking),2,1,1976 Mar,[Urinary excretion of catecholamines in obese subjects and in diabetics (author's transl)].,11-3,,"95 obese subjects, 40 diabetics and 22 normal controls were investigated. The weight of all obese subjects was at least 20% higher than the ideal weight. Catecholamine excretion was determined a few days after hospitalization to minimize the influence of environmental changes. Spectrofluorimetric estimation of adrenaline and noradrenaline in the urine was carried out according to the method of von Euler and Lihajko. Statistical analysis of the results showed a significant increase in both adrenaline and noradrenaline excretion in the group of obeses subjects compared with the diabetics. The increased catecholamine excretion may represent the response of the adrenal medulla to the stress of the disease. Such an increase may be responsible for perpheral insulin resistence and hence acts as a diabetogenic factor. The results obtained emphasize the influence of catecholamines on insulin responsiveness, possibly constituting a major contribution to the diabetic state.","['Giorgino, R', 'Nardelli, G M', 'Scardapane, R']","['Giorgino R', 'Nardelli GM', 'Scardapane R']",,['fre'],"['Comparative Study', 'English Abstract', 'Journal Article']",France,Diabete Metab,Diabete & metabolisme,7604157,"['X4W3ENH1CV (Norepinephrine)', 'YKH834O4BH (Epinephrine)']",IM,"['Adrenal Medulla/physiopathology', 'Adult', 'Diabetes Mellitus/physiopathology/*urine', 'Epinephrine/*urine', 'Female', 'Humans', 'Male', 'Norepinephrine/*urine', 'Obesity/physiopathology/*urine']",,,,,1976/03/01 00:00,2000/03/11 09:00,['1976/03/01 00:00'],"['1976/03/01 00:00 [pubmed]', '2000/03/11 09:00 [medline]', '1976/03/01 00:00 [entrez]']",,ppublish,Diabete Metab. 1976 Mar;2(1):11-3.,,,,,,,,,Excretion urinaire des catecholamines chez les sujets obeses et chez les diabetiques.,,,,,,,,,,,
5474985,NLM,MEDLINE,19701211,20131121,0032-7867 (Print) 0032-7867 (Linking),78,44,1970 Oct 24,[Metabolic effects of protein diet in 41 obese persons].,1917-20,,,"['Apfelbaum, M', 'Boudon, P', 'Lacatis, D', 'Nillus, P']","['Apfelbaum M', 'Boudon P', 'Lacatis D', 'Nillus P']",,['fre'],['Journal Article'],France,Presse Med (1893),La Presse medicale,0312556,"['0 (Dietary Proteins)', '0 (Proteins)', '0 (Steroids)', '268B43MJ25 (Uric Acid)', '97C5T2UQ7J (Cholesterol)', '9NEZ333N27 (Sodium)', 'N762921K75 (Nitrogen)', 'RWP5GA015D (Potassium)', 'SY7Q814VUP (Calcium)', 'WI4X0X7BPJ (Hydrocortisone)']",IM,"['Adolescent', 'Adult', 'Body Weight', 'Calcium/analysis', 'Cholesterol/blood', '*Diet Therapy', '*Dietary Proteins/metabolism', 'Female', 'Humans', 'Hydrocortisone/blood', 'Middle Aged', 'Nitrogen/analysis', 'Obesity/*metabolism/*therapy', 'Potassium/analysis', 'Proteins/metabolism', 'Sodium/analysis', 'Steroids/urine', 'Uric Acid/blood']",,,,,1970/10/24 00:00,1970/10/24 00:01,['1970/10/24 00:00'],"['1970/10/24 00:00 [pubmed]', '1970/10/24 00:01 [medline]', '1970/10/24 00:00 [entrez]']",,ppublish,Presse Med (1893). 1970 Oct 24;78(44):1917-20.,,,,,,,,,Effets metaboliques de la diete protidique chez 41 sujets obeses.,,,,,,,,,,,
1048607,NLM,MEDLINE,19761020,20050418,1293-8505 (Print) 1293-8505 (Linking),26,7,1976 Jul-Sep,[How to select obese patients amenable for hospitalization in a specialized center].,569-72,,,"['Lambert, J']",['Lambert J'],,['fre'],['Journal Article'],France,Rev Infirm,Revue de l'infirmiere,1267175,,,"['Diet, Reducing', 'France', 'Hospitals, Special', 'Humans', 'Obesity/*diet therapy', '*Patient Acceptance of Health Care']",,,,,1976/07/01 00:00,1976/07/01 00:01,['1976/07/01 00:00'],"['1976/07/01 00:00 [pubmed]', '1976/07/01 00:01 [medline]', '1976/07/01 00:00 [entrez]']",,ppublish,Rev Infirm. 1976 Jul-Sep;26(7):569-72.,,,,,,,,,Comment selectionner les obeses justiciables d'une hospitalisation en centre specialise.,,,,,,,,,,,
18868099,NLM,MEDLINE,20081016,20201005,0021-7913 (Print) 0021-7913 (Linking),119,6,1948 Jun,[Metabolic exchanges during thinness and endocrine and constitutional obesities; confrontation and deductions].,111-5,,,"['SCHACHTER, M']",['SCHACHTER M'],,['fre'],['Journal Article'],France,J Med Chir Prat,Journal de medecine et de chirurgie pratiques,2985083R,,OM,"['Humans', '*Metabolism', '*Obesity', '*Thinness']",,['NLM'],"['*METABOLISM/endocrine aspects', '*OBESITY/endocrine aspects', '*THINNESS/endocrine aspects']",,1948/06/01 00:00,1948/06/01 00:01,['1948/06/01 00:00'],"['1948/06/01 00:00 [pubmed]', '1948/06/01 00:01 [medline]', '1948/06/01 00:00 [entrez]']",,ppublish,J Med Chir Prat. 1948 Jun;119(6):111-5.,,,,,,,,,Echanges metaboliques au cours des maigreurs et des obesites endocriniennes et constitutionnelles; confrontation et deductions.,,,,['CLML: 4815:513b'],,,,,,,
5386401,NLM,MEDLINE,19701020,20041117,0046-3515 (Print) 0046-3515 (Linking),21,5,1969 Nov-Dec,[The Watkins-Wertheim-Schauta operation in the treatment of genital prolapse in obese women].,530-1,,,"['Hoang-Ngoc-Minh', 'Nguyen-Thi-Long', 'Tran-Thi-Hien']","['Hoang-Ngoc-Minh', 'Nguyen-Thi-Long', 'Tran-Thi-Hien']",,['fre'],['Journal Article'],France,Bull Fed Soc Gynecol Obstet Lang Fr,Bulletin de la Federation des societes de gynecologie et dobstetrique de langue francaise,7503396,,IM,"['Adult', 'Female', 'Humans', 'Menopause', 'Middle Aged', 'Obesity/*complications', 'Uterine Prolapse/complications/*surgery']",,,,,1969/11/01 00:00,1969/11/01 00:01,['1969/11/01 00:00'],"['1969/11/01 00:00 [pubmed]', '1969/11/01 00:01 [medline]', '1969/11/01 00:00 [entrez]']",,ppublish,Bull Fed Soc Gynecol Obstet Lang Fr. 1969 Nov-Dec;21(5):530-1.,,,,,,,,,L'operation de Watkins-Wertheim-Schauta dans le traitement des prolapsus genitaux chez les femmes obeses.,,,,,,,,,,,
5288784,NLM,MEDLINE,19720225,20080226,0367-5971 (Print) 0367-5971 (Linking),,,1970 Jun,[Direct calorimetric measurement of isolated skin temperature in slim and obese subjects].,Suppl 50:118,,,"['Jequier, E', 'Ruedi, B', 'Magnenat, P', 'Vannotti, A']","['Jequier E', 'Ruedi B', 'Magnenat P', 'Vannotti A']",,['fre'],['Journal Article'],Switzerland,Helv Med Acta Suppl,Helvetica medica acta. Supplementum,7706034,,IM,"['Calorimetry', 'Female', 'Humans', 'Male', 'Methods', '*Obesity', '*Skin Temperature']",,,,,1970/06/01 00:00,1970/06/01 00:01,['1970/06/01 00:00'],"['1970/06/01 00:00 [pubmed]', '1970/06/01 00:01 [medline]', '1970/06/01 00:00 [entrez]']",,ppublish,Helv Med Acta Suppl. 1970 Jun:Suppl 50:118.,,,,,,,,,Mesure par calorimetrie directe de l'isolation thermique cutanee chez des sujets maigres et obeses.,,,,,,,,,,,
5607434,NLM,MEDLINE,19690411,20051117,0012-1770 (Print) 0012-1770 (Linking),15,2,1967 Apr-Jun,[Study of carbohydrate metabolism during 33 total fasting treatments 30 obese patients].,103-14,,,"['Linquette, M', 'Fossati, P', 'Lefebvre, J', 'Fourlinnie, J C', 'Decoulx, M']","['Linquette M', 'Fossati P', 'Lefebvre J', 'Fourlinnie JC', 'Decoulx M']",,['fre'],['Journal Article'],France,Diabete,Le Diabete,2984746R,['0 (Blood Glucose)'],IM,"['Adolescent', 'Adult', 'Blood Glucose/analysis', '*Carbohydrate Metabolism', '*Fasting', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*therapy']",,,,,1967/04/01 00:00,1967/04/01 00:01,['1967/04/01 00:00'],"['1967/04/01 00:00 [pubmed]', '1967/04/01 00:01 [medline]', '1967/04/01 00:00 [entrez]']",,ppublish,Diabete. 1967 Apr-Jun;15(2):103-14.,,,,,,,,,Etude du metabolisme glucidique au cours de 33 cures de jeune total chez 30 obeses.,,,,,,,,,,,
5853216,NLM,MEDLINE,19660317,20041117,0003-3014 (Print) 0003-3014 (Linking),22,4,1965 Oct-Dec,[Preparation of obese patients for surgical operation by Gordon's low-calory dietary regime].,705-19,,,"['Ledoux, P', 'Forster, E', 'Mole, L', 'Schnoebelen, R', 'Cakmur, D']","['Ledoux P', 'Forster E', 'Mole L', 'Schnoebelen R', 'Cakmur D']",,['fre'],['Journal Article'],France,Anesth Analg (Paris),"Anesthesie, analgesie, reanimation",0404017,,IM,"['*Diet, Reducing', 'Humans', 'Obesity/*complications', '*Preoperative Care']",,,,,1965/10/01 00:00,1965/10/01 00:01,['1965/10/01 00:00'],"['1965/10/01 00:00 [pubmed]', '1965/10/01 00:01 [medline]', '1965/10/01 00:00 [entrez]']",,ppublish,Anesth Analg (Paris). 1965 Oct-Dec;22(4):705-19.,,,,,,,,,Preparation des malades obeses a l'intervention chirurgicale par le regime alimentaire a faibles calories de Gordon.,,,,,,,,,,,
25038727,NLM,MEDLINE,20141010,20220331,1532-8600 (Electronic) 0026-0495 (Linking),63,9,2014 Sep,Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter?,1084-92,S0026-0495(14)00176-0 [pii] 10.1016/j.metabol.2014.06.009 [doi],"Up to 30% of obese people do not display the ""typical"" metabolic obesity-associated complications. For this group of patients, the term ""metabolically healthy obese (MHO)"" has been established during the past years and has been the focus of research activities. The development and severity of insulin resistance as well as (subclinical) inflammations seems to play a key role in distinguishing metabolically healthy from metabolically non-healthy individuals. However, an internationally consistent and accepted classification that might also include inflammatory markers as well as features of non-alcoholic fatty liver disease is missing to date, and available data - in terms of prevalence, definition and severity - are heterogeneous, both during childhood/adolescence and during adulthood. In addition, the impact of MHO on future morbidity and mortality compared to obese, metabolically non-healthy as well as normal weight, metabolically healthy individuals is absolutely not clear to date and even conflicting. This review summarizes salient literature related to that topic and provides insight into our current understanding of MHO, covering all age spans from childhood to adulthood.","['Bluher, Susann', 'Schwarz, Peter']","['Bluher S', 'Schwarz P']","['Leipzig University Medical Center, IFB Adiposity Diseases, University of Leipzig, Germany. Electronic address: susann.blueher@medizin.uni-leipzig.de.', 'Technical University Dresden, Department of Prevention and Care of Diabetes, Germany; Paul Langerhans Institute Dresden, German Center for Diabetes Research (DZD), Germany.']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Metabolism,Metabolism: clinical and experimental,0375267,,IM,"['Adolescent', 'Adolescent Development', 'Adult', 'Body Mass Index', 'Child', 'Child Development', '*Evidence-Based Medicine', '*Health Status', 'Humans', 'Insulin Resistance', 'Obesity/immunology/metabolism/*physiopathology/therapy', 'Pediatric Obesity/immunology/metabolism/*physiopathology/therapy', 'Precision Medicine']",,['NOTNLM'],"['Adulthood', 'Childhood', 'Insulin resistance', 'Metabolically healthy obese (MHO)', 'Obesity']",,2014/07/21 06:00,2014/10/11 06:00,['2014/07/21 06:00'],"['2014/03/06 00:00 [received]', '2014/06/13 00:00 [revised]', '2014/06/14 00:00 [accepted]', '2014/07/21 06:00 [entrez]', '2014/07/21 06:00 [pubmed]', '2014/10/11 06:00 [medline]']","['S0026-0495(14)00176-0 [pii]', '10.1016/j.metabol.2014.06.009 [doi]']",ppublish,Metabolism. 2014 Sep;63(9):1084-92. doi: 10.1016/j.metabol.2014.06.009. Epub 2014 Jun 19.,,20140619,,['Copyright (c) 2014 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
7301059,NLM,MEDLINE,19820128,20061115,0222-9617 (Print) 0222-9617 (Linking),29,10,1981 Oct,[Eating habits and psychic dynamics of obese adolescents (author's transl)].,519-26,,,"['Gonthier, G']",['Gonthier G'],,['fre'],"['English Abstract', 'Journal Article']",France,Neuropsychiatr Enfance Adolesc,Neuropsychiatrie de l'enfance et de l'adolescence,7905300,,IM,"['Adolescent', '*Feeding Behavior', 'Humans', 'Obesity/*psychology/therapy']",,,,,1981/10/01 00:00,1981/10/01 00:01,['1981/10/01 00:00'],"['1981/10/01 00:00 [pubmed]', '1981/10/01 00:01 [medline]', '1981/10/01 00:00 [entrez]']",,ppublish,Neuropsychiatr Enfance Adolesc. 1981 Oct;29(10):519-26.,,,,,,,,,Comportement alimentaire et dynamique psychique chez l'adolescent obese.,,,,,,,,,,,
29929712,NLM,MEDLINE,20180629,20180629,1558-1373 (Electronic) 0030-5898 (Linking),49,3,2018 Jul,Obesity in the Polytrauma Patient.,307-315,S0030-5898(18)30034-8 [pii] 10.1016/j.ocl.2018.02.004 [doi],"The rates of obesity continue to increase in the United States and the overall impact of obesity on health care spending and patient outcomes after trauma is considerable. The unique physiology of the obese places them at higher risk for complications, including infection, failure of fixation, nonunion, multiorgan failure, and death. These physiologic differences and overall patient size can make orthopedic care in obese patients with trauma more difficult, but appropriate initial resuscitation, careful preoperative planning, meticulous surgical technique, diligent postoperative medical management, and specialized rehabilitation give these patients their best opportunity for a good outcome.","['Spitler, Clay A', 'Hulick, R Miles', 'Graves, Matthew L', 'Russell, George V', 'Bergin, Patrick F']","['Spitler CA', 'Hulick RM', 'Graves ML', 'Russell GV', 'Bergin PF']","['Department of Orthopaedic Surgery, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA. Electronic address: clayspitler@yahoo.com.', 'Department of Orthopaedic Surgery, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.', 'Department of Orthopaedic Surgery, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.', 'Department of Orthopaedic Surgery, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.', 'Department of Orthopaedic Surgery, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, USA.']",['eng'],"['Journal Article', 'Review']",United States,Orthop Clin North Am,The Orthopedic clinics of North America,0254463,,IM,"['Humans', 'Multiple Trauma/*complications/*therapy', 'Obesity/*complications/epidemiology/physiopathology']",,['NOTNLM'],"['Fracture care', 'Obesity', 'Polytrauma', 'Resuscitation']",,2018/06/23 06:00,2018/06/30 06:00,['2018/06/23 06:00'],"['2018/06/23 06:00 [entrez]', '2018/06/23 06:00 [pubmed]', '2018/06/30 06:00 [medline]']","['S0030-5898(18)30034-8 [pii]', '10.1016/j.ocl.2018.02.004 [doi]']",ppublish,Orthop Clin North Am. 2018 Jul;49(3):307-315. doi: 10.1016/j.ocl.2018.02.004. Epub 2018 Apr 26.,,20180426,,['Copyright (c) 2018 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
7413794,NLM,MEDLINE,19801124,20190712,0031-9384 (Print) 0031-9384 (Linking),24,6,1980 Jun,Sexual behavior of the obese male Zucker rat.,1139-41,,Obese male Zucker rats displayed inadequate sexual behavior at four months placed with ovariectomized lean females pretreated with estrogen and progesterone. Only one out of seven obese males ejaculated during the test sessions. Diet-restricting the obese males at five months of age did not improve their sexual behavior when tested at six months of age. At ten months of age none of the obese males ejaculated during the test sessions. Lean littermates ejaculated during the sessions at all ages tested. Obese males which do ejaculate are capable of inducing pseudopregnancy in intact lean females. These findings suggest that inadequate sexual behavior is one factor contributing to the reduced reproductive capacity of obese male Zucker rats.,"['Edmonds, E S', 'Withyachumnarnkul, B']","['Edmonds ES', 'Withyachumnarnkul B']",,['eng'],['Journal Article'],United States,Physiol Behav,Physiology & behavior,0151504,,IM,"['Animals', 'Diet, Reducing/psychology', 'Fertility', 'Obesity/genetics/physiopathology/*psychology', 'Rats', 'Sexual Behavior, Animal/*physiology']",,,,,1980/06/01 00:00,1980/06/01 00:01,['1980/06/01 00:00'],"['1980/06/01 00:00 [pubmed]', '1980/06/01 00:01 [medline]', '1980/06/01 00:00 [entrez]']","['0031-9384(80)90060-8 [pii]', '10.1016/0031-9384(80)90060-8 [doi]']",ppublish,Physiol Behav. 1980 Jun;24(6):1139-41. doi: 10.1016/0031-9384(80)90060-8.,,,,,,,,,,,,,,,,,,,,
28851241,NLM,MEDLINE,20190207,20190215,1476-4954 (Electronic) 1476-4954 (Linking),32,1,2019 Jan,Obesity's impact on intrapartum electronic fetal monitoring.,92-94,10.1080/14767058.2017.1371696 [doi],"OBJECTIVE: The objective of this study is to evaluate the impact maternal obesity has on the percentage of unmonitored electronic fetal monitoring (EFM). STUDY DESIGN: Women undergoing induction of labor at term were categorized into three groups: Group 1 (body mass index (BMI) < 30 kg/m(2)), Group 2 (30 < BMI < 40 kg/m(2)), and Group 3 (BMI >/= 40 kg/m(2)). External EFM tracings were reviewed from the time of induction of labor until amniotomy; the percentage of time off of EFM was calculated. Statistical analysis was performed using commercially available software. RESULTS: Three hundred and thirty-seven patients were stratified into the following groups: 104 patients in Group 1, 156 patients in Group 2, and 77 in Group 3. No significant differences were found between groups when analyzed for gestational age, bishop score, parity, race, and 5 min APGAR less than 7 or admission to the NICU. The mean percentage unmonitored by EFM was 5% for Group 1, 7% for Group 2 and 11% for Group 3. There was a significant association between percent of time unmonitored by EFM and BMI (r = 0.344 p < .0001). CONCLUSION: At term gestation, the fetuses of obese women spend more time unmonitored by external intrapartum EFM than non-obese women. This represents a disparity among a high-risk group that may result in poor pregnancy outcomes if fetal distress is present.","['Brocato, Brian', 'Lewis, David', 'Mulekar, Madhuri', 'Baker, Susan']","['Brocato B', 'Lewis D', 'Mulekar M', 'Baker S']","['a Department of Obstetrics and Gynecology , University of South Alabama , Mobile , AL , USA.', 'b Department of Obstetrics and Gynecology , Louisiana State University - Shreveport , Shreveport , LA , USA.', 'c Department of Mathematics and Statistics , University of South Alabama , Mobile , AL , USA.', 'a Department of Obstetrics and Gynecology , University of South Alabama , Mobile , AL , USA.']",['eng'],['Journal Article'],England,J Matern Fetal Neonatal Med,"The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians",101136916,,IM,"['Adult', 'Cardiotocography/*statistics & numerical data', 'Female', 'Humans', '*Obesity', 'Pregnancy', '*Pregnancy Complications', 'Young Adult']",,['NOTNLM'],"['Electronic fetal monitoring', 'induction of labor', 'obesity', 'term pregnancy']",,2017/08/31 06:00,2019/02/08 06:00,['2017/08/31 06:00'],"['2017/08/31 06:00 [pubmed]', '2019/02/08 06:00 [medline]', '2017/08/31 06:00 [entrez]']",['10.1080/14767058.2017.1371696 [doi]'],ppublish,J Matern Fetal Neonatal Med. 2019 Jan;32(1):92-94. doi: 10.1080/14767058.2017.1371696. Epub 2017 Sep 17.,,20170917,,,,,,,,,,,,,,,,,,
27058472,NLM,MEDLINE,20170118,20181113,1536-5948 (Electronic) 1076-2752 (Print) 1076-2752 (Linking),58,4,2016 Apr,Prevalence of Injury in Occupation and Industry: Role of Obesity in the National Health Interview Survey 2004 to 2013.,335-43,10.1097/JOM.0000000000000670 [doi],"OBJECTIVES: The aim of this study was to estimate prevalence of injury by occupation and industry and obesity's role. METHODS: Self-reported injuries were collected annually for US workers during 2004 to 2013. Prevalence ratios (PRs) and 95% confidence intervals (CIs) were obtained from fitted logistic regression models. RESULTS: Overall weighted injury prevalence during the previous three months was 77 per 10,000 workers. Age-adjusted injury prevalence was greatest for Construction and Extraction workers (169.7/10,000) followed by Production (160.6) among occupations, while workers in the Construction industry sector (147.9) had the highest injury prevalence followed by the Agriculture/Forestry/Fishing/Mining/Utilities sector (122.1). Overweight and obese workers were 26% to 45% more likely to experience injuries than normal-weight workers. CONCLUSION: The prevalence of injury, highest for Construction workers, gradually increased as body mass index levels increased in most occupational and industry groups.","['Gu, Ja K', 'Charles, Luenda E', 'Fekedulegn, Desta', 'Ma, Claudia C', 'Andrew, Michael E', 'Burchfiel, Cecil M']","['Gu JK', 'Charles LE', 'Fekedulegn D', 'Ma CC', 'Andrew ME', 'Burchfiel CM']","['Biostatistics and Epidemiology Branch, Health Effects Laboratory Division, National Health Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia.']",['eng'],['Journal Article'],United States,J Occup Environ Med,Journal of occupational and environmental medicine,9504688,,IM,"['Adolescent', 'Adult', 'Body Mass Index', 'Female', 'Health Surveys', 'Humans', 'Industry/*statistics & numerical data', 'Male', 'Middle Aged', 'Obesity/*epidemiology', 'Occupational Injuries/*epidemiology', 'Occupations/*statistics & numerical data', 'Prevalence', 'Self Report', 'United States/epidemiology', 'Young Adult']",PMC4922363,,,,2016/04/09 06:00,2017/01/19 06:00,['2016/04/09 06:00'],"['2016/04/09 06:00 [entrez]', '2016/04/09 06:00 [pubmed]', '2017/01/19 06:00 [medline]']","['00043764-201604000-00004 [pii]', '10.1097/JOM.0000000000000670 [doi]']",ppublish,J Occup Environ Med. 2016 Apr;58(4):335-43. doi: 10.1097/JOM.0000000000000670.,['CC999999/Intramural CDC HHS/United States'],,,,,['NIHMS795606'],,,,,,,['NLM: HHSPA795606'],,,,,,,
8942235,NLM,MEDLINE,19970107,20051116,0037-5675 (Print) 0037-5675 (Linking),37,3,1996 Jun,Current management of obesity.,299-303,,"Obesity is common and its prevalence is rising. In Singapore, a national health survey in 1992 showed that 5% of the adult population were obese and 21% were overweight. Obesity causes much morbidity and mortality and treatment is desirable. The majority of obese patients have no known cause but it is essential to exclude any underlying cause before treatment. Antiobesity drugs should be used as an adjunct to an adequate programme of dietary restriction, exercise and behavior modification. Serotonergic drugs and adrenergic agents are available in the treatment of obesity. The short-term efficacy and safety of antiobesity drugs such as fenfluramine and d-fenfluramine are proven. The long-term use of antiobesity drugs used singly or in combination remains to be established. Many peptides (cholecystokinin, glucagon, bombesin, neurotensin, etc) with weight reduction properties are undergoing extensive studies: their clinical applications are experimental. The treatment of obesity is difficult and frustrating and antiobesity drugs have an established short-term role. In morbid obesity where the life of the patient is in danger, surgery such as gastric plication may be life-saving. The recent discovery of leptin (1994) and neuropeptide Y (1995) are important breakthrough in obesity research; hopefully further research may produce more effective treatment of obesity in man.","['Cheah, J S']",['Cheah JS'],"['Department of Medicine, National University Hospital, Singapore.']",['eng'],"['Journal Article', 'Review']",India,Singapore Med J,Singapore medical journal,0404516,,IM,"['Adult', 'Combined Modality Therapy', 'Female', 'Humans', 'Incidence', 'Male', 'Obesity/diagnosis/epidemiology/*therapy', 'Prognosis']",,,,,1996/06/01 00:00,1996/06/01 00:01,['1996/06/01 00:00'],"['1996/06/01 00:00 [pubmed]', '1996/06/01 00:01 [medline]', '1996/06/01 00:00 [entrez]']",,ppublish,Singapore Med J. 1996 Jun;37(3):299-303.,,,,,,,32,,,,,,,,,,,,,
36607201,NLM,MEDLINE,20230110,20230111,1533-9866 (Electronic) 0029-7828 (Linking),78,1,2023 Jan,Obesity in Pregnancy: A Comprehensive Review of Influential Guidelines.,50-68,10.1097/OGX.0000000000001091 [doi],"IMPORTANCE: Obesity is one of the most common clinical entities complicating pregnancies and is associated with short- and long-term consequences for both the mother and the offspring. OBJECTIVE: The aim of this study were to review and compare the most recently published influential guidelines on the management of maternal obesity in the preconceptional, antenatal, intrapartum, and postpartum period. EVIDENCE ACQUISITION: A descriptive review of guidelines from the American College of Obstetricians and Gynecologists, the International Federation of Gynecology and Obstetrics, the Society of Obstetricians and Gynecologists of Canada, the Royal College of Obstetricians and Gynecologists, and the Royal Australian and New Zealand College of Obstetricians and Gynecologists on obesity in pregnancy was carried out. RESULTS: There is an overall agreement among the reviewed guidelines regarding the importance of prepregnancy weight loss with behavioral modification, optimization of gestational weight gain, and screening for comorbidities in improving pregnancy outcomes of obese women. Women with previous bariatric surgery should be screened for nutritional deficiencies and have a closer antenatal surveillance, according to all guidelines. In addition, folic acid supplementation is recommended for 1 to 3 months before conception and during the first trimester, but several discrepancies were identified with regard to other vitamins, iodine, calcium, and iron supplementation. All medical societies recommend early screening for gestational diabetes mellitus and early anesthetic assessment in obese women and suggest the use of aspirin for the prevention of preeclampsia when additional risk factors are present, although the optimal dosage is controversial. The International Federation of Gynecology and Obstetrics, Society of Obstetricians and Gynecologists of Canada, Royal College of Obstetricians and Gynecologists, and Royal Australian and New Zealand College of Obstetricians and Gynecologists point out that specific equipment and adequate resources must be readily available in all health care facilities managing obese pregnant women. Moreover, thromboprophylaxis and prophylactic antibiotics are indicated in case of cesarean delivery, and intrapartum fetal monitoring is justified during active labor in obese patients. However, there are no consistent protocols regarding the fetal surveillance, the monitoring of multiple gestations, the timing and mode of delivery, and the postpartum follow-up, although weight loss and breastfeeding are unanimously supported. CONCLUSIONS: Obesity in pregnancy is a significant contributor to maternal and perinatal morbidity with a constantly rising global prevalence among reproductive-aged women. Thus, the development of uniform international protocols for the effective management of obese women is of paramount importance to safely guide clinical practice and subsequently improve pregnancy outcomes.","['Giouleka, Sonia', 'Tsakiridis, Ioannis', 'Koutsouki, Georgia', 'Kostakis, Nikolaos', 'Mamopoulos, Apostolos', 'Kalogiannidis, Ioannis', 'Athanasiadis, Apostolos', 'Dagklis, Themistoklis']","['Giouleka S', 'Tsakiridis I', 'Koutsouki G', 'Kostakis N', 'Mamopoulos A', 'Kalogiannidis I', 'Athanasiadis A', 'Dagklis T']","['Resident.', 'Consultant in Maternal-Fetal Medicine.', 'Resident.', 'Resident.', 'Professor.', 'Associate Professor.', 'Professor.', 'Assistant Professor, Third Department of Obstetrics and Gynaecology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.']",['eng'],"['Journal Article', 'Review']",United States,Obstet Gynecol Surv,Obstetrical & gynecological survey,0401007,['0 (Anticoagulants)'],IM,"['Pregnancy', 'Female', 'Humans', 'Adult', '*Obesity, Maternal', 'Anticoagulants', 'Australia/epidemiology', '*Venous Thromboembolism', 'Obesity/complications/epidemiology/therapy']",,,,,2023/01/07 06:00,2023/01/11 06:00,['2023/01/06 09:44'],"['2023/01/06 09:44 [entrez]', '2023/01/07 06:00 [pubmed]', '2023/01/11 06:00 [medline]']",['10.1097/OGX.0000000000001091 [doi]'],ppublish,Obstet Gynecol Surv. 2023 Jan;78(1):50-68. doi: 10.1097/OGX.0000000000001091.,,,,,,,,,,,,,,,,,,,,
10761526,NLM,MEDLINE,20000427,20161209,0755-4982 (Print) 0755-4982 (Linking),29,10,2000 Mar 18,[Psychological approaches to the obese].,556-63,,"AN ESSENTIAL ELEMENT: Interest in psychological factors of obesity has been clearly on the decline over the last thirty years. Despite this fact, the psychological approach to obese subjects is a fundamental element both in understanding the causal mechanisms but also to follow therapeutic effects in the long run. However, everything cannot be explained by the fact that many nutritionists lack a formation in psychology and many psychiatrists lack interest for corporal diseases. What is missing is a theoretical background allowing each participant to find his/her role in this multifactorial condition which requires a multidisciplinary management. COLLABORATIVE CARE: The nutritionist-psychiatrist pair would appear to be the best choice for a large number of obese subjects who may or may not have eating habit disorders. The type of psychological help will depend on many factors: the subject's background, environment, demands, and most importantly, capacity for mentalization. There are many possibilities for simple supportive care: psychoanalytic approach, behavioral therapy, cognitive therapy, etc. The choice of a therapeutic method depends on the clinician's competence and on the subject's characteristics. An emphatic active attitude is indispensable for those patients whose demand for psychological help is often buried in the somatic condition.","['Waysfeld, B']",['Waysfeld B'],"[""Unite d'Endocrinologie-Nutrition, Hopital Saint Michel, Paris. Bernard.Waysfeld@wanadoo.fr""]",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Presse Med,"Presse medicale (Paris, France : 1983)",8302490,,IM,"['Energy Intake', 'Energy Metabolism', 'Feeding and Eating Disorders/psychology/therapy', 'Humans', 'Mother-Child Relations', 'Obesity/complications/*psychology/*therapy', 'Psychotherapy/*methods']",,,,,2000/04/13 09:00,2000/04/29 09:00,['2000/04/13 09:00'],"['2000/04/13 09:00 [pubmed]', '2000/04/29 09:00 [medline]', '2000/04/13 09:00 [entrez]']",,ppublish,Presse Med. 2000 Mar 18;29(10):556-63.,,,,,,,34,,Abords psychologiques de l'obese.,,,,,,,,,,,
20158938,NLM,MEDLINE,20100812,20130424,1475-2719 (Electronic) 0029-6651 (Linking),69,2,2010 May,Prevention of obesity in preschool children.,204-10,10.1017/S0029665110000029 [doi],"Obesity is a serious problem that affects children from diverse ethnic backgrounds in both industrialised and developing countries. Worldwide, an estimated twenty-two million children <5 years of age were overweight in 2007. In the UK if current trends continue an estimated one-quarter of all children <16 years of age will be obese by 2050. Recent evidence suggests that most obesity is established during the preschool years, and because one in five obese 4 year olds will become obese adults this situation has major implications for public health. The causes of obesity in preschool children are complex and multifactorial. Although 30-50% of the predisposition towards obesity in preschool children can be explained by genetic factors, environmental influences also play a crucial role. The preschool period in particular is a pivotal time during which long-term dietary and physical activity habits are established, with potential lifelong effects on health. However, research in this age-group is limited. Previous studies have aimed to improve diet, increase physical activity and achieve behavioural change. However, few of these studies have been successful and there is an urgent need, therefore, for the development of evidence-based interventions aimed at the prevention of preschool obesity.","['Lanigan, Julie', 'Barber, Sally', 'Singhal, Atul']","['Lanigan J', 'Barber S', 'Singhal A']","['The MRC Childhood Nutrition Research Centre, University College London, Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK. j.lanigan@ich.ucl.ac.uk']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Proc Nutr Soc,The Proceedings of the Nutrition Society,7505881,,IM,"['Child, Preschool', 'Diet', 'Exercise', '*Health Promotion', 'Humans', 'Obesity/epidemiology/etiology/*prevention & control']",,,,,2010/02/18 06:00,2010/08/13 06:00,['2010/02/18 06:00'],"['2010/02/18 06:00 [entrez]', '2010/02/18 06:00 [pubmed]', '2010/08/13 06:00 [medline]']","['S0029665110000029 [pii]', '10.1017/S0029665110000029 [doi]']",ppublish,Proc Nutr Soc. 2010 May;69(2):204-10. doi: 10.1017/S0029665110000029. Epub 2010 Feb 17.,"['G0700349/Medical Research Council/United Kingdom', 'ID81585/Medical Research Council/United Kingdom']",20100217,,,,,87,,,,,,,,,,,,,
27061140,NLM,MEDLINE,20171019,20181202,1879-0518 (Electronic) 0010-7824 (Linking),93,6,2016 Jun,Obesity's effect on contraceptive failure is diluted by grouping of progestins.,565,S0010-7824(15)30211-0 [pii] 10.1016/j.contraception.2015.12.011 [doi],,"['Cherala, Ganesh', 'Edelman, Alison']","['Cherala G', 'Edelman A']","['CONRAD/ Eastern Virginia Medical School, Arlington, VA 22209, USA. Electronic address: gcherala@conrad.org.', 'Oregon Health & Science University, Portland, OR 97239, USA.']",['eng'],"['Comment', 'Letter']",United States,Contraception,Contraception,0234361,"['0 (Contraceptive Agents)', '0 (Progestins)']",IM,"['*Contraceptive Agents', 'Contraceptive Devices', 'Humans', 'Obesity', '*Progestins']",,,,,2016/04/12 06:00,2017/10/20 06:00,['2016/04/11 06:00'],"['2015/11/23 00:00 [received]', '2015/12/22 00:00 [accepted]', '2016/04/11 06:00 [entrez]', '2016/04/12 06:00 [pubmed]', '2017/10/20 06:00 [medline]']","['S0010-7824(15)30211-0 [pii]', '10.1016/j.contraception.2015.12.011 [doi]']",ppublish,Contraception. 2016 Jun;93(6):565. doi: 10.1016/j.contraception.2015.12.011. Epub 2016 Apr 7.,,20160407,,,,,,,,,['Contraception. 2015 Nov;92(5):445-52. PMID: 26247330'],,,,,,,,,
1462080,NLM,MEDLINE,19930108,20041117,0035-3655 (Print) 0035-3655 (Linking),112,11,1992 Nov,[Food diaries in the follow-up of obese patients].,923,,,"['Collet, C']",['Collet C'],"['Policlinique medicale, Lausanne.']",['fre'],['Journal Article'],Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,,IM,"['*Diet Records', 'Feeding Behavior', 'Humans', 'Obesity/*diagnosis/psychology']",,,,,1992/11/01 00:00,1992/11/01 00:01,['1992/11/01 00:00'],"['1992/11/01 00:00 [pubmed]', '1992/11/01 00:01 [medline]', '1992/11/01 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1992 Nov;112(11):923.,,,,,,,,,Le journal alimentaire dans le suivi du patient obese.,,,,,,,,,,,
16526252,NLM,MEDLINE,20060510,20190922,0025-8105 (Print) 0025-8105 (Linking),58,9-10,2005 Sep-Oct,[Familial obesity as a predictor of child obesity].,486-9,,"INTRODUCTION: Studies carried out in various parts of the world indicate that family obesity significantly affects the incidence of obesity in children. This is especially a characteristic of children whose both parents are obese. MATERIAL AND METHODS: The study was conducted using a polling method. Questionnaires were filled out by parents and brothers and sisters, including their body height and weight. The collected data served as the basis for assessing the family nutritional status. RESULTS: Statistical analysis of the results showed that obese children frequently have obese parents, brothers and sisters in regard to normal-weight children. Differences are statistically significant in relation to fathers (p=0.043), i.e. statistically obese schoolchildren have more frequently obese fathers than those of normal nutritional status. Other differences could not be considered significant (p > 0.05). DISCUSSION: Obese children have more often obese parents, brothers and sisters than normal-weight children. It was found that the nutritional status of moderately and extremely obese children was quite different from that of normal-weight children and that there was a statistically significant dependence between the nutritional status of children and their fathers. CONCLUSION: This research showed that family obesity is a potential contributing factor to obesity of schoolchildren.","['Mirilov, Jelena']",['Mirilov J'],['Institut za zastitu zdravlja Novi Sad. miril@neobee.net'],['srp'],"['English Abstract', 'Journal Article']",Serbia,Med Pregl,Medicinski pregled,2985249R,,IM,"['Child', 'Family Health', 'Humans', 'Nutritional Status', 'Obesity/etiology/*genetics']",,,,,2006/03/11 09:00,2006/05/11 09:00,['2006/03/11 09:00'],"['2006/03/11 09:00 [pubmed]', '2006/05/11 09:00 [medline]', '2006/03/11 09:00 [entrez]']",['10.2298/mpns0510486m [doi]'],ppublish,Med Pregl. 2005 Sep-Oct;58(9-10):486-9. doi: 10.2298/mpns0510486m.,,,,,,,,,,,,,,,,,,,,
21182728,NLM,MEDLINE,20110119,20220316,1467-789X (Electronic) 1467-7881 (Linking),11,11,2010 Nov,"M, M, M & M: a mnemonic for assessing obesity.",808-9,10.1111/j.1467-789X.2010.00766.x [doi],"Obese individuals can present with a wide range of medical and psychosocial problems, which can promote weight gain, provide important indications for treatment but, in some cases, also pose significant barriers to management. To ensure a complete assessment and consideration of these factors, I propose the use of a simple mnemonic consisting of four Ms or 'M, M, M, & M' that stand for Mental, Mechanical, Metabolic and Monetory, respectively, and may help the busy practitioner navigate through a thorough assessment of clients presenting with excess weight.","['Sharma, A M']",['Sharma AM'],"['Division of Endocrinology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. amsharm@ualberta.ca']",['eng'],['Journal Article'],England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['*Attitude to Health', 'Humans', '*Obesity/economics/etiology/physiopathology/psychology', 'Risk Assessment']",,,,,2010/12/25 06:00,2011/01/20 06:00,['2010/12/25 06:00'],"['2010/12/25 06:00 [entrez]', '2010/12/25 06:00 [pubmed]', '2011/01/20 06:00 [medline]']",['10.1111/j.1467-789X.2010.00766.x [doi]'],ppublish,Obes Rev. 2010 Nov;11(11):808-9. doi: 10.1111/j.1467-789X.2010.00766.x.,,,,"['(c) 2010 The Author. obesity reviews (c) 2010 International Association for the Study', 'of Obesity.']",,,,,,,,,,,,,,,,
20170029,NLM,MEDLINE,20100504,20100222,1660-9379 (Print) 1660-9379 (Linking),6,232,2010 Jan 20,"[Adolescent medicine in Guglera: a novel approach for unemployed, severely obese adolescents].",120-2,,"The Center ""la Guglera"", located in the canton of Fribourg (Switzerland) provides a novel approach to the care of severely obese adolescents who are currently unemployed. These young people, whose BMI is usually higher than 35 to 40 kg/m2 spend a 6 to 12 months long stay in an in-patient institution which also takes care of other unemployed non obese adolescents on an outpatient basis. Besides a nutritional education which is part of the everyday life of the institution, the program includes a generous amount of hours of physical activities and sports. The adolescents also participate in a rehabilitation training program which fosters the future integration in a professional milieu, such as an apprenticeship. The short term results of la Guglera seem very promising. The program is financially co-supported by the Swiss and cantonal administrations, the insurance companies and the parents.","['Michaud, P-A']",['Michaud PA'],"['Unite multidisciplinaire de sante des adolescents, CHUV, 1011 Lausanne. pierre-andre.michaud@chuv.ch']",['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Adolescent', 'Adolescent Health Services/*organization & administration', 'Hospitalization', 'Humans', 'Obesity, Morbid/*therapy', 'Switzerland', '*Unemployment']",,,,,2010/02/23 06:00,2010/05/05 06:00,['2010/02/23 06:00'],"['2010/02/23 06:00 [entrez]', '2010/02/23 06:00 [pubmed]', '2010/05/05 06:00 [medline]']",,ppublish,Rev Med Suisse. 2010 Jan 20;6(232):120-2.,,,,,,,,,Medecine de l'adolescence. La Guglera: une reponse nouvelle et originale aux adolescents gravement obeses et sans travail.,,,,,,,,,,,
4923394,NLM,MEDLINE,19710212,20111117,0012-1770 (Print) 0012-1770 (Linking),16,2,1968 Apr-Jun,[Comparative effects of glucagon injection in normal-weight and obese nondiabetic subjects. Preliminary report].,126-31,,,"['Scornavachi, J C', 'Vague, P', 'Rouvier-Leroy, C']","['Scornavachi JC', 'Vague P', 'Rouvier-Leroy C']",,['fre'],"['Clinical Trial', 'Journal Article']",France,Diabete,Le Diabete,2984746R,"['0 (Blood Glucose)', '0 (Fatty Acids, Nonesterified)', '0 (Insulin)', '9007-92-5 (Glucagon)']",IM,"['*Blood Glucose', 'Clinical Trials as Topic', 'Fatty Acids, Nonesterified/*blood', 'Glucagon/*administration & dosage', 'Humans', 'Injections, Intramuscular', 'Injections, Intravenous', 'Insulin/*blood', 'Obesity/*blood']",,,,,1968/04/01 00:00,1968/04/01 00:01,['1968/04/01 00:00'],"['1968/04/01 00:00 [pubmed]', '1968/04/01 00:01 [medline]', '1968/04/01 00:00 [entrez]']",,ppublish,Diabete. 1968 Apr-Jun;16(2):126-31.,,,,,,,,,Effets compares de l'injection de glucagon chez des sujets non diabetiques de poids normal et obeses. Communication preliminaire.,,,,,,,,,,,
29135487,NLM,MEDLINE,20190206,20190215,1752-2978 (Electronic) 1752-296X (Linking),25,1,2018 Feb,Update on endocrine aspects of childhood obesity.,55-60,10.1097/MED.0000000000000381 [doi],"PURPOSE OF REVIEW: Although childhood obesity has leveled off in the last decade, 'severe obesity' continues to be on the rise. Various genetic, environmental and hormonal factors contribute to obesity. This article reviews the most current understanding of obesity's multifactorial origin and recent recommendations for its management in childhood and adolescence. RECENT FINDINGS: Epigenetics plays a key role in transmitting obesity risk to offspring. Single-nucleotide polymorphisms at genetic loci for adipokines and their receptors are associated with obesity. Gut microbiota is an important regulator of weight status, and Bifidobacterium species improves metabolic status. The incidence of comorbidities including prediabetes and type 2 diabetes has increased. Novel biomarkers such as alpha-hydroxybutyrate and branched-chain amino acids correlate with insulin sensitivity and predict glycemic control in adolescents. Lifestyle modifications and pharmacotherapy can produce small BMI changes. Bariatric surgery induces substantial weight loss and remission of comorbidities. SUMMARY: Alterations in genetics, epigenetics and microbiota influence childhood obesity. Lifestyle modification remains the mainstay of management and pharmacotherapy with Food and Drug Administration approved medications is recommended only for patients resistant to lifestyle changes and for comorbidities. Bariatric surgery produces sustained weight loss and cardiovascular benefits and is an effective option for adolescents with severe obesity.","['Baskaran, Charumathi', 'Kandemir, Nurgun']","['Baskaran C', 'Kandemir N']","['Pediatric Endocrinology, Massachusetts General Hospital for Children, Boston, Massachusetts, USA.']",['eng'],"['Journal Article', 'Review']",England,Curr Opin Endocrinol Diabetes Obes,"Current opinion in endocrinology, diabetes, and obesity",101308636,"['0 (Blood Glucose)', '0 (Hormones)']",IM,"['Adolescent', 'Bariatric Surgery', 'Blood Glucose/metabolism', 'Child', 'Diabetes Mellitus, Type 2/blood/complications', 'Endocrine System Diseases/diagnosis/*etiology/therapy', 'Endocrinology/*trends', 'Hormones/physiology', 'Humans', 'Insulin Resistance/physiology', 'Life Style', 'Obesity, Morbid/blood/complications/diagnosis/therapy', '*Pediatric Obesity/blood/diagnosis/etiology/therapy', 'Weight Loss']",,,,,2017/11/15 06:00,2019/02/07 06:00,['2017/11/15 06:00'],"['2017/11/15 06:00 [pubmed]', '2019/02/07 06:00 [medline]', '2017/11/15 06:00 [entrez]']",['10.1097/MED.0000000000000381 [doi]'],ppublish,Curr Opin Endocrinol Diabetes Obes. 2018 Feb;25(1):55-60. doi: 10.1097/MED.0000000000000381.,,,,,,,,,,,,,,,,,,,,
2020262,NLM,MEDLINE,19910530,20041117,0195-9131 (Print) 0195-9131 (Linking),23,3,1991 Mar,"Introduction: obesity: diet composition, energy expenditure, and treatment of the obese patient.",273-4,,"The association of obesity with increased risks for developing hypertension, diabetes, cardiovascular disease, and cancer has made it a complex health problem. Exacerbating the problem is the realization that there are multiple factors, both physiological and psychological, that interact to induce obesity, as well as a myriad of components that may be useful in the curtailment of obesity. The aim of this symposium is to provide a wider understanding of the elements behind the development and reduction of obesity.","['Miller, W C']",['Miller WC'],"['Department of Kinesiology, Indiana University, Bloomington 47405.']",['eng'],['Journal Article'],United States,Med Sci Sports Exerc,Medicine and science in sports and exercise,8005433,,IM,"['Adipose Tissue/pathology', 'Animals', 'Body Composition', 'Diet', 'Energy Metabolism', 'Humans', '*Obesity/etiology/metabolism/pathology/therapy', 'Weight Loss']",,,,,1991/03/01 00:00,1991/03/01 00:01,['1991/03/01 00:00'],"['1991/03/01 00:00 [pubmed]', '1991/03/01 00:01 [medline]', '1991/03/01 00:00 [entrez]']",,ppublish,Med Sci Sports Exerc. 1991 Mar;23(3):273-4.,,,,,,,,,,,,,,,,,,,,
21678274,NLM,MEDLINE,20110809,20110616,0047-262X (Print),58,3 Suppl,2011 Jun,[Self-regulation effect in dietary control of obesity].,97-103,,"Problems associated with excess bodyweight and obesity are increasing worldwide. These problems increase risks of metabolic syndrome, cardiovascular disorders and hypertension. Improving diet and exercise control and self-monitoring, self-evaluating and self-adjusting are critical to modify risky lifestyles. In this paper, the author's designed a diet control protocol and then applied it to an obese adult. The project ran from Feb 2nd to July 30th, 2009, and used the principles and concepts of self-regulation theory, a daily diet plan, and body weight chart to guide the patient to consider and appreciate the gaps between his behavior and the standard in order to encourage improvement. The processes related to the goal and effect are significant. By learning self-regulation skills the patient's weight declined from 106.1kg to 84.4kg. Self-efficacy also improved. The author predict the efficacy of the approach in helping prevent chronic disease. The author wishes to share their experience with nursing colleagues and propose this protocol as an effective diet control approach for obese patients.","['Lin, Tsai-Rung']",['Lin TR'],"['Surgical Intensive Care Unit, Kaohsiung Medical University Chung-Ho Memorial Hospital, ROC. arainings@yahoo.com.tw']",['chi'],"['Case Reports', 'English Abstract', 'Journal Article']",China (Republic : 1949- ),Hu Li Za Zhi,Hu li za zhi The journal of nursing,0073267,,IM,"['Adult', 'Humans', 'Male', 'Obesity/*diet therapy/*nursing/psychology', '*Social Control, Informal']",,,,,2011/07/27 06:00,2011/08/10 06:00,['2011/06/17 06:00'],"['2011/06/17 06:00 [entrez]', '2011/07/27 06:00 [pubmed]', '2011/08/10 06:00 [medline]']",,ppublish,Hu Li Za Zhi. 2011 Jun;58(3 Suppl):97-103.,,,,,,,,,,,,,,,,,,,,
17513811,NLM,MEDLINE,20070608,20220330,1527-7755 (Electronic) 0732-183X (Linking),25,15,2007 May 20,Obesity and outcome in pediatric acute lymphoblastic leukemia.,2063-9,,"PURPOSE: To evaluate the effect of obesity (defined as a body mass index > 95th percentile for age and sex at diagnosis) on outcome of pediatric acute lymphoblastic leukemia (ALL). PATIENTS AND METHODS: We retrospectively analyzed data from 4,260 patients with newly diagnosed ALL enrolled from 1988 to 1995 onto five concurrent Children's Cancer Group studies. Results were verified in a second cohort of 1,733 patients enrolled onto a sixth study from 1996 to 2002. RESULTS: The 1988 to 1995 cohort included 343 obese and 3,971 nonobese patients. The 5-year event-free survival rate and risk of relapse in obese versus nonobese patients were 72% +/- 2.4% v 77% +/- 0.6% (P = .02) and 26 +/- 2.4 v 20 +/- 0.6 (P = .02), respectively. After adjusting for other prognostic variables, obesity's hazard ratios (HRs) of events and relapses were 1.36 (95% CI, 1.04 to 1.77; P = .021) and 1.29 (95% CI, 1.02 to 1.56; P = .04), respectively. The effect of obesity was prominent in the 1,003 patients > or = 10 years old at diagnosis; in this subset, obesity's adjusted HRs of events and relapses were 1.5 (95% CI, 1.1 to 2.1; P = .009) and 1.5 (95% CI, 1.2 to 2.1; P = .013), respectively. In a second cohort of 1,160 patients 10 years old, obesity's adjusted HRs of events and relapses were 1.42 (95% CI, 1.03 to 1.96; P = .032) and 1.65 (95% CI, 1.13 to 2.41; P = .009), respectively. The effect of obesity on outcome was unrelated to changes in chemotherapy doses, length of intervals between chemotherapy cycles, or incidence and severity of therapy-related toxicity. CONCLUSION: Obesity at diagnosis independently predicts likelihood of relapse and cure in preteenagers and adolescents with ALL.","['Butturini, Anna M', 'Dorey, Frederick J', 'Lange, Beverly J', 'Henry, David W', 'Gaynon, Paul S', 'Fu, Cecilia', 'Franklin, Janet', 'Siegel, Stuart E', 'Seibel, Nita L', 'Rogers, Paul C', 'Sather, Harland', 'Trigg, Michael', 'Bleyer, W Archie', 'Carroll, William L']","['Butturini AM', 'Dorey FJ', 'Lange BJ', 'Henry DW', 'Gaynon PS', 'Fu C', 'Franklin J', 'Siegel SE', 'Seibel NL', 'Rogers PC', 'Sather H', 'Trigg M', 'Bleyer WA', 'Carroll WL']","['Childrens Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA. abutturini@chla.usc.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural']",United States,J Clin Oncol,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,8309333,,IM,"['Adolescent', 'Adult', 'Antineoplastic Combined Chemotherapy Protocols/*therapeutic use', 'Body Mass Index', 'Child', 'Child, Preschool', 'Cohort Studies', 'Disease-Free Survival', 'Female', 'Humans', 'Male', 'Obesity/*complications', 'Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications/*drug therapy/pathology', 'Retrospective Studies', 'Treatment Outcome']",,,,,2007/05/22 09:00,2007/06/09 09:00,['2007/05/22 09:00'],"['2007/05/22 09:00 [pubmed]', '2007/06/09 09:00 [medline]', '2007/05/22 09:00 [entrez]']","['25/15/2063 [pii]', '10.1200/JCO.2006.07.7792 [doi]']",ppublish,J Clin Oncol. 2007 May 20;25(15):2063-9. doi: 10.1200/JCO.2006.07.7792.,"['CA13539/CA/NCI NIH HHS/United States', 'CA98543/CA/NCI NIH HHS/United States']",,,,,,,,,,,,,,,,,,,
18751711,NLM,MEDLINE,20090811,20211020,1432-1084 (Electronic) 0938-7994 (Linking),19,2,2009 Feb,European obesity and the radiology department. What can we do to help?,298-309,10.1007/s00330-008-1154-z [doi],"Obesity is a chronic disease that is now a global epidemic. The numbers of obese people are exponentially rising in Europe, and it is projected that in Europe by 2010 there will be 150 million obese people. The obesity-related health crisis does not only affect adults, with one in four European children now overweight. Radiologists, both adult and paediatric, need to be aware of the magnitude of the problem, and obese patients cannot be denied radiologic evaluation due to their size. Missed diagnosis, appointment cancellation and embarrassing situations for patients when they are referred for a radiological examination for which they are not suitable are all issues that can be avoided if careful provision is made to accommodate the needs of the obese patient requiring radiologic evaluation. This paper will discuss the epidemiology of obesity and the role of radiology in the assessment of obesity and disorders of fat metabolism. The limitations obesity poses to current radiological equipment and how the radiologist can optimise imaging in the obese patient will be described. Dose reference levels and dose control are discussed. Examples of how obesity both hinders and helps the radiologist will be illustrated. Techniques and pre-procedural preparation to help the obese patient in the interventional suite are discussed.","['Buckley, O', 'Ward, E', 'Ryan, A', 'Colin, Walsh', 'Snow, A', 'Torreggiani, W C']","['Buckley O', 'Ward E', 'Ryan A', 'Colin W', 'Snow A', 'Torreggiani WC']","['Department of Radiology, Adelaide and Meath Hospital, Dublin, Ireland.']",['eng'],['Journal Article'],Germany,Eur Radiol,European radiology,9114774,,IM,"['Adolescent', 'Adult', 'Child', 'Equipment Design', 'Europe', 'Female', 'Fluoroscopy/methods', 'Humans', 'Magnetic Resonance Imaging/methods', 'Male', 'Obesity/diagnosis/*epidemiology/*therapy', 'Radiology/*methods', 'Radiometry/methods', 'Tomography, X-Ray Computed', 'Ultrasonography/methods']",,,,,2008/08/30 09:00,2009/08/12 09:00,['2008/08/30 09:00'],"['2008/03/29 00:00 [received]', '2008/07/03 00:00 [accepted]', '2008/06/08 00:00 [revised]', '2008/08/30 09:00 [pubmed]', '2009/08/12 09:00 [medline]', '2008/08/30 09:00 [entrez]']",['10.1007/s00330-008-1154-z [doi]'],ppublish,Eur Radiol. 2009 Feb;19(2):298-309. doi: 10.1007/s00330-008-1154-z. Epub 2008 Aug 27.,,20080827,,,,,,,,,,,,,,,,,,
7013664,NLM,MEDLINE,19810623,20041117,0066-4219 (Print) 0066-4219 (Linking),32,,1981,The problem of obesity.,221-31,,"In view of the conflicting data, the patent cultural biases under which we labor, and the possible harmful effects of therapy, it seems best that physicians examine the problems of obesity with the same keen scepticism and science they apply to other unsettled issues. To treat disease in the obese is obviously good. To treat simple obesity as a disease may be another matter entirely.","['Fitzgerald, F T']",['Fitzgerald FT'],,['eng'],"['Journal Article', 'Review']",United States,Annu Rev Med,Annual review of medicine,2985151R,,IM,"['Attitude', 'Eating', 'Humans', 'Morals', 'Obesity/complications/physiopathology/*therapy']",,,,,1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",['10.1146/annurev.me.32.020181.001253 [doi]'],ppublish,Annu Rev Med. 1981;32:221-31. doi: 10.1146/annurev.me.32.020181.001253.,,,,,,,88,,,,,,,,,,,,,
18074486,NLM,MEDLINE,20080129,20220716,0960-8923 (Print) 0960-8923 (Linking),17,9,2007 Sep,Regional anesthesia and obesity.,1146-9,,"The potential advantages of regional anesthesia include minimal airway intervention, less cardiopulmonary depression, excellent postoperative analgesia, less postoperative nausea and vomiting, and shorter recovery room and hospital stays. These concerns are particularly important for the obese surgical patient. This review discusses the application of regional anesthetic techniques in obesity. Further clinical studies are needed to fill the knowledge gap about regional anesthesia and outcome in obese and morbidly obese patients.","['Brodsky, Jay B', 'Lemmens, Harry J M']","['Brodsky JB', 'Lemmens HJ']","['Department of Anesthesia, Stanford University School of Medicine, Stanford, CA 94305, USA. Jbrodsky@stanford.edu']",['eng'],"['Journal Article', 'Review']",United States,Obes Surg,Obesity surgery,9106714,,IM,"['*Anesthesia, Conduction', 'Humans', '*Obesity/complications/surgery']",,,,,2007/12/13 09:00,2008/01/30 09:00,['2007/12/13 09:00'],"['2007/12/13 09:00 [pubmed]', '2008/01/30 09:00 [medline]', '2007/12/13 09:00 [entrez]']",['10.1007/s11695-007-9207-y [doi]'],ppublish,Obes Surg. 2007 Sep;17(9):1146-9. doi: 10.1007/s11695-007-9207-y.,,,,,,,31,,,,,,,,,,,,,
17908531,NLM,MEDLINE,20071030,20131213,0025-6196 (Print) 0025-6196 (Linking),82,10,2007 Oct,Evaluation and management of childhood and adolescent obesity.,1258-64,,"The prevalence of obesity in children and adolescents has increased dramatically in the past 3 decades. Childhood and adolescent obesity are associated with serious comorbidities including type 2 diabetes mellitus, hyperlipidemia, and hypertension. Most obese children and adolescents have no defined underlying endocrine or genetic syndrome. Evaluation of an obese child or adolescent involves a detailed personal and family history, physical examination, and selected laboratory evaluation. Lifestyle interventions and behavioral modification aimed at decreasing caloric intake and increasing caloric expenditure are essential to management of childhood and adolescent obesity. Surgical approaches have a role in management of morbid obesity and serious obesity-related comorbidities in adolescents. Further research is needed to evaluate the role of various dietary approaches and pharmacotherapy in the treatment of obesity in childhood and adolescence.","['Singhal, Vibha', 'Schwenk, W Frederick', 'Kumar, Seema']","['Singhal V', 'Schwenk WF', 'Kumar S']","['Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.']",['eng'],"['Journal Article', 'Review']",England,Mayo Clin Proc,Mayo Clinic proceedings,0405543,,IM,"['Adolescent', 'Child', 'Humans', 'Obesity/*diagnosis/*therapy']",,,,,2007/10/03 09:00,2007/10/31 09:00,['2007/10/03 09:00'],"['2007/10/03 09:00 [pubmed]', '2007/10/31 09:00 [medline]', '2007/10/03 09:00 [entrez]']","['S0025-6196(11)61398-0 [pii]', '10.4065/82.10.1258 [doi]']",ppublish,Mayo Clin Proc. 2007 Oct;82(10):1258-64. doi: 10.4065/82.10.1258.,,,,,,,32,,,,,,,,,,,,,
11186765,NLM,MEDLINE,20010104,20041117,1531-5681 (Print) 1531-5681 (Linking),6,8,2000 Aug,Pioneering programs making a dent in childhood obesity.,123-7,,"Childhood obesity has doubled over the past two decades, and while health care organizations know about the costly medical complications sure to follow obese children into adulthood, they are nonetheless hesitant to pay for interventions. Find out how a few pioneering weight-management programs for youth are making headway against this growing problem.",,,,['eng'],['Journal Article'],United States,Dis Manag Advis,Disease management advisor,100961635,,,"['Child', '*Disease Management', 'Health Behavior', 'Humans', 'Life Style', 'Obesity/economics/psychology/*therapy', 'Patient-Centered Care', 'Reimbursement Mechanisms', 'United States']",,,,,2001/02/24 12:00,2001/02/28 10:01,['2001/02/24 12:00'],"['2001/02/24 12:00 [pubmed]', '2001/02/28 10:01 [medline]', '2001/02/24 12:00 [entrez]']",,ppublish,Dis Manag Advis. 2000 Aug;6(8):123-7.,,,,,,,,,,,,,,,,,,,,
25172506,NLM,MEDLINE,20150623,20211021,2325-6621 (Electronic) 2329-6933 (Print) 2325-6621 (Linking),11,8,2014 Oct,Physiological and management implications of obesity in critical illness.,1286-97,10.1513/AnnalsATS.201404-159FR [doi],"Obesity is highly prevalent in the United States and is becoming increasingly common worldwide. The anatomic and physiological changes that occur in obese individuals may have an impact across the spectrum of critical illness. Obese patients may be more susceptible to hypoxemia and hypercapnia. During mechanical ventilation, elevated end-expiratory pressures may be required to improve lung compliance and to prevent ventilation-perfusion mismatch due to distal airway collapse. Several studies have shown an increased risk of organ dysfunction such as the acute respiratory distress syndrome and acute kidney injury in obese patients. Predisposition to ventricular hypertrophy and increases in blood volume should be considered in fluid management decisions. Obese patients have accelerated muscle losses in critical illness, making nutrition essential, although the optimal predictive equation to estimate nutritional needs or formulation for obese patients is not well established. Many common intensive care unit medications are not well studied in obese patients, necessitating understanding of pharmacokinetic concepts and consultation with pharmacists. Obesity is associated with higher risk of deep venous thrombosis and catheter-associated bloodstream infections, likely related to greater average catheter dwell times. Logistical issues such as blood pressure cuff sizing, ultrasound assistance for procedures, diminished quality of some imaging modalities, and capabilities of hospital equipment such as beds and lifts are important considerations. Despite the physiological alterations and logistical challenges involved, it is not clear whether obesity has an effect on mortality or long-term outcomes from critical illness. Effects may vary by type of critical illness, obesity severity, and obesity-associated comorbidities.","['Shashaty, Michael G S', 'Stapleton, Renee D']","['Shashaty MG', 'Stapleton RD']","['1 Pulmonary, Allergy, and Critical Care Division and Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and.']",['eng'],"['Case Reports', 'Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",United States,Ann Am Thorac Soc,Annals of the American Thoracic Society,101600811,,IM,"['Critical Care/*methods', 'Critical Illness/*therapy', '*Disease Management', 'Humans', 'Intensive Care Units', 'Male', 'Middle Aged', 'Obesity/complications/physiopathology/*therapy']",PMC4298999,['NOTNLM'],"['artificial respiration', 'critical illness', 'obesity', 'patient outcome assessment', 'physiology']",,2014/08/31 06:00,2015/06/24 06:00,['2014/08/31 06:00'],"['2014/08/31 06:00 [entrez]', '2014/08/31 06:00 [pubmed]', '2015/06/24 06:00 [medline]']",['10.1513/AnnalsATS.201404-159FR [doi]'],ppublish,Ann Am Thorac Soc. 2014 Oct;11(8):1286-97. doi: 10.1513/AnnalsATS.201404-159FR.,"['K23 DK097307/DK/NIDDK NIH HHS/United States', 'K23 HL105654/HL/NHLBI NIH HHS/United States', 'K23-HL105654/HL/NHLBI NIH HHS/United States', 'K23-DK097307/DK/NIDDK NIH HHS/United States']",,,,,,,,,,,,,,,,,,,
12688172,NLM,MEDLINE,20030429,20181130,0036-5327 (Print) 0036-5327 (Linking),103,4,2002,[Cognitive-behavioral therapy in obesity and activities of the STOB (Stop to Obesity) society].,559-63,,"STOB Society (STop to OBesity) was founded in the Czech Republic in 1991. It joins together psychologists, medical doctors, instructors of appropriate physical exercises and other professionals whose aim is to help obese people in the struggle with their excess weight. Activities of STOB Society are based on the method of cognitive behavioural psychotherapy, it proceeds from the assumption that inappropriate habits are learnt and so with a help of various techniques they can be also unlearnt. The aim is to induce desirable changes in behaviour, that is in eating and physical activity habits, and at the same time to get rid of the emotions and thoughts that lead to an inappropriate behaviour. The basis of cognitive-behavioural therapy is described. STOB Society popularizes appropriate and healthy way of weight reduction through articles in newspapers and journals, through programmes in radio and television and through brochure, audio and wide tapes, calendar etc. STOB Society organizes national campaigns in which it prompts thousands of obese people in the Czech Republic to appropriate eating and physical activity habits. It organizes ""Weight reduction courses"" in 70 towns in the Czech Republic.","['Malkova, I']",['Malkova I'],"['Spolecnost STOB, Poljanovova 3158, Praha 4, Czech Republic. malkova@stob.cz']",['cze'],['Journal Article'],Czech Republic,Sb Lek,Sbornik lekarsky,0025770,,IM,"['*Cognitive Behavioral Therapy', 'Humans', 'Obesity/psychology/*therapy']",,,,,2003/04/12 05:00,2003/04/30 05:00,['2003/04/12 05:00'],"['2003/04/12 05:00 [pubmed]', '2003/04/30 05:00 [medline]', '2003/04/12 05:00 [entrez]']",,ppublish,Sb Lek. 2002;103(4):559-63.,,,,,,,,,Kognitivne-behavioralni terapie obezity a aktivity spolecnosti stob.,,,,,,,,,,,
26047878,NLM,MEDLINE,20160421,20150622,1768-3181 (Electronic) 0003-3928 (Linking),64,3,2015 Jun,"[Relationship between blood pressure, heart rate and cardiac autonomic dysfunction in non-diabetic obese patients].",139-44,S0003-3928(15)00080-3 [pii] 10.1016/j.ancard.2015.04.021 [doi],"RATIONALE: Some studies suggest that a high heart rate (HR) would be predictive of the incidence of an elevated blood pressure (BP). Cardiac autonomic dysfunction (CAD) affects a high proportion of obese patients. CAD could be involved in BP increase. Our aim was to examine the relationship between CAD, HR and BP in obese patients without known diabetes. PATIENTS AND METHODS: We included 428 overweight or obese patients. CAD was assessed by analyzing HR variations during three standard tests (Valsalva, deep breathing, lying-to-standing), which are mostly dependent on vagal control. An oral load in glucose was performed and the Matsuda index was calculated. RESULTS: The population was separated in 4 groups according to the grade of CAD (no or only one abnormal test, 2 or 3 abnormal tests) and HR (< or >/= 75 bpm). Age was similar in the four groups. Systolic (P=0.05), diastolic (P<0.005) and mean BP (P<0.001) differed significantly between the 4 groups, and was the highest in the group of patients who had 2 or 3 abnormal tests and HR >/= 75 bpm. Matsuda index differed across the groups (P=0.018) and was the lowest in this group. CONCLUSION: These data indicate that among overweight or obese patients with a defect in cardiac vagal activity BP is elevated only in those with a high heart rate, which is indicative of a more marked insulin resistance and probably an excess in sympathetic activity.","['Banu, I', 'Nguyen, M T', 'Hamo-Tchatchouang, E', 'Cosson, E', 'Valensi, P']","['Banu I', 'Nguyen MT', 'Hamo-Tchatchouang E', 'Cosson E', 'Valensi P']","[""Service d'endocrinologie-diabetologie-nutrition, hopital Jean-Verdier, Assistance publique-Hopitaux de Paris, CRNH-IdF, universite Paris-Nord, avenue du 14-Juillet, 93143 Bondy cedex, France. Electronic address: isabela.banu@jvr.aphp.fr."", ""Service d'endocrinologie-diabetologie-nutrition, hopital Jean-Verdier, Assistance publique-Hopitaux de Paris, CRNH-IdF, universite Paris-Nord, avenue du 14-Juillet, 93143 Bondy cedex, France."", ""Service d'endocrinologie-diabetologie-nutrition, hopital Jean-Verdier, Assistance publique-Hopitaux de Paris, CRNH-IdF, universite Paris-Nord, avenue du 14-Juillet, 93143 Bondy cedex, France."", ""Service d'endocrinologie-diabetologie-nutrition, hopital Jean-Verdier, Assistance publique-Hopitaux de Paris, CRNH-IdF, universite Paris-Nord, avenue du 14-Juillet, 93143 Bondy cedex, France."", ""Service d'endocrinologie-diabetologie-nutrition, hopital Jean-Verdier, Assistance publique-Hopitaux de Paris, CRNH-IdF, universite Paris-Nord, avenue du 14-Juillet, 93143 Bondy cedex, France.""]",['fre'],"['English Abstract', 'Journal Article']",France,Ann Cardiol Angeiol (Paris),Annales de cardiologie et d'angeiologie,0142167,,IM,"['Adult', 'Autonomic Nervous System/*physiopathology', '*Blood Pressure', 'Diabetes Mellitus', 'Female', 'Heart/*innervation/*physiopathology', '*Heart Rate', 'Humans', 'Male', 'Obesity/*physiopathology']",,['NOTNLM'],"['Cardiac autonomic dysfunction', 'Dysfonction autonome cardiaque', 'Frequence cardiaque', 'Heart rate', 'Hypertension', 'Hypertension arterielle', 'Insulin resistance', 'Insulinoresistance', 'Obesity', 'Obesite']",,2015/06/07 06:00,2016/04/22 06:00,['2015/06/07 06:00'],"['2015/04/20 00:00 [received]', '2015/04/28 00:00 [accepted]', '2015/06/07 06:00 [entrez]', '2015/06/07 06:00 [pubmed]', '2016/04/22 06:00 [medline]']","['S0003-3928(15)00080-3 [pii]', '10.1016/j.ancard.2015.04.021 [doi]']",ppublish,Ann Cardiol Angeiol (Paris). 2015 Jun;64(3):139-44. doi: 10.1016/j.ancard.2015.04.021. Epub 2015 Jun 2.,,20150602,,['Copyright (c) 2015 Elsevier Masson SAS. All rights reserved.'],,,,,"Relation entre pression arterielle, frequence cardiaque et dysfonction autonome cardiaque chez les obeses non diabetiques.",,,,,,,,,,,
5653925,NLM,MEDLINE,19680730,20041117,0025-4363 (Print) 0025-4363 (Linking),17,5,1968 May,Studying and treating the obese patient.,64-9,,,"['Solomon, N']",['Solomon N'],,['eng'],['Journal Article'],United States,Md State Med J,Maryland state medical journal,2985229R,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Male', 'Obesity/mortality/physiopathology/*therapy']",,,,,1968/05/01 00:00,1968/05/01 00:01,['1968/05/01 00:00'],"['1968/05/01 00:00 [pubmed]', '1968/05/01 00:01 [medline]', '1968/05/01 00:00 [entrez]']",,ppublish,Md State Med J. 1968 May;17(5):64-9.,,,,,,,,,,,,,,,,,,,,
18379563,NLM,MEDLINE,20080618,20221207,1930-7381 (Print) 1930-7381 (Linking),16,4,2008 Apr,"Obesity and C-reactive protein levels among white, black, and hispanic US adults.",875-80,10.1038/oby.2008.7 [doi],"OBJECTIVE: Studies suggest that obesity's adverse impact on cardiovascular mortality may be reduced in African Americans relative to white Americans. We examined whether obesity's association with novel cardiovascular risk factors such as C-reactive protein (CRP) also varies by race and ethnicity. METHODS AND PROCEDURES: We analyzed data from 10,492 white, African-American, and Hispanic-American participants of the 1999-2004 National Health and Nutrition Examination Survey, who were aged 20 years and older, with a BMI > or =18.5 kg/m(2) and CRP < or =10 mg/l. We fit sex-specific multivariable models of the association of BMI or waist circumference with log CRP levels and tested for interactions of BMI or waist circumference with race/ethnicity. RESULTS: Higher BMI was significantly associated with higher CRP in all racial/ethnic groups for both men and women (P > 0.05 for BMI-race/ethnicity interaction) before and after adjustment for age, education, and health behaviors. Larger waist circumference was also associated with higher CRP levels in all racial/ethnic groups before and after adjustment; among women, the relationship was strongest for Mexican Hispanics (P < 0.01 for waist circumference-race/ethnicity interaction). Results were similar after additional adjustment for medications that might affect CRP levels. DISCUSSION: The association between obesity and CRP is at least as strong in African Americans and Hispanic Americans as in white Americans. Racial differences in the relationship between obesity and cardiovascular mortality are unlikely to be due to racial differences in obesity's impact on CRP.","['Wee, Christina C', 'Mukamal, Kenneth J', 'Huang, Annong', 'Davis, Roger B', 'McCarthy, Ellen P', 'Mittleman, Murray A']","['Wee CC', 'Mukamal KJ', 'Huang A', 'Davis RB', 'McCarthy EP', 'Mittleman MA']","['Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA. cwee@bidmc.harvard.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Obesity (Silver Spring),"Obesity (Silver Spring, Md.)",101264860,['9007-41-4 (C-Reactive Protein)'],IM,"['Adult', 'Black or African American/statistics & numerical data', 'Body Mass Index', 'C-Reactive Protein/*metabolism', 'Female', 'Hispanic or Latino/statistics & numerical data', 'Humans', 'Male', 'Middle Aged', 'Nutrition Surveys', 'Obesity/*blood/*ethnology', 'Predictive Value of Tests', 'Racial Groups/*statistics & numerical data', 'Risk Factors', 'United States/epidemiology', 'Waist-Hip Ratio', 'White People/statistics & numerical data']",PMC2848449,,,['DISCLOSURE The authors declared no conflict of interest.'],2008/04/02 09:00,2008/06/19 09:00,['2008/04/02 09:00'],"['2008/04/02 09:00 [pubmed]', '2008/06/19 09:00 [medline]', '2008/04/02 09:00 [entrez]']","['oby20087 [pii]', '10.1038/oby.2008.7 [doi]']",ppublish,Obesity (Silver Spring). 2008 Apr;16(4):875-80. doi: 10.1038/oby.2008.7. Epub 2008 Feb 7.,"['R01 DK071083/DK/NIDDK NIH HHS/United States', 'R01 DK071083-02/DK/NIDDK NIH HHS/United States', 'R01 DK071083-03/DK/NIDDK NIH HHS/United States']",20080207,,,,['NIHMS156043'],,,,,,,,,,,,,,
363493,NLM,MEDLINE,19790212,20190816,0012-186X (Print) 0012-186X (Linking),15,6,1978 Dec,Obesity: do fat cells from genetically obese mice (C57BL/6J ob/ob) have an innate capacity for increased fat storage?,465-70,,"Fat tissue from the genetically obese mouse (C57BL/6J ob/ob) and its lean littermate (+/?) was transplanted into lean hosts(+/+). Chemical induced obesity in the host mice caused no greater increase in the size of 'obese' fat cells than it did in the size of 'lean' fat cells. 'Obese' fat cells, therefore, have no innate capacity for increased fat storage.","['Ashwell, M', 'Meade, C J']","['Ashwell M', 'Meade CJ']",,['eng'],['Journal Article'],Germany,Diabetologia,Diabetologia,0006777,['2P2V9Q0E78 (Aurothioglucose)'],IM,"['Adipose Tissue/cytology/*physiology/transplantation', 'Animals', 'Aurothioglucose/pharmacology', 'Lipid Metabolism', 'Male', 'Obesity/chemically induced/*genetics/metabolism', 'Rats', 'Transplantation, Homologous']",,,,,1978/12/01 00:00,1978/12/01 00:01,['1978/12/01 00:00'],"['1978/12/01 00:00 [pubmed]', '1978/12/01 00:01 [medline]', '1978/12/01 00:00 [entrez]']",['10.1007/BF02342871 [doi]'],ppublish,Diabetologia. 1978 Dec;15(6):465-70. doi: 10.1007/BF02342871.,,,,,,,,,,,,,,,,,,,,
10933311,NLM,MEDLINE,20001116,20051116,1071-7323 (Print) 1071-7323 (Linking),8,4,2000 Jul,The obesity epidemic: metabolic imprinting on genetically susceptible neural circuits.,342-7,,"The apparent obesity epidemic in the industrialized world is not explained completely by increased food intake or decreased energy expenditure. Once obesity develops in genetically predisposed individuals, their obese body weight is avidly defended against chronic caloric restriction. In animals genetically predisposed toward obesity, there are multiple abnormalities of neural function that prime them to become obese when dietary caloric density and quantity are raised. Once obesity is fully developed, these abnormalities largely disappear. This suggests that obesity might be the normal state for such individuals. Formation of new neural circuits involved in energy homeostasis might underlie the near permanence of the obese body weight. Such neural plasticity can occur during both nervous system development and in adult life. Maternal diabetes, obesity, and undernutrition have all been associated with obesity in the offspring of such mothers, especially in genetically predisposed individuals. Altered brain neural circuitry and function often accompanies such obesity. This enhanced obesity may then be passed on to subsequent generations in a feed-forward, upward spiral of increasing body weight across generations. Such findings suggest a form of ""metabolic imprinting"" upon genetically predisposed neural circuits involved in energy homeostasis. Centrally acting drugs used for obesity treatment lower the defended body weight and alter the function of neural pathways involved in energy homeostasis. But they generally have no permanent effect on body weight or neural function. Thus, early identification of obesity-prone mothers, infants, and adults and treatment of early obesity may be the only way to prevent the formation of permanent neural connections that promote and perpetuate obesity in genetically predisposed individuals.","['Levin, B E']",['Levin BE'],"['Department of Neurosciences, NJ Medical School, Newark 07103, USA. levin@umdnj.edu']",['eng'],"['Journal Article', 'Review']",United States,Obes Res,Obesity research,9305691,,IM,"['Animals', 'Brain/embryology/*physiopathology', 'Diet', 'Energy Intake', 'Energy Metabolism/genetics', 'Female', 'Genomic Imprinting', 'Humans', 'Neuronal Plasticity', 'Obesity/epidemiology/*genetics/*metabolism/therapy', 'Pregnancy']",,,,,2000/08/10 11:00,2001/02/28 10:01,['2000/08/10 11:00'],"['2000/08/10 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/08/10 11:00 [entrez]']",['10.1038/oby.2000.41 [doi]'],ppublish,Obes Res. 2000 Jul;8(4):342-7. doi: 10.1038/oby.2000.41.,,,,,,,93,,,,,,,,,,,,,
14726719,NLM,MEDLINE,20040308,20220408,0890-8567 (Print) 0890-8567 (Linking),43,2,2004 Feb,Psychiatric aspects of child and adolescent obesity: a review of the past 10 years.,134-50,,"OBJECTIVE: To review the past 10 years of published research on psychiatric aspects of child and adolescent obesity and highlight information mental health professionals need for preventing obesity in youths and diagnosing and treating it. METHOD: Researchers performed computerized and manual searches of the literature and summarized the most relevant articles. RESULTS: The growing epidemic of child and adolescent obesity deserves attention for its immediate mental health and long-term medical complications. Mental health professionals working with obese youths should be aware of recent advances in neuroscience, genetics, and etiologies associated with obesity. Those who assess and treat obese youth should view obesity as a chronic disease. Currently, no approved pharmacological or surgical approaches exist to treat childhood obesity. CONCLUSIONS: Health care providers should focus on modest weight-loss goals that correlate with significant health benefits. The most effective treatments include substantial parental involvement. Mental health professionals should help obese children build self-esteem to help them lead full lives regardless of weight.","['Zametkin, Alan J', 'Zoon, Christine K', 'Klein, Hannah W', 'Munson, Suzanne']","['Zametkin AJ', 'Zoon CK', 'Klein HW', 'Munson S']","['Mood and Anxiety Disorders Program, Intramural Research Program, National Institute of Mental Health, Bethesda, MD 20892, USA. zametkin@mail.nih.gov']",['eng'],"['Journal Article', 'Review']",United States,J Am Acad Child Adolesc Psychiatry,Journal of the American Academy of Child and Adolescent Psychiatry,8704565,,IM,"['Adolescent', 'Body Mass Index', 'Child', 'Female', 'Health Status', 'Humans', '*Obesity/epidemiology/psychology/therapy', 'Prevalence', 'Self Concept']",,,,,2004/01/17 05:00,2004/03/09 05:00,['2004/01/17 05:00'],"['2004/01/17 05:00 [pubmed]', '2004/03/09 05:00 [medline]', '2004/01/17 05:00 [entrez]']","['S0890-8567(09)61269-7 [pii]', '10.1097/00004583-200402000-00008 [doi]']",ppublish,J Am Acad Child Adolesc Psychiatry. 2004 Feb;43(2):134-50. doi: 10.1097/00004583-200402000-00008.,,,,,,,141,['J Am Acad Child Adolesc Psychiatry. 2004 Feb;43(2):151-3. PMID: 14726720'],,,,,,,,,,,,
10593355,NLM,MEDLINE,19991229,20221207,0025-6196 (Print) 0025-6196 (Linking),74,12,1999 Dec,Safe and effective management of the obese patient.,1255-9; quiz 1259-60,,"The prevalence of overweight and obesity has increased dramatically in the recent decades, and obesity is now a major public health problem. Obesity negatively influences an individual's health by increasing mortality and raising the risk for multiple medical conditions such as type 2 diabetes mellitus, hypertension, dyslipidemia, and coronary heart disease. In addition, the obese individual is often the brunt of social discrimination. Weight loss has been shown to reduce the risk for many of these comorbid conditions. A multifaceted approach to the obese patient should include identifying potential causes for weight gain, outlining medical conditions that would benefit by weight loss, and tailoring a weight loss program that is safe and effective for the individual. Components of a successful weight loss program include dietary intervention, recommendations for physical activity, behavior modification, and, in a select group of patients, pharmacologic or surgical intervention.","['Collazo-Clavell, M L']",['Collazo-Clavell ML'],"['Division of Endocrinology, Metabolism, Nutrition and Internal Medicine, Mayo Clinic Rochester, Minn 55905, USA.']",['eng'],"['Journal Article', 'Review']",England,Mayo Clin Proc,Mayo Clinic proceedings,0405543,"['0 (Anti-Obesity Agents)', '0 (Appetite Depressants)', '0 (Cyclobutanes)', '0 (Lactones)', '0 (Serotonin Uptake Inhibitors)', '95M8R751W8 (Orlistat)', 'EC 3.1.1.3 (Lipase)', 'WV5EC51866 (sibutramine)']",IM,"['Anti-Obesity Agents/therapeutic use', 'Appetite Depressants/therapeutic use', 'Cognitive Behavioral Therapy', 'Cyclobutanes/therapeutic use', 'Exercise', 'Gastric Bypass', 'Humans', 'Lactones/therapeutic use', 'Lipase/antagonists & inhibitors', 'Obesity/complications/drug therapy/psychology/surgery/*therapy', 'Obesity, Morbid/therapy', 'Orlistat', 'Selective Serotonin Reuptake Inhibitors/therapeutic use', 'Weight Loss']",,,,,1999/12/11 00:00,1999/12/11 00:01,['1999/12/11 00:00'],"['1999/12/11 00:00 [pubmed]', '1999/12/11 00:01 [medline]', '1999/12/11 00:00 [entrez]']","['S0025-6196(11)64159-1 [pii]', '10.4065/74.12.1255 [doi]']",ppublish,Mayo Clin Proc. 1999 Dec;74(12):1255-9; quiz 1259-60. doi: 10.4065/74.12.1255.,,,,,,,12,,,,,,,,,,,,,
7246212,NLM,MEDLINE,19810827,20081121,0044-6033 (Print) 0044-6033 (Linking),32,1,1981 Jan-Feb,Energy expenditure in obese women on a reducing diet.,99-102,,Energy expenditure during rest and exercise was studied in 13 obese women on a 400 kcal weight-reducing diet. The resting metabolic rate did not decrease during weight reduction. Diminished energy expenditure during standard ergometer test indicates that a progressively increasing physical activity is needed during dietetic treatment to achieve the optimal weight loss.,"['Zahorska-Markiewicz, B']",['Zahorska-Markiewicz B'],,['eng'],['Journal Article'],Poland,Acta Physiol Pol,Acta physiologica Polonica,2985166R,,IM,"['Adolescent', 'Adult', 'Basal Metabolism', 'Body Weight', '*Energy Metabolism', 'Female', 'Humans', 'Middle Aged', 'Obesity/diagnosis/*diet therapy/metabolism', 'Physical Exertion']",,,,,1981/01/01 00:00,1981/01/01 00:01,['1981/01/01 00:00'],"['1981/01/01 00:00 [pubmed]', '1981/01/01 00:01 [medline]', '1981/01/01 00:00 [entrez]']",,ppublish,Acta Physiol Pol. 1981 Jan-Feb;32(1):99-102.,,,,,,,,,,,,,,,,,,,,
11575236,NLM,MEDLINE,20011018,20090213,0003-9683 (Print) 0003-9683 (Linking),94,8,2001 Aug,[Relationship between vasosympathetic activity and insulin resistance in normotensive and mildly hypertensive obese patients].,941-3,,"Several studies have well demonstrated that obesity is associated with changes in cardiovascular vagosympathetic activity. The aim of the present work was to evaluate this activity in normotensive and in mildly hypertensive obese patients, and to correlate this activity with clinical and biological indexes of insulin resistance. Heart rate (HR) and systolic blood pressure (sBP) were examined by spectral analysis in 70 normotensive obese patients (group 1), 32 mildly hypertensive obese patients (group 2), and 21 controls. The high frequency peak of HR variations at a controlled breathing rate (vagal activity) was significantly reduced in both groups (p < 0.001). The mid frequency peak of sBP in the standing position (sympathetic activity) was similar in both groups and in the control group. In groups 1 and 2, the high frequency peak correlated negatively with age (p = 0.005 and 0.034 respectively). In group 1, the mid frequency peak correlated positively with fat mass, fasting plasma insulin and triglyceride levels, and insulin resistance index (p < or = 0.03). In group 2, the mid frequency peak correlated positively with fasting insulin and insulin resistance index (p = 0.006 and 0.007 respectively). This study shows that, in obese patients: 1. cardiac vagal activity is reduced in normotensive and mildly hypertensive subjects; 2. vascular sympathetic activity is unchanged in means but may be increased as a consequence of adiposity, hyperinsulinemia and insulin resistance, and this increase is likely to be involved in the increase of blood pressure.","['Valensi, P', 'Dabire, H', 'Brahimi, M', 'Paries, J', 'Platon, P', 'Attali, J R']","['Valensi P', 'Dabire H', 'Brahimi M', 'Paries J', 'Platon P', 'Attali JR']","[""Service d'endocrinologie-diabetologie-nutrition, hopital Jean-Verdier, Bondy.""]",['fre'],"['English Abstract', 'Journal Article']",France,Arch Mal Coeur Vaiss,Archives des maladies du coeur et des vaisseaux,0406011,,IM,"['Adult', 'Blood Pressure', 'Female', 'Heart Rate', 'Humans', 'Hypertension/*complications', '*Insulin Resistance', 'Male', 'Middle Aged', 'Obesity/*complications', 'Sympathetic Nervous System/physiology', 'Vasoconstriction']",,,,,2001/09/29 10:00,2001/10/19 10:01,['2001/09/29 10:00'],"['2001/09/29 10:00 [pubmed]', '2001/10/19 10:01 [medline]', '2001/09/29 10:00 [entrez]']",,ppublish,Arch Mal Coeur Vaiss. 2001 Aug;94(8):941-3.,,,,,,,,,Relations entre activite vagosympathique et insulinoresistance chez les obeses normotendus et moderement hypertendus.,,,,,,,,,,,
1884411,NLM,MEDLINE,19911009,20041117,0069-2328 (Print) 0069-2328 (Linking),46,1,1991 Jan,[How can we really help obese children?].,34-5,,,"['Kalvachova, B', 'Pflegerova, Z']","['Kalvachova B', 'Pflegerova Z']","['Detska klinika ILF, Praha.']",['cze'],['Journal Article'],Czech Republic,Cesk Pediatr,Ceskoslovenska pediatrie,0403576,,IM,"['Adolescent', 'Child', 'Health Resorts', 'Humans', 'Obesity/psychology/*therapy']",,,,,1991/01/01 00:00,1991/01/01 00:01,['1991/01/01 00:00'],"['1991/01/01 00:00 [pubmed]', '1991/01/01 00:01 [medline]', '1991/01/01 00:00 [entrez]']",,ppublish,Cesk Pediatr. 1991 Jan;46(1):34-5.,,,,,,,,,Jak konkretne pomoci obeznim detem?,,,,,,,,,,,
17991136,NLM,MEDLINE,20080205,20071109,1399-543X (Print) 1399-543X (Linking),8 Suppl 9,,2007 Dec,An overview of pediatric obesity.,76-87,10.1111/j.1399-5448.2007.00337.x [doi],"Pediatric obesity is increasing worldwide and disproportionately affects the economically and socially disadvantaged. Obese children are at risk of developing the (dys)metabolic syndrome, insulin resistance, early-onset type 2 diabetes mellitus, polycystic ovarian syndrome, hypertension, hyperlipidemia, and obstructive sleep apnoea. Those with diabetes may have mixed features of type 1 and type 2 diabetes mellitus. Pediatric obesity is the result of persistent adverse changes in food intake, lifestyle, and energy expenditure. It may be because of underlying a genetic syndrome or a conduct disorder. Children living in urban settings often lack safe, affordable, and accessible recreational facilities. Tight educational schedules mean less free time, while computer games and television have become preferred recreational activities. More families are eating out or eating take-out meals and processed foods at home because of pressures of work and time constraints. Consumer advertising targeted at children and the ready availability of vending machines encourage unwise food choices. Some children eat excessively because they are depressed, anxious, sad, or lonely. Often families and obese children are aware of the need for healthy eating and exercise but are unable to translate knowledge into weight loss. Population-based measures such as public education, school meal reforms, child-safe exercise friendly environments, and school-based and community-based exercise programs have been shown to be successful to varying degrees, but there remain individuals who will need special help to overcome obesity. Overeating (e.g. binge eating) may be a manifestation of disordered coping behavior but may also be because of defects in the neural and hormonal control of appetite and satiety. New pharmacological approaches are targeting these areas. We need a coordinated approach involving government, communities, and healthcare providers to provide a continuum of population-based interventions, focused screening, and personalized multidisciplinary interventions for the obese child and family.","['Lee, Warren W R']",['Lee WW'],"[""Department of Paediatric Medicine, KK Women's and Children's Hospital, Singapore 229899, Singapore. warren.lee@kkh.com.sg""]",['eng'],"['Journal Article', 'Review']",Denmark,Pediatr Diabetes,Pediatric diabetes,100939345,,IM,"['Adiposity/physiology', 'Adult', 'Child', 'Comorbidity', 'Genetic Diseases, Inborn/complications', 'Health Care Costs', '*Health Promotion', 'Humans', 'Obesity/diagnosis/epidemiology/*etiology/therapy']",,,,,2008/01/03 09:00,2008/02/06 09:00,['2008/01/03 09:00'],"['2008/01/03 09:00 [pubmed]', '2008/02/06 09:00 [medline]', '2008/01/03 09:00 [entrez]']","['PDI337 [pii]', '10.1111/j.1399-5448.2007.00337.x [doi]']",ppublish,Pediatr Diabetes. 2007 Dec;8 Suppl 9:76-87. doi: 10.1111/j.1399-5448.2007.00337.x.,,,,,,,154,,,,,,,,,,,,,
34032681,NLM,MEDLINE,20210719,20210719,1526-7598 (Electronic) 0003-2999 (Linking),132,6,2021 Jun 1,"The Obese Patient: Facts, Fables, and Best Practices: Comment.",e117,10.1213/ANE.0000000000005515 [doi],,"['Gross, Jeffrey B', 'Flores, Mario']","['Gross JB', 'Flores M']","['Department of Anesthesiology, University Connecticut School of Medicine, Farmington, Connecticut, gross@uchc.edu.']",['eng'],"['Comment', 'Journal Article']",United States,Anesth Analg,Anesthesia and analgesia,1310650,,IM,"['Humans', '*Obesity/diagnosis/epidemiology']",,,,,2021/05/26 06:00,2021/07/20 06:00,['2021/05/25 13:52'],"['2021/05/25 13:52 [entrez]', '2021/05/26 06:00 [pubmed]', '2021/07/20 06:00 [medline]']","['00000539-202106000-00052 [pii]', '10.1213/ANE.0000000000005515 [doi]']",ppublish,Anesth Analg. 2021 Jun 1;132(6):e117. doi: 10.1213/ANE.0000000000005515.,,,,,,,,['Anesth Analg. 2021 Jun 1;132(6):e117. PMID: 34032682'],,,['Anesth Analg. 2021 Jan;132(1):53-64. PMID: 32282384'],,,,,,,,,
3831769,NLM,MEDLINE,19860429,20041117,0391-1977 (Print) 0391-1977 (Linking),10,3,1985 Jul-Sep,[Anthropometric and metabolic evaluation in young obese subjects].,197,,,"['Ciprandi, G', 'Martini, F', 'Fazzuoli, L', 'Magnani, M']","['Ciprandi G', 'Martini F', 'Fazzuoli L', 'Magnani M']",,['ita'],['Letter'],Italy,Minerva Endocrinol,Minerva endocrinologica,8406505,,IM,"['Humans', 'Italy', 'Obesity/diagnosis/*epidemiology']",,,,,1985/07/01 00:00,1985/07/01 00:01,['1985/07/01 00:00'],"['1985/07/01 00:00 [pubmed]', '1985/07/01 00:01 [medline]', '1985/07/01 00:00 [entrez]']",,ppublish,Minerva Endocrinol. 1985 Jul-Sep;10(3):197.,,,,,,,,,Valutazione antropometrica e metabolica in giovani obesi.,,,,,,,,,,,
10439201,NLM,MEDLINE,19990910,20220331,1040-8703 (Print) 1040-8703 (Linking),11,4,1999 Aug,"Adolescent obesity, a need for greater awareness and improved treatment.",297-302,,"Obesity is arguably the most important medical problem in America today. About 25% of children are considered either overweight or obese, according to newly established national criteria. These teenagers are at significant risk for becoming obese adults, and adolescent obesity predisposes to a range of short- and long-term medical, and psychosocial problems. Despite the enormous medical and economic implications of obesity, effective prevention and treatment strategies are lacking. This review summarizes the epidemiology, evaluation, and management of adolescent obesity, focusing on promising treatment strategies for the future.","['Trent, M E', 'Ludwig, D S']","['Trent ME', 'Ludwig DS']","[""Department of Medicine, Children's Hospital, Boston, Massachusetts 02115, USA. Trent_M@a1.tch.harvard.edu""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S."", 'Review']",United States,Curr Opin Pediatr,Current opinion in pediatrics,9000850,['0 (Appetite Depressants)'],IM,"['Adolescent', 'Appetite Depressants/therapeutic use', 'Body Mass Index', 'Diet, Reducing', 'Exercise', 'Humans', 'Needs Assessment', 'Obesity/*diagnosis/epidemiology/etiology/*therapy', 'Patient Care Team', 'United States/epidemiology']",,,,,1999/08/10 00:00,1999/08/10 00:01,['1999/08/10 00:00'],"['1999/08/10 00:00 [pubmed]', '1999/08/10 00:01 [medline]', '1999/08/10 00:00 [entrez]']",['10.1097/00008480-199908000-00005 [doi]'],ppublish,Curr Opin Pediatr. 1999 Aug;11(4):297-302. doi: 10.1097/00008480-199908000-00005.,"['K0802440/PHS HHS/United States', 'MCJ-MA259195/PHS HHS/United States']",,,,,,55,,,,,,,,,,,,,
20176518,NLM,MEDLINE,20100616,20100223,1937-4186 (Electronic) 0739-5175 (Linking),29,1,2010 Jan-Feb,Biomedical engineering and the obesity epidemic: treatments for weight reduction.,24-30,10.1109/MEMB.2009.935469 [doi],"Obesity is becoming increasingly common, with at least 400 million obese adults worldwide and the World Health Organization (WHO) projecting that this statistic will reach 700 million in another five years. Ironically, despite the fact that a majority of adults in developed nations are overweight or obese, society stigmatizes the obese severely. Still, obese people have more than just social motivations for losing weight; obesity commonly goes hand in hand with life-threatening comorbidities like cardiovascular disease and type 2 diabetes and some forms of cancer. It severely threatens quality of life, limiting the ability to move and work, navigate public places, and provide care for others and is a factor in musculoskeletal disorders like osteoarthritis. Both obesity and its comorbidities lead obese patients to hospitals at greater rates than patients of normal weight, and these factors, along with social pressures, motivate patients and their physicians to pursue solutions for obesity, its comorbidities, or both.","['Rutherford, Jesse Jayne']",['Rutherford JJ'],['stilljesse@yahoo.com'],['eng'],['Journal Article'],United States,IEEE Eng Med Biol Mag,IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society,8305985,,IM,"['Biomedical Engineering/*instrumentation/*methods', 'Equipment Design', 'Equipment and Supplies', 'Humans', 'Obesity/*diagnosis/epidemiology/*therapy', 'Therapy, Computer-Assisted/*instrumentation/*methods', '*Weight Loss']",,,,,2010/02/24 06:00,2010/06/17 06:00,['2010/02/24 06:00'],"['2010/02/24 06:00 [entrez]', '2010/02/24 06:00 [pubmed]', '2010/06/17 06:00 [medline]']",['10.1109/MEMB.2009.935469 [doi]'],ppublish,IEEE Eng Med Biol Mag. 2010 Jan-Feb;29(1):24-30. doi: 10.1109/MEMB.2009.935469.,,,,,,,,,,,,,,,,,,,,
26847444,NLM,MEDLINE,20170118,20181113,1563-258X (Electronic) 0043-5341 (Linking),166,3-4,2016 Mar,[Not Available].,75-8,10.1007/s10354-016-0440-7 [doi],"Obesity is increasing worldwide in both sexes and a challenge for health professionals and the health care system. Women have more subcutaneous fat and are more insulin sensitive while men have more visceral and liver fat and higher cardiovascular risk. Women more often show the metabolically healthy obese phenotype than males. However, with increasing BMI the risk for type 2 diabetes and cardiovascular diseases increases more dramatically in women compared to males. Obese women suffer more from weight-related problems, have a higher rate of depression and seek more often medical help to reduce weight. Both biological factors and psychosocial factors contribute to the disease and interact with each other. In this special edition of the journal sex and gender aspects in prevention, treatment and development of complications will be discussed, as proposed by the Austrian Obesity Association. Data available from the Austrian population will be included in the Austrian Gender Obesity Report.","['Kautzky-Willer, Alexandra']",['Kautzky-Willer A'],"['Gender Medicine Unit, Klinische Abteilung fur Endokrinologie & Stoffwechsel, Universitatsklinik fur Innere Medizin III, Medizinische Universitat Wien, Wahringer Gurtel 18-20, 1090, Wien, Osterreich. alexandra.kautzky-willer@meduniwien.ac.at.']",['ger'],['Editorial'],Austria,Wien Med Wochenschr,Wiener medizinische Wochenschrift (1946),8708475,,IM,"['Adult', 'Aged', 'Austria', 'Cross-Sectional Studies', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications/*epidemiology/physiopathology/prevention & control', 'Risk Factors', '*Sex Characteristics']",,,,,2016/02/06 06:00,2017/01/19 06:00,['2016/02/06 06:00'],"['2016/02/06 06:00 [entrez]', '2016/02/06 06:00 [pubmed]', '2017/01/19 06:00 [medline]']","['10.1007/s10354-016-0440-7 [pii]', '10.1007/s10354-016-0440-7 [doi]']",ppublish,Wien Med Wochenschr. 2016 Mar;166(3-4):75-8. doi: 10.1007/s10354-016-0440-7.,,,,,,,,,Brennpunkt Adipositas: what gender has to do with ...!,,,,,,,,,,,
20122135,NLM,MEDLINE,20110304,20220321,1467-789X (Electronic) 1467-7881 (Linking),12,2,2011 Feb,The economic burden of obesity worldwide: a systematic review of the direct costs of obesity.,131-41,10.1111/j.1467-789X.2009.00712.x [doi],"In the last decade, the prevalence of obesity has increased significantly in populations worldwide. A less dramatic, but equally important increase has been seen in our knowledge of its effects on health and the burden it places on healthcare systems. This systematic review aims to assess the current published literature on the direct costs associated with obesity. A computerized search of English language articles published between 1990 and June 2009 yielded 32 articles suitable for review. Based on these articles, obesity was estimated to account for between 0.7% and 2.8% of a country's total healthcare expenditures. Furthermore, obese individuals were found to have medical costs that were approximately 30% greater than their normal weight peers. Although variations in inclusion/exclusion criteria, reporting methods and included costs varied widely between the studies, a lack of examination of how and why the excess costs were being accrued appeared to be a commonality between most studies. Accordingly, future studies must better explore how costs accrue among obese populations, in order to best facilitate health and social policy interventions.","['Withrow, D', 'Alter, D A']","['Withrow D', 'Alter DA']","[""Department of Life Sciences, Queen's University, Toronto, ON, Canada.""]",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review', 'Systematic Review']",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['*Cost of Illness', '*Health Care Costs', 'Humans', 'Obesity/complications/*economics/epidemiology']",,,,,2010/02/04 06:00,2011/03/05 06:00,['2010/02/04 06:00'],"['2010/02/04 06:00 [entrez]', '2010/02/04 06:00 [pubmed]', '2011/03/05 06:00 [medline]']","['OBR712 [pii]', '10.1111/j.1467-789X.2009.00712.x [doi]']",ppublish,Obes Rev. 2011 Feb;12(2):131-41. doi: 10.1111/j.1467-789X.2009.00712.x.,,,,"['(c) 2010 The Authors. obesity reviews (c) 2010 International Association for the', 'Study of Obesity.']",,,,,,,,,,,,,,,,
29561568,NLM,MEDLINE,20190429,20190429,1660-9379 (Print) 1660-9379 (Linking),14,599,2018 Mar 21,[Food reward circuitry in obese patients].,612-614,,"Besides hormonal regulation of appetite and satiety, food intake depends on the activity of certain brain systems. Functional imaging studies are useful to better understand this central regulation of energy intake. Obesity is associated with increased brain responses to food stimuli at the level of the reward system. More specifically, studies have shown in obese individuals an increased motivation to obtain food reward as well as a decrease in pleasure during its actual consumption. Food consumption may be, in some instances, comparable to addiction, and be reflected by irresistible cravings for certain foods.","['Coppin, Geraldine', 'Sander, David', 'Golay, Alain', 'Pataky, Zoltan']","['Coppin G', 'Sander D', 'Golay A', 'Pataky Z']","['Centre interfacultaire en sciences affectives (CISA), Campus Biotech, Universite de Geneve, 1211 Geneve 4.', ""Laboratoire Emergence et Expression de l'Emotion (E3 Lab), Section de psychologie, FPSE, Universite de Geneve, 1211 Geneve 4."", 'Formation universitaire a distance, Uberlandstrasse 12, Case postale 265, 3900 Brigue.', 'Centre interfacultaire en sciences affectives (CISA), Campus Biotech, Universite de Geneve, 1211 Geneve 4.', ""Laboratoire Emergence et Expression de l'Emotion (E3 Lab), Section de psychologie, FPSE, Universite de Geneve, 1211 Geneve 4."", ""Service d'enseignement therapeutique pour maladies chroniques, Centre collaborateur de l'OMS, Departement de medecine communautaire, de premier recours et des urgences, HUG, Universite de Geneve, Chemin Venel 7, 1206 Geneve."", ""Service d'enseignement therapeutique pour maladies chroniques, Centre collaborateur de l'OMS, Departement de medecine communautaire, de premier recours et des urgences, HUG, Universite de Geneve, Chemin Venel 7, 1206 Geneve.""]",['fre'],['Journal Article'],Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['*Appetite', 'Energy Intake', 'Food', 'Humans', '*Obesity', '*Reward']",,,,"[""Les auteurs n'ont declare aucun conflit d'interets en relation avec cet article.""]",2018/03/22 06:00,2019/04/30 06:00,['2018/03/22 06:00'],"['2018/03/22 06:00 [entrez]', '2018/03/22 06:00 [pubmed]', '2019/04/30 06:00 [medline]']",['RMS0599-003 [pii]'],ppublish,Rev Med Suisse. 2018 Mar 21;14(599):612-614.,,,,,,,,,Circuits de la recompense alimentaire chez les patients obeses.,,,,,,,,,,,
21151142,NLM,MEDLINE,20110411,20171116,1476-5497 (Electronic) 0307-0565 (Linking),34 Suppl 2,,2010 Dec,Open questions about metabolically normal obesity.,S18-23,10.1038/ijo.2010.235 [doi],"Subsets of obese subjects without any cardiometabolic risk factors have been repeatedly described. This raises questions whether obesity 'per se' enhances the risk for cardiovascular or metabolic diseases and whether healthy obese subjects would benefit from a medical treatment. In order to answer these questions, as a first step, an expert consensus should be reached for the definition of metabolic normality. In fact, up to now, different parameters related to the metabolic syndrome and/or to insulin sensitivity have been utilized across studies. Once an agreement is reached, population-based studies should be undertaken to establish the incidence of metabolic normality among obese subjects. Furthermore, many other parameters such as age, sex, race, fat distribution and physical activity should be monitored to obtain results representative of a general population. Longitudinal studies aimed at investigating the evolution of the cardiometabolic profile of healthy obese subjects are also needed. In conclusion, data from the literature strongly suggest that a regular surveillance of the cardiometabolic parameters and a prevention of any further weight gain should be applied to healthy obese individuals, whereas possible benefits of a weight loss treatment are still a matter of debate.","['Pataky, Z', 'Bobbioni-Harsch, E', 'Golay, A']","['Pataky Z', 'Bobbioni-Harsch E', 'Golay A']","['Department of Community Medicine, WHO Collaborating Centre, University Hospitals of Geneva and University of Geneva, Geneva, Switzerland.']",['eng'],"['Journal Article', 'Review']",England,Int J Obes (Lond),International journal of obesity (2005),101256108,,IM,"['Body Mass Index', 'Female', 'Health Status', 'Humans', 'Insulin Resistance/genetics/physiology', 'Intra-Abdominal Fat/physiology', 'Life Style', 'Male', 'Metabolic Syndrome/diagnosis', '*Obesity/complications/epidemiology/genetics/metabolism/therapy', 'Risk Factors', 'Weight Loss']",,,,,2010/12/15 06:00,2011/04/13 06:00,['2010/12/15 06:00'],"['2010/12/15 06:00 [entrez]', '2010/12/15 06:00 [pubmed]', '2011/04/13 06:00 [medline]']","['ijo2010235 [pii]', '10.1038/ijo.2010.235 [doi]']",ppublish,Int J Obes (Lond). 2010 Dec;34 Suppl 2:S18-23. doi: 10.1038/ijo.2010.235.,,,,,,,,['Int J Obes (Lond). 2012 Jan;36(1):164; author reply 165. PMID: 21407170'],,,,,,,,,,,,
24951979,NLM,MEDLINE,20151022,20140622,1699-5198 (Electronic) 0212-1611 (Linking),29,5,2014 May 1,Super obese behave different from simple and morbid obese patients in the changes of body composition after tailored one anastomosis gastric bypass (BAGUA).,1013-9,10.3305/nh.2014.29.5.7334 [doi],"INTRODUCTION: Super obese patients behave different from simple and morbid obese patients when they reach final changes of body composition (BC) after bariatric surgery. This has led us to tailor One Anastomosis Gastric Bypass (BAGUA) to achieve better results in this group of patients. PATIENTS AND METHODS: We studied 83 (37 diabetic and 46 nondiabetic BMI 30 and up) patients who completed all evaluation appointment (preoperative, 10 days, 1, 3, 6 and 12 months) after tailored BAGUA for diabesity. We used the Tanita body composition analyzer BC-420 MA by the method of single frequency impedance to analyze the evolution of BC in patients classified by BMI 30 - 34,9, 35 - 50, and >50. RESULTS: While preoperative excess weight presented dramatic decreases after tailored BAGUA in all the groups, super obese have different final BC. Diabetics retained more fat mass and visceral fat, where super obese have double (14 kg) that simple obese patients (6 kg), they lost more muscle mass, and have higher basal metabolism. The final BC is altered in all parameters if diabetes is added. CONCLUSIONS: The reduction of the preoperative excess weight is motivated largely by the tailored effect of BAGUA. Patients BMI 30-50 behaved homogeneous in BC after surgery while patients BMI >50 behave different. Super obese lose less weight, retained more fat mass, visceral fat, bone mass, and total water. This effect should be treated by more aggressive surgery by measuring the entire small intestine to make a proper exclusion (tailored) to achieve homogeneous effects.","['Garcia-Caballero, M', 'Reyes-Ortiz, A', 'Garcia, M', 'Martinez-Moreno, J M', 'Toval-Mata, J-A-']","['Garcia-Caballero M', 'Reyes-Ortiz A', 'Garcia M', 'Martinez-Moreno JM', 'Toval-Mata JA']","['Dept. of Surgery University Malaga, Spain.. gcaballe@uma.es.', 'Dept. of Surgery University Malaga, Spain.. alexxanderhola@yahoo.com.mx.', 'Dept. of Surgery University Malaga, Spain.. manugarciasillero@gmail.com.', 'Dept. of Surgery University Malaga, Spain. Autonomous University of the State of Mexico (UAEMex). U.M.F. 229, Del. 16. Mexican Social Security Institute. Mexico.. jmmartinezm@uma.es.', 'Dept. of Surgery University Malaga, Spain.. josetoval@telefonica.net.']",['eng'],['Journal Article'],Spain,Nutr Hosp,Nutricion hospitalaria,9100365,,IM,"['*Body Composition', 'Diabetes Complications', 'Follow-Up Studies', 'Gastric Bypass/*psychology', 'Humans', 'Obesity/*psychology/*surgery', 'Obesity, Morbid/*psychology/*surgery', 'Treatment Outcome']",,,,,2014/06/22 06:00,2015/10/23 06:00,['2014/06/22 06:00'],"['2014/06/22 06:00 [entrez]', '2014/06/22 06:00 [pubmed]', '2015/10/23 06:00 [medline]']",['10.3305/nh.2014.29.5.7334 [doi]'],epublish,Nutr Hosp. 2014 May 1;29(5):1013-9. doi: 10.3305/nh.2014.29.5.7334.,,20140501,,"['Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights', 'reserved.']",,,,,,,,,,,,,,,,
2091855,NLM,MEDLINE,19910607,20191210,0379-8577 (Print) 0379-8577 (Linking),13,3-4,1990 Dec,[A self-development program for obese female students].,30-2,,"The purpose of this study is to construct and evaluate a self-development programme for obese female students. The important role of psychological factors in the etiology of obesity, affects self-development in the client through methods of growth stimulation, and will promote ego strength to assist in the demands of mass control. A self-development programme is constructed and applied to a group of obese female students. The experimental design comprised a pre, post and post-post evaluation with physical and psychological measuring instruments on an experimental and a control group. No significant changes in body mass occurred. Psychologically the programme promoted self-actualisation in terms of (intrapersonally) increased spontaneity, self-regard, confidence, worthiness and decreased nervousness, and (interpersonally) increased general social adaptation and the capacity for intimate, personal contact. It is recommended that the stimulation of psychological growth be stressed even more in mass control programmes. Also, the contents of this type of programme should be investigated to promote behaviour change over a longer period of time.","['Oelofse, L', 'Cilliers, F', 'Poggenpoel, M']","['Oelofse L', 'Cilliers F', 'Poggenpoel M']",,['afr'],['Journal Article'],South Africa,Curationis,Curationis,7901092,,,"['Adolescent', 'Female', 'Humans', 'Obesity/etiology/*prevention & control/psychology', 'Program Evaluation', 'Programmed Instructions as Topic/*standards', 'Students, Nursing/*psychology']",,,,,1990/12/01 00:00,1990/12/01 00:01,['1990/12/01 00:00'],"['1990/12/01 00:00 [pubmed]', '1990/12/01 00:01 [medline]', '1990/12/01 00:00 [entrez]']",,ppublish,Curationis. 1990 Dec;13(3-4):30-2.,,,,,,,,,'N selfontwikkelings-program vir obese damestudente.,,,,,,,,,,,
8685025,NLM,MEDLINE,19960819,20161123,0391-5387 (Print) 0391-5387 (Linking),18,1,1996 Jan-Feb,[Liver damage and obesity in pediatric age].,57-9,,"In adult obese patients both an increase of aminotranspherase values and hepatic steatosis have been frequently showed. Conversely in childhood the existence of a liver's damage is often not investigated. To assess the prevalence of hepatic alterations in obese children, we studied 135 subjects, all affected by simple obesity, showing in a 20% of them the presence of ultrasonographic evidence of hepatic steatosis and/or hyperaminotransferasemia. Our study demonstrates the existence of silent hepatic alterations also in obese children and suggests to improve the treatment of obesity in childhood to prevent the progression of liver's damage.","['Iughetti, L', 'Bacchini, E', 'Dodi, I', 'Bianchi, A', 'Caselli, G', 'Cozzini, A', 'Ottaviani, A', 'Bernasconi, S']","['Iughetti L', 'Bacchini E', 'Dodi I', 'Bianchi A', 'Caselli G', 'Cozzini A', 'Ottaviani A', 'Bernasconi S']","['Divisione di Pediatria, Azienda U.S.L. di Parma, Italia.']",['ita'],['Journal Article'],Italy,Pediatr Med Chir,La Pediatria medica e chirurgica : Medical and surgical pediatrics,8100625,['EC 2.6.1.- (Transaminases)'],IM,"['Adolescent', 'Age Factors', 'Child', 'Child, Preschool', 'Fatty Liver/diagnostic imaging/enzymology/*etiology', 'Female', 'Humans', 'Liver Diseases/diagnostic imaging/enzymology/*etiology', 'Male', 'Obesity/*complications/diagnostic imaging/enzymology/therapy', 'Obesity, Morbid/*complications/diagnostic imaging/enzymology/therapy', 'Transaminases/*analysis', 'Ultrasonography']",,,,,1996/01/01 00:00,1996/01/01 00:01,['1996/01/01 00:00'],"['1996/01/01 00:00 [pubmed]', '1996/01/01 00:01 [medline]', '1996/01/01 00:00 [entrez]']",,ppublish,Pediatr Med Chir. 1996 Jan-Feb;18(1):57-9.,,,,,,,,,Alterazioni epatiche e obesita in eta pediatrica.,,,,,,,,,,,
2741716,NLM,MEDLINE,19890809,20091109,0375-8338 (Print) 0375-8338 (Linking),43,2,1989,[Android and gynecoid types of obesity as factors in the onset of certain related diseases].,95-102,,"The prevalence of some diseases was studied in 238 android and 720 gynoid obese women and 180 android obese men with the aim to establish the relationship between the type of obesity and relevant diseases. In the selected group of obese patients (25 android and 90 gynoid obese women and 26 android obese men) fed on a reducing diet (1000 kcal--4.2 M.J.) 67 women were engaged in intensified physical activity during the 90 days of dieting. The relationship between the weight loss and the type of obesity as well as the relationship between the weight loss in women engaged in intensified physical activity and those abstaining from it was investigated. The investigation has shown that the prevalence of hypertension, coronary heart disease and diabetes was much higher in men and women affected by the android type of obesity than in women affected by the gynoid type of obesity. The prevalence of gallbladder's as well as venous system diseases and spondylosis in women affected by both types of obesity was much higher than in android obese men, but the prevalence of constipation was higher in gynoid obese women. From data relating to response to reducing diet it is concluded that the weight loss was equal among the women affected by the android and gynoid types of obesity, but the weight loss in android and gynoid obese women engaged in intensified physical activity was significantly higher than in those abstaining from it.2+herefore, for the prevention and","['Simic, B S', 'Jorga, J', 'Dimitrijevic, D', 'Gec, M P', 'Rsumovic, S', 'Neradovic-Mladenovski, L']","['Simic BS', 'Jorga J', 'Dimitrijevic D', 'Gec MP', 'Rsumovic S', 'Neradovic-Mladenovski L']",,['hrv'],"['English Abstract', 'Journal Article']",Croatia,Acta Med Iugosl,Acta medica Iugoslavica,0370324,,IM,"['Adult', 'Anthropometry', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications/pathology']",,,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Acta Med Iugosl. 1989;43(2):95-102.,,,,,,,,,Androidni i ginoidni tip gojaznosti kao faktor u nastajanju nekih relevantnih bolesti.,,,,,,,,,,,
10932678,NLM,MEDLINE,20000821,20191104,1532-1908 (Print),13,1,1999 Apr,Behavioural treatment of the overweight patient.,93-107,,"The goal of obesity treatment has changed significantly in the past decade. Where once the goal was a reduction to ideal weight, the current objective is the achievement of a healthier weight. For many obese individuals, this means losing as little as 5-15% of their initial weight. This article briefly describes behavioural methods to help obese individuals modify their eating and activity habits in order to achieve these new goals. A review of recent studies shows that patients treated by a comprehensive group behavioural programme lose approximately 9% of their initial weight in 20 weeks and, without further treatment, maintain a loss of 5% 1 year later. Methods of improving the maintenance of weight loss include increasing physical activity, extending the length of behavioural treatment and, with appropriately selected individuals, combining behavioural and pharmacological interventions. The importance of helping obese individuals adopt realistic treatment expectations is also discussed.","['Wadden, T A', 'Sarwer, D B', 'Berkowitz, R I']","['Wadden TA', 'Sarwer DB', 'Berkowitz RI']","['Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, USA.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S."", 'Review']",England,Baillieres Best Pract Res Clin Endocrinol Metab,Bailliere's best practice & research. Clinical endocrinology & metabolism,100957144,['0 (Anti-Obesity Agents)'],IM,"['Anti-Obesity Agents/therapeutic use', 'Behavior Therapy/*methods', 'Diet, Reducing', 'Energy Intake', 'Exercise', 'Female', 'Humans', 'Obesity/drug therapy/psychology/*therapy']",,,,,2000/08/10 11:00,2000/08/29 11:01,['2000/08/10 11:00'],"['2000/08/10 11:00 [pubmed]', '2000/08/29 11:01 [medline]', '2000/08/10 11:00 [entrez]']",['10.1053/beem.1999.0008 [doi]'],ppublish,Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Apr;13(1):93-107. doi: 10.1053/beem.1999.0008.,['DK50058-04/DK/NIDDK NIH HHS/United States'],,,,,,67,,,,,,,,,,,,,
35710094,NLM,MEDLINE,20221115,20230317,2666-335X (Electronic) 2666-335X (Linking),3,4,2022 Nov,Obesity-induced follicular phase endometrial proteome dysregulation in a well-phenotyped population.,367-375,S2666-335X(22)00043-X [pii] 10.1016/j.xfss.2022.06.002 [doi],"OBJECTIVE: Despite obesity's significant impact on reproduction, its influence on the physiology of the human endometrium is largely understudied. We hypothesized that endometrial proteomic differences exist between obese (OW; body mass index [BMI] >/=30 kg/m(2)) and normal-weight women (NWW; BMI, 18.5-24.9 kg/m(2)). DESIGN: Clinical cross-sectional study. SETTING: Academic Medical Center. PATIENT(S): Healthy, normally-cycling, 18 to 40-year-old women (n = 6 OW and n = 6 NWW). MAIN OUTCOME MEASURE(S): Participants underwent screening and midfollicular phase visits. Demographic and anthropometric characteristics, blood samples, ultrasounds, and follicular phase endometrial biopsies were collected. Proteomic analyses of endometrial samples (liquid chromatography-mass spectrometry) were performed. Proteins with >/=2-fold difference and a false discovery rate of <0.1 were considered statistically significant (Benjamini-Hochberg adjustment). RESULT(S): Reproductive hormone levels did not differ between the two groups. Mean BMI, serum leptin concentration, and bioelectrical impedance analysis indices of adiposity were higher in OW than in NWW. Histological examination of the endometrial samples confirmed normal-appearing endometrium in both OW and NWW. A total of 2,930 proteins were detected across all samples, with an average number of proteins per sample of 2,059 +/- 482 in NWW and 2,437 +/- 187 in OW. A total of 17 proteins were differentially expressed in OW vs. NWW; 2 were more abundant, whereas 15 were underexpressed in OW, including the progesterone receptor. CONCLUSION(S): In this well-phenotyped population of healthy women, obesity was associated with significant endometrial proliferative phase proteomic differences affecting the hormonal and immunologic pathways. These could contribute to an increased risk of menstrual bleeding abnormalities and create an altered environment for future luteinization.","['Giuliani, Emma', 'Schon, Samantha B', 'Yang, Kun', 'Burns, Gregory W', 'Neff, Lisa M', 'Remmer, Henriette A', 'Teixeira, Jose M', 'Marsh, Erica E']","['Giuliani E', 'Schon SB', 'Yang K', 'Burns GW', 'Neff LM', 'Remmer HA', 'Teixeira JM', 'Marsh EE']","['Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.', 'Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.', 'Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan.', 'Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.', 'Chicago, Illinois.', 'Biomedical Research Core Facilities, University of Michigan, Ann Arbor, Michigan.', 'Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, Michigan.', 'Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, University of Michigan, Ann Arbor, Michigan. Electronic address: marshee@med.umich.edu.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",United States,F S Sci,F&S science,101765857,['0 (Proteome)'],IM,"['Female', 'Humans', 'Adolescent', 'Young Adult', 'Adult', '*Proteome/metabolism', '*Follicular Phase', 'Proteomics', 'Cross-Sectional Studies', 'Endometrium/metabolism', 'Obesity/metabolism']",,['NOTNLM'],"['Obesity', 'endometrium', 'leptin', 'progesterone', 'proliferative phase', 'proteome']",,2022/06/17 06:00,2022/11/16 06:00,['2022/06/16 19:35'],"['2022/03/01 00:00 [received]', '2022/05/24 00:00 [revised]', '2022/06/07 00:00 [accepted]', '2022/06/17 06:00 [pubmed]', '2022/11/16 06:00 [medline]', '2022/06/16 19:35 [entrez]']","['S2666-335X(22)00043-X [pii]', '10.1016/j.xfss.2022.06.002 [doi]']",ppublish,F S Sci. 2022 Nov;3(4):367-375. doi: 10.1016/j.xfss.2022.06.002. Epub 2022 Jun 13.,,20220613,,['Copyright (c) 2022. Published by Elsevier Inc.'],,,,,,,,,,,,,,,,
21508764,NLM,MEDLINE,20130708,20210107,1873-233X (Electronic) 0029-7844 (Linking),117,5,2011 May,Global obesity and the effect on women's health.,1213-1222,10.1097/AOG.0b013e3182161732 [doi],The rates of obesity are increasing in all areas of the world. The pattern of diseases in many areas of the world is shifting rapidly to diseases that are chronic and noncommunicable. These changes are occurring so rapidly that existing health care infrastructure in many parts of the world are likely to be stressed. Many aspects of women's health will be worsened as they become more obese. Coordinated efforts to reverse the obesity trend are being made and individuals and teams working within women's health globally should coordinate with existing efforts to provide data and consistent messages.,"['Chescheir, Nancy C']",['Chescheir NC'],"['From the University of North Carolina, Department of Obstetrics and Gynecology, Chapel Hill, North Carolina.']",['eng'],['Journal Article'],United States,Obstet Gynecol,Obstetrics and gynecology,0401101,,IM,"['Contraception', 'Cost of Illness', 'Female', '*Global Health', 'Humans', '*Obesity/complications/economics/epidemiology/therapy', ""*Women's Health"", ""Women's Health Services""]",,,,,2011/04/22 06:00,2013/07/09 06:00,['2011/04/22 06:00'],"['2011/04/22 06:00 [entrez]', '2011/04/22 06:00 [pubmed]', '2013/07/09 06:00 [medline]']","['00006250-201105000-00028 [pii]', '10.1097/AOG.0b013e3182161732 [doi]']",ppublish,Obstet Gynecol. 2011 May;117(5):1213-1222. doi: 10.1097/AOG.0b013e3182161732.,,,,,,,,,,,,,,,,,,,,
9581417,NLM,MEDLINE,19980602,20041117,0882-5963 (Print) 0882-5963 (Linking),13,2,1998 Apr,Prevalence and correlates of obesity in preschool children.,68-76,,"Obesity, a common nutritional disorder in childhood, is a complex problem that is poorly understood. The purpose of this study was to identify the prevalence of obesity in preschool children, and to examine the relationships between obesity and gender, race, socioeconomic status, and health problems. Data were collected from 309 charts of children enrolled in a Head Start program. Ninety-nine (32%) of the children were obese. Obese children had significantly higher blood pressure readings than those who were not obese. This study represents a beginning effort to learn more about the prevalence of, and factors associated with, obesity in preschoolers.","['Hernandez, B', 'Uphold, C R', 'Graham, M V', 'Singer, L']","['Hernandez B', 'Uphold CR', 'Graham MV', 'Singer L']","['University of Florida, College of Medicine, Department of Community Health and Family Medicine, College of Nursing, Gainesville, USA.']",['eng'],['Journal Article'],United States,J Pediatr Nurs,Journal of pediatric nursing,8607529,,IM,"['Age Distribution', 'Child, Preschool', 'Female', 'Florida/epidemiology', 'Humans', 'Hypertension/*etiology', 'Male', 'Obesity/*complications/*epidemiology/ethnology/nursing', 'Prevalence', 'Retrospective Studies', 'Sex Distribution', 'Socioeconomic Factors']",,,,,1998/05/15 00:00,1998/05/15 00:01,['1998/05/15 00:00'],"['1998/05/15 00:00 [pubmed]', '1998/05/15 00:01 [medline]', '1998/05/15 00:00 [entrez]']","['S0882-5963(98)80033-X [pii]', '10.1016/S0882-5963(98)80033-X [doi]']",ppublish,J Pediatr Nurs. 1998 Apr;13(2):68-76. doi: 10.1016/S0882-5963(98)80033-X.,,,,,,,,,,,,,,,,,,,,
3920570,NLM,MEDLINE,19850516,20171206,0026-4075 (Print) 0026-4075 (Linking),150,3,1985 Mar,The assessment of improved physiologic function with a short term exercise program in mildly to moderately obese people.,135-7,,,"['South-Paul, J E', 'Tenholder, M F']","['South-Paul JE', 'Tenholder MF']",,['eng'],"['Comparative Study', 'Journal Article']",England,Mil Med,Military medicine,2984771R,,IM,"['Adult', 'Diet, Reducing', 'Female', '*Hemodynamics', 'Humans', 'Male', 'Obesity/diagnosis/physiopathology/*therapy', '*Physical Exertion', 'Physical Fitness']",,,,,1985/03/01 00:00,1985/03/01 00:01,['1985/03/01 00:00'],"['1985/03/01 00:00 [pubmed]', '1985/03/01 00:01 [medline]', '1985/03/01 00:00 [entrez]']",,ppublish,Mil Med. 1985 Mar;150(3):135-7.,,,,,,,,,,,,,,,,,,,,
17985031,NLM,MEDLINE,20080501,20211020,1995-1892 (Print) 1680-0745 (Electronic) 1015-9657 (Linking),18,5,2007 Sep-Oct,"Survey of abdominal obesities in an adult urban population of Kinshasa, Democratic Republic of Congo.",300-7,,"BACKGROUND: The prevalence of overweight/obesity, which is an important cardiovascular risk factor, is rapidly increasing worldwide. Abdominal obesity, a fundamental component of the metabolic syndrome, is not defined by appropriate cutoff points for sub-Saharan Africa. OBJECTIVE: To provide baseline and reference data on the anthropometry/body composition and the prevalence rates of obesity types and levels in the adult urban population of Kinshasa, DRC, Central Africa. METHODS: During this cross-sectional study carried out within a random sample of adults in Kinshasa town, body mass index, waist circumference and fatty mass were measured using standard methods. Their reference and local thresholds (cut-off points) were compared with those of WHO, NCEP and IFD to define the types and levels of obesity in the population. RESULTS: From this sample of 11 511 subjects (5 676 men and 5 835 women), the men presented with similar body mass index and fatty mass values to those of the women, but higher waist measurements. The international thresholds overestimated the prevalence of denutrition, but underscored that of general and abdominal obesity. The two types of obesity were more prevalent among women than men when using both international and local thresholds. Body mass index was negatively associated with age; but abdominal obesity was more frequent before 20 years of age and between 40 and 60 years old. Local thresholds of body mass index ( > or = 23, > or = 27 and > or = 30 kg/m(2)) and waist measurement ( > or = 80, > or = 90 and > or = 94 cm) defined epidemic rates of overweight/general obesity (52%) and abdominal obesity (40.9%). The threshold of waist circumference > or = 94 cm (90th percentile) corresponding to the threshold of the body mass index > or = 30 kg/m(2) (90th percentile) was proposed as the specific threshold of definition of the metabolic syndrome, without reference to gender, for the cities of sub-Saharan Africa. CONCLUSION: Further studies are required to define the optimal threshold of waist circumference in rural settings. The present local cut-off points of body mass index and waist circumference could be appropriate for the identification of Africans at risk of obesity-related disorders, and indicate the need to implement interventions to reverse increasing levels of obesity.","[""Kasiam Lasi On'kin, J B"", 'Longo-Mbenza, B', 'Nge Okwe, A', 'Kangola Kabangu, N']","[""Kasiam Lasi On'kin JB"", 'Longo-Mbenza B', 'Nge Okwe A', 'Kangola Kabangu N']","['Department of Internal Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo.']",['eng'],['Journal Article'],South Africa,Cardiovasc J Afr,Cardiovascular journal of Africa,101313864,,IM,"['Abdominal Fat/*pathology', 'Adult', 'Body Composition', 'Body Mass Index', 'Cross-Sectional Studies', 'Democratic Republic of the Congo/epidemiology', 'Female', 'Health Surveys', 'Humans', 'Male', 'Middle Aged', 'Nutritional Status', 'Obesity/*epidemiology/pathology/physiopathology', 'Prevalence', 'Urban Health/*statistics & numerical data']",PMC3975547,,,,2007/11/07 09:00,2008/05/02 09:00,['2007/11/07 09:00'],"['2007/11/07 09:00 [pubmed]', '2008/05/02 09:00 [medline]', '2007/11/07 09:00 [entrez]']",,ppublish,Cardiovasc J Afr. 2007 Sep-Oct;18(5):300-7.,,,,,,,,,,,,,,,,,,,,
11720637,NLM,MEDLINE,20011214,20041117,1521-737X (Print) 1521-737X (Linking),1,5,1999 Nov-Dec,New perspectives on diagnosis and treatment of obesity.,295-304,,"The alarming increase in the prevalence of obesity in the past decade, as demonstrated by ongoing systematic population-based studies, and increased recognition of the adverse health consequences associated with excess body weight have generated widespread interest in the management of obesity. After an extensive review, the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health issued a consensus statement with comprehensive clinical treatment guidelines in 1998 that is relevant to cardiologists as well as primary care physicians. A new focus on obesity research has advanced our understanding of the complexity of this disorder and provided new molecular targets for intervention, including beta(3)-adrenergic receptor agonists, leptin analogues, and uncoupling proteins (UCPs) that stimulate energy expenditure. Two newly available pharmacotherapeutic agents approved by the United States Food and Drug Administration (FDA) and increasing acceptance of bariatric surgery for specific categories of obese patients have expanded current therapeutic options for the management of obesity. Nonetheless, the cornerstone of lifetime weight regulation and the prevention and treatment of obesity inevitably will remain lifestyle modification and long-term vigilance.","['Mogul, H R', 'Rau, J', 'Weinstein, B I', 'Zhang, S', 'Peterson, S J']","['Mogul HR', 'Rau J', 'Weinstein BI', 'Zhang S', 'Peterson SJ']","['Division of Endocrinology, Department of Medicine, New York Medical College, Valhalla, New York 10595, USA.']",['eng'],['Journal Article'],United States,Heart Dis,"Heart disease (Hagerstown, Md.)",100887299,,IM,"['Humans', 'Life Style', 'Obesity/*diagnosis/diet therapy/drug therapy/*therapy']",,,,,2001/11/27 10:00,2002/01/05 10:01,['2001/11/27 10:00'],"['2001/11/27 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/11/27 10:00 [entrez]']",,ppublish,Heart Dis. 1999 Nov-Dec;1(5):295-304.,,,,,,,,,,,,,,,,,,,,
7251874,NLM,MEDLINE,19810915,20081121,0196-206X (Print) 0196-206X (Linking),1,1,1980 Mar,Obesity in children and adolescents.,43-7,,"The literature regarding etiology and consequences of childhood and juvenile obesity is briefly surveyed with special reference to recent trends in behavioral research. Major emphasis is focused on issues of differential diagnosis, and treatment. The objective is to offer a logical and coherent plan for approaching and managing obesity in childhood and adolescence. The importance of an awareness and understanding of both the patient's and therapist's attitudes toward the problem of obesity is addressed. Furthermore, the necessity for a cooperative approach, utilizing nonmedical professionals, in developing a coordinated treatment plan for obese young people is discussed.","['Turner, T J']",['Turner TJ'],,['eng'],['Journal Article'],United States,J Dev Behav Pediatr,Journal of developmental and behavioral pediatrics : JDBP,8006933,,IM,"['Adipose Tissue/physiopathology', 'Adolescent', 'Child', 'Feeding Behavior', 'Humans', 'Obesity/*diagnosis/psychology/therapy', 'Physical Exertion']",,,,,1980/03/01 00:00,1980/03/01 00:01,['1980/03/01 00:00'],"['1980/03/01 00:00 [pubmed]', '1980/03/01 00:01 [medline]', '1980/03/01 00:00 [entrez]']",,ppublish,J Dev Behav Pediatr. 1980 Mar;1(1):43-7.,,,,,,,,,,,,,,,,,,,,
9083722,NLM,MEDLINE,19970603,20051116,0098-8243 (Print) 0098-8243 (Linking),23,2,1997 Feb,Office management of the adult obese patient.,116-23,,,"['Kushner, R F']",['Kushner RF'],"['Clinical Nutrition Research Unit, University of Chicago, IL 60637, USA.']",['eng'],"['Journal Article', 'Review']",United States,Compr Ther,Comprehensive therapy,7605837,['0 (Anti-Obesity Agents)'],IM,"['Adult', 'Anti-Obesity Agents/administration & dosage', 'Body Mass Index', 'Humans', 'Obesity/classification/complications/*therapy', 'Office Visits']",,,,,1997/02/01 00:00,1997/02/01 00:01,['1997/02/01 00:00'],"['1997/02/01 00:00 [pubmed]', '1997/02/01 00:01 [medline]', '1997/02/01 00:00 [entrez]']",,ppublish,Compr Ther. 1997 Feb;23(2):116-23.,,,,,,,27,,,,,,,,,,,,,
23948004,NLM,MEDLINE,20131112,20221207,1541-0048 (Electronic) 0090-0036 (Print) 0090-0036 (Linking),103,10,2013 Oct,The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates.,1895-901,10.2105/AJPH.2013.301379 [doi],"OBJECTIVES: To estimate the percentage of excess death for US Black and White men and women associated with high body mass, we examined the combined effects of age variation in the obesity-mortality relationship and cohort variation in age-specific obesity prevalence. METHODS: We examined 19 National Health Interview Survey waves linked to individual National Death Index mortality records, 1986-2006, for age and cohort patterns in the population-level association between obesity and US adult mortality. RESULTS: The estimated percentage of adult deaths between 1986 and 2006 associated with overweight and obesity was 5.0% and 15.6% for Black and White men, and 26.8% and 21.7% for Black and White women, respectively. We found a substantially stronger association than previous research between obesity and mortality risk at older ages, and an increasing percentage of mortality attributable to obesity across birth cohorts. CONCLUSIONS: Previous research has likely underestimated obesity's impact on US mortality. Methods attentive to cohort variation in obesity prevalence and age variation in obesity's effect on mortality risk suggest that obesity significantly shapes US mortality levels, placing it at the forefront of concern for public health action.","['Masters, Ryan K', 'Reither, Eric N', 'Powers, Daniel A', 'Yang, Y Claire', 'Burger, Andrew E', 'Link, Bruce G']","['Masters RK', 'Reither EN', 'Powers DA', 'Yang YC', 'Burger AE', 'Link BG']","['At the time of the study, Ryan K. Masters was with Robert Wood Johnson Foundation Health and Society Scholars Program, Columbia University, New York, NY. Eric N. Reither and Andrew E. Burger were with Department of Sociology, Social Work, and Anthropology, Utah State University, Logan. Daniel A. Powers was with Department of Sociology, University of Texas at Austin. Y. Claire Yang was with Department of Sociology and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill. Bruce G. Link was with Department of Epidemiology and Department of Sociomedical Sciences, Columbia University.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Am J Public Health,American journal of public health,1254074,,IM,"['Adult', 'Black or African American', 'Age Factors', 'Aged', 'Aged, 80 and over', 'Body Mass Index', 'Cohort Studies', 'Confidence Intervals', 'Female', 'Health Surveys', 'Humans', 'Male', 'Middle Aged', 'Mortality/trends', 'Obesity/epidemiology/*mortality', 'Proportional Hazards Models', 'United States/epidemiology', 'White People']",PMC3780738,,,,2013/08/21 06:00,2013/11/13 06:00,['2013/08/17 06:00'],"['2013/08/17 06:00 [entrez]', '2013/08/21 06:00 [pubmed]', '2013/11/13 06:00 [medline]']","['301379 [pii]', '10.2105/AJPH.2013.301379 [doi]']",ppublish,Am J Public Health. 2013 Oct;103(10):1895-901. doi: 10.2105/AJPH.2013.301379. Epub 2013 Aug 15.,"['K01 AG036745/AG/NIA NIH HHS/United States', 'P50 CA058223/CA/NCI NIH HHS/United States', 'R24 HD050924/HD/NICHD NIH HHS/United States']",20130815,['Am J Public Health. 2016 Jul;106(7):e15. PMID: 27285268'],,,['NIHMS554429'],,"['Am J Public Health. 2014 Apr;104(4):e3-4. PMID: 24524495', 'Am J Public Health. 2014 Apr;104(4):e3. PMID: 24524498', 'Am J Public Health. 2014 Apr;104(4):e5-6. PMID: 24524518', 'Am J Public Health. 2014 Jul;104(7):e3-4. PMID: 24832412', 'Am J Public Health. 2017 Apr;107(4):505-506. PMID: 28272945', 'Am J Public Health. 2017 Apr;107(4):503-505. PMID: 28272961', 'Am J Public Health. 2017 Apr;107(4):502. PMID: 28272963', 'Am J Epidemiol. 2017 Mar 15;185(6):409-411. PMID: 28399572', 'Am J Epidemiol. 2017 Mar 15;185(6):407-408. PMID: 28399573', 'Am J Epidemiol. 2017 Mar 15;185(6):412-413. PMID: 28399574']",,,,,,,,,,,,
8003389,NLM,MEDLINE,19940720,20051116,0393-9340 (Print) 0393-9340 (Linking),9,1,1994 Jan-Mar,Obesity and cardiovascular diseases.,27-31,,"Obesity and overweight have great clinical and social significance and are associated with a number of medical and surgical complications. We attempt here to summarize current knowledge on the subject and describe the research we are presently carrying out in this field. After a brief introduction, definition, and discussion of etiopathogenesis, the indexes of ponderal excess and epidemiology are illustrated. The cardiovascular adjustments and the relationships between obesity and hypertension, ischemic heart disease and congestive heart failure are then treated. One aim of our investigation was to study the modifications of an entire set of biological and clinical parameters which could concretely formulate and/or identify some pathophysiological links between obesity and heart disease. We thus studied obese subjects with hypertension, diabetes and multiple cardiovascular risk factors. We also studied a group of asymptomatic obese subjects, whom we define as ""the healthy obese"". Our results, supported by the medical literature, led to the conclusion that obesity is an important and/or independent cardiovascular risk factor. We think, however, that it would be prudent to await for the results of interventional trials and follow-up studies involving a large number of young, healthy obese subjects in order to monitor the most important biological variables over the long term.","['Licata, G', 'Corrao, S', 'Parrinello, G', 'Scaglione, R']","['Licata G', 'Corrao S', 'Parrinello G', 'Scaglione R']","['Cattedra di Patologia Medica I, Universita degli Studi di Palermo.']",['eng'],"['Journal Article', 'Review']",Italy,Ann Ital Med Int,Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna,8806705,,IM,"['Adult', 'Body Weight', 'Cardiovascular Diseases/epidemiology/*etiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications/epidemiology/etiology', 'Risk Factors']",,,,,1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",,ppublish,Ann Ital Med Int. 1994 Jan-Mar;9(1):27-31.,,,,,,,38,,,,,,,,,,,,,
26467348,NLM,MEDLINE,20160921,20220129,1365-2702 (Electronic) 0962-1067 (Linking),24,23-24,2015 Dec,A qualitative study to explore the attitude of clinical staff to the challenges of caring for obese patients.,3594-604,10.1111/jocn.13016 [doi],"AIMS AND OBJECTIVES: To examine, from the perspective of staff, if obese patients have any additional care needs, and what the impact of these care requirements are on care provision. We have selected obese patients with venous leg ulceration as an example patient population to explore these questions. BACKGROUND: Anecdotal evidence indicates obesity can increase care requirements and have implications for obesity for care provision. However, little research exists nationally or internationally that provides evidence from a health care perspective. Obesity is a contributory causative factor of lower limb ulceration. In addition to affecting the development of venous leg ulceration, obesity may also impact on the care an obese patient may require and receive. DESIGN: Qualitative study using semi-structured in interviews and framework analysis. METHODS: Interviews were conducted with 18 health care professionals and one focus group with 12 health care professionals who cared for patients with venous ulceration. Data were analysed to identify recurring themes relating to the impact of obesity on care provision. RESULTS: This study found that the increasing numbers of obese patients with leg ulcers are currently presenting challenges to care delivery in many different ways. There was an impact of obesity on patient experience in terms of dignity, safety and quality. Data indicated that neither hospital nor community care services were adequately set up to meet the needs of obese patients in general. CONCLUSION: Health care providers need to recognise that increasing numbers of overweight and obese patients are presenting challenges to care delivery. The study also indicated the need for senior strategic leadership in planning for meeting the needs of obese patients. RELEVANCE TO CLINICAL PRACTICE: Nursing is well placed to provide specialist support to co-ordinate services for obese/oversize patients if a suitable strategic and leadership role is developed. Nurses are used to offering patients help in areas of health promotion such as smoking cessation. Lessons learnt from this area could be applied to help and encourage staff to support patients with weight management.","['Lumley, Elizabeth', 'Homer, Catherine V', 'Palfreyman, Simon', 'Shackley, Phil', 'Tod, Angela Mary']","['Lumley E', 'Homer CV', 'Palfreyman S', 'Shackley P', 'Tod AM']","['Sheffield Teaching Hospitals Foundation Trust, NIHR CLAHRC-SYH, D-Floor Royal Hallamshire Hospital, Sheffield, UK.', 'Centre for Health and Social Care Research, Sheffield Hallam University, Sheffield, UK.', 'School of Health and Related Research, University of Sheffield, Sheffield, UK.', 'School of Health and Related Research, University of Sheffield, Sheffield, UK.', 'Centre for Health and Social Care Research, Sheffield Hallam University, Sheffield, UK.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,J Clin Nurs,Journal of clinical nursing,9207302,,,"['*Attitude of Health Personnel', 'Empathy', 'Focus Groups', 'Humans', 'Obesity/complications/psychology/*therapy', 'Qualitative Research', 'Varicose Ulcer/etiology/psychology/*therapy']",,['NOTNLM'],"['impact on care', 'leg ulcer', 'nursing', 'obesity', 'overweight', 'qualitative research.', 'venous leg ulcers']",,2015/10/16 06:00,2016/09/23 06:00,['2015/10/16 06:00'],"['2015/08/06 00:00 [accepted]', '2015/10/16 06:00 [entrez]', '2015/10/16 06:00 [pubmed]', '2016/09/23 06:00 [medline]']",['10.1111/jocn.13016 [doi]'],ppublish,J Clin Nurs. 2015 Dec;24(23-24):3594-604. doi: 10.1111/jocn.13016. Epub 2015 Oct 14.,['CAT/CL10/006/DH_/Department of Health/United Kingdom'],20151014,,['(c) 2015 John Wiley & Sons Ltd.'],,,,,,,,,,,,,,,,
15383644,NLM,MEDLINE,20050201,20151119,1060-0280 (Print) 1060-0280 (Linking),38,11,2004 Nov,Combating the obesity epidemic: community pharmacists' counseling on obesity management.,1800-4,,"BACKGROUND: Obesity is reaching an epidemic proportion in the US. Nearly two-thirds (64.7%) of US adults are overweight or obese. Given the myriad of issues related to the management of obesity, community pharmacists can facilitate weight loss among their patients. OBJECTIVE: To identify factors that influence the frequency of counseling obese patients by community pharmacists. METHODS: A mail survey was sent to a random sample of 400 Texas community pharmacists. The questionnaire collected information on frequency of counseling obese patients, perceived comfort level with counseling obese patients, perceived effectiveness of various obesity treatments, and perceived confidence in achieving positive outcomes as a result of counseling. Demographic information was also collected. Descriptive statistics, correlational analyses, and t-tests were used to examine the data. RESULTS: A usable response rate of 35.2% was obtained (139 completed surveys out of 395 assumed delivered). Overall, pharmacists counseled patients rarely to sometimes about various aspects of obesity management. Correlational analyses revealed that pharmacists' frequency of counseling about obesity management was significantly and positively associated with their comfort level with counseling obese patients (r = 0.47; p < 0.001). Higher levels of confidence in achieving positive outcomes as a result of counseling (r = 0.39; p < 0.001) and higher levels of perceived effectiveness of obesity management options (r = 0.18; p = 0.037) were also significantly associated with higher levels of counseling about obesity management. CONCLUSIONS: Obesity counseling by pharmacists was positively correlated with their perceived comfort with counseling obese patients, confidence in achieving positive outcomes, and effectiveness of obesity management options.","['Dastani, Homa B', 'Brown, Carolyn M', ""O'Donnell, Dannielle C""]","['Dastani HB', 'Brown CM', ""O'Donnell DC""]","['Division of Pharmacy Administration, The University of Texas at Austin, Austin, TX, USA. homa@mail.utexas.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Ann Pharmacother,The Annals of pharmacotherapy,9203131,,IM,"['*Community Pharmacy Services', 'Counseling/*statistics & numerical data', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/epidemiology/prevention & control/*therapy', 'Surveys and Questionnaires', 'Texas/epidemiology']",,,,,2004/09/24 05:00,2005/02/03 09:00,['2004/09/24 05:00'],"['2004/09/24 05:00 [pubmed]', '2005/02/03 09:00 [medline]', '2004/09/24 05:00 [entrez]']","['aph.1E205 [pii]', '10.1345/aph.1E205 [doi]']",ppublish,Ann Pharmacother. 2004 Nov;38(11):1800-4. doi: 10.1345/aph.1E205. Epub 2004 Sep 21.,,20040921,,,,,,['Ann Pharmacother. 2004 Nov;38(11):1961-3. PMID: 15454586'],,,,,,,,,,,,
33941481,NLM,MEDLINE,20210701,20210701,1878-7533 (Electronic) 1550-7289 (Linking),17,7,2021 Jul,Evaluation of super-obesity and super-super-obesity as risk factors for difficult intubation in patients undergoing bariatric surgery.,1279-1285,S1550-7289(21)00184-2 [pii] 10.1016/j.soard.2021.03.028 [doi],"BACKGROUND: Super-obesity is a serious disorder which requires bariatric surgery. The association of super-obesity and difficult intubation was not adequately established. OBJECTIVES: To determine if super-obesity and super-super-obesity are associated with difficult intubation or not. SETTING: University Hospital. METHODS: A cohort of obese patients scheduled for bariatric surgery was prospectively recruited. Super-obesity and super-super-obesity were defined as body mass index >/=50 kg/m(2) and 60 kg/m(2), respectively. Intubation difficulty was assessed by 2 methods: (1) intubation difficulty scale; (2) number of intubation attempts. Risk factors for difficult intubation were recorded. Univariate and multivariate analysis for risk factors for difficult intubation and difficult mask ventilation were performed. RESULTS: A total of 658 patients were enrolled in the study including 205 (31%) super-obese and 52 (8%) super-super-obese patients. Ninety-nine (15%) patients required more than 1 intubation attempt, while 215 (33%) patients had intubation difficulty scale >/=5. Ninety-four (14.4%) patients had mask ventilation of moderate difficulty, while only 2 (.3%) patients needed 2-person ventilation. The independent risk factors for difficult intubation using the two stated definitions were STOP-Bang and Mallampati score values. The independent risk factors for mask ventilation of moderate difficulty were STOP-Bang score, Mallampati score, and limited neck extension. CONCLUSION: Within obese patients, neither super-obesity nor super-super-obesity was associated with difficult intubation or difficult mask ventilation. High STOP-Bang and Mallampati score are the independent factors for difficult intubation.","['Mahmoud, Mohamed', 'Hasanin, Ahmed M', 'Mostafa, Maha', 'Alhamade, Fatema', 'Abdelhamid, Bassant', 'Elsherbeeny, Mona']","['Mahmoud M', 'Hasanin AM', 'Mostafa M', 'Alhamade F', 'Abdelhamid B', 'Elsherbeeny M']","['Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.', 'Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt. Electronic address: ahmedmohamedhasanin@gmail.com.', 'Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.', 'Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.', 'Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.', 'Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt.']",['eng'],['Journal Article'],United States,Surg Obes Relat Dis,Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery,101233161,,IM,"['*Bariatric Surgery', 'Body Mass Index', 'Humans', '*Intubation, Intratracheal/adverse effects', 'Obesity/complications/epidemiology/surgery', 'Risk Factors']",,['NOTNLM'],"['Bariatric surgery', 'Difficult intubation', 'Difficult mask ventilation', 'Super-obese', 'Super-super-obese']",,2021/05/05 06:00,2021/07/02 06:00,['2021/05/04 06:05'],"['2020/10/20 00:00 [received]', '2020/12/13 00:00 [revised]', '2021/03/31 00:00 [accepted]', '2021/05/05 06:00 [pubmed]', '2021/07/02 06:00 [medline]', '2021/05/04 06:05 [entrez]']","['S1550-7289(21)00184-2 [pii]', '10.1016/j.soard.2021.03.028 [doi]']",ppublish,Surg Obes Relat Dis. 2021 Jul;17(7):1279-1285. doi: 10.1016/j.soard.2021.03.028. Epub 2021 Apr 6.,,20210406,,"['Copyright (c) 2021 American Society for Bariatric Surgery. Published by Elsevier', 'Inc. All rights reserved.']",,,,,,,,,,,,,,,,
31770349,NLM,MEDLINE,20200601,20200601,1538-9766 (Electronic) 1042-895X (Linking),42,6,2019 Nov/Dec,"Using Physiologic, Genetic, and Epigenetic Information to Provide Care to Clients Who Are Obese.",478-485,10.1097/SGA.0000000000000384 [doi],"The pathology of obesity is a complex process involving interactions among behavioral, environmental, immunologic, genetic, and epigenetic factors. This article gives a broad overview of obesity. The physiology of fat storage, influence of eating behaviors on obesity, and the genetic relationship between eating and food sources are discussed. Specific genes that have been associated with obesity are introduced, with information on leptin and genes such as FTO, GLUT4, and others. This synopsis of obesity expands into environmental influences and epigenetic factors. These include food selection, gut microbiota, pregnancy, and exercise. The nurse will gain specific knowledge to assist in tailoring therapies specific to clients who are working to overcome the long-term effects of this disorder.","['Elder, Betty', 'Pile, Debra', 'Bett, Carol']","['Elder B', 'Pile D', 'Bett C']","['Betty Elder, PhD, RN, is Associate Professor, College of Health Professions, Wichita State University, Wichita, Kansas. Debra Pile, DNP, APRN, is Associate Professor, College of Health Professions, Wichita State University, Wichita, Kansas. Carol Bett, PhD, RN, is Associate Teaching Professor, College of Health Professions, Wichita State University, Wichita, Kansas.']",['eng'],"['Journal Article', 'Review']",United States,Gastroenterol Nurs,Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates,8915377,,,"['Epigenesis, Genetic', 'Feeding Behavior', 'Health Behavior', 'Humans', 'Obesity/*etiology/psychology/*therapy']",,,,,2019/11/27 06:00,2020/06/02 06:00,['2019/11/27 06:00'],"['2019/11/27 06:00 [entrez]', '2019/11/27 06:00 [pubmed]', '2020/06/02 06:00 [medline]']","['00001610-201911000-00003 [pii]', '10.1097/SGA.0000000000000384 [doi]']",ppublish,Gastroenterol Nurs. 2019 Nov/Dec;42(6):478-485. doi: 10.1097/SGA.0000000000000384.,,,,,,,,['Gastroenterol Nurs. 2019 Nov/Dec;42(6):E1-E2. PMID: 31770350'],,,,,,,,,,,,
10780140,NLM,MEDLINE,20000524,20190513,0146-8693 (Print) 0146-8693 (Linking),25,3,2000 Apr-May,Children's attitudes and behavioral intentions toward a peer presented as obese: does a medical explanation for the obesity make a difference?,137-45,,"OBJECTIVE: To examine the effect of information on children's attitudes and behavioral intentions toward a peer presented as obese. METHODS: Children (N = 184) were randomly assigned to observe a video of a boy or girl in one of three conditions: average-weight, obese, obese with medical information explaining the obesity. They rated stereotypical attitudes on the Adjective Checklist and behavioral intentions on the Shared Activities Questionnaire (SAQ-B). RESULTS: Ratings were generally more favorable for the average-weight than for the obese condition. However, provision of medical information had a positive effect on attitudes toward the obese peer only for younger children and a negative effect on willingness of older children to share academic activities with the peer. Boys and girls showed more positive behavioral intentions toward the same-sex target child regardless of obesity condition. CONCLUSIONS: Information explaining obesity has a minimal positive effect on children's attitudes and behavioral intentions toward a peer presented as obese.","['Bell, S K', 'Morgan, S B']","['Bell SK', 'Morgan SB']","['University of Memphis, Tennessee 38138, USA.']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial', ""Research Support, Non-U.S. Gov't""]",United States,J Pediatr Psychol,Journal of pediatric psychology,7801773,,IM,"['Analysis of Variance', '*Attitude to Health', 'Child', 'Female', 'Humans', 'Male', 'Obesity/etiology/*psychology', '*Psychology, Child', '*Social Desirability', '*Stereotyping']",,,,,2000/04/26 09:00,2000/06/08 09:00,['2000/04/26 09:00'],"['2000/04/26 09:00 [pubmed]', '2000/06/08 09:00 [medline]', '2000/04/26 09:00 [entrez]']",['10.1093/jpepsy/25.3.137 [doi]'],ppublish,J Pediatr Psychol. 2000 Apr-May;25(3):137-45. doi: 10.1093/jpepsy/25.3.137.,,,,,,,,['J Pediatr Psychol. 2000 Apr-May;25(3):147-9. PMID: 10780141'],,,,,,,,,,,,
3578107,NLM,MEDLINE,19870615,20180507,0002-9165 (Print) 0002-9165 (Linking),45,5 Suppl,1987 May,Classification of obese patients and complications related to the distribution of surplus fat.,1120-5,10.1093/ajcn/45.5.1120 [doi],,"['Bjorntorp, P']",['Bjorntorp P'],,['eng'],['Journal Article'],United States,Am J Clin Nutr,The American journal of clinical nutrition,0376027,,IM,"['Adipose Tissue/metabolism/*pathology', 'Energy Metabolism', 'Humans', 'Lipid Metabolism', 'Neoplasms/etiology', 'Obesity/*classification/complications/metabolism']",,,,,1987/05/01 00:00,1987/05/01 00:01,['1987/05/01 00:00'],"['1987/05/01 00:00 [pubmed]', '1987/05/01 00:01 [medline]', '1987/05/01 00:00 [entrez]']",['10.1093/ajcn/45.5.1120 [doi]'],ppublish,Am J Clin Nutr. 1987 May;45(5 Suppl):1120-5. doi: 10.1093/ajcn/45.5.1120.,,,,,,,,,,,,,,,,,,,,
24236162,NLM,MEDLINE,20140725,20211021,1932-6203 (Electronic) 1932-6203 (Linking),8,11,2013,Application of the UK foresight obesity model in Ireland: the health and economic consequences of projected obesity trends in Ireland.,e79827,10.1371/journal.pone.0079827 [doi] e79827,"BACKGROUND: Given the scale of the current obesity epidemic and associated health consequences there has been increasing concern about the economic burden placed on society in terms of direct healthcare costs and indirect societal costs. In the Republic of Ireland these costs were estimated at euro1.13 billion for 2009. The total direct healthcare costs for six major obesity related conditions (coronary heart disease & stroke, cancer, hypertension, type 2 diabetes and knee osteoarthritis) in the same year were estimated at euro2.55 billion. The aim of this research is to project disease burden and direct healthcare costs for these conditions in Ireland to 2030 using the established model developed by the Health Forum (UK) for the Foresight: Tackling Obesities project. METHODOLOGY: Routine data sources were used to derive incidence, prevalence, mortality and survival for six conditions as inputs for the model. The model utilises a two stage modelling process to predict future BMI rates, disease prevalence and costs. Stage 1 employs a non-linear multivariate regression model to project BMI trends; stage 2 employs a microsimulation approach to produce longitudinal projections and test the impact of interventions upon future incidence of obesity-related disease. RESULTS: Overweight and obesity are projected to reach levels of 89% and 85% in males and females respectively by 2030. This will result in an increase in the obesity related prevalence of CHD & stroke by 97%, cancers by 61% and type 2 diabetes by 21%. The direct healthcare costs associated with these increases will amount to euro5.4 billion by 2030. A 5% reduction in population BMI levels by 2030 is projected to result in euro495 million less being spent in obesity-related direct healthcare costs over twenty years. DISCUSSION: These findings have significant implications for policy, highlighting the need for effective strategies to prevent this avoidable health and economic burden.","['Keaver, Laura', 'Webber, Laura', 'Dee, Anne', 'Shiely, Frances', 'Marsh, Tim', 'Balanda, Kevin', 'Perry, Ivan J']","['Keaver L', 'Webber L', 'Dee A', 'Shiely F', 'Marsh T', 'Balanda K', 'Perry IJ']","['Department of Epidemiology and Public Health, University College Cork, Cork, Ireland.']",['eng'],"['Journal Article', 'Meta-Analysis', ""Research Support, Non-U.S. Gov't""]",United States,PLoS One,PloS one,101285081,,IM,"['Body Mass Index', 'Coronary Disease/etiology', 'Diabetes Mellitus, Type 2/etiology', 'Female', 'Health Care Costs', 'Humans', 'Incidence', 'Ireland/epidemiology', 'Male', '*Models, Theoretical', 'Obesity/complications/*economics/*epidemiology', 'Overweight/epidemiology', 'Patient Outcome Assessment', 'Prevalence']",PMC3827424,,,"['Competing Interests: The authors have declared that no competing interested', 'exist.']",2013/11/16 06:00,2014/07/26 06:00,['2013/11/16 06:00'],"['2013/06/07 00:00 [received]', '2013/10/03 00:00 [accepted]', '2013/11/16 06:00 [entrez]', '2013/11/16 06:00 [pubmed]', '2014/07/26 06:00 [medline]']","['PONE-D-13-23794 [pii]', '10.1371/journal.pone.0079827 [doi]']",epublish,PLoS One. 2013 Nov 13;8(11):e79827. doi: 10.1371/journal.pone.0079827. eCollection 2013.,,20131113,"['PLoS One. 2013;8(12).', 'doi:10.1371/annotation/3dd20b6b-2a94-4542-a058-2cc7effe881a. Perry, Ivan', '[corrected to Perry, Ivan J]']",,,,,,,,,,,,,,,,,
35644913,NLM,MEDLINE,20220916,20221015,1758-8111 (Electronic) 1758-8103 (Print) 1758-8103 (Linking),12,5,2022 Oct,What is it like to live with obesity in Peninsular Malaysia? A qualitative study.,e12538,10.1111/cob.12538 [doi] e12538,"Understanding the experience of people living with obesity is crucial for delivering holistic care relevant to the socio-cultural context. Although half of the Malaysian adults have excessive weight, the lived experience of people with obesity in the Malaysian context is not well studied. Using the principles of hermeneutic phenomenology, this study explores the lived experience of adults with obesity in Malaysia and their perspective on the environmental influences on obesity. Participants were adults from Peninsular Malaysia living with obesity recruited from social media, clinics and snowball sampling. Twenty-five teleconference interviews in Malay were audio-recorded and transcribed verbatim. Data were analysed inductively using a reflexive thematic analysis approach, and quotes were translated into English. We identified five themes: (1) Malaysian life is centred around food; (2) social norms shape people living with obesity's perceptions of themselves and obesity; (3) people living with obesity are physically restricted by their body; (4) people living with obesity have repeated thoughts about efforts to lose weight; and (5) stigmatization of people living with obesity leads to negative emotions. Socio-cultural influences were highly impactful on participants' lifeworld, and these influences need to be considered in clinical practice and policy for obesity management in Malaysia. Clinical management should focus on assisting patients in navigating the unsupportive food and social environment instead of overfocusing on the individual's responsibility for weight reduction.","['Yunus, Nor Akma', 'Russell, Grant', 'Muhamad, Rosediani', 'Barton, Chris', 'Sturgiss, Elizabeth']","['Yunus NA', 'Russell G', 'Muhamad R', 'Barton C', 'Sturgiss E']","['School of Primary and Allied Health Care, Monash University, Melbourne, Victoria, Australia.', 'Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia.', 'Department of General Practice, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.', 'Department of Family Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia.', 'Department of General Practice, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.', 'School of Primary and Allied Health Care, Monash University, Melbourne, Victoria, Australia.']",['eng'],['Journal Article'],England,Clin Obes,Clinical obesity,101560587,,IM,"['Adult', 'Humans', 'Malaysia', '*Obesity/psychology', 'Qualitative Research', '*Weight Loss']",PMC9541318,['NOTNLM'],"['Malaysia', 'lived experience', 'obesity', 'phenomenology', 'qualitative']",['The authors declare no conflict of interest.'],2022/06/02 06:00,2022/09/17 06:00,['2022/06/01 10:58'],"['2022/05/05 00:00 [revised]', '2022/02/01 00:00 [received]', '2022/05/12 00:00 [accepted]', '2022/06/02 06:00 [pubmed]', '2022/09/17 06:00 [medline]', '2022/06/01 10:58 [entrez]']","['COB12538 [pii]', '10.1111/cob.12538 [doi]']",ppublish,Clin Obes. 2022 Oct;12(5):e12538. doi: 10.1111/cob.12538. Epub 2022 May 29.,"['FRGS/1/2021/SKK04/USM/02/2/Fundamental Research Grant Scheme (FRGS), Ministry of', 'Higher Education Malaysia/']",20220529,,"['(c) 2022 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf', 'of World Obesity Federation.']","['ORCID: 0000-0002-3291-6406', 'ORCID: 0000-0003-4428-4060']",,,,,,,,,,,,,,,
4062122,NLM,MEDLINE,19851210,20190415,0003-4819 (Print) 0003-4819 (Linking),103,6 ( Pt 2),1985 Dec,Morbid obesity and related health risks.,1043-7,10.7326/0003-4819-103-6-1043 [doi],"Persons 45.4 kg (100 lb) or more above desirable weight have exponential increases in mortality and serious morbidity compared with normal persons. The presence of a complication or an independent coronary risk factor along with obesity increases the mortality further. Among the ""threshold conditions"" that appear at a critical level of body weight (60% or more above desirable weight), the most important are sudden unexplained death, ventilatory disorders, circulatory congestion, and functional limitations in activities of daily living. Recent epidemiologic data on extreme obesity and data on cardiac dysfunction show impaired quality of life in young, morbidly obese patients. Because of the malignant nature of morbid obesity and the inability to achieve and maintain sufficient weight reduction by non-surgical means, surgery is justified in this population.","['Kral, J G']",['Kral JG'],,['eng'],['Journal Article'],United States,Ann Intern Med,Annals of internal medicine,0372351,,IM,"['Activities of Daily Living', 'Adolescent', 'Adult', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/classification/*complications/mortality/psychology/therapy', 'Quality of Life', 'Risk', 'Unemployment']",,,,,1985/12/01 00:00,1985/12/01 00:01,['1985/12/01 00:00'],"['1985/12/01 00:00 [pubmed]', '1985/12/01 00:01 [medline]', '1985/12/01 00:00 [entrez]']",['10.7326/0003-4819-103-6-1043 [doi]'],ppublish,Ann Intern Med. 1985 Dec;103(6 ( Pt 2)):1043-7. doi: 10.7326/0003-4819-103-6-1043.,,,,,,,,,,,,,,,,,,,,
1897470,NLM,MEDLINE,19911024,20180330,0002-9165 (Print) 0002-9165 (Linking),54,4,1991 Oct,Taste preferences in human obesity: environmental and familial factors.,635-41,,"Taste-response profiles influence food selection and may help distinguish among potential subgroups of obese individuals. A representative community-based sample of 61 obese and 31 lean adults tasted five sucrose solutions and nine fat-containing solid stimuli resembling cake icings. Solid stimuli contained 15-35% fat and 20-70% sucrose (by weight). No significant differences in taste responsiveness were observed between obese and lean groups. Obese subjects were then divided into subgroups based on age at onset of obesity and past fluctuations in body weight. Obese subjects characterized by large weight fluctuations showed elevated preferences for sugar and fat mixtures compared with the stable subgroup. In contrast, early age at onset of obesity (less than 10 y), thought to be a measure of familial risk, had no significant effects on taste preferences. Environmental as opposed to familial factors may be more immediate determinants of taste preferences and food choice.","['Drewnowski, A', 'Kurth, C L', 'Rahaim, J E']","['Drewnowski A', 'Kurth CL', 'Rahaim JE']","['Program in Human Nutrition, School of Public Health, University of Michigan, Ann Arbor 48109-2029.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Clin Nutr,The American journal of clinical nutrition,0376027,"['0 (Dietary Fats)', '57-50-1 (Sucrose)']",IM,"['Adult', 'Analysis of Variance', 'Dietary Fats', 'Female', '*Food Preferences', 'Humans', 'Male', 'Obesity/etiology/genetics/*physiopathology', 'Sucrose', '*Taste']",,,,,1991/10/01 00:00,1991/10/01 00:01,['1991/10/01 00:00'],"['1991/10/01 00:00 [pubmed]', '1991/10/01 00:01 [medline]', '1991/10/01 00:00 [entrez]']",['10.1093/ajcn/54.4.635 [doi]'],ppublish,Am J Clin Nutr. 1991 Oct;54(4):635-41. doi: 10.1093/ajcn/54.4.635.,"['DK37011/DK/NIDDK NIH HHS/United States', 'DK38073/DK/NIDDK NIH HHS/United States']",,,,,,,,,,,,,,,,,,,
4480659,NLM,MEDLINE,19760602,20061115,0015-5535 (Print) 0015-5535 (Linking),27,6pt2,1974 Dec,"[Effects of fasting, of weight reduction and realimentation on the endocrine-metabolic function of the obese subjects].",614-25,,,"['Fraioli, F', 'Genazzani, A R', 'Conte, D', 'Piro, C', 'Dondero, F']","['Fraioli F', 'Genazzani AR', 'Conte D', 'Piro C', 'Dondero F']",,['ita'],"['English Abstract', 'Journal Article']",Italy,Folia Endocrinol,Folia endocrinologica,0417431,,IM,"['Adult', '*Diet, Reducing', 'Endocrine Glands/*physiopathology', '*Fasting', 'Humans', 'Male', 'Obesity/metabolism/*physiopathology/therapy']",,,,,1974/12/01 00:00,1974/12/01 00:01,['1974/12/01 00:00'],"['1974/12/01 00:00 [pubmed]', '1974/12/01 00:01 [medline]', '1974/12/01 00:00 [entrez]']",,ppublish,Folia Endocrinol. 1974 Dec;27(6pt2):614-25.,,,,,,,,,"Effetti del digiuno, del dimagramento e della rialimentazione sull'assetto endocrino-metabolico di soggetti obesi.",,,,,,,,,,,
7159075,NLM,MEDLINE,19830311,20071114,0195-6663 (Print) 0195-6663 (Linking),3,3,1982 Sep,Ovariectomy without obesity and obesity without hyperadipocytocity. Supermarket dietary and ovariectomy-induced obesities compared in weanlings and adult rats.,243-53,,,"['Simson, E L', 'Jones, A P', 'Schwarz, M J', 'Gold, R M']","['Simson EL', 'Jones AP', 'Schwarz MJ', 'Gold RM']",,['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Appetite,Appetite,8006808,,IM,"['Adipose Tissue/cytology', 'Age Factors', 'Animals', 'Body Height', 'Body Weight', '*Castration', '*Diet', 'Disease Models, Animal', 'Female', 'Obesity/*etiology', 'Rats', 'Rats, Inbred Strains', 'Time Factors']",,,,,1982/09/01 00:00,1982/09/01 00:01,['1982/09/01 00:00'],"['1982/09/01 00:00 [pubmed]', '1982/09/01 00:01 [medline]', '1982/09/01 00:00 [entrez]']",,ppublish,Appetite. 1982 Sep;3(3):243-53.,['MH 26251/MH/NIMH NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
25211791,NLM,MEDLINE,20141030,20220323,0032-6518 (Print) 0032-6518 (Linking),258,1773,2014 Jul-Aug,Improving outcomes for patients with obesity.,"29-31, 3",,"In England there has been a sharp increase in the prevalence of overweight and obesity in adults. In 1993 58% of men and 49% of women were classified as overweight or obese compared with 65% and 58% respectively in 2011; 24% of men and 26% of women were classed as obese in 2011. Body mass index (BMI) is the most commonly used measure to classify people into weight categories. While the use of BMI has limitations, as it does not take into account the difference between muscle and fat, it is a good quick indicator of increased risks. Obesity increases the risk of hypertension, coronary heart disease, deep vein thrombosis and pulmonary embolism. It is also associated with an increased risk of certain cancers. Obesity is an important risk factor for non-alcoholic fatty liver disease which if left untreated can progress to severe forms of liver disease, such as non-alcoholic steatohepatitis, fibrosis and cirrhosis. The risk of sleep apnoea is raised in obese individuals as is that for gastro-oesophageal reflux and gallstones, stress incontinence in women and erectile dysfunction in men. Lifestyle weight management programmes should be multicomponent, developed by a multidisciplinary team, and delivered by individuals who have undergone appropriate training. They should focus on long-term weight loss and prevention of weight regain and continue for a minimum of three months. Effective programmes include setting dietary targets, such as specific reductions in energy intake. Other options that GPs and practice nurses might offer within the practice, over and above referral to lifestyle programmes, include help with intermittent or regular motivational support, and/or drug therapy.","['Jolly, Kate', 'Chambers, Ruth']","['Jolly K', 'Chambers R']",,['eng'],['Journal Article'],England,Practitioner,The Practitioner,0404245,,IM,"['Adult', 'Body Mass Index', 'Female', 'Humans', 'Male', 'Obesity/complications/epidemiology/*therapy', 'Weight Loss']",,,,,2014/09/13 06:00,2014/10/31 06:00,['2014/09/13 06:00'],"['2014/09/13 06:00 [entrez]', '2014/09/13 06:00 [pubmed]', '2014/10/31 06:00 [medline]']",,ppublish,"Practitioner. 2014 Jul-Aug;258(1773):29-31, 3.",,,,,,,,,,,,,,,,,,,,
14893567,NLM,MEDLINE,20040215,20181201,0041-5782 (Print) 0041-5782 (Linking),113,38,1951 Sep 20,[Obese patients hospitalized in a medical department].,1307-9,,,"['KRARUP, B', 'SCHWENSEN, C J']","['KRARUP B', 'SCHWENSEN CJ']",,['und'],['Journal Article'],Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,OM,"['*Hospital Departments', 'Humans', 'Obesity/*epidemiology/*statistics & numerical data']",,['NLM'],['*OBESITY/epidemiology and statistics'],,1951/09/20 00:00,1951/09/20 00:01,['1951/09/20 00:00'],"['1951/09/20 00:00 [pubmed]', '1951/09/20 00:01 [medline]', '1951/09/20 00:00 [entrez]']",,ppublish,Ugeskr Laeger. 1951 Sep 20;113(38):1307-9.,,,,,,,,,Adipositaspatienternes belastning af en medicinsk afdeling.,,,,['CLML: 5221:23944:264'],,,,,,,
16353604,NLM,MEDLINE,20060124,20191109,1071-7323 (Print) 1071-7323 (Linking),2,1,1994 Jan,Do obese eat faster than lean subjects? Food intake studies in Pima Indian men.,19-23,,"Food intake rate has previously been derived from observation of eating behavior in laboratory settings or in public eating establishments. Although it has been suggested that obese individuals eat faster than lean individuals, observations of such an ""obese eating style"" have yielded mixed results. In the present study, the relationship between ad-libitum food intake rate and obesity was evaluated over 4 days on a metabolic ward in 28 healthy Pima Indian men (Mean +/- SD; 29 +/- 7 y, 100.4 +/- 27.1 kg, 33 +/- 10% body fat) using an automated food selection system containing a large variety of foods. Total energy intake averaged 18829 +/- 3299 kJ/d consisting of 47 +/- 4, 40 +/- 3, and 13 +/- 1 percent of carbohydrate, fat and protein, respectively. The average meal duration was 25 +/- 7 min. Food intake rate was 68 +/- 21 g/min while carbohydrate, fat and protein intake rates were 23 +/- 6, 9 +/- 3 and 6 +/- 2 g/min, respectively. Food intake rate correlated negatively with % body fat (r = -0.61, P < 0.01). Similar relationships were found between the intake rates of carbohydrate, fat and protein and body fatness. Only prospective studies will indicate whether a slow food intake rate may contribute to the etiology of obesity by possibly reducing satiety.","['Rising, R', 'Larson, D E', 'Ravussin, E']","['Rising R', 'Larson DE', 'Ravussin E']","['Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 4212 North Sixteenth Street, Room 541, Phoenix, Arizona 85016, USA.']",['eng'],['Journal Article'],United States,Obes Res,Obesity research,9305691,,IM,"['Adult', 'Eating', 'Energy Intake', '*Feeding Behavior', 'Humans', 'Indians, North American', 'Male', 'Middle Aged', 'Obesity/*etiology/metabolism/psychology']",,,,,1994/01/01 00:00,2006/01/25 09:00,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '2006/01/25 09:00 [medline]', '1994/01/01 00:00 [entrez]']",['10.1002/j.1550-8528.1994.tb00039.x [doi]'],ppublish,Obes Res. 1994 Jan;2(1):19-23. doi: 10.1002/j.1550-8528.1994.tb00039.x.,,,,,,,,,,,,,,,,,,,,
9573749,NLM,MEDLINE,19980601,20061115,0031-0808 (Print) 0031-0808 (Linking),40,1,1998 Mar,Many factors can affect the prevalence of hypertension in obese patients: role of cuff size and type of obesity.,22-7,,"OBJECTIVE: To determine to what extent methodological errors, including measurements taken with inappropriate cuffs and/or inaccuracies in patient enrollment, can contribute to overestimating the prevalence of hypertension in overweight or obese women. EXPERIMENTAL DESIGN: Randomized and comparative investigation in overweight or obese outpatient women of the Obesity Clinic, Internal Medicine Institute, Chieti University. PATIENTS: In 1,791 overweight or obese women, randomly selected and stratified by age (41-60 years), blood pressure (BP) was taken with casual measurement in the morning. The entire study group was divided into two subgroups. In the first one, causal BP was measured with a standard-size cuff (RCS), while an appropriate large-size cuff was used for the second one (LCS). Patients of the latter subgroup were also divided by type of obesity (android and gynoid), based on their waist-to-hip ratio. RESULTS: In the LCS subgroup, the hypertension prevalence rate was strikingly lower among overweight and obese women, as well as in the younger and older age groups, when compared with the corresponding RCS subgroups (p < 0.001). The hypertension prevalence rate was higher for all android obese subjects (53%), including younger (34%) and older (64%) groups, when compared with gynoid obese patients (29%, 18% and 42%, respectively). CONCLUSIONS: A comparison of different reports on the prevalence of hypertension in obesity reveals considerable differences, due mainly to age, sex, race and income level. Nevertheless, our data seem to indicate that even after adjusting for the above-mentioned variables, two significant confounding factors, cuff hypertension and the prevalence of android obesity in the obese study population, could be responsible for over-estimating the prevalence of hypertension. It should be noted that for certain groups of overweight and obese women, the prevalence of hypertension becomes similar to the rate found among the general population, as reported in many large epidemiological surveys.","['Guagnano, M T', 'Palitti, V P', 'Murri, R', 'Marchione, L', 'Merlitti, D', 'Sensi, S']","['Guagnano MT', 'Palitti VP', 'Murri R', 'Marchione L', 'Merlitti D', 'Sensi S']","['Institute of Internal Medicine, University of Chieti, Italy.']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial', ""Research Support, Non-U.S. Gov't""]",Italy,Panminerva Med,Panminerva medica,0421110,,IM,"['Adult', 'Blood Pressure Determination/instrumentation', 'Female', 'Humans', 'Hypertension/diagnosis/*etiology', 'Male', 'Middle Aged', 'Obesity/classification/*complications/pathology', 'Risk Factors', 'Somatotypes']",,,,,1998/05/09 00:00,1998/05/09 00:01,['1998/05/09 00:00'],"['1998/05/09 00:00 [pubmed]', '1998/05/09 00:01 [medline]', '1998/05/09 00:00 [entrez]']",,ppublish,Panminerva Med. 1998 Mar;40(1):22-7.,,,,,,,,,,,,,,,,,,,,
22567791,NLM,MEDLINE,20120605,20150602,2158-7833 (Print) 2158-7833 (Linking),41,4,2012 Apr,How obesity impacts patients health and EMS. EMS systems need to know how to handle the increase in bariatric patients.,40-9,,"Obesity is a serious disease that poses many problems for EMS. Morbidly obese patients do not fit on standard EMS equipment and the need for the safe transport of obese patients is rising. In addition to posing many logistical dilemmas, obese patients are prone to many serious medical conditions that are likely to increase their exposure to EMS systems. Prepare yourself and your program for the management and transport of obese patients by designing a safe patient transport model and policy with protocols geared toward the obese patient.","['Collopy, Kevin T', 'Kivlehan, Sean', 'Snyder, Scott R']","['Collopy KT', 'Kivlehan S', 'Snyder SR']","['Vitalink/Airlink, Wilmington, NC, USA. kcollopy@colgatealumni.org']",['eng'],['Journal Article'],United States,EMS World,EMS world,101547538,,,"['Emergency Medical Services/*methods', 'Humans', '*Obesity/epidemiology/physiopathology', 'United States/epidemiology']",,,,,2012/05/10 06:00,2012/06/06 06:00,['2012/05/10 06:00'],"['2012/05/10 06:00 [entrez]', '2012/05/10 06:00 [pubmed]', '2012/06/06 06:00 [medline]']",,ppublish,EMS World. 2012 Apr;41(4):40-9.,,,,,,,,,,,,,,,,,,,,
10418258,NLM,MEDLINE,19990803,20071115,0023-7205 (Print) 0023-7205 (Linking),96,25,1999 Jun 23,[A person who suffers of obesity is obese!].,3081,,,"['Holmen, J']",['Holmen J'],,['swe'],['Journal Article'],Sweden,Lakartidningen,Lakartidningen,0027707,,IM,"['Body Mass Index', 'Humans', '*Obesity/diagnosis/therapy', '*Terminology as Topic']",,,,,1999/07/27 00:00,1999/07/27 00:01,['1999/07/27 00:00'],"['1999/07/27 00:00 [pubmed]', '1999/07/27 00:01 [medline]', '1999/07/27 00:00 [entrez]']",,ppublish,Lakartidningen. 1999 Jun 23;96(25):3081.,,,,,,,,,Den som lider av fetma ar fet!,,,,,,,,,,,
19371937,NLM,MEDLINE,20090701,20220321,1527-9995 (Electronic) 0090-4295 (Print) 0090-4295 (Linking),73,6,2009 Jun,Effect of obesity on urethroplasty outcome.,1352-5,10.1016/j.urology.2008.12.073 [doi],"OBJECTIVES: To determine whether obesity increases the risk of urethroplasty failure. METHODS: A total of 381 patients underwent urethroplasty and had complete body mass index (BMI) data. Stricture recurrence-free survival was defined as subjective and objective improvement in urinary flow, an absence of radiographic evidence of stricture, and no further need for urethral instrumentation. Cox proportional hazards regression analysis was used to identify both univariate and multivariate predictors of urethroplasty outcome. RESULTS: The median patient age was 40 years (range 18-90). The median follow-up was 5.9 years (range 1 month to 10 years). Of the 381 patients, 60 developed recurrent stricture (15.7%). Overweight (BMI 25-30 kg/m(2)) and obese (BMI 30-35 kg/m(2)) patients were more likely to have urethroplasty failure, reaching significance and near significance on univariate and multivariate analysis, respectively (P = .03 and P = .07, respectively). Patients who were severely (BMI 35-40 kg/m(2)) or morbidly obese (BMI >40 kg/m(2)) did not have an increased risk of urethroplasty failure. CONCLUSIONS: Although obesity's relationship with urethroplasty failure is not linear, it does appear to affect outcomes after urethroplasty.","['Breyer, Benjamin N', 'McAninch, Jack W', 'Whitson, Jared M', 'Eisenberg, Michael L', 'Master, Viraj A', 'Voelzke, Bryan B', 'Elliott, Sean P']","['Breyer BN', 'McAninch JW', 'Whitson JM', 'Eisenberg ML', 'Master VA', 'Voelzke BB', 'Elliott SP']","['Department of Urology, University of California, School of Medicine, San Francisco, California 94117, USA.']",['eng'],['Journal Article'],United States,Urology,Urology,0366151,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Follow-Up Studies', 'Humans', 'Middle Aged', 'Obesity/*complications', 'Risk Factors', 'Treatment Failure', 'Urethra/*surgery', 'Urethral Stricture/*complications/*surgery', 'Young Adult']",PMC4113077,,,,2009/04/18 09:00,2009/07/02 09:00,['2009/04/18 09:00'],"['2008/06/09 00:00 [received]', '2008/12/08 00:00 [revised]', '2008/12/15 00:00 [accepted]', '2009/04/18 09:00 [entrez]', '2009/04/18 09:00 [pubmed]', '2009/07/02 09:00 [medline]']","['S0090-4295(09)00178-2 [pii]', '10.1016/j.urology.2008.12.073 [doi]']",ppublish,Urology. 2009 Jun;73(6):1352-5. doi: 10.1016/j.urology.2008.12.073. Epub 2009 Apr 15.,['K12 DK083021/DK/NIDDK NIH HHS/United States'],20090415,,,,['NIHMS596273'],,['Urology. 2009 Jun;73(6):1356. PMID: 19482157'],,,,,,,,,,,,
21199663,NLM,MEDLINE,20110701,20131121,1873-507X (Electronic) 0031-9384 (Linking),103,1,2011 Apr 18,"Traits of the metabolic syndrome alter corpulent obesity in LAN, SHR and DSS rats: behavioral and metabolic interactions with adrenalectomy.",98-103,10.1016/j.physbeh.2010.12.020 [doi],"Obesity results from a complex interaction of genes with environmental factors. Our experimental design compared obesity in three rat strains with the corpulent (cp) mutation. The three strains included Lister and Albany NIH (LAN) rats, Spontaneously Hypertensive Rats (SHR) and Dahl Salt Sensitive (DSS) rats that were congenically bred. The strains were selected because of different reported metabolic complications generally clustered with obesity, and defined as the metabolic syndrome. Body weight, food intake, carcass composition, plasma hormones and hypothalamic expression of Y5 receptors were assessed in obese (cp) and lean (wt) rats after adrenalectomy (ADX) or sham surgeries. Plasma corticosterone in sham-operated wtDSS and cpDSS were significantly higher (approx. 165ng/ml) than that in cpLAN and cpSHR (~77 and 68ng/ml respectively). All cp groups had a higher % carcass fat than wt groups. The % carcass fat was greater in cpDSS>cpLAN>cpSHR but plasma leptin was greatest in cpLAN>cpSHR>cpDSS. Hypothalamic expression of the Y5R after ADX resulted in a phenotypexsurgery interaction since Y5R expression was slightly increased in cp rats and slightly decreased in wt rats. The strain with greatest number of metabolic syndrome traits, SHR, was not the fattest of the strains and had little response to ADX. The strains with fewer metabolic syndrome traits LAN and DSS had more extreme obesities which were attenuated after ADX. The results of the current experiment provide evidence that the corpulent mutation is not fully characterized in one strain.","['Brown, Lynda M', 'Hansen, Carl T', 'Huberty, Andrea F', 'Castonguay, T W']","['Brown LM', 'Hansen CT', 'Huberty AF', 'Castonguay TW']","['Department of Nutrition, University of North Carolina of Greensboro, Greensboro, NC 27402, United States. lmbrown6@uncg.edu']",['eng'],['Journal Article'],United States,Physiol Behav,Physiology & behavior,0151504,"['0 (Leptin)', '0 (RNA, Messenger)', '0 (Receptors, Neuropeptide Y)', '0 (neuropeptide Y5 receptor)', 'W980KJ009P (Corticosterone)']",IM,"['Adipose Tissue/pathology', '*Adrenalectomy', 'Analysis of Variance', 'Animals', 'Behavior, Animal/*physiology', 'Body Composition/genetics', 'Body Weight/genetics', 'Corticosterone/blood', 'Disease Models, Animal', 'Eating/genetics', 'Hypothalamus/metabolism', 'Leptin/blood', 'Male', 'Metabolic Diseases/*genetics', '*Obesity/blood/genetics/physiopathology', 'RNA, Messenger/metabolism', 'Rats', 'Rats, Inbred Dahl', 'Rats, Inbred SHR', 'Receptors, Neuropeptide Y/genetics/metabolism', 'Time Factors']",,,,,2011/01/05 06:00,2011/07/02 06:00,['2011/01/05 06:00'],"['2010/09/02 00:00 [received]', '2010/12/02 00:00 [revised]', '2010/12/20 00:00 [accepted]', '2011/01/05 06:00 [entrez]', '2011/01/05 06:00 [pubmed]', '2011/07/02 06:00 [medline]']","['S0031-9384(10)00468-3 [pii]', '10.1016/j.physbeh.2010.12.020 [doi]']",ppublish,Physiol Behav. 2011 Apr 18;103(1):98-103. doi: 10.1016/j.physbeh.2010.12.020. Epub 2010 Dec 31.,,20101231,,['Copyright (c) 2011 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
21809934,NLM,MEDLINE,20120529,20220318,1532-7027 (Electronic) 1041-0236 (Linking),27,1,2012,Obesity in the new media: a content analysis of obesity videos on YouTube.,86-97,10.1080/10410236.2011.569003 [doi],"This study examines (1) how the topics of obesity are framed and (2) how obese persons are portrayed on YouTube video clips. The analysis of 417 obesity videos revealed that a newer medium like YouTube, similar to traditional media, appeared to assign responsibility and solutions for obesity mainly to individuals and their behaviors, although there was a tendency that some video categories have started to show other causal claims or solutions. However, due to the prevailing emphasis on personal causes and solutions, numerous YouTube videos had a theme of weight-based teasing, or showed obese persons engaging in stereotypical eating behaviors. We discuss a potential impact of YouTube videos on shaping viewers' perceptions about obesity and further reinforcing stigmatization of obese persons.","['Yoo, Jina H', 'Kim, Junghyun']","['Yoo JH', 'Kim J']","['Department of Communication, University of Missouri-St. Louis, One University Boulevard, St. Louis, MO 63121-4400, USA. yooji@umsl.edu']",['eng'],['Journal Article'],England,Health Commun,Health communication,8908762,,IM,"['Feeding Behavior', 'Genetic Predisposition to Disease', 'Health Communication/*methods', 'Humans', 'Information Dissemination', '*Internet', 'Obesity/*etiology/genetics/*psychology', 'Perception', 'Prejudice', 'United States', 'Videotape Recording']",,,,,2011/08/04 06:00,2012/05/30 06:00,['2011/08/04 06:00'],"['2011/08/04 06:00 [entrez]', '2011/08/04 06:00 [pubmed]', '2012/05/30 06:00 [medline]']",['10.1080/10410236.2011.569003 [doi]'],ppublish,Health Commun. 2012;27(1):86-97. doi: 10.1080/10410236.2011.569003. Epub 2011 Aug 2.,,20110802,,,,,,,,,,,,,,,,,,
8262498,NLM,MEDLINE,19940125,20180215,0301-0163 (Print) 0301-0163 (Linking),39 Suppl 3,,1993,Therapeutic strategies in childhood obesity.,86-90,,"Childhood obesity leads to approximately 30% of adult obesity. However, the natural history of childhood obesity that persists into adulthood suggests that the obese child who becomes an obese adult will have more severe adult obesity than adults whose obesity began in adulthood. Therefore, to the extent that the severity of obesity predicts morbidity, persistence of childhood obesity may be expected to account for a disproportionate share of the adult sequelae of obesity. Fifty-year follow-up studies of a cohort with adolescent obesity have demonstrated that the mortality and morbidity of cardiovascular disease was significantly increased compared with a cohort that was lean throughout adolescence. Furthermore, the effect of adolescent obesity on adult morbidity and mortality appeared independent of the effects of adolescent obesity on adult weight status. Because truncal fat is deposited during adolescence, adolescent onset obesity may entrain both adult obesity and the effects of adolescent onset obesity on mortality and morbidity. These observations suggest that successful treatment of childhood and adolescent obesity is an effective approach to the prevention of severe adult disease. Recently, follow-up of children treated with diet, exercise and behaviour modification showed significantly lower weights 10 years later than children treated in other ways (p < 0.01). These and other family-based treatments appear to be the most appropriate approaches to the treatment of childhood obesity. However, the prevalence of childhood and adolescent obesity suggests that even the most successful treatment may be of limited benefit if it relies on the traditional medical model (doctor/patient interaction).(ABSTRACT TRUNCATED AT 250 WORDS)","['Dietz, W H']",['Dietz WH'],"['Department of Pediatric Gastroenterology/Nutrition, New England Medical Center, Boston, Mass. 02111.']",['eng'],"['Journal Article', 'Review']",Switzerland,Horm Res,Hormone research,0366126,,IM,"['Adolescent', 'Behavior Therapy', 'Child', 'Diet, Reducing', 'Exercise', 'Humans', 'Obesity/diet therapy/prevention & control/*therapy']",,,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",['10.1159/000182791 [doi]'],ppublish,Horm Res. 1993;39 Suppl 3:86-90. doi: 10.1159/000182791.,,,,,,,18,,,,,,,,,,,,,
17065688,NLM,MEDLINE,20061215,20161124,0149-5992 (Print) 0149-5992 (Linking),29,11,2006 Nov,"Obese women and the relation between cardiovascular risk profile and hormone therapy, glucose tolerance, and psychosocial conditions.",2477-82,,"OBJECTIVE: To evaluate the relation between cardiovascular disease (CVD) risk factors and hormone therapy, serum hormone levels, glucose tolerance, and psychosocial and psychological conditions in subjectively healthy obese female subjects. RESEARCH DESIGN AND METHODS: The study included 606 women, aged 50-64 years, with BMI 30-40 kg/m(2) and no history of cardiovascular or other severe diseases. One group with a CVD risk profile (n = 473) (i.e., cholesterol >7.0 mmol/l, HDL cholesterol <1.2 mmol/l, triglycerides >2.0 mmol/l, systolic or diastolic blood pressure >140/90 mmHg, or waist-to-hip ratio >0.85) was compared with women without such risk (n = 133). Steroid hormones, leptin, insulin, and oral glucose tolerance tests (OGTTs) were analyzed. A subgroup of women with baseline impaired glucose tolerance (IGT) completed a 2.5-year follow-up OGTT. RESULTS: Fewer obese postmenopausal women with CVD risk had ever used hormone therapy (odds ratio 0.24 [95% CI 0.07-0.75]), after multivariate adjustments. Furthermore, women with CVD risk had a higher testosterone index (1.07 [1.01-1.13]) and more had insulin resistance (1.04 [1.00-1.08]) and IGT (2.92 [1.50-5.69]), while OGTT was similar at follow-up. No differences were observed regarding family history or lifestyle, except that fewer women with CVD risk consumed fruits, boiled vegetables, or whole-grain cereals. More women with CVD risk lived alone (3.26 [1.28-8.31]) and had more mental problems (1.16 [1.05-1.28]). CONCLUSIONS: Previously healthy obese women with a CVD risk profile seemed to have a high risk of diabetes, as well as psychosocial or psychological problems. Hormone therapy was associated with reduced CVD risk. Obesity's growing burden on society makes it more important to further target individuals that are at greatest risk of future health hazards.","['Lidfeldt, Jonas', 'Samsioe, Goran', 'Agardh, Carl-David']","['Lidfeldt J', 'Samsioe G', 'Agardh CD']","['Department of Clinical Sciences/Primary Care/University Hospital MAS, SE-20502 Malmo, Sweden. jonas.lidfeldt@med.lu.se']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Diabetes Care,Diabetes care,7805975,"['0 (Insulin)', '0 (Leptin)', '3XMK78S47O (Testosterone)', '4TI98Z838E (Estradiol)', '97C5T2UQ7J (Cholesterol)']",IM,"['Adult', 'Cardiovascular Diseases/blood/*epidemiology/psychology', 'Cholesterol/blood', 'Estradiol/blood', '*Estrogen Replacement Therapy', 'Family Health', 'Feeding Behavior', 'Female', 'Glucose Intolerance/blood/*epidemiology/psychology', 'Glucose Tolerance Test', 'Humans', 'Insulin/blood', 'Leptin/blood', 'Life Style', 'Multivariate Analysis', 'Obesity/blood/*epidemiology/psychology', 'Occupations', 'Psychology', 'Quality of Life', 'Risk Factors', 'Testosterone/blood']",,,,,2006/10/27 09:00,2006/12/16 09:00,['2006/10/27 09:00'],"['2006/10/27 09:00 [pubmed]', '2006/12/16 09:00 [medline]', '2006/10/27 09:00 [entrez]']","['29/11/2477 [pii]', '10.2337/dc06-1262 [doi]']",ppublish,Diabetes Care. 2006 Nov;29(11):2477-82. doi: 10.2337/dc06-1262.,,,,,,,,,,,,,,,,,,,,
1518922,NLM,MEDLINE,19921002,20180217,0033-3190 (Print) 0033-3190 (Linking),57,3,1992,Alexithymia and obesity. Study of the impaired symbolic function by the Rorschach test.,88-93,,Many authors consider alexithymia a predisposing factor to psychosomatic and somatopsychic pathologies. In this study we investigated the presence of alexithymic characteristics in a group of 106 massive obese patients who requested a surgical intervention. 6 Rorschach alexithymia variables in the protocols of patients and a non-patient reference group (n = 600) were studied. Findings supported the presence of a striking alexithymic element among severely obese patients in comparison with their lean counterparts.,"['Clerici, M', 'Albonetti, S', 'Papa, R', 'Penati, G', 'Invernizzi, G']","['Clerici M', 'Albonetti S', 'Papa R', 'Penati G', 'Invernizzi G']","['Institute of Psychiatric Clinic, University of Milan, Italy.']",['eng'],['Journal Article'],Switzerland,Psychother Psychosom,Psychotherapy and psychosomatics,0024046,,IM,"['Adult', 'Affective Symptoms/*diagnosis', 'Female', 'Humans', 'Male', 'Obesity/diagnosis/*psychology/surgery', 'Psychological Tests', 'Psychophysiologic Disorders/diagnosis/psychology', 'Rorschach Test']",,,,,1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",['10.1159/000288580 [doi]'],ppublish,Psychother Psychosom. 1992;57(3):88-93. doi: 10.1159/000288580.,,,,,,,,,,,,,,,,,,,,
24445587,NLM,MEDLINE,20141020,20211021,1546-9549 (Electronic) 1546-9530 (Linking),11,1,2014 Mar,The obesity paradox in chronic heart failure: what does it mean?,111-7,10.1007/s11897-013-0184-2 [doi],"Heart failure (HF) is a growing health problem, at least in part due to the concurrent obesity epidemic plaguing developed countries. However, once a patient develops HF, an elevated BMI appears to confer a survival benefit--a phenomenon termed the ""obesity paradox."" The exact explanation for this paradox has been difficult to ascertain. Numerous plausible mechanisms have been asserted, including the fact that obese patients tend to be younger and more symptomatic, leading them to seek medical attention earlier in the course of their HF. Obese patients may also have larger energy reserves that help to offset the catabolic changes seen with HF. Other hypotheses highlight the limitations of BMI as an obesity classifier. The purpose of this review is to examine the various theories for the obesity paradox in HF and discuss the implications for the clinical management of obese patients with HF.","['Chase, Paul J', 'Davis, Paul G', 'Bensimhon, Daniel R']","['Chase PJ', 'Davis PG', 'Bensimhon DR']","['LeBauer Cardiovascular Research Foundation, Cone Health, 1200 N. Elm St, Greensboro, NC, 27401, USA, paul.chase@conehealth.com.']",['eng'],"['Journal Article', 'Review']",United States,Curr Heart Fail Rep,Current heart failure reports,101196487,,IM,"['Body Mass Index', 'Heart Failure/*complications/mortality/physiopathology', 'Humans', 'Obesity/*complications/mortality/physiopathology/therapy', 'Physical Fitness/physiology', 'Prognosis', 'Weight Loss']",,,,,2014/01/22 06:00,2014/10/21 06:00,['2014/01/22 06:00'],"['2014/01/22 06:00 [entrez]', '2014/01/22 06:00 [pubmed]', '2014/10/21 06:00 [medline]']",['10.1007/s11897-013-0184-2 [doi]'],ppublish,Curr Heart Fail Rep. 2014 Mar;11(1):111-7. doi: 10.1007/s11897-013-0184-2.,,,,,,,,,,,,,,,,,,,,
31521434,NLM,MEDLINE,20200427,20200427,1776-2588 (Electronic) 0761-8425 (Linking),36,8,2019 Oct,[Preoperative risk and perioperative management of obese patients].,985-1001,S0761-8425(19)30274-8 [pii] 10.1016/j.rmr.2019.01.009 [doi],"The obese patient is at an increased risk of perioperative complications. Most importantly, these include difficult access to the airways (intubation, difficult or impossible ventilation), and post-extubation respiratory distress secondary to the development of atelectasis or obstruction of the airways, sometimes associated with the use of morphine derivatives. The association of obstructive sleep apnea syndrome (OSA) with obesity is very common, and induces a high risk of peri- and postoperative complications. Preoperative OSA screening is crucial in the obese patient, as well as its specific management: use of continuous positive pre, per and postoperative pressure. For any obese patient, the implementation of protocols for mask ventilation and/or difficult intubation and the use of protective ventilation, morphine-sparing strategies and a semi-seated positioning throughout the care, is recommended, combined with close monitoring postoperatively. The dosage of anesthetic drugs should be based on the theoretical ideal weight and then titrated, rather than dosed to the total weight. Monitoring of neuromuscular blocking should be used where appropriate, as well as monitoring of the depth of anesthesia. The occurrence of intraoperative recall is indeed more frequent in the obese patient than in the non-obese patient. Appropriate prophylaxis against venous thromboembolic disease and early mobilization are recommended, as thromboembolic disease is increased in the obese patient. The use of non-invasive ventilation to prevent the occurrence of acute post-operative respiratory failure and for its treatment is particularly effective in obese patients. In case of admission to ICU, an individualized ventilatory management based on pathophysiology and careful monitoring should be initiated.","['De Jong, A', 'Verzilli, D', 'Chanques, G', 'Futier, E', 'Jaber, S']","['De Jong A', 'Verzilli D', 'Chanques G', 'Futier E', 'Jaber S']","[""PhyMedExp, University of Montpellier, Inserm, CNRS, CHU Montpellier, 371 avenue du doyen Gaston Giraud, 34080 Montpellier, France; Departement d'Anesthesie-Reanimation, hopital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France."", ""Departement d'Anesthesie-Reanimation, hopital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France."", ""PhyMedExp, University of Montpellier, Inserm, CNRS, CHU Montpellier, 371 avenue du doyen Gaston Giraud, 34080 Montpellier, France; Departement d'Anesthesie-Reanimation, hopital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France."", 'CHU de Clermont-Ferrand, Department of Perioperative Medicine, GReD, UMR/CNRS6293, University, Clermont Auvergne, Inserm, U1103, Clermont-Ferrand, France.', ""PhyMedExp, University of Montpellier, Inserm, CNRS, CHU Montpellier, 371 avenue du doyen Gaston Giraud, 34080 Montpellier, France; Departement d'Anesthesie-Reanimation, hopital Saint-Eloi, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France. Electronic address: s-jaber@chu-montpellier.fr.""]",['fre'],"['Journal Article', 'Review']",France,Rev Mal Respir,Revue des maladies respiratoires,8408032,"['0 (Analgesics)', '0 (Anesthetics)']",IM,"['Analgesics/therapeutic use', 'Anesthetics/administration & dosage', 'Antibiotic Prophylaxis', 'Cardiovascular Diseases/prevention & control', 'Diabetes Mellitus/therapy', 'Dose-Response Relationship, Drug', 'Humans', 'Obesity/*complications', 'Obesity Hypoventilation Syndrome/etiology/therapy', 'Oxygen Inhalation Therapy', '*Perioperative Care', 'Postoperative Complications/prevention & control', 'Respiration, Artificial', 'Respiratory Insufficiency/prevention & control', 'Sleep Apnea, Obstructive/etiology/therapy', 'Venous Thromboembolism/prevention & control']",,['NOTNLM'],"['Anaesthesia', 'Anesthesie', 'Bariatric surgery', 'Chirurgie bariatrique', 'Obesity', 'Obesite', 'Perioperative', 'Peri-operatoire', 'Sleep apnoea', ""Syndrome d'apnees du sommeil""]",,2019/09/16 06:00,2020/04/28 06:00,['2019/09/16 06:00'],"['2018/09/19 00:00 [received]', '2019/01/07 00:00 [accepted]', '2019/09/16 06:00 [pubmed]', '2020/04/28 06:00 [medline]', '2019/09/16 06:00 [entrez]']","['S0761-8425(19)30274-8 [pii]', '10.1016/j.rmr.2019.01.009 [doi]']",ppublish,Rev Mal Respir. 2019 Oct;36(8):985-1001. doi: 10.1016/j.rmr.2019.01.009. Epub 2019 Sep 11.,,20190911,,['Copyright (c) 2019 SPLF. Published by Elsevier Masson SAS. All rights reserved.'],,,,,Risque pre-operatoire et gestion peri-operatoire des patients obeses.,,,,,,,,,,,
5366611,NLM,MEDLINE,19700305,20181217,0031-4021 (Print) 0031-4021 (Linking),24,7,1969 Oct-Nov,"[Radioimmunologic determination of plasma insulin during orally provoked hyperglycemia in 70 children: normal, obese, diabetic or with post-transfusion hemosiderosis].",777-86,,,"['Pierron, H', 'Vague, P', 'Leroy-Rouvier, C', 'Vague, J', 'Orsini, A']","['Pierron H', 'Vague P', 'Leroy-Rouvier C', 'Vague J', 'Orsini A']",,['fre'],['Journal Article'],France,Pediatrie,Pediatrie,0401127,"['0 (Insulin)', '0 (Iodine Radioisotopes)']",IM,"['Adolescent', 'Child', 'Child, Preschool', 'Diabetes Mellitus, Type 1/*diagnosis', 'Female', 'Glucose Tolerance Test', 'Hemosiderosis/*diagnosis', 'Humans', 'Insulin/*blood/metabolism', 'Insulin Secretion', 'Iodine Radioisotopes', 'Male', 'Methods', 'Obesity/*diagnosis', 'Radioimmunoassay']",,,,,1969/10/01 00:00,2000/05/05 09:00,['1969/10/01 00:00'],"['1969/10/01 00:00 [pubmed]', '2000/05/05 09:00 [medline]', '1969/10/01 00:00 [entrez]']",,ppublish,Pediatrie. 1969 Oct-Nov;24(7):777-86.,,,,,,,,,"Le dosage radio-immunologique de l'insuline plasmatique au cours de l'hyperglycemie provoquee par voie orale chez 70 infants normaux, obeses, diabetiques ou porteurs d'une hemosiderose post-transfusionnelle.",,,,,,,,,,,
23974763,NLM,MEDLINE,20140331,20211021,1752-2978 (Electronic) 1752-296X (Print) 1752-296X (Linking),20,5,2013 Oct,Healthy obese persons: how can they be identified and do metabolic profiles stratify risk?,369-76,10.1097/01.med.0000433058.78485.b3 [doi],"PURPOSE OF REVIEW: New research supports the intuitive observation that many persons classified as obese are healthy, and should not be treated and categorized medically as diseased. There is increasing agreement that major blood biomarkers are often not discriminatory, as for example, the return to normal blood glucose levels in bariatric patients who do not have long-term benefits. Although weight loss is appreciated to improve metabolic and inflammatory parameters, the cellular and immune factors that couple obesity to cardiometabolic risk are only partially understood. RECENT FINDINGS: Reduced BMI upon successful bariatric surgery does not always result in reduced pericardial fat; certain patients gain ectopic fat, which should be considered an adverse response. There is emerging evidence that pericardial fat volume and brown fat stores may provide individualized patient assessments. SUMMARY: Some obese persons can be relieved of the additional stigma of classification in a major disease category, and unnecessary medical interventions and costs can be reduced. Other patients should be monitored more closely for unexpected adverse outcomes.","['Denis, Gerald V', 'Hamilton, James A']","['Denis GV', 'Hamilton JA']","['Cancer Research Center and Department of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, Massachusetts 02118, USA.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",England,Curr Opin Endocrinol Diabetes Obes,"Current opinion in endocrinology, diabetes, and obesity",101308636,,IM,"['Animals', 'Cardiovascular Diseases/epidemiology/etiology', 'Diagnosis, Differential', 'Health', 'Humans', 'Metabolic Diseases/diagnosis/*etiology', 'Neoplasms/epidemiology/etiology', 'Obesity/complications/*diagnosis/epidemiology/*metabolism', 'Risk']",PMC3934493,,,,2013/08/27 06:00,2014/04/01 06:00,['2013/08/27 06:00'],"['2013/08/27 06:00 [entrez]', '2013/08/27 06:00 [pubmed]', '2014/04/01 06:00 [medline]']",['10.1097/01.med.0000433058.78485.b3 [doi]'],ppublish,Curr Opin Endocrinol Diabetes Obes. 2013 Oct;20(5):369-76. doi: 10.1097/01.med.0000433058.78485.b3.,"['P30 DK046200/DK/NIDDK NIH HHS/United States', 'P30 DK057521/DK/NIDDK NIH HHS/United States', 'R56 DK090455/DK/NIDDK NIH HHS/United States', 'U01 CA182898/CA/NCI NIH HHS/United States']",,,,,['NIHMS556176'],,,,,,,,,,,,,,
16385746,NLM,MEDLINE,20060731,20191109,0307-0565 (Print) 0307-0565 (Linking),29 Suppl 2,,2005 Sep,Psychological profile to become and to stay obese.,S19-23,,"OBJECTIVE: The presentation will successively deal with the psychological models to explain for the onset or maintenance of child obesity. DESIGN: Five psychological perspectives on childhood obesity are selected. The boundary model of Herman and Polivy (1980) was brought forward as an explanation model for understanding the overeating behaviour in obese people. Others describe obese children as over-responsive to external cues and this over-responsiveness is seen as a personality trait. Learning theories put forward how (dysfunctional) learning mechanisms can explain also why obese people eat in front of food cues, without feeling hungry. Finally, obesity can be seen as an expression of a family pathology or an emotional problem. CONCLUSIONS: Psychological explanation models are still subject of discussion. Personality variables, eating behaviour, restraint attitudes, psychopathlogy and emotional factors, learning mechanisms as well as the role of the family are to be considered in an assessment process. It may help to better empathize with both parent and child. Furthermore, it can help to tailor the treatment program to the individual needs of an obese child. Further research is needed to find out whether already during the intake psychological indicators can be found that are predictors of negative therapy outcome.","['Braet, C']",['Braet C'],"['Department of Developmental, Personality and Social Psychology, Ghent University, Ghent, Belgium. Caroline.Braet@ugent.be']",['eng'],['Journal Article'],England,Int J Obes (Lond),International journal of obesity (2005),101256108,,IM,"['Child', 'Cues', 'Family Health', 'Humans', 'Impulsive Behavior', '*Models, Psychological', 'Obesity/*psychology/therapy', 'Parenting', 'Psychotherapy']",,,,,2005/12/31 09:00,2006/08/01 09:00,['2005/12/31 09:00'],"['2005/12/31 09:00 [pubmed]', '2006/08/01 09:00 [medline]', '2005/12/31 09:00 [entrez]']",['10.1038/sj.ijo.0803100 [doi]'],ppublish,Int J Obes (Lond). 2005 Sep;29 Suppl 2:S19-23. doi: 10.1038/sj.ijo.0803100.,,,,,,,,,,,,,,,,,,,,
15025034,NLM,MEDLINE,20040608,20130211,0172-6390 (Print) 0172-6390 (Linking),51,55,2004 Jan-Feb,Intragastric balloon: another option for treatment of obesity and morbid obesity.,294-7,,"BACKGROUND/AIMS: The BioEnterics Intragrastric Balloon (BIB, BioEnterics, Santa Barbara, CA) in association with restricted diet has been used for the treatment of obesity and morbid obesity. METHODOLOGY: Since March 1998, 349 BIB were placed in 303 obese and morbidly obese patients; 95 patients were male and 208 female; mean age was 41.5 years (19-70); mean weight was 118.8 Kg (67-229); mean BMI was 42 Kg/m2, % excess weight was 62.3% (4.6-216.3). The balloon was inserted and removed endoscopically under general anesthesia. Patients were given a balanced diet of 1000 Kcal/day. RESULTS: After 4 months of balloon treatment, the mean weight loss was 13.9 Kg and the mean reduction in BMI was 4.8 Kg/m2. Weight loss was greater in male patients. Weight loss was accompanied by an improvement of the diseases associated with obesity, in particular diabetes. CONCLUSIONS: The best indications for BIB were: morbidly obese (BMI >40) and super-obese patients (BMI >50) in preparation for bariatric operations; obese patients with BMI 35-40 with co-morbidity in preparation for bariatric surgery; obese patients with BMI 30-35 with a chronic disease otherwise unresolved; patients with BMI <30 only in a multidisciplinary approach.","['Doldi, S B', 'Micheletto, G', 'Perrini, M N', 'Rapetti, R']","['Doldi SB', 'Micheletto G', 'Perrini MN', 'Rapetti R']","[""Dipartimento di Scienze Chirurgiche dell'Universita degli Studi di Milano-Divisione di Chirurgia, Istituto Clinico Sant'Ambrogio di Milano, Centro per la Farmacoterapia delle malattie nutrizionali e metaboliche, Italy. santo.bressani@unimi.it""]",['eng'],"['Journal Article', 'Retracted Publication']",Greece,Hepatogastroenterology,Hepato-gastroenterology,8007849,,IM,"['Adult', 'Aged', 'Comorbidity', 'Diabetes Mellitus/surgery', 'Diet, Reducing', 'Female', '*Gastric Balloon', 'Humans', 'Hypertension/epidemiology', 'Male', 'Middle Aged', 'Obesity/diet therapy/*therapy', 'Obesity, Morbid/diet therapy/epidemiology/*therapy']",,,,,2004/03/18 05:00,2004/06/21 10:00,['2004/03/18 05:00'],"['2004/03/18 05:00 [pubmed]', '2004/06/21 10:00 [medline]', '2004/03/18 05:00 [entrez]']",,ppublish,Hepatogastroenterology. 2004 Jan-Feb;51(55):294-7.,,,,,,,,,,,,,,,,,,,,['Hepatogastroenterology. 2012 Nov-Dec;59(120):2683. PMID: 23393648']
19480125,NLM,MEDLINE,20090624,20171116,0038-3139 (Print) 0038-3139 (Linking),105,2,2009 Apr,"Practice guidelines for the diagnosis, treatment and prevention of childhood and adolescent obesity.",46-50,,"Obesity affects one third of children and adolescents, many of whom already have serious medical consequences. Therefore primary care providers must deliver clinical service that incorporates preventive practices, improves early diagnosis, and evaluates co-morbid conditions. In addition physicians must become more knowledgeable about changing practice in treating overweight and obese children.","['Hocevar, Susan N', 'Key, Janice D']","['Hocevar SN', 'Key JD']","['MUSC, 135 Rutledge Ave., Charleston, SC 29425, USA. hocevars@musc.edu']",['eng'],"['Journal Article', 'Practice Guideline']",United States,J S C Med Assoc,Journal of the South Carolina Medical Association (1975),7503045,,IM,"['Adolescent', 'Body Mass Index', 'Child', 'Family Health', 'Health Behavior', 'Humans', 'Metabolic Syndrome/epidemiology', 'Obesity/*diagnosis/epidemiology/prevention & control/*therapy']",,,,,2009/06/02 09:00,2009/06/25 09:00,['2009/06/02 09:00'],"['2009/06/02 09:00 [entrez]', '2009/06/02 09:00 [pubmed]', '2009/06/25 09:00 [medline]']",,ppublish,J S C Med Assoc. 2009 Apr;105(2):46-50.,,,,,,,,,,,,,,,,,,,,
17852553,NLM,MEDLINE,20080429,20151119,1747-7166 (Print) 1747-7166 (Linking),2,4,2007,Low-intensity family therapy intervention is useful in a clinical setting to treat obese and extremely obese children.,211-7,,"AIMS: To study the influence of low-intensity solution-focused family therapy with obese and extremely obese pediatric subjects on body mass index (BMI) z-scores and self-esteem. MATERIALS AND METHODS: Fifty-four obese children, aged 6-17 years, were referred to an outpatient obesity clinic. The families received solution-focused family therapy provided by a multidisciplinary team. Height and weight were recorded; BMI and BMI z-scores were derived. Self-esteem was assessed with a validated questionnaire, ""I Think I Am."" Parents completed ""The Family Climate Scale"" assessing family dynamics. RESULTS: Eighty-one percent of the children (n =44, mean age 11.9 years, mean BMI z-score 3.67, range 2.46-5.48) and their parents participated in the follow-up. Eleven children were treated for 6-12 months, and 33 for more than 12 months. On average, the families received 3.8 family therapy sessions. Intervention resulted in a mean decrease in BMI z-score of 0.12 (p =0.0001). Self-esteem on the global scale improved after intervention (p =0.002), and also on sub-scales, depicting physical characteristics (p <0.001), psychological well-being (p =0.026), and relations with others (p =0.046). The Family Climate Scale showed improvement in the sub-scales for Expressiveness (p = 0.002) and Chaos (p =0.002). CONCLUSIONS: Solution-focused family therapy provided by a multidisciplinary team to obese and extremely obese children may prove useful in the clinical setting, with a positive impact on obesity and self-esteem.","['Nowicka, Paulina', 'Pietrobelli, Angelo', 'Flodmark, Carl-Erik']","['Nowicka P', 'Pietrobelli A', 'Flodmark CE']","['Childhood Obesity Unit, University Hospital Malmo, Malmo, Sweden. paulina.nowicka@skane.se']",['eng'],"['Clinical Trial', 'Journal Article']",England,Int J Pediatr Obes,International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity,101256330,,IM,"['Adolescent', '*Body Mass Index', 'Child', '*Family Relations', '*Family Therapy', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Obesity/physiopathology/psychology/*therapy', 'Obesity, Morbid/physiopathology/psychology/*therapy', 'Patient Care Team', '*Psychology, Adolescent', '*Psychology, Child', '*Self Concept', 'Severity of Illness Index', 'Surveys and Questionnaires', 'Time Factors', 'Treatment Outcome']",,,,,2007/09/14 09:00,2008/04/30 09:00,['2007/09/14 09:00'],"['2007/09/14 09:00 [pubmed]', '2008/04/30 09:00 [medline]', '2007/09/14 09:00 [entrez]']","['778943492 [pii]', '10.1080/17477160701379810 [doi]']",ppublish,Int J Pediatr Obes. 2007;2(4):211-7. doi: 10.1080/17477160701379810.,,,,,,,,,,,,,,,,,,,,
18539769,NLM,MEDLINE,20080717,20220330,0021-972X (Print) 0021-972X (Linking),93,6,2008 Jun,Update on obesity.,2027-34,10.1210/jc.2008-0520 [doi],"Endocrinologists have unique skills in evaluating and caring for patients with metabolic diseases. As such, they have a special role to play within the organizations in which they work as leaders in the approach to managing obese patients. Recent epidemiological data demonstrate that the prevalence of obesity is beginning to plateau. However, the rate of severe obesity in adults and the prevalence of overweight among children continue to grow, suggesting that in the future there will be an increasing burden of obesity-related illnesses. A number of recent studies have identified a number of novel mechanisms that predispose to obesity including several newly identified genes, the role of intestinal microflora, and even social networks. The selection of treatment for obese patients remains a complex issue. Recent studies demonstrate that a range of dietary approaches including the Atkins diet can provide modest weight loss, although the key feature appears to be adherence in the dietary strategy. High levels of physical activity appear to be necessary to maintain a reduced state, although modest increases in activity improve fitness. Although the new understanding of biology of weight regulation has provided a wide range of potential drug targets, available pharmacotherapy options remain limited although a number of potential targets show promise. Recent data provides the most enthusiasm for surgical treatment of obesity. Several recent studies demonstrate a reduction in mortality and dramatic benefits in diabetes in obese patients treated surgically. Questions remain as to the best surgical approach and the cost effectiveness. Research advances in obesity continue to move at a rapid pace and raise hopes for more effective management strategies in the future.","['Bessesen, Daniel H']",['Bessesen DH'],"['Division of Endocrinology, Denver Health Medical Center, and University of Colorado School of Medicine, Aurora, CO 80045, USA. daniel.bessesen@uchsc.edu']",['eng'],"['Journal Article', 'Review']",United States,J Clin Endocrinol Metab,The Journal of clinical endocrinology and metabolism,0375362,['0 (Anti-Obesity Agents)'],IM,"['Anti-Obesity Agents/therapeutic use', 'Bariatric Surgery/trends', 'Diet Therapy/trends', 'Exercise Therapy', 'Forecasting', 'Humans', 'Obesity/epidemiology/etiology/mortality/*therapy', 'Weight Gain/physiology']",,,,,2008/06/10 09:00,2008/07/18 09:00,['2008/06/10 09:00'],"['2008/06/10 09:00 [pubmed]', '2008/07/18 09:00 [medline]', '2008/06/10 09:00 [entrez]']","['93/6/2027 [pii]', '10.1210/jc.2008-0520 [doi]']",ppublish,J Clin Endocrinol Metab. 2008 Jun;93(6):2027-34. doi: 10.1210/jc.2008-0520.,,,,,,,46,,,,,,,,,,,,,
12490657,NLM,MEDLINE,20030604,20220409,1071-7323 (Print) 1071-7323 (Linking),10 Suppl 2,,2002 Dec,"Obesity as a disease: etiology, treatment, and management considerations for the obese patient.",95S-96S,,,"['Aronne, Louis J']",['Aronne LJ'],"['Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA. ljaronne@med.cornell.edu']",['eng'],"['Journal Article', 'Review']",United States,Obes Res,Obesity research,9305691,,IM,"['Diet', 'Exercise', 'Humans', 'Life Style', 'Obesity/epidemiology/*etiology/*therapy', 'Patient Education as Topic', ""Physician's Role"", 'Weight Loss']",,,,,2002/12/20 04:00,2003/06/05 05:00,['2002/12/20 04:00'],"['2002/12/20 04:00 [pubmed]', '2003/06/05 05:00 [medline]', '2002/12/20 04:00 [entrez]']",['10.1038/oby.2002.201 [doi]'],ppublish,Obes Res. 2002 Dec;10 Suppl 2:95S-96S. doi: 10.1038/oby.2002.201.,,,,,,,4,,,,,,,,,,,,,
6919929,NLM,MEDLINE,19820807,20041117,0029-6465 (Print) 0029-6465 (Linking),17,2,1982 Jun,Obesity and the school-age child.,207-16,,"The need for nursing involvement in the care of the obese school-age child and his family has been identified. The use of the nursing process based on the MSI Model of nursing has been discussed. The nurse plays an important role in identifying overweight children and in working with these children and their families when the need arises. the focus of nursing care may be preventing future weight gain, weight reduction, or regain after reduction. Linda, the obese child in Blubber, was ridiculed by her peers. This is a common, everyday experience for the obese child. It is hoped that the obese school-age child will have a better success rate for weight reduction and will ultimately be able to maintain the weight loss through the interventions of a professional nurse who uses this holistic approach to nursing care.","['Hagenbuch, V E']",['Hagenbuch VE'],,['eng'],['Journal Article'],United States,Nurs Clin North Am,The Nursing clinics of North America,0042033,,IM,"['Adolescent', 'Adult', 'Body Image', 'Child', 'Diet, Reducing', 'Family', 'Female', 'Health Education', 'Humans', 'Male', 'Models, Theoretical', '*Nursing Process', 'Obesity/diet therapy/nursing/*psychology']",,,,,1982/06/01 00:00,1982/06/01 00:01,['1982/06/01 00:00'],"['1982/06/01 00:00 [pubmed]', '1982/06/01 00:01 [medline]', '1982/06/01 00:00 [entrez]']",,ppublish,Nurs Clin North Am. 1982 Jun;17(2):207-16.,,,,,,,,,,,,,,,,,,,,
11590316,NLM,MEDLINE,20011101,20191025,0029-7828 (Print) 0029-7828 (Linking),56,10,2001 Oct,"Focus on primary care: evaluation, management, and treatment of obesity in women.",650-63,,"Obesity is the number one nutritional disorder in the developed world. It is now well recognized that obesity is a disease that represents a rapidly growing epidemic. It is often a lifelong problem that preferentially affects women. Modern science and medicine are just beginning to unravel the multifactorial pathophysiology of obesity. Current literature emphasizes the metabolic, hormonal, and behavioral interactions as well as genetic predisposition. This understanding has led to new recommendations for the management of the obese patient and to new pharmaceutical approaches for those at high risk. These risks include diabetes, cardiovascular disease, hypertension, gallbladder disease, and osteoarthritis. In addition, there are a number of reproductive health problems unique to obese women. Until recently, however, the evidence for benefit of weight loss was not clear. There are now numerous Category A data indicating significant benefit for weight loss as it affects multiple comorbidities It is, therefore, incumbent upon the providers of women's health care to assess patient risk and to offer resources, guidance, assistance, and reassurance to the overweight and obese patient as she embarks on a program of renewed health through weight loss. LEARNING OBJECTIVES: After completion of this article, the reader will be able to describe the classification of overweight and obesity, explain the pathophysiology of obesity, outline the evaluation and screening of the obese patient, and list potential therapeutic interventions for weight loss.","['Dickerson, V M']",['Dickerson VM'],"['Department of Obstetrics and Gynecology, University of California, Irvine Medical Center, Orange, CA 92868, USA. vdickers@uci.edu']",['eng'],"['Journal Article', 'Review']",United States,Obstet Gynecol Surv,Obstetrical & gynecological survey,0401007,,IM,"['Education, Medical, Continuing', 'Female', 'Humans', 'Obesity/*diagnosis/*therapy', '*Primary Health Care', 'Weight Loss', ""Women's Health""]",,,,,2001/10/09 10:00,2001/11/03 10:01,['2001/10/09 10:00'],"['2001/10/09 10:00 [pubmed]', '2001/11/03 10:01 [medline]', '2001/10/09 10:00 [entrez]']",['10.1097/00006254-200110000-00024 [doi]'],ppublish,Obstet Gynecol Surv. 2001 Oct;56(10):650-63. doi: 10.1097/00006254-200110000-00024.,,,,,,,109,,,,,,,,,,,,,
26592916,NLM,MEDLINE,20160520,20220330,1941-9260 (Electronic) 0032-5481 (Linking),128,1,2016 Jan,Diagnosing binge eating disorder in a primary care setting.,115-23,10.1080/00325481.2016.1115330 [doi],"Binge eating disorder (BED), now recognized as a distinct eating disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, is the most prevalent eating disorder. Although nearly half of individuals with BED are obese, BED also occurs in nonobese individuals. Despite the relatively high percentage of weight loss treatment-seeking individuals meeting BED criteria, primary care physicians may not be familiar with or have ever diagnosed BED. Many providers may also have difficulty distinguishing BED as a contributory factor in obesity. This review differentiates BED from other causes of obesity by describing how obese individuals with BED differ from obese individuals without BED and from nonobese individuals with BED in areas including psychopathology, behavior, genetics, physiology, quality of life and productivity. The ways in which health-care providers can identify individuals who may have BED are also highlighted so the proper course of treatment is pursued. Overall, obese individuals with BED demonstrate a number of key characteristics that differentiate them from obese individuals without eating disorders, including increased impulsivity in response to food stimuli with loss of control over eating, resulting in the consumption of more calories. They also experience significant guilt and other negative emotions following a meal. In addition, individuals with BED patients have more psychiatric comorbidity, display more psychopathology, exhibit longer binge durations, consume more meals as snacks during the day and have less dietary restraint compared with individuals with BED who are not obese. However, the differences between individuals with BED who are obese versus not obese are not as prominent. Taken together, the evidence appears to support the conclusion that BED is a unique and treatable neurobehavioral disorder associated with distinct behavioral and psychological profiles and distinct medical and functional outcomes, and that it is not merely a subtype of obesity.","['Montano, C Brendan', 'Rasgon, Natalie L', 'Herman, Barry K']","['Montano CB', 'Rasgon NL', 'Herman BK']","['a Connecticut Clinical Research Center, Private Practice, Internal Medicine , Cromwell , CT , USA.', 'b Department of Psychiatry and Behavioral Sciences , Stanford University School of Medicine , Stanford , CA , USA.', 'c Global Medical Affairs , Shire , Wayne , PA , USA.']",['eng'],"['Journal Article', 'Review']",England,Postgrad Med,Postgraduate medicine,0401147,,IM,"['Binge-Eating Disorder/complications/*diagnosis', 'Diagnosis, Differential', 'Humans', 'Obesity/diagnosis/*etiology', '*Primary Health Care']",,['NOTNLM'],"['Binge eating disorder', 'Diagnosis', 'Differentiation', 'Obesity', 'Primary care']",,2015/11/26 06:00,2016/05/21 06:00,['2015/11/24 06:00'],"['2015/11/24 06:00 [entrez]', '2015/11/26 06:00 [pubmed]', '2016/05/21 06:00 [medline]']",['10.1080/00325481.2016.1115330 [doi]'],ppublish,Postgrad Med. 2016 Jan;128(1):115-23. doi: 10.1080/00325481.2016.1115330. Epub 2015 Nov 23.,,20151123,,,,,,,,,,,,,,,,,,
16881200,NLM,MEDLINE,20060915,20171116,0375-0906 (Print) 0375-0906 (Linking),69 Suppl 3,,2004 Nov,[New concepts in the diagnosis and classification of the obese patient].,66-9,,,"['Garcia, Eduardo']",['Garcia E'],"['Clinica de Obesidad Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Tlalpan, DF Mexico.']",['spa'],"['Case Reports', 'Journal Article', 'Review']",Mexico,Rev Gastroenterol Mex,Revista de gastroenterologia de Mexico,0404271,,IM,"['Adult', 'Biopsy', 'Diabetes Complications', 'Female', 'Humans', 'Metabolic Syndrome/complications', 'Obesity/*classification/*diagnosis/psychology']",,,,,2006/08/03 09:00,2006/09/16 09:00,['2006/08/03 09:00'],"['2006/08/03 09:00 [pubmed]', '2006/09/16 09:00 [medline]', '2006/08/03 09:00 [entrez]']",,ppublish,Rev Gastroenterol Mex. 2004 Nov;69 Suppl 3:66-9.,,,,,,,8,,Nuevos conceptos en el diagnostico y clasificacion del paciente obeso.,,,,,,,,,,,
18824817,NLM,MEDLINE,20081118,20141120,1941-9260 (Electronic) 0032-5481 (Linking),120,3,2008 Sep 15,Maternal obesity and pregnancy.,E01-9,10.3810/pgm.2008.09.1920 [doi],"Obesity is a global health problem that is increasing in prevalence. The World Health Organization characterizes obesity as a pandemic issue, with a higher prevalence in females than males. Thus, many pregnant patients are seen with high body mass index (BMI). Obesity during pregnancy is considered a high-risk state because it is associated with many complications. Compared with normal-weight patients, obese patients have a higher prevalence of infertility. Once they conceive, they have higher rate of early miscarriage and congenital anomalies, including neural tube defects. Besides the coexistence of preexisting diabetes mellitus and chronic hypertension, obese women are more likely to have pregnancy-induced hypertension, gestational diabetes, thromboembolism, macrosomia, and spontaneous intrauterine demises in the latter half of pregnancy. Obese women also require instrument or Cesarean section delivery more often than average-weight women. Following Cesarean section delivery, obese women have a higher incidence of wound infection and disruption. Irrespective of the delivery mode, children born to obese mothers have a higher incidence of macrosomia and associated shoulder dystocia, which can be highly unpredictable. In addition to being large at birth, children born to obese mothers are also more susceptible to obesity in adolescence and adulthood. Prevention is the best way to prevent this problem. As pregnancy is the worst time to lose weight, women with a high BMI should be encouraged to lose weight prior to conceiving. During preconception counseling, they should be educated about the complications associated with high a BMI. Obese women should also be screened for hypertension and diabetes mellitus. In early pregnancy, besides being watchful about the higher association of miscarriage, obese women should be screened with ultrasound for congenital anomalies around 18 to 22 weeks. The ultrasound should be repeated close to term to check on the estimated fetal weight to rule out macrosomia. Obese pregnant women are screened for gestational diabetes around 24 to 28 weeks. During the second half of pregnancy, one needs to closely watch for signs and symptoms of pregnancy-induced hypertension. Once in labor, an early anesthesia consultation is highly recommended irrespective of delivery mode. When Cesarean section is performed, many obstetricians prefer an incision above the pannus to avoid skin infection. However, the incision should be decided upon the discretion of the surgeon. Peripartum, special attention is given to avoid thromboembolism by using compression stockings and early ambulation.","['Satpathy, Hemant K', 'Fleming, Alfred', 'Frey, Donald', 'Barsoom, Michael', 'Satpathy, Chabi', 'Khandalavala, Jimmy']","['Satpathy HK', 'Fleming A', 'Frey D', 'Barsoom M', 'Satpathy C', 'Khandalavala J']","['Department of OB-GYN, Creighton University Medical Center, Omaha, NE 68105, USA.']",['eng'],"['Journal Article', 'Review']",England,Postgrad Med,Postgraduate medicine,0401147,,IM,"['Bariatric Surgery', '*Disease Outbreaks', 'Female', '*Global Health', 'Humans', 'Obesity/complications/*epidemiology/therapy', 'Pregnancy', 'Pregnancy Complications/*epidemiology/therapy', 'Pregnancy Outcome', 'Prevalence']",,,,,2008/10/01 09:00,2008/11/19 09:00,['2008/10/01 09:00'],"['2008/10/01 09:00 [pubmed]', '2008/11/19 09:00 [medline]', '2008/10/01 09:00 [entrez]']",['10.3810/pgm.2008.09.1920 [doi]'],epublish,Postgrad Med. 2008 Sep 15;120(3):E01-9. doi: 10.3810/pgm.2008.09.1920.,,20080915,,,,,104,,,,,,,,,,,,,
27875563,NLM,MEDLINE,20170622,20181113,1932-6203 (Electronic) 1932-6203 (Linking),11,11,2016,Multimodal Body Representation of Obese Children and Adolescents before and after Weight-Loss Treatment in Comparison to Normal-Weight Children.,e0166826,10.1371/journal.pone.0166826 [doi] e0166826,"OBJECTIVE: The aim of the study was to investigate whether obese children and adolescents have a disturbed body representation as compared to normal-weight participants matched for age and gender and whether their body representation changes in the course of an inpatient weight-reduction program. METHODS: Sixty obese (OBE) and 27 normal-weight (NW) children and adolescents (age: 9-17) were assessed for body representation using a multi-method approach. Therefore, we assessed body size estimation, tactile size estimation, heartbeat detection accuracy, and attitudes towards one's own body. OBE were examined upon admission and before discharge of an inpatient weight-reduction program. NW served as cross-sectional control group. RESULTS: Body size estimation and heartbeat detection accuracy were similar in OBE and NW. OBE overestimated sizes in tactile size estimation and were more dissatisfied with their body as compared to NW. In OBE but not in NW, several measures of body size estimation correlated with negative body evaluation. After weight-loss treatment, OBE had improved in heartbeat detection accuracy and were less dissatisfied with their body. None of the assessed variables predicted weight-loss success. CONCLUSIONS: Although OBE children and adolescents generally perceived their body size and internal status of the body accurately, weight reduction improved their heartbeat detection accuracy and body dissatisfaction.","['Molbert, Simone Claire', 'Sauer, Helene', 'Dammann, Dirk', 'Zipfel, Stephan', 'Teufel, Martin', 'Junne, Florian', 'Enck, Paul', 'Giel, Katrin Elisabeth', 'Mack, Isabelle']","['Molbert SC', 'Sauer H', 'Dammann D', 'Zipfel S', 'Teufel M', 'Junne F', 'Enck P', 'Giel KE', 'Mack I']","['Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, Tubingen, Germany.', 'Max Planck Institute for Biological Cybernetics, Tubingen, Germany.', 'Graduate Training Centre of Neuroscience, International Max Planck Research School, University Tubingen, Tubingen, Germany.', 'Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, Tubingen, Germany.', 'Fachkliniken Wangen i.A., Children Rehabilitation Hospital for Respiratory Diseases, Allergies and Psychosomatics, Wangen i.A., Germany.', 'Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, Tubingen, Germany.', 'Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, Tubingen, Germany.', 'Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, Tubingen, Germany.', 'Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, Tubingen, Germany.', 'Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, Tubingen, Germany.', 'Department of Psychosomatic Medicine and Psychotherapy, University Medical Hospital, Tubingen, Germany.']",['eng'],"['Clinical Trial', 'Comparative Study', 'Journal Article']",United States,PLoS One,PloS one,101285081,,IM,"['Adolescent', '*Body Size', 'Child', 'Cross-Sectional Studies', 'Female', '*Heart Rate', 'Humans', 'Male', 'Obesity/*pathology/*physiopathology/*psychology/*therapy', '*Weight Loss']",PMC5119783,,,['The authors have declared that no competing interests exist.'],2016/11/23 06:00,2017/06/24 06:00,['2016/11/23 06:00'],"['2016/09/21 00:00 [received]', '2016/11/05 00:00 [accepted]', '2016/11/23 06:00 [entrez]', '2016/11/23 06:00 [pubmed]', '2017/06/24 06:00 [medline]']","['PONE-D-16-37718 [pii]', '10.1371/journal.pone.0166826 [doi]']",epublish,PLoS One. 2016 Nov 22;11(11):e0166826. doi: 10.1371/journal.pone.0166826. eCollection 2016.,,20161122,,,['ORCID: 0000-0002-0430-5245'],,,,,,,,,,,,,,,
2197073,NLM,MEDLINE,19900827,20181113,0012-6667 (Print) 0012-6667 (Linking),39 Suppl 3,,1990,"Management strategies for weight control. Eating, exercise and behaviour.",20-32,,"Obesity is a major health and social problem worldwide for which no single satisfactory treatment exists. Because of the prevalence of the disease, numerous therapeutic strategies have been attempted--often unsuccessfully. Weight loss programmes based on dietary restriction of caloric intake and nutritional education, exercise, surgical (gastroplasty, gastric bypass) and procedural (gastric balloon, waist cord, jaw wiring, liposuction) intervention and pharmacotherapy (appetite suppressants, thermogenic agents, bulking agents) used alone or in combination, have produced weight loss in the short to medium term; however, weight is generally regained on discontinuation of treatment. Behaviour modification programmes appear to offer the highest success rate in the long term. Weight loss is not rapid, although losses of 10 to 15 kg have been achieved after 6 months, and this may be increased when behaviour modification therapy is combined with more aggressive treatments such as severe caloric restriction or jaw wiring. Behaviour modification is particularly beneficial in special patient groups such as the obese elderly, children or adolescents, and disabled patients. Thus, although it appears that each of the treatments developed for the management of obese patients has its place, the cornerstone of therapy for most patients remains a programme of dietary restriction, combined with exercise and behaviour modification.","['Caterson, I D']",['Caterson ID'],"['Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, Australia.']",['eng'],"['Journal Article', 'Review']",New Zealand,Drugs,Drugs,7600076,,IM,"['Behavior Therapy', 'Eating', 'Exercise', 'Humans', 'Obesity/diet therapy/drug therapy/*therapy']",,,,,1990/01/01 00:00,1990/01/01 00:01,['1990/01/01 00:00'],"['1990/01/01 00:00 [pubmed]', '1990/01/01 00:01 [medline]', '1990/01/01 00:00 [entrez]']",['10.2165/00003495-199000393-00004 [doi]'],ppublish,Drugs. 1990;39 Suppl 3:20-32. doi: 10.2165/00003495-199000393-00004.,,,,,,,123,,,,,,,,,,,,,
21222170,NLM,MEDLINE,20111027,20221207,1525-1497 (Electronic) 0884-8734 (Print) 0884-8734 (Linking),26,6,2011 Jun,Ethnic differences in the self-recognition of obesity and obesity-related comorbidities: a cross-sectional analysis.,616-20,10.1007/s11606-010-1623-3 [doi],"BACKGROUND: Obesity and its related co-morbidities place a huge burden on the health care system. Patients who know they are obese may better control their weight or seek medical attention. Self-recognition may be affected by race/ethnicity, but little is known about racial/ethnic differences in knowledge of obesity's health risks. OBJECTIVE: To examine awareness of obesity and attendant health risks among US whites, Hispanics and African-Americans. DESIGN: Cross-sectional self-administered survey. PARTICIPANTS: Adult patients at three general medical clinics and one cardiology clinic. MAIN MEASURES: Thirty-one questions regarding demographics, height and weight, and perceptions and attitudes regarding obesity and associated health risks. Multiple logistic regression was used to quantify the association between ethnicity and obesity awareness, controlling for socio-demographic confounders. KEY RESULTS: Of 1,090 patients who were offered the survey, 1,031 completed it (response rate 95%); a final sample size of 970 was obtained after exclusion for implausible BMI, mixed or Asian ethnicity. Mean age was 47 years; 64% were female, 39% were white, 39% Hispanic and 22% African-American; 48% were obese (BMI >/=30 kg/m(2)). Among obese subjects, whites were more likely to self-report obesity than minorities (adjusted proportions: 95% of whites vs. 84% of African-American and 86% of Hispanics, P = 0.006). Ethnic differences in obesity recognition disappeared when BMI was >35 kg/m(2). African-Americans were significantly less likely than whites or Hispanics to view obesity as a health problem (77% vs. 90% vs. 88%, p < 0.001); African-Americans and Hispanics were less likely than whites to recognize the link between obesity and hypertension, diabetes and heart disease. Of self-identified obese patients, 99% wanted to lose weight, but only 60% received weight loss advice from their health care provider. CONCLUSIONS: African-Americans and Hispanics are significantly less likely to self report obesity and associated health risks. Educational efforts may be necessary, especially for patients with BMIs between 30 and 35.","['Sivalingam, Senthil K', 'Ashraf, Javed', 'Vallurupalli, Neelima', 'Friderici, Jennifer', 'Cook, James', 'Rothberg, Michael B']","['Sivalingam SK', 'Ashraf J', 'Vallurupalli N', 'Friderici J', 'Cook J', 'Rothberg MB']","['Division of Cardiology, Baystate Medical Center, Springfield, MA, USA. senthilkumar_mmc@yahoo.com']",['eng'],"['Comparative Study', 'Journal Article', 'Multicenter Study']",United States,J Gen Intern Med,Journal of general internal medicine,8605834,,IM,"['Adult', 'Black or African American/ethnology/psychology', 'Aged', 'Body Weight/physiology', 'Comorbidity', 'Cross-Sectional Studies', 'Diabetes Mellitus/ethnology/psychology', '*Diagnostic Self Evaluation', 'Ethnicity/*ethnology/*psychology', 'Female', 'Hispanic or Latino/ethnology/psychology', 'Humans', 'Hypertension/ethnology/psychology', 'Male', 'Middle Aged', 'Obesity/*ethnology/*psychology', 'Pilot Projects', '*Recognition, Psychology', 'Self Concept', 'Surveys and Questionnaires', 'White People/ethnology/psychology']",PMC3101976,,,,2011/01/12 06:00,2011/10/28 06:00,['2011/01/12 06:00'],"['2010/07/29 00:00 [received]', '2010/12/09 00:00 [accepted]', '2010/12/03 00:00 [revised]', '2011/01/12 06:00 [entrez]', '2011/01/12 06:00 [pubmed]', '2011/10/28 06:00 [medline]']","['1623 [pii]', '10.1007/s11606-010-1623-3 [doi]']",ppublish,J Gen Intern Med. 2011 Jun;26(6):616-20. doi: 10.1007/s11606-010-1623-3. Epub 2011 Jan 11.,,20110111,,,,,,,,,,,,,,,,,,
16310662,NLM,MEDLINE,20060208,20190227,0889-8537 (Print) 0889-8537 (Linking),23,4,2005 Dec,Anesthesia for pediatric obesity.,"745-64, x",,"This article discusses the unique anesthetic implications of obesity, with an emphasis on children and adolescents. It also touches on the issues surrounding bariatric surgery in the morbidly obese adolescent population. Adolescent bariatric surgery is moving to the forefront as a treatment modality because weight-loss programs alone are not keeping pace with the growth of the problem. Bariatric surgery offers the potential to achieve the weight reductions necessary to reverse the debilitating and costly comorbidities of obesity.","['Brenn, B Randall']",['Brenn BR'],"['Department of Anesthesiology, Alfred I. duPont Hospital for Children, Wilmington, DE 19899, USA. brbrenn@nemours.org']",['eng'],"['Journal Article', 'Review']",United States,Anesthesiol Clin North Am,Anesthesiology clinics of North America,8810131,,IM,"['Anastomosis, Roux-en-Y', '*Anesthesia', 'Child', 'Gastric Bypass', 'Humans', 'Obesity/complications/epidemiology/physiopathology/*surgery', 'Terminology as Topic', 'United States/epidemiology']",,,,,2005/11/29 09:00,2006/02/09 09:00,['2005/11/29 09:00'],"['2005/11/29 09:00 [pubmed]', '2006/02/09 09:00 [medline]', '2005/11/29 09:00 [entrez]']","['S0889-8537(05)00089-1 [pii]', '10.1016/j.atc.2005.08.008 [doi]']",ppublish,"Anesthesiol Clin North Am. 2005 Dec;23(4):745-64, x. doi: 10.1016/j.atc.2005.08.008.",,,,,,,65,,,,,,,,,,,,,
6394525,NLM,MEDLINE,19850301,20140603,,8,5,1984,Enzymatic alterations in the obese: long or short-term regulatory errors?,561-9,,,"['Greenwood, M R']",['Greenwood MR'],,['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S."", 'Review']",England,Int J Obes,International journal of obesity,7703240,['EC 2.7.1.21 (Thymidine Kinase)'],IM,"['Adipose Tissue/pathology', 'Animals', 'Cell Division', 'Feeding Behavior', 'Female', 'Humans', 'Male', 'Obesity/*enzymology/etiology/pathology/physiopathology/psychology', 'Rats', 'Satiety Response/physiology', 'Thymidine Kinase/analysis']",,,,,1984/01/01 00:00,1984/01/01 00:01,['1984/01/01 00:00'],"['1984/01/01 00:00 [pubmed]', '1984/01/01 00:01 [medline]', '1984/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1984;8(5):561-9.,"['AM25141/AM/NIADDK NIH HHS/United States', 'HD00283/HD/NICHD NIH HHS/United States', 'HD12637/HD/NICHD NIH HHS/United States']",,,,,,36,,,,,,,,,,,,,
31502911,NLM,MEDLINE,20191224,20191224,1502-4725 (Electronic) 0803-9488 (Linking),73,8,2019 Nov,Levels of childhood traumatic experiences and dissociative symptoms in extremely obese patients with and without binge eating disorder.,527-531,10.1080/08039488.2019.1662085 [doi],"Background: It has been suggested that obese patients with binge eating disorder (BED) show higher levels of dissociation and childhood trauma. Aim: This study assesses childhood trauma history and dissociative symptoms in obese patients with BED compared to obese patients without BED. Methods: The 241 patients participating in the study had to meet obesity criteria. These patients were applicants for bariatric surgery and were consulted by a psychiatry service. Patients were separated into two groups that were accompanied by BED diagnoses according to structured clinical interviews administered according to the DSM-IV (SCID-I). Patients were assessed using the Dissociation Questionnaire (DIS-Q) and the Childhood Trauma Questionnaire (CTQ). The two groups of patients were compared. Results: A total of 75 (31.1%) of the 241 obese patients were diagnosed with BED. The study showed that obese patients with BED had higher dissociative scores than those without BED (p < .05). The results showed higher total scores and two different types of childhood trauma (physical abuse and emotional abuse) in BED patients compared to non-BED patients (p < .05). Conclusions: Clinicians should be fully aware of BED, dissociative symptoms and childhood traumatic experiences. These results show that, for at least a sub-group of obese patients, BED is associated with obesity and may be connected with dissociative symptoms and childhood physical abuse and emotional abuse.","['Belli, Hasan', 'Ural, Cenk', 'Akbudak, Mahir', 'Sagaltici, Eser']","['Belli H', 'Ural C', 'Akbudak M', 'Sagaltici E']","['Department of Psychiatry, Bagcilar Education and Research Hospital, University of Health Sciences , Istanbul , Turkey.', 'Department of Psychiatry, Bagcilar Education and Research Hospital, University of Health Sciences , Istanbul , Turkey.', 'Department of Psychiatry, Mardin State Hospital , Mardin , Turkey.', 'Department of Psychiatry, Bagcilar Education and Research Hospital, University of Health Sciences , Istanbul , Turkey.']",['eng'],"['Comparative Study', 'Journal Article']",England,Nord J Psychiatry,Nordic journal of psychiatry,100927567,,IM,"['Adult', 'Binge-Eating Disorder/diagnosis/epidemiology/*psychology', 'Child', 'Child Abuse/*psychology/*trends', 'Cross-Sectional Studies', 'Dissociative Disorders/diagnosis/epidemiology/*psychology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/diagnosis/epidemiology/psychology', 'Obesity, Morbid/diagnosis/epidemiology/*psychology', 'Surveys and Questionnaires']",,['NOTNLM'],"['Obesity', 'binge eating disorder', 'childhood trauma', 'dissociation']",,2019/09/11 06:00,2019/12/25 06:00,['2019/09/11 06:00'],"['2019/09/11 06:00 [pubmed]', '2019/12/25 06:00 [medline]', '2019/09/11 06:00 [entrez]']",['10.1080/08039488.2019.1662085 [doi]'],ppublish,Nord J Psychiatry. 2019 Nov;73(8):527-531. doi: 10.1080/08039488.2019.1662085. Epub 2019 Sep 10.,,20190910,,,,,,,,,,,,,,,,,,
11964194,NLM,MEDLINE,20020603,20041117,0014-0139 (Print) 0014-0139 (Linking),45,1,2002 Jan 15,Quantitative prediction of body diameter in severely obese individuals.,49-60,,"The prevalence of obesity and severe obesity continues to increase in the developed world. Apart from obesity's strong association with a variety of health conditions, severely obese individuals (i.e. > or = 300 lb [136 kg]) sometimes have difficulty with ambulation, and often cannot use regular sized clothes, furniture, and assistive devices such as walkers and wheelchairs. The purpose of this study was to assess the relationship between linear body measurements (anthropometry) and weight in severely obese people in order to generate equations to predict such measurements from weight alone. Various body size measurements were obtained from three independent data sets (74 severely obese individuals evaluated at the New York Obesity Research Center, 103 severely obese individuals who participated in the National Center for Health Statistics' National Health and Nutrition Examination Survey III, and a further 90 severely obese individuals evaluated at the New York Obesity Research Center). Linear regression analyses revealed that for each increase of 10 kg (22.04 lb) above 136 kg (300 lb), body diameter measurements increase by 0.9-1.1 cm. These analyses provide body size-to-weight estimates that may help manufacturers develop products and services that are more appropriate for increasing numbers of severely obese individuals.","['Fontaine, Kevin R', 'Gadbury, Gary', 'Heymsfield, Steven B', 'Kral, John', 'Albu, Jeanine B', 'Allison, David']","['Fontaine KR', 'Gadbury G', 'Heymsfield SB', 'Kral J', 'Albu JB', 'Allison D']","['Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD, USA.']",['eng'],['Journal Article'],England,Ergonomics,Ergonomics,0373220,,IM,"['Adolescent', 'Adult', 'Aged', '*Anthropometry', 'Body Composition/physiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'New York', 'Obesity, Morbid/*physiopathology', 'United States']",,,,,2002/04/20 10:00,2002/06/04 10:01,['2002/04/20 10:00'],"['2002/04/20 10:00 [pubmed]', '2002/06/04 10:01 [medline]', '2002/04/20 10:00 [entrez]']",['10.1080/00140130110112627 [doi]'],ppublish,Ergonomics. 2002 Jan 15;45(1):49-60. doi: 10.1080/00140130110112627.,,,,,,,,,,,,,,,,,,,,
8977058,NLM,MEDLINE,19970318,20191101,0889-8529 (Print) 0889-8529 (Linking),25,4,1996 Dec,Surgery for obesity.,1005-27,,"The medical risks of obesity increase exponentially as weight increases, and these risks are reduced by sustained weight loss. Behavior modification and dieting provide an approximately 6% loss of body weight at 1 year. Fenfluramine provides an approximately 8% weight loss at 1 year, which can be doubled to 16% when a drug such as phentermine, which works through a different biochemical mechanism, is added to it. This amount of weight loss is insufficient for many severely obese individuals. It was with these facts in mind that the National Institutes of Health Consensus Conference in 1992 recommended that obesity surgery is an appropriate treatment for patients with a body mass index greater than 40 kg/m2 who had failed in attempts at medical treatment and for patients with a body mass index greater than 35 kg/m2 with severe complications of obesity. Vertically banded gastroplasty and Roux-en-Y gastric bypass are the two operations presently recommended because of their relative safety and effectiveness. This article reviews previous procedures that have provided insight into the mechanisms by which these surgeries cause weight loss. The presently used surgeries and their results also are reviewed because until medical therapy improves substantially, surgery remains the most reasonable treatment option for most morbidly obese patients.","['Greenway, F L']",['Greenway FL'],"['Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, USA.']",['eng'],"['Journal Article', 'Review']",United States,Endocrinol Metab Clin North Am,Endocrinology and metabolism clinics of North America,8800104,,IM,"['Humans', 'Obesity/*surgery/therapy']",,,,,1996/12/01 00:00,1996/12/01 00:01,['1996/12/01 00:00'],"['1996/12/01 00:00 [pubmed]', '1996/12/01 00:01 [medline]', '1996/12/01 00:00 [entrez]']","['S0889-8529(05)70367-4 [pii]', '10.1016/s0889-8529(05)70367-4 [doi]']",ppublish,Endocrinol Metab Clin North Am. 1996 Dec;25(4):1005-27. doi: 10.1016/s0889-8529(05)70367-4.,,,,,,,190,,,,,,,,,,,,,
707675,NLM,MEDLINE,19781227,20191210,0002-9548 (Print) 0002-9548 (Linking),38,2,1978 Summer,Cultural counterresistance in the analytic treatment of the obese women.,155-61,,,"['Ingram, D H']",['Ingram DH'],,['eng'],['Journal Article'],England,Am J Psychoanal,American journal of psychoanalysis,0372630,,IM,"['Attitude', 'Attitude of Health Personnel', '*Countertransference', '*Culture', 'Empathy', 'Female', 'Humans', 'Neurotic Disorders/*therapy', 'Obesity/etiology/genetics/*therapy', '*Psychoanalytic Therapy']",,,,,1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",['10.1007/BF01252198 [doi]'],ppublish,Am J Psychoanal. 1978 Summer;38(2):155-61. doi: 10.1007/BF01252198.,,,,,,,,,,,,,,,,,,,,
17272943,NLM,MEDLINE,20070222,20191110,1590-1262 (Electronic) 1124-4909 (Linking),11,4,2006 Dec,Cognitive distortions in obese patients with or without eating disorders.,e123-6,,"In the normal weight population, cognitive distortions are more often found in people with eating disorders such as anorexia and bulimia than in a control population. With these cognitive distortions, weight and body image become central elements in self-esteem. This exploratory study investigated cognitive distortions in obese patients suffering from binge eating disorder or not. The hypothesis was that the patients suffering from binge eating disorder would have more cognitive distortions. Twenty-nine obese women (11 without and 18 with binge eating disorder) and 13 non-obese female controls were selected. To evaluate the cognitive distortions, subjects completed the Mizes Anorectic Cognitions-Revised (MAC-R) questionnaire. Contrary to our hypothesis, we found no difference in evidence between the two obese groups with or without eating disorders. Possible perspectives for treatment are discussed.","['Volery, M', 'Carrard, I', 'Rouget, P', 'Archinard, M', 'Golay, A']","['Volery M', 'Carrard I', 'Rouget P', 'Archinard M', 'Golay A']","['Geneva University Hospital, Geneva, Switzerland.']",['eng'],['Journal Article'],Germany,Eat Weight Disord,Eating and weight disorders : EWD,9707113,,IM,"['*Body Image', 'Bulimia Nervosa/*complications/psychology', 'Case-Control Studies', 'Cognitive Behavioral Therapy', 'Female', 'Humans', 'Obesity/complications/*psychology/therapy', '*Self Concept', 'Surveys and Questionnaires']",,,,,2007/02/03 09:00,2007/02/23 09:00,['2007/02/03 09:00'],"['2007/02/03 09:00 [pubmed]', '2007/02/23 09:00 [medline]', '2007/02/03 09:00 [entrez]']","['3353 [pii]', '10.1007/BF03327577 [doi]']",ppublish,Eat Weight Disord. 2006 Dec;11(4):e123-6. doi: 10.1007/BF03327577.,,,,,,,,,,,,,,,,,,,,
12533726,NLM,MEDLINE,20030307,20041117,0891-5245 (Print) 0891-5245 (Linking),17,1,2003 Jan-Feb,The obese child: motivation as a tool for exercise.,11-7,,"The purpose of this article is to describe the importance of motivation in enhancing the participation of obese children in exercise activities. Recognizing the different influence that are important determinants of exercise behavior in children may help pediatric nurse practitioners play a significant role in advising parents and others of the need to offer positive, constructive, and immediate feedback without being evaluative, critical, or demanding. By addressing the problems of obesity and low fitness levels early in the child's life, a significant step can be taken toward reversing the negative trends of this unhealthy and potentially dangerous condition.","['McWhorter, J Wesley', 'Wallmann, Harvey W', 'Alpert, Patricia T']","['McWhorter JW', 'Wallmann HW', 'Alpert PT']","['Department of Physical Therapy, College of Health Sciences, University of Nevada, Las Vegas 89154, USA. jmcwhorter@ccmail.nevada.edu']",['eng'],['Journal Article'],United States,J Pediatr Health Care,Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners,8709735,,,"['Adolescent', 'Child', 'Exercise/*psychology', 'Health Knowledge, Attitudes, Practice', 'Health Promotion/methods', 'Humans', 'Interpersonal Relations', 'Life Style', '*Motivation', 'Obesity/complications/nursing/psychology/*therapy', 'Pediatric Nursing/methods']",,,,,2003/01/21 04:00,2003/03/08 04:00,['2003/01/21 04:00'],"['2003/01/21 04:00 [pubmed]', '2003/03/08 04:00 [medline]', '2003/01/21 04:00 [entrez]']","['S0891524502883250 [pii]', '10.1067/mph.2003.25 [doi]']",ppublish,J Pediatr Health Care. 2003 Jan-Feb;17(1):11-7. doi: 10.1067/mph.2003.25.,,,,,,,,,,,,,,,,,,,,
22319902,NLM,MEDLINE,20120302,20120210,0019-5499 (Print) 0019-5499 (Linking),55,2,2011 Apr-Jun,Comparison of VO2max in obese and non-obese young Indian population.,188-92,,"Incidence of obesity in early life is increasing nowadays because of faulty food habits and lack of exercise. This study was aimed to find out whether obesity affects cardiorespiratory efficiency of young adults. As VO2max is the most accepted indicator of cardiorespiratory efficiency it was compared in 30 obese and 30 non-obese subjects aged around 18-20 years. VO2mx was estimated by Queen's college step test. Various other parameters measured and calculated are weight, height, BMI, skin fold thickness, percentage body fat, lean body mass, fat mass. The results showed that cardiorespiratory efficiency (absolute VO2max & VO2max/kg lean body mass) was not affected (P > 0.05) in obese group in both sexes. Ability to do exhausting work (VO2max/kg body weight) was less in obese group (P = 0.001) compared to non-obese group & in obese males (P < 0.01) as compared to non-obese males. Percentage body fat (r = -0.416), triceps skin fold thickness (r = -0.427) and calf skin fold thickness (r = -0.381) strongly correlate to VO2max/kg body weight. Therefore the exercise programs can be best designed to increase caloric expenditure and thus to decrease body fat rather than to improve aerobic fitness.","['Patkar, Kshitija Umesh', 'Joshi, Anjali S']","['Patkar KU', 'Joshi AS']","['Department of Physiology, Seth G. S. Medical College & KEM Hospital, Parel, Mumbai--400 012. drkpatil@gmail.com']",['eng'],['Journal Article'],India,Indian J Physiol Pharmacol,Indian journal of physiology and pharmacology,0374707,,IM,"['Adiposity', 'Adolescent', 'Body Mass Index', 'Case-Control Studies', '*Exercise', 'Exercise Test', 'Exercise Tolerance', 'Female', 'Humans', 'India/epidemiology', 'Male', 'Obesity/diagnosis/ethnology/*metabolism/physiopathology', '*Oxygen Consumption', 'Skinfold Thickness', 'Young Adult']",,,,,2012/02/11 06:00,2012/03/03 06:00,['2012/02/11 06:00'],"['2012/02/11 06:00 [entrez]', '2012/02/11 06:00 [pubmed]', '2012/03/03 06:00 [medline]']",,ppublish,Indian J Physiol Pharmacol. 2011 Apr-Jun;55(2):188-92.,,,,,,,,,,,,,,,,,,,,
28155782,NLM,MEDLINE,20170523,20170523,0995-3914 (Print) 0995-3914 (Linking),28 Suppl 1,,2016 Jun 8,[Female obesity and physical activity: a better understanding of the stakes linked to stigmatization].,S127-134,,"<ce:para>Obesity remains a major public health concern in Western societies. In most industrialized countries, this condition, which is now associated with numerous chronic diseases and incapacities, is more prevalent in women than in men. While regular physical activity is highly recommended in the management of obesity, very few obese women invest in regular physical activity. Various social factors have been identified as influencing investment in preventive health practices such as physical activity. Weight stigmatization is now considered to be one of them. In order to contribute to a better understanding of the factors related to the investment of obese women in physical activity, this narrative review will focus on the stigmatization of obesity as a potential factor compromising their investment in regular physical activity and threatening their health. Messages from public health and exercise specialists targeting obesity have been recognized as contributing to weight stigmatization and Western women are more vulnerable than men to this type of discrimination. The authors discuss the various alternatives allowing public health and exercise professionals to review some of their interventions in order to help decrease weight stigmatization and its impacts on obese women in Western societies. Health and exercise professionals are influent actors who can collaborate in such initiatives in order to improve health and wellbeing of obese women.</ce:para>.","['Audet, Melisa', 'Baillot, Aurelie', 'Vibarel-Rebot, Nancy']","['Audet M', 'Baillot A', 'Vibarel-Rebot N']",,['fre'],"['Journal Article', 'Review']",France,Sante Publique,"Sante publique (Vandoeuvre-les-Nancy, France)",9216153,,IM,"['*Exercise', 'Female', 'Humans', 'Obesity/*psychology/rehabilitation', 'Sex Factors', '*Stereotyping']",,,,,2017/02/06 06:00,2017/05/24 06:00,['2017/02/04 06:00'],"['2017/02/04 06:00 [entrez]', '2017/02/06 06:00 [pubmed]', '2017/05/24 06:00 [medline]']",,ppublish,Sante Publique. 2016 Jun 8;28 Suppl 1:S127-134.,,,,,,,,,Obesite feminine et activite physique : mieux comprendre les enjeux lies a la stigmatisation.,,,,,,,,,,,
26072156,NLM,MEDLINE,20170309,20181113,1573-2614 (Electronic) 1387-1307 (Linking),30,3,2016 Jun,Impact of obesity on recovery and pulmonary functions of obese women undergoing major abdominal gynecological surgeries.,333-9,10.1007/s10877-015-9722-7 [doi],"To determine impact of obesity on recovery parameters and pulmonary functions of women undergoing major abdominal gynecological surgeries. Eighty women undergoing major gynecological surgeries were included in this study. Anesthesia was induced by remifentanil bolus, followed by propofol and cisatracurium to facilitate oro-tracheal intubation and was maintained by balanced anesthesia of remifentanil intravenous infusion and sevoflurane in oxygen and air. Time from discontinuation of maintenance anesthesia to fully awake were recorded at 1-min intervals and time from discontinuation of anesthesia until patient was transferred to post-anesthesia care unit (PACU) and discharged from PACU was also recorded. Pulmonary function tests were performed before surgery and repeated 4 h, days 1, 2 and 3 post-operative for evaluation of forced vital capacity, forced expiratory volume in 1 s and peak expiratory flow rate. Occurrence of post-operative complications, re-admission to ICU, hospital stay and morbidities were also recorded. Induction of anesthesia using remifentanil bolus injection resulted in significant decrease of heart rate and arterial pressures compared to pre-operative and pre-induction values. Recovery times were significantly shorter in obese compared to morbidly obese women. Post-operative pulmonary function tests showed significant deterioration compared to pre-operative measures but showed progressive improvement through first 3 post-operative days. Hospital stay was significantly shorter for obese compared to morbid obese women. Obesity delays recovery from general anesthesia, adversely affects pulmonary functions and increases post-operative complications. Remifentanil infusion and sevoflurane could be appropriate combination for obese and morbidly obese women undergoing major surgeries.","['Moustafa, Ahmed A M', 'Abdelazim, Ibrahim A']","['Moustafa AA', 'Abdelazim IA']","['Benha University, Cairo, Egypt.', 'Ahmadi Hospital, Kuwait Oil Company (KOC), P. O. Box: 9758, 61008, Ahmadi, Kuwait.', 'Ahmadi Hospital, Kuwait Oil Company (KOC), P. O. Box: 9758, 61008, Ahmadi, Kuwait. dr.ibrahimanwar@gmail.com.', 'Ain Shams University, Cairo, Egypt. dr.ibrahimanwar@gmail.com.']",['eng'],['Journal Article'],Netherlands,J Clin Monit Comput,Journal of clinical monitoring and computing,9806357,,IM,"['Adult', 'Anesthesia Recovery Period', 'Anesthesia, General', 'Female', '*Gynecologic Surgical Procedures/adverse effects/rehabilitation', 'Hemodynamics', 'Humans', 'Length of Stay', 'Middle Aged', 'Obesity/complications/*physiopathology/surgery', 'Obesity, Morbid/complications/physiopathology/surgery', 'Postoperative Complications/etiology/physiopathology', 'Postoperative Period', 'Respiratory Function Tests']",,['NOTNLM'],"['Major abdominal gynecological surgeries', 'Obese women', 'Obesity', 'Pulmonary functions', 'Recovery']",,2015/06/15 06:00,2017/03/10 06:00,['2015/06/15 06:00'],"['2014/06/05 00:00 [received]', '2015/06/08 00:00 [accepted]', '2015/06/15 06:00 [entrez]', '2015/06/15 06:00 [pubmed]', '2017/03/10 06:00 [medline]']","['10.1007/s10877-015-9722-7 [pii]', '10.1007/s10877-015-9722-7 [doi]']",ppublish,J Clin Monit Comput. 2016 Jun;30(3):333-9. doi: 10.1007/s10877-015-9722-7. Epub 2015 Jun 14.,,20150614,,,,,,,,,,,,,,,,,,
7755344,NLM,MEDLINE,19950622,20161123,0003-4266 (Print) 0003-4266 (Linking),56,2,1995,[Obesity. Impairment of energy intake or of energy expenditure].,87-92,,"Obesity may result from two mechanisms: a chronic excess of energy intake and/or a reduced energy expenditure. Most studies failed to show a correlation between food intake and body weight; however, no efficient mechanism to spare energy has been demonstrated in obese subjects. Although an impaired thermic effect of food has been reported in obese subjects, this effect does not result in a substantial economy of energy. Total energy expenditure in humans is positively correlated with body size. This demonstrates that energy requirements of obese subjects is larger than those of lean sedentary individuals. The reason for these discrepant observations is the under-reporting of food intake by obese subjects. Obesity is therefore mainly due to a chronic excess of energy intake. Investigations on nutrient balances have shown interesting mechanisms which are relevant for the development of obesity. Carbohydrate balance is accurately regulated: ingested carbohydrates over 24 hours are mainly oxidized during this period of time. The other metabolic pathways of carbohydrates, such as de novo lipogenesis or synthesis of non essential amino acids, are of minor importance. Another property of carbohydrates is to elicit a greater satiating effect than lipids. Protein balance is also accurately regulated; the daily protein ingestion is matched by a similar amount of protein oxidation. In addition, protein ingestion has the greatest satiating effect among the three macronutrients. By contrast, lipid balance is not regulated because lipid oxidation. Overfeeding with a mixed diet shows that fat oxidation is negatively correlated with energy and fat intakes.(ABSTRACT TRUNCATED AT 250 WORDS)","['Jequier, E']",['Jequier E'],"['Institut de Physiologie, Lausanne, Suisse.']",['fre'],"['Journal Article', 'Review']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,['0 (Dietary Carbohydrates)'],IM,"['Dietary Carbohydrates/metabolism', 'Energy Intake', '*Energy Metabolism', '*Feeding Behavior', 'Humans', 'Lipid Metabolism', 'Obesity/*etiology/metabolism', 'Obesity, Morbid/*etiology/metabolism']",,,,,1995/01/01 00:00,1995/01/01 00:01,['1995/01/01 00:00'],"['1995/01/01 00:00 [pubmed]', '1995/01/01 00:01 [medline]', '1995/01/01 00:00 [entrez]']",,ppublish,Ann Endocrinol (Paris). 1995;56(2):87-92.,,,,,,,25,,L'obesite. Alteration des entrees ou defaut des depenses d'energie.,,,,,,,,,,,
8299886,NLM,MEDLINE,19940310,20190516,0892-6638 (Print) 0892-6638 (Linking),8,1,1994 Jan,The case of the disappearing silver.,132-3,,,"['LaNoue, K F', 'Berdanier, C D']","['LaNoue KF', 'Berdanier CD']","['Hershey Medical Center, Pennsylvania State University, Hershey 17033.']",['eng'],"['Historical Article', 'Journal Article']",United States,FASEB J,FASEB journal : official publication of the Federation of American Societies for Experimental Biology,8804484,,IM,"['Animals', 'History, 20th Century', 'Mice', 'Mice, Obese', 'Obesity/etiology/*history', 'Rats']",,,,,1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",['10.1096/fasebj.8.1.8299886 [doi]'],ppublish,FASEB J. 1994 Jan;8(1):132-3. doi: 10.1096/fasebj.8.1.8299886.,,,,,,,,,,,,,,,,,,,,
27058997,NLM,MEDLINE,20170613,20220316,1467-789X (Electronic) 1467-7881 (Linking),17,5,2016 May,"Framing obesity in UK policy from the Blair years, 1997-2015: the persistence of individualistic approaches despite overwhelming evidence of societal and economic factors, and the need for collective responsibility.",397-411,10.1111/obr.12386 [doi],"Since 1997, and despite several political changes, obesity policy in the UK has overwhelmingly framed obesity as a problem of individual responsibility. Reports, policies and interventions have emphasized that it is the responsibility of individual consumers to make personal changes to reduce obesity. The Foresight Report 'Tackling Obesities: Future Choices' (2007) attempted to reframe obesity as a complex problem that required multiple sites of intervention well beyond the range of personal responsibility. This framing formed the basis for policy and coincided with increasing acknowledgement of the complex nature of obesity in obesity research. Yet policy and interventions developed following Foresight, such as the Change4Life social marketing campaign, targeted individual consumer behaviour. With the Conservative-Liberal Democrat government of 2011, intervention shifted to corporate and individual responsibility, making corporations voluntarily responsible for motivating individual consumers to change. This article examines shifts in the framing of obesity from a problem of individual responsibility, towards collective responsibility, and back to the individual in UK government reports, policies and interventions between 1997 and 2015. We show that UK obesity policies reflect the landscape of policymakers, advisors, political pressures and values, as much as, if not more than, the landscape of evidence. The view that the individual should be the central site for obesity prevention and intervention has remained central to the political framing of population-level obesity, despite strong evidence contrary to this. Power dynamics in obesity governance processes have remained unchallenged by the UK government, and individualistic framing of obesity policy continues to offer the path of least resistance.","['Ulijaszek, Stanley J', 'McLennan, Amy K']","['Ulijaszek SJ', 'McLennan AK']","['School of Anthropology and Museum Ethnography, University of Oxford, Oxford, UK.', 'School of Anthropology and Museum Ethnography, University of Oxford, Oxford, UK.']",['eng'],['Journal Article'],England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['Health Policy', 'Health Promotion', 'Humans', 'Individuation', 'Obesity/*prevention & control', '*Socioeconomic Factors', 'United Kingdom']",,['NOTNLM'],"['Consumption', 'UK', 'individualism', 'obesity policy']",,2016/04/10 06:00,2017/06/14 06:00,['2016/04/10 06:00'],"['2015/10/23 00:00 [received]', '2015/12/15 00:00 [revised]', '2016/01/01 00:00 [accepted]', '2016/04/10 06:00 [entrez]', '2016/04/10 06:00 [pubmed]', '2017/06/14 06:00 [medline]']",['10.1111/obr.12386 [doi]'],ppublish,Obes Rev. 2016 May;17(5):397-411. doi: 10.1111/obr.12386.,,,,['(c) 2016 World Obesity.'],,,,,,,,,,,,,,,,
24805913,NLM,MEDLINE,20150626,20211021,1708-0428 (Electronic) 0960-8923 (Linking),24,8,2014 Aug,Bariatric surgical practice revisited: unrecorded or overlooked problems in the severely obese.,1408-9,10.1007/s11695-014-1269-z [doi],"Severe loss of activities of daily living, if noted, is a potent reason for weight-loss surgery.","['Deitel, Mervyn']",['Deitel M'],"['Obesity Surgery, 39 Bassano Road, Toronto, ON, M2N 2J9, Canada, book@obesitysurgery.com.']",['eng'],['Journal Article'],United States,Obes Surg,Obesity surgery,9106714,,IM,"['Activities of Daily Living', 'Comorbidity', 'Humans', 'Life Style', 'Obesity/*epidemiology/psychology', 'Obesity, Morbid/epidemiology/psychology']",,,,,2014/05/09 06:00,2015/06/27 06:00,['2014/05/09 06:00'],"['2014/05/09 06:00 [entrez]', '2014/05/09 06:00 [pubmed]', '2015/06/27 06:00 [medline]']",['10.1007/s11695-014-1269-z [doi]'],ppublish,Obes Surg. 2014 Aug;24(8):1408-9. doi: 10.1007/s11695-014-1269-z.,,,,,,,,,,,,,,,,,,,,
10661190,NLM,MEDLINE,20000216,20041117,0029-6570 (Print) 0029-6570 (Linking),13,47,1999 Aug 11-17,Obesity management.,43-6,,Recent national initiatives to reduce the numbers of people classified as obese appear to have failed. Norma Crombie summarises some current thinking on the subject and outlines the role of the nurse in helping obese people to set and meet realistic targets for their weight management.,"['Crombie, N']",['Crombie N'],"['Centre for Nutrition and Food Research, Queen Margaret University College, Edinburgh.']",['eng'],"['Journal Article', 'Review']",England,Nurs Stand,Nursing standard (Royal College of Nursing (Great Britain) : 1987),9012906,['0 (Dietary Carbohydrates)'],,"['Anthropometry', 'Body Mass Index', 'Dietary Carbohydrates/administration & dosage', 'Exercise', 'Humans', 'Nursing Assessment', 'Obesity/classification/*diagnosis/*therapy']",,,,,2000/02/08 09:00,2000/02/19 09:00,['2000/02/08 09:00'],"['2000/02/08 09:00 [pubmed]', '2000/02/19 09:00 [medline]', '2000/02/08 09:00 [entrez]']",['10.7748/ns1999.08.13.47.43.c2659 [doi]'],ppublish,Nurs Stand. 1999 Aug 11-17;13(47):43-6. doi: 10.7748/ns1999.08.13.47.43.c2659.,,,,,,,34,,,,,,,,,,,,,
21568059,NLM,MEDLINE,20110607,20161125,0017-7768 (Print) 0017-7768 (Linking),149,10,2010 Oct,[Gain for pain: a model of a healthy lifestyle intervention in a population of mentally disabled adults].,"645-9, 684 , 683",,"INTRODUCTION: Mental retardation is an intellectual disability affecting adaptable, conceptual, social and practical skills, with onset prior to 18 years of age. Prevalence of obesity among women with mental retardation is 18-30% greater than that among women without mental retardation. In the Nachman Village, a governmental institution for adults with mental retardation, the main nutritional difficulties result from residents eating snacks in addition to their balanced meals. Psychological complexity and the ambivalent attitude of families, caregivers and residents prevented the achievement of balanced diets and healthy body weights. The women's house mother took upon herself to detect residents with nutritional problems and started an intervention program aiming at promoting a healthy lifestyle and maintenance of normal body weight. METHODS: The program 'House Queen' was Launched on a voluntary basis. The staff encouraged the residents to engage in physical activity, restrict snack consumption and amounts of food at meals, eat vegetables and not waste pocket money on non-nutritional foods. Each month one or two residents who lost weight while maintaining a healthy lifestyle received a prize and the title ""House Queen"". The statistical analysis included 22 residents and was conducted retrospectively from data coLlected during a routine medical follow-up. RESULTS: A total of 59.1% of the residents were morbidly obese and 27.3% were obese at the beginning of the program. Seventeen months later, they weighed an average of 8 kg Less, and only 36.4% and 18.2% of them were morbidly obese and obese, respectively. CONCLUSION: These results suggest a correlation between the 'House Queen' program and Lowering body weight, which encourage the authors to broaden the program to other residents in the Village and combine supportive and restrictive attitudes towards a healthy lifestyle for mentally disabled people.","['Bardugo, Esther', 'Moses, Lilach', 'Shemmer, Martha', 'Dubman, Innesa']","['Bardugo E', 'Moses L', 'Shemmer M', 'Dubman I']",['Nachman Village Infirmary.'],['heb'],['Journal Article'],Israel,Harefuah,Harefuah,0034351,,IM,"['Adult', 'Feeding Behavior', 'Female', 'Follow-Up Studies', 'Humans', 'Intellectual Disability/*complications', '*Life Style', 'Middle Aged', 'Motivation', 'Obesity/epidemiology/etiology/*therapy', 'Obesity, Morbid/epidemiology/etiology/*therapy', 'Residential Facilities', 'Retrospective Studies', 'Reward']",,,,,2011/05/17 06:00,2011/06/08 06:00,['2011/05/17 06:00'],"['2011/05/17 06:00 [entrez]', '2011/05/17 06:00 [pubmed]', '2011/06/08 06:00 [medline]']",,ppublish,"Harefuah. 2010 Oct;149(10):645-9, 684 , 683.",,,,,,,,,,,,,,,,,,,,
18616061,NLM,MEDLINE,20080918,20081104,0746-1739 (Print) 0746-1739 (Linking),26,3,2008 May-Jun,Call to arms: time to fight an epidemic.,202-5,,"According to the National Institutes of Health (2008), 108 million Americans are overweight and/or obese. In 1997, the World Health Organization noted that this was a major public health problem and it is no longer just an American problem. Clinically, nurses must find ways to have conversations with clients about weight and healthy lifestyles in ways that do blame the victim. Take a look at the vending machines for patients and their families in waiting rooms. Is there anything in those machines that we could consider healthy? Nurse leaders are in the ideal position to help their organizations consider the development and implementation of a wellness program. Most importantly, we have to start talking about the issue and find ways to develop multi-pronged approaches to confront the obesity epidemic.","['Lucey, Paula A']",['Lucey PA'],"['Lamplighter Consulting, LLC, Greenfield, WI, USA. palrn@sbcglobal.net']",['eng'],['Journal Article'],United States,Nurs Econ,Nursing economic$,8404213,,,"['Adult', '*Disaster Planning', 'Humans', 'Obesity/*epidemiology/nursing/prevention & control/therapy', 'United States/epidemiology']",,,,,2008/07/12 09:00,2008/09/19 09:00,['2008/07/12 09:00'],"['2008/07/12 09:00 [pubmed]', '2008/09/19 09:00 [medline]', '2008/07/12 09:00 [entrez]']",,ppublish,Nurs Econ. 2008 May-Jun;26(3):202-5.,,,['Nurs Econ. 2008 Sep-Oct;26(5):292'],,,,,,,,,,,,,,,,,
18504263,NLM,MEDLINE,20081002,20220408,1940-1574 (Electronic) 0003-3197 (Linking),59,2 Suppl,2008 Apr-May,Childhood obesity: looking into the future.,30S-3S,10.1177/0003319708318788 [doi],"A major concern related to childhood obesity is that obese children tend to become obese adults, with all the risks/ comorbidities associated (ie, diabetes, cardiovascular diseases among many others). The challenges of childhood obesity are not limited to one country but confront most nations around the world. Efforts to manage and to prevent childhood obesity involve education, research, and intervention. Research could drive new directions in prevention and could develop public policy that might help manage the problem. Additionally, research is needed to test these issues. Looking into the future, 6 relevant levels may be involved in the prevention and treatment of pediatric obesity, and each of these needs investigation: family, schools, health care, government, industry, and media. Together, these 6 levels could promote childhood obesity as a high research priority and put it as the first point in the international public agenda.","['Pietrobelli, Angelo', 'Espinoza, Maivin Cuevas', 'De Cristofaro, Paolo']","['Pietrobelli A', 'Espinoza MC', 'De Cristofaro P']","['Pediatric Unit, Verona University Medical School, Verona, Italy. angpie@tin.it']",['eng'],"['Journal Article', 'Review']",United States,Angiology,Angiology,0203706,,IM,"['Anthropometry', 'Child', 'Health Policy/*trends', 'Humans', 'Obesity/complications/diagnosis/*therapy', 'Reproducibility of Results']",,,,,2008/05/28 09:00,2008/10/03 09:00,['2008/05/28 09:00'],"['2008/05/28 09:00 [pubmed]', '2008/10/03 09:00 [medline]', '2008/05/28 09:00 [entrez]']","['0003319708318788 [pii]', '10.1177/0003319708318788 [doi]']",ppublish,Angiology. 2008 Apr-May;59(2 Suppl):30S-3S. doi: 10.1177/0003319708318788. Epub 2008 May 25.,,20080525,,,,,16,,,,,,,,,,,,,
9436523,NLM,MEDLINE,19980211,20220410,0753-3322 (Print) 0753-3322 (Linking),51,8,1997,Regulation of ob gene and overexpression in obesity.,318-23,,"The ob gene product, called leptin, is a recently discovered hormone secreted by the adipose cells. By acting as a satiety factor and increasing energy expenditure, leptin plays a major role in body weight homeostasis in mice. Ob gene and leptin production by the adipose cells are under the control of various hormonal and metabolic factors. Ob mRNA levels are markedly reduced by fasting and restored to normal by refeeding. High-fat feeding increases ob gene and plasma leptin, and induces a state of resistance to leptin. Two hormones, insulin and corticosterone, increase leptin production in rodent and human adipose cells. In contrast, the activity of the sympathetic nervous system exerts an opposite effect, mainly through activation of the adipose beta 3-adrenergic receptors. Leptin synthesis is also decreased by thiazolidinediones, a new class of antidiabetic drugs. The obese Zucker fa/fa rats bear a mutation in the leptin receptor gene (OB-R) and are leptin resistant. In these rats, ob mRNA levels are increased early in life and are not reduced by fasting. This suggests that functional OB-Rs are required for the generation of the signal(s) that downregulates ob gene expression in the adipose cell. The extent to which this is relevant to human obesities, which are characterized by increased leptin levels, remains to be determined.","['Guerre-Millo, M']",['Guerre-Millo M'],"['U 465 INSERM, Institut Biomedical des Cordeliers, Paris, France.']",['eng'],"['Journal Article', 'Review']",France,Biomed Pharmacother,Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,8213295,"['0 (Carrier Proteins)', '0 (Leptin)', '0 (Proteins)', '0 (Receptors, Cell Surface)', '0 (Receptors, Leptin)']",IM,"['Adipocytes/metabolism', 'Animals', 'Carrier Proteins/genetics/metabolism', 'Down-Regulation', '*Gene Expression Regulation', 'Humans', 'Leptin', 'Mice', 'Mice, Obese', 'Obesity/*genetics', 'Proteins/genetics/metabolism', 'Rats', 'Rats, Zucker', '*Receptors, Cell Surface', 'Receptors, Leptin']",,,,,1997/01/01 00:00,1998/01/22 00:01,['1997/01/01 00:00'],"['1997/01/01 00:00 [pubmed]', '1998/01/22 00:01 [medline]', '1997/01/01 00:00 [entrez]']","['S0753-3322(97)88048-1 [pii]', '10.1016/S0753-3322(97)88048-1 [doi]']",ppublish,Biomed Pharmacother. 1997;51(8):318-23. doi: 10.1016/S0753-3322(97)88048-1.,,,,,,,60,,,,,,,,,,,,,
17056407,NLM,MEDLINE,20070206,20191210,1471-0153 (Print) 1471-0153 (Linking),7,4,2006 Nov,Why obese children cannot resist food: the role of impulsivity.,315-22,,"Facing the undesirable health consequences of being obese, an important question is why some people are not able to resist eating to excess. It is theorized that increased impulsivity at least partly underlies the inability to control eating behaviour; being more impulsive is supposed to make it more difficult to resist food intake. Thirty-three obese children in a residential setting and 31 lean control children are tested. Impulsivity is measured with two behavioural measures (inhibitory control and sensitivity to reward) and questionnaires. Results show that the obese children in treatment were more sensitive to reward and showed less inhibitory control than normal weight children. In addition, the obese children with eating binges were more impulsive than the obese children without eating binges. Most interesting finding was that the children that were the least effective in inhibiting responses, lost less weight in the residential treatment program. To conclude: impulsivity is a personality characteristic that potentially has crucial consequences for the development and maintenance, as well as treatment of obesity.","['Nederkoorn, Chantal', 'Braet, Caroline', 'Van Eijs, Yvonne', 'Tanghe, Ann', 'Jansen, Anita']","['Nederkoorn C', 'Braet C', 'Van Eijs Y', 'Tanghe A', 'Jansen A']","['Department of Experimental Psychology, Maastricht University, The Netherlands. c.nederkoorn@psychology.unimaas.nl']",['eng'],['Journal Article'],United States,Eat Behav,Eating behaviors,101090048,,IM,"['Adolescent', '*Attitude', 'Child', '*Feeding Behavior', 'Female', 'Humans', 'Impulsive Behavior/*epidemiology/*psychology', 'Inhibition, Psychological', 'Male', 'Obesity/*epidemiology/*psychology/therapy', 'Patient Care Team', 'Residential Treatment', 'Reward', 'Surveys and Questionnaires']",,,,,2006/10/24 09:00,2007/02/07 09:00,['2006/10/24 09:00'],"['2005/06/07 00:00 [received]', '2005/10/27 00:00 [revised]', '2005/11/01 00:00 [accepted]', '2006/10/24 09:00 [pubmed]', '2007/02/07 09:00 [medline]', '2006/10/24 09:00 [entrez]']","['S1471-0153(05)00075-9 [pii]', '10.1016/j.eatbeh.2005.11.005 [doi]']",ppublish,Eat Behav. 2006 Nov;7(4):315-22. doi: 10.1016/j.eatbeh.2005.11.005. Epub 2005 Nov 22.,,20051122,,,,,,,,,,,,,,,,,,
1778659,NLM,MEDLINE,19920309,20140603,,15,11,1991 Nov,Toward an empirically derived typology of obese persons.,741-54,,"The MMPI, medical, anthropomorphic, and laboratory evaluations were completed by 260 obese patients (211 females, 49 males) at a New York hospital. Biological and psychological variables were separately subjected to principal components analyses. Fifteen biological and five psychological components were extracted. A three-cluster solution was selected from a K-means clustering on biological components, replicated via Ward's method, and validated via a discriminant analysis on psychological components. Cluster 1, 'android obesity', contained 75 percent of the males and was characterized by 'masculine phenotypy', 'poor conditioning' and 'adverse serum lipids', and less 'feminine' responding on the MMPI. Cluster 2, 'gynoid obesity', was low on components measuring physical stress and masculine phenotypy, was 95 percent female, moderately obese compared to clusters 1 and 3, and had a relatively healthy profile. Cluster 3 had elevations on overall fatness and physiological and psychological stress, and low scores on a 'healthy blood synthesis' component. This cluster, labeled 'morbidly obese', was the most obese and had profiles suggesting adverse effects of obesity.","['Allison, D B', 'Heshka, S']","['Allison DB', 'Heshka S']","['Department of Psychology, Hofstra University, Hempstead, New York 11550.']",['eng'],['Journal Article'],England,Int J Obes,International journal of obesity,7703240,,IM,"['Adult', 'Algorithms', 'Cluster Analysis', 'Discriminant Analysis', 'Female', 'Humans', 'Male', 'Obesity/*pathology/psychology', 'Obesity, Morbid/*pathology/psychology', 'Phenotype', 'Physical Fitness', 'Reproducibility of Results']",,,,,1991/11/01 00:00,1991/11/01 00:01,['1991/11/01 00:00'],"['1991/11/01 00:00 [pubmed]', '1991/11/01 00:01 [medline]', '1991/11/01 00:00 [entrez]']",,ppublish,Int J Obes. 1991 Nov;15(11):741-54.,,,,,,,,,,,,,,,,,,,,
29900845,NLM,MEDLINE,20181211,20181211,1958-5381 (Electronic) 0767-0974 (Linking),34,5,2018 May,[Adipose tissue fibrosis: an aggravating factor in obesity].,424-431,10.1051/medsci/20183405015 [doi],"Obesity can be defined as the adaptive response of organism facing chronic nutrient overflow. In this context, the adipose tissue (AT) can expand, through increased adipocyte size and number, to function as the main energy-storing organ. However, over the course of obesity progression, the AT undergo continual remodeling, evolving into pathological alterations. It is now clear that pro-inflammatory cell accumulation favors local AT injury. More recently, we and others described excess levels of extracellular matrix (ECM) and fibrosis in AT depots from obese individuals. In obese mice, targeting ECM-remodeling improves glucose tolerance and insulin sensitivity. Therefore AT fibrosis represents a maladaptive mechanism contributing to obesity-related metabolic complications such as diabetes, cardiometabolic and liver diseases. Here, we review the current knowledge about obesity-induced adipose tissue remodeling and its local and systemic consequences.","['Marcelin, Genevieve', 'Clement, Karine']","['Marcelin G', 'Clement K']","[""Inserm, UMRS 1166 equipe 6 NutriOmique, Sorbonne Universite, institut de cardio-metabolisme et nutrition (ICAN), Hopital Pitie-Salpetriere, 91, boulevard de l'Hopital, F-75013 Paris, France."", ""Inserm, UMRS 1166 equipe 6 NutriOmique, Sorbonne Universite, institut de cardio-metabolisme et nutrition (ICAN), Hopital Pitie-Salpetriere, 91, boulevard de l'Hopital, F-75013 Paris, France - Assistance Publique Hopitaux de Paris, AP-HP, Hopital Pitie-Salpetriere, service de Nutrition, 91, boulevard de l'Hopital, F-75013 Paris, France.""]",['fre'],"['Journal Article', 'Review']",France,Med Sci (Paris),Medecine sciences : M/S,8710980,,IM,"['Adipose Tissue/*pathology/physiology', 'Animals', 'Fibrosis/complications', 'Humans', 'Inflammation/metabolism', 'Mice', 'Mice, Obese', 'Obesity/*etiology/metabolism/*pathology']",,,,,2018/06/15 06:00,2018/12/12 06:00,['2018/06/15 06:00'],"['2018/06/15 06:00 [entrez]', '2018/06/15 06:00 [pubmed]', '2018/12/12 06:00 [medline]']","['medsci180115s [pii]', '10.1051/medsci/20183405015 [doi]']",ppublish,Med Sci (Paris). 2018 May;34(5):424-431. doi: 10.1051/medsci/20183405015. Epub 2018 Jun 13.,,20180613,,['(c) 2018 medecine/sciences - Inserm.'],,,,,La fibrose du tissu adipeux - Un facteur aggravant de l'obesite.,,,,,,,,,,,
6637860,NLM,MEDLINE,19831217,20180330,0002-9165 (Print) 0002-9165 (Linking),38,5,1983 Nov,Energy expenditure and postprandial thermogenesis in obese women before and after weight loss.,680-93,,"In six young obese women (mean weight 85 +/- 3 kg) with a childhood history of obesity, and in six young nonobese women (mean weight 55 +/- 2 kg), the energy expenditure was measured during 24 h in a respiratory chamber with a maintenance energy intake. The next day, the thermogenic response to a mixed meal was investigated by using an open circuit indirect calorimetry hood system. In addition, five of the same obese women were similarly studied after a mean weight loss of 12.1 kg (14% of initial body weight) consecutive to an 11-wk hypocaloric diet (protein-supplemented modified fast). Expressed in absolute terms, the total 24 h and basal energy expenditures were found to be significantly greater in the obese (2208 +/- 105 and 1661 +/- 56 kcal/24 h, respectively) than in the controls (1746 +/- 61 and 1230 +/- 40 kcal/24 h, respectively). After weight loss, both the total 24-h and the basal energy expenditures were significantly reduced (2009 +/- 99 kcal/24 h and 1423 +/- 43 kcal/24 h respectively), but both values were still greater than that of the control subjects. The thermogenic response to the mixed meal (a liquid diet containing 17, 54, and 29% as protein, carbohydrate, and lipid calories, respectively, and an energy level determined to cover 60% of the basal energy expenditure computed for 24 h) was found to be significantly reduced in the obese as compared to controls (ie, 7.6 +/- 0.4% versus 9.5 +/- 0.4% of the energy content of the load, respectively, p less than 0.025). After weight loss, the postprandial thermogenesis of the obese was still markedly reduced (ie, 6.2 +/- 0.8%). Both before and after weight loss, the relative increase in diurnal urinary norepinephrine excretion was found to be lower in the obese than in controls, when compared to the nocturnal values. These results show that the greater 24 h energy expenditure of obese women is entirely due to their higher basal metabolic rate. The lower thermogenic response to the meal in the obese supports the concept of a thermogenic defect which can favor energy gain; furthermore, the unchanged response after weight loss in the obese suggests that the thermogenic defect may be a cause rather than a consequence of obesity.","['Bessard, T', 'Schutz, Y', 'Jequier, E']","['Bessard T', 'Schutz Y', 'Jequier E']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Am J Clin Nutr,The American journal of clinical nutrition,0376027,,IM,"['Adipose Tissue/metabolism', 'Adult', 'Basal Metabolism', 'Body Composition', '*Body Temperature Regulation', 'Calorimetry, Indirect', '*Energy Metabolism', 'Female', 'Humans', 'Obesity/diet therapy/*metabolism/physiopathology', 'Oxygen Consumption', 'Respiration']",,,,,1983/11/01 00:00,1983/11/01 00:01,['1983/11/01 00:00'],"['1983/11/01 00:00 [pubmed]', '1983/11/01 00:01 [medline]', '1983/11/01 00:00 [entrez]']",['10.1093/ajcn/38.5.680 [doi]'],ppublish,Am J Clin Nutr. 1983 Nov;38(5):680-93. doi: 10.1093/ajcn/38.5.680.,,,,,,,,,,,,,,,,,,,,
26211282,NLM,MEDLINE,20150810,20191210,1660-9379 (Print) 1660-9379 (Linking),11,477,2015 Jun 3,[GLP-1 receptor agonists versus SGLT-2 inhibitors in obese type 2 diabetes patients].,"1227-8, 1230-3",,"Who never had a type 2 obese diabetic patient, treated by several oral antidiabetic drugs and insulin, with consequent weight gain associated with the therapeutic escalation and uncontrolled diabetes? The arrival of GLP-1 agonists and SGLT-2 inhibitors allows to reevaluate the management of these patients, with their favorable effects on glycemic control, weight and the risk of hypoglycemia and their complementary mechanisms to conventional treatments. The vicious cycle of weight gain and increased need of insulin is limited. The choice between these two molecules must be based on several factors (glycemic target, weight, comorbidities, route of administration, side effects, etc.), and the balanced enthusiasm of these new treatments with the insufficient data regarding their long-term safety and their impact on micro- and macrovascular complications.","['Marques, Ana Rita Forte', 'Jaafar, Jaafar', 'de Kalbermatten, Benedicte', 'Philippe, Jacques']","['Marques AR', 'Jaafar J', 'de Kalbermatten B', 'Philippe J']",,['fre'],"['Comparative Study', 'Journal Article', 'Review']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,"['0 (Dipeptidyl-Peptidase IV Inhibitors)', '0 (GLP1R protein, human)', '0 (Glucagon-Like Peptide-1 Receptor)', '0 (Hypoglycemic Agents)', '0 (Incretins)', '0 (Receptors, Glucagon)', '0 (SLC5A2 protein, human)', '0 (Sodium-Glucose Transporter 2)', '0 (Sodium-Glucose Transporter 2 Inhibitors)', '89750-14-1 (Glucagon-Like Peptide 1)']",IM,"['Diabetes Mellitus, Type 2/complications/*drug therapy', 'Dipeptidyl-Peptidase IV Inhibitors/therapeutic use', 'Glucagon-Like Peptide 1/analogs & derivatives', 'Glucagon-Like Peptide-1 Receptor', 'Humans', 'Hypoglycemic Agents/*therapeutic use', 'Incretins/therapeutic use', 'Obesity/complications/*drug therapy', 'Practice Guidelines as Topic', 'Receptors, Glucagon/*agonists', 'Sodium-Glucose Transporter 2', '*Sodium-Glucose Transporter 2 Inhibitors']",,,,,2015/07/28 06:00,2015/08/11 06:00,['2015/07/28 06:00'],"['2015/07/28 06:00 [entrez]', '2015/07/28 06:00 [pubmed]', '2015/08/11 06:00 [medline]']",,ppublish,"Rev Med Suisse. 2015 Jun 3;11(477):1227-8, 1230-3.",,,,,,,,,Analogues du GLP-1 versus inhibiteurs du SGLT-2 pour les diabetiques de type 2 obeses.,,,,,,,,,,,
2681326,NLM,MEDLINE,19891212,20190908,0731-5724 (Print) 0731-5724 (Linking),8 Suppl,,1989,Obesity.,13S-21S,,"Over the past 20 years, obesity has represented a significant focus of research conducted in Clinical Research Centers (CRCs) in the United States. This review will focus on the progress in our understanding of the disease that CRC-based research has produced; therefore, the reference list is not exhaustive and consists primarily of CRC-based research. Obesity is defined as an excess of body fat as measured by triceps skinfold thickness. The time of onset of obesity is an important factor; for example, early onset is associated with an increase in the number of fat cells. Weight loss reduces the size but not the number of fat cells. Type II diabetes mellitus is a common complication in obese adults; this condition has been related to fat cell size and, in women, to predominantly upper-body fat distribution. Pregnant obese women and their babies are at risk for a number of problems. Abnormalities commonly found in obese persons include increased plasma lipid levels, hyperinsulinism, increased cholesterol synthesis, high frequency of gallstones, and hypertension. Under a variety of experimental conditions, the only difference in the response of obese and normal weight subjects to food was that the obese subjects appeared to consume more, but other data suggest that the obese may have greater energy needs. Carbohydrate intake has been studied extensively. Metabolic rate increases with over-feeding, especially in response to carbohydrate. Basal metabolic rates are higher in obese adults and rise in response to overfeeding; they decrease after weight reduction. This decrease can be counteracted with sucrose, perhaps because sucrose maintains triiodothyronine levels.(ABSTRACT TRUNCATED AT 250 WORDS)","['Dietz, W H']",['Dietz WH'],"['New England Medical Center, Boston, Massachusetts 02111.']",['eng'],"['Journal Article', 'Review']",United States,J Am Coll Nutr,Journal of the American College of Nutrition,8215879,,IM,"['Energy Metabolism', 'Humans', '*Obesity/metabolism/pathology', 'Research', 'Weight Loss']",,,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",['10.1080/07315724.1989.10737966 [doi]'],ppublish,J Am Coll Nutr. 1989;8 Suppl:13S-21S. doi: 10.1080/07315724.1989.10737966.,,,,,,,94,,,,,,,,,,,,,
27153316,NLM,MEDLINE,20170201,20170201,1941-9260 (Electronic) 0032-5481 (Linking),128 Suppl 1,,2016 Oct,Proactive and Progressive Approaches in Managing Obesity.,21-30,10.1080/00325481.2016.1181412 [doi],"Despite the advice clinicians have been giving patients about the importance of restricting their food intake and increasing physical activity levels, the Centers for Disease Control and Prevention (CDC) states that 78.6 million adults in the United States (US) are still obese. With these statistics in mind, this symposium provided insights on the genetic, cultural, and environmental underpinning of obesity and discussed the latest research on pharmacotherapy, surgery, and the need to individualize treatment.","['Eckel, Robert H', 'Bays, Harold E', 'Klein, Samuel', 'Bade Horn, Deborah']","['Eckel RH', 'Bays HE', 'Klein S', 'Bade Horn D']","['a Medicine, Physiology and Biophysics, Charles A. Boettcher II Chair in Atherosclerosis , University of Colorado Anschutz Medical Campus , Aurora , CO , USA.', 'b Louisville Metabolic and Atherosclerosis Research Center , Louisville , KY , USA.', 'c Medicine and Nutritional Science, Division of Geriatrics and Nutritional Sciences, Center for Human Nutrition , Washington University School of Medicine , St. Louis , MO , USA.', 'd Center for Obesity Medicine and Metabolic Performance , University of Texas , Austin , TX , USA.', 'e Obesity Medicine Association , University of Texas Medical School , Houston , TX , USA.']",['eng'],['Journal Article'],England,Postgrad Med,Postgraduate medicine,0401147,,IM,"['Adult', 'Attitude to Health', '*Disease Management', 'Energy Intake', 'Energy Metabolism', '*Epigenomics', 'Humans', '*Life Style', '*Obesity/diagnosis/etiology/metabolism/physiopathology/psychology/therapy', '*Preventive Health Services/methods/organization & administration', 'Public Health', 'Risk Reduction Behavior']",,['NOTNLM'],"['Epigenetic dysregulation', 'gut/brain crosstalk', 'long-term weight management', 'obesity', 'pharmacotherapy']",,2016/05/07 06:00,2017/02/02 06:00,['2016/05/07 06:00'],"['2016/05/07 06:00 [entrez]', '2016/05/07 06:00 [pubmed]', '2017/02/02 06:00 [medline]']",['10.1080/00325481.2016.1181412 [doi]'],ppublish,Postgrad Med. 2016 Oct;128 Suppl 1:21-30. doi: 10.1080/00325481.2016.1181412. Epub 2016 May 6.,,20160506,,,,,,,,,,,,,,,,,,
29599941,NLM,MEDLINE,20191120,20191120,2040-2295 (Print) 2040-2309 (Electronic) 2040-2295 (Linking),2018,,2018,Systems and WBANs for Controlling Obesity.,1564748,10.1155/2018/1564748 [doi] 1564748,"According to World Health Organization (WHO) estimations, one out of five adults worldwide will be obese by 2025. Worldwide obesity has doubled since 1980. In fact, more than 1.9 billion adults (39%) of 18 years and older were overweight and over 600 million (13%) of these were obese in 2014. 42 million children under the age of five were overweight or obese in 2014. Obesity is a top public health problem due to its associated morbidity and mortality. This paper reviews the main techniques to measure the level of obesity and body fat percentage, and explains the complications that can carry to the individual's quality of life, longevity and the significant cost of healthcare systems. Researchers and developers are adapting the existing technology, as intelligent phones or some wearable gadgets to be used for controlling obesity. They include the promoting of healthy eating culture and adopting the physical activity lifestyle. The paper also shows a comprehensive study of the most used mobile applications and Wireless Body Area Networks focused on controlling the obesity and overweight. Finally, this paper proposes an intelligent architecture that takes into account both, physiological and cognitive aspects to reduce the degree of obesity and overweight.","['Mohammed, Maali Said', 'Sendra, Sandra', 'Lloret, Jaime', 'Bosch, Ignacio']","['Mohammed MS', 'Sendra S', 'Lloret J', 'Bosch I']","['University of Gezira, Wad Madani, Sudan.', 'Universitat Politecnica de Valencia, Valencia, Spain.', 'Departamento de Teoria de la Senal, Telematica y Comunicaciones, Universidad de Granada, Granada, Spain.', 'Universitat Politecnica de Valencia, Valencia, Spain.', 'Universitat Politecnica de Valencia, Valencia, Spain.']",['eng'],"['Journal Article', 'Review']",England,J Healthc Eng,Journal of healthcare engineering,101528166,,IM,"['Adolescent', 'Adult', 'Child', 'Female', 'Global Health', 'Health Promotion', 'Humans', 'Male', '*Monitoring, Physiologic', '*Obesity/etiology/prevention & control/therapy', '*Wearable Electronic Devices', '*Wireless Technology', 'Young Adult']",PMC5823412,,,,2018/03/31 06:00,2019/11/21 06:00,['2018/03/31 06:00'],"['2017/08/20 00:00 [received]', '2017/12/03 00:00 [accepted]', '2018/03/31 06:00 [entrez]', '2018/03/31 06:00 [pubmed]', '2019/11/21 06:00 [medline]']",['10.1155/2018/1564748 [doi]'],epublish,J Healthc Eng. 2018 Feb 1;2018:1564748. doi: 10.1155/2018/1564748. eCollection 2018.,,20180201,,,"['ORCID: 0000-0002-0862-0533', 'ORCID: 0000-0003-3190-3635']",,,,,,,,,,,,,,,
19700054,NLM,MEDLINE,20100115,20151119,1557-8216 (Electronic) 0272-5231 (Linking),30,3,2009 Sep,Obesity in the intensive care unit.,"581-99, x",10.1016/j.ccm.2009.05.007 [doi],"The exact prevalence of obesity among critically ill patients is not known, but some evidence suggests that in the United States one in four patients in the intensive care unit is obese. The authors review the physiologic alterations in obesity that are relevant in critical illness and highlight some common diseases associated with obesity. Various practical challenges in the care of the critically ill obese patient, including drug dosing, are also reviewed.","['Honiden, Shyoko', 'McArdle, John R']","['Honiden S', 'McArdle JR']","['Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT 06520-8057, USA.']",['eng'],"['Journal Article', 'Review']",United States,Clin Chest Med,Clinics in chest medicine,7907612,,IM,"['Cardiovascular Diseases/etiology/physiopathology/therapy', '*Critical Care', 'Critical Illness', 'Humans', 'Lung Diseases/etiology/physiopathology/therapy', 'Obesity/*complications/*physiopathology/therapy']",,,,,2009/08/25 09:00,2010/01/16 06:00,['2009/08/25 09:00'],"['2009/08/25 09:00 [entrez]', '2009/08/25 09:00 [pubmed]', '2010/01/16 06:00 [medline]']","['S0272-5231(09)00055-0 [pii]', '10.1016/j.ccm.2009.05.007 [doi]']",ppublish,"Clin Chest Med. 2009 Sep;30(3):581-99, x. doi: 10.1016/j.ccm.2009.05.007.",,,,,,,156,,,,,,,,,,,,,
614758,NLM,MEDLINE,19780828,20031114,0001-5318 (Print) 0001-5318 (Linking),36,9,1977,Basal hyperinsulinemia in Wistar-rats rendered obese by a high-fat diet.,1343-6,,"Basal plasma insulin levels were measured in Wistar-rats rendered obese by feeding a high-fat diet (50% fat, w/w). During the period of rapid weight-gaining (""dynamic phase"" of the development of obesity) fat-fed rats show elevated basal insulin levels in the peripheral blood plasma. No further enhancement occurred in the so-called ""static phase"" of obesity. Changing the feeding schedule at 20 weeks of age, e.g. feeding control diets (3% fat, w/v) for 4 weeks to fatty rats, results in a depression of insulin levels to control values together with a reduction of the body weight. The findings are discussed in relation to the dietary induced alterations of carbohydrate and lipid metabolism of obese rats.","['Peters, W H', 'Gottschling, D', 'Ziegler, M', 'Haude, W']","['Peters WH', 'Gottschling D', 'Ziegler M', 'Haude W']",,['eng'],['Journal Article'],Germany,Acta Biol Med Ger,Acta biologica et medica Germanica,0370276,['0 (Dietary Fats)'],IM,"['Animals', 'Dietary Fats', 'Hyperinsulinism/*etiology', 'Obesity/*complications/etiology', 'Rats']",,,,,1977/01/01 00:00,1977/01/01 00:01,['1977/01/01 00:00'],"['1977/01/01 00:00 [pubmed]', '1977/01/01 00:01 [medline]', '1977/01/01 00:00 [entrez]']",,ppublish,Acta Biol Med Ger. 1977;36(9):1343-6.,,,,,,,,,,,,,,,,,,,,
25583095,NLM,MEDLINE,20160104,20220331,1873-2933 (Electronic) 0009-9120 (Linking),48,6,2015 Apr,Laboratory assessment of cardiometabolic risk in overweight and obese children.,370-6,S0009-9120(14)00824-8 [pii] 10.1016/j.clinbiochem.2014.12.024 [doi],"Childhood obesity has been identified as one of the most important risk factors of developing cardiovascular diseases. The global prevalence of overweight and obesity among children shows an increasing tendency. Many of overweight or obese children will become obese adults with enhanced risk for cardiovascular diseases. Childhood obesity is often accompanied by serious consequences such as dyslipidemia, hypertension, diabetes, pro-inflammatory state and non-alcoholic fatty liver disease. Hypertension, high LDL-cholesterol and triglyceride concentrations, insulin resistance, inflammation and disturbances in adipocytokines secretion are associated with endothelial dysfunction which precedes the development of atherosclerosis. Obese children and adolescents with a clinically-proven non-alcoholic fatty liver disease, which is currently recognized as the hepatic component of metabolic syndrome, are at more severe cardiovascular risk compared with normal-weight. Obesity-related insulin resistance is highly prevalent in children and adolescents, and is associated with the increased lifetime risk of type 2 diabetes and cardiovascular disease. Adipokines contribute to obesity-atherosclerosis relationships yet among several recently discovered adipokines only few (adiponectin, resistin, chemerin, fibroblast growth factor 21, apelin) have been partly studied in obese pediatric population. The aim of this review was to describe the spectrum of cardiovascular abnormalities observed in children with overweight and obesity and the role of laboratory in the assessment of cardiometabolic risk in order to differentiate between healthy obese and those at risk to most effectively prevent progression of cardiovascular disease in childhood.","['Sypniewska, Grazyna']",['Sypniewska G'],"['Department of Laboratory Medicine, Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Sklodowskiej-Curie 9, 85-094 Bydgoszcz, Poland. Electronic address: grazynaodes@interia.pl.']",['eng'],"['Journal Article', 'Review']",United States,Clin Biochem,Clinical biochemistry,0133660,,IM,"['Cardiovascular Diseases/*diagnosis/etiology/metabolism', 'Child', 'Humans', 'Metabolic Diseases/*diagnosis/etiology/metabolism', 'Obesity/complications/*metabolism/pathology', 'Risk Factors']",,['NOTNLM'],"['Adipocytokines', 'Cardiometabolic risk factors', 'Cardiovascular diseases', 'Childhood obesity', 'Dyslipidemia', 'Familial hypercholesterolemia', 'Non-alcoholic fatty liver disease']",,2015/01/15 06:00,2016/01/05 06:00,['2015/01/14 06:00'],"['2014/08/28 00:00 [received]', '2014/12/23 00:00 [revised]', '2014/12/24 00:00 [accepted]', '2015/01/14 06:00 [entrez]', '2015/01/15 06:00 [pubmed]', '2016/01/05 06:00 [medline]']","['S0009-9120(14)00824-8 [pii]', '10.1016/j.clinbiochem.2014.12.024 [doi]']",ppublish,Clin Biochem. 2015 Apr;48(6):370-6. doi: 10.1016/j.clinbiochem.2014.12.024. Epub 2015 Jan 10.,,20150110,,"['Copyright (c) 2015 The Canadian Society of Clinical Chemists. Published by Elsevier', 'Inc. All rights reserved.']",,,,,,,,,,,,,,,,
22981746,NLM,MEDLINE,20131219,20220409,1877-0665 (Electronic) 1877-0657 (Linking),55,9-10,2012 Dec,Relevance of the measure of perceived exertion for the rehabilitation of obese patients.,623-40,S1877-0657(12)00098-X [pii] 10.1016/j.rehab.2012.07.003 [doi],"The most common tool used for measuring effort perception is the rating scale of perceived exertion (RPE) developed by Borg. This scale is also used for various outcomes in the general population. The validity and reliability of this scale have already been reported in obese patients. However, the relevance of measuring perceived exertion in obese patients is still poorly known. This review of the literature presents the Borg RPE scale (i.e., validity, reliability and recommendations) and its main advantages during graded exercise tests (e.g., comparison of physical capacity, predicting physiological variables, verifying exhaustion and exercise safety) and rehabilitation programs (e.g., individualized exercise intensity, evaluation of the impact of a rehabilitation program and even determining the perceptual preference) in obese patients. This review of the literature underlines the relevance and usefulness of the Borg RPE scale, which is still underused in obese patients. However, additional studies are still necessary before using this scale routinely in all obese patients (regardless of the severity of their obesity or associated complications).","['Coquart, J-B', 'Tourny-Chollet, C', 'Lemaitre, F', 'Lemaire, C', 'Grosbois, J-M', 'Garcin, M']","['Coquart JB', 'Tourny-Chollet C', 'Lemaitre F', 'Lemaire C', 'Grosbois JM', 'Garcin M']","[""EA 3832, centre d'etudes des transformations des activites physiques et sportives, faculte des sciences du sport, universite de Rouen, 76000 Rouen, France. jeremy.coquart@voila.fr""]","['eng', 'fre']","['Journal Article', 'Review']",Netherlands,Ann Phys Rehabil Med,Annals of physical and rehabilitation medicine,101502773,,IM,"['Exercise Tolerance', 'Humans', 'Obesity/*psychology/*rehabilitation', '*Physical Exertion', 'Psychometrics']",,,,,2012/09/18 06:00,2013/12/20 06:00,['2012/09/18 06:00'],"['2011/10/14 00:00 [received]', '2012/07/05 00:00 [revised]', '2012/07/16 00:00 [accepted]', '2012/09/18 06:00 [entrez]', '2012/09/18 06:00 [pubmed]', '2013/12/20 06:00 [medline]']","['S1877-0657(12)00098-X [pii]', '10.1016/j.rehab.2012.07.003 [doi]']",ppublish,Ann Phys Rehabil Med. 2012 Dec;55(9-10):623-40. doi: 10.1016/j.rehab.2012.07.003. Epub 2012 Sep 4.,,20120904,,['Copyright (c) 2012 Elsevier Masson SAS. All rights reserved.'],,,,,,,,,,,,,,,,
3352430,NLM,MEDLINE,19880427,20041117,0023-7205 (Print) 0023-7205 (Linking),85,8,1988 Feb 24,[Swedish Obese Subjects--an intervention study on obesity].,636-9,,,"['Sjostrom, L']",['Sjostrom L'],,['swe'],['Journal Article'],Sweden,Lakartidningen,Lakartidningen,0027707,,IM,"['Body Weight', 'Female', 'Humans', 'Male', 'Obesity/mortality/*prevention & control/therapy', 'Risk Factors', 'Sweden']",,,,,1988/02/24 00:00,1988/02/24 00:01,['1988/02/24 00:00'],"['1988/02/24 00:00 [pubmed]', '1988/02/24 00:01 [medline]', '1988/02/24 00:00 [entrez]']",,ppublish,Lakartidningen. 1988 Feb 24;85(8):636-9.,,,,,,,,,SOS--en interventionsstudie av fetma.,,,,,,,,,,,
7416710,NLM,MEDLINE,19801125,20161031,0003-4266 (Print) 0003-4266 (Linking),41,3,1980 May-Jun,[On the role of glucagon in natriuresis of fast (author's transl)].,237-8,,"Glucagon administered to fasting obeses enhanced natriuresis as well as ketonuria while devoid of influence on ketonemia. This suggest that glucagon reduces ketone body reabsorption by renal tubule cells, which accounts for the natriuretic properties of this hormone.","['Kolanowski, J']",['Kolanowski J'],,['fre'],"['English Abstract', 'Journal Article']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,"['0 (Ketone Bodies)', '9007-92-5 (Glucagon)']",IM,"['*Fasting', 'Glucagon/pharmacology/*physiology', 'Humans', 'Ketone Bodies/metabolism', '*Natriuresis/drug effects', 'Obesity/diet therapy']",,,,,1980/05/01 00:00,1980/05/01 00:01,['1980/05/01 00:00'],"['1980/05/01 00:00 [pubmed]', '1980/05/01 00:01 [medline]', '1980/05/01 00:00 [entrez]']",,ppublish,Ann Endocrinol (Paris). 1980 May-Jun;41(3):237-8.,,,,,,,,,Le role du glucagon dans la natriurese du jeune.,,,,,,,,,,,
8873786,NLM,MEDLINE,19961230,20041117,0033-2941 (Print) 0033-2941 (Linking),79,1,1996 Aug,The role of emotional and socio-cognitive patterns in obesity: eating attitudes in obese adolescents before and after a dietary-behavioural therapy.,35-46,,"The aim was to examine attitudes towards eating in a group of obese and nonobese female adolescents (N = 200), in particular whether obese subjects have characteristic attitudinal patterns associated with obesity. Analysis concluded that our sample, both overweight and normal subjects, share the negative stereotypic attitudes towards obese persons. However, there was a considerable difference in emotional evaluation of eating behaviour. If normal subjects attribute a strong negative emotional connotation, obese subjects not only did not recognise the ""abnormality"" of overeating, but preferred it. This can be explained by the presence of an association of strength and power with overeating: at the moment of eating, obese subjects feel themselves ""strong"" and even ""superior,"" thereby compensating for their rather weak and fragile personalities. The emotional evaluation of eating behavior did not change after a 10-week dietary/behavioural treatment.","['Riva, G']",['Riva G'],"['Catholic University of Milan, Italy. auxo.psylab@gse.it']",['eng'],['Journal Article'],United States,Psychol Rep,Psychological reports,0376475,,IM,"['Adolescent', 'Adolescent Behavior', '*Affect', 'Body Mass Index', 'Diet Therapy', '*Feeding Behavior', 'Female', 'Humans', 'Obesity/*psychology/*therapy']",,,,,1996/08/01 00:00,1996/08/01 00:01,['1996/08/01 00:00'],"['1996/08/01 00:00 [pubmed]', '1996/08/01 00:01 [medline]', '1996/08/01 00:00 [entrez]']",,ppublish,Psychol Rep. 1996 Aug;79(1):35-46.,,,,,,,,,,,,,,,,,,,,
10101987,NLM,MEDLINE,19990414,20191024,1063-3987 (Print) 1063-3987 (Linking),8,2,1999 Mar-Apr,Treating the obese patient. Suggestions for primary care practice.,156-67,,"Obesity is a major health problem in America. Weight loss is associated with improvements in obesity-related health complications, but patients and practitioners are frequently disappointed by the long-term results of weight control efforts. Recent research has yielded new findings concerning the causes of obesity, as well as new goals for obesity treatment. Traditionally, the goal of therapy has been reduction to ideal weight. Several scientific bodies, however, now recommend a more modest 5% to 15% reduction in initial weight. Current options for weight loss include behavioral or pharmacological management provided during primary care visits, self-help and commercial programs, hospital-based interventions, and bariatric surgery. Regardless of the approach selected, long-term care usually is required to facilitate the maintenance of weight loss.","['Anderson, D A', 'Wadden, T A']","['Anderson DA', 'Wadden TA']","['Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, USA. drewa@csc.albany.edu']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S."", 'Review']",United States,Arch Fam Med,Archives of family medicine,9300357,,IM,"['Behavior Therapy', 'Body Mass Index', 'Diet, Reducing', 'Exercise Therapy', 'Humans', 'Obesity/*diagnosis/diet therapy/drug therapy/psychology/surgery/*therapy', 'Weight Loss']",,,,,1999/04/02 00:00,1999/04/02 00:01,['1999/04/02 00:00'],"['1999/04/02 00:00 [pubmed]', '1999/04/02 00:01 [medline]', '1999/04/02 00:00 [entrez]']",['10.1001/archfami.8.2.156 [doi]'],ppublish,Arch Fam Med. 1999 Mar-Apr;8(2):156-67. doi: 10.1001/archfami.8.2.156.,"['DK50058-03/DK/NIDDK NIH HHS/United States', 'KO2-MH00702-08/MH/NIMH NIH HHS/United States']",,,,,,98,,,,,,,,,,,,,
17265999,NLM,MEDLINE,20070301,20161124,0954-7762 (Print) 0954-7762 (Linking),103,3,2007 Jan 16-22,Tackling the obesity burden.,23-4,,"NICE has issued its first guidance on the prevention, identification, assessment and management of overweight and obesity in adults and children. This article looks at how nurses will be expected to assist overweight and obese patients.","['Torjesen, Ingrid']",['Torjesen I'],,['eng'],['Journal Article'],England,Nurs Times,Nursing times,0423236,['0 (Anti-Obesity Agents)'],,"['Anti-Obesity Agents/therapeutic use', 'Diet', 'Gastric Bypass', 'Humans', 'Obesity/epidemiology/nursing/*therapy', 'Referral and Consultation', 'United Kingdom/epidemiology']",,,,,2007/02/03 09:00,2007/03/03 09:00,['2007/02/03 09:00'],"['2007/02/03 09:00 [pubmed]', '2007/03/03 09:00 [medline]', '2007/02/03 09:00 [entrez]']",,ppublish,Nurs Times. 2007 Jan 16-22;103(3):23-4.,,,,,,,,,,,,,,,,,,,,
3440685,NLM,MEDLINE,19880412,20140603,,11 Suppl 3,,1987,Morbid obesity: medical or surgical treatment? The case for medical treatment.,1-4,,"We should ask about any therapy: (1) is it safe? and (2) is it effective? The best therapy is that which has the greatest chance to do good with the least chance to cause harm. Medical treatment is certainly safer than surgery, since (by my definition) surgery always involves a general anaesthetic, and morbidly obese patients are bad anaesthetic risks. Obesity also increases other surgical risks, so all published series of surgically-treated obese patients report some mortality. Surgeons will claim that surgery is much more effective than medical treatment, which has negligible success in morbid obesity. However all surgical bypass or banding procedures cause weight loss by restricting food intake, so if food intake can be equally restricted without surgery the results are just as good. In our experience jaw-wiring (which does not require a general anaesthetic) produces similar weight loss to gastroplasty. However the most difficult problem in morbid obesity is the maintenance of reduced weight many years after treatment. We have too few good long-term follow-up data after either medical or surgical treatment, but about half our patients treated with jaw-wiring and a waist cord maintain their weight loss on 3 years follow-up, zero mortality from the procedure. The results of surgical and medical treatments depend on the skill and care with which they are applied, and the way in which patients are selected. If patients are given treatment B if they are considered unsuitable for treatment A then the results from treatment A will be better.(ABSTRACT TRUNCATED AT 250 WORDS)","['Garrow, J S']",['Garrow JS'],"['Nutrition Research Group, Clinical Research Centre, Harrow, U.K.']",['eng'],['Journal Article'],England,Int J Obes,International journal of obesity,7703240,,IM,"['Adult', 'Body Weight', 'Female', 'Humans', 'Male', 'Obesity/metabolism/surgery/*therapy']",,,,,1987/01/01 00:00,1987/01/01 00:01,['1987/01/01 00:00'],"['1987/01/01 00:00 [pubmed]', '1987/01/01 00:01 [medline]', '1987/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1987;11 Suppl 3:1-4.,,,,,,,,,,,,,,,,,,,,
8926858,NLM,MEDLINE,19961125,20151119,0374-9320 (Print) 0374-9320 (Linking),37,2,1996 Jun,[Psychopathological and clinical features among the ambulatory population of obese patients].,53-8,,"Aim of the present study is the evaluation of psychopathological and clinical features of these outpatients followed by the Outpatient Clinic of the Section of Metabolic Diseases and Diabetes, University of Florence. 84 obese patients and 217 non-obese control subjects were studied using the Structured Clinical Interview for DSM-III-R (SCID), and applying DSM-IV criteria for Binge Eating Disorder. BITE self-reported questionnaire, STAI inventory and Ham-D rating scale were also used. Lifetime prevalence of Binge Eating Disorder in obese patient was 11.9%, markedly lower than that reported in studies on North American samples. Prevalence of depressive disorder (Major Depression and Dysthymia) was significantly higher (p < 0.005) in obese patients than in control subjects. This confirms the important relationships between eating and mood disorders. The prevalence of subclinical eating disorders resulted to be significantly higher in obese patients (p < 0.01) when compared with control subjects. Significant correlations (p < 0.01) of BITE scores were observed with STAI and Ham-D scores, but not with body mass index. These results underline the need for an accurate psychopathological assessment in obese patients, in order to formulate a correct diagnosis and plan adequate therapeutical interventions.","['Ricca, V', 'Mannucci, E', 'Di Bernardo, M', 'Mezzani, B', 'Carrara, S', 'Rizzello, S M', 'La Malfa, G', 'Rotella, C M', 'Cabras, P L']","['Ricca V', 'Mannucci E', 'Di Bernardo M', 'Mezzani B', 'Carrara S', 'Rizzello SM', 'La Malfa G', 'Rotella CM', 'Cabras PL']","['Dipartimento di Scienze, Universita degli Studi, Firenze.']",['ita'],"['Comparative Study', 'English Abstract', 'Journal Article']",Italy,Minerva Psichiatr,Minerva psichiatrica,7707981,,IM,"['Adolescent', 'Adult', 'Affect', 'Aged', '*Ambulatory Care', 'Depressive Disorder/psychology', 'Feeding and Eating Disorders/diagnosis', 'Humans', 'Male', 'Middle Aged', 'Obesity/etiology/*psychology/rehabilitation', 'Psychiatric Status Rating Scales']",,,,,1996/06/01 00:00,1996/06/01 00:01,['1996/06/01 00:00'],"['1996/06/01 00:00 [pubmed]', '1996/06/01 00:01 [medline]', '1996/06/01 00:00 [entrez]']",,ppublish,Minerva Psichiatr. 1996 Jun;37(2):53-8.,,,,,,,,,Caratteristiche psicopatologiche e cliniche di una popolazione ambulatoriale di pazienti obesi.,,,,,,,,,,,
1670317,NLM,MEDLINE,19940801,20051116,0012-7183 (Print) 0012-7183 (Linking),106,6,1990,[The obese child].,537-41,,,"['Lautala, P']",['Lautala P'],"['OYKS:n lastentautien klinikka, Oulu, Finland.']",['fin'],"['Journal Article', 'Review']",Finland,Duodecim,Duodecim; laaketieteellinen aikakauskirja,0373207,,IM,"['Central Nervous System Diseases/complications', 'Child', 'Diseases in Twins', 'Endocrine System Diseases/complications', 'Genetic Diseases, Inborn/etiology', 'Humans', '*Obesity/diagnosis/etiology/therapy', 'Risk Factors', 'Syndrome']",,,,,1990/01/01 00:00,1990/01/01 00:01,['1990/01/01 00:00'],"['1990/01/01 00:00 [pubmed]', '1990/01/01 00:01 [medline]', '1990/01/01 00:00 [entrez]']",,ppublish,Duodecim. 1990;106(6):537-41.,,,,,,,33,,Lihava lapsi.,,,,,,,,,,,
2320847,NLM,MEDLINE,19900503,20041117,0210-5020 (Print) 0210-5020 (Linking),13,138,1990 Feb,[The tracking of obese patients in a nursing consultation. A protocol for action].,"63-5, 67-8",,,"['Cao Torija, M J']",['Cao Torija MJ'],,['spa'],['Journal Article'],Spain,Rev Enferm,"Revista de enfermeria (Barcelona, Spain)",8309920,,,"['Diet, Reducing/nursing', 'Humans', 'Obesity/complications/diet therapy/*nursing', '*Referral and Consultation']",,,,,1990/02/01 00:00,1990/02/01 00:01,['1990/02/01 00:00'],"['1990/02/01 00:00 [pubmed]', '1990/02/01 00:01 [medline]', '1990/02/01 00:00 [entrez]']",,ppublish,"Rev Enferm. 1990 Feb;13(138):63-5, 67-8.",,,,,,,,,Seguimiento de obesos en consulta de enfermeria. Protocolo de actuacion.,,,,,,,,,,,
29138674,NLM,MEDLINE,20180719,20181113,1942-0994 (Electronic) 1942-0900 (Print) 1942-0994 (Linking),2017,,2017,Exercise Training Restores Cardiac MicroRNA-1 and MicroRNA-29c to Nonpathological Levels in Obese Rats.,1549014,10.1155/2017/1549014 [doi] 1549014,"We previously reported that aerobic exercise training (AET) consisted of 10 weeks of 60-min swimming sessions, and 5 days/week AET counteracts CH in obesity. Here, we evaluated the role of microRNAs and their target genes that are involved in heart collagen deposition and calcium signaling, as well as the cardiac remodeling induced by AET in obese Zucker rats. Among the four experimental Zucker groups: control lean rats (LZR), control obese rats (OZR), trained lean rats (LZR + TR), and trained obese rats (OZR + TR), heart weight was greater in the OZR than in the LZR group due to increased cardiac intramuscular fat and collagen. AET seems to exert a protective role in normalizing the heart weight in the OZR + TR group. Cardiac microRNA-29c expression was decreased in OZR compared with the LZR group, paralleled by an increase in the collagen volumetric fraction (CVF). MicroRNA-1 expression was upregulated while the expression of its target gene NCX1 was decreased in OZR compared with the LZR group. Interestingly, AET restored cardiac microRNA-1 to nonpathological levels in the OZR-TR group. Our findings suggest that AET could be used as a nonpharmacological therapy for the reversal of pathological cardiac remodeling and cardiac dysfunction in obesity.","['Silveira, Andre C', 'Fernandes, Tiago', 'Soci, Ursula P R', 'Gomes, Joao L P', 'Barretti, Diego L', 'Mota, Gloria G F', 'Negrao, Carlos Eduardo', 'Oliveira, Edilamar M']","['Silveira AC', 'Fernandes T', 'Soci UPR', 'Gomes JLP', 'Barretti DL', 'Mota GGF', 'Negrao CE', 'Oliveira EM']","['Laboratory of the Biochemistry and Molecular Biology of Exercise, School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratory of the Biochemistry and Molecular Biology of Exercise, School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratory of the Biochemistry and Molecular Biology of Exercise, School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratory of the Biochemistry and Molecular Biology of Exercise, School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratory of the Biochemistry and Molecular Biology of Exercise, School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratory of the Biochemistry and Molecular Biology of Exercise, School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratory of the Biochemistry and Molecular Biology of Exercise, School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Heart Institute (InCor), Medical School, University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Laboratory of the Biochemistry and Molecular Biology of Exercise, School of Physical Education and Sport, University of Sao Paulo, Sao Paulo, SP, Brazil.']",['eng'],['Journal Article'],United States,Oxid Med Cell Longev,Oxidative medicine and cellular longevity,101479826,"['0 (MIRN1 microRNA, rat)', '0 (MIRN29 microRNA, rat)', '0 (MicroRNAs)']",IM,"['Animals', 'Heart/*physiopathology', 'Male', 'MicroRNAs/*metabolism', 'Obesity/*genetics/pathology/physiopathology/*therapy', 'Physical Conditioning, Animal/*physiology', 'Rats', 'Rats, Zucker']",PMC5613694,,,,2017/11/16 06:00,2018/07/20 06:00,['2017/11/16 06:00'],"['2017/02/16 00:00 [received]', '2017/06/10 00:00 [revised]', '2017/07/13 00:00 [accepted]', '2017/11/16 06:00 [entrez]', '2017/11/16 06:00 [pubmed]', '2018/07/20 06:00 [medline]']",['10.1155/2017/1549014 [doi]'],ppublish,Oxid Med Cell Longev. 2017;2017:1549014. doi: 10.1155/2017/1549014. Epub 2017 Aug 23.,,20170823,['Oxid Med Cell Longev. 2018 Feb 25;2018:4818310. PMID: 29683145'],,"['ORCID: 0000-0003-2549-5452', 'ORCID: 0000-0002-8374-2004', 'ORCID: 0000-0002-7101-312X']",,,,,,,,,,,,,,,
8252152,NLM,MEDLINE,19940113,20191023,1063-3987 (Print) 1063-3987 (Linking),2,3,1993 Mar,A practical approach to treatment of the obese patient.,309-16,,"Obesity is one of the most common conditions encountered by primary care physicians, yet both physicians and patients are often frustrated by current approaches to its management. Recent advances in our understanding of obesity enable the physician to evaluate the contributions of biologic and environmental factors to the patient's obesity, to determine the degree of medical risk posed by the obesity, and to establish realistic goals for treatment. The chronic and relapsing nature of obesity requires ongoing support and vigilance. An individualized approach to obesity management, based on careful evaluation of biologic, psychologic, and social factors, can be successfully developed and implemented by the office-based primary care physician.","['Yanovski, S Z']",['Yanovski SZ'],"['Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md.']",['eng'],"['Journal Article', 'Review']",United States,Arch Fam Med,Archives of family medicine,9300357,,IM,"['Adult', 'Chronic Disease', 'Family Practice', 'Humans', 'Obesity/diagnosis/prevention & control/*therapy', 'Patient Care Planning']",,,,,1993/03/01 00:00,1993/03/01 00:01,['1993/03/01 00:00'],"['1993/03/01 00:00 [pubmed]', '1993/03/01 00:01 [medline]', '1993/03/01 00:00 [entrez]']",['10.1001/archfami.2.3.309 [doi]'],ppublish,Arch Fam Med. 1993 Mar;2(3):309-16. doi: 10.1001/archfami.2.3.309.,,,,,,,73,['Arch Fam Med. 1993 Aug;2(8):813-4. PMID: 8111507'],,,,,,,,,,,,
34102165,NLM,MEDLINE,20210908,20210908,1096-0384 (Electronic) 0003-9861 (Linking),708,,2021 Sep 15,Biochemical and immunological changes in obesity.,108951,S0003-9861(21)00200-9 [pii] 10.1016/j.abb.2021.108951 [doi],"Obesity is a syndemia that promotes high expenditures for public health, and is defined by the excess of adipose tissue that is classified according to its function and anatomical distribution. In obese people, this tissue generates oxidative stress associated with a chronic inflammatory response, in which there is an imbalance in relation to the release of hormones and adipokines that cause loss of body homeostasis and predisposition to the development of some comorbidities. The purpose of this review is to summarize the main events that occur during the onset and progression of obesity with a special focus on biochemical and immunological changes. Hypertrophied and hyperplasia adipocytes have biomarkers and release adipokines capable of regulating pathways and expressing genes that culminate in the development of metabolic changes, such as changes in energy balance and intestinal microbiota, and the development of some comorbidities, diabetes mellitus, dyslipidemias, arterial hypertension, liver disease, cancer, allergies, osteoporosis, sarcopenia and obstructive sleep apnea. Thus, it is necessary to treat and/or prevent pathology, using traditional methods based on healthy eating, and regular physical and leisure activities.","['Barakat, Beatriz', 'Almeida, Martha E F']","['Barakat B', 'Almeida MEF']","['Institute of Biological and Health Sciences, Federal University of Vicosa (UFV), Rio Paranaiba Campus, Rio Paranaiba, Minas Gerais, Brazil. Electronic address: beatrizbarakat@hotmail.com.', 'Institute of Biological and Health Sciences, Federal University of Vicosa (UFV), Rio Paranaiba Campus, Rio Paranaiba, Minas Gerais, Brazil.']",['eng'],"['Journal Article', 'Review']",United States,Arch Biochem Biophys,Archives of biochemistry and biophysics,0372430,,IM,"['Animals', 'Humans', 'Obesity/*immunology/*metabolism/pathology/therapy']",,['NOTNLM'],"['Adipose tissue', 'Cytokines', 'Diseases', 'Hormones', 'Inflammation', 'Intestinal microbiota']",,2021/06/09 06:00,2021/09/09 06:00,['2021/06/08 20:17'],"['2021/01/13 00:00 [received]', '2021/05/25 00:00 [revised]', '2021/05/31 00:00 [accepted]', '2021/06/09 06:00 [pubmed]', '2021/09/09 06:00 [medline]', '2021/06/08 20:17 [entrez]']","['S0003-9861(21)00200-9 [pii]', '10.1016/j.abb.2021.108951 [doi]']",ppublish,Arch Biochem Biophys. 2021 Sep 15;708:108951. doi: 10.1016/j.abb.2021.108951. Epub 2021 Jun 5.,,20210605,,['Copyright (c) 2021 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
32118387,NLM,MEDLINE,20201117,20201117,1827-1928 (Electronic) 0022-4707 (Linking),60,6,2020 Jun,Thirty-two weeks of randomized interdisciplinary therapy or combined physical training promote similar improvements in anthropometric and biochemical parameters of obese women.,903-911,10.23736/S0022-4707.20.10036-7 [doi],"BACKGROUND: Obesity is a multicausal illness that generates large expenses to health systems and also for the families of obese individuals. It is important to note that obesity disrupts all systems, generating metabolic consequences that may be irreversible. Interdisciplinary therapy is recommended as the primary method for treating obesity. However, the cost of interdisciplinary treatment can be high due to the need for various professionals, from different areas of expertise. This study compares the effects of 32 weeks of physical training combined with interdisciplinary therapy on anthropometric and biochemical parameters in obese women. METHODS: Seventy-six subjects were randomized into two groups: Group Physical Exercise (EXE) and Group Interdisciplinary Treatment (INTER), being evaluated in the initial moment and after 32 weeks. 30 subjects completed the intervention and were evaluated (EXE: N.=13; INTER: N.=17). RESULTS: Psychobiological and biochemical variables were measured. EXE and INTER were similar before treatment and both showed significantly improvements in anthropometric and biochemical parameters after interventions, without difference between groups. CONCLUSIONS: The results confirmed the relevant role of physical training or the interdisciplinary therapy on metabolic profile of obese women. We realized that physical training can be incorporated into public or private health systems as an alternative strategy for obesity control, especially in locations that do not have the possibility of offering a complete interdisciplinary therapy.","['Cerrone, Leticia A', 'Caranti, Danielle A', 'Fidalgo, Joao P', 'Sanches, Ricardo B', 'Nascimento, Maythe A', 'Astride, Renata R', 'Poli, Vanessa F', 'de Campos, Carlos E', 'Oyama, Lila M', 'Yi, Liu C', 'Damaso, Ana R', 'Teixeira, Caue V', 'Gomes, Ricardo J']","['Cerrone LA', 'Caranti DA', 'Fidalgo JP', 'Sanches RB', 'Nascimento MA', 'Astride RR', 'Poli VF', 'de Campos CE', 'Oyama LM', 'Yi LC', 'Damaso AR', 'Teixeira CV', 'Gomes RJ']","['Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil - leticia.ac9@gmail.com.', 'Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil.', 'Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil.', 'Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil.', 'State University of Campinas, Campinas, SP, Brazil.', 'Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil.', 'Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil.', 'Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil.', 'Cellula Mater Laboratory, Santos, SP, Brazil.', 'Federal University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Federal University of Sao Paulo, Sao Paulo, SP, Brazil.', 'Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil.', 'Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil.', 'Obesity Study Group, Federal University of Sao Paulo, Santos, SP, Brazil.']",['eng'],"['Journal Article', 'Randomized Controlled Trial']",Italy,J Sports Med Phys Fitness,The Journal of sports medicine and physical fitness,0376337,,IM,"['Adult', 'Anthropometry', 'Combined Modality Therapy', 'Exercise', '*Exercise Therapy', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/blood/psychology/*therapy', '*Physical Therapy Modalities']",,,,,2020/03/03 06:00,2020/11/18 06:00,['2020/03/03 06:00'],"['2020/03/03 06:00 [pubmed]', '2020/11/18 06:00 [medline]', '2020/03/03 06:00 [entrez]']","['S0022-4707.20.10036-7 [pii]', '10.23736/S0022-4707.20.10036-7 [doi]']",ppublish,J Sports Med Phys Fitness. 2020 Jun;60(6):903-911. doi: 10.23736/S0022-4707.20.10036-7. Epub 2020 Feb 27.,,20200227,,,,,,,,,,,,,,,,,,
21689505,NLM,MEDLINE,20110811,20110621,1603-6824 (Electronic) 0041-5782 (Linking),173,25,2011 Jun 20,[Psychological consequences of severe overweight in teenagers].,1785-91,,"Obese adolescents are adversely affected by the psychosocial consequences of their obesity, which affects their identity development negatively. Further, the obesity-associated psychosocial consequences deteriorate increasingly as the children grow older. Obese adolescents have poor health related quality of life and tend to develop serious emotional and social problems, and a negative body image compared to normal weight peers. Obese adolescents represent approximately 5% of all youths in Denmark, but the treatment options available do not meet the demands of this vulnerable group.","['Gronbaek, Helle N', 'Holm, Jens-Christian']","['Gronbaek HN', 'Holm JC']","['Paediatrisk Afdeling, Enheden for Overvaegtige Born og Unge, Holbaek Sygehus, Smedelundsgade 60, 4300 Holbaek, Denmark. hngr@regionsjaelland.dk']",['dan'],"['Comparative Study', 'English Abstract', 'Journal Article', 'Review']",Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,IM,"['Adolescent', 'Body Image', 'Bullying', 'Denmark/epidemiology', 'Female', 'Health Status', 'Humans', 'Male', 'Obesity/complications/epidemiology/*psychology', 'Quality of Life', 'Stereotyping', 'Young Adult']",,,,,2011/06/22 06:00,2011/08/13 06:00,['2011/06/22 06:00'],"['2011/06/22 06:00 [entrez]', '2011/06/22 06:00 [pubmed]', '2011/08/13 06:00 [medline]']",['VP10100390 [pii]'],ppublish,Ugeskr Laeger. 2011 Jun 20;173(25):1785-91.,,,,,,,,,Psykologiske konsekvenser af svaer overvaegt hos teenagere.,,,,,,,,,,,
12035338,NLM,MEDLINE,20020822,20191106,0741-5206 (Print) 0741-5206 (Linking),22,1,2002 Spring,Promoting positive outcomes in obese patients.,"10-7, 28; quiz 18",,"Obese patients are seen in every practice setting. Obesity is a chronic disease that may lead to physical and emotional problems, which may have an impact on the social and psychological functioning of the patient. With appropriate preoperative, intraoperative, and postoperative precautions; monitoring; and restructuring the environment to promote care and safety, the incidence of poor surgical outcomes can be minimized. This paper will address the significance of obesity, related diseases, and proper care of the obese patient.","['Troia, Cecilia']",['Troia C'],"['Center for Wound Healing, Nebraska Health Systems, Clarkson Hospital, Omaha, NE, USA.']",['eng'],"['Journal Article', 'Review']",United States,Plast Surg Nurs,Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses,8403490,,,"['Comorbidity', 'Humans', 'Obesity/*complications/epidemiology/*nursing', 'Perioperative Care', 'Postoperative Complications', 'Risk Factors', 'Surgical Procedures, Operative/*adverse effects/nursing', 'Treatment Outcome']",,,,,2002/05/31 10:00,2002/08/23 10:01,['2002/05/31 10:00'],"['2002/05/31 10:00 [pubmed]', '2002/08/23 10:01 [medline]', '2002/05/31 10:00 [entrez]']",['10.1097/00006527-200222010-00003 [doi]'],ppublish,"Plast Surg Nurs. 2002 Spring;22(1):10-7, 28; quiz 18. doi: 10.1097/00006527-200222010-00003.",,,,,,,26,,,,,,,,,,,,,
31250122,NLM,MEDLINE,20200303,20200303,1539-0829 (Electronic) 1534-4827 (Linking),19,8,2019 Jun 27,Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?,51,10.1007/s11892-019-1180-z [doi],"PURPOSE OF REVIEW: The aim of this review is to summarize the current data available on the metabolic effects of fecal microbiota transplantation (FMT) including obesity and glucose metabolism in humans. RECENT FINDINGS: Gut microbiota dysbiosis is a frequent characteristic observed in obesity and related metabolic diseases. Pieces of evidence mostly generated in mouse models suggest that rescuing this dysbiosis associates with improved metabolism. In humans, dietary or bariatric surgery interventions are often accompanied by complete or partial restoration of this dysbiosis together with weight reduction and metabolic amelioration. FMT is an interesting option to modify gut microbiota and has been associated with improved clinical outcomes, albeit only used in routine care for Clostridium difficile infection. However, there are only limited data on using FMT in the metabolic context. FMT from lean donors significantly improves insulin sensitivity in obese subjects with metabolic syndrome. However, there is a wide range of clinical responses. Interestingly in subjects with high microbial gene richness at baseline and when FMT donors that are metabolically compromised are used, no metabolic improvement is seen. Moreover, more studies evaluating the effect of FMT in patients with overt type 2 diabetes are warranted. Furthermore, interventions (in the receiver prior to FMT) aiming to enhance FMT response also need evaluation.","['Aron-Wisnewsky, Judith', 'Clement, Karine', 'Nieuwdorp, Max']","['Aron-Wisnewsky J', 'Clement K', 'Nieuwdorp M']","['Sorbonne Universite, INSERM, Nutrition and Obesities: Systemic Approaches (NutriOMics) Research Unit, Paris, France. judith.aron-wisnewsky@psl.aphp.fr.', 'Assistante Publique Hopitaux de Paris, Nutrition Department, Pitie-Salpetriere Hospital, 75013, Paris, France. judith.aron-wisnewsky@psl.aphp.fr.', 'Amsterdam UMC, Location AMC and VUMC, Department of Internal and Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands. judith.aron-wisnewsky@psl.aphp.fr.', 'Sorbonne Universite, INSERM, Nutrition and Obesities: Systemic Approaches (NutriOMics) Research Unit, Paris, France.', 'Assistante Publique Hopitaux de Paris, Nutrition Department, Pitie-Salpetriere Hospital, 75013, Paris, France.', 'Amsterdam UMC, Location AMC and VUMC, Department of Internal and Vascular Medicine, University of Amsterdam, Amsterdam, The Netherlands.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Curr Diab Rep,Current diabetes reports,101093791,,IM,"['Animals', '*Clostridium Infections', '*Diabetes Mellitus', '*Fecal Microbiota Transplantation', 'Feces', 'Humans', 'Obesity', 'Treatment Outcome']",,['NOTNLM'],"['Encapsulated feces', 'Fecal microbiota transplantation', 'Microbiota', 'Obesity', 'Type 2 diabetes']",,2019/06/30 06:00,2020/03/04 06:00,['2019/06/29 06:00'],"['2019/06/29 06:00 [entrez]', '2019/06/30 06:00 [pubmed]', '2020/03/04 06:00 [medline]']","['10.1007/s11892-019-1180-z [pii]', '10.1007/s11892-019-1180-z [doi]']",epublish,Curr Diab Rep. 2019 Jun 27;19(8):51. doi: 10.1007/s11892-019-1180-z.,,20190627,,,,,,,,,,,,,,,,,,
27166909,NLM,MEDLINE,20180201,20220316,1678-4561 (Electronic) 1413-8123 (Linking),21,5,2016 May,"Gender and obesity interaction in quality of life in adults assisted by family doctor program in Niteroi, Brazil.",1617-24,S1413-81232016000501617 [pii] 10.1590/1413-81232015215.10832015 [doi],"Obesity impacts the quality of life (HRQL). Studies about the effects of a possible interaction between gender and body mass are rare. The objective of the present paper is to estimate the biological interaction between gender and obesity on HRQL. This was a cross-sectional study based on data from CAMELIA study with population assisted by the Family Doctor Program of Niteroi visited between June 2006 and December 2007. HRQL was assessed by the SF-36. The exposure categories were: obese women, non-obese women, obese men and non-obese men, the reference category. Obese women showed higher percentages of low overall, physical and mental quality of life with the largest associations in the physical component. The excess risk due to interaction was statistically significant in physical dimension: RERI = 1.97 (0.40-3.52) and RERIa = 1,97 (0.40-1.7). Among the Brazilian population aged 20-64 years, obesity was independently associated with low HRQL. This association differed by gender, being significant for women. The possibility of the combined effect takes greater importance in the context of increasing incidence of obesity globally. Healthcare professionals in primary care settings should pay attention to gender differences in the impact of obesity on HRQL.","['Torres, Karla Dala Paula', 'Rosa, Maria Luiza Garcia', 'Moscavitch, Samuel Datum']","['Torres KD', 'Rosa ML', 'Moscavitch SD']","['Departamento de Epidemiologia e Bioestatistica, Universidade Federal Fluminense, Niteroi, RJ, Brasil, karladptorres@gmail.com.', 'Departamento de Epidemiologia e Bioestatistica, Universidade Federal Fluminense, Niteroi, RJ, Brasil, karladptorres@gmail.com.', 'Departamento de Epidemiologia e Bioestatistica, Universidade Federal Fluminense, Niteroi, RJ, Brasil, karladptorres@gmail.com.']",['eng'],['Journal Article'],Brazil,Cien Saude Colet,Ciencia & saude coletiva,9713483,,IM,"['Adult', 'Brazil', 'Cross-Sectional Studies', 'F Factor', 'Family Practice', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*epidemiology/physiopathology/psychology', 'Primary Health Care/*organization & administration', '*Quality of Life', 'Young Adult']",,,,,2016/05/12 06:00,2018/02/02 06:00,['2016/05/12 06:00'],"['2015/06/20 00:00 [received]', '2015/11/16 00:00 [accepted]', '2016/05/12 06:00 [entrez]', '2016/05/12 06:00 [pubmed]', '2018/02/02 06:00 [medline]']","['S1413-81232016000501617 [pii]', '10.1590/1413-81232015215.10832015 [doi]']",ppublish,Cien Saude Colet. 2016 May;21(5):1617-24. doi: 10.1590/1413-81232015215.10832015.,,,,,,,,,,,,,,,,,,,,
3078225,NLM,MEDLINE,19900309,20131121,0567-8250 (Print) 0567-8250 (Linking),126,,1988,New trends in obesitology.,9-222,,"Several new problems in obesitology were pointed out in this book and commented with respect to experiments and experiences of our working group. The problem of the low triiodothyronine (T3) syndrome was treated in chapter 2. The decrease of serum T3 and increase of serum reverse T3 in obese subjects was induced by several factors, namely by fasting. A resistance to administered thyroxine and triiodothyronine was observed in these patients. This energy saving mechanism is at variance with slimming regimens. The prevention and treatment of this awkward complication was discussed. The next chapter (3) is concerned with the hormonal and metabolic effects of diet and motor activity in the course of slimming regimens. The different effects of diet and motor activity on epinephrine and norepinephrine in obese subjects were similar to those obtained by other investigators in nonobese humans. A great importance was attributed to an increased plasma level of cortisol in obese and nonobese subjects in the course of different forms of motor activity and related to a different intensity of exercise. Parallel to several of these experiments, beta-endorphin, thyroid hormones and glucagon were also estimated. It was suggested that motor activity for exercising subjects should not lead to an enhanced secretion of cortisol in view of the health deteriorating effects of increased cortisolemia and in view of an already stimulated secretion of this hormone in obese subjects on basal conditions. Vice versa, a decreased cortisolemia should be obtained in obese subjects treated with an appropriate motor activity and diet. It has been shown that diet without motor activity reduced the level of plasma androgens but in cooperation with motor activity, the level of androgens remained unaltered in the course of the reducing regimen. The conservation of a normal or even higher level of androgens is probably prerequisite for a positive nitrogen balance observed in the course of a combined slimming regimen, while diet without motor activity led in the studied conditions to a negative nitrogen balance. Chapter 4 was devoted to the role of motor activity in slimming regimens. In view of the metabolic effects of motor activity and the clinical late effects of obesity (osteoarthritis of the knees, hips and spine, arterial hypertension, overload of the cardiovascular system, diabetes mellitus etc.), a selection of motor activities was proposed. According to our long experience, we do not recommend jogging, running, jumping and all sports leading to collisions of players.(ABSTRACT TRUNCATED AT 400 WORDS)","['Sonka, J']",['Sonka J'],"['Laboratory for Endocrinology and Metabolism, Charles University Medical Faculty.']",['eng'],"['Journal Article', 'Review']",Czech Republic,Acta Univ Carol Med Monogr,Acta Universitatis Carolinae. Medica. Monographia,0177667,['IY9XDZ35W2 (Glucose)'],IM,"['Glucose/metabolism', 'Humans', 'Motor Activity/physiology', '*Obesity/metabolism/physiopathology/psychology']",,,,,1988/01/01 00:00,1988/01/01 00:01,['1988/01/01 00:00'],"['1988/01/01 00:00 [pubmed]', '1988/01/01 00:01 [medline]', '1988/01/01 00:00 [entrez]']",,ppublish,Acta Univ Carol Med Monogr. 1988;126:9-222.,,,,,,,442,,,,,,,,,,,,,
27028448,NLM,MEDLINE,20161213,20220317,1421-9875 (Electronic) 0257-2753 (Linking),34,3,2016,The Gut Bacteria-Driven Obesity Development.,221-9,10.1159/000443356 [doi],"It is now well established that a healthy gut flora is largely responsible for the overall health of the host, while a perturbation in gut microbial communities can contribute to disease susceptibility. Obesity is a complex process involving genetic and environmental factors with an epidemiological burden that makes it a major public health issue. Studies of germ-free or gnotobiotic mice provided evidence that the diversity, as well as the presence and relative proportion of different microbes in the gut play active roles in energy homeostasis. Similarly, human studies showed that both the diversity of the microbiota and the Bacteroidetes/Firmicutes ratio are decreased in obese individuals. The 'obese microbiota' seems to be able to increase dietary energy harvest and favor weight gain and fat deposition. Although research in this field has just started and many of the available data are still conflicting, the results are providing exciting perspectives, and gut microbiota manipulation has already become a new target for both prevention and treatment of obesity.","['Compare, Debora', 'Rocco, Alba', 'Sanduzzi Zamparelli, Marco', 'Nardone, Gerardo']","['Compare D', 'Rocco A', 'Sanduzzi Zamparelli M', 'Nardone G']","['Department of Clinical Medicine and Surgery, Hepatogastroenterology Unit, University Federico II, Naples, Italy.']",['eng'],"['Journal Article', 'Review']",Switzerland,Dig Dis,"Digestive diseases (Basel, Switzerland)",8701186,,IM,"['Animals', 'Bacteria/*metabolism', 'Diet', 'Disease Models, Animal', '*Gastrointestinal Microbiome', 'Health', 'Humans', 'Obesity/*microbiology/*pathology/therapy']",,,,,2016/03/31 06:00,2016/12/15 06:00,['2016/03/31 06:00'],"['2016/03/31 06:00 [entrez]', '2016/03/31 06:00 [pubmed]', '2016/12/15 06:00 [medline]']","['000443356 [pii]', '10.1159/000443356 [doi]']",ppublish,Dig Dis. 2016;34(3):221-9. doi: 10.1159/000443356. Epub 2016 Mar 30.,,20160330,,"['(c) 2016 S. Karger AG, Basel.']",,,,,,,,,,,,,,,,
18426601,NLM,MEDLINE,20080527,20211020,1471-2458 (Electronic) 1471-2458 (Linking),8,,2008 Apr 21,The body politic: the relationship between stigma and obesity-associated disease.,128,10.1186/1471-2458-8-128 [doi],"BACKGROUND: It is commonly believed that the pathophysiology of obesity arises from adiposity. In this paper, I forward a complementary explanation; this pathophysiology arises not from adiposity alone, but also from the psychological stress induced by the social stigma associated with being obese. METHODS: In this study, I pursue novel lines of evidence to explore the possibility that obesity-associated stigma produces obesity-associated medical conditions. I also entertain alternative hypotheses that might explain the observed relationships. RESULTS: I forward four lines of evidence supporting the hypothesis that psychological stress plays a role in the adiposity-health association. First, body mass index (BMI) is a strong predictor of serological biomarkers of stress. Second, obesity and stress are linked to the same diseases. Third, body norms appear to be strong determinants of morbidity and mortality among obese persons; obese whites and women - the two groups most affected by weight-related stigma in surveys - disproportionately suffer from excess mortality. Finally, statistical models suggest that the desire to lose weight is an important driver of weight-related morbidity when BMI is held constant. CONCLUSION: Obese persons experience a high degree of stress, and this stress plausibly explains a portion of the BMI-health association. Thus, the obesity epidemic may, in part, be driven by social constructs surrounding body image norms.","['Muennig, Peter']",['Muennig P'],"['Department of Health Policy and Management, Mailman School of Public Health, Columbia University, New York, USA. pm124@columbia.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,BMC Public Health,BMC public health,100968562,,IM,"['Adiposity', 'Age Factors', 'Body Mass Index', 'Electric Impedance', 'Female', 'Humans', 'Male', 'Obesity/complications/ethnology/mortality/*psychology', '*Prejudice', 'Risk Factors', 'Sex Factors', 'Stress, Psychological/*complications']",PMC2386473,,,,2008/04/23 09:00,2008/05/28 09:00,['2008/04/23 09:00'],"['2007/11/27 00:00 [received]', '2008/04/21 00:00 [accepted]', '2008/04/23 09:00 [pubmed]', '2008/05/28 09:00 [medline]', '2008/04/23 09:00 [entrez]']","['1471-2458-8-128 [pii]', '10.1186/1471-2458-8-128 [doi]']",epublish,BMC Public Health. 2008 Apr 21;8:128. doi: 10.1186/1471-2458-8-128.,,20080421,,,,,,,,,,,,,,,,,,
17920618,NLM,MEDLINE,20080313,20221207,0022-0965 (Print) 0022-0965 (Linking),99,1,2008 Jan,"There's something about obesity: culture, contagion, rationality, and children's responses to drinks ""created"" by obese children.",58-74,,"Theories of the development of obesity stereotypes cannot easily explain the stigma associated with being obese. Evidence that important similarities exist between the symptoms of obesity and contagious illnesses, young children have ""theories"" of illnesses, and obesity stereotypes are among the earliest that children develop led to the hypothesis that children would find beverages purportedly created by obese children less tasteful and more memorable than beverages created by average weight children. After assignment to two story conditions in which a child became ill after eating an unfamiliar food, Caucasian-American and Chinese 7- and 10-year-olds sampled identically flavored ""obese-created"" and ""average-created"" beverages. Taste ratings were lower, ratings of the chances of feeling sick were higher, and memory was superior for obese-created drinks than for average-created drinks, particularly when the character in the story contracted a contagious illness and memory was scored for ""gist."" Finally, children often created the false memory that the story character was an obese beverage creator. The roles of contagion and magical beliefs are discussed, as are the rationality of children's responses and the relevance of the findings for theories of obesity stereotypes.","['Klaczynski, Paul A']",['Klaczynski PA'],"['School of Psychological Sciences, University of Northern Colorado, Greeley, CO 80631, USA. paul.klaczynski@unco.edu']",['eng'],['Journal Article'],United States,J Exp Child Psychol,Journal of experimental child psychology,2985128R,,IM,"['Asian People', '*Attitude to Health', 'Child', '*Culture', '*Drinking Behavior', 'Humans', 'Obesity/*ethnology/*psychology', 'White People']",,,,,2007/10/09 09:00,2008/03/14 09:00,['2007/10/09 09:00'],"['2007/05/31 00:00 [received]', '2007/07/29 00:00 [revised]', '2007/08/03 00:00 [accepted]', '2007/10/09 09:00 [pubmed]', '2008/03/14 09:00 [medline]', '2007/10/09 09:00 [entrez]']","['S0022-0965(07)00106-3 [pii]', '10.1016/j.jecp.2007.08.005 [doi]']",ppublish,J Exp Child Psychol. 2008 Jan;99(1):58-74. doi: 10.1016/j.jecp.2007.08.005. Epub 2007 Oct 24.,,20071024,,,,,,,,,,,,,,,,,,
11029864,NLM,MEDLINE,20001030,20061115,1086-5802 (Print) 1086-5802 (Linking),40,5 Suppl 1,2000 Sep-Oct,Obesity: managing comorbidities of the disease.,S42-3,,"Obesity poses a serious health risk and is associated with a wide range of comorbid conditions. Obese patients with comorbid conditions such as type 2 diabetes and hypertension should be educated about the potential benefits of weight loss therapy. Pharmacists can offer consultative weight loss programs either on their own or by forming multidisciplinary teams with other practitioners, such as dietitians.","['Small, R E', 'Reeves, R', 'Ferst, K']","['Small RE', 'Reeves R', 'Ferst K']","['Medical College of Virginia, Richmond, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,J Am Pharm Assoc (Wash),"Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)",9601004,,IM,"['Humans', 'Obesity/complications/prevention & control/*therapy', 'Pharmacists', 'Risk', 'Weight Loss']",,,,,2000/10/13 11:00,2001/02/28 10:01,['2000/10/13 11:00'],"['2000/10/13 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/10/13 11:00 [entrez]']",,ppublish,J Am Pharm Assoc (Wash). 2000 Sep-Oct;40(5 Suppl 1):S42-3.,,,,,,,,,,,,,,,,,,,,
11523296,NLM,MEDLINE,20010927,20150826,0370-629X (Print) 0370-629X (Linking),56,7,2001 Jul,[Multidisciplinary management of the obese patient: example from the Obesity Center at the University of Liege].,474-9,,"Obesity is a mulfactorial disease whose prevalence is progressively increasing. Ideally, it requires a multidisciplinary management by medical doctors, dieticians, psychologists and kinetherapists. The new ""Centre de l'Obesite"" at the University of Liege aims at fulfilling such objectives with: 1) a first outpatient visit including the simultaneous participation of an endocrinologist, a dietician and a psychologist; 2) a structured and individualized programme of physical rehabilitation; 3) an individualized management of obese subjects as in-(hospital) and/or outpatients, using medical and/or surgical approaches; and 4) an opportunity to benefit of other specialized medical advices, if necessary, in order to increase both the efficacy and safety of the treatment. Owing to the increasing importance of obesity and the well-known difficulties to succeed in treating it, general practitioners should consider this new centre as a valuable help rather than a competitive structure for the management of their patients, especially those with severe or morbid obesity.","['Scheen, A J', 'Rorive, M', 'Letiexhe, M', 'Devoitille, L', 'Jandrain, B']","['Scheen AJ', 'Rorive M', 'Letiexhe M', 'Devoitille L', 'Jandrain B']",['Universite de Liege.'],['fre'],"['English Abstract', 'Journal Article']",Belgium,Rev Med Liege,Revue medicale de Liege,0404317,,IM,"['Counseling', 'Diet Therapy', 'Endocrinology', 'Humans', '*Interprofessional Relations', 'Obesity/psychology/rehabilitation/*therapy', 'Patient Compliance', 'Physical Therapy Modalities', 'Primary Health Care', '*Referral and Consultation', 'Social Support']",,,,,2001/08/29 10:00,2001/09/28 10:01,['2001/08/29 10:00'],"['2001/08/29 10:00 [pubmed]', '2001/09/28 10:01 [medline]', '2001/08/29 10:00 [entrez]']",,ppublish,Rev Med Liege. 2001 Jul;56(7):474-9.,,,,,,,,,Un sujet obese par une approche multidisciplinaire: l'exemple du Centre de l'Obesite du CHU Ourthe-Ambleve.,,,,,,,,,,,
22724644,NLM,MEDLINE,20121126,20120625,1369-1627 (Electronic) 0954-0261 (Linking),24,3,2012 Jun,Overview of paediatric obesity for the paediatric mental health provider.,231-40,10.3109/09540261.2012.678816 [doi],"Childhood obesity represents a significant challenge for paediatric healthcare delivery. As obesity rates increase, obese children and adolescents are at significant risk for the development of a myriad of medical and surgical problems as well as mental health problems. Moreover, children with mental health problems are increasingly presenting to their psychiatrists with obesity. Treatment of paediatric obesity requires a multidisciplinary approach with incorporation of the family into the treatment plan although still typically only offering suboptimal results. Paediatric providers from all disciplines should focus efforts primarily on obesity prevention and encouragement of healthy lifestyles, while incorporating treatment for obesity when such efforts fail. The goals of this article are to provide an overview of the epidemiology, pathophysiology, genetics, clinical features and treatment strategies for paediatric obesity.","['Scheimann, Ann O']",['Scheimann AO'],"['Division of Pediatric Gastroenterology and Nutrition, Johns Hopkins School of Medicine, Baltimore, MD 21287-2631, USA. ascheim1@jhmi.edu']",['eng'],"['Journal Article', 'Review']",England,Int Rev Psychiatry,"International review of psychiatry (Abingdon, England)",8918131,,IM,"['Adolescent', 'Child', 'Child Health Services/*standards', 'Child, Preschool', 'Humans', '*Obesity/epidemiology/genetics/physiopathology/therapy']",,,,,2012/06/26 06:00,2012/12/10 06:00,['2012/06/26 06:00'],"['2012/06/26 06:00 [entrez]', '2012/06/26 06:00 [pubmed]', '2012/12/10 06:00 [medline]']",['10.3109/09540261.2012.678816 [doi]'],ppublish,Int Rev Psychiatry. 2012 Jun;24(3):231-40. doi: 10.3109/09540261.2012.678816.,,,,,,,,,,,,,,,,,,,,
8289051,NLM,MEDLINE,19940222,20100324,0094-3509 (Print) 0094-3509 (Linking),38,1,1994 Jan,Patient attitudes toward physician treatment of obesity.,45-8,,"BACKGROUND: Family physicians are frequently faced with the problem of caring for overweight patients since 30% to 40% of American adults are overweight and 10% are obese. The traditional approach of physicians treating obese patients, which includes diet instruction, dietitian referral, and supportive therapy, has demonstrated little success. METHODS: A focus group of obese patients was formed to discuss weight-loss therapy from a patient viewpoint. Three sessions were completed, one each for patients' feelings and life experiences, exercise, and eating habits. The traditional medical approach to weight-loss therapy was discussed. RESULTS: All participants reported having failed physicians' attempts to aid them in weight loss. Similarly, all related negative life experiences, job discrimination, and derogatory remarks that they attributed to their weight. Participants were not supportive of physicians' traditional approach to aiding patients with weight loss. CONCLUSIONS: The results suggest that the traditional approach to treating patients' excessive weight is not helpful from the patient viewpoint. Study participants were more supportive of a group approach to the treatment of obesity that would include group exercise and modification of currently used foods rather than new low-calorie recipes. The issues of transportation and child care must be addressed by weight-loss programs.","['Murphree, D']",['Murphree D'],"['Department of Community Health and Family Medicine, University of Florida Health Science Center-Jacksonville 32208.']",['eng'],['Journal Article'],United States,J Fam Pract,The Journal of family practice,7502590,,IM,"['Adult', '*Attitude to Health', 'Diet, Reducing', 'Exercise Therapy', '*Family Practice', 'Focus Groups', 'Humans', 'Obesity/diet therapy/*psychology/*therapy', 'Psychotherapy, Group']",,,,,1994/01/01 00:00,1994/01/01 00:01,['1994/01/01 00:00'],"['1994/01/01 00:00 [pubmed]', '1994/01/01 00:01 [medline]', '1994/01/01 00:00 [entrez]']",,ppublish,J Fam Pract. 1994 Jan;38(1):45-8.,,,,,,,,,,,,,,,,,,,,
7361952,NLM,MEDLINE,19800514,20190514,0090-0036 (Print) 1541-0048 (Electronic) 0090-0036 (Linking),70,4,1980 Apr,Do the obese remain obese and the lean remain lean?,351-3,,,"['Garn, S M', 'Cole, P E']","['Garn SM', 'Cole PE']",,['eng'],['Journal Article'],United States,Am J Public Health,American journal of public health,1254074,,IM,"['Adipose Tissue', 'Female', 'Growth', 'Humans', '*Life Style', 'Male', 'Obesity/genetics/*psychology']",PMC1619387,,,,1980/04/01 00:00,1980/04/01 00:01,['1980/04/01 00:00'],"['1980/04/01 00:00 [pubmed]', '1980/04/01 00:01 [medline]', '1980/04/01 00:00 [entrez]']",['10.2105/ajph.70.4.351 [doi]'],ppublish,Am J Public Health. 1980 Apr;70(4):351-3. doi: 10.2105/ajph.70.4.351.,,,,,,,,,,,,,,,,,,,,
9813588,NLM,MEDLINE,19981124,20051116,0002-8223 (Print) 0002-8223 (Linking),98,11,1998 Nov,Obesity in older persons.,1308-11,,"The prevalence of obesity among older persons is growing. This trend has adverse medical, functional, psychosocial, and health care resource consequences. Many obese older persons were obese middle-aged adults. A sedentary lifestyle may be the dominant contributing factor. Intervention should focus on moderate weight reduction through the modification of diet, exercise, and behavior. Improvements in health and quality of life can be achieved with moderate weight reduction. Strategies tailored to the older population will facilitate successful interventions. Dietitians must be key participants in the effort to raise awareness of obesity as a serious health concern for older persons. The focus must be on achieving a more healthful weight.","['Jensen, G L', 'Rogers, J']","['Jensen GL', 'Rogers J']","['Division of Gastroenterology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.']",['eng'],"['Journal Article', 'Review']",United States,J Am Diet Assoc,Journal of the American Dietetic Association,7503061,,IM,"['Aged', 'Aged, 80 and over', 'Diet', 'Exercise', 'Female', 'Health Behavior', 'Humans', 'Life Style', 'Male', 'Obesity/*epidemiology/etiology/therapy', 'Prevalence', 'United States/epidemiology']",,,,,1998/11/14 00:00,1998/11/14 00:01,['1998/11/14 00:00'],"['1998/11/14 00:00 [pubmed]', '1998/11/14 00:01 [medline]', '1998/11/14 00:00 [entrez]']","['S0002-8223(98)00293-4 [pii]', '10.1016/S0002-8223(98)00293-4 [doi]']",ppublish,J Am Diet Assoc. 1998 Nov;98(11):1308-11. doi: 10.1016/S0002-8223(98)00293-4.,,,,,,,44,['J Am Diet Assoc. 1999 Sep;99(9):1050. PMID: 10491670'],,,,,,,,,,,,
36897046,NLM,MEDLINE,20230510,20230510,1097-0215 (Electronic) 0020-7136 (Linking),153,1,2023 Jul 1,Independent and joint associations of general and abdominal obesity with the risk of conventional adenomas and serrated polyps: A large population-based study in East Asia.,54-63,10.1002/ijc.34503 [doi],"Evidence regarding associations of general and abdominal obesity with the risk of conventional adenomas (ADs) and serrated polyps (SPs) from Asian population is scarce. Our study aimed to investigate the independent and joint associations of general obesity assessed by body mass index (BMI) and abdominal obesity assessed by waist circumference (WC) or waist-to-hip ratio (WHR) with the risk of ADs and SPs among 25 222 participants recruited by a population-based screening program. Compared to participants with normal BMI, those with a BMI >/=28 kg/m(2) had increased risk of ADs (odds ratio [OR] 1.52, 95% confidence interval [CI]: 1.36-1.70) and SPs (OR 1.69, 95% CI: 1.38-2.07). For participants with a WC >/=102 cm (>/=88 cm for females), the risk of ADs (OR 1.37, 95% CI: 1.25-1.51) and SPs (OR 1.81, 95% CI: 1.52-2.16) was higher than that of the reference group. For participants with a WHR >/=0.95 (>/=0.90 for females), the risk of ADs (OR 1.26, 95% CI: 1.16-1.36) and SPs (OR 1.46, 95% CI: 1.26-1.69) was higher than that of the reference group. Moreover, participants with both BMI >/=28 kg/m(2) and WC >/=102 cm (>/=88 cm for females) had 61% and 119% higher risk of ADs (OR 1.61, 95% CI: 1.39-1.85) and SPs (OR 2.19, 95% CI: 1.70-2.82) compared to those with both normal BMI and WC. These findings indicate that both general and abdominal obesity are associated with SPs and ADs, presenting stronger association with SPs than ADs. Moreover, the association is more evident when both obesities exist.","['Bai, Hao', 'Xu, Zenghao', 'Li, Jiayu', 'Zhang, Xiaocong', 'Gao, Kai', 'Fei, Xinglin', 'Yang, Jinhua', 'Li, Qilong', 'Qian, Sangni', 'Zhang, Wanting', 'Gao, Xiangrong', 'Tang, Mengling', 'Wang, Jianbing', 'Chen, Kun', 'Jin, Mingjuan']","['Bai H', 'Xu Z', 'Li J', 'Zhang X', 'Gao K', 'Fei X', 'Yang J', 'Li Q', 'Qian S', 'Zhang W', 'Gao X', 'Tang M', 'Wang J', 'Chen K', 'Jin M']","['Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', 'Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', 'Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', 'Department of Epidemiology, Zhejiang Chinese Medical University School of Public Health, Hangzhou, China.', 'Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', 'Shanghai Municipal Center for Disease Control & Prevention, Shanghai, China.', 'Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', 'Jiashan Institute of Cancer Prevention and Treatment, Jiashan, China.', 'Jiashan Institute of Cancer Prevention and Treatment, Jiashan, China.', 'Jiashan Institute of Cancer Prevention and Treatment, Jiashan, China.', 'Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', 'Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', 'Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', 'Department of Public Health, Fourth Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', ""Department of Public Health, National Clinical Research Center for Child Health of Children's Hospital Zhejiang University School of Medicine, Hangzhou, China."", 'Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.', 'Department of Public Health, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Int J Cancer,International journal of cancer,0042124,,IM,"['Female', 'Humans', '*Obesity, Abdominal/complications/epidemiology', 'Obesity/complications/epidemiology', 'Waist-Hip Ratio', 'Waist Circumference', 'Body Mass Index', 'Asia, Eastern', '*Adenoma/epidemiology/etiology', 'Risk Factors']",,['NOTNLM'],"['abdominal obesity', 'conventional adenoma', 'general obesity', 'serrated polyp']",,2023/03/11 06:00,2023/05/10 06:41,['2023/03/10 08:33'],"['2023/02/18 00:00 [revised]', '2022/12/17 00:00 [received]', '2023/02/28 00:00 [accepted]', '2023/05/10 06:41 [medline]', '2023/03/11 06:00 [pubmed]', '2023/03/10 08:33 [entrez]']",['10.1002/ijc.34503 [doi]'],ppublish,Int J Cancer. 2023 Jul 1;153(1):54-63. doi: 10.1002/ijc.34503. Epub 2023 Mar 27.,,20230327,,['(c) 2023 UICC.'],['ORCID: 0000-0003-2358-0186'],,,,,,,,,,,,,,,
645947,NLM,MEDLINE,19780612,20061115,0002-953X (Print) 0002-953X (Linking),135,5,1978 May,Obesity and psychoanalysis.,547-51,,"Seventy-two psychoanalysts collected information on 84 obese patients and on a control sample of 63 of their patients of normal weight. Despite the fact that obesity was the chief complaint of only 6% of the obese patients, weight losses at 42 months of psychoanalytic treatment compared favorably with those after traditional medical efforts: 47% of the obese psychoanalytic patients lost more than 9 kg, and 19% lost more than 18 kg. There was also a striking decrease in the percentage of obese patients suffering from body image disparagement--from 44% to 12%, an unexpectedly good result for this chronic and intractable disorder.","['Rand, C', 'Stunkard, A J']","['Rand C', 'Stunkard AJ']",,['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Am J Psychiatry,The American journal of psychiatry,0370512,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Anxiety/therapy', '*Body Image', 'Body Weight', 'Depression/therapy', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/genetics/*psychology/therapy', '*Psychoanalytic Therapy', 'Self Concept']",,,,,1978/05/01 00:00,1978/05/01 00:01,['1978/05/01 00:00'],"['1978/05/01 00:00 [pubmed]', '1978/05/01 00:01 [medline]', '1978/05/01 00:00 [entrez]']",['10.1176/ajp.135.5.547 [doi]'],ppublish,Am J Psychiatry. 1978 May;135(5):547-51. doi: 10.1176/ajp.135.5.547.,,,,,,,,,,,,,,,,,,,,
33500372,NLM,MEDLINE,20210917,20210917,1857-8985 (Electronic) 1857-9345 (Linking),41,3,2020 Dec 8,Diagnostic Central Obesity Indexes Cut - Off Point Values Determined with Dual-Energy X-Ray Absorptiometry in Cushing's and Obese Women.,13-21,10.2478/prilozi-2020-0041 [doi],"AIM: The aim of this study was to develop quantiative criteria for defining visceral obesity and to establish dual-energy X-ray absorptiometric (DXA) diagnostic cut-off points (CP) for normal and abnormal values of the central obesity indexes (COI) that best differentiate extreme visceral obesity in Cushing's syndrome (CS) from non CS obese and non obese women. MATERIAL AND METHODS: COI1-4 values calculated as a ratio of android to gynoid tissue mass, fat mass and their % were determined in 4 groups, each consisting of 18 women: 1st group of CS, 2nd group of obese women (O1) not different according to their age and BMI from CS, 3rd group of obese women (O2) with BMI of 35 +/- 1.2 kg and 4th group of non obese healthy women (C) with normal BMI. Diagnostic accuracy (DG) of CP values of COI1m-4m indexes of abdominal obesity and CP values of COI1n-4n indexes of normal body fat distribution (BFD) was determined. RESULTS: COI1-4 indexes values were highly significantly different among the 4 examined groups and were significantly highest in CS patients and lowest in group C (p < 0.0001). COI1m-4m CP values differentiated extreme visceral, abdominal obesity in CS with highest DG as well as COI1n-4n CP values differentiated normal BFD in group C. COI1m CP of 0.55 best differentiated CS from O1 for DG of 100%. COI2n of 0.38 best differentiated C from CS and O2 for highest DG of 100% compared to O1 because of the significantly higher BMI and COI1n-4n values in O2 that were associated with more pronounced abdominal obesity and highly significantly positive correlation with BMI. CONCLUSIONS: DXA cut-off point values of indexes COI1m-4m and COI1n-4n were established as diagnostic indexes and criteria useful in discovering extreme abdominal and normal BFD. COI1m CP value of 0.55 was discovered as a diagnostic criterion of extreme abdominal obesity and COI2n of 0.38 as a diagnostic criterion of normal BFD that excluded abdominal obesity. The other indexes COI1m-4m and COI1n-4n CP values had also high DG in discovering abdominal and normal body fat distribution.","['Stratrova, Slavica Shubeska', 'Mishevska, Sasha Jovanovska', 'Bitoska, Iskra', 'Kafedziska, Irena']","['Stratrova SS', 'Mishevska SJ', 'Bitoska I', 'Kafedziska I']","['University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Faculty of Medicine, University Ss Cyril and Methodius, Skopje, R. N. Macedonia.', 'University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Faculty of Medicine, University Ss Cyril and Methodius, Skopje, R. N. Macedonia.', 'University Clinic of Endocrinology, Diabetes and Metabolic Disorders, Faculty of Medicine, University Ss Cyril and Methodius, Skopje, R. N. Macedonia.', 'University Clinic of Rheumatology, Faculty of Medicine, University Ss Cyril and Methodius, Skopje, R. N. Macedonia.']",['eng'],['Journal Article'],North Macedonia,Pril (Makedon Akad Nauk Umet Odd Med Nauki),Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki),101677081,,IM,"['Absorptiometry, Photon', 'Body Fat Distribution', 'Female', 'Humans', 'Obesity/complications/diagnostic imaging', '*Obesity, Abdominal/diagnostic imaging']",,['NOTNLM'],"['DXA', 'abdominal obesity', 'central obesity indexes', 'cut-off point values']",,2021/01/28 06:00,2021/09/18 06:00,['2021/01/27 05:45'],"['2021/01/27 05:45 [entrez]', '2021/01/28 06:00 [pubmed]', '2021/09/18 06:00 [medline]']","['prilozi-2020-0041 [pii]', '10.2478/prilozi-2020-0041 [doi]']",epublish,Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2020 Dec 8;41(3):13-21. doi: 10.2478/prilozi-2020-0041.,,20201208,,,,,,,,,,,,,,,,,,
34240761,NLM,MEDLINE,20220126,20220126,1365-2826 (Electronic) 0953-8194 (Linking),33,8,2021 Aug,The gravitostat protects diet-induced obese rats against fat accumulation and weight gain.,e12997,10.1111/jne.12997 [doi],"The gravitostat is a novel homeostatic body weight-regulating mechanism, mostly studied in mice, and recently confirmed in obese humans. In the present study, we explored the effect of weight loading on metabolic outcomes, meal patterns and parameters linked to energy expenditure in both obese and lean rats. Diet-induced obese (DIO) and lean rats were implanted with capsules weighing either 15% of biological body weight (load) or empty capsules (1.3% of body weight; controls). Loading protected against fat accumulation more markedly in the DIO group. In line with this, the obesity-related impairment in insulin sensitivity was notably ameliorated in DIO rats upon loading, as revealed by the reduction in serum insulin levels and homeostatic model assessment for insulin resistance index scores. Although 24-hour caloric intake was reduced in both groups, this effect was greater in loaded DIO rats than in loaded lean peers. During days 10-16, after recovery from surgery, loading: (i) decreased meal size in both groups (only during the light phase in DIO rats) but this was compensated in lean rats by an increase in meal frequency; (ii) reduced dark phase locomotor activity only in lean rats; and (iii) reduced mean caloric efficiency in DIO rats. Muscle weight was unaffected by loading in either group. Dietary-obese rats are therefore more responsive than lean rats to loading.","['Bake, Tina', 'Peris-Sampedro, Fiona', 'Waczek, Zita', 'Ohlsson, Claes', 'Palsdottir, Vilborg', 'Jansson, John-Olov', 'Dickson, Suzanne L']","['Bake T', 'Peris-Sampedro F', 'Waczek Z', 'Ohlsson C', 'Palsdottir V', 'Jansson JO', 'Dickson SL']","['Department of Physiology/Endocrine, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.', 'Department of Physiology/Endocrine, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.', 'Department of Physiology/Endocrine, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.', 'Centre of Bone and Arthritis Research, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.', 'Department of Drug Treatment, Sahlgrenska University Hospital, Region Vastra Gotaland, Gothenburg, Sweden.', 'Department of Physiology/Endocrine, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.', 'Department of Physiology/Endocrine, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.', 'Department of Physiology/Endocrine, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden.']",['eng'],['Journal Article'],United States,J Neuroendocrinol,Journal of neuroendocrinology,8913461,,IM,"['Adipose Tissue/*metabolism', 'Animals', 'Body Weight Maintenance/physiology', 'Diet', 'Energy Intake/physiology', 'Female', 'Homeostasis/*physiology', 'Male', '*Obesity/metabolism/pathology/physiopathology/prevention & control', 'Rats', 'Rats, Sprague-Dawley', '*Weight Gain', 'Weight-Bearing/*physiology']",,['NOTNLM'],"['diet-induced obesity', 'energy homeostasis', 'fat mass', 'gravitostat', 'meal patterns']",,2021/07/10 06:00,2022/01/27 06:00,['2021/07/09 08:47'],"['2021/04/23 00:00 [revised]', '2020/11/30 00:00 [received]', '2021/05/31 00:00 [accepted]', '2021/07/10 06:00 [pubmed]', '2022/01/27 06:00 [medline]', '2021/07/09 08:47 [entrez]']",['10.1111/jne.12997 [doi]'],ppublish,J Neuroendocrinol. 2021 Aug;33(8):e12997. doi: 10.1111/jne.12997. Epub 2021 Jul 9.,,20210709,,"['(c) 2021 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons', 'Ltd on behalf of British Society for Neuroendocrinology.']","['ORCID: 0000-0003-0500-5129', 'ORCID: 0000-0002-3822-5294']",,,,,,,,,,,,,,,
25350036,NLM,MEDLINE,20150312,20170126,0022-4707 (Print) 0022-4707 (Linking),54,6,2014 Dec,Impact of a supervised exercise program supporting autonomy on the adoption of an active lifestyle among obese adolescents: a Self-Determination Theory perspective.,793-801,,"AIM: Regular physical activity (PA) practice represents a key component of obesity treatment. Drawing upon Self-Determination Theory, the purpose of this study was twofold. The first aim was to evaluate among obese adolescents the impact of a supervised exercise program supporting autonomy on their motivation to practice PA at the end of the intervention. The second aim was to evaluate the impact of the program on their level of PA one month after the end of the intervention. METHODS: Eighteen obese adolescents (mean age=14.3 years, mean BMI=33.47 kg/m(2)) were recruited to participate in an 11-week residential obesity treatment program. They received a 45-minute supervised exercise session each week. Motivational regulations were assessed at baseline and at the end of the intervention (via the Exercise Motivation Scale). PA practice was assessed at baseline and one month after the end of the intervention (via the 7-day PA recall interview). RESULTS: The analyses revealed that adolescents' levels of autonomy increased, that their levels of intrinsic motivation tended to increase, and that their level of external regulation tended to decrease. In addition, the participants increased their habitual PA practice one month after the end of the intervention in comparison to baseline. CONCLUSION: This study highlights that supporting autonomy during supervised exercise sessions appears as an effective strategy to promote PA among obese adolescents because it fosters internalization of the behavior.","['Gourlan, M', 'Sant, F', 'Boiche, J']","['Gourlan M', 'Sant F', 'Boiche J']","['Laboratory Epsylon EA4556 Dynamics of Human Capacities and Health Behaviors, University Montpellier 1 Montpellier, France - mathieugourlan@yahoo.fr.']",['eng'],['Journal Article'],Italy,J Sports Med Phys Fitness,The Journal of sports medicine and physical fitness,0376337,,IM,"['Adolescent', 'Energy Metabolism', '*Exercise Therapy', 'Female', 'Humans', 'Life Style', 'Male', 'Motivation', 'Motor Activity', 'Obesity/metabolism/*psychology/*therapy', '*Personal Autonomy']",,,,,2014/10/29 06:00,2015/03/13 06:00,['2014/10/29 06:00'],"['2014/10/29 06:00 [entrez]', '2014/10/29 06:00 [pubmed]', '2015/03/13 06:00 [medline]']",['R40Y2014N06A0793 [pii]'],ppublish,J Sports Med Phys Fitness. 2014 Dec;54(6):793-801.,,,,,,,,,,,,,,,,,,,,
7762646,NLM,MEDLINE,19950629,20171213,0002-9513 (Print) 0002-9513 (Linking),268,5 Pt 1,1995 May,Energy expenditure in children of lean and obese parents.,E917-24,,"We evaluated whether children of obese parents have defects in energy expenditure in a study of 73 children (5 +/- 0.9 yr of age) of lean and obese parents. Total energy expenditure (TEE) was measured over 14 days by use of doubly labeled water and physical activity energy expenditure (AEE) derived by subtracting resting energy expenditure (REE) under postprandial conditions. Fat and fat-free mass (FFM) were measured in children and parents with use of bioelectrical resistance. There were no significant correlations between TEE, REE, or AEE in children (after adjustment for FFM) and body fat in children or body fat in mothers or fathers. In three-way analysis of covariance (ANCOVA, with FFM as a covariate), there were no significant effects of gender in children, obesity in mothers, or obesity in fathers on TEE or AEE in children. There was a significant effect of gender and a significant interaction between obesity in mothers and obesity in fathers on REE; relative to children with two nonobese or two obese parents, REE was approximately 6% lower in children when mothers only or fathers only were obese. In conclusion, our data do not support the hypothesis that children of obese parents have major defects in energy expenditure.","['Goran, M I', 'Carpenter, W H', 'McGloin, A', 'Johnson, R', 'Hardin, J M', 'Weinsier, R L']","['Goran MI', 'Carpenter WH', 'McGloin A', 'Johnson R', 'Hardin JM', 'Weinsier RL']","['Department of Nutrition Sciences, University of Alabama at Birmingham 35294, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Physiol,The American journal of physiology,0370511,,IM,"['Adult', 'Analysis of Variance', 'Body Composition', 'Child', 'Child, Preschool', '*Energy Metabolism', 'Female', 'Humans', 'Male', 'Obesity/*genetics/metabolism/pathology', 'Parents', 'Physical Exertion', 'Reference Values']",,,,,1995/05/01 00:00,1995/05/01 00:01,['1995/05/01 00:00'],"['1995/05/01 00:00 [pubmed]', '1995/05/01 00:01 [medline]', '1995/05/01 00:00 [entrez]']",['10.1152/ajpendo.1995.268.5.E917 [doi]'],ppublish,Am J Physiol. 1995 May;268(5 Pt 1):E917-24. doi: 10.1152/ajpendo.1995.268.5.E917.,['RR-109/RR/NCRR NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
906582,NLM,MEDLINE,19771125,20061115,0044-2542 (Print) 0044-2542 (Linking),32,10,1977 May 15,[Epidemiology of obesity].,145-6 concl,,"In the GDR about 20% of the males and 40% of the females were estimated to be obese. In the country obesity is more spread than in the town. Increased disablement of obese persons leads to reduction of the national income. With higher expenses for nutrition the frequency of obestiy increases. Hypophages and hyperphages are differently distributed in persons with normal weight and obese ones, so that the average establishments do not reflect the differentiated situation in nutrition. Obesity correlates with the type of structure; with increasing obesity dominate pyknomorphous tendencies of growth. Also in normal weight pyknomorphous persons have a higher proportion of fat. We should speak of obesity in such a case, when, taking into consideration biological differentiations, the normal proportion of the fat in the body is increased by more than 1/3. For epidemiological serial examinations the degrees of relative weight basing on optimum weight are a favourable basis for the classification of obesity.","['Mohr, M']",['Mohr M'],,['ger'],"['English Abstract', 'Journal Article']",Germany,Z Gesamte Inn Med,Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,21730470R,,IM,"['Body Weight', 'Female', 'Germany, East', 'Humans', 'Male', 'Obesity/classification/*epidemiology', 'Sex Factors']",,,,,1977/05/15 00:00,1977/05/15 00:01,['1977/05/15 00:00'],"['1977/05/15 00:00 [pubmed]', '1977/05/15 00:01 [medline]', '1977/05/15 00:00 [entrez]']",,ppublish,Z Gesamte Inn Med. 1977 May 15;32(10):145-6 concl.,,,,,,,,,Zur Epidemiologie der Fettsucht.,,,,,,,,,,,
15773372,NLM,MEDLINE,20050429,20050318,1531-5681 (Print) 1531-5681 (Linking),10,10,2004 Oct,Tackling the challenge of obesity in children and adolescents.,"113-5, 109",,"A window of opportunity in the battle against obesity. Weight management programs are in plentiful supply for adults, but experts suggest the best opportunity for success occurs in childhood when unhealthy behaviors typically begin. Further, when children are morbidly obese, some experts argue that aggressive interventions--including a conservative form of weight loss surgery--need to be considered. See how one prominent health care center is approaching the problem.",,,,['eng'],['Journal Article'],United States,Dis Manag Advis,Disease management advisor,100961635,,,"['Adolescent', 'Child', 'Disease Management', 'Family Therapy', 'Female', 'Humans', 'Male', '*Obesity/complications/prevention & control/surgery', 'United States']",,,,,2005/03/19 09:00,2005/04/30 09:00,['2005/03/19 09:00'],"['2005/03/19 09:00 [pubmed]', '2005/04/30 09:00 [medline]', '2005/03/19 09:00 [entrez]']",,ppublish,"Dis Manag Advis. 2004 Oct;10(10):113-5, 109.",,,,,,,,,,,,,,,,,,,,
1512622,NLM,MEDLINE,19920930,20141120,0737-0016 (Print) 0737-0016 (Linking),9,3,1992,Intervention program for obese school children.,183-90,,"The purpose of this study was to implement and evaluate a program for obese school children. A pretest-posttest design was utilized. Data was collected related to weight status, skinfold measurements, self-esteem, and nutritional knowledge. A convenience sample of 26 children, in the fourth to sixth grades, completed this 9-week program. The results indicate that self-esteem increased significantly (p less than .001) between the pretest and posttest interval. Weight status and nutritional knowledge showed no improvement. Exercise was difficult to assess on self-report, therefore no conclusions were were drawn in relation to this variable. Future research will be directed toward refining this intervention program.","['Sherman, J B', 'Alexander, M A', 'Gomez, D', 'Kim, M', 'Marole, P']","['Sherman JB', 'Alexander MA', 'Gomez D', 'Kim M', 'Marole P']",,['eng'],['Journal Article'],United States,J Community Health Nurs,Journal of community health nursing,8411341,,,"['Child', 'Female', 'Humans', 'Male', 'Obesity/nursing/*prevention & control/psychology', 'Program Evaluation', 'Psychology, Child', 'School Health Services/*organization & administration', 'Self Concept']",,,,,1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",['10.1207/s15327655jchn0903_6 [doi]'],ppublish,J Community Health Nurs. 1992;9(3):183-90. doi: 10.1207/s15327655jchn0903_6.,,,,,,,,,,,,,,,,,,,,
16129723,NLM,MEDLINE,20051207,20061115,1071-7323 (Print) 1071-7323 (Linking),13,8,2005 Aug,Obesity and weight control practices in 2000 among veterans using VA facilities.,1405-11,,"OBJECTIVE: To examine obesity prevalence and weight control practices among veterans who use Department of Veterans Affairs (VA) medical facilities (VA users). RESEARCH METHODS AND PROCEDURES: Data from the 2000 Behavioral Risk Factor Surveillance System, a telephone survey of 184,450 adults, were analyzed. Outcome measures included BMI, weight control practices (the intent to manage weight, and diet and physical activity patterns), and receipt of professional weight control advice. RESULTS: Of VA users, 44% were overweight and 25% were obese. After controlling for demographic factors, VA users were somewhat less likely to be overweight (odds ratio, 0.86; 95% confidence interval, 0.74 to 1.00) but equally likely to be obese (odds ratio, 1.08; 95% confidence interval, 0.92 to 1.27), compared with non-VA users. Among obese VA users, 75% reported trying to lose weight, and another 17% reported trying to maintain weight. Of these, only 40% decreased both calorie and fat intake. Only 27% of obese VA users who reported increasing exercise to lose weight followed recommendations for regular and sustained physical activity. Of obese VA users, 59% were inactive or irregularly active. Only 51% of obese VA users received professional advice to lose weight. Obese VA users were more likely than obese non-VA users to report trying to lose weight, modifying diet to lose weight by decreasing both calories and fat intake, and receiving professional weight control advice. DISCUSSION: Interventions for weight management programs in VA facilities need to take into account the high prevalence of overweight/obesity among VA users and should emphasize effective weight control practices.","['Wang, Anthea', 'Kinsinger, Linda S', 'Kahwati, Leila C', 'Das, Sandeep R', 'Gizlice, Ziya', 'Harvey, Richard T', 'Burdick, Mary B', 'Yevich, Steven J']","['Wang A', 'Kinsinger LS', 'Kahwati LC', 'Das SR', 'Gizlice Z', 'Harvey RT', 'Burdick MB', 'Yevich SJ']","['Department of Social Medicine, University of North Carolina, Chapel Hill, NC, USA.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Obes Res,Obesity research,9305691,,IM,"['Data Collection', 'Exercise', 'Humans', 'Obesity/*epidemiology/*prevention & control/therapy', 'Overweight', 'United States/epidemiology', 'United States Department of Veterans Affairs', '*Veterans']",,,,,2005/09/01 09:00,2005/12/13 09:00,['2005/09/01 09:00'],"['2005/09/01 09:00 [pubmed]', '2005/12/13 09:00 [medline]', '2005/09/01 09:00 [entrez]']","['13/8/1405 [pii]', '10.1038/oby.2005.170 [doi]']",ppublish,Obes Res. 2005 Aug;13(8):1405-11. doi: 10.1038/oby.2005.170.,,,,,,,,,,,,,,,,,,,,
23789286,NLM,MEDLINE,20131203,20190918,0042-8450 (Print) 0042-8450 (Linking),70,5,2013 May,The influence of retrobulbar adipose tissue volume upon intraocular pressure in obesity.,469-76,,"BACKGROUND/AIM: It is known that glaucoma is associated with elevated intraocular pressure and obesity, yet the precise etiology remains unclear. The aim of this study was to determine whether there is a potential causality between the volume of retrobulbar adipose tissue and the level of intraocular pressure in obese subjects compared with non-obese. METHODS: A total of 100 subjects were divided according to the body mass index (BMI), into two groups: normal weight (n = 50, BMI = 18-24.9 kg/m2) and obese (n = 50, BMI > or = 30 kg/m2) subjects. Anthropometric measurements, body composition analysis, measurement of intraocular pressure, as well as magnetic resonance imaging (MRI) of the head at the level of the optic nerve, and the derived retrobulbar adipose tissue volume, were undertaken in all subjects. RESULTS: The obese subjects, as compared with normal weight ones, had a significantly higher mean retrobulbar adipose tissue volume (6.23 cm3 vs 4.85 cm3, p < 0.01) and intraocular pressure (15.96 mmHg vs 12.99 mmHg, p < 0.01). Furthermore, intraocular pressure correlated positively with retrobulbar adipose tissue volume. CONCLUSION: In obese people, elevated intraocular pressure may be caused by changes in ocular blood flow, affected by the physical pressure exerted by higher retrobulbar adiposity, and/or by internal vascular changes secondary to complications of obesity. These findings indicate the need for more frequent measurement of intraocular pressure in obese individuals to earlier detect glaucoma, and in so doing prevent irreversible blindness.","['Stojanov, Oliver', 'Stokic, Edita', 'Sveljo, Olivera', 'Naumovic, Nada']","['Stojanov O', 'Stokic E', 'Sveljo O', 'Naumovic N']","['Department of Ophthalmology, Health Center Novi Sad, Novi Sad, Serbia. olis@neobee.net']",['eng'],['Journal Article'],Serbia,Vojnosanit Pregl,Vojnosanitetski pregled,21530700R,,IM,"['Adipose Tissue/pathology/*physiopathology', 'Adult', 'Aged', 'Female', 'Glaucoma/etiology', 'Humans', 'Intraocular Pressure/*physiology', 'Male', 'Middle Aged', 'Obesity/complications/pathology/*physiopathology']",,,,,2013/06/26 06:00,2013/12/16 06:00,['2013/06/25 06:00'],"['2013/06/25 06:00 [entrez]', '2013/06/26 06:00 [pubmed]', '2013/12/16 06:00 [medline]']",['10.2298/vsp1305469s [doi]'],ppublish,Vojnosanit Pregl. 2013 May;70(5):469-76. doi: 10.2298/vsp1305469s.,,,,,,,,,,,,,,,,,,,,
32384097,NLM,MEDLINE,20200803,20201217,1932-6203 (Electronic) 1932-6203 (Linking),15,5,2020,Identifying underlying medical causes of pediatric obesity: Results of a systematic diagnostic approach in a pediatric obesity center.,e0232990,10.1371/journal.pone.0232990 [doi] e0232990,"BACKGROUND: Underlying medical causes of obesity (endocrine disorders, genetic obesity disorders, cerebral or medication-induced obesities) are thought to be rare. Even in specialized pediatric endocrinology clinics, low diagnostic yield is reported, but evidence is limited. Identifying these causes is vital for patient-tailored treatment. OBJECTIVES: To present the results of a systematic diagnostic workup in children and adolescents referred to a specialized pediatric obesity center. METHODS: This is a prospective observational study. Prevalence of underlying medical causes was determined after a multidisciplinary, systematic diagnostic workup including growth charts analysis, extensive biochemical and hormonal assessment and genetic testing in all patients. RESULTS: The diagnostic workup was completed in n = 282 patients. Median age was 10.8 years (IQR 7.7-14.1); median BMI +3.7SDS (IQR +3.3-+4.3). In 54 (19%) patients, a singular underlying medical cause was identified: in 37 patients genetic obesity, in 8 patients cerebral and in 9 patients medication-induced obesities. In total, thirteen different genetic obesity disorders were diagnosed. Obesity onset <5 years (p = 0.04) and hyperphagia (p = 0.001) were indicators of underlying genetic causes, but only in patients without intellectual disability (ID). Patients with genetic obesity with ID more often had a history of neonatal feeding problems (p = 0.003) and short stature (p = 0.005). BMI-SDS was not higher in patients with genetic obesity disorders (p = 0.52). Patients with cerebral and medication-induced obesities had lower height-SDS than the rest of the cohort. CONCLUSIONS: To our knowledge, this is the first study to report the results of a systematic diagnostic workup aimed at identifying endocrine, genetic, cerebral or medication-induced causes of pediatric obesity. We found that a variety of singular underlying causes were identified in 19% of the patients with severe childhood obesity. Because of this heterogeneity, an extensive diagnostic approach is needed to establish the underlying medical causes and to facilitate disease-specific, patient-tailored treatment.","['Kleinendorst, Lotte', 'Abawi, Ozair', 'van der Voorn, Bibian', 'Jongejan, Mieke H T M', 'Brandsma, Annelies E', 'Visser, Jenny A', 'van Rossum, Elisabeth F C', 'van der Zwaag, Bert', 'Alders, Marielle', 'Boon, Elles M J', 'van Haelst, Mieke M', 'van den Akker, Erica L T']","['Kleinendorst L', 'Abawi O', 'van der Voorn B', 'Jongejan MHTM', 'Brandsma AE', 'Visser JA', 'van Rossum EFC', 'van der Zwaag B', 'Alders M', 'Boon EMJ', 'van Haelst MM', 'van den Akker ELT']","['Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.', 'Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.', 'Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.', 'Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.', ""Division of Endocrinology, Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands."", 'Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.', ""Division of Endocrinology, Department of Pediatrics, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands."", 'Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.', 'Department of Pediatrics, Obesity Center CGG, Franciscus Gasthuis, Rotterdam, The Netherlands.', 'Department of Pediatrics, Obesity Center CGG, Maasstad Ziekenhuis, Rotterdam, The Netherlands.', 'Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.', 'Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.', 'Obesity Center CGG, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.', 'Division of Endocrinology, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.', 'Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.', 'Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.', 'Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.', 'Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.', 'Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.', 'Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.', 'Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.', 'Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.']",['eng'],"['Journal Article', 'Observational Study']",United States,PLoS One,PloS one,101285081,,IM,"['Adolescent', 'Ambulatory Care Facilities', 'Brain Diseases/complications', 'Child', 'Child, Preschool', 'Drug-Related Side Effects and Adverse Reactions/diagnosis/etiology', 'Endocrine System Diseases/complications', 'Female', 'Genetic Testing', 'Humans', 'Infant', 'Infant, Newborn', 'Intellectual Disability/complications', 'Male', 'Netherlands', 'Pediatric Obesity/diagnosis/*etiology/genetics', 'Phenotype', 'Prospective Studies']",PMC7209105,,,['The authors have declared that no competing interests exist.'],2020/05/10 06:00,2020/08/04 06:00,['2020/05/09 06:00'],"['2020/02/25 00:00 [received]', '2020/04/24 00:00 [accepted]', '2020/05/09 06:00 [entrez]', '2020/05/10 06:00 [pubmed]', '2020/08/04 06:00 [medline]']","['PONE-D-20-05457 [pii]', '10.1371/journal.pone.0232990 [doi]']",epublish,PLoS One. 2020 May 8;15(5):e0232990. doi: 10.1371/journal.pone.0232990. eCollection 2020.,,20200508,['PLoS One. 2020 Dec 17;15(12):e0244508. PMID: 33332451'],,"['ORCID: 0000-0002-1343-6562', 'ORCID: 0000-0001-7182-3571', 'ORCID: 0000-0001-5352-9328']",,,,,,,,,,,,,,,
4167668,NLM,MEDLINE,19671216,20051117,0323-4347 (Print) 0323-4347 (Linking),86,3,1966,[The behavior of basophilic granulocytes in obese children].,341-4,,,"['Blau, H J']",['Blau HJ'],,['ger'],['Journal Article'],Germany,Folia Haematol Int Mag Klin Morphol Blutforsch,"Folia haematologica (Leipzig, Germany : 1928)",0374615,,IM,"['Basophils/*analysis', 'Child', 'Female', 'Humans', '*Lipid Metabolism', 'Male', 'Obesity/*blood/metabolism/therapy']",,,,,1966/01/01 00:00,1966/01/01 00:01,['1966/01/01 00:00'],"['1966/01/01 00:00 [pubmed]', '1966/01/01 00:01 [medline]', '1966/01/01 00:00 [entrez]']",,ppublish,Folia Haematol Int Mag Klin Morphol Blutforsch. 1966;86(3):341-4.,,,,,,,,,Das Verhalten der Basophilen Granulozyten bei adiposen Kindern.,,,,,,,,,,,
23731886,NLM,MEDLINE,20140124,20151119,1878-1594 (Electronic) 1521-690X (Linking),27,2,2013 Apr,Obesity in anesthesia and intensive care.,247-60,S1521-690X(13)00019-5 [pii] 10.1016/j.beem.2013.02.001 [doi],"Obesity is a global epidemic increasingly affecting management of anesthesia as well as intensive care medicine. Possible improvements in therapy require consideration of the specific pathophysiology of the obese, their concomitant diseases, and the complications associated with morbid obesity. Systematic assessment of perioperative risk factors is essential for an appropriate management. Paradoxically, overweight and moderately obese patients undergoing surgery have a lower risk when compared to patients with normal weight. The highest mortality and morbidity rates in this setting are reported for underweight and morbidly obese patients. The better chance of survival when compared to normal-weight individuals in the perioperative setting has been described the obesity paradox. In particular, the commitment of all involved physicians to improve all aspects of care will reduce the perioperative risk in obese patients. Physiological and pharmacological characteristics of the obese should also be considered. Furthermore, adequate technical equipment and practical skills of all members of the anesthesia team significantly contribute to risk reduction and therapeutic success in obese patients.","['Huschak, Gerald', 'Busch, Thilo', 'Kaisers, Udo X']","['Huschak G', 'Busch T', 'Kaisers UX']","['Department of Anesthesiology and Intensive Care Medicine, University of Leipzig, Medical Faculty, Leipzig, Germany.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Netherlands,Best Pract Res Clin Endocrinol Metab,Best practice & research. Clinical endocrinology & metabolism,101120682,,IM,"['Anesthesia/*methods', 'Body Mass Index', 'Comorbidity', 'Critical Care/*methods', 'Humans', 'Obesity/complications/epidemiology/*therapy', 'Postoperative Complications/epidemiology/etiology', 'Risk Factors']",,,,,2013/06/05 06:00,2014/01/25 06:00,['2013/06/05 06:00'],"['2013/06/05 06:00 [entrez]', '2013/06/05 06:00 [pubmed]', '2014/01/25 06:00 [medline]']","['S1521-690X(13)00019-5 [pii]', '10.1016/j.beem.2013.02.001 [doi]']",ppublish,Best Pract Res Clin Endocrinol Metab. 2013 Apr;27(2):247-60. doi: 10.1016/j.beem.2013.02.001. Epub 2013 Mar 5.,,20130305,,['Copyright (c) 2013 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
34848545,NLM,MEDLINE,20220328,20230322,1943-3654 (Electronic) 0020-1324 (Linking),67,2,2022 Feb,Evaluation of Esophageal Pressures in Mechanically Ventilated Obese Patients.,184-190,10.4187/respcare.08978 [doi],"BACKGROUND: Patients who are obese are at risk for developing high pleural pressure, which leads to alveolar collapse. Esophageal pressure (P(es)) can be used as a surrogate for pleural pressure and can be used to guide PEEP titration. Although recent clinical data on P(es)-guided PEEP has shown no benefit, its utility in the subgroup of patients who are obese has not been studied. METHODS: The Medical Information Mart for Intensive Care-III critical care database was queried to gather data on P(es) in subjects on mechanical ventilation. P(es) in obese and non-obese groups were compared, and a subgroup analysis was performed in subjects with class III obesity. Thereafter, empirical and P(es)-guided PEEP protocols of a recently published trial were theoretically applied to the obese group and ventilator outcomes were compared. RESULTS: A total of 105 subjects were included in the study. The average end-expiratory P(es) in the obese group was 18.8 +/- 5 cm H(2)O compared with 16.8 +/- 4.8 cm H(2)O in the non-obese group (P < .05). If P(es)-guided PEEP protocol was to be applied to those in the obese group, then the PEEP setting would be significantly higher than empirical PEEP setting. These findings were accentuated in the subgroup of subjects with class III obesity. CONCLUSIONS: Individualization of PEEP with P(es) guidance may have a role in patients who are obese.","['Thind, Guramrinder Singh', 'Mireles-Cabodevila, Eduardo', 'Chatburn, Robert L', 'Duggal, Abhijit']","['Thind GS', 'Mireles-Cabodevila E', 'Chatburn RL', 'Duggal A']","['Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio. thindg@ccf.org.', 'Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.', 'Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.', 'Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.']",['eng'],['Journal Article'],United States,Respir Care,Respiratory care,7510357,,IM,"['Humans', 'Obesity/complications/therapy', '*Positive-Pressure Respiration/methods', '*Respiration, Artificial/methods', 'Ventilators, Mechanical']",,['NOTNLM'],"['PEEP', 'Pleural pressure', 'esophageal pressure', 'mechanical ventilation', 'obesity', 'respiratory failure']",,2021/12/02 06:00,2022/03/29 06:00,['2021/12/01 06:06'],"['2021/12/02 06:00 [pubmed]', '2022/03/29 06:00 [medline]', '2021/12/01 06:06 [entrez]']","['respcare.08978 [pii]', '10.4187/respcare.08978 [doi]']",ppublish,Respir Care. 2022 Feb;67(2):184-190. doi: 10.4187/respcare.08978. Epub 2021 Nov 30.,,20211130,,['Copyright (c) 2022 by Daedalus Enterprises.'],,,,,,,,,,,,,,,,
20485173,NLM,MEDLINE,20101104,20220321,1531-6963 (Electronic) 1040-8711 (Print) 1040-8711 (Linking),22,5,2010 Sep,The evolving role of obesity in knee osteoarthritis.,533-7,10.1097/BOR.0b013e32833b4682 [doi],"PURPOSE OF REVIEW: The frequency of knee osteoarthritis continues to accelerate, likely because of the increasing proliferation of obesity, particularly in men and women 40-60 years of age at the leading edge of the 'baby boom' demographic expansion. The increasing pervasiveness of obesity and the growing appreciation of obesity's accompanying metabolic/inflammatory activities suggest rethinking the knee osteoarthritis paradigm. RECENT FINDINGS: Whereas once knee osteoarthritis was considered a 'wear-and-tear' condition, it is now recognized that knee osteoarthritis exists in the highly metabolic and inflammatory environments of adiposity. Cytokines associated with adipose tissue, including leptin, adiponectin, and resistin, may influence osteoarthritis though direct joint degradation or control of local inflammatory processes. Further, pound-for-pound, not all obesity is equivalent for the development of knee osteoarthritis; development appears to be strongly related to the co-existence of disordered glucose and lipid metabolism. Additionally, obesity loads may be detected by mechanoreceptors on chondrocyte surfaces triggering intracellular signaling cascades of cytokines, growth factors, and metalloproteinases. SUMMARY: This review summarizes recent literature about obesity, knee osteoarthritis and joint pain. Consideration of adipocytokines, metabolic factors, and mechanical loading-metabolic factor interactions will help to broaden the thinking about targets for both prevention and intervention for knee osteoarthritis.","['Sowers, MaryFran R', 'Karvonen-Gutierrez, Carrie A']","['Sowers MR', 'Karvonen-Gutierrez CA']","['Department of Epidemiology, Unversity of Michigan School of Public Health, Ann Arbor, Michigan, USA. mfsowers@umich.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",United States,Curr Opin Rheumatol,Current opinion in rheumatology,9000851,,IM,"['Adipose Tissue/metabolism', 'Female', 'Humans', 'Inflammation/complications/metabolism', 'Male', 'Obesity/*complications/metabolism', 'Osteoarthritis, Knee/*etiology/metabolism', 'Pain/etiology']",PMC3291123,,,,2010/05/21 06:00,2010/11/05 06:00,['2010/05/21 06:00'],"['2010/05/21 06:00 [entrez]', '2010/05/21 06:00 [pubmed]', '2010/11/05 06:00 [medline]']",['10.1097/BOR.0b013e32833b4682 [doi]'],ppublish,Curr Opin Rheumatol. 2010 Sep;22(5):533-7. doi: 10.1097/BOR.0b013e32833b4682.,"['AR040088/AR/NIAMS NIH HHS/United States', 'R01 AR051384-05/AR/NIAMS NIH HHS/United States', 'R01 AG017104-09/AG/NIA NIH HHS/United States', 'R01 AG017104-10/AG/NIA NIH HHS/United States', 'AR051384/AR/NIAMS NIH HHS/United States', 'AR020557/AR/NIAMS NIH HHS/United States', 'R01 AG017104/AG/NIA NIH HHS/United States', 'R01 AR051384/AR/NIAMS NIH HHS/United States']",,,,,['NIHMS358648'],,,,,,,,,,,,,,
18519110,NLM,MEDLINE,20080724,20220318,1538-9375 (Electronic) 1525-8610 (Linking),9,5,2008 Jun,Is obesity bad for older persons? A systematic review of the pros and cons of weight reduction in later life.,302-12,10.1016/j.jamda.2008.01.006 [doi],"OBJECTIVES: The purpose of this review was to describe the characteristics of late-life obesity, including prevalence, pathophysiology, and influences on morbidity and mortality. A second objective was to systematically review the empiric evidence on the effects of intentional weight loss interventions in older individuals. DESIGN: We summarized the characteristics and known impact of late-life obesity and conducted a systematic review of the outcomes of weight loss interventions in obese older subjects. The inclusion criteria for the review were the following: randomized controlled trial; subjects aged 60 years or older; baseline BMI 27 or higher; weight loss versus baseline 3% or more or 2 kg; and trial duration 6 months or longer. RESULTS: The search strategy yielded 16 articles on weight loss interventions that were examined in detail. Overall, these interventions led to significant benefits for those with osteoarthritis, coronary heart disease, and type 2 diabetes mellitus (DM-2), while having slightly negative effects on bone mineral density and lean body mass. CONCLUSION: Longitudinal trials examining mortality and body weight suggest that maintaining weight is beneficial in older persons who become obese after age 65; in contrast, intervention trials show clinically important benefits of weight reduction with regard to osteoarthritis, physical function, and possibly DM-2 and coronary heart disease. Given these findings, we recommend that decisions about whether or not to institute a weight loss intervention for obese older persons be carefully considered on an individualized basis with special attention to the weight history and the medical conditions of each individual.","['Bales, Connie W', 'Buhr, Gwendolen']","['Bales CW', 'Buhr G']","['Geriatric Research Education and Clinical Center, Durham VA Medical Center, Durham, NC, USA. bales001@duke.edu']",['eng'],"['Journal Article', 'Review', 'Systematic Review']",United States,J Am Med Dir Assoc,Journal of the American Medical Directors Association,100893243,,IM,"['Adult', 'Aged', 'Evidence-Based Medicine', 'Humans', 'Longitudinal Studies', 'Middle Aged', '*Obesity/complications/epidemiology/mortality/physiopathology', 'Weight Loss/*physiology']",,,,,2008/06/04 09:00,2008/07/25 09:00,['2008/06/04 09:00'],"['2008/01/10 00:00 [received]', '2008/01/14 00:00 [accepted]', '2008/06/04 09:00 [pubmed]', '2008/07/25 09:00 [medline]', '2008/06/04 09:00 [entrez]']","['S1525-8610(08)00008-X [pii]', '10.1016/j.jamda.2008.01.006 [doi]']",ppublish,J Am Med Dir Assoc. 2008 Jun;9(5):302-12. doi: 10.1016/j.jamda.2008.01.006.,,,,,,,73,,,,,,,,,,,,,
11126648,NLM,MEDLINE,20001228,20060328,0026-4946 (Print) 0026-4946 (Linking),52,9,2000 Sep,[The obese adolescent].,441-3,,,"['Chiumello, G', 'Brambilla, P', 'Bosio, L', 'Testolin, C', 'Grazioli, R', 'Renzetti, F']","['Chiumello G', 'Brambilla P', 'Bosio L', 'Testolin C', 'Grazioli R', 'Renzetti F']","[""Clinica Pediatrica III, Universita degli Studi di Milano, Centro di Endocrinologia dell'Infanzia e dell'Adolescenza Istituto Scientifico H San Raffaele, Milano. chiumello.giuseppe@hsr.it""]",['ita'],['Journal Article'],Italy,Minerva Pediatr,Minerva pediatrica,0400740,,IM,"['Adolescent', 'Body Weight', 'Humans', '*Obesity/complications/diagnosis/psychology', 'Risk Factors', 'Sex Factors']",,,,,2000/12/29 11:00,2001/02/28 10:01,['2000/12/29 11:00'],"['2000/12/29 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/12/29 11:00 [entrez]']",,ppublish,Minerva Pediatr. 2000 Sep;52(9):441-3.,,,,,,,,,L'adolescente obeso.,,,,,,,,,,,
15941679,NLM,MEDLINE,20051129,20050719,1570-677X (Print) 1570-677X (Linking),3,2,2005 Jul,Health and wealth. The late-20th century obesity epidemic in the U.S.,296-313,,"Obesity is a rapidly growing public health issue. This paper investigates obesity's relationship to individuals' wealth by analyzing data from a large U.S. longitudinal socio-economic survey. The results show a large negative association between BMI and White female's net worth, a smaller negative association for Black women and White males and no relationship for Black males. Weight changes and dieting also appear associated with wealth changes. Individuals who lose small amounts of weight experience little change in net worth, but those who lose large amounts of weight have a dramatically improved financial position, with Whites showing larger changes than Blacks.","['Zagorsky, Jay L']",['Zagorsky JL'],"['Center for Human Resource Research, Ohio State University, 921 Chatham Lane, Suite 100, Columbus, OH 43221, USA. zagorsky.1@osu.edu']",['eng'],['Journal Article'],Netherlands,Econ Hum Biol,Economics and human biology,101166135,,IM,"['Adult', 'Data Collection', 'Female', 'Health Status', 'Humans', 'Longitudinal Studies', 'Male', 'Obesity/*epidemiology', '*Social Class', 'United States/epidemiology']",,,,,2005/06/09 09:00,2005/12/13 09:00,['2005/06/09 09:00'],"['2005/05/11 00:00 [received]', '2005/05/11 00:00 [accepted]', '2005/06/09 09:00 [pubmed]', '2005/12/13 09:00 [medline]', '2005/06/09 09:00 [entrez]']","['S1570-677X(05)00030-4 [pii]', '10.1016/j.ehb.2005.05.003 [doi]']",ppublish,Econ Hum Biol. 2005 Jul;3(2):296-313. doi: 10.1016/j.ehb.2005.05.003.,,,,,,,,,,,,,,,,,,,,
20236577,NLM,MEDLINE,20121105,20100318,1000-503X (Print) 1000-503X (Linking),32,1,2010 Feb,[Integrated multidisciplinary treatment modalities for obesity].,1-3,10.3881/j.issn.1000-503X.2010.01.001 [doi],"The rapid increase of obesity nationwide and worldwide has threatened human health and caused the increase of metabolic diseases and the changes of disease spectrum. Its co-morbidities, mortality, and relevant socio-economic issues have became global concerns. Integrated multidisciplinary treatment modalities have emerged in recent years. For severely obese patients body mass index (BMI>40 kg/m(2) or obese patients (BMI 35 - 40 kg/m(2)) with co-morbidities such as severe diabetes, obesity-associated cardiac lesions, severe sleep apnea, infertility, and osteoarthritis that affect the daily life, minimally invasive laparoscopic bariatric surgery (such as Lap Banding) can achieve satisfactory results by reducing body weight in long term, treating or preventing the co-morbidities, and ultimately decreasing mortality. Multidisciplinary treatment modalities for tumors, obesity, and other diseases have been widely adopted. This strategy may play increasingly important roles in improving the treatment effectiveness, upgrading healthcare services, and addressing interdisciplinary problems.","['Yu, Jian-chun']",['Yu JC'],"['Department of General Surgery, PUMC Hospital, CAMS and PUMC, Beijing 100730, China. yu-jch@163.com']",['chi'],"['English Abstract', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",China,Zhongguo Yi Xue Ke Xue Yuan Xue Bao,Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,8006230,,IM,"['Combined Modality Therapy', 'Humans', 'Obesity/surgery/*therapy']",,,,,2010/03/20 06:00,2012/11/06 06:00,['2010/03/19 06:00'],"['2010/03/19 06:00 [entrez]', '2010/03/20 06:00 [pubmed]', '2012/11/06 06:00 [medline]']",['10.3881/j.issn.1000-503X.2010.01.001 [doi]'],ppublish,Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Feb;32(1):1-3. doi: 10.3881/j.issn.1000-503X.2010.01.001.,,,,,,,,,,,,,,,,,,,,
11011956,NLM,MEDLINE,20010105,20220309,0340-6199 (Print) 0340-6199 (Linking),159 Suppl 1,,2000 Sep,Prevention and treatment of overweight and obesity in children and adolescents.,S56-68,,"Increasing numbers of obese children and adolescents all over the world demand an investment in the primary and secondary prevention of obesity and overweight in this age group. The goal of preventive measures in children is to avoid the negative short- and long-term health problems associated with obesity. Primary prevention aims at establishing a healthy, active lifestyle and keeping children and adolescents within a range of body weight which is considered to be healthy. Constant availability and affordability of palatable and energy-dense food in the affluent society of the western world demands preventive strategies. Universal or public health prevention seems to be the most suitable form because several other cofactors of morbidity and mortality of affluent societies can also be prevented. However, in most European countries there is a lack of awareness of the necessity of prevention programmes, not only among the general population but also among the medical society. More awareness and consciousness to the problem of obesity must be generated in order to lead to effective therapeutic programmes. For those children and adolescents who are already obese, secondary prevention is mandatory. Therapeutic intervention programmes for the obese aim at long-term weight maintenance and normalisation of body weight and body fat. They have to modify eating and exercise behaviour of the obese child and establish new, healthier behaviour and lifestyle. Treatments programmes must include behavioural components in order to permanently change nutrition and physical exercise of the obese children and adolescents. However, long-term results of treatment programmes in European countries are scarce and the reported results, even of multidisciplinary regimens, are not impressive. CONCLUSION: In most European countries there is an urgent need not only for a growing awareness of the problem of obesity in children and adolescents but also for development of new comprehensive approaches in treating this group.","['Zwiauer, K F']",['Zwiauer KF'],"['Department of Paediatrics, Saint Poelten General Hospital, Austria. zwiauer@kfs.at']",['eng'],"['Journal Article', 'Review']",Germany,Eur J Pediatr,European journal of pediatrics,7603873,,IM,"['Adolescent', 'Behavior Therapy', 'Child', 'Clinical Trials as Topic', 'Diet', 'Europe', 'Female', 'Humans', 'Male', '*Obesity/etiology/prevention & control/therapy', 'Primary Prevention/*methods', 'Psychotherapy, Group', 'Risk Factors']",,,,,2000/09/30 11:00,2001/02/28 10:01,['2000/09/30 11:00'],"['2000/09/30 11:00 [pubmed]', '2001/02/28 10:01 [medline]', '2000/09/30 11:00 [entrez]']",['10.1007/pl00014367 [doi]'],ppublish,Eur J Pediatr. 2000 Sep;159 Suppl 1:S56-68. doi: 10.1007/pl00014367.,,,,,,,113,,,,,,,,,,,,,
11244800,NLM,MEDLINE,20010322,20150826,0370-629X (Print) 0370-629X (Linking),55,10,2000 Oct,[Obesity and hypertension: from physiopathology to treatment].,921-8,,Obesity constitutes a problem of major concern in our industrialized countries. Overweight is frequently associated with hypertension (50% of hypertensive subjects are obese and the prevalence of hypertension in obese patients is twice that of the normal population). Both pathologies are major cardiovascular risk factors. This review aims at a better understanding of the relationship between hypertension and overweight and at giving to the clinicians simple and consistent guidelines to treat these two medical entities.,"['Geronooz, I', 'Krzesinski, J M']","['Geronooz I', 'Krzesinski JM']",['Service de Nephrologie et Hypertension arterielle (Pr. G. Rorive) CHU Liege.'],['fre'],"['English Abstract', 'Journal Article', 'Review']",Belgium,Rev Med Liege,Revue medicale de Liege,0404317,,IM,"['Body Mass Index', 'Developed Countries', 'Humans', 'Hypertension/epidemiology/*etiology/metabolism/physiopathology/*therapy', 'Insulin Resistance', 'Obesity/*complications/epidemiology/metabolism/physiopathology/*therapy', 'Practice Guidelines as Topic', 'Prevalence', 'Risk Factors', 'Severity of Illness Index']",,,,,2001/03/14 10:00,2001/03/27 10:01,['2001/03/14 10:00'],"['2001/03/14 10:00 [pubmed]', '2001/03/27 10:01 [medline]', '2001/03/14 10:00 [entrez]']",,ppublish,Rev Med Liege. 2000 Oct;55(10):921-8.,,,,,,,31,,Obesite et hypertension arterielle: de la physiopathologie au traitement.,,,,,,,,,,,
23601528,NLM,MEDLINE,20131101,20191210,1467-789X (Electronic) 1467-7881 (Linking),14,7,2013 Jul,Modelling obesity outcomes: reducing obesity risk in adulthood may have greater impact than reducing obesity prevalence in childhood.,523-31,10.1111/obr.12029 [doi],"A common policy response to the rise in obesity prevalence is to undertake interventions in childhood, but it is an open question whether this is more effective than reducing the risk of becoming obese during adulthood. In this paper, we model the effect on health outcomes of (i) reducing the prevalence of obesity when entering adulthood; (ii) reducing the risk of becoming obese throughout adult life; and (iii) combinations of both approaches. We found that, while all approaches reduce the prevalence of chronic diseases and improve life expectancy, a given percentage reduction in obesity prevalence achieved during childhood had a smaller effect than the same percentage reduction in the risk of becoming obese applied throughout adulthood. A small increase in the probability of becoming obese during adulthood offsets a substantial reduction in prevalence of overweight/obesity achieved during childhood, with the gains from a 50% reduction in child obesity prevalence offset by a 10% increase in the probability of becoming obese in adulthood. We conclude that both policy approaches can improve the health profile throughout the life course of a cohort, but they are not equivalent, and a large reduction in child obesity prevalence may be reversed by a small increase in the risk of becoming overweight or obese in adulthood.","['Lhachimi, S K', 'Nusselder, W J', 'Lobstein, T J', 'Smit, H A', 'Baili, P', 'Bennett, K', 'Kulik, M C', 'Jackson-Leach, R', 'Boshuizen, H C', 'Mackenbach, J P']","['Lhachimi SK', 'Nusselder WJ', 'Lobstein TJ', 'Smit HA', 'Baili P', 'Bennett K', 'Kulik MC', 'Jackson-Leach R', 'Boshuizen HC', 'Mackenbach JP']","['Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands. s.lhachimi@erasmusmc.nl']",['eng'],"['Journal Article', 'Review']",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['Adult', 'Child', 'Chronic Disease', 'Humans', 'Life Expectancy', '*Models, Biological', 'Obesity/*complications/*epidemiology/mortality', '*Outcome Assessment, Health Care', 'Prevalence', '*Risk Assessment']",,,,,2013/04/23 06:00,2013/11/02 06:00,['2013/04/23 06:00'],"['2012/11/02 00:00 [received]', '2013/02/01 00:00 [revised]', '2013/02/19 00:00 [accepted]', '2013/04/23 06:00 [entrez]', '2013/04/23 06:00 [pubmed]', '2013/11/02 06:00 [medline]']",['10.1111/obr.12029 [doi]'],ppublish,Obes Rev. 2013 Jul;14(7):523-31. doi: 10.1111/obr.12029. Epub 2013 Apr 18.,,20130418,,"['(c) 2013 The Authors. obesity reviews (c) 2013 International Association for the', 'Study of Obesity.']",,,,,,,,,,,,,,,,
7512475,NLM,MEDLINE,19940519,20181113,0012-6667 (Print) 0012-6667 (Linking),46 Suppl 2,,1993,The pathogenesis of hypertension in obese subjects.,197-208; discussion 208-9,,"Obese subjects are at an increased risk of becoming hypertensive and vice versa. Essential hypertension and obesity are commonly accompanied by insulin resistance (defined as impaired insulin-mediated glucose disposal) and hyperinsulinaemia. In the offspring of patients with essential hypertension, insulin resistance and hyperinsulinaemia, as well as related increases in serum low density lipoproteins and triglycerides, often occur prior to the development of essential hypertension, overweight or central redistribution of body fat. Moreover, once obesity, and in particular central obesity, is present, insulin resistance is more marked in hypertensive than in normotensive obese subjects. Hyperinsulinaemia and/or insulin resistance in turn promote body fat deposition and impaired glucose tolerance. This cycle helps to explain why a familial predisposition to essential hypertension poses an increased risk of developing not only hypertension but also dyslipidaemia, obesity and non-insulin-dependent (type 2) diabetes. It is still unclear whether insulin resistance and/or hyperinsulinaemia also promote hypertension per se. Regardless of insulin's exact pathogenic role, obesity and/or a high dietary intake of carbohydrates, salt, etc. can induce several potential pressor mechanisms: 1) higher plasma noradrenaline (norepinephrine) and adrenaline (epinephrine) levels, suggesting a higher sympathetic tone in obese than in nonobese subjects, and in hypertensive obese than in normotensive obese subjects; 2) similarly, a tendency to hyperaldosteronism, with largely normal plasma renin activity, in obese hypertensive patients; 3) enhanced sensitivity of blood pressure to salt; 4) increased total blood volume (although it is normal relative to body surface area), leading to increased cardiac output and eventually eccentric left ventricular hypertrophy; and 5) increased cytosolic free Ca++ levels and reduced intracellular Mg++ levels in the blood cells of obese hypertensive patients and patients with non-insulin-dependent diabetes, although this finding cannot necessarily be extrapolated to cationic levels in vascular muscle cells. Total peripheral vascular resistance is usually low in normotensive obese subjects and rises with the development of hypertension; compared with lean patients with essential hypertension, obese hypertensive patients tend to have a slightly lower level of total peripheral vasoconstriction and a slightly higher cardiac output. Considering the intimate association between essential hypertension and obesity, as well as the prevalence and prognostic relevance of this combination, the spectrum of accompanying metabolic and cardiovascular abnormalities deserves careful consideration in the evaluation of therapeutic care for such patients.","['Weidmann, P', 'de Courten, M', 'Boehlen, L', 'Shaw, S']","['Weidmann P', 'de Courten M', 'Boehlen L', 'Shaw S']","['Medizinische Poliklinik, University of Berne, Switzerland.']",['eng'],"['Journal Article', 'Review']",New Zealand,Drugs,Drugs,7600076,,IM,"['Humans', 'Hypertension/complications/*physiopathology', 'Obesity/complications/*physiopathology']",,,,,1993/01/01 00:00,1993/01/01 00:01,['1993/01/01 00:00'],"['1993/01/01 00:00 [pubmed]', '1993/01/01 00:01 [medline]', '1993/01/01 00:00 [entrez]']",['10.2165/00003495-199300462-00030 [doi]'],ppublish,Drugs. 1993;46 Suppl 2:197-208; discussion 208-9. doi: 10.2165/00003495-199300462-00030.,,,,,,,107,,,,,,,,,,,,,
33624090,NLM,MEDLINE,20220214,20231112,2047-4881 (Electronic) 2047-4873 (Print) 2047-4873 (Linking),28,18,2022 Feb 9,Fatty liver disease in obese patients with COVID-19: a tale of two pandemics?,e49,10.1093/eurjpc/zwaa059 [doi] zwaa059,,"['Yeoh, Seng Lim', 'Flaherty, Gerard Thomas']","['Yeoh SL', 'Flaherty GT']","['School of Medicine, National University of Ireland Galway, Ireland.', 'National Institute for Prevention and Cardiovascular Health, Galway, Ireland.', 'School of Medicine, National University of Ireland Galway, Ireland.', 'National Institute for Prevention and Cardiovascular Health, Galway, Ireland.']",['eng'],"['Comment', 'Journal Article']",England,Eur J Prev Cardiol,European journal of preventive cardiology,101564430,,IM,"['*COVID-19', 'Humans', '*Liver Diseases', 'Obesity/complications/diagnosis/epidemiology', 'Pandemics', 'SARS-CoV-2']",PMC7665449,,,,2021/02/25 06:00,2022/02/15 06:00,['2021/02/24 05:46'],"['2021/02/25 06:00 [pubmed]', '2022/02/15 06:00 [medline]', '2021/02/24 05:46 [entrez]']","['5939828 [pii]', 'zwaa059 [pii]', '10.1093/eurjpc/zwaa059 [doi]']",ppublish,Eur J Prev Cardiol. 2022 Feb 9;28(18):e49. doi: 10.1093/eurjpc/zwaa059.,,,,,['ORCID: 0000-0002-5987-1658'],,,,,,['Eur J Prev Cardiol. 2020 Jul;27(10):1017-1025. PMID: 32391719'],,,,,,,,,
9759681,NLM,MEDLINE,19981014,20220410,0003-9926 (Print) 0003-9926 (Linking),158,17,1998 Sep 28,"Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults.",1855-67,,"An estimated 97 million adults in the United States are overweight or obese, a condition that substantially raises their risk of morbidity from hypertension, dyslipidemia, type 2 diabetes, coronary heart disease, stroke, gallbladder disease, osteoarthritis, sleep apnea and respiratory problems, and endometrial, breast, prostate, and colon cancers. Higher body weights are also associated with increases in all-cause mortality. Obese individuals may also suffer from social stigmatization and discrimination. As a major contributor to preventive death in the United States today, overweight and obesity pose a major public health challenge.",,,,['eng'],"['Guideline', 'Journal Article', 'Practice Guideline', 'Review']",United States,Arch Intern Med,Archives of internal medicine,0372440,,IM,"['Behavior Therapy', 'Body Mass Index', 'Evidence-Based Medicine', 'Humans', 'Life Style', 'Obesity/*diagnosis/drug therapy/epidemiology/*therapy', 'Risk', 'Risk Factors', 'Severity of Illness Index', 'United States/epidemiology', 'Weight Loss']",,,,,1998/10/06 00:00,1998/10/06 00:01,['1998/10/06 00:00'],"['1998/10/06 00:00 [pubmed]', '1998/10/06 00:01 [medline]', '1998/10/06 00:00 [entrez]']",['10.1001/archinte.158.17.1855 [doi]'],ppublish,Arch Intern Med. 1998 Sep 28;158(17):1855-67. doi: 10.1001/archinte.158.17.1855.,,,,,,,4,,,,,,,,,,,,,
27816159,NLM,MEDLINE,20170301,20170302,1558-0474 (Electronic) 0889-8545 (Linking),43,4,2016 Dec,Obesity and the Critical Care Pregnant Patient.,767-778,S0889-8545(16)30042-0 [pii] 10.1016/j.ogc.2016.07.012 [doi],"The rise of obesity among gravid women has been tracked and documented in many first-world countries, but a dramatic rise has been noted over the last 15 years. Definitions of ""normal-weight, overweight and obese"" have been defined; however, new terms are used to describe more severe degrees of obesity. Obesity in any form or degree increases morbidities in mothers. The unique physiologic characteristics of the obese gravida set up unique challenges in her management, especially in an acute setting such as labor. The definitions, trends, and management decisions pertaining to the obese parturient will be described in this review.","['Lam, Garrett K']",['Lam GK'],"['Department of Obstetrics and Gynecology, University of Tennessee College of Medicine Chattanooga, 979 East 3rd Street, Suite C-720, Chattanooga, TN 37403, USA; Regional Obstetrical Consultants Chattanooga, TN, USA. Electronic address: Garrett.Lam@erlanger.org.']",['eng'],"['Journal Article', 'Review']",United States,Obstet Gynecol Clin North Am,Obstetrics and gynecology clinics of North America,8709551,,IM,"['Body Mass Index', 'Clinical Decision-Making', 'Female', 'Humans', '*Obesity/diagnosis/physiopathology/therapy', 'Obstetric Labor Complications/*therapy', 'Patient Care Management/methods', 'Pregnancy', '*Pregnancy Complications/diagnosis/physiopathology/therapy', 'Pregnancy Outcome']",,['NOTNLM'],"['BMI', 'Maternal mortality', 'National Health and Nutrition Examination Survey', 'Obesity (morbid, super)']",,2016/11/07 06:00,2017/03/03 06:00,['2016/11/07 06:00'],"['2016/11/07 06:00 [entrez]', '2016/11/07 06:00 [pubmed]', '2017/03/03 06:00 [medline]']","['S0889-8545(16)30042-0 [pii]', '10.1016/j.ogc.2016.07.012 [doi]']",ppublish,Obstet Gynecol Clin North Am. 2016 Dec;43(4):767-778. doi: 10.1016/j.ogc.2016.07.012. Epub 2016 Oct 14.,,20161014,,['Copyright (c) 2016 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
25959452,NLM,MEDLINE,20150908,20150629,1873-1740 (Electronic) 0033-0620 (Linking),58,1,2015 Jul-Aug,Role of Fitness in the Metabolically Healthy but Obese Phenotype: A Review and Update.,76-86,S0033-0620(15)00030-4 [pii] 10.1016/j.pcad.2015.05.001 [doi],"Despite the strong and consistent evidence supporting that a high physical fitness (PF) level at any age is a major predictor of a healthier metabolic profile, major studies focused on the metabolically healthy but obese (MHO) phenotype have ignored the role of PF when examining this phenotype and its prognosis. Particularly, the role of its main health-related components such as higher cardiorespiratory fitness (CRF) and muscular fitness in the MHO phenotype needs to be reviewed in depth. The present review aimed to: 1) contribute to the characterization of the MHO phenotype by examining whether MHO individuals are fitter than metabolically abnormal obese (MAO) individuals in terms of CRF and other PF components; 2) review the role of CRF and other PF components in the prognosis of MHO. The studies reviewed suggest that a higher CRF level should be considered a characteristic of the MHO phenotype. Likewise, CRF seems to play a key role in the prognosis of the MHO individuals, yet this statement is based on a single study and future studies need to confirm or contrast these findings. Comparability of studies is difficult due to the different definitions used for MHO; consequently, the present review makes a proposal for harmonizing this definition in adults and in youth. Obesity is still related to an important number of comorbidities; therefore, the public health message remains to fight against both obesity and low CRF in both adult and pediatric populations.","['Ortega, Francisco B', 'Cadenas-Sanchez, Cristina', 'Sui, Xuemei', 'Blair, Steven N', 'Lavie, Carl J']","['Ortega FB', 'Cadenas-Sanchez C', 'Sui X', 'Blair SN', 'Lavie CJ']","['PROFITH ""PROmoting FITness and Health through physical activity"" Research Group, Department of Physical Education and Sports, School of Sport Sciences, University of Granada, Spain; Department of Biosciences and Nutrition at NOVUM, Karolinska Institutet, Huddinge, Sweden. Electronic address: ortegaf@ugr.es.', 'PROFITH ""PROmoting FITness and Health through physical activity"" Research Group, Department of Physical Education and Sports, School of Sport Sciences, University of Granada, Spain.', 'Department of Exercise Science, University of South Carolina, Columbia, SC, USA.', 'Department of Exercise Science, University of South Carolina, Columbia, SC, USA; Department of Epidemiology and Biostatistics, University of South Carolina, Columbia, SC, USA.', 'Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School-the University of Queensland School of Medicine, New Orleans, LA, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Prog Cardiovasc Dis,Progress in cardiovascular diseases,0376442,,IM,"['Body Mass Index', '*Energy Metabolism', 'Evidence-Based Medicine', '*Health Status', 'Humans', 'Obesity/diagnosis/metabolism/mortality/*physiopathology', 'Phenotype', '*Physical Fitness', 'Prognosis', 'Risk Assessment', 'Risk Factors']",,['NOTNLM'],"['Cardiorespiratory fitness', 'Metabolically abnormal obese', 'Metabolically healthy but obese', 'Mortality', 'Muscular strength', 'Physical fitness', 'Prognosis']",,2015/05/12 06:00,2015/09/09 06:00,['2015/05/12 06:00'],"['2015/05/12 06:00 [entrez]', '2015/05/12 06:00 [pubmed]', '2015/09/09 06:00 [medline]']","['S0033-0620(15)00030-4 [pii]', '10.1016/j.pcad.2015.05.001 [doi]']",ppublish,Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):76-86. doi: 10.1016/j.pcad.2015.05.001. Epub 2015 May 7.,,20150507,,['Copyright (c) 2015 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
1802223,NLM,MEDLINE,19920430,20131121,0899-9007 (Print) 0899-9007 (Linking),7,4,1991 Jul-Aug,Obesity: determinants and therapeutic initiatives.,292-4,,"There are several possible determinants of obesity, including impaired thermogenesis and the differential utilization of fuels in different tissues. Whereas hypometabolism may initiate obesity in some people, once obese, individuals tend to manifest a higher resting metabolic rate because of their greater fat-free mass, exhibit an impaired thermic response to food, and expend more calories than lean individuals for equivalent amounts of activity. As a result, over a 24-h period, obese people generally expend more energy than lean people. A second determinant of obesity is related to fuel utilization and suggests that those predisposed to be obese may have an innate insulin resistance in muscle, leading to decreased uptake, oxidation, and storage of glucose in this tissue. As a result, the glucose is shunted to adipose tissue, where it is stored. With regard to treatment of obesity, emphasis on increased energy expenditure through the inclusion of reasonable amounts of activity is essential. However, this must always be combined with restraint in caloric intake.","['Pi-Sunyer, F X']",['Pi-Sunyer FX'],"[""St. Luke's/Roosevelt Hospital, Columbia University, New York, New York.""]",['eng'],"['Journal Article', 'Review']",United States,Nutrition,"Nutrition (Burbank, Los Angeles County, Calif.)",8802712,['IY9XDZ35W2 (Glucose)'],IM,"['Energy Intake', 'Energy Metabolism', 'Exercise', 'Glucose/metabolism', 'Humans', 'Obesity/*metabolism/*therapy']",,,,,1991/07/01 00:00,1991/07/01 00:01,['1991/07/01 00:00'],"['1991/07/01 00:00 [pubmed]', '1991/07/01 00:01 [medline]', '1991/07/01 00:00 [entrez]']",,ppublish,Nutrition. 1991 Jul-Aug;7(4):292-4.,,,,,,,17,['Nutrition. 1992 May-Jun;8(3):198. PMID: 1525435'],,,,,,,,,,,,
17475160,NLM,MEDLINE,20070821,20080804,1533-7294 (Electronic) 0094-3509 (Linking),56,5 Suppl Managing,2007 May,Managing obesity: options for obese and morbidly obese patients.,S1-9,,,"['Saltzman, Edward', 'Tarnoff, Michael', 'Shikora, Scott']","['Saltzman E', 'Tarnoff M', 'Shikora S']","['Tufts University School of Medicine, and Obesity Consultation Center, Tufts-New England Medical Center, Boston, MA, USA.']",['eng'],"['Journal Article', 'Review']",United States,J Fam Pract,The Journal of family practice,7502590,,IM,"['Bariatric Surgery/adverse effects/*methods', 'Body Mass Index', 'Diet, Fat-Restricted', 'Exercise/physiology', 'Female', 'Humans', 'Incidence', '*Life Style', 'Male', 'Obesity/diagnosis/epidemiology/therapy', 'Obesity, Morbid/diagnosis/*epidemiology/*therapy', 'Patient Education as Topic', 'Physician-Patient Relations', 'Risk Assessment', 'Weight Loss']",,,,,2007/05/04 09:00,2007/08/22 09:00,['2007/05/04 09:00'],"['2007/05/04 09:00 [pubmed]', '2007/08/22 09:00 [medline]', '2007/05/04 09:00 [entrez]']",['jfp_0507_5605t [pii]'],ppublish,J Fam Pract. 2007 May;56(5 Suppl Managing):S1-9.,,,,,,,53,,,,,,,,,,,,,
9239191,NLM,MEDLINE,19970821,20190616,0077-8923 (Print) 0077-8923 (Linking),817,,1997 May 28,Management of childhood obesity in pediatric practice.,225-40,,"Evaluation of obese children and adolescents in the pediatric office or clinic should include baseline assessment of weight for height and body fatness; rule out endocrine and genetic causes of obesity; and evaluate other health-risk factors, such as those for cardiovascular disease, cancer, diabetes, and hypertension. Treatment of obesity is most successful if realistic goals are set; a balanced low-fat/high-fiber diet is stressed; a safe rate of weight loss of 1 to 2 pounds per week is achieved through a moderate reduction of caloric intake (approximately 20-25% decrease); increased physical activity is stressed as much as diet; parental support is strong; and behavior therapy is provided during the course of treatment to help both child and parent achieve the diet, exercise, and behavior goals.","['Williams, C L', 'Campanaro, L A', 'Squillace, M', 'Bollella, M']","['Williams CL', 'Campanaro LA', 'Squillace M', 'Bollella M']","['Child Health Center, American Health Foundation, Valhalla, New York 10595, USA. chrisw@pol.net']",['eng'],"['Journal Article', 'Review']",United States,Ann N Y Acad Sci,Annals of the New York Academy of Sciences,7506858,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Humans', '*Obesity/physiopathology/prevention & control/therapy']",,,,,1997/05/28 00:00,1997/05/28 00:01,['1997/05/28 00:00'],"['1997/05/28 00:00 [pubmed]', '1997/05/28 00:01 [medline]', '1997/05/28 00:00 [entrez]']",['10.1111/j.1749-6632.1997.tb48209.x [doi]'],ppublish,Ann N Y Acad Sci. 1997 May 28;817:225-40. doi: 10.1111/j.1749-6632.1997.tb48209.x.,,,,,,,40,,,,,,,,,,,,,
16824359,NLM,MEDLINE,20060830,20061115,0033-0205 (Print) 0033-0205 (Linking),59,1,2006 Jan-Mar,[The obese person undergoing non invasive treatment: description of a case study].,13-23,,"In the last years, there are always more people with obesity those recourses at the specifics therapeutics treatments to answer at the behaviour food disorders. In this case, to cure the obesity more people to resort at bariatric surgical treatments or with not invasion treatments, with the objective to improve the quality of life. In reference at this problem, will be introduced a typical case as evidence towards a problem who the national nursing literature do not to be concerned with enough attention. The object will be that to increase the awareness towards mental and physical problems that obese people lived today in the society and the importance about this problem of the management nursing care.","['Vario, Massimiliano', 'Di Pilato, Simona']","['Vario M', 'Di Pilato S']","[""DAI Dott. Docente di Inferm. Clinica, Universita La Sapienza di Roma-Coordinatore Inf.co, Ospedale Sant'Andrea di Roma.""]",['ita'],"['Case Reports', 'English Abstract', 'Journal Article']",Italy,Prof Inferm,Professioni infermieristiche,0244135,,,"['Combined Modality Therapy', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/epidemiology/*therapy']",,,,,2006/07/11 09:00,2006/08/31 09:00,['2006/07/11 09:00'],"['2006/07/11 09:00 [pubmed]', '2006/08/31 09:00 [medline]', '2006/07/11 09:00 [entrez]']",,ppublish,Prof Inferm. 2006 Jan-Mar;59(1):13-23.,,,,,,,,,La persona obesa sottoposta a trattamento terapeutico non invasivo. Descrizione di un caso studio.,,,,,,,,,,,
37178509,NLM,MEDLINE,20230601,20230606,1090-2104 (Electronic) 0006-291X (Linking),666,,2023 Jul 23,Differential alternative polyadenylation response to high-fat diet between polygenic obese and healthy lean mice.,83-91,S0006-291X(23)00561-2 [pii] 10.1016/j.bbrc.2023.05.005 [doi],"Obesity's complex etiology due to the interplay of environment and genetics makes it a more challenging research and health problem. Some of the contributing genetic factors that have not yet been examined in detail entail mRNA polyadenylation (PA). Genes with multiple PA sites express mRNA isoforms differing in coding sequence or 3'UTR through alternative polyadenylation (APA). Alterations in PA have been associated with various diseases; however, its contribution to obesity is not well-researched. Following an 11-week high-fat diet, the APA sites in the hypothalamus of two unique mouse models for polygenic obesity (Fat line) and healthy leanness (Lean line) were determined using whole transcriptome termini site sequencing (WTTS-seq). We found 17 genes of interest with differentially expressed APA (DE-APA) isoforms, among which seven were previously associated with obesity or obesity-related traits (Pdxdc1, Smyd3, Rpl14, Copg1, Pcna, Ric3, Stx3) but have not yet been studied in the context of APA. The remaining ten genes (Ccdc25, Dtd2, Gm14403, Hlf, Lyrm7, Mrpl3, Pisd-ps3, Sbsn, Slx1b, Spon1) represent novel candidates associated with obesity/adiposity due to variability brought about by differential usage of APA sites. Our results provide insights into the relationship between PA and the hypothalamus in the context of obesity, by being the first study of DE-APA sites and DE-APA isoforms in these mouse models. Future studies are needed further to explore the role of APA isoforms in polygenic obesity by expanding the scope of research to other metabolically important tissues (such as liver and adipose tissues) and investigating the potential for targeting PA as a therapeutic strategy for obesity management.","['Mikec, Spela', 'Horvat, Simon', 'Wang, Hongyang', 'Michal, Jennifer', 'Kunej, Tanja', 'Jiang, Zhihua']","['Mikec S', 'Horvat S', 'Wang H', 'Michal J', 'Kunej T', 'Jiang Z']","['University of Ljubljana, Biotechnical Faculty, Department of Animal Science, Domzale, Slovenia; Washington State University, Department of Animal Sciences, Pullman, WA, 99164-7620, USA.', 'University of Ljubljana, Biotechnical Faculty, Department of Animal Science, Domzale, Slovenia.', 'Washington State University, Department of Animal Sciences, Pullman, WA, 99164-7620, USA.', 'Washington State University, Department of Animal Sciences, Pullman, WA, 99164-7620, USA.', 'University of Ljubljana, Biotechnical Faculty, Department of Animal Science, Domzale, Slovenia. Electronic address: tanja.kunej@bf.uni-lj.si.', 'Washington State University, Department of Animal Sciences, Pullman, WA, 99164-7620, USA. Electronic address: jiangz@wsu.edu.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S.""]",United States,Biochem Biophys Res Commun,Biochemical and biophysical research communications,0372516,"[""0 (3' Untranslated Regions)""]",IM,"['Mice', 'Animals', '*Polyadenylation/genetics', '*Diet, High-Fat/adverse effects', 'Obesity/genetics', ""3' Untranslated Regions""]",,['NOTNLM'],"['Alternative polyadenylation (APA)', 'Differentially expressed alternative polyadenylation sites (DE-APA)', 'Fat and lean selection mouse lines', 'Hypothalamus']","['Declaration of competing interest The authors declare that they have no known', 'competing financial interests or personal relationships that could have appeared', 'to influence the work reported in this paper.']",2023/05/14 01:07,2023/06/01 06:42,['2023/05/13 18:02'],"['2023/04/26 00:00 [received]', '2023/05/02 00:00 [accepted]', '2023/06/01 06:42 [medline]', '2023/05/14 01:07 [pubmed]', '2023/05/13 18:02 [entrez]']","['S0006-291X(23)00561-2 [pii]', '10.1016/j.bbrc.2023.05.005 [doi]']",ppublish,Biochem Biophys Res Commun. 2023 Jul 23;666:83-91. doi: 10.1016/j.bbrc.2023.05.005. Epub 2023 May 2.,,20230502,,['Copyright (c) 2023 The Authors. Published by Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
21122113,NLM,MEDLINE,20110315,20211020,1755-8794 (Electronic) 1755-8794 (Linking),3,,2010 Dec 1,Gene expression profiling in whole blood identifies distinct biological pathways associated with obesity.,56,10.1186/1755-8794-3-56 [doi],"BACKGROUND: Obesity is reaching epidemic proportions and represents a significant risk factor for cardiovascular disease, diabetes, and cancer. METHODS: To explore the relationship between increased body mass and gene expression in blood, we conducted whole-genome expression profiling of whole blood from seventeen obese and seventeen well matched lean subjects. Gene expression data was analyzed at the individual gene and pathway level and a preliminary assessment of the predictive value of blood gene expression profiles in obesity was carried out. RESULTS: Principal components analysis of whole-blood gene expression data from obese and lean subjects led to efficient separation of the two cohorts. Pathway analysis by gene-set enrichment demonstrated increased transcript levels for genes belonging to the ""ribosome"", ""apoptosis"" and ""oxidative phosphorylation"" pathways in the obese cohort, consistent with an altered metabolic state including increased protein synthesis, enhanced cell death from proinflammatory or lipotoxic stimuli, and increased energy demands. A subset of pathway-specific genes acted as efficient predictors of obese or lean class membership when used in Naive Bayes or logistic regression based classifiers. CONCLUSION: This study provides a comprehensive characterization of the whole blood transcriptome in obesity and demonstrates that the investigation of gene expression profiles from whole blood can inform and illustrate the biological processes related to regulation of body mass. Additionally, the ability of pathway-related gene expression to predict class membership suggests the feasibility of a similar approach for identifying clinically useful blood-based predictors of weight loss success following dietary or surgical interventions.","['Ghosh, Sujoy', 'Dent, Robert', 'Harper, Mary-Ellen', 'Gorman, Shelby A', 'Stuart, Joan S', 'McPherson, Ruth']","['Ghosh S', 'Dent R', 'Harper ME', 'Gorman SA', 'Stuart JS', 'McPherson R']","['Biomedical Biotechnology Research Institute, North Carolina Central University, Durham, USA. sghosh@nccu.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",England,BMC Med Genomics,BMC medical genomics,101319628,,IM,"['Case-Control Studies', 'Female', '*Gene Expression Profiling', 'Humans', 'Male', '*Metabolic Networks and Pathways', 'Middle Aged', 'Obesity/blood/epidemiology/*genetics/*metabolism', 'Principal Component Analysis', 'Sex Factors']",PMC3014865,,,,2010/12/03 06:00,2011/03/16 06:00,['2010/12/03 06:00'],"['2010/06/18 00:00 [received]', '2010/12/01 00:00 [accepted]', '2010/12/03 06:00 [entrez]', '2010/12/03 06:00 [pubmed]', '2011/03/16 06:00 [medline]']","['1755-8794-3-56 [pii]', '10.1186/1755-8794-3-56 [doi]']",epublish,BMC Med Genomics. 2010 Dec 1;3:56. doi: 10.1186/1755-8794-3-56.,"['R21 DK088319-02/DK/NIDDK NIH HHS/United States', '1R21DK088319-01/DK/NIDDK NIH HHS/United States', 'R21 DK088319/DK/NIDDK NIH HHS/United States', 'R21 DK088319-01/DK/NIDDK NIH HHS/United States', '5R25HL059868-10/HL/NHLBI NIH HHS/United States']",20101201,,,,,,,,,,,,,,,,,,
16198769,NLM,MEDLINE,20051018,20231024,1474-547X (Electronic) 0140-6736 (Linking),366,9492,2005 Oct 1,Obesity.,1197-209,,"Excess bodyweight is the sixth most important risk factor contributing to the overall burden of disease worldwide. 1.1 billion adults and 10% of children are now classified as overweight or obese. Average life expectancy is already diminished; the main adverse consequences are cardiovascular disease, type 2 diabetes, and several cancers. The complex pathological processes reflect environmental and genetic interactions, and individuals from disadvantaged communities seem to have greater risks than more affluent individuals partly because of fetal and postnatal imprinting. Obesity, with its array of comorbidities, necessitates careful clinical assessment to identify underlying factors and to allow coherent management. The epidemic reflects progressive secular and age-related decreases in physical activity, together with substantial dietary changes with passive over-consumption of energy despite the neurobiological processes controlling food intake. Effective long-term weight loss depends on permanent changes in dietary quality, energy intake, and activity. Neither the medical management nor the societal preventive challenges are currently being met.","['Haslam, David W', 'James, W Philip T']","['Haslam DW', 'James WP']","['National Obesity Forum, Watton Place Clinic, Watton-at-Stone, Hertfordshire, SG14 3SY, UK. Dwhaslam@aol.com']",['eng'],"['Journal Article', 'Review']",England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Humans', '*Obesity/complications/physiopathology/therapy']",,,,,2005/10/04 09:00,2005/10/19 09:00,['2005/10/04 09:00'],"['2005/10/04 09:00 [pubmed]', '2005/10/19 09:00 [medline]', '2005/10/04 09:00 [entrez]']","['S0140-6736(05)67483-1 [pii]', '10.1016/S0140-6736(05)67483-1 [doi]']",ppublish,Lancet. 2005 Oct 1;366(9492):1197-209. doi: 10.1016/S0140-6736(05)67483-1.,,,,,,,122,,,,,,,,,,,,,
11896484,NLM,MEDLINE,20020417,20151119,,26,3,2002 Mar,Binge eating disorder: a review.,299-307,,"Binge eating disorder (BED) is a new proposed eating disorder in the DSM-IV. BED is not a formal diagnosis within the DSM-IV, but in day-to-day clinical practice the diagnosis seems to be generally accepted. People with the BED-syndrome have binge eating episodes as do subjects with bulimia nervosa, but unlike the latter they do not engage in compensatory behaviours. Although the diagnosis BED was created with the obese in mind, obesity is not a criterion. This paper gives an overview of its epidemiology, characteristics, aetiology, criteria, course and treatment. BED seems to be highly prevalent among subjects seeking weight loss treatment (1.3-30.1%). Studies with compared BED, BN and obesity indicated that individuals with BED exhibit levels of psychopathology that fall somewhere between the high levels reported by individuals with BN and the low levels reported by obese individuals. Characteristics of BED seemed to bear a closer resemblance to those of BN than of those of obesity.A review of RCT's showed that presently cognitive behavioural treatment is the treatment of choice but interpersonal psychotherapy, self-help and SSRI's seem effective. The first aim of treatment should be the cessation of binge eating. Treatment of weight loss may be offered to those who are able to abstain from binge eating.","['Dingemans, A E', 'Bruna, M J', 'van Furth, E F']","['Dingemans AE', 'Bruna MJ', 'van Furth EF']","['Robert-Fleury Stichting, National Centre for Eating Disorders, Leidschendam, The Netherlands. a.dingemans@robertfleury.nl']",['eng'],"['Comparative Study', 'Journal Article', 'Review']",England,Int J Obes Relat Metab Disord,International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,9313169,,IM,"['Bulimia', '*Feeding and Eating Disorders/complications/diagnosis/epidemiology/therapy', 'Humans', 'Obesity/complications/epidemiology/psychology/therapy', 'Prognosis', 'Randomized Controlled Trials as Topic', 'Weight Loss']",,,,,2002/03/16 10:00,2002/04/18 10:01,['2002/03/16 10:00'],"['2000/12/06 00:00 [received]', '2001/03/14 00:00 [revised]', '2001/11/07 00:00 [accepted]', '2002/03/16 10:00 [pubmed]', '2002/04/18 10:01 [medline]', '2002/03/16 10:00 [entrez]']",['10.1038/sj.ijo.0801949 [doi]'],ppublish,Int J Obes Relat Metab Disord. 2002 Mar;26(3):299-307. doi: 10.1038/sj.ijo.0801949.,,,,,,,91,,,,,,,,,,,,,
21626434,NLM,MEDLINE,20120830,20211020,1573-6601 (Electronic) 0047-2891 (Linking),41,1,2012 Jan,Invited commentary: childhood and adolescent obesity: psychological and behavioral issues in weight loss treatment.,98-104,10.1007/s10964-011-9677-z [doi],"The prevalence of childhood and adolescent obesity has tripled in the past three decades. This increase has been accompanied by a dramatic rise in obesity-related health complications among American youth. Thus, many obese youth are now experiencing illnesses that will threaten their life expectancy in the absence of significant weight loss. Despite these concerns, a relatively modest body of research has focused on the treatment of adolescent obesity. Results from trials investigating the efficacy of behavioral and pharmacological treatments, like studies of these interventions with adults, suggest that individuals typically lose 5-10% of their initial weight. Unfortunately, weight regain is common. Given the increase in the number of obese adolescents, coupled with the modest results from more conservative treatment approaches, it is not surprising that bariatric surgery for adolescents who suffer from extreme obesity has grown in popularity. The weight losses after surgery are impressive and many adolescents, like adults, experience significant improvements in their physical and mental health postoperatively. However, only a small fraction of adolescents and adults who are heavy enough for bariatric surgery present for surgical treatment. Among those who undergo surgery, a significant minority appear to struggle with a number of behavioral and psychosocial issues that threaten their lifelong success. With all of this in mind, the current obesity problem in the United States and other Westernized countries likely will present a significant challenge to both current and future medical and mental health professionals who work with adolescents and young adults.","['Sarwer, David B', 'Dilks, Rebecca J']","['Sarwer DB', 'Dilks RJ']",,['eng'],['Editorial'],United States,J Youth Adolesc,Journal of youth and adolescence,0333507,['0 (Anti-Obesity Agents)'],IM,"['Adolescent', 'Anti-Obesity Agents/therapeutic use', 'Bariatric Surgery/psychology', 'Behavior Therapy', 'Binge-Eating Disorder/complications', 'Child', 'Humans', 'Obesity/complications/epidemiology/psychology/*therapy', 'United States/epidemiology', 'Weight Reduction Programs']",,,,,2011/06/01 06:00,2012/08/31 06:00,['2011/06/01 06:00'],"['2011/05/05 00:00 [received]', '2011/05/11 00:00 [accepted]', '2011/06/01 06:00 [entrez]', '2011/06/01 06:00 [pubmed]', '2012/08/31 06:00 [medline]']",['10.1007/s10964-011-9677-z [doi]'],ppublish,J Youth Adolesc. 2012 Jan;41(1):98-104. doi: 10.1007/s10964-011-9677-z. Epub 2011 May 31.,['R01 DK080738/DK/NIDDK NIH HHS/United States'],20110531,,,,,,,,,,,,,,,,,,
15067842,NLM,MEDLINE,20040621,20061115,0210-5020 (Print) 0210-5020 (Linking),27,2,2004 Feb,[Pediatric obesity. An increasing epidemic].,49-54,,"Throughout the world, the incidence of adults and children who are overweight or obese is increasing at a near epidemic rate. Childhood obesity bears implications on health over the short, medium and long term life of these children; therefore, the prevention of childhood obesity has become a world health necessity. Nonetheless, there are few existing studies which prove to be effective in the prevention and control of obesity over the long term. The objective of this first section is to review the effectiveness of programs for the prevention and control of childhood obesity by analysing research articles. A bibliography will be included in the second section.","['Jimenez-Cruz, Arturo', 'Bacardi-Gascon, Montserrat', 'Perez-Morales, M Eugenia']","['Jimenez-Cruz A', 'Bacardi-Gascon M', 'Perez-Morales ME']","['Facultad de Medicina, Universidad Autonoma de Baja California, USA']",['spa'],"['English Abstract', 'Journal Article', 'Review']",Spain,Rev Enferm,"Revista de enfermeria (Barcelona, Spain)",8309920,,,"['Behavior', 'Child', 'Humans', 'Obesity/*epidemiology/prevention & control/therapy', 'Risk Factors']",,,,,2004/04/08 05:00,2004/06/24 05:00,['2004/04/08 05:00'],"['2004/04/08 05:00 [pubmed]', '2004/06/24 05:00 [medline]', '2004/04/08 05:00 [entrez]']",,ppublish,Rev Enferm. 2004 Feb;27(2):49-54.,,,,,,,12,,Obesidad infantil. Una epidemia en ascenso.,,,,,,,,,,,
24019418,NLM,MEDLINE,20131129,20151119,1098-4275 (Electronic) 0031-4005 (Linking),132,4,2013 Oct,Eating disorders in adolescents with a history of obesity.,e1026-30,10.1542/peds.2012-3940 [doi],"Adolescent patients with obesity are at significant risk of developing an eating disorder (ED), yet due to their higher weight status their symptoms often go unrecognized and untreated. Although not widely known, individuals with a weight history in the overweight (BMI-for-age >/=85th percentile but <95th percentile, as defined by Centers for Disease Control and Prevention growth charts) or obese (BMI-for-age >/=95th percentile, as defined by the Centers for Disease Control and Prevention growth charts) range, represent a substantial portion of adolescents presenting for ED treatment. Given research that suggests that early intervention promotes the best chance of recovery, it is imperative that these children's and adolescents' ED symptoms are identified and that intervention is offered before the disease progresses. This report presents 2 examples of EDs that developed in the context of obese adolescents' efforts to reduce their weight. Each case shows specific challenges in the identification of ED behaviors in adolescents with this weight history and the corresponding delay such teenagers experience accessing appropriate treatment.","['Sim, Leslie A', 'Lebow, Jocelyn', 'Billings, Marcie']","['Sim LA', 'Lebow J', 'Billings M']","['Mayo Clinic, 200 First St SW, Rochester, MN 55905. sim.leslie@mayo.edu.']",['eng'],"['Case Reports', 'Journal Article', 'Review']",United States,Pediatrics,Pediatrics,0376422,,IM,"['Adolescent', 'Adolescent Behavior/psychology', 'Feeding and Eating Disorders/*complications/*diagnosis/psychology', 'Female', 'Humans', 'Male', 'Obesity/*complications/*diagnosis/psychology']",,['NOTNLM'],"['eating disorders', 'obesity']",,2013/09/11 06:00,2013/12/16 06:00,['2013/09/11 06:00'],"['2013/09/11 06:00 [entrez]', '2013/09/11 06:00 [pubmed]', '2013/12/16 06:00 [medline]']","['peds.2012-3940 [pii]', '10.1542/peds.2012-3940 [doi]']",ppublish,Pediatrics. 2013 Oct;132(4):e1026-30. doi: 10.1542/peds.2012-3940. Epub 2013 Sep 9.,,20130909,,,,,,,,,,,,,,,,,,
37302712,NLM,MEDLINE,20230814,20230815,1935-3456 (Electronic) 1933-0219 (Linking),16,4,2023 Aug,Obesity-induced hyperglycemia impairs oral tolerance induction and aggravates food allergy.,513-526,S1933-0219(23)00039-9 [pii] 10.1016/j.mucimm.2023.05.008 [doi],"Obesity and type 2 diabetes (T2D) have been found to be associated with abnormalities in several organs, including the intestine. These conditions can lead to changes in gut homeostasis, compromising tolerance to luminal antigens and increasing susceptibility to food allergies. The underlying mechanisms for this phenomenon are not yet fully understood. In this study, we investigated changes in the intestinal mucosa of diet-induced obese mice and found that they exhibited increased gut permeability and reduced Treg cells frequency. Upon oral treatment with ovalbumin (OVA), obese mice failed to develop oral tolerance. However, hyperglycemia treatment improved intestinal permeability and oral tolerance induction in mice. Furthermore, we observed that obese mice exhibited a more severe food allergy to OVA, and this allergy was alleviated after treatment with a hypoglycemic drug. Importantly, our findings were translated to obese humans. Individuals with T2D had higher serum IgE levels and downregulated genes related to gut homeostasis. Taken together, our results suggest that obesity-induced hyperglycemia can lead to a failure in oral tolerance and to exacerbation of food allergy. These findings shed light on the mechanisms underlying the relationship among obesity, T2D, and gut mucosal immunity, which could inform the development of new therapeutic approaches.","['Torres, Licia', 'Camila Goncalves Miranda, Mariana', 'Dantas Martins, Vinicius', 'Caixeta, Felipe', 'de Almeida Oliveira, Mariana', 'Martins Trindade, Luisa', 'Carvalho de Assis, Helder', 'Nascimento, Valbert', 'Pinheiro Rosa, Natalia', 'Gomes, Eliane', 'Oliveira Almeida, Sophia', 'Marquet, Florian', 'Genser, Laurent', 'Marcelin, Genevieve', 'Clement, Karine', 'Russo, Momtchilo', 'Maria Caetano Faria, Ana', 'Uceli Maioli, Tatiani']","['Torres L', 'Camila Goncalves Miranda M', 'Dantas Martins V', 'Caixeta F', 'de Almeida Oliveira M', 'Martins Trindade L', 'Carvalho de Assis H', 'Nascimento V', 'Pinheiro Rosa N', 'Gomes E', 'Oliveira Almeida S', 'Marquet F', 'Genser L', 'Marcelin G', 'Clement K', 'Russo M', 'Maria Caetano Faria A', 'Uceli Maioli T']","['Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Elliot and Roslyn Jaffe Food Allergy Institute Icahn School of Medicine at Mount Sinai, New York, USA.', 'Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Programa de Pos-Graduacao em Ciencias dos Alimentos, Faculdade de Farmacia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Laboratorio de Imuno-inflamacao, Departamento de Genetica, Evolucao, Microbiologia e Imunologia, Instituto de Biologia, Universidade de Campinas, Campinas, Brazil.', 'Programa de Pos-Graduacao em Ciencias dos Alimentos, Faculdade de Farmacia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Laboratorio de Imunobiologia, Departamento de Imunologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo (ICB/USP), Sao Paulo, Brazil.', 'Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Sorbonne Universite, INSERM, Nutrition et Obesities; Systemic Approaches, NutriOmique, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition et Obesities; systemic approaches, NutriOmique, Assistance Publique-Hopitaux de Paris, Nutrition Department, Hopital Pitie-Salpetriere, Paris, France; Sorbonne Universite, INSERM, Nutrition et Obesities; systemic approaches, NutriOmique, Assistance Publique-Hopitaux de Paris, Visceral Surgery Department, Hopital Pitie-Salpetriere, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition et Obesities; Systemic Approaches, NutriOmique, Paris, France.', 'Sorbonne Universite, INSERM, Nutrition et Obesities; systemic approaches, NutriOmique, Assistance Publique-Hopitaux de Paris, Nutrition Department, Hopital Pitie-Salpetriere, Paris, France; Sorbonne Universite, INSERM, Nutrition et Obesities; systemic approaches, NutriOmique, Assistance Publique-Hopitaux de Paris, Visceral Surgery Department, Hopital Pitie-Salpetriere, Paris, France.', 'Laboratorio de Imunobiologia, Departamento de Imunologia, Instituto de Ciencias Biomedicas, Universidade de Sao Paulo (ICB/USP), Sao Paulo, Brazil.', 'Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.', 'Departamento de Bioquimica e Imunologia, Instituto de Ciencias Biologicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Departamento de Nutricao, Escola de Enfermagem, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Electronic address: tatianimaioli@gmail.com.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Mucosal Immunol,Mucosal immunology,101299742,"['0 (Allergens)', '9006-59-1 (Ovalbumin)']",IM,"['Humans', 'Mice', 'Animals', '*Diabetes Mellitus, Type 2', 'Mice, Obese', '*Food Hypersensitivity', 'Obesity', 'Immune Tolerance', 'Allergens', 'Administration, Oral', 'Ovalbumin', 'Mice, Inbred BALB C']",,,,,2023/06/12 00:42,2023/08/14 06:41,['2023/06/11 19:17'],"['2022/12/21 00:00 [received]', '2023/05/04 00:00 [revised]', '2023/05/16 00:00 [accepted]', '2023/08/14 06:41 [medline]', '2023/06/12 00:42 [pubmed]', '2023/06/11 19:17 [entrez]']","['S1933-0219(23)00039-9 [pii]', '10.1016/j.mucimm.2023.05.008 [doi]']",ppublish,Mucosal Immunol. 2023 Aug;16(4):513-526. doi: 10.1016/j.mucimm.2023.05.008. Epub 2023 Jun 10.,,20230610,,['Copyright (c) 2023 The Author(s). Published by Elsevier Inc. All rights reserved.'],,,,,,,,"['ClinicalTrials.gov/NCT01655017', 'ClinicalTrials.gov/NCT01454232']",,,,,,,,
20112602,NLM,MEDLINE,20100226,20220311,0041-4301 (Print) 0041-4301 (Linking),51,5,2009 Sep-Oct,Psychopathology and its effect on treatment compliance in pediatric obesity patients.,466-71,,"Obesity is a common health problem in children and adolescents and has life-threatening physical complications as well as psychological consequences, including negative self-image, low self-esteem and social difficulties. Psychiatric disorders, especially depression and anxiety disorders, are present at higher rates in obese patients. The aim of this study was to investigate the presence and type of psychopathology in a group of obese children and to determine the effect of comorbid psychiatric disorders on treatment compliance. Fifty-four obese patients were evaluated by clinical interviews as well as Schedule for Affective Disorders and Schizophrenia for School-Age Children, Present and Lifetime Version (KIDI-SADS-PL) for psychiatric diagnosis. Fifty percent of the sample was found to have psychopathology and treatment compliance was found to be poor in the group with comorbid psychiatric disorders. This shows that child and adolescent psychiatrists should be included as team members while treating pediatric obese patients.","['Taner, Yasemen', 'Torel-Ergur, Ayca', 'Bahcivan, Gulbag', 'Gurdag, Mahinur']","['Taner Y', 'Torel-Ergur A', 'Bahcivan G', 'Gurdag M']","['Department of Child and Adolescent Psychiatry, Ufuk University Faculty of Medicine, Ankara, Turkey.']",['eng'],['Journal Article'],Turkey,Turk J Pediatr,The Turkish journal of pediatrics,0417505,,IM,"['Adolescent', 'Child', 'Comorbidity', 'Cross-Sectional Studies', 'Female', 'Humans', 'Interview, Psychological', 'Male', 'Mental Disorders/classification/*epidemiology', 'Obesity/epidemiology/*psychology/therapy', 'Patient Compliance/*psychology', 'Psychiatric Status Rating Scales']",,,,,2010/02/02 06:00,2010/02/27 06:00,['2010/02/02 06:00'],"['2010/02/02 06:00 [entrez]', '2010/02/02 06:00 [pubmed]', '2010/02/27 06:00 [medline]']",,ppublish,Turk J Pediatr. 2009 Sep-Oct;51(5):466-71.,,,,,,,,,,,,,,,,,,,,
17439070,NLM,MEDLINE,20070504,20171116,0034-1193 (Print) 0034-1193 (Linking),98,2,2007 Feb,"[Obesity in adolescents: physical correlated pathologies, and therapeutic state of art].",97-111,,"Obese adolescents are prone to several pathologies, which may begin in this period of life and have a continuity in adult age. In this review the author tries first to explain the obesity definition in infants, children, and adolescents. Some pathologies may appear in adolescent age. First of all, some features of the so called metabolic syndrome; furthermore, hormonal alteration during and after puberty, genital appearance in the obese adolescent male, respiratory problems as apnea, asthma, and the Pickwick syndrome. The non alcoholic fat liver disease is also described, and the orthopedic problems as well, owing to the overweight: from abnormal body posture to structural consequences on the skeleton. Finally, some remarks concerning pharmacological and surgical approach are presented.","['Giorgi, Pier Luigi']",['Giorgi PL'],"['Clinica Pediatrica, Universita, Ancona. profgiorgi@libero.it']",['ita'],"['Comparative Study', 'Journal Article', 'Review']",Italy,Recenti Prog Med,Recenti progressi in medicina,0401271,,IM,"['*Adolescent', 'Adult', 'Age Factors', 'Apnea/etiology', 'Bariatric Surgery', 'Bariatrics', 'Body Mass Index', 'Cardiovascular Diseases/etiology', 'Child', 'Diabetes Mellitus, Type 2/diagnosis/drug therapy', 'Fatty Liver/etiology', 'Female', 'Flatfoot/etiology', 'Humans', 'Life Style', 'Male', 'Metabolic Syndrome/diagnosis', '*Obesity/complications/diagnosis/drug therapy/genetics/surgery/therapy', 'Obesity Hypoventilation Syndrome/diagnosis', 'Obesity, Morbid/surgery/therapy']",,,,,2007/04/19 09:00,2007/05/05 09:00,['2007/04/19 09:00'],"['2007/04/19 09:00 [pubmed]', '2007/05/05 09:00 [medline]', '2007/04/19 09:00 [entrez]']",,ppublish,Recenti Prog Med. 2007 Feb;98(2):97-111.,,,,,,,109,,L'adolescente e l'obesita: patologie organiche correlate e proposte terapeutiche.,,,,,,,,,,,
3329341,NLM,MEDLINE,19880531,20191029,0257-2761 (Print) 0257-2761 (Linking),6,4,1987,Assessment of animal models for investigating the cardiovascular adaptations to obesity.,284-300,,"Several animal models of obesity have been reviewed with respect to the cardiovascular adaptations to this disorder. While some cardiovascular data are available for each model reviewed, the spontaneously obese rat has been most extensively characterized. Biochemical adaptations of the myocardium to experimental obesity have been reported, but this area has not been investigated extensively. The combined effects of obesity and hypertension upon the heart have been observed recently in the aortic-coarcted, obese rat, which may serve in the future as a useful model for investigating the basis of heart failure that occurs when these disorders are observed concurrently in the clinical setting.","['Crandall, D L', 'Cervoni, P']","['Crandall DL', 'Cervoni P']","['Department of Cardiovascular Biological Research, American Cyanamid Company, Pearl River, N.Y.']",['eng'],"['Journal Article', 'Review']",Switzerland,Pathol Immunopathol Res,Pathology and immunopathology research,8708069,,IM,"['Adaptation, Physiological', 'Animals', 'Cardiovascular System/*physiopathology', 'Disease Models, Animal', 'Microscopy, Electron', 'Myocardium/ultrastructure', 'Obesity/etiology/pathology/*physiopathology', 'Rats']",,,,,1987/01/01 00:00,1987/01/01 00:01,['1987/01/01 00:00'],"['1987/01/01 00:00 [pubmed]', '1987/01/01 00:01 [medline]', '1987/01/01 00:00 [entrez]']",['10.1159/000157059 [doi]'],ppublish,Pathol Immunopathol Res. 1987;6(4):284-300. doi: 10.1159/000157059.,,,,,,,47,,,,,,['NASA: 88203408'],,,,,,,
22797374,NLM,MEDLINE,20121126,20220316,1662-4033 (Electronic) 1662-4025 (Linking),5,3,2012,"Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline.",460-83,10.1159/000341193 [doi],"The prevalence of obesity is rising progressively, even among older age groups. By the year 2030-2035 over 20% of the adult US population and over 25% of the Europeans will be aged 65 years and older. The predicted prevalence of obesity in Americans, 60 years and older was 37% in 2010. The predicted prevalence of obesity in Europe in 2015 varies between 20 and 30% dependent on the model used. This means 20.9 million obese 60+ people in the USA in 2010 and 32 million obese elders in 2015 in the EU. Although cut-off values of BMI, waist circumference and percentages of fat mass have not been defined for the elderly (nor for the elderly of different ethnicity), it is clear from several meta-analyses that mortality and morbidity associated with overweight and obesity only increases at a BMI above 30 kg/m(2). Thus, treatment should only be offered to patients who are obese rather than overweight and who also have functional impairments, metabolic complications or obesity-related diseases, that can benefit from weight loss. The weight loss therapy should aim to minimize muscle and bone loss but also vigilance as regards the development of sarcopenic obesity - a combination of an unhealthy excess of body fat with a detrimental loss of muscle and fat-free mass including bone - is important in the elderly, who are vulnerable to this outcome. Life-style intervention should be the first step and consists of a diet with a 500 kcal (2.1 MJ) energy deficit and an adequate intake of protein of high biological quality together with calcium and vitamin D, behavioural therapy and multi-component exercise. Multi-component exercise includes flexibility training, balance training, aerobic exercise and resistance training. The adherence rate in most studies is around 75%. Knowledge of constraints and modulators of physical inactivity should be of help to engage the elderly in physical activity. The role of pharmacotherapy and bariatric surgery in the elderly is largely unknown as in most studies people aged 65 years and older have been excluded.","['Mathus-Vliegen, Elisabeth M H']",['Mathus-Vliegen EM'],"['Department of Gastroenterology and Hepatology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. e.mathus-vliegen@amc.uva.nl']",['eng'],"['Journal Article', 'Review']",Switzerland,Obes Facts,Obesity facts,101469429,['0 (Anti-Obesity Agents)'],IM,"['Anti-Obesity Agents/therapeutic use', 'Behavior Therapy', '*Diet', '*Exercise', 'Health Behavior', 'Humans', 'Life Style', '*Obesity/complications/epidemiology/physiopathology/therapy', '*Practice Guidelines as Topic', '*Weight Loss']",,,,,2012/07/17 06:00,2012/12/10 06:00,['2012/07/17 06:00'],"['2012/05/28 00:00 [received]', '2012/06/04 00:00 [accepted]', '2012/07/17 06:00 [entrez]', '2012/07/17 06:00 [pubmed]', '2012/12/10 06:00 [medline]']","['000341193 [pii]', '10.1159/000341193 [doi]']",ppublish,Obes Facts. 2012;5(3):460-83. doi: 10.1159/000341193. Epub 2012 Jun 30.,,20120630,['Obes Facts. 2016;9(1):40. PMID: 26901504'],,,,,,,"['Obesity Management Task Force of the European Association for the Study of', 'Obesity']",,,,"['Basdevant, Arnaud', 'Finer, Nick', 'Hainer, Vojtech', 'Hauner, Hans', 'Micic, Dragan', 'Maislos, Maximo', 'Roman, Gabriela', 'Schutz, Yves', 'Tsigos, Constantine', 'Toplak, Hermann', 'Yumuk, Volkan', 'Zahorska-Markiewicz, Barbara']","['Basdevant A', 'Finer N', 'Hainer V', 'Hauner H', 'Micic D', 'Maislos M', 'Roman G', 'Schutz Y', 'Tsigos C', 'Toplak H', 'Yumuk V', 'Zahorska-Markiewicz B']",,,,,
2354490,NLM,MEDLINE,19900725,20061115,0008-7335 (Print) 0008-7335 (Linking),129,20,1990 May 18,[Neurotic symptoms in obese women].,619-21,,In a group of 129 obese women with a body mass index (BMI) above 25 by means of questionnaire N5 the frequency and intensity of neurotic symptoms was examined. It was revealed that in the sub-group of 61 probands with pathological obesity (BMI above 30) both values were highly significantly higher (p less than 0.01) than in 68 women with simple obesity (BMI 25-30). Among ten most frequent neurotic symptoms in obese women above all depressive and vegetative symptoms predominated.,"['Danes, L', 'Raboch, J Jr', 'Sonka, J', 'Raboch, J']","['Danes L', 'Raboch J Jr', 'Sonka J', 'Raboch J']","['Sexuologicky ustav fakulty vseobecneho lekarstvi Univerzity Karlovy, Praha.']",['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Cas Lek Cesk,Casopis lekaru ceskych,0004743,,IM,"['Adult', 'Female', 'Humans', 'Middle Aged', 'Neurotic Disorders/complications/*diagnosis', 'Obesity/complications/*psychology']",,,,,1990/05/18 00:00,2001/03/28 10:01,['1990/05/18 00:00'],"['1990/05/18 00:00 [pubmed]', '2001/03/28 10:01 [medline]', '1990/05/18 00:00 [entrez]']",,ppublish,Cas Lek Cesk. 1990 May 18;129(20):619-21.,,,,,,,,,Neuroticke priznaky u obeznich zen.,,,,,,,,,,,
12026313,NLM,MEDLINE,20020702,20061115,0097-9805 (Print) 0097-9805 (Linking),26,1,2000 Jan-Feb,Parental perceptions of the preschool obese child.,23-30,,"Childhood obesity is a serious public health problem today with many potential complications and adverse outcomes for children. How parents view their children's weight is an important consideration for nurses. The purpose of this study was to increase staff understanding of parents' views so that interventions could be developed to achieve improved outcomes in attenuating the rate of weight gain in obese children. A questionnaire was administered to 200 parents, mostly Hispanic, of obese children to determine the parents' perceptions of their child's obesity. The study revealed that 35% of parents did not believe their obese child was overweight and 53% had no problem controlling what their child eats. However, 78% of parents expressed concern about heart disease as a consequence of childhood obesity. The study demonstrated that parents acknowledge some health risks of obesity but that interventions in treating childhood obesity need to begin with the understanding of parents' perceptions of their own child's obesity.","['Myers, S', 'Vargas, Z']","['Myers S', 'Vargas Z']","['Arlington County Health Department, Arlington, VA, USA.']",['eng'],"['Comparative Study', 'Journal Article']",United States,Pediatr Nurs,Pediatric nursing,7505804,,,"['*Attitude to Health', 'Child, Preschool', 'Cross-Cultural Comparison', 'Female', 'Humans', 'Male', ""Nurse's Role/*psychology"", 'Nursing Assessment', 'Obesity/ethnology/nursing/*psychology', 'Parents/*psychology', 'Professional-Family Relations']",,,,,2002/05/25 10:00,2002/07/03 10:01,['2002/05/25 10:00'],"['2002/05/25 10:00 [pubmed]', '2002/07/03 10:01 [medline]', '2002/05/25 10:00 [entrez]']",,ppublish,Pediatr Nurs. 2000 Jan-Feb;26(1):23-30.,,,,,,,,,,,,,,,,,,,,
25961828,NLM,MEDLINE,20150922,20230919,2168-6211 (Electronic) 2168-6203 (Print) 2168-6203 (Linking),169,7,2015 Jul,Drug Dosing and Pharmacokinetics in Children With Obesity: A Systematic Review.,678-85,10.1001/jamapediatrics.2015.132 [doi],"IMPORTANCE: Obesity affects nearly one-sixth of US children and results in alterations to body composition and physiology that can affect drug disposition, possibly leading to therapeutic failure or toxic side effects. The depth of available literature regarding obesity's effect on drug safety, pharmacokinetics, and dosing in obese children is unknown. OBJECTIVE: To perform a systematic literature review describing the current evidence of the effect of obesity on drug disposition in children. EVIDENCE REVIEW: We searched the MEDLINE, Cochrane, and EMBASE databases (January 1, 1970-December 31, 2012) and included studies if they contained data on drug clearance, volume of distribution, or drug concentration in obese children (aged </=18 years). We compared exposure and weight-normalized volume of distribution and clearance between obese and nonobese children. We explored the association between drug physicochemical properties and clearance and volume of distribution. FINDINGS: Twenty studies met the inclusion criteria and contained pharmacokinetic data for 21 drugs. The median number of obese children studied per drug was 10 (range, 1-112) and ages ranged from newborn to 29 years (1 study described pharmacokinetics in children and adults together). Dosing schema varied and were either a fixed dose (6 [29%]) or based on body weight (10 [48%]) and body surface area (4 [19%]). Clinically significant pharmacokinetic alterations were observed in obese children for 65% (11 of 17) of the studied drugs. Pharmacokinetic alterations resulted in substantial differences in exposure between obese and nonobese children for 38% (5 of 13) of the drugs. We found no association between drug lipophilicity or Biopharmaceutical Drug Disposition Classification System class and changes in volume of distribution or clearance due to obesity. CONCLUSIONS AND RELEVANCE: Consensus is lacking on the most appropriate weight-based dosing strategy for obese children. Prospective pharmacokinetic trials in obese children are needed to ensure therapeutic efficacy and enhance drug safety.","['Harskamp-van Ginkel, Margreet W', 'Hill, Kevin D', 'Becker, Kristian C', 'Testoni, Daniela', 'Cohen-Wolkowiez, Michael', 'Gonzalez, Daniel', 'Barrett, Jeffrey S', 'Benjamin, Daniel K Jr', 'Siegel, David A', 'Banks, Patricia', 'Watt, Kevin M']","['Harskamp-van Ginkel MW', 'Hill KD', 'Becker KC', 'Testoni D', 'Cohen-Wolkowiez M', 'Gonzalez D', 'Barrett JS', 'Benjamin DK Jr', 'Siegel DA', 'Banks P', 'Watt KM']","['Department of Pediatrics, Duke University, Durham, North Carolina2Duke Clinical Research Institute, Duke University, Durham, North Carolina3Academic Medical Center, Department of Public Health, Amsterdam, the Netherlands.', 'Department of Pediatrics, Duke University, Durham, North Carolina2Duke Clinical Research Institute, Duke University, Durham, North Carolina.', 'Department of Pediatrics, Duke University, Durham, North Carolina2Duke Clinical Research Institute, Duke University, Durham, North Carolina.', 'Department of Pediatrics, Duke University, Durham, North Carolina2Duke Clinical Research Institute, Duke University, Durham, North Carolina.', 'Department of Pediatrics, Duke University, Durham, North Carolina2Duke Clinical Research Institute, Duke University, Durham, North Carolina.', 'Department of Pediatrics, Duke University, Durham, North Carolina2Duke Clinical Research Institute, Duke University, Durham, North Carolina4Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy.', ""Department of Clinical Pharmacology and Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania."", 'Department of Pediatrics, Duke University, Durham, North Carolina2Duke Clinical Research Institute, Duke University, Durham, North Carolina.', 'Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland.', 'Department of Pediatrics, Duke University, Durham, North Carolina2Duke Clinical Research Institute, Duke University, Durham, North Carolina.', 'Department of Pediatrics, Duke University, Durham, North Carolina2Duke Clinical Research Institute, Duke University, Durham, North Carolina.']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S."", 'Review', 'Systematic Review']",United States,JAMA Pediatr,JAMA pediatrics,101589544,,IM,"['Body Composition', 'Body Weight/*physiology', 'Child', 'Child, Preschool', 'Drug Dosage Calculations', 'Humans', 'Metabolic Clearance Rate/*physiology', 'Obesity/*drug therapy', 'Pharmacokinetics']",PMC4494887,,,,2015/05/12 06:00,2015/09/24 06:00,['2015/05/12 06:00'],"['2015/05/12 06:00 [entrez]', '2015/05/12 06:00 [pubmed]', '2015/09/24 06:00 [medline]']","['2291281 [pii]', '10.1001/jamapediatrics.2015.132 [doi]']",ppublish,JAMA Pediatr. 2015 Jul;169(7):678-85. doi: 10.1001/jamapediatrics.2015.132.,"['1U01FD004858-01/FD/FDA HHS/United States', 'UL1TR001117/TR/NCATS NIH HHS/United States', 'KL2 TR001115/TR/NCATS NIH HHS/United States', 'K23 HD064814/HD/NICHD NIH HHS/United States', 'HHSN275201000003I/HD/NICHD NIH HHS/United States', 'UL1 TR001117/TR/NCATS NIH HHS/United States', '1T32GM086330-01A1/GM/NIGMS NIH HHS/United States', 'K24 HD058735/HD/NICHD NIH HHS/United States', '1K23HD064814/HD/NICHD NIH HHS/United States', 'T32GM086330/GM/NIGMS NIH HHS/United States', 'R01 HD057956/HD/NICHD NIH HHS/United States', 'U01 FD004858/FD/FDA HHS/United States', 'T32 GM086330/GM/NIGMS NIH HHS/United States', '1K24HD058735-05/HD/NICHD NIH HHS/United States', 'K23 HD075891/HD/NICHD NIH HHS/United States', 'HHSN275201000003C/AA/NIAAA NIH HHS/United States', '1R01HD057956-05/HD/NICHD NIH HHS/United States', 'HHSN275201000001G/HD/NICHD NIH HHS/United States']",,"['JAMA Pediatr. 2015 Dec;169(12):1179. Becker, Kristian [corrected to Becker,', 'Kristian C]']",,,['NIHMS668851'],,['JAMA Pediatr. 2015 Jul;169(7):626-8. PMID: 25961595'],,"['Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative', 'Core Committee']",,,,"['Berezny, Katherine Y', 'Capparelli, Edmund', 'Kearns, Gregory L', 'Laughon, Matthew', 'Muelenaer, Andre', ""O'Shea, T Michael"", 'Paul, Ian M', 'van den Anker, John', 'Wade, Kelly', 'Walsh, Thomas J']","['Berezny KY', 'Capparelli E', 'Kearns GL', 'Laughon M', 'Muelenaer A', ""O'Shea TM"", 'Paul IM', 'van den Anker J', 'Wade K', 'Walsh TJ']",,,,,
5629965,NLM,MEDLINE,19691105,20051117,0046-3515 (Print) 0046-3515 (Linking),19,2,1967 Apr-May,[Apropos of 405 cases of pregnancy in obese women].,115-8,,,"['Chosson, J', 'Tournigand, P', 'Brochery, P']","['Chosson J', 'Tournigand P', 'Brochery P']",,['fre'],['Journal Article'],France,Bull Fed Soc Gynecol Obstet Lang Fr,Bulletin de la Federation des societes de gynecologie et dobstetrique de langue francaise,7503396,,IM,"['Female', 'Humans', 'Infant, Newborn', 'Infant, Premature, Diseases/*etiology', 'Kidney Diseases/etiology', '*Obesity', 'Obstetric Labor Complications/etiology', 'Obstetric Labor, Premature', 'Parity', 'Pregnancy', '*Pregnancy Complications']",,,,,1967/04/01 00:00,1967/04/01 00:01,['1967/04/01 00:00'],"['1967/04/01 00:00 [pubmed]', '1967/04/01 00:01 [medline]', '1967/04/01 00:00 [entrez]']",,ppublish,Bull Fed Soc Gynecol Obstet Lang Fr. 1967 Apr-May;19(2):115-8.,,,,,,,,,A propos de 405 observations de grossesse chez les obeses.,,,,,,,,,,,
28964729,NLM,MEDLINE,20181009,20181009,2468-7189 (Electronic) 2468-7189 (Linking),45,11,2017 Nov,[How do I prevent caesarean wound infections in obese patients in 2017?].,619-622,S2468-7189(17)30199-X [pii] 10.1016/j.gofs.2017.08.006 [doi],"Obesity is an important risk factor of cesarean section and is associated with an increased risk of wound complications such as infections. This review focuses on the available strategies to limit complications in this population. Choice of antiseptic solution, appropriate dose and type of antibiotic prophylaxy, suture closure of subcutaneous fat, suture skin closure and closed incision negative pressure wound therapy may reduce the risk of wound infections associated with cesarean section in obese patients. Vaginal desinfection, plastic adhesive draps, high-concentration supplemental perioperative oxygen, use of a barrier retractor, wound drainage and type of skin incision are discussed in this review. Clinical trials of good quality are needed to improve our clinical practice.","['Ripamonti, B', 'Raia-Barjat, T', 'Chauleur, C', 'Mathevet, P']","['Ripamonti B', 'Raia-Barjat T', 'Chauleur C', 'Mathevet P']","['Department of Gynecology and Obstetrics, University Hospital, Saint-Etienne, France. Electronic address: bertripa@hotmail.com.', 'Department of Gynecology and Obstetrics, University Hospital, Saint-Etienne, France; Research Unit EA3065, University Jean-Monnet, 42023 Saint-Etienne, France. Electronic address: tiphaine.barjat@chu-st-etienne.fr.', 'Department of Gynecology and Obstetrics, University Hospital, Saint-Etienne, France; Research Unit EA3065, University Jean-Monnet, 42023 Saint-Etienne, France. Electronic address: celine.chauleur@chu-st-etienne.fr.', 'Gynecology Department, University Hospital, University of Lausanne, Lausanne, Suisse. Electronic address: patrice.mathevet@chuv.ch.']",['fre'],"['Journal Article', 'Review']",France,Gynecol Obstet Fertil Senol,"Gynecologie, obstetrique, fertilite & senologie",101693805,,IM,"['Antibiotic Prophylaxis/methods', 'Antisepsis/methods', 'Cesarean Section/*adverse effects', 'Disinfection', 'Female', 'Humans', 'Obesity/*complications', 'Pregnancy', '*Pregnancy Complications', 'Surgical Wound Infection/*prevention & control', 'Suture Techniques', 'Vagina']",,['NOTNLM'],"['Cesarean section', 'Cesarienne', 'Grossesse', 'Infection de paroi', 'Obesity', 'Obesite', 'Pregnancy', 'Wound infections']",,2017/10/02 06:00,2018/10/10 06:00,['2017/10/02 06:00'],"['2017/03/03 00:00 [received]', '2017/08/24 00:00 [accepted]', '2017/10/02 06:00 [pubmed]', '2018/10/10 06:00 [medline]', '2017/10/02 06:00 [entrez]']","['S2468-7189(17)30199-X [pii]', '10.1016/j.gofs.2017.08.006 [doi]']",ppublish,Gynecol Obstet Fertil Senol. 2017 Nov;45(11):619-622. doi: 10.1016/j.gofs.2017.08.006. Epub 2017 Sep 28.,,20170928,,['Copyright (c) 2017 Elsevier Masson SAS. All rights reserved.'],,,,,Comment je previens les infections de paroi apres cesarienne chez des patientes obeses en 2017 ?,,,,,,,,,,,
6212104,NLM,MEDLINE,19820924,20131121,0037-9026 (Print) 0037-9026 (Linking),176,2,1982,"[Effects of 3,5,3'-triiodothyroacetic acid (TRIAC) on protein metabolism of genetically obese or non-obese Zucker rats].",178-83,,"Genetically obese female rats (fa/fa) and their lean littermates (Fa/-) were given oral administration of 3,5,3-triiodothyroacetic acid (TRIAC) (20 micrograms/ 100 g of body weight/ day) during 4 weeks. Metabolism of proteins was evaluated in several organs and in skeletal muscle after intraperitoneal injection of 14C and 3H-leucine 6 days and 16 hrs respectively before the sacrifice of animals. We have determined radioactivity of 14C and 3H and the 3H/14C ratio. No significant differences were found in lean and obese rats except in skeletal muscle. The relative protein turnover in skeletal muscle is significantly higher in the obese rats than in the lean rats. Treatment by TRIAC decreases the body weight gain in obese rats compared with controls but it has no statistically significant effect on the relative protein turnover in either obese or lean rats.","['Dumas, P', 'Autissier, N', 'Loireau, A', 'Michel, R']","['Dumas P', 'Autissier N', 'Loireau A', 'Michel R']",,['fre'],"['English Abstract', 'Journal Article']",France,C R Seances Soc Biol Fil,Comptes rendus des seances de la Societe de biologie et de ses filiales,7505439,"['0 (Carbon Radioisotopes)', '0 (Proteins)', '06LU7C9H1V (Triiodothyronine)', '10028-17-8 (Tritium)', ""29OQ9EU4R1 (3,3',5-triiodothyroacetic acid)"", 'GMW67QNF9C (Leucine)']",IM,"['Animals', 'Brain/metabolism', 'Carbon Radioisotopes', 'Female', 'Kidney/metabolism', 'Leucine/metabolism', 'Liver/metabolism', 'Muscles/metabolism', 'Myocardium/metabolism', 'Obesity/*metabolism', 'Proteins/*metabolism', 'Radioisotope Dilution Technique', 'Rats', 'Rats, Zucker', 'Triiodothyronine/*analogs & derivatives/pharmacology', 'Tritium']",,,,,1982/01/01 00:00,1982/01/01 00:01,['1982/01/01 00:00'],"['1982/01/01 00:00 [pubmed]', '1982/01/01 00:01 [medline]', '1982/01/01 00:00 [entrez]']",,ppublish,C R Seances Soc Biol Fil. 1982;176(2):178-83.,,,,,,,,,"Effets de l'acide 3,5,3'-triiodothyroacetique (TRIAC) sur le metabolisme proteique chez des rattes genetiquement obeses ou non-obeses Zucker.",,,,,,,,,,,
21458744,NLM,MEDLINE,20110818,20110404,1526-0550 (Electronic) 1526-0542 (Linking),12,2,2011 Jun,Anaesthetic considerations for the obese child.,144-7,10.1016/j.prrv.2010.10.002 [doi],"The prevalence of obesity in the paediatric population is increasing worldwide. As a result, more and more children will present for anaesthetic care for surgery and other procedures. This review aims to provide some recent information regarding the anaesthetic management of the obese child. Unfortunately, there is little evidence on which to base our clinical care of these children and what information is available is often extrapolated from adult practice. Further prospective studies are required, with careful attention to definitions and terminology, so that populations can be compared and appropriate conclusions drawn.","['Baines, David']",['Baines D'],"[""Clinical Associate Professor and Head, Department of Anaesthesia, The Children's Hospital at Westmead, Locked Bag 4001, Westmead NSW 2145, Australia. davidb@chw.edu.au""]",['eng'],"['Journal Article', 'Review']",England,Paediatr Respir Rev,Paediatric respiratory reviews,100898941,['0 (Anesthetics)'],IM,"['Anesthesia/*adverse effects', '*Anesthesiology', 'Anesthetics/therapeutic use', 'Child', 'Humans', 'Obesity/*complications/epidemiology/therapy', 'Prevalence']",,,,,2011/04/05 06:00,2011/08/19 06:00,['2011/04/05 06:00'],"['2011/04/05 06:00 [entrez]', '2011/04/05 06:00 [pubmed]', '2011/08/19 06:00 [medline]']","['S1526-0542(10)00096-5 [pii]', '10.1016/j.prrv.2010.10.002 [doi]']",ppublish,Paediatr Respir Rev. 2011 Jun;12(2):144-7. doi: 10.1016/j.prrv.2010.10.002. Epub 2010 Nov 20.,,20101120,,['Copyright (c) 2010 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
9225171,NLM,MEDLINE,19970827,20220316,,21 Suppl 3,,1997 Jun,The role of dietary fat in obesity.,S2-11,,"EPIDEMIOLOGY: Epidemiological evidence suggests that a high-fat diet promotes the development of obesity and that there is a direct relationship between the amount of dietary fat and the degree of obesity. The importance of this relationship has been shown in black prepubescent females, who consumed more calories as fat than white females. Moreover, black adult females are heavier and have significant higher cardiovascular disease mortality rates than white females. THE INFLUENCE OF DIETARY FAT ON FOOD INTAKE: An overview of animal studies had indicated that high-fat diets induce greater food intake and weight gain than high-carbohydrate diets. Several factors such as caloric density, satiety properties and post-absorbtive processing can contribute to this different response to high-fat diets. Accordingly, the satiating effects after meals with a high fat:carbohydrate ratio is less than for meals with a lower ratio. Some authors have reported that the most important variable influencing meal size is not the level of hunger but the nutrient content of the range of foods consumed. Thus dietary fat has a weak effect on satiety and we suggest that periodic exposure to a high-fat meal, particularly when hunger is high, may be sufficient to lead to overconsumption of energy as fat in obese patients. DIETARY FAT AND FAT BALANCE: Energy balance is well correlated with fat balance in lean controls, whereas there is no correlation with either carbohydrate or protein balances. Several authors have shown that carbohydrate and protein storage is closely regulated by adjusting oxidation to intake, whereas fat is almost exclusively used or stored in response to day-to-day fluctuations in energy balance. The positive relationship between fat intake and lipid oxidation seen in lean controls appears not to be present in obese patients. On high-fat diets, post-obese women failed to increase the ratio of fat to carbohydrate oxidation appropriately. Increasing dietary fat results in preferential fat storage in post-obese women, impaired suppression of carbohydrate and reduction of 24h energy expenditure. CONCLUSIONS: Dietary fat induces overconsumption and weight gain through its low satiety properties and high caloric density. Obese and post-obese subjects do not appear to adapt to dietary fat, and therefore fat storage is increased.","['Golay, A', 'Bobbioni, E']","['Golay A', 'Bobbioni E']","['Teaching Diabetic Division, Geneva University Hospital, Switzerland.']",['eng'],"['Journal Article', 'Review']",England,Int J Obes Relat Metab Disord,International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,9313169,['0 (Dietary Fats)'],IM,"['Adult', 'Animals', 'Cross-Sectional Studies', 'Dietary Fats/*adverse effects/*metabolism', 'Energy Intake', 'Female', 'Humans', 'Male', 'Obesity/diet therapy/epidemiology/*etiology/*metabolism']",,,,,1997/06/01 00:00,1997/06/01 00:01,['1997/06/01 00:00'],"['1997/06/01 00:00 [pubmed]', '1997/06/01 00:01 [medline]', '1997/06/01 00:00 [entrez]']",,ppublish,Int J Obes Relat Metab Disord. 1997 Jun;21 Suppl 3:S2-11.,,,,,,,64,,,,,,,,,,,,,
4769033,NLM,MEDLINE,19740305,20171116,0048-7147 (Print) 0048-7147 (Linking),26,1,1973,[Must ex-smokers become obese?].,12-7,,,"['Schneider, E']",['Schneider E'],,['ger'],['Journal Article'],Germany,Rehabilitation (Bonn),"Rehabilitation: Sozialmedizin, physikalische Medizin, Praventivmedizin; internationale Zeitschrift mit Zentralblatt",1302716,,IM,"['Diet Therapy', 'Humans', 'Obesity/*etiology/therapy', '*Smoking Prevention']",,,,,1973/01/01 00:00,1973/01/01 00:01,['1973/01/01 00:00'],"['1973/01/01 00:00 [pubmed]', '1973/01/01 00:01 [medline]', '1973/01/01 00:00 [entrez]']",,ppublish,Rehabilitation (Bonn). 1973;26(1):12-7.,,,,,,,,,Mussen Ex-Raucher verfetten.,,,,,,,,,,,
16929144,NLM,MEDLINE,20061018,20190806,0302-5144 (Print) 0302-5144 (Linking),151,,2006,Treatment of obesity: a challenging task.,212-220,10.1159/000095331 [doi],"BACKGROUND: Obesity is a chronic and heterogeneous medical condition. Weight loss is clearly the most desirable goal in obese subjects management. Successful obesity treatment should be defined as long-term weight loss maintenance. In this chapter, we briefly review the current evidences regarding the treatment of obesity. METHODS: We searched MEDLINE and PubMed for original articles published between 1995 and 2006, focusing on obesity treatment. The search terms we used, alone or in combination, were 'obesity', 'lifestyle changes', 'diet', 'exercise', 'pharmacological treatment', 'surgical treatment'. CONCLUSIONS: The conventional management of obese patients involves weight reduction with lifestyle changes, including dietary therapy and increased physical activity, or a combined approach with lifestyle changes and pharmacological or surgical interventions. Exercise appears crucial in the successful maintenance of weight loss and in fostering cardiovascular health in obese patients. Some anti-obesity drugs, such as sibutramine and orlistat, have been shown to induce a significant weight loss and long-term weight loss maintenance. Surgical therapy is often necessary in morbidly obese patients and generally results in more significant and long-lasting weight loss than other treatments.","['Sharma, Arya M', 'Iacobellis, Gianluca']","['Sharma AM', 'Iacobellis G']","['Department of Medicine, Cardiovascular Obesity Research and Management at the Michael G. deGroote School of Medicine, Hamilton, Canada.']",['eng'],"['Journal Article', 'Review']",Switzerland,Contrib Nephrol,Contributions to nephrology,7513582,['0 (Anti-Obesity Agents)'],IM,"['Anti-Obesity Agents/*therapeutic use', '*Exercise', 'Humans', '*Life Style', 'Obesity/*drug therapy/*surgery']",,,,,2006/08/25 09:00,2006/10/19 09:00,['2006/08/25 09:00'],"['2006/08/25 09:00 [pubmed]', '2006/10/19 09:00 [medline]', '2006/08/25 09:00 [entrez]']","['000095331 [pii]', '10.1159/000095331 [doi]']",ppublish,Contrib Nephrol. 2006;151:212-220. doi: 10.1159/000095331.,,,,,,,38,,,,,,,,,,,,,
3302902,NLM,MEDLINE,19870902,20190828,0031-3955 (Print) 0031-3955 (Linking),34,4,1987 Aug,Family-focused behavioral approach to weight control in children.,983-96,,"To treat the obese child or the child who is becoming obese appropriately, the clinician must determine if the adiposity is temporary or the beginning of a permanent trend that requires intervention. The concept of the ""adiposity rebound"" helps with this decision. The child's family is important and contributes to his or her body adiposity through both nature--an inherited metabolic tendency towards obesity--and nurture--the eating and activity environment and the family functioning. The activity level and energy intake, which although out of balance for the obese child, may not be low or excessive when compared to recommended amounts for children of that age or to that of peers. A child-family pattern can be defined in overweight children based on presence of a metabolic tendency, energy intake, activity level, and family functioning. In looking at the pattern rather than just the child's weight, the clinician can be much more effective with a weight control program, and with proper referral for changing family functioning prior to such a program if necessary.","['Mahan, L K']",['Mahan LK'],,['eng'],"['Journal Article', 'Review']",United States,Pediatr Clin North Am,Pediatric clinics of North America,0401126,,IM,"['Behavior Therapy/*methods', 'Child', 'Child, Preschool', '*Family', 'Humans', 'Obesity/psychology/*therapy']",,,,,1987/08/01 00:00,1987/08/01 00:01,['1987/08/01 00:00'],"['1987/08/01 00:00 [pubmed]', '1987/08/01 00:01 [medline]', '1987/08/01 00:00 [entrez]']","['S0031-3955(16)36298-8 [pii]', '10.1016/s0031-3955(16)36298-8 [doi]']",ppublish,Pediatr Clin North Am. 1987 Aug;34(4):983-96. doi: 10.1016/s0031-3955(16)36298-8.,,,,,,,30,,,,,,,,,,,,,
16570484,NLM,MEDLINE,20060606,20190907,0090-4481 (Print) 0090-4481 (Linking),35,3,2006 Mar,The obese adolescent.,180-6,,"Childhood obesity is one of the formidable challenges that healthcare providers face. Early recognition and implementation of preventive strategies is crucial in combating this problem. Inculcation of a healthy lifestyle in our youth by encouraging physical activity, decreasing sedentary pastimes, and making healthy food choices is critical right from the start, before poor habits become ingrained. More research is needed to find more effective ways to treat obesity in childhood and adolescence.","['Someshwar, Jean', 'Someshwar, Shiv', 'Perkins, Kathaleen C']","['Someshwar J', 'Someshwar S', 'Perkins KC']","['Department of Pediatrics, West Virginia University, Morgantown 26505, USA. jsomeshwar@hsc.wvu.edu']",['eng'],"['Journal Article', 'Review']",United States,Pediatr Ann,Pediatric annals,0356657,['0 (Appetite Depressants)'],IM,"['Adolescent', 'Appetite Depressants/therapeutic use', 'Bariatric Surgery', 'Body Mass Index', 'Diet', 'Exercise', 'Humans', 'Obesity/complications/epidemiology/physiopathology/*therapy', 'United States/epidemiology']",,,,,2006/03/31 09:00,2006/06/07 09:00,['2006/03/31 09:00'],"['2006/03/31 09:00 [pubmed]', '2006/06/07 09:00 [medline]', '2006/03/31 09:00 [entrez]']",['10.3928/0090-4481-20060301-11 [doi]'],ppublish,Pediatr Ann. 2006 Mar;35(3):180-6. doi: 10.3928/0090-4481-20060301-11.,,,,,,,37,,,,,,,,,,,,,
7637428,NLM,MEDLINE,19950912,20041117,0023-7205 (Print) 0023-7205 (Linking),92,25,1995 Jun 21,[Obese persons have low quality of life. Chubby and good is often thick and sick].,2577-9,,,"['Wolk, A', 'Rossner, S']","['Wolk A', 'Rossner S']","['Akademiska sjukhuset, Uppsala.']",['swe'],['Journal Article'],Sweden,Lakartidningen,Lakartidningen,0027707,,IM,"['Female', 'Humans', 'Male', 'Obesity/complications/epidemiology/*psychology', '*Quality of Life', 'Risk Factors', 'Social Support', 'Sweden/epidemiology']",,,,,1995/06/21 00:00,1995/06/21 00:01,['1995/06/21 00:00'],"['1995/06/21 00:00 [pubmed]', '1995/06/21 00:01 [medline]', '1995/06/21 00:00 [entrez]']",,ppublish,Lakartidningen. 1995 Jun 21;92(25):2577-9.,,,,,,,,,Feta personer lever med daligt valbefinnande. Rund och god ofta tjock och sjuklig.,,,,,,,,,,,
10358417,NLM,MEDLINE,19990629,20091111,0036-5327 (Print) 0036-5327 (Linking),99,3,1998,Clinical guidelines for diagnosis and management of obesity in the Czech Republic.,235-50,,"Guidelines for the management of obesity include recommendation about diet, exercise, behavioral modification, drug therapy and bariatric surgery in the comprehensive management of an obese patient. It is emphasized that the treatment of obesity should be individually tailored according to the age of the patient, degree and phase of obesity, body fat distribution and an expression of risk factors and comorbidities. The new realistic goals in obesity management do not focus on the weight loss per se but mainly on the risk factors reduction which accompanies even modest weight loss. The system of obesity management introduced in the Czech Republic includes obesity management centres attached to major teaching hospitals, obesity out-patient clinics (led by an obesity specialist), primary care physicians and weight reduction clubs. Postgraduate training in obesity management should be recognized by health authorities as a function specialty. A time demanding therapeutic strategy in obesity management should be taken into account by both health policy makers and health insurance companies.","['Hainer, V', 'Kunesova, M', 'Parizkova, J', 'Stich, V', 'Slaba, S', 'Fried, M', 'Malkova, I']","['Hainer V', 'Kunesova M', 'Parizkova J', 'Stich V', 'Slaba S', 'Fried M', 'Malkova I']","['General Faculty Hospital, IIIrd Department of Internal Medicine, Charles University, Prague, Czech Republic.']",['eng'],"['Guideline', 'Journal Article']",Czech Republic,Sb Lek,Sbornik lekarsky,0025770,,IM,"['Czech Republic', 'Female', 'Humans', 'Male', 'Obesity/complications/diagnosis/*therapy', 'Practice Guidelines as Topic']",,,,,1999/06/08 00:00,1999/06/08 00:01,['1999/06/08 00:00'],"['1999/06/08 00:00 [pubmed]', '1999/06/08 00:01 [medline]', '1999/06/08 00:00 [entrez]']",,ppublish,Sb Lek. 1998;99(3):235-50.,,,,,,,,,,,,,,,,,,,,
3535415,NLM,MEDLINE,19861208,20190912,0365-463X (Print) 0365-463X (Linking),711,,1986,Effect of exercise on obesity.,67-73,,"The changes in fitness and body composition which accompany physical training in people of normal weight would be very valuable in the treatment of obesity. However, one of the most marked disabilities arising from obesity is a reduced exercise tolerance, so severely obese patients are unable to perform the exercise which would bring these benefits. It has been suggested that exercise may confer benefits on the obese person by reducing voluntary food intake, or by causing a prolonged elevation of metabolic rate. There is no good evidence for these claims. Obesity is best treated by a combination of dietary restriction and exercise: the more severe the obesity the more important the diet component of treatment, but exercise becomes more important with the management of mild obesity or the prevention of obesity.","['Garrow, J S']",['Garrow JS'],,['eng'],"['Journal Article', 'Review']",Sweden,Acta Med Scand Suppl,Acta medica Scandinavica. Supplementum,0370331,,IM,"['Adult', 'Evaluation Studies as Topic', '*Exercise Therapy', 'Humans', 'Male', 'Obesity/prevention & control/*therapy']",,,,,1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",['10.1111/j.0954-6820.1986.tb08933.x [doi]'],ppublish,Acta Med Scand Suppl. 1986;711:67-73. doi: 10.1111/j.0954-6820.1986.tb08933.x.,,,,,,,28,,,,,,,,,,,,,
10932680,NLM,MEDLINE,20000821,20191104,1532-1908 (Print),13,1,1999 Apr,Physical activity and obesity.,121-9,,"The regular practice of physical activity promotes metabolic adaptations that facilitate the regulation of energy and fat balance. These effects are important for a better control of body weight in the obese individual and should enable him or her to involve adipose tissue to a lesser extent in this regulation. Physical activity favours a negative energy and fat balance, particularly if activities are prolonged and vigorous. The achievement of a negative energy and fat balance with physical activity also strongly depends on the nutritional context in which it is performed. In the long term, an active lifestyle and low-fat food habits are expected to induce a substantial body weight loss in the obese. This weight loss is progressively attenuated over time, presumably because of the decreased impact of a reduced adipose tissue mass on the regulation of energy and fat balance. For the obese individual complying with an activity programme and healthy food habits, a body weight loss of 10% is a realistic goal before the occurrence of resistance to further loss of body fat.","['Tremblay, A']",['Tremblay A'],"['Division of Kinesiology, Laval University, Ste-Foy, Quebec, Canada.']",['eng'],"['Journal Article', 'Review']",England,Baillieres Best Pract Res Clin Endocrinol Metab,Bailliere's best practice & research. Clinical endocrinology & metabolism,100957144,['0 (Dietary Fats)'],IM,"['*Diet, Fat-Restricted', 'Dietary Fats/metabolism', '*Energy Intake', '*Exercise', 'Humans', 'Obesity/diet therapy/metabolism/*therapy']",,,,,2000/08/10 11:00,2000/08/29 11:01,['2000/08/10 11:00'],"['2000/08/10 11:00 [pubmed]', '2000/08/29 11:01 [medline]', '2000/08/10 11:00 [entrez]']",['10.1053/beem.1999.0010 [doi]'],ppublish,Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Apr;13(1):121-9. doi: 10.1053/beem.1999.0010.,,,,,,,59,,,,,,,,,,,,,
25236686,NLM,MEDLINE,20150805,20141210,1398-9995 (Electronic) 0105-4538 (Linking),70,1,2015 Jan,Asthma and obesity in children: current evidence and potential systems biology approaches.,26-40,10.1111/all.12525 [doi],"Both obesity and asthma are highly prevalent, complex diseases modified by multiple factors. Genetic, developmental, lung mechanical, immunological and behavioural factors have all been suggested as playing a causal role between the two entities; however, their complex mechanistic interactions are still poorly understood and evidence of causality in children remains scant. Equally lacking is evidence of effective treatment strategies, despite the fact that imbalances at vulnerable phases in childhood can impact long-term health. This review is targeted at both clinicians frequently faced with the dilemma of how to investigate and treat the obese asthmatic child and researchers interested in the topic. Highlighting the breadth of the spectrum of factors involved, this review collates evidence regarding the investigation and treatment of asthma in obese children, particularly in comparison with current approaches in 'difficult-to-treat' childhood asthma. Finally, the authors propose hypotheses for future research from a systems-based perspective.","['Frey, U', 'Latzin, P', 'Usemann, J', 'Maccora, J', 'Zumsteg, U', 'Kriemler, S']","['Frey U', 'Latzin P', 'Usemann J', 'Maccora J', 'Zumsteg U', 'Kriemler S']","[""University Children's Hospital Basel, UKBB, Basel, Switzerland.""]",['eng'],"['Journal Article', 'Review']",Denmark,Allergy,Allergy,7804028,,IM,"['Age Factors', 'Asthma/complications/*diagnosis/epidemiology/etiology/*therapy', 'Child', 'Child, Preschool', 'Humans', 'Obesity/complications/*diagnosis/epidemiology/etiology/*therapy', 'Systems Biology/methods']",,['NOTNLM'],"['asthma', 'children', 'lung function', 'obesity', 'systems physiology']",,2014/09/23 06:00,2015/08/06 06:00,['2014/09/20 06:00'],"['2014/09/13 00:00 [accepted]', '2014/09/20 06:00 [entrez]', '2014/09/23 06:00 [pubmed]', '2015/08/06 06:00 [medline]']",['10.1111/all.12525 [doi]'],ppublish,Allergy. 2015 Jan;70(1):26-40. doi: 10.1111/all.12525. Epub 2014 Oct 10.,,20141010,,['(c) 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.'],,,,,,,,,,,,,,,,
19085233,NLM,MEDLINE,20090305,20211020,1744-4160 (Electronic) 1381-3455 (Linking),114,5,2008 Dec,Characterization of a novel obesity phenotype caused by interspecific hybridization.,301-30,10.1080/13813450802542495 [doi],"Interspecific hybridization in mammals causes hybrid dysgenesis effects, such as sterility and abnormal placentation. Here, we describe a novel obesity syndrome caused by interspecific hybridization in the genus Mus and show that this obesity, appearing sporadically in F1 littermates derived from inbred strains, has an epigenetic basis. Mus hybrids from various strains of M. musculus and M. spretus were generated and the sporadic obese phenotype was confirmed through assessment of physiological and biochemical parameters in littermates. To understand the underlying mechanisms, large-scale and candidate gene expression assays, global DNA methylation assays and allelic expression analysis were performed. Studies showed that obese hybrids are similar to other known models of obesity. While increased axial growth indicated a defect in POMC pathway, comparison of global gene expression patterns in brain of obese F1 and obese Pomc mutant mice showed little similarity. In F1 obese mice many genes involved in the maintenance of epigenetic states, as well as several imprinted genes, were differentially expressed. Global DNA methylation analysis in brain showed that increased methylation levels were associated with obesity. The imprinted gene Gnasxl, known to be important in lipid homeostasis, was found over expressed in the obese hybrids. Allelic expression and methylation analysis of Gnasxl showed that alterations of epigenetic marks underlying F1 obesity are probably many and multi-factorial. CONCLUSIONS: This model of obesity, which is both spontaneous and epigenetic, may be a useful tool to address the epigenetic aspects of clinical obesity.","['Singh, Umashankar', 'Rizvi, Farhan', 'Yu, Yang', 'Shi, Wei', 'Orth, Annie', 'Karimi, Mohsen', 'Ekstrom, Tomas J', 'Plagge, Antonius', 'Kelsey, Gavin', 'Fundele, Reinald']","['Singh U', 'Rizvi F', 'Yu Y', 'Shi W', 'Orth A', 'Karimi M', 'Ekstrom TJ', 'Plagge A', 'Kelsey G', 'Fundele R']","['Department of Development and Genetics, Evolutionary Biology Center, Uppsala University, Uppsala, Sweden.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Arch Physiol Biochem,Archives of physiology and biochemistry,9510153,,IM,"['Animals', 'DNA Methylation/genetics', 'Epigenesis, Genetic', 'Female', 'Gene Expression Profiling', 'Homeostasis/genetics', 'Hybridization, Genetic/*genetics', 'Lipid Metabolism/genetics', 'Male', 'Mice', 'Mice, Obese', 'Obesity/*genetics/metabolism/pathology/physiopathology', 'Oligonucleotide Array Sequence Analysis', 'Phenotype']",,,,,2008/12/17 09:00,2009/03/06 09:00,['2008/12/17 09:00'],"['2008/12/17 09:00 [entrez]', '2008/12/17 09:00 [pubmed]', '2009/03/06 09:00 [medline]']","['906578311 [pii]', '10.1080/13813450802542495 [doi]']",ppublish,Arch Physiol Biochem. 2008 Dec;114(5):301-30. doi: 10.1080/13813450802542495.,"['BBS/E/B/00001169/BB_/Biotechnology and Biological Sciences Research', 'Council/United Kingdom', 'BBS/E/B/0000C169/BB_/Biotechnology and Biological Sciences Research', 'Council/United Kingdom', 'G0400155/MRC_/Medical Research Council/United Kingdom']",,,,,,,,,,,,,,,,,,,
7309688,NLM,MEDLINE,19820225,20041117,0160-6689 (Print) 0160-6689 (Linking),42,12,1981 Dec,Super-obesity: a psychiatric profile of patients electing gastric stapling for the treatment of morbid obesity.,458-62,,"This is a preliminary report designed to identify personality characteristics which are unique to those super-obese electing a surgical intervention for weight loss. We have laid the groundwork to determine prognostic signs for the success or failure of the gastric stapling surgical technique for the treatment of morbid obesity, Self-report rating scales, demographic data forms, and MMPI's were administered to super-obese subjects and psychiatric consultations performed preoperatively and at various intervals postoperatively. Patients report satisfaction with their weight loss and few physical or psychological complications in the immediate post-op period. The MMPI and psychiatric consultations identify fairly high levels of psychopathology in this group. An aggregate psychiatric profile of the female and male morbidly obese patient is discussed.","['Hutzler, J C', 'Keen, J', 'Molinari, V', 'Carey, L']","['Hutzler JC', 'Keen J', 'Molinari V', 'Carey L']",,['eng'],['Journal Article'],United States,J Clin Psychiatry,The Journal of clinical psychiatry,7801243,,IM,"['Adult', 'Female', 'Humans', 'MMPI', 'Male', 'Obesity/*psychology/therapy', 'Sex Factors', 'Stomach/*surgery']",,,,,1981/12/01 00:00,1981/12/01 00:01,['1981/12/01 00:00'],"['1981/12/01 00:00 [pubmed]', '1981/12/01 00:01 [medline]', '1981/12/01 00:00 [entrez]']",,ppublish,J Clin Psychiatry. 1981 Dec;42(12):458-62.,,,,,,,,,,,,,,,,,,,,
2134538,NLM,MEDLINE,19920430,20041117,0899-9007 (Print) 0899-9007 (Linking),6,2,1990 Mar-Apr,Classification of obese patients related to distribution of surplus fat.,191,,,"['Seidell, J C']",['Seidell JC'],,['eng'],['Editorial'],United States,Nutrition,"Nutrition (Burbank, Los Angeles County, Calif.)",8802712,,IM,"['Adipose Tissue/pathology', 'Humans', 'Obesity/*classification/pathology']",,,,,1990/03/01 00:00,1990/03/01 00:01,['1990/03/01 00:00'],"['1990/03/01 00:00 [pubmed]', '1990/03/01 00:01 [medline]', '1990/03/01 00:00 [entrez]']",,ppublish,Nutrition. 1990 Mar-Apr;6(2):191.,,,,,,,,,,,,,,,,,,,,
1539732,NLM,MEDLINE,19920401,20171213,0002-9513 (Print) 0002-9513 (Linking),262,2 Pt 2,1992 Feb,Cholecystokinin and satiety: effect of hypothalamic obesity and gastric bubble insertion.,R241-4,,"Cholecystokinin (CCK) is a gut peptide whose proposed effect on satiety is thought to be related to gastric volume and to be signaled through vagal afferent fibers to the medial hypothalamus. To test these hypotheses we infused CCK C-terminal octapeptide (CCK-8) or saline in a random double-blind fashion in three groups of subjects: 17 obese subjects, 6 of whom subsequently received a gastric bubble, and 5 obese subjects whose obesity was due to hypothalamic injury. The number of sandwich canapes eaten after saline or CCK-8 infusion was recorded during three consecutive 10-min eating periods. Each subject served as his/her own control. The prior infusion of CCK-8 significantly decreased the consumption of sandwich canapes in the first eating period in both the control obese subjects and the subjects with obesity due to hypothalamic injury. Insertion of a gastric bubble did not enhance the satiety effect of CCK-8. These studies support the hypothesis that CCK produces satiety in a time-dependent manner that is not enhanced after the insertion of a gastric bubble but is operative in obese subjects with hypothalamic injury.","['Boosalis, M G', 'Gemayel, N', 'Lee, A', 'Bray, G A', 'Laine, L', 'Cohen, H']","['Boosalis MG', 'Gemayel N', 'Lee A', 'Bray GA', 'Laine L', 'Cohen H']","['Department of Clinical Sciences, University of Kentucky, Lexington 40536.']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Physiol,The American journal of physiology,0370511,['9011-97-6 (Cholecystokinin)'],IM,"['Cholecystokinin/*pharmacology', 'Eating/drug effects', 'Female', '*Gastric Balloon', 'Humans', 'Hypothalamic Diseases/*complications', 'Male', 'Obesity/etiology/*physiopathology/therapy', 'Satiety Response/*drug effects', 'Time Factors']",,,,,1992/02/01 00:00,1992/02/01 00:01,['1992/02/01 00:00'],"['1992/02/01 00:00 [pubmed]', '1992/02/01 00:01 [medline]', '1992/02/01 00:00 [entrez]']",['10.1152/ajpregu.1992.262.2.R241 [doi]'],ppublish,Am J Physiol. 1992 Feb;262(2 Pt 2):R241-4. doi: 10.1152/ajpregu.1992.262.2.R241.,['MO1 RR43/RR/NCRR NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
16750079,NLM,MEDLINE,20060824,20191110,0210-5691 (Print) 0210-5691 (Linking),30,4,2006 May,[Mortality and prognostic indexes in obese patients admitted to the intensive care unit].,162-6,,,"['Rivera-Fernandez, R', 'Diaz-Contreras, R', 'Chavero-Magro, M J']","['Rivera-Fernandez R', 'Diaz-Contreras R', 'Chavero-Magro MJ']","['Unidad de Cuidados Intensivos, C. R. Traumatologia, Hospital Virgen de las Nieves.,Granada, Espana. ricardo.rivera.sspa@juntadeandalucia.es']",['spa'],['Journal Article'],Spain,Med Intensiva,Medicina intensiva,9207689,,IM,"['Hospitalization', 'Humans', '*Intensive Care Units', '*Obesity/epidemiology/mortality/rehabilitation', 'Prognosis']",,,,,2006/06/06 09:00,2006/08/25 09:00,['2006/06/06 09:00'],"['2006/06/06 09:00 [pubmed]', '2006/08/25 09:00 [medline]', '2006/06/06 09:00 [entrez]']","['13088699 [pii]', '10.1016/s0210-5691(06)74497-7 [doi]']",ppublish,Med Intensiva. 2006 May;30(4):162-6. doi: 10.1016/s0210-5691(06)74497-7.,,,,,,,,,Mortalidad e indices pronosticos en pacientes obesos que ingresan en la UCI.,,,,,,,,,,,
11964031,NLM,MEDLINE,20020524,20041117,0334-018X (Print) 0334-018X (Linking),14 Suppl 5,,2001,Childhood onset of obesity: does an obese child become an obese adult?,1335-8; discussion 1365,,"The aim of this study was to highlight the influence of age of obesity onset on anthropometric parameters in obese adults. We examined 1,451 obese adults with childhood or adolescent onset of obesity, divided into three subgroups in regard to age of onset of obesity: group A--onset before 4 years, group B--onset between 5 and 11 years, and group C--onset between 12 and 19 years. Significantly higher values for body mass index (BMI) and waist circumference (WC) were found in groups with earlier obesity onset, but not for body fat percent (%BF) and waist to hip ratio (WHR). Age of obesity onset may have a significant influence in the persistence of obesity and adverse consequences in adult life. Treatment of obesity and other risk factors for cardiovascular diseases should be initiated as early as possible.","['Mijailovic, M', 'Mijailovic, V', 'Micic, D']","['Mijailovic M', 'Mijailovic V', 'Micic D']","['Institute for Thyroid Gland and Metabolism, Cigota, Zlatibor, Yugoslavia. mijailm@infosky.net']",['eng'],['Journal Article'],Germany,J Pediatr Endocrinol Metab,Journal of pediatric endocrinology & metabolism : JPEM,9508900,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Age of Onset', 'Algorithms', 'Body Mass Index', 'Child', 'Diet, Reducing', 'Electrocardiography', 'Female', 'Humans', 'Male', 'Obesity/*epidemiology/mortality/therapy', 'Yugoslavia/epidemiology']",,,,,2002/04/20 10:00,2002/05/25 10:01,['2002/04/20 10:00'],"['2002/04/20 10:00 [pubmed]', '2002/05/25 10:01 [medline]', '2002/04/20 10:00 [entrez]']",,ppublish,J Pediatr Endocrinol Metab. 2001;14 Suppl 5:1335-8; discussion 1365.,,,,,,,,,,,,,,,,,,,,
4062123,NLM,MEDLINE,19851210,20190619,0003-4819 (Print) 0003-4819 (Linking),103,6 ( Pt 2),1985 Dec,Obesity and hypertension.,1047-9,,"Obesity and hypertension are closely associated. Hypertension occurs frequently in industrialized populations that gain weight with advancing age, and is infrequent in primitive populations that are not obese. There are two reasons for concern about the relationship of obesity to hypertension. Weight gain in young adult life is a potent risk factor for later development of hypertension. Weight reduction in obese hypertensive persons often reduces arterial pressure. Mechanisms of obesity hypertension are as yet unidentified; an earlier hypothesis that it is related to salt intake has not been supported by recent studies. Hemodynamic studies have shown that obesity is associated with an elevated cardiac output and expanded blood volume; in normotensive obese persons peripheral vascular resistance is reduced, and in hypertensive persons it is normal or elevated. Studies of hormonal and neural factors have failed to explain the presence of hypertension in some obese persons and its absence in others.","['Dustan, H P']",['Dustan HP'],,['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Ann Intern Med,Annals of internal medicine,0372351,,IM,"['Adult', 'Aging', 'Blood Pressure', 'Body Weight', 'Child', 'Humans', 'Hypertension/epidemiology/*etiology/physiopathology', 'Obesity/*complications/epidemiology/physiopathology']",,,,,1985/12/01 00:00,1985/12/01 00:01,['1985/12/01 00:00'],"['1985/12/01 00:00 [pubmed]', '1985/12/01 00:01 [medline]', '1985/12/01 00:00 [entrez]']",['10.7326/0003-4819-103-6-1047 [doi]'],ppublish,Ann Intern Med. 1985 Dec;103(6 ( Pt 2)):1047-9. doi: 10.7326/0003-4819-103-6-1047.,['HL 25451-05/HL/NHLBI NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
33760245,NLM,MEDLINE,20210518,20210521,1932-8737 (Electronic) 0160-9289 (Print) 0160-9289 (Linking),44,5,2021 May,"COVID-19, Virchow's triad and thromboembolic risk in obese pregnant women.",593-594,10.1002/clc.23602 [doi],,"['Carbillon, Lionel', 'Fermaut, Marion', 'Benbara, Amelie', 'Boujenah, Jeremy']","['Carbillon L', 'Fermaut M', 'Benbara A', 'Boujenah J']","['Hopital Jean Verdier, Assistance Publique-Hopitaux de Paris, Bondy, France.', 'Universite Sorbonne Paris Nord, Bobigny, France.', 'Hopital Jean Verdier, Assistance Publique-Hopitaux de Paris, Bondy, France.', 'Hopital Jean Verdier, Assistance Publique-Hopitaux de Paris, Bondy, France.', 'Hopital Jean Verdier, Assistance Publique-Hopitaux de Paris, Bondy, France.']",['eng'],"['Comment', 'Letter']",United States,Clin Cardiol,Clinical cardiology,7903272,,IM,"['*COVID-19', 'Female', 'Humans', 'Obesity/complications/diagnosis/epidemiology', 'Pregnancy', 'Pregnant Women', 'SARS-CoV-2', '*Thrombosis']",PMC8119852,,,['The authors declare no potential conflict of interest.'],2021/03/25 06:00,2021/05/19 06:00,['2021/03/24 13:03'],"['2021/03/04 00:00 [revised]', '2020/12/29 00:00 [received]', '2021/03/08 00:00 [accepted]', '2021/03/25 06:00 [pubmed]', '2021/05/19 06:00 [medline]', '2021/03/24 13:03 [entrez]']","['CLC23602 [pii]', '10.1002/clc.23602 [doi]']",ppublish,Clin Cardiol. 2021 May;44(5):593-594. doi: 10.1002/clc.23602. Epub 2021 Mar 24.,,20210324,,,['ORCID: 0000-0001-6367-4828'],,,['Clin Cardiol. 2021 May;44(5):595. PMID: 33760240'],,,"['Clin Rheumatol. 2020 Sep;39(9):2529-2543. PMID: 32654082', 'Clin Cardiol. 2020 Dec;43(12):1362-1367. PMID: 33176009']",,,,,,,,,
2670295,NLM,MEDLINE,19890927,20181113,0042-9686 (Print) 0042-9686 (Linking),67,3,1989,Weight control in the management of hypertension. World Hypertension League.,245-52,,"This article, which includes a brief description of the mechanisms and some epidemiological findings in obesity and high blood pressure, sums up present knowledge on a complex subject and provides guidance to medical practitioners on the management of obese hypertensive patients. Weight reduction, together with drug therapy in severe and moderate hypertension, and other non-pharmacological methods and continuing observation in mild hypertension are the essential measures to be applied. In addition to the lowering of blood pressure, weight loss offers several other metabolic and haemodynamic benefits.",,,,['eng'],"['Journal Article', 'Review']",Switzerland,Bull World Health Organ,Bulletin of the World Health Organization,7507052,,IM,"['Behavior Therapy', 'Diet, Reducing', 'Humans', 'Hypertension/*etiology', 'Obesity/complications/diagnosis/*therapy', 'Patient Education as Topic']",PMC2491251,,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Bull World Health Organ. 1989;67(3):245-52.,,,,,,,,,,,,,,,,,,,,
17615489,NLM,MEDLINE,20070710,20191110,1590-1262 (Electronic) 1124-4909 (Linking),12,2,2007 Jun,Responses to weight loss treatment among obese individuals with and without BED: a matched-study meta-analysis.,54-60,,"The moderating influence of binge eating status on obese individuals' responses to weight loss treatment was evaluated with a meta-analysis of 36 tests of weight loss treatment (n=792) that were matched to control key background variables. After controlling for pre-treatment weight, treatment produced more weight loss in samples of obese non-BED compared with obese BED participants. Weight loss treatment produced large posttreatment reductions in depression in both obese BED and non-BED samples. The results indicate that BED status moderated post-treatment weight loss among people in weight treatment programs. Obese BED (average weight loss=1.3 kg) samples lost negligible weight compared to obese non-BED (average weight loss=10.5 kg) samples. BED status did not moderate psychological responses to treatment: both BED and non-BED samples experienced large post-treatment reductions in depression. The clinical implications of these findings are discussed.","['Blaine, B', 'Rodman, J']","['Blaine B', 'Rodman J']","['Psychology Department, St. John Fisher College, Rochester, NY 14618, USA. bblaine@sjfc.edu']",['eng'],"['Journal Article', 'Meta-Analysis']",Germany,Eat Weight Disord,Eating and weight disorders : EWD,9707113,,IM,"['Adult', 'Body Mass Index', 'Bulimia/*complications/psychology', 'Depressive Disorder/*complications', 'Female', 'Humans', 'Male', 'Obesity/complications/psychology/*therapy', '*Weight Loss']",,,,,2007/07/07 09:00,2007/07/11 09:00,['2007/07/07 09:00'],"['2007/07/07 09:00 [pubmed]', '2007/07/11 09:00 [medline]', '2007/07/07 09:00 [entrez]']","['3743 [pii]', '10.1007/BF03327579 [doi]']",ppublish,Eat Weight Disord. 2007 Jun;12(2):54-60. doi: 10.1007/BF03327579.,,,,,,,,,,,,,,,,,,,,
77950,NLM,MEDLINE,19780828,20150616,0140-6736 (Print) 0140-6736 (Linking),1,8075,1978 Jun 3,Helping obese children.,1189-90,,,,,,['eng'],['Editorial'],England,Lancet,"Lancet (London, England)",2985213R,,IM,"['Child', 'Diet, Reducing', 'Humans', 'Motivation', 'Obesity/*diet therapy/psychology']",,,,,1978/06/03 00:00,1978/06/03 00:01,['1978/06/03 00:00'],"['1978/06/03 00:00 [pubmed]', '1978/06/03 00:01 [medline]', '1978/06/03 00:00 [entrez]']",['S0140-6736(78)90974-1 [pii]'],ppublish,Lancet. 1978 Jun 3;1(8075):1189-90.,,,,,,,,,,,,,,,,,,,,
6102975,NLM,MEDLINE,19800728,20140530,,157,4,1980 Apr,Evaluation of a program for weight control for obese children and adolescents.,232-5,,,"['Choksi, R', 'Bower, P B', 'Pollard, V', 'Mankad, V N']","['Choksi R', 'Bower PB', 'Pollard V', 'Mankad VN']",,['eng'],['Journal Article'],United States,IMJ Ill Med J,IMJ. Illinois medical journal,7703940,,IM,"['Adolescent', 'Child', 'Evaluation Studies as Topic', 'Growth', 'Health Education', 'Humans', 'Illinois', 'Nutritional Physiological Phenomena', 'Obesity/diet therapy/prevention & control/*therapy', 'Physical Exertion']",,,,,1980/04/01 00:00,1980/04/01 00:01,['1980/04/01 00:00'],"['1980/04/01 00:00 [pubmed]', '1980/04/01 00:01 [medline]', '1980/04/01 00:00 [entrez]']",,ppublish,IMJ Ill Med J. 1980 Apr;157(4):232-5.,,,,,,,,,,,,,,,,,,,,
639111,NLM,MEDLINE,19780628,20061115,0009-0565 (Print) 0009-0565 (Linking),32,1,1978 Jan,[Changes of the neurovegetative reactivity in obese women during reducing treatment (author's transl)].,25-9,,,"['Zdichynec, B']",['Zdichynec B'],,['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Cesk Gastroenterol Vyz,Ceskoslovenska gastroenterologie a vyziva,0402356,['0 (Appetite Depressants)'],IM,"['Adult', 'Appetite Depressants/therapeutic use', 'Autonomic Nervous System/*physiopathology', 'Female', 'Humans', 'Obesity/diet therapy/drug therapy/*physiopathology']",,,,,1978/01/01 00:00,1978/01/01 00:01,['1978/01/01 00:00'],"['1978/01/01 00:00 [pubmed]', '1978/01/01 00:01 [medline]', '1978/01/01 00:00 [entrez]']",,ppublish,Cesk Gastroenterol Vyz. 1978 Jan;32(1):25-9.,,,,,,,,,Zmeny neurovegetativni reaktibility u obeznich zen v prubehu redukcni lecby.,,,,,,,,,,,
3065795,NLM,MEDLINE,19890323,20061115,0031-8280 (Print) 0031-8280 (Linking),41,3,1988 Jul-Oct,[Leg ulcers in the obese: data from the literature].,609-18,,"The authors survey 131 publications on the epidemiology of leg ulcers in the obese patient, by successively interrogating computer data banks. By analysing this information they aim to determine the frequency of obesity in a population of patients with stasic ulcers, to see whether the ulcer has particular clinical characteristics in the obese patient, and finally, to know whether obesity affects the speed with which the ulcer heals. The results are given and assessed.","['Boivin, P', 'Cornu-Thenard, A']","['Boivin P', 'Cornu-Thenard A']","['Service de Chirurgie Vasculaire, Hopital de la Salpetriere, Paris.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Phlebologie,Phlebologie,0376212,,IM,"['Humans', 'Leg Ulcer/*complications/physiopathology', 'Obesity/*complications/physiopathology']",,,,,1988/07/01 00:00,1988/07/01 00:01,['1988/07/01 00:00'],"['1988/07/01 00:00 [pubmed]', '1988/07/01 00:01 [medline]', '1988/07/01 00:00 [entrez]']",,ppublish,Phlebologie. 1988 Jul-Oct;41(3):609-18.,,,,,,,131,,Ulceres de jambe chez l'obese: donnees de la litterature.,,,,,,,,,,,
17384521,NLM,MEDLINE,20070402,20220716,1590-1262 (Electronic) 1124-4909 (Linking),12,1,2007 Mar,Comparison of obese men and women with binge eating disorder seeking weight management.,e19-23,,"OBJECTIVE: This study examined whether obese males with binge eating disorder (BED) seeking weight loss treatment differed significantly from obese females with BED seeking weight loss treatment in developmental variables, weight loss history, current and lifetime prevalence of psychiatric disorders, and metabolic abnormalities. METHODS: Psychiatric (using the Structural Clinical Interview for DSM-IV), medical, and laboratory assessments of 44 obese males with BED were compared with assessments from 44 age- and race-matched obese females with BED seeking weight loss treatment. RESULTS: High rates of mood disorders, anxiety disorders, and metabolic syndrome were observed in the population as a whole. Obese males with BED had attempted significantly fewer diets, medications and supplements for weight loss before seeking weight loss treatment. The two genders did not differ significantly in any other of the examined variables. CONCLUSIONS: Our results suggest that while obese men and women with BED who present for weight management are very similar, males had fewer previous attempts at weight loss, possibly related to their less pronounced body dissatisfaction or fewer help-seeking behaviors as compared to females. Our results also support findings of substantial comorbidity among obesity, BED, mood and anxiety disorders, and metabolic syndrome in weight loss seeking populations, in men as well as women.","['Guerdjikova, A I', 'McElroy, S L', 'Kotwal, R', 'Keck, P E Jr']","['Guerdjikova AI', 'McElroy SL', 'Kotwal R', 'Keck PE Jr']","['Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0559, USA. guerdja@ucmail.uc.edu']",['eng'],"['Comparative Study', 'Journal Article']",Germany,Eat Weight Disord,Eating and weight disorders : EWD,9707113,,IM,"['Adult', 'Body Image', 'Bulimia Nervosa/*psychology', 'Diet, Reducing', 'Female', '*Health Behavior', 'Humans', 'Male', 'Middle Aged', 'Obesity/metabolism/*psychology/*therapy', 'Retrospective Studies', 'Sex Factors', 'Weight Loss']",,,,,2007/03/27 09:00,2007/04/03 09:00,['2007/03/27 09:00'],"['2007/03/27 09:00 [pubmed]', '2007/04/03 09:00 [medline]', '2007/03/27 09:00 [entrez]']","['3465 [pii]', '10.1007/BF03327777 [doi]']",ppublish,Eat Weight Disord. 2007 Mar;12(1):e19-23. doi: 10.1007/BF03327777.,,,,,,,,,,,,,,,,,,,,
6695009,NLM,MEDLINE,19840309,20190511,0031-9023 (Print) 0031-9023 (Linking),64,2,1984 Feb,Effects of physical conditioning on self-concept of adult obese males.,194-8,,"The purpose of the study was to investigate possible psychological changes in obese men after participating in an eight-week nutrition and physical conditioning program. The subjects, 45 male, metropolitan policemen who were considered at least 20 percent over their optimum body weights, were placed on diets and received weekly instruction on topics of nutrition and exercise. The subjects were randomly divided into two groups, one that participated in aerobic conditioning and one that did not. The amount of oxygen consumption, as an index of physical fitness, and performance on selected subscales of the Tennessee Self-concept Scale (TSCS) were measured before and after the training and conditioning programs. Both groups displayed significant increases in oxygen consumption and on the Physical Self and Self-satisfaction subscales, but on all these measures, the Conditioning Group increased significantly (2 to 3 times) more. For both groups, the Total Variability measure from the TSCS showed significant reductions, which have been associated with personality integration. These results demonstrate that physical conditioning and dietary educational sessions or educational sessions alone are associated with positive changes in self-concept in obese individuals and also corroborate other studies that show links between physical and psychological fitness.","['Short, M A', 'DiCarlo, S', 'Steffee, W P', 'Pavlou, K']","['Short MA', 'DiCarlo S', 'Steffee WP', 'Pavlou K']",,['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial', ""Research Support, Non-U.S. Gov't""]",United States,Phys Ther,Physical therapy,0022623,,IM,"['Adult', 'Exercise Test', 'Humans', 'Male', 'Middle Aged', 'Obesity/metabolism/*psychology/therapy', 'Oxygen Consumption', '*Physical Education and Training', 'Physical Fitness', 'Psychological Tests', '*Self Concept']",,,,,1984/02/01 00:00,1984/02/01 00:01,['1984/02/01 00:00'],"['1984/02/01 00:00 [pubmed]', '1984/02/01 00:01 [medline]', '1984/02/01 00:00 [entrez]']",['10.1093/ptj/64.2.194 [doi]'],ppublish,Phys Ther. 1984 Feb;64(2):194-8. doi: 10.1093/ptj/64.2.194.,,,,,,,,,,,,,,,,,,,,
12446860,NLM,MEDLINE,20030513,20191210,1071-7323 (Print) 1071-7323 (Linking),10 Suppl 1,,2002 Nov,Economic outcomes of the obese patient.,58S-62S,,,"['Wolf, Anne M']",['Wolf AM'],"['Department of Health Evaluation Sciences, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. annewolfhsd@earthlink.net']",['eng'],"['Journal Article', 'Review']",United States,Obes Res,Obesity research,9305691,,IM,"['*Cost of Illness', '*Health Care Costs', 'Humans', 'Obesity/complications/*economics/therapy', 'Outcome Assessment, Health Care', 'Weight Loss']",,,,,2002/11/26 04:00,2003/05/14 05:00,['2002/11/26 04:00'],"['2002/11/26 04:00 [pubmed]', '2003/05/14 05:00 [medline]', '2002/11/26 04:00 [entrez]']",['10.1038/oby.2002.191 [doi]'],ppublish,Obes Res. 2002 Nov;10 Suppl 1:58S-62S. doi: 10.1038/oby.2002.191.,,,,,,,39,,,,,,,,,,,,,
15343262,NLM,MEDLINE,20040930,20071115,0002-9378 (Print) 0002-9378 (Linking),191,2,2004 Aug,Obesity: physiologic changes and challenges during laparoscopy.,669-74,,"OBJECTIVE: The purpose of this report was to describe the evidence for the benefits of laparoscopic surgery in obese patients, to review the physiologic abnormalities that are associated with obesity, and to explore surgical techniques that will enable surgeons to perform laparoscopy successfully in obese patients. STUDY DESIGN: This article is a review of the available literature on obesity, the physiologic changes that occur in obese patients, and the impact of these changes on laparoscopy outcomes. RESULTS: Obesity is associated with sudden death and a wide range of morbid conditions such as hypertension, atherosclerosis, angina, chronic obstructive disease, and diabetes mellitus. Recent studies have demonstrated that obese patients who undergo laparoscopy have shorter hospital stays, less postoperative pain, and fewer wound infections when compared with obese patients who undergo laparotomy. Laparoscopy patients also have fewer postoperative ileus and fevers. CONCLUSION: With thorough preparation and careful preoperative evaluation, laparoscopy can be performed safely and is the preferred surgical method in obese patients.","['Lamvu, Georgine', 'Zolnoun, Denniz', 'Boggess, John', 'Steege, John F']","['Lamvu G', 'Zolnoun D', 'Boggess J', 'Steege JF']","['Department of Obstetrics and Gynecology, Division of Advanced Laparoscopy and Gynecologic Surgery, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA. glamvu@med.unc.edu']",['eng'],"['Journal Article', 'Review']",United States,Am J Obstet Gynecol,American journal of obstetrics and gynecology,0370476,,IM,"['Adipose Tissue', 'Comorbidity', 'Female', 'Hemodynamics', 'Humans', '*Laparoscopy', 'Length of Stay', 'Obesity/*epidemiology/*physiopathology', 'Obesity, Morbid/epidemiology/physiopathology', 'Physical Examination', 'Pneumoperitoneum, Artificial', 'Respiratory Mechanics', 'Treatment Outcome']",,,,,2004/09/03 05:00,2004/10/01 05:00,['2004/09/03 05:00'],"['2004/09/03 05:00 [pubmed]', '2004/10/01 05:00 [medline]', '2004/09/03 05:00 [entrez]']","['S0002937804005630 [pii]', '10.1016/j.ajog.2004.05.077 [doi]']",ppublish,Am J Obstet Gynecol. 2004 Aug;191(2):669-74. doi: 10.1016/j.ajog.2004.05.077.,,,,,,,37,,,,,,,,,,,,,
19557916,NLM,MEDLINE,20090804,20161125,0952-2271 (Print) 0952-2271 (Linking),119,6149,2009 Mar 26,Obesity management. The fat of the land.,18-20,,Sixty per cent of men and 50 per cent of women in the UK could be obese by 2050. The government wants to reduce the number of obese and overweight children by 2020. Obesity management is far less embedded in general healthcare than smoking cessation.,"['Dent, Emma']",['Dent E'],,['eng'],['Journal Article'],England,Health Serv J,The Health service journal,8605800,,,"['*Health Promotion', 'Humans', 'Obesity/epidemiology/*prevention & control', 'State Medicine', 'United Kingdom/epidemiology']",,,,,2009/06/27 09:00,2009/08/06 09:00,['2009/06/27 09:00'],"['2009/06/27 09:00 [entrez]', '2009/06/27 09:00 [pubmed]', '2009/08/06 09:00 [medline]']",,ppublish,Health Serv J. 2009 Mar 26;119(6149):18-20.,,,,,,,,,,,,,,,,,,,,
8070430,NLM,MEDLINE,19940929,20220331,0889-8529 (Print) 0889-8529 (Linking),23,2,1994 Jun,Obesity and hypertension.,405-27,,"Obesity is associated with a spectrum of metabolic and cardiovascular disorders, including hypertension. Both the degree and the distribution of excess adipose tissue impact on the risk of hypertension and associated cardiovascular diseases. The mechanisms that may lead to hypertension in obese individuals include increased SNS activity, insulin resistance and hyperinsulinemia, sodium retention, and enhanced vascular reactivity. These abnormalities are interrelated in a complex fashion, making it difficult to determine which, if any, of them is the primary process leading to elevated blood pressure in obese individuals. Nonetheless, the metabolic abnormalities and hypertension diminish with weight loss and chronic exercise, providing a strong rationale for hypocaloric diets and aerobic exercise in the treatment of obesity-related hypertension. Patients who fail to achieve acceptable blood pressure control with diet and exercise therapy require pharmacologic treatment. Of the available antihypertensive agents, calcium entry blockers, ACE inhibitors, and alpha 1-receptor blockers appear to offer good blood pressure control without worsening--and sometimes while improving--the lipid and carbohydrate abnormalities that often occur in obese patients. New drugs developed to ameliorate insulin resistance show promise as antihypertensive agents as well, and may prove to be ideal in reversing multiple cardiovascular risk factors in obese, hypertensive patients.","['Hsueh, W A', 'Buchanan, T A']","['Hsueh WA', 'Buchanan TA']","['Department of Medicine, University of Southern California Medical Center.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S."", 'Review']",United States,Endocrinol Metab Clin North Am,Endocrinology and metabolism clinics of North America,8800104,,IM,"['Aging', 'Animals', 'Disease Models, Animal', 'Humans', 'Hypertension/*complications/physiopathology/therapy', 'Insulin Resistance', 'Obesity/*complications/physiopathology/therapy']",,,,,1994/06/01 00:00,1994/06/01 00:01,['1994/06/01 00:00'],"['1994/06/01 00:00 [pubmed]', '1994/06/01 00:01 [medline]', '1994/06/01 00:00 [entrez]']",,ppublish,Endocrinol Metab Clin North Am. 1994 Jun;23(2):405-27.,['1 P50 44404-04/PHS HHS/United States'],,,,,,154,,,,,,,,,,,,,
20880769,NLM,MEDLINE,20110404,20181201,1878-7886 (Electronic) 1878-7886 (Linking),147,5 Suppl,2010 Oct,Who is considered obese? Why? Clinical and therapeutic implications.,e5-9,10.1016/j.jviscsurg.2010.08.012 [doi],,"['Ciangura, C', 'Touizer, E', 'Basdevant, A']","['Ciangura C', 'Touizer E', 'Basdevant A']","[""Pole d'endocrinologie de la Pitie-Salpetriere, AP-HP, 75013 Paris, France.""]",['eng'],['Journal Article'],France,J Visc Surg,Journal of visceral surgery,101532664,,IM,"['*Body Mass Index', 'Cardiovascular Diseases/prevention & control', 'Diabetes Complications/prevention & control', 'France/epidemiology', 'Humans', 'Neoplasms/prevention & control', 'Obesity/complications/*diagnosis/epidemiology/*prevention & control/therapy', 'Prevalence', 'Risk Assessment', 'Risk Factors', 'Sedentary Behavior', '*Skinfold Thickness', '*Waist-Hip Ratio']",,,,,2010/10/01 06:00,2011/04/05 06:00,['2010/10/01 06:00'],"['2010/10/01 06:00 [entrez]', '2010/10/01 06:00 [pubmed]', '2011/04/05 06:00 [medline]']","['S1878-7886(10)00095-0 [pii]', '10.1016/j.jviscsurg.2010.08.012 [doi]']",ppublish,J Visc Surg. 2010 Oct;147(5 Suppl):e5-9. doi: 10.1016/j.jviscsurg.2010.08.012. Epub 2010 Sep 28.,,20100928,,,,,,,,,,,,,,,,,,
3089358,NLM,MEDLINE,19860917,20190501,0267-0623 (Print) 0267-0623 (Linking),292,6537,1986 Jun 28,Obese deceivers?,1692-3,,,"['Southgate, D A']",['Southgate DA'],,['eng'],['Editorial'],England,Br Med J (Clin Res Ed),British medical journal (Clinical research ed.),8302911,,IM,"['Diet', '*Energy Intake', 'Female', 'Humans', 'Obesity/metabolism/*psychology']",PMC1340628,,,,1986/06/28 00:00,1986/06/28 00:01,['1986/06/28 00:00'],"['1986/06/28 00:00 [pubmed]', '1986/06/28 00:01 [medline]', '1986/06/28 00:00 [entrez]']",['10.1136/bmj.292.6537.1692 [doi]'],ppublish,Br Med J (Clin Res Ed). 1986 Jun 28;292(6537):1692-3. doi: 10.1136/bmj.292.6537.1692.,,,,,,,,,,,,,,,,,,,,
19090356,NLM,MEDLINE,20090130,20081218,0954-7762 (Print) 0954-7762 (Linking),104,48,2008 Dec 2-8,'People who are obese need our help and support'.,12,,,"['Nazarko, Linda']",['Nazarko L'],['Ealing PCT.'],['eng'],['Journal Article'],England,Nurs Times,Nursing times,0423236,,,"['Humans', '*Nurse-Patient Relations', 'Obesity/*complications/therapy', 'Weight Loss']",,,,,2008/12/19 09:00,2009/01/31 09:00,['2008/12/19 09:00'],"['2008/12/19 09:00 [entrez]', '2008/12/19 09:00 [pubmed]', '2009/01/31 09:00 [medline]']",,ppublish,Nurs Times. 2008 Dec 2-8;104(48):12.,,,,,,,,,,,,,,,,,,,,
17557543,NLM,MEDLINE,20070803,20091111,0024-3477 (Print) 0024-3477 (Linking),129,3-4,2007 Mar-Apr,[Croatian National Consensus on diagnosis and treatment of obesity].,51-3,,"Obesity is one of the leading public health problems. Over half of women and two thirds of men in Croatia are either overweight or obese, and about one fifth is overweight. Especially worrying is the rising prevalence of obesity in children and adolescents. Obesity is a chronic disease characterised by metabolic and endocrine disorders, resulting in serious chronic complications. The Croatia Obesity Society was founded in 2002 under the umbrella of the Croatian Medical Association and has so far organised two national congresses on obesity. At each congress a national consensus on diagnosing and treating obesity was adopted. Taking into account that treating obesity only with recommendations about dieaty modification and increased physical activity has not given satisfactory results, the 2006 Congress Consesus recommends an earlier start of pharmacologic therapy and surgical treatment of obesity compared to 2003 Congress Consensus. We expect that the new recommendations will improve diagnostics and treatment of obesity in Croatia.","['Jelcic, Jozo', 'Korsic, Mirko', 'Croatian Obesity Society']","['Jelcic J', 'Korsic M', 'Croatian Obesity Society']","['Klinika za unutarnje bolesti, Medicinski fakultet i KBC Zagreb.']",['hrv'],"['Consensus Development Conference', 'English Abstract', 'Journal Article', 'Practice Guideline', 'Review']",Croatia,Lijec Vjesn,Lijecnicki vjesnik,0074253,,IM,"['Humans', 'Obesity/diagnosis/*therapy']",,,,,2007/06/15 09:00,2007/08/04 09:00,['2007/06/15 09:00'],"['2007/06/15 09:00 [pubmed]', '2007/08/04 09:00 [medline]', '2007/06/15 09:00 [entrez]']",,ppublish,Lijec Vjesn. 2007 Mar-Apr;129(3-4):51-3.,,,,,,,0,,Hrvatski nacionalni konsenzus o dijagnostici i lijecenju debljine.,,,,,,,,,,,
22253978,NLM,MEDLINE,20120412,20211021,2072-6643 (Electronic) 2072-6643 (Linking),1,2,2009 Feb,Pediatric obesity: looking into treatment.,197-209,10.3390/nu1020197 [doi],"Prevalence of pediatric obesity continues to rise worldwide. Increasing the number of health care practitioners as well as pediatricians with expertise in obesity treatment is necessary. Because many obese patients suffer obesity-associated cardiovascular, metabolic and other health complications that could increase the severity of obesity, it is fundamental not only to identify the child prone to obesity as early as possible, but to recognize, treat and monitor obesity-related diseases during adolescence. This short review outlines the treatment of pediatric obesity that may have applications in the primary care setting. It examines current information on eating behavior, sedentary behavior, and details studies of multidisciplinary, behavior-based, obesity treatment programs. We also report the less common and more aggressive forms of treatment, such as medication and bariatric surgery. We emphasize that health care providers have the potential to improve outcomes by performing early identification, helping families create the best possible home environment, and by providing structured guidance to obese children and their families.","['Pietrobelli, Angelo', 'Rugolotto, Simone', 'Cristofaro, Paolo De', 'Malavolti, Marcella']","['Pietrobelli A', 'Rugolotto S', 'Cristofaro PD', 'Malavolti M']","['Pediatric Unit, Verona University Medical School, Verona, 37134, Italy. angpie@tin.it']",['eng'],"['Journal Article', 'Review']",Switzerland,Nutrients,Nutrients,101521595,,IM,"['Child', 'Eating', 'Exercise', 'Humans', 'Obesity/complications/*therapy']",PMC3257594,['NOTNLM'],"['adiposity', 'adolescents', 'cardio-vascular risk factors', 'children', 'lifestyle changes', 'nutritional assessment', 'physical activity']",,2009/02/01 00:00,2012/04/13 06:00,['2012/01/19 06:00'],"['2009/10/30 00:00 [received]', '2009/11/23 00:00 [accepted]', '2012/01/19 06:00 [entrez]', '2009/02/01 00:00 [pubmed]', '2012/04/13 06:00 [medline]']","['nu1020197 [pii]', 'nutrients-01-00197 [pii]', '10.3390/nu1020197 [doi]']",ppublish,Nutrients. 2009 Feb;1(2):197-209. doi: 10.3390/nu1020197. Epub 2009 Nov 30.,,20091130,,,,,,,,,,,,,,,,,,
11735101,NLM,MEDLINE,20020102,20220408,0026-0495 (Print) 0026-0495 (Linking),50,12,2001 Dec,"Are there persons who are obese, but metabolically healthy?",1499-504,,"The aim of this article was to review the evidence for a metabolically normal subset of the obese and its implications for clinical and research work. The methods included literature review and correspondence with authors. Since 1947, when Vague described a relation between distribution of body fat and the risk factors for cardiovascular disease, much evidence has suggested that early onset of the obesity, hyperplasia of normal adipocytes, and normal quantities of visceral abdominal fat may be associated with a favorable metabolic response in obese subjects. Analyses in 1973 by Keyes and later by Reuben Andres in 1980 suggested that obesity for some was not a risk factor and might even be an asset. Recently, in the study by Bonora et al of the relation between insulin resistance and the 4 main disorders of the metabolic syndrome in the Bruneck epidemiologic study, a subgroup of obese individuals with a normal metabolic response was evident. In a current study by Brochu et al of an obese metabolically normal subgroup of postmenopausal women, visceral abdominal fat estimated by computed tomography (CT) scan and age of onset were significant variables. The obese, metabolically normal subgroup (OBMN) must be taken into consideration in both clinical and research work. Persons with OBMN and their parents may be wrongly blamed because of the obesity. Attempts at weight loss may be counterproductive. The criteria for selection of obese research subjects may favor inclusion of an OBMN subset, which may invalidate statistical analysis. Findings suggesting the OBMN subset include family members with uncomplicated obesity, early onset of the obesity, fasting plasma insulin within normal range, and normal distribution of the excess fat. Hormonal, genetic studies, and prospective studies will help to clarify the significance and underlying mechanisms of this subset.","['Sims, E A']",['Sims EA'],"['Endocrinology, Diabetes, and Metabolism Unit, Department of Medicine, College of Medicine, University of Vermont, Burlington VT, USA.']",['eng'],"['Journal Article', 'Review']",United States,Metabolism,Metabolism: clinical and experimental,0375267,"['0 (Cholesterol, HDL)']",IM,"['Adipose Tissue', 'Body Composition', 'Cholesterol, HDL/blood', '*Health Status', 'Humans', 'Insulin Resistance', 'Obesity/classification/diagnosis/*metabolism']",,,,,2001/12/06 10:00,2002/01/05 10:01,['2001/12/06 10:00'],"['2001/12/06 10:00 [pubmed]', '2002/01/05 10:01 [medline]', '2001/12/06 10:00 [entrez]']","['S0026-0495(01)61910-3 [pii]', '10.1053/meta.2001.27213 [doi]']",ppublish,Metabolism. 2001 Dec;50(12):1499-504. doi: 10.1053/meta.2001.27213.,,,['Metabolism 2002 Apr;51(4):536'],['Copyright 2001 by W.B. Saunders Company'],,,47,,,,,,,,,,,,,
8581087,NLM,MEDLINE,19960321,20140603,,19 Suppl 4,,1995 Oct,Exercise and obesity treatment: psychological aspects.,S122-5,,"Exercise is clearly beneficial as a means for losing weight and keeping it off. Given recent studies showing its association with maintenance, it would be difficult to argue that any factor is more important than exercise. For an exercise program to be helpful for obese persons, the challenges of exercise adherence must be considered, as must the mechanisms linking exercise to weight control. Both argue for whatever activity an individual will undertake that will produce the psychological effects that promote weight control.","['Brownell, K D']",['Brownell KD'],"['Department of Psychology, Yale University, New Haven, CT 06520-8205, USA.']",['eng'],"['Journal Article', 'Review']",England,Int J Obes Relat Metab Disord,International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,9313169,,IM,"['Exercise/*psychology', 'Female', 'Humans', 'Male', 'Obesity/physiopathology/*psychology/therapy', 'Weight Loss/physiology']",,,,,1995/10/01 00:00,1995/10/01 00:01,['1995/10/01 00:00'],"['1995/10/01 00:00 [pubmed]', '1995/10/01 00:01 [medline]', '1995/10/01 00:00 [entrez]']",,ppublish,Int J Obes Relat Metab Disord. 1995 Oct;19 Suppl 4:S122-5.,,,,,,,24,,,,,,,,,,,,,
7072250,NLM,MEDLINE,19820621,20161123,0043-5341 (Print) 0043-5341 (Linking),132,1,1982 Jan 15,[Care of the obese child].,1-3,,,"['Borkenstein, M']",['Borkenstein M'],,['ger'],['Journal Article'],Austria,Wien Med Wochenschr,Wiener medizinische Wochenschrift (1946),8708475,,IM,"['Adolescent', 'Behavior Therapy', 'Child', 'Diet Therapy', 'Diet, Reducing', 'Exercise Therapy', 'Family', 'Feeding Behavior', 'Humans', 'Obesity/prevention & control/psychology/*therapy', 'Social Isolation']",,,,,1982/01/15 00:00,1982/01/15 00:01,['1982/01/15 00:00'],"['1982/01/15 00:00 [pubmed]', '1982/01/15 00:01 [medline]', '1982/01/15 00:00 [entrez]']",,ppublish,Wien Med Wochenschr. 1982 Jan 15;132(1):1-3.,,,,,,,,,Die Betreuung des adiposen Kindes.,,,,,,,,,,,
19746348,NLM,MEDLINE,20130729,20090911,1940-8315 (Electronic) 1940-8307 (Linking),31,6,2009 Jun,Feline obesity: clinical recognition and management.,E3,,"Obesity is one of the most common clinical problems in cats presenting to veterinary practitioners. Because it is a risk factor for other conditions, such as diabetes mellitus and hepatic lipidosis, it not only increases the morbidity of affected cats but may also shorten their life span. In cats, a body weight of greater than 20% over the ideal weight of the animal is generally accepted as obese. The goal of this article is to help all members of the health care team understand how to prevent the development of obesity in young cats and, when confronted with an obese adult cat, how to develop a safe and effective weight-loss program.","['Zoran, Debra L']",['Zoran DL'],"['Texas A&M University, TX, USA.']",['eng'],"['Journal Article', 'Review']",United States,Compend Contin Educ Vet,"Compendium (Yardley, PA)",101290247,,IM,"['Animal Nutritional Physiological Phenomena/*physiology', 'Animals', 'Cat Diseases/*diagnosis/*prevention & control', 'Cats', 'Diagnosis, Differential', 'Diet/*veterinary', 'Diet, Reducing/veterinary', 'Obesity/complications/diagnosis/prevention & control/*veterinary', 'Physical Conditioning, Animal/physiology', 'Risk Factors']",,,,,2009/09/12 06:00,2013/07/31 06:00,['2009/09/12 06:00'],"['2009/09/12 06:00 [entrez]', '2009/09/12 06:00 [pubmed]', '2013/07/31 06:00 [medline]']",,ppublish,Compend Contin Educ Vet. 2009 Jun;31(6):E3.,,,,,,,,,,,,,,,,,,,,
16860279,NLM,MEDLINE,20060915,20061115,1631-0691 (Print) 1631-0691 (Linking),329,8,2006 Aug,Genetics of human obesity.,608-22; discussion 653-5,,"We present the knowledge acquired in the field of the genetics of human obesity. The molecular approach proved to be powerful to define new syndromes associated to obesity. The pivotal role of leptin and melanocortin pathways were recognized but in rare obesity cases. In the commoner form of obesities, a multitude of polymorphisms located in genes and candidate regions participate in an individual susceptibility to weight gain in a permissive environment. The effects are often uncertain and the results not always confirmed. It is now necessary to integrate data of various origins (environment, genotype, expression) to clarify the domain.","['Clement, Karine']",['Clement K'],"['INSERM, U755 & IFR58, universite Pierre-et-Marie Curie (Paris-6), 75004 Paris, France. karine.clement@htd.aphp.fr']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",France,C R Biol,Comptes rendus biologies,101140040,"['0 (Leptin)', '0 (Receptor, Melanocortin, Type 4)', '581-05-5 (alpha-MSH)', '9007-49-2 (DNA)']",IM,"['Animals', 'Brain/physiopathology', 'DNA/genetics', 'Disease Models, Animal', 'Humans', 'Leptin/genetics', 'Mice', 'Mice, Obese', 'Mutation', 'Obesity/*genetics', 'Polymorphism, Genetic', 'Receptor, Melanocortin, Type 4/genetics', 'alpha-MSH/genetics']",,,,,2006/07/25 09:00,2006/09/16 09:00,['2006/07/25 09:00'],"['2005/10/13 00:00 [received]', '2005/10/18 00:00 [accepted]', '2006/07/25 09:00 [pubmed]', '2006/09/16 09:00 [medline]', '2006/07/25 09:00 [entrez]']","['S1631-0691(06)00077-1 [pii]', '10.1016/j.crvi.2005.10.009 [doi]']",ppublish,C R Biol. 2006 Aug;329(8):608-22; discussion 653-5. doi: 10.1016/j.crvi.2005.10.009. Epub 2006 May 15.,,20060515,,,,,68,,,,,,,,,,,,,
8977054,NLM,MEDLINE,19970318,20191101,0889-8529 (Print) 0889-8529 (Linking),25,4,1996 Dec,Behavioral therapy for obesity.,943-54,,"The research literature pertaining to behavior therapy for obesity is reviewed. Procedures used in behavioral treatment programs are described, and treatment outcome research is reviewed. During the past 30 years, average weight loss has increased, but the problem of regaining body weight following treatment has persisted. It was concluded that obesity should be treated as a chronic health problem and that behavior therapy may have an important role in assisting some obese persons to maintain weight loss if they are enrolled in very long-term treatment programs.","['Williamson, D A', 'Perrin, L A']","['Williamson DA', 'Perrin LA']","['Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, USA.']",['eng'],"['Journal Article', 'Review']",United States,Endocrinol Metab Clin North Am,Endocrinology and metabolism clinics of North America,8800104,,IM,"['Behavior Therapy/*methods', 'Humans', 'Obesity/psychology/*therapy']",,,,,1996/12/01 00:00,1996/12/01 00:01,['1996/12/01 00:00'],"['1996/12/01 00:00 [pubmed]', '1996/12/01 00:01 [medline]', '1996/12/01 00:00 [entrez]']","['S0889-8529(05)70363-7 [pii]', '10.1016/s0889-8529(05)70363-7 [doi]']",ppublish,Endocrinol Metab Clin North Am. 1996 Dec;25(4):943-54. doi: 10.1016/s0889-8529(05)70363-7.,,,,,,,47,,,,,,,,,,,,,
20394615,NLM,MEDLINE,20101122,20220408,1464-410X (Electronic) 1464-4096 (Linking),106,9,2010 Nov,Obesity might not be a risk factor for female sexual dysfunction.,1357-61,10.1111/j.1464-410X.2010.09348.x [doi],"OBJECTIVE: To evaluate female sexual dysfunction (FSD) in obese women in comparison with age-matched control group, emphasising their hormonal and psychological status. PATIENTS, SUBJECTS AND METHODS: Sixty-four sexually active obese premenauposal women were compared with a control group of 27 age-matched healthy volunteers with a normal body mass index (BMI). The obese group was evaluated in three categories according to BMI (kg/m(2)), as group 1 (30-34.9), group 2 (35-39.9) and group 3 (> 40). All women were evaluated with Female Sexual Function Index (FSFI) questionnaire and Beck Depression Inventory (BDI). In addition, serum levels of follicle-stimulating hormone, luteinizing hormone, prolactin, dehydroepiandrosterone-SO(4) , free testosterone, 17alpha-hydroxyprogestrone, androstenedione, oestradiol, free thyroxine and thyrotropin were determined. RESULTS: The mean FSFI scores were not statistically significant between control and obese patients (P = 0.29). FSD was diagnosed in 50% (32/64) and 41% (11/27) of the patients in the obese and control groups, respectively (P = 0.34). There were no differences between total FSFI and FSFI domain scores among BMI categories. BDI scores were significantly higher in the obese groups than in healthy controls, and negatively correlated with total FSFI and all FSFI domain scores. Among hormonal analyses, only free testosterone levels were negatively correlated with total FSFI scores. CONCLUSION: This study showed that obesity has no significant relationship with FSD, but obese patients were found to be in a more depressive mood than age-matched normal counterparts.","['Kadioglu, Pinar', 'Yetkin, Demet Ozgil', 'Sanli, Oner', 'Yalin, Ayse Serap', 'Onem, Kadir', 'Kadioglu, Ates']","['Kadioglu P', 'Yetkin DO', 'Sanli O', 'Yalin AS', 'Onem K', 'Kadioglu A']","['Department of Endocrinology and Metabolism, Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey.']",['eng'],['Journal Article'],England,BJU Int,BJU international,100886721,,IM,"['Adult', 'Body Mass Index', 'Depressive Disorder/*etiology', 'Epidemiologic Methods', 'Female', 'Humans', 'Mental Status Schedule', 'Obesity/*complications/physiopathology/psychology', 'Orgasm', '*Personal Satisfaction', 'Sexual Behavior', 'Sexual Dysfunction, Physiological/*etiology', 'Sexual Dysfunctions, Psychological/*etiology']",,,,,2010/04/17 06:00,2010/12/14 06:00,['2010/04/17 06:00'],"['2010/04/17 06:00 [entrez]', '2010/04/17 06:00 [pubmed]', '2010/12/14 06:00 [medline]']","['BJU9348 [pii]', '10.1111/j.1464-410X.2010.09348.x [doi]']",ppublish,BJU Int. 2010 Nov;106(9):1357-61. doi: 10.1111/j.1464-410X.2010.09348.x.,,,,['(c) 2010 THE AUTHORS. JOURNAL COMPILATION (c) 2010 BJU INTERNATIONAL.'],,,,,,,,,,,,,,,,
21717817,NLM,MEDLINE,20110802,20110701,0038-3317 (Print) 0038-3317 (Linking),Spec No,,2011,"An overview of the medical model for prevention, assessment and treatment of childhood obesity.",63-7,,"South Dakota physicians are confronted by an epidemic of obesity. Developing an effective management strategy for patients with this condition can be daunting. This article reviews the evidence behind dietary, exercise-based, and pharmacological approaches to the care of the overweight and obese patient, offering recommendations to the clinician based on this evidence.","['Tiongson, Chris']",['Tiongson C'],"[""Sanford Children's, Fargo, ND, USA.""]",['eng'],['Journal Article'],United States,S D Med,South Dakota medicine : the journal of the South Dakota State Medical Association,101265265,,IM,"['Body Mass Index', 'Humans', 'Obesity/epidemiology/prevention & control/*therapy', '*Practice Guidelines as Topic', 'Risk Factors']",,,,,2011/07/02 06:00,2011/08/04 06:00,['2011/07/02 06:00'],"['2011/07/02 06:00 [entrez]', '2011/07/02 06:00 [pubmed]', '2011/08/04 06:00 [medline]']",,ppublish,S D Med. 2011;Spec No:63-7.,,,,,,,,,,,,,,,,,,,,
16475416,NLM,MEDLINE,20060321,20191210,0026-556X (Print) 0026-556X (Linking),88,9,2005 Sep,Obesity in children: epidemic and opportunity.,62-6,,"Obesity has become widespread among both adults and children in the United States, with the prevalence of overweight and obese children increasing from 15% in 1971 to more than 30% in 2000. This article discusses how to determine whether a child is overweight or obese, the causes of childhood obesity, as well as how physicians can treat this disease using family-based diet, exercise, and behavior modification programs; weight-loss medications; protein-sparing modified fasting; and bariatric surgery.","['Schwarzenberg, Sarah Jane']",['Schwarzenberg SJ'],"[""University of Minnesota Children's Hospital, USA.""]",['eng'],['Journal Article'],United States,Minn Med,Minnesota medicine,8000173,['0 (Anti-Obesity Agents)'],IM,"['Adolescent', 'Adult', 'Anti-Obesity Agents/therapeutic use', 'Bariatric Surgery', 'Behavior Therapy', 'Body Mass Index', 'Child', 'Cross-Sectional Studies', '*Disease Outbreaks', 'Exercise', 'Family Therapy', 'Humans', 'Incidence', 'Minnesota', 'Obesity/diagnosis/*epidemiology/etiology/therapy', 'Outcome and Process Assessment, Health Care', 'Risk Factors']",,,,,2006/02/16 09:00,2006/03/22 09:00,['2006/02/16 09:00'],"['2006/02/16 09:00 [pubmed]', '2006/03/22 09:00 [medline]', '2006/02/16 09:00 [entrez]']",,ppublish,Minn Med. 2005 Sep;88(9):62-6.,,,,,,,,,,,,,,,,,,,,
18307694,NLM,MEDLINE,20080425,20220410,1467-789X (Electronic) 1467-7881 (Linking),9 Suppl 1,,2008 Mar,Overview of obesity in Mainland China.,14-21,10.1111/j.1467-789X.2007.00433.x [doi],"This overview describes the study of obesity issues over the last 8 years in Mainland China. A disease risk-based body mass index classification for Chinese adults was developed and verified by the results of the 2002 China Nationwide Nutrition and Health Survey. Age and gender-specific BMI cut-offs for Chinese children and adolescents aged 7-18 years were also developed. As the first step in the obesity control effort, the public health implications of the prevalence of overweight and obesity were set out and publicized by the government of China. The overweight prevalence in 2002 was 22.8% and for obesity 7.1%, these having increased by 40.7% and 97.2%, respectively, since 1992. In children, dramatic increases in overweight/obesity have occurred with a two- to threefold increase in Beijing and Shanghai between 1985 and 1995; the prevalence of overweight plus obesity in 7- to 12-year-old boys approached 29% in 2000 and in girls 15-17%. The rapid development of overweight/obesity in China will undoubtedly push up the prevalence of chronic disease. The relative risk for adult hypertension and diabetes in the overweight and obese populations was 2-5 in 2002. In adolescents, the relative risk of hypertension in the overweight was 3.3 and in the obese 3.9, with a clustering of cardiovascular risk factors in the obese Chinese children of whom 90.5% had evidence of abdominal obesity. Even the overweight group had 15.8% with abdominal obesity. Based on the population attributable risks of overweight and obesity in 2002 and data on the direct medical costs of hypertension, diabetes, stroke and coronary heart disease, 25% of these comorbidity costs could be attributed to overweight and obesity. As the improvement in linear growth of young children is usually slower than their improvements in weight during the economic development of China, the long-term adult implications of having a problem of 'Stunted obesity' rather than simple obesity in young children are raised. Analysis of the associations between adult obesity with the individuals' fetal and early nutrition highlights the need for further investigation.","['Chen, C M']",['Chen CM'],"['International Life Science Institute Focal Point in China, Beijing, China. chencm@ilsichina.org']",['eng'],"['Journal Article', 'Review']",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['Adolescent', 'Adult', 'Body Mass Index', 'Child', 'Child Development/physiology', 'China/epidemiology', 'Diabetes Mellitus, Type 2/etiology', 'Humans', 'Obesity/complications/diagnosis/*epidemiology/physiopathology', 'Prevalence']",,,,,2008/03/01 09:00,2008/04/26 09:00,['2008/03/01 09:00'],"['2008/03/01 09:00 [pubmed]', '2008/04/26 09:00 [medline]', '2008/03/01 09:00 [entrez]']","['OBR433 [pii]', '10.1111/j.1467-789X.2007.00433.x [doi]']",ppublish,Obes Rev. 2008 Mar;9 Suppl 1:14-21. doi: 10.1111/j.1467-789X.2007.00433.x.,,,,,,,21,,,,,,,,,,,,,
8267311,NLM,MEDLINE,19940124,20190616,0077-8923 (Print) 0077-8923 (Linking),699,,1993 Oct 29,Treatment of childhood obesity in pediatric practice.,207-19,,"Evaluation of obese children and adolescents in the pediatric office or clinic should include baseline assessment of weight for height, and body fatness; should rule out endocrine and genetic causes of obesity; and should evaluate other cardiovascular risk factors. Treatment of obesity is most successful if realistic goals are set; if a safe rate of weight loss of one to two pounds per week can be achieved through a reduction of caloric intake that amounts to 500 calories less per day; if increased physical activity is stressed as much as diet; if parental support is strong; and if behavior therapy is provided during the course of treatment to help both child and parent achieve the diet, exercise, and behavior goals.","['Williams, C L', 'Bollella, M', 'Carter, B J']","['Williams CL', 'Bollella M', 'Carter BJ']","['Child Health Center, American Health Foundation, Valhalla, New York 10595.']",['eng'],"['Journal Article', 'Review']",United States,Ann N Y Acad Sci,Annals of the New York Academy of Sciences,7506858,,IM,"['Adolescent', 'Behavior Therapy', 'Child', 'Child, Preschool', '*Diet, Reducing', 'Exercise', 'Female', 'Humans', 'Male', 'Obesity/complications/diagnosis/*diet therapy/psychology', 'Pediatrics/*methods']",,,,,1993/10/29 00:00,1993/10/29 00:01,['1993/10/29 00:00'],"['1993/10/29 00:00 [pubmed]', '1993/10/29 00:01 [medline]', '1993/10/29 00:00 [entrez]']",['10.1111/j.1749-6632.1993.tb18851.x [doi]'],ppublish,Ann N Y Acad Sci. 1993 Oct 29;699:207-19. doi: 10.1111/j.1749-6632.1993.tb18851.x.,,,,,,,36,,,,,,,,,,,,,
10342496,NLM,MEDLINE,19990708,20051116,0785-3890 (Print) 0785-3890 (Linking),31 Suppl 1,,1999 Apr,Role of genetic factors in childhood obesity and in susceptibility to dietary variations.,19-25,,"The concern about the current epidemic of obesity is heightened by recent data showing an increase in the prevalence of overweight and obesity in children and adolescents. As obese children are at increased risk of becoming obese adults, early identification of individuals at risk of becoming obese is important for the implementation of preventive measures. In that context, it is important to assess the role of genetic and nongenetic factors in childhood obesity as well as in susceptibility to dietary variations. This paper reviews recent data regarding the prevalence of obesity in childhood as well as the role of genetic factors in phenotypes related to obesity, with emphasis on studies conducted on children, when available. The existence of severe cases of obesity, such as those encountered in Mendelian syndromes of obesity or those caused by mutations in single genes, provides strong evidence for a role of genetic factors in the aetiology of childhood obesity. Furthermore, results from family studies suggest that the maximal heritability of obesity phenotypes ranges from about 30% to 50% and that the major affectors of body fat content, energy intake and energy expenditure are also influenced by genetic factors. Finally, there is increasing evidence that responsiveness to dietary intervention is genetically determined.","['Perusse, L', 'Bouchard, C']","['Perusse L', 'Bouchard C']","['Department of Social and Preventive Medicine, Laval University, Ste-Foy, Que, Canada. louis.perusse@kin.msp.ulaval.ca']",['eng'],"['Journal Article', 'Review']",England,Ann Med,Annals of medicine,8906388,,IM,"['Adolescent', 'Adult', 'Cardiovascular Diseases/epidemiology', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Male', 'Obesity/*diet therapy/epidemiology/*genetics', 'Phenotype', 'Prevalence', 'Risk Factors']",,,,,1999/05/26 00:00,1999/05/26 00:01,['1999/05/26 00:00'],"['1999/05/26 00:00 [pubmed]', '1999/05/26 00:01 [medline]', '1999/05/26 00:00 [entrez]']",,ppublish,Ann Med. 1999 Apr;31 Suppl 1:19-25.,,,,,,,44,,,,,,,,,,,,,
5370916,NLM,MEDLINE,19700402,20051117,0042-8833 (Print) 0042-8833 (Linking),28,5,1969 Sep-Oct,[Resting energy metabolism in normal and obese persons].,37-40,,,"['Borisov, A P']",['Borisov AP'],,['rus'],['Journal Article'],Russia (Federation),Vopr Pitan,Voprosy pitaniia,2984870R,,IM,"['Adipose Tissue/metabolism', '*Basal Metabolism', 'Body Weight', 'Female', 'Humans', 'Lipid Metabolism', 'Male', 'Metabolic Diseases/complications/diagnosis/*metabolism', 'Muscles/metabolism', 'Obesity/diagnosis/etiology/*metabolism/pathology', 'Sex Factors', 'Somatotypes']",,,,,1969/09/01 00:00,1969/09/01 00:01,['1969/09/01 00:00'],"['1969/09/01 00:00 [pubmed]', '1969/09/01 00:01 [medline]', '1969/09/01 00:00 [entrez]']",,ppublish,Vopr Pitan. 1969 Sep-Oct;28(5):37-40.,,,,,,,,,Energeticheskii obmen v pokoe u zdorovykh i tuchnykh liudei.,,,,,,,,,,,
12368141,NLM,MEDLINE,20021115,20081121,0003-3898 (Print) 0003-3898 (Linking),60,5,2002 Sep-Oct,[VNTR3' polymorphism of apoliproprotein B gene in obese people].,559-64,,"Apolipoprotein B (apo B) is the major component of LDL, VLDL and chylomicrons. Variations of lipid concentrations in obese people result from obesity, nutritional and genetic factors. Many genetic polymorphisms of the apo B have been described, associated with variation of lipid concentrations. The aim of the present study was to assess the effect of VNTR3' polymorphism of the apoB gene on lipid and lipoprotein concentrations in overweight subjects. 234 unrelated outpatients (160 women and 74 men, aged 39.3 y 10.5; BMI: 32.8 kg/m2 4.7) were recruited. Using the polymerase chain reaction followed by electrophoresis in polyacrylamide gels, 15 different alleles have been identified. Among them four have been observed less than 5 times in our study. Alleles with 21, 25, 35 and 42 repeats have been observed once. The most frequent is VNTR36 allele (38%), followed by alleles 34, 30, 48, and 46 repeats whose frequencies are 20, 9, 8, and 7% respectively. The possible association between alleles of the VNTR3' of the apoB and anthroprometric and lipid variables was examined. Subjects with 50 repeat allele had significantly higher BMI, and subjects with 32 repeat allele had significantly higher HDL-C and ApoAI levels. Our study confirms in the obese subjects, results published in the general litterature, and shows that the apoB has an important role in the metabolism of plasma lipids and most particulary its gene variants.","['Jemaa, R', 'El-Asmi, M', 'Mebazaa, A']","['Jemaa R', 'El-Asmi M', 'Mebazaa A']","['Laboratoire de biochimie, Hopital la Rabta, 1007 Jabbari Tunis, Tunisie.']",['fre'],"['English Abstract', 'Journal Article']",France,Ann Biol Clin (Paris),Annales de biologie clinique,2984690R,"['0 (Apolipoprotein A-I)', '0 (Apolipoproteins B)', '0 (Cholesterol, HDL)', '0 (Cholesterol, LDL)']",IM,"['Adult', 'Anthropometry', 'Apolipoprotein A-I/blood', 'Apolipoproteins B/*genetics', 'Body Mass Index', 'Cholesterol, HDL/blood', 'Cholesterol, LDL/blood', 'Electrophoresis, Polyacrylamide Gel', 'Female', 'Genetic Variation', 'Humans', 'Hyperlipidemias/*blood/diagnosis/*etiology', 'Male', 'Minisatellite Repeats/*genetics', 'Obesity/*complications/diagnosis/*genetics', 'Polymerase Chain Reaction', 'Polymorphism, Genetic/*genetics', 'Risk Factors']",,,,,2002/10/09 04:00,2002/11/26 04:00,['2002/10/09 04:00'],"['2002/10/09 04:00 [pubmed]', '2002/11/26 04:00 [medline]', '2002/10/09 04:00 [entrez]']",,ppublish,Ann Biol Clin (Paris). 2002 Sep-Oct;60(5):559-64.,,,,,,,,,Polymorphisme VNTR3' du gene de l'apolipoproteine B chez les sujets obeses.,,,,,,,,,,,
8653554,NLM,MEDLINE,19960731,20191101,1071-7323 (Print) 1071-7323 (Linking),3 Suppl 5,,1995 Dec,"Energy homeostasis, autonomic activity and obesity.",721S-727S,,"Obesity is often accompanied by alterations in both sympathetic and parasympathetic autonomic functions. The present paper summarizes the results of a number of studies designed to investigate autonomic functioning in normal, genetically, and experimentally obese rats. Particular emphasis is given to autonomic functioning and dysfunctioning in relation to the processes that are involved in the regulation of peripheral energy substrate homeostasis. It is concluded that alterations in autonomic regulation in obesity are determined by causal factors such as overeating, genetic make-up, age and/or the duration of obesity.","['Scheurink, A J', 'Balkan, B', 'Nyakas, C', 'van Dijk, G', 'Steffens, A B', 'Bohus, B']","['Scheurink AJ', 'Balkan B', 'Nyakas C', 'van Dijk G', 'Steffens AB', 'Bohus B']","['Department of Animal Physiology, University of Groningen, Haren, The Netherlands.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Obes Res,Obesity research,9305691,,IM,"['Animals', 'Autonomic Nervous System/*physiopathology', '*Energy Metabolism', '*Homeostasis', 'Humans', 'Obesity/etiology/genetics/*physiopathology']",,,,,1995/12/01 00:00,1995/12/01 00:01,['1995/12/01 00:00'],"['1995/12/01 00:00 [pubmed]', '1995/12/01 00:01 [medline]', '1995/12/01 00:00 [entrez]']",['10.1002/j.1550-8528.1995.tb00491.x [doi]'],ppublish,Obes Res. 1995 Dec;3 Suppl 5:721S-727S. doi: 10.1002/j.1550-8528.1995.tb00491.x.,,,,,,,54,,,,,,,,,,,,,
24216042,NLM,MEDLINE,20140616,20131112,1877-5764 (Electronic) 1877-5756 (Linking),4,4,2013 Dec,An exploration of obese pregnant women's views of being referred by their midwife to a weight management service.,139-40,S1877-5756(13)00053-0 [pii] 10.1016/j.srhc.2013.10.006 [doi],"Midwives have previously reported concerns about discussing and referring obese pregnant women to weight management services, with some women stating that this referral can be upsetting. The current study interviewed obese women who had declined a weight management service during pregnancy to explore if it was the referral process that made them decline the service. Fifteen women participated and reported that being informed about and referred to a service by their midwife was acceptable to them. Participants also mentioned they would expect this information from their midwife. No participants reported being upset by this referral.","['Patel, Chloe', 'Atkinson, Lou', 'Olander, Ellinor K']","['Patel C', 'Atkinson L', 'Olander EK']","['Faculty of Health and Life Sciences, Coventry University, UK. Electronic address: patelc5@uni.coventry.ac.uk.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Netherlands,Sex Reprod Healthc,Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives,101530546,,IM,"['*Emotions', 'Female', 'Humans', 'Interviews as Topic', '*Midwifery', 'Obesity/*complications/psychology/therapy', '*Patient Acceptance of Health Care', 'Pregnancy', '*Pregnancy Complications/psychology', 'Pregnant Women/psychology', 'Prenatal Care/*psychology', '*Referral and Consultation']",,['NOTNLM'],"['Gestational weight management', 'Maternal obesity', 'Midwife', 'Pregnancy', 'Service']",,2013/11/13 06:00,2014/06/17 06:00,['2013/11/13 06:00'],"['2013/02/22 00:00 [received]', '2013/10/04 00:00 [revised]', '2013/10/08 00:00 [accepted]', '2013/11/13 06:00 [entrez]', '2013/11/13 06:00 [pubmed]', '2014/06/17 06:00 [medline]']","['S1877-5756(13)00053-0 [pii]', '10.1016/j.srhc.2013.10.006 [doi]']",ppublish,Sex Reprod Healthc. 2013 Dec;4(4):139-40. doi: 10.1016/j.srhc.2013.10.006. Epub 2013 Oct 18.,,20131018,,['Copyright (c) 2013 Elsevier B.V. All rights reserved.'],,,,,,,,,,,,,,,,
25105139,NLM,MEDLINE,20150410,20211021,2314-6141 (Electronic) 2314-6133 (Print),2014,,2014,"Perceived difficulty with physical tasks, lifestyle, and physical performance in obese children.",735764,10.1155/2014/735764 [doi] 735764,"We estimated perceived difficulty with physical tasks, lifestyle, and physical performance in 382 children and adolescents (163 obese, 54 overweight, and 165 normal-weight subjects) and the relationship between perceived physical difficulties and sports participation, sedentary behaviors, or physical performance. Perceived difficulty with physical tasks and lifestyle habits was assessed by interview using a structured questionnaire, while physical performance was assessed through the six-minute walking test (6 MWT). Obese children had higher perceived difficulty with several activities of daily living, were less engaged in sports, and had lower physical performance than normal-weight or overweight children; on the contrary, they did not differ with regard to time spent in sedentary behaviors. Perceived difficulty in running and hopping negatively predicted sports participation (P < 0.05 and <0.01, resp.), while perceived difficulty in almost all physical activities negatively predicted the 6 MWT, independently of BMI (P < 0.01). Our results indicate that perception of task's difficulty level may reflect an actual difficulty in obese children. These findings may have practical implications for approaching physical activity in obese children. Exploring both the perception of a task's difficulty level and physical performance may be useful to design exercise programs that allow safe and successful participation.","['Valerio, Giuliana', 'Gallarato, Valeria', ""D'Amico, Osvaldo"", 'Sticco, Maura', 'Tortorelli, Paola', 'Zito, Eugenio', 'Nugnes, Rosa', 'Mozzillo, Enza', 'Franzese, Adriana']","['Valerio G', 'Gallarato V', ""D'Amico O"", 'Sticco M', 'Tortorelli P', 'Zito E', 'Nugnes R', 'Mozzillo E', 'Franzese A']","['Department of Movement Science and Wellness, University of Naples Parthenope, 80133 Naples, Italy.', 'Department of Movement Science and Wellness, University of Naples Parthenope, 80133 Naples, Italy.', 'Department of Translational Medicine, University of Naples Federico II, 80131 Naples, Italy.', 'Department of Translational Medicine, University of Naples Federico II, 80131 Naples, Italy.', 'Department of Movement Science and Wellness, University of Naples Parthenope, 80133 Naples, Italy.', 'Department of Translational Medicine, University of Naples Federico II, 80131 Naples, Italy.', 'Department of Translational Medicine, University of Naples Federico II, 80131 Naples, Italy.', 'Department of Movement Science and Wellness, University of Naples Parthenope, 80133 Naples, Italy ; Department of Translational Medicine, University of Naples Federico II, 80131 Naples, Italy.', 'Department of Translational Medicine, University of Naples Federico II, 80131 Naples, Italy.']",['eng'],"['Clinical Trial', 'Journal Article']",United States,Biomed Res Int,BioMed research international,101600173,,IM,"['Adolescent', 'Child', 'Cross-Sectional Studies', '*Habits', 'Humans', '*Life Style', 'Male', '*Motor Activity', 'Obesity/*physiopathology/*psychology/therapy', '*Psychomotor Performance']",PMC4106089,,,,2014/08/12 06:00,2015/04/11 06:00,['2014/08/09 06:00'],"['2013/12/04 00:00 [received]', '2014/06/22 00:00 [accepted]', '2014/08/09 06:00 [entrez]', '2014/08/12 06:00 [pubmed]', '2015/04/11 06:00 [medline]']",['10.1155/2014/735764 [doi]'],ppublish,Biomed Res Int. 2014;2014:735764. doi: 10.1155/2014/735764. Epub 2014 Jul 6.,,20140706,,,"['ORCID: 0000-0001-5063-4333', 'ORCID: 0000-0001-7748-1584', 'ORCID: 0000-0002-8789-1920', 'ORCID: 0000-0001-7637-914X']",,,,,,,,,,,,,,,
26600056,NLM,MEDLINE,20160907,20151125,1439-3646 (Electronic) 0947-7349 (Linking),123,10,2015 Nov,The Association between Bone Age Advancement and Insulin Resistance in Prepubertal Obese Children.,604-7,10.1055/s-0035-1559795 [doi],"OBJECTIVE: Obesity is associated with bone age (BA) advancement, but the underlying mechanisms remain unclear. The objective of this study was to investigate the association between BA maturation and insulin levels in obese children. METHODS: In this cross-sectional study of 93 prepubertal obese children, anthropometric data and hormonal values were measured. Subjects were divided into 2 groups based on the difference between BA and chronological age (CA) (noted as BA-CA). RESULTS: The study population included 39 (41.9%) males and 54 (58.1%) females with a mean age of 7.4+/-1.5 years. The advanced bone age group defined as BA-CA>1 year (n=44) had significantly higher HOMA-IR and fasting insulin levels, and lower quantitative insulin sensitivity check index (QUICKI). BA-CA was significantly correlated with fasting insulin (r=0.255, P=0.014), HOMA-IR (r=0.230, P=0.027), and QUICKI (r=- 0.301, P=0.003). Also, height SDS was significantly associated with DeltaBA-CA (r=0.417, P<0.001). In the multiple regression analysis, HOMA-IR was identified as a significant independent predictor of BA-CA. CONCLUSION: Bone age is more advanced in obese children with hyperinsulinemia and insulin resistance. These findings suggest that insulin may affect skeletal maturation.","['Lee, H S', 'Shim, Y S', 'Jeong, H R', 'Kwon, E B', 'Hwang, J S']","['Lee HS', 'Shim YS', 'Jeong HR', 'Kwon EB', 'Hwang JS']","['Department of Pediatrics, Ajou University School of Medicine, Ajou University Hospital, Suwon, Korea.', 'Department of Pediatrics, Hallym University School of Medicine, Dongtan Sacred Heart Hospital, Dongtan, Korea.', 'Department of Pediatrics, Ajou University School of Medicine, Ajou University Hospital, Suwon, Korea.', 'Department of Pediatrics, Ajou University School of Medicine, Ajou University Hospital, Suwon, Korea.', 'Department of Pediatrics, Ajou University School of Medicine, Ajou University Hospital, Suwon, Korea.']",['eng'],['Journal Article'],Germany,Exp Clin Endocrinol Diabetes,"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association",9505926,,IM,"['*Age Determination by Skeleton', 'Child', 'Female', 'Humans', '*Insulin Resistance', 'Male', 'Obesity/*metabolism/pathology/*physiopathology', 'Retrospective Studies']",,,,,2015/11/26 06:00,2016/09/08 06:00,['2015/11/25 06:00'],"['2015/11/25 06:00 [entrez]', '2015/11/26 06:00 [pubmed]', '2016/09/08 06:00 [medline]']",['10.1055/s-0035-1559795 [doi]'],ppublish,Exp Clin Endocrinol Diabetes. 2015 Nov;123(10):604-7. doi: 10.1055/s-0035-1559795. Epub 2015 Nov 24.,,20151124,,['(c) Georg Thieme Verlag KG Stuttgart . New York.'],,,,,,,,,,,,,,,,
25199546,NLM,MEDLINE,20151022,20181202,0008-7335 (Print) 0008-7335 (Linking),153,4,2014,[Monogenic obesity - current status of molecular genetic research and clinical importance].,200-6,,"Obesity and its comorbidities represent one of the major health problems worldwide. A positive energy balance due to inappropriate life-style changes plays a key role in the current obesity epidemic. The influence of genetic factors is also significant - several studies concluded that genes contribute to the development of obesity by 40-70%. Genetic variability predisposes an individual to tendency or resistance to increase body weight in obesogenic environment. Polygenic type of inheritance is responsible in most of obese individuals. However, an intensive research of the past 20 years has led to an identification of several genes causing monogenic forms of obesity. To date, several monogenic genes (leptin, leptin receptor, prohormon convertase 1, proopiomelanocortin, melanocortin 4 receptor, single-minded homolog 1, brain-derived neurotrophic factor, neurotrophic tyrosine kinase receptor type 2) that are either involved in the neuronal differentiation of the paraventricular nucleus or in the leptin-melanocortin pathway are known to cause obesity. Mutation carriers apart from severe early onset obesity manifest with additional phenotypic characteristics as adrenal insufficiency, impaired immunity and impaired fertility. This review provides an overview of molecular-genetic and clinical research in the field of monogenic obesities including therapeutical approaches.","['Aldhoon-Hainerova, Irena', 'Vcelak, Josef', 'Zamrazilova, Hana']","['Aldhoon-Hainerova I', 'Vcelak J', 'Zamrazilova H']",,['cze'],"['Journal Article', 'Review']",Czech Republic,Cas Lek Cesk,Casopis lekaru ceskych,0004743,,IM,"['Body Weight/genetics', 'DNA Mutational Analysis', 'Energy Metabolism/*genetics', '*Gene-Environment Interaction', 'Genetic Carrier Screening', 'Genetic Predisposition to Disease/*genetics', 'Genetic Research', 'Humans', 'Life Style', 'Obesity/*genetics']",,,,,2014/09/10 06:00,2015/10/23 06:00,['2014/09/10 06:00'],"['2014/09/10 06:00 [entrez]', '2014/09/10 06:00 [pubmed]', '2015/10/23 06:00 [medline]']",['49537 [pii]'],ppublish,Cas Lek Cesk. 2014;153(4):200-6.,,,,,,,,,Monogenne podminena obezita - soucasny stav molekularne genetickeho vyzkumu a vyznam v klinicke praxi*.,,,,,,,,,,,
8797754,NLM,MEDLINE,19961031,20061115,0094-3509 (Print) 0094-3509 (Linking),43,3,1996 Sep,Health-related quality of life in obese persons seeking treatment.,265-70,,"BACKGROUND: The relationship between obesity and increased risks of morbidity and mortality is well established. Less is known about the impact of obesity on functional health status and subjective well-being. METHODS: We examined health-related quality of life (HRQL), measured by the Medical Outcomes Study Short Form-36 Health Survey (SF-36), and clinical characteristics of 312 consecutive persons seeking outpatient treatment for obesity at a university-based weight management center. SF-36 scores were adjusted for sociodemographic factors and various comorbidities, including depression, to better estimate the effect of obesity on HRQL. Health-related quality of life of the obese patients was then compared with that of the general population and with a sample of patients who have other chronic medical conditions. RESULTS: Compared with general population norms, participants who had a mean body-mass index (BMI) of 38.1 reported significantly lower scores (i.e., more impairment) on all eight quality-of-life domains, especially bodily pain and vitality. The morbidly obese (mean BMI, 48.7) reported significantly worse physical, social, and role functioning, worse perceived general health, and greater bodily pain than did either the mildly (mean BMI, 29.2) or moderately to severely obese (mean BMI, 34.5). The obese also reported significantly greater disability due to bodily pain than did patients with other chronic medical conditions. CONCLUSIONS: Obesity profoundly affects quality of life. Bodily pain is a prevalent problem among obese persons seeking weight loss and may be an important consideration in the treatment of this population.","['Fontaine, K R', 'Cheskin, L J', 'Barofsky, I']","['Fontaine KR', 'Cheskin LJ', 'Barofsky I']","['Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.']",['eng'],"['Comparative Study', 'Journal Article']",United States,J Fam Pract,The Journal of family practice,7502590,,IM,"['Adolescent', 'Adult', 'Aged', 'Chronic Disease', 'Female', '*Health Status', 'Health Surveys', 'Humans', 'Male', 'Middle Aged', 'Obesity/classification/*complications/physiopathology/therapy', 'Outpatient Clinics, Hospital', 'Pain/classification/*etiology', '*Quality of Life', 'Severity of Illness Index', 'United States']",,,,,1996/09/01 00:00,1996/09/01 00:01,['1996/09/01 00:00'],"['1996/09/01 00:00 [pubmed]', '1996/09/01 00:01 [medline]', '1996/09/01 00:00 [entrez]']",,ppublish,J Fam Pract. 1996 Sep;43(3):265-70.,,,,,,,,,,,,,,,,,,,,
10373799,NLM,MEDLINE,20000713,20091119,1096-6293 (Print) 1096-6293 (Linking),7,3,1999 Mar,Obesity in children.,46-50,,"The most common definition of obesity in childhood is weight in excess of 20% above ideal weight for age and gender and skinfold thickness in excess of the 85th percentile for age and gender. Any treatment plan for overweight children and adolescents should include three major components: diet, exercise and family-based behavior management. Children and adolescents should not be placed on restrictive diets because adequate calories are needed for proper growth and development. Aside from calorie excess and inactivity, genetics and environment predispose a child to be obese. Therefore, any program or treatment plan must include the caretakers, who in most cases are also overweight or obese.","['Quinzi, D R']",['Quinzi DR'],"[""Children's Hospital at Strong Memorial Hospital, University of Rochester Medical Center, N.Y., USA.""]",['eng'],"['Journal Article', 'Review']",United States,Adv Nurse Pract,Advance for nurse practitioners,9892010,,,"['Behavior Therapy', 'Child', 'Child Nutrition Sciences/education', 'Diet, Reducing', 'Exercise', 'Humans', 'Information Services', 'Menu Planning', 'Nurse Practitioners', 'Nutritional Requirements', 'Obesity/*diagnosis/etiology/*therapy', 'Patient Education as Topic']",,,,,1999/06/22 10:00,2000/07/15 11:00,['1999/06/22 10:00'],"['1999/06/22 10:00 [pubmed]', '2000/07/15 11:00 [medline]', '1999/06/22 10:00 [entrez]']",,ppublish,Adv Nurse Pract. 1999 Mar;7(3):46-50.,,,,,,,13,,,,,,,,,,,,,
16917886,NLM,MEDLINE,20061221,20060824,1042-0533 (Print) 1042-0533 (Linking),18,5,2006 Sep-Oct,"Effects of daily exercise on blood pressure, plasma glucose, and obesity measures in 55-64-year-old obese Asian Indian men: the Calcutta longitudinal study.",718-21,,"The present longitudinal study was undertaken to study the effect of brisk walking on blood pressure, plasma glucose, and obesity measures in 55-64-year-old obese Asian Indian men. A total of 45 obese (body mass index > or =25 kg/m(2)) men took part in the study. They were monitored for 20 weeks. Obesity measures, blood pressure, fasting plasma glucose (FPG), and 30 min of brisk walking were recorded for each participant. Brisk walking was defined as 2 km of walking by 30 min with moderate sweating. A general linear model (GLM) repeated-measures analysis procedure with Scheffe's post hoc test revealed that group I (up to 5 weeks of exercise) had significantly greater means compared to groups II (6-10 weeks), III (11-15 weeks), and IV (16-20 weeks) for body mass index (P < 0.01), waist-hip ratio (P < 0.001), percent body fat (P < 0.05), systolic blood pressure (P < 0.001), diastolic blood pressure (P < 0.001), and FPG (P < 0.001), whereas group I had a significantly lower mean than groups II, III, and IV for frequency of brisk walking (P < 0.01). It was also observed that change in Delta blood pressure and Delta FPG had a significant positive association with Delta obesity measures, independent of age effect. Therefore, brisk walking is recommended to lower blood pressure, blood glucose, and obesity (particularly central obesity) in middle-aged obese individuals.","['Ghosh, Arnab']",['Ghosh A'],"['Palli Charcha Kendra, Visva Bharati University, Santiniketan 731 236, West Bengal, India. arnab_cu@rediffmail.com']",['eng'],['Journal Article'],United States,Am J Hum Biol,American journal of human biology : the official journal of the Human Biology Council,8915029,['0 (Blood Glucose)'],IM,"['Blood Glucose/*analysis', 'Blood Pressure', 'Body Mass Index', '*Exercise Therapy/methods', 'Humans', 'India', 'Longitudinal Studies', 'Male', 'Middle Aged', 'Obesity/*blood/epidemiology/physiopathology/therapy']",,,,,2006/08/19 09:00,2006/12/22 09:00,['2006/08/19 09:00'],"['2006/08/19 09:00 [pubmed]', '2006/12/22 09:00 [medline]', '2006/08/19 09:00 [entrez]']",['10.1002/ajhb.20545 [doi]'],ppublish,Am J Hum Biol. 2006 Sep-Oct;18(5):718-21. doi: 10.1002/ajhb.20545.,,,,,,,,,,,,,,,,,,,,
11330867,NLM,MEDLINE,20010816,20220321,0263-6352 (Print) 0263-6352 (Linking),19,4,2001 Apr,Choice of drug treatment for obesity-related hypertension: where is the evidence?,667-74,,"Hypertension and obesity are common medical conditions independently associated with increased cardiovascular risk. Many large epidemiological studies have demonstrated associations between body mass index and blood pressure, and there is evidence to suggest that obesity is a causal factor in the development of hypertension in obese individuals. Consequently, all hypertension management guidelines consider weight reduction as a first step in the management of increased blood pressure in obese individuals. Weight reduction may be achieved by behaviour modification, diet and exercise, or by the use of anti-obesity medications. However, the long-term outcomes of weight management programmes for obesity are generally poor, and most hypertensive patients will require antihypertensive drug treatment. Some classes of antihypertensive agents may have potentially unwanted effects on some of the metabolic and haemodynamic abnormalities that link obesity and hypertension, yet most hypertension guidelines fail to provide specific advice on the pharmacological management of obese patients. This may be because there are currently no studies examining the efficacy of specific antihypertensive agents in reducing mortality in obese hypertensive patients. This paper reviews the theoretical reasons for the differential use of the major classes of antihypertensive agents in the pharmacological management of obesity-related hypertension and also considers the potential role of anti-obesity agents.","['Sharma, A M', 'Pischon, T', 'Engeli, S', 'Scholze, J']","['Sharma AM', 'Pischon T', 'Engeli S', 'Scholze J']","['Franz-Volhard Klinik, Max-Delbruck Centre for Molecular Medicine, Berlin, Germany. sharma@fvk-berlin.de']",['eng'],"['Journal Article', 'Review']",Netherlands,J Hypertens,Journal of hypertension,8306882,['0 (Antihypertensive Agents)'],IM,"['Antihypertensive Agents/*therapeutic use', 'Humans', 'Hypertension/*drug therapy/*etiology', 'Obesity/*complications/therapy']",,,,,2001/05/02 10:00,2001/08/17 10:01,['2001/05/02 10:00'],"['2001/05/02 10:00 [pubmed]', '2001/08/17 10:01 [medline]', '2001/05/02 10:00 [entrez]']",['10.1097/00004872-200104000-00001 [doi]'],ppublish,J Hypertens. 2001 Apr;19(4):667-74. doi: 10.1097/00004872-200104000-00001.,,,,,,,95,,,,,,,,,,,,,
8759385,NLM,MEDLINE,19960930,20061115,0041-5782 (Print) 0041-5782 (Linking),158,32,1996 Aug 5,[Treatment of obesity in patient groups].,4509-12,,"The purpose of this study was to assess the results of group treatment in obesity. Patients referred to a department of endocrinology were on referral given individual diet counselling, and the patients were then seen every second week for control weighing and supplemental counselling either in groups of 10-12, or individually. One hundred and twenty-three (97 female and 26 male) patients who during a two year period, 1991-1993, were referred to the outpatient clinic of the Department of Endocrinology were identified. Ninety-five percent of the patients were markedly obese, body mass index > 30 m2/kg. Seventy percent of the patients continued the treatment and were either followed in the groups or individually. The patients followed in the groups (n = 66) lost 5.2 kg during 127 days (median), and this is not significantly different from those followed individually (n = 22) who lost 4.9 kg during 98 days. In conclusion, only a small weight reduction is seen in obese patients treated either in groups or individually. These results are comparable with previously reported results from a Danish study only using individual counselling.","['Balle, J', 'Almdal, T P']","['Balle J', 'Almdal TP']","['Hvidovre Hospital, endokrinologisk afdeling.']",['dan'],"['English Abstract', 'Journal Article']",Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,IM,"['Adult', 'Counseling', 'Diet, Reducing', 'Female', 'Humans', 'Male', 'Obesity/diet therapy/psychology/*therapy', 'Psychotherapy, Group', 'Retrospective Studies']",,,,,1996/08/05 00:00,1996/08/05 00:01,['1996/08/05 00:00'],"['1996/08/05 00:00 [pubmed]', '1996/08/05 00:01 [medline]', '1996/08/05 00:00 [entrez]']",,ppublish,Ugeskr Laeger. 1996 Aug 5;158(32):4509-12.,,,,,,,,,Behandling af adipositas i patientgrupper.,,,,,,,,,,,
3810355,NLM,MEDLINE,19870311,20140912,0256-9574 (Print),71,2,1987 Jan 24,The relationship between stress and weight loss in a diet-exercise programme for obese women.,93-7,,"Forty-two obese women participated in two successive 3-month diet-exercise programmes. A stress questionnaire was answered on commencement, after 1 1/2 and 3 months (38 subjects), and after 6 months (30 subjects). A discussion group, informal counselling and in-depth interviews (12 subjects) provided reliable additional data. The hypothesis that subjects with juvenile-onset obesity experience greater stress on the programme and are less successful, was unsupported. The semistructured interviews indicated: that stress is inherent in dieting; that the compensatory effect of exercise mediates the loss of eating as a stress-coping mechanism; and that as goal weight is approached, a serious emotional crisis is experienced, due to the loss of the obese state as a defence. Negative findings from the stress questionnaire, and the patterns which emerged from the interviews, are conceptualised in terms of a general model of reactions to weight loss, which is based on a postulated homeostatic mechanism to maintain acceptable stress levels.","['Burbach, F R', 'Schomer, H H']","['Burbach FR', 'Schomer HH']",,['eng'],['Journal Article'],South Africa,S Afr Med J,South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,0404520,,IM,"['Adult', '*Body Weight', 'Diet, Reducing/psychology', 'Exercise Therapy', 'Family', 'Female', 'Humans', 'Obesity/*diet therapy/psychology/therapy', 'Self Concept', '*Stress, Psychological']",,,,,1987/01/24 00:00,1987/01/24 00:01,['1987/01/24 00:00'],"['1987/01/24 00:00 [pubmed]', '1987/01/24 00:01 [medline]', '1987/01/24 00:00 [entrez]']",,ppublish,S Afr Med J. 1987 Jan 24;71(2):93-7.,,,,,,,,,,,,,,,,,,,,
36522657,NLM,MEDLINE,20221219,20221222,1471-2253 (Electronic) 1471-2253 (Linking),22,1,2022 Dec 15,The effect of positive end-expiratory pressure on intracranial pressure in obese and non-obese severe brain injury patients: a retrospective observational study.,388,10.1186/s12871-022-01934-9 [doi] 388,"BACKGROUND: The effect of positive end-expiratory pressure (PEEP) on intracranial pressure (ICP) had never been studied in obese patients with severe brain injury (SBI). The main aim was to evaluate the effect of PEEP on ICP in SBI patients with mechanical ventilation according to obesity status. METHODS: SBI patients admitted to the ICU with mechanical ventilation between 2014 and 2015 were included. Demographic, hemodynamic, arterial blood gas, and ventilator data at the time of the paired PEEP and ICP observations were recorded and compared between obese (body mass index >/= 30 kg/m(2)) and non-obese SBI patients. Generalized estimating equation (GEE) model was used to assess the relationship between PEEP and ICP in obese and non-obese SBI patients, respectively. RESULTS: Six hundred twenty-seven SBI patients were included, 407 (65%) non-obese and 220 (35%) obese patients. A total of 30,415 paired PEEP and ICP observations were recorded in these patients, 19,566 (64.3%) for non-obese and 10,849 (35.7%) for obese. In the multivariable analysis, a statistically significant relationship between PEEP and ICP was found in obese SBI patients, but not in non-obese ones. For every cmH(2)O increase in PEEP, there was a 0.19 mmHg increase in ICP (95% CI [0.05, 0.33], P = 0.007) and a 0.15 mmHg decrease in CPP (95% CI [-0.29, -0.01], P = 0.036) in obese SBI patients after adjusting for confounders. CONCLUSIONS: The results suggested that, contrary to non-obese SBI patients, the application of PEEP may produce an increase in ICP in obese SBI patients. However, the effect was modest and may be clinically inconsequential.","['Zhou, Dawei', 'Li, Tong', 'Fei, Shuyang', 'Wang, Chao', 'Lv, Yi']","['Zhou D', 'Li T', 'Fei S', 'Wang C', 'Lv Y']","['Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.', 'Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China. tricumd@126.com.', 'Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.', 'Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.', 'Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing, China.']",['eng'],"['Journal Article', 'Observational Study']",England,BMC Anesthesiol,BMC anesthesiology,100968535,,IM,"['Humans', '*Intracranial Pressure', 'Positive-Pressure Respiration/methods', 'Hemodynamics', '*Brain Injuries', 'Obesity/complications/therapy']",PMC9753360,['NOTNLM'],"['Cerebral perfusion pressure', 'Intracranial pressure', 'Obesity', 'Positive end-expiratory pressure', 'Severe brain injury']",['None of the authors has declared a conflict of interest.'],2022/12/16 06:00,2022/12/20 06:00,['2022/12/15 23:45'],"['2022/07/26 00:00 [received]', '2022/12/06 00:00 [accepted]', '2022/12/15 23:45 [entrez]', '2022/12/16 06:00 [pubmed]', '2022/12/20 06:00 [medline]']","['10.1186/s12871-022-01934-9 [pii]', '1934 [pii]', '10.1186/s12871-022-01934-9 [doi]']",epublish,BMC Anesthesiol. 2022 Dec 15;22(1):388. doi: 10.1186/s12871-022-01934-9.,,20221215,,['(c) 2022. The Author(s).'],,,,,,,,,,,,,,,,
33833357,NLM,MEDLINE,20211108,20211108,2045-2322 (Electronic) 2045-2322 (Linking),11,1,2021 Apr 8,Comparison of Argentinean microbiota with other geographical populations reveals different taxonomic and functional signatures associated with obesity.,7762,10.1038/s41598-021-87365-x [doi] 7762,"Accumulating evidence suggests that various genetic and environmental factors contribute to the development of obesity. Among the latter, the gut microbiota has emerged as a critical player in the regulation of human metabolism and health and the development of non-communicable chronic diseases. Considering that no information on this matter is available in Argentina, our aim was to identify the microorganisms associated with obesity as well as their potential functionality. Using high throughput sequencing of 16SrRNA bacterial gene and diverse bioinformatics tools, we observed that the gut microbiota of obese and overweight individuals differs qualitatively and quantitatively from that from their lean counterparts. The comparison of the gut microbiota composition in obese subjects from Argentina, US and UK showed that the beta diversity significantly differs among the three countries, indicating that obesity-associated microbiota composition changes according to the geographical origin of the individuals. Moreover, four distinct microbiotypes were identified in obese individuals, whose prevalence and metabolic pathway signature differed according to the country, indicating that obesity associated dysbiosis would comprise several structures. In summary, identification of distinct taxonomic signatures associated with obesity might be a novel promising tool to stratify patients based on their microbiome configuration to design strategies for managing obesity.","['Pesoa, Susana A', 'Portela, Nestor', 'Fernandez, Eduardo', 'Elbarcha, Osvaldo', 'Gotteland, Martin', 'Magne, Fabien']","['Pesoa SA', 'Portela N', 'Fernandez E', 'Elbarcha O', 'Gotteland M', 'Magne F']","['Department of Molecular Diagnosis, LACE Laboratories, Avda Velez Sarsfield 528, Cordoba, Argentina. susana.pesoa@laboratoriolace.com.ar.', 'Department of Molecular Diagnosis, LACE Laboratories, Avda Velez Sarsfield 528, Cordoba, Argentina.', 'Department of Molecular Diagnosis, LACE Laboratories, Avda Velez Sarsfield 528, Cordoba, Argentina.', 'Department of Molecular Diagnosis, LACE Laboratories, Avda Velez Sarsfield 528, Cordoba, Argentina.', 'Department of Nutrition, Faculty of Medicine, University of Chile, Santiago, Chile.', 'Institute of Nutrition and Food Technology (INTA), University of Chile, Santiago, Chile.', 'Microbiology and Mycology Program, Biomedical Sciences Institute (ICBM), School of Medicine, University of Chile, Av. Independencia 1027, Independencia, Santiago, Chile. fabienmagne@med.uchile.cl.']",['eng'],"['Comparative Study', 'Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Sci Rep,Scientific reports,101563288,,IM,"['Adult', 'Argentina', 'Female', '*Gastrointestinal Microbiome', 'Humans', 'Male', '*Microbiota', 'Middle Aged', 'Obesity/*genetics/microbiology/physiopathology']",PMC8032766,,,['The authors declare no competing interests.'],2021/04/10 06:00,2021/11/09 06:00,['2021/04/09 06:13'],"['2020/03/20 00:00 [received]', '2021/02/15 00:00 [accepted]', '2021/04/09 06:13 [entrez]', '2021/04/10 06:00 [pubmed]', '2021/11/09 06:00 [medline]']","['10.1038/s41598-021-87365-x [pii]', '87365 [pii]', '10.1038/s41598-021-87365-x [doi]']",epublish,Sci Rep. 2021 Apr 8;11(1):7762. doi: 10.1038/s41598-021-87365-x.,,20210408,,,,,,,,,,,,,,,,,,
2462194,NLM,MEDLINE,19890126,20161123,0391-1993 (Print) 0391-1993 (Linking),34,3,1988 Jul-Sep,[Comparison of treatment only with diet and diet + diethylaminoethyl dextran (DEAE-D) of obese subjects].,187-9,,,"['Gizzi, S', 'Laurenti, O', 'Tullo, M G', 'Ziantoni, R', 'Ventura, C', 'Albi, F', 'De Mattia, G']","['Gizzi S', 'Laurenti O', 'Tullo MG', 'Ziantoni R', 'Ventura C', 'Albi F', 'De Mattia G']",,['ita'],"['Comparative Study', 'Journal Article']",Italy,Minerva Dietol Gastroenterol,Minerva dietologica e gastroenterologica,7708555,"['0 (Dextrans)', '9015-73-0 (DEAE-Dextran)']",IM,"['Adult', 'DEAE-Dextran/*therapeutic use', 'Dextrans/*therapeutic use', 'Drug Evaluation', 'Female', 'Humans', 'Male', 'Obesity/diet therapy/drug therapy/*therapy']",,,,,1988/07/01 00:00,1988/07/01 00:01,['1988/07/01 00:00'],"['1988/07/01 00:00 [pubmed]', '1988/07/01 00:01 [medline]', '1988/07/01 00:00 [entrez]']",,ppublish,Minerva Dietol Gastroenterol. 1988 Jul-Sep;34(3):187-9.,,,,,,,,,Confronto del trattamento con solo dieta e dieta+dietilaminoetildestrano (DEAE-D) in soggetti obesi.,,,,,,,,,,,
18798228,NLM,MEDLINE,20090713,20151119,1098-108X (Electronic) 0276-3478 (Linking),42,2,2009 Mar,The effects of causal beliefs and binge eating on the stigmatization of obesity.,118-24,10.1002/eat.20588 [doi],"OBJECTIVE: Weight disorders and overeating are increasingly labeled as addictions. It is important to identify the consequences of this label on the stigmatization of obesity. METHOD: Participants (N = 374) were assigned randomly to one of six conditions, in which they read a scenario about an obese woman either with or without binge eating, followed by an account of the cause of her obesity as psychological, a biological addiction, or ambiguous. Participants then completed questionnaires designed to assess stigma and prognostic beliefs. RESULTS: Participants in the obesity with binge eating condition rated obese persons more negatively and as having a worse prognosis. The causal manipulation check revealed no difference between groups and there were no significant effects of this condition. DISCUSSION: Behavior (binge eating) has important implications for understanding the stigmatization of obesity.","['Bannon, Katie L', 'Hunter-Reel, Dorian', 'Wilson, G Terence', 'Karlin, Robert A']","['Bannon KL', 'Hunter-Reel D', 'Wilson GT', 'Karlin RA']","['Department of Psychology, Rutgers, the State University of New Jersey, Piscataway, New Jersey, USA. katelbannon@gmail.com']",['eng'],"['Journal Article', 'Randomized Controlled Trial']",United States,Int J Eat Disord,The International journal of eating disorders,8111226,,IM,"['Adipose Tissue', 'Adult', 'Attitude to Health', 'Bulimia Nervosa/*epidemiology/therapy', '*Culture', 'Female', 'Humans', 'Male', 'Obesity/*epidemiology/*psychology/therapy', 'Psychotherapy', '*Stereotyping', 'Surveys and Questionnaires', 'Young Adult']",,,,,2008/09/18 09:00,2009/07/14 09:00,['2008/09/18 09:00'],"['2008/09/18 09:00 [pubmed]', '2009/07/14 09:00 [medline]', '2008/09/18 09:00 [entrez]']",['10.1002/eat.20588 [doi]'],ppublish,Int J Eat Disord. 2009 Mar;42(2):118-24. doi: 10.1002/eat.20588.,,,,,,,,,,,,,,,,,,,,
2219654,NLM,MEDLINE,19901121,20031114,0042-4900 (Print) 0042-4900 (Linking),127,7,1990 Aug 18,Treatment of obese dogs.,191-2,,,"['Stanley, H']",['Stanley H'],,['eng'],['Letter'],England,Vet Rec,The Veterinary record,0031164,,IM,"['Animal Feed', 'Animals', 'Dog Diseases/*diet therapy', 'Dogs', 'Obesity/diet therapy/*veterinary']",,,,,1990/08/18 00:00,1990/08/18 00:01,['1990/08/18 00:00'],"['1990/08/18 00:00 [pubmed]', '1990/08/18 00:01 [medline]', '1990/08/18 00:00 [entrez]']",,ppublish,Vet Rec. 1990 Aug 18;127(7):191-2.,,,,,,,,,,,,,,,,,,,,
2533520,NLM,MEDLINE,19900320,20131121,0037-9026 (Print) 0037-9026 (Linking),183,4,1989,[Naloxone doesn't determine the response of growth hormone to clonidine in obese patients].,337-41,,"The effect of naloxone (opioid receptor blocker) on the impairment of growth hormone (GH) release after clonidine (alfa 2-adrenergic agonist) was investigated in 10 volunteer obese subjects. The patients (4 males and 6 females, 16-22 year old) with fat excess (15 +/- 2 kg) estimated by bioelectrical impedance analysis (BIA) were studied repeatedly. The patients, were perfused by a slow saline infusion. 30 min later they received a bolus dose of clonidine (150 micrograms p.o.), followed 30 min later by a bolus dose of naloxone (10 mg i.v.) or a corresponding volume of isotonic sodium cloride (I.S.) for control. No significant changes occurred in blood GH concentration after clonidine administration and naloxone did not induce GH response at clonidine. These results suggest that in obese subjects the impairment of GH release after clonidine is not mediated via receptors sensitivity to naloxone.","['Satta, M A', 'Castelli, A', 'Maussier, M L', 'Scoppola, A', 'Valenza, V', 'Saletnich, I', 'Monaco, F', 'Roche, J']","['Satta MA', 'Castelli A', 'Maussier ML', 'Scoppola A', 'Valenza V', 'Saletnich I', 'Monaco F', 'Roche J']","[""Cattedra di Endocrinologia Universita G. D'Annunzio, Chieti.""]",['fre'],"['English Abstract', 'Journal Article']",France,C R Seances Soc Biol Fil,Comptes rendus des seances de la Societe de biologie et de ses filiales,7505439,"['36B82AMQ7N (Naloxone)', '9002-72-6 (Growth Hormone)', 'MN3L5RMN02 (Clonidine)']",IM,"['Adolescent', 'Adult', 'Clonidine/*pharmacology', 'Female', 'Growth Hormone/*blood', 'Humans', 'Male', 'Naloxone/*pharmacology', 'Obesity/*metabolism']",,,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,C R Seances Soc Biol Fil. 1989;183(4):337-41.,,,,,,,,,La naloxone ne determine pas de reponse de l'hormone de croissance a la clonidine chez les obeses.,,,,,,,,,,,
19915462,NLM,MEDLINE,20100326,20220410,1473-6535 (Electronic) 0957-9672 (Linking),21,1,2010 Feb,The distinction of metabolically 'healthy' from 'unhealthy' obese individuals.,38-43,10.1097/MOL.0b013e3283346ccc [doi],"PURPOSE OF REVIEW: The prevalence and severity of obesity are dramatically increasing throughout the world. Obesity causes a decline in life expectancy due to its associated metabolic and cardiovascular comorbid disorders. Therefore, it will become more important to distinguish obese individuals at high risk for obesity-related metabolic diseases from those who are metabolically 'healthy'. This review focuses on recent evidence suggesting that normal adipose tissue function contributes to the healthy obese phenotype. RECENT FINDINGS: The majority of individuals with obesity develop insulin resistance, type 2 diabetes, dyslipidemia, gout, hypertension and cardiovascular disease. However, approximately 10-25% of obese individuals are metabolically healthy most likely due to preserved insulin sensitivity. Recent studies suggest that inflammation of visceral adipose tissue, ectopic fat deposition and adipose tissue dysfunction mediate insulin resistance in human obesity independently of total body fat mass. This suggests that mechanisms beyond a positive caloric balance such as inflammation and adipokine release determine the pathological metabolic consequences in patients with obesity. SUMMARY: Recommendations for obesity treatment should distinguish the metabolically 'healthy' from 'unhealthy' obese phenotype to identify early the obese person who will benefit the most from losing weight. In addition, novel antiobesity treatment strategies targeting adipose tissue dysfunction are needed.","['Bluher, Matthias']",['Bluher M'],"['Department of Medicine, University of Leipzig, Leipzig, Germany. bluma@medizin.uni-leipzig.de']",['eng'],"['Comparative Study', 'Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Curr Opin Lipidol,Current opinion in lipidology,9010000,,IM,"['Behavior', 'Environment', '*Health', 'Humans', 'Intra-Abdominal Fat/metabolism', 'Obesity/*metabolism/*physiopathology']",,,,,2009/11/17 06:00,2010/03/27 06:00,['2009/11/17 06:00'],"['2009/11/17 06:00 [entrez]', '2009/11/17 06:00 [pubmed]', '2010/03/27 06:00 [medline]']",['10.1097/MOL.0b013e3283346ccc [doi]'],ppublish,Curr Opin Lipidol. 2010 Feb;21(1):38-43. doi: 10.1097/MOL.0b013e3283346ccc.,"['Howard Hughes Medical Institute/United States', 'Wellcome Trust/United Kingdom']",,,,,,37,,,,,,,,,,,,,
15859181,NLM,MEDLINE,20050526,20201230,1210-7778 (Print) 1210-7778 (Linking),13,1,2005 Mar,The effectiveness of a body mass reduction program in obese women in perimenopausal and menopausal age compared with the effectiveness of such a program in younger (18-44 years of age) women living in Poland.,40-6,,"OBJECTIVE: The aim of the work was: to compare the effectiveness of body mass reducing program in women of perimenopausal (and menopausal) age with the effectiveness of such a program when it was applied to women aged 18-44 years. METHODS: The paper deals with observation study of the group of obese patients recruited and treated in Bialystok's Clinical Center for Cardiology and Body Mass Reduction. The authors summarize 12 months of clinical observation (as it was initially planned) of the two groups of obese women, taking part in the special body mass reduction program; Group I - 81 women in perimenopausal and menopausal age, Group II - 107 women in 18-44 years of age. The proposed treatment contained diet, physical exercises, psychological support and pharmacotherapy. RESULTS: The positive reaction for the treatment of obesity was less visible in obese women in perimenopausal and menopausal age, than in the group of obese women in 18-44 years of age (change of BMI in the group of younger women was -3.44 kg/m2 vs. -2.65 kg/m2 in older women). As it was observed, the weaker reaction for the proposed treatment in the group of older women, was not related to lower BMR, than in the group of younger obese women. Provisional result shows that use of HRT (Hormonal Replace Therapy) may probably result in better response of body mass reduction in perimenopausal and menopausal women. CONCLUSION: The high dropout of the patients included into the study does not allow to formulate unequivocal conclusions but it seems that body mass reduction program for women in perimenopausal and menopausal age should concentrate on building the motivation of the patients, HRT may play some role in improvement of effectiveness of such program but this should be confirmed by further studies.","['Ostrowska, L', 'Lech, M M']","['Ostrowska L', 'Lech MM']","['Department of Hygiene and Epidemiology in Medical University of Bialystok, Poland.']",['eng'],['Journal Article'],Czech Republic,Cent Eur J Public Health,Central European journal of public health,9417324,['0 (Anti-Obesity Agents)'],IM,"['Adolescent', 'Adult', 'Anti-Obesity Agents/therapeutic use', 'Combined Modality Therapy', 'Energy Intake', 'Exercise', 'Female', 'Humans', '*Menopause', 'Middle Aged', 'Obesity/drug therapy/physiopathology/*therapy', '*Perimenopause', 'Poland']",,,,,2005/04/30 09:00,2005/05/27 09:00,['2005/04/30 09:00'],"['2005/04/30 09:00 [pubmed]', '2005/05/27 09:00 [medline]', '2005/04/30 09:00 [entrez]']",,ppublish,Cent Eur J Public Health. 2005 Mar;13(1):40-6.,,,,,,,,,,,,,,,,,,,,
23149391,NLM,MEDLINE,20130903,20220408,1308-5735 (Electronic) 1308-5727 (Print),5 Suppl 1,Suppl 1,2013,Thyroid function and obesity.,40-4,10.4274/jcrpe.856 [doi],"Nowadays, childhood obesity is one of the biggest health emergencies in the developed countries. Obesity leads to multiple metabolic alterations which increase the risk of developing diabetes and cardiovascular diseases. Thyroid function has been often described as altered in obese children, however, it is not clear whether the altered thyroid function is the cause or the consequence of fat excess. On the other hand, thyroid structure seems also to be affected. Nevertheless, both functional and structural alterations seem to improve after weight loss and therefore no treatment is needed.","['Longhi, Silvia', 'Radetti, Giorgio']","['Longhi S', 'Radetti G']","['Regional Hospital of Bolzano, Pediatrics, Bolzano, Italy.']",['eng'],"['Journal Article', 'Review']",Turkey,J Clin Res Pediatr Endocrinol,Journal of clinical research in pediatric endocrinology,101519456,,IM,"['Humans', 'Obesity/*etiology/*therapy', 'Thyroid Gland/*physiopathology']",PMC3608008,,,,2012/11/15 06:00,2013/09/04 06:00,['2012/11/15 06:00'],"['2012/11/15 06:00 [entrez]', '2012/11/15 06:00 [pubmed]', '2013/09/04 06:00 [medline]']","['264 [pii]', '10.4274/jcrpe.856 [doi]']",ppublish,J Clin Res Pediatr Endocrinol. 2013;5 Suppl 1(Suppl 1):40-4. doi: 10.4274/jcrpe.856. Epub 2012 Nov 1.,,20121101,,,,,,,,,,,,,,,,,,
7659060,NLM,MEDLINE,19951005,20170214,0884-5336 (Print) 0884-5336 (Linking),10,4,1995 Aug,Obesity: nutrition support practice and application to critical care.,144-9,,"Much controversy exists regarding the nutritional care of obese, hospitalized patients. There is no real agreement among health care professionals in the nutritional support of obese patients. A survey was designed to determine the methods used to provide for the nutritional needs of obese, hospitalized patients. The survey included questions on definition of obesity, equations used to calculate energy and protein needs, and body weight used for calculations. The information received from this survey describes the variability of nutritional care for obese, hospitalized patients. In addition, a review of the current literature is provided regarding the metabolic response of the obese.","['Ireton-Jones, C S', 'Francis, C']","['Ireton-Jones CS', 'Francis C']",,['eng'],['Journal Article'],United States,Nutr Clin Pract,Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition,8606733,,,"['*Critical Care', 'Humans', 'Nutritional Requirements', 'Nutritional Support/*methods', 'Obesity/metabolism/*therapy', ""*Practice Patterns, Physicians'"", 'Surveys and Questionnaires']",,,,,1995/08/01 00:00,1995/08/01 00:01,['1995/08/01 00:00'],"['1995/08/01 00:00 [pubmed]', '1995/08/01 00:01 [medline]', '1995/08/01 00:00 [entrez]']",['10.1177/0115426595010004144 [doi]'],ppublish,Nutr Clin Pract. 1995 Aug;10(4):144-9. doi: 10.1177/0115426595010004144.,,,,,,,,,,,,,,,,,,,,
29262266,NLM,MEDLINE,20181023,20181023,1715-5320 (Electronic) 1715-5312 (Linking),43,6,2018 Jun,Effect of a short-term physical activity intervention on liver fat content in obese children.,553-557,10.1139/apnm-2017-0406 [doi],"Nonalcoholic fatty liver disease is the most common chronic liver disease and can present with advanced fibrosis or nonalcoholic steatohepatitis. The purpose of this study was to investigate the effect of a 7-day intense physical activity intervention on liver fat content in children with obesity. Fifty-seven obese children (mean body mass index: 26.5 +/- 3.2 kg/m(2); mean age: 12.0 +/- 0.8 years) participated in a 7-day physical activity program. All participants were housed together, and their food intake and energy expenditure were strictly controlled. Anthropometric measurements, abdominal computerized tomography scans, and blood analyses were conducted at baseline and post-intervention. Participants lost weight by 2.53 +/- 0.85 kg on average (61.0 +/- 9.8 vs. 58.5 +/- 9.5 kg, p < 0.05), fat mass (16.7 +/- 5.1 vs. 15.7 +/- 4.9 kg, p < 0.05), and serum insulin (13.7 +/- 6.7 vs. 3.5 +/- 2.0 muU/mL, p < 0.05). However, liver fat content was increased, presented as liver-to-spleen ratio (LSR) where lower LSR represents higher liver fat content. The intervention increased aspartate transaminase level (29.42 +/- 6.78 IU/L vs. 33.50 +/- 9.60 IU/L, p < 0.001). The change in liver fat content was not associated with the change in fasting insulin and liver enzymes. Short-term intense physical activity increased liver fat content independent of change in fasting insulin level and liver enzymes. This is the first human study to report increased liver fat content after physical activity-induced rapid weight loss.","['Kang, Dong-Woo', 'Park, Ji-Hye', 'Lee, Mi Kyung', 'Kim, YoonMyung', 'Kong, In Deok', 'Chung, Choon Hee', 'Lee, Young Hee', 'Jeon, Justin Y']","['Kang DW', 'Park JH', 'Lee MK', 'Kim Y', 'Kong ID', 'Chung CH', 'Lee YH', 'Jeon JY']","['a Behavioural Medicine Laboratory, Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB T6G 2H9, Canada.', 'b Exercise Medicine and Rehabilitation Laboratory, Department of Sport Industry Studies, Yonsei University, Seoul 03722, Korea.', 'c Exercise Medicine Center for Diabetes and Cancer Patients, Institute of Convergence Science (ICONS), Yonsei University, Seoul 03722, Korea.', 'b Exercise Medicine and Rehabilitation Laboratory, Department of Sport Industry Studies, Yonsei University, Seoul 03722, Korea.', 'c Exercise Medicine Center for Diabetes and Cancer Patients, Institute of Convergence Science (ICONS), Yonsei University, Seoul 03722, Korea.', 'd University College of Yonsei, Incheon 21983, Korea.', 'e Department of Physiology, Yonsei University Wonju College of Medicine, Wonju 26493, Korea.', 'f Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26493, Korea.', 'g Department of Rehabilitation Medicine, Yonsei University Wonju College of Medicine, Wonju 26493, Korea.', 'b Exercise Medicine and Rehabilitation Laboratory, Department of Sport Industry Studies, Yonsei University, Seoul 03722, Korea.', 'c Exercise Medicine Center for Diabetes and Cancer Patients, Institute of Convergence Science (ICONS), Yonsei University, Seoul 03722, Korea.']",['eng'],"['Clinical Trial', 'Journal Article']",Canada,Appl Physiol Nutr Metab,"Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme",101264333,"['0 (Biomarkers)', '0 (Insulin)', 'EC 2.6.1.1 (Aspartate Aminotransferases)']",IM,"['*Adiposity', 'Age Factors', 'Aspartate Aminotransferases/blood', 'Biomarkers/blood', 'Body Mass Index', 'Child', 'Exercise Therapy/*methods', 'Female', 'Humans', 'Insulin/blood', 'Insulin Resistance', '*Lipid Metabolism', 'Liver/*metabolism', 'Male', 'Non-alcoholic Fatty Liver Disease/blood/diagnosis/etiology/*therapy', 'Pediatric Obesity/blood/complications/diagnosis/*therapy', 'Republic of Korea', 'Time Factors', 'Treatment Outcome', 'Weight Loss']",,['NOTNLM'],"['activite physique', 'enfants obeses', 'gras hepatique', 'intervention', 'liver fat', 'obese children', 'physical activity']",,2017/12/21 06:00,2018/10/24 06:00,['2017/12/21 06:00'],"['2017/12/21 06:00 [pubmed]', '2018/10/24 06:00 [medline]', '2017/12/21 06:00 [entrez]']",['10.1139/apnm-2017-0406 [doi]'],ppublish,Appl Physiol Nutr Metab. 2018 Jun;43(6):553-557. doi: 10.1139/apnm-2017-0406. Epub 2017 Dec 20.,,20171220,,,,,,,,,,,,,,,,,,
2393896,NLM,MEDLINE,19901010,20131121,0008-7335 (Print) 0008-7335 (Linking),129,29,1990 Jul 20,[The effect of euphylline on energy expenditure in obese patients during treatment with a reducing diet].,907-10,,"The energy economy induced by a reducing diet and manifested by a reduced energy output at rest threatens greatly the long-term success of reducing regimes. The authors investigated the effect of a four-week therapy of obese patients by a low energy protein diet with an energy value of 1560 kJ on the resting metabolic rate (RMR), the serum concentration of thyroid hormones and TSH and on the Achilles tendon reflex time. Four weeks' treatment with a low energy protein diet caused a significant drop of the energy output at rest in the control group of obese men (by 17.5%), as well as in the control group of obese women (by 16.9 per cent). In the group of obese women who were given during the last two weeks of treatment depot methyl xanthine derivative, Euphilline (Byk Gulden), the energy output at rest did not decline as a result of dietetic treatment and the decline of the BMI was significantly higher than in the control group of obese women, although the two groups did not differ in the initial BMI, mean age and the degree of physical activity during treatment. With the exception of the control group of men where the serum triiodothyronine level declined, in the investigated obese subjects no significant changes of the investigated thyroid function parameters were recorded. The syndrome of low T3 thus does not participate in a substantial way in the drop of the metabolism at rest during treatment with a low energy protein diet, obviously due to the intake of 50 g carbohydrate per day.(ABSTRACT TRUNCATED AT 250 WORDS)","['Hainer, V', 'Kunesova, M', 'Stich, V', 'Stukavec, V', 'Wernischova, V', 'Hrabak, P']","['Hainer V', 'Kunesova M', 'Stich V', 'Stukavec V', 'Wernischova V', 'Hrabak P']","['IV. interni katedra I. lekarske fakulty Univerzity Karlovy, Praha.']",['cze'],"['English Abstract', 'Journal Article']",Czech Republic,Cas Lek Cesk,Casopis lekaru ceskych,0004743,['27Y3KJK423 (Aminophylline)'],IM,"['Adult', 'Aminophylline/*therapeutic use', '*Energy Metabolism', 'Female', 'Humans', 'Male', 'Obesity/*diet therapy/drug therapy/metabolism']",,,,,1990/07/20 00:00,1990/07/20 00:01,['1990/07/20 00:00'],"['1990/07/20 00:00 [pubmed]', '1990/07/20 00:01 [medline]', '1990/07/20 00:00 [entrez]']",,ppublish,Cas Lek Cesk. 1990 Jul 20;129(29):907-10.,,,,,,,,,Vliv euphyllinu na energetickou uspornost obeznich pacientu pri lecbe redukcni dietou.,,,,,,,,,,,
33297684,NLM,MEDLINE,20201211,20201214,0008-7335 (Print) 0008-7335 (Linking),159,3-4,2020 Summer,Adult obese patient in primary care.,104-110,,"Overweight and obesity prevalence in middle aged subjects in the Czech Republic is more than 50 per cent, obesity is found in around 26 per cent of population. Obesity management is a long-term and time-consuming process. Early start of the treatment can prevent continuous weight gain and development of co-morbidities. General practitioners see obese patients usually as the first and they represent the first point of contact for adults with obesity. The basis of obesity management is a change of the lifestyle with added pharmacotherapy and/or bariatric/metabolic surgery. The paper presents overview of methods in obesity diagnostics and management and possibilities of their use in GPs daily practice.","['Kunesova, Marie', 'Kalouskova, Pavla', 'Braunerova, Radka Taxova', 'Jakoubkova, Martina', 'Zamrazilova, Hana', 'Wagenknecht, Martin', 'Sucharda, Petr', 'Mullerova, Dana', 'Fried, Martin', 'Haluzik, Martin', 'Hainer, Vojtech']","['Kunesova M', 'Kalouskova P', 'Braunerova RT', 'Jakoubkova M', 'Zamrazilova H', 'Wagenknecht M', 'Sucharda P', 'Mullerova D', 'Fried M', 'Haluzik M', 'Hainer V']",,['eng'],['Journal Article'],Czech Republic,Cas Lek Cesk,Casopis lekaru ceskych,0004743,,IM,"['Adult', 'Czech Republic/epidemiology', 'Humans', 'Middle Aged', '*Obesity/complications/diagnosis/epidemiology', '*Overweight', 'Primary Health Care', 'Weight Gain']",,['NOTNLM'],"['bariatric/metabolic surgery', 'diet', 'obesity diagnostics', 'pharmacotherapy']",,2020/12/11 06:00,2020/12/15 06:00,['2020/12/10 05:33'],"['2020/12/10 05:33 [entrez]', '2020/12/11 06:00 [pubmed]', '2020/12/15 06:00 [medline]']",['123288 [pii]'],ppublish,Cas Lek Cesk. 2020 Summer;159(3-4):104-110.,,,,,,,,,Obezni pacient v ordinaci praktickeho leka&#345;e.,,,,,,,,,,,
29120260,NLM,MEDLINE,20180904,20180904,1532-5040 (Electronic) 0959-3985 (Linking),34,5,2018 May,"Physiotherapists' encounters with ""obese"" patients: Exploring how embodied approaches gain significance.",346-358,10.1080/09593985.2017.1400140 [doi],"BACKGROUND: Obesity is regarded as a modern lifestyle problem, causing illness, stigma, discrimination, and psychological problems. To help patients avoid these problems, physiotherapists increasingly engage in lifestyle programs specialized in weight loss. OBJECTIVE: To explore how physiotherapists' encounters with patients diagnosed as ""obese"" acquire significance for their development as clinicians. METHOD: The material draws on semi-structured interviews with eight physiotherapists. We conducted a thematic analysis inspired by van Manen's hermeneutic-phenomenological approach combined with Kvale and Brinkman's critical approach. FINDINGS: The analysis identified the following four themes: 1) Striving to find one's own style of communication; 2) Relating to bodily discrepancies; 3) Developing clinical competence through bodily encounters; and 4) Gaining insight into the dilemmas of group-based lifestyle programs. Taken together, our findings highlight bodily encounters between patients and physiotherapists as an invaluable source of insight. Such insight can shape physiotherapists' development as clinicians inspiring them to develop their unique ways of communicating so that patients diagnosed as obese can feel empowerment rather than failure and shame. At the same time, our findings point to the need of critically reflecting on ones' own approach entering a double role of both controller and supporter. As such, our findings complicate and extend previous work on stigma and shame. CONCLUSION: Our research leads us to conclude that more emphasis on critical thinking in physiotherapy is necessary. We suggest that this should be given more priority in research, education, as well as in clinical practice.","['Groven, Karen Synne', 'Heggen, Kristin']","['Groven KS', 'Heggen K']","['a Institute of Health and Society, Faculty of Medicine , University of Oslo , Oslo , Norway.', 'b Department of Health and society , Oslo University College , Norway.', 'a Institute of Health and Society, Faculty of Medicine , University of Oslo , Oslo , Norway.']",['eng'],['Journal Article'],England,Physiother Theory Pract,Physiotherapy theory and practice,9015520,,IM,"['*Attitude of Health Personnel', 'Clinical Competence', '*Communication', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Interviews as Topic', 'Obesity/diagnosis/physiopathology/psychology/*therapy', 'Physical Therapists/*psychology', '*Professional Role', '*Professional-Patient Relations', 'Qualitative Research', '*Risk Reduction Behavior', 'Thinking', 'Treatment Outcome', 'Weight Loss']",,['NOTNLM'],"['Embodyment', 'experience', 'lifestyle program', 'obesity', 'professional development']",,2017/11/10 06:00,2018/09/05 06:00,['2017/11/10 06:00'],"['2017/11/10 06:00 [pubmed]', '2018/09/05 06:00 [medline]', '2017/11/10 06:00 [entrez]']",['10.1080/09593985.2017.1400140 [doi]'],ppublish,Physiother Theory Pract. 2018 May;34(5):346-358. doi: 10.1080/09593985.2017.1400140. Epub 2017 Nov 9.,,20171109,,,,,,,,,,,,,,,,,,
13025376,NLM,MEDLINE,20030501,20181201,,41-42,7,1952 Sep,[The equilibrium of the liquids in the organism in the course of spongiform obesities].,740-5,,,"['GIRAUD, G', 'LATOUR, H', 'LEVY, A', 'COMBIER, C', 'ALRAM, D']","['GIRAUD G', 'LATOUR H', 'LEVY A', 'COMBIER C', 'ALRAM D']",,['und'],['Journal Article'],France,Montp Med,Montpellier medical,18820540R,['059QF0KO0R (Water)'],OM,"['Humans', '*Obesity', 'Water/*metabolism']",,['NLM'],"['*OBESITY', '*WATER/metabolism']",,1952/09/01 00:00,1952/09/01 00:01,['1952/09/01 00:00'],"['1952/09/01 00:00 [pubmed]', '1952/09/01 00:01 [medline]', '1952/09/01 00:00 [entrez]']",,ppublish,Montp Med. 1952 Sep;41-42(7):740-5.,,,,,,,,,L'equilibre des liquides de l'organisme au cours des obesites spongieuses.,,,,['CLML: 5323:50335:383:599'],,,,,,,
35724044,NLM,MEDLINE,20220622,20220630,0297-2964 (Print) 0297-2964 (Linking),147,4,2022,[Not Available].,92-99,10.3917/rsi.147.0092 [doi],"Introduction : At least one preoperative shower is recommended to avoid surgical site infection. Caregivers must explain the showering technique, help the patient if necessary, and assess skin cleanliness after showering.Context : Showering may be more difficult for obese patients because of inadequate equipment and difficulties moving, as well as insufficient explanation regarding the showering technique and an insufficient skin cleanliness assessment from caregivers.Objective : to assess whether patients and/or caregivers report difficulties in the preoperative shower process that could be linked to patient obesity. Methods : pilot qualitative survey with semi-structured interviews conducted with 9 obese surgery patients and 11 surgery caregivers.Results : Patients did not report feelings of discrimination. They described no problem with equipment, but declared having received little explanation on the showering technique and no visual skin cleanliness assessment. Caregivers reported equipment as inadequate, they stated having delivered detailed information, but found the skin cleanliness assessment difficult.Discussion : The lack of skin cleanliness assessment by caregivers after preoperative showering is new information. Limits : preliminary study with a small number of interviews and no non-obese patients.Conclusion : the subject warrants additional work with both quantitative and qualitative surveys to better understand the difficulties with preoperative showering.","['Consiglio, Melanie', 'Delfrate, Elodie', 'Lourenco, Marie-Jeanne', 'Boulet, Ludivine', 'Petel, Tristan', 'Bergeot, Francois', 'Magnen, Line', 'Meret, Caroline', 'Folope, Vanessa', 'Dujardin, Franck', 'Huet, Emmanuel', 'Merle, Veronique']","['Consiglio M', 'Delfrate E', 'Lourenco MJ', 'Boulet L', 'Petel T', 'Bergeot F', 'Magnen L', 'Meret C', 'Folope V', 'Dujardin F', 'Huet E', 'Merle V']",,['fre'],['Journal Article'],France,Rech Soins Infirm,Recherche en soins infirmiers,9715370,,,"['*Baths/methods', '*Caregivers', 'Humans', 'Obesity', 'Preoperative Care', 'Surgical Wound Infection']",,,,,2022/06/21 06:00,2022/06/23 06:00,['2022/06/20 13:08'],"['2022/06/20 13:08 [entrez]', '2022/06/21 06:00 [pubmed]', '2022/06/23 06:00 [medline]']",['10.3917/rsi.147.0092 [doi]'],ppublish,Rech Soins Infirm. 2022;147(4):92-99. doi: 10.3917/rsi.147.0092.,,,,,,,,,La douche preoperatoire chez les patients obeses : ce qu'en disent les patients et les soignants.,,,,,,,,,,,
9456879,NLM,MEDLINE,19980212,20041117,0347-0911 (Print) 0347-0911 (Linking),21,3,1997 Mar 10,[The obese must learn a new behavior pattern. Interview by Birgitta Dalenstam].,32-3,,,"['Ofstad-Brand, M']",['Ofstad-Brand M'],,['swe'],['Interview'],Sweden,Vardfacket,Vardfacket,7708473,,,"['Behavior Therapy/*methods', 'Feeding Behavior', 'Humans', 'Obesity/*psychology/therapy', '*Social Behavior']",,,,,1997/03/10 00:00,1998/02/11 00:01,['1997/03/10 00:00'],"['1997/03/10 00:00 [pubmed]', '1998/02/11 00:01 [medline]', '1997/03/10 00:00 [entrez]']",,ppublish,Vardfacket. 1997 Mar 10;21(3):32-3.,,,,,,,,,Feta maste lara in nya beteendemonster.,,,,,,,,,,,
20078376,NLM,MEDLINE,20110118,20100914,1747-7174 (Electronic) 1747-7166 (Linking),5,5,2010 Oct,Examining the relationship between obesity and math performance among Canadian school children: a prospective analysis.,412-9,10.3109/17477160903496995 [doi],"OBJECTIVES: To determine whether obesity during the pre-school to primary school years was related to math performance, independently of other factors, in a large representative sample of Canadian children. Our main hypothesis was that obese children would obtain lower overall math scores than their non-obese peers. METHODS: Participants of the National Longitudinal Survey of Children and Youth comprised the sample for our analysis (n = 4 664). Obesity was based on mother-reported height and weight and IOTF age- and sex-specific body mass index cut-offs, and was assessed when the cohort was aged 2-5 years and 8-11 years. Children were classified as 'never obese', 'grew out of obesity', 'developed obesity' or 'always obese', depending on their obesity status at these two time points. The outcome was performance on a standardized math test that was administered when the cohort was aged 8-11 years. Statistical analysis was conducted using multivariate linear regression methods. RESULTS: Children who 'grew out of obesity' scored on average 11 points higher on the math test (p<0.0001) than children who were 'never obese.' Children who were 'always obese' and those that 'developed obesity' performed no differently on the math test than children who were 'never obese'. No interactions between sex and obesity status were found. CONCLUSIONS: Childhood obesity in this study did not lead to poor math performance. Being obese in the pre-school years and normal weight in primary school, however, was associated with improved math performance. This finding points to a potential nutritional window for early child development.","['Carter, Megan Ann', 'Dubois, Lise', 'Ramsay, Tim']","['Carter MA', 'Dubois L', 'Ramsay T']","['Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa, ON, Canada. mcart037@uottawa.ca']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Int J Pediatr Obes,International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity,101256330,,IM,"['Age Factors', 'Canada/epidemiology', 'Child', 'Child, Preschool', 'Cognition', 'Female', 'Humans', 'Intelligence', 'Linear Models', 'Longitudinal Studies', 'Male', '*Mathematics', 'Multivariate Analysis', 'Obesity/*epidemiology/ethnology/*psychology', 'Prospective Studies']",,,,,2010/01/19 06:00,2011/01/19 06:00,['2010/01/19 06:00'],"['2010/01/19 06:00 [entrez]', '2010/01/19 06:00 [pubmed]', '2011/01/19 06:00 [medline]']",['10.3109/17477160903496995 [doi]'],ppublish,Int J Pediatr Obes. 2010 Oct;5(5):412-9. doi: 10.3109/17477160903496995.,,,,,,,,,,,,,,,,,,,,
26909498,NLM,MEDLINE,20180301,20181113,2193-6226 (Electronic) 2193-6218 (Linking),112,1,2017 Feb,[Mobilization of obese patients : Increasing demands on personnel and equipment].,53-58,10.1007/s00063-015-0139-3 [doi],"The number of overweight people in Germany is constantly increasing, thus, forcing nurses and therapists to adjust to new challenges in patient care. Therefore, it is necessary to redefine the methods and goals in treating obese people. Working in an interprofessional team, using state of the art techniques, seems to be of crucial importance in facing the complex treatment that is associated with these patients. The occupational safety and health of personnel is of utmost importance.In this article, the problems associated with patient care and consequences for medical staff are considered. Finally, possibilities to facilitate work in treating obese patients are discussed.","['Klarmann, S', 'Klocke, J']","['Klarmann S', 'Klocke J']","['Zentrale Einrichtung Physiotherapie (ZEPT), Universitatsklinikum Schleswig Holstein (UKSH), Campus Kiel, Arnold-Heller-Str.3, 24105, Kiel, Deutschland. silke.klarmann@uksh.de.', 'Zentrale Einrichtung Physiotherapie (ZEPT), Universitatsklinikum Schleswig Holstein (UKSH), Campus Kiel, Arnold-Heller-Str.3, 24105, Kiel, Deutschland.']",['ger'],['Journal Article'],Germany,Med Klin Intensivmed Notfmed,"Medizinische Klinik, Intensivmedizin und Notfallmedizin",101575086,,IM,"['Body Mass Index', 'Cross-Sectional Studies', 'Early Ambulation', '*Equipment and Supplies, Hospital', 'Germany', 'Health Care Costs', 'Health Services Needs and Demand', 'Humans', '*Interdisciplinary Communication', '*Intersectoral Collaboration', '*Moving and Lifting Patients', 'Obesity/economics/epidemiology/psychology/*therapy', '*Patient Care Team', 'Postoperative Care', 'Professional-Patient Relations']",,['NOTNLM'],"['Body mass index', 'Body weights and measures', 'Economic evaluation', 'Life style', 'Physical therapy techniques']",,2016/02/26 06:00,2018/03/02 06:00,['2016/02/25 06:00'],"['2015/03/04 00:00 [received]', '2015/11/24 00:00 [accepted]', '2015/08/14 00:00 [revised]', '2016/02/26 06:00 [pubmed]', '2018/03/02 06:00 [medline]', '2016/02/25 06:00 [entrez]']","['10.1007/s00063-015-0139-3 [pii]', '10.1007/s00063-015-0139-3 [doi]']",ppublish,Med Klin Intensivmed Notfmed. 2017 Feb;112(1):53-58. doi: 10.1007/s00063-015-0139-3. Epub 2016 Feb 24.,,20160224,,,,,,,Mobilisation des adiposen Patienten : Steigende Anforderungen an Personal und Ausstattung.,,,,,,,,,,,
20385042,NLM,MEDLINE,20100616,20211020,1478-7083 (Electronic) 0035-8843 (Print) 0035-8843 (Linking),92,4,2010 May,Barriers to weight loss in obese patients with knee osteoarthritis.,338-40,10.1308/003588410X12628812458653 [doi],"INTRODUCTION: Obesity contributes to the development of knee osteoarthritis and complicates its surgical treatment. The aim of this study was to explore barriers to effective weight management in obese patients with knee osteoarthritis. PATIENTS AND METHODS: A cross-sectional questionnaire study was performed in an elective out-patient setting and on an orthopaedic ward on patients with a body mass index (BMI) of 30 kg/m2 or over and knee osteoarthritis. RESULTS: Of 47 patients approached, 45 agreed to participate. Forty of 45 patients (89%) had tried to lose weight at some point, 35 of 40 (87.5%) by adjusting their diet. Forty of 45 (89%) patients considered lack of motivation to be the greatest barrier to weight loss and only 13 of 45 (28%) pain in the knee. Patients with a BMI of less than 40 kg/m2 expressed a preference for dietary advice to help with weight loss, compared with those with a BMI of over 40 kg/m2 who expressed a preference for an NHS or other support group. CONCLUSIONS: Obesity is a significant problem for many patients with knee osteoarthritis. Attendance at an orthopaedic clinic is an opportunity to address obesity, by providing information about diet and possibly support groups for morbidly obese patients. Patients may be motivated to lose weight to improve their symptoms.","['Howarth, David', 'Inman, Dominic', 'Lingard, Elizabeth', 'McCaskie, Andrew', 'Gerrand, Craig']","['Howarth D', 'Inman D', 'Lingard E', 'McCaskie A', 'Gerrand C']","['Department of Orthopaedics, Freeman Hospital, Newcastle upon Tyne, UK. d.c.howarth@newcastle.ac.uk']",['eng'],['Journal Article'],England,Ann R Coll Surg Engl,Annals of the Royal College of Surgeons of England,7506860,,IM,"['Aged', 'Aged, 80 and over', 'Attitude to Health', 'Body Mass Index', 'Cross-Sectional Studies', 'Female', 'Humans', 'Male', 'Middle Aged', 'Motivation', 'Obesity/*complications/physiopathology/psychology/therapy', 'Osteoarthritis, Knee/*etiology/physiopathology', '*Weight Loss']",PMC3025198,,,,2010/04/14 06:00,2010/06/17 06:00,['2010/04/14 06:00'],"['2010/04/14 06:00 [entrez]', '2010/04/14 06:00 [pubmed]', '2010/06/17 06:00 [medline]']","['02 [pii]', '10.1308/003588410X12628812458653 [doi]']",ppublish,Ann R Coll Surg Engl. 2010 May;92(4):338-40. doi: 10.1308/003588410X12628812458653.,,,,,,,,['Ann R Coll Surg Engl. 2010 Sep;92(6):537. PMID: 20819343'],,,,,,,,,,,,
19840716,NLM,MEDLINE,20110504,20091020,1558-3481 (Electronic) 0899-5885 (Linking),21,3,2009 Sep,Trauma in obese patients: implications for nursing practice.,"377-89, vi-vii",10.1016/j.ccell.2009.07.004 [doi],"Recently, the impact of obesity on the outcomes of trauma patients has been the focus of several investigations. There have been several studies addressing the impact of obesity on trauma patients. These studies have explicated the impact of obesity on negative outcomes of trauma patients. Several studies have identified a relationship between obesity and injury pattern, increased complications in outcomes related to surgical procedures, and increase mortality and morbidity rates in obese trauma patients. However, the literature in nursing management in this patient population is virtually nonexistent and vague. The purpose of this article is to delineate the nursing implications of obesity in trauma patients and to provide guidelines for care of obese trauma patients.","['VanHoy, Sherry N', 'Laidlow, V Tereceita']","['VanHoy SN', 'Laidlow VT']","['Department of Emergency Medicine, Sinai Hospital of Baltimore, 2401 W. Belvedere Avenue, Baltimore, MD 21215, USA. svanhoy@lifebridgehealth.org']",['eng'],"['Journal Article', 'Review']",United States,Crit Care Nurs Clin North Am,Critical care nursing clinics of North America,8912620,,,"['Emergency Medical Services', 'Humans', 'Obesity/classification/*complications', 'Resuscitation/methods', 'Wounds and Injuries/etiology/nursing/*therapy']",,,,,2009/10/21 06:00,2011/05/05 06:00,['2009/10/21 06:00'],"['2009/10/21 06:00 [entrez]', '2009/10/21 06:00 [pubmed]', '2011/05/05 06:00 [medline]']","['S0899-5885(09)00044-6 [pii]', '10.1016/j.ccell.2009.07.004 [doi]']",ppublish,"Crit Care Nurs Clin North Am. 2009 Sep;21(3):377-89, vi-vii. doi: 10.1016/j.ccell.2009.07.004.",,,,,,,,,,,,,,,,,,,,
246901,NLM,MEDLINE,19780724,20150901,0047-262X (Print),24,4,1977 Oct,[Weight reduction and weight control strategies for obese individuals: a case for behavior modification].,22-5,,,"['Lee, C M']",['Lee CM'],,['chi'],['Journal Article'],China (Republic : 1949- ),Hu Li Za Zhi,Hu li za zhi The journal of nursing,0073267,,,"['*Behavior Therapy', '*Body Weight', 'Humans', 'Obesity/psychology/*therapy']",,,,,1977/10/01 00:00,1977/10/01 00:01,['1977/10/01 00:00'],"['1977/10/01 00:00 [pubmed]', '1977/10/01 00:01 [medline]', '1977/10/01 00:00 [entrez]']",,ppublish,Hu Li Za Zhi. 1977 Oct;24(4):22-5.,,,,,,,,,,,,,,,,,,,,
8966462,NLM,MEDLINE,19961219,20051116,0035-3655 (Print) 0035-3655 (Linking),116,10,1996 Oct,[Obesity: a frequently neglected pathology].,829-38,,,"['Dubuis, J M']",['Dubuis JM'],"['Departement de pediatrie, Hopital des Enfants, Hopitaux universitaires de Geneve.']",['fre'],"['Journal Article', 'Review']",Switzerland,Rev Med Suisse Romande,Revue medicale de la Suisse romande,0421524,"['0 (Leptin)', '0 (Proteins)']",IM,"['Animals', 'Diet, Reducing', 'Energy Metabolism', 'Exercise', 'Humans', 'Leptin', 'Life Style', 'Mice', 'Mice, Obese/genetics', 'Obesity/complications/genetics/*physiopathology/prevention & control', 'Proteins/genetics']",,,,,1996/10/01 00:00,1996/10/01 00:01,['1996/10/01 00:00'],"['1996/10/01 00:00 [pubmed]', '1996/10/01 00:01 [medline]', '1996/10/01 00:00 [entrez]']",,ppublish,Rev Med Suisse Romande. 1996 Oct;116(10):829-38.,,,,,,,13,,L'obesite: une pathologie trop souvent negligee.,,,,,,,,,,,
26545654,NLM,MEDLINE,20170131,20170131,1699-5198 (Electronic) 0212-1611 (Linking),32,5,2015 Nov 1,[TWELVE WEEKS OF PHYSICAL EXERCISE INTERVAL WITH SURCHARGE IMPROVES THE ANTHROPOMETRIC VARIABLES OF OBESE MORBID AND OBESE WITH COMORBIDITIES CANDIDATES TO BARIATRIC SURGERY].,2007-11,10.3305/nh.2015.32.5.9610 [doi],"INTRODUCTION: for the morbid obesity the bariatric surgery is effective, but to major preoperative weight it might increase morbidity and mortality, for such a motive it is necessary to implement programs that improve this condition. OBJECTIVE: to determine the effects of a program of physical exercise interval on the anthropometric profile of the morbidly obese and obese with comorbidities candidates to bariatric surgery. MATERIAL AND METHODS: three men and twenty-five women between 18 and 60 years old candidates to bariatric surgery, with morbid obesity (n = 16) or obese and comorbidities (type-II diabetes mellitus, hypertension, dyslipidemia, insulin resistance) (n = 12), they were subjected to a program of physical exercise with interval overload of three months duration (36 sessions). Before and 72 hours after the last intervention session was evaluated on fasting (>/= 12 hours): body weight, body mass index (BMI), waist contour (WC) and contour hip. RESULTS: the average age corresponds to 36.96 years, prior to intervention the weight had an average of 102.66 +/- 15.96 kg, BMI of 40.84 +/- 4.94, the WC 114.22 +/- 10.35 cm and the contour hip 126.84 +/- 10.65 cm. After twelve weeks of intervention showed significant decreases in weight variables (p = 0.000), BMI (p = 0.001), WC (p = 0.000) and hip contour (0.000). CONCLUSIONS: twelve weeks of interval exercise improved preoperative anthropometric conditions, without presenting risks in health and with high adherence to the program, which is why it may be recommended for this type of treatment.","['Delgado Floody, Pedro', 'Jerez Mayorga, Daniel', 'Caamano Navarrete, Felipe', 'Osorio Poblete, Aldo', 'Thuillier Lepeley, Nicole', 'Alarcon Hormazabal, Manuel']","['Delgado Floody P', 'Jerez Mayorga D', 'Caamano Navarrete F', 'Osorio Poblete A', 'Thuillier Lepeley N', 'Alarcon Hormazabal M']","['Programa de Tratamiento Integral de la Obesidad Morbida, Universidad Santo Tomas, Temuco. Carrera de Pedagogia en Educacion Fisica, Escuela de Educacion, Universidad Santo Tomas, Temuco.. pedrodelgadofloody@gmail.com.', 'Carrera de Kinesiologia, Facultad de Ciencias de la Salud, Universidad San Sebastian.. pedrodelgadofloody@gmail.com.', 'Carrera de Pedagogia en Educacion Fisica, Facultad de Educacion, Universidad Catolica de Temuco, Temuco.. pedrodelgadofloody@gmail.com.', 'Programa de Tratamiento Integral de la Obesidad Morbida, Universidad Santo Tomas, Temuco. Carrera de Pedagogia en Educacion Fisica, Escuela de Educacion, Universidad Santo Tomas, Temuco.. pedrodelgadofloody@gmail.com.', 'Programa de Tratamiento Integral de la Obesidad Morbida, Universidad Santo Tomas, Temuco. Escuela de Kinesiologia, Universidad Santo Tomas, Temuco.. pedrodelgadofloody@gmail.com.', 'Programa de Tratamiento Integral de la Obesidad Morbida, Universidad Santo Tomas, Temuco. Escuela de Nutricion, Universidad Santo Tomas (Temuco), Chile.. pedrodelgadofloody@gmail.com.']",['spa'],['Journal Article'],Spain,Nutr Hosp,Nutricion hospitalaria,9100365,,IM,"['Adolescent', 'Adult', 'Anthropometry', 'Bariatric Surgery/*statistics & numerical data', 'Body Mass Index', 'Comorbidity', '*Exercise', 'Exercise Therapy', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/complications/*surgery/*therapy', 'Obesity, Morbid/complications/*surgery/*therapy', 'Waist Circumference', 'Waist-Hip Ratio', 'Young Adult']",,,,,2015/11/08 06:00,2017/02/01 06:00,['2015/11/08 06:00'],"['2015/11/08 06:00 [entrez]', '2015/11/08 06:00 [pubmed]', '2017/02/01 06:00 [medline]']",['10.3305/nh.2015.32.5.9610 [doi]'],epublish,Nutr Hosp. 2015 Nov 1;32(5):2007-11. doi: 10.3305/nh.2015.32.5.9610.,,20151101,,"['Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights', 'reserved.']",,,,,DOCE SEMANAS DE EJERCICIO FISICO INTERVALADO CON SOBRECARGA MEJORA LAS VARIABLES ANTROPOMETRICAS DE OBESOS MORBIDOS Y OBESOS CON COMORBILIDADES POSTULANTES A CIRUGIA BARIATRICA.,,,,,,,,,,,
35343242,NLM,MEDLINE,20230612,20230612,1555-9823 (Electronic) 0003-1348 (Linking),89,5,2023 May,Outcomes in Obese vs Non-Obese Injured Patients at a Level 1 Trauma Center and Bariatric Surgery Center of Excellence.,1899-1905,10.1177/00031348221083954 [doi],"BACKGROUND: We hypothesized that the outcomes of trauma patients with a body mass index (BMI) equal to or greater than 30 compared to patients with BMI less than 30 would not differ at a level 1 trauma center that is also a Metabolic and Bariatric Surgery Center of Excellence in the Metabolic and Bariatric Surgery Accreditation Quality Improvement Program (MBSAQIP). STUDY DESIGN: Patients equal to and greater than 18 years old treated between 1/1/2018 and 12/31/2020 were included. Demographics, BMI, comorbidities, and outcomes (hospital-LOS, ICU-LOS, blood products used, and mortality) were compared between 2 groups: obese (BMI >/=30) vs non-obese (BMI <30). RESULTS: Of the 4192 patients identified, 3821 met the inclusion criteria; 3019 patients had a BMI <30, and 802 had a BMI >/=30. There was a statistically significant difference between the 2 groups with respect to gender (females: 57% vs 47%, P < .0001) and age (median: 80 [IQR: 63-88] vs 69 [IQR: 55-81], P < .0001). When adjusted for age, sex, DM, dementia, ISS, and ICU admission, there was no statistically significant difference in hospital-LOS (4.30 [95% CI: 4.10, 4.52] vs 4.48 [95% CI: 4.18, 4.79]) or mortality. No statistical differences were seen between the 2 groups in blood product use. CONCLUSIONS: Obesity did not correlate with poorer outcomes at an ACS-verified level 1 Trauma Center and Bariatric Surgery Center of Excellence. Further studies are needed to determine whether outcomes vary at hospitals without both designations.","['Petrone, Patrizio', ""Joseph, D'Andrea K"", 'Baltazar, Gerard', 'Akerman, Meredith', 'Howell, Raelina S', 'Brathwaite, Collin E M']","['Petrone P', 'Joseph DK', 'Baltazar G', 'Akerman M', 'Howell RS', 'Brathwaite CEM']","['Department of Surgery, NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, Mineola, NY, USA. RINGGOLD: 24998', 'Department of Surgery, NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, Mineola, NY, USA. RINGGOLD: 24998', 'Department of Surgery, NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, Mineola, NY, USA. RINGGOLD: 24998', 'Department of Biostatistics, NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, Mineola, NY, USA. RINGGOLD: 24998', 'Department of Surgery, NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, Mineola, NY, USA. RINGGOLD: 24998', 'Department of Surgery, NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, Mineola, NY, USA. RINGGOLD: 24998']",['eng'],['Journal Article'],United States,Am Surg,The American surgeon,0370522,,IM,"['Female', 'Humans', 'Adolescent', 'Trauma Centers', 'Obesity/complications/surgery/epidemiology', '*Bariatric Surgery', 'Body Mass Index', 'Comorbidity', 'Retrospective Studies', '*Obesity, Morbid/complications/surgery']",,['NOTNLM'],"['bariatric surgery center of excellence', 'injury', 'obesity', 'trauma center', 'trauma surgery']",,2022/03/29 06:00,2023/06/12 06:42,['2022/03/28 08:52'],"['2023/06/12 06:42 [medline]', '2022/03/29 06:00 [pubmed]', '2022/03/28 08:52 [entrez]']",['10.1177/00031348221083954 [doi]'],ppublish,Am Surg. 2023 May;89(5):1899-1905. doi: 10.1177/00031348221083954. Epub 2022 Mar 27.,,20220327,,,,,,,,,,,,,,,,,,
10744853,NLM,MEDLINE,20000512,20191025,0276-3478 (Print) 0276-3478 (Linking),27,4,2000 May,Maternal child feeding practices and obesity: a discordant sibling analysis.,459-63,,"BACKGROUND: The relationship between maternal feeding practices and weight status of 7-12 year-old obese and nonobese siblings was evaluated in 18 families using a discordant sibling design. METHOD: Mothers completed measures of concern and perception of children's weight and eating behavior, their control over child feeding, and maternal eating behavior. RESULTS: Intraclass correlations suggested similarity between obese and nonobese siblings in maternal control over feeding. Mothers perceived differences between their obese and nonobese children's eating regulation. Mothers' weight status was positively associated with disinhibition of their own eating as well as concern about both their obese and nonobese children's weight and health. DISCUSSION: These findings fail to support the hypothesis that maternal control over child feeding is related to childhood obesity, but highlight the impact of maternal weight history and eating habits on her impression of children's future weight and health independent of the child's weight status.","['Saelens, B E', 'Ernst, M M', 'Epstein, L H']","['Saelens BE', 'Ernst MM', 'Epstein LH']","['Department of Psychology, San Diego State University, San Diego, CA, USA.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Int J Eat Disord,The International journal of eating disorders,8111226,,IM,"['Adult', 'Body Weight', 'Child', '*Child Rearing', '*Feeding Behavior', 'Female', 'Humans', 'Male', '*Mother-Child Relations', 'Nuclear Family', 'Obesity/*etiology/genetics/psychology']",,,,,2000/04/01 09:00,2000/05/20 09:00,['2000/04/01 09:00'],"['2000/04/01 09:00 [pubmed]', '2000/05/20 09:00 [medline]', '2000/04/01 09:00 [entrez]']","['10.1002/(SICI)1098-108X(200005)27:4<459::AID-EAT11>3.0.CO;2-C [pii]', '10.1002/(sici)1098-108x(200005)27:4<459::aid-eat11>3.0.co;2-c [doi]']",ppublish,Int J Eat Disord. 2000 May;27(4):459-63. doi: 10.1002/(sici)1098-108x(200005)27:4<459::aid-eat11>3.0.co;2-c.,['HD 25997/HD/NICHD NIH HHS/United States'],,,"['Copyright 2000 by John Wiley & Sons, Inc.']",,,,,,,,,,,,,,,,
28052689,NLM,MEDLINE,20190314,20190314,1552-3799 (Electronic) 1054-7738 (Linking),27,4,2018 May,Nurses' Weight Bias in Caring for Obese Patients: Do Weight Controllability Beliefs Influence the Provision of Care to Obese Patients?,414-432,10.1177/1054773816687443 [doi],"Given the pervasive stigma faced by obese individuals in family, work, and health care settings, the present study aimed to explore whether nurses' weight controllability beliefs influence their perception of how care is provided to obese patients. To this end, 73 nurses from an acute care hospital completed the Weight Control/Blame Subscale of the Antifat Attitudes Test and reported on their perception of discrimination in, and available resources for, the provision of care to obese patients. Nurses endorsing stronger beliefs that weight lies under individual control were more likely to report discrimination of obese patients in clinical practice. Weight bias, higher care intensity, and lack of necessary resources were the main reasons reported for perceived weight discrimination. Our results support theories placing internal attribution of overweight and conflict over resources at the origin of weight stigma and call for appropriate interventions to improve nurses' work environment and reduce their weight bias.","['Tanneberger, Anne', 'Ciupitu-Plath, Cristina']","['Tanneberger A', 'Ciupitu-Plath C']","['1 Charite-Universitatsmedizin Berlin, Germany.', '1 Charite-Universitatsmedizin Berlin, Germany.']",['eng'],['Journal Article'],United States,Clin Nurs Res,Clinical nursing research,9208508,,,"['Adult', '*Attitude of Health Personnel', 'Delivery of Health Care', 'Female', 'Humans', 'Male', 'Nurses/*psychology', '*Obesity/nursing/psychology', '*Social Stigma']",,['NOTNLM'],"['nursing', 'obesity', 'obesity stigma', 'weight bias', 'weight controllability']",,2017/01/06 06:00,2019/03/15 06:00,['2017/01/06 06:00'],"['2017/01/06 06:00 [pubmed]', '2019/03/15 06:00 [medline]', '2017/01/06 06:00 [entrez]']",['10.1177/1054773816687443 [doi]'],ppublish,Clin Nurs Res. 2018 May;27(4):414-432. doi: 10.1177/1054773816687443. Epub 2017 Jan 4.,,20170104,,,,,,,,,,,,,,,,,,
19164989,NLM,MEDLINE,20090507,20090123,1536-3732 (Electronic) 1049-2275 (Linking),20,1,2009 Jan,Obese oral and maxillofacial surgical patient.,53-7,10.1097/SCS.0b013e3181945a9e [doi],"The incidence of obesity is rising in many countries around the world. With obesity exerting a direct impact on oral health, more obese patients are likely to report for oral and maxillofacial surgical procedures. The obese patient population presents with unique anatomic and physiologic challenges that can significantly influence treatment strategies. The implications of obesity must be understood by the maxillofacial surgeon to avoid potential pitfalls. This study focuses on the relevant issues concerning obesity with regard to oral and maxillofacial surgery.","['Krishnan, Balasubramanian']",['Krishnan B'],"['Department of Oral and Maxillofacial Surgery, Mahatma Gandhi Postgraduate Institute of Dental Sciences, Pondicherry, India. krishident@yahoo.co.uk']",['eng'],"['Journal Article', 'Review']",United States,J Craniofac Surg,The Journal of craniofacial surgery,9010410,,,"['Adipose Tissue/pathology/physiopathology', 'Body Fat Distribution/classification', 'Body Mass Index', 'Humans', 'Intraoperative Complications', 'Obesity/*complications/pathology/physiopathology', '*Oral Surgical Procedures', 'Postoperative Complications']",,,,,2009/01/24 09:00,2009/05/08 09:00,['2009/01/24 09:00'],"['2009/01/24 09:00 [entrez]', '2009/01/24 09:00 [pubmed]', '2009/05/08 09:00 [medline]']","['00001665-200901000-00015 [pii]', '10.1097/SCS.0b013e3181945a9e [doi]']",ppublish,J Craniofac Surg. 2009 Jan;20(1):53-7. doi: 10.1097/SCS.0b013e3181945a9e.,,,,,,,50,,,,,,,,,,,,,
4070428,NLM,MEDLINE,19860116,20190712,0031-9384 (Print) 0031-9384 (Linking),35,4,1985 Oct,Thermal preference behavior of genetically obese (ob/ob) and genetically lean (+/?) mice.,545-8,,"Chronically lower colonic temperatures (TcS) of genetically-obese (ob/ob) mice at ambient temperatures below thermoneutrality have led to speculation that these mutants regulate a lowered thermal setpoint relative to lean mice. Previous experiments, however, have not provided an opportunity for obese mice to exhibit compensatory thermoregulatory behaviors which might reinstate normal body temperature. In the present experiment, adult obese and lean (+/?) mice were tested at room temperature (25 degrees C) on a copper bar, thermal gradient to determine what temperatures they would select and what effect their selection would have on their TcS. The data revealed that ob/obs were more frequently observed within 25-35 degrees C locales than were lean controls, which spent more time in the below-25 degrees C zone (p less than 0.005). Ob/obs also raised their TcS to pretest values of leans' TcS, although ob/obs' TcS remained significantly lower than those of leans at the conclusion of testing. These data suggest that the hypothermia exhibited by the ob/ob may reflect both the absence of the opportunity to behaviorally thermoregulate and a genetic defect in thermogenesis.","['Wilson, L M', 'Sinha, H L']","['Wilson LM', 'Sinha HL']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Physiol Behav,Physiology & behavior,0151504,,IM,"['Animals', '*Body Temperature Regulation', 'Choice Behavior', 'Environment', 'Female', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Obese', 'Obesity/genetics/*physiopathology/psychology', 'Temperature']",,,,,1985/10/01 00:00,1985/10/01 00:01,['1985/10/01 00:00'],"['1985/10/01 00:00 [pubmed]', '1985/10/01 00:01 [medline]', '1985/10/01 00:00 [entrez]']","['0031-9384(85)90138-6 [pii]', '10.1016/0031-9384(85)90138-6 [doi]']",ppublish,Physiol Behav. 1985 Oct;35(4):545-8. doi: 10.1016/0031-9384(85)90138-6.,,,,,,,,,,,,,,,,,,,,
27180568,NLM,MEDLINE,20170406,20170406,1768-3181 (Electronic) 0003-3928 (Linking),65,3,2016 Jun,[Effect of N-3 polyunsaturated fatty acids on the modulation of T lymphocytes in vitro and redox status in obese women with hypertension].,126-30,S0003-3928(16)30303-1 [pii] 10.1016/j.ancard.2016.04.012 [doi],"OBJECTIVES: Deepen our knowledge of the immune system alterations associated with obesity-related hypertension and demonstrate that polyunsaturated fatty acids can enhance the proliferation and their profile oxidant/antioxidant and subsequently involved in the strategy prevention and treatment in obese hypertensives. METHODS: T cells are isolated from the blood of the control and obese women with hypertension the University Hospital of Tlemcen (Algeria), these cells are incubated in the presence of a synthetic mixture of PUFA to 30muM (DHA/EPA/LA) and stimulated by mitogens for 48hours. The cells are counted and used to assess intracellular oxidative status. The biochemical parameters are determined by the use of plasma. RESULTS: In obese women with hypertension, a significant increase in plasma levels of (glucose, uric acid, creatinine, urea, total cholesterol and triglycerides) compared to controls. In addition, decreased cell proliferation, basal or stimulated by Con A was observed in obese women with hypertension compared with controls. The mixture of PUFA to 30muM reduced lymphoproliferation as well in obese women with hypertension than in controls. The rates in malondialdehyde (MDA) and protein carbonyl lymphocytes are elevated in hypertensive obese women. PUFA supplementation to 30muM seems correct this redox status in hypertensive obese since rates in protein carbonyl, are similar to those of controls. CONCLUSION: The mixture of PUFA (n-3 and n-6) can modulate the activity of T lymphocyte proliferation and correct the intracellular redox status in hypertensive obese women.","['Baba Ahmed, F Z', 'Bouanane, S', 'Merzouk, H', 'Soufi, N']","['Baba Ahmed FZ', 'Bouanane S', 'Merzouk H', 'Soufi N']","['Laboratoire de physiologie, physiopathologie et biochimie de la nutrition PPABIONUT, departement de biologie, faculte SNVTU, universite de Tlemcen, Rocade 2, BP 119, Tlemcen, Algerie. Electronic address: fatimazohra_7@yahoo.fr.', 'Laboratoire de physiologie, physiopathologie et biochimie de la nutrition PPABIONUT, departement de biologie, faculte SNVTU, universite de Tlemcen, Rocade 2, BP 119, Tlemcen, Algerie.', 'Laboratoire de physiologie, physiopathologie et biochimie de la nutrition PPABIONUT, departement de biologie, faculte SNVTU, universite de Tlemcen, Rocade 2, BP 119, Tlemcen, Algerie.', 'Service de cardiologie, CHU de Tlemcen, Tlemcen, Algerie.']",['fre'],['Journal Article'],France,Ann Cardiol Angeiol (Paris),Annales de cardiologie et d'angeiologie,0142167,"['0 (Fatty Acids, Omega-3)']",IM,"['Adult', 'Body Mass Index', 'Fatty Acids, Omega-3/*pharmacology', 'Female', 'Humans', 'Hypertension/*metabolism', 'In Vitro Techniques/methods', 'Obesity/*metabolism', 'Oxidation-Reduction/*drug effects', 'T-Lymphocytes/*drug effects']",,['NOTNLM'],"['Acides gras polyinsatures', 'High blood pressure', 'Hypertension arterielle', 'Lymphocytes T', 'Obesity', 'Obesite', 'Oxidative stress', 'Polyunsaturated fatty acids', 'Stress oxydatif', 'T cells']",,2016/05/18 06:00,2017/04/07 06:00,['2016/05/17 06:00'],"['2016/04/06 00:00 [received]', '2016/04/12 00:00 [accepted]', '2016/05/17 06:00 [entrez]', '2016/05/18 06:00 [pubmed]', '2017/04/07 06:00 [medline]']","['S0003-3928(16)30303-1 [pii]', '10.1016/j.ancard.2016.04.012 [doi]']",ppublish,Ann Cardiol Angeiol (Paris). 2016 Jun;65(3):126-30. doi: 10.1016/j.ancard.2016.04.012. Epub 2016 May 12.,,20160512,,['Copyright (c) 2016 Elsevier Masson SAS. All rights reserved.'],,,,,Effet des acides gras polyinsatures N-3 sur la modulation in vitro des lymphocytes T et le statut redox chez les femmes obeses hypertendues.,,,,,,,,,,,
31903602,NLM,MEDLINE,20200720,20200720,1365-2168 (Electronic) 0007-1323 (Linking),107,2,2020 Jan,Perioperative care of the obese patient.,e39-e55,10.1002/bjs.11447 [doi],"BACKGROUND: Obesity has become an increasing problem worldwide during the past few decades. Hence, surgeons and anaesthetists will care for an increasing number of obese patients in the foreseeable future, and should be prepared to provide optimal management for these individuals. This review provides an update of recent evidence regarding perioperative strategies for obese patients. METHODS: A search for papers on the perioperative care of obese patients (English language only) was performed in July 2019 using the PubMed, Scopus, Web of Science and Cochrane Library electronic databases. The review focused on the results of RCTs, although observational studies, meta-analyses, reviews, guidelines and other reports discussing the perioperative care of obese patients were also considered. When data from obese patients were not available, relevant data from non-obese populations were used. RESULTS AND CONCLUSION: Obese patients require comprehensive preoperative evaluation. Experienced medical teams, appropriate equipment and monitoring, careful anaesthetic management, and an adequate perioperative ventilation strategy may improve postoperative outcomes. Additional perioperative precautions are necessary in patients with severe morbid obesity, metabolic syndrome, untreated or severe obstructive sleep apnoea syndrome, or obesity hypoventilation syndrome; patients receiving home ventilatory support or postoperative opioid therapy; and obese patients undergoing open operations, long procedures or revisional surgery.","['Carron, M', 'Safaee Fakhr, B', 'Ieppariello, G', 'Foletto, M']","['Carron M', 'Safaee Fakhr B', 'Ieppariello G', 'Foletto M']","['Department of Medicine - DIMED, Section of Anaesthesiology and Intensive Care, University of Padua, Padua, Italy.', 'Department of Medicine - DIMED, Section of Anaesthesiology and Intensive Care, University of Padua, Padua, Italy.', 'Department of Medicine - DIMED, Section of Anaesthesiology and Intensive Care, University of Padua, Padua, Italy.', 'Department of Surgical, Oncological and Gastroenterological Sciences, Section of Surgery, University of Padua, Padua, Italy.']",['eng'],"['Journal Article', 'Review']",England,Br J Surg,The British journal of surgery,0372553,,IM,"['Airway Management', 'Humans', 'Obesity/*complications/surgery', 'Patient Positioning', '*Perioperative Care/methods', 'Surgical Procedures, Operative']",,,,,2020/01/07 06:00,2020/07/21 06:00,['2020/01/07 06:00'],"['2019/11/07 00:00 [received]', '2019/11/07 00:00 [accepted]', '2020/01/07 06:00 [entrez]', '2020/01/07 06:00 [pubmed]', '2020/07/21 06:00 [medline]']",['10.1002/bjs.11447 [doi]'],ppublish,Br J Surg. 2020 Jan;107(2):e39-e55. doi: 10.1002/bjs.11447.,,,,['(c) 2020 BJS Society Ltd Published by John Wiley & Sons Ltd.'],,,,,,,,,,,,,,,,
20224654,NLM,MEDLINE,20100531,20181113,1466-1861 (Electronic) 0962-9351 (Print) 0962-9351 (Linking),2010,,2010,"Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.",364957,10.1155/2010/364957 [doi] 364957,"Overweight and obesity are highly prevalent in developed countries and are also becoming more frequent in the developing world. Overweight and obese patients have elevated levels of several inflammatory markers and this inflammatory state might contribute to their increased vascular risk. We summarize the effects of lifestyle changes, antiobesity agents, and bariatric surgery on serological inflammatory markers in overweight and obese patients. Most studies showed a decrease in inflammation with all 3 interventions. However, it remains to be established whether the decrease in inflammatory markers induced by lifestyle changes or (where indicated) with antiobesity agents or bariatric surgery will translate into reduced vascular morbidity and mortality in overweight and obese patients.","['Tziomalos, Konstantinos', 'Dimitroula, Hariklia V', 'Katsiki, Niki', 'Savopoulos, Christos', 'Hatzitolios, Apostolos I']","['Tziomalos K', 'Dimitroula HV', 'Katsiki N', 'Savopoulos C', 'Hatzitolios AI']","['First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, 54646, Thessaloniki, Greece. ktziomalos@yahoo.com']",['eng'],"['Journal Article', 'Review']",United States,Mediators Inflamm,Mediators of inflammation,9209001,"['0 (Anti-Obesity Agents)', '0 (Biomarkers)']",IM,"['Animals', 'Anti-Obesity Agents/*therapeutic use', '*Bariatric Surgery', 'Biomarkers/*metabolism', 'Diet', 'Exercise', 'Humans', 'Inflammation/*blood', '*Life Style', '*Obesity/blood/immunology/therapy']",PMC2833317,,,,2010/03/13 06:00,2010/06/01 06:00,['2010/03/13 06:00'],"['2009/12/01 00:00 [received]', '2010/01/25 00:00 [revised]', '2010/02/06 00:00 [accepted]', '2010/03/13 06:00 [entrez]', '2010/03/13 06:00 [pubmed]', '2010/06/01 06:00 [medline]']",['10.1155/2010/364957 [doi]'],ppublish,Mediators Inflamm. 2010;2010:364957. doi: 10.1155/2010/364957. Epub 2010 Mar 7.,,20100307,,,,,,,,,,,,,,,,,,
22640529,NLM,MEDLINE,20130109,20211021,1873-6130 (Electronic) 1570-677X (Print) 1570-677X (Linking),10,4,2012 Dec,"Obesity, family instability, and socioemotional health in adolescence.",375-84,10.1016/j.ehb.2012.04.005 [doi],"The last two decades have witnessed dramatic increases in obesity and family instability. To the extent that the social stigma of obesity is a risk factor and family instability represents the potential compromise of important protective factors, their convergence may disrupt socioemotional health, especially during periods of heightened social uncertainty. Drawing on data from the National Longitudinal Study of Adolescent Health, this study found that obese youth at the start of high school had higher levels of internalizing symptoms and lower levels of perceived social integration in school only when they had also experienced multiple family transitions since birth. This pattern, however, did not hold for boys, and it did not extend to overweight (as opposed to obese) adolescents of either gender.","['Crosnoe, Robert']",['Crosnoe R'],"['Department of Sociology and Population Research Center, University of Texas at Austin, Austin, TX 78712-1088, United States. crosnoe@austin.utexas.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't""]",Netherlands,Econ Hum Biol,Economics and human biology,101166135,,IM,"['Adolescent', 'Family Characteristics', '*Family Relations', 'Female', 'Health Surveys', 'Humans', 'Male', 'Obesity/epidemiology/etiology/*psychology', '*Psychology, Adolescent', 'Regression Analysis', 'Sex Factors', 'United States/epidemiology']",PMC5555845,,,,2012/05/30 06:00,2013/01/10 06:00,['2012/05/30 06:00'],"['2012/04/16 00:00 [received]', '2012/04/16 00:00 [accepted]', '2012/05/30 06:00 [entrez]', '2012/05/30 06:00 [pubmed]', '2013/01/10 06:00 [medline]']","['S1570-677X(12)00061-5 [pii]', '10.1016/j.ehb.2012.04.005 [doi]']",ppublish,Econ Hum Biol. 2012 Dec;10(4):375-84. doi: 10.1016/j.ehb.2012.04.005. Epub 2012 May 15.,"['R01 HD055359/HD/NICHD NIH HHS/United States', 'R24 HD042849/HD/NICHD NIH HHS/United States']",20120515,,['Copyright (c) 2012 Elsevier B.V. All rights reserved.'],,['NIHMS889521'],,,,,,,,,,,,,,
24735219,NLM,MEDLINE,20151005,20220318,2042-3306 (Electronic) 0425-1644 (Linking),47,2,2015 Mar,Prevalence of and risk factors for equine obesity in Great Britain based on owner-reported body condition scores.,196-201,10.1111/evj.12275 [doi],"REASONS FOR PERFORMING THE STUDY: Few data are available on the prevalence of obesity in the general equine population of Great Britain (GB), and its associated risk factors. OBJECTIVES: To estimate the prevalence of owner-reported obesity in veterinary-registered horses and ponies in GB, and identify factors associated with obesity. STUDY DESIGN: A cross-sectional survey of horse/pony owners in GB was undertaken using a postal questionnaire. METHODS: Thirty veterinary practices randomly selected horse/pony owners to complete a self-administered postal questionnaire. Owners estimated body condition score using a modified Carroll and Huntington method (1-6 scale), and animals were classified as obese if they were scored as either 5 (fat) or 6 (very fat). Factors associated with obesity were assessed using logistic regression analysis. RESULTS: Prevalence of obesity was 31.2% (n = 247/792; 95% confidence interval [CI] 27.9-34.2%). Factors associated with increased odds of obesity were breed (P<0.001), ease of maintaining weight (P<0.001) and primary use (P = 0.002). Compared to Thoroughbreds, draught-type (odds ratio [OR] 7.3; 95% CI 3.1-17.1), cob-type (OR 5.6; 95% CI 2.5-12.5), native (OR 3.2; 95% CI 1.8-5.78) and Welsh breeds (OR 3.5; 95% CI 1.9-6.2) were more likely to be obese. Animals described as 'good doers' were more likely to be obese than those described as readily maintaining normal weight (OR 3.7; 95% CI 2.6-5.3). Compared to competition animals, animals used for pleasure riding (OR 2.5; 95% CI 1.4-4.4) and nonridden animals (OR 2.9; 95% CI 1.5-5.5) were more likely to be obese. CONCLUSIONS: Identification of at-risk breeds and other horse- and management-level risk factors for obesity will enable optimal targeting of owner education regarding management strategies to reduce the frequency of equine obesity.","['Robin, C A', 'Ireland, J L', 'Wylie, C E', 'Collins, S N', 'Verheyen, K L P', 'Newton, J R']","['Robin CA', 'Ireland JL', 'Wylie CE', 'Collins SN', 'Verheyen KL', 'Newton JR']","['Epidemiology and Disease Surveillance Department, Animal Health Trust, Newmarket, Suffolk, UK.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Equine Vet J,Equine veterinary journal,0173320,,IM,"['Animal Husbandry', 'Animals', 'Data Collection', 'Horse Diseases/epidemiology/*etiology', 'Horses', 'Obesity/epidemiology/etiology/*veterinary', 'Prevalence', 'Risk Factors', 'Surveys and Questionnaires']",,['NOTNLM'],"['condition score', 'horse', 'obese', 'risk factors', 'weight']",,2014/04/17 06:00,2015/10/06 06:00,['2014/04/17 06:00'],"['2013/11/14 00:00 [received]', '2014/04/05 00:00 [accepted]', '2014/04/17 06:00 [entrez]', '2014/04/17 06:00 [pubmed]', '2015/10/06 06:00 [medline]']",['10.1111/evj.12275 [doi]'],ppublish,Equine Vet J. 2015 Mar;47(2):196-201. doi: 10.1111/evj.12275. Epub 2014 May 23.,,20140523,,['(c) 2014 EVJ Ltd.'],,,,,,,,,,,,,,,,
30352035,NLM,MEDLINE,20190111,20210217,1553-3840 (Electronic) 1553-3840 (Linking),15,4,2018 Oct 20,Yoga practice to improve sleep quality and body composition parameters of obese male - a randomized controlled trial.,,10.1515/jcim-2016-0077 [doi],"Background Globally obesity increase is a big challenge. Obesity causes many non-communicable diseases. Options to control obesity are in search. Aim: To assess the outcome of 3 months follow-up period, after 14 weeks yoga intervention, for body composition and sleep quality parameters on obese male in urban setting. Materials and methods Design: Parallel group RCT (randomized controlled trial) on obese male. The two groups were yoga and control groups, with yoga (n = 37, age 40.03 +/- 8.74), control (n = 35, age 42.20 +/- 12.06). The IAYT (integrated approach of yoga therapy) training was given to yoga group for 14 weeks, and the unsupervised yoga practice was continued by the subjects at their home, for further 3 months. Training was 1.5 hour daily for 5 days in a week, which included the IAYT module of Suryanamaskara Asana Pranayama and relaxation. No yoga activity but walking etc. for the same time, was given to control group. Body composition parameters were assessed through BIA (bioelectrical impedance) method using InBody R 20 model. The sleep quality was assessed using PSQI (Pittsburgh sleep quality index). Within group and between group analysis were performed, using SPSS version 21. The correlation analysis was carried out on the difference in pre follow-up values. Results During the follow-up period within the group, the body composition parameters improved and the parameters of quality of sleep showed trends of improvement. Also some of the gain obtained during 14 weeks intervention was lost during follow-up period. Conclusions The changes observed may indicate the long-term benefits of yoga practice for control of obesity in urban setting for males.","['Rshikesan, P B', 'Subramanya, Pailoor', 'Nidhi, Ram']","['Rshikesan PB', 'Subramanya P', 'Nidhi R']","['Department of Yoga and life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, India.', 'Department of Yoga and life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, India.', 'Department of Yoga and life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, India.']",['eng'],"['Journal Article', 'Randomized Controlled Trial']",Germany,J Complement Integr Med,Journal of complementary & integrative medicine,101313855,,IM,"['Adult', 'Body Composition', 'Female', 'Humans', 'Male', '*Meditation', 'Middle Aged', 'Obesity/*physiopathology/psychology/*therapy', 'Relaxation', 'Sleep', '*Yoga']",,['NOTNLM'],"['BMI (body mass index)', 'PSQI', 'body composition', 'sleep', 'yoga']",,2018/10/24 06:00,2019/01/12 06:00,['2018/10/24 06:00'],"['2016/06/23 00:00 [received]', '2018/05/02 00:00 [accepted]', '2018/10/24 06:00 [pubmed]', '2019/01/12 06:00 [medline]', '2018/10/24 06:00 [entrez]']","['jcim-2016-0077 [pii]', '10.1515/jcim-2016-0077 [doi]']",epublish,J Complement Integr Med. 2018 Oct 20;15(4). doi: 10.1515/jcim-2016-0077.,,20181020,,,,,,,,,,,,,,,,,,
18167330,NLM,MEDLINE,20080402,20080102,1471-0153 (Print) 1471-0153 (Linking),9,1,2008 Jan,Defense mechanisms in a sample of non-psychiatric obese subjects.,120-3,10.1016/j.eatbeh.2007.06.005 [doi],"The aim was to assess the prevalent defense mechanisms in a sample of obese subjects; since specific defensive styles may interfere with the management of stressors and emotions, they may also influence the onset, the severity, and the maintenance of obesity. 70 obese subjects and 70 healthy normal-weight volunteers were assessed using the Defense Mechanisms Inventory -- DMI. Significant differences between groups have emerged at Turning Against Object (t=-5.30; p<0.0001), Projection (t=-5.55; p<0.0001), Turning Against Self (t=-4.87; p<0.0001) and Reversal (t=-3.61; p<0.0001) variables. Within the obese group, significant differences have been found at Turning Against Object (U=264; p=.001) and Projection (U=359; p=.042) scales, both higher in males. No significant differences on DMI scores in relation to the severity of obesity have been observed. An inadequate defensive structure might represent a vulnerability to emotional states and stressful life events. The assessment of defense mechanisms may provide a valid tool for long-term treatments of obesity.","['Zoccali, Rocco', 'Bruno, Antonio', 'Muscatello, Maria Rosaria', 'Mico, Umberto', 'Corica, Francesco', 'Meduri, Mario']","['Zoccali R', 'Bruno A', 'Muscatello MR', 'Mico U', 'Corica F', 'Meduri M']","['Section of Psychiatry, Department of Neurosciences, Psychiatric and Anesthesiological Sciences, University Hospital, Messina, Italy. Rocco.Zocccali@unime.it']",['eng'],['Journal Article'],United States,Eat Behav,Eating behaviors,101090048,,IM,"['Adaptation, Psychological', 'Adolescent', 'Adult', 'Aged', '*Defense Mechanisms', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*epidemiology/*psychology']",,,,,2008/01/03 09:00,2008/04/03 09:00,['2008/01/03 09:00'],"['2006/11/20 00:00 [received]', '2007/05/02 00:00 [revised]', '2007/06/06 00:00 [accepted]', '2008/01/03 09:00 [pubmed]', '2008/04/03 09:00 [medline]', '2008/01/03 09:00 [entrez]']","['S1471-0153(07)00036-0 [pii]', '10.1016/j.eatbeh.2007.06.005 [doi]']",ppublish,Eat Behav. 2008 Jan;9(1):120-3. doi: 10.1016/j.eatbeh.2007.06.005. Epub 2007 Jun 20.,,20070620,,,,,,,,,,,,,,,,,,
25252747,NLM,MEDLINE,20160126,20150501,2191-0251 (Electronic) 0334-018X (Linking),28,5-6,2015 May,The effect of lifestyle change and metformin therapy on serum arylesterase and paraoxonase activity in obese children.,551-6,10.1515/jpem-2013-0486 [doi],"AIM: Obesity is known to be associated with many diseases in the long and short terms. Elevated oxidative stress contributes to the development of such obesity-related diseases as dyslipidemia, diabetes mellitus and hypertension. Levels of the endogenous antioxidants paraoxonase and arylesterase have been shown to decrease in such diseases. The purpose of this study was to investigate whether or not changes in lifestyle and metformin therapy would affect serum paraoxonase and arylesterase levels. MATERIALS AND METHODS: The study was performed with 25 overweight, 26 obese and 25 morbidly obese patients aged 6-15 years as well as 27 healthy children. Serum paraoxonase (PON1) and arylesterase (ARE) activity levels and total cholesterol, triglyceride, low-density protein, high-density protein, very low-density protein, glucose, aspartate amino transferase and alanine amino transferase levels were measured. Enrolled patients were assessed at initial presentation and again at 6 months. No procedure was performed in the control group, while the overweight, obese and morbidly obese groups were recommended diet and exercise and given metformin therapy (insulin-resistant subjects only). RESULTS: Serum PON1 activity levels in patients with metabolic syndrome were significantly lower than those in individuals without metabolic syndrome (p<0.05), while lipid concentrations were significantly higher (p<0.05). Metabolic syndrome patients had higher serum glucose, total cholesterol, low-density protein, very low-density protein and triglyceride values compared to those of the control group but significantly lower high-density protein values (p<0.05). No difference was determined between the groups in terms of PON1 and ARE levels following diet and exercise and metformin therapy. CONCLUSION: Measurement of PON1 and ARE enzyme levels may be useful in monitoring the effectiveness of treatment aimed at reducing oxidative stress in obese children.","['Cayir, Atilla', 'Turan, Mehmet Ibrahim', 'Gurbuz, Fatih', 'Kurt, Nezahat', 'Yildirim, Abdulkadir']","['Cayir A', 'Turan MI', 'Gurbuz F', 'Kurt N', 'Yildirim A']",,['eng'],['Journal Article'],Germany,J Pediatr Endocrinol Metab,Journal of pediatric endocrinology & metabolism : JPEM,9508900,"['9100L32L2N (Metformin)', 'EC 3.1.1.- (Carboxylic Ester Hydrolases)', 'EC 3.1.1.2 (arylesterase)', 'EC 3.1.8.1 (Aryldialkylphosphatase)']",IM,"['Adult', 'Aryldialkylphosphatase/*blood', 'Carboxylic Ester Hydrolases/*blood', 'Child', 'Humans', '*Life Style', 'Metformin/*therapeutic use', 'Obesity/*drug therapy/enzymology/physiopathology/*therapy']",,,,,2014/09/26 06:00,2016/01/27 06:00,['2014/09/26 06:00'],"['2013/12/15 00:00 [received]', '2014/08/14 00:00 [accepted]', '2014/09/26 06:00 [entrez]', '2014/09/26 06:00 [pubmed]', '2016/01/27 06:00 [medline]']","['/j/jpem.ahead-of-print/jpem-2013-0486/jpem-2013-0486.xml [pii]', '10.1515/jpem-2013-0486 [doi]']",ppublish,J Pediatr Endocrinol Metab. 2015 May;28(5-6):551-6. doi: 10.1515/jpem-2013-0486.,,,,,,,,,,,,,,,,,,,,
3429114,NLM,MEDLINE,19880302,20140603,,11,5,1987,The development of perirenal fat depots in obese and lean pig fetuses.,545-57,,"The differentiation of perirenal adipose tissue was ascertained in fetuses from Ossabaw (wild and obese) and cross-bred lean dams at 70, 90 and 110 days gestation and from domestic lean and obese dams (USDA) at 110 days gestation. Condensation of presumptive adipocyte clusters was more apparent in Ossabaw sections than in cross-bred (lean) sections at 90 and 110 days gestation. Enzyme and lipid histochemistry showed fat cell cluster development to be largely independent of fetal strain (Ossabaw vs crossbred). However, adipocytes in Ossabaw fetuses were larger (110 days) and more reactive for esterase activity (all three ages) than were adipocytes from crossbred fetuses. Fetuses from USDA-obese dams had larger fat cell diameters (P less than 0.01), a higher percentage of lipoprotein lipase (LPL) positive cells than did fetuses from USDA-lean dams. Perirenal fat pad weights, percent depot lipid, percentages of glucose-6-phosphate dehydrogenase (G6PDH) and succinate dehydrogenase (SDH) positive cells were independent of fetal strain (USDA, lean vs obese). Fat cell cluster development was independent of fetal strain but large cellular condensations of presumptive cells were only present in sections from lean fetuses. Immature capillary beds (devoid of adipocytes) were demonstrable in lean sections but were not observed in obese sections. Morphological and histochemical results from both studies provide no evidence for brown adipocyte-like cells in fetal perirenal tissues.","['Hausman, G J', 'Thomas, G B']","['Hausman GJ', 'Thomas GB']","['Animal Physiology Research Unit, R. B. Russell Agricultural Research Center, USDA-ARS, Athens, GA 30613.']",['eng'],['Journal Article'],England,Int J Obes,International journal of obesity,7703240,,IM,"['Adipose Tissue/*embryology/enzymology', 'Animals', 'Female', 'Fetus', 'Kidney', 'Male', 'Obesity/*embryology/enzymology/metabolism', 'Pregnancy', 'Swine']",,,,,1987/01/01 00:00,1987/01/01 00:01,['1987/01/01 00:00'],"['1987/01/01 00:00 [pubmed]', '1987/01/01 00:01 [medline]', '1987/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1987;11(5):545-57.,,,,,,,,,,,,,,,,,,,,
7301963,NLM,MEDLINE,19820109,20190712,0031-9384 (Print) 0031-9384 (Linking),27,2,1981 Aug,Copulatory behavior and reproductive capacity of the genetically obese female Zucker rat.,331-5,,,"['Chelich, A M', 'Edmonds, E S']","['Chelich AM', 'Edmonds ES']",,['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Physiol Behav,Physiology & behavior,0151504,,IM,"['Animals', 'Female', 'Male', 'Obesity/*genetics/physiopathology/psychology', 'Rats', 'Rats, Zucker', '*Reproduction', 'Sexual Behavior, Animal/*physiology']",,,,,1981/08/01 00:00,1981/08/01 00:01,['1981/08/01 00:00'],"['1981/08/01 00:00 [pubmed]', '1981/08/01 00:01 [medline]', '1981/08/01 00:00 [entrez]']","['0031-9384(81)90276-6 [pii]', '10.1016/0031-9384(81)90276-6 [doi]']",ppublish,Physiol Behav. 1981 Aug;27(2):331-5. doi: 10.1016/0031-9384(81)90276-6.,,,,,,,,,,,,,,,,,,,,
37061360,NLM,MEDLINE,20230501,20230501,1769-664X (Electronic) 0929-693X (Linking),30,4,2023 May,Characterization of lymphocyte profiles in children with syndromic obesity.,212-218,S0929-693X(23)00038-6 [pii] 10.1016/j.arcped.2023.02.009 [doi],"BACKGROUND: Little is known about blood lymphocyte subpopulations in children with common (CO) or syndromic (SO) obesity. We aimed to describe the blood lymphocyte profiles of obese children and to search for associations with clinical phenotypes. METHODS: Main blood lymphocyte subpopulations were analyzed in 159 children with CO and 34 with SO in a retrospective cohort. Phenotypes included obesity history, body mass index (BMI) Z score, percentage fat mass, and inflammatory parameters. Correlations were performed between phenotypes and circulating lymphocyte profiles. RESULTS: Children with SO had a higher BMI Z score (5.5 +/- 1.7 SD) than children with CO (4.7 +/- 0.9 SD; p = 0.01). Significant differences were found for lymphocyte counts, including a higher percentage of CD19(+) B cells (SO = 20.1 +/- 6.7 vs. CO = 17.1 +/- 6.1%, p = 0.03), despite lower absolute numbers (SO = 0.57 +/- 0.20 vs. CO = 0.63 +/- 1.9 g/L, p < 0.01). However, no difference in the lymphocyte profile was found between children with SO and those with the most severe CO (BMI Z score >/= 4.7 SD). CONCLUSION: Children with SO have altered blood lymphocyte profiles with increased prevalence of CD19(+) B cells, which is closely linked to the degree of obesity severity and inflammatory markers.","['Dieme, A', 'Andre, S', 'Lapillonne, H', 'Tounian, P', 'Clement, K', 'Dubern, B']","['Dieme A', 'Andre S', 'Lapillonne H', 'Tounian P', 'Clement K', 'Dubern B']","[""Armand-Trousseau Children's Hospital, Pediatric Nutrition and Gastroenterology Department, Paris, France."", 'Sorbonne Universite, INSERM, Nutrition and Obesities, Systemic Approaches, Nutriomics, Paris, France.', ""Armand-Trousseau Children's Hospital, Biological Hematology Department, Paris, France."", ""Armand-Trousseau Children's Hospital, Pediatric Nutrition and Gastroenterology Department, Paris, France."", 'Sorbonne Universite, INSERM, Nutrition and Obesities, Systemic Approaches, Nutriomics, Paris, France; Hopital Universitaire Pitie Salpetriere, Nutrition Department, Paris, France.', ""Armand-Trousseau Children's Hospital, Pediatric Nutrition and Gastroenterology Department, Paris, France; Sorbonne Universite, INSERM, Nutrition and Obesities, Systemic Approaches, Nutriomics, Paris, France. Electronic address: beatrice.dubern@aphp.fr.""]",['eng'],['Journal Article'],France,Arch Pediatr,Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,9421356,,IM,"['Child', 'Humans', '*Pediatric Obesity/epidemiology', 'Retrospective Studies', 'Body Mass Index', 'Lymphocytes']",,['NOTNLM'],"['Adipose tissue', 'Childhood obesity', 'Immunology', 'Inflammation']",['Declaration of Competing Interest The authors declare no conflict of interest.'],2023/04/16 06:00,2023/05/01 06:42,['2023/04/15 21:57'],"['2022/11/15 00:00 [received]', '2023/02/12 00:00 [accepted]', '2023/05/01 06:42 [medline]', '2023/04/16 06:00 [pubmed]', '2023/04/15 21:57 [entrez]']","['S0929-693X(23)00038-6 [pii]', '10.1016/j.arcped.2023.02.009 [doi]']",ppublish,Arch Pediatr. 2023 May;30(4):212-218. doi: 10.1016/j.arcped.2023.02.009. Epub 2023 Apr 13.,,20230413,,"['Copyright (c) 2023 French Society of Pediatrics. Published by Elsevier Masson SAS.', 'All rights reserved.']",,,,,,,,,,,,,,,,
7342479,NLM,MEDLINE,19820722,20190825,0364-2313 (Print) 0364-2313 (Linking),5,6,1981 Nov,Psychological evaluation of extremely obese patients before and after surgical treatment.,833-8,,,"['Husemann, B', 'Erzigkeit, H']","['Husemann B', 'Erzigkeit H']",,['eng'],['Journal Article'],United States,World J Surg,World journal of surgery,7704052,,IM,"['Adult', 'Body Weight', 'Female', 'Humans', 'Male', 'Obesity/*psychology/therapy']",,,,,1981/11/01 00:00,1981/11/01 00:01,['1981/11/01 00:00'],"['1981/11/01 00:00 [pubmed]', '1981/11/01 00:01 [medline]', '1981/11/01 00:00 [entrez]']",['10.1007/BF01657971 [doi]'],ppublish,World J Surg. 1981 Nov;5(6):833-8. doi: 10.1007/BF01657971.,,,,,,,,,,,,,,,,,,,,
2744930,NLM,MEDLINE,19890815,20140603,,13,2,1989,Validity of anthropometry in classifying youths as obese.,183-93,,"Using densitometrically-determined percentage body fat as the criterion of true obesity, 316 youths aged 8.4-18.99 years were classified as obese or not obese using conventional referent values for five anthropometric indicators of obesity (weight, BMI, triceps skinfold, subscapular skinfold and percent body fat estimated from the sum of four skinfolds). Estimates of sensitivity, specificity, predictive value and efficiency were used to describe the relative validity of the anthropometric indicators, and the nature of misclassification resulting when the indicators were applied. The indicators were characterized generally by low levels of sensitivity and corresponding high rates of false negatives, i.e. truly obese youths who were considered not obese by the indicators. Although indicators had high specificities, there were significant differences among indicators. The general pattern of high specificity is desirable, given the nature of obesity in youths. Using the validity criteria and conventional referent values, triceps skinfold thickness in boys and BMI in girls are the preferred single anthropometric indicators of obesity in youths.","['Himes, J H', 'Bouchard, C']","['Himes JH', 'Bouchard C']","['Division of Human Development and Nutrition, School of Public Health, University of Minnesota, Minneapolis 55455.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Int J Obes,International journal of obesity,7703240,,IM,"['Adolescent', 'Age Factors', 'Anthropometry/*methods', 'Child', 'Densitometry/methods', 'Female', 'Humans', 'Male', 'Obesity/*classification/diagnosis']",,,,,1989/01/01 00:00,1989/01/01 00:01,['1989/01/01 00:00'],"['1989/01/01 00:00 [pubmed]', '1989/01/01 00:01 [medline]', '1989/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1989;13(2):183-93.,,,,,,,,,,,,,,,,,,,,
15487525,NLM,MEDLINE,20041019,20060328,0041-5782 (Print) 0041-5782 (Linking),166,23,2004 May 31,[Should obese patients follow a low-glycemic index diet?].,2259-61,,,"['Raben, Anne']",['Raben A'],"['Den Kongelige Veterinaer- og Landbohojskole, Institut for Human Ernaering. anne.tomas@get2net.dk']",['dan'],"['Journal Article', 'Review']",Denmark,Ugeskr Laeger,Ugeskrift for laeger,0141730,,IM,"['Energy Intake', 'Energy Metabolism', 'Glycemic Index/*physiology', 'Humans', 'Obesity/*diet therapy/metabolism/physiopathology']",,,,,2004/10/19 09:00,2004/10/20 09:00,['2004/10/19 09:00'],"['2004/10/19 09:00 [pubmed]', '2004/10/20 09:00 [medline]', '2004/10/19 09:00 [entrez]']",,ppublish,Ugeskr Laeger. 2004 May 31;166(23):2259-61.,,,,,,,19,,Bor overvaegtige spise en kost med lavt glykaemisk indeks? Beviserne mangler stadig.,,,,,,,,,,,
16030047,NLM,MEDLINE,20051202,20060629,0931-0509 (Print) 0931-0509 (Linking),20,10,2005 Oct,Indexing glomerular filtration rate for body surface area in obese patients is misleading: concept and example.,2024-8,,,"['Delanaye, Pierre', 'Radermecker, Regis P', 'Rorive, Marcelle', 'Depas, Gisele', 'Krzesinski, Jean Marie']","['Delanaye P', 'Radermecker RP', 'Rorive M', 'Depas G', 'Krzesinski JM']",,['eng'],"['Editorial', 'Historical Article', 'Review']",England,Nephrol Dial Transplant,"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",8706402,,IM,"['*Body Surface Area', '*Glomerular Filtration Rate', 'History, 19th Century', 'History, 20th Century', 'Humans', 'Obesity/history/*pathology/*physiopathology', 'Reference Values', 'Regression Analysis']",,,,,2005/07/21 09:00,2005/12/13 09:00,['2005/07/21 09:00'],"['2005/07/21 09:00 [pubmed]', '2005/12/13 09:00 [medline]', '2005/07/21 09:00 [entrez]']","['gfh983 [pii]', '10.1093/ndt/gfh983 [doi]']",ppublish,Nephrol Dial Transplant. 2005 Oct;20(10):2024-8. doi: 10.1093/ndt/gfh983. Epub 2005 Jul 19.,,20050719,,,,,43,['Nephrol Dial Transplant. 2006 Mar;21(3):821; author reply 821-2. PMID: 16280371'],,,,,,,,,,,,
7706588,NLM,MEDLINE,19950505,20190909,0731-5724 (Print) 0731-5724 (Linking),13,6,1994 Dec,Body fat distribution and energy metabolism in obese men and women.,569-74,,"OBJECTIVE: Upper body obesity seems to be associated with a better prognosis for weight loss than does lower body obesity. However, the impact of body fat distribution on energy metabolism is not clear. SUBJECTS: One hundred fifteen non-diabetic obese Caucasians (64 males and 51 females) and 108 Caucasian lean controls (82 males and 26 females) were studied. METHODS: Body composition was assessed by hydrodensitometry and body fat distribution was estimated by the waist-to-thigh circumference ratio (W/T). Values of 24-hour energy expenditure (24h-EE), basal metabolic rate (BMR), sleeping metabolic rate (SMR) and respiratory quotient (RQ) were measured in a respiration chamber. RESULTS: BMR, adjusted for differences in fat-free mass, fat mass, age and sex, correlated with W/T in obese males (r = 0.40; p < 0.01), but not in obese females. Obese male subjects with upper body obesity had BMR significantly higher than those with lower body obesity (2189 +/- 268 vs 1974 +/- 141 kcal/day; p < 0.01), independently of differences in fat-free mass, fat mass and age. No correlations were found between W/T and adjusted 24h-EE, SMR or RQ in all examined groups. CONCLUSION: These findings indicate that in obese males, upper body obesity is associated with increased metabolic rate, possibly related to higher levels of lipid turnover in visceral fat.","['Tataranni, P A', 'Larson, D E', 'Ravussin, E']","['Tataranni PA', 'Larson DE', 'Ravussin E']","['Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona.']",['eng'],"['Comparative Study', 'Journal Article']",United States,J Am Coll Nutr,Journal of the American College of Nutrition,8215879,,IM,"['Adipose Tissue/*pathology', 'Adolescent', 'Adult', 'Basal Metabolism', 'Body Composition/*physiology', 'Circadian Rhythm/physiology', 'Densitometry', 'Energy Metabolism/*physiology', 'Female', 'Humans', 'Lipid Metabolism', 'Male', 'Middle Aged', 'Obesity/*metabolism/*pathology/physiopathology', 'Respiration/physiology']",,,,,1994/12/01 00:00,1994/12/01 00:01,['1994/12/01 00:00'],"['1994/12/01 00:00 [pubmed]', '1994/12/01 00:01 [medline]', '1994/12/01 00:00 [entrez]']",['10.1080/07315724.1994.10718449 [doi]'],ppublish,J Am Coll Nutr. 1994 Dec;13(6):569-74. doi: 10.1080/07315724.1994.10718449.,,,,,,,,,,,,,,,,,,,,
15309901,NLM,MEDLINE,20040903,20190721,0163-2116 (Print) 0163-2116 (Linking),49,6,2004 Jun,New concepts of physiology in obese patients.,1062-4,,"According to recent statistical observations, obesity is one of the most common and steadily increasing diseases in the United States, with more than 7.5% of the population suffering from its morbid form. Many different studies have been undertaken with a focus on behavioral, genetic, and epidemiological aspects of this serious health concern, but its etiology and characteristics have not yet been fully defined. The obese patient represents multiple problems for the clinical physician. The biggest is the fact that the bariatric patient does not follow the common physiology learned during medical school, and therefore some morbidities and mortalities have been underevaluated and not treated adequately or promptly. To fully understand all the causes relating to the higher incidence of morbidity and mortality in obese patients, further delineation of the underlying pathophysiology is necessary. In the present article, several new physiologic concepts, based on clinical observation and specific to this population, are presented. Further clinical and experimental studies are necessary to further elucidate the etiology and to define all possible contributing factors for a full understanding of this fastest-growing disease of the new century.","['Frezza, Ermenegildo Eldo']",['Frezza EE'],"['Division of Bariatric and Minimally Invasive Surgery, Department of Surgery, Texas Tech University Health Sciences Center. Lubbock, Texas 79415, USA. eldo.frezza@ttuhsc.edu']",['eng'],"['Journal Article', 'Review']",United States,Dig Dis Sci,Digestive diseases and sciences,7902782,,IM,"['Humans', 'Obesity/complications/*physiopathology']",,,,,2004/08/18 05:00,2004/09/04 05:00,['2004/08/18 05:00'],"['2004/08/18 05:00 [pubmed]', '2004/09/04 05:00 [medline]', '2004/08/18 05:00 [entrez]']",['10.1023/b:ddas.0000034572.76687.2d [doi]'],ppublish,Dig Dis Sci. 2004 Jun;49(6):1062-4. doi: 10.1023/b:ddas.0000034572.76687.2d.,,,,,,,0,,,,,,,,,,,,,
28287332,NLM,MEDLINE,20170724,20170724,1521-0669 (Electronic) 0888-0018 (Linking),34,1,2017 Feb,Association of energy intake and expenditure with obesity: A cross-sectional study of 150 pediatric patients following treatment for leukemia.,29-35,10.1080/08880018.2016.1272025 [doi],"Increased obesity in leukemia survivors has been attributed to chemotherapy and radiation. Data on total energy intake (TEI) and total energy expenditure (TEE) are lacking in obese childhood leukemia patients after completion of therapy from India. We conducted a cross-sectional study in pediatric acute leukemia patients after completion of therapy wherein energy intake was assessed by 24-hour recall method. TEE was calculated using Harris-Benedict equation, by assessing the physical activity level using Physical Activity Questionnaire for children and basal metabolic rate by World Health Organization equation. Indian Academy of Pediatrics 2015 guidelines for BMI were used for defining overweight and obesity. Nutritional status was assessed in 150 leukemia patients after completion of therapy. Twenty-five percent of leukemia patients after completion of therapy were overweight and obese versus 11% of healthy controls (p = 0.042). The mean ratio of TEI/required energy intake (REI), TEE/required energy expenditure (REE), and (TEI:REI)/(TEE:REE) were significantly higher in overweight and obese group versus nonobese survivors (p < 0.001, p = 0.091, p < 0.001, respectively). Multivariate analysis showed higher income (HR-2.3, p = 0.04), increased TEI/REI (HR-4, p = 0.049) and higher (TEI:REI)/(TEE:REE) (HR-3.1, p = 0.039) to be significant factors predicting obesity. Obesity in leukemia patients after completion of therapy is associated with increased energy intake, causing imbalance between energy intake and TEE in these patients.","['Srivastava, Richa', 'Batra, Atul', 'Dhawan, Deepa', 'Bakhshi, Sameer']","['Srivastava R', 'Batra A', 'Dhawan D', 'Bakhshi S']","['a Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital , All India Institute of Medical Sciences , Ansari Nagar, New Delhi , India.', 'a Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital , All India Institute of Medical Sciences , Ansari Nagar, New Delhi , India.', 'a Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital , All India Institute of Medical Sciences , Ansari Nagar, New Delhi , India.', 'a Department of Medical Oncology, Dr. B. R. A. Institute Rotary Cancer Hospital , All India Institute of Medical Sciences , Ansari Nagar, New Delhi , India.']",['eng'],"['Clinical Trial', 'Journal Article']",England,Pediatr Hematol Oncol,Pediatric hematology and oncology,8700164,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Cross-Sectional Studies', '*Energy Intake', '*Energy Metabolism', 'Female', 'Humans', 'Leukemia/*therapy', 'Male', '*Obesity/etiology/physiopathology/therapy', '*Surveys and Questionnaires']",,['NOTNLM'],"['Acute lymphoblastic leukemia', 'body mass index', 'obesity', 'pediatric', 'physical activity']",,2017/03/14 06:00,2017/07/25 06:00,['2017/03/14 06:00'],"['2017/03/14 06:00 [pubmed]', '2017/07/25 06:00 [medline]', '2017/03/14 06:00 [entrez]']",['10.1080/08880018.2016.1272025 [doi]'],ppublish,Pediatr Hematol Oncol. 2017 Feb;34(1):29-35. doi: 10.1080/08880018.2016.1272025. Epub 2017 Mar 13.,,20170313,,,,,,,,,,,,,,,,,,
25212654,NLM,MEDLINE,20150105,20211021,1558-3597 (Electronic) 0735-1097 (Linking),64,11,2014 Sep 16,Metabolically healthy obese versus cardiorespiratory fit obese: is it time to bring them together?,1183-4,S0735-1097(14)04422-2 [pii] 10.1016/j.jacc.2014.05.061 [doi],,"['Babu, Abraham Samuel', 'Veluswamy, Sundar Kumar', 'Myers, Jonathan', 'Lavie, Carl J']","['Babu AS', 'Veluswamy SK', 'Myers J', 'Lavie CJ']",,['eng'],['Letter'],United States,J Am Coll Cardiol,Journal of the American College of Cardiology,8301365,,IM,"['Cardiovascular System', 'Humans', 'Obesity/*metabolism/*physiopathology', 'Physical Fitness', 'Respiratory System']",,,,,2014/09/13 06:00,2015/01/06 06:00,['2014/09/13 06:00'],"['2014/05/21 00:00 [received]', '2014/05/22 00:00 [accepted]', '2014/09/13 06:00 [entrez]', '2014/09/13 06:00 [pubmed]', '2015/01/06 06:00 [medline]']","['S0735-1097(14)04422-2 [pii]', '10.1016/j.jacc.2014.05.061 [doi]']",ppublish,J Am Coll Cardiol. 2014 Sep 16;64(11):1183-4. doi: 10.1016/j.jacc.2014.05.061.,['IK6 RX002477/RX/RRD VA/United States'],,,,,,,,,,,,,,,,,,,
14569041,NLM,MEDLINE,20040720,20220409,1071-7323 (Print) 1071-7323 (Linking),11,10,2003 Oct,Primary care physicians' attitudes about obesity and its treatment.,1168-77,,"OBJECTIVE: This study was designed to assess physicians' attitudes toward obese patients and the causes and treatment of obesity. RESEARCH METHODS AND PROCEDURES: A questionnaire assessed attitudes in 2 geographically representative national random samples of 5000 primary care physicians. In one sample (N = 2500), obesity was defined as a BMI of 30 to 40 kg/m(2), and in the other (N = 2500), obesity was defined as a BMI > 40. RESULTS: Six hundred twenty physicians responded. They rated physical inactivity as significantly more important than any other cause of obesity (p < 0.0009). Two other behavioral factors-overeating and a high-fat diet-received the next highest mean ratings. More than 50% of physicians viewed obese patients as awkward, unattractive, ugly, and noncompliant. The treatment of obesity was rated as significantly less effective (p < 0.001) than therapies for 9 of 10 chronic conditions. Most respondents (75%), however, agreed with the consensus recommendations that a 10% reduction in weight is sufficient to improve obesity-related health complications and viewed a 14% weight loss (i.e., 78 +/- 5 kg from an initial weight of 91 kg) as an acceptable treatment outcome. More than one-half (54%) would spend more time working on weight management issues if their time was reimbursed appropriately. DISCUSSION: Primary care physicians view obesity as largely a behavioral problem and share our broader society's negative stereotypes about the personal attributes of obese persons. Practitioners are realistic about treatment outcomes but view obesity treatment as less effective than treatment of most other chronic conditions.","['Foster, Gary D', 'Wadden, Thomas A', 'Makris, Angela P', 'Davidson, Duncan', 'Sanderson, Rebecca Swain', 'Allison, David B', 'Kessler, Amy']","['Foster GD', 'Wadden TA', 'Makris AP', 'Davidson D', 'Sanderson RS', 'Allison DB', 'Kessler A']","['University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Obes Res,Obesity research,9305691,,IM,"['Adult', '*Attitude of Health Personnel', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/etiology/*psychology/therapy', 'Physicians, Family/*psychology', 'Pilot Projects', 'Surveys and Questionnaires', 'Weight Loss']",,,,,2003/10/22 05:00,2004/07/21 05:00,['2003/10/22 05:00'],"['2003/10/22 05:00 [pubmed]', '2004/07/21 05:00 [medline]', '2003/10/22 05:00 [entrez]']",['10.1038/oby.2003.161 [doi]'],ppublish,Obes Res. 2003 Oct;11(10):1168-77. doi: 10.1038/oby.2003.161.,"['P30DK056336/DK/NIDDK NIH HHS/United States', 'R01 DK56114/DK/NIDDK NIH HHS/United States']",,,,,,,,,,,,,,,,,,,
31987886,NLM,MEDLINE,20200812,20200812,1879-1220 (Electronic) 0960-0760 (Linking),198,,2020 Apr,Bifidobacterium pseudolongum reduces triglycerides by modulating gut microbiota in mice fed high-fat food.,105602,S0960-0760(19)30676-4 [pii] 10.1016/j.jsbmb.2020.105602 [doi],"Obesity has become a growing concern around the world. The purpose of this study was to investigate the potential benefit of Bifidobacterium pseudolongum (B. pseudolongum) on obesity, gut microbiota, and its physiological mechanism. The obese mice model was established with a high-fat diet (HFD), and the treatment were used the strain B. pseudolongum. We investigated the changes in fat content, plasma metabolites and gut microbiota on obese mice and B. pseudolongum treated obese mice. We found that B. pseudolongum treatment significantly decreased the body mass (about 12 %), plasma triglycerides (about 12.4 %), gross energy intake (about 12.8 %), and visceral fat (about 26.5 %) in obese mice. Further, High-throughput pyrosequencing of the 16S rRNA demonstrated that B. pseudolongum treatment markedly recovered the gut microbiota dysbiosis in obese mice, including the diversity of microbiota and the ratio of Firmicutes to Bacteroidetes. B. pseudolongum treatment increased the abundance of the bacterial genus Butyricimonas and Bifidobacterium. Therefore, B. pseudolongum may have therapeutic potential for the treatment of diet-induced obesity (DIO). B. pseudolongum treatment could change host gut microbiota and provide benefits to host digestive processes that mitigate metabolic diseases.","['Bo, Ting-Bei', 'Wen, Jing', 'Zhao, Yuan-Chun', 'Tian, Shuang-Jie', 'Zhang, Xue-Ying', 'Wang, De-Hua']","['Bo TB', 'Wen J', 'Zhao YC', 'Tian SJ', 'Zhang XY', 'Wang DH']","['State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; CAS Center for Excellence in Biotic Interactions, University of Chinese Academy of Sciences, Beijing 100049, China.', 'State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; CAS Center for Excellence in Biotic Interactions, University of Chinese Academy of Sciences, Beijing 100049, China.', 'State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; CAS Center for Excellence in Biotic Interactions, University of Chinese Academy of Sciences, Beijing 100049, China.', 'State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; CAS Center for Excellence in Biotic Interactions, University of Chinese Academy of Sciences, Beijing 100049, China.', 'State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; CAS Center for Excellence in Biotic Interactions, University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: zhangxy@ioz.ac.cn.', 'State Key Laboratory of Integrated Management of Pest Insects and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; CAS Center for Excellence in Biotic Interactions, University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address: wangdh@ioz.ac.cn.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,J Steroid Biochem Mol Biol,The Journal of steroid biochemistry and molecular biology,9015483,['0 (Triglycerides)'],IM,"['Animals', 'Bifidobacterium/*physiology', 'Diet, High-Fat/*adverse effects', '*Gastrointestinal Microbiome', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Obesity/*blood/etiology/microbiology/*therapy', 'Triglycerides/*blood']",,['NOTNLM'],"['Bifidobacterium B. Pseudolongum', 'Diet-induced obesity', 'Gut microbiota', 'Triglyceride', 'Visceral fat']",['Declaration of Competing Interest The authors declare no conflict of interest.'],2020/01/29 06:00,2020/08/13 06:00,['2020/01/29 06:00'],"['2019/11/08 00:00 [received]', '2020/01/16 00:00 [revised]', '2020/01/17 00:00 [accepted]', '2020/01/29 06:00 [pubmed]', '2020/08/13 06:00 [medline]', '2020/01/29 06:00 [entrez]']","['S0960-0760(19)30676-4 [pii]', '10.1016/j.jsbmb.2020.105602 [doi]']",ppublish,J Steroid Biochem Mol Biol. 2020 Apr;198:105602. doi: 10.1016/j.jsbmb.2020.105602. Epub 2020 Jan 24.,,20200124,,['Copyright (c) 2020 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
30718009,NLM,MEDLINE,20200326,20200326,1873-5347 (Electronic) 0277-9536 (Linking),223,,2019 Feb,"Perceived causes of obesity, emotions, and attitudes about Discrimination Policy.",97-103,S0277-9536(19)30019-X [pii] 10.1016/j.socscimed.2019.01.019 [doi],"RATIONALE: Although obesity represents a potential public health crisis, our understanding of public perceptions of obesity, emotional responses to the obese, and related policy preferences is limited. OBJECTIVE: We employed Weiner's attribution theory of controllability (Weiner, 1988, 2011) to examine perceived causes of obesity, emotional responses, and related policy implications. If the perceived cause is controllable (eating and lifestyle habits), we expected less sympathy and greater anger toward obese people and support for prejudicial hiring policies based on weight. If the cause is perceived as uncontrollable (genetic), sympathy is anticipated as well as opposition to such hiring policies. METHOD: We conducted multivariate analyses with data from two nationally representative surveys of U.S. adults. CONCLUSION: Our findings supported the hypotheses, showing that sympathy and lack of anger toward obese people are strongly determined by a genetic attribution for obesity. Moreover, sympathy and the genetic attribution are significant predictors of opposition to hiring policies that discriminate against obese people. Finally, in a second study, chief among several causal attributions for obesity-lack of will power, lack of exercise, marketing of foods, and genetics-we discovered biological attribution functions as the key predictor of perceptions that obese people are frequent targets of discrimination. We suggest governments and the food industry should be more attuned to the underlying beliefs of the public about the causes of obesity when formulating programs and policies to address the issue.","['Joslyn, Mark R', 'Haider-Markel, Donald P']","['Joslyn MR', 'Haider-Markel DP']","['Department of Political Science, 1541 Lilac Lane, 504 Blake Hall, University of Kansas, Lawrence, KS, 66044, USA.', 'Department of Political Science, 1541 Lilac Lane, 504 Blake Hall, University of Kansas, Lawrence, KS, 66044, USA. Electronic address: dhmarkel@ku.edu.']",['eng'],['Journal Article'],England,Soc Sci Med,Social science & medicine (1982),8303205,,IM,"['Adult', '*Attitude', '*Emotions', 'Female', 'Humans', 'Male', 'Multivariate Analysis', 'Obesity/etiology/*psychology', '*Policy', '*Prejudice', 'Surveys and Questionnaires', 'United States']",,['NOTNLM'],"['Attitudes', 'Causal attributions', 'Discrimination', 'Emotions', 'Obesity', 'Policy']",,2019/02/06 06:00,2020/03/27 06:00,['2019/02/06 06:00'],"['2018/08/25 00:00 [received]', '2018/12/13 00:00 [revised]', '2019/01/12 00:00 [accepted]', '2019/02/06 06:00 [pubmed]', '2020/03/27 06:00 [medline]', '2019/02/06 06:00 [entrez]']","['S0277-9536(19)30019-X [pii]', '10.1016/j.socscimed.2019.01.019 [doi]']",ppublish,Soc Sci Med. 2019 Feb;223:97-103. doi: 10.1016/j.socscimed.2019.01.019. Epub 2019 Jan 19.,,20190119,,['Copyright (c) 2019 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
22130312,NLM,MEDLINE,20120416,20220321,1873-3492 (Electronic) 0009-8981 (Linking),413,3-4,2012 Feb 18,Thyroid function in childhood obesity and metabolic comorbidity.,396-405,10.1016/j.cca.2011.11.013 [doi],"Childhood obesity is a worldwide health problem and its prevalence is increasing steadily and dramatically all over the world. Obese subjects have a much greater likelihood than normal-weight children of acquiring dyslipidemia, elevated blood pressure, and impaired glucose metabolism, which significantly increase their risk of cardiovascular and metabolic diseases. Elevated TSH concentrations in association with normal or slightly elevated free T4 and/or free T3 levels have been consistently found in obese subjects, but the mechanisms underlying these thyroid hormonal changes are still unclear. Whether higher TSH in childhood obesity is adaptive, increasing metabolic rate in an attempt to reduce further weight gain, or indicates subclinical hypothyroidism or resistance and thereby contributes to lipid and/or glucose dysmetabolism, remains controversial. This review highlights current evidence on thyroid involvement in obese children and discusses the current controversy regarding the relationship between thyroid hormonal derangements and obesity-related metabolic changes (hypertension, dyslipidemia, hyperglycemia and insulin resistance, nonalcoholic fatty liver disease) in such population. Moreover, the possible mechanisms linking thyroid dysfunction and pediatric obesity are reviewed. Finally, the potential role of lifestyle intervention as well as of therapy with thyroid hormone in the treatment of thyroid abnormalities in childhood obesity is discussed.","['Pacifico, Lucia', 'Anania, Caterina', 'Ferraro, Flavia', 'Andreoli, Gian Marco', 'Chiesa, Claudio']","['Pacifico L', 'Anania C', 'Ferraro F', 'Andreoli GM', 'Chiesa C']","['Department of Pediatrics, Sapienza University of Rome, Rome, Italy.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Netherlands,Clin Chim Acta,Clinica chimica acta; international journal of clinical chemistry,1302422,['0 (Thyroid Hormones)'],IM,"['Animals', 'Child', 'Comorbidity', 'Humans', 'Metabolic Diseases/*epidemiology', 'Obesity/*epidemiology/immunology/metabolism/*physiopathology', 'Thyroid Gland/immunology/metabolism/*physiopathology', 'Thyroid Hormones/metabolism', 'Weight Loss']",,,,,2011/12/02 06:00,2012/04/17 06:00,['2011/12/02 06:00'],"['2011/09/07 00:00 [received]', '2011/11/10 00:00 [revised]', '2011/11/15 00:00 [accepted]', '2011/12/02 06:00 [entrez]', '2011/12/02 06:00 [pubmed]', '2012/04/17 06:00 [medline]']","['S0009-8981(11)00640-1 [pii]', '10.1016/j.cca.2011.11.013 [doi]']",ppublish,Clin Chim Acta. 2012 Feb 18;413(3-4):396-405. doi: 10.1016/j.cca.2011.11.013. Epub 2011 Nov 27.,,20111127,,['Copyright (c) 2011 Elsevier B.V. All rights reserved.'],,,,,,,,,,,,,,,,
24734453,NLM,MEDLINE,20140603,20190907,1438-3276 (Print) 1438-3276 (Linking),155 Spec No 2,,2013 Nov 14,"[Is there a ""healthy"" obese?].",37,,,"['Wirth, A']",['Wirth A'],,['ger'],"['Comment', 'Journal Article']",Germany,MMW Fortschr Med,MMW Fortschritte der Medizin,100893959,,IM,"['Female', 'Humans', 'Male', 'Obesity/*metabolism/*mortality']",,,,,2014/04/17 06:00,2014/06/04 06:00,['2014/04/17 06:00'],"['2014/04/17 06:00 [entrez]', '2014/04/17 06:00 [pubmed]', '2014/06/04 06:00 [medline]']",['10.1007/s15006-013-2388-5 [doi]'],ppublish,MMW Fortschr Med. 2013 Nov 14;155 Spec No 2:37. doi: 10.1007/s15006-013-2388-5.,,,,,,,,,"Gibt es ""gesunde"" Dicke?",,['Diabetes Care. 2013 Aug;36(8):2294-300. PMID: 23637352'],,,,,,,,,
1318286,NLM,MEDLINE,19920714,20161123,,16,4,1992 Apr,Ultrasonographic study of gall-bladder emptying in obese patients.,313-5,,"In order to assess gall-bladder (GB) motility in obese patients, we measured by ultrasound the GB fasting volume (FV) in 45 women (23 obese, 22 controls) and 43 men (21 obese, 22 controls). The FV was larger in obese women (45.9 +/- 21.6 cm3) than in controls (26.6 +/- 10.7 cm3) (P less than 0.001), and also in obese men (39.2 +/- 20.2 vs. 23.8 +/- 9.9 cm3) (P less than 0.01). In obese women, GB FV correlated with relative body weight. No correlation was found between GB volume and age in obese subjects. In controls, but not in obese subjects, the GB ejection fraction was significantly greater in men (65.3 +/- 19.9%) than in women (51.3 +/- 9.0%) (P less than 0.02). Gall-bladder contraction was not decreased in obese subjects vs. controls, suggesting that GB hypocontractility is not a lithogenic risk factor in obesity. The observation that GB emptying does not correlate with body weight represents another argument that obesity does not impair GB contraction.","['Acalovschi, M', 'Badea, R']","['Acalovschi M', 'Badea R']","['Departamentul de Gastroenterologie, Universitatea de Medicina si Farmacie, Cluj-Napoca, Romania.']",['eng'],['Journal Article'],England,Int J Obes Relat Metab Disord,International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,9313169,,IM,"['Adult', 'Body Weight', 'Cholelithiasis/*etiology', 'Female', 'Gallbladder/*diagnostic imaging/physiopathology', '*Gallbladder Emptying', 'Humans', 'Male', 'Middle Aged', 'Obesity/complications/diagnostic imaging/*physiopathology', 'Risk Factors', 'Ultrasonography']",,,,,1992/04/01 00:00,1992/04/01 00:01,['1992/04/01 00:00'],"['1992/04/01 00:00 [pubmed]', '1992/04/01 00:01 [medline]', '1992/04/01 00:00 [entrez]']",,ppublish,Int J Obes Relat Metab Disord. 1992 Apr;16(4):313-5.,,,,,,,,,,,,,,,,,,,,
11982736,NLM,MEDLINE,20020715,20190906,0954-6820 (Print) 0954-6820 (Linking),251,5,2002 May,Who cares about the obese hypertensive patient?,369-71,,,"['Sharma, A M', 'Rossner, S']","['Sharma AM', 'Rossner S']",,['eng'],['Editorial'],England,J Intern Med,Journal of internal medicine,8904841,,IM,"['Humans', 'Hypertension/*complications/therapy', 'Obesity/*complications/therapy']",,,,,2002/05/02 10:00,2002/07/16 10:01,['2002/05/02 10:00'],"['2002/05/02 10:00 [pubmed]', '2002/07/16 10:01 [medline]', '2002/05/02 10:00 [entrez]']","['982 [pii]', '10.1046/j.1365-2796.2002.00982.x [doi]']",ppublish,J Intern Med. 2002 May;251(5):369-71. doi: 10.1046/j.1365-2796.2002.00982.x.,,,,,,,,,,,,,,,,,,,,
7208738,NLM,MEDLINE,19810526,20190825,0033-2917 (Print) 0033-2917 (Linking),11,1,1981 Feb,Body image in obese adults.,147-54,,"Data were gathered on 38 obese women and 16 obese men attending a weight-reduction programme and on an equal number of normal weight controls, regarding accuracy of perception of body width in 4 regions, as well as attitudes towards body size. Obese subjects, particularly women, tended to overestimate body width and to dislike their bodies, but neither of these factors predicted success in losing weight. Age of onset of obesity was not related to degree of adult obesity or to accuracy of estimation of body width.","['Pearlson, G D', 'Flournoy, L H', 'Simonson, M', 'Slavney, P R']","['Pearlson GD', 'Flournoy LH', 'Simonson M', 'Slavney PR']",,['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",England,Psychol Med,Psychological medicine,1254142,,IM,"['Adult', '*Body Image', 'Diet, Reducing/psychology', 'Female', 'Humans', 'Male', 'Obesity/diet therapy/*psychology']",,,,,1981/02/01 00:00,1981/02/01 00:01,['1981/02/01 00:00'],"['1981/02/01 00:00 [pubmed]', '1981/02/01 00:01 [medline]', '1981/02/01 00:00 [entrez]']",['10.1017/s0033291700053368 [doi]'],ppublish,Psychol Med. 1981 Feb;11(1):147-54. doi: 10.1017/s0033291700053368.,['MH05361-31/MH/NIMH NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
22832045,NLM,MEDLINE,20121002,20120726,1097-6833 (Electronic) 0022-3476 (Linking),161,2,2012 Aug,50 years ago in the Journal of Pediatrics: basal oxygen consumption in the obese patient.,302,10.1016/j.jpeds.2012.02.053 [doi],,"['Washington, Reginald']",['Washington R'],"['Rocky Mountain Hospital for Children, Denver, Colorado, USA.']",['eng'],"['Historical Article', 'Journal Article']",United States,J Pediatr,The Journal of pediatrics,0375410,,IM,"['Basal Metabolism', 'Child', 'History, 20th Century', 'Humans', 'Obesity/*history/metabolism', '*Oxygen Consumption']",,,,,2012/07/27 06:00,2012/10/04 06:00,['2012/07/27 06:00'],"['2012/07/27 06:00 [entrez]', '2012/07/27 06:00 [pubmed]', '2012/10/04 06:00 [medline]']","['S0022-3476(12)00256-9 [pii]', '10.1016/j.jpeds.2012.02.053 [doi]']",ppublish,J Pediatr. 2012 Aug;161(2):302. doi: 10.1016/j.jpeds.2012.02.053.,,,,,,,,,,,,,,,,,,,,
21570782,NLM,MEDLINE,20110930,20180206,1873-4111 (Electronic) 0378-5122 (Linking),69,3,2011 Jul,Cost-effectiveness of bariatric surgery: should it be universally available?,230-8,10.1016/j.maturitas.2011.04.007 [doi],"This paper is the first to conduct cost-effectiveness analyses of bariatric surgery comparing obese patients with obesity-related diseases to obese people without comorbidities across different BMI categories, using the meta-analysis results of surgery outcomes for our effectiveness inputs. We find that surgery treatment is in general cost-effective for people whose BMI is greater than 35 kg/m(2) with or without obesity-related comorbidities, and it is even cost-saving for super obese (BMI >/= 50 kg/m(2)) with obesity-related comorbidities. Our results also suggest that surgery can be cost-effective for the mildly obese (BMI >/= 30 kg/m(2)). The bottom line is that bariatric surgery should be universally available to all classes of obese people.","['Chang, Su-Hsin', 'Stoll, Carolyn R T', 'Colditz, Graham A']","['Chang SH', 'Stoll CR', 'Colditz GA']","['Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO 63110, USA. changsh@wudosis.wustl.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Ireland,Maturitas,Maturitas,7807333,,IM,"['Bariatric Surgery/*economics', 'Body Mass Index', 'Comorbidity', 'Cost-Benefit Analysis', 'Health Services Accessibility/*economics', 'Humans', 'Obesity/economics/*surgery', 'Obesity, Morbid/economics/surgery']",,,,,2011/05/17 06:00,2011/10/01 06:00,['2011/05/17 06:00'],"['2011/04/01 00:00 [received]', '2011/04/15 00:00 [accepted]', '2011/05/17 06:00 [entrez]', '2011/05/17 06:00 [pubmed]', '2011/10/01 06:00 [medline]']","['S0378-5122(11)00143-5 [pii]', '10.1016/j.maturitas.2011.04.007 [doi]']",ppublish,Maturitas. 2011 Jul;69(3):230-8. doi: 10.1016/j.maturitas.2011.04.007. Epub 2011 May 14.,,20110514,,['Copyright (c) 2011 Elsevier Ireland Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
19440652,NLM,MEDLINE,20091211,20211020,1432-2323 (Electronic) 0364-2313 (Linking),33,10,2009 Oct,Impact of obesity and bariatric surgery on survival.,2022-7,10.1007/s00268-009-0050-2 [doi],"Bariatric surgery is the only reliable treatment that offers sustained, long-term weight loss. This results in cure or improvement in almost all of the obesity-associated diseases and translates into reduction in the relative risk of death or increased longevity of the operated morbidly obese population. Since the treatment of obesity-associated conditions is very costly, bariatric surgery also results in significant reductions in healthcare costs with a return on investment of 3 years. It is not just weight loss, it is health gain.","['Christou, Nicolas V']",['Christou NV'],"['Section of Bariatric Surgery, Department of Surgery, McGill University Health Center, McGill University, Room S6.24, 687 Pine Avenue West, Montreal, QC, H3A 1A1, Canada. Nicolas.christou@muhc.mcgill.ca']",['eng'],['Journal Article'],United States,World J Surg,World journal of surgery,7704052,,IM,"['Bariatric Surgery/economics/*mortality', 'Humans', 'Obesity/complications/*mortality/*surgery/therapy', 'Time Factors', 'Weight Loss']",,,,,2009/05/15 09:00,2009/12/16 06:00,['2009/05/15 09:00'],"['2009/05/15 09:00 [entrez]', '2009/05/15 09:00 [pubmed]', '2009/12/16 06:00 [medline]']",['10.1007/s00268-009-0050-2 [doi]'],ppublish,World J Surg. 2009 Oct;33(10):2022-7. doi: 10.1007/s00268-009-0050-2.,,,,,,,,,,,,,,,,,,,,
12463866,NLM,MEDLINE,20030401,20181113,1531-605X (Print) 1531-605X (Linking),,,2002,A spatial analysis of obesogenic environments for children.,459-63,,"In this study, we use spatial analysis techniques to explore environmental and social predictors of obesity in children. We constructed a merged database, incorporating clinical data from an electronic medical record system, the Regenstrief Medical Record System (RMRS) and societal & environmental data from a geographical information system, the Social Assets and Vulnerabilities Indicators (SAVI) Project. We used the RMRS to identify cohorts of children that were normal weight, overweight, or obese. The RMRS records were geocoded and merged into the SAVI database. Using the merged databases, we analyzed the relationships between markers of socioeconomic status and obesity outcomes in children. Our preliminary analyses show that markers of low socioeconomic status at the census tract level correlate with both overweight and obese outcomes in our study population. Utilization of geographic information systems (GIS) for the study of health epidemiology is discussed.","['Liu, Gilbert C', 'Cunningham, Cynthia', 'Downs, Stephen M', 'Marrero, David G', 'Fineberg, Naomi']","['Liu GC', 'Cunningham C', 'Downs SM', 'Marrero DG', 'Fineberg N']","[""Children's Health Services Research Prog, Indiana University, Riley Hospital, Indianapolis, IN, USA.""]",['eng'],['Journal Article'],United States,Proc AMIA Symp,Proceedings. AMIA Symposium,100883449,,IM,"['Adolescent', 'Body Mass Index', 'Child', 'Child, Preschool', '*Environment', 'Female', 'Geographic Information Systems', 'Humans', 'Male', 'Models, Theoretical', 'Obesity/*epidemiology/ethnology/etiology/prevention & control', 'Sex Distribution', 'Social Class', 'United States/epidemiology']",PMC2244277,,,,2002/12/05 04:00,2003/04/02 05:00,['2002/12/05 04:00'],"['2002/12/05 04:00 [pubmed]', '2003/04/02 05:00 [medline]', '2002/12/05 04:00 [entrez]']",['D020002134 [pii]'],ppublish,Proc AMIA Symp. 2002:459-63.,,,,,,,,,,,,,,,,,,,,
10793648,NLM,MEDLINE,20000515,20190817,0025-7125 (Print) 0025-7125 (Linking),84,2,2000 Mar,Evaluation of the obese patient. Practical considerations.,"387-99, vi",,"The evaluation process for obesity uses the same framework of a history, physical examination and interpretation of selected laboratory and diagnostic tests that are used for other chronic care patient encounters. What makes this evaluation process different is knowing how to take an obesity focused history, what to examine, and which tests to order. An assessment of risk status is then determined based on the National Heart, Lung, and Blood Institute Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. Other important aspects of the evaluation process include determining the patient's goals, expectations, and motivation for weight loss along with support systems and/or barriers to behavior change.","['Kushner, R F', 'Weinsier, R L']","['Kushner RF', 'Weinsier RL']","['Department of Medicine, Northwestern University School of Medicine, Chicago, Illinois, USA. rkushner@nmh.org']",['eng'],"['Journal Article', 'Review']",United States,Med Clin North Am,The Medical clinics of North America,2985236R,,IM,"['Adult', 'Diagnostic Tests, Routine', 'Female', 'Humans', 'Male', '*Medical History Taking', 'Motivation', 'Obesity/diagnosis/*etiology/therapy', '*Physical Examination', 'Weight Loss']",,,,,2000/05/04 09:00,2000/05/20 09:00,['2000/05/04 09:00'],"['2000/05/04 09:00 [pubmed]', '2000/05/20 09:00 [medline]', '2000/05/04 09:00 [entrez]']","['S0025-7125(05)70227-3 [pii]', '10.1016/s0025-7125(05)70227-3 [doi]']",ppublish,"Med Clin North Am. 2000 Mar;84(2):387-99, vi. doi: 10.1016/s0025-7125(05)70227-3.",,,,,,,26,,,,,,,,,,,,,
22724646,NLM,MEDLINE,20121126,20220408,1369-1627 (Electronic) 0954-0261 (Linking),24,3,2012 Jun,Psychological consequences of obesity: weight bias and body image in overweight and obese youth.,247-53,10.3109/09540261.2012.678817 [doi],"Over the past several decades, the prevalence of overweight and obesity in children has increased considerably. While it has been widely documented that childhood obesity is related to a variety of negative health consequences, and numerous campaigns have focused on increasing physical activity and healthy food choices in children, less research has focused on the negative psychological consequences of childhood obesity, namely body image disturbance. This article examines research on body image disturbance in overweight/obese children, comorbidity of psychological disorders and childhood overweight/obesity, and factors that contribute to body image disturbance in overweight and obese youths. Additionally, the authors present research pertaining to treatment and prevention of body image disturbance in overweight/obese youths and discuss potential future directions for research, prevention and advocacy.","['Harriger, Jennifer A', 'Thompson, J Kevin']","['Harriger JA', 'Thompson JK']","['Department of Psychology, Pepperdine University, Malibu, CA 90263, USA. jennifer.harriger@pepperdine.edu']",['eng'],"['Journal Article', 'Review']",England,Int Rev Psychiatry,"International review of psychiatry (Abingdon, England)",8918131,,IM,"['Adolescent', 'Body Image/*psychology', 'Child', 'Humans', 'Mental Disorders/etiology/prevention & control/*psychology', 'Obesity/complications/*psychology']",,,,,2012/06/26 06:00,2012/12/10 06:00,['2012/06/26 06:00'],"['2012/06/26 06:00 [entrez]', '2012/06/26 06:00 [pubmed]', '2012/12/10 06:00 [medline]']",['10.3109/09540261.2012.678817 [doi]'],ppublish,Int Rev Psychiatry. 2012 Jun;24(3):247-53. doi: 10.3109/09540261.2012.678817.,,,,,,,,,,,,,,,,,,,,
19149339,NLM,MEDLINE,20090313,20190513,0026-4075 (Print) 0026-4075 (Linking),173,12,2008 Dec,"Identification, evaluation, and management of pediatric obesity in military academic and nonacademic settings.",1199-202,,"OBJECTIVE: The goal was to evaluate the recognition and management of pediatric obesity in an academic military medical treatment facility and an affiliated branch medical clinic. METHODS: Retrospective chart review of 1,876 well-child visits for patients 4 to 17 years of age was performed, comparing compliance with obesity screening recommendations. RESULTS: A total of 16.7% of patients were obese. The proportion of obese patients was greater at the branch clinic, but providers in the medical treatment facility had a higher obesity recognition rate (40% vs. 26%). Thirty-one percent of obese patients at both locations were noted to have hypertension. Providers at the medical treatment facility performed significantly better in documentation of hypertension and screening for orthopedic complications. Branch clinic providers performed better in screening for abdominal complaints. CONCLUSIONS: A high percentage of military dependents presenting for well-child care are obese. Overall screening and intervention rates were poor, but rates were slightly better at the medical treatment facility.","['Podraza, John', 'Roberts, Timothy A']","['Podraza J', 'Roberts TA']","['Department of Pediatrics, Naval Medical Center Portsmouth, Portsmouth, VA 23708, USA.']",['eng'],"['Comparative Study', 'Journal Article']",England,Mil Med,Military medicine,2984771R,,IM,"['Adolescent', 'Age Factors', 'Child', 'Child Welfare', 'Child, Preschool', 'Female', 'Humans', 'Male', '*Mass Screening', '*Military Personnel', '*Naval Medicine', 'Obesity/*diagnosis/epidemiology/prevention & control', 'Prevalence', 'United States/epidemiology']",,,,,2009/01/20 09:00,2009/03/14 09:00,['2009/01/20 09:00'],"['2009/01/20 09:00 [entrez]', '2009/01/20 09:00 [pubmed]', '2009/03/14 09:00 [medline]']",['10.7205/milmed.173.12.1199 [doi]'],ppublish,Mil Med. 2008 Dec;173(12):1199-202. doi: 10.7205/milmed.173.12.1199.,,,,,,,,,,,,,,,,,,,,
2101435,NLM,MEDLINE,19910909,20161123,0391-1977 (Print) 0391-1977 (Linking),15,3,1990 Jul-Sep,[Cardioscintigraphic evaluation of obese subjects with or without arterial hypertension].,185-9,,"A group of normotensive obese subjects (group A), a group of hypertensive obese subjects (group B) and a group of control subjects (group C) were submitted to radionuclide ventriculography using 99mTc to investigate cardiac function and haemodynamic situation in the presence of an increased preload (group A), preload and afterload (group B). Results show a significant reduction in ejection fraction and systolic blood pressure/end systolic volume in group A. Group B shows better cardiac function probably for the presence of cardiac concentric hypertrophy. Left ventricle work either in a minute and for each beat is greatest in patients of group B. Thus the simultaneous presence of obesity and hypertension can cause a worse prognosis in such patients for cardiac ischaemia and/or sudden death.","['Ferraro, S', 'Santomauro, M', 'Maddalena, G', ""D'Agosto, V"", 'Mossetti, G', 'De Simone, G', 'Turco, S', 'Gravina, E', 'Fazio, S', 'Sacca, L']","['Ferraro S', 'Santomauro M', 'Maddalena G', ""D'Agosto V"", 'Mossetti G', 'De Simone G', 'Turco S', 'Gravina E', 'Fazio S', 'Sacca L', 'et al.']","['Istituto di Medicina Interna, Cardiologia e Cardiochirurgia, Universita di Napoli.']",['ita'],"['Comparative Study', 'Journal Article']",Italy,Minerva Endocrinol,Minerva endocrinologica,8406505,,IM,"['Adult', 'Female', 'Hemodynamics', 'Humans', 'Hypertension/complications/*diagnostic imaging/physiopathology', 'Male', 'Middle Aged', 'Obesity/complications/*diagnostic imaging/physiopathology', '*Radionuclide Ventriculography']",,,,,1990/07/01 00:00,1990/07/01 00:01,['1990/07/01 00:00'],"['1990/07/01 00:00 [pubmed]', '1990/07/01 00:01 [medline]', '1990/07/01 00:00 [entrez]']",,ppublish,Minerva Endocrinol. 1990 Jul-Sep;15(3):185-9.,,,,,,,,,Valutazione cardioscintigrafica dell'obeso con o senza ipertensione arteriosa.,,,,,,,,,,,
21842287,NLM,MEDLINE,20120319,20211020,1708-0428 (Electronic) 0960-8923 (Linking),21,11,2011 Nov,The two major epidemics of the twenty-first century: obesity and cancer.,1792-7,10.1007/s11695-011-0490-2 [doi],"It is a well-known fact that severe obesity is associated with the metabolic syndrome, type 2 diabetes, cardiovascular disease, hypertension, and other diseases. Epidemiological studies have suggested that obesity is also associated with increased risk of several cancer types. The number of people who are suffering from severe obesity is growing, and clinical data suggest that severely obese patients belong to a unique population with regards to risk, efficacy of screening, and cancer treatment. This review will point out the potential mechanism linking obesity and cancer and will discuss several challenges in various treatment modalities of cancer in obese patients.","['Kaidar-Person, Orit', 'Bar-Sela, Gil', 'Person, Benjamin']","['Kaidar-Person O', 'Bar-Sela G', 'Person B']","['Division of Oncology, Rambam Health Care Campus and Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.']",['eng'],"['Journal Article', 'Review']",United States,Obes Surg,Obesity surgery,9106714,,IM,"['Humans', 'Neoplasms/*epidemiology', 'Obesity/*epidemiology/therapy', 'Risk Factors']",,,,,2011/08/16 06:00,2012/03/20 06:00,['2011/08/16 06:00'],"['2011/08/16 06:00 [entrez]', '2011/08/16 06:00 [pubmed]', '2012/03/20 06:00 [medline]']",['10.1007/s11695-011-0490-2 [doi]'],ppublish,Obes Surg. 2011 Nov;21(11):1792-7. doi: 10.1007/s11695-011-0490-2.,,,,,,,,,,,,,,,,,,,,
5389387,NLM,MEDLINE,19700107,20161122,0021-4493 (Print) 0021-4493 (Linking),62,3,1969 Aug 1,[Epidemiological considerations on obese children].,249-58,,,"['Sonoda, M', 'Eguchi, K', 'Fukunaga, K', 'Kijima, R', 'Matsushita, I']","['Sonoda M', 'Eguchi K', 'Fukunaga K', 'Kijima R', 'Matsushita I']",,['jpn'],['Journal Article'],Japan,Nihon Ishikai Zasshi,Nihon Ishikai zasshi. Journal of the Japan Medical Association,0413545,,IM,"['Adolescent', 'Age Factors', 'Child', 'Child, Preschool', 'Feeding Behavior', 'Female', 'Humans', 'Japan', 'Male', 'Obesity/*epidemiology/genetics/prevention & control', 'Sex Factors']",,,,,1969/08/01 00:00,1969/08/01 00:01,['1969/08/01 00:00'],"['1969/08/01 00:00 [pubmed]', '1969/08/01 00:01 [medline]', '1969/08/01 00:00 [entrez]']",,ppublish,Nihon Ishikai Zasshi. 1969 Aug 1;62(3):249-58.,,,,,,,,,,,,,,,,,,,,
2582734,NLM,MEDLINE,19900111,20190919,0144-5979 (Print) 0144-5979 (Linking),9,5,1989 Oct,Meal-induced thermogenesis in obese patients before and after weight reduction.,481-98,,"The purpose of this study was to find out whether human obesity is associated with a diminished meal-induced thermogenesis and, if so, to what extent this response is influenced by weight reduction. Ten obese subjects (body mass index 42 +/- 2) and 10 age- and sex-matched non-obese volunteers were studied with continuous indirect calorimetry in the basal state and after the ingestion of a standardized test meal. Six obese subjects (body mass index 44 +/- 2) were examined on two occasions, once before and once after gastric banding and an average weight reduction of 18 +/- 3 kg. Basal oxygen uptake and energy expenditure were 30% (P less than 0.001) greater in the obese subjects compared to non-obese controls. After the meal, pulmonary oxygen uptake and energy expenditure increased rapidly and reached a relatively constant level after 60 min; for pulmonary oxygen uptake the average rise above basal was less in the obese (17.7 +/- 1.6%) than the non-obese (27.8 +/- 1.9%, P less than 0.001); the increase in energy expenditure was 18.5 +/- 1.7% in obese and 30.8 +/- 2.1% in non-obese subjects (P less than 0.001). After weight reduction, oxygen uptake and energy expenditure in the basal state were 20% lower (P less than 0.05) than before weight reduction. The average post-prandial increase in oxygen uptake was greater after weight reduction (24.8 +/- 2.0%) than before (16.7 +/- 1.6%, P less than 0.001). Corresponding values for energy expenditure were 27.2 +/- 2.2 and 18.2 +/- 2.2% (P less than 0.001). It is concluded that: (1) the thermogenic response to a mixed meal is lower in obese compared to non-obese individuals; and, (2) this impaired response is partly normalized after weight reduction. These findings suggest that a diminished meal-induced thermogenesis is a secondary phenomenon rather than a primary pathogenic factor in human obesity.","['Thorne, A', 'Hallberg, D', 'Wahren, J']","['Thorne A', 'Hallberg D', 'Wahren J']","['Department of Surgery, Huddinge University Hospital, Sweden.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Clin Physiol,"Clinical physiology (Oxford, England)",8309768,,IM,"['Adult', 'Calorimetry, Indirect', 'Eating/*physiology', 'Energy Metabolism/*physiology', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/blood/*physiopathology/surgery', 'Time Factors', 'Weight Loss/*physiology']",,,,,1989/10/01 00:00,1989/10/01 00:01,['1989/10/01 00:00'],"['1989/10/01 00:00 [pubmed]', '1989/10/01 00:01 [medline]', '1989/10/01 00:00 [entrez]']",['10.1111/j.1475-097x.1989.tb01002.x [doi]'],ppublish,Clin Physiol. 1989 Oct;9(5):481-98. doi: 10.1111/j.1475-097x.1989.tb01002.x.,,,,,,,,,,,,,,,,,,,,
36429349,NLM,MEDLINE,20221129,20230124,1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking),19,22,2022 Nov 8,Effects of Recreational Physical Activity on Abdominal Obesity in Obese South Korean Adults.,,10.3390/ijerph192214634 [doi] 14634,"This study investigated the effects of general characteristics, health behaviors, and level of physical activity on abdominal obesity in obese adults (BMI (body mass index) >/= 25 kg/m(2)) using data from the seventh period (2016-2018) of the Korea National Health and Nutrition Examination Survey (KNHANES). We also prepared basic data on the improvement and management of abdominal obesity. The participants were 2343 obese adults (men, 1338; women, 1005) from the KNHANES. Factors relevant to abdominal obesity in obese Korean women were general characteristics (age, marital status, occupation, education, and menopause) and health behaviors (time for recreational physical activities and energy intake). In men, these factors tended to be health behaviors, including time spent on leisure physical activity, and sitting. It was found that over 600 Mets/week of recreational physical activity for both adult men and women reduced the incidence of abdominal obesity after adjusting for general characteristics and health behaviors (odds ratio (95% CI); men 0.69 (0.51-0.92); women, 0.61 (0.40-0.94)). Therefore, to prevent or improve abdominal obesity in obese adults in Korea, it is necessary to consider general characteristics and health behaviors according to sex. In addition, maintaining a physical activity rate of over 600 Mets/week is also recommended.","['Lee, Yoonmi', 'Kwak, Sungjung', 'Shin, Jieun']","['Lee Y', 'Kwak S', 'Shin J']","[""Department of Health Exercise Management, Sungshin Women's University, Seoul 02844, Republic of Korea."", 'Robotic Surgery Center, Konyang University Hospital, Daejeon 35365, Republic of Korea.', 'Department of Biomedical Informatics, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Switzerland,Int J Environ Res Public Health,International journal of environmental research and public health,101238455,,IM,"['Adult', 'Male', 'Humans', 'Female', '*Obesity, Abdominal/complications', 'Nutrition Surveys', '*Obesity/epidemiology/etiology', 'Body Mass Index', 'Exercise']",PMC9689999,['NOTNLM'],"['Korea National Health and Nutrition Examination Survey (KNHANES)', 'abdominal obesity', 'recreational physical activity']",['The author declares no conflict of interest.'],2022/11/27 06:00,2022/11/30 06:00,['2022/11/26 01:09'],"['2022/09/26 00:00 [received]', '2022/11/04 00:00 [revised]', '2022/11/04 00:00 [accepted]', '2022/11/26 01:09 [entrez]', '2022/11/27 06:00 [pubmed]', '2022/11/30 06:00 [medline]']","['ijerph192214634 [pii]', 'ijerph-19-14634 [pii]', '10.3390/ijerph192214634 [doi]']",epublish,Int J Environ Res Public Health. 2022 Nov 8;19(22):14634. doi: 10.3390/ijerph192214634.,,20221108,,,"['ORCID: 0000-0002-2056-4685', 'ORCID: 0000-0002-4092-3948', 'ORCID: 0000-0002-6192-2610']",,,,,,,,,,,,,,,
17655508,NLM,MEDLINE,20071011,20220331,0277-0008 (Print) 0277-0008 (Linking),27,8,2007 Aug,Antimicrobial dosing considerations in obese adult patients.,1081-91,,"As obesity continues to increase in prevalence throughout the world, it becomes important to explore the effects that obesity has on antimicrobial disposition. Physiologic changes in obesity can alter both the volume of distribution and clearance of many commonly used antimicrobials. These changes often present challenges such as estimation of creatinine clearance to predict drug clearance. Although these physiologic changes are increasingly being characterized, few studies assessing alterations in tissue drug distribution and the effects of obesity on antimicrobial pharmacokinetics have been published. The available data are most plentiful for antibiotics that historically have included clinical therapeutic drug monitoring. These data suggest that dosing of vancomycin and aminoglycosides be based on total body weight and adjusted body weight, respectively. Obese patients may require larger doses of beta-lactams to achieve similar concentrations as those of patients who are not obese. Fluoroquinolone pharmacokinetics are variably altered by obesity, which prevents a uniform approach. Data on the pharmacokinetics of drugs that have activity against gram-positive organisms-quinupristin-dalfopristin, linezolid, and daptomycin-reveal that they are altered in the presence of obesity, but more data are needed to solidify dosing recommendations. Limited data are available on nonantibacterials. An understanding of the physiologic changes in obesity and the available literature on specific antibiotics is valuable in providing a framework for rational selection of dosages in this increasingly common population of obese patients.","['Pai, Manjunath P', 'Bearden, David T']","['Pai MP', 'Bearden DT']","['Division of Pharmacy Practice, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA.']",['eng'],"['Journal Article', 'Review']",United States,Pharmacotherapy,Pharmacotherapy,8111305,['0 (Anti-Infective Agents)'],IM,"['Anti-Infective Agents/administration & dosage/*pharmacokinetics', 'Body Weight', 'Clinical Trials as Topic', 'Dose-Response Relationship, Drug', 'Drug Monitoring', 'Humans', 'Obesity/classification/epidemiology/*physiopathology', 'Tissue Distribution']",,,,,2007/07/28 09:00,2007/10/12 09:00,['2007/07/28 09:00'],"['2007/07/28 09:00 [pubmed]', '2007/10/12 09:00 [medline]', '2007/07/28 09:00 [entrez]']",['10.1592/phco.27.8.1081 [doi]'],ppublish,Pharmacotherapy. 2007 Aug;27(8):1081-91. doi: 10.1592/phco.27.8.1081.,,,,,,,81,,,,,,,,,,,,,
18241135,NLM,MEDLINE,20090107,20080204,1087-3244 (Print) 1087-3244 (Linking),32,5,2008 Sep-Oct,Do obese persons comprehend their personal health risks?,508-16,10.5555/ajhb.2008.32.5.508 [doi],"OBJECTIVES: To test whether overweight and obese individuals believe they are at greater risk of obesity-related diseases and premature mortality. METHODS: Telephone survey of 1139 US adults analyzed using linear and ordered logistic regressions. RESULTS: Obese (overweight) adults forecast life expectancies 3.9 (2.4) years shorter than those of normal weight adults. Excess weight was associated with greater self-perceived risk of developing diabetes, cancer, heart disease, and stroke. All results were statistically significant. CONCLUSIONS: Overweight and obese adults recognize several personal health risks associated with obesity. Interventions focusing only on health risks of obesity may provide minimal new information and induce little new weight loss.","['Finkelstein, Eric A', 'Brown, Derek S', 'Evans, W Douglas']","['Finkelstein EA', 'Brown DS', 'Evans WD']","['Public Health Economics Program, RTI International, Research Triangle Park, NC 27709-2194, USA. finkelse@rti.org']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Am J Health Behav,American journal of health behavior,9602338,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Female', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Life Expectancy', 'Logistic Models', 'Male', 'Middle Aged', 'Obesity/*complications/epidemiology/*psychology', 'United States/epidemiology', 'Young Adult']",,,,,2008/02/05 09:00,2009/01/08 09:00,['2008/02/05 09:00'],"['2008/02/05 09:00 [pubmed]', '2009/01/08 09:00 [medline]', '2008/02/05 09:00 [entrez]']",['10.5555/ajhb.2008.32.5.508 [doi]'],ppublish,Am J Health Behav. 2008 Sep-Oct;32(5):508-16. doi: 10.5555/ajhb.2008.32.5.508.,,,,,,,,,,,,,,,,,,,,
7069326,NLM,MEDLINE,19820621,20190904,0022-0736 (Print) 0022-0736 (Linking),15,2,1982 Apr,The electrocardiogram in obesity.,115-8,,"The electrocardiographic abnormalities ascribed to morbid obesity were analyzed in a group of 144 patients without apparent clinical cardiovascular pathology and compared with a control group of 100 normal weight patients. Fifty-eight patients in the obese group were re-analyzed after significant weight loss and the electrocardiographic findings compared with their initial changes when they entered the program. The QRS voltage for the obese group was slightly lower than the voltage of the normal population; but in a significant number of the patients restudied after weight loss, the QRS voltage decreased (37 out of 58 patients). In inferolateral leads non specific flattening of the T wave was observed in the obese group (71/144); it became normal as they lost weight. The P and QRS axes of the obese group initially were within normal limits but more to the left; they moved slightly to the right, although still within normal limits as the patients lost weight. Two conclusions can be drawn from the study: a) low voltage is not a significant feature in the ECG of the obese and, b) the most consistent finding in obese patients is a flattening of the T wave.","['Eisenstein, I', 'Edelstein, J', 'Sarma, R', 'Sanmarco, M', 'Selvester, R H']","['Eisenstein I', 'Edelstein J', 'Sarma R', 'Sanmarco M', 'Selvester RH']",,['eng'],['Journal Article'],United States,J Electrocardiol,Journal of electrocardiology,0153605,,IM,"['Adolescent', 'Adult', 'Body Weight', '*Electrocardiography', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*physiopathology/therapy']",,,,,1982/04/01 00:00,1982/04/01 00:01,['1982/04/01 00:00'],"['1982/04/01 00:00 [pubmed]', '1982/04/01 00:01 [medline]', '1982/04/01 00:00 [entrez]']",['10.1016/s0022-0736(82)80003-4 [doi]'],ppublish,J Electrocardiol. 1982 Apr;15(2):115-8. doi: 10.1016/s0022-0736(82)80003-4.,,,,,,,,,,,,,,,,,,,,
19437243,NLM,MEDLINE,20100706,20100408,1747-7174 (Electronic) 1747-7166 (Linking),5,1,2010,Obese children playing towards an active lifestyle.,64-71,10.3109/17477160902957166 [doi],"AIM: To determine whether five months of guided active play in overweight or obese children and adolescents under multi-disciplinary management for weight reduction leads to increased physical activity levels in leisure time, as well as changes in aerobic fitness and body composition. METHODS: Sixty overweight or obese children and adolescents were randomly assigned to an intervention or control group. All participants received dietary advice and were encouraged to increase physical activity level. The intervention group additionally participated in 60-minute guided active play/physical activity twice a week for 5 months. Physical activity was recorded; aerobic fitness and body composition were measured at inclusion and after cessation of intervention. RESULTS: Physical activity level during weekend days was significantly higher for the intervention group compared with the controls after 5 months intervention (p=0.04). The mean reduction in percentage of body fat was 1.8% (95%CI: 0.6, 3.1) in the intervention group (p=0.04) and not significant among the controls (0.9 [-0.9, 2.7]). There was no change in aerobic fitness. CONCLUSION: Five months of guided active play was associated with increased physical activity levels during weekend days and reduced body fat, although weakly, in overweight and obese children and adolescents participating in multi-disciplinary weight reduction programmes.","['Berntsen, Sveinung', 'Mowinckel, Petter', 'Carlsen, Kai-Hakon', 'Lodrup Carlsen, Karin C', 'Pollestad Kolsgaard, Magnhild L', 'Joner, Geir', 'Anderssen, Sigmund A']","['Berntsen S', 'Mowinckel P', 'Carlsen KH', 'Lodrup Carlsen KC', 'Pollestad Kolsgaard ML', 'Joner G', 'Anderssen SA']","['Department of Paediatrics, Woman and Child division, Ulleval University Hospital, 0806 Oslo, Norway. sveinung.berntsen@nih.no']",['eng'],"['Journal Article', 'Randomized Controlled Trial', ""Research Support, Non-U.S. Gov't""]",England,Int J Pediatr Obes,International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity,101256330,,IM,"['Adolescent', 'Body Composition', 'Chi-Square Distribution', 'Child', 'Child Behavior', 'Combined Modality Therapy', '*Exercise Therapy', 'Female', 'Health Behavior', 'Humans', '*Life Style', 'Male', '*Motor Activity', 'Norway', 'Obesity/diet therapy/physiopathology/psychology/*therapy', 'Oxygen Consumption', 'Physical Fitness', '*Play and Playthings', 'Time Factors', 'Treatment Outcome']",,,,,2009/05/14 09:00,2010/07/07 06:00,['2009/05/14 09:00'],"['2009/05/14 09:00 [entrez]', '2009/05/14 09:00 [pubmed]', '2010/07/07 06:00 [medline]']","['911129456 [pii]', '10.3109/17477160902957166 [doi]']",ppublish,Int J Pediatr Obes. 2010;5(1):64-71. doi: 10.3109/17477160902957166.,,,,,,,,,,,,,,,,,,,,
23385184,NLM,MEDLINE,20130503,20151119,0040-5930 (Print) 0040-5930 (Linking),70,2,2013 Feb,[Eating behavior and eating disorders in obesity].,81-4,10.1024/0040-5930/a000369 [doi],"Obesity is not an eating disorder. Nevertheless, dysfunctional eating pattersn and eating disorders have a substantial impact on emergence and maintenance of obesity. In this article we describe problematic eating patterns that are common in obese patients and how these eating behaviors should be explored. Eating disorders are differentiated from subclinical dysfunctional eating behavior. A classification system for dysfunctional eating patterns in obesity doesn't exist so far.","['Terpitz, Corinna', 'Remund, Livia']","['Terpitz C', 'Remund L']","['Universitatspoliklinik fur Endokrinologie, Diabetologie und Klinische Ernahrung, Kompetenzbereich Ernahrungspsychologie und Adipositas Team, Inselspital Bern, Switzerland. corinna.terpitz@insel.ch']",['ger'],"['English Abstract', 'Journal Article', 'Review']",Switzerland,Ther Umsch,Therapeutische Umschau. Revue therapeutique,0407224,,IM,"['*Feeding Behavior', 'Feeding and Eating Disorders/complications/*diagnosis/*physiopathology', 'Humans', 'Obesity/complications/*diagnosis/*physiopathology']",,,,,2013/02/07 06:00,2013/05/04 06:00,['2013/02/07 06:00'],"['2013/02/07 06:00 [entrez]', '2013/02/07 06:00 [pubmed]', '2013/05/04 06:00 [medline]']","['F07L4948JQ568187 [pii]', '10.1024/0040-5930/a000369 [doi]']",ppublish,Ther Umsch. 2013 Feb;70(2):81-4. doi: 10.1024/0040-5930/a000369.,,,,,,,,,Essverhalten und essstorungen bei adipositas.,,,,,,,,,,,
38027204,NLM,MEDLINE,20231201,20231201,1664-2392 (Print) 1664-2392 (Electronic) 1664-2392 (Linking),14,,2023,High-frequency variants in PKA signaling-related genes within a large pediatric cohort with obesity or metabolic abnormalities.,1272939,10.3389/fendo.2023.1272939 [doi] 1272939,"INTRODUCTION: Pediatric obesity has steadily increased in recent decades. Large-scale genome-wide association studies (GWAS) conducted primarily in Eurocentric adult populations have identified approximately 100 loci that predispose to obesity and type II diabetes. GWAS in children and individuals of non-European descent, both disproportionately affected by obesity, are fewer. Rare syndromic and monogenic obesities account for only a small portion of childhood obesity, so understanding the role of other genetic variants and their combinations in heritable obesities is key to developing targeted and personalized therapies. Tight and responsive regulation of the cAMP-dependent protein kinase (PKA) signaling pathway is crucial to maintaining healthy energy metabolism, and mutations in PKA-linked genes represent the most common cause of monogenic obesity. METHODS: For this study, we performed targeted exome sequencing of 53 PKA signaling-related genes to identify variants in genomic DNA from a large, ethnically diverse cohort of obese or metabolically challenged youth. RESULTS: We confirmed 49 high-frequency variants, including a novel variant in the PDE11A gene (c.152C>T). Several other variants were associated with metabolic characteristics within ethnic groups. DISCUSSION: We conclude that a PKA pathway-specific variant search led to the identification of several new genetic associations with obesity in an ethnically diverse population.","['Bloyd, Michelle', 'Sinaii, Ninet', 'Faucz, Fabio Rueda', 'Iben, James', 'Coon, Steven L', 'Caprio, Sonia', 'Santoro, Nicola', 'Stratakis, Constantine A', 'London, Edra']","['Bloyd M', 'Sinaii N', 'Faucz FR', 'Iben J', 'Coon SL', 'Caprio S', 'Santoro N', 'Stratakis CA', 'London E']","['Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, MD, United States.', 'Biostatistics and Clinical Epidemiology Service, National Institutes of Health (NIH) Clinical Center, Bethesda, MD, United States.', 'Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, MD, United States.', 'Molecular Genomics Core, National Institute of Child Health and Human Development (NICHD), Bethesda, MD, United States.', 'Molecular Genomics Core, National Institute of Child Health and Human Development (NICHD), Bethesda, MD, United States.', 'Section on Pediatric Endocrinology and Diabetes, Yale University, New Haven, CT, United States.', 'Section on Pediatric Endocrinology and Diabetes, Yale University, New Haven, CT, United States.', 'Department of Medicine and Health Sciences, ""V. Tiberio"" University of Molise, Campobasso, Italy.', 'Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, MD, United States.', 'Human Genetics and Precision Medicine, Institute for Molecular Biology and Biotechnology (IMBB), Foundation for Research & Technology Hellas (FORTH), Heraklion, ELPEN Research Institute, Athens, Greece.', 'Section on Endocrinology and Genetics, Program on Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, MD, United States.']",['eng'],['Journal Article'],Switzerland,Front Endocrinol (Lausanne),Frontiers in endocrinology,101555782,,IM,"['Adult', 'Adolescent', 'Humans', 'Child', '*Pediatric Obesity/genetics', 'Genome-Wide Association Study', '*Diabetes Mellitus, Type 2', 'Mutation']",PMC10679389,['NOTNLM'],"['GPCRs', 'T2DM', 'genetics', 'liver disease', 'obesity', 'pediatric', 'protein kinase A', 'targeted exome sequencing']","['The authors declare that the research was conducted in the absence of any', 'commercial or financial relationships that could be construed as a potential', 'conflict of interest.']",2023/11/29 18:42,2023/12/01 06:45,['2023/11/29 17:02'],"['2023/08/04 00:00 [received]', '2023/10/05 00:00 [accepted]', '2023/12/01 06:45 [medline]', '2023/11/29 18:42 [pubmed]', '2023/11/29 17:02 [entrez]']",['10.3389/fendo.2023.1272939 [doi]'],epublish,Front Endocrinol (Lausanne). 2023 Nov 13;14:1272939. doi: 10.3389/fendo.2023.1272939. eCollection 2023.,,20231113,,"['Copyright (c) 2023 Bloyd, Sinaii, Faucz, Iben, Coon, Caprio, Santoro, Stratakis and', 'London.']",,,,,,,,['figshare/10.6084/m9.figshare.14120888.v1'],,,,,,,,
12951281,NLM,MEDLINE,20040512,20190910,0168-8227 (Print) 0168-8227 (Linking),61,2,2003 Aug,Assessing weight-related quality of life in obese persons with type 2 diabetes.,125-32,,"Because approximately 80% of individuals with type 2 diabetes are obese, we examined weight-related QOL in obese persons with diabetes using the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) questionnaire. Study participants were enrolled in a clinical trial for an obesity medication or a clinical study of gastric bypass surgery. Psychometric properties of the IWQOL-Lite were evaluated separately for obese persons with (n = 225) and without (n = 972) type 2 diabetes. Internal consistency reliabilities were similar for persons with and without diabetes (0.981 versus 0.980). Correlations between IWQOL-Lite scores and body mass index were significant and comparable for persons with and without diabetes. The IWQOL-Lite factor structure was similar for both the diabetic and non-diabetic subjects and consistent with earlier studies. There was no difference between diabetic and non-diabetic subjects on weight-related QOL as measured by the IWQOL-Lite; however, subjects in this study had more impaired weight-related QOL relative to a reference sample of overweight/obese community persons. We recommend the use of weight-related QOL measures in addition to generic and diabetes-specific measures when assessing quality of life in type 2 diabetes, particularly when patients are overweight or obese.","['Kolotkin, Ronette L', 'Crosby, Ross D', 'Williams, G Rhys']","['Kolotkin RL', 'Crosby RD', 'Williams GR']","['Obesity and Quality of Life Consulting, 1004 Norwood Avenue, Durham, NC 27707, USA. rkolotkin@yahoo.com']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Ireland,Diabetes Res Clin Pract,Diabetes research and clinical practice,8508335,,IM,"['Body Mass Index', 'Diabetes Mellitus, Type 2/*complications', 'Female', 'Humans', 'Male', 'Obesity/complications/pathology/*physiopathology', '*Quality of Life', 'Surveys and Questionnaires']",,,,,2003/09/03 05:00,2004/05/13 05:00,['2003/09/03 05:00'],"['2003/09/03 05:00 [pubmed]', '2004/05/13 05:00 [medline]', '2003/09/03 05:00 [entrez]']","['S016882270300113X [pii]', '10.1016/s0168-8227(03)00113-x [doi]']",ppublish,Diabetes Res Clin Pract. 2003 Aug;61(2):125-32. doi: 10.1016/s0168-8227(03)00113-x.,,,,,,,,,,,,,,,,,,,,
10569196,NLM,MEDLINE,19991222,20190818,0300-8177 (Print) 0300-8177 (Linking),200,1-2,1999 Oct,Ammonium uptake and urea production in hepatocytes from lean and obese Zucker rats.,163-7,,"The metabolic differences in vitro between genetic and dietary obese rats in the uptake of ammonium and amino acids by the liver and their use for ureogenesis have been assayed using hepatocytes isolated from Lean, Obese Zucker (Genetic obese) rats and Dietary obese rats. The hepatocytes of genetic obese animals took up more ammonium and produced higher amounts of urea from ammonium and alanine than those of lean and dietary obese groups (2 and 5 times more respectively). In the lean and dietary obese groups urea synthesis accounted for almost all the nitrogen taken up as ammonium. Thus, dietary and genetic obesity show a widely different handling of nitrogen, and the genetic obese rats need to break down protein to maintain their hepatocyte function.","['Herrero, M C', 'Remesar, X', 'Arola, L', 'Blade, C']","['Herrero MC', 'Remesar X', 'Arola L', 'Blade C']","['Departament de Bioquimica i Biotecnologia, Universitat Rovira i Virgili, Tarragona, Spain.']",['eng'],"['Comparative Study', 'Journal Article']",Netherlands,Mol Cell Biochem,Molecular and cellular biochemistry,0364456,"['0 (Quaternary Ammonium Compounds)', '8W8T17847W (Urea)', 'N762921K75 (Nitrogen)', 'OF5P57N2ZX (Alanine)']",IM,"['Alanine/metabolism', 'Animals', 'Biological Transport, Active', 'In Vitro Techniques', 'Liver/*metabolism', 'Male', 'Nitrogen/metabolism', 'Obesity/etiology/genetics/*metabolism', 'Quaternary Ammonium Compounds/*metabolism', 'Rats', 'Rats, Zucker', 'Urea/*metabolism']",,,,,1999/11/24 00:00,1999/11/24 00:01,['1999/11/24 00:00'],"['1999/11/24 00:00 [pubmed]', '1999/11/24 00:01 [medline]', '1999/11/24 00:00 [entrez]']",['10.1023/a:1007003519678 [doi]'],ppublish,Mol Cell Biochem. 1999 Oct;200(1-2):163-7. doi: 10.1023/a:1007003519678.,,,,,,,,,,,,,,,,,,,,
1518506,NLM,MEDLINE,19921008,20200304,0300-8177 (Print) 0300-8177 (Linking),113,2,1992 Aug 18,Genetic aspects of susceptibility to obesity and related dyslipidemias.,151-69,,"Obesity has a multifactorial origin. However, although environmental variables undoubtedly play a role in the development of obesity, it is now clear that genetic variation is also involved in the determination of an individual's susceptibility to body fat accumulation. In addition, it is also widely accepted that obesity is not a single homogeneous phenotype. It is also heterogeneous regarding its causes and metabolic complications. The regional distribution of body fat appears to be an important correlate of the metabolic complications that have been related to obesity. Due to their higher accumulation of abdominal fat, men are generally more at risk for the metabolic complications of obesity than women whereas some obese women, with large gluteal-femoral adipose depots may have a cosmetic problem which may not necessarily require medical intervention. Several studies have been conducted to understand the mechanisms by which abdominal obesity is related to diabetes, hypertension and cardiovascular disease. It appears that the increased risk of abdominal obesity is the result of complex hormonal and metabolic interactions. Studies in genetic epidemiology have shown that both total body fatness and the regional distribution of body fat have a significant genetic component. Standardized intervention studies using an identical twin design have shown that individuals that have the same genetic background tend to show similar changes in body fat and in plasma lipoprotein levels when exposed to standardized caloric excess or energy restriction. Finally, although abdominal obesity is a significant risk factor for cardiovascular disease, not every abdominal obese subject will experience metabolic complications, suggesting that some obese individuals may be more susceptible than others. Variation in several genes relevant to lipid and lipoprotein metabolism may alter the relation of abdominal obesity to dyslipoproteinemias. Abdominal obesity should therefore be considered as a factor that exacerbates an individual's susceptibility to cardiovascular disease.","['Despres, J P', 'Moorjani, S', 'Lupien, P J', 'Tremblay, A', 'Nadeau, A', 'Bouchard, C']","['Despres JP', 'Moorjani S', 'Lupien PJ', 'Tremblay A', 'Nadeau A', 'Bouchard C']","['Physical Activity Sciences Laboratory, Laval University, Ste-Foy, Quebec, Canada.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",Netherlands,Mol Cell Biochem,Molecular and cellular biochemistry,0364456,['0 (Lipoproteins)'],IM,"['Adipose Tissue/metabolism', 'Disease Susceptibility', 'Exercise', 'Female', 'Humans', '*Lipid Metabolism', 'Lipoproteins/*metabolism', 'Male', 'Obesity/etiology/*genetics/metabolism', 'Twins, Monozygotic']",,,,,1992/08/18 00:00,1992/08/18 00:01,['1992/08/18 00:00'],"['1992/08/18 00:00 [pubmed]', '1992/08/18 00:01 [medline]', '1992/08/18 00:00 [entrez]']",['10.1007/BF00231535 [doi]'],ppublish,Mol Cell Biochem. 1992 Aug 18;113(2):151-69. doi: 10.1007/BF00231535.,,,,,,,82,,,,,,,,,,,,,
35162313,NLM,MEDLINE,20220302,20220302,1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking),19,3,2022 Jan 24,Obese Patients Experience More Severe CSA than Non-Obese Patients.,,10.3390/ijerph19031289 [doi] 1289,"OBJECTIVE: To investigate whether central sleep apnea (CSA) is associated with an increased risk of obesity. MATERIALS AND METHODS: From 1 January 2000 to 31 December 2015, we screened 24,363 obese patients from the 2005 longitudinal health insurance database, which is part of the Taiwan National Health Insurance Research Database. From the same database, 97,452 non-obese patients were also screened out. Age, gender, and index dates were matched. Multiple logistic regression was used to analyze the previous exposure risk of obese and CSA patients. A p-value of <0.05 was considered significant. RESULTS: Obese patients were more likely to be exposed to CSA than non-obese patients would (AOR = 2.234, 95% CI = 1.483-4.380, p < 0.001). In addition, the closeness of the exposure time to the index time is positively correlated with the severity of obesity and has a dose-response effect (CSA exposure < 1 year, AOR = 2.386; CSA exposure >/= 1 year and <5 years, AOR = 1.725; CSA exposure time >/= 5 years, AOR = 1.422). The CSA exposure time of obese patients was 1.693 times that of non-obese patients. Longer exposure time is associated with more severe obesity and has a dose-response effect (CSA exposure < 1 year, AOR = 1.420; CSA exposure >/= 1 year and <5 years, AOR = 2.240; CSA >/= 5 years, AOR = 2.863). CONCLUSIONS: In this case-control study, patients with CSA had a significantly increased risk of obesity. Long-term exposure to CSA and obesity is more likely and has a dose-response effect.","['Huang, Yao-Ching', 'Huang, Shi-Hao', 'Chung, Ren-Jei', 'Wang, Bing-Long', 'Chung, Chi-Hsiang', 'Chien, Wu-Chien', 'Sun, Chien-An', 'Yu, Pi-Ching', 'Lu, Chieh-Hua']","['Huang YC', 'Huang SH', 'Chung RJ', 'Wang BL', 'Chung CH', 'Chien WC', 'Sun CA', 'Yu PC', 'Lu CH']","['Department of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei 10608, Taiwan.', 'Department of Medical Research, Tri-Service General Hospital, Taipei 11490, Taiwan.', 'Department of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei 10608, Taiwan.', 'Department of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei 10608, Taiwan.', 'School of Public Health, National Defense Medical Center, Taipei 11490, Taiwan.', 'Department of Medical Research, Tri-Service General Hospital, Taipei 11490, Taiwan.', 'Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 11490, Taiwan.', 'Taiwanese Injury Prevention and Safety Promotion Association (TIPSPA), Taipei 11490, Taiwan.', 'Department of Medical Research, Tri-Service General Hospital, Taipei 11490, Taiwan.', 'Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 11490, Taiwan.', 'Taiwanese Injury Prevention and Safety Promotion Association (TIPSPA), Taipei 11490, Taiwan.', 'Department of Public Health, College of Medicine, Fu-Jen Catholic University, New Taipei City 242062, Taiwan.', 'Big Data Center, College of Medicine, Fu-Jen Catholic University, New Taipei City 242062, Taiwan.', 'Graduate Institute of Medicine, National Defense Medical Center, Taipei 11490, Taiwan.', 'Cardiovascular Intersive Care Unit, Department of Critical Care Medicine, Far-Eastern Memorial Hospital, New Taipei City 10602, Taiwan.', 'Division of Endocrinology and Metabolism, Department of Internal Medicine, Tri-Service General Hospital, School of Medicine, National Defense Medical Center, Taipei 11490, Taiwan.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Switzerland,Int J Environ Res Public Health,International journal of environmental research and public health,101238455,,IM,"['Case-Control Studies', 'Humans', 'Logistic Models', 'Obesity/complications/epidemiology', '*Obesity, Morbid', '*Sleep Apnea, Central/etiology']",PMC8835470,['NOTNLM'],"['National Health Insurance Research Database', 'case-control study', 'central sleep apnea', 'obesity']",['The authors declare no conflict of interest.'],2022/02/16 06:00,2022/03/03 06:00,['2022/02/15 01:13'],"['2021/12/22 00:00 [received]', '2022/01/17 00:00 [revised]', '2022/01/18 00:00 [accepted]', '2022/02/15 01:13 [entrez]', '2022/02/16 06:00 [pubmed]', '2022/03/03 06:00 [medline]']","['ijerph19031289 [pii]', 'ijerph-19-01289 [pii]', '10.3390/ijerph19031289 [doi]']",epublish,Int J Environ Res Public Health. 2022 Jan 24;19(3):1289. doi: 10.3390/ijerph19031289.,,20220124,,,"['ORCID: 0000-0001-6360-3958', 'ORCID: 0000-0002-9304-3418', 'ORCID: 0000-0002-0655-3680', 'ORCID: 0000-0002-4576-9900', 'ORCID: 0000-0002-3286-0780', 'ORCID: 0000-0001-9041-0537', 'ORCID: 0000-0002-2179-9486']",,,,,,,,,,,,,,,
21717816,NLM,MEDLINE,20110802,20110701,0038-3317 (Print) 0038-3317 (Linking),Spec No,,2011,Behavioral and medical management of obesity.,51-5,,"South Dakota physicians are confronted by an epidemic of obesity. Developing an effective management strategy for patients with this condition can be daunting. This article reviews the evidence behind dietary, exercise-based, and pharmacological approaches to the care of the overweight and obese patient, offering recommendations to the clinician based on this evidence.","['Huntington, Mark K', 'Shewmake, Roger A']","['Huntington MK', 'Shewmake RA']","['Center for Family Medicine, Department of Family Medicine, Sanford School of Medicine, University of South Dakota, Sioux Fall, USA.']",['eng'],"['Journal Article', 'Review']",United States,S D Med,South Dakota medicine : the journal of the South Dakota State Medical Association,101265265,['0 (Dietary Carbohydrates)'],IM,"['*Behavior Therapy', 'Caloric Restriction', 'Dietary Carbohydrates/administration & dosage', 'Exercise/physiology', 'Humans', 'Obesity/diet therapy/physiopathology/prevention & control/*therapy']",,,,,2011/07/02 06:00,2011/08/04 06:00,['2011/07/02 06:00'],"['2011/07/02 06:00 [entrez]', '2011/07/02 06:00 [pubmed]', '2011/08/04 06:00 [medline]']",,ppublish,S D Med. 2011;Spec No:51-5.,,,,,,,,,,,,,,,,,,,,
32888856,NLM,MEDLINE,20210913,20210913,1871-403X (Print) 1871-403X (Linking),14,5,2020 Sep-Oct,Delays in healthcare consultations about obesity - Barriers and implications.,487-490,S1871-403X(20)30570-6 [pii] 10.1016/j.orcp.2020.08.003 [doi],"BACKGROUND: The prevalence of obesity continues to rise, affecting nearly a third of Australian adults in 2017-18. The stigma and bias people with obesity (PwO) experience is one of the barriers hindering the dialogue between PwO and their Health Care Professionals (HCPs). The results from the ACTION IO Australian cohort are reported here. Identification of local barriers can inform strategies to improve access to quality obesity care within Australia. METHODS: The ACTION-IO study was an online cross-sectional survey conducted in 11 countries during June-October 2018. In Australia 1,000 community based adult PwO (body mass index >/=30 kg/m based on self-reported height and weight) and 200 HCPs involved with direct patient care (seeing >/=10 patients with obesity/month) completed the survey. RESULTS: There was a mean delay of 8.9 years from when a PwO first started to struggle with their weight, and the initial discussion with an HCP about this. HCPs acknowledged weight loss efforts in only 38.5% of their patients, although 74.6% of PwO had attempted weight loss. Most PwO (82.0%) assumed full responsibility for their weight loss. HCPs identified short appointment times (60.5%) and the cost of obesity medication, programmes and services (58.5%) as barriers to weight management conversations and weight loss, respectively. Most PwO want their HCP to raise the issue of weight with 64 % reporting finding such conversations positive and helpful. CONCLUSION: Compared to global results, Australian PwO took 3 years longer to seek medical care about their weight. Better recognition of obesity's impact and targeting barriers to care are needed.","['Rigas, Georgia', 'Williams, Kathryn', 'Sumithran, Priya', 'Brown, Wendy A', 'Swinbourne, Jessica', 'Purcell, Katrina', 'Caterson, Ian D']","['Rigas G', 'Williams K', 'Sumithran P', 'Brown WA', 'Swinbourne J', 'Purcell K', 'Caterson ID']","['Department of Bariatric Surgery, St. George Private Hospital, Kogarah, Sydney, Australia. Electronic address: georgiar@uppergisurgery.com.au.', 'Department of Bariatric Surgery, St. George Private Hospital, Kogarah, Sydney, Australia; Nepean Hospital, Nepean Blue Mountains Local Health District, Kingswood, New South Wales, Australia. Electronic address: kath.williams@sydney.edu.au.', 'Department of Medicine (Austin), University of Melbourne, Heidelberg, Australia.', 'Department of Surgery, Monash University, Melbourne, Australia.', 'Boden Collaboration, Charles Perkins Centre, University of Sydney, New South Wales, Australia.', 'Novo Nordisk, Baulkham Hills, New South Wales, Australia.', 'Boden Collaboration, Charles Perkins Centre, University of Sydney, New South Wales, Australia.']",['eng'],"['Letter', ""Research Support, Non-U.S. Gov't""]",Netherlands,Obes Res Clin Pract,Obesity research & clinical practice,101303911,,IM,"['Adult', '*Attitude of Health Personnel', 'Australia', 'Cross-Sectional Studies', 'Humans', '*Obesity/diagnosis', '*Referral and Consultation']",,['NOTNLM'],"['Barriers', 'Misconceptions', 'Obesity']",,2020/09/06 06:00,2021/09/14 06:00,['2020/09/05 12:19'],"['2020/08/03 00:00 [received]', '2020/08/06 00:00 [accepted]', '2020/09/06 06:00 [pubmed]', '2021/09/14 06:00 [medline]', '2020/09/05 12:19 [entrez]']","['S1871-403X(20)30570-6 [pii]', '10.1016/j.orcp.2020.08.003 [doi]']",ppublish,Obes Res Clin Pract. 2020 Sep-Oct;14(5):487-490. doi: 10.1016/j.orcp.2020.08.003. Epub 2020 Sep 1.,,20200901,,['Copyright (c) 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.'],,,,,,,,,,,,,,,,
1344457,NLM,MEDLINE,19940510,20091109,0025-8105 (Print) 0025-8105 (Linking),45,7-8,1992,[Psychological characteristics of obese persons with special reference to periods of modified fasting].,277-81,,"It is well known fact that the results of modified fasting can be improved if the basic therapeutic method is combined with psychotherapeutic procedures. We have analyzed the data taken by a poll from 55 extremely obese women treated by modified fasting regimen. The results absolutely justify the above mentioned remark that radical reduction cures may cause critical moments most frequently recognized in hunger crisis when patients feel a need for conversion with medical staff. With no doubt, any help from a qualified person might be perfectly beneficial. Besides, obese persons are more inclined to depressive moods which may aggravate during these cures. In order to maintain the achieved result for a longer period of time if not for good, a continuous team work which include psychotherapeutic measures is of special significance. On the highest level it would be smart to establish an association of treated obese people, which would be a link between a patient and a professional.","['Ivkovic-Lazar, T', 'Stokic, E', 'Lepsanovic, L', 'Vukcevic, L', 'Mrksic, S']","['Ivkovic-Lazar T', 'Stokic E', 'Lepsanovic L', 'Vukcevic L', 'Mrksic S']","['Klinika za interne bolesti, Medicinski fakultet, Novi Sad.']",['hrv'],"['English Abstract', 'Journal Article']",Serbia,Med Pregl,Medicinski pregled,2985249R,,IM,"['Adult', 'Emotions', 'Fasting/*psychology', 'Female', 'Humans', 'Obesity/*psychology/therapy']",,,,,1992/01/01 00:00,1992/01/01 00:01,['1992/01/01 00:00'],"['1992/01/01 00:00 [pubmed]', '1992/01/01 00:01 [medline]', '1992/01/01 00:00 [entrez]']",,ppublish,Med Pregl. 1992;45(7-8):277-81.,,,,,,,,,Neke psiholoske karakteristike gojaznih osoba s posebnim osvrtom na period sprovodenja modifikovanog gladovanja.,,,,,,,,,,,
30512576,NLM,MEDLINE,20190516,20190516,2101-017X (Electronic) 0035-2640 (Linking),66,5,2016 May,[Living with morbid obesity].,525-526,,,"['Joly, Anne-Sophie']",['Joly AS'],"[""Presidente du Collectif National des Associations d'Obeses (CNAO).""]",['fre'],['Journal Article'],France,Rev Prat,La Revue du praticien,0404334,,IM,"['Humans', '*Obesity, Morbid']",,['NOTNLM'],['Une obesite morbide'],"[""Anne-Sophie Joly n'a pas transmis de declaration d'interets.""]",2016/05/01 00:00,2016/05/01 00:01,['2018/12/05 06:00'],"['2018/12/05 06:00 [entrez]', '2016/05/01 00:00 [pubmed]', '2016/05/01 00:01 [medline]']",,ppublish,Rev Prat. 2016 May;66(5):525-526.,,,,,,,,,La chirurgie de l'obesite impose ensuite une surveillance pour la vie.,,,,,,,,,,,
20616984,NLM,MEDLINE,20101005,20231105,1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking),7,2,2010 Feb,Do health beliefs and behaviors differ according to severity of obesity? A qualitative study of Australian adults.,443-59,10.3390/ijerph7020443 [doi],"Public responses to obesity have focused on providing standardized messages and supports to all obese individuals, but there is limited understanding of the impact of these messages on obese adults. This descriptive qualitative study using in-depth interviews and a thematic method of analysis, compares the health beliefs and behaviors of 141 Australian adults with mild to moderate (BMI 30-39.9) and severe (BMI > or = 40) obesity. Mildly obese individuals felt little need to change their health behaviors or to lose weight for health reasons. Most believed they could ""lose weight"" if they needed to, distanced themselves from the word obesity, and stigmatized those ""fatter"" than themselves. Severely obese individuals felt an urgent need to change their health behaviors, but felt powerless to do so. They blamed themselves for their weight, used stereotypical language to describe their health behaviors, and described being ""at war"" with their bodies. Further research, particularly about the role of stigma and stereotyping, is needed to fully understand the impact of obesity messaging on the health beliefs, behaviors, and wellbeing of obese and severely obese adults.","['Lewis, Sophie', 'Thomas, Samantha L', 'Blood, R Warwick', 'Hyde, Jim', 'Castle, David J', 'Komesaroff, Paul A']","['Lewis S', 'Thomas SL', 'Blood RW', 'Hyde J', 'Castle DJ', 'Komesaroff PA']","['Consumer Health Research Group (CHaRGe), Primary Care Research Unit, School of Primary Health Care, Monash University, Building 1, 270 Ferntree Gully Rd, Notting Hill, Victoria 3168, Australia. Sophie.Lewis@med.monash.edu.au']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Switzerland,Int J Environ Res Public Health,International journal of environmental research and public health,101238455,,IM,"['Adult', 'Aged', 'Australia', 'Female', '*Health Behavior', 'Humans', 'Male', 'Middle Aged', 'Obesity/*physiopathology/psychology', '*Severity of Illness Index', 'Stereotyping']",PMC2872289,['NOTNLM'],"['consumer perspectives', 'health behaviors', 'health beliefs', 'obesity', 'public health', 'qualitative research', 'stigma']",,2010/07/10 06:00,2010/10/06 06:00,['2010/07/10 06:00'],"['2009/12/11 00:00 [received]', '2010/02/01 00:00 [accepted]', '2010/07/10 06:00 [entrez]', '2010/07/10 06:00 [pubmed]', '2010/10/06 06:00 [medline]']","['ijerph7020443 [pii]', 'ijerph-07-00443 [pii]', '10.3390/ijerph7020443 [doi]']",ppublish,Int J Environ Res Public Health. 2010 Feb;7(2):443-59. doi: 10.3390/ijerph7020443. Epub 2010 Feb 3.,,20100203,,,,,,,,,,,,,,,,,,
20046661,NLM,MEDLINE,20111123,20211020,1932-2968 (Electronic) 1932-2968 (Linking),3,1,2009 Jan,Medical implications of obesity in horses--lessons for human obesity.,163-74,,"There is growing recognition that obesity is common and represents a significant detriment to the health of companion animals in a manner similar to that by which it is affecting the human population. As is the case for other species, obesity appears to promote insulin resistance in horses and it is through this pathophysiological process that many of the adverse medical consequences of obesity are being characterized. Equine medical conditions that have been described in the context of obesity and insulin resistance differ from those in humans. Chronic human conditions that have been attributed to obesity and insulin resistance, such as atherosclerosis and diabetes mellitus, are rarely described in obese horses. Significant current interest is centered on the recognition that insulin resistance plays a role in the pathogenesis of laminitis, a potentially severe and debilitating cause of lameness in the equine species. Other equine medical conditions that are more likely in obese, insulin-resistant individuals include hyperlipemia (hepatic lipidosis) and developmental orthopedic disease (osteochondrosis). Pituitary pars intermedia dysfunction (equine Cushing's syndrome) represents another common endocrinopathic condition of older horses associated with insulin resistance. This review presents an introductory overview of the present understanding of obesity and insulin resistance and how these conditions may be associated with disease conditions in horses.","['Johnson, Philip J', 'Wiedmeyer, Charles E', 'Messer, Nat T', 'Ganjam, Venkataseshu K']","['Johnson PJ', 'Wiedmeyer CE', 'Messer NT', 'Ganjam VK']","['Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Missouri 65211, USA. JohnsonPJ@missouri.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, Non-P.H.S."", 'Review']",United States,J Diabetes Sci Technol,Journal of diabetes science and technology,101306166,,IM,"['Animals', 'Horse Diseases/*physiopathology', 'Horses', 'Humans', 'Insulin Resistance/physiology', 'Obesity/complications/physiopathology/*veterinary']",PMC2769846,['NOTNLM'],"[""Cushing's"", 'horse', 'insulin resistance', 'laminitis', 'nutrition', 'obesity', 'pituitary gland']",,2010/01/05 06:00,2011/12/13 00:00,['2010/01/05 06:00'],"['2010/01/05 06:00 [entrez]', '2010/01/05 06:00 [pubmed]', '2011/12/13 00:00 [medline]']","['dst.3.1.0163 [pii]', '10.1177/193229680900300119 [doi]']",ppublish,J Diabetes Sci Technol. 2009 Jan;3(1):163-74. doi: 10.1177/193229680900300119.,,,,['(c) Diabetes Technology Society'],,,,,,,,,,,,,,,,
10334085,NLM,MEDLINE,19990614,20191103,0098-6151 (Print) 0098-6151 (Linking),99,4 Suppl,1999 Apr,The role of physical activity in the management of obesity.,S15-9,,"Sedentary lifestyle is associated with obesity and obesity-related chronic diseases. Increased physical activity can produce clinically significant changes in body composition and a reduction in risk of obesity-related chronic diseases in obese people. Because a great proportion of a primary care physician's patient population will be obese, it is essential that physicians know the scientific facts about the role of physical activity in the treatment of obesity and how to effectively prescribe it. This article summarizes significant research conclusions about the relationship between physical activity, obesity, and health. It also provides practical strategies for helping obese patients integrate physical activity into their lives.","['Harris, J E']",['Harris JE'],"['Department of Health, West Chester University, Pa., USA. jharris@wcupa.edu']",['eng'],"['Journal Article', 'Review']",United States,J Am Osteopath Assoc,The Journal of the American Osteopathic Association,7503065,,IM,"['Body Composition', '*Exercise Therapy', 'Female', 'Humans', 'Life Style', 'Male', 'Obesity/prevention & control/*rehabilitation', 'Weight Loss']",,,,,1999/05/20 00:00,1999/05/20 00:01,['1999/05/20 00:00'],"['1999/05/20 00:00 [pubmed]', '1999/05/20 00:01 [medline]', '1999/05/20 00:00 [entrez]']",['10.7556/jaoa.1999.99.4.s15 [doi]'],ppublish,J Am Osteopath Assoc. 1999 Apr;99(4 Suppl):S15-9. doi: 10.7556/jaoa.1999.99.4.s15.,,,,,,,15,,,,,,,,,,,,,
11593138,NLM,MEDLINE,20020221,20190817,0277-2116 (Print) 0277-2116 (Linking),33,3,2001 Sep,Nutritional knowledge of obese and nonobese children.,351,,,"['Reinehr, T', 'Kersting, D M', 'Chahda, C', 'Wollenhaupt, A', 'Andler, W']","['Reinehr T', 'Kersting DM', 'Chahda C', 'Wollenhaupt A', 'Andler W']",,['eng'],"['Comparative Study', 'Letter']",United States,J Pediatr Gastroenterol Nutr,Journal of pediatric gastroenterology and nutrition,8211545,,IM,"['Adolescent', 'Case-Control Studies', 'Child', 'Feeding Behavior/psychology', '*Health Knowledge, Attitudes, Practice', 'Humans', '*Nutritional Sciences/education', 'Obesity/etiology/prevention & control/*psychology', 'Surveys and Questionnaires']",,,,,2001/10/11 10:00,2002/02/22 10:01,['2001/10/11 10:00'],"['2001/10/11 10:00 [pubmed]', '2002/02/22 10:01 [medline]', '2001/10/11 10:00 [entrez]']",['10.1097/00005176-200109000-00026 [doi]'],ppublish,J Pediatr Gastroenterol Nutr. 2001 Sep;33(3):351. doi: 10.1097/00005176-200109000-00026.,,,,,,,,,,,,,,,,,,,,
8760195,NLM,MEDLINE,19961008,20171213,0002-9513 (Print) 0002-9513 (Linking),271,1 Pt 2,1996 Jul,"Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity.",H373-8,,"Although obesity is a major risk factor for morbidity and mortality, the mechanisms mediating cardiovascular abnormalities in response to weight gain are unclear. One reason for the paucity of information in this area is the lack of appropriate animal models for the study of human obesity. Therefore, the goal of the present study was to develop a small animal model of dietary-induced obesity that mimics many of the characteristics of human obesity. We studied female New Zealand White rabbits fed either a normal (n = 17) or high-fat diet (n = 15) and examined the cardiovascular consequences of obesity, including changes in blood pressure, humoral activation, and end-organ effects such as cardiac hypertrophy. After 12 wk, rabbits on the high-fat diet were 46% heavier than their lean counterparts (5.49 +/- 0.09 vs. 3.77 +/- 0.06 kg, respectively; P = 0.0001). Obese rabbits had higher resting heart rates than lean rabbits (220 +/- 7 vs. 177 +/- 6 beats/min; P = 0.0001) and developed hypertension (96 +/- 2 vs. 85 +/- 1 mmHg; P = 0.0001), hyperinsulinemia (32.5 +/- 3.4 vs. 15.5 +/- 1.0 microU/ml; P = 0.0001), hyperglycemia (162.4 +/- 2.9 vs. 141.9 +/- 2.7 mg/dl; P = 0.0001), and elevated triglycerides (102.3 +/- 9.1 vs. 48.5 +/- 4.0 mg/dl; P = 0.0001). Obese rabbits also developed cardiac hypertrophy, as evidenced by left ventricular (LV) dry weights that were 52% greater in obese than in lean rabbits (P = 0.0003). In addition, LV total protein was increased in proportion to the increase in LV weight. The results of this study suggest that rabbits fed a high-fat diet for a period of 12 wk develop many of the characteristics of human obesity. The obese rabbit should provide a small and relatively inexpensive animal model to investigate mechanisms of obesity-related cardiovascular abnormalities.","['Carroll, J F', 'Dwyer, T M', 'Grady, A W', 'Reinhart, G A', 'Montani, J P', 'Cockrell, K', 'Meydrech, E F', 'Mizelle, H L']","['Carroll JF', 'Dwyer TM', 'Grady AW', 'Reinhart GA', 'Montani JP', 'Cockrell K', 'Meydrech EF', 'Mizelle HL']","['Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson 39216-4505, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S.""]",United States,Am J Physiol,The American journal of physiology,0370511,['0 (Neurotransmitter Agents)'],IM,"['Animals', 'Cardiomegaly/*etiology', 'Diet', 'Disease Models, Animal', 'Female', 'Hypertension/*etiology', 'Neurotransmitter Agents/*metabolism', 'Obesity/*complications/etiology/*metabolism', 'Rabbits']",,,,,1996/07/01 00:00,1996/07/01 00:01,['1996/07/01 00:00'],"['1996/07/01 00:00 [pubmed]', '1996/07/01 00:01 [medline]', '1996/07/01 00:00 [entrez]']",['10.1152/ajpheart.1996.271.1.H373 [doi]'],ppublish,Am J Physiol. 1996 Jul;271(1 Pt 2):H373-8. doi: 10.1152/ajpheart.1996.271.1.H373.,['HL-51971/HL/NHLBI NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
23876574,NLM,MEDLINE,20140114,20220410,1873-6963 (Electronic) 0965-2299 (Linking),21,4,2013 Aug,The role of mindfulness based interventions in the treatment of obesity and eating disorders: an integrative review.,430-9,S0965-2299(13)00096-4 [pii] 10.1016/j.ctim.2013.06.003 [doi],"More than one-third of U.S. adults over the age of 20 years are classified as obese and nearly two-thirds are overweight or obese. The prevalence of obesity among U.S. children and adolescents has almost tripled since 1980, with 17% of all youth and children now considered obese. Nine million children aged 6-19 years are overweight, making obesity the largest health care threat facing today's children. Historically, the arsenal against obesity has been primarily focused on interventions that increase physical activity and decrease caloric intake. American weight loss strategies that incorporate dietary modifications and exercise have proven effective in achieving weight loss, but most of the weight is regained over time. Mindfulness based interventions, combined with other traditional weight loss strategies, have the potential to offer a long-term, holistic approach to wellness. However, research reports examining the complementary addition of mindfulness based approaches in the treatment obesity and eating disorders are relatively scarce in the empirical literature. This paper describes what is currently known about the role of mindfulness based interventions when used alone, or in combination with, other traditional approaches in the treatment of obesity and eating disorders.","['Godsey, Judi']",['Godsey J'],"['Xavier University, School of Nursing, 3800 Victory Parkway, Cincinnati, OH 45207, United States. nurse.judi@yahoo.com']",['eng'],"['Journal Article', 'Review']",Scotland,Complement Ther Med,Complementary therapies in medicine,9308777,,IM,"['Complementary Therapies/*methods', 'Feeding and Eating Disorders/psychology/*therapy', 'Female', 'Humans', 'Male', '*Mindfulness', 'Obesity/psychology/*therapy']",,['NOTNLM'],"['Complementary and alternative medicine', 'Eating disorders', 'Mindfulness', 'Obesity']",,2013/07/24 06:00,2014/01/15 06:00,['2013/07/24 06:00'],"['2013/02/07 00:00 [received]', '2013/05/31 00:00 [revised]', '2013/06/05 00:00 [accepted]', '2013/07/24 06:00 [entrez]', '2013/07/24 06:00 [pubmed]', '2014/01/15 06:00 [medline]']","['S0965-2299(13)00096-4 [pii]', '10.1016/j.ctim.2013.06.003 [doi]']",ppublish,Complement Ther Med. 2013 Aug;21(4):430-9. doi: 10.1016/j.ctim.2013.06.003. Epub 2013 Jul 9.,,20130709,,['Copyright (c) 2013 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
6658340,NLM,MEDLINE,19840215,20041117,0377-1202 (Print) 0377-1202 (Linking),21,4,1983 Oct-Dec,Arterial hypertension in diabetic patients. Role of obesity.,273-8,,"In order to assess the role of obesity and to correlate it with other possible factors which cause the well-known higher prevalence of arterial hypertension in diabetic patients without nephropathy, 829 non-proteinuric diabetic outpatients and 856 controls have been investigated. A significantly higher prevalence of arterial hypertension was found in obese patients than in normal-weight subjects. Likewise, hypertensive diabetic patients were more frequently obese than those with normal blood pressure. Arterial hypertension was more often encountered in female diabetics, since women were more obese. The duration of diabetes and age-related increase of arterial hypertension was augmented by the presence of obesity. The practical implications of the observations are emphasized.","['Fekete, T', 'Levi, L', 'Teszler, A']","['Fekete T', 'Levi L', 'Teszler A']",,['eng'],['Journal Article'],Romania,Med Interne,Medecine interne,7506353,,IM,"['Adult', 'Age Factors', '*Diabetes Complications', 'Female', 'Humans', 'Hypertension/*etiology', 'Male', 'Middle Aged', '*Obesity/complications/etiology', 'Sex Factors']",,,,,1983/10/01 00:00,1983/10/01 00:01,['1983/10/01 00:00'],"['1983/10/01 00:00 [pubmed]', '1983/10/01 00:01 [medline]', '1983/10/01 00:00 [entrez]']",,ppublish,Med Interne. 1983 Oct-Dec;21(4):273-8.,,,,,,,,,,,,,,,,,,,,
22924228,NLM,MEDLINE,20121010,20221207,1046-7041 (Print) 1046-7041 (Linking),23,3,2012 Summer,Scholarly perspectives on obesity among black women.,46-50,,"There are a disproportionate number of Black women who are either overweight or obese. Health professionals who are overweight or obese were found to have less confidence in weight management practice. Studies show that overweight and obese nurses avoid the topic of obesity with their overweight and obese patients. This article describes the biological, psychological, social and cultural factors which may influence obesity in Black women. Specifically, this synthesis of the literature raises the question whether Black nurses with relevant health knowledge have different rates of obesity when compared to Black women that are not registered nurses.","['Johnson, Portia', 'Wesley, Yvonne']","['Johnson P', 'Wesley Y']","['Department of Nursing at Seton Hall University in West Orange, NJ, USA. Pjohnson056@yahoo.com']",['eng'],['Journal Article'],United States,ABNF J,"The ABNF journal : official journal of the Association of Black Nursing Faculty in Higher Education, Inc",9112807,,,"['Adult', '*Black or African American', 'Aged', 'Female', 'Food Preferences/ethnology', '*Health Status Disparities', 'Humans', 'Middle Aged', 'Obesity/*ethnology/prevention & control/psychology', 'Prejudice', 'United States/epidemiology']",,,,,2012/08/29 06:00,2012/10/12 06:00,['2012/08/29 06:00'],"['2012/08/29 06:00 [entrez]', '2012/08/29 06:00 [pubmed]', '2012/10/12 06:00 [medline]']",,ppublish,ABNF J. 2012 Summer;23(3):46-50.,,,,,,,,,,,,,,,,,,,,
10941299,NLM,MEDLINE,20000919,20150826,0370-629X (Print) 0370-629X (Linking),55,5,2000 May,[Recommendations for the treatment of obesity].,367-71,,"Obesity represents a major medical problem which is now considered more seriously from a scientific, clinical and economical point of view. Such an evolution was mandatory when considering the usual contempt for what is now considered as a chronic disease and especially the charlatanism which was observed among medical and non-medical spheres. Hence, as for numerous other pathologies, international guidelines have recently been published to optimize the management of obesity, from the view point of efficacy and, more particularly, safety. We will summarize the main recommendations as far as diet and physical treatment, pharmacotherapy and bariatric surgery are concerned. Finally, we will briefly describe general guidelines on the management of obese subjects taking into account the degree of weight excess and the presence of complications.","['Luyckx, F', 'Scheen, A J']","['Luyckx F', 'Scheen AJ']","['Service de Diabetologie, Nutrition et Maladies metaboliques, Universite de Liege.']",['fre'],"['English Abstract', 'Journal Article']",Belgium,Rev Med Liege,Revue medicale de Liege,0404317,,IM,"['Diet', 'Humans', 'Obesity/complications/*drug therapy/*surgery', 'Physical Therapy Modalities', 'Practice Guidelines as Topic']",,,,,2000/08/15 11:00,2000/09/23 11:01,['2000/08/15 11:00'],"['2000/08/15 11:00 [pubmed]', '2000/09/23 11:01 [medline]', '2000/08/15 11:00 [entrez]']",,ppublish,Rev Med Liege. 2000 May;55(5):367-71.,,,,,,,,,Recommandations pour le traitement de l'obesite.,,,,,,,,,,,
19840717,NLM,MEDLINE,20110504,20091020,1558-3481 (Electronic) 0899-5885 (Linking),21,3,2009 Sep,Obesity-related risks and prevention strategies for critically ill adults.,"391-401, vii",10.1016/j.ccell.2009.07.006 [doi],"In America today, more than one third of adults are obese. Increasingly, obese patients are admitted to critical care units. Critical care nurses must have additional knowledge and skills to identify health risks to obese patients and implement interventions to prevent untoward problems. Critical care nurses are also at risk when taking care of obese patients. The purpose of this article is to identify risks to both patients and nurses and to provide recommendations to address those risks.","['McAtee, Margaret', 'Personett, Rebecca J']","['McAtee M', 'Personett RJ']","['Education Department, Baylor All Saints Medical Center, 1400 Eighth Avenue, Fort Worth, TX 76104, USA. Margaret.McAtee@baylorhealth.edu']",['eng'],"['Journal Article', 'Review']",United States,Crit Care Nurs Clin North Am,Critical care nursing clinics of North America,8912620,,,"['Adult', '*Critical Illness', 'Humans', 'Obesity/*nursing/physiopathology', 'Preventive Health Services', 'Risk Factors']",,,,,2009/10/21 06:00,2011/05/05 06:00,['2009/10/21 06:00'],"['2009/10/21 06:00 [entrez]', '2009/10/21 06:00 [pubmed]', '2011/05/05 06:00 [medline]']","['S0899-5885(09)00046-X [pii]', '10.1016/j.ccell.2009.07.006 [doi]']",ppublish,"Crit Care Nurs Clin North Am. 2009 Sep;21(3):391-401, vii. doi: 10.1016/j.ccell.2009.07.006.",,,,,,,,,,,,,,,,,,,,
1938048,NLM,MEDLINE,19911209,20071114,1041-1232 (Print) 1041-1232 (Linking),55,2,1991 Summer,Body weight and longevity in genetically obese and non-obese mice fed fat-modified diets.,81-9,,"Polygenically obese and genetically related non-obese male mice were fed ad libitum purified diets differing in quantity or type of fat from weaning onward to determine effects upon weight gain and life span. Non-obese mice lived 71% longer than mice in the obese line (mean = 753 d versus 441 d). Obese mice fed a low-fat diet containing 1% corn oil by weight lived 26% longer than their obese counterparts fed high fat diets containing 20% additional fat as either corn oil or beef tallow. The low fat diet had more of a normalizing effect upon longevity than upon body weight in polygenically obese mice. Conversely, dietary fat concentration had little effect upon longevity in non-obese mice and more effect upon body weight than in genetically obese mice. Type of dietary fat had little effect upon body weight and no effect upon longevity. The results of this study suggest that life span was only partially explained by body weight, and furthermore, that genetics play a greater role than body weight or dietary fat concentration in determining life span.","['Smith, B A', 'Edwards, M S', 'Ballachey, B E', 'Cramer, D A', 'Sutherland, T M']","['Smith BA', 'Edwards MS', 'Ballachey BE', 'Cramer DA', 'Sutherland TM']","['Department of Food Science and Human Nutrition, Colorado State University, Fort Collins 80523.']",['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Growth Dev Aging,"Growth, development, and aging : GDA",8809704,['0 (Dietary Fats)'],IM,"['Animals', 'Body Weight', 'Dietary Fats/*administration & dosage', 'Longevity', 'Male', 'Mice', 'Mice, Obese', 'Obesity/etiology/*genetics/pathology']",,,,,1991/01/01 00:00,1991/01/01 00:01,['1991/01/01 00:00'],"['1991/01/01 00:00 [pubmed]', '1991/01/01 00:01 [medline]', '1991/01/01 00:00 [entrez]']",,ppublish,Growth Dev Aging. 1991 Summer;55(2):81-9.,['AM18275/AM/NIADDK NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
25659049,NLM,MEDLINE,20161107,20161230,1699-5198 (Electronic) 0212-1611 (Linking),31 Suppl 1,,2015 Feb 7,[Role of probiotics in obesity management].,10-8,10.3305/nh.2015.31.sup1.8702 [doi],"Obesity is a major public health issue as it is related to several chronic disorders, including type-2 diabetes, high blood pressure, dyslipemia, cardiovascular diseases and cancer, among others. Novel research shows that the gut microbiota is involved in obesity and metabolic disorders, revealing that obese animal and human subjects have alterations in the composition of the gut microbiota compared to their lean counterparts. Moreover, it has been observed in germ-free mice that transplantation of the microbiota of either obese or lean mice influences body weight, suggesting that the gut ecosystem is a relevant target for weight management. Certain strains of probiotics may regulate body weight by influencing the host's metabolic, neuroendocrine and immune functions. Taken together, our knowledge about the influence of gut microbiota on obesity is progressing. Therefore, modulation of its composition through probiotics may provide new opportunities to manage overweight and obesity.","['Prados-Bo, Andreu', 'Gomez-Martinez, Sonia', 'Nova, Esther', 'Marcos, Ascension']","['Prados-Bo A', 'Gomez-Martinez S', 'Nova E', 'Marcos A']","['Grupo de Inmunonutricion, Departamento de Metabolismo y Nutricion, Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN), Consejo Superior de Investigaciones Cientificas (CSIC). Espana..', 'Grupo de Inmunonutricion, Departamento de Metabolismo y Nutricion, Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN), Consejo Superior de Investigaciones Cientificas (CSIC). Espana..', 'Grupo de Inmunonutricion, Departamento de Metabolismo y Nutricion, Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN), Consejo Superior de Investigaciones Cientificas (CSIC). Espana..', 'Grupo de Inmunonutricion, Departamento de Metabolismo y Nutricion, Instituto de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN), Consejo Superior de Investigaciones Cientificas (CSIC). Espana.. amarcos@ictan.csic.es.']",['spa'],"['Journal Article', 'Review']",Spain,Nutr Hosp,Nutricion hospitalaria,9100365,,IM,"['Animals', 'Disease Management', 'Gastrointestinal Tract/microbiology', 'Humans', '*Microbiota', 'Obesity/complications/drug therapy/*therapy', 'Probiotics/*therapeutic use']",,,,,2015/02/07 06:00,2016/11/08 06:00,['2015/02/07 06:00'],"['2015/02/07 06:00 [entrez]', '2015/02/07 06:00 [pubmed]', '2016/11/08 06:00 [medline]']",['10.3305/nh.2015.31.sup1.8702 [doi]'],epublish,Nutr Hosp. 2015 Feb 7;31 Suppl 1:10-8. doi: 10.3305/nh.2015.31.sup1.8702.,,20150207,,"['Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights', 'reserved.']",,,,,El papel de los probioticos en el manejo de la obesidad.,,,,,,,,,,,
18221480,NLM,MEDLINE,20080421,20230411,1467-789X (Electronic) 1467-7881 (Linking),9,2,2008 Mar,"Maternal obesity: pregnancy complications, gestational weight gain and nutrition.",140-50,10.1111/j.1467-789X.2007.00464.x [doi],"The obesity epidemic affects all, including women of reproductive age. One in five women attending prenatal care in the UK is obese. Prepregnancy obesity is associated with serious short- and long-term complications for mother and child. Furthermore, gestational weight gain (GWG) of obese pregnant women generally exceeds the Institute of Medicine recommended ranges. This observation can partially be explained by an unbalanced diet and lack of daily physical activity. Despite this, few lifestyle intervention trials in obese pregnant women are available. Two out of seven intervention trials focusing on GWG, nutrition and physical activity, reached a significant decrease in GWG. Developing guidelines to promote appropriated weight gain and healthy lifestyle in overweight and obese pregnant women remains a challenge. This review aims to summarize the complications associated with maternal prepregnancy overweight and obesity and to discuss possible strategies to improve the lifestyle habits of pregnant women.","['Guelinckx, I', 'Devlieger, R', 'Beckers, K', 'Vansant, G']","['Guelinckx I', 'Devlieger R', 'Beckers K', 'Vansant G']","['Department of Nutrition and Health-Preventive Medicine, Catholic University Leuven, University Hospital Gasthuisberg, Leuven, Belgium. isabelle.guelinckx@uz.kuleuven.ac.be']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Obes Rev,Obesity reviews : an official journal of the International Association for the Study of Obesity,100897395,,IM,"['Exercise/physiology', 'Female', 'Fetal Diseases/etiology', 'Humans', '*Life Style', 'Obesity/*complications/epidemiology/physiopathology/therapy', 'Pregnancy', '*Pregnancy Complications/epidemiology/physiopathology/therapy', '*Prenatal Nutritional Physiological Phenomena', 'Prevalence', 'United Kingdom/epidemiology', 'Weight Gain/*physiology']",,,,,2008/01/29 09:00,2008/04/22 09:00,['2008/01/29 09:00'],"['2008/01/29 09:00 [pubmed]', '2008/04/22 09:00 [medline]', '2008/01/29 09:00 [entrez]']","['OBR464 [pii]', '10.1111/j.1467-789X.2007.00464.x [doi]']",ppublish,Obes Rev. 2008 Mar;9(2):140-50. doi: 10.1111/j.1467-789X.2007.00464.x. Epub 2008 Jan 21.,,20080121,,,,,80,,,,,,,,,,,,,
5006561,NLM,MEDLINE,19901220,20041117,0014-9446 (Print) 0014-9446 (Linking),25,1,1966 Jan-Feb,Physical activity and anthropometric measurements of obese adolescents.,11-4,,,"['Mayer, J']",['Mayer J'],,['eng'],['Journal Article'],United States,Fed Proc,Federation proceedings,0372771,,IM,"['Adolescent', 'Anthropometry', 'Humans', 'Obesity/pathology/*physiopathology']",,,,,1966/01/01 00:00,1966/01/01 00:01,['1966/01/01 00:00'],"['1966/01/01 00:00 [pubmed]', '1966/01/01 00:01 [medline]', '1966/01/01 00:00 [entrez]']",,ppublish,Fed Proc. 1966 Jan-Feb;25(1):11-4.,,,,,,,,,,,,,,,,,,,,
8362892,NLM,MEDLINE,19930930,20220321,0002-9629 (Print) 0002-9629 (Linking),306,2,1993 Aug,Obesity and the heart.,117-23,,"Obesity can result in alterations in cardiac structure and function even in the absence of systemic hypertension and underlying organic heart disease. Increased total blood volume creates a high cardiac output state that may cause ventricular dilatation and ultimately eccentric hypertrophy of the left (and possibly the right) ventricle. Eccentric left ventricular (LV) hypertrophy produces diastolic dysfunction. Systolic dysfunction may ensue due to excessive wall stress if wall thickening fails to keep pace with dilatation. This disorder is referred to as obesity cardiomyopathy. The presence of systemic hypertension in obese individuals facilitates development of LV dilatation and hypertrophy. Congestive heart failure may occur in such individuals, and may be attributable to LV diastolic dysfunction or to combined LV diastolic and systolic dysfunction. The sleep apnea/obesity hypoventilation syndrome occurs in 5% of morbidly obese individuals and is potentially life-threatening. Treatment of obesity cardiomyopathy consists of weight loss, salt restriction, and diuretics. Digitalis and vasodilators may be useful in selected cases. Central obesity is probably a risk factor for the development of coronary heart disease. Alterations in lipid and insulin metabolism may facilitate development of coronary heart disease in obese patients.","['Alpert, M A', 'Hashimi, M W']","['Alpert MA', 'Hashimi MW']","['Division of Cardiology, University of South Alabama, College of Medicine, Mobile.']",['eng'],"['Journal Article', 'Review']",United States,Am J Med Sci,The American journal of the medical sciences,0370506,,IM,"['Heart Diseases/*etiology/*physiopathology', 'Humans', 'Obesity/*complications/physiopathology', 'Obesity Hypoventilation Syndrome/etiology/physiopathology', 'Obesity, Morbid/complications']",,,,,1993/08/01 00:00,1993/08/01 00:01,['1993/08/01 00:00'],"['1993/08/01 00:00 [pubmed]', '1993/08/01 00:01 [medline]', '1993/08/01 00:00 [entrez]']","['S0002-9629(15)35462-8 [pii]', '10.1097/00000441-199308000-00011 [doi]']",ppublish,Am J Med Sci. 1993 Aug;306(2):117-23. doi: 10.1097/00000441-199308000-00011.,,,,,,,75,,,,,,,,,,,,,
17879121,NLM,MEDLINE,20071106,20181113,1525-1497 (Electronic) 0884-8734 (Print) 0884-8734 (Linking),22,11,2007 Nov,Is information on genetic determinants of obesity helpful or harmful for obese people?--A randomized clinical trial.,1553-9,,"BACKGROUND AND OBJECTIVES: Although more and more genetic information is available, it is unclear whether this information is helpful for patients. Therefore, we assessed the positive and negative effects of informing obese people about the genetic etiology of being overweight. DESIGN, PARTICIPANTS: Two hundred ninety-four obese people were randomized to 2 interventions (a 1-session consultation for obese people on how to manage obesity either including genetic information or not); their results were compared to a control group (116). Subjects were assessed before and after consultation and 6 months later. MEASUREMENTS: Weight, scales on feeling guilty for being overweight, self-control, negative mood (primary endpoint), body acceptance, restraint eating. RESULTS: Both types of consultations were considered helpful by the participants, and had comparable effects on body weight. The consultation with genetic information was rated superior in terms of leading to new insights (advantage for consultation with genetic information, even 6 months later; p = 0.046). No negative effects (e.g., loss of self-efficacy/self-control, increase of body weight; all p > 0.20 for interaction consultation x time) were observed for informing obese people about the genetic etiology of being overweight. The consultation resulted in long-term improvement of negative mood if it included genetic information in the case of participants with a family history of obesity and if it included no genetic information in the case of obese people without a family history of obesity (p = 0.03 for interaction of group, intervention, and time). CONCLUSIONS: Consultations in obesity can be helpful in general. These consultations should include genetic information if people have a family history of obesity.","['Rief, Winfried', 'Conradt, Matthias', 'Dierk, Jan-Michael', 'Rauh, Elisabeth', 'Schlumberger, Pia', 'Hinney, Anke', 'Hebebrand, Johannes']","['Rief W', 'Conradt M', 'Dierk JM', 'Rauh E', 'Schlumberger P', 'Hinney A', 'Hebebrand J']","['Department of Clinical Psychology and Psychotherapy, University of Marburg, Marburg, Germany. rief@staff.uni-marburg.de']",['eng'],"['Journal Article', 'Randomized Controlled Trial', ""Research Support, Non-U.S. Gov't""]",United States,J Gen Intern Med,Journal of general internal medicine,8605834,,IM,"['Aged', 'Eating', 'Educational Status', 'Female', '*Genetic Predisposition to Disease', 'Guilt', 'Humans', 'Male', 'Middle Aged', 'Obesity/epidemiology/*genetics/prevention & control', '*Patient Education as Topic', 'Referral and Consultation', 'Risk Factors']",PMC2219810,,,,2007/09/20 09:00,2007/11/07 09:00,['2007/09/20 09:00'],"['2007/03/06 00:00 [received]', '2007/08/22 00:00 [accepted]', '2007/07/17 00:00 [revised]', '2007/09/20 09:00 [pubmed]', '2007/11/07 09:00 [medline]', '2007/09/20 09:00 [entrez]']","['353 [pii]', '10.1007/s11606-007-0353-7 [doi]']",ppublish,J Gen Intern Med. 2007 Nov;22(11):1553-9. doi: 10.1007/s11606-007-0353-7. Epub 2007 Sep 19.,,20070919,,,,,,,,,,,,,,,,,,
32303425,NLM,MEDLINE,20210427,20210427,1878-7533 (Electronic) 1550-7289 (Linking),16,7,2020 Jul,Reverse epidemiology and the obesity paradox for patients with chronic kidney disease: a Markov decision model.,948-954,S1550-7289(20)30116-7 [pii] 10.1016/j.soard.2020.02.015 [doi],"BACKGROUND: Obesity has been associated with both increased progression of chronic kidney disease (CKD) as well as with a paradoxical improvement in survival among end-stage renal disease patients undergoing hemodialysis. As such, the optimal weight management strategy for obese CKD patients remains unclear. OBJECTIVE: To estimate the outcomes of obese, CKD stage 3b patients after 3 weight loss interventions, including medical weight management, sleeve gastrectomy (SG), and Roux-en-Y gastric bypass (RYGB), were followed to determine which strategy optimizes long-term survival. SETTING: University hospital, Aurora, Colorado. METHODS: A decision analytic Markov state transition model was created to simulate the life of 30,000 obese patients with CKD stage 3b, as they progressed to end-stage renal disease, transplantation, and death. Life expectancy after conservative medical weight management, RYGB, and SG were estimated. Base case patients were defined as being 50 years old and having a preintervention BMI of 40 kg/m(2). Sensitivity analysis of initial BMI was performed. All Markov parameters were extracted from literature review. RESULTS: RYGB and SG were associated with improved survival for patients with preintervention body mass index of >38 kg/m(2). Compared with conservative weight management, base case patients who underwent RYGB gained 10.6 months of life, and gained 8.3 months of life after SG. CONCLUSIONS: Balancing progression of CKD with improved survival on end-stage renal disease for obese patients requires selective use of weight management strategies. RYGB and SG improved survival for CKD patients with Class II and III obesity, but not for patients with Class I obesity. As such, aggressive weight loss interventions should be reserved for patients with Class II and III obesity, while more conservative methods should be offered to those with Class I obesity.","['Choudhury, Rashikh A', 'Yoeli, Dor', 'Moore, Hunter B', 'Yaffe, Hillary', 'Hoeltzel, Gerard D', 'Dumon, Kristoffel R', 'Williams, Noel N', 'Abt, Peter L', 'Conzen, Kendra D', 'Nydam, Trevor L']","['Choudhury RA', 'Yoeli D', 'Moore HB', 'Yaffe H', 'Hoeltzel GD', 'Dumon KR', 'Williams NN', 'Abt PL', 'Conzen KD', 'Nydam TL']","['University of Colorado Hospital, Department of Surgery- Division of Transplant Surgery, Aurora, Colorado. Electronic address: rashikh.choudhury@cuanschutz.edu.', 'University of Colorado Hospital, Department of Surgery- Division of Transplant Surgery, Aurora, Colorado.', 'University of Colorado Hospital, Department of Surgery- Division of Transplant Surgery, Aurora, Colorado.', 'University of Colorado Hospital, Department of Surgery- Division of Transplant Surgery, Aurora, Colorado.', 'University of Pennsylvania Hospital, Department of Surgery, Philadelphia, Pennsylvania.', 'University of Pennsylvania Hospital, Department of Surgery, Philadelphia, Pennsylvania.', 'University of Pennsylvania Hospital, Department of Surgery, Philadelphia, Pennsylvania.', 'University of Pennsylvania Hospital, Department of Surgery, Philadelphia, Pennsylvania.', 'University of Colorado Hospital, Department of Surgery- Division of Transplant Surgery, Aurora, Colorado.', 'University of Colorado Hospital, Department of Surgery- Division of Transplant Surgery, Aurora, Colorado.']",['eng'],['Journal Article'],United States,Surg Obes Relat Dis,Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery,101233161,,IM,"['Gastrectomy', '*Gastric Bypass', 'Humans', 'Middle Aged', 'Obesity/complications/epidemiology', '*Obesity, Morbid/complications/surgery', 'Weight Loss']",,['NOTNLM'],"['Kidney disease', 'Markov', 'Obesity paradox']",,2020/04/19 06:00,2021/04/28 06:00,['2020/04/19 06:00'],"['2019/11/13 00:00 [received]', '2020/02/14 00:00 [revised]', '2020/02/22 00:00 [accepted]', '2020/04/19 06:00 [pubmed]', '2021/04/28 06:00 [medline]', '2020/04/19 06:00 [entrez]']","['S1550-7289(20)30116-7 [pii]', '10.1016/j.soard.2020.02.015 [doi]']",ppublish,Surg Obes Relat Dis. 2020 Jul;16(7):948-954. doi: 10.1016/j.soard.2020.02.015. Epub 2020 Mar 10.,,20200310,,"['Copyright (c) 2020 American Society for Bariatric Surgery. Published by Elsevier', 'Inc. All rights reserved.']",,,,,,,,,,,,,,,,
2373509,NLM,MEDLINE,19900828,20110418,0018-7143 (Print) 0018-7143 (Linking),62,3,1990 Jun,Enzyme polymorphism and clinical variability of diseases: study of acid phosphatase locus 1 (ACP1) in obese subjects.,403-11,,"The ACP1*A allele of erythrocyte acid phosphatase (ACP1) has a lower enzymatic activity when compared to other ACP1 alleles and is associated with maximal rate of body growth during intrauterine life. In three different samples of obese subjects (total number = 218). ACP1*A was associated with extreme body mass deviations. No difference in ACP1 allele distribution was observed between obese and nonobese subjects. These data suggest that a genetically determined variability of ACP1 influences the degree of obesity, but only when obesity itself has been triggered by some other factors.","['Bottini, E', 'Lucarini, N', 'Gerlini, G', 'Finocchi, G', 'Scire, G', 'Gloria-Bottini, F']","['Bottini E', 'Lucarini N', 'Gerlini G', 'Finocchi G', 'Scire G', 'Gloria-Bottini F']","['Chair of Human Development, 2d University of Rome, School of Medicine, Italy.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Hum Biol,Human biology,0116717,['EC 3.1.3.2 (Acid Phosphatase)'],IM,"['Acid Phosphatase/*genetics', 'Adolescent', 'Body Mass Index', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant, Newborn', 'Male', 'Obesity/enzymology/*genetics/pathology']",,,,,1990/06/01 00:00,1990/06/01 00:01,['1990/06/01 00:00'],"['1990/06/01 00:00 [pubmed]', '1990/06/01 00:01 [medline]', '1990/06/01 00:00 [entrez]']",,ppublish,Hum Biol. 1990 Jun;62(3):403-11.,,,,,,,,,,,,,,,,,,,,
19550304,NLM,MEDLINE,20100119,20090902,1473-6500 (Electronic) 0952-7907 (Linking),22,5,2009 Oct,Regional anesthesia and obesity.,683-6,10.1097/ACO.0b013e32832eb7bd [doi],"PURPOSE OF REVIEW: Worldwide, the number of overweight and obese patients has increased dramatically. As a result, anesthesiologists routinely encounter obese patients daily in their clinical practice. The use of regional anesthesia is becoming increasingly popular for these patients. When appropriate, a regional anesthetic offers advantages and should be considered in the anesthetic management plan of obese patients. The following is a review of regional anesthesia in obesity, with special consideration of the unique challenges presented to the anesthesiologist by the obese patient. RECENT FINDINGS: Recent studies report difficulty in achieving peripheral and neuraxial blockade in obese patients. For example, there is an increased incidence of failed blocks in obese patients compared with similar, normal weight patients. Despite difficulties, regional anesthesia can be used successfully in obese patients, even in the ambulatory surgery setting. SUMMARY: Successful peripheral and neuraxial blockade in obese patients requires an anesthesiologist experienced in regional techniques, and one with the knowledge of the physiologic and pharmacologic differences that are unique to the obese patient.","['Ingrande, Jerry', 'Brodsky, Jay B', 'Lemmens, Hendrikus Jm']","['Ingrande J', 'Brodsky JB', 'Lemmens HJ']","['Department of Anesthesia, Stanford University School of Medicine, Stanford, California 94305, USA.']",['eng'],"['Journal Article', 'Review']",United States,Curr Opin Anaesthesiol,Current opinion in anaesthesiology,8813436,,IM,"['Ambulatory Surgical Procedures/*methods', 'Anesthesia, Conduction/*methods', 'Bariatric Surgery/*methods', 'Humans', '*Obesity/complications/surgery', 'Postoperative Complications/*prevention & control']",,,,,2009/06/25 09:00,2010/01/20 06:00,['2009/06/25 09:00'],"['2009/06/25 09:00 [entrez]', '2009/06/25 09:00 [pubmed]', '2010/01/20 06:00 [medline]']",['10.1097/ACO.0b013e32832eb7bd [doi]'],ppublish,Curr Opin Anaesthesiol. 2009 Oct;22(5):683-6. doi: 10.1097/ACO.0b013e32832eb7bd.,,,,,,,38,,,,,,,,,,,,,
12090178,NLM,MEDLINE,20020820,20041117,0023-7205 (Print) 0023-7205 (Linking),99,21,2002 May 23,[Ethical aspects of the meeting with the obese patient: Why don't we see the obesity?].,2429-30,,,"['Falkenberg, Melcher', 'Vikinge, Lars']","['Falkenberg M', 'Vikinge L']","['Kungsgatans vardcentral, Linkoping, Halsouniversitetet, Linkoping. melcher@melcher.nu']",['swe'],['Journal Article'],Sweden,Lakartidningen,Lakartidningen,0027707,,IM,"['Attitude of Health Personnel', 'Attitude to Health', 'Empathy', '*Ethics, Medical', 'Humans', 'Obesity/diagnosis/epidemiology/*psychology', 'Patient Rights', '*Physician-Patient Relations', '*Professional-Patient Relations', 'Sweden/epidemiology']",,,,,2002/07/02 10:00,2002/08/21 10:01,['2002/07/02 10:00'],"['2002/07/02 10:00 [pubmed]', '2002/08/21 10:01 [medline]', '2002/07/02 10:00 [entrez]']",,ppublish,Lakartidningen. 2002 May 23;99(21):2429-30.,,,,,,,,['Lakartidningen. 2002 Jul 11;99(28-29):3054. PMID: 12170521'],Vardetiska aspekter pa motet med den feta patienten: Varfor ser vi inte fetman?,,,,,,,,,,,
16164875,NLM,MEDLINE,20051011,20051116,0002-9343 (Print) 0002-9343 (Linking),118,9,2005 Sep,Practice tips: how to intervene with overweight and obese patients.,936-8,,,"['Powers, Pamela J']",['Powers PJ'],,['eng'],"['Editorial', 'Review']",United States,Am J Med,The American journal of medicine,0267200,,IM,"['Behavior Therapy', 'Caloric Restriction', 'Exercise', 'Health Promotion/*methods', 'Humans', 'Life Style', 'Obesity/diagnosis/*prevention & control/psychology', ""*Physician's Role"", 'Risk Assessment']",,,,,2005/09/17 09:00,2005/10/12 09:00,['2005/09/17 09:00'],"['2005/06/27 00:00 [received]', '2005/09/17 09:00 [pubmed]', '2005/10/12 09:00 [medline]', '2005/09/17 09:00 [entrez]']","['S0002-9343(05)00576-0 [pii]', '10.1016/j.amjmed.2005.07.006 [doi]']",ppublish,Am J Med. 2005 Sep;118(9):936-8. doi: 10.1016/j.amjmed.2005.07.006.,,,,,,,10,,,,,,,,,,,,,
26733631,NLM,MEDLINE,20160516,20160525,2049-4408 (Electronic) 2049-4394 (Linking),98-B,1 Suppl A,2016 Jan,The obese patient: a problem of larger consequence.,3-5,10.1302/0301-620X.98B1.36415 [doi],"Obesity is a worldwide epidemic that has both economic and health implications of enormous consequence. The obese patients tend to have earlier symptoms related to osteoarthritis, more peri-operative medical problems, higher rates of infection and more technical difficulties intra-operatively following hip and knee arthroplasty. Nevertheless, these patients have good long-term clinical outcomes and implant survival rates and are often some of the most satisfied patients after joint arthroplasty. Therefore, obese patients should not be denied surgery based on their weight alone.","['Perry, K I', 'MacDonald, S J']","['Perry KI', 'MacDonald SJ']","['200 1st Street Rochester, Minnesota, 55905, USA.', 'London Health Sciences Centre, 339 Windermere Road, London, Ontario, N6G 2V4, Canada.']",['eng'],['Journal Article'],England,Bone Joint J,The bone & joint journal,101599229,,IM,"['Arthroplasty, Replacement', 'Humans', '*Obesity/complications/epidemiology', 'Postoperative Complications/etiology', 'Risk Factors']",,['NOTNLM'],"['Obesity', 'arthroplasty', 'complications']",,2016/01/07 06:00,2016/05/18 06:00,['2016/01/07 06:00'],"['2016/01/07 06:00 [entrez]', '2016/01/07 06:00 [pubmed]', '2016/05/18 06:00 [medline]']","['98-B/1_Supple_A/3 [pii]', '10.1302/0301-620X.98B1.36415 [doi]']",ppublish,Bone Joint J. 2016 Jan;98-B(1 Suppl A):3-5. doi: 10.1302/0301-620X.98B1.36415.,,,,['(c)2016 The British Editorial Society of Bone & Joint Surgery.'],,,,,,,,,,,,,,,,
7825449,NLM,MEDLINE,19950214,20190913,0374-5600 (Print) 0374-5600 (Linking),36,5,1994 Oct,What are parents of obese children concerned about in their children?,493-6,,"We retrospectively examined the issues that concern parents of obese children to determine the most effective means of motivating them to seek treatment for obesity in their children. Children with an obesity index > or = 40%, aged six to 12 years, were screened in Kagoshima City in 1992. Parents were notified if their children needed an evaluation that included a family history and measurements of the blood pressure, total cholesterol, high density lipoprotein (HDL)-cholesterol, atherogenic index (ASI), triglycerides, aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Parents were informed of the results of the evaluation and invited to attend a lecture on the treatment of obesity in children. A total of 378 obese children were evaluated. However, the parents of only 39 children attended the lecture. Children whose parents attended had higher mean total levels of cholesterol (190 +/- 25 vs 175 +/- 28, P < 0.01) and ASI values (3.2 +/- 0.9 vs 2.7 +/- 0.9, P < 0.02) than those whose parents did not attend. There were no significant differences in other factors. Only 4.2% of parents whose children showed no abnormal values, except for obesity, attended the lecture, compared with 20.3% (P < 0.01) or 16.9% (P < 0.05) of parents whose children had abnormal levels of cholesterol or abnormal ASI. Parents may be more concerned about hypercholesterolemia or arteriosclerosis than obesity per se. We should perhaps use the total cholesterol or ASI values, not just the severity of obesity, to motivate parents to enter their children into treatment programs for obesity.","['Yoshinaga, M', 'Yuasa, Y', 'Kitahara, T', 'Shimago, A', 'Miyata, K', 'Sameshima, K', 'Imamura, M', 'Arima, K', 'Matsuoka, K']","['Yoshinaga M', 'Yuasa Y', 'Kitahara T', 'Shimago A', 'Miyata K', 'Sameshima K', 'Imamura M', 'Arima K', 'Matsuoka K']","['Department of Pediatrics, Faculty of Medicine, Kagoshima University, Japan.']",['eng'],['Journal Article'],Australia,Acta Paediatr Jpn,Acta paediatrica Japonica : Overseas edition,0370357,,IM,"['Adult', 'Child', 'Female', 'Humans', 'Male', 'Motivation', 'Obesity/blood/*psychology/therapy', 'Parents/*psychology', '*Patient Acceptance of Health Care', 'Retrospective Studies']",,,,,1994/10/01 00:00,1994/10/01 00:01,['1994/10/01 00:00'],"['1994/10/01 00:00 [pubmed]', '1994/10/01 00:01 [medline]', '1994/10/01 00:00 [entrez]']",['10.1111/j.1442-200x.1994.tb03232.x [doi]'],ppublish,Acta Paediatr Jpn. 1994 Oct;36(5):493-6. doi: 10.1111/j.1442-200x.1994.tb03232.x.,,,,,,,,,,,,,,,,,,,,
10918536,NLM,MEDLINE,20001012,20191210,,24,7,2000 Jul,Open-loop feedback to increase physical activity in obese children.,888-92,,"OBJECTIVE: The present study investigated whether making access to sedentary activities contingent on physical activity would increase physical activity. DESIGN: Experimental. PARTICIPANTS: Thirty-four obese children aged 8-12 y were randomized to one of three groups in which children had to accumulate 750 or 1500 pedometer counts to earn 10 min of access to video games or movies, or to a control group in which access to sedentary behaviors was provided noncontingently. MEASUREMENTS: Physical activity in the 20 min experimental session was measured by electronic pedometer and triaxial accelerometer (ie TriTrac(R)). Activity liking was measured by visual analog scales. Anthropometric and demographic characteristics were also assessed. RESULTS: Children in the 750 and 1500 count contingency groups engaged in significantly more physical activity and spent more time in moderate intensity activity or higher compared with controls. Children in the Contingent 1500 group engaged in more activity and spent more time in moderate or greater intensity activity compared to children in the Contingent 750 group. CONCLUSION: Findings suggest that contingent access to sedentary activities can reinforce physical activity in obese children, and changes in physical activity level depend in part on the targeted physical activity goal.","['Goldfield, G S', 'Kalakanis, L E', 'Ernst, M M', 'Epstein, L H']","['Goldfield GS', 'Kalakanis LE', 'Ernst MM', 'Epstein LH']","['Department of Psychology, University at Buffalo, Buffalo, NY 14260, USA.']",['eng'],"['Clinical Trial', 'Journal Article', 'Randomized Controlled Trial', ""Research Support, U.S. Gov't, P.H.S.""]",England,Int J Obes Relat Metab Disord,International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity,9313169,,IM,"['Child', 'Child Behavior/*psychology', 'Exercise/*psychology', '*Feedback', 'Female', 'Humans', 'Male', 'Obesity/prevention & control/psychology/*therapy', '*Reinforcement, Psychology']",,,,,2000/08/05 11:00,2000/10/14 11:01,['2000/08/05 11:00'],"['2000/08/05 11:00 [pubmed]', '2000/10/14 11:01 [medline]', '2000/08/05 11:00 [entrez]']",['10.1038/sj.ijo.0801248 [doi]'],ppublish,Int J Obes Relat Metab Disord. 2000 Jul;24(7):888-92. doi: 10.1038/sj.ijo.0801248.,"['R01HD25997/HD/NICHD NIH HHS/United States', 'R01HD38284/HD/NICHD NIH HHS/United States']",,,,,,,,,,,,,,,,,,,
1264240,NLM,MEDLINE,19760706,20190617,0028-0836 (Print) 0028-0836 (Linking),260,5553,1976 Apr 22,Energy expenditure in small children of obese and non-obese parents.,698-700,,,"['Griffiths, M', 'Payne, P R']","['Griffiths M', 'Payne PR']",,['eng'],['Journal Article'],England,Nature,Nature,0410462,,IM,"['Child, Preschool', '*Energy Metabolism', 'Heart Rate', 'Humans', 'Obesity/*genetics/metabolism', 'Oxygen Consumption', 'Physical Exertion']",,,,,1976/04/22 00:00,1976/04/22 00:01,['1976/04/22 00:00'],"['1976/04/22 00:00 [pubmed]', '1976/04/22 00:01 [medline]', '1976/04/22 00:00 [entrez]']",['10.1038/260698a0 [doi]'],ppublish,Nature. 1976 Apr 22;260(5553):698-700. doi: 10.1038/260698a0.,,,,,,,,,,,,,,,,,,,,
9929138,NLM,MEDLINE,19990318,20181201,0195-6663 (Print) 0195-6663 (Linking),31,3,1998 Dec,"Columbia University Seminar on Appetitive Behavior. Food Intake, Longevity and Renal Disease in Genetically Obese Zucker Rats. 11 June 1998.",453,,,,,,['eng'],"['Congress', ""Research Support, Non-U.S. Gov't""]",England,Appetite,Appetite,8006808,,IM,"['Animals', '*Eating', 'Kidney Diseases/*etiology', '*Longevity', 'Obesity/complications/*genetics/physiopathology', 'Rats', 'Rats, Zucker']",,,,,1999/02/03 00:00,1999/02/03 00:01,['1999/02/03 00:00'],"['1999/02/03 00:00 [pubmed]', '1999/02/03 00:01 [medline]', '1999/02/03 00:00 [entrez]']",,ppublish,Appetite. 1998 Dec;31(3):453.,,,,,,,,,,,,,,,,,,,,
16207651,NLM,MEDLINE,20051222,20170214,0884-5336 (Print) 0884-5336 (Linking),20,1,2005 Feb,Lipid oxidation and nitrogen balance in critically ill obese patients.,98-102,,,"['Breen, Heather B']",['Breen HB'],"['Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612-7342. hbbreen@aol.com']",['eng'],"['Journal Article', 'Review']",United States,Nutr Clin Pract,Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition,8606733,['N762921K75 (Nitrogen)'],IM,"['Critical Illness/*therapy', 'Lipid Peroxidation/*physiology', 'Nitrogen/*metabolism', '*Nutritional Status', 'Obesity/complications/epidemiology/*metabolism/therapy', 'Parenteral Nutrition', 'Perioperative Care/methods', 'Treatment Outcome', 'United States/epidemiology']",,,,,2005/10/07 09:00,2005/12/24 09:00,['2005/10/07 09:00'],"['2005/10/07 09:00 [pubmed]', '2005/12/24 09:00 [medline]', '2005/10/07 09:00 [entrez]']","['20/1/98 [pii]', '10.1177/011542650502000198 [doi]']",ppublish,Nutr Clin Pract. 2005 Feb;20(1):98-102. doi: 10.1177/011542650502000198.,,,,,,,28,,,,,,,,,,,,,
16669111,NLM,MEDLINE,20060619,20060412,0362-1332 (Print) 0362-1332 (Linking),39,6,2005 Nov-Dec,More U.S. adults at risk of becoming overweight or obese.,7,,,,,,['eng'],['Journal Article'],United States,FDA Consum,FDA consumer,0344327,,,"['Adult', 'Humans', 'Obesity/complications/*epidemiology/ethnology', 'Overweight', 'Risk', 'United States/epidemiology']",,,,,2006/05/04 09:00,2006/06/20 09:00,['2006/05/04 09:00'],"['2006/05/04 09:00 [pubmed]', '2006/06/20 09:00 [medline]', '2006/05/04 09:00 [entrez]']",,ppublish,FDA Consum. 2005 Nov-Dec;39(6):7.,,,,,,,,,,,,,,,,,,,,
11521350,NLM,MEDLINE,20010906,20041117,0023-7205 (Print) 0023-7205 (Linking),98,30-31,2001 Jul 25,[Thanks for better referrals of obese patients!].,3360,,,"['Linne, Y', 'Rossner, S']","['Linne Y', 'Rossner S']",,['swe'],['Letter'],Sweden,Lakartidningen,Lakartidningen,0027707,,IM,"['Body Mass Index', 'Humans', '*Obesity/diagnosis/therapy', '*Referral and Consultation/standards']",,,,,2001/08/28 10:00,2001/09/08 10:01,['2001/08/28 10:00'],"['2001/08/28 10:00 [pubmed]', '2001/09/08 10:01 [medline]', '2001/08/28 10:00 [entrez]']",,ppublish,Lakartidningen. 2001 Jul 25;98(30-31):3360.,,,,,,,,,Tack for battre remisser om feta!,,,,,,,,,,,
26033636,NLM,MEDLINE,20160114,20220310,1440-1843 (Electronic) 1323-7799 (Linking),20,5,2015 Jul,Optimizing respiratory function assessments to elucidate the impact of obesity on respiratory health.,715-21,10.1111/resp.12563 [doi],"There is an increasing prevalence of obesity worldwide and its impact on respiratory health is of significant concern. Obesity affects the respiratory system by several mechanisms, including by direct mechanical changes due to fat deposition in the chest wall, abdomen and upper airway, as well as via systemic inflammation. The increased mechanical load in obese individuals leads to reduced chest wall and lung compliance and increased work of breathing. While there is generally minimal effect on spirometric values, as body mass index increases, the expiratory reserve volume, and hence functional residual capacity, reduces, often approaching residual volume in more severe obesity. The majority of evidence however suggests that obese individuals free from lung disease have relatively normal gas exchange. The link between asthma and obesity, while initially unclear, is now recognized as being a distinct asthma phenotype. While studies investigating objective markers of asthma have shown that there is no association between obesity and airway hyper-responsiveness, a recent working group identified obesity as a major risk factor for the development of asthma in all demographic groups. Although the temptation may be to attribute obesity as the cause of dyspnoea in symptomatic obese patients, accurate respiratory assessment of these individuals is necessary. Lung function tests can confirm that any altered physiology are the known respiratory consequences of obesity. However, given that obesity causes minimal changes in lung function, significant abnormalities warrant further investigation. An important consideration is the knowledge that many of the respiratory physiology consequences of obesity are reversible by weight loss.","['Brazzale, Danny J', 'Pretto, Jeffrey J', 'Schachter, Linda M']","['Brazzale DJ', 'Pretto JJ', 'Schachter LM']","['Department of Respiratory and Sleep Medicine, Austin Hospital, Melbourne, Victoria, Australia.', 'Institute for Breathing and Sleep, Austin Hospital, Melbourne, Victoria, Australia.', 'Institute for Breathing and Sleep, Austin Hospital, Melbourne, Victoria, Australia.', 'Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia.', 'Centre for Obesity Research and Education, Monash University, Melbourne, Victoria, Australia.']",['eng'],"['Journal Article', 'Review']",Australia,Respirology,"Respirology (Carlton, Vic.)",9616368,,IM,"['Body Mass Index', 'Humans', '*Lung Diseases/complications/diagnosis/physiopathology', '*Obesity/complications/diagnosis/physiopathology', 'Respiration', 'Respiratory Function Tests/*methods', 'Respiratory System/physiopathology', 'Symptom Assessment']",,['NOTNLM'],"['asthma', 'lung volume measurement', 'obesity', 'pulmonary gas exchange', 'respiratory function test']",,2015/06/03 06:00,2016/01/15 06:00,['2015/06/03 06:00'],"['2014/10/31 00:00 [received]', '2014/11/09 00:00 [revised]', '2014/11/21 00:00 [revised]', '2014/11/23 00:00 [accepted]', '2015/06/03 06:00 [entrez]', '2015/06/03 06:00 [pubmed]', '2016/01/15 06:00 [medline]']",['10.1111/resp.12563 [doi]'],ppublish,Respirology. 2015 Jul;20(5):715-21. doi: 10.1111/resp.12563. Epub 2015 Jun 1.,,20150601,,['(c) 2015 Asian Pacific Society of Respirology.'],,,,,,,,,,,,,,,,
77995,NLM,MEDLINE,19780814,20190610,0140-6736 (Print) 0140-6736 (Linking),1,8076,1978 Jun 10,Increased adipose-tissue lipoprotein-lipase activity in moderately obese men after weight reduction.,1230-1,,"Most of the many metabolic abnormalities associated with obesity are corrected by weight reduction. Adipose-tissue lipoprotein-lipase activity per cell is increased in obesity. Adipose-tissue lipoprotein-lipase was significantly higher in seven previously obese men studied at a stable reduced weight than in a control population. In fact, enzyme activity was significantly higher than would have been predicted from the obese men's maximum weight. These results indicate that abnormalities in adipose-tissue lipoprotein lipase may have a primary role in the development of obesity.","['Schwartz, R S', 'Brunzell, J D']","['Schwartz RS', 'Brunzell JD']",,['eng'],"['Journal Article', ""Research Support, U.S. Gov't, Non-P.H.S."", ""Research Support, U.S. Gov't, P.H.S.""]",England,Lancet,"Lancet (London, England)",2985213R,['EC 3.1.1.34 (Lipoprotein Lipase)'],IM,"['Adipose Tissue/*enzymology', 'Adult', 'Body Weight', 'Cell Count', 'Humans', 'Lipoprotein Lipase/*metabolism', 'Male', 'Obesity/*enzymology/etiology/pathology']",,,,,1978/06/10 00:00,1978/06/10 00:01,['1978/06/10 00:00'],"['1978/06/10 00:00 [pubmed]', '1978/06/10 00:01 [medline]', '1978/06/10 00:00 [entrez]']","['S0140-6736(78)92465-0 [pii]', '10.1016/s0140-6736(78)92465-0 [doi]']",ppublish,Lancet. 1978 Jun 10;1(8076):1230-1. doi: 10.1016/s0140-6736(78)92465-0.,,,,,,,,,,,,,,,,,,,,
17234087,NLM,MEDLINE,20070504,20070119,1646-0758 (Electronic) 0870-399X (Linking),19,3,2006 May-Jun,[Obesity and quality of life].,247-9,,"Obesity is considered one of the most relevant health problems of modern societies, as it constitutes a predominant risk factor in the development of various other diseases. The negative impact of obesity on the quality of life of individuals has been the subject of diverse research. The results of a test carried out at Gothenburg University in Sweden suggest that severe obesity is a debilitating factor both for health and psychosocial functioning. Research carried out in Madrid permitted identification of a profile of obese patients with impaired quality of life, which has enabled prophylactic intervention or early treatment of these cases to be considered. The results of a study carried out in the USA propose that pain would appear to be directly related with quality of life and could be considered a covariant of obesity, and should therefore be taken into account in obesity treatments. A study carried out in Oxford concluded that obese subjects or subjects with another chronic disease presented a deterioration in physical wellbeing, however only subjects with another chronic disease (without associated obesity) presented a deterioration in psychological wellbeing. The majority of studies suggest the negative influence of obesity and overweight on health and psychosocial functioning, however it is not possible to clearly define a linear relation between obesity and diminished quality of life.","['Da Silva, M Paes', 'Jorge, Z', 'Domingues, A', 'Nobre, E Lacerda', 'Chambel, P', 'De Castro, J Jacome']","['Da Silva MP', 'Jorge Z', 'Domingues A', 'Nobre EL', 'Chambel P', 'De Castro JJ']","['Servico de Endocrinologia, Diabetes e Metabolismo, Hospital Militar Principal, Lisboa, Portugal.']",['por'],"['English Abstract', 'Journal Article', 'Review']",Portugal,Acta Med Port,Acta medica portuguesa,7906803,,IM,"['Humans', '*Obesity/complications/psychology', '*Quality of Life']",,,,,2007/01/20 09:00,2007/05/05 09:00,['2007/01/20 09:00'],"['2007/01/20 09:00 [pubmed]', '2007/05/05 09:00 [medline]', '2007/01/20 09:00 [entrez]']",,ppublish,Acta Med Port. 2006 May-Jun;19(3):247-9. Epub 2006 Sep 7.,,20060907,,,,,13,,Obesidade e qualidade de vida.,,,,,,,,,,,
20054204,NLM,MEDLINE,20100128,20211020,1662-4025 (Print) 1662-4033 (Electronic) 1662-4025 (Linking),2,1,2009,Obesity in print: an analysis of daily newspapers.,46-51,10.1159/000195697 [doi],"BACKGROUND: Stigmatizing attitudes towards obese people are common in the public. Based on findings that portrayals of obesity in entertainment media foster weight-related stigmatization, the goal of the current study was to analyze media coverage of obesity in daily newspapers. METHODS: For the year 2006, all 1,563 issues of five high-circulation daily newspapers (two national newspapers, one tabloid newspaper, and two local newspapers) in Germany were systematically searched for obesity-related terms. Out of these issues, 222 articles about human overweight were identified and subjected to a quantitative content analysis using a reliable coding system. RESULTS: The national and local newspapers examined offered more comprehensive and less incorrect information about obesity than the tabloid newspaper. Compared with the other types of papers, the information about obesity in the local papers was less negative and less catastrophizing. The national newspapers presented more attributions of obesity to internal, controllable causes than the other newspaper types, and the tabloid newspaper used more personalized descriptions of cases with extreme features. CONCLUSION: The current coverage of obesity in daily newspapers may contribute to stigmatization. Future research should examine readers' reception of newspaper information and potential destigmatization through more precise and less subjective coverage of obesity.","['Hilbert, Anja', 'Ried, Jens']","['Hilbert A', 'Ried J']","['Department of Psychology, Philipps University of Marburg, Germany. hilbert@staff.uni-marburg.de']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Switzerland,Obes Facts,Obesity facts,101469429,,IM,"['Germany', 'Health Education', 'Humans', 'Information Dissemination', '*Newspapers as Topic', 'Obesity/etiology/*psychology/therapy', '*Stereotyping']",PMC6444496,,,,2010/01/08 06:00,2010/01/29 06:00,['2010/01/08 06:00'],"['2010/01/08 06:00 [entrez]', '2010/01/08 06:00 [pubmed]', '2010/01/29 06:00 [medline]']","['000195697 [pii]', 'ofa-0002-0046 [pii]', '10.1159/000195697 [doi]']",ppublish,Obes Facts. 2009;2(1):46-51. doi: 10.1159/000195697. Epub 2009 Feb 9.,,20090209,,"['Copyright 2009 S. Karger AG, Basel.']",,,,,,,,,,,,,,,,
22573071,NLM,MEDLINE,20120831,20120510,1473-5598 (Electronic) 0263-6352 (Linking),30,6,2012 Jun,Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.,1047-55,10.1097/HJH.0b013e3283537347 [doi],"Obese patients are prone to arterial hypertension, require more antihypertensive medications, and have an increased risk of treatment-resistant arterial hypertension. Obesity-induced neurohumoral activation appears to be involved. The association between obesity and hypertension shows large inter-individual variability, likely through genetic mechanisms. Obesity affects overall cardiovascular and metabolic risk; yet, the relationship between obesity and cardiovascular risk is complex and not sufficiently addressed in clinical guidelines. The epidemiological observation that obesity may be protective in patients with established cardiovascular disease is difficult to translate into clinical experience and practice. Weight loss is often recommended as a means to lower blood pressure. However, current hypertension guidelines do not provide evidence-based guidance on how to institute weight loss. In fact, weight loss influences on blood pressure may be overestimated. Nevertheless, weight loss through bariatric surgery appears to decrease cardiovascular risk in severely obese patients. Eventually, most obese hypertensive patients will require antihypertensive medications. Data from large-scale studies with hard clinical endpoints on antihypertensive medications specifically addressing obese patients are lacking and the morbidity from the growing population of severely obese patients is poorly recognized or addressed. Because of their broad spectrum of beneficial effects, renin-angiotensin system inhibitors are considered to be the most appropriate drugs for antihypertensive treatment of obese patients. Most obese hypertensive patients require two or more antihypertensive drugs. Finally, how to combine weight loss strategies and antihypertensive treatment to achieve an optimal clinical outcome is unresolved.","['Jordan, Jens', 'Yumuk, Volkan', 'Schlaich, Markus', 'Nilsson, Peter M', 'Zahorska-Markiewicz, Barbara', 'Grassi, Guido', 'Schmieder, Roland E', 'Engeli, Stefan', 'Finer, Nick']","['Jordan J', 'Yumuk V', 'Schlaich M', 'Nilsson PM', 'Zahorska-Markiewicz B', 'Grassi G', 'Schmieder RE', 'Engeli S', 'Finer N']","['Institute of Clinical Pharmacology, Medical School Hannover, Germany. jordan.jens@mh-hannover.de']",['eng'],['Journal Article'],Netherlands,J Hypertens,Journal of hypertension,8306882,['0 (Antihypertensive Agents)'],IM,"['Antihypertensive Agents/therapeutic use', 'Bariatric Surgery', 'Blood Pressure', 'Europe', 'Humans', 'Hypertension/*complications/epidemiology/therapy', 'Life Style', 'Obesity/*complications/epidemiology/physiopathology', 'Practice Guidelines as Topic', 'Weight Loss/drug effects']",,,,,2012/05/11 06:00,2012/09/01 06:00,['2012/05/11 06:00'],"['2012/05/11 06:00 [entrez]', '2012/05/11 06:00 [pubmed]', '2012/09/01 06:00 [medline]']","['00004872-201206000-00001 [pii]', '10.1097/HJH.0b013e3283537347 [doi]']",ppublish,J Hypertens. 2012 Jun;30(6):1047-55. doi: 10.1097/HJH.0b013e3283537347.,,,,,,,,['J Hypertens. 2012 Jun;30(6):1103-5. PMID: 22573076'],,,,,,,,,,,,
2785752,NLM,MEDLINE,19890609,20180330,0002-9165 (Print) 0002-9165 (Linking),49,5,1989 May,"Obesity in northern Canadian Indians: patterns, determinants, and consequences.",786-93,,"A survey of 704 adult Cree and Ojibwa Indians in northern Canada found that a large proportion of individuals in all age-sex groups was obese. Almost 90% of females aged 45-54 y had a body mass index (BMI) greater than or equal to 26. The obesity was primarily of the central type as gauged by skinfold thickness and girth ratios. Multivariate analyses showed that age, sex, smoking, alcohol use, marital status, and employment were associated with the levels of BMI and/or the sum of skinfold thicknesses. When three categories of BMI were compared, higher age-adjusted mean serum lipids, blood pressures, glucose, and glycosylated hemoglobin were observed in the obese subjects whereas total energy was decreased. Calorie-adjusted carbohydrate intake was higher in the obese subjects. BMI was an independent and significant predictor of both diabetic and hypertensive status. Obesity is a significant public health problem for Indians and poses particular risks for future chronic diseases.","['Young, T K', 'Sevenhuysen, G']","['Young TK', 'Sevenhuysen G']","['Department of Community Health Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Am J Clin Nutr,The American journal of clinical nutrition,0376027,,IM,"['Adult', 'Anthropometry', 'Body Height', 'Body Weight', 'Canada', 'Cross-Sectional Studies', 'Diet', 'Female', 'Humans', '*Indians, North American', 'Male', 'Middle Aged', 'Obesity/complications/epidemiology/*ethnology/metabolism', 'Risk Factors', 'Sex Factors']",,,,,1989/05/01 00:00,1989/05/01 00:01,['1989/05/01 00:00'],"['1989/05/01 00:00 [pubmed]', '1989/05/01 00:01 [medline]', '1989/05/01 00:00 [entrez]']",['10.1093/ajcn/49.5.786 [doi]'],ppublish,Am J Clin Nutr. 1989 May;49(5):786-93. doi: 10.1093/ajcn/49.5.786.,,,,,,,,,,,,,,,,,,,,
3941794,NLM,MEDLINE,19860217,20191210,0361-1817 (Print) 0361-1817 (Linking),11,1,1986 Jan,Behavioral intervention for the obese client.,"27-8, 30, 32-4",,"Nurse practitioners usually follow obese clients in outpatient settings. The behavioral approach to treating obesity has been demonstrated to help clients lose weight and maintain their weight loss. This article presents one such behavioral approach to treating obesity. Utilizing the nursing process as a framework, the components of a behavioral program are explored. Assessments of motivation, assets and limitations and target behaviors are described. Coverage of treatment planning includes contracting, problem lists and realistic commitments. Intervention techniques such as stimulus control, shaping, pairing and problem solving are presented. Evaluation using objective data gathered through monitoring is stressed. The characteristics of the practitioner which might positively or negatively affect a behavioral program for the obese client are discussed.","['White, J H']",['White JH'],,['eng'],['Journal Article'],United States,Nurse Pract,The Nurse practitioner,7603663,,IM,"['Behavior Therapy/*methods', 'Conditioning, Psychological', 'Humans', 'Nurse Practitioners', 'Nursing Process', 'Obesity/nursing/*therapy', 'Patient Care Planning', 'Reinforcement, Psychology']",,,,,1986/01/01 00:00,1986/01/01 00:01,['1986/01/01 00:00'],"['1986/01/01 00:00 [pubmed]', '1986/01/01 00:01 [medline]', '1986/01/01 00:00 [entrez]']",,ppublish,"Nurse Pract. 1986 Jan;11(1):27-8, 30, 32-4.",,,,,,,,,,,,,,,,,,,,
20421863,NLM,MEDLINE,20100803,20100427,1121-421X (Print) 1121-421X (Linking),56,2 Suppl 1,2010 Jun,The obese patient: clinical effectiveness of a high-protein low-calorie diet and its usefulness in the field of surgery.,1-65,,"Obesity has become a concern of epidemic proportion involving globally both children and adults. Although genetically linked, lack of physical activity and the outstanding growing of the food market are the main behavioral causes of obesity. Furthermore, it is related to several diseases which may impair the life quality, but also lead to death. Atkins nutritional approach has become really popular since the publication of Dr Atkins' first book ""Dr. Atkins' Diet Revolution"" in 1972. This approach, although very criticized by some dieticians, has been used as a model for a lot of high-protein, low-carbohydrate diets that are nowadays widely used. The evidence that obese people experience a more adverse outcome in a medical and surgical Intensive Care Unit, compared with non-obese pairs, has risen the issue of the importance of an appropriate feeding. Could obese people benefit from a high-protein diet? Is this approach related to adverse effects? Can a high-protein diet bring benefits to obese patients undergoing surgery? This review deals with this matters reporting the use of high-protein diets in clinical trials involving obese subjects.","['Iannitti, T', 'Palmieri, B']","['Iannitti T', 'Palmieri B']","['Department of Biological and Biomedical Sciences Glasgow Caledonian University, UK. tommaso.iannitti@gmail.com']",['eng'],"['Journal Article', 'Review']",Italy,Minerva Gastroenterol Dietol,Minerva gastroenterologica e dietologica,9109791,"['0 (Dietary Proteins)', '0 (Fatty Acids, Unsaturated)']",IM,"['Clinical Trials as Topic', 'Combined Modality Therapy', '*Diet, Reducing', 'Dietary Proteins/*administration & dosage', 'Fatty Acids, Unsaturated/administration & dosage', 'Humans', 'Obesity/*diet therapy/etiology/*surgery']",,,,,2010/05/29 06:00,2010/08/04 06:00,['2010/04/28 06:00'],"['2010/04/28 06:00 [entrez]', '2010/05/29 06:00 [pubmed]', '2010/08/04 06:00 [medline]']",['R08101928 [pii]'],ppublish,Minerva Gastroenterol Dietol. 2010 Jun;56(2 Suppl 1):1-65.,,,,,,,194,,,,,,,,,,,,,
25055476,NLM,MEDLINE,20140925,20140724,1660-9379 (Print) 1660-9379 (Linking),10,436,2014 Jun 25,[The obesity paradox].,1413-7,,"In general population, cardiovascular (CV) mortality increases in parallel with obesity severity, determined by body mass index (BMI). However in cohorts of patients with coronary diseases or heart failure a decrease of the global mortality has been observed in patients aged more than 65 years old with moderate obesity (BMI = 30-35) compared to normal weight people (BMI = 20-25) and morbid obese (BMI > 35). This ""obesity paradox"" could result from the selection of obese people with healthy metabolic profile and way of life. BMI does not allow to distinguish lean body mass from fat mass and therefore to evaluate abdominal obesity which is associated with metabolic syndrome and CV risk.","['Du Pan, Remi C Martin', 'Golay, Alain']","['Du Pan RC', 'Golay A']",,['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Aged', 'Body Mass Index', 'Cardiovascular Diseases/etiology/*mortality', 'Hemodynamics', 'Humans', 'Obesity/complications/*mortality/physiopathology', 'Obesity, Morbid/mortality', 'Risk Factors']",,,,,2014/07/25 06:00,2014/09/26 06:00,['2014/07/25 06:00'],"['2014/07/25 06:00 [entrez]', '2014/07/25 06:00 [pubmed]', '2014/09/26 06:00 [medline]']",,ppublish,Rev Med Suisse. 2014 Jun 25;10(436):1413-7.,,,,,,,,,Le paradoxe de l'obesite.,,,,,,,,,,,
6169628,NLM,MEDLINE,19811221,20191031,0363-2792 (Print) 0363-2792 (Linking),13,3,1981 Oct,Symbolic interactionism: a conceptual framework useful for nurses working with obese persons.,78-81,,,"['Schroeder, M A']",['Schroeder MA'],,['eng'],['Journal Article'],United States,Image (IN),Image,0435746,,,"['*Communication', 'Female', 'Humans', 'Male', 'Nursing Assessment', 'Obesity/*nursing/psychology', '*Symbolism']",,,,,1981/10/01 00:00,1981/10/01 00:01,['1981/10/01 00:00'],"['1981/10/01 00:00 [pubmed]', '1981/10/01 00:01 [medline]', '1981/10/01 00:00 [entrez]']",['10.1111/j.1547-5069.1981.tb01489.x [doi]'],ppublish,Image (IN). 1981 Oct;13(3):78-81. doi: 10.1111/j.1547-5069.1981.tb01489.x.,,,,,,,,,,,,,,,,,,,,
989500,NLM,MEDLINE,19761201,20190630,0098-7484 (Print) 0098-7484 (Linking),236,15,1976 Oct 11,Evaluation of the obese patient.,1671-2,,,"['Gillette, R D']",['Gillette RD'],,['eng'],['Letter'],United States,JAMA,JAMA,7501160,,IM,"['Clinical Laboratory Techniques', 'Endocrine Glands/metabolism', 'Feeding Behavior', 'Humans', 'Obesity/*diagnosis/physiopathology']",,,,,1976/10/11 00:00,1976/10/11 00:01,['1976/10/11 00:00'],"['1976/10/11 00:00 [pubmed]', '1976/10/11 00:01 [medline]', '1976/10/11 00:00 [entrez]']",['10.1001/jama.236.15.1671 [doi]'],ppublish,JAMA. 1976 Oct 11;236(15):1671-2. doi: 10.1001/jama.236.15.1671.,,,,,,,,,,,,,,,,,,,,
6741685,NLM,MEDLINE,19840807,20190913,0306-4603 (Print) 0306-4603 (Linking),9,2,1984,Obese and nonobese individuals: behavioral and personality characteristics.,223-6,,"In order to determine if there were differences in individuals who were currently obese, previously obese now average, and always average, a battery of behavioral and personality measures were administered which included the assessment of self-concept, self-control, health locus of control, comparative reinforcement hierarchy and various activities. Significant differences were obtained in physical self-concept; time spent in vigorous activity, passive activity, with friends and social activities; and the reinforcement value of eating, time with friends or family, and taking it easy. The possible significance of these findings was discussed in terms of maintaining factors in obesity and treatment suggestions.","['Jacobs, S B', 'Wagner, M K']","['Jacobs SB', 'Wagner MK']",,['eng'],['Journal Article'],England,Addict Behav,Addictive behaviors,7603486,,IM,"['Adolescent', 'Adult', 'Female', 'Humans', 'Internal-External Control', 'Male', 'Middle Aged', 'Obesity/*psychology/therapy', '*Personality', 'Physical Exertion', '*Self Concept', 'Social Adjustment']",,,,,1984/01/01 00:00,1984/01/01 00:01,['1984/01/01 00:00'],"['1984/01/01 00:00 [pubmed]', '1984/01/01 00:01 [medline]', '1984/01/01 00:00 [entrez]']","['0306-4603(84)90062-5 [pii]', '10.1016/0306-4603(84)90062-5 [doi]']",ppublish,Addict Behav. 1984;9(2):223-6. doi: 10.1016/0306-4603(84)90062-5.,,,,,,,,,,,,,,,,,,,,
11746306,NLM,MEDLINE,20020514,20191025,0276-3478 (Print) 0276-3478 (Linking),30,4,2001 Dec,Parental influences on eating behavior in obese and nonobese preadolescents.,447-53,,"OBJECTIVE: To determine parental influences on obesity, the eating behavior of 80 obese and normal weight children (aged 8-12 years) was investigated in the laboratory. METHOD: A controlled repeated measures design was used. The mother was either present or absent while the child was eating in the laboratory. The eating style was measured by recording cumulative eating curves with a universal eating monitor, using yoghurt as a standardized experimental meal. RESULTS: The eating behavior of obese children differed significantly from normal weight children only when the mother was present in the laboratory. Overweight children ate faster with larger bites and showed an acceleration of their eating rate toward the end of the meal. DISCUSSION: Such an eating style can be hypothesized to explain an increased calorie intake in obese children, promoting a positive energy balance in the long term. The data support a learning model of obesity in childhood, which also has implications for family treatment.","['Laessle, R G', 'Uhl, H', 'Lindel, B']","['Laessle RG', 'Uhl H', 'Lindel B']","['Center for Psychobiological and Psychosomatic Research, University of Trier, Trier, Germany. laessle@uni-trier.de']",['eng'],['Journal Article'],United States,Int J Eat Disord,The International journal of eating disorders,8111226,,IM,"['Body Mass Index', 'Child', 'Energy Intake', 'Family/psychology', 'Feeding Behavior/*psychology', 'Humans', 'Obesity/epidemiology/etiology/*psychology', '*Parent-Child Relations', '*Parents', 'Prevalence']",,,,,2001/12/18 10:00,2002/05/15 10:01,['2001/12/18 10:00'],"['2001/12/18 10:00 [pubmed]', '2002/05/15 10:01 [medline]', '2001/12/18 10:00 [entrez]']","['10.1002/eat.1106 [pii]', '10.1002/eat.1106 [doi]']",ppublish,Int J Eat Disord. 2001 Dec;30(4):447-53. doi: 10.1002/eat.1106.,,,,"['Copyright 2001 by John Wiley & Sons, Inc.']",,,,,,,,,,,,,,,,
8609847,NLM,MEDLINE,19960528,20201219,0025-729X (Print) 0025-729X (Linking),164,7,1996 Apr 1,"Of mice and (wo)men: the obesity (ob) gene, its product, leptin, and obesity.",393-4,,,"['Zimmet, P Z', 'Collier, G R']","['Zimmet PZ', 'Collier GR']",,['eng'],['Editorial'],Australia,Med J Aust,The Medical journal of Australia,0400714,"['0 (Leptin)', '0 (Proteins)']",IM,"['Animals', 'Female', 'Gene Expression Regulation', 'Humans', 'Leptin', 'Mice', 'Mice, Inbred NOD', 'Mice, Obese', 'Obesity/drug therapy/*genetics/metabolism', 'Proteins/analysis/*genetics/physiology/therapeutic use']",,,,,1996/04/01 00:00,1996/04/01 00:01,['1996/04/01 00:00'],"['1996/04/01 00:00 [pubmed]', '1996/04/01 00:01 [medline]', '1996/04/01 00:00 [entrez]']",['10.5694/j.1326-5377.1996.tb122083.x [doi]'],ppublish,Med J Aust. 1996 Apr 1;164(7):393-4. doi: 10.5694/j.1326-5377.1996.tb122083.x.,,,,,,,,,,,,,,,,,,,,
23899283,NLM,MEDLINE,20140303,20220321,1747-4132 (Electronic) 1747-4124 (Linking),7,5,2013 Jul,Role of the gastroenterologist in managing obesity.,439-51,10.1586/17474124.2013.811061 [doi],"Obesity has become a major public health problem as a consequence of its prevalence, negative impact on morbidity, mortality and quality of life and its associated direct and indirect healthcare costs. The etiology of obesity is multifactorial and reflects complex interactions of genetic, neurohumoral, environmental, behavioral and possibly, microbial factors. Available treatments for obesity include diet and exercise, behavioral modification, medications and surgery. Gastroenterologists are becoming increasingly involved in the care of obese patients. Although much of this care has historically centered on the preoperative and postoperative care of the bariatric patient, gastroenterologists are also evaluating and managing a variety of gastrointestinal symptoms and disorders that occur more commonly among obese individuals and are increasingly involved in the primary treatment of obesity. In this review, the gastrointestinal symptoms and disorders that are associated with obesity will be reviewed, the gastrointestinal contribution to the pathogenesis of obesity will be described and the current treatment options of obesity and where the gastroenterologist typically plays a role in the management will be discussed.","['Dibaise, John K', 'Foxx-Orenstein, Amy E']","['Dibaise JK', 'Foxx-Orenstein AE']","['Division of Gastroenterology, Mayo Clinic in Arizona, Scottsdale, AZ, USA. dibaise.john@mayo.edu']",['eng'],"['Journal Article', 'Review']",England,Expert Rev Gastroenterol Hepatol,Expert review of gastroenterology & hepatology,101278199,,IM,"['Gastroenterology/*methods', 'Gastrointestinal Diseases/diagnosis/epidemiology/*therapy', 'Humans', 'Obesity/diagnosis/epidemiology/*therapy', 'Risk Factors', 'Treatment Outcome', 'Weight Loss']",,,,,2013/08/01 06:00,2014/03/04 06:00,['2013/08/01 06:00'],"['2013/08/01 06:00 [entrez]', '2013/08/01 06:00 [pubmed]', '2014/03/04 06:00 [medline]']",['10.1586/17474124.2013.811061 [doi]'],ppublish,Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5):439-51. doi: 10.1586/17474124.2013.811061.,,,,,,,,,,,,,,,,,,,,
17914130,NLM,MEDLINE,20071206,20190911,0731-5724 (Print) 0731-5724 (Linking),26,5,2007 Oct,Ecologic correlates of obesity in rural obese adults.,424-33,,"OBJECTIVE: We examined relationships of individual and environmental factors with obesity and trying to lose weight in rural residents. METHODS: The joint contributions of individual and environmental factors on obesity status (obese vs. morbidly obese) and trying to lose weight (yes vs. no) were evaluated using generalized estimating equations. Patients at 29 clinics in rural areas (N = 414, M age 55.0 years (SD = 15.4), 66.3% female) completed anthropometric assessments of weight and height along with survey assessments of individual sociodemographics and trying to lose weight. Rural environments were assessed on aggregated physician access, and sociodemographic context. RESULTS: Most participants (70%, M BMI = 38.3) were obese and 30% morbidly obese. A majority (73%, n = 302) of the sample was trying to lose weight. Compared to obese, morbidly obese participants were more likely to be younger, disproportionately female, not have private insurance, have more comorbid conditions, and rate themselves in worse health in comparison to their obese peers. Compared to not trying to lose weight, trying to lose weight participants were more likely to be younger, disproportionately female, have fewer comorbid conditions, and have attempted to lose weight more times through exercise. Few relationships were seen between environmental variables and obesity or trying to lose weight. CONCLUSIONS: There was no consistent pattern of relationships between environment factors and obesity or trying to lose weight was seen. Unique aspects of rural living may not be captured by traditionally available neighborhood measures.","['Lee, Rebecca E', 'Greiner, K Allen', 'Hall, Sandra', 'Born, Wendi', 'Kimminau, Kim S', 'Allison, Andrew', 'Ahluwalia, Jasjit S']","['Lee RE', 'Greiner KA', 'Hall S', 'Born W', 'Kimminau KS', 'Allison A', 'Ahluwalia JS']","['Department of Health and Human Performance, University of Houston, Giarrison Gymnasium 104 E, 3855 Holman Rd., Houston, TX 77004, USA. releephd@yahoo.com']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,J Am Coll Nutr,Journal of the American College of Nutrition,8215879,,IM,"['Adult', 'Age Factors', 'Aged', 'Attitude to Health', 'Body Mass Index', 'Comorbidity', 'Diet, Reducing/psychology', '*Environment', 'Exercise/physiology/psychology', 'Female', '*Health Status', 'Humans', 'Insurance, Health', 'Male', 'Middle Aged', 'Obesity/*epidemiology/*psychology/therapy', 'Obesity, Morbid/epidemiology/psychology', 'Risk Factors', 'Rural Population', 'Sex Factors', 'Weight Loss']",,,,,2007/10/05 09:00,2007/12/07 09:00,['2007/10/05 09:00'],"['2007/10/05 09:00 [pubmed]', '2007/12/07 09:00 [medline]', '2007/10/05 09:00 [entrez]']","['26/5/424 [pii]', '10.1080/07315724.2007.10719632 [doi]']",ppublish,J Am Coll Nutr. 2007 Oct;26(5):424-33. doi: 10.1080/07315724.2007.10719632.,,,,,,,,,,,,,,,,,,,,
24916593,NLM,MEDLINE,20150413,20181202,1526-4610 (Electronic) 0017-8748 (Linking),54,6,2014 Jun,Perceived body weight status of youngsters interferes with headache in obese and non-obese subjects.,1062-3,10.1111/head.12374 [doi],,"['Trovato, Guglielmo', 'Brischetto, Daniela', 'Pace, Patrizia', 'Fabio Martines, G']","['Trovato G', 'Brischetto D', 'Pace P', 'Fabio Martines G']","['Medical and Pediatric Sciences - Health Psychology, University of Catania, Catania, Italy.']",['eng'],"['Comment', 'Letter']",United States,Headache,Headache,2985091R,,IM,"['Headache/*epidemiology/*etiology', 'Humans', 'Obesity/*complications/*epidemiology']",,,,,2014/06/12 06:00,2015/04/14 06:00,['2014/06/12 06:00'],"['2014/06/12 06:00 [entrez]', '2014/06/12 06:00 [pubmed]', '2015/04/14 06:00 [medline]']",['10.1111/head.12374 [doi]'],ppublish,Headache. 2014 Jun;54(6):1062-3. doi: 10.1111/head.12374.,,,,,,,,,,,['Headache. 2014 Feb;54(2):219-34. PMID: 24512574'],,,,,,,,,
21095441,NLM,MEDLINE,20110120,20101124,1558-1373 (Electronic) 0030-5898 (Linking),42,1,2011 Jan,Financial implications of obesity.,"123-7, vii",10.1016/j.ocl.2010.09.003 [doi],"The obesity epidemic continues to grow. As the number of obese people increases, it is logical to expect an increasing number of obese patients and increasing costs to care for these patients. Orthopedic surgeons will see many of these patients who need treatment for injuries and chronic conditions. Care of obese patients requires more work and time in providing nonoperative and operative care. No system has been proposed to handle reimbursement disparities, particularly for providers. The model for health care will change and, along with it, should be all parties coming together to address inequalities and inequities in care for obese and morbidly obese patients.","['Russell, George V', 'Pierce, Christine W', 'Nunley, Loren']","['Russell GV', 'Pierce CW', 'Nunley L']","['Department of Orthopaedic Surgery, University of Mississippi Medical Center, Jackson, MS 39216, USA. gvrussell@umc.edu']",['eng'],"['Journal Article', 'Review']",United States,Orthop Clin North Am,The Orthopedic clinics of North America,0254463,,IM,"['Delivery of Health Care/*economics', '*Fractures, Bone/complications/epidemiology/therapy', '*Health Care Costs', 'Humans', 'Incidence', 'Insurance, Health/*economics', '*Obesity/economics/epidemiology/therapy', 'United States/epidemiology']",,,,,2010/11/26 06:00,2011/01/21 06:00,['2010/11/25 06:00'],"['2010/11/25 06:00 [entrez]', '2010/11/26 06:00 [pubmed]', '2011/01/21 06:00 [medline]']","['S0030-5898(10)00089-1 [pii]', '10.1016/j.ocl.2010.09.003 [doi]']",ppublish,"Orthop Clin North Am. 2011 Jan;42(1):123-7, vii. doi: 10.1016/j.ocl.2010.09.003.",,,,['Copyright (c) 2011 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
16713630,NLM,MEDLINE,20060929,20080417,0165-1781 (Print) 0165-1781 (Linking),142,1,2006 May 30,Exposure to early life trauma is associated with adult obesity.,31-7,,"Exposure to traumatic events during childhood is associated with an elevated risk of adult obesity. It has been hypothesized that the psychological sequelae from childhood trauma account for this risk, though no study has examined whether an increased risk of obesity is found in persons without psychological disorders. We examined exposure to early life stressors and body mass index (BMI) in 696 adults without significant medical or psychiatric history. Bivariate correlation showed that the total number of early life stressors (r=0.08), age (r=0.19), and sex (r=0.16) were significantly related to adult BMI. Given the relationship between sex and BMI, we examined the contribution of early life stressors to adult obesity separately for men and women. In men, hierarchical regression showed that exposure to early life stressors predicted adult obesity. Specifically, history of being bullied/rejected (Obese 31%, Normal weight, 9%) and emotional abuse (Obese, 17%; Normal weight, 2%) predicted adult obesity after controlling for the effects of age. In women, no relationship between early life stressors and adult obesity was found. These findings suggest that multiple processes mediate the relationship between early life stress and adult obesity and that their relative contributions may differ between men and women.","['Gunstad, John', 'Paul, Robert H', 'Spitznagel, Mary Beth', 'Cohen, Ronald A', 'Williams, Leanne M', 'Kohn, Michael', 'Gordon, Evian']","['Gunstad J', 'Paul RH', 'Spitznagel MB', 'Cohen RA', 'Williams LM', 'Kohn M', 'Gordon E']","['Kent State University, Department of Psychology, Kent Hall, Kent OH 44242, USA. jgunstad@kent.edu']",['eng'],['Journal Article'],Ireland,Psychiatry Res,Psychiatry research,7911385,,IM,"['Adult', 'Body Mass Index', 'Female', 'Humans', 'Life Change Events', 'Male', 'Middle Aged', 'Obesity/etiology/*psychology', 'Risk Factors']",,,,,2006/05/23 09:00,2006/09/30 09:00,['2006/05/23 09:00'],"['2005/06/13 00:00 [received]', '2005/11/02 00:00 [revised]', '2005/11/14 00:00 [accepted]', '2006/05/23 09:00 [pubmed]', '2006/09/30 09:00 [medline]', '2006/05/23 09:00 [entrez]']","['S0165-1781(05)00372-0 [pii]', '10.1016/j.psychres.2005.11.007 [doi]']",ppublish,Psychiatry Res. 2006 May 30;142(1):31-7. doi: 10.1016/j.psychres.2005.11.007. Epub 2006 May 19.,,20060519,,,,,,,,,,,,,,,,,,
26565543,NLM,MEDLINE,20161213,20161230,2191-0251 (Electronic) 0334-018X (Linking),29,3,2016 Mar,"Anxiety, depression and self-esteem levels in obese children: a case-control study.",357-61,10.1515/jpem-2015-0254 [doi],"BACKGROUND: Obesity is a global health problem affecting all age groups. Childhood obesity, which may cause chronic diseases including diabetes mellitus, cardiovascular disease and cancer, etc., deserves more attention. However, few studies highlight the association between childhood obesity and psychological diseases. In the present study, we aimed to evaluate the psychological condition in obese children. METHODS: One hundred and sixty-seven obese (body mass index (BMI) >95th percentile) and 200 normal weight children (BMI between 5th and 85th percentile) aged 9-16 years were enrolled into this case-control study. In order to assess the self-concept, anxiety and depression levels: the Piers-Harris Children's Self-Concept Scale (PHCSCS), state and trait anxiety inventory for children (STAI-C) and the children depression inventory (CDI) were administered both obese and control groups. RESULTS: There were significant differences among obese and control groups in terms of the total score of PHCSCS [55 (22-69) versus 65 (57-74)], STAI-C [37 (20-55) versus 28 (20-42)], and CDI [12 (4-39)] versus [8 (3-19)]; respectively (p<0.001, p<0.001, p<0.001). We also found statistically significant differences among groups in all of the subscales parameters of PHCSCS (p<0.001). CONCLUSIONS: Our results indicate that obese children may experience psychiatric disorders more than normal-weight peers.","['Topcu, Seda', 'Orhon, Filiz Simsek', 'Tayfun, Meltem', 'Ucakturk, Seyit Ahmet', 'Demirel, Fatma']","['Topcu S', 'Orhon FS', 'Tayfun M', 'Ucakturk SA', 'Demirel F']",,['eng'],"['Comparative Study', 'Journal Article']",Germany,J Pediatr Endocrinol Metab,Journal of pediatric endocrinology & metabolism : JPEM,9508900,,IM,"['Anxiety/etiology/*psychology', 'Body Image', 'Case-Control Studies', 'Child', 'Depression/etiology/*psychology', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Obesity/*complications/physiopathology/*psychology', '*Self Concept']",,,,,2015/11/14 06:00,2016/12/15 06:00,['2015/11/14 06:00'],"['2015/06/23 00:00 [received]', '2015/09/18 00:00 [accepted]', '2015/11/14 06:00 [entrez]', '2015/11/14 06:00 [pubmed]', '2016/12/15 06:00 [medline]']","['/j/jpem.ahead-of-print/jpem-2015-0254/jpem-2015-0254.xml [pii]', '10.1515/jpem-2015-0254 [doi]']",ppublish,J Pediatr Endocrinol Metab. 2016 Mar;29(3):357-61. doi: 10.1515/jpem-2015-0254.,,,,,,,,,,,,,,,,,,,,
20531281,NLM,MEDLINE,20101004,20231106,1745-7262 (Electronic) 1008-682X (Print) 1008-682X (Linking),12,4,2010 Jul,Obesity: modern man's fertility nemesis.,480-9,10.1038/aja.2010.38 [doi],"The obesity pandemic has grown to concerning proportions in recent years, not only in the Western World, but in developing countries as well. The corresponding decrease in male fertility and fecundity may be explained in parallel to obesity, and obesity should be considered as an etiology of male fertility. Studies show that obesity contributes to infertility by reducing semen quality, changing sperm proteomes, contributing to erectile dysfunction, and inducing other physical problems related to obesity. Mechanisms for explaining the effect of obesity on male infertility include abnormal reproductive hormone levels, an increased release of adipose-derived hormones and adipokines associated with obesity, and other physical problems including sleep apnea and increased scrotal temperatures. Recently, genetic factors and markers for an obesity-related infertility have been discovered and may explain the difference between fertile obese and infertile obese men. Treatments are available for not only infertility related to obesity, but also as a treatment for the other comorbidities arising from obesity. Natural weight loss, as well as bariatric surgery are options for obese patients and have shown promising results in restoring fertility and normal hormonal profiles. Therapeutic interventions including aromatase inhibitors, exogenous testosterone replacement therapy and maintenance and regulation of adipose-derived hormones, particularly leptin, may also be able to restore fertility in obese males. Because of the relative unawareness and lack of research in this area, controlled studies should be undertaken and more focus should be given to obesity as an etiolgy of male infertility.","['Cabler, Stephanie', 'Agarwal, Ashok', 'Flint, Margot', 'du Plessis, Stefan S']","['Cabler S', 'Agarwal A', 'Flint M', 'du Plessis SS']","['Center for Reproductive Medicine, The Cleveland Clinic, Cleveland, OH 44195, USA.']",['eng'],"['Journal Article', 'Review']",China,Asian J Androl,Asian journal of andrology,100942132,"['0 (Adipokines)', '0 (Aromatase Inhibitors)', '0 (Gonadal Steroid Hormones)']",IM,"['Adipokines/physiology', 'Aromatase Inhibitors/therapeutic use', 'Body Mass Index', 'Erectile Dysfunction/etiology', 'Fertility', 'Gonadal Steroid Hormones/physiology', 'Humans', 'Infertility, Male/*etiology', 'Life Style', 'Male', 'Obesity/*complications/genetics/physiopathology/therapy', 'Semen Analysis', 'Waist Circumference']",PMC3739371,,,,2010/06/10 06:00,2010/10/05 06:00,['2010/06/10 06:00'],"['2010/06/10 06:00 [entrez]', '2010/06/10 06:00 [pubmed]', '2010/10/05 06:00 [medline]']","['aja201038 [pii]', '10.1038/aja.2010.38 [doi]']",ppublish,Asian J Androl. 2010 Jul;12(4):480-9. doi: 10.1038/aja.2010.38. Epub 2010 Jun 7.,,20100607,,,,,,,,,,,,,,,,,,
16005827,NLM,MEDLINE,20051108,20190227,0889-8537 (Print) 0889-8537 (Linking),23,3,2005 Sep,Nonsurgical and surgical treatment of obesity.,"501-23, vii",,"An increasing number of morbidly obese patients are presenting for surgery, with the potential for increased perioperative morbidity and mortality. This article reviews surgical and nonsurgical options in the management of morbidly obese patients. Overweight and obese individuals should be treated with diet, exercise, and behavioral therapy. The failure of this approach is an indication for pharmacologic therapy. Bariatric surgery reduces obesity-related complications and reduces long-term morbidity, mortality, and health care resources use.","['Neligan, Patrick J', 'Williams, Noel']","['Neligan PJ', 'Williams N']","['Department of Anesthesia, University of Pennsylvania School of Medicine, 3400 Spruce Street, Philadelphia, PA 19104, USA. neliganp@uphs.upenn.edu']",['eng'],"['Journal Article', 'Review']",United States,Anesthesiol Clin North Am,Anesthesiology clinics of North America,8810131,,IM,"['Anastomosis, Roux-en-Y/methods', 'Bariatrics/*methods', 'Behavior Therapy/methods', 'Biliopancreatic Diversion/*methods', 'Gastric Bypass/*methods', 'Humans', 'Obesity/drug therapy/surgery/*therapy', 'Postoperative Complications/prevention & control', 'Preoperative Care/methods']",,,,,2005/07/12 09:00,2005/11/09 09:00,['2005/07/12 09:00'],"['2005/07/12 09:00 [pubmed]', '2005/11/09 09:00 [medline]', '2005/07/12 09:00 [entrez]']","['S0889-8537(05)00037-4 [pii]', '10.1016/j.atc.2005.03.008 [doi]']",ppublish,"Anesthesiol Clin North Am. 2005 Sep;23(3):501-23, vii. doi: 10.1016/j.atc.2005.03.008.",,,,,,,86,,,,,,,,,,,,,
5063486,NLM,MEDLINE,19720717,20190713,0032-5481 (Print) 0032-5481 (Linking),51,5,1972 May,Clinical management of the obese adult.,125-30,,,"['Bray, G A']",['Bray GA'],,['eng'],['Journal Article'],England,Postgrad Med,Postgraduate medicine,0401147,"['0 (Appetite Depressants)', '0 (Thyroid Hormones)', '0 (Vitamins)']",IM,"['Adult', 'Age Factors', 'Appetite Depressants/therapeutic use', 'Calorimetry', 'Diet, Reducing', 'Feeding Behavior', 'Health Education', 'Humans', 'Ileum/surgery', 'Jejunum/surgery', 'Obesity/drug therapy/etiology/genetics/surgery/*therapy', 'Physical Exertion', 'Social Desirability', 'Social Environment', 'Thyroid Hormones/therapeutic use', 'Vitamins/therapeutic use']",,,,,1972/05/01 00:00,1972/05/01 00:01,['1972/05/01 00:00'],"['1972/05/01 00:00 [pubmed]', '1972/05/01 00:01 [medline]', '1972/05/01 00:00 [entrez]']",['10.1080/00325481.1972.11698241 [doi]'],ppublish,Postgrad Med. 1972 May;51(5):125-30. doi: 10.1080/00325481.1972.11698241.,,,,,,,,,,,,,,,,,,,,
33561645,NLM,MEDLINE,20210719,20210719,1950-6007 (Electronic) 0753-3322 (Linking),137,,2021 May,Adipose tissue and insulin resistance in obese.,111315,S0753-3322(21)00100-1 [pii] 10.1016/j.biopha.2021.111315 [doi],"Currently, obesity has become a global health issue and is referred to as an epidemic. Dysfunctional obese adipose tissue plays a pivotal role in the development of insulin resistance. However, the mechanism of how dysfunctional obese-adipose tissue develops insulin-resistant circumstances remains poorly understood. Therefore, this review attempts to highlight the potential mechanisms behind obesity-associated insulin resistance. Multiple risk factors are directly or indirectly associated with the increased risk of obesity; among them, environmental factors, genetics, aging, gut microbiota, and diets are prominent. Once an individual becomes obese, adipocytes increase in their size; therefore, adipose tissues become larger and dysfunctional, recruit macrophages, and then these polarize to pro-inflammatory states. Enlarged adipose tissues release excess free fatty acids (FFAs), reactive oxygen species (ROS), and pro-inflammatory cytokines. Excess systemic FFAs and dietary lipids enter inside the cells of non-adipose organs such as the liver, muscle, and pancreas, and are deposited as ectopic fat, generating lipotoxicity. Toxic lipids dysregulate cellular organelles, e.g., mitochondria, endoplasmic reticulum, and lysosomes. Dysregulated organelles release excess ROS and pro-inflammation, resulting in systemic inflammation. Long term low-grade systemic inflammation prevents insulin from its action in the insulin signaling pathway, disrupts glucose homeostasis, and results in systemic dysregulation. Overall, long-term obesity and overnutrition develop into insulin resistance and chronic low-grade systemic inflammation through lipotoxicity, creating the circumstances to develop clinical conditions. This review also shows that the liver is the most sensitive organ undergoing insulin impairment faster than other organs, and thus, hepatic insulin resistance is the primary event that leads to the subsequent development of peripheral tissue insulin resistance.","['Ahmed, Bulbul', 'Sultana, Rifat', 'Greene, Michael W']","['Ahmed B', 'Sultana R', 'Greene MW']","['Department of Nutrition, Auburn University, Auburn, AL, 36849, United States. Electronic address: bza0017@auburn.edu.', 'Department of Biology and Microbiology, South Dakota State University, Brookings, SD, 57007, United States.', 'Department of Nutrition, Auburn University, Auburn, AL, 36849, United States.']",['eng'],"['Journal Article', 'Review']",France,Biomed Pharmacother,Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,8213295,,IM,"['Adipose Tissue/*pathology', 'Animals', 'Humans', '*Insulin Resistance', 'Obesity/*metabolism/*pathology']",,['NOTNLM'],"['Adipose tissue', 'Insulin resistance', 'Lipotoxicity', 'Obesity', 'Pro-inflammation']",,2021/02/10 06:00,2021/07/20 06:00,['2021/02/09 20:11'],"['2020/12/09 00:00 [received]', '2021/01/19 00:00 [revised]', '2021/01/21 00:00 [accepted]', '2021/02/10 06:00 [pubmed]', '2021/07/20 06:00 [medline]', '2021/02/09 20:11 [entrez]']","['S0753-3322(21)00100-1 [pii]', '10.1016/j.biopha.2021.111315 [doi]']",ppublish,Biomed Pharmacother. 2021 May;137:111315. doi: 10.1016/j.biopha.2021.111315. Epub 2021 Feb 6.,,20210206,,"['Copyright (c) 2021 The Authors. Published by Elsevier Masson SAS.. All rights', 'reserved.']",,,,,,,,,,,,,,,,
7395581,NLM,MEDLINE,19800923,20190913,0306-4603 (Print) 0306-4603 (Linking),5,1,1980,"Correlates of success and retention in a multifaceted, long-term behavior modification program for obese adolescent girls.",25-34,,,"['Harris, M B', 'Sutton, M', 'Kaufman, E M', 'Carmichael, C W']","['Harris MB', 'Sutton M', 'Kaufman EM', 'Carmichael CW']",,['eng'],['Journal Article'],England,Addict Behav,Addictive behaviors,7603486,,IM,"['Adolescent', 'Adult', '*Behavior Therapy', 'Child', 'Female', 'Humans', 'Obesity/psychology/*therapy', 'Psychotherapy, Group', 'Self-Assessment']",,,,,1980/01/01 00:00,1980/01/01 00:01,['1980/01/01 00:00'],"['1980/01/01 00:00 [pubmed]', '1980/01/01 00:01 [medline]', '1980/01/01 00:00 [entrez]']","['0306-4603(80)90018-0 [pii]', '10.1016/0306-4603(80)90018-0 [doi]']",ppublish,Addict Behav. 1980;5(1):25-34. doi: 10.1016/0306-4603(80)90018-0.,,,,,,,,,,,,,,,,,,,,
9677222,NLM,MEDLINE,19980903,20190501,0959-8138 (Print) 1468-5833 (Electronic) 0959-8138 (Linking),317,7153,1998 Jul 25,Helping an obese patient make informed choices.,266-7,,,"['Mulrow, C D']",['Mulrow CD'],"['Audie L Murphy Memorial Veterans Hospital, San Antonio, TX 78284, USA. mulrowc@uthscsa.edu']",['eng'],"['Case Reports', 'Journal Article', 'Review']",England,BMJ,BMJ (Clinical research ed.),8900488,,IM,"['*Choice Behavior', 'Decision Making', 'Evidence-Based Medicine', 'Female', 'Humans', 'Middle Aged', 'Obesity/diet therapy/drug therapy/*psychology', 'Patient Education as Topic', 'Physician-Patient Relations', 'Randomized Controlled Trials as Topic']",PMC1113590,,,,1998/07/24 00:00,1998/07/24 00:01,['1998/07/24 00:00'],"['1998/07/24 00:00 [pubmed]', '1998/07/24 00:01 [medline]', '1998/07/24 00:00 [entrez]']",['10.1136/bmj.317.7153.266 [doi]'],ppublish,BMJ. 1998 Jul 25;317(7153):266-7. doi: 10.1136/bmj.317.7153.266.,,,,,,,,,,,,,,,,,,,,
2286142,NLM,MEDLINE,19910322,20190907,0168-8227 (Print) 0168-8227 (Linking),10 Suppl 1,,1990,Decreased social activity in obese adults.,S265-9,,,"['Kuskowska-Wolk, A', 'Rossner, S']","['Kuskowska-Wolk A', 'Rossner S']","['Health Behaviour Research Unit, Karolinska Institute, Stockholm, Sweden.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",Ireland,Diabetes Res Clin Pract,Diabetes research and clinical practice,8508335,,IM,"['Adolescent', 'Adult', 'Aged', 'Aged, 80 and over', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/epidemiology/*physiopathology/psychology', 'Population', '*Social Behavior', 'Sweden/epidemiology']",,,,,1990/01/01 00:00,1990/01/01 00:01,['1990/01/01 00:00'],"['1990/01/01 00:00 [pubmed]', '1990/01/01 00:01 [medline]', '1990/01/01 00:00 [entrez]']","['0168-8227(90)90174-R [pii]', '10.1016/0168-8227(90)90174-r [doi]']",ppublish,Diabetes Res Clin Pract. 1990;10 Suppl 1:S265-9. doi: 10.1016/0168-8227(90)90174-r.,,,,,,,,,,,,,,,,,,,,
16122600,NLM,MEDLINE,20051004,20051116,0278-2391 (Print) 0278-2391 (Linking),63,9,2005 Sep,Anesthetic considerations for the obese and morbidly obese oral and maxillofacial surgery patient.,1348-53,,The purpose of this article is to review the problems of anesthetic management of the obese patient and review current literature on this topic. Obesity is associated with a wide spectrum of medical problems. Anesthetic management requires being familiar with the pathophysiologic changes associated with obesity as well as the specific management issues that can arise. We will review recommendations from the literature on anesthesia management as they apply to the oral and maxillofacial surgeon.,"['Todd, David W']",['Todd DW'],['rdtodd@madbbs.com'],['eng'],"['Journal Article', 'Review']",United States,J Oral Maxillofac Surg,Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons,8206428,"['0 (Anesthetics, Intravenous)']",IM,"['*Anesthesia, Dental', 'Anesthetics, Intravenous/administration & dosage', 'Humans', 'Obesity/complications/*physiopathology', 'Obesity, Morbid/complications/*physiopathology', '*Oral Surgical Procedures', 'Patient Care Planning']",,,,,2005/08/27 09:00,2005/10/05 09:00,['2005/08/27 09:00'],"['2005/08/27 09:00 [pubmed]', '2005/10/05 09:00 [medline]', '2005/08/27 09:00 [entrez]']","['S0278-2391(05)00889-X [pii]', '10.1016/j.joms.2005.05.307 [doi]']",ppublish,J Oral Maxillofac Surg. 2005 Sep;63(9):1348-53. doi: 10.1016/j.joms.2005.05.307.,,,,,,,49,,,,,,,,,,,,,
18326394,NLM,MEDLINE,20080429,20220318,0748-383X (Print) 0748-383X (Linking),17,2,2007 Spring,The link between fast food and the obesity epidemic.,291-317,,"Over thirty percent of adults are obese and over fifteen percent of children are considered obese. RESEARCH STUDY: Fat, sugar, and cholesterol have addictive qualities similar to the drug nicotine.","['Frazier, Dustin A']",['Frazier DA'],,['eng'],['Journal Article'],United States,Health Matrix Clevel,"Health matrix (Cleveland, Ohio : 1991)",9311154,,,"['Humans', 'Obesity/epidemiology/*etiology', 'Restaurants/*legislation & jurisprudence', 'United States/epidemiology']",,,,,2008/03/11 09:00,2008/04/30 09:00,['2008/03/11 09:00'],"['2008/03/11 09:00 [pubmed]', '2008/04/30 09:00 [medline]', '2008/03/11 09:00 [entrez]']",,ppublish,Health Matrix Clevel. 2007 Spring;17(2):291-317.,,,,,,,,,,,,,,,,,,,,
1670305,NLM,MEDLINE,19940801,20151119,0012-7183 (Print) 0012-7183 (Linking),106,6,1990,[Who is obese?].,457-63,,,"['Heliovaara, M']",['Heliovaara M'],"['Kansanelakelaitos, Helsinki, Finland.']",['fin'],"['Journal Article', 'Review']",Finland,Duodecim,Duodecim; laaketieteellinen aikakauskirja,0373207,['0 (Krypton Radioisotopes)'],IM,"['Adipose Tissue/metabolism/pathology', 'Body Constitution', 'Body Mass Index', 'Female', 'Humans', 'Hyperplasia', 'Hypertrophy', 'Krypton Radioisotopes', 'Male', 'Obesity/*diagnosis/metabolism/pathology', 'Somatotypes']",,,,,1990/01/01 00:00,1990/01/01 00:01,['1990/01/01 00:00'],"['1990/01/01 00:00 [pubmed]', '1990/01/01 00:01 [medline]', '1990/01/01 00:00 [entrez]']",,ppublish,Duodecim. 1990;106(6):457-63.,,,,,,,43,,Kuka on lihava?,,,,,,,,,,,
7569289,NLM,MEDLINE,19951121,20061115,0034-1193 (Print) 0034-1193 (Linking),86,7-8,1995 Jul-Aug,[What is the real prevalence of hypertension in obesity?].,306-11,,"Many confounding variables (age, sex, race, income level) may contribute to an incorrect estimate of the prevalence of hypertension in the obese population. Furthermore, as far as methodology is concerned, both casual morning BP measurement and, the use, in the obese patient, of inappropriate cuffs both also contribute significantly to the overestimation with the inclusion of false positives even in relevant percentages. Different types of obesity (android or gynoid; visceral or subcutaneous) should be considered when enrolling obese patients in prevalence studies being android or visceral obesity at a higher hypertensive risk. At last and overall, universally recognized cutoff-points for obesity and hypertension should always be used when studying prevalence of hypertension among general population and/or among obese patients. When such conditions are not taken into account, inaccurate and misleading conclusions on the real prevalence of hypertension in obesity may result.","['Guagnano, M T', 'Murri, R', 'Marchione, L', 'Merlitti, D', 'Palitti, V P', 'Sensi, S']","['Guagnano MT', 'Murri R', 'Marchione L', 'Merlitti D', 'Palitti VP', 'Sensi S']",,['ita'],"['Comparative Study', 'Editorial', 'English Abstract']",Italy,Recenti Prog Med,Recenti progressi in medicina,0401271,,IM,"['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Aged, 80 and over', 'Blood Pressure Monitors', 'Body Mass Index', 'Circadian Rhythm', 'Cross-Sectional Studies', 'Female', 'Humans', 'Hypertension/diagnosis/*epidemiology', 'Male', 'Middle Aged', 'Obesity/classification/*complications/epidemiology', 'Sex Factors']",,,,,1995/07/01 00:00,1995/07/01 00:01,['1995/07/01 00:00'],"['1995/07/01 00:00 [pubmed]', '1995/07/01 00:01 [medline]', '1995/07/01 00:00 [entrez]']",,ppublish,Recenti Prog Med. 1995 Jul-Aug;86(7-8):306-11.,,,,,,,,,Qual e la reale prevalenza dell'ipertensione nell'obesita?,,,,,,,,,,,
21211165,NLM,MEDLINE,20110502,20220408,1941-4927 (Electronic) 1941-4935 (Linking),,50,2010 Dec,"Obesity and socioeconomic status in adults: United States, 2005-2008.",1-8,,"Data from the National Health and Nutrition Examination Survey, 2005-2008. Among men, obesity prevalence is generally similar at all income levels, however, among non-Hispanic black and Mexican-American men those with higher income are more likely to be obese than those with low income. Higher income women are less likely to be obese than low income women, but most obese women are not low income. There is no significant trend between obesity and education among men. Among women, however, there is a trend, those with college degrees are less likely to be obese compared with less educated women. Between 1988-1994 and 2007-2008 the prevalence of obesity increased in adults at all income and education levels.","['Ogden, Cynthia L', 'Lamb, Molly M', 'Carroll, Margaret D', 'Flegal, Katherine M']","['Ogden CL', 'Lamb MM', 'Carroll MD', 'Flegal KM']","['Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, Maryland 20782, USA.']",['eng'],['Journal Article'],United States,NCHS Data Brief,NCHS data brief,101495625,,IM,"['Adult', 'Body Mass Index', 'Female', 'Humans', 'Male', 'Middle Aged', 'Nutrition Surveys', 'Obesity/economics/*epidemiology/ethnology', 'Prevalence', 'Sex Factors', '*Social Class', 'United States/epidemiology', 'Young Adult']",,,,,2011/01/08 06:00,2011/05/03 06:00,['2011/01/08 06:00'],"['2011/01/08 06:00 [entrez]', '2011/01/08 06:00 [pubmed]', '2011/05/03 06:00 [medline]']",,ppublish,NCHS Data Brief. 2010 Dec;(50):1-8.,,,,"['All material appearing in this report is in the public domain and may be', 'reproduced or copied without permission; citation as to source, however, is', 'appreciated.']",,,,,,,,,,,,,,,,
21547645,NLM,MEDLINE,20110928,20181201,1437-1588 (Electronic) 1436-9990 (Linking),54,5,2011 May,"[Obesity in children and adolescents. Risks, causes, and therapy from a psychological perspective].",548-54,10.1007/s00103-011-1263-8 [doi],"The proportion of overweight and obese children and adolescents in Germany and Europe has increased dramatically since the 1990s. About a third of obese preschool children and half of obese school children will become obese adults; the economic, medical, and psychosocial consequences are substantial. This article presents an overview of psychological risk factors and causes of obesity in children and adolescents, including comorbidity with psychological disorders, stigmatization, and relationships with peers, family, and other environment factors, as well as interactions between genes and behavior. Understanding risk factors and causes for obesity is the basis for adequate psychological interventions. We provide an overview of psychological aspects of obesity, such as motivation and impulsivity, and present components of cognitive behavioral therapy and modalities of intervention. A better understanding of psychological factors is necessary to achieve more effective interventions and long-term success of behavior change. This also holds true for changes in the social, media, and physical environment structures with the goal of promoting healthy eating and physical activity.","['Mata, J', 'Munsch, S']","['Mata J', 'Munsch S']","['Abteilung Klinische Psychologie und Epidemiologie, Universitat Basel, Schweiz. jutta.mata@unibas.ch']",['ger'],['Journal Article'],Germany,Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz,"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz",101181368,,IM,"['Adolescent', 'Causality', 'Child', 'Cognitive Behavioral Therapy/*statistics & numerical data/*trends', 'Germany/epidemiology', 'Humans', 'Obesity/epidemiology/*psychology/*therapy', 'Prevalence', 'Risk Assessment', 'Risk Factors']",,,,,2011/05/07 06:00,2011/09/29 06:00,['2011/05/07 06:00'],"['2011/05/07 06:00 [entrez]', '2011/05/07 06:00 [pubmed]', '2011/09/29 06:00 [medline]']",['10.1007/s00103-011-1263-8 [doi]'],ppublish,Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 May;54(5):548-54. doi: 10.1007/s00103-011-1263-8.,,,,,,,,,"Adipositas von Kindern und Jugendlichen. Risiken, Ursachen und Therapie aus psychologischer Sicht.",,,,,,,,,,,
17196425,NLM,MEDLINE,20070322,20220317,1297-9589 (Print) 1297-9589 (Linking),35,1,2007 Jan,[Pregnancy in obese patients: which risks is it necessary to fear?].,19-24,,"OBJECTIVE: To evaluate the deleterious effects of maternal obesity on obstetrical complications and neonatal outcomes. PATIENTS AND METHODS: Historical cohort study including all patients delivered in our maternity between 1st January 2002 and 31st December 2004. Intra uterine death and fetal loss before 22 weeks were excluded. Women were categorized by the Body Mass Index: less than 25, between 25 and 30, and more than 30. Maternal data, obstetrical complications, labor and its complications, and neonatal outcomes were studied. RESULTS: During these 3 years, 23.5% (1336/5686) of patients were overweight and 7.5% (425/5686) were obese. Obstetrical pathologies (gestational diabetes mellitus, hypertension, preeclampsia and fetal macrosomia) and labour induction were more significantly frequent in obese patients (P < 0.01). We noted twice more caesarean sections during labour in obese patients. The rate of artificial placental delivery was significantly higher in obese patients (P < 0.01). Obese patients with prior caesarean sections had a rate of vaginal delivery significantly lower than non obese patients with prior C-sections (23.6 vs 43.8%; P < 0.01). Mean children birth weight was significantly higher in obese patients (3305 vs 3181 g; P < 0.01) with no impact on Apgar score. DISCUSSION AND CONCLUSION: Our study confirms that obesity is responsible for major obstetrical complications, for what should no doubt be considered as high risk pregnancies. Our practices must take these complications into account by ensuring an adapted and early management in order to improve maternal and neonatal issues.","['Ducarme, G', 'Rodrigues, A', 'Aissaoui, F', 'Davitian, C', 'Pharisien, I', 'Uzan, M']","['Ducarme G', 'Rodrigues A', 'Aissaoui F', 'Davitian C', 'Pharisien I', 'Uzan M']","['Service de gynecologie-obstetrique, APHP, CHU Jean-Verdier, avenue du 14-Juillet, 93143 Bondy cedex, France. gducarme@gmail.com']",['fre'],"['English Abstract', 'Journal Article']",France,Gynecol Obstet Fertil,"Gynecologie, obstetrique & fertilite",100936305,,IM,"['Adult', 'Body Mass Index', 'Cesarean Section', 'Cohort Studies', 'Female', 'Humans', 'Infant, Newborn', 'Obesity/*complications', 'Obstetric Labor Complications/*epidemiology/etiology', 'Pregnancy', 'Pregnancy Complications/*epidemiology/etiology', 'Pregnancy Outcome', 'Risk Factors']",,,,,2007/01/02 09:00,2007/03/23 09:00,['2007/01/02 09:00'],"['2006/06/13 00:00 [received]', '2006/10/30 00:00 [accepted]', '2007/01/02 09:00 [pubmed]', '2007/03/23 09:00 [medline]', '2007/01/02 09:00 [entrez]']","['S1297-9589(06)00456-5 [pii]', '10.1016/j.gyobfe.2006.10.029 [doi]']",ppublish,Gynecol Obstet Fertil. 2007 Jan;35(1):19-24. doi: 10.1016/j.gyobfe.2006.10.029. Epub 2006 Dec 28.,,20061228,,,,,,,Grossesse des patientes obeses: quels risques faut-il craindre?,,,,,,,,,,,
28607830,NLM,MEDLINE,20180501,20181113,2165-8242 (Electronic) 2165-8218 (Print) 2165-8242 (Linking),76,6,2017 Jun,University of Hawai'i John A. Burns School of Medicine Medical Students' Attitudes Towards Obese Patients.,143-146,,"Studies have shown that healthcare professionals often demonstrate obesity biases, which in turn reduce the quality of care obese patients receive. The purpose of the current study was to describe third and fourth year University of Hawai'i, John A. Burns School of Medicine medical students' attitudes towards obese patients. Data were collected using previously validated questions from a pilot study assessing how healthcare providers react and recommend medical care to patients with varying characteristics. The responses of 114 medical students were analyzed. Overall, the majority of students' responses reflected the belief that obesity may be a behavioral issue. There were no statistically significant differences between the third and fourth year students' responses. Important areas of future research include assessing students' awareness of the social determinants of health and ability to self-identify possible biases in caring for obese patients.","['Chin, Kristen M', 'Tschann, Mary', 'Salcedo, Jennifer', 'Soon, Reni', 'Kajiwara, Kasey', 'Kaneshiro, Bliss']","['Chin KM', 'Tschann M', 'Salcedo J', 'Soon R', 'Kajiwara K', 'Kaneshiro B']","[""Department of Obstetrics, Gynecology and Women's Health, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI."", ""Department of Obstetrics, Gynecology and Women's Health, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI."", ""Department of Obstetrics, Gynecology and Women's Health, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI."", ""Department of Obstetrics, Gynecology and Women's Health, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI."", ""Department of Obstetrics, Gynecology and Women's Health, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI."", ""Department of Obstetrics, Gynecology and Women's Health, John A. Burns School of Medicine, University of Hawai'i, Honolulu, HI.""]",['eng'],['Journal Article'],United States,Hawaii J Med Public Health,Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health,101579076,,IM,"['Adult', '*Attitude of Health Personnel', 'Education, Medical, Graduate', 'Female', 'Humans', 'Male', 'Obesity/complications/*psychology', 'Students, Medical/*psychology', 'Surveys and Questionnaires']",PMC5458578,['NOTNLM'],"['attitude', 'bias', 'medical students', 'obese patients', 'obesity']",['No conflicts of interest were identified for this study.'],2017/06/14 06:00,2018/05/02 06:00,['2017/06/14 06:00'],"['2017/06/14 06:00 [entrez]', '2017/06/14 06:00 [pubmed]', '2018/05/02 06:00 [medline]']",['2165-8218-76-6-1 [pii]'],ppublish,Hawaii J Med Public Health. 2017 Jun;76(6):143-146.,['U54 MD007584/MD/NIMHD NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
33244655,NLM,MEDLINE,20210419,20210701,1708-0428 (Electronic) 0960-8923 (Print) 0960-8923 (Linking),31,3,2021 Mar,Effect of Intraoperative Goal-Directed Fluid Management on Tissue Oxygen Tension in Obese Patients: a Randomized Controlled Trial.,1129-1138,10.1007/s11695-020-05106-x [doi],"BACKGROUND: Perioperative subcutaneous tissue oxygen tension (PsqO(2)) is substantially reduced in obese surgical patients. Goal-directed fluid therapy optimizes cardiac performance and thus tissue perfusion and oxygen delivery. We therefore tested the hypothesis that intra- and postoperative PsqO(2) is significantly reduced in obese patients undergoing standard fluid management compared to goal-directed fluid administration. METHODS: We randomly assigned 60 obese patients (BMI >/= 30 kg/m(2)) undergoing laparoscopic bariatric surgery to receive either esophageal Doppler-guided goal-directed fluid management or conventional fluid treatment. Our primary outcome parameter was intra- and postoperative PsqO(2) measured with a polarographic electrode in the subcutaneous tissue of the upper arm. A random effects linear regression model was used to analyze the effect of intervention. RESULTS: Overall, mean (+/- SD) PsqO(2) was significantly higher in obese patients receiving goal-directed therapy compared to conventional fluid therapy (65.8 +/- 28.0 mmHg vs. 53.7 +/- 21.7, respectively; repeated measures design adjusted difference: 13.0 mmHg [95% CI 2.3 to 23.7; p = 0.017]). No effect was seen intraoperatively (69.6 +/- 27.9 mmHg vs. 61.4 +/- 28.8, difference: 9.7 mmHg [95% CI -3.8 to 23.2; p = 0.160]); however, goal-directed fluid management improved PsqO(2) in the early postoperative phase (63.1 +/- 27.9 mmHg vs. 48.4 +/- 12.5, difference: 14.5 mmHg [95% CI 4.1 to 24.9; p = 0.006]). Intraoperative fluid requirements did not differ between the two groups. CONCLUSIONS: Goal-directed fluid therapy improved subcutaneous tissue oxygenation in obese patients. This effect was more pronounced in the early postoperative period. CLINICAL TRIAL NUMBER AND REGISTRY: The study was registered at ClinicalTrials.gov (NCT01052519).","['Muhlbacher, Jakob', 'Luf, Florian', 'Zotti, Oliver', 'Herkner, Harald', 'Fleischmann, Edith', 'Kabon, Barbara']","['Muhlbacher J', 'Luf F', 'Zotti O', 'Herkner H', 'Fleischmann E', 'Kabon B']","['Department of Surgery, Division of General Surgery, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.', 'Department of Anaesthesiology and Intensive Care, Hanusch Hospital, Heinrich-Collin-Strasse 30, 1140, Vienna, Austria.', 'Department of Emergency Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.', 'Department of Emergency Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.', 'Department of Emergency Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. edith.fleischmann@meduniwien.ac.at.', 'Department of Anaesthesia, General Intensive Care and Pain Medicine, Medical University Vienna, Spitalgasse 23, A-1090, Vienna, Austria. edith.fleischmann@meduniwien.ac.at.', 'Department of Emergency Medicine, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.']",['eng'],"['Journal Article', 'Randomized Controlled Trial', ""Research Support, Non-U.S. Gov't""]",United States,Obes Surg,Obesity surgery,9106714,['S88TT14065 (Oxygen)'],IM,"['Fluid Therapy', '*Goals', 'Humans', 'Obesity/complications/surgery', '*Obesity, Morbid/surgery', 'Oxygen']",PMC7921017,['NOTNLM'],"['Goal-directed fluid therapy', 'Laparoscopic surgery', 'Obesity', 'Tissue oxygen tension']",['The authors declare that they have no conflict of interest.'],2020/11/28 06:00,2021/04/20 06:00,['2020/11/27 05:47'],"['2020/08/17 00:00 [received]', '2020/11/09 00:00 [accepted]', '2020/11/05 00:00 [revised]', '2020/11/28 06:00 [pubmed]', '2021/04/20 06:00 [medline]', '2020/11/27 05:47 [entrez]']","['10.1007/s11695-020-05106-x [pii]', '5106 [pii]', '10.1007/s11695-020-05106-x [doi]']",ppublish,Obes Surg. 2021 Mar;31(3):1129-1138. doi: 10.1007/s11695-020-05106-x. Epub 2020 Nov 27.,,20201127,,,['ORCID: 0000-0001-7738-870X'],,,,,,,['ClinicalTrials.gov/NCT01052519'],,,,,,,,
7432093,NLM,MEDLINE,19810126,20041117,0024-3507 (Print) 0024-3507 (Linking),25,7,1980 Aug-Sep,[How to understand the obese patient who is candidate for eventual lipectomy].,379-83,,,"['Parquet, P J', 'Debaere, A', 'van den Bussche, F']","['Parquet PJ', 'Debaere A', 'van den Bussche F']",,['fre'],"['Case Reports', 'Journal Article']",France,Lille Med,Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,8203780,,IM,"['Adipose Tissue/*surgery', 'Adult', 'Family', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/psychology/*surgery']",,,,,1980/08/01 00:00,1980/08/01 00:01,['1980/08/01 00:00'],"['1980/08/01 00:00 [pubmed]', '1980/08/01 00:01 [medline]', '1980/08/01 00:00 [entrez]']",,ppublish,Lille Med. 1980 Aug-Sep;25(7):379-83.,,,,,,,,,Comment comprendre l'obese candidat eventuel a la lipectomie.,,,,,,,,,,,
21144326,NLM,MEDLINE,20110331,20101214,1646-0758 (Electronic) 0870-399X (Linking),23,5,2010 Sep-Oct,[Obesity and the kidney].,853-8,,"Obesity represents an important risk factor for the development of chronic kidney disease (CKD), due to its known strong association with diabetes mellitus and hypertension, the two major causes of CKD, but also as an independent renal risk factor. This direct relationship between obesity and kidney injury has been undervalued. The aim of this revision is to point out the mechanisms of kidney injury induced by obesity, underline the importance of this association and alert for the prevention, education and treatment of the obese patient, as a way to control this heavy modifiable risk factor.","['Guedes, Anabela Malho', 'Cabrita, Ana', 'Pinho, Ana Teixeira', 'Silva, Ana Paula', 'Lopes, Ana', 'Santos, Viriato', 'Neves, Pedro Leao']","['Guedes AM', 'Cabrita A', 'Pinho AT', 'Silva AP', 'Lopes A', 'Santos V', 'Neves PL']","['Servico de Nefrologia, Hospital de Faro, Faro.']",['por'],"['English Abstract', 'Journal Article', 'Review']",Portugal,Acta Med Port,Acta medica portuguesa,7906803,,IM,"['Chronic Disease', 'Humans', 'Kidney Diseases/*etiology', 'Obesity/*complications/immunology/metabolism/physiopathology', 'Risk Factors']",,,,,2010/12/15 06:00,2011/04/01 06:00,['2010/12/15 06:00'],"['2009/03/14 00:00 [received]', '2009/06/04 00:00 [accepted]', '2010/12/15 06:00 [entrez]', '2010/12/15 06:00 [pubmed]', '2011/04/01 06:00 [medline]']",,ppublish,Acta Med Port. 2010 Sep-Oct;23(5):853-8. Epub 2010 Oct 22.,,20101022,,,,,,,O risco renal da obesidade.,,,,,,,,,,,
3959858,NLM,MEDLINE,19860429,20081121,0195-9131 (Print) 0195-9131 (Linking),18,1,1986 Feb,Exercise as a partial therapy for the extremely obese.,19-24,,"The management of the extremely obese patient is best accomplished by a multidisciplinary approach which includes exercise training as an integral component. While diet alone is a potent factor in improving the metabolic complications associated with obesity, the combination of diet and exercise training can further improve these complications and greatly enhance cardiorespiratory function. Although the fitness of extremely obese people is low, individualized exercise programs can be used to safely and progressively train these patients, reduce fatigue, and greatly increase maximum work tolerance. Additional benefits derived from exercise training include improved insulin-mediated glucose utilization, lower serum lipid concentrations, and improved psychological distress scores and anxiety levels. Thus, exercise training can contribute to the success of a weight reducing program by improving metabolic, cardiorespiratory, and psychological factors. Additional important interventions in a multidisciplinary treatment of severe obesity include psychiatric, psychosocial, and vocational counseling.","['Lampman, R M', 'Schteingart, D E', 'Foss, M L']","['Lampman RM', 'Schteingart DE', 'Foss ML']",,['eng'],"['Journal Article', ""Research Support, U.S. Gov't, P.H.S.""]",United States,Med Sci Sports Exerc,Medicine and science in sports and exercise,8005433,,IM,"['Behavior Therapy', 'Body Weight', '*Diet, Reducing', 'Heart Function Tests', 'Heart Rate', 'Humans', 'Obesity/psychology/rehabilitation/*therapy', 'Physical Endurance', '*Physical Exertion', 'Physical Fitness']",,,,,1986/02/01 00:00,1986/02/01 00:01,['1986/02/01 00:00'],"['1986/02/01 00:00 [pubmed]', '1986/02/01 00:01 [medline]', '1986/02/01 00:00 [entrez]']",,ppublish,Med Sci Sports Exerc. 1986 Feb;18(1):19-24.,['MO1RR00042/RR/NCRR NIH HHS/United States'],,,,,,,,,,,,,,,,,,,
22569623,NLM,MEDLINE,20130116,20181201,1806-9282 (Electronic) 0104-4230 (Linking),58,2,2012 Mar-Apr,Beliefs and practices of healthcare providers regarding obesity: a systematic review.,254-62,S0104-42302012000200024 [pii],"Despite the implementation of various intervention measures, the number of obese individuals remain high; thus, it is important to consider what is contributing to this scenario. Authors have been striving to understand the role healthcare providers, especially in primary healthcare, seem to play in this context. The present review aims to synthesize the main investigation results regarding beliefs, attitudes, and practices of healthcare providers, as they seem to negatively influence the practitioner's actions. The words ""obesity"", ""beliefs"", ""healthcare professionals"", ""general practitioners"", ""attitudes"", ""practices"", ""health physicians"", and ""family practitioners"" were entered into databases, such as EBSCOHost, ScienceDirect, Psychlnfo, PubMed, and SciELO. Thirteen studies from 1991 to 2011 were reviewed. The data indicate a lack of appropriate understanding and adequate competence regarding obesity, which likely contributes to ambivalent belief development and negative attitudes toward obese individuals, who are described as unmotivated, lazy, and lacking self-control. These professionals consider it hard to deal with obesity, manifesting low expectations of success regarding weight loss, thus considering themselves unsuccessful. Their practices are inconsistent, mirroring a certain skepticism towards the efficacy of available interventions. Either during graduation or as active practitioners, it is imperative to make healthcare providers aware of the impact their beliefs regarding obesity can exert on their practices, as these may impair appropriate and effective treatment delivery to obese individuals.","['Teixeira, Filipa Valente', 'Pais-Ribeiro, Jose Luis', 'Maia, Angela Rosa Pinho da Costa']","['Teixeira FV', 'Pais-Ribeiro JL', 'Maia AR']","['Psychology and Education Science School, Universidade do Porto, Portugal. filipa.v.teixeira@gmail.com']","['eng', 'por']","['Journal Article', 'Review', 'Systematic Review']",Brazil,Rev Assoc Med Bras (1992),Revista da Associacao Medica Brasileira (1992),9308586,,IM,"['Attitude of Health Personnel', '*Health Knowledge, Attitudes, Practice', 'Humans', 'Obesity/*psychology/therapy', 'Physician-Patient Relations', 'Weight Loss']",,,,,2012/05/10 06:00,2013/01/17 06:00,['2012/05/10 06:00'],"['2011/07/20 00:00 [received]', '2012/05/10 06:00 [entrez]', '2012/05/10 06:00 [pubmed]', '2013/01/17 06:00 [medline]']",['S0104-42302012000200024 [pii]'],ppublish,Rev Assoc Med Bras (1992). 2012 Mar-Apr;58(2):254-62.,,,,,,,,,,,,,,,,,,,,
1820447,NLM,MEDLINE,19920803,20190828,0301-4800 (Print) 0301-4800 (Linking),37 Suppl,,1991 Dec,Obesity as a determinant of regional bone mineral density.,S65-70,,"Total body and regional bone mineral density (BMD) and bone mineral content (BMC) in obese patients and healthy controls were assessed by dual-photon absorptiometry (DPA) in this study. In both men and women, BMD values in total body, pelvis, upper and lower extremities were significantly (p less than 0.05) higher in the obese group (body mass index greater than 28) than in the non-obese group (body mass index less than 23). These BMD values correlated significantly with body weights and with percentages of body fat. In the obese group, 8 massively obese women were treated with an 8-week very low calorie diet (VLCD), resulting in a 13.4 kg of mean body weight reduction. Although BMC in total body and in pelvis were maintained, significant decreases of BMC in the upper (from 275 +/- 30 to 255 +/- 26 g) and lower (from 871 +/- 47 to 805 +/- 31 g) extremities were observed following the 8-week VLCD treatment. These results suggest that body fat mass affects BMD and BMC preferentially in weight bearing bone, the changes of which are not always associated with changes in total body BMD or BMC.","['Nishizawa, Y', 'Koyama, H', 'Shoji, T', 'Aratani, H', 'Hagiwara, S', 'Miki, T', 'Morii, H']","['Nishizawa Y', 'Koyama H', 'Shoji T', 'Aratani H', 'Hagiwara S', 'Miki T', 'Morii H']","['Second Department of Internal Medicine, Osaka City University Medical School, Japan.']",['eng'],"['Comparative Study', 'Journal Article']",Japan,J Nutr Sci Vitaminol (Tokyo),Journal of nutritional science and vitaminology,0402640,,IM,"['Adult', '*Bone Density', 'Energy Intake', 'Female', 'Humans', 'Male', 'Obesity/diet therapy/*metabolism']",,,,,1991/12/01 00:00,1991/12/01 00:01,['1991/12/01 00:00'],"['1991/12/01 00:00 [pubmed]', '1991/12/01 00:01 [medline]', '1991/12/01 00:00 [entrez]']",['10.3177/jnsv.37.supplement_s65 [doi]'],ppublish,J Nutr Sci Vitaminol (Tokyo). 1991 Dec;37 Suppl:S65-70. doi: 10.3177/jnsv.37.supplement_s65.,,,,,,,,,,,,,,,,,,,,
20120156,NLM,MEDLINE,20100323,20100202,0001-4079 (Print) 0001-4079 (Linking),193,6,2009 Jun,[Childhood obesity: a new vision].,1243-54; discussion 1254-7,,"There is considerable evidence that, in an obesogenic environment, constitutional susceptibility to fat gain is necessary for a given child to become obese. Only children highly sensitive to abundant palatable food and with conditions favouring little physical activity are at risk of obesity. A high-risk environment has no effect on non predisposed children. An obesogenic environment is therefore a trigger but not the primary cause of obesity: it simply enables phenotypic expression of a genetic predisposition. As most children are not constitutionally predisposed to obesity, prevention strategies should focus on children at risk. This is supported by the disappointing results of most collective interventions, particularly at school. In addition, broad-reaching preventive campaigns may increase discrimination towards obese children and induce eating behaviour disorders in non predisposed children. Children at risk of becoming obese are those who have adiposity rebound before 6 years of age. These at-risk children must be detected early and offered personalized interventions aimed at preventing further fat gain. In the future, the improvement of obesity pathophysiology knowledge will probably allow the development of more promising preventive approaches.","['Tounian, Patrick']",['Tounian P'],"['Gastro-enterologie et nutrition pediatriques, Hopital Armand Trousseau, 26, avenue du Docteur Arnold Netter, 75012 Paris. p.tounian@trs.aphp.fr']",['fre'],"['English Abstract', 'Journal Article']",Netherlands,Bull Acad Natl Med,Bulletin de l'Academie nationale de medecine,7503383,,IM,"['Child', 'Genetic Predisposition to Disease', 'Humans', 'Obesity/genetics/*prevention & control', 'Social Environment']",,,,,2010/02/03 06:00,2010/03/24 06:00,['2010/02/03 06:00'],"['2010/02/03 06:00 [entrez]', '2010/02/03 06:00 [pubmed]', '2010/03/24 06:00 [medline]']",,ppublish,Bull Acad Natl Med. 2009 Jun;193(6):1243-54; discussion 1254-7.,,,,,,,,,Obesite de l'enfant: une nouvelle vision.,,,,,,,,,,,
6639792,NLM,MEDLINE,19840107,20140530,0231-441X (Print) 0231-441X (Linking),24,2,1983,Prevention of adult cardiovascular disease in obese children.,195-9,,An investigation was carried out to establish the risk factors of cardiovascular disease among obese children. Among 173 obese children 38% were endangered in respect of cardiovascular disease. The frequency of hyperlipoproteinaemia was near to 20%. It is considered necessary to separate these children from the group of obese children and to treat them according to the outlined aspects.,"['Czinner, A', 'Tichy, M', 'Barta, L']","['Czinner A', 'Tichy M', 'Barta L']",,['eng'],['Journal Article'],Hungary,Acta Paediatr Hung,Acta paediatrica Hungarica,8307729,,IM,"['Adolescent', 'Cardiovascular Diseases/etiology/*prevention & control', 'Child', 'Female', 'Humans', 'Male', 'Obesity/classification/*complications', 'Risk']",,,,,1983/01/01 00:00,1983/01/01 00:01,['1983/01/01 00:00'],"['1983/01/01 00:00 [pubmed]', '1983/01/01 00:01 [medline]', '1983/01/01 00:00 [entrez]']",,ppublish,Acta Paediatr Hung. 1983;24(2):195-9.,,,,,,,,,,,,,,,,,,,,
22328443,NLM,MEDLINE,20140513,20211021,1532-7558 (Electronic) 1070-5503 (Linking),20,1,2013 Mar,Testing the effectiveness of motivational interviewing as a weight reduction strategy for obese cardiac patients: a pilot study.,77-81,10.1007/s12529-011-9219-9 [doi],"BACKGROUND: Obesity has reached epidemic proportions in the USA and is a particular threat to those with coronary disease. Motivational interviewing (MI) is a client-centered, directive method for enhancing intrinsic motivation to change by exploring and resolving ambivalence about altering behavior. PURPOSE: This study examined the efficacy of MI compared to nutritional counseling for weight loss in a small sample of obese cardiac patients. METHOD: Participants were assigned to either MI or to nutrition counseling and followed up over 3 months. Trained undergraduate students delivered the MI intervention. RESULTS: There were significant reductions in weight in women in the MI intervention, but not in men. CONCLUSION: The results suggest that MI may be effective for obese female cardiac patients, in particular, even when delivered by nonprofessional interviewers. Limitations of the study include a small sample size, nonrandomized assignment to conditions, and attrition over time.","['Low, Kathryn Graff', 'Giasson, Hannah', 'Connors, Stephanie', 'Freeman, Deborah', 'Weiss, Robert']","['Low KG', 'Giasson H', 'Connors S', 'Freeman D', 'Weiss R']","['Department of Psychology, Bates College, Lewiston, ME 04240, USA., klow@bates.edu']",['eng'],['Journal Article'],England,Int J Behav Med,International journal of behavioral medicine,9421097,,IM,"['Adult', 'Aged', 'Cardiovascular Diseases/*complications', 'Counseling', 'Female', 'Humans', 'Male', 'Middle Aged', '*Motivational Interviewing', 'Obesity/complications/psychology/*therapy', 'Pilot Projects', 'Sex Factors', 'Treatment Outcome', '*Weight Loss']",,,,,2012/02/14 06:00,2014/05/14 06:00,['2012/02/14 06:00'],"['2012/02/14 06:00 [entrez]', '2012/02/14 06:00 [pubmed]', '2014/05/14 06:00 [medline]']",['10.1007/s12529-011-9219-9 [doi]'],ppublish,Int J Behav Med. 2013 Mar;20(1):77-81. doi: 10.1007/s12529-011-9219-9.,,,,,,,,,,,,,,,,,,,,
10486673,NLM,MEDLINE,19991022,20090213,0003-9683 (Print) 0003-9683 (Linking),92,8,1999 Aug,[Insulin resistance and alteration of cardiac vagal activity in obese patients].,1101-3,,"We have previously shown that alterations of vagal control of heart rate variations are found in more than half of non diabetic obese subjects (Int J Obes 1995) and are associated with a more severe insulin resistance in noninsulin dependent diabetic patients (Metabolism 1998). The aim of this study was to examine whether parasympathetic alterations are also associated with a more severe insulin resistance in non diabetic obese subjects. 245 obese subjects (BMI = 34.2 +/- 0.4 kg/m2) aged 38.6 +/- 0.8 years, with a normal oral glucose tolerance test were included. Parasympathetic activity was evaluated by heart rate variations during three standardised tests: Valsalva, deep-breathing and active lying-to-standing, with age being taken into account. The Valsalva maneuver was abnormal in 17.5%, the deep-breathing test in 18% and the lying-to-standing test in 30.3% of the cases. One hundred and thirty subjects (52.1%) had at least one abnormal test. Compared with those with three normal tests, the obese subjects with parasympathetic alterations had very similar BMI and blood pressure, but significantly higher values of heart rate (75.5 +/- 1.4 vs 71.3 +/- 1.1 beats/min, p = 0.02), fasting blood glucose (5.0 +/- 0.1 vs 4.8 +/- 0.1 mmol/L, p = 0.03) and plasma insulin (98 +/- 6 vs 82 +/- 4 pmol/L, p = 0.03). In the whole series of obese subjects, heart rate variations during the deep-breathing and lying-to-standing tests correlated negatively with blood glucose (p = 0.001 and p = 0.03 respectively), and during the deep-breathing test they correlated negatively with the waist/hip ratio (p = 0.004). This data suggests that cardiac parasympathetic alterations should take part in the insulin-resistance syndrome and might account for the poor cardiovascular prognosis linked to this syndrome.","['Valensi, P', 'Paries, J', 'Assad, N', 'Lormeau, B', 'Attali, J R']","['Valensi P', 'Paries J', 'Assad N', 'Lormeau B', 'Attali JR']","[""Service d'endocrinologie-diabetologie-nutrition, hopital Jean-Verdier, universite Paris-Nord, Bondy.""]",['fre'],"['Clinical Trial', 'English Abstract', 'Journal Article']",France,Arch Mal Coeur Vaiss,Archives des maladies du coeur et des vaisseaux,0406011,,IM,"['Adult', 'Heart Rate/*physiology', 'Humans', '*Insulin Resistance', 'Obesity/*physiopathology', 'Vagus Nerve/*physiology']",,,,,1999/09/16 00:00,1999/09/16 00:01,['1999/09/16 00:00'],"['1999/09/16 00:00 [pubmed]', '1999/09/16 00:01 [medline]', '1999/09/16 00:00 [entrez]']",,ppublish,Arch Mal Coeur Vaiss. 1999 Aug;92(8):1101-3.,,,,,,,,,Insulinoresistance et alteration de l'activite vagale cardiaque chez les obeses.,,,,,,,,,,,
21572387,NLM,MEDLINE,20110929,20110516,1531-698X (Electronic) 1040-8703 (Linking),23,3,2011 Jun,Contemporary surgical management of the obese adolescent.,351-5,10.1097/MOP.0b013e3283465923 [doi],"PURPOSE OF REVIEW: Adolescent obesity is rapidly becoming a significant public health issue. To date, there are no medical therapies that provide significant and durable weight loss. The surgical treatment of adolescent obesity is a rapidly evolving field. RECENT FINDINGS: Recent publications have focused on the increase in the morbidity and mortality of adolescent obesity into adulthood. There have been significant findings that overweight children and adolescents progress towards severe obesity as adults. Firm guidelines for bariatric surgery in adults have been established for over 15 years, but there have been insufficient data in regards to guidelines for adolescents. The trend has always been to be more conservative, but a recent paper reviews the available literature to establish new guidelines. Adolescents can see a significant amount of weight loss in the first year after bariatric surgery with a resolution of diabetes and other cardiovascular risk factors. Bariatric surgery is well tolerated and effective, but carries with it long-term nutritional deficiencies, which need to be assessed and supplemented. SUMMARY: Given the recent rise in obesity seen in this population, the surgical management of the adolescent has increased in popularity. Bariatric surgery is well tolerated and provides significant weight loss in those who are severely obese.","['Barnett, Sean J']",['Barnett SJ'],"[""Surgical Weight Loss Program for Teens, Cincinnati Children's Hospital Medical Center, Ohio 45229, USA. Sean.Barnett@cchmc.org""]",['eng'],"['Journal Article', 'Review']",United States,Curr Opin Pediatr,Current opinion in pediatrics,9000850,,IM,"['Adolescent', '*Bariatric Surgery', 'Comorbidity', 'Humans', 'Nutritional Requirements', 'Obesity/complications/physiopathology/*surgery', 'Patient Selection', 'Treatment Outcome']",,,,,2011/05/17 06:00,2011/10/01 06:00,['2011/05/17 06:00'],"['2011/05/17 06:00 [entrez]', '2011/05/17 06:00 [pubmed]', '2011/10/01 06:00 [medline]']","['00008480-201106000-00017 [pii]', '10.1097/MOP.0b013e3283465923 [doi]']",ppublish,Curr Opin Pediatr. 2011 Jun;23(3):351-5. doi: 10.1097/MOP.0b013e3283465923.,,,,,,,,,,,,,,,,,,,,
11428749,NLM,MEDLINE,20010712,20041117,0231-424X (Print) 0231-424X (Linking),87,3,2000,The effect of moderate weight loss on echocardiographic parameters in obese female patients.,241-51,,"Based on the data collected by KNOLL Hungary Ltd. in Hungary in 1999, 37% of the adult population is overweight while 23% is obese. Inappropriate diet containing excess calories and physical inactivity are responsible for these statistical values. In their former studies, the authors investigated the effects of different stages of obesity on the cardiovascular system, and have verified that even moderate obesity elicits pathological geometric and functional changes in the heart. In the present study, effect of a half-year-long life-style modification program on the morphologic and functional characteristics of the heart was investigated in twenty-one obese women. Life-style modification contained a diet with reduced energy uptake (1000-1300 Cal/day) and a regular physical training of minimum 3-4 hours weekly. By the end of the sixth month the weight loss was 5.1 kg (5.9%) on an average. There was a marked reduction in cardiac dimensions measured by echocardiography, with a very slight, non-significant decrease in left ventricular internal diameter, and a marked, significant reduction in the left ventricular wall thickness. Decrease of the left ventricular muscle mass exceeded the decrease of body weight. A marked elevation was found in the E/A quotient that reflected a definite improvement in diastolic function. Results indicate that physical training programs have a favourable effect on the echocardiographic parameters, therefore the process is reversible even without a pharmacological intervention.","['Sido, Z', 'Jako, P', 'Pavlik, G']","['Sido Z', 'Jako P', 'Pavlik G']","['National Institute for Sports Medicine, Department of Conditioning and Internal Medicine, Budapest, Hungary.']",['eng'],"['Clinical Trial', 'Journal Article']",Hungary,Acta Physiol Hung,Acta physiologica Hungarica,8309201,,IM,"['Adult', 'Echocardiography', '*Electrocardiography', 'Female', 'Humans', 'Middle Aged', 'Obesity/diet therapy/*physiopathology/therapy', 'Ventricular Function, Left', 'Weight Loss/*physiology']",,,,,2001/06/29 10:00,2001/07/13 10:01,['2001/06/29 10:00'],"['2001/06/29 10:00 [pubmed]', '2001/07/13 10:01 [medline]', '2001/06/29 10:00 [entrez]']",['10.1556/APhysiol.87.2000.3.3 [doi]'],ppublish,Acta Physiol Hung. 2000;87(3):241-51. doi: 10.1556/APhysiol.87.2000.3.3.,,,,,,,,,,,,,,,,,,,,
18483474,NLM,MEDLINE,20090305,20090202,1930-7381 (Print) 1930-7381 (Linking),16,9,2008 Sep,Exercise intensity prescription in obese individuals.,2088-95,10.1038/oby.2008.272 [doi],"The main purpose of this study was to evaluate the relationship between different methods proposed by the American College of Sports Medicine (ACSM) to prescribe exercise intensity using heart rate (HR) and oxygen uptake (VO2) in obese individuals. Sixty-eight overweight to severely obese adults were divided into three groups (tertile) based on their BMI. The groups were T1 group (BMI = 30.5 +/- 1.5, n = 23), T2 group (BMI = 34.3 +/- 1.0, n = 23), and T3 group (BMI = 40.2 +/- 3.7, n = 22). All subjects performed a graded exercise test using a ramp protocol on a treadmill. Individual linear regressions between %HR reserve (%HRR) and %VO2 reserve (%VO2R), %HRR and %VO2 peak (%VO2peak), %maximal HR (%HRmax) and %VO2R, and %HRmax and %VO2peak were calculated. When all the subjects were grouped together, the %HRR-%VO2R mean regression was partially related to the line of identity, while the %HRR-%VO2peak, %HRmax-%VO2R, and %HRmax-%VO2peak mean regressions were all significantly different than the line of identity (P < 0.001). The degree of obesity accounted for approximately 15% of the variation for both %HRR-%VO2R and %HRR-%VO2peak mean regressions. The %HRmax-%VO2R and %HRmax-%VO2peak mean regressions were not affected by the degree of obesity but resting HR accounted for 28-37% of the variation. The relationship between the exercise intensity determined by the %HRR-%VO2R and the %HRR-%VO2peak mean regression seems to be influenced by the degree of obesity. The degree of obesity does not affect the relationship between exercise intensity generated by the %HRmax-%VO2R or %HRmax-%VO2peak equations but the resting HR does.","['Pinet, Bernard M', ""Prud'homme, Denis"", 'Gallant, Chantal A', 'Boulay, Pierre']","['Pinet BM', ""Prud'homme D"", 'Gallant CA', 'Boulay P']","['School of Human Kinetics, Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.']",['eng'],['Journal Article'],United States,Obesity (Silver Spring),"Obesity (Silver Spring, Md.)",101264860,,IM,"['Adult', 'Exercise/*physiology', 'Female', 'Heart Rate/physiology', 'Humans', 'Male', 'Middle Aged', 'Obesity/metabolism/physiopathology/*therapy', 'Oxygen Consumption/physiology', 'Young Adult']",,,,,2008/05/17 09:00,2009/03/06 09:00,['2008/05/17 09:00'],"['2008/05/17 09:00 [pubmed]', '2009/03/06 09:00 [medline]', '2008/05/17 09:00 [entrez]']","['oby2008272 [pii]', '10.1038/oby.2008.272 [doi]']",ppublish,Obesity (Silver Spring). 2008 Sep;16(9):2088-95. doi: 10.1038/oby.2008.272.,,,,,,,,,,,,,,,,,,,,
16516655,NLM,MEDLINE,20060725,20151119,0022-3999 (Print) 0022-3999 (Linking),60,3,2006 Mar,A comparison of maladaptive schemata in treatment-seeking obese adults and normal-weight control subjects.,245-52,,"OBJECTIVES: The aims of this study were to determine whether treatment-seeking obese adults display a greater severity of maladaptive schemata than normal-weight adults and to investigate the possible correlates of maladaptive schemata among obese individuals. METHODS: The sample included 52 obese adults participating in a weight loss treatment and 39 normal-weight adults. Participants in the obese and normal-weight control groups completed standardized self-report questionnaires designed to assess attitudes and behaviors regarding eating and weight (Questionnaire on Eating and Weight Patterns-Revised and Binge Eating Scale), maladaptive schemata (Young Schema Questionnaire-Short Version), mood disturbance (Profile of Mood States-Adolescents) and socially desirable responding (Balanced Inventory of Desirable Responding). RESULTS: The obese patients reported a significantly greater severity of maladaptive schemata (after controlling for demographic variables and binge eating disorder status) than the normal-weight control subjects. In addition, within the obese group, there were significant positive correlations between the severity of maladaptive schema scores and both mood disturbance and problem eating scores. CONCLUSION: The present findings suggest that obesity may be associated with a higher severity of maladaptive schemata, at least among those obese individuals who have sought treatment. Possible etiological and treatment implications of the findings are discussed.","['Anderson, Kate', 'Rieger, Elizabeth', 'Caterson, Ian']","['Anderson K', 'Rieger E', 'Caterson I']","['School of Psychology, University of Sydney, NSW 2006, Australia.']",['eng'],['Journal Article'],England,J Psychosom Res,Journal of psychosomatic research,0376333,,IM,"['*Adaptation, Psychological', 'Adult', 'Aged', 'Body Mass Index', '*Body Weight', 'Cognition', 'Female', 'Humans', 'Male', 'Middle Aged', 'Mood Disorders/epidemiology', 'Obesity/epidemiology/*psychology/*therapy', '*Patient Acceptance of Health Care', 'Social Desirability', 'Surveys and Questionnaires']",,,,,2006/03/07 09:00,2006/07/26 09:00,['2006/03/07 09:00'],"['2005/06/08 00:00 [received]', '2006/03/07 09:00 [pubmed]', '2006/07/26 09:00 [medline]', '2006/03/07 09:00 [entrez]']","['S0022-3999(05)00287-4 [pii]', '10.1016/j.jpsychores.2005.08.002 [doi]']",ppublish,J Psychosom Res. 2006 Mar;60(3):245-52. doi: 10.1016/j.jpsychores.2005.08.002.,,,,,,,,,,,,,,,,,,,,
35659650,NLM,MEDLINE,20220608,20220716,1471-2474 (Electronic) 1471-2474 (Linking),23,1,2022 Jun 4,Obesity and perioperative adverse events in patients undergoing complex revision surgery for the thoracolumbar spine.,534,10.1186/s12891-022-05505-4 [doi] 534,"BACKGROUND: There are no previous studies that evaluate the effect of obesity on patients undergoing complex revision thoracolumbar spine surgery. The primary objective was to determine the relationship between obesity and perioperative adverse events (AEs) with patients undergoing complex revision thoracolumbar spine surgery while controlling for psoas muscle index (PMI) as a confounding variable. The secondary objective was to determine the relationship between obesity and 30-day readmission rates, 30-day re-operation rates, rate of discharge to a facility, and post-operative length of stay (LOS). METHODS: Between May 2016 and February 2020, a retrospective analysis of individuals undergoing complex revision surgery of the thoracolumbar spine was performed at a single institution. Obesity was defined as BMI >/= 30.0 kg/m(2). PMI < 500 mm(2)/m(2) for males and < 412 mm(2)/m(2) for females were used to define low muscle mass. A Spine Surgical Invasiveness Index (SSII) > 10 was used to define complex revision surgery. A multivariable logistic regression model was used to ascertain the effects of low muscle mass, obesity, age, and gender on the likelihood of the occurrence of any AE. RESULTS: A total of 114 consecutive patients were included in the study. Fifty-four patients were in the obese cohort and 60 patients in the non-obese cohort. There was not a significant difference in perioperative outcomes of both the obese and non-obese patients. There were 22 obese patients (40.7%) and 33 non-obese patients (55.0%) that experienced any AE (p = 0.130). Multivariable analysis demonstrated that individuals with low muscle mass had a significantly higher likelihood for an AE than individuals with normal or high muscle mass (OR: 7.53, 95% CI: 3.05-18.60). Obesity did not have a significant effect in predicting AEs. CONCLUSIONS: Obesity is not associated with perioperative AEs, 30-day readmission rates, 30-day re-operation rates, rate of discharge to a facility, or post-operative length of stay (LOS) among patients undergoing complex revision thoracolumbar spine surgery. LEVEL OF EVIDENCE: III.","['Hirase, Takashi', 'Ling, Jeremiah F', 'Haghshenas, Varan', 'Fuld, Richard 3rd', 'Dong, David', 'Hanson, Darrell S', 'Meyer, B Christoph', 'Marco, Rex A W']","['Hirase T', 'Ling JF', 'Haghshenas V', 'Fuld R 3rd', 'Dong D', 'Hanson DS', 'Meyer BC', 'Marco RAW']","['Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, 6445 Main St Suite 2500, Houston, TX, 77030, USA. thirase@houstonmethodist.org.', 'Texas A&M University Health Science Center College of Medicine, 8447 Riverside Pkwy, Bryan, TX, 77807, USA. thirase@houstonmethodist.org.', 'Texas A&M University Health Science Center College of Medicine, 8447 Riverside Pkwy, Bryan, TX, 77807, USA.', 'Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, 6445 Main St Suite 2500, Houston, TX, 77030, USA.', 'Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, 6445 Main St Suite 2500, Houston, TX, 77030, USA.', 'Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, 6445 Main St Suite 2500, Houston, TX, 77030, USA.', 'Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, 6445 Main St Suite 2500, Houston, TX, 77030, USA.', 'Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, 6445 Main St Suite 2500, Houston, TX, 77030, USA.', 'Department of Orthopedics and Sports Medicine, Houston Methodist Hospital, 6445 Main St Suite 2500, Houston, TX, 77030, USA.']",['eng'],['Journal Article'],England,BMC Musculoskelet Disord,BMC musculoskeletal disorders,100968565,,IM,"['Female', 'Humans', 'Male', 'Obesity/complications/diagnosis/epidemiology', '*Postoperative Complications/epidemiology/etiology/surgery', 'Reoperation', 'Retrospective Studies', '*Spine/surgery']",PMC9166525,['NOTNLM'],"['Complex', 'Low muscle mass', 'Obesity', 'Predictor', 'Revision thoracolumbar spine surgery']","['Takashi Hirase, Jeremiah Ling, Varan Haghshenas, Richard Fuld III, David Dong,', 'and B Christoph Meyer declare no potential conflicts of interest with respect to', 'research, authorship, and/or publication of this article. Rex AW Marco has the', 'following disclosures: DePuy, A Johnson & Johnson Company: Paid presenter or', 'speaker; Globus Medical: Paid presenter or speaker; Musculoskeletal Tumor', 'Society: Board or committee member; Stryker: Paid presenter or speaker; Synaptive', 'Medical: Paid presenter or speaker. Darrell S Hanson has the following', 'disclosures: DePuy, A Johnson & Johnson Company: IP royalties; Paid consultant;', 'Paid presenter or speaker; Medtronic Sofamor Danek: Paid consultant; Paid', 'presenter or speaker.']",2022/06/07 06:00,2022/06/09 06:00,['2022/06/06 11:02'],"['2021/08/07 00:00 [received]', '2022/06/01 00:00 [accepted]', '2022/06/06 11:02 [entrez]', '2022/06/07 06:00 [pubmed]', '2022/06/09 06:00 [medline]']","['10.1186/s12891-022-05505-4 [pii]', '5505 [pii]', '10.1186/s12891-022-05505-4 [doi]']",epublish,BMC Musculoskelet Disord. 2022 Jun 4;23(1):534. doi: 10.1186/s12891-022-05505-4.,,20220604,,['(c) 2022. The Author(s).'],,,,,,,,,,,,,,,,
10372851,NLM,MEDLINE,19990629,20190702,0038-4348 (Print) 0038-4348 (Linking),92,6,1999 Jun,Motivating the obese child to move: the role of structured exercise in pediatric weight management.,577-84,,"BACKGROUND: The prevalence of childhood obesity is rapidly increasing. Successful prevention and treatment of childhood obesity depends on increasing the physical activity patterns of obese youth. However, motivating the obese child to participate in physical activity is difficult. METHODS: We designed a four-phase physical activity intervention, consisting of a structured progressive exercise program of moderate intensity, along with motivational methods to increase physical activity and improve body movement awareness. RESULTS: Seventy-three overweight children participated in the weight management program. They had a significant weight loss and reduction in body fat, which was maintained at 1-year follow-up. Subjects also maintained lean body mass and showed improved physical activity patterns. CONCLUSIONS: Progressive exercise, used in conjunction with nutrition and behavior modification, provides successful motivational strategies. These strategies encourage increased physical activity patterns, the adoption of regular structured exercise training, and the loss of excess body fat.","['Sothern, M S', 'Hunter, S', 'Suskind, R M', 'Brown, R', 'Udall, J N Jr', 'Blecker, U']","['Sothern MS', 'Hunter S', 'Suskind RM', 'Brown R', 'Udall JN Jr', 'Blecker U']","['Department of Pediatrics, Louisiana State University Medical School, New Orleans, USA.']",['eng'],['Journal Article'],United States,South Med J,Southern medical journal,0404522,,IM,"['Adolescent', 'Child', '*Exercise', 'Female', 'Humans', 'Male', '*Motivation', 'Obesity/psychology/*therapy', 'Weight Loss']",,,,,1999/06/18 10:00,2001/03/28 10:01,['1999/06/18 10:00'],"['1999/06/18 10:00 [pubmed]', '2001/03/28 10:01 [medline]', '1999/06/18 10:00 [entrez]']",['10.1097/00007611-199906000-00006 [doi]'],ppublish,South Med J. 1999 Jun;92(6):577-84. doi: 10.1097/00007611-199906000-00006.,,,,,,,,,,,,,,,,,,,,
18448705,NLM,MEDLINE,20081106,20080501,1473-4257 (Electronic) 0306-6800 (Linking),34,5,2008 May,Should we force the obese to diet?,319,10.1136/jme.2007.023598 [doi],,"['Giordano, Simona']",['Giordano S'],,['eng'],['Editorial'],England,J Med Ethics,Journal of medical ethics,7513619,,IM,"['Anorexia/psychology', '*Attitude of Health Personnel', 'Coercion', 'Female', 'Humans', 'Obesity/*diet therapy/psychology']",,,,,2008/05/02 09:00,2008/11/07 09:00,['2008/05/02 09:00'],"['2008/05/02 09:00 [pubmed]', '2008/11/07 09:00 [medline]', '2008/05/02 09:00 [entrez]']","['34/5/319 [pii]', '10.1136/jme.2007.023598 [doi]']",ppublish,J Med Ethics. 2008 May;34(5):319. doi: 10.1136/jme.2007.023598.,,,,,,,,,,,,,,,,,,,,
16339115,NLM,MEDLINE,20060126,20220330,1071-7323 (Print) 1071-7323 (Linking),13,11,2005 Nov,"Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society.",1849-63,,"Obesity causes serious medical complications and impairs quality of life. Moreover, in older persons, obesity can exacerbate the age-related decline in physical function and lead to frailty. However, appropriate treatment for obesity in older persons is controversial because of the reduction in relative health risks associated with increasing body mass index and the concern that weight loss could have potential harmful effects in the older population. This joint position statement from the American Society for Nutrition and NAASO, The Obesity Society reviews the clinical issues related to obesity in older persons and provides health professionals with appropriate weight-management guidelines for obese older patients. The current data show that weight-loss therapy improves physical function, quality of life, and the medical complications associated with obesity in older persons. Therefore, weight-loss therapy that minimizes muscle and bone losses is recommended for older persons who are obese and who have functional impairments or medical complications that can benefit from weight loss.","['Villareal, Dennis T', 'Apovian, Caroline M', 'Kushner, Robert F', 'Klein, Samuel']","['Villareal DT', 'Apovian CM', 'Kushner RF', 'Klein S']","['Division of Geriatrics and Nutritional Sciences, Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO 63110, USA.']",['eng'],"['Journal Article', 'Practice Guideline', 'Research Support, N.I.H., Extramural', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Obes Res,Obesity research,9305691,,IM,"['Aged', 'Aging/*physiology', 'Body Composition/*physiology', 'Bone Density/physiology', 'Exercise/physiology', 'Female', 'Humans', 'Male', 'Middle Aged', '*Obesity/complications/epidemiology/etiology/therapy', 'Quality of Life', 'United States/epidemiology', 'Weight Loss']",,,,,2005/12/13 09:00,2006/01/27 09:00,['2005/12/13 09:00'],"['2005/12/13 09:00 [pubmed]', '2006/01/27 09:00 [medline]', '2005/12/13 09:00 [entrez]']","['13/11/1849 [pii]', '10.1038/oby.2005.228 [doi]']",ppublish,Obes Res. 2005 Nov;13(11):1849-63. doi: 10.1038/oby.2005.228.,['DK56341/DK/NIDDK NIH HHS/United States'],,,,,,205,,,"['American Society for Nutrition', 'NAASO, The Obesity Society']",,,,,,,,,,
5531149,NLM,MEDLINE,19710224,20190908,0022-4510 (Print) 0022-4510 (Linking),11,9,1970 Sep,The obese dog and some clinical repercussions.,601-6,,,"['Joshua, J O']",['Joshua JO'],,['eng'],['Journal Article'],England,J Small Anim Pract,The Journal of small animal practice,0165053,,IM,"['Adipose Tissue', 'Animals', '*Dog Diseases', 'Dogs', 'Obesity/complications/*veterinary', 'Osteoarthritis/veterinary']",,,,,1970/09/01 00:00,1970/09/01 00:01,['1970/09/01 00:00'],"['1970/09/01 00:00 [pubmed]', '1970/09/01 00:01 [medline]', '1970/09/01 00:00 [entrez]']",['10.1111/j.1748-5827.1970.tb05621.x [doi]'],ppublish,J Small Anim Pract. 1970 Sep;11(9):601-6. doi: 10.1111/j.1748-5827.1970.tb05621.x.,,,,,,,,,,,,,,,,,,,,
7561545,NLM,MEDLINE,19951024,20041117,0125-2208 (Print) 0125-2208 (Linking),78,5,1995 May,Behavior modification in the treatment of obesity: acceptability profiles.,232-7,,"Seventy obese subjects, after receiving an 8-week group therapy program of behavior modification, showed that they had lost weight from fat tissue. There were significant decreases of per cent body fat, biceps, subscapular and iliac skinfold thickness while maintaining arm muscle area. There were significant decreases of both systolic and diastolic blood pressure during the program. The acceptability profiles of heart rate, liver and renal function test, fasting blood sugar, uric acid, serum iron, total iron binding capacity, minerals, electrolytes, hematological and lipid profiles were within normal limits before and after the treatment. The obese subjects rated the behavior modification program as more effective and indicated helpfulness of concepts, information and techniques of the program.","['Roongpisuthipong, C', 'Boontawee, A', 'Kulapongse, S']","['Roongpisuthipong C', 'Boontawee A', 'Kulapongse S']","['Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.']",['eng'],['Journal Article'],Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,,IM,"['Adolescent', 'Adult', 'Aged', 'Analysis of Variance', '*Behavior Therapy', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Middle Aged', 'Obesity/physiopathology/psychology/*therapy', '*Patient Satisfaction', 'Psychotherapy, Group']",,,,,1995/05/01 00:00,1995/05/01 00:01,['1995/05/01 00:00'],"['1995/05/01 00:00 [pubmed]', '1995/05/01 00:01 [medline]', '1995/05/01 00:00 [entrez]']",,ppublish,J Med Assoc Thai. 1995 May;78(5):232-7.,,,,,,,,,,,,,,,,,,,,
33496808,NLM,MEDLINE,20210223,20210223,1432-1289 (Electronic) 0020-9554 (Linking),62,2,2021 Feb,[Life expectancy after bariatric surgery : Swedish Obese Subjects Study].,212-214,10.1007/s00108-021-00947-9 [doi],,"['Hauner, H', 'Nitschmann, S']","['Hauner H', 'Nitschmann S']","['Institut fur Ernahrungsmedizin, Klinikum rechts der Isar, Georg-Brauchle-Ring 62, 80992, Munchen, Deutschland. hans.hauner@tum.de.', 'Else Kroner-Fresenius-Zentrum fur Ernahrungsmedizin, Georg-Brauchle-Ring 62, 80992, Munchen, Deutschland. hans.hauner@tum.de.', ', Lippetal, Deutschland.']",['ger'],['Journal Article'],Germany,Internist (Berl),Der Internist,0264620,,IM,"['Bariatric Surgery/*adverse effects', 'Humans', '*Life Expectancy', 'Obesity/epidemiology/*surgery', 'Obesity, Morbid/epidemiology/*surgery', 'Sweden/epidemiology']",,,,,2021/01/27 06:00,2021/02/24 06:00,['2021/01/26 12:10'],"['2021/01/08 00:00 [accepted]', '2021/01/27 06:00 [pubmed]', '2021/02/24 06:00 [medline]', '2021/01/26 12:10 [entrez]']","['10.1007/s00108-021-00947-9 [pii]', '10.1007/s00108-021-00947-9 [doi]']",ppublish,Internist (Berl). 2021 Feb;62(2):212-214. doi: 10.1007/s00108-021-00947-9. Epub 2021 Jan 26.,,20210126,,,,,,,Lebenserwartung nach bariatrischer Chirurgie : Swedish Obese Subjects Study.,,,,,,,,,,,
7174189,NLM,MEDLINE,19830214,20151119,,6,5,1982,Some effects of meal-feeding and consequent weight reduction in obese mice.,443-56,,,"['Jagot, S A', 'Dickerson, J W', 'Webb, G P']","['Jagot SA', 'Dickerson JW', 'Webb GP']",,['eng'],"['Comparative Study', 'Journal Article']",England,Int J Obes,International journal of obesity,7703240,"['0 (Mustard Compounds)', 'O95518658Z (bipiperidyl mustard)']",IM,"['Adipose Tissue/pathology', 'Animals', 'Body Composition', 'Body Weight', '*Eating', 'Female', 'Male', 'Mice', 'Mice, Inbred C57BL', 'Mice, Obese', 'Mustard Compounds', 'Obesity/chemically induced/pathology/*physiopathology', 'Time Factors']",,,,,1982/01/01 00:00,1982/01/01 00:01,['1982/01/01 00:00'],"['1982/01/01 00:00 [pubmed]', '1982/01/01 00:01 [medline]', '1982/01/01 00:00 [entrez]']",,ppublish,Int J Obes. 1982;6(5):443-56.,,,,,,,,,,,,,,,,,,,,
33232208,NLM,MEDLINE,20201130,20210317,1524-4636 (Electronic) 1079-5642 (Linking),40,12,2020 Dec,von Willebrand Factor: A Loyal Ally of Venous Thrombosis in Obesity.,2809-2811,10.1161/ATVBAHA.120.315380 [doi],,"['Campos, Joana', 'Brill, Alexander']","['Campos J', 'Brill A']","['Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, United Kingdom (J.C., A.B.).', 'Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, United Kingdom (J.C., A.B.).', 'Department of Pathophysiology, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia (A.B.).']",['eng'],"['Comment', 'Editorial']",United States,Arterioscler Thromb Vasc Biol,"Arteriosclerosis, thrombosis, and vascular biology",9505803,['0 (von Willebrand Factor)'],IM,"['Animals', 'Diet', 'Mice', 'Obesity/complications/diagnosis/epidemiology', '*Venous Thrombosis/diagnostic imaging', '*von Willebrand Diseases', 'von Willebrand Factor']",,['NOTNLM'],"['Editorials', 'diet, high-fat', 'endothelial cell', 'obese mice', 'risk factor', 'venous thrombosis', 'von Willebrand factor']",,2020/11/25 06:00,2020/12/01 06:00,['2020/11/24 17:12'],"['2020/11/24 17:12 [entrez]', '2020/11/25 06:00 [pubmed]', '2020/12/01 06:00 [medline]']",['10.1161/ATVBAHA.120.315380 [doi]'],ppublish,Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2809-2811. doi: 10.1161/ATVBAHA.120.315380. Epub 2020 Nov 24.,"['FS/19/30/34173/BHF_/British Heart Foundation/United Kingdom', 'FS/19/30/34173/BB_/Biotechnology and Biological Sciences Research Council/United', 'Kingdom']",20201124,,,,,,,,,['Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2860-2874. PMID: 32967458'],,,,,,,,,
1568366,NLM,MEDLINE,19920522,20131121,0009-9074 (Print) 0009-9074 (Linking),140,3,1992 Mar,[Changes in dietary intake of obese patients treated by diet associated with d-fenfluramine].,235-8,,"The object of the present research was to study the effect of dexfenfluramine (d-F) and placebo (P) on compliance with dietary treatment, especially as far as changes in kcal and macronutrient intake are concerned. A double-blind study d-F vs P was performed in 36 obese females, age range 20-59 years (mean 37.22 +/- 12.41), with a mean BMI of 33.95 +/- 5.36, suffering from obesity due to overeating without complications: Outpatient control every 30 days. The study protocol provided for a 14-month double-blind treatment with daily administration of either P (2 capsules) or d-F (two 15 mg capsules). Dietary prescription of 1200 kcal (5016 kJ) was given 15 days before enrollment (T/0) and during this period enrollment criteria were checked prior to randomization. Dietary intake was checked by a three-day recall (one working day, one half-holiday and one full holiday) in basal conditions and after 6-12 and 14 months. Administration of d-F and P brought about changes in alimentary behaviour in obese patients according to the dietary regime prescribed. In our patients, no highly significant differences between d-F and P were observed; however, the effect of P on macronutrient intake (carbohydrates, lipids and proteins) tended to peter out around the 12th month. Treatment with d-F reduced the consumption of simple carbohydrates, animal fats but not of animal proteins.","['Cairella, M', 'Cairella, G', 'Graziani, P', 'Mirante, M G', 'Taghva, A R']","['Cairella M', 'Cairella G', 'Graziani P', 'Mirante MG', 'Taghva AR']","['Servizio Speciale di Dietologia, Universita degli Studi di Roma La Sapienza.']",['ita'],"['Clinical Trial', 'Comparative Study', 'English Abstract', 'Journal Article', 'Randomized Controlled Trial']",Italy,Clin Ter,La Clinica terapeutica,0372604,"['0 (Placebos)', '2DS058H2CF (Fenfluramine)']",IM,"['Adult', '*Diet, Reducing', 'Double-Blind Method', 'Female', 'Fenfluramine/*therapeutic use', 'Humans', 'Middle Aged', 'Obesity/diet therapy/drug therapy/*therapy', 'Placebos', 'Time Factors']",,,,,1992/03/01 00:00,1992/03/01 00:01,['1992/03/01 00:00'],"['1992/03/01 00:00 [pubmed]', '1992/03/01 00:01 [medline]', '1992/03/01 00:00 [entrez]']",,ppublish,Clin Ter. 1992 Mar;140(3):235-8.,,,,,,,,,Modificazioni dei consumi alimentari di pazienti obese indotte dal trattamento dietetico associato a d-fenfluramina.,,,,,,,,,,,
34365247,NLM,MEDLINE,20210924,20210924,1873-7072 (Electronic) 0308-8146 (Linking),367,,2022 Jan 15,Comparative study of the anti-obesity and gut microbiota modulation effects of green tea phenolics and their oxidation products in high-fat-induced obese mice.,130735,S0308-8146(21)01741-6 [pii] 10.1016/j.foodchem.2021.130735 [doi],"Green and black teas are regarded to possess therapeutic potential for the treatment of obesity, however it is not clear which tea performs better in body weight control. In this study, aiming to eliminate cultivar variation, green tea phenolics (GTP) were oxidized by tyrosinase to obtain oxidized tea phenolics (OTP). Thereafter, their anti-obesity effect on high-fat diet induced obese mice were compared. The results showed that despite their distinctive phenolic profiles, GTP and OTP exerted similar anti-obesity properties after 12 weeks of dietary intervention. Furthermore, cecal microbiota profiling exhibited comparable modulatory effects of GTP and OTP on multiple bacterial taxa, including Parabacteroides distasonis, Bifidobacterium, Prevotella, and Akkermansia muciniphila, which were strongly associated with obesity related indexes. Putative bacterial function profiling implicated that both GTP and OTP might regulate the lipid metabolism similarly. Collectively, the oxidation of GTP did not influence the anti-obesity and gut microbiota modulatory effects to any large extent.","['Liu, Zhibin', 'Chen, Qin', 'Zhang, Chen', 'Ni, Li']","['Liu Z', 'Chen Q', 'Zhang C', 'Ni L']","['Institute of Food Science & Technology, Fuzhou University, Fuzhou 350108, China.', 'Institute of Food Science & Technology, Fuzhou University, Fuzhou 350108, China.', 'Institute of Food Science & Technology, Fuzhou University, Fuzhou 350108, China. Electronic address: chen.zhang@fzu.edu.cn.', 'Institute of Food Science & Technology, Fuzhou University, Fuzhou 350108, China. Electronic address: nili@fzu.edu.cn.']",['eng'],['Journal Article'],England,Food Chem,Food chemistry,7702639,"['0 (Tea)', 'Parabacteroides distasonis']",IM,"['Animals', 'Bacteroidetes', '*Gastrointestinal Microbiome', 'Mice', 'Mice, Obese', 'Obesity/drug therapy/etiology', '*Tea']",,['NOTNLM'],"['Anti-obesity', 'Green tea phenolics', 'Gut microbiota', 'Lipid metabolism', 'Oxidized tea phenolics']",,2021/08/09 06:00,2021/09/25 06:00,['2021/08/08 20:49'],"['2021/04/10 00:00 [received]', '2021/07/27 00:00 [revised]', '2021/07/28 00:00 [accepted]', '2021/08/09 06:00 [pubmed]', '2021/09/25 06:00 [medline]', '2021/08/08 20:49 [entrez]']","['S0308-8146(21)01741-6 [pii]', '10.1016/j.foodchem.2021.130735 [doi]']",ppublish,Food Chem. 2022 Jan 15;367:130735. doi: 10.1016/j.foodchem.2021.130735. Epub 2021 Jul 30.,,20210730,,['Copyright (c) 2021 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
22724639,NLM,MEDLINE,20121126,20220408,1369-1627 (Electronic) 0954-0261 (Print) 0954-0261 (Linking),24,3,2012 Jun,The global childhood obesity epidemic and the association between socio-economic status and childhood obesity.,176-88,10.3109/09540261.2012.688195 [doi],"Abstract This paper describes the current prevalence and time trends of childhood obesity worldwide, and the association between childhood obesity and socio-economic status (SES). Childhood obesity has become a global public health crisis. The prevalence is highest in western and industrialized countries, but still low in some developing countries. The prevalence also varies by age and gender. The WHO Americas and eastern Mediterranean regions had higher prevalence of overweight and obesity (30-40%) than the European (20-30%), south-east Asian, western Pacific, and African regions (10-20% in the latter three). A total of 43 million children (35 million in developing countries) were estimated to be overweight or obese; 92 million were at risk of overweight in 2010. The global overweight and obesity prevalence has increased dramatically since 1990, for example in preschool-age children, from approximately 4% in 1990 to 7% in 2010. If this trend continues, the prevalence may reach 9% or 60 million people in 2020. The obesity-SES association varies by gender, age, and country. In general, SES groups with greater access to energy-dense diets (low-SES in industrialized countries and high-SES in developing countries) are at increased risk of being obese than their counterparts.","['Wang, Youfa', 'Lim, Hyunjung']","['Wang Y', 'Lim H']","['Johns Hopkins Global Center for Childhood Obesity, Department of International Health, Human Nutrition Program, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD 21205, USA. ywang@jhsph.edu']",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",England,Int Rev Psychiatry,"International review of psychiatry (Abingdon, England)",8918131,,IM,"['Adolescent', 'Child', 'Child, Preschool', 'Global Health/*economics', 'Humans', 'Obesity/classification/*economics/*epidemiology', '*Social Class']",PMC4561623,,,,2012/06/26 06:00,2012/12/10 06:00,['2012/06/26 06:00'],"['2012/06/26 06:00 [entrez]', '2012/06/26 06:00 [pubmed]', '2012/12/10 06:00 [medline]']",['10.3109/09540261.2012.688195 [doi]'],ppublish,Int Rev Psychiatry. 2012 Jun;24(3):176-88. doi: 10.3109/09540261.2012.688195.,"['1U54 HD070725 - 01/HD/NICHD NIH HHS/United States', 'R01 HD064685/HD/NICHD NIH HHS/United States', 'R01 DK081335/DK/NIDDK NIH HHS/United States', 'U54 HD070725/HD/NICHD NIH HHS/United States', 'R01DK81335 - 01A1/DK/NIDDK NIH HHS/United States']",,,,,['NIHMS688226'],,,,,,,,,,,,,,
3994333,NLM,MEDLINE,19850612,20041117,0003-5548 (Print) 0003-5548 (Linking),43,1,1985 Mar,A morphotypological analysis of an Italian population: association with obesity.,41-50,,The morphotypological method of Brian (1960) was applied to the data collected in Aosta (N. Italy) during an investigation on human obesity. The data consist of anthropometric measurements on members of families ascertained by the presence of obesity in the children and therefore the frequency of obesity is much higher than in the general population. One of the morphotypes was found only among the obese and two others were much more common among the obese than among the non-obese. More than 80% of the obese (vs. 10% of the non-obese) belonged to these three classes. There was a positive parent-offspring association for two of the components of the morphotype (morphy and somy).,"['Formenti, D', 'De Stefano, G F', 'Zonta Sgaramella, L', 'Jayakar, S D', 'Astolfi, P', 'Galante, A', 'Pennetti, V']","['Formenti D', 'De Stefano GF', 'Zonta Sgaramella L', 'Jayakar SD', 'Astolfi P', 'Galante A', 'Pennetti V']",,['eng'],['Journal Article'],Germany,Anthropol Anz,Anthropologischer Anzeiger; Bericht uber die biologisch-anthropologische Literatur,0372377,,IM,"['Adolescent', 'Adult', 'Aging', 'Anthropometry', 'Child', 'Female', 'Humans', 'Italy', 'Male', 'Obesity/*classification/genetics', 'Sex Characteristics', '*Somatotypes']",,,,,1985/03/01 00:00,1985/03/01 00:01,['1985/03/01 00:00'],"['1985/03/01 00:00 [pubmed]', '1985/03/01 00:01 [medline]', '1985/03/01 00:00 [entrez]']",,ppublish,Anthropol Anz. 1985 Mar;43(1):41-50.,,,,,,,,,,,,,,,,,,,,
3314451,NLM,MEDLINE,19871209,20190622,0002-9149 (Print) 0002-9149 (Linking),60,12,1987 Oct 30,Medical evaluation and treatment of the obese patient with cardiovascular disease.,55G-58G,,"The incidence of coronary artery disease only weakly correlates with the percent of excess body weight; however, obesity in humans is not a homogeneous condition. Classification of obesity based on anatomic distribution of body fat allows for identification of a group of patients at increased risk for cardiovascular disease. Abdominal (upper body) obesity, measured as the waist/hip ratio, is a strong independent risk factor of cardiovascular disease and should be used to assess a subgroup in need of medical weight loss treatment. A focus on dietary fat intake and the magnitude of overeating ""caloric intake"" are central to the pathogenesis of cardiovascular disease observed in the obese person. Identification of the process of overeating (magnitude of recent weight gain, episodes of weight cycling) is important in the design of successful medical nutrition treatment programs. A nutrition/medical history that includes age of obesity onset and duration of obesity provides additional criteria for assessment of risk of disease. Childhood-onset obesity and prolonged obesity (greater than 15 years) has been associated with increased cardiovascular disease risk. Recently, grades of obesity based on body mass index have provided a valuable marker for treatment. Each reduction in obesity grade (equal to delta 5 body mass index or delta 11.6 kg) is associated with a decrease in risk of medical illness. The new focus of obesity treatment should be to decrease body weight in 10% to 15% increments (equal to 1 grade) with emphasis on reducing the risk of medical illness and treatment intensity (e.g., number of existing medical visits, hospitalization).(ABSTRACT TRUNCATED AT 250 WORDS)","['Blackburn, G L', 'Kanders, B S']","['Blackburn GL', 'Kanders BS']","['Cancer Research Institute, New England Deaconess Hospital, Boston, Massachusetts 02215.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", ""Research Support, U.S. Gov't, P.H.S."", 'Review']",United States,Am J Cardiol,The American journal of cardiology,0207277,,IM,"['Body Weight', 'Cardiovascular Diseases/*etiology/physiopathology', 'Humans', 'Obesity/classification/complications/*therapy', 'Risk Factors']",,,,,1987/10/30 00:00,1987/10/30 00:01,['1987/10/30 00:00'],"['1987/10/30 00:00 [pubmed]', '1987/10/30 00:01 [medline]', '1987/10/30 00:00 [entrez]']","['0002-9149(87)90592-3 [pii]', '10.1016/0002-9149(87)90592-3 [doi]']",ppublish,Am J Cardiol. 1987 Oct 30;60(12):55G-58G. doi: 10.1016/0002-9149(87)90592-3.,['HL 31989-01/HL/NHLBI NIH HHS/United States'],,,,,,46,,,,,,,,,,,,,
10389468,NLM,MEDLINE,19990831,20150826,0370-629X (Print) 0370-629X (Linking),54,4,1999 Apr,[Obesity and women: esthetic preoccupation or medical problem?].,262-7,,"Women more and more frequently refer to medical doctors for treating weight excess. Even if the primum movens is usually a pure esthetic concern, medical aspects should not be neglected. Indeed, if obesity with gynoid adipose tissue distribution is less deleterious than android obesity from a metabolic point of view, severe obesity is frequently associated with cardiovascular risk factors which may hinder the prognosis of these female patients. Other complications are common in obese women, such as oestrogen-related cancers, osteoarticular problems and psychological disturbances. Various therapeutic approaches are available which permit an encouraging weight loss and a rapid improvement of risk factors. Unfortunately, long-term results are often disappointing, essentially because of the difficulty to follow on the long term a strict diet regimen and practice physical exercise and because of the usual unrealistic expectations of the obese women who consult medical doctors.","['Luyckx, F H', 'Scheen, A J', 'Lefebvre, P J']","['Luyckx FH', 'Scheen AJ', 'Lefebvre PJ']","['Service de Diabetologie, CHU, Sart Tilman, Liege.']",['fre'],"['English Abstract', 'Journal Article']",Belgium,Rev Med Liege,Revue medicale de Liege,0404317,,IM,"['Adult', 'Cardiovascular Diseases/etiology', 'Exercise', 'Female', 'Humans', 'Middle Aged', 'Morbidity', 'Mortality', 'Obesity/complications/*psychology/therapy', 'Risk Factors', '*Self Concept', 'Weight Loss', ""*Women's Health""]",,,,,1999/07/02 00:00,1999/07/02 00:01,['1999/07/02 00:00'],"['1999/07/02 00:00 [pubmed]', '1999/07/02 00:01 [medline]', '1999/07/02 00:00 [entrez]']",,ppublish,Rev Med Liege. 1999 Apr;54(4):262-7.,,,,,,,,,L'obesite feminine: souci esthetique ou probleme medical?,,,,,,,,,,,
19750439,NLM,MEDLINE,20091117,20090914,1439-1074 (Electronic) 0939-2661 (Linking),44,9,2009 Sep,[Anaesthesia management of the obese patient].,600-8; quiz 610,10.1055/s-0029-1241164 [doi],"Obesity is a global epidemic, and approximately 20 % of the German population are obese. Therefore anaesthesiologists will be increasingly involved in the care of obese and morbidly obese patients in the near future. As a prerequisite, the hospital must focus on this patient population with respect to facilities and the availability of tailored medical equipment and supplies. Comorbidities such as diabetes, hypertension, coronary heart disease and sleep apnea considerably increase the risk of obese patients. A thorough preoperative evaluation of comorbidities, an anaesthesia induction and intraoperative ventilation tailored to the pathophysiological sequelae of obesity and a sound knowledge of pharmokocinetics are necessary to ensure optimal care for obese patients.","['Bein, Berthold', 'Hocker, Jan', 'Fudickar, Axel', 'Scholz, Jens']","['Bein B', 'Hocker J', 'Fudickar A', 'Scholz J']","['Klinik fur Anasthesiologie und Operative Intensivmedizin, Universitatsklinikum Schleswig-Holstein, Campus Kiel. bein@anaesthesie.uni-kiel.de']",['ger'],"['English Abstract', 'Journal Article', 'Review']",Germany,Anasthesiol Intensivmed Notfallmed Schmerzther,"Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS",9109478,['0 (Anesthetics)'],IM,"['Adiposity/physiology', 'Adolescent', 'Adult', 'Aged', '*Anesthesia/mortality', 'Anesthetics/pharmacokinetics', 'Body Mass Index', 'Female', 'Germany/epidemiology', 'Humans', 'Intraoperative Care', 'Male', 'Middle Aged', 'Obesity/*complications/epidemiology/metabolism/mortality', 'Pharmacokinetics', 'Premedication', 'Preoperative Care', 'Young Adult']",,,,,2009/09/15 06:00,2009/11/18 06:00,['2009/09/15 06:00'],"['2009/09/15 06:00 [entrez]', '2009/09/15 06:00 [pubmed]', '2009/11/18 06:00 [medline]']",['10.1055/s-0029-1241164 [doi]'],ppublish,Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 Sep;44(9):600-8; quiz 610. doi: 10.1055/s-0029-1241164. Epub 2009 Sep 11.,,20090911,,,,,7,,Begleiterkrankungen und perioperatives Management bei adiposen Erwachsenen.,,,,,,,,,,,
683556,NLM,MEDLINE,19781027,20061115,0026-4806 (Print) 0026-4806 (Linking),69,23,1978 May 9,[Psychiatric (psychodynamic and psychotherapeutic) aspects of obesity].,1541-50,,"An account is given for non-psychiatric physicians of the psychodynamic, psychiatric, and psychoterapeutic aspects of obesity. A primarily psychoanalytic explanation is presented of the unconscious meanings that the words involved assume in children and ""fixed"" obese subjects with regression to the ""oral stage"" of their libido development. The meanings associated with food and feeding are examined in an interpersonal, familial, social and environmental context. A summary psychopathological classification is made of obesity, together with an evaluation of what appears to be the direct opposite of obesity, i. e. mental anorexia. Lastly, the relevant prognostic and therapeutic criteria are considered. The latter are mainly centred on the various forms of psychotherapeutic intervention (individual, group, analytical and inspiration therapy, etc.).","['Conforto, C', 'Giberti, F']","['Conforto C', 'Giberti F']",,['ita'],"['English Abstract', 'Journal Article']",Italy,Minerva Med,Minerva medica,0400732,,IM,"['Humans', 'Obesity/*psychology/therapy', '*Psychoanalytic Interpretation', 'Psychoanalytic Therapy', '*Psychotherapy', 'Psychotherapy, Group']",,,,,1978/05/09 00:00,1978/05/09 00:01,['1978/05/09 00:00'],"['1978/05/09 00:00 [pubmed]', '1978/05/09 00:01 [medline]', '1978/05/09 00:00 [entrez]']",,ppublish,Minerva Med. 1978 May 9;69(23):1541-50.,,,,,,,,,Aspetti psichiatrici (psicodinamici e psicoterapeutici) dell'obesita.,,,,,,,,,,,
18201646,NLM,MEDLINE,20080331,20211203,0749-3797 (Print) 0749-3797 (Linking),34,2,2008 Feb,Pediatric obesity: the unique issues in Latino-American male youth.,153-60,10.1016/j.amepre.2007.09.034 [doi],"Pediatric obesity in the United States has been steadily rising over the past few decades, and it is a clear risk factor for adult obesity and obesity-related morbidity and mortality. A review of the literature from three major national databases reveals that the prevalence rates of obesity within Latino male children and adolescents is, in general, higher than other major gender-ethnic groups. Additionally, obese Latino male youth seem to be especially prone to a variety of obesity-related morbidities. Given the rising percentage of Latinos among our nation's youth, there is an urgency to develop and implement clinical and community research strategies to prevent and treat obesity within this high-risk gender-ethnic group. This article reviews the prevalence of pediatric obesity within the three largest databases in the U.S. with Latino representation. The paper then discusses unique issues in the etiology and ramifications of obesity within young Latino-American boys, reviews the few intervention studies that focus on Latino youth, and discusses potential strategies for further research.","['Stovitz, Steven D', 'Schwimmer, Jeffrey B', 'Martinez, Homero', 'Story, Mary T']","['Stovitz SD', 'Schwimmer JB', 'Martinez H', 'Story MT']","['Department of Family Medicine and Community Health, University of Minnesota, Minneapolis, Minnesota, USA. stovi001@umn.edu']",['eng'],['Journal Article'],Netherlands,Am J Prev Med,American journal of preventive medicine,8704773,,IM,"['Adolescent', 'Adult', 'Child', 'Child, Preschool', 'Female', 'Genetic Predisposition to Disease', 'Health Surveys', '*Hispanic or Latino', 'Humans', 'Male', 'Obesity/complications/epidemiology/genetics/metabolism/*prevention & control/therapy', '*Pediatrics', 'United States/epidemiology']",,,,,2008/01/19 09:00,2008/04/01 09:00,['2008/01/19 09:00'],"['2007/05/29 00:00 [received]', '2007/08/07 00:00 [revised]', '2007/09/26 00:00 [accepted]', '2008/01/19 09:00 [pubmed]', '2008/04/01 09:00 [medline]', '2008/01/19 09:00 [entrez]']","['S0749-3797(07)00667-8 [pii]', '10.1016/j.amepre.2007.09.034 [doi]']",ppublish,Am J Prev Med. 2008 Feb;34(2):153-60. doi: 10.1016/j.amepre.2007.09.034.,,,,,,,,,,,,,,,,,,,,
23299146,NLM,MEDLINE,20130402,20220913,1462-4753 (Print) 1462-4753 (Linking),18,1,2013 Jan,Public health and obesity: the role of the district nurse.,26-33,,"The World Health Organization (WHO) (2012) estimates that half a billion adults in the world are classified as obese. This article outlines initiatives that could be undertaken by district nurses to reduce the prevalence of obesity and improve the statistics relating to morbidity and mortality from obesity-related conditions. As district nurses already have a complex caseload, the initiatives discussed by the author are simple enough to be incorporated into the assessments and health screening already being undertaken.","['Sellwood, Lynn']",['Sellwood L'],"['Staffordshire ans Stoke on Trent Partnership Trust, UK. lynn.sellwood@nhs.net']",['eng'],['Journal Article'],England,Br J Community Nurs,British journal of community nursing,9815827,,,"['*Community Health Nursing', 'Humans', 'Obesity/epidemiology/*nursing/prevention & control', 'Public Health', 'Socioeconomic Factors', 'United Kingdom/epidemiology']",,,,,2013/01/10 06:00,2013/04/03 06:00,['2013/01/10 06:00'],"['2013/01/10 06:00 [entrez]', '2013/01/10 06:00 [pubmed]', '2013/04/03 06:00 [medline]']",['10.12968/bjcn.2013.18.Sup6.S26 [doi]'],ppublish,Br J Community Nurs. 2013 Jan;18(1):26-33. doi: 10.12968/bjcn.2013.18.Sup6.S26.,,,,,,,,,,,,,,,,,,,,
1389094,NLM,MEDLINE,19921102,20190918,0785-3890 (Print) 0785-3890 (Linking),24,4,1992 Aug,Binge eating in the obese.,303-8,,"This review will first describe problems in the definition of the term binge eating, especially in the absence of purging (vomiting, laxative abuse). We highlight current approaches in the classification of obesity, and then provide an overview of the available literature on differences between obese binge eaters and obese non-binge eaters. Many studies indicate that binge eating is common among the female obese, with a frequency ranging from 23 to 46% among those seeking treatment for weight reduction. Despite differences in the definitions of binge eating and variability among the samples investigated, there is strong evidence that binge eaters represent a distinct subgroup among the obese. Binge eating obese exhibit significantly more eating and weight-related pathology, as well as more psychopathology compared to their non-binge eating obese counterparts.","['de Zwaan, M', 'Mitchell, J E']","['de Zwaan M', 'Mitchell JE']","['Department of Psychiatry, University of Minnesota, Minneapolis 55455.']",['eng'],"['Journal Article', 'Review']",England,Ann Med,Annals of medicine,8906388,,IM,"['Age Factors', 'Feeding and Eating Disorders/classification/*complications', 'Female', 'Humans', 'Obesity/*complications/psychology', 'Prevalence', 'Sex Factors']",,,,,1992/08/01 00:00,1992/08/01 00:01,['1992/08/01 00:00'],"['1992/08/01 00:00 [pubmed]', '1992/08/01 00:01 [medline]', '1992/08/01 00:00 [entrez]']",['10.3109/07853899209149959 [doi]'],ppublish,Ann Med. 1992 Aug;24(4):303-8. doi: 10.3109/07853899209149959.,,,,,,,46,,,,,,,,,,,,,
9361540,NLM,MEDLINE,19971125,20190501,0959-8138 (Print) 1468-5833 (Electronic) 0959-8138 (Linking),315,7113,1997 Oct 11,Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study.,912-6,,"OBJECTIVES: To investigate the consequences of longstanding obesity on left ventricular mass and structure and to examine the effects of weight loss on these variables. DESIGN: Cross sectional survey and controlled intervention study. SETTING: City of Gothenburg and surrounding areas. Sweden. SUBJECTS: 41 obese patients treated with weight reducing gastric surgery, 31 obese patients treated conventionally, and 43 non-obese subjects. MAIN OUTCOME MEASURES: Changes in left ventricular mass and relative wall thickness. RESULTS: Obese patients had higher blood pressure, greater left ventricular mass, and increased relative wall thickness than did matched non-obese control subjects. Obese subjects treated with gastric surgery had a substantial weight loss and a significant reduction in all variables when compared with conventionally treated obese subjects. Univariate and multivariate analysis of pooled data from the two groups of obese subjects showed that changes in relative wall thickness and left ventricular mass were more closely related to the change in weight than to the concomitant change in blood pressure. CONCLUSIONS: Structural heart abnormalities occurring in conjunction with obesity diminish after weight loss. The regression in these structural aberrations is better predicted by the weight loss than by the accompanying reduction in blood pressure. To prevent or improve abnormalities of heart structure in obese people, weight control should be the primary goal; it should be regarded as at least as important as regulating blood pressure.","['Karason, K', 'Wallentin, I', 'Larsson, B', 'Sjostrom, L']","['Karason K', 'Wallentin I', 'Larsson B', 'Sjostrom L']","['Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,BMJ,BMJ (Clinical research ed.),8900488,,IM,"['Adult', 'Analysis of Variance', 'Blood Pressure', 'Body Mass Index', 'Cross-Sectional Studies', 'Female', 'Heart Ventricles/*pathology', 'Humans', 'Male', 'Middle Aged', 'Obesity/*pathology/physiopathology/surgery', 'Weight Loss/*physiology']",PMC2127625,,,,1997/11/15 00:00,1997/11/15 00:01,['1997/11/15 00:00'],"['1997/11/15 00:00 [pubmed]', '1997/11/15 00:01 [medline]', '1997/11/15 00:00 [entrez]']",['10.1136/bmj.315.7113.912 [doi]'],ppublish,BMJ. 1997 Oct 11;315(7113):912-6. doi: 10.1136/bmj.315.7113.912.,,,,,,,,,,,,,,,,,,,,
18278632,NLM,MEDLINE,20080513,20220316,1747-7174 (Electronic) 1747-7166 (Linking),3 Suppl 1,,2008,Family in pediatric obesity management: a literature review.,44-50,10.1080/17477160801896994 [doi],"A dramatic increase in prevalence of pediatric obesity has occurred in most countries over the past few decades. This is of particular significance given the fact that overweight children and adolescents are at increased risk for multiple medical co-morbidities, as well as psychosocial and behavioral difficulties. While considerable attention has recently been paid to identifying obesity and the importance of associated co-morbidities, there has been less focus on considerations related to effective interventions. Interventions aimed at childhood obesity include prevention and treatment. Both prevention and treatment need improvement to be useful in the clinical setting. Few investigators have demonstrated that treatment is effective. The aim of this review is to examine the effectiveness of family-based interventions in obese pediatric subjects and to explore what specific components of family-based programs are of particular significance when treating obese children. A literature search was performed and relevant studies are presented. A majority of the studies support the use of family-based treatment. Furthermore, to develop a fully interactive model, more focus is needed on the specific techniques used in evidence-based programs.","['Nowicka, Paulina', 'Flodmark, Carl-Erik']","['Nowicka P', 'Flodmark CE']","['Childhood Obesity Unit, University Hospital Malmo, Malmo, Sweden.']",['eng'],"['Journal Article', 'Review']",England,Int J Pediatr Obes,International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity,101256330,,IM,"['Adolescent', 'Child', 'Child Nutrition Disorders/epidemiology/prevention & control/psychology/*therapy', '*Environment', 'Evidence-Based Medicine', 'Family/*psychology', 'Family Therapy/*methods', 'Humans', 'Obesity/epidemiology/prevention & control/psychology/*therapy']",,,,,2008/02/20 09:00,2008/05/14 09:00,['2008/02/20 09:00'],"['2008/02/20 09:00 [pubmed]', '2008/05/14 09:00 [medline]', '2008/02/20 09:00 [entrez]']","['790629350 [pii]', '10.1080/17477160801896994 [doi]']",ppublish,Int J Pediatr Obes. 2008;3 Suppl 1:44-50. doi: 10.1080/17477160801896994.,,,,,,,28,,,,,,,,,,,,,
2354489,NLM,MEDLINE,19900725,20061115,0008-7335 (Print) 0008-7335 (Linking),129,20,1990 May 18,[Obesity and hyperlipoproteinemia. II. The effect of a low energy diet on lipid levels in the blood of obese persons].,614-8,,"In 287 obese men and women with BMI values of 29-50 kg/m2, divided by sex and age, the effect of a low-energy diet on triacylglycerol (TG), total cholesterol (TC) and HDL-cholesterol (HDL-C) serum levels was investigated. On a diet of 2500 kJ/day (4 weeks) and 4000-7000 kJ/day (6 weeks) the body weight declined by 10-11% from the initial value. There was a significant drop of TG in obese men above 25 years and in obese women above 35 years of age. The mean TC values did not change significantly after weight reduction. The mean HDL-C levels increased significantly after weight reduction, as compared with initial values in both sexes in the groups aged 26-35 years. In this group there was also an increase of the relative ratio of HDL-C in TC and the value of the atherogenic index declined. The authors draw attention to the fact that with regard to preserving normal blood lipid levels, in particular in obese men, it is necessary to reduce or normalize body weight in the course of the third decade.","['Beno, I', 'Ovecka, M', 'Chorvathova, V']","['Beno I', 'Ovecka M', 'Chorvathova V']","[""Vyskumny ustav vyzivy l'udu, Bratislava.""]",['slo'],"['English Abstract', 'Journal Article']",Czech Republic,Cas Lek Cesk,Casopis lekaru ceskych,0004743,['0 (Lipids)'],IM,"['Adolescent', 'Adult', '*Energy Intake', 'Female', 'Humans', 'Hyperlipoproteinemias/complications', 'Lipids/*blood', 'Male', 'Middle Aged', 'Obesity/blood/complications/*diet therapy']",,,,,1990/05/18 00:00,1990/05/18 00:01,['1990/05/18 00:00'],"['1990/05/18 00:00 [pubmed]', '1990/05/18 00:01 [medline]', '1990/05/18 00:00 [entrez]']",,ppublish,Cas Lek Cesk. 1990 May 18;129(20):614-8.,,,,,,,,,Obezita a hyperlipoproteinemia. II. Vplyv nizkoenergetickej diety na hladiny lipidov v krvi obeznych osob.,,,,,,,,,,,
37242264,NLM,MEDLINE,20230529,20230529,2072-6643 (Electronic) 2072-6643 (Linking),15,10,2023 May 19,Gender and Liver Steatosis Discriminate Different Physiological Patterns in Obese Patients Undergoing Bariatric Surgery: Obesity Center Cohort.,,10.3390/nu15102381 [doi] 2381,"BACKGROUND: Obesity is a major public health problem worldwide. Bariatric surgery can reduce body weight, and it is one of the better ways to improve metabolic disease and lifestyle. The aim of this study was to explore a new cohort of patients with obesity and evaluate the gender differences and the steatosis status within the gender group. METHODS: A cohort of 250 adult obese patients with BMI >/= 30 and age >18 years, eligible for gastric bariatric surgery at Pineta Grande Hospital, Castel Volturno (Italy) was studied. RESULTS: The prevalence in women was higher (72.40%) than men (27.60%). Overall, results indicated many statistically significant gender differences in hematological and clinical parameters. Analysis of the subcohorts based on the severity of steatosis revealed differences of this condition between the genders. Steatosis was more prevalent in the male subcohort, but female patients revealed greater within-group differences. CONCLUSIONS: Many differences were found not only in the total cohort but also between the gender subcohorts, both in the presence and absence of steatosis. We can conclude that the pathophysiological, genetic, and hormonal patterns affecting these patients delineate different individual profiles.","['Donghia, Rossella', 'Schiano Di Cola, Rita', 'Cesaro, Filomena', 'Vitale, Andrea', 'Lippolis, Giuseppe', 'Lisco, Teresa', 'Isernia, Roberta', 'De Pergola, Giovanni', 'De Nucci, Sara', 'Rinaldi, Roberta', 'Liso, Marina', 'Giardiello, Cristiano']","['Donghia R', 'Schiano Di Cola R', 'Cesaro F', 'Vitale A', 'Lippolis G', 'Lisco T', 'Isernia R', 'De Pergola G', 'De Nucci S', 'Rinaldi R', 'Liso M', 'Giardiello C']","['National Institute of Gastroenterology-IRCCS ""Saverio de Bellis"", 70013 Castellana Grotte, Italy.', 'Pineta Grande Hospital, 81030 Castel Volturno, Italy.', 'Pineta Grande Hospital, 81030 Castel Volturno, Italy.', 'Pineta Grande Hospital, 81030 Castel Volturno, Italy.', 'National Institute of Gastroenterology-IRCCS ""Saverio de Bellis"", 70013 Castellana Grotte, Italy.', 'National Institute of Gastroenterology-IRCCS ""Saverio de Bellis"", 70013 Castellana Grotte, Italy.', 'National Institute of Gastroenterology-IRCCS ""Saverio de Bellis"", 70013 Castellana Grotte, Italy.', 'National Institute of Gastroenterology-IRCCS ""Saverio de Bellis"", 70013 Castellana Grotte, Italy.', 'National Institute of Gastroenterology-IRCCS ""Saverio de Bellis"", 70013 Castellana Grotte, Italy.', 'National Institute of Gastroenterology-IRCCS ""Saverio de Bellis"", 70013 Castellana Grotte, Italy.', 'National Institute of Gastroenterology-IRCCS ""Saverio de Bellis"", 70013 Castellana Grotte, Italy.', 'National Institute of Gastroenterology-IRCCS ""Saverio de Bellis"", 70013 Castellana Grotte, Italy.', 'Pineta Grande Hospital, 81030 Castel Volturno, Italy.']",['eng'],['Journal Article'],Switzerland,Nutrients,Nutrients,101521595,,IM,"['Adult', 'Humans', 'Female', 'Male', 'Adolescent', '*Obesity, Morbid/complications/surgery/epidemiology', '*Fatty Liver/epidemiology', 'Obesity/complications/epidemiology/surgery', '*Bariatric Surgery']",PMC10221192,['NOTNLM'],"['bariatric surgery', 'gender', 'obesity', 'steatosis']",['The authors declare no conflict of interest.'],2023/05/27 09:42,2023/05/29 06:42,['2023/05/27 01:27'],"['2023/03/01 00:00 [received]', '2023/03/20 00:00 [revised]', '2023/03/20 00:00 [accepted]', '2023/05/29 06:42 [medline]', '2023/05/27 09:42 [pubmed]', '2023/05/27 01:27 [entrez]']","['nu15102381 [pii]', 'nutrients-15-02381 [pii]', '10.3390/nu15102381 [doi]']",epublish,Nutrients. 2023 May 19;15(10):2381. doi: 10.3390/nu15102381.,,20230519,,,"['ORCID: 0000-0002-9140-673X', 'ORCID: 0000-0001-9759-5378', 'ORCID: 0000-0002-3817-8643', 'ORCID: 0000-0002-8766-1869']",,,,,,,,,,,,,,,
15712629,NLM,MEDLINE,20050308,20161124,0163-2116 (Print) 0163-2116 (Linking),50,1,2005 Jan,"Gastric emptying, CCK release, and satiety in weight-stable obese subjects.",7-14,,"Scintigraphic gastric emptying studies are far from conclusive in obesity. The aim was to investigate gastric emptying and CCK release in weight-stable obese subjects on their usual diet and to study the impact of factors known to determine gastric emptying. Patients entering a weight reduction program were asked to participate in a study examining gastric emptying by scintigraphy and CCK release in response to a meal with questionnaires on feelings of satiety. Forty-five patients (9 M, 36 F) with a mean (SD) BMI of 37.0 (4.0) kg/m2 entered the study. The mean T50 (emptying of 50%) of fluids was 20.7 (10.3) min, and that of solids 141.9 (168.3) min. The percentage emptying of solids was 34.5 (19.9)%/hr. CCK values peaked within 42 min and paralleled the subjective ratings of satiety but did not correlate with gastric emptying. Five of 45 subjects (11%) had very prolonged gastric emptying of solids; they showed higher caloric intakes and higher insulin levels. They did not differ in CCK values and ratings of satiety but scored higher in being active and awake. Without these five subjects the T50 of solids was 94.3 (36.1) min, and the percentage of emptying 37.9 (18.4)%/hr. Liquid emptying was faster and solid emptying similar compared with those of normal-weight individuals. Height, fat-free mass, and waist-hip circumference were positively related to solid emptying. In weight-stable obese subjects liquid emptying was faster and solid emptying similar to those in normal-weight subjects. Higher caloric intakes and insulin levels were present in subjects with prolonged solid emptying; they also appeared more vigilant. Body size and composition were the only determinants suggesting a faster solid emptying in taller and muscular subjects or in subjects with more intraabdominal fat.","['Mathus-Vliegen, E M H', 'Van Ierland-Van Leeuwen, M L', 'Roolker, W']","['Mathus-Vliegen EM', 'Van Ierland-Van Leeuwen ML', 'Roolker W']","['Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. e.mathus-vliegen@amc.uva.nl']",['eng'],['Journal Article'],United States,Dig Dis Sci,Digestive diseases and sciences,7902782,['9011-97-6 (Cholecystokinin)'],IM,"['Adult', '*Body Weight', 'Cholecystokinin/*metabolism', 'Female', '*Gastric Emptying', 'Humans', 'Male', 'Middle Aged', 'Obesity/diagnostic imaging/metabolism/*pathology/*physiopathology', 'Radionuclide Imaging', '*Satiety Response', 'Time Factors']",,,,,2005/02/17 09:00,2005/03/09 09:00,['2005/02/17 09:00'],"['2005/02/17 09:00 [pubmed]', '2005/03/09 09:00 [medline]', '2005/02/17 09:00 [entrez]']",,ppublish,Dig Dis Sci. 2005 Jan;50(1):7-14.,,,,,,,,,,,,,,,,,,,,
22008790,NLM,MEDLINE,20120406,20181201,1536-7312 (Electronic) 0196-206X (Linking),32,9,2011 Nov,Can a pediatrician effectively treat a 9-year-old obese girl?,688-91,10.1097/DBP.0b013e318235ee1a [doi],": Maria is a 9-year-old Latina girl who was followed up by her pediatrician since birth with normal developmental milestones, good school achievement, and without significant medical problems. She was not in the pediatric office for the past 3 years. At the age of 9 years, she presented for a health supervision visit. Her pediatrician looked at her growth chart-90 pounds (95th percentile) and height 52 inches (50th percentile)-that confirmed a clinical impression of obesity on physical examination. Her body mass index was 23.4 (>95th percentile for age).During 10 years in primary care pediatric practice, the pediatrician typically prescribed a management plan for obese school-aged and adolescent patients that started with parent and child education about potential health problems associated with obesity followed by a recommendation to decrease the caloric intake and encourage active exercise each day. She then arranged for follow-up visits to monitor weight and adherence to the management plan. However, a moment of self-refection suggested that most of her patients did not follow her advice in a sustained way. Obesity persisted in most cases. The pediatrician wondered if there was an alternative-better yet, evidence-based-approach to pediatric obesity that might provide a better outcome.","['Rhee, Kyung Kay', 'Boutelle, Kerri', 'McKenna, Matthew', 'Stein, Martin T']","['Rhee KK', 'Boutelle K', 'McKenna M', 'Stein MT']","['Division of Child Development and Community Health (Department of Pediatrics), University of California San Diego, USA.']",['eng'],"['Case Reports', 'Journal Article']",United States,J Dev Behav Pediatr,Journal of developmental and behavioral pediatrics : JDBP,8006933,,IM,"['Body Mass Index', 'Child', 'Cognitive Behavioral Therapy/methods', 'Female', 'Humans', 'Obesity/*diagnosis/psychology/*therapy', 'Parents/psychology', 'Pediatrics/*methods']",,,,,2011/10/20 06:00,2012/04/07 06:00,['2011/10/20 06:00'],"['2011/10/20 06:00 [entrez]', '2011/10/20 06:00 [pubmed]', '2012/04/07 06:00 [medline]']",['10.1097/DBP.0b013e318235ee1a [doi]'],ppublish,J Dev Behav Pediatr. 2011 Nov;32(9):688-91. doi: 10.1097/DBP.0b013e318235ee1a.,,,,,,,,,,,,,,,,,,,,
20415166,NLM,MEDLINE,20100610,20100426,0041-4131 (Print) 0041-4131 (Linking),88,2,2010 Feb,[Predictive factors of obstructive sleep apnea syndrome in obesity].,92-6,,"BACKGROUND: Obstructive sleep apnea (OSA) syndrome is frequent, and misdiagnosed. THE AIM: Of this study is to assess the prevalence of OSA syndrome in a Tunisian population of obese (body mass index > or = 30 Kg/m2) and to determine its predictive factors. METHODS: It's a transversal study. One hundred patients (63 females, 37 males) were inculded. All patients underwent nocturnal polysomnography or respiratory polygraphy. RESULTS: Sixty-five patients had an OSA syndrome: mild (24.6%), moderate (30.7%) and severe (44.6%). We compared, by a statistical analysis, the group with OSA syndrome and the group without OSA syndrome. There was a predominance of men (81% of men vs 55.5 of women had OSA). Age was higher in the group with OSA syndrome (56.8 years +/- 10 vs 48.1 +/- 12, P = 0.04). Clinical symptoms such as snoring, daytime sleepiness, nocturnal awakening and respiratory pauses were more frequent in the group with OSA syndrome. Morphological abnormalities such as retrognathy and/or short neck were significantly more frequent in the group with OSA syndrome (p = 0.05 and 0.02 respectively). Cardiopathies and diabetes were more frequent in obese with OSA syndrome. CONCLUSION: In obese persons, male gender, comorbidities and /or clinical symptoms such as snoring, daytime sleepiness, nocturnal awakening and respiratory pauses, retrognathy and/or short neck are predictive of OSA syndrome. So, we propose a nocturnal recording in obese presenting at least one of these predictive factors.","['Maalej, Sonia', 'Aouadi, Samira', 'Ben Moussa, Hatem', 'Bourguiba, Meherzia', 'Ben Kheder, Ali', 'Drira, Ikram']","['Maalej S', 'Aouadi S', 'Ben Moussa H', 'Bourguiba M', 'Ben Kheder A', 'Drira I']","['Pneumologue AHU, Service de Pneumologie, D. Hopital Abderrahmen Mami, Ariana, Tunis.']",['fre'],"['English Abstract', 'Journal Article']",Tunisia,Tunis Med,La Tunisie medicale,0413766,,IM,"['Age Factors', 'Cross-Sectional Studies', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*complications', 'Severity of Illness Index', 'Sex Factors', 'Sleep Apnea, Obstructive/*complications', 'Smoking/epidemiology']",,,,,2010/04/27 06:00,2010/06/11 06:00,['2010/04/27 06:00'],"['2010/04/27 06:00 [entrez]', '2010/04/27 06:00 [pubmed]', '2010/06/11 06:00 [medline]']",,ppublish,Tunis Med. 2010 Feb;88(2):92-6.,,,,,,,,,Facteurs predictifs du syndrome d'apnees obstructives du sommeil chez les obeses.,,,,,,,,,,,
2704954,NLM,MEDLINE,19890515,20151119,0035-2640 (Print) 0035-2640 (Linking),39,5,1989 Feb 16,[Eating disorders and obesity].,394-8,,"In most cases, obesity does not stem from a specific psychologic disturbance. Some obese people overeat, as do their family or their socio-professional peers, and this cannot be considered a pathologic behaviour. Many obese patients increase their energy intake when frustrated, anxious, or tired, like many normal individuals who enjoy a better weight regulation. But when obesity increases suddenly and/or severely in these circumstances, and in gross obesity, abnormal feeding behaviour is usually responsible: prandial or, more often extraprandial overeating (nibbling, gorging, binge eating, night eating, excess alcohol, carbohydrate craving). Serotoninergic mechanisms of the latter have focused wide interest. Conflicting situations and/or anxiety are usually a factor in child obesity. Deppreciated self-image and feelings of culpability, partly secondary to obesity itself and dietary failures often contribute to feeding disturbances, sometimes surreptitious, carrying a risk of vicious circle. But weight reduction itself, while improving self image, carries a risk of unmasking depressive tendencies, especially when too quick. Hence the importance of careful and comprehensive management.","['Wolf, L M', 'Houdent, C']","['Wolf LM', 'Houdent C']",,['fre'],"['English Abstract', 'Journal Article']",France,Rev Prat,La Revue du praticien,0404334,,,"['Feeding and Eating Disorders/*complications/psychology/therapy', 'Humans', 'Obesity/*complications/psychology']",,,,,1989/02/16 00:00,1989/02/16 00:01,['1989/02/16 00:00'],"['1989/02/16 00:00 [pubmed]', '1989/02/16 00:01 [medline]', '1989/02/16 00:00 [entrez]']",,ppublish,Rev Prat. 1989 Feb 16;39(5):394-8.,,,,,,,,,Troubles du comportement alimentaire et obesite.,,,,,,,,,,,
3269270,NLM,MEDLINE,19891226,20140530,0231-441X (Print) 0231-441X (Linking),29,3-4,1988-1989,The joint influence of diet and increased physical activity in obese children.,373-81,,"The authors performed a three week treatment and examination of 20 children with obesity of non-endocrine origin, and they compared the examination results with those of healthy children. The treatment of the obese children consisted of a diet and an individually determined training programme. In the course of the examinations it was established that the weight of the obese children decreased, their physical working capacity increased, their glucose and fat metabolism showed a tendency to improve. On the basis of all their findings authors wish to stress the importance of the primary and secondary prevention of cardio-vascular diseases as early as in childhood.","['Peja, M', 'Velkey, L']","['Peja M', 'Velkey L']","['Department of Rehabilitation Miskolc, Hungary.']",['eng'],['Journal Article'],Hungary,Acta Paediatr Hung,Acta paediatrica Hungarica,8307729,['0 (Lipids)'],IM,"['Blood Pressure', 'Cardiovascular Diseases/prevention & control', 'Child', '*Diet, Reducing', '*Exercise', 'Female', 'Humans', 'Lipids/blood', 'Male', 'Obesity/blood/diet therapy/*therapy', 'Vital Capacity']",,,,,1988/01/01 00:00,1988/01/01 00:01,['1988/01/01 00:00'],"['1988/01/01 00:00 [pubmed]', '1988/01/01 00:01 [medline]', '1988/01/01 00:00 [entrez]']",,ppublish,Acta Paediatr Hung. 1988-1989;29(3-4):373-81.,,,,,,,,,,,,,,,,,,,,
21760634,NLM,MEDLINE,20120412,20220518,1930-739X (Electronic) 1930-7381 (Linking),20,1,2012 Jan,Obesity in preschoolers: behavioral correlates and directions for treatment.,3-29,10.1038/oby.2011.201 [doi],"Nearly 14% of American preschoolers (ages 2-5) are obese (BMI >/= 95th percentile for age and gender), yet this group has received little attention in the obesity intervention literature. This review examines what is known about behavioral correlates of obesity in preschoolers and the developmental context for lifestyle modification in this age group. Information was used to critically evaluate existing weight management prevention and intervention programs for preschoolers and formulate suggestions for future intervention research development. A systematic search of the medical and psychological/behavioral literatures was conducted with no date restrictions, using PubMed, PsycInfo, and MEDLINE electronic databases and bibliographies of relevant manuscripts. Evidence suggests several modifiable behaviors, such as sugar sweetened beverage intake, television use, and inadequate sleep, may differentiate obese and healthy weight preschoolers. Developmental barriers, such as food neophobia, food preferences, and tantrums challenge caregiver efforts to modify preschoolers' diet and activity and parental feeding approaches, and family routines appear related to the negative eating and activity patterns observed in obese preschoolers. Prevention programs yield modest success in slowing weight gain, but their effect on already obese preschoolers is unclear. Multi-component, family-based, behavioral interventions show initial promise in positive weight management for already obese preschoolers. Given that obesity intervention research for preschoolers is in its infancy, and the multitude of modifiable behavioral correlates for obesity in this age group, we discuss the use of an innovative and efficient research paradigm (Multiphase Optimization Strategy; MOST) to develop an optimized intervention that includes only treatment components that are found to empirically reduce obesity in preschoolers.","['Kuhl, Elizabeth S', 'Clifford, Lisa M', 'Stark, Lori J']","['Kuhl ES', 'Clifford LM', 'Stark LJ']","[""Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA. Elizabeth.Kuhl@cchmc.org""]",['eng'],"['Journal Article', 'Research Support, N.I.H., Extramural', 'Review']",United States,Obesity (Silver Spring),"Obesity (Silver Spring, Md.)",101264860,,IM,"['*Behavior Therapy', '*Child Behavior/psychology', 'Child, Preschool', 'Energy Intake', 'Exercise', 'Family Health', '*Feeding Behavior/psychology', 'Female', 'Food Preferences', 'Humans', 'Male', 'Obesity/epidemiology/*prevention & control/psychology', 'Parenting', 'United States/epidemiology']",,,,,2011/07/16 06:00,2012/04/13 06:00,['2011/07/16 06:00'],"['2011/07/16 06:00 [entrez]', '2011/07/16 06:00 [pubmed]', '2012/04/13 06:00 [medline]']","['oby2011201 [pii]', '10.1038/oby.2011.201 [doi]']",ppublish,Obesity (Silver Spring). 2012 Jan;20(1):3-29. doi: 10.1038/oby.2011.201. Epub 2011 Jul 14.,"['K24 DK059492/DK/NIDDK NIH HHS/United States', 'T32 DK063929/DK/NIDDK NIH HHS/United States']",20110714,['Obesity (Silver Spring). 2012 Sep;20(9):1955'],,,,,,,,,,,,,,,,,
37500214,NLM,MEDLINE,20230731,20230731,1558-0474 (Electronic) 0889-8545 (Linking),50,3,2023 Sep,Prenatal Care for the Obese and Severely Obese Pregnant Patient.,525-534,S0889-8545(23)00060-8 [pii] 10.1016/j.ogc.2023.03.013 [doi],"Modifications of prenatal care will be needed in expected weight gain, nutritional recommendations, screening tests, thromboprophylaxis, ultrasound, antenatal testing, and timing and mode of delivery.","['Palaszewski, Dawn']",['Palaszewski D'],['University of South Florida Morsani College of Medicine. Electronic address: dawnpalaszewski@gmail.com.'],['eng'],"['Journal Article', 'Review']",United States,Obstet Gynecol Clin North Am,Obstetrics and gynecology clinics of North America,8709551,['0 (Anticoagulants)'],IM,"['Pregnancy', 'Female', 'Humans', 'Prenatal Care', 'Anticoagulants', '*Pregnancy Complications/therapy/prevention & control', '*Venous Thromboembolism', 'Obesity/complications/therapy']",,['NOTNLM'],"['Antepartum', 'Obese', 'Obesity', 'Pregnancy', 'Prenatal care']",,2023/07/28 01:08,2023/07/31 06:42,['2023/07/27 20:56'],"['2023/07/31 06:42 [medline]', '2023/07/28 01:08 [pubmed]', '2023/07/27 20:56 [entrez]']","['S0889-8545(23)00060-8 [pii]', '10.1016/j.ogc.2023.03.013 [doi]']",ppublish,Obstet Gynecol Clin North Am. 2023 Sep;50(3):525-534. doi: 10.1016/j.ogc.2023.03.013. Epub 2023 May 8.,,20230508,,['Copyright (c) 2023 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
28475603,NLM,MEDLINE,20170915,20190208,1932-6203 (Electronic) 1932-6203 (Linking),12,5,2017,The impact of obesity on neuropsychological functioning in adults with and without major depressive disorder.,e0176898,10.1371/journal.pone.0176898 [doi] e0176898,"BACKGROUND: Evidence suggests obesity exerts a negative impact on cognition. Major Depressive Disorder (MDD) is also linked to problems in cognitive functioning. Obesity is highly prevalent in individuals with MDD and is linked to a failure to return to a full level of functioning. The study's objective was to investigate the effect of obesity on cognitive impairment in participants with MDD. METHODS: This study compared cognitive performance in obese individuals with MDD and two control populations (obese individuals without a psychiatric illness and non-obese controls). A standardized battery of neuropsychological tests specifically designed to assess performance in declarative memory, executive functioning, processing speed and attention was administered. Mood ratings, physical measurements, nutritional and health questionnaires were also completed. RESULTS: We observed a consistent pattern across measures of memory, executive functioning, attention and processing speed. Whereas healthy controls performed better than both bariatric groups across the majority of measures administered, bariatric controls tended to outperform bariatric MDD patients. LIMITATIONS: The overall sample size of our study was small and thus largely explorative in nature. However, it provides compelling results (while controlling for extraneous variables such as medication load, nutritional status and common metabolic comordidities) that strongly urges for further investigation and study replication with larger sample sizes. CONCLUSIONS: We found obesity has a subtle impact on cognition in obese individuals, and when obesity is present in individuals with MDD, this impact may be significant. It is important to minimize all modifiable variables that can add to cognitive burden in this population.","['Restivo, Maria R', 'McKinnon, Margaret C', 'Frey, Benicio N', 'Hall, Geoffrey B', 'Syed, Wasimuddin', 'Taylor, Valerie H']","['Restivo MR', 'McKinnon MC', 'Frey BN', 'Hall GB', 'Syed W', 'Taylor VH']","[""Womens College Research Institute, Women's College Hospital, Toronto, Ontario, Canada."", 'Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.', ""Mood Disorders Program and Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada."", 'Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada.', ""Mood Disorders Program and Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada."", 'Department of Psychology, Neuroscience & Behaviour, McMaster University, Hamilton, Ontario, Canada.', 'Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.', ""Womens College Research Institute, Women's College Hospital, Toronto, Ontario, Canada."", 'Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.']",['eng'],['Journal Article'],United States,PLoS One,PloS one,101285081,,IM,"['Adult', 'Depressive Disorder, Major/*complications', 'Female', 'Humans', 'Male', 'Middle Aged', '*Neuropsychological Tests', 'Obesity/complications/*psychology']",PMC5419516,,,"['Competing Interests: Dr. Valerie Taylor received an unrestricted educational', 'grant from Bristol Myers Squibb to help fund this study. They had no role in', 'study design, data collection and analysis, decision to publish, or preparation', 'of the manuscript. This does not alter our adherence to PLOS ONE policies on', 'sharing data and materials. This unrestricted educational grant did not provide', 'any interference whatsoever with the full and objective presentation, peer', 'review, editorial decision-making, or publication of research or non-research', 'articles submitted to PLOS ONE.']",2017/05/06 06:00,2017/09/16 06:00,['2017/05/06 06:00'],"['2016/09/29 00:00 [received]', '2017/03/18 00:00 [accepted]', '2017/05/06 06:00 [entrez]', '2017/05/06 06:00 [pubmed]', '2017/09/16 06:00 [medline]']","['PONE-D-16-38919 [pii]', '10.1371/journal.pone.0176898 [doi]']",epublish,PLoS One. 2017 May 5;12(5):e0176898. doi: 10.1371/journal.pone.0176898. eCollection 2017.,,20170505,,,['ORCID: 0000-0003-2519-9143'],,,,,,,,,,,,,,,
34283409,NLM,MEDLINE,20220510,20220510,1590-1262 (Electronic) 1124-4909 (Linking),27,4,2022 May,The role of body image in obese identity changes post bariatric surgery.,1269-1278,10.1007/s40519-021-01270-w [doi],"PURPOSE: Body image is a multidimensional construct that encompasses perceptions about body size, emotions, and cognition about physical appearance. Obese identity is related to body image in the lifetime, and according to scientific literature body image dissatisfaction among obese patient persist after bariatric surgery. The objective of this review is to examine the body image changes in patients with obesity pre-and post-bariatric surgery. METHODS: We have carried out a systematic review of literature on PubMed. Initially, 169 publications have been identified, but in total, in compliance with inclusion and exclusion criteria, 15 studies have been analyzed. RESULTS: According to the examined literature, body image does not change after bariatric surgery. These patients will be difficult to adapt for a new body, because there is a persistent obese view of self. Furthermore, ex-obese patients are dissatisfied with the excessive skin after bariatric surgery. Excessive body weight, and negative self-image are replaced with dissatisfaction with excessive skin, and the factors associated with body image stability are still unknown. CONCLUSION: Literature examination raises the issue of body image dissatisfaction, but does not explain why it varies so widely across bariatric patients. Obese identity is related to body image across the lifetime and is an important factor of post-surgical outcomes. Longitudinal studies based on ideal body image pre- and post- bariatric surgery and evidence-based controlled studies on psychotherapeutic treatment for body image dissatisfaction are strongly recommended. Psychotherapy could improve body image quality and wellbeing. LEVEL I: Evidence obtained from: systematic reviews of experimental studies.","['Mento, Carmela', 'Silvestri, Maria Catena', 'Muscatello, Maria Rosaria Anna', 'Rizzo, Amelia', 'Celebre, Laura', 'Cedro, Clemente', 'Zoccali, Rocco Antonio', 'Navarra, Giuseppe', 'Bruno, Antonio']","['Mento C', 'Silvestri MC', 'Muscatello MRA', 'Rizzo A', 'Celebre L', 'Cedro C', 'Zoccali RA', 'Navarra G', 'Bruno A']","['Clinical Psychology, Psychiatric Unit, Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Policlinico Hospital Messina, University of Messina, Consolare Valeria str. 1, 98125, Messina, Italy. cmento@unime.it.', 'University of Messina, Messina, Italy.', 'Psychiatric Unit, BIOMORF Department, Policlinico Hospital in Messina, University of Messina, Messina, Italy.', 'Psychiatric Unit, Policlinico Hospital Messina, University of Messina, Messina, Italy.', 'Psychiatric Unit, Policlinico Hospital Messina, University of Messina, Messina, Italy.', 'University of Messina, Messina, Italy.', 'Psychiatric Unit, BIOMORF Department, Policlinico Hospital in Messina, University of Messina, Messina, Italy.', 'General Surgery Unit, Department of Human Pathology of Adult and Evolutive Age, University Hospital of Messina, Via Consolare Valeria 1, 98125, Messina, ME, Italy.', 'Psychiatric Unit, BIOMORF Department, Policlinico Hospital in Messina, University of Messina, Messina, Italy.']",['eng'],"['Journal Article', 'Review', 'Systematic Review']",Germany,Eat Weight Disord,Eating and weight disorders : EWD,9707113,,IM,"['*Bariatric Surgery/psychology', 'Body Image/psychology', 'Humans', 'Obesity/psychology/surgery', '*Obesity, Morbid/surgery', 'Self Concept', 'Weight Loss']",,['NOTNLM'],"['Bariatric patients', 'Body image', 'Eating disorders', 'Obese identity']",,2021/07/21 06:00,2022/05/11 06:00,['2021/07/20 12:32'],"['2020/12/28 00:00 [received]', '2021/07/07 00:00 [accepted]', '2021/07/21 06:00 [pubmed]', '2022/05/11 06:00 [medline]', '2021/07/20 12:32 [entrez]']","['10.1007/s40519-021-01270-w [pii]', '10.1007/s40519-021-01270-w [doi]']",ppublish,Eat Weight Disord. 2022 May;27(4):1269-1278. doi: 10.1007/s40519-021-01270-w. Epub 2021 Jul 20.,,20210720,,"['(c) 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.']",['ORCID: 0000-0003-4611-3740'],,,,,,,,,,,,,,,
22306619,NLM,MEDLINE,20131211,20211021,1720-8386 (Electronic) 0391-4097 (Linking),36,2,2013 Feb,Measuring changes after multidisciplinary rehabilitation of obese individuals.,72-7,10.3275/8240 [doi],"BACKGROUND: In 2009, the Italian Society of Obesity developed the short-form questionnaire for Obesity-related Disabilities (TSD-OC). AIMS: To stage the degree of disability in obese patients using TSD-OC; to verify its sensitivity to change after rehabilitation. SUBJECTS: Three hundred and fifty-five adult obese individuals [body mass index (BMI) >30 kg/m2] undergoing rehabilitation. Exclusion criteria were severe cardiovascular or respiratory diseases, neurological and psychological conditions. Sensitivity to change of TSD-OC was evaluated in 194 patients out of the initial sample. METHODS: To define the disability levels according to TSD-OC, the method of interquartile range was applied to the initial sample. The 194 in-patients were assessed with Roland-Morris Disability Questionnaire, Functional Independence Measure (FIM), Functional Visual Analogue Scale, and TSD-OC before (S0) and after 4 weeks (S1) of intensive (3 h daily) rehabilitation multidisciplinary program. Individuals were grouped according to age (1: age 30-59 yr; 2: age over 60 yr) and degree of obesity (BMI: A, 30-40 kg/m2; B, 40-50 kg/m2). RESULTS: At S1, BMI and all the clinical scores improved significantly in the whole study sample. The younger individuals with higher level of obesity showed a higher functional improvement (-51.3%). In the older subjects, improvement was not statistically different when varying BMI (A2 -13.7% vs B2 -14.6%). In the whole group, the TSD-OC improvement was statistically greater than the physical FIM gain (-25.9% vs +5.4%, p<0.05). CONCLUSIONS: Our data evidenced that the TSD-OC is a sensitive measure of short-term changes in disability status of obese individuals after rehabilitation.","['Precilios, H', 'Brunani, A', 'Cimolin, V', 'Tacchini, E', 'Donini, L M', 'Fabris De Souza, S', 'Capodaglio, P']","['Precilios H', 'Brunani A', 'Cimolin V', 'Tacchini E', 'Donini LM', 'Fabris De Souza S', 'Capodaglio P']","['Rehabilitation Unit and Laboratory of Research in Biomechanics and Rehabilitation, S. Giuseppe Hospital, Istituto Auxologico Italiano IRCCS, Verbania-Piancavallo, Italy.']",['eng'],['Journal Article'],Italy,J Endocrinol Invest,Journal of endocrinological investigation,7806594,,IM,"['Adult', 'Aged', 'Aged, 80 and over', 'Combined Modality Therapy/methods', 'Disabled Persons/*rehabilitation', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/diagnosis/*epidemiology/*rehabilitation', 'Surveys and Questionnaires/*standards']",,,,,2012/02/07 06:00,2013/12/16 06:00,['2012/02/07 06:00'],"['2012/02/07 06:00 [entrez]', '2012/02/07 06:00 [pubmed]', '2013/12/16 06:00 [medline]']","['8240 [pii]', '10.3275/8240 [doi]']",ppublish,J Endocrinol Invest. 2013 Feb;36(2):72-7. doi: 10.3275/8240. Epub 2012 Jan 31.,,20120131,,,,,,,,,,,,,,,,,,
18375777,NLM,MEDLINE,20080811,20180307,0145-7217 (Print) 0145-7217 (Linking),34,2,2008 Mar-Apr,A qualitative assessment of barriers and facilitators to achieving behavior goals among obese inner-city adolescents in a weight management program.,277-84,10.1177/0145721708314182 [doi],"PURPOSE: The purpose of this study was (1) to examine the reasons for managing weight, (2) to investigate the barriers and facilitators to achieving behavior goals, and (3) to assess how a behavior coach affects the goal-setting process of obese inner-city adolescents in a weight management program. METHODS: Obese adolescents participating in a pilot study assessing the role of a behavior coach on successful weight management (n = 18) were interviewed to identify barriers and facilitators to reaching behavior goals. Data were analyzed using descriptive statistics and the constant comparative method of qualitative analysis. RESULTS: In the rationale for weight control, adolescent girls and boys reported a desire to improve physical appearance and physical conditioning, respectively. Barriers to reaching physical activity goals among girls included unsafe neighborhoods and a negative body image. Maintaining unrealistic behavior and weight goals hindered satisfaction with behavior change and weight loss in both genders. Overall, coaching provided support that helped the obese teens feel more successful in the goal-setting process and address issues related to their disruptive environments. CONCLUSIONS: Diabetes educators can include a behavior coach as part of a weight management program to help teens set behavior goals and overcome barriers to reaching behavior goals.","['Alm, Mary', 'Soroudi, Nafisseh', 'Wylie-Rosett, Judith', 'Isasi, Carmen R', 'Suchday, Sonia', 'Rieder, Jessica', 'Khan, Unab']","['Alm M', 'Soroudi N', 'Wylie-Rosett J', 'Isasi CR', 'Suchday S', 'Rieder J', 'Khan U']","['The Department of Pediatrics and Adolescent Health, University of Minnesota, Minneapolis, Minnesota (MA)', 'Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts (NS)', 'Department of Epidemiology and Population Health, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York (JW-R, CRI, SS)', 'Department of Epidemiology and Population Health, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York (JW-R, CRI, SS)', 'Department of Epidemiology and Population Health, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York (JW-R, CRI, SS)', 'Department of Pediatrics, Division of Adolescent Medicine, Montefiore Medical Center, Bronx, New York (JR, UK)', 'Department of Pediatrics, Division of Adolescent Medicine, Montefiore Medical Center, Bronx, New York (JR, UK)']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Diabetes Educ,The Diabetes educator,7701401,,,"['Adolescent', 'Diabetes Mellitus, Type 2/prevention & control', 'Female', 'Health Behavior', 'Humans', 'Male', 'New York City', 'Obesity/complications/psychology/*rehabilitation', 'Obesity, Morbid/rehabilitation', 'Pilot Projects', 'Psychology, Adolescent', '*Urban Population', '*Weight Loss']",,,,,2008/04/01 09:00,2008/08/12 09:00,['2008/04/01 09:00'],"['2008/04/01 09:00 [pubmed]', '2008/08/12 09:00 [medline]', '2008/04/01 09:00 [entrez]']","['34/2/277 [pii]', '10.1177/0145721708314182 [doi]']",ppublish,Diabetes Educ. 2008 Mar-Apr;34(2):277-84. doi: 10.1177/0145721708314182.,,,,,,,,,,,,,,,,,,,,
26018910,NLM,MEDLINE,20160404,20181113,1932-6203 (Electronic) 1932-6203 (Linking),10,5,2015,Relationship between Body Mass Index and Percent Body Fat in Vietnamese: Implications for the Diagnosis of Obesity.,e0127198,10.1371/journal.pone.0127198 [doi] e0127198,"BACKGROUND: The burden of obesity in Vietnam has not been well defined because there is a lack of reference data for percent body fat (PBF) in Asians. This study sought to define the relationship between PBF and body mass index (BMI) in the Vietnamese population. METHODS: The study was designed as a comparative cross-sectional investigation that involved 1217 individuals of Vietnamese background (862 women) aged 20 years and older (average age 47 yr) who were randomly selected from the general population in Ho Chi Minh City. Lean mass (LM) and fat mass (FM) were measured by DXA (Hologic QDR 4500). PBF was derived as FM over body weight. RESULTS: Based on BMI >/=30, the prevalence of obesity was 1.1% and 1.3% for men and women, respectively. The prevalence of overweight and obesity combined (BMI >/=25) was ~24% and ~19% in men and women, respectively. Based on the quadratic relationship between BMI and PBF, the approximate PBF corresponding to the BMI threshold of 30 (obese) was 30.5 in men and 41 in women. Using the criteria of PBF >30 in men and PBF >40 in women, approximately 15% of men and women were considered obese. CONCLUSION: These data suggest that body mass index underestimates the prevalence of obesity. We suggest that a PBF >30 in men or PBF >40 in women is used as criteria for the diagnosis of obesity in Vietnamese adults. Using these criteria, 15% of Vietnamese adults in Ho Chi Minh City was considered obese.","['Ho-Pham, Lan T', 'Lai, Thai Q', 'Nguyen, Mai T T', 'Nguyen, Tuan V']","['Ho-Pham LT', 'Lai TQ', 'Nguyen MT', 'Nguyen TV']","[""Bone and Muscle Research Division, Faculty of Applied Sciences, Ton DucThang University, Ho Chi Minh City, Vietnam; Department of Internal Medicine, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam; Department of Rheumatology, People's Hospital 115, Ho Chi Minh City, Vietnam."", ""Department of Rheumatology, People's Hospital 115, Ho Chi Minh City, Vietnam."", 'Department of Medical Ethic-Behavioral Science, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.', 'Bone and Muscle Research Division, Faculty of Applied Sciences, Ton DucThang University, Ho Chi Minh City, Vietnam; Osteoporosis and Bone Biology, Garvan Institute of Medical Research, Sydney, Australia; School of Public Health and Community Medicine, UNSW Australia, Sydney, Australia; Centre for Health Technologies, University of Technology, Sydney, Australia.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,PLoS One,PloS one,101285081,,IM,"['Adipose Tissue/*metabolism', 'Adolescent', 'Adult', '*Body Mass Index', 'Female', 'Humans', 'Male', 'Middle Aged', 'Obesity/*diagnosis/epidemiology/*metabolism', 'Vietnam/epidemiology', 'Young Adult']",PMC4446298,,,['Competing Interests: The authors have declared that no competing interests exist.'],2015/05/29 06:00,2016/04/05 06:00,['2015/05/29 06:00'],"['2015/02/20 00:00 [received]', '2015/04/13 00:00 [accepted]', '2015/05/29 06:00 [entrez]', '2015/05/29 06:00 [pubmed]', '2016/04/05 06:00 [medline]']","['PONE-D-15-07812 [pii]', '10.1371/journal.pone.0127198 [doi]']",epublish,PLoS One. 2015 May 27;10(5):e0127198. doi: 10.1371/journal.pone.0127198. eCollection 2015.,,20150527,,,,,,,,,,,,,,,,,,
855817,NLM,MEDLINE,19770622,20180330,0002-9165 (Print) 0002-9165 (Linking),30,5,1977 May,A behavioral approach to obesity.,785-9,,"For many individuals, the practice of overeating is crucial in the development and maintenance of the obese state. Behavior theory views excessive eating leading to obesity as an overlearned habit, strongly conditioned to numerous internal and external cues. A number of studies are reviewed that assess the relationship between emotional arousal and food consumption. Obese persons who successfully lost and maintained a weight loss appeared able to reduce the number of inappropriate stimuli they previously responded to with food intake. The specific behavior modification techniques employed to change eating patterns are discussed, and weight loss maintenance follow-up statistics using these procedures are presented.","['Leon, G R']",['Leon GR'],,['eng'],['Journal Article'],United States,Am J Clin Nutr,The American journal of clinical nutrition,0376027,,IM,"['Arousal', '*Behavior Therapy', 'Diet', 'Emotions', 'Feeding Behavior', 'Female', 'Follow-Up Studies', 'Humans', 'Male', 'Obesity/etiology/*therapy']",,,,,1977/05/01 00:00,1977/05/01 00:01,['1977/05/01 00:00'],"['1977/05/01 00:00 [pubmed]', '1977/05/01 00:01 [medline]', '1977/05/01 00:00 [entrez]']",['10.1093/ajcn/30.5.785 [doi]'],ppublish,Am J Clin Nutr. 1977 May;30(5):785-9. doi: 10.1093/ajcn/30.5.785.,,,,,,,,,,,,,,,,,,,,
30973930,NLM,MEDLINE,20200129,20200309,1932-6203 (Electronic) 1932-6203 (Linking),14,4,2019,Relationship between individual ventilatory threshold and maximal fat oxidation (MFO) over different obesity classes in women.,e0215307,10.1371/journal.pone.0215307 [doi] e0215307,"OBJECTIVE: The use of the Individual Ventilatory Threshold (IVT), as parameter to prescribe exercise intensity in individuals with obesity, has become more frequent during the last years. This study aimed to evaluate the relationship between IVT and Maximal Fat Oxidation (MFO) in women with obesity. METHODS: Fifty-two obese female adults (age = 43.6+/-10.9 years; BMI = 38.5+/-5.2 kg/m2) were included in this study. According to the BMI classification, subjects were divided into three groups: Obese Class I (OBI, n = 16); Obese Class II (OBII, n = 20) and Obese Class III (OBIII, n = 16). All subjects performed an incremental graded exercise test to evaluate peak oxygen uptake (VO2peak), IVT and MFO. MFO was evaluated using a stoichiometric equation. Fat max zone was determined for each subject within 10% of fat oxidation rates at MFO. For each HR, %HRmax, VO2 and %VO2peak variable, Pearson's correlation test was done between IVT and MFO exercise intensity. When statistical correlation was found we used a comparative statistical analysis to assess differences between IVT and MFO. Statistical significance was set at P </= 0.05. RESULTS: For each HR, %HRmax, VO2 and %VO2peak variable there was a positive significant correlation (P<0.01) between IVT and MFO. No significant differences were found for HR, %HRmax, and VO2 between IVT and MFO. %VO2peak was significantly higher at IVT than at MFO (P = 0.03). MFO rates were significantly higher in OBIII women than in women of the other two classes. In all subjects, IVT was within the fat max zone. CONCLUSION: The use of HR and VO2 corresponding to IVT could be a useful parameter not only to improve cardiorespiratory fitness but also to prescribe physical activity that maximize fat oxidation in obese subjects.","['Emerenziani, Gian Pietro', 'Ferrari, Dafne', 'Marocco, Chiara', 'Greco, Emanuela A', 'Migliaccio, Silvia', 'Lenzi, Andrea', 'Baldari, Carlo', 'Guidetti, Laura']","['Emerenziani GP', 'Ferrari D', 'Marocco C', 'Greco EA', 'Migliaccio S', 'Lenzi A', 'Baldari C', 'Guidetti L']","['Department of Experimental and Clinical Medicine, University of Magna Graecia of Catanzaro, Catanzaro, Italy.', 'Department of Movement, Human and Health Sciences, Section of Health Sciences, University of Rome ""Foro Italico"", Rome, Italy.', 'Department of Movement, Human and Health Sciences, Section of Health Sciences, University of Rome ""Foro Italico"", Rome, Italy.', 'Department of Experimental Medicine, Section of Medical Pathophysiology, Endocrinology and Nutrition, Sapienza University of Rome, Rome, Italy.', 'Department of Movement, Human and Health Sciences, Section of Health Sciences, University of Rome ""Foro Italico"", Rome, Italy.', 'Department of Experimental Medicine, Section of Medical Pathophysiology, Endocrinology and Nutrition, Sapienza University of Rome, Rome, Italy.', 'University eCampus, Novedrate, Italy.', 'Department of Movement, Human and Health Sciences, Section of Health Sciences, University of Rome ""Foro Italico"", Rome, Italy.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,PLoS One,PloS one,101285081,,IM,"['Adipose Tissue/metabolism', 'Adult', 'Calorimetry, Indirect', 'Cardiorespiratory Fitness/*physiology', 'Exercise/physiology', 'Exercise Test', 'Female', 'Heart Rate/physiology', 'Humans', 'Middle Aged', 'Obesity/metabolism/*physiopathology/therapy', 'Obesity, Morbid/metabolism/physiopathology/therapy', 'Oxidation-Reduction', 'Oxygen Consumption']",PMC6459513,,,['The authors have declared that no competing interests exist.'],2019/04/12 06:00,2020/01/30 06:00,['2019/04/12 06:00'],"['2018/11/12 00:00 [received]', '2019/03/29 00:00 [accepted]', '2019/04/12 06:00 [entrez]', '2019/04/12 06:00 [pubmed]', '2020/01/30 06:00 [medline]']","['PONE-D-18-32476 [pii]', '10.1371/journal.pone.0215307 [doi]']",epublish,PLoS One. 2019 Apr 11;14(4):e0215307. doi: 10.1371/journal.pone.0215307. eCollection 2019.,,20190411,,,"['ORCID: 0000-0001-6227-3571', 'ORCID: 0000-0002-1419-4550']",,,,,,,,,,,,,,,
9648381,NLM,MEDLINE,19980723,20061115,1165-1083 (Print) 1165-1083 (Linking),26,5,1998 May,[Influence of weight and distribution of adipose tissue in functional hyperandrogenism].,372-5,,"Approximately half the women with the polycystic ovary syndrome (PCOS) are obese or overweight. Obesity and body fat distribution have independent roles in the development of hyperandrogenism in PCOS. Most obese and normal weight PCOS are insulin resistant and hyperinsulinemic. Moreover, a significant positive correlation exists between the degree of hyperandrogenism and that of hyperinsulinism. The pathogenetic role of obesity may involve different mechanisms, the major one being the hyperinsulemic state, since insulin is capable of stimulating ovarian androgen secretion and controlling androgen metabolism and transport in peripheral tissues. Abdominal body fat distribution in obese women with PCOS amplifies the degree of hyperandrogenism and related clinical symptoms and signs. Both loss of body weight and/or the reduction of the degree of hyperinsuliemia, induced by diet or insulin-sensitizing drugs, have important effects, since they reduce blood androgen levels and can improve ovulation and clinical signs of hyperandrogenism.","['Pasquali, R', 'Vicennati, V', 'Gambineri, A']","['Pasquali R', 'Vicennati V', 'Gambineri A']","['Departement de Medecine Interne et Gastro-enterologie, Hopital S. Orsola-Malpighi, Bologne, Italie.']",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Contracept Fertil Sex,"Contraception, fertilite, sexualite (1992)",9314045,,IM,"['Adipose Tissue/pathology', '*Body Composition', '*Body Weight', 'Female', 'Humans', 'Hyperandrogenism/*etiology', 'Hyperinsulinism/etiology', 'Obesity/*complications/metabolism/*pathology/prevention & control', 'Polycystic Ovary Syndrome/*complications']",,,,,1998/07/02 00:00,1998/07/02 00:01,['1998/07/02 00:00'],"['1998/07/02 00:00 [pubmed]', '1998/07/02 00:01 [medline]', '1998/07/02 00:00 [entrez]']",,ppublish,Contracept Fertil Sex. 1998 May;26(5):372-5.,,,,,,,20,,Influence du poids et de la distribution du tissu adipeux sur les hyperandrogenies fonctionnelles.,,,,,,,,,,,
4563577,NLM,MEDLINE,19730109,20190913,0016-6723 (Linking),20,1,1972 Aug,Genetic control of metabolism: enzyme studies of the obese and adipose mutants in the mouse.,51-64,,,"['Bulfield, G']",['Bulfield G'],,['eng'],['Journal Article'],England,Genet Res,Genetical research,0370741,"['0 (Fatty Acids)', '2P2V9Q0E78 (Aurothioglucose)', 'EC 1.- (Oxidoreductases)']",IM,"['Animals', 'Aurothioglucose', 'Crosses, Genetic', 'Fatty Acids/analysis', 'Heterozygote', 'Homozygote', 'Liver/*enzymology', 'Mice', 'Obesity/chemically induced/*enzymology/genetics', 'Oxidoreductases/analysis']",,,,,1972/08/01 00:00,1972/08/01 00:01,['1972/08/01 00:00'],"['1972/08/01 00:00 [pubmed]', '1972/08/01 00:01 [medline]', '1972/08/01 00:00 [entrez]']",['10.1017/s0016672300013586 [doi]'],ppublish,Genet Res. 1972 Aug;20(1):51-64. doi: 10.1017/s0016672300013586.,,,,,,,,,,,,,,,,,,,,
15865357,NLM,MEDLINE,20050616,20061115,1660-9379 (Print) 1660-9379 (Linking),1,12,2005 Mar 23,[Impact of bariatric surgery on health and quality life of obese patients].,837-40,,"The important weight loss due to bariatric surgery allows to improve and even correct, a great part of the comorbidities induced by obesity, as well as quality of life, and to reduce the coming out of cardiovascular and metabolic diseases in operated patients. The impact of surgical treatment on the patient's health and quality of life also allows to reduce direct and indirect costs of morbid obesity. However, its effects on mortality have not yet been clearly proved. The preoperative evaluation and the long term follow-up by a skilled team are essential to reduce potential complications, especially on the nutritional field and the risks of recovered weight linked to binge eating disorders.","['Suter, M', 'Giusti, V']","['Suter M', 'Giusti V']","['Service de chirurgie viscerale, CHUV, 1011 Lausanne. michelsuter@netplus.ch']",['fre'],"['English Abstract', 'Journal Article', 'Review']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['*Gastric Bypass/economics', 'Humans', 'Obesity/mortality/psychology/*surgery', '*Quality of Life']",,,,,2005/05/04 09:00,2005/06/17 09:00,['2005/05/04 09:00'],"['2005/05/04 09:00 [pubmed]', '2005/06/17 09:00 [medline]', '2005/05/04 09:00 [entrez]']",,ppublish,Rev Med Suisse. 2005 Mar 23;1(12):837-40.,,,,,,,19,,Impact de la chirurgie bariatrique sur la sante et la qualite de vie du patient obese.,,,,,,,,,,,
32770198,NLM,MEDLINE,20211117,20211117,1477-4054 (Electronic) 1467-5463 (Linking),22,3,2021 May 20,Integrated omics analysis reveals the alteration of gut microbe-metabolites in obese adults.,,bbaa165 [pii] 10.1093/bib/bbaa165 [doi],"Obesity, a risk to health, is a global problem in modern society. The prevalence of obesity was approximately 13% among world's adult population. Recently, several reports suggested that the interference of gut microbiota composition and function is associated with metabolic disorders, including obesity. Gut microbiota produce a board range of metabolites involved in energy and glucose homeostasis, leading to the alteration in host metabolism. However, systematic evaluation of the relationship between gut microbiota, gut metabolite and host metabolite profiles in obese adults is still lacking. In this study, we used comparative metagenomics and metabolomics analysis to determine the gut microbiota and gut-host metabolite profiles in six normal and obese adults of Chinese origin, respectively. Following the functional and pathway analysis, we aimed to understand the possible impact of gut microbiota on the host metabolites via the change in gut metabolites. The result showed that the change in gut microbiota may result in the modulation of gut metabolites contributing to glycolysis, tricarboxylic acid cycle and homolactic fermentation. Furthermore, integrated metabolomic analysis demonstrated a possible positive correlation of dysregulated metabolites in the gut and host, including l-phenylalanine, l-tyrosine, uric acid, kynurenic acid, cholesterol sulfate and glucosamine, which were reported to contribute to metabolic disorders such as obesity and diabetes. The findings of this study provide the possible association between gut microbiota-metabolites and host metabolism in obese adults. The identified metabolite changes could serve as biomarkers for the evaluation of obesity and metabolic disorders.","['Li, Rong', 'Huang, Xue', 'Liang, Xiao', 'Su, Min', 'Lai, Keng Po', 'Chen, Jian']","['Li R', 'Huang X', 'Liang X', 'Su M', 'Lai KP', 'Chen J']","['Guilin Medical University.', 'Department of Gastroenterology.', 'Guilin Medical University.', 'Guilin Medical University.', 'Guilin Medical University.', 'Guilin Medical University.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",England,Brief Bioinform,Briefings in bioinformatics,100912837,,IM,"['Adult', 'Body Mass Index', 'Case-Control Studies', 'Feces/microbiology', 'Female', '*Gastrointestinal Microbiome', 'Humans', 'Male', 'Metabolomics', 'Obesity/blood/*metabolism/*microbiology']",,['NOTNLM'],"['LC-MS', 'gut microbiota', 'metabolite', 'metagenomics', 'obesity']",,2020/08/10 06:00,2021/11/18 06:00,['2020/08/10 06:00'],"['2020/05/28 00:00 [received]', '2020/07/01 00:00 [revised]', '2020/07/02 00:00 [accepted]', '2020/08/10 06:00 [pubmed]', '2021/11/18 06:00 [medline]', '2020/08/10 06:00 [entrez]']","['5882185 [pii]', '10.1093/bib/bbaa165 [doi]']",ppublish,Brief Bioinform. 2021 May 20;22(3):bbaa165. doi: 10.1093/bib/bbaa165.,,,,"['(c) The Author(s) 2020. Published by Oxford University Press. All rights reserved.', 'For Permissions, please email: journals.permissions@oup.com.']",['ORCID: 0000-0001-8237-6658'],,,,,,,,,,,,,,,
3600567,NLM,MEDLINE,19870728,20061115,0026-4946 (Print) 0026-4946 (Linking),39,5-6,1987 Mar 31,"[Effects of a balanced hypocaloric diet on body weight, blood pressure, lipid and lipoprotein picture of the obese child].",163-6,,,"['Pappini, A', 'Picciotti, M', 'Cordoni, A', 'Bianchi, C', 'Sterpa, A']","['Pappini A', 'Picciotti M', 'Cordoni A', 'Bianchi C', 'Sterpa A']",,['ita'],"['English Abstract', 'Journal Article']",Italy,Minerva Pediatr,Minerva pediatrica,0400740,"['0 (Lipids)', '0 (Lipoproteins)']",IM,"['Adolescent', 'Blood Pressure', 'Body Weight', 'Child', '*Diet, Reducing', 'Humans', 'Lipids/blood', 'Lipoproteins/blood', 'Obesity/blood/*diet therapy/pathology/physiopathology']",,,,,1987/03/31 00:00,1987/03/31 00:01,['1987/03/31 00:00'],"['1987/03/31 00:00 [pubmed]', '1987/03/31 00:01 [medline]', '1987/03/31 00:00 [entrez]']",,ppublish,Minerva Pediatr. 1987 Mar 31;39(5-6):163-6.,,,,,,,,,"Effetti di una dieta ipocalorica bilanciata sul peso, valori pressori, quadro lipidico e lipoproteico del ragazzo obeso.",,,,,,,,,,,
25779677,NLM,MEDLINE,20150615,20181023,1756-1833 (Electronic) 0959-8138 (Linking),350,,2015 Mar 16,We need a drug formulary for obese people.,h1356,10.1136/bmj.h1356 [doi],,"['Head, Stephen']",['Head S'],,['eng'],['Journal Article'],England,BMJ,BMJ (Clinical research ed.),8900488,,IM,"['*Formularies as Topic', 'Health Services Needs and Demand', 'Humans', 'Obesity/*drug therapy/metabolism']",,,,,2015/03/18 06:00,2015/06/16 06:00,['2015/03/18 06:00'],"['2015/03/18 06:00 [entrez]', '2015/03/18 06:00 [pubmed]', '2015/06/16 06:00 [medline]']",['10.1136/bmj.h1356 [doi]'],epublish,BMJ. 2015 Mar 16;350:h1356. doi: 10.1136/bmj.h1356.,,20150316,,,,,,,,,,,,,,,,,,
19650530,NLM,MEDLINE,20090821,20170214,0091-2174 (Print) 0091-2174 (Linking),39,1,2009,Psychiatric comorbidity and quality of life in obese patients. Results from a case-control study.,63-78,,"OBJECTIVE: The authors sought to evaluate psychiatric comorbidity, subjective quality of life, and impact of psychopathology on quality of life measures in a clinical sample of patients attending a center for the diagnosis and treatment of obesity compared to a matched sample of non-obese subjects. METHODS: Two hundred ninety-three consecutive obese patients (48 males, 245 females, mean age 45.41 +/- 13.55 yrs; mean BMI 35.60 +/- 6.20) were compared with a control group made of 293 non obese subjects (48 males, 245 females, mean age 45.66 +/- 13.86 yrs; mean BMI 21.8 +/- 2.06); all subjects were interviewed by means of SCID I and SCID II and completed the WHO-QoL-Bref, a self-administered instrument for evaluation of subjective quality of life. RESULTS: Obesity was associated with a significant lifetime major risk both for axis I (OR = 3.47, p = 0.000) and axis II disorders (OR = 2.27, p = 0.000); obesity was also associated with significantly lower measures of subjective quality of life on physical, social, and psychological domains; comorbidity with axis I/II disorders was associated with lower QoL measures on WHO-QoL-Bref, in particular among obese patients. CONCLUSIONS: Obesity is significantly associated with a significant major risk of psychiatric comorbidity and poor quality of life; comorbid mental disorders play a significant role in worsening quality of life of obese patients; a multimodal approach to the treatment of obesity, including psychiatric evaluation and intervention, is needed to improve quality of life of patients.","['Carpiniello, Bernardo', 'Pinna, Federica', 'Pillai, Gianluca', 'Nonnoi, Valentina', 'Pisano, Enrica', 'Corrias, Silvia', 'Orru, Maria Germana', 'Orru, Walter', 'Velluzzi, Fernanda', 'Loviselli, Andrea']","['Carpiniello B', 'Pinna F', 'Pillai G', 'Nonnoi V', 'Pisano E', 'Corrias S', 'Orru MG', 'Orru W', 'Velluzzi F', 'Loviselli A']","['Department of Public Health, Section of Psychiatry, University of Cagliari, Italy. bcarpini@iol.it']",['eng'],['Journal Article'],United States,Int J Psychiatry Med,International journal of psychiatry in medicine,0365646,,IM,"['Adult', 'Body Mass Index', 'Combined Modality Therapy', 'Comorbidity', 'Diagnostic and Statistical Manual of Mental Disorders', 'Female', 'Humans', 'Italy', 'Male', 'Mental Disorders/*epidemiology/psychology/therapy', 'Middle Aged', 'Obesity/*epidemiology/psychology/therapy', 'Personality Assessment', 'Psychopathology', 'Quality of Life/*psychology']",,,,,2009/08/05 09:00,2009/08/22 09:00,['2009/08/05 09:00'],"['2009/08/05 09:00 [entrez]', '2009/08/05 09:00 [pubmed]', '2009/08/22 09:00 [medline]']",['10.2190/PM.39.1.e [doi]'],ppublish,Int J Psychiatry Med. 2009;39(1):63-78. doi: 10.2190/PM.39.1.e.,,,,,,,,,,,,,,,,,,,,
17128689,NLM,MEDLINE,20061219,20181113,0027-9684 (Print) 0027-9684 (Linking),98,11,2006 Nov,Mobile health unit for minority obesity education: local residents' attitudes and perceptions.,1792-6,,"OBJECTIVE: To provide educational material to the Bronx community in their places of recreation as well as uncover attitudes and perceptions about the obesity epidemic. METHODS: Our medical team equipped a mobile health unit, called Vehicle Assisted Nutrition (VAN), with educational material and drove it to seven recreation sites in the Bronx. At these sites, participants completed a short survey, and our staff took body mass index (BMI) measurements. The medical team also distributed patient education materials pertaining to lifestyle modification and obesity. BMI and survey responses were compared and analyzed with statistical software. RESULTS: Obesity rates at these sites averaged 29.9% normal weight, 40.2% overweight, 18% class-1 obese and 11% class-2 obese or greater. Only 22.2% of normal weight, 23.3% of overweight and 43.6% of class-1 obese respondents stated that their weight was a problem (p<0.001). Most (80.6%) of the class-2 obese or greater respondents, however, stated that their weight was a problem (p<0.001). More than 44% of normal weight, 59.4% of overweight, 71.3 of class-1 obese and 90.3% of the class-2 obese or greater participants stated they were willing to do something about it (p=0.006). Of those surveyed, 37.5% of the normal weight, 54.7% of the overweight, 56.9% of the class-1 obese and 63.6% of the class-2 obese or greater indicated that they would like our help (p=0.035). More than 66% of normal weight, 41.8% of the overweight, 56.9% of the class-1 obese, and 68.9% of the class-2 obese or greater stated that they would be interested in a class to lose weight (p=0.008). CONCLUSION: Medical practitioners need to recognize the role of patients' attitudes about weight loss and clarify for patients the definitions of exercise.","['Rodriguez, Jose E', 'Burg, Jean R', 'Brown, L Steven']","['Rodriguez JE', 'Burg JR', 'Brown LS']","['Florida State University College of Medicine, Tallahassee, FL, USA. jose.rodriguez@med.fsu.edu']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,J Natl Med Assoc,Journal of the National Medical Association,7503090,,IM,"['*Attitude to Health', 'Health Behavior', 'Health Education/*organization & administration', 'Humans', '*Mobile Health Units', 'New York City', '*Obesity/prevention & control/psychology']",PMC2569789,,,,2006/11/30 09:00,2006/12/21 09:00,['2006/11/30 09:00'],"['2006/11/30 09:00 [pubmed]', '2006/12/21 09:00 [medline]', '2006/11/30 09:00 [entrez]']",,ppublish,J Natl Med Assoc. 2006 Nov;98(11):1792-6.,,,,,,,,,,,,,,,,,,,,
26541589,NLM,MEDLINE,20160915,20181113,1432-1173 (Electronic) 0017-8470 (Linking),66,12,2015 Dec,"[The ""obese"" and ""old"" male patient in dermatological practice. When should hypogonadism be considered?].",898-906,10.1007/s00105-015-3716-8 [doi],"Hypogonadism refers to reduced endocrine function of the testicles and leads to testosterone deficiency. It is often observed in older and obese men. Symptoms with the highest predictive value are reduced sexual thoughts, decreased spontaneous erections, and erectile dysfunction. After excluding contraindications (e.g., desire for children), various forms of replacement therapy are available. Studies have shown that testosterone therapy is safe if regularly checked.","['Varwig-Janssen, D', 'Ochsendorf, F']","['Varwig-Janssen D', 'Ochsendorf F']","['Klinik und Poliklinik fur Dermatologie u. Venerologie, Universitatsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246, Hamburg, Deutschland. d.varwig-janssen@uke.de.', 'Klinik fur Dermatologie, Venerologie und Allergologie, Universitatsklinikum Frankfurt, Frankfurt am Main, Deutschland.']",['ger'],"['English Abstract', 'Journal Article', 'Review']",Germany,Hautarzt,"Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete",0372755,['3XMK78S47O (Testosterone)'],IM,"['Diagnosis, Differential', 'Hormone Replacement Therapy/*methods', 'Humans', 'Hypogonadism/complications/*diagnosis/*therapy', 'Male', 'Obesity/complications/*diagnosis/therapy', 'Physical Examination/*methods', 'Testosterone/*therapeutic use']",,['NOTNLM'],"['Diabetes mellitus', 'Erectile dysfunction', 'Metabolic syndrome', 'Obesity', 'Testosterone']",,2015/11/07 06:00,2016/09/16 06:00,['2015/11/07 06:00'],"['2015/11/07 06:00 [entrez]', '2015/11/07 06:00 [pubmed]', '2016/09/16 06:00 [medline]']","['10.1007/s00105-015-3716-8 [pii]', '10.1007/s00105-015-3716-8 [doi]']",ppublish,Hautarzt. 2015 Dec;66(12):898-906. doi: 10.1007/s00105-015-3716-8.,,,,,,,,,"Der ""dicke"" und der ""alte"" Patient in der dermatologischen Praxis. Wann muss man an Hypogonadismus denken?",,,,,,,,,,,
30071209,NLM,MEDLINE,20190211,20220330,1873-7528 (Electronic) 0149-7634 (Linking),94,,2018 Nov,Hungry brains: A meta-analytical review of brain activation imaging studies on food perception and appetite in obese individuals.,271-285,S0149-7634(18)30355-5 [pii] 10.1016/j.neubiorev.2018.07.017 [doi],"The dysregulation of food intake in chronic obesity has been explained by different theories. To assess their explanatory power, we meta-analyzed 22 brain-activation imaging studies. We found that obese individuals exhibit hyper-responsivity of the brain regions involved in taste and reward for food-related stimuli. Consistent with a Reward Surfeit Hypothesis, obese individuals exhibit a ventral striatum hyper-responsivity in response to pure tastes, particularly when fasting. Furthermore, we found that obese subjects display more frequent ventral striatal activation for visual food cues when satiated: this continued processing within the reward system, together with the aforementioned evidence, is compatible with the Incentive Sensitization Theory. On the other hand, we did not find univocal evidence in favor of a Reward Deficit Hypothesis nor for a systematic deficit of inhibitory cognitive control. We conclude that the available brain activation data on the dysregulated food intake and food-related behavior in chronic obesity can be best framed within an Incentive Sensitization Theory. Implications of these findings for a brain-based therapy of obesity are briefly discussed.","['Devoto, F', 'Zapparoli, L', 'Bonandrini, R', 'Berlingeri, M', 'Ferrulli, A', 'Luzi, L', 'Banfi, G', 'Paulesu, E']","['Devoto F', 'Zapparoli L', 'Bonandrini R', 'Berlingeri M', 'Ferrulli A', 'Luzi L', 'Banfi G', 'Paulesu E']","['fMRI Unit, IRCSS Istituto Ortopedico Galeazzi, Milan, Italy; Department of Psychology and PhD Program in Neuroscience of the School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.', 'fMRI Unit, IRCSS Istituto Ortopedico Galeazzi, Milan, Italy.', 'Department of Psychology and NeuroMi - Milan Centre for Neuroscience, University of Milano-Bicocca, Milan, Italy.', 'DISTUM, Department of Humanistic Studies, University of Urbino Carlo Bo, Urbino, Italy; Center of Developmental Neuropsychology, ASUR Marche, Area Vasta 1, Pesaro, Italy.', 'Endocrinology and Metabolic Diseases Unit, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.', 'Endocrinology and Metabolic Diseases Unit, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy; Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.', 'fMRI Unit, IRCSS Istituto Ortopedico Galeazzi, Milan, Italy; University Vita e Salute San Raffaele, Milan, Italy.', 'fMRI Unit, IRCSS Istituto Ortopedico Galeazzi, Milan, Italy; Department of Psychology and NeuroMi - Milan Centre for Neuroscience, University of Milano-Bicocca, Milan, Italy. Electronic address: eraldo.paulesu@unimib.it.']",['eng'],"['Journal Article', 'Meta-Analysis', ""Research Support, Non-U.S. Gov't"", 'Review']",United States,Neurosci Biobehav Rev,Neuroscience and biobehavioral reviews,7806090,,IM,"['Animals', 'Appetite/*physiology', 'Brain/*diagnostic imaging/physiopathology', '*Food', 'Humans', '*Neuroimaging', 'Obesity/*diagnostic imaging/physiopathology/psychology', 'Perception/*physiology']",,['NOTNLM'],"['Activation likelihood estimation', 'Hierarchical clustering', 'Meta-analysis', 'Neuroimaging', 'Obesity', 'Reward system']",,2018/08/03 06:00,2019/02/12 06:00,['2018/08/03 06:00'],"['2018/05/22 00:00 [received]', '2018/07/06 00:00 [revised]', '2018/07/25 00:00 [accepted]', '2018/08/03 06:00 [pubmed]', '2019/02/12 06:00 [medline]', '2018/08/03 06:00 [entrez]']","['S0149-7634(18)30355-5 [pii]', '10.1016/j.neubiorev.2018.07.017 [doi]']",ppublish,Neurosci Biobehav Rev. 2018 Nov;94:271-285. doi: 10.1016/j.neubiorev.2018.07.017. Epub 2018 Jul 30.,,20180730,,['Copyright (c) 2018 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
11013799,NLM,MEDLINE,20001019,20181113,0008-350X (Print) 1715-5258 (Electronic) 0008-350X (Linking),46,,2000 Sep,Treating obesity. Lost cause or new opportunity?,1806-13,,"OBJECTIVE: To review therapies for treating obese patients. QUALITY OF EVIDENCE: Advice in this paper is based mainly on the results of randomized controlled trials. Some data from smaller, more physiologic studies are included. When appropriate, advice is based on consensus. MAIN MESSAGE: Recent medical evidence indicates that a modest weight loss (5% to 10%) can alleviate symptoms of obesity-related comorbidity. Treatment of obesity should be comprehensive and integrated into a multi-component approach and should involve both patients and their families. The main challenge of obesity is maintaining a reduced weight. CONCLUSION: A multi-component approach to treating obesity can help make treatment less frustrating and more rewarding for patients and physicians.","['Plourde, G']",['Plourde G'],"['Obesity Research Centre, Columbia University, New York, NY, USA. dr_plourde@hotmail.com']",['eng'],"['Journal Article', 'Review']",Canada,Can Fam Physician,Canadian family physician Medecin de famille canadien,0120300,['0 (Anti-Obesity Agents)'],IM,"['Anti-Obesity Agents/therapeutic use', 'Behavior Therapy', 'Body Weight', 'Combined Modality Therapy', 'Comorbidity', 'Diet, Reducing', 'Evidence-Based Medicine', 'Exercise Therapy', 'Humans', 'Medical History Taking', 'Obesity/classification/diagnosis/epidemiology/etiology/*therapy', 'Physical Examination', 'Prevalence', 'Risk Factors', 'Treatment Outcome', 'Weight Loss']",PMC2145045,,,,2000/10/03 11:00,2000/10/21 11:01,['2000/10/03 11:00'],"['2000/10/03 11:00 [pubmed]', '2000/10/21 11:01 [medline]', '2000/10/03 11:00 [entrez]']",,ppublish,Can Fam Physician. 2000 Sep;46:1806-13.,,,,,,,,,,,,,,,,,,,,
24246648,NLM,MEDLINE,20150406,20171116,1532-2971 (Electronic) 1090-0233 (Linking),199,1,2014 Jan,Is the metabolic syndrome a useful clinical concept in dogs? A review of the evidence.,24-30,S1090-0233(13)00485-1 [pii] 10.1016/j.tvjl.2013.09.057 [doi],"The metabolic syndrome is a set of risk factors for the development of type 2 diabetes, atherosclerosis, coronary heart disease and stroke in human beings. The term has recently been applied to dogs that exhibit components of the human metabolic syndrome, specifically visceral obesity, hypercholesterolaemia, hypertriglyceridaemia, hypertension and fasting hyperglycaemia. Obese dogs, like obese humans, are known to develop resistance to the glucose-lowering effects of insulin, and develop increased circulating concentrations of triglycerides, cholesterol and blood pressure. Unlike humans, however, obese dogs do not develop fasting hyperglycaemia or atherogenic hyperlipidaemia. Importantly, there is no evidence that dogs develop type 2 diabetes. Atherosclerosis, coronary heart disease and stroke are rare and not known to be associated with obesity in dogs. On the basis of current knowledge, the use of the term 'metabolic syndrome' in dogs does not appear to have merit.","['Verkest, Kurt R']",['Verkest KR'],"['School of Veterinary Science, The University of Queensland, Brisbane, Queensland 4072, Australia. Electronic address: VetWrite@gmail.com.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't"", 'Review']",England,Vet J,"Veterinary journal (London, England : 1997)",9706281,,IM,"['Animals', 'Dog Diseases/diagnosis/*pathology', 'Dogs', 'Metabolic Syndrome/*veterinary', 'Obesity/pathology/*veterinary']",,['NOTNLM'],"['Canine', 'Insulin resistance syndrome', 'Obesity', 'Type 2 diabetes mellitus']",,2013/11/20 06:00,2015/04/07 06:00,['2013/11/20 06:00'],"['2013/02/18 00:00 [received]', '2013/09/08 00:00 [revised]', '2013/09/22 00:00 [accepted]', '2013/11/20 06:00 [entrez]', '2013/11/20 06:00 [pubmed]', '2015/04/07 06:00 [medline]']","['S1090-0233(13)00485-1 [pii]', '10.1016/j.tvjl.2013.09.057 [doi]']",ppublish,Vet J. 2014 Jan;199(1):24-30. doi: 10.1016/j.tvjl.2013.09.057. Epub 2013 Sep 29.,,20130929,,['Copyright (c) 2013 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
21571600,NLM,MEDLINE,20111129,20220310,1695-9531 (Electronic) 1695-4033 (Linking),75,2,2011 Aug,[Obesity-related metabolic disorders in childhood and adolescence].,135.e1-9,10.1016/j.anpedi.2011.03.025 [doi],"Obesity is the most frequent nutritional disorder in childhood and adolescence. The rise in its prevalence and severity has underlined the numerous and significant obesity-related metabolic disorders. Altered glucose metabolism, manifested as impaired glucose tolerance, appears early in severely obese children and adolescents. Obese young people with glucose intolerance are characterized by marked peripheral insulin resistance and relative beta-cell failure. Lipid deposition in muscle and the visceral compartment, and not only obesity per se, is related to increased peripheral insulin resistance, the triggering factor of the metabolic syndrome. Other elements of the metabolic syndrome, such as dyslipidaemia, and hypertension, are already present in obese youngsters and worsen with the degree of obesity. The long-term impact of obesity-related insulin resistance on cardiovascular morbidity in these patients is expected to emerge as these youngsters become young adults.","['Yeste, D', 'Carrascosa, A']","['Yeste D', 'Carrascosa A']","[""Servicio de Pediatria, Unidades de Endocrinologia y Obesidad Pediatrica, Hospital Universitario Vall d' Hebron, Barcelona, Universidad Autonoma de Barcelona, Espana. dyeste@vhebron.net""]",['spa'],['Journal Article'],Spain,An Pediatr (Barc),"Anales de pediatria (Barcelona, Spain : 2003)",101162596,,IM,"['Adolescent', 'Child', 'Humans', 'Insulin Resistance', 'Metabolic Syndrome/*etiology', 'Obesity/*complications/metabolism']",,,,,2011/05/17 06:00,2011/12/13 00:00,['2011/05/17 06:00'],"['2011/01/16 00:00 [received]', '2011/03/22 00:00 [revised]', '2011/03/30 00:00 [accepted]', '2011/05/17 06:00 [entrez]', '2011/05/17 06:00 [pubmed]', '2011/12/13 00:00 [medline]']","['S1695-4033(11)00210-4 [pii]', '10.1016/j.anpedi.2011.03.025 [doi]']",ppublish,An Pediatr (Barc). 2011 Aug;75(2):135.e1-9. doi: 10.1016/j.anpedi.2011.03.025. Epub 2011 May 14.,,20110514,,"['Copyright (c) 2011 Asociacion Espanola de Pediatria. Published by Elsevier Espana.', 'All rights reserved.']",,,,,Complicaciones metabolicas de la obesidad infantil.,,,,,,,,,,,
17542702,NLM,MEDLINE,20070823,20131121,0002-9645 (Print) 0002-9645 (Linking),68,6,2007 Jun,Association of expiratory airway dysfunction with marked obesity in healthy adult dogs.,670-5,,"OBJECTIVE: To evaluate the effects of obesity on pulmonary function in healthy adult dogs. ANIMALS: 36 Retrievers without cardiopulmonary disease. PROCEDURES: Dogs were assigned to 1 of 3 groups on the basis of body condition score (1 through 9): nonobese (score, 4.5 to 5.5), moderately obese (score, 6.0 to 6.5), and markedly obese (score, 7.0 to 9.0). Pulmonary function tests performed in conscious dogs included spirometry and measurement of inspiratory and expiratory airway resistance (R(aw)) and specific R(aw) (sR(aw)) during normal breathing and during hyperpnea via head-out whole-body plethysmography. Functional residual capacity (FRC; measured by use of helium dilution), diffusion capacity of lungs for carbon monoxide (DLCO), and arterial blood gas variables (PaO(2), PaCO(2), and alveolar-arterial gradient) were assessed. RESULTS: During normal breathing, body condition score did not influence airway function, DLCO, or arterial blood gas variables. During hyperpnea, expiratory sR(aw) was significantly greater in markedly obese dogs than nonobese dogs and R(aw) was significantly greater in markedly obese dogs, compared with nonobese and moderately obese dogs. Although not significantly different, markedly obese dogs had a somewhat lower FRC, compared with other dogs. CONCLUSIONS AND CLINICAL RELEVANCE: In dogs, obesity appeared to cause airflow limitation during the expiratory phase of breathing, but this was only evident during hyperpnea. This suggests that flow limitation is dynamic and likely occurs in the distal (rather than proximal) portions of the airways. Further studies are warranted to localize the flow-limited segment and understand whether obesity is linked to exercise intolerance via airway dysfunction in dogs.","['Bach, Jonathan F', 'Rozanski, Elizabeth A', 'Bedenice, Daniela', 'Chan, Daniel L', 'Freeman, Lisa M', 'Lofgren, Jennifer L S', 'Oura, Trisha J', 'Hoffman, Andrew M']","['Bach JF', 'Rozanski EA', 'Bedenice D', 'Chan DL', 'Freeman LM', 'Lofgren JL', 'Oura TJ', 'Hoffman AM']","['Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, USA.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,Am J Vet Res,American journal of veterinary research,0375011,"['0 (Endothelin-1)', 'B7IN85G1HY (Dinoprost)']",IM,"['Animals', 'Dinoprost/pharmacology', 'Dog Diseases/*etiology/*physiopathology', 'Dogs', 'Dose-Response Relationship, Drug', 'Endothelin-1/pharmacology', 'Health', 'Obesity/complications/physiopathology/*veterinary', 'Peak Expiratory Flow Rate/*physiology']",,,,,2007/06/05 09:00,2007/08/24 09:00,['2007/06/05 09:00'],"['2007/06/05 09:00 [pubmed]', '2007/08/24 09:00 [medline]', '2007/06/05 09:00 [entrez]']",['10.2460/ajvr.68.6.670 [doi]'],ppublish,Am J Vet Res. 2007 Jun;68(6):670-5. doi: 10.2460/ajvr.68.6.670.,,,,,,,,,,,,,,,,,,,,
20462085,NLM,MEDLINE,20100722,20221207,0125-2208 (Print) 0125-2208 (Linking),93,4,2010 Apr,"A comparison of body-image perception, health outlook and eating behavior in mildly obese versus moderately-to-severely obese adolescents.",429-35,,"BACKGROUND: Adolescent obesity is rapidly becoming a majorpubic health concern in Thailand. Factors that contribute to adolescent obesity are increasingly sedentary behaviors, changes in eating habits and physical activity Body-image perception and peer influence are substantial for adolescents. As a result, knowing the obesity-relatedpsychological impacts in adolescent will be the great benefit for health care providers in taking care of obese adolescents. OBJECTIVE: The purpose of this study was to investigate the impact ofobesity has on the behaviors and attitudes regarding self-perception, health outlook, and eating behavior in the mildly obese and the moderately-to-severely obese Thai adolescents. MATERIAL AND METHOD: Participants were obese students who were being followed at the school-based Teen Health Clinic on a regular basis. All participants were followed regularly at their respective school-based Teen Health Clinics. Each participant s percent weight for height was calculated by using Thai National Growth charts. Participants were categorized into 2 groups according to the percent weight for height (% WFH). Those with% WFH below 120% was considered not obese and excluded from the study. The two participating groups were% WFH of 120-140% who are mildly obese (M-O group) and % WFH of greater than 140% who are moderately-severely obese (M-S-O group). A 3-part questionnaire was used to assess the impact of obesity on emotional and psychosocial aspects of each participant, their eating and nutritional attitude and their level of physical activity. RESULTS: Of the 5366 students, grade 7-12 who attended 2 metropolitan Bangkok schools, 678 were diagnosed as overweight or obese. There were 175 obese students who attended the clinic regularly were asked to participate in this study and there were 167 adolescents who completed the questionnaires recruited for this study. Both the M-O and M-S-O groups reported dissatisfaction with their body weight (85.9% and 91.7% respectively) and perceived their need for weight reduction. The M-S-O groups expressed more concerns to lose their weight for medical reasons than the M-O group (52.1% vs. 35.2%, p-value < 0.03). Being obese was shown to have more significant impact to their confidence in M-S-O group than the M-O group (71.9% vs. 50.7%, p < 0.005). The students in M-O group eat lunch regularly otherwise M-S-O group, few of them, skips lunch meal (100% vs. 93.8%, p < 0.032). CONCLUSION: From our study, significant obese adolescents were shown to have poorer self-image with greater prevalence being shown in the significantly obese group.","['In-iw, Supinya', 'Manaboriboon, Boonying', 'Chomchai, Chulathida']","['In-iw S', 'Manaboriboon B', 'Chomchai C']","['Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.']",['eng'],"['Comparative Study', 'Journal Article']",Thailand,J Med Assoc Thai,Journal of the Medical Association of Thailand = Chotmaihet thangphaet,7507216,,IM,"['Adolescent', '*Asian People', '*Attitude to Health', '*Body Image', 'Body Mass Index', 'Cohort Studies', '*Feeding Behavior', 'Female', 'Health Behavior', 'Humans', 'Life Style', 'Male', 'Obesity/complications/epidemiology/*psychology', '*Self Concept', 'Severity of Illness Index', 'Thailand']",,,,,2010/05/14 06:00,2010/07/23 06:00,['2010/05/14 06:00'],"['2010/05/14 06:00 [entrez]', '2010/05/14 06:00 [pubmed]', '2010/07/23 06:00 [medline]']",,ppublish,J Med Assoc Thai. 2010 Apr;93(4):429-35.,,,,,,,,,,,,,,,,,,,,
5078335,NLM,MEDLINE,19721221,20180330,0002-9165 (Print) 0002-9165 (Linking),25,10,1972 Oct,Energy expenditure of obese women during weight loss.,971-5,,,"['Bradfield, R B', 'Jourdan, M']","['Bradfield RB', 'Jourdan M']",,['eng'],['Journal Article'],United States,Am J Clin Nutr,The American journal of clinical nutrition,0376027,,IM,"['Adult', 'Basal Metabolism', 'Body Weight', 'Diet, Reducing', 'Female', 'Heart Rate', 'Humans', '*Metabolism', 'Middle Aged', 'Obesity/etiology/*metabolism/therapy', 'Oxygen Consumption', 'Physical Exertion', 'Statistics as Topic', 'Time Factors']",,,,,1972/10/01 00:00,1972/10/01 00:01,['1972/10/01 00:00'],"['1972/10/01 00:00 [pubmed]', '1972/10/01 00:01 [medline]', '1972/10/01 00:00 [entrez]']",['10.1093/ajcn/25.10.971 [doi]'],ppublish,Am J Clin Nutr. 1972 Oct;25(10):971-5. doi: 10.1093/ajcn/25.10.971.,,,,,,,,,,,,,,,,,,,,
19588731,NLM,MEDLINE,20090729,20211020,1138-7548 (Print) 1138-7548 (Linking),65,1,2009 Mar,Serum transaminases concentrations in obese children and adolescents.,51-9,,"The aim of the study was to investigate the relationship between liver transaminase levels and metabolic syndrome (MS) features in obese children and adolescents. A total of 132 children and adolescents (73 males and 59 females) aged 8 - 16, participated in the study. All were studied at the department of Paediatrics, University Hospital of Zaragoza (Spain). Inclusion criteria were the existence of obesity as defined by body mass index (BMI) according to Cole cut-off values (when BMI was higher than the age and sex specific equivalent to 30 kg/m2). The definition of metabolic syndrome was according to the International Diabetes Federation criteria. Weight (kg), height (cm), waist circumference (cm), blood pressure and BMI were measured. Laboratory determinations after overnight fasting included: transaminases (ALT, AST, GGT), fasting glucose, insulin, triglycerides and HDL-C. The MS was found in 21.6% of the obese children and adolescents and the prevalence was higher in males (25.9%) than in females (15.9%). Serum transaminases (ALT, AST and GGT) mean concentrations were higher in males than in females, and decreased during pubertal development. The obese children and adolescents with the MS did not show higher transaminases concentrations when compared with those without the MS. Some MS manifestations (mainly waist circumference) showed a correlation with ALT, although all transaminases values were normal according to adult references. Liver transaminases, a surrogate marker of NAFLD, did not show an early and consistent manifestation of abnormalities in the obese children and adolescents studied. In order to define the presence of the disease, it would be necessary to obtain aminotransferase reference standards for children and adolescents, considering pubertal stage and gender.","['Gonzalez-Gil, E M', 'Bueno-Lozano, G', 'Bueno-Lozano, O', 'Moreno, L A', 'Cuadron-Andres, L', 'Huerta-Blas, P', 'Garagorri, J M', 'Bueno, M']","['Gonzalez-Gil EM', 'Bueno-Lozano G', 'Bueno-Lozano O', 'Moreno LA', 'Cuadron-Andres L', 'Huerta-Blas P', 'Garagorri JM', 'Bueno M']","['Growth, Exercise, Nutrition and Development (GENUD) Research Group, University of Zaragoza, Spain.']",['eng'],['Journal Article'],Spain,J Physiol Biochem,Journal of physiology and biochemistry,9812509,['EC 2.6.1.- (Transaminases)'],IM,"['Adolescent', 'Child', 'Female', 'Humans', 'Male', 'Obesity/*blood/*enzymology/epidemiology', 'Transaminases/*metabolism']",,,,,2009/07/11 09:00,2009/07/30 09:00,['2009/07/11 09:00'],"['2009/07/11 09:00 [entrez]', '2009/07/11 09:00 [pubmed]', '2009/07/30 09:00 [medline]']",['10.1007/BF03165969 [doi]'],ppublish,J Physiol Biochem. 2009 Mar;65(1):51-9. doi: 10.1007/BF03165969.,,,,,,,,,,,,,,,,,,,,
34850407,NLM,MEDLINE,20220310,20220311,1745-4514 (Electronic) 0145-8884 (Linking),46,1,2022 Jan,Anti-obesity effect of Auricularia heimuer fruiting body alcohol extraction on obese mice and crucial metabolite pathway analysis by liquid chromatography-tandem mass spectrometry.,e14002,10.1111/jfbc.14002 [doi],"In recent years, the increasing obese and overweight population has become a worldwide public health problem, as there is no effective medication to control obesity. Auricularia heimuer is rich in active substances that have potential biologically active functions. The anti-obesity effect and mechanism of Auricularia heimuer fruiting body alcohol extraction (AHA, 150-600 mg/kg.bw) was investigated in obese mice by assessing changes in endogenous liver metabolites using a liquid chromatography-tandem mass spectrometry approach. The aim of this study was to identify an effective food to control human obesity. AHA of 600 mg/kg.bw (HC) significantly decreased body weight and improved serum biochemistry indices. Sixty-eight liver metabolites were identified and significantly separated among the normal, high-fat diet (HFD), and HC groups. Moreover, the metabolic analysis revealed that HC significantly regulated specific metabolites in mice including amino acids, lipids, and carbohydrate compounds. Kyoto Encyclopedia of Genes and Genomes enrichment analysis revealed that HC was significantly involved in different metabolite pathways including arachidonic acid metabolism, galactose metabolism, carbohydrate digestion and absorption, linoleic acid metabolism, and starch and sucrose metabolism. Eight weeks after supplementing with HC, major metabolites in related pathways that were disrupted by an HFD were restored to normal levels, suggesting that HC had anti-obesity activity.","['Yang, Juan', 'Zhou, Tianfeng', 'Huang, Linxiang', 'Chen, Bingzhi', 'Jiang, Yuji']","['Yang J', 'Zhou T', 'Huang L', 'Chen B', 'Jiang Y']","['College of Food Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.', 'College of Food Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.', 'College of Food Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.', 'College of Food Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.', 'College of Food Sciences, Fujian Agriculture and Forestry University, Fuzhou, China.']",['eng'],"['Journal Article', ""Research Support, Non-U.S. Gov't""]",United States,J Food Biochem,Journal of food biochemistry,7706045,['Auricularia heimuer'],IM,"['Animals', 'Auricularia', 'Chromatography, Liquid', 'Mice', 'Mice, Obese', '*Obesity/etiology/genetics', '*Tandem Mass Spectrometry']",,['NOTNLM'],"['Auricularia heimuer', 'alcohol extraction', 'high-fat diet', 'metabolites analysis']",,2021/12/02 06:00,2022/03/11 06:00,['2021/12/01 07:39'],"['2021/10/23 00:00 [revised]', '2021/07/25 00:00 [received]', '2021/10/29 00:00 [accepted]', '2021/12/02 06:00 [pubmed]', '2022/03/11 06:00 [medline]', '2021/12/01 07:39 [entrez]']",['10.1111/jfbc.14002 [doi]'],ppublish,J Food Biochem. 2022 Jan;46(1):e14002. doi: 10.1111/jfbc.14002. Epub 2021 Dec 1.,,20211201,,['(c) 2021 Wiley Periodicals LLC.'],['ORCID: 0000-0003-4680-463X'],,,,,,,,,,,,,,,
6301972,NLM,MEDLINE,19830610,20190908,8750-2836 (Print) 8750-2836 (Linking),18,3,1983 Mar,The management of obesity.,"117-21, 125-9, 134-5 passim",,The ineffectiveness of most weight-reduction protocols is notorious. Improvement of current management depends on individualizing the approach and recognizing the importance of the chronology of onset and the duration of the obesity.,"['Ackerman, S']",['Ackerman S'],,['eng'],['Journal Article'],United States,Hosp Pract (Off Ed),Hospital practice (Office ed.),8404149,['0 (Ion Channels)'],IM,"['Adipose Tissue/metabolism', 'Adult', 'Animals', 'Behavior Therapy', 'Body Image', 'Body Weight', 'Diet', 'Humans', 'Ion Channels/metabolism', 'Mice', 'Mice, Obese', 'Obesity/classification/diet therapy/*therapy', 'Physical Exertion']",,,,,1983/03/01 00:00,1983/03/01 00:01,['1983/03/01 00:00'],"['1983/03/01 00:00 [pubmed]', '1983/03/01 00:01 [medline]', '1983/03/01 00:00 [entrez]']",['10.1080/21548331.1983.11702497 [doi]'],ppublish,"Hosp Pract (Off Ed). 1983 Mar;18(3):117-21, 125-9, 134-5 passim. doi: 10.1080/21548331.1983.11702497.",,,,,,,,,,,,,,,,,,,,
9275967,NLM,MEDLINE,19970919,20191102,2154-8331 (Print) 2154-8331 (Linking),32,8,1997 Aug 15,An etiologic approach to obesity.,"123-4, 126, 128 passim",,Emotional or social barriers to a healthy diet and physical activity are typical in obese patients. Counseling can help identify the barriers and improve either the situation or patients' response to it. Long-term success most often occurs when there is a cognitive shift from focusing on weight to focusing on health. Drugs can be a useful adjunct but cannot substitute for lifestyle modification.,"['Foreyt, J P']",['Foreyt JP'],"['Nutrition Research Clinic, Baylor College of Medicine, Houston, USA.']",['eng'],"['Case Reports', 'Journal Article']",England,Hosp Pract (1995),Hospital practice (1995),101268948,,IM,"['Adult', 'Algorithms', 'Combined Modality Therapy', 'Counseling', 'Diet Therapy', 'Emotions', 'Exercise Therapy', 'Female', 'Follow-Up Studies', 'Humans', 'Life Style', 'Obesity/*etiology/psychology/therapy', 'Social Support']",,,,,1997/08/15 00:00,1997/08/15 00:01,['1997/08/15 00:00'],"['1997/08/15 00:00 [pubmed]', '1997/08/15 00:01 [medline]', '1997/08/15 00:00 [entrez]']",['10.1080/21548331.1997.11443547 [doi]'],ppublish,"Hosp Pract (1995). 1997 Aug 15;32(8):123-4, 126, 128 passim. doi: 10.1080/21548331.1997.11443547.",,,,,,,,"['Hosp Pract (1995). 1998 Jan 15;33(1):36, 39. PMID: 9464229']",,,,,,,,,,,,
17503570,NLM,MEDLINE,20070622,20220408,0370-8179 (Print) 0370-8179 (Linking),135,1-2,2007 Jan-Feb,[Factors mediating the depression in the adult obese outpatients].,61-6,,"INTRODUCTION: The prevalence of obesity is rising to epidemic proportions at the alarming rate in both developed and underdeveloped countries around the world. Current prevalence data from individual national studies suggest that the obesity prevalence in the European countries ranges from 10% to 20% for men, and 10% to 25% for women. Health consequences of obesity imply both a number of fatal and non-fatal health problems (out of which the most common are cardiovascular problems, non-insulin dependent diabetes mellitus, cancers), and also a wide spectrum of psychological consequences from diminished self-esteem to clinical depression. Causal relationship between obesity and many chronic diseases is evidence-based. At the same time, there are marked differences in research data regarding causal obesity-depression relationship. Several studies have found no direct association between obesity and depression, while in others the prevalence of depression in obese patients was up to 50%. Gender, obesity grade, socioeconomic status and asking for professional help are named as moderators and mediators of this relationship. Among recommended screening methods, BDI-II is the most frequently used in the adult outpatient departments. OBJECTIVE: The aim of the study was to determine possible risk factors of depression in adult obese patients treated for obesity. Gender, obesity and education level as well as marital status were analyzed as possible moderators of depression-obesity relationship. METHOD: The research included 267 patients, 38.0 +/- 14.6 years of age, who referred to the Outpatient Nutrition Department for dietetic consultation or nutritional medical therapy. Nutritional status was assessed by BMI (kg/m2), calculated from measured values of body weight and height according to WHO recommendations. An estimate of the existence and/or depression level was investigated by Beck Depression Inventory--self-administered questionnaire recommended for use in Serbian population. RESULTS: The results revealed higher average BDI score values in obese patients (F(267,1) = 6.014, p = 0.015) in comparison to their non-obese counterparts. In addition, the percentage of depressive obese patients was significantly higher (55.1%, chi2(267.1) = 22.64, p < 0.001). There was significant correlation of BMI and BDI scores (r = 0.246, p < 0.001). The number of women with depression was significantly higher in comparison to men (chi2(267.1) = 4.261, p = 0.039). Women also had higher average BDI score (p = 0.003). MANOVA showed that BDI score was influenced by gender (F(267.1) = 8.936, p = 0.030) and nutritional status (F(267.1) = 6.115, p = 0.014), but combined effect of the above-mentioned moderators was not significant. CONCLUSION: Depression is ten times more frequent in obese patients undergoing the obesity treatment vs. general population and, therefore, screening for depression is needed. Special attention should be paid to women and more obese patients due to higher incidence of depression in these groups.","['Gudelj-Radic, Jelena', 'Davidovic, Dragana', 'Avramovic, Dusan', 'Backovic, Dusan', 'Jorga, Jagoda']","['Gudelj-Radic J', 'Davidovic D', 'Avramovic D', 'Backovic D', 'Jorga J']",,['srp'],"['English Abstract', 'Journal Article']",Serbia,Srp Arh Celok Lek,Srpski arhiv za celokupno lekarstvo,0027440,,IM,"['Adult', 'Body Mass Index', 'Depressive Disorder/*complications/diagnosis', 'Female', 'Humans', 'Male', 'Obesity/*psychology/therapy']",,,,,2007/05/17 09:00,2007/06/23 09:00,['2007/05/17 09:00'],"['2007/05/17 09:00 [pubmed]', '2007/06/23 09:00 [medline]', '2007/05/17 09:00 [entrez]']",['10.2298/sarh0702061g [doi]'],ppublish,Srp Arh Celok Lek. 2007 Jan-Feb;135(1-2):61-6. doi: 10.2298/sarh0702061g.,,,,,,,,,,,,,,,,,,,,
15959396,NLM,MEDLINE,20050712,20161031,0003-4266 (Print) 0003-4266 (Linking),66,2 Pt 3,2005 Apr,[How to manage my patients' psychological disturbances?].,2S46-9,,"Psychological disturbances are frequently encountered in obese patients. The physician specialised in nutrition should take them into account within the therapeutic project and all along the patient's management. This review describe, according to the main obese patients' profiles (typology), the conditions for an optimal adequation between hopes and expectations from both the patient and the physician, as well as the psychiatrist role within the therapeutic project and during the management period.","['Laville, M', 'Renault, F']","['Laville M', 'Renault F']","[""Service d'Endocrinologie Diabetologie-Nutrition. Hopital Edouard Herriot, Lyon, France. martine.laville@chu-lyon.fr""]",['fre'],"['English Abstract', 'Journal Article', 'Review']",France,Ann Endocrinol (Paris),Annales d'endocrinologie,0116744,,IM,"['Humans', 'Mental Disorders/etiology/*psychology/*therapy', 'Nutritional Physiological Phenomena', 'Obesity/complications/*psychology']",,,,,2005/06/17 09:00,2005/07/13 09:00,['2005/06/17 09:00'],"['2005/06/17 09:00 [pubmed]', '2005/07/13 09:00 [medline]', '2005/06/17 09:00 [entrez]']",['MDOI-AE-04-2005-66-2-C3-0003-4266-101019-200503908 [pii]'],ppublish,Ann Endocrinol (Paris). 2005 Apr;66(2 Pt 3):2S46-9.,,,,,,,3,,Comment gerer les troubles psychologiques de mes patients?,,,,,,,,,,,
17424767,NLM,MEDLINE,20070802,20091111,0556-6177 (Print) 0556-6177 (Linking),50,4,2006 Oct-Dec,[Obesity and functional foods: are the new ingredients and products effective?].,31-8,,"According to WHO data, obesity and overweight have reached the level of a world-wide epidemic: more than one billion adults are overweight, and at least three hundred million of them are obese. Obesity is associated with the main chronic diseases of our time. Obesity can reduce the life expectancy by 10 years and in Spain it is calculated that the health care costs account for 7% of the total. In the Spanish adult population, 14.5% are obese, and 38.5% are overweight. In the fight against obesity, the food industry has been incorporating new ingredients intended to help consumers obtain a suitable weight. In this study, we review the scientific evidence about some products and ingredients, discussing the fact that the main problem is their scant scientific support. Advertisers make much of supposed benefits which often lack a scientific basis, as in the case of products with a supposed effect on thermogenesis, metabolism and oxidation of fats, products which make people feel full, products affecting fat absorption, diuretics, laxatived, sedatives and substances affecting the central nervous system.","['Martinez-Alvarez Jr', 'Gomez-Candela, C', 'Villarino-Marin, A L']","['Martinez-Alvarez Jr', 'Gomez-Candela C', 'Villarino-Marin AL']",['Sociedad Espanola de Dietetica y Ciencias de la Alimentacion. Jrmartin@med.ucm.es'],['spa'],"['English Abstract', 'Journal Article', 'Review']",Spain,Rev Med Univ Navarra,Revista de medicina de la Universidad de Navarra,0123071,,IM,"['*Food, Formulated', 'Humans', 'Obesity/*diet therapy/metabolism']",,,,,2007/04/12 09:00,2007/08/03 09:00,['2007/04/12 09:00'],"['2007/04/12 09:00 [pubmed]', '2007/08/03 09:00 [medline]', '2007/04/12 09:00 [entrez]']",,ppublish,Rev Med Univ Navarra. 2006 Oct-Dec;50(4):31-8.,,,,,,,62,,Obesidad y alimentos funcionales: son eficaces los nuevos ingredientes y productos?,,,,,,,,,,,
21262432,NLM,MEDLINE,20110513,20110125,1879-2472 (Electronic) 0049-3848 (Linking),127 Suppl 3,,2011 Feb,Murine models of obesity and hormonal therapy.,S17-20,10.1016/S0049-3848(11)70006-8 [doi],"Obesity is a common disorder, and related diseases such as diabetes, atherosclerosis, hypertension, cardiovascular disease and cancer are a major cause of mortality and morbidity in Westerntype societies. Development of obesity is associated with extensive modifications in adipose tissue involving adipogenesis, angiogenesis and extracellular matrix proteolysis. The fibrinolytic (plasminogen/plasmin) and matrix metalloproteinase (MMP) systems cooperate in these processes. Adipogenesis is tightly associated with angiogenesis, as shown by the findings that adipose tissue expiants trigger blood vessel formation, whereas in turn adipose tissue endothelial cells promote preadipocyte differentiation. A nutritionally induced obesity model in transgenic mice has been used extensively to study the role of the fibrinolytic and MMP systems and of angiogenesis in the development of obesity. Most studies support a role of these systems in adipogenesis and obesity, and suggest that their modulation may affect development of adipose tissue. Such models have also shown that treatment of obese female mice with estrogens has the potential to improve obesity, insulin resistance and glucose intolerance, via decreased expression of lipogenic genes. Thus, murine models of obesity have been very useful tools to study mechanisms of adipose tissue development, as well as effects of hormonal therapy.","['Lijnen, H R']",['Lijnen HR'],"['Center for Molecular and Vascular Biology, Katholieke Universiteit Leuven, Leuven, Belgium. roger.lijnen@med.kuleuven.be']",['eng'],"['Journal Article', 'Review']",United States,Thromb Res,Thrombosis research,0326377,"['0 (Hormones)', 'EC 3.4.24.- (Matrix Metalloproteinases)']",IM,"['Adipogenesis', 'Animals', '*Disease Models, Animal', 'Hormones/*therapeutic use', 'Matrix Metalloproteinases/metabolism', 'Mice', 'Mice, Obese', 'Neovascularization, Physiologic', 'Obesity/*drug therapy/metabolism/*physiopathology']",,,,,2011/01/26 06:00,2011/05/14 06:00,['2011/01/26 06:00'],"['2011/01/26 06:00 [entrez]', '2011/01/26 06:00 [pubmed]', '2011/05/14 06:00 [medline]']","['S0049-3848(11)70006-8 [pii]', '10.1016/S0049-3848(11)70006-8 [doi]']",ppublish,Thromb Res. 2011 Feb;127 Suppl 3:S17-20. doi: 10.1016/S0049-3848(11)70006-8.,,,,['(c) 2011 Elsevier Ltd. All rights reserved.'],,,,,,,,,,,,,,,,
22404044,NLM,MEDLINE,20120914,20211021,1526-4610 (Electronic) 0017-8748 (Print) 0017-8748 (Linking),52,4,2012 Apr,The association of obesity with episodic and chronic migraine.,663-71,10.1111/j.1526-4610.2012.02114.x [doi],About 18% of adolescents and 33% of adults are obese in the United States. Recent studies demonstrating an association between migraine and obesity raise fascinating questions about the mechanism for this association and suggest new potential avenues of treatment for migraine.,"['Evans, Randolph W', 'Williams, Michelle A', 'Rapoport, Alan M', 'Peterlin, B Lee']","['Evans RW', 'Williams MA', 'Rapoport AM', 'Peterlin BL']","['Baylor College of Medicine, Houston, TX, USA.']",['eng'],"['Case Reports', 'Journal Article']",United States,Headache,Headache,2985091R,,IM,"['Adult', 'Female', 'Humans', 'Migraine Disorders/*diagnosis/*etiology/therapy', 'Obesity/*complications/*diagnosis/therapy']",PMC3973149,,,['Conflict of Interest: The authors report no conflict of interest.'],2012/03/13 06:00,2012/09/15 06:00,['2012/03/13 06:00'],"['2012/03/13 06:00 [entrez]', '2012/03/13 06:00 [pubmed]', '2012/09/15 06:00 [medline]']",['10.1111/j.1526-4610.2012.02114.x [doi]'],ppublish,Headache. 2012 Apr;52(4):663-71. doi: 10.1111/j.1526-4610.2012.02114.x. Epub 2012 Mar 8.,['K23 NS078345/NS/NINDS NIH HHS/United States'],20120308,,,,['NIHMS566025'],,,,,,,,,,,,,,
23759736,NLM,MEDLINE,20140416,20181202,1532-1983 (Electronic) 0261-5614 (Linking),32,5,2013 Oct,Obesity and nursing home: a review and an update.,679-85,S0261-5614(13)00147-7 [pii] 10.1016/j.clnu.2013.05.008 [doi],"BACKGROUND & AIMS: The prevalence of obese in nursing home resident is increasing, causing an important change in patient's management and health assistance. Although evidence suggests that obesity is associated with comorbidity, disability, and mortality in older persons, such relationship has rarely been explored in the nursing home population and research is still mainly conducted in community-dwelling people. METHODS: A review of the literature identified 11 suitable papers that discuss current knowledge about the management of obesity in nursing home. RESULTS: The specificity of the obese nursing home residents is often to be disabled survivors of previous complications related to obesity with short life expectancy. Whether nutritional treatment and physical activity can improve clinical condition and quality of life in the obese remains an open question. Strengths and weaknesses of current methodologies in the assessment of adiposity are needed to be carefully considered, especially in a clinical setting with limited resources. CONCLUSIONS: More investigations are required to understand obesity as a risk factor for institutionalization and a criterion of non-admission in nursing home at the same time. Although difficulties to implement these approaches are present, effective and feasible treatments for obesity should be tested.","['Zanandrea, Valeria', 'Barreto de Souto, Philippe', 'Cesari, Matteo', 'Vellas, Bruno', 'Rolland, Yves']","['Zanandrea V', 'Barreto de Souto P', 'Cesari M', 'Vellas B', 'Rolland Y']","['Clinica Geriatrica, University of Verona, Italy; Gerontopole de Toulouse, Institut du Vieillissement, Centre Hospitalo-Universitaire de Toulouse, France. Electronic address: valeria.zanandrea@gmail.com.']",['eng'],"['Journal Article', 'Review']",England,Clin Nutr,"Clinical nutrition (Edinburgh, Scotland)",8309603,,IM,"['Adiposity', 'Aged', 'Aged, 80 and over', '*Aging', 'Comorbidity', 'Diet, Reducing', 'Disabled Persons', 'Geriatric Assessment', 'Homes for the Aged', 'Humans', 'Mortality', 'Motor Activity', 'Nursing Homes', 'Nutrition Assessment', 'Obesity/*epidemiology/physiopathology/prevention & control/therapy', 'Weight Loss', 'Workforce']",,['NOTNLM'],"['Disability', 'Elderly', 'Nursing home', 'Obesity']",,2013/06/14 06:00,2014/04/17 06:00,['2013/06/14 06:00'],"['2012/11/08 00:00 [received]', '2013/04/19 00:00 [revised]', '2013/05/14 00:00 [accepted]', '2013/06/14 06:00 [entrez]', '2013/06/14 06:00 [pubmed]', '2014/04/17 06:00 [medline]']","['S0261-5614(13)00147-7 [pii]', '10.1016/j.clnu.2013.05.008 [doi]']",ppublish,Clin Nutr. 2013 Oct;32(5):679-85. doi: 10.1016/j.clnu.2013.05.008. Epub 2013 May 21.,,20130521,,"['Copyright (c) 2013 Elsevier Ltd and European Society for Clinical Nutrition and', 'Metabolism. All rights reserved.']",,,,,,,,,,,,,,,,
29358013,NLM,MEDLINE,20190116,20190116,1532-8422 (Electronic) 1053-0770 (Linking),32,4,2018 Aug,Perioperative Care of the Obese Cardiac Surgical Patient.,1911-1921,S1053-0770(17)31010-8 [pii] 10.1053/j.jvca.2017.12.025 [doi],"Morbid obesity is associated with impairment of cardiovascular, pulmonary, gastrointestinal, and renal physiology with significant perioperative consequences and has been linked with higher morbidity and mortality after cardiac surgery. Cardiac surgery patients have a higher incidence of difficult airway and difficult laryngoscopy than general surgery patients do, and obesity is associated with difficult mask ventilation and direct laryngoscopy. Positioning injuries occur more frequently because obese patients are at greater risk of pressure injury, such as rhabdomyolysis and compartment syndrome. Despite the association between obesity and several chronic disease states, the effects of obesity on perioperative outcomes are conflicting. Studies examining outcomes of overweight and obese patients in cardiac surgery have reported varying results. An ""obesity paradox"" has been described, in which the mortality for overweight and obese patients is lower compared with patients of normal weight. This review describes the physiologic abnormalities and clinical implications of obesity in cardiac surgery and summarizes recommendations for anesthesiologists to optimize perioperative care of the obese cardiac surgical patient.","['Chacon, M Megan', 'Cheruku, Sreekanth R', 'Neuburger, Peter J', 'Lester, Laeben', 'Shillcutt, Sasha K']","['Chacon MM', 'Cheruku SR', 'Neuburger PJ', 'Lester L', 'Shillcutt SK']","['University of Nebraska Medical Center, Omaha, NE. Electronic address: mchacon@unmc.edu.', 'UT Southwestern Medical Center, Dallas, TX.', 'NYU Langone Health, New York, NY.', 'Johns Hopkins Medicine, Baltimore, MD.', 'University of Nebraska Medical Center, Omaha, NE.']",['eng'],"['Journal Article', 'Review']",United States,J Cardiothorac Vasc Anesth,Journal of cardiothoracic and vascular anesthesia,9110208,,IM,"['Cardiac Surgical Procedures/adverse effects/*methods', 'Humans', 'Obesity/diagnosis/physiopathology/*surgery', 'Perioperative Care/*methods', 'Postoperative Complications/etiology/physiopathology/*prevention & control', 'Risk Factors']",,['NOTNLM'],"['cardiac surgery', 'morbid obesity', 'obesity', 'postoperative outcomes']",,2018/01/24 06:00,2019/01/17 06:00,['2018/01/24 06:00'],"['2017/09/06 00:00 [received]', '2018/01/24 06:00 [pubmed]', '2019/01/17 06:00 [medline]', '2018/01/24 06:00 [entrez]']","['S1053-0770(17)31010-8 [pii]', '10.1053/j.jvca.2017.12.025 [doi]']",ppublish,J Cardiothorac Vasc Anesth. 2018 Aug;32(4):1911-1921. doi: 10.1053/j.jvca.2017.12.025. Epub 2017 Dec 13.,,20171213,,['Copyright (c) 2017 Elsevier Inc. All rights reserved.'],,,,,,,,,,,,,,,,
21400944,NLM,MEDLINE,20110531,20110314,1660-9379 (Print) 1660-9379 (Linking),7,278,2011 Jan 19,[Adolescent medicine. Is the weight of the obese adolescent difficult for their family?].,125-7,,"The increasing prevalence of obesity creates a need to develop healthcare services that address both obesity and the health problems common to all young people. It is particularly important to involve parents and significant adults to promote easy access and continuity. Improved quality of life is as important as weight loss and prevention of complications. The family has an important role to play in helping adolescents develop their autonomy and enter adulthood. When family structures are affected by a child's chronic condition, it is necessary to provide support to parents during these changes. Feelings of isolation and discouragement are best tackled by involving parents and helping them to find ways to motivate and assist their children on their developmental path.","['Narring, Francoise', 'Chamay-Weber, Catherine', 'Shehu-Brovina, Shqipe', 'Lanza, Lydia']","['Narring F', 'Chamay-Weber C', 'Shehu-Brovina S', 'Lanza L']","[""Unite Sante Jeunes, Departement de l'enfant et de l'adolescent, HUG, 1211 Geneve 14. francoise.narring@hcuge.ch""]",['fre'],"['English Abstract', 'Journal Article']",Switzerland,Rev Med Suisse,Revue medicale suisse,101219148,,IM,"['Adolescent', '*Family Health', 'Humans', 'Obesity/*complications/*prevention & control/psychology', 'Parents', 'Social Support']",,,,,2011/03/16 06:00,2011/06/01 06:00,['2011/03/16 06:00'],"['2011/03/16 06:00 [entrez]', '2011/03/16 06:00 [pubmed]', '2011/06/01 06:00 [medline]']",,ppublish,Rev Med Suisse. 2011 Jan 19;7(278):125-7.,,,,,,,,,Medecine de l'adolescence. Le poids des adolescents: un poids pour la famille?,,,,,,,,,,,
17300531,NLM,MEDLINE,20070510,20070215,1041-2972 (Print) 1041-2972 (Linking),19,2,2007 Feb,Integrating the transtheoretical model into the management of overweight and obese adults.,63-71,,"PURPOSE: To show how the nurse practitioner (NP) can incorporate stage-specific interventions from the transtheoretical model in the management of overweight and obese adults. DATA SOURCES: Research articles, clinical articles, and government guidelines pertaining to the management of overweight and obesity in adults. CONCLUSIONS: Overweight and obesity are complex and chronic conditions that require lifelong management. The NP can help clients to safely and successfully lose weight by developing stage-specific interventions, by using an expert multidisciplinary team, and by providing ongoing monitoring and motivation. IMPLICATIONS FOR PRACTICE: The prevalence of overweight and obesity continues to increase at an alarming rate and is a major public health concern. The NP has an important role in the assessment and management of clients with this condition.","['Seals, Judy Gainey']",['Seals JG'],"['Chicago Heart and Vascular Consultants, Mercy Hospital and Medical Center, Chicago, Illinois 60616, USA. judygainey@yahoo.com']",['eng'],['Journal Article'],United States,J Am Acad Nurse Pract,Journal of the American Academy of Nurse Practitioners,8916634,,,"['Adult', 'Chronic Disease', 'Humans', 'Medical History Taking', '*Models, Nursing', '*Models, Psychological', '*Nurse Practitioners', 'Nursing Assessment/standards', 'Obesity/*nursing/*psychology/therapy', '*Overweight', 'Risk Reduction Behavior']",,,,,2007/02/16 09:00,2007/05/11 09:00,['2007/02/16 09:00'],"['2007/02/16 09:00 [pubmed]', '2007/05/11 09:00 [medline]', '2007/02/16 09:00 [entrez]']","['JAAN196 [pii]', '10.1111/j.1745-7599.2006.00196.x [doi]']",ppublish,J Am Acad Nurse Pract. 2007 Feb;19(2):63-71. doi: 10.1111/j.1745-7599.2006.00196.x.,,,,,,,,,,,,,,,,,,,,
